Citrus Sinensis ID: 003385
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 824 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGI2 | 929 | Probable LRR receptor-lik | no | no | 0.973 | 0.863 | 0.494 | 0.0 | |
| Q9FZB8 | 871 | Probable LRR receptor-lik | no | no | 0.911 | 0.862 | 0.349 | 1e-122 | |
| Q9ZQR3 | 868 | Leucine-rich repeat recep | no | no | 0.904 | 0.858 | 0.364 | 1e-117 | |
| Q9FZB1 | 872 | Probable LRR receptor-lik | no | no | 0.893 | 0.844 | 0.346 | 1e-116 | |
| Q9ZQQ7 | 886 | Putative leucine-rich rep | no | no | 0.930 | 0.865 | 0.362 | 1e-116 | |
| O64556 | 877 | Putative leucine-rich rep | no | no | 0.889 | 0.835 | 0.343 | 1e-115 | |
| C0LGD6 | 852 | Probable LRR receptor-lik | no | no | 0.910 | 0.880 | 0.352 | 1e-115 | |
| C0LGG4 | 890 | Probable LRR receptor-lik | no | no | 0.890 | 0.824 | 0.342 | 1e-112 | |
| Q9LIG2 | 899 | Receptor-like protein kin | no | no | 0.890 | 0.816 | 0.345 | 1e-112 | |
| O65924 | 881 | Putative leucine-rich rep | no | no | 0.898 | 0.839 | 0.337 | 1e-112 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 804 bits (2077), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/823 (49%), Positives = 547/823 (66%), Gaps = 21/823 (2%)
Query: 15 SVLILLLLDSSSAQMPGFVSLNCGGNENFTD-EIGLQWIADDHLI-YGEISNISVANETR 72
+V L L+ +Q+ FVS++CG + N+TD GL W++D +I G+ ++ N
Sbjct: 9 AVTCLFLVPFVLSQVTEFVSIDCGCSSNYTDPRTGLGWVSDSEIIKQGKPVTLANTNWNS 68
Query: 73 KQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTI 132
QY R FP D++KYCY+L R RY++R TFLYG + YPKF + L T W+T+
Sbjct: 69 MQYRRRRDFPTDNKKYCYRLSTKERRRYIVRTTFLYGGLGSEEAYPKFQLYLDATKWATV 128
Query: 133 VISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLS 192
I + + + V ELI A+S +DVC+ A TG PF+STLELR N S+Y T +ED ++L
Sbjct: 129 TIQEVSRVYVEELIVRATSSYVDVCVCCAITGSPFMSTLELRPLNLSMYATDYEDNFFLK 188
Query: 193 VSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDEL 252
V+AR+NFGA + +RYPDDP+DRIWESD K+ NYLV VA GT +++T I+ + E
Sbjct: 189 VAARVNFGAPNMDALRYPDDPYDRIWESDINKRPNYLVGVAPGTTRINTSKTINTLTREY 248
Query: 253 PPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDV 312
PP KVMQTAVVGT G ++YRLNL+ FP A YFAEIE+L +E+RKF+LV P PD
Sbjct: 249 PPMKVMQTAVVGTQGLISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYFPDY 308
Query: 313 SKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYL---- 368
S A+VNI ENA G Y +YEP Y N++L FVL+F FGKT DS++GPLLNA+EI+KYL
Sbjct: 309 SNAVVNIAENANGSYTLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLPISV 368
Query: 369 --ERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSK 426
+R+D S+ + ++ S+ +DWA EGGDPC+PV WSW+ C+S P +T I LS K
Sbjct: 369 KTDRSDVSV----LDAIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRK 424
Query: 427 NLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNL 486
NL G IP + + +L ELWLD N LTG +PD S +L+I+HLE+NQL+G LP L +L
Sbjct: 425 NLRGEIPPGINYMEALTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHL 484
Query: 487 PNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVL- 545
PNL+EL ++NN G +PS+LL V+ Y N L + KH I+G S+ A +
Sbjct: 485 PNLQELSIENNSFKGKIPSALLKGKVLFKYNNNPELQNEAQ-RKHFWQILGISIAAVAIL 543
Query: 546 ----LLATVVSCLFMHKGKKNNYDK-EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIED 600
+ V+ C + + D E + L V + A+ +L +E+
Sbjct: 544 LLLVGGSLVLLCALRKTKRADKGDSTETKKKGLVAYSAVRGGHLLDEGVAYFISLPVLEE 603
Query: 601 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 660
AT KK+G G FG VYYG++KDGKE+AVK+ S R+F EV LLSRIHHRNLV
Sbjct: 604 ATDNFSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLV 663
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
+GYC+E R +LVYE+MHNG+L +HL+G+ ++ ++W+ RL+IA+DAAKG+EYLHTG
Sbjct: 664 PLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKP-LDWLTRLQIAQDAAKGLEYLHTG 722
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
C P+IIHRD+KSSNILLD +MRAKVSDFGLS+ + +HVSS+ +GTVGYLDPEYY SQ
Sbjct: 723 CNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYASQ 782
Query: 781 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWVKS 823
QLT+KSDVYSFGV+L EL+SG++ +S E FG NIV W +S
Sbjct: 783 QLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPEL-NIVHWARS 824
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FZB8|Y5181_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51810 OS=Arabidopsis thaliana GN=At1g51810 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 440 bits (1131), Expect = e-122, Method: Compositional matrix adjust.
Identities = 301/862 (34%), Positives = 465/862 (53%), Gaps = 111/862 (12%)
Query: 1 MERRRRLLLPFSVASVLILLLLDSSSAQMP-GFVSLNCG----GNENFTDEIGLQWIADD 55
MER + FS L+L AQ P GF++L+CG G+ GL + +DD
Sbjct: 1 MERHCLFFVIFS-------LILHLVQAQDPIGFINLDCGLSIQGSPYKESSTGLTYTSDD 53
Query: 56 HLIY-GEISNISVANET--RKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFD 112
+ G+I I+ E+ +K TLR+FP D + C+ L+V T+YLI+ TFLYGN+D
Sbjct: 54 GFVQSGKIGKITKELESLYKKPERTLRYFP-DGVRNCFSLNVTRGTKYLIKPTFLYGNYD 112
Query: 113 NNNVYPKFDISLGPTHWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLE 172
NV P FD+ +GP W T+ + ++E++ ++ S + VCL T P+I+TLE
Sbjct: 113 GRNVIPDFDLYIGPNMWITVNTDNT----IKEILHVSKSNTLQVCLVKTGTSIPYINTLE 168
Query: 173 LRQFNGSVYLTPFEDRYYLSVSARINF-----GADSEAPVRYPDDPFDRIWESDSLKKAN 227
LR P D Y + S +N+ ++ + + YPDD DRIW+ L +
Sbjct: 169 LR---------PLADDIYTNESGSLNYLFRVYYSNLKGYIEYPDDVHDRIWK-QILPYQD 218
Query: 228 YLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGSLT---YRLNLDGFPGFGWA 284
+ + ++T L I++ +D PQ+VM+TAV S T + NL+ +
Sbjct: 219 WQI--------LTTNLQINVSNDYDLPQRVMKTAVTPIKASTTTMEFPWNLEPPTSQFYL 270
Query: 285 VTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLS 344
+FAE++ L +E+R+F +VL N ++ Y P + + + +
Sbjct: 271 FLHFAELQSLQANETREFNVVL---------------NGNVTFKSYSPKFLEMQTVYSTA 315
Query: 345 ----------FKFGKTYDSSRGPLLNAMEINKYLE--RNDGSIDGV-AIVSVISLY--SS 389
+ KT S+ PL+NAME L+ + + ++D V AI ++ S Y S
Sbjct: 316 PKQCDGGKCLLQLVKTSRSTLPPLINAMEAYTVLDFPQIETNVDEVIAIKNIQSTYGLSK 375
Query: 390 ADWAQEGGDPCLPVPWSW--LQCNSDPQ---PSITVIHLSSKNLTGNIPSDLTKLSSLVE 444
W GDPC+P + W L CN+ P IT ++LSS LTG I + L++L E
Sbjct: 376 TTWQ---GDPCVPKKFLWDGLNCNNSDDSTPPIITSLNLSSSGLTGIIVLTIQNLANLQE 432
Query: 445 LWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTV 503
L L N+L+G +P+F + L +I+L N L+G +P L+ L+ N L+ TV
Sbjct: 433 LDLSNNNLSGGVPEFLADMKSLLVINLSGNNLSGVVPQKLIEKKMLKLNIEGNPKLNCTV 492
Query: 504 PSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAV-LLLATVVSCLFMHKGKKN 562
S ++K+ EGGR K + I I +S+G+ V +A ++ C+ +KN
Sbjct: 493 -ESCVNKD-----------EEGGRQIKSMTIPIVASIGSVVAFTVALMIFCVV----RKN 536
Query: 563 NYDKEQHRHSLPVQRPVSSLNDAPAEAAHC--FTLSDIEDATKMLEKKIGSGGFGVVYYG 620
N ++ S P S + P FT +++ T +K +G GGFG+VYYG
Sbjct: 537 NPSNDEAPTS--CMLPADSRSSEPTIVTKNKKFTYAEVLTMTNNFQKILGKGGFGIVYYG 594
Query: 621 KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680
+ +++AVK+L+ +S QG ++F EV LL R+HH+NLV +GYC+E + L+YE+M
Sbjct: 595 SVNGTEQVAVKMLSHSSAQGYKQFKAEVELLLRVHHKNLVGLVGYCEEGDKLALIYEYMA 654
Query: 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 740
NG L EH+ G +NW RL+IA +AA+G+EYLH GC P ++HRD+K++NILL++H
Sbjct: 655 NGDLDEHMSGK-RGGSILNWGTRLKIALEAAQGLEYLHNGCKPLMVHRDVKTTNILLNEH 713
Query: 741 MRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI 799
K++DFGLS+ F ++G +HVS++V GT+GYLDPEYY + LT+KSDVYSFGV+LL +I
Sbjct: 714 FDTKLADFGLSRSFPIEGETHVSTVVAGTIGYLDPEYYRTNWLTEKSDVYSFGVVLLVMI 773
Query: 800 SGQEAISNEKFGANCRNIVQWV 821
+ Q I + R+I +WV
Sbjct: 774 TNQPVIDQNR---EKRHIAEWV 792
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQR3|Y2451_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14510 OS=Arabidopsis thaliana GN=At2g14510 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 422 bits (1085), Expect = e-117, Method: Compositional matrix adjust.
Identities = 312/857 (36%), Positives = 447/857 (52%), Gaps = 112/857 (13%)
Query: 1 MERRRRLLLPFSVASVLILLLLDSSSAQMPGFVSLNCG--GNENFTD-EIGLQWIADDHL 57
ME R + +L + A+ I+ L+ S + Q GF+SL+CG E++ + L +I+D +
Sbjct: 1 METRNKFML-LACATFSIMSLVKSQNQQ--GFISLDCGLPSKESYIEPSSNLTFISDVNF 57
Query: 58 IYG----EISNISVANETRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDN 113
I G I N S N K + LR+FP D + CY L V T+YLIR F YGN+D
Sbjct: 58 IRGGKTGNIQNNSRTNFIFKPFKVLRYFP-DGIRNCYSLSVKQGTKYLIRTLFYYGNYDG 116
Query: 114 NNVYPKFDISLGPTHWSTI--VISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTL 171
N P+FD+ LGP W+++ +I+D V E++ + S +D+CL T P IS +
Sbjct: 117 LNTSPRFDLFLGPNIWTSVDVLIADVGDGVVEEIVHVTRSNILDICLVKTGTSTPMISAI 176
Query: 172 ELRQFNGSVYLTPFEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVD 231
ELR Y L A F EA +RYP+D +DR+W S +
Sbjct: 177 ELRPLRYDTYTARTGS---LKSMAHFYFTNSDEA-IRYPEDVYDRVWMPYSQPEWT---- 228
Query: 232 VAAGTEKVSTKLPIDLRSDEL-PPQKVMQTAVVGTNGS--LTYRLNLDGFPGFGWAVTYF 288
+++T + SD PPQ V+QTA + TNGS LT+ NL+ +A +F
Sbjct: 229 ------QINTTRNVSGFSDGYNPPQGVIQTASIPTNGSEPLTFTWNLESSDDETYAYLFF 282
Query: 289 AEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPF------- 341
AEI+ L +E+R+F+++ G + Y ++ LS P
Sbjct: 283 AEIQQLKVNETREFKILANGVDYID-------------YTPWKFEARTLSNPAPLKCEGG 329
Query: 342 VLSFKFGKTYDSSRGPLLNAMEINKYLE--RNDGSIDGV-AIVSVISLY--SSADWAQEG 396
V + KT S+ PL+NA+EI ++ ++D + D V AI + S Y S W
Sbjct: 330 VCRVQLSKTPKSTLPPLMNAIEIFSVIQFPQSDTNTDEVIAIKKIQSTYQLSRISWQ--- 386
Query: 397 GDPCLPVPWSWL--QCN----SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGN 450
GDPC+P +SW+ CN S P P I + LS LTG I + L+ L EL L N
Sbjct: 387 GDPCVPKQFSWMGVSCNVIDISTP-PRIISLDLSLSGLTGVISPSIQNLTMLRELDLSNN 445
Query: 451 SLTGPIPDF-SGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
+LTG +P+F + L +IHL N L G +P +L + RE
Sbjct: 446 NLTGEVPEFLATIKPLLVIHLRGNNLRGSVPQALQD----RE------------------ 483
Query: 510 KNVVLNYAGNINLHEGGRGAKH--LNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKE 567
KN L + N+ G+ L I+ S AV ++ V+ +F+ + +K++ K
Sbjct: 484 KNDGLKLFVDPNITRRGKHQPKSWLVAIVASISCVAVTIIVLVL--IFIFRRRKSSTRK- 540
Query: 568 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE 627
V RP + + F S++++ T E +G GGFGVVY+G L + ++
Sbjct: 541 -------VIRPSLEMKN------RRFKYSEVKEMTNNFEVVLGKGGFGVVYHGFL-NNEQ 586
Query: 628 IAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH 687
+AVKVL+ +S QG +EF EV LL R+HH NLV +GYC E L+YEFM NG LKEH
Sbjct: 587 VAVKVLSQSSTQGYKEFKTEVELLLRVHHVNLVSLVGYCDEGIDLALIYEFMENGNLKEH 646
Query: 688 LYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 747
L G +NW RL+IA ++A GIEYLH GC P ++HRD+KS+NILL AK++D
Sbjct: 647 LSGK-RGGSVLNWSSRLKIAIESALGIEYLHIGCQPPMVHRDVKSTNILLGLRFEAKLAD 705
Query: 748 FGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 806
FGLS+ F V +HVS+ V GT+GYLDPEYY+ LT+KSDVYSFG++LLE I+GQ I
Sbjct: 706 FGLSRSFLVGSQAHVSTNVAGTLGYLDPEYYLKNWLTEKSDVYSFGIVLLESITGQPVIE 765
Query: 807 NEKFGANCRNIVQWVKS 823
+ + IV+W KS
Sbjct: 766 QSR---DKSYIVEWAKS 779
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 421 bits (1081), Expect = e-116, Method: Compositional matrix adjust.
Identities = 289/835 (34%), Positives = 443/835 (53%), Gaps = 99/835 (11%)
Query: 20 LLLDSSSAQ-MPGFVSLNCG---GNENFTDEI-GLQWIADDHLI-YGEISNISV--ANET 71
++L+S AQ GF+SL+CG N +T++ + + +D + I G + IS +
Sbjct: 16 VILESVQAQDQLGFISLDCGLVPKNATYTEKTTNITYKSDANYIDSGLVGRISAEYKAQL 75
Query: 72 RKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWST 131
++Q T+R FP R CY ++ ++RYLIRATF YGN+D PKFDI +GP+ W++
Sbjct: 76 QQQTWTVRSFPEGERN-CYNFNLTAKSRYLIRATFTYGNYDGLRQVPKFDIHIGPSKWTS 134
Query: 132 IVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYL 191
+ + V E+I + + ++ +CL G PFIS+LELR N + YLT L
Sbjct: 135 VKLDGVGNGAVLEMIHVLTQDRLQICLVKTGKGIPFISSLELRPLNNNTYLT---QSGSL 191
Query: 192 SVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDE 251
AR+ F A + +RY +D DR+W + G + +ST L +D +
Sbjct: 192 IGFARVFFSA-TPTFIRYDEDIHDRVW----------VRQFGNGLKSISTDLLVDTSNPY 240
Query: 252 LPPQKVMQTAVVGTNGS--LTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQ 309
PQ V +TA V +N S L + LD + +FAEI+ L ++ R+F + G
Sbjct: 241 DVPQAVAKTACVPSNASQPLIFDWTLDNITSQSYVYMHFAEIQTLKDNDIREFNITYNG- 299
Query: 310 PDVSKAIVNIQENAQGKYRVYEPGYTNLSLPF----------VLSFKFGKTYDSSRGPLL 359
Q Y P +S F S F KT +S+ PL+
Sbjct: 300 -------------GQNVYSYLRPEKFEISTLFDSKPLSSPDGSFSLSFTKTGNSTLPPLI 346
Query: 360 NAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQE---GGDPCLPVPWSW--LQC---N 411
N +EI K L+ + D + ++I++ ++ D +++ GDPC P + W L C N
Sbjct: 347 NGLEIYKVLDLLELETDQDEVSAMINIKATYDLSKKVSWQGDPCAPKSYQWEGLNCSYPN 406
Query: 412 SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHL 470
SD QP I ++L+ LTG I +++KL+ L+EL L N L+G IP+ F+ L++I+L
Sbjct: 407 SD-QPRIISLNLAENKLTGTITPEISKLTQLIELDLSKNDLSGEIPEFFADMKLLKLINL 465
Query: 471 EDN-QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGA 529
N L +P S+ + + L + +LS TV +K V L G+
Sbjct: 466 SGNLGLNSTIPDSIQQRLDSKSLIL---ILSKTV-----TKTVTLK----------GKSK 507
Query: 530 KHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEA 589
K I I +SV A V L +++ F+ + K +K + + +R +
Sbjct: 508 KVPMIPIVASV-AGVFALLVILAIFFVVRRKNGESNKGTNPSIITKERRI---------- 556
Query: 590 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVT 649
T ++ T E+ +G GGFG VY+G L+D ++AVK+L+ +S QG +EF EV
Sbjct: 557 ----TYPEVLKMTNNFERVLGKGGFGTVYHGNLED-TQVAVKMLSHSSAQGYKEFKAEVE 611
Query: 650 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 709
LL R+HHRNLV +GYC + L+YE+M NG LKE++ G + W R++IA +
Sbjct: 612 LLLRVHHRNLVGLVGYCDDGDNLALIYEYMANGDLKENMSGK-RGGNVLTWENRMQIAVE 670
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGT 768
AA+G+EYLH GC P ++HRD+K++NILL++ AK++DFGLS+ F VDG SHVS++V GT
Sbjct: 671 AAQGLEYLHNGCTPPMVHRDVKTTNILLNERYGAKLADFGLSRSFPVDGESHVSTVVAGT 730
Query: 769 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWVKS 823
GYLDPEYY + L++KSDVYSFGV+LLE+++ Q + +I +WV S
Sbjct: 731 PGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVTDKTR---ERTHINEWVGS 782
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQQ7|Y2144_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14440 OS=Arabidopsis thaliana GN=At2g14440 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 421 bits (1081), Expect = e-116, Method: Compositional matrix adjust.
Identities = 309/853 (36%), Positives = 452/853 (52%), Gaps = 86/853 (10%)
Query: 1 MERRRRLLLPFSVASVLILLLLDSSSAQMPGFVSLNCGGNENFTDEI----GLQWIADDH 56
ME R +L+L + A+ I+ L+ S + Q GF+SL CG N + I L +I+D +
Sbjct: 1 METRSKLML-LACATFSIISLVKSQNQQ--GFISLYCGLPSNESPYIEPLTNLTYISDVN 57
Query: 57 LIYG----EISNISVANETRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFD 112
+ G I N S + T + Y LR+FP R CY L V T+YLIR F YGN+D
Sbjct: 58 FVRGGKTGNIKNNSDIDFTSRPYKVLRYFPEGIRN-CYSLSVKQGTKYLIRTLFFYGNYD 116
Query: 113 NNNVYPKFDISLGPTHWSTIVIS--DAATIEVRELIFLASSPKIDVCLSNATTGQPFIST 170
N P+FD+ LGP W+++ + D + E+I + +D+CL T P IS
Sbjct: 117 GLNTSPRFDLFLGPNIWTSVDVQKVDGGDGVIEEIIHVTRCNILDICLVKTGTTTPMISA 176
Query: 171 LELRQFNGSVYLTPFEDRYYLSVSARINF-GADSEAPVRYPDDPFDRIWESDSLKKANYL 229
+ELR Y S+ ++F +S VRYP+D +DR+W S +
Sbjct: 177 IELRPLRYDTYTARTG-----SLKKILHFYFTNSGKEVRYPEDVYDRVWIPHSQPEWT-- 229
Query: 230 VDVAAGTEKVSTKLPIDLRSDEL-PPQKVMQTAVVGTNGS--LTYRLNLDGFPGFGWAVT 286
+++T + SD PPQ V++TA + TN S LT+ + +A
Sbjct: 230 --------QINTTRNVSGFSDGYNPPQDVIKTASIPTNVSEPLTFTWMSESSDDETYAYL 281
Query: 287 YFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPF---VL 343
YFAEI+ L +E+R+F++++ G V + K+ E T +L V
Sbjct: 282 YFAEIQQLKANETRQFKILVNG--------VYYIDYIPRKFEA-ETLITPAALKCGGGVC 332
Query: 344 SFKFGKTYDSSRGPLLNAMEINKYLE--RNDGSIDGV-AIVSVISLY--SSADWAQEGGD 398
+ KT S+ P +NA+EI ++ ++D + D V AI ++ S Y S W GD
Sbjct: 333 RVQLSKTPKSTLPPQMNAIEIFSVIQFPQSDTNTDEVIAIKNIQSTYKVSRISWQ---GD 389
Query: 399 PCLPVPWSWL--QCN----SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSL 452
PC+P+ +SW+ CN S P P I + LSS LTG I + L+ L EL L N+L
Sbjct: 390 PCVPIQFSWMGVSCNVIDISTP-PRIISLDLSSSGLTGVITPSIQNLTMLRELDLSNNNL 448
Query: 453 TGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 511
TG IP LR + L +N LTG +P L + L ++++ N L G+VP +L +
Sbjct: 449 TGVIPPSLQNLTMLRELDLSNNNLTGEVPEFLATIKPLLVIHLRGNNLRGSVPQALQDRE 508
Query: 512 VVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRH 571
N G + L G K + I +S+ + + +V +F+ + +K++ K
Sbjct: 509 ---NNDG-LKLLRGKHQPKSWLVAIVASISCVAVTIIVLV-LIFIFRRRKSSTRK----- 558
Query: 572 SLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVK 631
V RP + + F S++++ T E +G GGFGVVY+G L + +++AVK
Sbjct: 559 ---VIRPSLEMKN------RRFKYSEVKEMTNNFEVVLGKGGFGVVYHGFL-NNEQVAVK 608
Query: 632 VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGT 691
VL+ +S QG +EF EV LL R+HH NLV +GYC + L+YEFM NG LKEHL G
Sbjct: 609 VLSQSSTQGYKEFKTEVELLLRVHHVNLVSLVGYCDKGNDLALIYEFMENGNLKEHLSGK 668
Query: 692 LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751
+NW RL+IA ++A GIEYLH GC P ++HRD+KS+NILL AK++DFGLS
Sbjct: 669 -RGGPVLNWPGRLKIAIESALGIEYLHIGCKPPMVHRDVKSTNILLGLRFEAKLADFGLS 727
Query: 752 K-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810
+ F V +HVS+ V GT+GYLDPEYY LT+KSDVYSFG++LLE+I+GQ I +
Sbjct: 728 RSFLVGSQTHVSTNVAGTLGYLDPEYYQKNWLTEKSDVYSFGIVLLEIITGQPVIEQSR- 786
Query: 811 GANCRNIVQWVKS 823
+ IV+W KS
Sbjct: 787 --DKSYIVEWAKS 797
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64556|Y2923_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g19230 OS=Arabidopsis thaliana GN=At2g19230 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 416 bits (1070), Expect = e-115, Method: Compositional matrix adjust.
Identities = 290/845 (34%), Positives = 450/845 (53%), Gaps = 112/845 (13%)
Query: 8 LLPF-SVASVLILLLLDSSSAQMPGFVSLNCGGNEN---FTDEIGLQWIADDHLI-YGEI 62
LP S AS +++L+L + Q GFVS++CG E+ + ++ +++I+D + G I
Sbjct: 6 FLPLVSFASFVVVLVLVCAQDQ-SGFVSIDCGIPEDSSYYDEKTDIKYISDAAFVESGTI 64
Query: 63 SNISVANETR---KQYMTLRHFPADSRKYCYKLDVITRT--RYLIRATFLYGNFDNNNVY 117
+I + + KQ+ +R FP + +K CY + +YLIR F+YGN+DN
Sbjct: 65 HSIDSKFQKKNLEKQFQKVRSFP-EGKKNCYDVQPPQGKGFKYLIRTRFMYGNYDNLGKA 123
Query: 118 PKFDISLGPTHWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFN 177
P FD+ LG W ++ + ++ TI +E+I+ S K+ VCL + G PF+S LELR
Sbjct: 124 PDFDLYLGVNLWDSVTLENSTTIVTKEIIYTLRSDKVHVCLVDKERGTPFLSVLELRLLK 183
Query: 178 GSVYLTPFEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTE 237
++Y T + L + R + GA + P RY DD FDR W L N+L+
Sbjct: 184 NNIYETASDS---LMLYRRWDLGATGDLPARYKDDIFDRFWMP--LMFPNFLI------- 231
Query: 238 KVSTKLPIDLRSDE--LPPQKVMQTAVVGTNGS----LTYRLNLDGFPGFGWAV-TYFAE 290
++T L ID S LPP VM TAV N S + Y D P + + + +FAE
Sbjct: 232 -LNTSLMIDPTSSNGFLPPSVVMSTAVAPMNSSIEQIMVYWEPRD--PNWKFYIYIHFAE 288
Query: 291 IEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTN--LSLPFVLSFKFG 348
+E L +E+R+F + L +K ++ + Y + Y +S PF L F
Sbjct: 289 VEKLPSNETREFSVFL------NKEQIDTTSVFRPSYLYTDTLYVQNPVSGPF-LEFVLR 341
Query: 349 KTYDSSRGPLLNAMEI---NKYLERNDGSIDGVAIVSVISLYSSA-DWAQEGGDPCLPV- 403
+ S+R P++NA+E N++L+ D AI+ + + Y +W GDPC P
Sbjct: 342 QGVKSTRPPIMNAIETYRTNEFLDLPTDQNDVDAIMKIKTKYKVKKNWL---GDPCAPFG 398
Query: 404 -PWSWLQCN--SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFS 460
PW + C+ ++ P I ++LS LTG I P F
Sbjct: 399 YPWQGINCSYTANNPPRIISVNLSFSGLTGQID-----------------------PVFI 435
Query: 461 GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN----VVLNY 516
L+ + L +N+LTG +P L NLP+L EL ++ N L+G +P LL ++ + L
Sbjct: 436 TLTPLQKLDLSNNRLTGTVPDFLANLPDLTELNLEENKLTGILPEKLLERSKDGSLSLRV 495
Query: 517 AGNINL--HEGGRGAK-----HLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQH 569
GN +L + R K ++ + S G LLLA + F + +
Sbjct: 496 GGNPDLCVSDSCRNKKTERKEYIIPSVASVTGLFFLLLALISFWQFKKRQQ--------- 546
Query: 570 RHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIA 629
S+ P + + S+I + T E+ +G GGFG VYYG L+ G+++A
Sbjct: 547 -----------SVKTGPLDTKRYYKYSEIVEITNNFERVLGQGGFGKVYYGVLR-GEQVA 594
Query: 630 VKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY 689
+K+L+ +S QG +EF EV LL R+HH+NL+ +GYC E + L+YE++ NGTL ++L
Sbjct: 595 IKMLSKSSAQGYKEFRAEVELLLRVHHKNLIALIGYCHEGDQMALIYEYIGNGTLGDYLS 654
Query: 690 GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749
G + ++W +RL+I+ DAA+G+EYLH GC P I+HRD+K +NIL+++ ++AK++DFG
Sbjct: 655 GK--NSSILSWEERLQISLDAAQGLEYLHNGCKPPIVHRDVKPTNILINEKLQAKIADFG 712
Query: 750 LSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808
LS+ F ++G S VS+ V GT+GYLDPE+Y QQ ++KSDVYSFGV+LLE+I+GQ IS
Sbjct: 713 LSRSFTLEGDSQVSTEVAGTIGYLDPEHYSMQQFSEKSDVYSFGVVLLEVITGQPVISRS 772
Query: 809 KFGAN 813
+ N
Sbjct: 773 RTEEN 777
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD6|Y1570_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g05700 OS=Arabidopsis thaliana GN=At1g05700 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 416 bits (1068), Expect = e-115, Method: Compositional matrix adjust.
Identities = 291/825 (35%), Positives = 437/825 (52%), Gaps = 75/825 (9%)
Query: 1 MERRRRLLLPFSVASVLILLLLDSSSAQMPGFVSLNCG---GNENFTDEIGLQWIADDHL 57
ME R L L +S A L L++ + Q GF+S++CG G+ D G+ +++D
Sbjct: 1 MEEFRFLYLIYSAAFALCLVVSVLAQDQ-SGFISIDCGIPSGSSYKDDTTGINYVSDSSF 59
Query: 58 IYGEISNISVANETRKQYMTLRHFPADSRKYCYKLDVI--TRTRYLIRATFLYGNFDNNN 115
+ +S S+ ++Q LR FP SR CY L I +YLIRA+F+YGN+D N
Sbjct: 60 VETGVSK-SIPFTAQRQLQNLRSFPEGSRN-CYTLIPIQGKGKKYLIRASFMYGNYDGEN 117
Query: 116 VYPKFDISLGPTHWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQ 175
P+FD+ LG W T+++S+ ++I +E+++L+ S I VCL N G PFISTLELR
Sbjct: 118 GSPEFDLFLGGNIWDTVLLSNGSSIVSKEVVYLSQSENIFVCLGNKGKGTPFISTLELR- 176
Query: 176 FNGSVYLTPFEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAG 235
F G+ T L S R + + +PVRY DD +DRIW +
Sbjct: 177 FLGNDNTTYDSPNGALFFSRRWDLRSLMGSPVRYDDDVYDRIWIPRNFGYC--------- 227
Query: 236 TEKVSTKLPIDLRSDELPPQK-VMQTAVVGTNGSLTYRLNLDGF-PGFGWAV-TYFAEIE 292
+++T LP+ ++ VM TA+ N + + L+ P + V +FAE+E
Sbjct: 228 -REINTSLPVTSDNNSYSLSSLVMSTAMTPINTTRPITMTLENSDPNVRYFVYMHFAEVE 286
Query: 293 DLD--PDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKT 350
DL P+++R+F D+S V + KY + N ++F +T
Sbjct: 287 DLSLKPNQTREF--------DISINGVTVAAGFSPKYLQTNTFFLNPESQSKIAFSLVRT 338
Query: 351 YDSSRGPLLNAMEI---NKYLERNDGSIDGVAIVSVISLYS-SADWAQEGGDPCLPVPWS 406
S+ P++NA+EI N + + DG A+ S+ + Y +W GDPCLP +
Sbjct: 339 PKSTLPPIVNALEIYVANSFSQSLTNQEDGDAVTSLKTSYKVKKNWH---GDPCLPNDYI 395
Query: 407 W--LQCNSDP--QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SG 461
W L C+ D P IT ++LSS LTG+I S + L+ + EL L N LTG IP+F S
Sbjct: 396 WEGLNCSYDSLTPPRITSLNLSSSGLTGHISSSFSNLTMIQELDLSNNGLTGDIPEFLSK 455
Query: 462 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 521
LR+++LE+N LTG +PS L+ N ++ L +
Sbjct: 456 LKFLRVLNLENNTLTGSVPSELLERSNTGSFSLR------------------LGENPGLC 497
Query: 522 LHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSS 581
R + ++I A L + ++S +F + N + +S P P+
Sbjct: 498 TEISCRKSNSKKLVIPLVASFAALFILLLLSGVFWRIRNRRN----KSVNSAPQTSPM-- 551
Query: 582 LNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK 641
A +E FT +D+ T + +G GGFG VY+G D ++AVK+L+ S QG
Sbjct: 552 ---AKSENKLLFTFADVIKMTNNFGQVLGKGGFGTVYHG-FYDNLQVAVKLLSETSAQGF 607
Query: 642 REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 701
+EF +EV +L R+HH NL +GY E + L+YEFM NG + +HL G H ++W
Sbjct: 608 KEFRSEVEVLVRVHHVNLTALIGYFHEGDQMGLIYEFMANGNMADHLAGKYQHT--LSWR 665
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASH 760
+RL+IA DAA+G+EYLH GC P I+HRD+K+SNILL++ RAK++DFGLS+ F + SH
Sbjct: 666 QRLQIALDAAQGLEYLHCGCKPPIVHRDVKTSNILLNEKNRAKLADFGLSRSFHTESRSH 725
Query: 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 805
VS++V GT GYLDP + + L +KSD+YSFGV+LLE+I+G+ I
Sbjct: 726 VSTLVAGTPGYLDPLCFETNGLNEKSDIYSFGVVLLEMITGKTVI 770
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 408 bits (1048), Expect = e-112, Method: Compositional matrix adjust.
Identities = 287/838 (34%), Positives = 438/838 (52%), Gaps = 104/838 (12%)
Query: 16 VLILLLLDSSSAQ-MPGFVSLNCG---GNENFTDE-IGLQWIAD-DHLIYGEISNISVAN 69
++ +L S AQ GF+SL+CG +T++ + + +D D++ G + I+ A
Sbjct: 12 IIAFTVLRSVEAQNQAGFISLDCGLVPKETTYTEKSTNITYKSDVDYIDSGLVGKINDAY 71
Query: 70 ETR--KQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPT 127
+T+ +Q +R FP R CY +++ +YLIR TF+YGN+D N +P FD+ +GP
Sbjct: 72 KTQFQQQVWAVRSFPVGQRN-CYNVNLTANNKYLIRGTFVYGNYDGLNQFPSFDLHIGPN 130
Query: 128 HWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFED 187
WS++ I + E+I + ++VCL PFIS+LE+R N YLT
Sbjct: 131 KWSSVKILGVTNTSMHEIIHVVPQDSLEVCLVKTGPTTPFISSLEVRPLNNESYLT---Q 187
Query: 188 RYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDL 247
L + AR+ F + S + +RY +D DR+W S + + T +ST LPID
Sbjct: 188 SGSLMLFARVYFPSSSSSFIRYDEDIHDRVWNSFTDDE----------TVWISTDLPIDT 237
Query: 248 RSDELPPQKVMQTAVVGTNGSLTYRL--NLDGFPGFGWAVTYFAEIEDLDPDESRKFRLV 305
+ PQ VM+TA V N S + L LD + +FAE+++L +E+R+F
Sbjct: 238 SNSYDMPQSVMKTAAVPKNASEPWLLWWTLDENTAQSYVYMHFAEVQNLTANETREF--- 294
Query: 306 LPGQPDVSKAIVNIQENAQGKYRVY-EPGYTNLSLPF----------VLSFKFGKTYDSS 354
NI N ++ Y P ++S F + +F F T +S+
Sbjct: 295 ------------NITYNGGLRWFSYLRPPNLSISTIFNPRAVSSSNGIFNFTFAMTGNST 342
Query: 355 RGPLLNAMEINKY-----LERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSW-- 407
PLLNA+EI LE N + A++++ Y + GDPC P + W
Sbjct: 343 LPPLLNALEIYTVVDILQLETNKDEVS--AMMNIKETYGLSKKISWQGDPCAPQLYRWEG 400
Query: 408 LQCN-SDPQPS-ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPD 464
L C+ D + S I ++L+ LTG+I SD++KL+ L L L N L+G IP F+
Sbjct: 401 LNCSYPDSEGSRIISLNLNGSELTGSITSDISKLTLLTVLDLSNNDLSGDIPTFFAEMKS 460
Query: 465 LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL----SKNVVLNYAGNI 520
L++I+L N PNL N+ + +P SL SK++ L N+
Sbjct: 461 LKLINLSGN-------------PNL-------NLTA--IPDSLQQRVNSKSLTLILGENL 498
Query: 521 NLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLP------ 574
L K + I +SV A V L +++ F+ K K + + H+ P
Sbjct: 499 TLTPKKESKKVPMVAIAASV-AGVFALLVILAIFFVIKRK----NVKAHKSPGPPPLVTP 553
Query: 575 --VQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKV 632
V+ S N + T ++ T E+ +G GGFG VY+G L DG E+AVK+
Sbjct: 554 GIVKSETRSSNPSIITRERKITYPEVLKMTNNFERVLGKGGFGTVYHGNL-DGAEVAVKM 612
Query: 633 LTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL 692
L+ +S QG +EF EV LL R+HHR+LV +GYC + L+YE+M NG L+E++ G
Sbjct: 613 LSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSGK- 671
Query: 693 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
+ W R++IA +AA+G+EYLH GC P ++HRD+K++NILL++ AK++DFGLS+
Sbjct: 672 RGGNVLTWENRMQIAVEAAQGLEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSR 731
Query: 753 -FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809
F +DG HVS++V GT GYLDPEYY + L++KSDVYSFGV+LLE+++ Q I +
Sbjct: 732 SFPIDGECHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVIDKTR 789
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LIG2|RLK6_ARATH Receptor-like protein kinase At3g21340 OS=Arabidopsis thaliana GN=At3g21340 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 406 bits (1044), Expect = e-112, Method: Compositional matrix adjust.
Identities = 288/833 (34%), Positives = 424/833 (50%), Gaps = 99/833 (11%)
Query: 31 GFVSLNCGGNEN---FTD-EIGLQWIADDHLIY-GEISNISVANET--RKQYMTLRHFPA 83
GF+SL+CG N + D GL + DD + G+ I A E+ K + LR+FP
Sbjct: 32 GFISLDCGSLPNEPPYNDPSTGLTYSTDDGFVQSGKTGRIQKAFESIFSKPSLKLRYFP- 90
Query: 84 DSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVR 143
D + CY L+V T YLI+A F+YGN+D N P FD+ LGP W T+ ++ ++
Sbjct: 91 DGFRNCYTLNVTQDTNYLIKAVFVYGNYDGLNNPPSFDLYLGPNLWVTVDMNGRTNGTIQ 150
Query: 144 ELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLT-----PFEDRYYLSVSARIN 198
E+I S + VCL T P I+TLELR + Y T + RYY S S +
Sbjct: 151 EIIHKTISKSLQVCLVKTGTSSPMINTLELRPLKNNTYNTQSGSLKYFFRYYFSGSGQ-- 208
Query: 199 FGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVM 258
+RYPDD DR W D TE ++T L I+ + PP+ VM
Sbjct: 209 -------NIRYPDDVNDRKWYP--------FFDAKEWTE-LTTNLNINSSNGYAPPEVVM 252
Query: 259 QTAV--VGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAI 316
+A + T G+ + L + +FAEI+ L ++R+F++ L
Sbjct: 253 ASASTPISTFGTWNFSWLLPSSTTQFYVYMHFAEIQTLRSLDTREFKVTL---------- 302
Query: 317 VNIQENAQGKYRVYEPGYTNLSLPFVLS----------FKFGKTYDSSRGPLLNAMEINK 366
N + Y Y P F + + KT S+ PL+NA+E+
Sbjct: 303 -----NGKLAYERYSPKTLATETIFYSTPQQCEDGTCLLELTKTPKSTLPPLMNALEVFT 357
Query: 367 YL---ERNDGSIDGVAIVSVISLY--SSADWAQEGGDPCLPVPWSW--LQCN----SDPQ 415
+ + D AI S+ S Y S W GDPC+P + W L CN S P
Sbjct: 358 VIDFPQMETNPDDVAAIKSIQSTYGLSKISWQ---GDPCVPKQFLWEGLNCNNLDNSTP- 413
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQ 474
P +T ++LSS +LTG I + L+ L EL L N+LTG IP+F + L +I+L N
Sbjct: 414 PIVTSLNLSSSHLTGIIAQGIQNLTHLQELDLSNNNLTGGIPEFLADIKSLLVINLSGNN 473
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNI 534
G +P L+ L+ + N L + + +N AGN GAK +N+
Sbjct: 474 FNGSIPQILLQKKGLKLILEGNANL-------ICPDGLCVNKAGN-------GGAKKMNV 519
Query: 535 IIG--SSVGAAVLL---LATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEA 589
+I +SV V+L LA + + V R + S A
Sbjct: 520 VIPIVASVAFVVVLGSALAFFFIFKKKKTSNSQDLGPSSYTQVSEV-RTIRSSESAIMTK 578
Query: 590 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVT 649
FT S++ T E+ +G GGFG+VY+G + + +++AVK+L+ +S QG +EF EV
Sbjct: 579 NRRFTYSEVVTMTNNFERVLGKGGFGMVYHGTVNNTEQVAVKMLSHSSSQGYKEFKAEVE 638
Query: 650 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 709
LL R+HH+NLV +GYC E L+YE+M NG L+EH+ G +NW RL+I +
Sbjct: 639 LLLRVHHKNLVGLVGYCDEGENLALIYEYMANGDLREHMSGK-RGGSILNWETRLKIVVE 697
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGT 768
+A+G+EYLH GC P ++HRD+K++NILL++H+ AK++DFGLS+ F ++G +HVS++V GT
Sbjct: 698 SAQGLEYLHNGCKPPMVHRDVKTTNILLNEHLHAKLADFGLSRSFPIEGETHVSTVVAGT 757
Query: 769 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWV 821
GYLDPEYY + L +KSDVYSFG++LLE+I+ Q I+ + +I +WV
Sbjct: 758 PGYLDPEYYRTNWLNEKSDVYSFGIVLLEIITNQLVINQSR---EKPHIAEWV 807
|
Probable receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 406 bits (1044), Expect = e-112, Method: Compositional matrix adjust.
Identities = 290/858 (33%), Positives = 451/858 (52%), Gaps = 118/858 (13%)
Query: 8 LLPFSVASVLILLLLDSSSAQMPGFVSLNCGGNEN--FTDEI-GLQWIADDHLI-YGEIS 63
L+ F+ + +LL+ + GFVS++CG E+ + DE +++++D + G I
Sbjct: 9 LIIFACFFAVFVLLV--RAQDQSGFVSIDCGIPEDSSYNDETTDIKYVSDAAFVESGTIH 66
Query: 64 NISVANET---RKQYMTLRHFPADSRKYCYKLDVITRT--RYLIRATFLYGNFDNNNVYP 118
+I +T KQ+ +R FP +R CY + +YLIR F+YGN+DN P
Sbjct: 67 SIDPEFQTSSLEKQFQNVRSFPEGNRN-CYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAP 125
Query: 119 KFDISLGPTHWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNG 178
FD+ LG W ++ I +A TI +E+I S + VCL + G PF+S LE+R
Sbjct: 126 DFDLYLGFNIWDSVTIDNATTIVTKEIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLLKS 185
Query: 179 SVYLTPFEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEK 238
+ Y TP++ L + R + G PVRY DD FDRIW L+ Y +
Sbjct: 186 NTYETPYDS---LILFKRWDLGGLGALPVRYKDDVFDRIWI--PLRFPKYTI-------- 232
Query: 239 VSTKLPIDLRSDE--LPPQKVMQTAVVGTNGSLTYRLNLD-GFPGFGWAV-TYFAEIEDL 294
+ L ID ++E P + VM TA + S + + P + + V +FAE+ +L
Sbjct: 233 FNASLTIDSNNNEGFQPARFVMNTATSPEDLSQDIIFSWEPKDPTWKYFVYMHFAEVVEL 292
Query: 295 DPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFV--------LSFK 346
+E+R+F+++L ++ +N+ + P Y FV L F+
Sbjct: 293 PSNETREFKVLL------NEKEINMSS--------FSPRYLYTDTLFVQNPVSGPKLEFR 338
Query: 347 FGKTYDSSRGPLLNAME---INKYLERNDGSIDGVAIVSVISLYS-SADWAQEGGDPCLP 402
+T S+ P++NA+E +N++L+ D AI+ + S Y W GDPC P
Sbjct: 339 LQQTPRSTLPPIINAIETYRVNEFLQSPTDQQDVDAIMRIKSKYGVKKSWL---GDPCAP 395
Query: 403 V--PWSWLQCN--SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD 458
V PW + C+ + P I ++LSS LTG I + + L+ L L L NSLTG IPD
Sbjct: 396 VKYPWKDINCSYVDNESPRIISVNLSSSGLTGEIDAAFSNLTLLHILDLSNNSLTGKIPD 455
Query: 459 FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN----VVL 514
F G NL NL EL ++ N LSG +P LL ++ ++L
Sbjct: 456 FLG-----------------------NLHNLTELNLEGNKLSGAIPVKLLERSNKKLILL 492
Query: 515 NYAGNINLHEGG-------RGAKHLNII--IGSSVGAAVLLLATVVSCLFMHKGKKNNYD 565
GN +L + K++ II + S VG L+LA + L+
Sbjct: 493 RIDGNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVLGLVLAIALFLLY---------- 542
Query: 566 KEQHRHSLPVQRPVSSLNDAPAEAA-HCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD 624
K++HR + P + + S++ T E+ +G GGFG VY+G L D
Sbjct: 543 KKRHRRG-----GSGGVRAGPLDTTKRYYKYSEVVKVTNNFERVLGQGGFGKVYHGVLND 597
Query: 625 GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684
++AVK+L+ +S QG +EF EV LL R+HH+NL +GYC E + L+YEFM NGTL
Sbjct: 598 -DQVAVKILSESSAQGYKEFRAEVELLLRVHHKNLTALIGYCHEGKKMALIYEFMANGTL 656
Query: 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 744
++L G ++ ++W +RL+I+ DAA+G+EYLH GC P I+ RD+K +NIL+++ ++AK
Sbjct: 657 GDYLSGEKSY--VLSWEERLQISLDAAQGLEYLHNGCKPPIVQRDVKPANILINEKLQAK 714
Query: 745 VSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 803
++DFGLS+ A+DG + ++ V GT+GYLDPEY+++Q+L++KSD+YSFGV+LLE++SGQ
Sbjct: 715 IADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLEVVSGQP 774
Query: 804 AISNEKFGANCRNIVQWV 821
I+ + A +I V
Sbjct: 775 VIARSRTTAENIHITDRV 792
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 824 | ||||||
| 356570730 | 936 | PREDICTED: probable LRR receptor-like se | 0.961 | 0.846 | 0.811 | 0.0 | |
| 224068652 | 924 | predicted protein [Populus trichocarpa] | 0.967 | 0.862 | 0.814 | 0.0 | |
| 356503698 | 937 | PREDICTED: probable LRR receptor-like se | 0.983 | 0.864 | 0.792 | 0.0 | |
| 224138590 | 921 | predicted protein [Populus trichocarpa] | 0.967 | 0.865 | 0.813 | 0.0 | |
| 297741494 | 924 | unnamed protein product [Vitis vinifera] | 0.987 | 0.880 | 0.793 | 0.0 | |
| 225439769 | 927 | PREDICTED: probable LRR receptor-like se | 0.972 | 0.864 | 0.797 | 0.0 | |
| 255568426 | 900 | Nodulation receptor kinase precursor, pu | 0.936 | 0.857 | 0.808 | 0.0 | |
| 357510569 | 932 | Leucine-rich repeat receptor-like protei | 0.963 | 0.851 | 0.790 | 0.0 | |
| 356545961 | 902 | PREDICTED: probable LRR receptor-like se | 0.935 | 0.854 | 0.782 | 0.0 | |
| 79568805 | 933 | putative receptor protein kinase [Arabid | 0.968 | 0.855 | 0.753 | 0.0 |
| >gi|356570730|ref|XP_003553538.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1367 bits (3537), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 649/800 (81%), Positives = 714/800 (89%), Gaps = 8/800 (1%)
Query: 29 MPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPADSRKY 88
M GFVSL+CGG E FTDE+GL W DD L YG+IS ISVANETRKQY TLRHFPADSRKY
Sbjct: 30 MQGFVSLDCGGTEKFTDELGLHWTPDDKLTYGQISTISVANETRKQYTTLRHFPADSRKY 89
Query: 89 CYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVRELIFL 148
CY L+V++RTRYL+RA+FLYGNFDNNNVYPKFDIS+G THWSTIVISDA +IE+RELIFL
Sbjct: 90 CYTLEVVSRTRYLLRASFLYGNFDNNNVYPKFDISVGATHWSTIVISDANSIEMRELIFL 149
Query: 149 ASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSEAPVR 208
ASSP + VCLSNATTGQPFISTLELRQFNGSVY T FE +YLSVSARINFGA+S+AP+R
Sbjct: 150 ASSPTVSVCLSNATTGQPFISTLELRQFNGSVYYTQFEQHFYLSVSARINFGAESDAPIR 209
Query: 209 YPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGS 268
YPDDPFDRIWESDS+KKANYLVDVAAGTEK+ST +PID+ DE+PP KVMQTAVVGTNGS
Sbjct: 210 YPDDPFDRIWESDSVKKANYLVDVAAGTEKISTTVPIDVNRDEMPPVKVMQTAVVGTNGS 269
Query: 269 LTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYR 328
LTYRLNLDGFPG GWA TYFAEIEDLDPDESRKFRLVLPGQPD+SKA+VNI+ENAQGKYR
Sbjct: 270 LTYRLNLDGFPGTGWAFTYFAEIEDLDPDESRKFRLVLPGQPDISKAVVNIEENAQGKYR 329
Query: 329 VYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYS 388
+YEPG+TN+SLPFVLSF+FGKTYDSSRGPLLNAMEIN YLE+NDGS+DG I +++S YS
Sbjct: 330 LYEPGFTNISLPFVLSFRFGKTYDSSRGPLLNAMEINMYLEKNDGSLDGATISNILSHYS 389
Query: 389 SADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLD 448
+ADW QEGGDPCLPVPWSW++CNSDPQP I I LS+KNLTGNIP D+TKL LVELWLD
Sbjct: 390 AADWLQEGGDPCLPVPWSWVRCNSDPQPRIVSILLSNKNLTGNIPLDITKLVGLVELWLD 449
Query: 449 GNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL 508
GN LTGP PDF+GC DL+IIHLE+NQLTG LP+SL NLP+LRELYVQNNMLSGT+PS LL
Sbjct: 450 GNMLTGPFPDFTGCMDLKIIHLENNQLTGVLPTSLTNLPSLRELYVQNNMLSGTIPSELL 509
Query: 509 SKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQ 568
SK++VLNY+GNINLH R H+ +IIGSSVGA+VLLLAT++SCL+MHKGK+ + EQ
Sbjct: 510 SKDLVLNYSGNINLHRESRIKGHMYVIIGSSVGASVLLLATIISCLYMHKGKRRYH--EQ 567
Query: 569 HR------HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKL 622
R SLP QR S +D PAEAAHCF+ S+IE+AT EKKIGSGGFGVVYYGKL
Sbjct: 568 GRILNSCIDSLPTQRLASWKSDDPAEAAHCFSYSEIENATNNFEKKIGSGGFGVVYYGKL 627
Query: 623 KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682
KDGKEIAVKVLTSNSYQGKREF+NEVTLLSRIHHRNLVQ LGYC++E S+LVYEFMHNG
Sbjct: 628 KDGKEIAVKVLTSNSYQGKREFSNEVTLLSRIHHRNLVQLLGYCRDEENSMLVYEFMHNG 687
Query: 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 742
TLKEHLYG L H + INWIKRLEIAEDAAKGIEYLHTGCVP +IHRDLKSSNILLDKHMR
Sbjct: 688 TLKEHLYGPLVHGRSINWIKRLEIAEDAAKGIEYLHTGCVPVVIHRDLKSSNILLDKHMR 747
Query: 743 AKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
AKVSDFGLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ
Sbjct: 748 AKVSDFGLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 807
Query: 803 EAISNEKFGANCRNIVQWVK 822
EAISNE FG NCRNIVQW K
Sbjct: 808 EAISNESFGVNCRNIVQWAK 827
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224068652|ref|XP_002326166.1| predicted protein [Populus trichocarpa] gi|222833359|gb|EEE71836.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1365 bits (3532), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 651/799 (81%), Positives = 725/799 (90%), Gaps = 2/799 (0%)
Query: 24 SSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPA 83
+SSAQ PGF+SL+CGG NFTD++GL W +D + YG ++ISVANETRKQY T+RHFPA
Sbjct: 19 ASSAQ-PGFLSLDCGGPVNFTDDLGLSWTSDFNFSYGAAASISVANETRKQYTTVRHFPA 77
Query: 84 DSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVR 143
DSRKYCY+LDV +RTRYL+RATFLYGNFD+NNVYPKFDIS+GPTHWSTIVISDA TIE
Sbjct: 78 DSRKYCYRLDVTSRTRYLLRATFLYGNFDSNNVYPKFDISVGPTHWSTIVISDANTIEST 137
Query: 144 ELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADS 203
ELIFLASS + VCLSNATTGQPFISTLELRQFNGSVY T FE+++YLS+SARINFGAD+
Sbjct: 138 ELIFLASSSSMSVCLSNATTGQPFISTLELRQFNGSVYYTEFENQFYLSMSARINFGADN 197
Query: 204 EAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVV 263
EAP+RYPDDP+DRIWESDS+KKANYLVDVAAGT+KVST +PID+ DE PP++VMQTAVV
Sbjct: 198 EAPIRYPDDPYDRIWESDSVKKANYLVDVAAGTKKVSTDMPIDVNIDERPPERVMQTAVV 257
Query: 264 GTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENA 323
GTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDP+ESRKFRLVLPG PD+SKAIVNI+ENA
Sbjct: 258 GTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPEESRKFRLVLPGYPDMSKAIVNIEENA 317
Query: 324 QGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSV 383
QGKYR+YEPGYTNLSLPFVLSF+FGKT DSSRGPL+NAMEI+KYLE+NDG++DG I V
Sbjct: 318 QGKYRLYEPGYTNLSLPFVLSFRFGKTSDSSRGPLVNAMEIHKYLEKNDGTLDGYVISRV 377
Query: 384 ISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLV 443
I +S+ DWAQEGGDPCLPVPWSW+QCNSD +P I + LSSKNL+GN+PS LT L+ LV
Sbjct: 378 ILSHSTEDWAQEGGDPCLPVPWSWVQCNSDARPRIVKLSLSSKNLSGNVPSGLTMLTGLV 437
Query: 444 ELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTV 503
ELWLDGNSLTGPIPDF+GC L IIHLE+NQLTG LPSSL+NLPNLRELYVQNN+LSGT+
Sbjct: 438 ELWLDGNSLTGPIPDFTGCTGLEIIHLENNQLTGELPSSLLNLPNLRELYVQNNLLSGTI 497
Query: 504 PSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNN 563
PS LS+ V LNY+GNINL EG R +H++IIIGSSVGAAVLL+AT+VSCLFMHKGKK +
Sbjct: 498 PSG-LSRKVALNYSGNINLREGARRGRHMDIIIGSSVGAAVLLIATIVSCLFMHKGKKRH 556
Query: 564 YDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK 623
D+EQ R SLP+Q VSSL +AP EAAHCFT +IEDATK EKKIGSGGFGVVYYGK+K
Sbjct: 557 PDQEQLRDSLPMQMVVSSLRNAPGEAAHCFTTFEIEDATKKFEKKIGSGGFGVVYYGKMK 616
Query: 624 DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683
DG+EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE+G+S+LVYEFMHNGT
Sbjct: 617 DGREIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEDGKSMLVYEFMHNGT 676
Query: 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 743
LKEHLYG L + INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL+DK+MRA
Sbjct: 677 LKEHLYGPLKRGKSINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILVDKNMRA 736
Query: 744 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 803
KV+DFGLSK AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLEL+SGQE
Sbjct: 737 KVADFGLSKLAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELMSGQE 796
Query: 804 AISNEKFGANCRNIVQWVK 822
AISNE FG NCRNIVQW K
Sbjct: 797 AISNESFGVNCRNIVQWAK 815
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503698|ref|XP_003520642.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1361 bits (3522), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 648/818 (79%), Positives = 721/818 (88%), Gaps = 8/818 (0%)
Query: 11 FSVASVLILLLLDSSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANE 70
F+++ LIL SS+ M GFVSL+CGG E F DEIGL W DD L YG+IS ISV NE
Sbjct: 13 FALSLSLILHSPFSSAQIMQGFVSLDCGGTEKFADEIGLHWTPDDKLTYGQISTISVVNE 72
Query: 71 TRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWS 130
TRKQY TLRHFPADSRKYCY L+V++RTRYL+RA+FLYGNFD+NNVYPKFDIS+GPTHWS
Sbjct: 73 TRKQYTTLRHFPADSRKYCYTLEVVSRTRYLLRASFLYGNFDDNNVYPKFDISIGPTHWS 132
Query: 131 TIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYY 190
TIVISDA +IE+RELIFLASSP + VCLSNATTGQPFISTLELRQFNGSVY T FE+ +Y
Sbjct: 133 TIVISDANSIEMRELIFLASSPTVSVCLSNATTGQPFISTLELRQFNGSVYYTQFEEHFY 192
Query: 191 LSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSD 250
LSVSARINFGA+S+AP+RYPDDPFDRIWESDS+KKANYLVDVAAGTEK+ST +PID+ D
Sbjct: 193 LSVSARINFGAESDAPIRYPDDPFDRIWESDSVKKANYLVDVAAGTEKISTTVPIDVNRD 252
Query: 251 ELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQP 310
E+PP KVMQTAVVGTNGSLTYRLNLDGFPG GWA TYFAEIEDLDP+ESRKFRLVLPGQP
Sbjct: 253 EMPPVKVMQTAVVGTNGSLTYRLNLDGFPGTGWAFTYFAEIEDLDPNESRKFRLVLPGQP 312
Query: 311 DVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLER 370
D+SKA+VNI+ENAQGKYR+YEPG+TN+SLPFVLSF+FGKTYDSSRGPLLNAMEIN YLE+
Sbjct: 313 DISKAVVNIEENAQGKYRLYEPGFTNISLPFVLSFRFGKTYDSSRGPLLNAMEINMYLEK 372
Query: 371 NDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTG 430
NDGS+DG I +++S YS+ DWAQEGGDPCLPVPWSW++CNSDPQP I I LS+KNLTG
Sbjct: 373 NDGSLDGATISNILSHYSAEDWAQEGGDPCLPVPWSWVRCNSDPQPRIVSILLSNKNLTG 432
Query: 431 NIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 490
NIP D+TKL LVELWLDGN LTGP PDF+GC DL+IIHLE+NQLTG LP+SL NLP+LR
Sbjct: 433 NIPMDITKLVGLVELWLDGNMLTGPFPDFTGCMDLKIIHLENNQLTGVLPTSLTNLPSLR 492
Query: 491 ELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATV 550
ELYVQNNMLSGT+PS LLSK++VLNY+GNINLH R H+ +IIGSSVGA+VLLLAT+
Sbjct: 493 ELYVQNNMLSGTIPSELLSKDLVLNYSGNINLHRESRIKGHMYVIIGSSVGASVLLLATI 552
Query: 551 VSCLFMHKGKKNNYDKEQHR------HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKM 604
+SCL+M KGK+ + EQ R SLP QR S +D PAEAAHCF+ +IE+AT
Sbjct: 553 ISCLYMRKGKRRYH--EQGRILNNRIDSLPTQRLASWKSDDPAEAAHCFSFPEIENATNN 610
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
E KIGSGGFG+VYYGKLKDGKEIAVKVLTSNSYQGKREF+NEVTLLSRIHHRNLVQ LG
Sbjct: 611 FETKIGSGGFGIVYYGKLKDGKEIAVKVLTSNSYQGKREFSNEVTLLSRIHHRNLVQLLG 670
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
YC++E S+LVYEFMHNGTLKEHLYG L H + INWIKRLEIAEDAAKGIEYLHTGC+P
Sbjct: 671 YCRDEESSMLVYEFMHNGTLKEHLYGPLVHGRSINWIKRLEIAEDAAKGIEYLHTGCIPV 730
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
+IHRDLKSSNILLDKHMRAKVSDFGLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTD
Sbjct: 731 VIHRDLKSSNILLDKHMRAKVSDFGLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTD 790
Query: 785 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWVK 822
KSDVYSFGVILLELISGQEAISNE FG NCRNIVQW K
Sbjct: 791 KSDVYSFGVILLELISGQEAISNESFGVNCRNIVQWAK 828
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224138590|ref|XP_002322852.1| predicted protein [Populus trichocarpa] gi|222867482|gb|EEF04613.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1360 bits (3519), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 650/799 (81%), Positives = 725/799 (90%), Gaps = 2/799 (0%)
Query: 24 SSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPA 83
+SSAQ PGF+SL+CGG NFTD +GL W +D + IYGE ++ISVANETRKQY T+RHFPA
Sbjct: 17 ASSAQ-PGFLSLDCGGPANFTDALGLSWTSDVNFIYGEAASISVANETRKQYTTVRHFPA 75
Query: 84 DSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVR 143
D+RKYCY+LDV +RTRYL+RATFLYG+FDNNNVYPKFDIS+GPTHWSTIVISDA TIE
Sbjct: 76 DTRKYCYRLDVTSRTRYLLRATFLYGDFDNNNVYPKFDISVGPTHWSTIVISDANTIESI 135
Query: 144 ELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADS 203
ELIFLASS I VCLSNATTGQPFISTLELRQFNGSVY T FE++++LSVSARINFGADS
Sbjct: 136 ELIFLASSSSISVCLSNATTGQPFISTLELRQFNGSVYFTAFENQFFLSVSARINFGADS 195
Query: 204 EAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVV 263
PVRYPDDP+DRIWESDS+KKANYLVDVAAGT+KVST +PI++ DE PP+KVMQTAVV
Sbjct: 196 VDPVRYPDDPYDRIWESDSVKKANYLVDVAAGTKKVSTDMPINVNIDERPPEKVMQTAVV 255
Query: 264 GTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENA 323
GTNGSLTYRLNLDGFPGFGWA TYFAEIEDLDP ESRKFRLVLPG PD+SKA+VNI+ENA
Sbjct: 256 GTNGSLTYRLNLDGFPGFGWACTYFAEIEDLDPTESRKFRLVLPGNPDMSKAVVNIEENA 315
Query: 324 QGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSV 383
QGKYR+YEPGYTNLSLPFVLSF+FGKT DSSRGPLLNAMEINKYLE+NDGS+DG I V
Sbjct: 316 QGKYRLYEPGYTNLSLPFVLSFRFGKTSDSSRGPLLNAMEINKYLEKNDGSLDGDVISGV 375
Query: 384 ISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLV 443
I LYS+ADWAQEGGDPC+PVPWSW+QCNS+ +P I + LSSKNL+G++PSDLTKL+ LV
Sbjct: 376 ILLYSTADWAQEGGDPCMPVPWSWVQCNSEARPRIVKLSLSSKNLSGSVPSDLTKLTGLV 435
Query: 444 ELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTV 503
ELWLDGNSLTGPIPDF+GC DL IIHLE+NQLTG LPSSL+NLPNLRELYVQNNMLSGT+
Sbjct: 436 ELWLDGNSLTGPIPDFTGCTDLEIIHLENNQLTGELPSSLLNLPNLRELYVQNNMLSGTI 495
Query: 504 PSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNN 563
PS L + VVLNY+GNINLHEG R +H+ IIIGSSVGAAVLL+ T+VSC+FM KGKK +
Sbjct: 496 PSG-LGRKVVLNYSGNINLHEGARRGRHMGIIIGSSVGAAVLLITTLVSCMFMQKGKKRH 554
Query: 564 YDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK 623
D+EQ R SLPVQR VS+L++AP EAAH FT +IEDATK EKKIGSGGFGVVYYGK+K
Sbjct: 555 PDQEQLRDSLPVQRVVSTLSNAPGEAAHRFTSFEIEDATKKFEKKIGSGGFGVVYYGKMK 614
Query: 624 DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683
DG+EIAVKVLTSNS+QGKREF+NEV+LLSRIHHRNLVQFLG+CQE G+S+LVYEFMHNGT
Sbjct: 615 DGREIAVKVLTSNSFQGKREFSNEVSLLSRIHHRNLVQFLGFCQEVGKSMLVYEFMHNGT 674
Query: 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 743
LKEHLYG L + I+WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK+SNILLDK+MRA
Sbjct: 675 LKEHLYGPLKQGRSISWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKTSNILLDKNMRA 734
Query: 744 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 803
KV+DFGLSK AVDGASHVSSIVRGTVGYLDPEYYISQQLT+KSDVYSFGVILLEL+SGQE
Sbjct: 735 KVADFGLSKLAVDGASHVSSIVRGTVGYLDPEYYISQQLTNKSDVYSFGVILLELMSGQE 794
Query: 804 AISNEKFGANCRNIVQWVK 822
AISNE FG NCRNIVQW K
Sbjct: 795 AISNESFGVNCRNIVQWAK 813
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297741494|emb|CBI32626.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1350 bits (3493), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 648/817 (79%), Positives = 726/817 (88%), Gaps = 3/817 (0%)
Query: 6 RLLLPFSVASVLILLLLDSSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNI 65
RLLL F +VL L+D+++AQMPGFVS +CGG+ENFTD++GL W +DD L+YGEI+ I
Sbjct: 4 RLLLLFLSVTVL---LMDAANAQMPGFVSFDCGGSENFTDDLGLWWTSDDQLMYGEIATI 60
Query: 66 SVANETRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLG 125
SVANETRKQY TLRHFPAD+RKYCY LDVI+RTRYL+RATFLYGNFDNN VYPKFDISLG
Sbjct: 61 SVANETRKQYTTLRHFPADNRKYCYTLDVISRTRYLVRATFLYGNFDNNKVYPKFDISLG 120
Query: 126 PTHWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPF 185
T WSTIVISDA TIE ELIFLAS P I VCLSNATTGQPFISTLELRQFNGS+Y T +
Sbjct: 121 ATPWSTIVISDANTIESSELIFLASDPTISVCLSNATTGQPFISTLELRQFNGSIYYTEY 180
Query: 186 EDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPI 245
E+ ++LSVSAR+NFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVA GTEKVST++PI
Sbjct: 181 EEDFFLSVSARVNFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAPGTEKVSTQMPI 240
Query: 246 DLRSDELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLV 305
D+ D PP+KVMQTAVVG NG+L+YRLNLDGFPGFGWA TY AEIEDL P+E+RKFRL+
Sbjct: 241 DVNKDSRPPEKVMQTAVVGRNGTLSYRLNLDGFPGFGWAFTYLAEIEDLGPEETRKFRLI 300
Query: 306 LPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEIN 365
LP PD+SK VNIQENAQGKYR+YEPGY N+SLPFVLSFKFGKT DSS+GPLLNAMEIN
Sbjct: 301 LPNMPDLSKPAVNIQENAQGKYRLYEPGYPNISLPFVLSFKFGKTSDSSQGPLLNAMEIN 360
Query: 366 KYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSS 425
KYLE+ DG +DG AI S++ YSS DWA+EGGDPCLPVPWSW+ CNSDPQP I IHLS
Sbjct: 361 KYLEKRDGCLDGSAIASIVLQYSSEDWAKEGGDPCLPVPWSWVACNSDPQPRIVSIHLSG 420
Query: 426 KNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMN 485
KNLTGNIP+DLTKLS LVELWLDGN+L GPIPDF+G +L+ IHLE+NQL+G LPSSL++
Sbjct: 421 KNLTGNIPTDLTKLSGLVELWLDGNALAGPIPDFTGLINLKTIHLENNQLSGELPSSLVD 480
Query: 486 LPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVL 545
L +L+ELYVQNNMLSG VPS LL++N+ NY+GN NLH+G G +H+ IIIGSSVGA VL
Sbjct: 481 LQSLKELYVQNNMLSGKVPSGLLNENLDFNYSGNDNLHKGSTGGRHIGIIIGSSVGAVVL 540
Query: 546 LLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKML 605
L+AT+ SCLFMHKGKK Y+++Q H LP QR VSSLNDA EAA+CF+LS+IEDAT+
Sbjct: 541 LIATIASCLFMHKGKKRYYEQDQLGHGLPAQRIVSSLNDAATEAANCFSLSEIEDATRKF 600
Query: 606 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
EKKIGSGGFGVVYYGK+KDGKEIAVKVL +NSYQG REF+NEVTLLSRIHHRNLVQFLGY
Sbjct: 601 EKKIGSGGFGVVYYGKMKDGKEIAVKVLINNSYQGNREFSNEVTLLSRIHHRNLVQFLGY 660
Query: 666 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 725
CQEEGRS+LVYEFMHNGTLKEHLYG LT E+ I+WIKRLEIAEDAAKGIEYLHTGCVP+I
Sbjct: 661 CQEEGRSMLVYEFMHNGTLKEHLYGPLTRERAISWIKRLEIAEDAAKGIEYLHTGCVPSI 720
Query: 726 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 785
IHRDLKSSNILLDK+M+AKVSDFGLSK AVDG+SHVSS+VRGTVGYLDPEYYISQQLTDK
Sbjct: 721 IHRDLKSSNILLDKYMKAKVSDFGLSKLAVDGSSHVSSVVRGTVGYLDPEYYISQQLTDK 780
Query: 786 SDVYSFGVILLELISGQEAISNEKFGANCRNIVQWVK 822
SDVYSFGVILLELISGQEAISNE FG NCRNIVQW K
Sbjct: 781 SDVYSFGVILLELISGQEAISNESFGVNCRNIVQWAK 817
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439769|ref|XP_002275389.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1340 bits (3469), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 640/803 (79%), Positives = 717/803 (89%), Gaps = 2/803 (0%)
Query: 22 LDSSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHF 81
+D+++AQMPGFVS +CGG+ENFTD++GL W +DD L+YGEI+ ISVANETRKQY TLRHF
Sbjct: 18 MDAANAQMPGFVSFDCGGSENFTDDLGLWWTSDDQLMYGEIATISVANETRKQYTTLRHF 77
Query: 82 PADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIE 141
PAD+RKYCY LDVI+RTRYL+RATFLYGNFDNN VYPKFDISLG T WSTIVISDA TIE
Sbjct: 78 PADNRKYCYTLDVISRTRYLVRATFLYGNFDNNKVYPKFDISLGATPWSTIVISDANTIE 137
Query: 142 VRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGA 201
ELIFLAS P I VCLSNATTGQPFISTLELRQFNGS+Y T +E+ ++LSVSAR+NFGA
Sbjct: 138 SSELIFLASDPTISVCLSNATTGQPFISTLELRQFNGSIYYTEYEEDFFLSVSARVNFGA 197
Query: 202 DSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTA 261
DSEAPVRYPDDPFDRIWESDSLKKANYLVDVA GTEKVST++PID+ D PP+KVMQTA
Sbjct: 198 DSEAPVRYPDDPFDRIWESDSLKKANYLVDVAPGTEKVSTQMPIDVNKDSRPPEKVMQTA 257
Query: 262 VVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQE 321
VVG NG+L+YRLNLDGFPGFGWA TY AEIEDL P+E+RKFRL+LP PD+SK VNIQE
Sbjct: 258 VVGRNGTLSYRLNLDGFPGFGWAFTYLAEIEDLGPEETRKFRLILPNMPDLSKPAVNIQE 317
Query: 322 NAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIV 381
NAQGKYR+YEPGY N+SLPFVLSFKFGKT DSS+GPLLNAMEINKYLE+ DG +DG AI
Sbjct: 318 NAQGKYRLYEPGYPNISLPFVLSFKFGKTSDSSQGPLLNAMEINKYLEKRDGCLDGSAIA 377
Query: 382 SVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSS 441
S++ YSS DWA+EGGDPCLPVPWSW+ CNSDPQP I IHLS KNLTGNIP+DLTKLS
Sbjct: 378 SIVLQYSSEDWAKEGGDPCLPVPWSWVACNSDPQPRIVSIHLSGKNLTGNIPTDLTKLSG 437
Query: 442 LVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 501
LVELWLDGN+L GPIPDF+G +L+ IHLE+NQL+G LPSSL++L +L+ELYVQNNMLSG
Sbjct: 438 LVELWLDGNALAGPIPDFTGLINLKTIHLENNQLSGELPSSLVDLQSLKELYVQNNMLSG 497
Query: 502 TVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKK 561
VPS LL++N+ NY+GN NLH+G G +H+ IIIGSSVGA VLL+AT+ SCLFMHKGKK
Sbjct: 498 KVPSGLLNENLDFNYSGNDNLHKGSTGGRHIGIIIGSSVGAVVLLIATIASCLFMHKGKK 557
Query: 562 NNYDKEQHR--HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYY 619
Y++ H+ H LP QR VSSLNDA EAA+CF+LS+IEDAT+ EKKIGSGGFGVVYY
Sbjct: 558 RYYEQGMHQLGHGLPAQRIVSSLNDAATEAANCFSLSEIEDATRKFEKKIGSGGFGVVYY 617
Query: 620 GKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679
GK+KDGKEIAVKVL +NSYQG REF+NEVTLLSRIHHRNLVQFLGYCQEEGRS+LVYEFM
Sbjct: 618 GKMKDGKEIAVKVLINNSYQGNREFSNEVTLLSRIHHRNLVQFLGYCQEEGRSMLVYEFM 677
Query: 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 739
HNGTLKEHLYG LT E+ I+WIKRLEIAEDAAKGIEYLHTGCVP+IIHRDLKSSNILLDK
Sbjct: 678 HNGTLKEHLYGPLTRERAISWIKRLEIAEDAAKGIEYLHTGCVPSIIHRDLKSSNILLDK 737
Query: 740 HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI 799
+M+AKVSDFGLSK AVDG+SHVSS+VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI
Sbjct: 738 YMKAKVSDFGLSKLAVDGSSHVSSVVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI 797
Query: 800 SGQEAISNEKFGANCRNIVQWVK 822
SGQEAISNE FG NCRNIVQW K
Sbjct: 798 SGQEAISNESFGVNCRNIVQWAK 820
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568426|ref|XP_002525187.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223535484|gb|EEF37153.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1336 bits (3457), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 645/798 (80%), Positives = 705/798 (88%), Gaps = 26/798 (3%)
Query: 25 SSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPAD 84
SSAQMPGFVSLNCGG ENFTDE+GL W +DD LIYGE + ISVANETRKQY TLRHFPAD
Sbjct: 19 SSAQMPGFVSLNCGGKENFTDELGLVWTSDDSLIYGEPATISVANETRKQYKTLRHFPAD 78
Query: 85 SRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVRE 144
SRKYCY LDVI+RTRYL+RATFLYGNFDNNNVYPKFDIS+G THWSTIVISDA TIE E
Sbjct: 79 SRKYCYTLDVISRTRYLLRATFLYGNFDNNNVYPKFDISVGATHWSTIVISDANTIESIE 138
Query: 145 LIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSE 204
LIFLASSP I VCLSNATTGQPFISTLELRQFNGSVY T FE+++YLS+SARINFGADSE
Sbjct: 139 LIFLASSPTISVCLSNATTGQPFISTLELRQFNGSVYYTSFENQFYLSISARINFGADSE 198
Query: 205 APVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVG 264
APVRYPDDPFDRIWESDS+KKANYLVDVAAGTEK+ST + ID+ +DE PP+KVMQTAVVG
Sbjct: 199 APVRYPDDPFDRIWESDSVKKANYLVDVAAGTEKISTNMSIDVSNDERPPEKVMQTAVVG 258
Query: 265 TNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQ 324
TNGSLTYRLNLDGFPGFGWAVTYFAEIEDL PDESRKFRL+LPG PD+SK IVNIQENAQ
Sbjct: 259 TNGSLTYRLNLDGFPGFGWAVTYFAEIEDLAPDESRKFRLILPGFPDMSKPIVNIQENAQ 318
Query: 325 GKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVI 384
GKYR+Y+PGY N+SLPFVLSF+FGKT DSSRGPLLNAMEINKYLE+NDGS+DG I SVI
Sbjct: 319 GKYRLYQPGYPNISLPFVLSFRFGKTSDSSRGPLLNAMEINKYLEKNDGSLDGEVIASVI 378
Query: 385 SLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVE 444
SLY+S DWAQEGGDPCLPVPWSWLQCNSD +P I I LSSKNLTGNIPSDL KL L E
Sbjct: 379 SLYTSTDWAQEGGDPCLPVPWSWLQCNSDARPRIIKISLSSKNLTGNIPSDLPKLKGLAE 438
Query: 445 LWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 504
L E+NQLTG LPSSLMNLP+LRELYVQNN+LSGTVP
Sbjct: 439 FHL-----------------------ENNQLTGGLPSSLMNLPHLRELYVQNNLLSGTVP 475
Query: 505 SSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNY 564
S LL KN+ LNY+GN+++HEGGR KH IIIGSSVGAAVLL+AT+ SC F+ +GKK+N+
Sbjct: 476 SGLLDKNLFLNYSGNLHVHEGGRREKHTGIIIGSSVGAAVLLIATIASCFFIRRGKKSNH 535
Query: 565 DKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD 624
D E HR PVQR VS+LND PAE A+CFT S+IEDAT+ LEKKIGSGGFG+VYYGKLK+
Sbjct: 536 DYEHHRVPPPVQRLVSTLNDNPAEGAYCFTFSEIEDATRKLEKKIGSGGFGIVYYGKLKN 595
Query: 625 GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684
GKEIAVKVLT+NS+QGKREF+NEVTLLSRIHHRNLVQFLG+CQE+GRS+LVYE+MHNGTL
Sbjct: 596 GKEIAVKVLTNNSFQGKREFSNEVTLLSRIHHRNLVQFLGFCQEDGRSMLVYEYMHNGTL 655
Query: 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 744
KEHLYG + + INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK+SNILLDKHMRAK
Sbjct: 656 KEHLYG--SRGRSINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKTSNILLDKHMRAK 713
Query: 745 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 804
VSDFGLSK A+DGASHVSS+VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLEL+SG+EA
Sbjct: 714 VSDFGLSKLALDGASHVSSVVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELMSGKEA 773
Query: 805 ISNEKFGANCRNIVQWVK 822
ISNE FG NCRNIVQW K
Sbjct: 774 ISNE-FGTNCRNIVQWAK 790
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357510569|ref|XP_003625573.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] gi|355500588|gb|AES81791.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1325 bits (3429), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 628/794 (79%), Positives = 703/794 (88%)
Query: 29 MPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPADSRKY 88
M GFVSL+CGG+E+FTD+IGL W D+ L YGEIS ISV NETRKQY TLRHFPADSRKY
Sbjct: 30 MQGFVSLDCGGSESFTDDIGLDWTPDNKLTYGEISTISVVNETRKQYTTLRHFPADSRKY 89
Query: 89 CYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVRELIFL 148
CY LDVI+RTRYL+RA+FLYGNFDNNNVYPKFDIS+G THWSTIVISDA IE+RELIFL
Sbjct: 90 CYTLDVISRTRYLLRASFLYGNFDNNNVYPKFDISVGATHWSTIVISDANIIEMRELIFL 149
Query: 149 ASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSEAPVR 208
ASS + VCLSNATTGQPFISTLELRQFNGS+Y T FE ++YLSVSARINFGA+++AP+R
Sbjct: 150 ASSSTVSVCLSNATTGQPFISTLELRQFNGSIYYTQFEQQFYLSVSARINFGAETDAPIR 209
Query: 209 YPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGS 268
YPDDPFDRIWESDS+KKANYLVDVA GTEKVST +PI + D++PP KVMQTAVVGTNGS
Sbjct: 210 YPDDPFDRIWESDSVKKANYLVDVAVGTEKVSTNVPILVNRDDVPPVKVMQTAVVGTNGS 269
Query: 269 LTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYR 328
LTYRLNLDGFPG WAVTYFAEIEDL P+ESRKFRLVLPGQP++SKAIVNI+ENA GKYR
Sbjct: 270 LTYRLNLDGFPGNAWAVTYFAEIEDLSPNESRKFRLVLPGQPEISKAIVNIEENAFGKYR 329
Query: 329 VYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYS 388
+YEPG+TNLSLPFVLSFKF KT DSS+GPL+NAMEINKYLE+NDGS D AI V+S YS
Sbjct: 330 LYEPGFTNLSLPFVLSFKFAKTPDSSKGPLVNAMEINKYLEKNDGSPDVEAISGVLSHYS 389
Query: 389 SADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLD 448
SA+W QEGGDPCLPVPWSW++C+SDPQP I I LS KNLTGNIPSD+TKL LVELWLD
Sbjct: 390 SANWTQEGGDPCLPVPWSWIRCSSDPQPRIISILLSGKNLTGNIPSDITKLVGLVELWLD 449
Query: 449 GNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL 508
GN LTGPIPDF+GC DL+IIHLE+NQ G LP+SL NLP+LRELYVQNNMLSG VP LL
Sbjct: 450 GNMLTGPIPDFTGCMDLKIIHLENNQFNGVLPASLANLPSLRELYVQNNMLSGEVPPHLL 509
Query: 509 SKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQ 568
SK+++LNY+GN NLH+ R H+ IIIGS+VGA+VLLLATV+SCL +HKGK+ Y+K+
Sbjct: 510 SKDLILNYSGNTNLHKQSRIKSHMYIIIGSAVGASVLLLATVISCLVIHKGKRRYYEKDH 569
Query: 569 HRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI 628
++P QRP S +D PAEAAHCF+L++IE AT EK+IGSGGFG+VYYGKLK+GKEI
Sbjct: 570 IVSAVPTQRPDSWKSDDPAEAAHCFSLAEIETATNNFEKRIGSGGFGIVYYGKLKEGKEI 629
Query: 629 AVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL 688
AVKVL +NSYQGKREF+NEVTLLSRIHHRNLVQ +GYC+EE S+LVYEFMHNGTLKEHL
Sbjct: 630 AVKVLRNNSYQGKREFSNEVTLLSRIHHRNLVQLIGYCREEENSILVYEFMHNGTLKEHL 689
Query: 689 YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 748
YGTL H + INWIKRLEIAEDAAKGIEYLHTGCVP +IHRDLK+SNILLD+ MRAKVSDF
Sbjct: 690 YGTLEHGRSINWIKRLEIAEDAAKGIEYLHTGCVPVVIHRDLKTSNILLDRQMRAKVSDF 749
Query: 749 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808
GLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE
Sbjct: 750 GLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 809
Query: 809 KFGANCRNIVQWVK 822
FG +CRNIVQW K
Sbjct: 810 SFGLHCRNIVQWAK 823
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545961|ref|XP_003541401.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1281 bits (3315), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 623/796 (78%), Positives = 682/796 (85%), Gaps = 25/796 (3%)
Query: 27 AQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPADSR 86
AQMPGFVSL+CGG ENFTDEIGL W D L YGEISNISVANETRKQY LRHFPADSR
Sbjct: 28 AQMPGFVSLDCGGKENFTDEIGLNWTPDK-LRYGEISNISVANETRKQYTALRHFPADSR 86
Query: 87 KYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVRELI 146
KYCY LDV++RTRYL+RA+FLYGNFD NNVYPKFDI +G THWSTIVISDA TIE+RELI
Sbjct: 87 KYCYTLDVVSRTRYLLRASFLYGNFDANNVYPKFDIFIGATHWSTIVISDANTIEMRELI 146
Query: 147 FLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSEAP 206
FLA SP + VCLSNATTG+PFISTLELRQFNGSVY T E+ +YLSVSARINFGADS+AP
Sbjct: 147 FLALSPTVSVCLSNATTGKPFISTLELRQFNGSVYYTYTEEHFYLSVSARINFGADSDAP 206
Query: 207 VRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTN 266
+RYPDDPFDRIWESDS+KKANYLVDVAAGT K+ST ID+ SDE+PP KVMQTAVVGTN
Sbjct: 207 IRYPDDPFDRIWESDSVKKANYLVDVAAGTRKISTNKSIDVNSDEMPPMKVMQTAVVGTN 266
Query: 267 GSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGK 326
GSLTYRLNLDGFPGF WA TYFAEIEDL +ESRKFRLVLPG D+SKA+VNI+ENA GK
Sbjct: 267 GSLTYRLNLDGFPGFAWAFTYFAEIEDLAENESRKFRLVLPGHSDISKAVVNIEENAPGK 326
Query: 327 YRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISL 386
YR+YEPGYTNLSLPFVLSF+FGKT DSSRGPLLNAMEIN+YLE+NDGS DG I SV+S
Sbjct: 327 YRLYEPGYTNLSLPFVLSFRFGKTSDSSRGPLLNAMEINEYLEKNDGSPDGEVISSVLSH 386
Query: 387 YSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELW 446
Y SADWAQEGGDPCLPVPWSW++C+SD QP I I LSSKNLTGNIP D+TKL+ LVEL
Sbjct: 387 YFSADWAQEGGDPCLPVPWSWVRCSSDQQPKIISILLSSKNLTGNIPLDITKLTGLVEL- 445
Query: 447 LDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS 506
HLE+NQLTG L +SL NLPNLRELYVQNNMLSGTVPS
Sbjct: 446 ----------------------HLENNQLTGALSTSLANLPNLRELYVQNNMLSGTVPSD 483
Query: 507 LLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDK 566
LLSK++ LNY GN NLH+G R HL +IIGS+VGAAVLL+AT++SCL M KGK Y++
Sbjct: 484 LLSKDLDLNYTGNTNLHKGSRKKSHLYVIIGSAVGAAVLLVATIISCLVMRKGKTKYYEQ 543
Query: 567 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGK 626
S P Q SS + P+E AHCF+ S+IE++T EKKIGSGGFGVVYYGKLKDGK
Sbjct: 544 NS-LVSHPSQSMDSSKSIGPSEVAHCFSFSEIENSTNNFEKKIGSGGFGVVYYGKLKDGK 602
Query: 627 EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 686
EIAVKVLTSNSYQGKREF+NEVTLLSRIHHRNLVQ LGYC+EEG S+L+YEFMHNGTLKE
Sbjct: 603 EIAVKVLTSNSYQGKREFSNEVTLLSRIHHRNLVQLLGYCREEGNSMLIYEFMHNGTLKE 662
Query: 687 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746
HLYG LTH + INW+KRLEIAED+AKGIEYLHTGCVPA+IHRDLKSSNILLDKHMRAKVS
Sbjct: 663 HLYGPLTHGRSINWMKRLEIAEDSAKGIEYLHTGCVPAVIHRDLKSSNILLDKHMRAKVS 722
Query: 747 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 806
DFGLSK AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSD+YSFGVILLELISGQEAIS
Sbjct: 723 DFGLSKLAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDIYSFGVILLELISGQEAIS 782
Query: 807 NEKFGANCRNIVQWVK 822
N+ FGANCRNIVQW K
Sbjct: 783 NDSFGANCRNIVQWAK 798
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|79568805|ref|NP_181242.3| putative receptor protein kinase [Arabidopsis thaliana] gi|330254248|gb|AEC09342.1| putative receptor protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1278 bits (3307), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 606/804 (75%), Positives = 692/804 (86%), Gaps = 6/804 (0%)
Query: 24 SSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPA 83
SSSAQ PGFVSL+CGG E FTDE+GL+W D+HLIYGE +NIS NETR QY TLRHFPA
Sbjct: 20 SSSAQAPGFVSLDCGGAEPFTDELGLKWSPDNHLIYGETANISSVNETRTQYTTLRHFPA 79
Query: 84 DSRKYCYKLDVITRTRYLIRATFLYGNFDN-NNVYPKFDISLGPTHWSTIVISDAATIEV 142
DSRKYCY L+V +R RYLIRATFLYGNFDN NNVYPKFDISLG THW+TIVIS+ IE
Sbjct: 80 DSRKYCYTLNVTSRNRYLIRATFLYGNFDNSNNVYPKFDISLGATHWATIVISETYIIET 139
Query: 143 RELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPF-EDRYYLSVSARINFGA 201
EL+FLASSP + VCLSNATTGQPFISTLELRQ +GS+Y + EDR+YLSV+ARINFGA
Sbjct: 140 AELVFLASSPTVSVCLSNATTGQPFISTLELRQLSGSMYGSMLSEDRFYLSVAARINFGA 199
Query: 202 DSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTA 261
+SEA VRYPDDP+DRIWESD KK NYLVDVAAGT +VST LPI+ R D+ PPQKVMQTA
Sbjct: 200 ESEASVRYPDDPYDRIWESDLQKKPNYLVDVAAGTVRVSTTLPIESRVDDRPPQKVMQTA 259
Query: 262 VVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQE 321
VVGTNGSLTYR+NLDGFPGFGWA TYFAEIEDL DESRKFRLVLP QP+ SK++VNI+E
Sbjct: 260 VVGTNGSLTYRMNLDGFPGFGWAFTYFAEIEDLAEDESRKFRLVLPEQPEYSKSVVNIKE 319
Query: 322 NAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIV 381
N Q YRVY PGY N++LPFVL+F+F KT DSSRGP+LNAMEI+KYL ++DGS+D +
Sbjct: 320 NTQRPYRVYAPGYPNITLPFVLNFRFAKTADSSRGPILNAMEISKYLRKSDGSVDATVMA 379
Query: 382 SVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSS 441
+V SLYSS +WAQEGGDPC P PWSW+QCNSDPQP + I LSS NLTGNIPSDL KL+
Sbjct: 380 NVASLYSSTEWAQEGGDPCSPSPWSWVQCNSDPQPRVVAIKLSSMNLTGNIPSDLVKLTG 439
Query: 442 LVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 501
LVELWLDGNS TGPIPDFS CP+L IIHLE+N+LTG +PSSL LPNL+ELY+QNN+L+G
Sbjct: 440 LVELWLDGNSFTGPIPDFSRCPNLEIIHLENNRLTGKIPSSLTKLPNLKELYLQNNVLTG 499
Query: 502 TVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKK 561
T+PS L+K+V+ N++GN+NL + G K L +IIG+SVGA VLL+AT++SC+ M K KK
Sbjct: 500 TIPSD-LAKDVISNFSGNLNLEKSGDKGKKLGVIIGASVGAFVLLIATIISCIVMCKSKK 558
Query: 562 NN---YDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY 618
NN E LP+QR S+L++A +AAHCFTL +IE+ATK EK+IGSGGFG+VY
Sbjct: 559 NNKLGKTSELTNRPLPIQRVSSTLSEAHGDAAHCFTLYEIEEATKKFEKRIGSGGFGIVY 618
Query: 619 YGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678
YGK ++GKEIAVKVL +NSYQGKREF NEVTLLSRIHHRNLVQFLGYCQEEG+++LVYEF
Sbjct: 619 YGKTREGKEIAVKVLANNSYQGKREFANEVTLLSRIHHRNLVQFLGYCQEEGKNMLVYEF 678
Query: 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738
MHNGTLKEHLYG + ++RI+WIKRLEIAEDAA+GIEYLHTGCVPAIIHRDLK+SNILLD
Sbjct: 679 MHNGTLKEHLYGVVPRDRRISWIKRLEIAEDAARGIEYLHTGCVPAIIHRDLKTSNILLD 738
Query: 739 KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLEL 798
KHMRAKVSDFGLSKFAVDG SHVSSIVRGTVGYLDPEYYISQQLT+KSDVYSFGVILLEL
Sbjct: 739 KHMRAKVSDFGLSKFAVDGTSHVSSIVRGTVGYLDPEYYISQQLTEKSDVYSFGVILLEL 798
Query: 799 ISGQEAISNEKFGANCRNIVQWVK 822
+SGQEAISNE FG NCRNIVQW K
Sbjct: 799 MSGQEAISNESFGVNCRNIVQWAK 822
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 824 | ||||||
| TAIR|locus:2057991 | 934 | AT2G37050 [Arabidopsis thalian | 0.963 | 0.850 | 0.727 | 0.0 | |
| TAIR|locus:2008565 | 929 | AT1G67720 [Arabidopsis thalian | 0.959 | 0.851 | 0.491 | 2.6e-205 | |
| TAIR|locus:2055165 | 868 | AT2G14510 [Arabidopsis thalian | 0.449 | 0.426 | 0.389 | 4.2e-115 | |
| TAIR|locus:2126540 | 876 | AT4G29990 [Arabidopsis thalian | 0.438 | 0.412 | 0.386 | 9.9e-114 | |
| TAIR|locus:2066158 | 884 | AT2G28990 [Arabidopsis thalian | 0.657 | 0.613 | 0.357 | 2.6e-113 | |
| TAIR|locus:2066133 | 880 | AT2G28960 [Arabidopsis thalian | 0.447 | 0.419 | 0.389 | 1.5e-110 | |
| TAIR|locus:2066163 | 872 | AT2G29000 [Arabidopsis thalian | 0.446 | 0.422 | 0.394 | 2.4e-110 | |
| TAIR|locus:2047675 | 881 | AT2G19210 [Arabidopsis thalian | 0.428 | 0.400 | 0.372 | 5.3e-110 | |
| TAIR|locus:2059093 | 876 | FRK1 "FLG22-induced receptor-l | 0.440 | 0.414 | 0.396 | 6.3e-110 | |
| TAIR|locus:2017572 | 882 | AT1G51790 [Arabidopsis thalian | 0.444 | 0.414 | 0.369 | 1.2e-109 |
| TAIR|locus:2057991 AT2G37050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3083 (1090.3 bits), Expect = 0., P = 0.
Identities = 583/801 (72%), Positives = 664/801 (82%)
Query: 28 QMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPADSRK 87
Q PGFVSL+CGG E FTDE+GL+W D+HLIYGE +NIS NETR QY TLRHFPADSRK
Sbjct: 24 QAPGFVSLDCGGAEPFTDELGLKWSPDNHLIYGETANISSVNETRTQYTTLRHFPADSRK 83
Query: 88 YCYKLDVITRTRYLIRATFLYGNFDN-NNVYPKFDISLGPTHWSTIVISDAATIEVRELI 146
YCY L+V +R RYLIRATFLYGNFDN NNVYPKFDISLG THW+TIVIS+ IE EL+
Sbjct: 84 YCYTLNVTSRNRYLIRATFLYGNFDNSNNVYPKFDISLGATHWATIVISETYIIETAELV 143
Query: 147 FLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPF-EDRYYLSVSARINFGADSEA 205
FLASSP + VCLSNATTGQPFISTLELRQ +GS+Y + EDR+YLSV+ARINFGA+SEA
Sbjct: 144 FLASSPTVSVCLSNATTGQPFISTLELRQLSGSMYGSMLSEDRFYLSVAARINFGAESEA 203
Query: 206 PVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGT 265
VRYPDDP+DRIWESD KK NYLVDVAAGT +VST LPI+ R D+ PPQKVMQTAVVGT
Sbjct: 204 SVRYPDDPYDRIWESDLQKKPNYLVDVAAGTVRVSTTLPIESRVDDRPPQKVMQTAVVGT 263
Query: 266 NGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQG 325
NGSLTYR+NLDGFPGFGWA TYFAEIEDL DESRKFRLVLP QP+ SK++VNI+EN Q
Sbjct: 264 NGSLTYRMNLDGFPGFGWAFTYFAEIEDLAEDESRKFRLVLPEQPEYSKSVVNIKENTQR 323
Query: 326 KYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVIS 385
YRVY PGY N++LPFVL+F+F KT DSSRGP+LNAMEI+KYL ++DGS+D + +V S
Sbjct: 324 PYRVYAPGYPNITLPFVLNFRFAKTADSSRGPILNAMEISKYLRKSDGSVDATVMANVAS 383
Query: 386 LYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEL 445
LYSS +WAQEGGDPC P PWSW+QCNSDPQP + I LSS NLTGNIPSDL KL+ LVEL
Sbjct: 384 LYSSTEWAQEGGDPCSPSPWSWVQCNSDPQPRVVAIKLSSMNLTGNIPSDLVKLTGLVEL 443
Query: 446 WLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLSGTVPS 505
WLDGNS TGPIPDFS CP+L IIHLE+N+LTG +ELY+QNN+L+GT+PS
Sbjct: 444 WLDGNSFTGPIPDFSRCPNLEIIHLENNRLTGKIPSSLTKLPNLKELYLQNNVLTGTIPS 503
Query: 506 SLLSKNVVLNYAGNINLHEGGRGAKHLNIIIXXXXXXXXXXXXXXXXCLFMHKGKKNNY- 564
L +K+V+ N++GN+NL + G K L +II C+ M K KKNN
Sbjct: 504 DL-AKDVISNFSGNLNLEKSGDKGKKLGVIIGASVGAFVLLIATIISCIVMCKSKKNNKL 562
Query: 565 ---DKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK 621
E LP+QR S+L++A +AAHCFTL +IE+ATK EK+IGSGGFG+VYYGK
Sbjct: 563 GKTSAELTNRPLPIQRVSSTLSEAHGDAAHCFTLYEIEEATKKFEKRIGSGGFGIVYYGK 622
Query: 622 LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681
++GKEIAVKVL +NSYQGKREF NEVTLLSRIHHRNLVQFLGYCQEEG+++LVYEFMHN
Sbjct: 623 TREGKEIAVKVLANNSYQGKREFANEVTLLSRIHHRNLVQFLGYCQEEGKNMLVYEFMHN 682
Query: 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 741
GTLKEHLYG + ++RI+WIKRLEIAEDAA+GIEYLHTGCVPAIIHRDLK+SNILLDKHM
Sbjct: 683 GTLKEHLYGVVPRDRRISWIKRLEIAEDAARGIEYLHTGCVPAIIHRDLKTSNILLDKHM 742
Query: 742 RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
RAKVSDFGLSKFAVDG SHVSSIVRGTVGYLDPEYYISQQLT+KSDVYSFGVILLEL+SG
Sbjct: 743 RAKVSDFGLSKFAVDGTSHVSSIVRGTVGYLDPEYYISQQLTEKSDVYSFGVILLELMSG 802
Query: 802 QEAISNEKFGANCRNIVQWVK 822
QEAISNE FG NCRNIVQW K
Sbjct: 803 QEAISNESFGVNCRNIVQWAK 823
|
|
| TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1986 (704.2 bits), Expect = 2.6e-205, P = 2.6e-205
Identities = 397/808 (49%), Positives = 527/808 (65%)
Query: 28 QMPGFVSLNCGGNENFTD-EIGLQWIADDHLI-YGEISNISVANETRKQYMTLRHFPADS 85
Q+ FVS++CG + N+TD GL W++D +I G+ ++ N QY R FP D+
Sbjct: 22 QVTEFVSIDCGCSSNYTDPRTGLGWVSDSEIIKQGKPVTLANTNWNSMQYRRRRDFPTDN 81
Query: 86 RKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVREL 145
+KYCY+L R RY++R TFLYG + YPKF + L T W+T+ I + + + V EL
Sbjct: 82 KKYCYRLSTKERRRYIVRTTFLYGGLGSEEAYPKFQLYLDATKWATVTIQEVSRVYVEEL 141
Query: 146 IFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSEA 205
I A+S +DVC+ A TG PF+STLELR N S+Y T +ED ++L V+AR+NFGA +
Sbjct: 142 IVRATSSYVDVCVCCAITGSPFMSTLELRPLNLSMYATDYEDNFFLKVAARVNFGAPNMD 201
Query: 206 PVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGT 265
+RYPDDP+DRIWESD K+ NYLV VA GT +++T I+ + E PP KVMQTAVVGT
Sbjct: 202 ALRYPDDPYDRIWESDINKRPNYLVGVAPGTTRINTSKTINTLTREYPPMKVMQTAVVGT 261
Query: 266 NGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQG 325
G ++YRLNL+ FP A YFAEIE+L +E+RKF+LV P PD S A+VNI ENA G
Sbjct: 262 QGLISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYFPDYSNAVVNIAENANG 321
Query: 326 KYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLE---RNDGSIDGVAIVS 382
Y +YEP Y N++L FVL+F FGKT DS++GPLLNA+EI+KYL + D S V+++
Sbjct: 322 SYTLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLPISVKTDRS--DVSVLD 379
Query: 383 VI-SLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSS 441
I S+ +DWA EGGDPC+PV WSW+ C+S P +T I LS KNL G IP + + +
Sbjct: 380 AIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKNLRGEIPPGINYMEA 439
Query: 442 LVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLSG 501
L ELWLD N LTG +PD S +L+I+HLE+NQL+G +EL ++NN G
Sbjct: 440 LTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLPNLQELSIENNSFKG 499
Query: 502 TVPSSLLSKNVVLNYAGNINLHEGGRGAKH----LNIIIXXXXXXXXXXXXXXXXCLFMH 557
+PS+LL V+ Y N L + KH L I I +
Sbjct: 500 KIPSALLKGKVLFKYNNNPELQNEAQ-RKHFWQILGISIAAVAILLLLVGGSLVLLCALR 558
Query: 558 KGKK-NNYDK-EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFG 615
K K+ + D E + L V + A+ +L +E+AT KK+G G FG
Sbjct: 559 KTKRADKGDSTETKKKGLVAYSAVRGGHLLDEGVAYFISLPVLEEATDNFSKKVGRGSFG 618
Query: 616 VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675
VYYG++KDGKE+AVK+ S R+F EV LLSRIHHRNLV +GYC+E R +LV
Sbjct: 619 SVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLVPLIGYCEEADRRILV 678
Query: 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 735
YE+MHNG+L +HL+G+ ++ ++W+ RL+IA+DAAKG+EYLHTGC P+IIHRD+KSSNI
Sbjct: 679 YEYMHNGSLGDHLHGSSDYKP-LDWLTRLQIAQDAAKGLEYLHTGCNPSIIHRDVKSSNI 737
Query: 736 LLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVIL 795
LLD +MRAKVSDFGLS+ + +HVSS+ +GTVGYLDPEYY SQQLT+KSDVYSFGV+L
Sbjct: 738 LLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYASQQLTEKSDVYSFGVVL 797
Query: 796 LELISGQEAISNEKFGANCRNIVQWVKS 823
EL+SG++ +S E FG NIV W +S
Sbjct: 798 FELLSGKKPVSAEDFGPEL-NIVHWARS 824
|
|
| TAIR|locus:2055165 AT2G14510 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 634 (228.2 bits), Expect = 4.2e-115, Sum P(2) = 4.2e-115
Identities = 153/393 (38%), Positives = 217/393 (55%)
Query: 435 DLTKLSSLVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELY 493
D++ ++ L L + LTG I P LR + L +N LTG ++
Sbjct: 406 DISTPPRIISLDLSLSGLTGVISPSIQNLTMLRELDLSNNNLTGEVPEFLATIKPLLVIH 465
Query: 494 VQNNMLSGTVPSSLLS--KNVVLNYAGNINLHEGGRGAKHLNIIIXXXXXXXXXXXXXXX 551
++ N L G+VP +L KN L + N+ G+ ++
Sbjct: 466 LRGNNLRGSVPQALQDREKNDGLKLFVDPNITRRGKHQPKSWLVAIVASISCVAVTIIVL 525
Query: 552 XCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGS 611
+F+ + +K++ K V RP + + F S++++ T E +G
Sbjct: 526 VLIFIFRRRKSSTRK--------VIRPSLEMKNRR------FKYSEVKEMTNNFEVVLGK 571
Query: 612 GGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 671
GGFGVVY+G L + +++AVKVL+ +S QG +EF EV LL R+HH NLV +GYC E
Sbjct: 572 GGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLLRVHHVNLVSLVGYCDEGID 630
Query: 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 731
L+YEFM NG LKEHL G +NW RL+IA ++A GIEYLH GC P ++HRD+K
Sbjct: 631 LALIYEFMENGNLKEHLSGKRGGSV-LNWSSRLKIAIESALGIEYLHIGCQPPMVHRDVK 689
Query: 732 SSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYS 790
S+NILL AK++DFGLS+ F V +HVS+ V GT+GYLDPEYY+ LT+KSDVYS
Sbjct: 690 STNILLGLRFEAKLADFGLSRSFLVGSQAHVSTNVAGTLGYLDPEYYLKNWLTEKSDVYS 749
Query: 791 FGVILLELISGQEAISNEKFGANCRNIVQWVKS 823
FG++LLE I+GQ I + + IV+W KS
Sbjct: 750 FGIVLLESITGQPVIEQSR---DKSYIVEWAKS 779
|
|
| TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 671 (241.3 bits), Expect = 9.9e-114, Sum P(2) = 9.9e-114
Identities = 148/383 (38%), Positives = 225/383 (58%)
Query: 434 SDLTKLSSLVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXREL 492
SD + L L + LTG I P F+ + + L +N LTG EL
Sbjct: 403 SDNNTSPKSIALNLSSSGLTGQIDPAFANLTSINKLDLSNNSLTGKVPDFLASLPNLTEL 462
Query: 493 YVQNNMLSGTVPSSLLSKN----VVLNYAGNINLHEGGR----GAKHLNIIIXXXXXXXX 544
++ N L+G++P+ LL K+ + L + GN +L + K + I+
Sbjct: 463 NLEGNKLTGSIPAKLLEKSKDGSLSLRFGGNPDLCQSPSCQTTTKKKIGYIVPVVASLAG 522
Query: 545 XXXXXXXXCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAA-HCFTLSDIEDATK 603
L H + K R ++ +P+ +N P + A F S++ + T
Sbjct: 523 LLIVLTALALIWH------FKKRSRRGTIS-NKPLG-VNTGPLDTAKRYFIYSEVVNITN 574
Query: 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
E+ +G GGFG VY+G L +G ++AVK+L+ S QG +EF EV LL R+HH NL +
Sbjct: 575 NFERVLGKGGFGKVYHGFL-NGDQVAVKILSEESTQGYKEFRAEVELLMRVHHTNLTSLI 633
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
GYC E+ L+YE+M NG L ++L G + ++W +RL+I+ DAA+G+EYLH GC P
Sbjct: 634 GYCNEDNHMALIYEYMANGNLGDYLSGKSS--LILSWEERLQISLDAAQGLEYLHYGCKP 691
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
I+HRD+K +NILL+++++AK++DFGLS+ F V+G+S VS++V GT+GYLDPEYY ++Q+
Sbjct: 692 PIVHRDVKPANILLNENLQAKIADFGLSRSFPVEGSSQVSTVVAGTIGYLDPEYYATRQM 751
Query: 783 TDKSDVYSFGVILLELISGQEAI 805
+KSDVYSFGV+LLE+I+G+ AI
Sbjct: 752 NEKSDVYSFGVVLLEVITGKPAI 774
|
|
| TAIR|locus:2066158 AT2G28990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 787 (282.1 bits), Expect = 2.6e-113, Sum P(2) = 2.6e-113
Identities = 218/610 (35%), Positives = 325/610 (53%)
Query: 239 VSTKLPIDLRSDELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTY--FAEIEDLDP 296
++T L I+ + P+ ++QTA + N S + D P Y FAEI+ L+
Sbjct: 224 ITTDLNINNSNAYEIPKNILQTAAIPRNASAPLIITWDPLPINAEVYLYMHFAEIQTLEA 283
Query: 297 DESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVY--EP---GYTNLSLPFVLSFKFGKTY 351
+E+R+F ++L G + S + +Y EP G L V KT
Sbjct: 284 NETRQFDVILRGNFNHS----GFSPTKLKVFTLYTEEPMKCGSEGCYLQLV------KTP 333
Query: 352 DSSRGPLLNAMEINKYLERN--DGSIDGV-AIVSVISLY--SSADWAQEGGDPCLPVPWS 406
+S+ PL+NA+E +E + + S+ V AI ++ + Y + W GDPCLP S
Sbjct: 334 NSTLPPLINAIEAYSVIEFSQLETSLSDVDAIKNIKNTYKLNKITWQ---GDPCLPQDLS 390
Query: 407 W--LQC---NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG 461
W ++C + P+I + LS L G+IP L + L EL L NSLTGP+P F
Sbjct: 391 WESIRCTYVDGSTSPTIISLDLSKSGLNGSIPQILQNFTQLQELDLSNNSLTGPVPIFLA 450
Query: 462 CPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLSGTVPSSLLSKN---VVLNYAG 518
+++ + L + L+G NN LSG+VP +LL K +VL G
Sbjct: 451 --NMKTLSLIN--LSG------------------NN-LSGSVPQALLDKEKEGLVLKLEG 487
Query: 519 NINLHEGG--RGAKHLNIIIXXXXXXXXXXXXXXXXCLFMHKGKKNNYDKEQHRH-SLPV 575
N +L + K ++ LF KK H S+PV
Sbjct: 488 NPDLCKSSFCNTEKKNKFLLPVIASAASLVIVVVVVALFFVFRKKKASPSNLHAPPSMPV 547
Query: 576 QRPV-SSLNDAPAEAAHC-FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL 633
P +S +++ + FT S++++ T +K +G GGFGVVY+G + +++AVK+L
Sbjct: 548 SNPGHNSQSESSFTSKKIRFTYSEVQEMTNNFDKALGEGGFGVVYHGFVNVIEQVAVKLL 607
Query: 634 TSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLT 693
+ +S QG + F EV LL R+HH NLV +GYC E L+YE+M NG LK+HL G
Sbjct: 608 SQSSSQGYKHFKAEVELLMRVHHINLVSLVGYCDEGEHLALIYEYMPNGDLKQHLSGK-- 665
Query: 694 HEQRI-NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
H + +W RL+I DAA G+EYLHTGCVP ++HRD+K++NILLD+H++AK++DFGLS+
Sbjct: 666 HGGFVLSWESRLKIVLDAALGLEYLHTGCVPPMVHRDIKTTNILLDQHLQAKLADFGLSR 725
Query: 753 -FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 811
F + +VS++V GT GYLDPEYY + LT+KSD+YSFG++LLE+IS + I +
Sbjct: 726 SFPIGNEKNVSTVVAGTPGYLDPEYYQTNWLTEKSDIYSFGIVLLEIISNRPIIQQSR-- 783
Query: 812 ANCRNIVQWV 821
+IV+WV
Sbjct: 784 -EKPHIVEWV 792
|
|
| TAIR|locus:2066133 AT2G28960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 627 (225.8 bits), Expect = 1.5e-110, Sum P(2) = 1.5e-110
Identities = 152/390 (38%), Positives = 209/390 (53%)
Query: 442 LVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLS 500
++ L L L G I P F +LR + L +N TG + + N L+
Sbjct: 410 IISLDLSSRGLKGVIAPAFQNLTELRKLDLSNNSFTGGVPEFLASMKSLSIINLNWNDLT 469
Query: 501 GTVPSSLLS--KN-VVLNYAGNINLHEGGRGAKHLN---II-IXXXXXXXXXXXXXXXXC 553
G +P LL KN + L GN L + N I+ +
Sbjct: 470 GPLPKLLLDREKNGLKLTIQGNPKLCNDASCKNNNNQTYIVPVVASVASVLIIIAVLILI 529
Query: 554 LFMHKGKKNNYDK-EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSG 612
L K + D +H LP RP S FT S++E T E+ +G G
Sbjct: 530 LVFKKRRPTQVDSLPTVQHGLP-NRP-SIFTQTKR-----FTYSEVEALTDNFERVLGEG 582
Query: 613 GFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672
GFGVVY+G L + IAVK+L+ +S QG +EF EV LL R+HH NLV +GYC EE
Sbjct: 583 GFGVVYHGILNGTQPIAVKLLSQSSVQGYKEFKAEVELLLRVHHVNLVSLVGYCDEESNL 642
Query: 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKS 732
L+YE+ NG LK+HL G + W RL+I + A+G+EYLHTGC P ++HRD+K+
Sbjct: 643 ALLYEYAPNGDLKQHLSGERGGSP-LKWSSRLKIVVETAQGLEYLHTGCKPPMVHRDVKT 701
Query: 733 SNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSF 791
+NILLD+H +AK++DFGLS+ F V G +HVS+ V GT GYLDPEYY + +L +KSDVYSF
Sbjct: 702 TNILLDEHFQAKLADFGLSRSFPVGGETHVSTAVAGTPGYLDPEYYRTNRLNEKSDVYSF 761
Query: 792 GVILLELISGQEAISNEKFGANCRNIVQWV 821
G++LLE+I+ + I + +I WV
Sbjct: 762 GIVLLEIITSRPVIQQTR---EKPHIAAWV 788
|
|
| TAIR|locus:2066163 AT2G29000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 652 (234.6 bits), Expect = 2.4e-110, Sum P(2) = 2.4e-110
Identities = 152/385 (39%), Positives = 209/385 (54%)
Query: 442 LVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLS 500
++ L L L G I P L + L N+L+G + + N L
Sbjct: 408 IISLDLSNRGLKGIIEPVLQNLTQLEKLDLSINRLSGEVPEFLANMKSLSNINLSWNNLK 467
Query: 501 GTVPSSLLSKN---VVLNYAGNINLHEGGRGAKHLNIIIXXXXXXXXXXXXXXXXCLFMH 557
G +P +L K + LN GN NL G + + L +
Sbjct: 468 GLIPPALEEKRKNGLKLNTQGNQNLCPGDECKRSIPKFPVTTVVSISAILLTVVVLLIVF 527
Query: 558 KGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVV 617
KK K +HR LP+ + S + FT S++E T E+ IG GGFG+V
Sbjct: 528 IYKKKKTSKVRHR--LPITK--SEILTKKRR----FTYSEVEAVTNKFERVIGEGGFGIV 579
Query: 618 YYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677
Y+G L D +++AVK+L+ +S QG ++F EV LL R+HH NLV +GYC EE LVYE
Sbjct: 580 YHGHLNDTEQVAVKLLSHSSTQGYKQFKAEVELLLRVHHTNLVNLVGYCNEEDHLALVYE 639
Query: 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 737
+ NG LK+HL G + +NW RL IA + A+G+EYLH GC P +IHRD+K++NILL
Sbjct: 640 YAANGDLKQHLSGE-SSSAALNWASRLGIATETAQGLEYLHIGCEPPMIHRDVKTTNILL 698
Query: 738 DKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL 796
D+H AK++DFGLS+ F V SHVS+ V GT GYLDPEYY + LT+KSDVYS G++LL
Sbjct: 699 DEHFHAKLADFGLSRSFPVGVESHVSTNVAGTPGYLDPEYYRTNWLTEKSDVYSMGIVLL 758
Query: 797 ELISGQEAISNEKFGANCRNIVQWV 821
E+I+ Q I + +I +WV
Sbjct: 759 EIITNQPVIQQVR---EKPHIAEWV 780
|
|
| TAIR|locus:2047675 AT2G19210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 613 (220.8 bits), Expect = 5.3e-110, Sum P(2) = 5.3e-110
Identities = 142/381 (37%), Positives = 217/381 (56%)
Query: 442 LVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLS 500
++ + L + LTG I FS L I+ L +N LTG EL ++ N LS
Sbjct: 415 IISVNLSSSGLTGEIDAAFSNLTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLS 474
Query: 501 GTVPSSLLSKN----VVLNYAGNINL------HEGGRGAKHLNIIIXXXXXXXXXXXXXX 550
G +P LL ++ ++L GN +L K II
Sbjct: 475 GAIPVKLLERSNKKLILLRIDGNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVLGLVL 534
Query: 551 XXCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAA-HCFTLSDIEDATKMLEKKI 609
LF+ Y K++HR + P + + S++ T E+ +
Sbjct: 535 AIALFLL------Y-KKRHRRG-----GSGGVRAGPLDTTKRYYKYSEVVKVTNNFERVL 582
Query: 610 GSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE 669
G GGFG VY+G L D ++AVK+L+ +S QG +EF EV LL R+HH+NL +GYC E
Sbjct: 583 GQGGFGKVYHGVLNDD-QVAVKILSESSAQGYKEFRAEVELLLRVHHKNLTALIGYCHEG 641
Query: 670 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRD 729
+ L+YEFM NGTL ++L G ++ ++W +RL+I+ DAA+G+EYLH GC P I+ RD
Sbjct: 642 KKMALIYEFMANGTLGDYLSGEKSYV--LSWEERLQISLDAAQGLEYLHNGCKPPIVQRD 699
Query: 730 LKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDV 788
+K +NIL+++ ++AK++DFGLS+ A+DG + ++ V GT+GYLDPEY+++Q+L++KSD+
Sbjct: 700 VKPANILINEKLQAKIADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDI 759
Query: 789 YSFGVILLELISGQEAISNEK 809
YSFGV+LLE++SGQ I+ +
Sbjct: 760 YSFGVVLLEVVSGQPVIARSR 780
|
|
| TAIR|locus:2059093 FRK1 "FLG22-induced receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 633 (227.9 bits), Expect = 6.3e-110, Sum P(2) = 6.3e-110
Identities = 154/388 (39%), Positives = 222/388 (57%)
Query: 432 IPSDLTKLSSLVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXR 490
I SD T +V L + + L G I P FS +R + L N LTG
Sbjct: 406 IQSDNTTNPRVVSLNISFSELRGQIDPAFSNLTSIRKLDLSGNTLTGEIPAFLANLPNLT 465
Query: 491 ELYVQNNMLSGTVPSSL--LSKN--VVLNYAGNINL----HEGGRGAKHLNIIIXXXXXX 542
EL V+ N L+G VP L SKN + L + N +L K+ N I
Sbjct: 466 ELNVEGNKLTGIVPQRLHERSKNGSLSLRFGRNPDLCLSDSCSNTKKKNKNGYIIPLVVV 525
Query: 543 XXXXXXXXXXCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDAT 602
LF + K+Q R +L +R N A F S++ + T
Sbjct: 526 GIIVVLLTALALF------RRFKKKQQRGTLG-ER-----NGPLKTAKRYFKYSEVVNIT 573
Query: 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF 662
E+ IG GGFG VY+G + +G+++AVKVL+ S QG +EF EV LL R+HH NL
Sbjct: 574 NNFERVIGKGGFGKVYHGVI-NGEQVAVKVLSEESAQGYKEFRAEVDLLMRVHHTNLTSL 632
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+GYC E VL+YE+M N L ++L G + ++W +RL+I+ DAA+G+EYLH GC
Sbjct: 633 VGYCNEINHMVLIYEYMANENLGDYLAGKRSFI--LSWEERLKISLDAAQGLEYLHNGCK 690
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
P I+HRD+K +NILL++ ++AK++DFGLS+ F+V+G+ +S++V G++GYLDPEYY ++Q
Sbjct: 691 PPIVHRDVKPTNILLNEKLQAKMADFGLSRSFSVEGSGQISTVVAGSIGYLDPEYYSTRQ 750
Query: 782 LTDKSDVYSFGVILLELISGQEAISNEK 809
+ +KSDVYS GV+LLE+I+GQ AI++ K
Sbjct: 751 MNEKSDVYSLGVVLLEVITGQPAIASSK 778
|
|
| TAIR|locus:2017572 AT1G51790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 588 (212.0 bits), Expect = 1.2e-109, Sum P(2) = 1.2e-109
Identities = 150/406 (36%), Positives = 221/406 (54%)
Query: 437 TKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGXXX-XXXXXXXXXRELYV 494
T + ++ L L LTG I D S L+I+ L +N L+G R L++
Sbjct: 408 TNMPRVIALNLSSAGLTGEITSDISRLSQLQILDLSNNNLSGPAVPAFLAQLQFLRVLHL 467
Query: 495 QNNMLSGTVPSSLLSKNVVLNYAGNINLHEGG--------RGAKH------LNIIIXXXX 540
NN LSG +PSSL+ + + +++GN ++ R K+ + ++
Sbjct: 468 ANNQLSGPIPSSLIER--LDSFSGNPSICSANACEEVSQNRSKKNKLPSFVIPLVASLAG 525
Query: 541 XXXXXXXXXXXXCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIED 600
+ M K KK +Y + V + + P+ FT ++I +
Sbjct: 526 LLLLFIISAAIFLILMRK-KKQDYGGNE--------TAVDAFDLEPSNRK--FTYAEIVN 574
Query: 601 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 660
T ++ G GFG Y GKL DGKE+ VK+++S S QG ++ EV L RIHH+NL+
Sbjct: 575 ITNGFDRDQGKVGFGRNYLGKL-DGKEVTVKLVSSLSSQGYKQLRAEVKHLFRIHHKNLI 633
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
LGYC E + ++YE+M NG LK+H+ T +W RL IA D A+G+EYLHTG
Sbjct: 634 TMLGYCNEGDKMAVIYEYMANGNLKQHISENSTTV--FSWEDRLGIAVDVAQGLEYLHTG 691
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA--SHVSSIVRGTVGYLDPEYYI 778
C P IIHR++K +N+ LD+ AK+ FGLS+ A D A SH+++ + GT GY+DPEYY
Sbjct: 692 CKPPIIHRNVKCTNVFLDESFNAKLGGFGLSR-AFDAAEGSHLNTAIAGTPGYVDPEYYT 750
Query: 779 SQQLTDKSDVYSFGVILLELISGQEAI-SNEKFGANCRNIVQWVKS 823
S LT+KSDVYSFGV+LLE+++ + AI NE+ +I QWV+S
Sbjct: 751 SNMLTEKSDVYSFGVVLLEIVTAKPAIIKNEER----MHISQWVES 792
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 824 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 5e-89 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-35 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-33 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-32 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-31 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-31 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-28 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-27 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-26 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-07 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 284 bits (729), Expect = 5e-89
Identities = 126/352 (35%), Positives = 180/352 (51%), Gaps = 36/352 (10%)
Query: 35 LNCG--GNENFTDEI-GLQWIADDHLIY-GEISNISVANETR---KQYMTLRHFPADSRK 87
++CG NE++TD G+ W++D I G+ NIS N + K Y TLR FP D ++
Sbjct: 1 IDCGLPSNESYTDPSTGITWVSDAGFIDTGKSGNISKENSSSFLSKPYKTLRSFP-DGKR 59
Query: 88 YCYKLDVIT--RTRYLIRATFLYGNFDNNN---VYPKFDISLGPTHWSTIVISDAA--TI 140
CY L V T+YLIRATFLYGN+D N P FD+ LG W+T+ +S+ + ++
Sbjct: 60 NCYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSPPSFDLYLGVNLWTTVNLSNDSGDSV 119
Query: 141 EVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFG 200
+I + S + VCL N TG PFIS LELR S+Y + L + AR+NFG
Sbjct: 120 VKEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLYPSSGGS-QALKLVARLNFG 178
Query: 201 ADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSD---ELPPQKV 257
+RYPDD +DRIWE + G ++ST L +D+ S+ +PP V
Sbjct: 179 GSEGT-IRYPDDVYDRIWEPFF---------SSPGWSQISTSLSVDISSNNAPYIPPSAV 228
Query: 258 MQTAVVGTNGSLTYRLNLD-GFPGFG-WAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKA 315
+QTAV TN S D P F + +FAEI+ L E+R+F + + G+
Sbjct: 229 LQTAVTPTNASAPLNFTWDLVDPNFEYYVYLHFAEIQSL---ETREFDIYINGKTVYGD- 284
Query: 316 IVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKY 367
V+ + +Y N+S +L+ T S+ PLLNA+EI K
Sbjct: 285 -VSPKYLGTDTGALYLDFPVNVSGGGLLNISLVPTSGSTLPPLLNALEIFKV 335
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 1e-50
Identities = 73/206 (35%), Positives = 111/206 (53%), Gaps = 13/206 (6%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGK-----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRN 658
L KK+G G FG VY GKLK E+AVK L + S Q EF E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+V+ LG C EE +V E+M G L +L + +++ L A A+G+EYL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778
+ IHRDL + N L+ +++ K+SDFGLS+ D + + + ++ PE
Sbjct: 120 SKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 779 SQQLTDKSDVYSFGVILLELIS-GQE 803
+ T KSDV+SFGV+L E+ + G++
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQ 202
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 2e-50
Identities = 73/206 (35%), Positives = 111/206 (53%), Gaps = 12/206 (5%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGK-----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRN 658
L KK+G G FG VY G LK E+AVK L + S Q EF E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+V+ LG C EE ++V E+M G L ++L + ++ L A A+G+EYL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778
+ IHRDL + N L+ +++ K+SDFGLS+ D + + + ++ PE
Sbjct: 121 SKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 779 SQQLTDKSDVYSFGVILLELIS-GQE 803
+ T KSDV+SFGV+L E+ + G+E
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEE 203
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 6e-49
Identities = 75/204 (36%), Positives = 117/204 (57%), Gaps = 13/204 (6%)
Query: 609 IGSGGFGVVYYGK-LKDGKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666
+G GGFG VY + K GK++A+K++ +S E E+ +L +++H N+V+ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 667 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-TGCVPAI 725
++E LV E+ G+LK+ L +E +++ + L I +G+EYLH G I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSNG----I 113
Query: 726 IHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ-LT 783
IHRDLK NILLD + + K++DFGLSK S + +IV GT Y+ PE + + +
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYS 172
Query: 784 DKSDVYSFGVILLELISGQEAISN 807
+KSD++S GVIL EL ++ I
Sbjct: 173 EKSDIWSLGVILYELPELKDLIRK 196
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 5e-46
Identities = 66/202 (32%), Positives = 112/202 (55%), Gaps = 15/202 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 662
+ +K+G G FG VY + K GK +A+KV+ + RE E+ +L ++ H N+V+
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
++E + LV E+ G L + L G L+ ++ +++ +I +EYLH+
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLR--QILS----ALEYLHSK 116
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
I+HRDLK NILLD+ K++DFGL++ +D +++ V GT Y+ PE + +
Sbjct: 117 G---IVHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEVLLGK 171
Query: 781 QLTDKSDVYSFGVILLELISGQ 802
D++S GVIL EL++G+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-44
Identities = 73/204 (35%), Positives = 114/204 (55%), Gaps = 16/204 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
L +K+GSG FG VY K K GK +AVK+L S + + E+ +L R+ H N+V+
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
+ +++ LV E+ G L ++L G L+ ++ ++ +G+EYLH
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQI------LRGLEYLH- 115
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
IIHRDLK NILLD++ K++DFGL+K + +S +++ V GT Y+ PE +
Sbjct: 116 --SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLG 172
Query: 780 QQL-TDKSDVYSFGVILLELISGQ 802
K DV+S GVIL EL++G+
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 75/221 (33%), Positives = 112/221 (50%), Gaps = 26/221 (11%)
Query: 607 KKIGSGGFGVVYYGKLKDGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQ 661
KK+G G FG VY GKLK E+AVK L + S + +++F E ++ ++ H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIEY 716
LG C EE LV E+M G L ++L + ++ L A AKG+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS-----IVRGTVGY 771
L + +HRDL + N L+ + + K+SDFGLS+ D + +R +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELIS-GQE---AISNE 808
+ PE T KSDV+SFGV+L E+ + G +SNE
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE 214
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 159 bits (406), Expect = 3e-44
Identities = 69/204 (33%), Positives = 108/204 (52%), Gaps = 13/204 (6%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE-----IAVKVLT-SNSYQGKREFTNEVTLLSRIHHRN 658
L KK+G G FG VY G LK E +AVK L S + + EF E +++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+V+ LG C + +V E+M G L + L H +++ L++A AKG+EYL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYY 777
+ +HRDL + N L+ +++ K+SDFGLS+ D + + ++ PE
Sbjct: 120 SKN---FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 778 ISQQLTDKSDVYSFGVILLELISG 801
+ T KSDV+SFGV+L E+ +
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 17/204 (8%)
Query: 607 KKIGSGGFGVVYYGKLKD-GKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ +G G FG VY KD G+ +AVK L+ +S + E+ +LS + H N+V++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 664 G-YCQEEGRSVLVY-EFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
G EE ++ ++ E++ G+L L +G L I++ +G+ YLH+
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKY--TRQILEGLAYLHS 119
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-SHVSSIVRGTVGYLDPEYYI 778
I+HRD+K +NIL+D K++DFG +K D + VRGT ++ PE
Sbjct: 120 NG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 779 SQQLTDKSDVYSFGVILLELISGQ 802
++ +D++S G ++E+ +G+
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 69/200 (34%), Positives = 111/200 (55%), Gaps = 15/200 (7%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
+KIG GGFG VY + + GKE+A+KV+ S + K + NE+ +L + H N+V++ G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 666 CQEEGRSVLVYEFMHNGTLKE---HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
++ +V EF G+LK+ TLT E +I ++ + + KG+EYLH+
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKSTNQTLT-ESQIAYVCK-----ELLKGLEYLHSN-- 117
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
IIHRD+K++NILL K+ DFGLS D + + + GT ++ PE +
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPY 174
Query: 783 TDKSDVYSFGVILLELISGQ 802
K+D++S G+ +EL G+
Sbjct: 175 DYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-33
Identities = 125/429 (29%), Positives = 209/429 (48%), Gaps = 52/429 (12%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
+ + LS L+G IP +L+ LV L L N L+G IP FS P L + L NQ
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS--LLSKNVVLNYAGNINLHEGG------ 526
L+G +P +L N+ +L ++ + +N L G++PS+ L+ N AGNI+L G
Sbjct: 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINAS-AVAGNIDLCGGDTTSGLP 617
Query: 527 -----RGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDK--EQHRHSLPVQRPV 579
R I ++GA L+LA V +G+ N K E + +Q
Sbjct: 618 PCKRVRKTPSWWFYITCTLGA-FLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD 676
Query: 580 SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNS 637
S + + T++DI + K E I G G Y GK +K+G + VK + NS
Sbjct: 677 S-------KVSKSITINDILSSLKE-ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS 728
Query: 638 YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 697
++E+ + ++ H N+V+ +G C+ E + L++E++ L E L
Sbjct: 729 IP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------- 776
Query: 698 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAV 755
++W +R +IA AK + +LH C PA++ +L I++D ++S GL
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGL--LCT 834
Query: 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 815
D +SS Y+ PE ++ +T+KSD+Y FG+IL+EL++G+ ++ +FG +
Sbjct: 835 DTKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSP-ADAEFGVH-G 886
Query: 816 NIVQWVKSS 824
+IV+W +
Sbjct: 887 SIVEWARYC 895
|
Length = 968 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-32
Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 7/198 (3%)
Query: 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
K++GSG FGVV+ GK + ++A+K++ + + +F E ++ ++ H NLVQ
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLY 65
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
G C ++ +V E+M NG L +L + ++ L++ D + +EYL +
Sbjct: 66 GVCTKQRPIFIVTEYMANGCLLNYLR---ERKGKLGTEWLLDMCSDVCEAMEYLESNGF- 121
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
IHRDL + N L+ + KVSDFGL+++ +D S + V + PE + + +
Sbjct: 122 --IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 784 DKSDVYSFGVILLELISG 801
KSDV+SFGV++ E+ S
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 68/195 (34%), Positives = 111/195 (56%), Gaps = 9/195 (4%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666
K++G+G FGVV YGK + ++A+K++ S + EF E ++ ++ H LVQ G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 667 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 726
++ +V E+M NG L +L H +R + LE+ +D +G+ YL + I
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLR---EHGKRFQPSQLLEMCKDVCEGMAYLES---KQFI 122
Query: 727 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDPEYYISQQLTDK 785
HRDL + N L+D KVSDFGLS++ +D + SS+ + V + PE + + + K
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 786 SDVYSFGVILLELIS 800
SDV++FGV++ E+ S
Sbjct: 182 SDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 607 KKIGSGGFGVVYYGKL-----KDGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLV 660
K++G G FG V + G+++AVK L S Q + +F E+ +L + H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 661 QFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
++ G C++ G L+ E++ +G+L+++L H +IN + L + KG++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLG 126
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV--DGASHVSSIVRGTVGYLDPEY 776
+ IHRDL + NIL++ K+SDFGL+K +V + + PE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 777 YISQQLTDKSDVYSFGVILLELIS 800
+ + + SDV+SFGV L EL +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 4e-31
Identities = 151/593 (25%), Positives = 250/593 (42%), Gaps = 68/593 (11%)
Query: 13 VASVLILLLLDSSSAQMPGFVSLNCGGNENF-TDEIGLQWIADDHLIYGEISNISVANET 71
+A+ +L +L S ++ P + ++CG N T W D G +N + +
Sbjct: 6 LAASALLAVLASLASPEPFTMRISCGARVNVRTAPTNTLWYKDFAYTGGIPANATRPSFI 65
Query: 72 RKQYMTLRHFP-ADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWS 130
TLR+FP +D + CY ++ + + Y +R F N + P FD+S+ T S
Sbjct: 66 APPLKTLRYFPLSDGPENCYNINRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQIS 125
Query: 131 TIVI---SDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYL--TPF 185
++ S + L+FL +C + G P I ++E+ Q + Y +
Sbjct: 126 SLKSGWSSHDEQVFAEALVFLTDG-SASICFHSTGHGDPAILSIEILQVDDKAYNFGPSW 184
Query: 186 EDRYYLSVSARINFGA-DSEAPVRYPDDPF--DRIWESDSLKKANYLVDVAAGTEKVSTK 242
L + R++ GA S+ Y D + DR W + D A TE V K
Sbjct: 185 GQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSG--SDQAISTENVIKK 242
Query: 243 LPIDLRSDELPPQKVMQTAVVGTNG--SLTYRLNLDGFPGFGWAV-TYFAEIED-LDPDE 298
+ P+ + Q+A+V T+ L+Y +++D P ++V +FAEI++ + +
Sbjct: 243 A---SNAPNFYPESLYQSALVSTDTQPDLSYTMDVD--PNRNYSVWLHFAEIDNSITAEG 297
Query: 299 SRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLP---FVLSFKFGKTYDSSR 355
R F +++ G D + V+I + + +Y T L L V +
Sbjct: 298 KRVFDVLING--DTAFKDVDIVKMSGERY-------TALVLNKTVAVSGRTLTIVLQPKK 348
Query: 356 GP--LLNAMEINKYLERNDGSIDGVA-----IVSVISLYSSADWAQEGGDPCLPV--PWS 406
G ++NA+E+ + + ++ + S + L W GDPC+P PWS
Sbjct: 349 GTHAIINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFGW---NGDPCVPQQHPWS 405
Query: 407 WLQCNSDPQPS---ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGC 462
C D I + L ++ L G IP+D++KL L + L GNS+ G IP
Sbjct: 406 GADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSI 465
Query: 463 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 519
L ++ L N G +P SL L +LR L + N LSG VP++L L N+ N
Sbjct: 466 TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
Query: 520 INL------HEGGR----GAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKN 562
L G GAK IG + G +V L V+ + K ++N
Sbjct: 526 AGLCGIPGLRACGPHLSVGAK-----IGIAFGVSVAFLFLVICAMCWWKRRQN 573
|
Length = 623 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 65/199 (32%), Positives = 108/199 (54%), Gaps = 13/199 (6%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
L ++IGSG FG+V+ G + +++A+K + + +F E ++ ++ H LVQ G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
C E LV+EFM +G L ++L G + E L + D +G+ YL +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQE------TLLGMCLDVCEGMAYLESSN 120
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
V IHRDL + N L+ ++ KVSDFG+++F +D S+ + V + PE + +
Sbjct: 121 V---IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK 177
Query: 782 LTDKSDVYSFGVILLELIS 800
+ KSDV+SFGV++ E+ S
Sbjct: 178 YSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 74/202 (36%), Positives = 103/202 (50%), Gaps = 20/202 (9%)
Query: 609 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 664
+G G FG V + KD GK A+KVL ++E E +LSRI+H +V+ L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK-LH 59
Query: 665 YC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 720
Y Q E + LV E+ G L HL G + E+R R AE +EYLH+ G
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFS-EERA----RFYAAE-IVLALEYLHSLG 113
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
II+RDLK NILLD K++DFGL+K S ++ GT YL PE + +
Sbjct: 114 ----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGK 168
Query: 781 QLTDKSDVYSFGVILLELISGQ 802
D +S GV+L E+++G+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 66/224 (29%), Positives = 110/224 (49%), Gaps = 19/224 (8%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-TSNSYQGKREFT-NEVTLLSRIHHRNLVQ 661
+ K+IG G FG VY + DGK +K + SN + +RE NEV +L +++H N+++
Sbjct: 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHL------YGTLTHEQRINWIKRLEIAEDAAKGIE 715
+ +E+G+ +V E+ G L + + EQ ++W +L ++
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALK 117
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
YLH+ I+HRD+K NI L + K+ DFG+SK ++V GT YL PE
Sbjct: 118 YLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE 173
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
++ KSD++S G +L EL + + E I++
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 5e-29
Identities = 70/212 (33%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVL---TSNSYQGKREFTNEVTLLSRI-HHRNL 659
+ +K+G G FG VY + D K +A+KVL + + F E+ +L+ + H N+
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
V+ + Q+EG LV E++ G+L++ L + + ++ + L I +EYLH+
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 720 GCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVS-----SIVRGTVGYLD 773
IIHRD+K NILLD+ K+ DFGL+K D S S S GT GY+
Sbjct: 120 KG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 774 PEYYISQQL---TDKSDVYSFGVILLELISGQ 802
PE + L + SD++S G+ L EL++G
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 66/192 (34%), Positives = 103/192 (53%), Gaps = 11/192 (5%)
Query: 609 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE 668
IG G FG V G + G+++AVK L +S + F E ++++ + H NLVQ LG +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 669 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHR 728
+V E+M G+L ++L I ++L A D +G+EYL +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEE---KNFVHR 126
Query: 729 DLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDV 788
DL + N+L+ + + AKVSDFGL+K AS + V + PE ++ + KSDV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182
Query: 789 YSFGVILLELIS 800
+SFG++L E+ S
Sbjct: 183 WSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 6/196 (3%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
LE+K+GSG FG V+ G K+ +A+K+L S+ +++F EV L R+ H++L+
Sbjct: 10 LERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFA 69
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
C ++ E M G+L L Q + +++A A+G+ YL
Sbjct: 70 VCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEE---QN 124
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
IHRDL + NIL+ + + KV+DFGL++ + ++SS + + PE +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASHGTFST 183
Query: 785 KSDVYSFGVILLELIS 800
KSDV+SFG++L E+ +
Sbjct: 184 KSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 7/203 (3%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 655
++E ++ K+G G +G VY G K +AVK L ++ + + EF E ++ I
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 60
Query: 656 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
H NLVQ LG C E ++ EFM G L ++L + Q +N + L +A + +E
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAME 118
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
YL IHRDL + N L+ ++ KV+DFGLS+ + + + + PE
Sbjct: 119 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175
Query: 776 YYISQQLTDKSDVYSFGVILLEL 798
+ + KSDV++FGV+L E+
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 68/197 (34%), Positives = 105/197 (53%), Gaps = 8/197 (4%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGY 665
+KIG G FG VY G LK E+AVK S KR+F E +L + H N+V+ +G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 666 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 725
C ++ +V E + G+L L + R+ K L+++ DAA G+EYL +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKNC--- 114
Query: 726 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT-VGYLDPEYYISQQLTD 784
IHRDL + N L+ ++ K+SDFG+S+ G VS ++ + + PE + T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 785 KSDVYSFGVILLELISG 801
+SDV+S+G++L E S
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
+KIG G G VY GKE+A+K + Q K NE+ ++ H N+V +
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYD- 82
Query: 666 CQEEGRSV-LVYEFMHNGTLKEHLYGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
G + +V E+M G+L + + +E +I ++ R E+ + G+EYLH+
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCR-EVLQ----GLEYLHSQ-- 135
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD---GASHVSSIVRGTVGYLDPEYYIS 779
+IHRD+KS NILL K K++DFG FA S +S+V GT ++ PE
Sbjct: 136 -NVIHRDIKSDNILLSKDGSVKLADFG---FAAQLTKEKSKRNSVV-GTPYWMAPEVIKR 190
Query: 780 QQLTDKSDVYSFGVILLELISGQ 802
+ K D++S G++ +E+ G+
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 57/204 (27%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 604 MLEKKIGSGGFGVVYYG-KLKDGKEIAVK--VLTSNSYQGKREFTNEVTLLSRIHHRNLV 660
L IG G FGVVY G L+ G +A+K L + + E+ LL + H N+V
Sbjct: 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+++G + ++ E+ NG+L++ + +G ++ ++ +G+ YLH
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV------LQGLAYLH 116
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778
+IHRD+K++NIL K K++DFG++ ++ S + V GT ++ PE
Sbjct: 117 E---QGVIHRDIKAANILTTKDGVVKLADFGVAT-KLNDVSKDDASVVGTPYWMAPEVIE 172
Query: 779 SQQLTDKSDVYSFGVILLELISGQ 802
+ SD++S G ++EL++G
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 64/197 (32%), Positives = 107/197 (54%), Gaps = 13/197 (6%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666
K++GSG FGVV+ GK + ++A+K + + + +F E ++ ++ H LVQ G C
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 667 QEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
++ +V EFM NG L +L G L+ + L + +D +G+EYL
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML------LSMCQDVCEGMEYLERN--- 119
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
+ IHRDL + N L+ KVSDFG++++ +D SS + V + PE + + +
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 784 DKSDVYSFGVILLELIS 800
KSDV+SFGV++ E+ +
Sbjct: 180 SKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 59/205 (28%), Positives = 108/205 (52%), Gaps = 16/205 (7%)
Query: 604 MLEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRN 658
+EK IG G FG V G+L K ++A+K L + S +R +F E +++ + H N
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+++ G + +++ E+M NG+L + L ++ + + + + A G++YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLR---ENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLDPE 775
+HRDL + NIL++ ++ KVSDFGLS+ S + +G + + PE
Sbjct: 124 EMNY---VHRDLAARNILVNSNLVCKVSDFGLSR--RLEDSEATYTTKGGKIPIRWTAPE 178
Query: 776 YYISQQLTDKSDVYSFGVILLELIS 800
++ T SDV+SFG+++ E++S
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 609 IGSGGFGVVYYG-KLKDGKEIAVKV--LTSNSYQGK---REFTNEVTLLSRIHHRNLVQF 662
+GSG FG VY G L DG AVK L + G+ ++ E+ LLS++ H N+VQ+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
LG +EE + E + G+L + L YG+ + +++ G+EYLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQI------LLGLEYLHDR 121
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
+HRD+K +NIL+D + K++DFG++K V+ + S +G+ ++ PE Q
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQQ 176
Query: 781 QLTD-KSDVYSFGVILLELISGQ 802
+D++S G +LE+ +G+
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 14/208 (6%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 656
+I+ + L +K+G+G FG V+ G + +AVK L + K +F E ++ ++ H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRH 60
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG----TLTHEQRINWIKRLEIAEDAAK 712
L+Q C E +V E M G+L E+L G L Q I ++A A
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI------DMAAQVAS 114
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 772
G+ YL IHRDL + N+L+ ++ KV+DFGL++ + + + +
Sbjct: 115 GMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT 171
Query: 773 DPEYYISQQLTDKSDVYSFGVILLELIS 800
PE + + + KSDV+SFG++L E+++
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 605 LEKKIGSGGFGVVYYGKL-----KDGKEI-AVKVLT-SNSYQGKREFTNEVTLLSRIHHR 657
L++++G G FG V+ G+ ++ KE+ AVK L + S +++F E LL+ H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL----------YGTLTHEQRINWIKRLEIA 707
N+V+F G C E ++V+E+M +G L + L + + + L+IA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 708 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 767
A G+ YL + +HRDL + N L+ + K+ DFG+S+ D + V G
Sbjct: 129 VQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYYRVGG 182
Query: 768 T----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ ++ PE + ++ T +SDV+SFGV+L E+ +
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 15/201 (7%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLG 664
K +G G GVVY + K GK A+K + + + +++ E+ L +V+ G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL---EIAEDAAKGIEYLHTGC 721
+EG +V E+M G+L + L +++ I IA KG++YLHT
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLL-------KKVGKIPEPVLAYIARQILKGLDYLHT-- 117
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
IIHRD+K SN+L++ K++DFG+SK + ++ V GTV Y+ PE +
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGES 176
Query: 782 LTDKSDVYSFGVILLELISGQ 802
+ +D++S G+ LLE G+
Sbjct: 177 YSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 6/196 (3%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
LE+K+G+G FG V+ G ++AVK L + F E ++ ++ H LVQ
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
C EE +V E+M G+L + L + R+ + +++A A+G+ YL +
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP--QLVDMAAQIAEGMAYLES---RN 123
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
IHRDL + NIL+ +++ K++DFGL++ D + + + PE + T
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTI 183
Query: 785 KSDVYSFGVILLELIS 800
KSDV+SFG++L E+++
Sbjct: 184 KSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 47/219 (21%)
Query: 607 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+++G G FG V Y L+D G+ +AVK L ++ + R+F E+ +L + H N+V+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 662 FLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
+ G C GR LV E++ G+L+++L H +R++ K L A KG+EYL +
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
+HRDL + NIL++ R K+ DFGL+K V D EYY
Sbjct: 127 ---KRYVHRDLATRNILVESENRVKIGDFGLTK----------------VLPQDKEYYKV 167
Query: 780 QQ-------------LTD-----KSDVYSFGVILLELIS 800
++ LT+ SDV+SFGV+L EL +
Sbjct: 168 REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLT-SNSYQGKREFT 645
LS + +++G G FG VY G+L +A+K L + + ++EF
Sbjct: 2 IPLSAVR-----FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR 56
Query: 646 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE---------- 695
E L+S + H N+V LG C +E + +++E++ +G L E L H
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116
Query: 696 --QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753
++ L IA A G+EYL + +HRDL + N L+ + + K+SDFGLS+
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSR- 172
Query: 754 AVDGASH----VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
D S V S V ++ PE + + T +SD++SFGV+L E+ S
Sbjct: 173 --DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 39/227 (17%)
Query: 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREF-TNEVTLLSRI-HHR 657
K IG G F V K K KE A+K+L + K ++ E +L+R+ H
Sbjct: 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKIL-DKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 715
+++ Q+E V E+ NG L +++ YG+L E+ + AE +E
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLD-EKCTRFY----AAE-ILLALE 116
Query: 716 YLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF----------AVDGASHVSSI 764
YLH+ G IIHRDLK NILLDK M K++DFG +K D + S I
Sbjct: 117 YLHSKG----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 765 VR---------GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
+ GT Y+ PE + SD+++ G I+ ++++G+
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 15/217 (6%)
Query: 609 IGSGGFG-VVYYGKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
+G G FG Y + +D + K LT S + +R+ NE+ +LS + H N++ + +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 666 CQEEGRSVLVYEFMHNGTLKE---HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
++ ++ E+ + GTL + G L E+ + W + Y+H
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY-----LFQIVSAVSYIHKA-- 120
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
I+HRD+K+ NI L K K+ DFG+SK S ++V GT Y+ PE +
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKY 178
Query: 783 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
KSD+++ G +L EL++ + IVQ
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 67/200 (33%), Positives = 107/200 (53%), Gaps = 18/200 (9%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
KKIG G FG +Y K K D + +K LT + K EV LL+++ H N+V F
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 719
QE GR +V E+ G L + + G L E +I +W ++ + G++++H
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHD 119
Query: 720 GCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778
I+HRD+KS NI L K+ M AK+ DFG+++ ++ + ++ GT YL PE
Sbjct: 120 ---RKILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPYYLSPEICQ 175
Query: 779 SQQLTDKSDVYSFGVILLEL 798
++ +K+D++S G +L EL
Sbjct: 176 NRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 66/196 (33%), Positives = 106/196 (54%), Gaps = 13/196 (6%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
L + IG G FG V G+ G+++AVK + + + F E +++++HH+NLV+ LG
Sbjct: 10 LGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLG 66
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
G + V E M G L L ++ I+ L+ + D A+G+EYL +
Sbjct: 67 VILHNGLYI-VMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLES---KK 120
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
++HRDL + NIL+ + AKVSDFGL++ G + V+ T PE ++ +
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTA----PEALKHKKFSS 176
Query: 785 KSDVYSFGVILLELIS 800
KSDV+S+GV+L E+ S
Sbjct: 177 KSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-23
Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 13/197 (6%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
L + IG G FG V G + G ++AVK + +++ + F E ++++++ H NLVQ LG
Sbjct: 10 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 665 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
EE + +V E+M G+L ++L + L+ + D + +EYL
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN--- 121
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
+HRDL + N+L+ + AKVSDFGL+K AS + V + PE ++ +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 784 DKSDVYSFGVILLELIS 800
KSDV+SFG++L E+ S
Sbjct: 178 TKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 21/205 (10%)
Query: 607 KKIGSGGFGVVYYGKLKD-GKEIAVKVLT--SNSYQGKRE---FTNEVTLLSRIHHRNLV 660
K +G G FG VY D G+E+AVK + +S + K+E E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 661 QFLGYCQEEGRSVLVY-EFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
Q+ G C + ++ ++ E+M G++K+ L YG LT + + +I E G+EYL
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR--QILE----GVEYL 120
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI--VRGTVGYLDPE 775
H+ I+HRD+K +NIL D K+ DFG SK S + + V GT ++ PE
Sbjct: 121 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 776 YYISQQLTDKSDVYSFGVILLELIS 800
+ K+DV+S G ++E+++
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 6e-23
Identities = 67/203 (33%), Positives = 105/203 (51%), Gaps = 19/203 (9%)
Query: 607 KKIGSGGFGVVYYG--KLKDGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQ 661
K++G G FG V G +K GKE+ AVK L GK+EF E ++++++ H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
+G C+ E +LV E G L ++L + I E+A A G+ YL +
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-- 113
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPE--YY 777
+HRDL + N+LL +AK+SDFG+S+ G+ + + G + + PE Y
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 778 ISQQLTDKSDVYSFGVILLELIS 800
+ + KSDV+S+GV L E S
Sbjct: 173 --GKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 66/209 (31%), Positives = 114/209 (54%), Gaps = 23/209 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 659
+E+ IG+G FG V G+LK GK +A+K L S + + +R+F +E +++ + H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
+ G + +++ EFM NG L L ++ + I+ + + A G++YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS---HVSSI-----VRGTVGY 771
+HRDL + NIL++ ++ KVSDFGLS+F D S + SS+ +R T
Sbjct: 125 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA-- 179
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELIS 800
PE ++ T SDV+S+G+++ E++S
Sbjct: 180 --PEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 62/210 (29%), Positives = 114/210 (54%), Gaps = 13/210 (6%)
Query: 598 IEDATKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLT---SNSYQGKREFTNEVTLLS 652
I+ + +EK IG+G FG V G+LK +EI V + T + + +R+F +E +++
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60
Query: 653 RIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 712
+ H N++ G + ++V E+M NG+L L H+ + I+ + + A
Sbjct: 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR---KHDGQFTVIQLVGMLRGIAS 117
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVG 770
G++YL +HRDL + NIL++ ++ KVSDFGLS+ D A++ + + +
Sbjct: 118 GMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 174
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ PE ++ T SDV+S+G+++ E++S
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 63/220 (28%), Positives = 110/220 (50%), Gaps = 9/220 (4%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+ KIG G FGVV+ K D + A+K L+ + + + E +E +L+++ +++
Sbjct: 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
+ ++G+ +V E+ NG L + L + + R I G+ +LH+
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QILLGLAHLHSK- 120
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
I+HRD+KS N+ LD + K+ D G++K D + ++IV GT YL PE +
Sbjct: 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKP 177
Query: 782 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWV 821
+KSDV++ GV+L E +G+ GA I++ V
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV 217
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-22
Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
L KK+G+G FG V+ G ++A+K L S F E L+ ++ H LV+
Sbjct: 10 LVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYA 68
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
+E ++ E+M NG+L + L + IN K +++A A+G+ ++
Sbjct: 69 VVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTIN--KLIDMAAQIAEGMAFIE---RKN 122
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
IHRDL+++NIL+ + + K++DFGL++ D + + + PE T
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 785 KSDVYSFGVILLELIS 800
KSDV+SFG++L E+++
Sbjct: 183 KSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 6e-22
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 608 KIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
++G G G V +LK+ I A+K + T + +++ E+ + +V++ G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 666 CQEEGRSVL--VYEFMHNGTLKEHLYG-TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+E S + E+ G+L + +Y RI +IAE KG+ YLH+
Sbjct: 68 FLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS--- 123
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
IIHRD+K SNILL + + K+ DFG+S V + ++ GT Y+ PE +
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTFTGTSFYMAPERIQGKPY 180
Query: 783 TDKSDVYSFGVILLELISG 801
+ SDV+S G+ LLE+
Sbjct: 181 SITSDVWSLGLTLLEVAQN 199
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 7e-22
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
LE K+G G FG V+ G +A+K L + F E ++ ++ H LVQ
Sbjct: 10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 68
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
EE +V E+M G+L + L G + R+ + +++A A G+ Y+
Sbjct: 69 VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVER---MN 122
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
+HRDL+++NIL+ +++ KV+DFGL++ D + + + PE + + T
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 785 KSDVYSFGVILLELIS 800
KSDV+SFG++L EL +
Sbjct: 183 KSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 22/212 (10%)
Query: 609 IGSGGFGVVYYGKLKDGKEIAVKVL---TSNSYQGKREFTN---EVTLLSRIHHRNLVQF 662
+G G +G VY G G+ IAVK + TSN ++E+ EV LL + H N+VQ+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
LG C ++ + EF+ G++ L +G L + K++ G+ YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI------LDGVAYLHNN 121
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSS----IVRGTVGYLDPE 775
CV +HRD+K +N++L + K+ DFG + + A G S + GT ++ PE
Sbjct: 122 CV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQEAISN 807
KSD++S G + E+ +G+ +++
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 65/207 (31%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLG 664
I G +G V+ K K +I A+KV+ K + E +LS+ +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 665 YCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
Q + LV E++ G L G+L + + R+ IAE +EYLH+
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDED-----VARIYIAE-IVLALEYLHSN-- 112
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV--------DGASHVSSIVRGTVGYLDP 774
IIHRDLK NIL+D + K++DFGLSK + D IV GT Y+ P
Sbjct: 113 -GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAP 170
Query: 775 EYYISQQLTDKSDVYSFGVILLELISG 801
E + Q + D +S G IL E + G
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 607 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFL 663
KIG G FG VY L G+ +AVK + K +E +E+ +L + H NLV++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHL-YGTLTHEQRIN-WIKRLEIAEDAAKGIEYLHTGC 721
G + + E+ GTL+E L +G + E I + +L +G+ YLH+
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL------LEGLAYLHSH- 118
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YLDPEYYI 778
I+HRD+K +NI LD + K+ DFG + + + + V+ G Y+ PE
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 779 SQQLTDK---SDVYSFGVILLELISG 801
+ +D++S G ++LE+ +G
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATG 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 59/202 (29%), Positives = 113/202 (55%), Gaps = 13/202 (6%)
Query: 606 EKKIGSGGFGVVYYGKLK-DGKE---IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLV 660
+K IG+G FG V+ G LK G++ +A+K L + +R +F +E +++ + H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
+ G + ++++ E+M NG L ++L H+ + + + + A G++YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLR---DHDGEFSSYQLVGMLRGIAAGMKYLSD- 125
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVGYLDPEYYI 778
+HRDL + NIL++ ++ KVSDFGLS+ D ++ +S + + + PE
Sbjct: 126 --MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 779 SQQLTDKSDVYSFGVILLELIS 800
++ T SDV+SFG+++ E++S
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 607 KKIGSGGFGVVYYGKLKDG------KEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 660
+ +G G FG+V+ + K K+I V+ +T + + NE +L + H N++
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNII 62
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
++ E+ ++V E+ GTL E++ ++ + + I + + LH
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYI-----QKRCNSLLDEDTILHFFVQILLALHHV 117
Query: 721 CVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
I+HRDLK+ NILLDKH M K+ DFG+SK + + + V GT Y+ PE
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISK--ILSSKSKAYTVVGTPCYISPELCEG 175
Query: 780 QQLTDKSDVYSFGVILLELISGQEAISNEKFGA 812
+ KSD+++ G +L EL S + A A
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEAANLPA 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 607 KKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLV 660
K +GSG FG VY G E +A+KVL S + +E +E +++ + H ++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYL 717
+ LG C + L+ + M G L +++ + + +NW AKG+ YL
Sbjct: 73 RLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL 125
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEY 776
++HRDL + N+L+ K++DFGL+K VD + + + + ++ E
Sbjct: 126 EE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 777 YISQQLTDKSDVYSFGVILLELIS 800
+ + T KSDV+S+GV + EL++
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 26/221 (11%)
Query: 609 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKRE----------FTNEVTLLSRIHHR 657
IG G +G VY + G+ +AVK + + R +E+ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 715
N+VQ+LG+ E + E++ G++ L YG EQ + + E +G+
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRF-EEQLVRFF-----TEQVLEGLA 122
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDP 774
YLH+ I+HRDLK+ N+L+D K+SDFG+SK + D + ++ ++G+V ++ P
Sbjct: 123 YLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 775 EYYISQQ--LTDKSDVYSFGVILLELISGQEAISN-EKFGA 812
E S + K D++S G ++LE+ +G+ S+ E A
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 609 IGSGGFGVVYYGKL--KDGKEI--AVKVLTS-NSYQGKREFTNEVTLLSRIHHRNLVQFL 663
IG G FG VY+G L DG++I AVK L + +F E ++ H N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 664 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-EIAEDAAKGIEYLHTGC 721
G C EG ++V +M +G L+ + E +K L AKG+EYL +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFI----RSETHNPTVKDLIGFGLQVAKGMEYLAS-- 116
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYI 778
+HRDL + N +LD+ KV+DFGL++ D + H + + V ++ E
Sbjct: 117 -KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 779 SQQLTDKSDVYSFGVILLELIS 800
+Q+ T KSDV+SFGV+L EL++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
++G+G GVV + GK +AVK L N K+ E+ +L + + +V F
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQ-ILRELDILHKCNSPYIVGFY 65
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL---EIAEDAAKGIEYLHTG 720
G G + E+M G+L + L ++ I +IA KG+ YLH
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKIL------KEVQGRIPERILGKIAVAVLKGLTYLHE- 118
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
IIHRD+K SNIL++ + K+ DFG+S V+ + GT Y+ PE
Sbjct: 119 -KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGN 174
Query: 781 QLTDKSDVYSFGVILLELISGQEAISNEKFGAN 813
+ KSD++S G+ L+EL +G+ E +
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPD 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 4e-21
Identities = 61/214 (28%), Positives = 111/214 (51%), Gaps = 21/214 (9%)
Query: 604 MLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 657
+L++++G G FG V+ + +D +AVK L S +++F E LL+ + H
Sbjct: 8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 67
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-----GTLTHE----QRINWIKRLEIAE 708
++V+F G C E ++V+E+M +G L + L L E + + L IA+
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 709 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSIVR 766
A G+ YL + +HRDL + N L+ +++ K+ DFG+S+ ++ D V
Sbjct: 128 QIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD-YYRVGGHTM 183
Query: 767 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ ++ PE + ++ T +SDV+S GV+L E+ +
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 9/197 (4%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLG 664
++IG G FG V+ G+L+ D +AVK K +F E +L + H N+V+ +G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
C ++ +V E + G L T R+ + +++ E+AA G+EYL +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLESKHC-- 115
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT-VGYLDPEYYISQQLT 783
IHRDL + N L+ + K+SDFG+S+ DG + ++ V + PE + +
Sbjct: 116 -IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 784 DKSDVYSFGVILLELIS 800
+SDV+SFG++L E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 5e-21
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 28/211 (13%)
Query: 609 IGSGGFGVVYYG-KLKDGKEIAVK--VLTSNSYQGKRE-------FTNEVTLLSRIHHRN 658
IGSG FG VY G G+ +AVK L S S K E+ LL + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEY 716
+VQ+LG + + E++ G++ L YG N+++++ KG+ Y
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI------LKGLNY 121
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK------FAVDGASHVSSIVRGTVG 770
LH IIHRD+K +NIL+D K+SDFG+SK + S+ +G+V
Sbjct: 122 LHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL-QGSVF 177
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELISG 801
++ PE T K+D++S G +++E+++G
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 5e-21
Identities = 62/222 (27%), Positives = 110/222 (49%), Gaps = 34/222 (15%)
Query: 604 MLEKKIGSGGFGVVYYGK------LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 657
+L++++G G FG V+ + KD +AVK L + +++F E LL+ + H
Sbjct: 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 67
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIKRLE 705
++V+F G C + ++V+E+M +G L + L + + + L
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 706 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-------FAVDGA 758
IA A G+ YL + +HRDL + N L+ ++ K+ DFG+S+ + V G
Sbjct: 128 IASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG- 183
Query: 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
H +R ++ PE + ++ T +SDV+SFGVIL E+ +
Sbjct: 184 -HTMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 7e-21
Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 35/224 (15%)
Query: 606 EKKIGSGGFGVVYYGK---LKDGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRN 658
+ IG G FG V+ + L + +AVK+L S + +F E L++ H N
Sbjct: 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQ------------------RINW 700
+V+ LG C L++E+M G L E L Q ++
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 701 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVD-- 756
++L IA+ A G+ YL +HRDL + N L+ ++M K++DFGLS+ ++ D
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
AS +I + ++ PE + T +SDV+++GV+L E+ S
Sbjct: 187 KASENDAI---PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 7e-21
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 18/204 (8%)
Query: 607 KKIGSGGFGVVY---YGKLKD--GKEIAVKVLTS-NSYQGKREFTNEVTLLSRIHHRNLV 660
+ +G G FG V Y D G+ +AVK L Q + E+ +L ++H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 661 QFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
++ G C E+G L+ E++ G+L+++L + ++N + L A+ +G+ YLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTVGYLDPEY 776
+ IHRDL + N+LLD K+ DFGL+K +G + V V + E
Sbjct: 125 S---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 777 YISQQLTDKSDVYSFGVILLELIS 800
+ + SDV+SFGV L EL++
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 9e-21
Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 19/209 (9%)
Query: 609 IGSGGFGVVYYGKLK----DGKE--IAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQ 661
+G G FG V+ K K +G E + VK L + + EF E+ + ++ H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-----QRINWIKRLEIAEDAAKGIEY 716
LG C+E ++ E+ G LK+ L T + + ++ +++ + A G+++
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSIVRGTVGYLDP 774
L +HRDL + N L+ KVS LSK + + ++++ + +L P
Sbjct: 133 LSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI--PLRWLAP 187
Query: 775 EYYISQQLTDKSDVYSFGVILLELISGQE 803
E + KSDV+SFGV++ E+ + E
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLV 660
+ IG G FG V + K DGK + K + Y + K++ +EV +L + H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEI---DYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 661 QFLGYCQEEGRSVL--VYEFMHNGTL--------KEHLYGTLTHEQRINWIKRLEIAEDA 710
++ + L V E+ G L KE Y + E + +L +A
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY--IEEEFIWRILTQLLLA--- 117
Query: 711 AKGIEYLHTGCVP--AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 768
+ H P ++HRDLK +NI LD + K+ DFGL+K +S + V GT
Sbjct: 118 ---LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GT 173
Query: 769 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
Y+ PE +KSD++S G ++ EL +
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 59/202 (29%), Positives = 86/202 (42%), Gaps = 23/202 (11%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-------AVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
IG G FG V + +D K++ K + S + NE +L ++H LV
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL---NERRILQELNHPFLVN 64
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
Q+E LV + + G L+ HL + EQ + I E +EYLH+
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ-----VKFWICE-IVLALEYLHS 118
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
IIHRD+K NILLD+ ++DF ++ S GT GY+ PE
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS--TSGTPGYMAPEVLCR 173
Query: 780 QQLTDKSDVYSFGVILLELISG 801
Q + D +S GV E + G
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRG 195
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 30/209 (14%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN--EVTLLSRIHHRNLVQFL 663
KIG G +GVVY + K EI A+K + T E+ LL ++H N+++ L
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 715
+ +G LV+EFM LY + QR + E K G+
Sbjct: 65 DVFRHKGDLYLVFEFMD-----TDLYKLIKDRQR-------GLPESLIKSYLYQLLQGLA 112
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDP 774
+ H+ I+HRDLK N+L++ K++DFGL++ F + +V T Y P
Sbjct: 113 FCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV--TRWYRAP 167
Query: 775 E-YYISQQLTDKSDVYSFGVILLELISGQ 802
E + + D++S G I EL+S +
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
L KK+G+G FG V+ G ++AVK L + F E ++ ++ H LVQ
Sbjct: 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYA 68
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
EE +V E+M G+L + L + + +++A A G+ Y+
Sbjct: 69 VVSEE-PIYIVTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIER---MN 122
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
IHRDL+S+NIL+ + K++DFGL++ D + + + PE + + T
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 785 KSDVYSFGVILLELIS 800
KSDV+SFG++L EL++
Sbjct: 183 KSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 23/216 (10%)
Query: 604 MLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 657
+L+ ++G G FG V+ + +D +AVK L S +++F E LL+ + H+
Sbjct: 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQ 67
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-----------GTLTHEQRINWIKRLEI 706
++V+F G C E ++V+E+M +G L L G ++ + L I
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 707 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSI 764
A A G+ YL + +HRDL + N L+ + + K+ DFG+S+ ++ D V
Sbjct: 128 ASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-YYRVGGR 183
Query: 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ ++ PE + ++ T +SD++SFGV+L E+ +
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 605 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHR 657
L + +G G FG VY G + D E+ V V T S S Q + +F E ++S+ +H+
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR---INWIKRLEIAEDAAKGI 714
N+V+ +G E ++ E M G LK L +R + L A D AKG
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 715 EYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGT--V 769
+YL IHRD+ + N LL AK++DFG+++ + AS+ R +
Sbjct: 130 KYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-DIYRASYYRKGGRAMLPI 185
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
++ PE ++ T K+DV+SFGV+L E+ S
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 41/222 (18%)
Query: 605 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHR 657
L +++G G FG+VY G K +A+K + N+ +R EF NE +++ +
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLE 705
++V+ LG +++V E M G LK +L G T ++ I
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM----- 124
Query: 706 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-------FAVDGA 758
A + A G+ YL +HRDL + N ++ + + K+ DFG+++ + G
Sbjct: 125 -AAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ VR ++ PE T KSDV+SFGV+L E+ +
Sbjct: 181 GLLP--VR----WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 29/209 (13%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQG-----KREFTNEVTLLSRIHHRNL 659
+IG G +G VY + K G+ +A+K + N +G RE + LL ++ H N+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIRE----IKLLQKLRHPNI 60
Query: 660 VQFLGYCQEEGR-SV-LVYEFM-H--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
V+ +G+ S+ +V+E+M H G L T Q ++K+L +G+
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV-KFTESQIKCYMKQL------LEGL 113
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 773
+YLH+ I+HRD+K SNIL++ K++DFGL+ + ++ ++ V T+ Y
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169
Query: 774 PEYYI-SQQLTDKSDVYSFGVILLELISG 801
PE + + + + D++S G IL EL G
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-20
Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 609 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQ 667
+G G FG V+ G LKD +AVK + Q K +F +E +L + H N+V+ +G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 668 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAII 726
+ +V E + G L + + + ++ A DAA G+ YL + C I
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLR---KKKDELKTKQLVKFALDAAAGMAYLESKNC----I 115
Query: 727 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 786
HRDL + N L+ ++ K+SDFG+S+ DG S + + + + PE + + +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 787 DVYSFGVILLELIS 800
DV+S+G++L E S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 6e-20
Identities = 69/238 (28%), Positives = 105/238 (44%), Gaps = 43/238 (18%)
Query: 604 MLEKKIGSGGFGVVYYGK---------LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI 654
+L++++G G FG VY K LK KEI V L N + E LLS++
Sbjct: 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSKL 59
Query: 655 HHRNLVQFLG-------------YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 701
H +V+F YC+ + E H G TL+ Q W
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK-------TLSENQVCEWF 112
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761
+L + G+ Y+H I+HRDLK+ NI L ++ K+ DFG+S+ + G+ +
Sbjct: 113 IQLLL------GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDL 161
Query: 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
++ GT Y+ PE Q KSD++S G IL E+ A + F + IV+
Sbjct: 162 ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 7e-20
Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 607 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLV 660
+ +G G FG V Y D G+++AVK L S + E+ +L ++H N+V
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 661 QFLGYCQEEG-RSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
++ G C E+G + L+ EF+ +G+LKE+L IN ++L+ A KG++YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYLG 126
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTVGYLDPEY 776
+ +HRDL + N+L++ + K+ DFGL+K + V + V + PE
Sbjct: 127 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 777 YISQQLTDKSDVYSFGVILLELIS 800
I + SDV+SFGV L EL++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (225), Expect = 7e-20
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 34/211 (16%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKV---------LTSNSYQGKREFTNEVTLLSRIHH 656
+K+G G +GVVY + K G+ +A+K + S + + E++LL + H
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-------EISLLKELKH 57
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKG 713
N+V+ L E + LV+E+ LK + G L+ N IK I +G
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLS----PNLIKS--IMYQLLRG 110
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYL 772
+ Y H+ I+HRDLK NIL+++ K++DFGL++ F + ++ +V T+ Y
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYR 165
Query: 773 DPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
PE + + + D++S G I E+I+G+
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 9e-20
Identities = 54/201 (26%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 600 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 659
++ K++ KK+G+G FG V+ G + ++AVK L + + F E L+ + H L
Sbjct: 6 ESIKLV-KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKL 63
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
V+ +E ++ E+M G+L + L ++ K ++ + A+G+ Y+
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER 121
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
IHRDL+++N+L+ + + K++DFGL++ D + + + PE
Sbjct: 122 ---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 178
Query: 780 QQLTDKSDVYSFGVILLELIS 800
T KSDV+SFG++L E+++
Sbjct: 179 GSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 7/204 (3%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 656
+I + LEKK+G+G FG V+ ++AVK + S F E ++ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQH 60
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
LV+ +E ++ EFM G+L + L +Q + K ++ + A+G+ +
Sbjct: 61 DKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAF 117
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
+ IHRDL+++NIL+ + K++DFGL++ D + + + PE
Sbjct: 118 IEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174
Query: 777 YISQQLTDKSDVYSFGVILLELIS 800
T KSDV+SFG++L+E+++
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 63/206 (30%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 607 KKIGSGGFGVVYYGKLKD--GKEI--AVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQ 661
KK+G G FGVV G+ GK I AVK L S+ +F E ++ + H NL++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-EIAEDAAKGIEYLHTG 720
G ++V E G+L + L I L + A A G+ YL +
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLDRLR---KDALGHFLISTLCDYAVQIANGMRYLES- 115
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV--GYLDPEYYI 778
IHRDL + NILL + K+ DFGL + H V + PE
Sbjct: 116 --KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 779 SQQLTDKSDVYSFGVILLELIS-GQE 803
++ + SDV+ FGV L E+ + G+E
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEE 199
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLK--DGK--EIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRN 658
L K +G G FG V G+L DG ++AVK L ++Y EF +E + H N
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPN 62
Query: 659 LVQFLGYC------QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI--KRLEIAEDA 710
+++ +G C Q+ + +++ FM +G L L + L+ D
Sbjct: 63 VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122
Query: 711 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS-IVRGTV 769
A G+EYL IHRDL + N +L + M V+DFGLSK G + I + V
Sbjct: 123 ALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQ 802
++ E + T KSDV++FGV + E+ + GQ
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-19
Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 24/206 (11%)
Query: 607 KKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKREF--TNEVTLLSRIHHRNLV 660
K +G G FG V+ + G + A+KVL + + + E +L+ ++H +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTL-----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
+ Q EG+ L+ +F+ G L KE ++ T E + +AE A ++
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF---TEED-----VKFYLAE-LALALD 112
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
+LH+ II+RDLK NILLD+ K++DFGLSK ++D S GTV Y+ PE
Sbjct: 113 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPE 168
Query: 776 YYISQQLTDKSDVYSFGVILLELISG 801
+ T +D +SFGV++ E+++G
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 604 MLEKKIGSGGFGVVYYGKLKDGKE---------------IAVKVLTSNSYQGKR-EFTNE 647
L++K+G G FG V+ + + E +AVK+L ++ + R +F E
Sbjct: 8 RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKE 67
Query: 648 VTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIK 702
+ ++SR+ + N+++ LG C + ++ E+M NG L + L T TH I +
Sbjct: 68 IKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 703 R---LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759
L +A A G++YL + +HRDL + N L+ H K++DFG+S+ G
Sbjct: 128 IANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184
Query: 760 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ + + ++ E + + T SDV++FGV L E+ +
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-19
Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 26/221 (11%)
Query: 601 ATKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTS-NSYQGKREFTNEVTLLSRI 654
A + +E+ +G FG +Y G L + +A+K L N+ Q EF E +L++ +
Sbjct: 6 AVRFMEE-LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL 64
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH-------------EQRINWI 701
HH N+V LG +E +++E+++ G L E L H + ++
Sbjct: 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGAS 759
L IA A G+EYL + +H+DL + NIL+ + + K+SD GLS+ ++ D
Sbjct: 125 DFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSAD-YY 180
Query: 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
V + ++ PE + + + SD++SFGV+L E+ S
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 74/230 (32%), Positives = 111/230 (48%), Gaps = 46/230 (20%)
Query: 599 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEI--AVKVLTS-NSYQGKREFTNEVTLLSRI 654
ED E IG G FG V +K DG ++ A+K+L S R+F E+ +L ++
Sbjct: 2 EDIK--FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59
Query: 655 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTL-----------------KEH-LYGTLTHE 695
HH N++ LG C+ G + E+ G L KEH TLT +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 696 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755
Q L+ A D A G++YL IHRDL + N+L+ +++ +K++DFGLS+
Sbjct: 120 QL------LQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGE- 169
Query: 756 DGASHVSSIVRGTVGYLDPEYYISQQL-----TDKSDVYSFGVILLELIS 800
V+ T+G L + + L T KSDV+SFGV+L E++S
Sbjct: 170 ------EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
KK+G G +G VY K L D + A+K L S S + + + NE+ +L+ ++H N++ +
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 664 GYCQEEGRSVLVYEFMHNGTL-----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+ + +V E+ G L K L EQ I W +++ +G++ LH
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI-WRIFIQLL----RGLQALH 120
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778
I+HRDLKS+NILL + K+ D G+SK +++ GT Y+ PE +
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWK 174
Query: 779 SQQLTDKSDVYSFGVILLELISG 801
+ + KSD++S G +L E+ +
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATF 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 5e-19
Identities = 68/254 (26%), Positives = 96/254 (37%), Gaps = 49/254 (19%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT----NEVTLLSRIHHRNLVQ 661
K IG G FG V+ + KD ++ A+KVL S KR E +L+ +V+
Sbjct: 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDILADADSPWIVK 65
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
Q+E LV E+M G L L E R IAE ++ +H
Sbjct: 66 LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-----TARFYIAELVL-ALDSVHK 119
Query: 720 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGAS------------------ 759
G IHRD+K NIL+D K++DFGL K
Sbjct: 120 LGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 760 ----------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809
+S V GT Y+ PE + D +S GVIL E++ G ++
Sbjct: 176 RRRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234
Query: 810 FGANCRNIVQWVKS 823
I+ W +S
Sbjct: 235 LQETYNKIINWKES 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-19
Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 29/208 (13%)
Query: 609 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ 667
+G G +G+VY + L IA+K + + + E+ L S + HRN+VQ+LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 668 EEGRSVLVYEFMHNGTLKEHL---YGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
E G + E + G+L L +G L +EQ I + + +I E G++YLH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QILE----GLKYLHDN--- 127
Query: 724 AIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
I+HRD+K N+L++ + K+SDFG SK + G + + GT+ Y+ PE +
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSK-RLAGINPCTETFTGTLQYMAPE------V 180
Query: 783 TDK--------SDVYSFGVILLELISGQ 802
DK +D++S G ++E+ +G+
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-19
Identities = 71/223 (31%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 609 IGSGGFGVVYYGKLKD----GKE---IAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLV 660
+GSG FG VY G D G +AVK L + Q K+EF E L+S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYG---TLTHEQRINWIKRLEIAEDAAKGIEYL 717
+ LG C ++ E M G L +L + + L+I D AKG YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 718 HTGCVPAIIHRDLKSSNILL-----DKHMRAKVSDFGLSKFAVDGASHVSSIVRG----T 768
IHRDL + N L+ D K+ DFGL++ D G
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR---DIYKSDYYRKEGEGLLP 176
Query: 769 VGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQE---AISN 807
V ++ PE + + T +SDV+SFGV++ E+++ GQ+ A++N
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN 219
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-18
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 609 IGSGGFGVVYYGKLK-DGKEI--AVKVLTS-NSYQGKREFTNEVTLLSRI-HHRNLVQFL 663
IG G FG V ++K DG + A+K + S R+F E+ +L ++ HH N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR------------LEIAEDAA 711
G C+ G L E+ +G L + L + E + L A D A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
+G++YL IHRDL + NIL+ ++ AK++DFGLS+ V+ T+G
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTMGR 172
Query: 772 LDPEYYISQQL-----TDKSDVYSFGVILLELIS 800
L + + L T SDV+S+GV+L E++S
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 609 IGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGK---REFTNEVTLLSRI-HHRNLVQFL 663
IG G FG V ++ KDG + + Y K R+F E+ +L ++ HH N++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE------------QRINWIKRLEIAEDAA 711
G C+ G L E+ +G L + L + E ++ + L A D A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
+G++YL IHRDL + NIL+ ++ AK++DFGLS+ V+ T+G
Sbjct: 135 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTMGR 184
Query: 772 LDPEYYISQQL-----TDKSDVYSFGVILLELIS 800
L + + L T SDV+S+GV+L E++S
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 61/225 (27%), Positives = 110/225 (48%), Gaps = 31/225 (13%)
Query: 604 MLEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTSNSYQGK-REFTNEVTLLSRIHH 656
+L K +G G FG V K +AVK+L N+ + R+ +E LL +++H
Sbjct: 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNH 62
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------------YGTLTH--EQ 696
++++ G C ++G +L+ E+ G+L+ L L + E+
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 697 RINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756
+ + A ++G++YL ++HRDL + N+L+ + + K+SDFGLS+ +
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 757 GASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
S+V S R V ++ E T +SDV+SFGV+L E+++
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-18
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG 664
+IGSG G VY + G+ A+KV+ N +R+ E+ +L ++H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
G ++ EFM G+L+ + EQ + ++A GI YLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGT---HIADEQFLA-----DVARQILSGIAYLHR---RH 188
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
I+HRD+K SN+L++ K++DFG+S+ +S V GT+ Y+ PE I+ L
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPE-RINTDLNH 246
Query: 785 ------KSDVYSFGVILLELISGQ 802
D++S GV +LE G+
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLG 664
+G GGFG V +++ GK A K L +G+ NE +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS-LA 66
Query: 665 YCQEEGRSV-LVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
Y E ++ LV M+ G LK H+Y G E+ + + A + G+E LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG----RAVFYAAEICCGLEDLHQ-- 120
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
I++RDLK NILLD H ++SD GL+ +G + + GTVGY+ PE +++
Sbjct: 121 -ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNER 177
Query: 782 LTDKSDVYSFGVILLELISGQEAISNEK 809
T D ++ G +L E+I+GQ K
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 61/200 (30%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 609 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 664
+G GGFG V ++K GK A K L + ++ NE +L ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVS-LA 59
Query: 665 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAKGIEYLHTGCV 722
Y E + LV M+ G LK H+Y + R A G+E+LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIY---NVGEPGFPEARAIFYAAQIICGLEHLHQ--- 113
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
I++RDLK N+LLD H ++SD GL+ G GT GY+ PE +
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA--GTPGYMAPEVLQGEVY 171
Query: 783 TDKSDVYSFGVILLELISGQ 802
D ++ G L E+I+G+
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
L+ K+G G FG V+ G ++A+K L + F E ++ ++ H LV
Sbjct: 10 LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLY-GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
EE +V EFM G+L + L G + + + +++A A G+ Y+
Sbjct: 69 VVSEE-PIYIVTEFMGKGSLLDFLKEGDGKY---LKLPQLVDMAAQIADGMAYIER---M 121
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
IHRDL+++NIL+ ++ K++DFGL++ D + + + PE + + T
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 784 DKSDVYSFGVILLELIS 800
KSDV+SFG++L EL++
Sbjct: 182 IKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 27/219 (12%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT----SNSYQGK--REFTNEVTLLSRIHHRNL 659
+++G+G F Y + +K G +AVK +T ++S Q + E+ L++R++H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
++ LG E+ L E+M G++ L YG IN+ ++L +G+ YL
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSYL 119
Query: 718 HTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLS-KFAVD--GASHVSSIVRGTVGYLD 773
H IIHRD+K +N+L+D R +++DFG + + A GA + GT+ ++
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 774 PEYYISQQLTDKSDVYSFGVILLELISGQ-----EAISN 807
PE +Q DV+S G +++E+ + + E SN
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 607 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
KIG G G+V G+++AVK + Q + NEV ++ H N+V+
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 666 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 725
+V EF+ G L + + T +E++I + K + +LH +
Sbjct: 85 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLAVLKALSFLHA---QGV 136
Query: 726 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD- 784
IHRD+KS +ILL R K+SDFG S+V GT ++ PE IS+
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPE-VISRLPYGT 194
Query: 785 KSDVYSFGVILLELISGQEAISNE 808
+ D++S G++++E++ G+ NE
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYFNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 21/219 (9%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFL 663
KKIG G FG K K DGK+ +K + + K E EV +LS + H N+VQ+
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 719
+E G +V ++ G L + + G L E +I +W ++ +A ++++H
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHD 119
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
I+HRD+KS NI L K K+ DFG+++ ++ ++ GT YL PE +
Sbjct: 120 ---RKILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYYLSPEICEN 175
Query: 780 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818
+ +KSD+++ G +L E+ + + A N +N+V
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAFE----AGNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-18
Identities = 64/224 (28%), Positives = 112/224 (50%), Gaps = 34/224 (15%)
Query: 604 MLEKKIGSGGFGVVY----YGKLKDGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRI 654
+L K +G G FG V YG K + +AVK+L N + + + +E+ L+ I
Sbjct: 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLI 74
Query: 655 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY------------GTLTHEQRINWI 701
H+N++ LG C +EG ++ E+ G L+E L T E+++++
Sbjct: 75 GKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++ G +
Sbjct: 135 DLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDI 187
Query: 762 -----SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+S R V ++ PE + T +SDV+SFG+++ E+ +
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 7e-18
Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 53/229 (23%)
Query: 595 LSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKR------EFT 645
L +D K+ ++IG G FG VY+ + E+ A+K + SY GK+ +
Sbjct: 7 LFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKM---SYSGKQSNEKWQDII 63
Query: 646 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF----------MHNGTLKEHLYGTLTHE 695
EV L ++ H N +++ G E + LV E+ +H L+E
Sbjct: 64 KEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQE--------- 114
Query: 696 QRINWIKRLEIA---EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
+EIA A +G+ YLH+ IHRD+K+ NILL + K++DFG +
Sbjct: 115 --------VEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSAS 163
Query: 753 FAVDGASHVSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLEL 798
S V GT ++ PE ++ Q K DV+S G+ +EL
Sbjct: 164 LVSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 57/201 (28%), Positives = 105/201 (52%), Gaps = 16/201 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ +K+G G +G VY K+ G+ +A+KV+ +E E+++L + +V++
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYY 64
Query: 664 GYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
G + +V E+ G+ + + TLT E+ I I KG+EYLH+
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLT-EEEIAAILY-----QTLKGLEYLHSN 118
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
IHRD+K+ NILL++ +AK++DFG+S D + ++++ GT ++ PE
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEI 174
Query: 781 QLTDKSDVYSFGVILLELISG 801
+K+D++S G+ +E+ G
Sbjct: 175 GYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 8e-18
Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 608 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666
KIG G G+V K GK++AVK + Q + NEV ++ HH N+V
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 667 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 726
+V EF+ G L + + T +E++I + + + YLH +I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLHN---QGVI 140
Query: 727 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 786
HRD+KS +ILL R K+SDFG S+V GT ++ PE +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199
Query: 787 DVYSFGVILLELISGQEAISNE 808
D++S G++++E+I G+ NE
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNE 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 600 DATKMLEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGK-REFTNEVTLLSRIHHR 657
D +++E IG G VVY E +A+K + Q E EV +S+ +H
Sbjct: 1 DDYELIEV-IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 658 NLVQFLGYCQ-EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA---EDAAK 712
N+V++ Y G + LV ++ G+L + + IA ++ K
Sbjct: 60 NVVKY--YTSFVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAIIATVLKEVLK 113
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR----GT 768
G+EYLH+ IHRD+K+ NILL + K++DFG+S DG + VR GT
Sbjct: 114 GLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD-RTRKVRKTFVGT 169
Query: 769 VGYLDPEYYISQQ--LTDKSDVYSFGVILLELISG 801
++ PE + Q K+D++SFG+ +EL +G
Sbjct: 170 PCWMAPE-VMEQVHGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 12/218 (5%)
Query: 594 TLSDIEDATKMLEK--KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTL 650
T+ I D K + KIG G G V+ + G+E+A+K + K NE+ +
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69
Query: 651 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 710
+ + + N+V FL +V E++ G+L + + T E +I + R +
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR-----EC 124
Query: 711 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770
+ +E+LH +IHRD+KS N+LL K++DFG S S++V GT
Sbjct: 125 LQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY 180
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808
++ PE + K D++S G++ +E++ G+ NE
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 31/212 (14%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
L ++IGSG +G VY + + G+ +A+KV+ E+++L H N+V +
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLY----GTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
G + +V E+ G+L++ +Y G L+ E +I ++ R + KG+ YLH
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLS-ELQIAYVCR-----ETLKGLAYLHE 119
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR-----GTVGYLDP 774
IHRD+K +NILL + K++DFG+S A ++I + GT ++ P
Sbjct: 120 TGK---IHRDIKGANILLTEDGDVKLADFGVS------AQLTATIAKRKSFIGTPYWMAP 170
Query: 775 EYYISQQLTD----KSDVYSFGVILLELISGQ 802
E + + K D+++ G+ +EL Q
Sbjct: 171 E-VAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 14/219 (6%)
Query: 594 TLSDIEDATKMLEK--KIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTL 650
T+ + D K + KIG G G VY + G+E+A+K + K NE+ +
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 651 LSRIHHRNLVQFL-GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 709
+ H N+V +L Y + V V E++ G+L + + T E +I + R +
Sbjct: 70 MRENKHPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTETCMDEGQIAAVCR-----E 123
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
+ +E+LH+ V IHRD+KS NILL K++DFG S S++V GT
Sbjct: 124 CLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTP 179
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808
++ PE + K D++S G++ +E++ G+ NE
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 608 KIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLG 664
+G G +GVV + K EI A+K S + ++ EV +L ++ H N+V
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHL----YGTLTHE-QRINWIKRLEIAEDAAKGIEYLHT 719
+ +GR LV+E++ TL E L G + W + I Y H+
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIW--------QLLQAIAYCHS 118
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI 778
IIHRD+K NIL+ + K+ DFG ++ AS ++ V T Y PE +
Sbjct: 119 H---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLV 174
Query: 779 SQQLTDKS-DVYSFGVILLELISGQ 802
K DV++ G I+ EL+ G+
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 14/210 (6%)
Query: 597 DIEDATKMLEK--KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSR 653
D D +LE KIG G G+V + K G+++AVK++ Q + NEV ++
Sbjct: 15 DQGDPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD 74
Query: 654 IHHRNLVQ-FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 712
H+N+V+ + Y E VL+ EF+ G L + + + R+N + + E +
Sbjct: 75 YQHQNVVEMYKSYLVGEELWVLM-EFLQGGALTD-----IVSQTRLNEEQIATVCESVLQ 128
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 772
+ YLH+ +IHRD+KS +ILL R K+SDFG S+V GT ++
Sbjct: 129 ALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWM 184
Query: 773 DPEYYISQQLTDKSDVYSFGVILLELISGQ 802
PE + D++S G++++E++ G+
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 607 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQ 661
++GSG FG V Y K K +AVK+L +N K E E ++ ++ + +V+
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
+G C+ E +LV E G L + L + + E+ + G++YL
Sbjct: 61 MIGICEAESW-MLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEET- 114
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYIS 779
+HRDL + N+LL AK+SDFGLSK ++ + G V + PE
Sbjct: 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 780 QQLTDKSDVYSFGVILLELIS-GQE 803
+ + KSDV+SFGV++ E S GQ+
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 607 KKIGSGGFGVVYYG-KLKDGKEIAVKVLT--SNSYQGKREFTN---EVTLLSRIHHRNLV 660
K +G G FG VY + G+E+A K + S + +E + E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 661 QFLGYCQEEGRSVLV--YEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEY 716
Q+ G ++ L E+M G++K+ L YG LT + +++ +G+ Y
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGMSY 121
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDGASHVSSIVRGTVGYL 772
LH+ I+HRD+K +NIL D K+ DFG SK + G S V GT ++
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS--VTGTPYWM 176
Query: 773 DPEYYISQQLTDKSDVYSFGVILLELIS 800
PE + K+DV+S G ++E+++
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSN--SYQGKREFTN---EVTLLSRIHHRN 658
L K +G G FG VY D G+E+AVK + + S + +E E+ LL + H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 659 LVQFLGYCQEEGRSVL--VYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGI 714
+VQ+ G ++ L E M G++K+ L YG LT + +++ +G+
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI------LEGV 119
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDGASHVSSIVRGTVG 770
YLH+ I+HRD+K +NIL D K+ DFG SK + G S V GT
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPY 174
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELIS 800
++ PE + K+D++S G ++E+++
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 17/202 (8%)
Query: 612 GGFGVVYYGKLKDGK-----EIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQFLGY 665
G FG ++YG L D K E+ VK + ++ + + E LL + H+N++ L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 666 CQEEGRSVLV-YEFMHNGTLKEHL----YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
C E+G V Y +M+ G LK L G + Q ++ + + +A A G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK- 135
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSIVRGTVGYLDPEYYI 778
+IH+D+ + N ++D+ ++ K++D LS+ F +D + R V ++ E +
Sbjct: 136 --RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR-PVKWMALESLV 192
Query: 779 SQQLTDKSDVYSFGVILLELIS 800
+++ + SDV+SFGV+L EL++
Sbjct: 193 NKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 6e-17
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 33/208 (15%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSY--QGKREFT-NEVTLLSRIHHRNLVQF 662
K +G+G FG V + K + A+K+L+ + E NE +L I H LV
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 714
G Q++ LV E++ G L HL R E A+ +
Sbjct: 67 YGSFQDDSNLYLVMEYVPGGELFSHL----------RKSGRFP--EPVARFYAAQVVLAL 114
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
EYLH+ I++RDLK N+LLD K++DFG +K + GT YL P
Sbjct: 115 EYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAP 167
Query: 775 EYYISQQLTDKS-DVYSFGVILLELISG 801
E I + K+ D ++ G+++ E+++G
Sbjct: 168 E-IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 23/222 (10%)
Query: 607 KKIGSGGFGVVY----YGKLKDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNL 659
+++G G FG+VY G +KD E V + T N RE F NE +++ + ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI------KRLEIAEDAAKG 713
V+ LG + ++++ E M G LK +L + K +++A + A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--TVGY 771
+ YL+ +HRDL + N ++ + K+ DFG+++ + + +G V +
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGGKGLLPVRW 187
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEK 809
+ PE T SDV+SFGV+L E+ + E +SNE+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 7e-17
Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 25/220 (11%)
Query: 599 EDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKR------EFTNEVTL 650
ED K+ ++IG G FG VY+ + D + V + SY GK+ + EV
Sbjct: 21 EDPEKLFTDLREIGHGSFGAVYFAR--DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKF 78
Query: 651 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 710
L RI H N +++ G E + LV E+ G+ + L H++ + ++ I A
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAITHGA 134
Query: 711 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770
+G+ YLH+ +IHRD+K+ NILL + + K++DFG + A S V GT
Sbjct: 135 LQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPY 186
Query: 771 YLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISN 807
++ PE ++ Q K DV+S G+ +EL + + N
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 8e-17
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 607 KKIGSGGFGVVY----YGKLKDGK--EIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 658
K +G+G FG V YG K ++AVK+L ++ +RE +E+ ++S + +H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+V LG C G +++ E+ G L L E + L + AKG+ +L
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 719 T-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT----VGYLD 773
+ C IHRDL + N+LL K+ DFGL++ D + + +V+G V ++
Sbjct: 159 SKNC----IHRDLAARNVLLTHGKIVKICDFGLAR---DIMNDSNYVVKGNARLPVKWMA 211
Query: 774 PEYYISQQLTDKSDVYSFGVILLELIS 800
PE + T +SDV+S+G++L E+ S
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 9e-17
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 608 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666
KIG G G+V +K GK +AVK + Q + NEV ++ H N+V+
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 667 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 726
+V EF+ G L + + T +E++I + K + LH +I
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QGVI 138
Query: 727 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 786
HRD+KS +ILL R K+SDFG S+V GT ++ PE +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEV 197
Query: 787 DVYSFGVILLELISGQEAISNE 808
D++S G++++E++ G+ NE
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 19/209 (9%)
Query: 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 664
+G GGFG V +++ GK A K L + ++ NE +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 66
Query: 665 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTG 720
Y E ++ LV M+ G LK H+Y E+R + A + G+E LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY-----AAEITCGLEDLHR- 120
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
I++RDLK NILLD + ++SD GL+ +G + + GTVGY+ PE ++
Sbjct: 121 --ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPEVVKNE 176
Query: 781 QLTDKSDVYSFGVILLELISGQEAISNEK 809
+ T D + G ++ E+I G+ K
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 608 KIGSGGFGVVYYGKLKDGK---EIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFL 663
++GSG FG V G K K ++A+KVL + + + R E E ++ ++ + +V+ +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
G C+ E +LV E G L + L G + I +E+ + G++YL
Sbjct: 62 GVCEAEAL-MLVMEMASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEG---K 114
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGASHVSSIVRGTVGYLDPEYYISQQ 781
+HRDL + N+LL AK+SDFGLSK A D S + + + PE ++
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 782 LTDKSDVYSFGVILLELIS-GQE 803
+ +SDV+S+G+ + E S GQ+
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTN---EVTLLSRIHHRN 658
L K +G G FG VY D G+E+AVK + +S + +E E+ LL + H
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 659 LVQFLGYCQ--EEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGI 714
+VQ+ G + EE + + E+M G++K+ L YG LT + +++ +G+
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI------LQGV 119
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDGASHVSSIVRGTVG 770
YLH+ I+HRD+K +NIL D K+ DFG SK + G S V GT
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS--VTGTPY 174
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELIS 800
++ PE + K+DV+S ++E+++
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+KIG G +GVVY + G+ +A+K L + + E++LL ++H N+V+ L
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
E + LV+EF+H LK+ + + + IK +G+ + H+ V
Sbjct: 66 DVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCHSHRV- 121
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 781
+HRDLK N+L++ K++DFGL++ F V ++ +V T+ Y PE + +
Sbjct: 122 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 177
Query: 782 LTDKSDVYSFGVILLELIS 800
+ D++S G I E+++
Sbjct: 178 YSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 607 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
+KIG G G VY + G+E+A++ + K NE+ ++ + N+V +L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 666 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 725
+V E++ G+L + + T E +I + R + + +E+LH+ +
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSN---QV 137
Query: 726 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 785
IHRD+KS NILL K++DFG S S++V GT ++ PE + K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196
Query: 786 SDVYSFGVILLELISGQEAISNE 808
D++S G++ +E+I G+ NE
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 607 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
+KIG G G VY + G+E+A+K + K NE+ ++ + N+V +L
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 666 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 725
+V E++ G+L + + T E +I + R + + +++LH+ +
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALDFLHSN---QV 136
Query: 726 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 785
IHRD+KS NILL K++DFG S S++V GT ++ PE + K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 786 SDVYSFGVILLELISGQEAISNE 808
D++S G++ +E++ G+ NE
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 606 EKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN-----EVTLLSRIHHRNL 659
KK+G G + VVY + + G+ +A+K + + ++ N E+ LL + H N+
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG----TLTHEQRINWIKRLEIAEDAAKGIE 715
+ L + LV+EFM T E + LT +++ +G+E
Sbjct: 65 IGLLDVFGHKSNINLVFEFME--TDLEKVIKDKSIVLTPADIKSYMLMT------LRGLE 116
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
YLH+ I+HRDLK +N+L+ K++DFGL++ ++ V T Y PE
Sbjct: 117 YLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPE 172
Query: 776 -YYISQQLTDKSDVYSFGVILLELI 799
+ ++ D++S G I EL+
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 605 LEKKIGSGGFGVVY---YGKLKDGK-EIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 659
L + IG G FG VY Y ++ K +AVK + + RE F E ++ + H ++
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI---AEDAAKGIEY 716
V+ +G E +V E G L+ +L + + + + + + Y
Sbjct: 70 VKLIGVI-TENPVWIVMELAPLGELRSYL------QVNKYSLDLASLILYSYQLSTALAY 122
Query: 717 LH-TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
L V HRD+ + N+L+ K+ DFGLS++ D + + +S + + ++ PE
Sbjct: 123 LESKRFV----HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 776 YYISQQLTDKSDVYSFGVILLELIS 800
++ T SDV+ FGV + E++
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 662
L + IG G +G VY + K G+ +A+K++ + E E +L + +H N+ F
Sbjct: 10 LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATF 68
Query: 663 LG-YCQEEGRSV-----LVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIAEDAAKGI 714
G + ++ LV E G++ + + G +R+ WI I + +G+
Sbjct: 69 YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILRETLRGL 126
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
YLH V IHRD+K NILL K+ K+ DFG+S +D + GT ++ P
Sbjct: 127 AYLHENKV---IHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLGRRNTFIGTPYWMAP 182
Query: 775 EYYISQQLTD-----KSDVYSFGVILLELISGQ 802
E + D +SDV+S G+ +EL G+
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 57/220 (25%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 605 LEKKIGSGGFGVVYYG--------KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI- 654
L K +G G FG V K K+ +AVK+L ++ + + +E+ ++ I
Sbjct: 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 78
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIK 702
H+N++ LG C ++G ++ E+ G L+E+L ++++ +
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 703 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762
+ A+G+EYL + IHRDL + N+L+ ++ K++DFGL++ V+ +
Sbjct: 139 LVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR-DVNNIDYYK 194
Query: 763 SIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
G V ++ PE + T +SDV+SFGV++ E+ +
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 62/224 (27%), Positives = 113/224 (50%), Gaps = 34/224 (15%)
Query: 604 MLEKKIGSGGFGVVYYG------KLKDGK--EIAVKVLTSNSYQGK-REFTNEVTLLSRI 654
+L K +G G FG V K K + ++AVK+L S++ + + +E+ ++ I
Sbjct: 21 VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 80
Query: 655 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWI 701
H+N++ LG C ++G ++ E+ G L+E+L T E+++++
Sbjct: 81 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++ H+
Sbjct: 141 DLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 193
Query: 762 SSIVRGTVG-----YLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ T G ++ PE + T +SDV+SFGV+L E+ +
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLG 664
+G GGFG V +++ GK A K L +G+ NE +L +++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN-LA 66
Query: 665 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTG 720
Y E ++ LV M+ G LK H+Y E+R L A + G+E LH
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERA-----LFYAAEILCGLEDLHR- 120
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
++RDLK NILLD + ++SD GL+ +G S + GTVGY+ PE +Q
Sbjct: 121 --ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLNNQ 176
Query: 781 QLTDKSDVYSFGVILLELISGQEAISNEK 809
+ T D + G ++ E+I GQ K
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 20/226 (8%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIA---VKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 660
+EKKIG G F VVY L DG+ +A V++ + +++ E+ LL ++ H N++
Sbjct: 6 IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVI 65
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIE 715
++L E +V E G L + L E+ I W +++ +E
Sbjct: 66 KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-WKYFVQLCS----ALE 120
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
++H+ I+HRD+K +N+ + K+ D GL +F + S+V GT Y+ PE
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG--ANCRNIVQ 819
KSD++S G +L E+ + Q +K + C+ I +
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 40/225 (17%)
Query: 605 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 656
L K +G G FG V + +AVK+L ++ + + +E+ ++ I H
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 75
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRL 704
+N++ LG C +EG +V E+ +G L++ L E+ + +
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 705 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS---------KFAV 755
A A+G+E+L + IHRDL + N+L+ + K++DFGL+ +
Sbjct: 136 SFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+G R V ++ PE + T +SDV+SFGV+L E+ +
Sbjct: 193 NG--------RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 27/225 (12%)
Query: 608 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGK---REFTNEVTLLSRIHHRNLVQFL 663
++G GG+G V+ K KD EI A+K + + R E +L+ LV+ L
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
Q++ L E++ G + L G L+ + R +AE ++ LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH-----ARFYMAEMFE-AVDALHE-- 119
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
IHRDLK N L+D K++DFGLSK V ++ +S+V G+ Y+ PE +
Sbjct: 120 -LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV---TYANSVV-GSPDYMAPEVLRGKG 174
Query: 782 LTDKSDVYSFGVILLELISGQEAIS----NEKFGANCRNIVQWVK 822
D +S G +L E + G S NE + N+ W +
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW----ENLKYWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 54/207 (26%), Positives = 105/207 (50%), Gaps = 17/207 (8%)
Query: 609 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRIHH---RNLVQFL 663
IG G +G VY GK + G+ +A+K++ ++ + EV LLS++ N+ ++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 664 GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
G +G + ++ E+ G+++ + E+ I+ I R + ++Y+H
Sbjct: 69 G-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIHKV-- 120
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
+IHRD+K++NIL+ K+ DFG++ +S S+ V GT ++ PE +
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 783 TD-KSDVYSFGVILLELISGQEAISNE 808
D K+D++S G+ + E+ +G S+
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDV 205
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 66/201 (32%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 661
K IG G FG V K K DGK AVKVL + K+E LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
Q + V ++++ G L HL E+ + A + A + YLH+
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHL----QRERSFPEPRARFYAAEIASALGYLHS-- 114
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
II+RDLK NILLD ++DFGL K ++ + S+ GT YL PE + +Q
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPE-VLRKQ 171
Query: 782 LTDKS-DVYSFGVILLELISG 801
D++ D + G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN-EVTLLSRIHHRNLVQF 662
L + IG G FG VY K + +A+KV+ + + E E+ LS+ + ++
Sbjct: 5 LLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKY 64
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHL-YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
G + + ++ E+ G+ + L G L E I +I R + G+EYLH
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGSCLDLLKPGKL-DETYIAFILR-----EVLLGLEYLHEEG 118
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
IHRD+K++NILL + K++DFG+S S ++ V GT ++ PE I Q
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPE-VIKQS 173
Query: 782 LTD-KSDVYSFGVILLELISG 801
D K+D++S G+ +EL G
Sbjct: 174 GYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-16
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 25/210 (11%)
Query: 608 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKR------EFTNEVTLLSRIHHRNLV 660
+IG G FG VY+ E+ AVK + SY GK+ + EV L ++ H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKM---SYSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
++ G +E + LV E+ G+ + L H++ + ++ I A +G+ YLH+
Sbjct: 85 EYKGCYLKEHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
+IHRD+K+ NILL + + K++DFG + + S V GT ++ PE ++
Sbjct: 141 N---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAM 192
Query: 781 ---QLTDKSDVYSFGVILLELISGQEAISN 807
Q K DV+S G+ +EL + + N
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPLFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 6e-16
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 19/214 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTS--NSYQGKREFTNEVTLLSRIHHRN 658
L + +G G FG V +LK +++AVK+L + S EF E + H N
Sbjct: 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPN 62
Query: 659 LVQFLG---YCQEEGR---SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR--LEIAEDA 710
+++ +G + +GR +++ FM +G L L + E+ + + D
Sbjct: 63 VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122
Query: 711 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTV 769
A G+EYL + IHRDL + N +L+++M V+DFGLSK G + + V
Sbjct: 123 ASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQ 802
+L E T SDV++FGV + E+++ GQ
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 9e-16
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEI---AVKVLTSN--SYQGKREFTNEVTLLSRIHHRNL 659
L K +G G FG V G+L I AVK + + +F +E + H N+
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62
Query: 660 VQFLGYC----QEEG--RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL--EIAEDAA 711
++ +G C + EG V++ FM +G L L + + ++ + D A
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS-IVRGTVG 770
G+EYL + + IHRDL + N +L+++M V+DFGLSK +G + I + V
Sbjct: 123 SGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELIS-GQ 802
++ E + T KSDV+SFGV + E+ + GQ
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQ 212
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 9e-16
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 608 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFLG 664
+IG G G+V+ K + G+ +A+K + +G + E+ L H +V+ L
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR---INWIKRLEIAEDAAKGIEYLHTGC 721
VLV E+M + L L E+R +K KG+ Y+H
Sbjct: 67 VFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSY--MRMLLKGVAYMHAN- 118
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE-YYISQ 780
I+HRDLK +N+L+ K++DFGL++ + + S T Y PE Y ++
Sbjct: 119 --GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 781 QLTDKSDVYSFGVILLELISGQ 802
+ D+++ G I EL++G
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 604 MLEKKIGSGGFG--VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+ + +G G FG ++ D K ++ S + E LL+++ H N+V
Sbjct: 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYL 717
F + +G +V E+ G L + + G L E I W ++ + G++++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 777
H ++HRD+KS NI L ++ + K+ DFG ++ ++ + V GT Y+ PE +
Sbjct: 117 HE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIW 172
Query: 778 ISQQLTDKSDVYSFGVILLEL 798
+ +KSD++S G IL EL
Sbjct: 173 ENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 609 IGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRI---HHRNLVQF 662
IG G +G VY + L G+ +A+K V S +G T E+ LL ++ H N+V+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 663 LGYCQ----EEGRSV-LVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
L C + + LV+E + T + I + R ++ +G++
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR-QLL----RGVD 121
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
+LH+ I+HRDLK NIL+ + K++DFGL++ + S +V T+ Y PE
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPE 176
Query: 776 YYISQQLTDKSDVYSFGVILLEL 798
+ D++S G I EL
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG 664
+G+G G V K + G +A KV+ + +++ E+ ++ +V F G
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
E + EFM G+L G + E +IA +G+ YL+ V
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVE------ILGKIAVAVVEGLTYLYN--V 122
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
I+HRD+K SNIL++ + K+ DFG+S ++ ++ GT Y+ PE +
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMSPERIQGGKY 179
Query: 783 TDKSDVYSFGVILLELISGQ 802
T KSDV+S G+ ++EL G+
Sbjct: 180 TVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT-----NEVTLLSR------I 654
K +G G FG V +LK E A+K L K++ E T++ R
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKAL-------KKDVVLEDDDVECTMVERRVLALAW 53
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
H L Q + V E+++ G L H+ + ++ EI G+
Sbjct: 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEII----CGL 109
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
++LH II+RDLK N+LLDK K++DFG+ K ++G S+ GT Y+ P
Sbjct: 110 QFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAP 165
Query: 775 EYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808
E Q+ + D +SFGV+L E++ GQ E
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 606 EK--KIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQG-KREFTNEVTLLSRIHHRNLV 660
EK +IG G +G+VY + EI KV N G E+TLL + H N+V
Sbjct: 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIV 69
Query: 661 QFLGYCQEEGRSV----LVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
+ G+ + LV E+ +L +++ + Q +K L + +G+
Sbjct: 70 ELKEVVV--GKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQ----VKCLML--QLLRGL 121
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
+YLH IIHRDLK SN+LL K++DFGL++ A ++ V T+ Y P
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAP 177
Query: 775 EYYI-SQQLTDKSDVYSFGVILLELISGQ 802
E + T D+++ G IL EL++ +
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 26/221 (11%)
Query: 588 EAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---- 642
+ A F D E L ++IG G FG VY+ + +++ + +A+K + SY GK+
Sbjct: 3 DVAELFFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKM---SYSGKQSNEK 58
Query: 643 --EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 700
+ EV L ++ H N +Q+ G E + LV E+ G+ + L H++ +
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQE 114
Query: 701 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760
++ + A +G+ YLH+ +IHRD+K+ NILL + K+ DFG +
Sbjct: 115 VEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF 171
Query: 761 VSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLEL 798
V GT ++ PE ++ Q K DV+S G+ +EL
Sbjct: 172 V-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 14/206 (6%)
Query: 600 DATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHH 656
D TK+ +KIG G +GVVY G+ K G+ +A+K + S + T E++LL + H
Sbjct: 1 DYTKI--EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH 58
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
N+V +E R L++EF+ + LK++L +L Q ++ +GI +
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFL-SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE 775
H+ ++HRDLK N+L+D K++DFGL++ F + + +V T+ Y PE
Sbjct: 117 CHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPE 171
Query: 776 YYI-SQQLTDKSDVYSFGVILLELIS 800
+ S + + D++S G I E+ +
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 67/216 (31%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTN-EVTLLS 652
D+ D + E IGSG G VY + K G +AVK + T N + KR + +V L S
Sbjct: 13 DLNDLENLGE--IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS 70
Query: 653 RIHHR--NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 710
H +V+ GY + + E M T + L + + + ++ +A
Sbjct: 71 ---HDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVA--I 123
Query: 711 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770
K + YL +IHRD+K SNILLD K+ DFG+S VD + S G
Sbjct: 124 VKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS--AGCAA 179
Query: 771 YLDPEYYISQQLTDK----SDVYSFGVILLELISGQ 802
Y+ PE K +DV+S G+ L+EL +GQ
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 59/208 (28%), Positives = 107/208 (51%), Gaps = 12/208 (5%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI 654
D E+ LEK IG G FG V+ G + K +A+K++ + + E E+T+LS+
Sbjct: 1 DPEELFTKLEK-IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
+ ++ G ++ + ++ E++ G+ + L E +I I R + KG+
Sbjct: 60 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGL 114
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
+YLH+ IHRD+K++N+LL +H K++DFG++ D ++ V GT ++ P
Sbjct: 115 DYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 170
Query: 775 EYYISQQLTDKSDVYSFGVILLELISGQ 802
E K+D++S G+ +EL G+
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 30/237 (12%)
Query: 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLG 664
+G GGFG V +++ GK A K L + ++ + E +L+++H R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
Q + LV M+ G L+ H+Y + G+E+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
II+RDLK N+LLD ++SD GL+ DG S GT G++ PE ++
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEEYDF 176
Query: 785 KSDVYSFGVILLELISGQ-------EAISN---------------EKFGANCRNIVQ 819
D ++ GV L E+I+ + E + N +KF ++ +
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCE 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEI----AVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLV 660
K +GSG FG V+ G + +G I A+K + S Q +E T+ + + + H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 661 QFLGYCQEEGRSV-LVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEY 716
+ LG C G S+ LV + G+L +H+ +L ++ +NW ++ AKG+ Y
Sbjct: 73 RLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYY 124
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPE 775
L ++HR+L + NILL +++DFG++ D + S + + ++ E
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 776 YYISQQLTDKSDVYSFGVILLELIS 800
+ + T +SDV+S+GV + E++S
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 58/221 (26%), Positives = 109/221 (49%), Gaps = 18/221 (8%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ +G G +G V + + DGK+ +K L + S + ++ E LLS++ H N+V +
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 664 GYCQ-EEGRSVLVYEFMHNG----TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+ E+G +V F G LKE L Q + W ++ +A ++YLH
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQYLH 119
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778
I+HRDLK+ N+ L + KV D G+++ ++ ++S + GT Y+ PE +
Sbjct: 120 E---KHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPELFS 175
Query: 779 SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
++ KSDV++ G + E+ + + A + + + I++
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 6e-15
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSR------IHHRNL 659
K +G G FG V+ +LK + A+K L + + E T++ + H L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFL 58
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
Q + V E+++ G L H+ + + + A + G+++LH+
Sbjct: 59 THLYCTFQTKENLFFVMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHS 114
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
I++RDLK NILLD K++DFG+ K + G + + GT Y+ PE +
Sbjct: 115 ---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLG 170
Query: 780 QQLTDKSDVYSFGVILLELISGQ 802
Q+ D +SFGV+L E++ GQ
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 19/209 (9%)
Query: 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLG 664
+G GGFG V +++ GK A K L +G+ NE +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS-LA 66
Query: 665 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTG 720
Y E ++ LV M+ G LK H+Y EQR + A + G+E L
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRA-----IFYAAELCCGLEDLQR- 120
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
I++RDLK NILLD ++SD GL+ +G + + GTVGY+ PE ++
Sbjct: 121 --ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVINNE 176
Query: 781 QLTDKSDVYSFGVILLELISGQEAISNEK 809
+ T D + G ++ E+I GQ K
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 7e-15
Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEI----AVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLV 660
K +GSG FG VY G + +G+ + A+K+L + + EF +E +++ + H +LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
+ LG C LV + M +G L ++++ H+ I L AKG+ YL
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVH---EHKDNIGSQLLLNWCVQIAKGMMYLEE- 127
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYIS 779
++HRDL + N+L+ K++DFGL++ D + + + + ++ E
Sbjct: 128 --RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 780 QQLTDKSDVYSFGVILLELIS 800
++ T +SDV+S+GV + EL++
Sbjct: 186 RKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 66/229 (28%), Positives = 98/229 (42%), Gaps = 29/229 (12%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR-----NLV 660
K I G FG VY K + G A+KVL + K + TN V I +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTN-VKAERAIMMIQGESPYVA 60
Query: 661 QFLGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
+ Q + LV E+++ G +L + L G L + W K+ IAE G+E L
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPED----WAKQY-IAE-VVLGVEDL 113
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 777
H IIHRD+K N+L+D+ K++DFGLS+ + GT YL PE
Sbjct: 114 HQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETI 165
Query: 778 ISQQLTDKSDVYSFGVILLELISGQ---EAISNEKFGANC-RNIVQWVK 822
+ SD +S G ++ E + G A + + N + W +
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE 214
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ 667
+G G FG VY + K+ A K++ S + +F E+ +LS H N+V
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 668 EEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
E + ++ EF G L L LT E +I ++ R + + +LH+
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLT-EPQIRYVCR-----QMLEALNFLHSH---K 123
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
+IHRDLK+ NILL K++DFG+S + + GT ++ PE + D
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKD 182
Query: 785 -----KSDVYSFGVILLEL 798
K+D++S G+ L+EL
Sbjct: 183 NPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV----- 660
K +G G FG V +LK G+ AVK L + + E T++ + R L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDV--ECTMVEK---RVLALAWEN 55
Query: 661 QFLG--YC--QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
FL YC Q + V EF++ G L H+ + R + + A + G+++
Sbjct: 56 PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHI----QDKGRFDLYRATFYAAEIVCGLQF 111
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
LH+ II+RDLK N++LD+ K++DFG+ K V G + S+ GT Y+ PE
Sbjct: 112 LHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEI 167
Query: 777 YISQQLTDKSDVYSFGVILLELISGQ 802
+ T D +SFGV+L E++ GQ
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 56/204 (27%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEI----AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLV 660
K +GSG FG VY G + DG+ + A+KVL N S + +E +E +++ + +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYL 717
+ LG C LV + M G L +++ + + +NW ++ AKG+ YL
Sbjct: 73 RLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL 125
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA-VDGASHVSSIVRGTVGYLDPEY 776
++HRDL + N+L+ K++DFGL++ +D + + + + ++ E
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 777 YISQQLTDKSDVYSFGVILLELIS 800
+ ++ T +SDV+S+GV + EL++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 608 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666
++G G FG VY K K+ G A KV+ + S + ++ E+ +L+ +H +V+ LG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 667 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 726
+G+ ++ EF G + + L ++ + + I + ++YLH+ II
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVICRQMLEALQYLHS---MKII 132
Query: 727 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-- 784
HRDLK+ N+LL K++DFG+S V S + GT ++ PE + + + D
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTP 191
Query: 785 ---KSDVYSFGVILLEL 798
K+D++S G+ L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-14
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 26/200 (13%)
Query: 625 GKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFL--GYCQEEGRSVLVYEFM 679
G E+A+K+L +++ + + + F E L +R++H N+V L G G V+E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 680 HNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 737
TL+E L G L + + ++ A A H I+HRDLK NI++
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACA------HNQ---GIVHRDLKPQNIMV 112
Query: 738 ---DKHMRAKVSDFGLSKFAVD-GASHVSSIVR-----GTVGYLDPEYYISQQLTDKSDV 788
AKV DFG+ + V+++ R GT Y PE + +T SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 789 YSFGVILLELISGQEAISNE 808
Y++G+I LE ++GQ +
Sbjct: 173 YAWGLIFLECLTGQRVVQGA 192
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 59/208 (28%), Positives = 109/208 (52%), Gaps = 22/208 (10%)
Query: 603 KMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLV 660
K LEK +G G + VY G+ + EI A+K + ++ +G E++L+ + H N+V
Sbjct: 3 KQLEK-LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIE 715
+ E + +LV+E+M + LK+++ G L ++ +L KGI
Sbjct: 62 RLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL------LKGIA 114
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDP 774
+ H ++HRDLK N+L++K K++DFGL++ F + + + +V T+ Y P
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAP 169
Query: 775 EYYI-SQQLTDKSDVYSFGVILLELISG 801
+ + S+ + D++S G I+ E+I+G
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 57/231 (24%), Positives = 112/231 (48%), Gaps = 37/231 (16%)
Query: 604 MLEKKIGSGGFGVVYYGKLKDGKE-----------------IAVKVLTSNSYQGKR-EFT 645
+ ++K+G G FG V+ ++ + ++ +AVK+L ++ + R +F
Sbjct: 8 LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFL 67
Query: 646 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR-------- 697
EV +LSR+ N+++ LG C +E ++ E+M NG L + L ++
Sbjct: 68 KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127
Query: 698 -------INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750
I++ L +A A G++YL + +HRDL + N L+ +++ K++DFG+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGM 184
Query: 751 SKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
S+ G + + + ++ E + + T SDV++FGV L E++
Sbjct: 185 SRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 28/202 (13%)
Query: 609 IGSGGFGVVYYG-KLKDGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666
+G G G VY L + +AVKV+ + + + +++ +E+ +L + ++ F G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 667 QEEGRSVLVYEFMHNGTLK------EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
E R + EFM G+L EH+ G IA KG+ YL +
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLG--------------RIAVAVVKGLTYLWS- 113
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
I+HRD+K SN+L++ + K+ DFG+S V+ ++ GT Y+ PE +
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGE 168
Query: 781 QLTDKSDVYSFGVILLELISGQ 802
Q SDV+S G+ +EL G+
Sbjct: 169 QYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 74/225 (32%), Positives = 109/225 (48%), Gaps = 28/225 (12%)
Query: 594 TLSDIEDATKMLEKKIGSGGFGVVY-YGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 652
+L D D +++E IG G +G VY KDG AVK+L S E E +L
Sbjct: 16 SLGDPTDTWEIIET-IGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQ 73
Query: 653 RI-HHRNLVQFLG--YCQEE---GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 706
+ +H N+V+F G Y ++ G+ LV E + G++ E + G L QR++ I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 707 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 766
A G+++LH IIHRD+K +NILL K+ DFG+S A S+ +R
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVS------AQLTSTRLR 184
Query: 767 -----GTVGYLDPEYYISQQLTDKS-----DVYSFGVILLELISG 801
GT ++ PE +Q D S DV+S G+ +EL G
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 65/224 (29%), Positives = 96/224 (42%), Gaps = 33/224 (14%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN----- 646
FT D++D +IG G FG V K G +AVK + S ++E
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV--DEKEQKRLLMDL 53
Query: 647 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-- 704
+V + S +V+F G EG + E M + Y + + + +
Sbjct: 54 DVVMRSS-DCPYIVKFYGALFREGDCWICMELMD--ISLDKFYKYVYEVLKSVIPEEILG 110
Query: 705 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764
+IA K + YL IIHRD+K SNILLD++ K+ DFG+S VD SI
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD------SI 162
Query: 765 VR----GTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISG 801
+ G Y+ PE +SDV+S G+ L E+ +G
Sbjct: 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 20/206 (9%)
Query: 609 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYC 666
+G+G +G VY G+ +K G+ A+KV+ + + E E+ +L + HHRN+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 667 QEEG------RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
++ + LV EF G++ + + T + + WI I + +G+ +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH 130
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
+IHRD+K N+LL ++ K+ DFG+S +D + GT ++ PE
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPEVIACD 186
Query: 781 QLTD-----KSDVYSFGVILLELISG 801
+ D KSD++S G+ +E+ G
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 61/236 (25%)
Query: 607 KKIGSGGFGVVYYGK--------LKDGKE---------IAVKVLTSN-SYQGKREFTNEV 648
+K+G G FG V+ + K E +AVKVL + S + +F EV
Sbjct: 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR----- 703
+LSR+ N+ + LG C + ++ E+M NG L + L H + +
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQ---KHVAETSGLACNSKSL 127
Query: 704 -----LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK------ 752
L +A A G+ YL + +HRDL + N L+ K+ K++DFG+S+
Sbjct: 128 SFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 753 -FAVDGASHV-------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ V G + + S++ G + T KSDV++FGV L E+++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLG-------------KFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 65/200 (32%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 661
K IG G FG V K K DG AVKVL + K+E + + LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
Q + V ++++ G L HL E+ + A + A I YLH+
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHL----QRERCFLEPRARFYAAEVASAIGYLHS-- 114
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
II+RDLK NILLD ++DFGL K V+ S+ GT YL PE +
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEP 172
Query: 782 LTDKSDVYSFGVILLELISG 801
D + G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQFLG 664
++IG G FG VY G KE+ A+K++ + + E E+T+LS+ + ++ G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
+ + ++ E++ G+ + L E I I R + KG++YLH+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR-----EILKGLDYLHS---ER 121
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
IHRD+K++N+LL + K++DFG++ D ++ V GT ++ PE I Q D
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE-VIKQSAYD 179
Query: 785 -KSDVYSFGVILLELISGQEAISN 807
K+D++S G+ +EL G+ S+
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-14
Identities = 66/201 (32%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 661
K IG G FG V K K DGK AVKVL ++E LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH-EQRINWIKRLEIAEDAAKGIEYLHTG 720
Q + V +F++ G L HL + E R R AE A + YLH+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPR----ARFYAAE-IASALGYLHS- 114
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
I++RDLK NILLD ++DFGL K + + ++ GT YL PE Q
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC-GTPEYLAPEVIRKQ 171
Query: 781 QLTDKSDVYSFGVILLELISG 801
+ D + G +L E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 605 LEKKIGSGGFGVVYYG------KLKDGK--EIAVKVLTSNSY-QGKREFTNEVTLLSRI- 654
L K +G G FG V K K K +AVK+L ++ + + +E+ ++ I
Sbjct: 16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL---------YGTLT---HEQRINWIK 702
H+N++ LG C ++G ++ E+ G L+E+L Y T E+++ +
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 703 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++ V +
Sbjct: 136 LVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLAR-DVHNIDYYK 191
Query: 763 SIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
G V ++ PE + T +SDV+SFGV+L E+ +
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 5e-14
Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 38/218 (17%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT---SNSYQGKREFTNEVTLLSRI-HHRNL 659
+ +K+G G +G+V+ + KE+ A+K + N+ +R F E+ L + H N+
Sbjct: 11 ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNI 69
Query: 660 VQFLG-YCQEEGRSV-LVYEFM----HN----GTLKEHLYGTLTHEQRINWIKRLEIAED 709
V+ L E + + LV+E+M H L++ H++ I +
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILED------VHKRYIMY--------Q 115
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGT 768
K ++Y+H+G +IHRDLK SNILL+ R K++DFGL++ + + + ++
Sbjct: 116 LLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY 172
Query: 769 VG---YLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 802
V Y PE + S + T D++S G IL E++ G+
Sbjct: 173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 22/222 (9%)
Query: 595 LSDIEDATKMLE--KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLL 651
LS + D + E + +G+G +G VY G+ +K G+ A+KV+ + + E E+ +L
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINML 66
Query: 652 SRI-HHRNLVQFLGY------CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 704
+ HHRN+ + G + + LV EF G++ + + T + + +WI
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY- 125
Query: 705 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764
I + +G+ +LH +IHRD+K N+LL ++ K+ DFG+S +D +
Sbjct: 126 -ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNT 180
Query: 765 VRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISG 801
GT ++ PE + D +SD++S G+ +E+ G
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEI----AVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLV 660
K +GSG FG VY G + +G+++ A+K L + S + +E +E +++ + + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
+ LG C L+ + M G L +++ H+ I L AKG+ YL
Sbjct: 73 RLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEE- 127
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYIS 779
++HRDL + N+L+ K++DFGL+K D + + + + ++ E +
Sbjct: 128 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH 185
Query: 780 QQLTDKSDVYSFGVILLELIS 800
+ T +SDV+S+GV + EL++
Sbjct: 186 RIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 6e-14
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 662
K +G G FG V + K GK A+K+L K E + +T +L H L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
Q + R V E+++ G L HL + E+ + + + ++YLH+G
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHL----SRERVFSEDRTRFYGAEIVSALDYLHSG-- 114
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
I++RDLK N++LDK K++DFGL K + A+ + + GT YL PE
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDY 172
Query: 783 TDKSDVYSFGVILLELISGQEAISNE 808
D + GV++ E++ G+ N+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 606 EKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQF 662
+KIG G +GVVY + + E IA+K + T E++LL + H N+V+
Sbjct: 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
E R LV+E++ + LK+H+ + + IK +GI Y H+
Sbjct: 67 QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTY--LYQILRGIAYCHSH-- 121
Query: 723 PAIIHRDLKSSNILLDKHMRA-KVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-S 779
++HRDLK N+L+D+ A K++DFGL++ F + + +V T+ Y PE + S
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILLGS 178
Query: 780 QQLTDKSDVYSFGVILLELIS 800
+ + D++S G I E+++
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 8e-14
Identities = 70/225 (31%), Positives = 95/225 (42%), Gaps = 48/225 (21%)
Query: 595 LSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREF--------- 644
LSD E + + +G+G FG V K K G+ A+K L KRE
Sbjct: 17 LSDFE-----MGETLGTGSFGRVRIAKHKGTGEYYAIKCLK------KREILKMKQVQHV 65
Query: 645 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 704
E ++L + H +V + Q+E R + EF+ G L HL K
Sbjct: 66 AQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR------------KAG 113
Query: 705 EIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756
D AK EYLH+ II+RDLK N+LLD KV+DFG +K D
Sbjct: 114 RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170
Query: 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
+ GT YL PE S+ D ++ GV+L E I+G
Sbjct: 171 RTFTLC----GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 63/225 (28%), Positives = 111/225 (49%), Gaps = 25/225 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHR 657
L +++G G FG+VY G +D +AVK + S S + + EF NE +++
Sbjct: 10 LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN-------WIKRLEIAEDA 710
++V+ LG + +++V E M +G LK +L +L E N + +++A +
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 711 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--T 768
A G+ YL+ +HRDL + N ++ K+ DFG+++ + + +G
Sbjct: 129 ADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYRKGGKGLLP 184
Query: 769 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEK 809
V ++ PE T SD++SFGV+L E+ S E +SNE+
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 58/226 (25%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 604 MLEKKIGSGGFGVVYYGK-LKDGKEIAVK---VLTSNSYQGKREFTNEVTLLSRIHHRNL 659
+EKKIG G F VY L D K +A+K + + +++ E+ LL +++H N+
Sbjct: 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNV 64
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE----QRINWIKRLEIAEDAAKGIE 715
+++L E+ +V E G L + + + +R W +++ +E
Sbjct: 65 IKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS----AVE 120
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
++H+ ++HRD+K +N+ + K+ D GL +F + S+V GT Y+ PE
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG--ANCRNIVQ 819
KSD++S G +L E+ + Q +K + C+ I Q
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 609 IGSGGFGVVYYGKLKDG-------KEIAVKVLTSNSYQGKRE-------FTNEVTLL-SR 653
+GSG FG VY + K+ KEI V + KRE +EVT++ +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNP--AFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 654 IHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713
+ H N+V++ E R +V + + L EH +QR + I
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
+ YLH I+HRDL +NI+L + + ++DFGL+K S ++S+V GT+ Y
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVV-GTILYSC 181
Query: 774 PEYYISQQLTDKSDVYSFGVILLEL 798
PE ++ +K+DV++FG IL ++
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 609 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRN--LVQF 662
IG GGFG VY + D GK A+K L QG+ NE +LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 663 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
+ Y + + + M+ G L HL +G + + + A + G+E++H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY------AAEIILGLEHMHN 115
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
V ++RDLK +NILLD+H ++SD GL+ H S GT GY+ PE
Sbjct: 116 RFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 169
Query: 780 QQLTDKS-DVYSFGVILLELISGQ 802
D S D +S G +L +L+ G
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-13
Identities = 44/120 (36%), Positives = 68/120 (56%), Gaps = 8/120 (6%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGC 462
W + CN+ + + I LS KN++G I S + +L + + L N L+GPIPD F+
Sbjct: 60 WQGITCNNSSR--VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTS 117
Query: 463 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNI 520
LR ++L +N TG +P ++PNL L + NNMLSG +P+ + S VL+ GN+
Sbjct: 118 SSLRYLNLSNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175
|
Length = 968 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 10/221 (4%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVK---VLTSNSYQGKREFTNEVTLLSRIHHRNLV 660
+EKKIG G F VY L DG +A+K + + + + E+ LL +++H N++
Sbjct: 6 IEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 65
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
++ E+ +V E G L + ++ I + +E++H+
Sbjct: 66 KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS- 124
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
++HRD+K +N+ + K+ D GL +F + S+V GT Y+ PE
Sbjct: 125 --RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHEN 181
Query: 781 QLTDKSDVYSFGVILLELISGQEAISNEKFG--ANCRNIVQ 819
KSD++S G +L E+ + Q +K + C+ I Q
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 609 IGSGGFGVVYYGKLK---DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+G G +GVV K++ G +AVK + T NS + KR + + + V F
Sbjct: 9 LGRGAYGVVD--KMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLY-GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
G EG + E M T + Y I +IA K +EYLH+
Sbjct: 67 GALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL- 123
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY---IS 779
++IHRD+K SN+L++++ + K+ DFG+S + VD S +I G Y+ PE ++
Sbjct: 124 -SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTIDAGCKPYMAPERINPELN 180
Query: 780 QQLTD-KSDVYSFGVILLELISG 801
Q+ D KSDV+S G+ ++EL +G
Sbjct: 181 QKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYG--KLKDGKEIAVKVLT---SNSYQGKREFTNEVTLL 651
++++ + +E+ +G+G FG + G KL +E+ V + T S + +R F E L
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 652 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 711
+ H N+V+ G ++V E+M NG L L HE ++ + + + A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLA 117
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--TV 769
G++YL +H+ L + +L++ + K+S F + D + + + + G V
Sbjct: 118 SGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPV 172
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ PE + SDV+SFG+++ E++S
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 2e-13
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 39/219 (17%)
Query: 604 MLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNL 659
L K IGSG +GVV + G+++A+K ++ + KR E+ LL + H N+
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHENI 61
Query: 660 VQ----FLGYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIK-RLEIAEDAAK- 712
+ E+ V +V E M T H IK + +D +
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELME----------TDLH----KVIKSPQPLTDDHIQY 107
Query: 713 -------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 765
G++YLH+ +IHRDLK SNIL++ + K+ DFGL++ +
Sbjct: 108 FLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 766 RGTVG--YLDPEYYISQQLTDKS-DVYSFGVILLELISG 801
V Y PE +S K+ D++S G I EL++
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN-----EVTLLS-RI----- 654
K +G G FG V +LK E+ AVKVL K++ E T+ R+
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVL-------KKDVILQDDDVECTMTEKRVLALAG 53
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAK 712
H L Q Q + R V E+++ G L H+ G + + A +
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY------AAEIVL 107
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 772
G+++LH II+RDLK N+LLD K++DFG+ K + G S+ GT Y+
Sbjct: 108 GLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYI 163
Query: 773 DPEYYISQQLTDKSDVYSFGVILLELISGQ 802
PE Q D ++ GV+L E+++GQ
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 609 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRN--LVQF 662
IG GGFG VY + D GK A+K L QG+ NE +LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 663 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
+ Y + + + M+ G L HL +G + ++ + A + G+E++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY------ATEIILGLEHMHN 115
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
V ++RDLK +NILLD+H ++SD GL+ H S GT GY+ PE
Sbjct: 116 RFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 169
Query: 780 QQLTDKS-DVYSFGVILLELISGQEAISNEK 809
D S D +S G +L +L+ G K
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 605 LEKKIGSGGFGVVYY----GKLKDGKEIAVKVLTSNSYQGKR---EFT-NEVTLLSRIHH 656
L + +G+G +G V+ G GK A+KVL + K E T E +L +
Sbjct: 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRR 63
Query: 657 RNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK---RLEIAEDAAK 712
+ L Y Q + + L+ ++++ G L HLY QR ++ + R+ IAE
Sbjct: 64 CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY------QREHFTESEVRVYIAE-IVL 116
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 772
+++LH II+RD+K NILLD ++DFGLSK + + GT+ Y+
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 773 DPEYYISQQL--TDKSDVYSFGVILLELISG 801
PE D +S GV+ EL++G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 5e-13
Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN--EVTLLSRI-HHRNLVQF 662
K++G G FG VY + K+ E+ A+K + + E N EV L ++ H N+V+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLREVKSLRKLNEHPNIVKL 63
Query: 663 LGYCQEEGRSVLVYEFMHN---GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
+E V+E+M +K+ + + I ++ +G+ ++H
Sbjct: 64 KEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQI------LQGLAHIHK 117
Query: 720 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
G HRDLK N+L+ K++DFGL++
Sbjct: 118 HG----FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 12/208 (5%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI 654
D E+ LE+ IG G FG V+ G + + +A+K++ + + E E+T+LS+
Sbjct: 1 DPEELFTKLER-IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
+ ++ G + + ++ E++ G+ + L E +I + ++ KG+
Sbjct: 60 DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI-----ATMLKEILKGL 114
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
+YLH+ IHRD+K++N+LL + K++DFG++ D ++ V GT ++ P
Sbjct: 115 DYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 170
Query: 775 EYYISQQLTDKSDVYSFGVILLELISGQ 802
E K+D++S G+ +EL G+
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 608 KIGSGGFGVVYYGKLKD-GKEIAVK--VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
KIG G +GVV+ + ++ G+ +A+K V + + K+ E+ +L ++ H NLV +
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 665 YCQEEGRSVLVYEFMHNGTLKE---HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 720
+ + + LV+E+ + L E + G H IK+ I + + + H
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHL-----IKK--IIWQTLQAVNFCHKHN 120
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
C IHRD+K NIL+ K + K+ DFG ++ + V T Y PE +
Sbjct: 121 C----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGD 175
Query: 781 -QLTDKSDVYSFGVILLELISGQ 802
Q DV++ G + EL++GQ
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEIA---VKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 662
+IG+G FG V G+ G A VK L S + + F EV ++H N++Q
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE-IAEDAAKGIEYLHTGC 721
LG C E +LV EF G LK +L ++ L+ +A + A G+ +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLS------KFAVDGASHVSSIVRGTVGYLDPE 775
IH DL N L + K+ D+GL+ + + H + +L PE
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPL-----RWLAPE 172
Query: 776 YYISQQ-------LTDKSDVYSFGVILLEL 798
+ T KS+++S GV + EL
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQFLG 664
+G G FG V +LK G+ AVKVL + + +T +LS + + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 665 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
C Q R V EF++ G L H+ + +R + + A + + +LH
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEITSALMFLHD---K 115
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYISQQL 782
II+RDLK N+LLD K++DFG+ K + +G + +S GT Y+ PE
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEMLY 173
Query: 783 TDKSDVYSFGVILLELISGQEAISNE 808
D ++ GV+L E++ G E
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 9e-13
Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 58/231 (25%)
Query: 605 LEKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGK-------REFTNEVTLLSRI 654
+E IG G +G VY K K DGKE A+K + Q RE + LL +
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLREL 59
Query: 655 HHRNLVQFLGYCQEEG-RSV-LVYEFMHNGTLKEH-LYGTLTHEQRINWIKRLEIAEDAA 711
H N+V + E +SV L++++ EH L+ + ++ KR+ I
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQA---KRVSIPPSMV 110
Query: 712 K--------GIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSK------- 752
K G+ YLH+ ++HRDLK +NIL+ + K+ D GL++
Sbjct: 111 KSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167
Query: 753 --FAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELIS 800
+D V T+ Y PE + ++ T D+++ G I EL++
Sbjct: 168 PLADLDP-------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 65/216 (30%), Positives = 98/216 (45%), Gaps = 14/216 (6%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLG 664
IG G FG V + +D + I A+K + + E T+ E T+L++++ +V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK-RLEIAEDAAKGIEYLHTGCVP 723
Q + LV F++ G L HL E R + + R AE +E LH V
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL----QREGRFDLSRARFYTAE-LLCALENLHKFNV- 114
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
I+RDLK NILLD + DFGL K + ++ GT YL PE + T
Sbjct: 115 --IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHGYT 171
Query: 784 DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
D ++ GV+L E+++G +E R I+Q
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-12
Identities = 43/106 (40%), Positives = 64/106 (60%), Gaps = 3/106 (2%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL 475
S+ + L+S L G IP +L ++ SL ++L N+L+G IP + G L + L N L
Sbjct: 189 SLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL 248
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
TGP+PSSL NL NL+ L++ N LSG +P S+ L K + L+ + N
Sbjct: 249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294
|
Length = 968 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 608 KIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLG 664
KIG G +G V+ K ++ EI +V + +G E+ LL + H+N+V+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 665 YCQEEGRSVLVYEFMHNGTLK--EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+ + LV+E+ K + G + E +++ +L KG+ + H+
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL------LKGLAFCHS--- 117
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
++HRDLK N+L++K+ K++DFGL++ F + + + +V T+ Y P+ +
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAK 175
Query: 782 LTDKS-DVYSFGVILLELISG 801
L S D++S G I EL +
Sbjct: 176 LYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHH 656
D+ + LEK +G G + VY GK K +GK +A+KV+ +G FT E +LL + H
Sbjct: 5 DSYEKLEK-LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKH 62
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713
N+V + LV+E++H + +H G ++ + L +G
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLL-------RG 115
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
+ Y+H I+HRDLK N+L+ K++DFGL++ A SH S T+ Y
Sbjct: 116 LSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRP 171
Query: 774 PEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEK 809
P+ + S + + D++ G I +E+I G A K
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 37/212 (17%)
Query: 609 IGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREF----TNEVTLLSRIHHRNLVQF 662
IG G +G VY + KD E+ KV N +G F E+ +L +++HRN+V
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG---FPITAIREIKILRQLNHRNIVNL 71
Query: 663 ----------LGYCQEEGRSVLVYEFM-HN--GTLKEHLYGTLTHEQRINWIKRLEIAED 709
L + +++G LV+E+M H+ G L+ L + + +++K+L
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV-HFSEDHIKSFMKQL----- 125
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGASHVSSIVRG 767
+G+ Y H +HRD+K SNILL+ + K++DFGL++ + + + + ++
Sbjct: 126 -LEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-- 179
Query: 768 TVGYLDPEYYISQQLTDKS-DVYSFGVILLEL 798
T+ Y PE + ++ + DV+S G IL EL
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 592 CFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK---REFTNEV 648
C DI+ T +L I +Y G + KE+ ++ K NE+
Sbjct: 14 CIESDDIDKYTSVL---IKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEI 69
Query: 649 TLLSRIHHRNLVQFLGY----CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 704
L RI N+++ G+ + R L+ E+ G L+E L E+ +++ +L
Sbjct: 70 KNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD----KEKDLSFKTKL 125
Query: 705 EIAEDAAKGIEYLHTGC-VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVS 762
++A D KG+ L+ P +++L S + L+ ++ + K+ GL K + +V+
Sbjct: 126 DMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN 182
Query: 763 SIVRGTVGYLDPEYY--ISQQLTDKSDVYSFGVILLELISG 801
+V Y + I + T K D+YS GV+L E+ +G
Sbjct: 183 FMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 29/205 (14%)
Query: 608 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFLG 664
KIG G +GVVY + G+ +A+K + + T E++LL ++H N+V+ L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEY 716
E + LV+EF+ LK+++ + + K GI Y
Sbjct: 66 VVHSENKLYLVFEFLDL-DLKKYM----------DSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE 775
H+ ++HRDLK N+L+D+ K++DFGL++ F V ++ +V T+ Y PE
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 169
Query: 776 YYI-SQQLTDKSDVYSFGVILLELI 799
+ S+Q + D++S G I E++
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 60/203 (29%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 662
K +G G FG V + K GK A+K+L K E + +T +L H L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
Q R V E+ + G L HL + ++ R AE + YLH+
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAE-IVSALGYLHSC 114
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYIS 779
+++RDLK N++LDK K++DFGL K + DGA+ GT YL PE
Sbjct: 115 ---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLED 169
Query: 780 QQLTDKSDVYSFGVILLELISGQ 802
D + GV++ E++ G+
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 58/208 (27%), Positives = 86/208 (41%), Gaps = 30/208 (14%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLL----------SRI 654
+G G FG V + K E+ A+K L K+ +EV L +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKAL-------KKGDIIARDEVESLMCEKRIFETANSE 59
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
H LV Q E V E+ G L H+ H + + + A G+
Sbjct: 60 RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-----HTDVFSEPRAVFYAACVVLGL 114
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
+YLH I++RDLK N+LLD K++DFGL K + G +S GT +L P
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM-GFGDRTSTFCGTPEFLAP 170
Query: 775 EYYISQQLTDKSDVYSFGVILLELISGQ 802
E T D + GV++ E++ G+
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGE 198
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 608 KIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
+G G +G+V K K+ G+ +A+K + + K+ E+ +L ++ H NLV +
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 665 YCQEEGRSVLVYEFMHNGTLK--EHLYGTLTHE--QRINWIKRLEIAEDAAKGIEYLHTG 720
+ + R LV+EF+ + L E L ++ + +GIE+ H+
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF--------QILRGIEFCHSH 119
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYIS 779
IIHRD+K NIL+ + K+ DFG ++ A G + + T Y PE +
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV--ATRWYRAPELLVG 174
Query: 780 QQLTDKS-DVYSFGVILLELISGQ 802
++ D+++ G ++ E+++G+
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 608 KIGSGGFGVVYYGKLKDGKEIAV-KVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666
++G G FG VY + K+ +A KV+ + S + ++ E+ +L+ H N+V+ L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 667 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 726
E ++ EF G + + L E+ + + + + + + YLH II
Sbjct: 72 YYENNLWILIEFCAGGAVDAVM---LELERPLTEPQIRVVCKQTLEALNYLHEN---KII 125
Query: 727 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-- 784
HRDLK+ NIL K++DFG+S S + GT ++ PE + + D
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRP 184
Query: 785 ---KSDVYSFGVILLEL 798
K+DV+S G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 70/218 (32%), Positives = 99/218 (45%), Gaps = 18/218 (8%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRN---LVQ 661
IG G FG VY + KD + I A+KVL+ K+E + E +L R +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK-RLEIAEDAAKGIEYLHTG 720
Q + LV ++M G L HL E R + + + IAE +E+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL----QKEGRFSEDRAKFYIAE-LVLALEHLHKY 115
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
I++RDLK NILLD + DFGLSK A + ++ GT YL PE + +
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 781 Q-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817
+ T D +S GV++ E+ G E RNI
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 60/234 (25%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVK-------VLTSNSYQGKREFTNEV 648
D+ K +E IGSG +GVV + GK++A+K V T KR E+
Sbjct: 2 DVGSRYKPIEN-IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTL----AKRTL-REL 55
Query: 649 TLLSRIHHRNLV---QFLGYCQEEGRSV-LVYEFM----H-----NGTLKEH-----LYG 690
+L H N++ L + + V +V + M H + L E LY
Sbjct: 56 KILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ 115
Query: 691 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG- 749
L +G++Y+H+ V IHRDLK SN+L+++ ++ DFG
Sbjct: 116 LL-------------------RGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGM 153
Query: 750 ---LSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELI 799
LS + ++ V T Y PE +S + T D++S G I E++
Sbjct: 154 ARGLSSSPTEHKYFMTEYV-ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 608 KIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRIH---HRNLVQ 661
+IG G +G VY + G +A+K V + G T EV LL R+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 662 FLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
+ C E + LV+E + + L+ +L IK ++ +G+++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDF 123
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
LH C I+HRDLK NIL+ + K++DFGL++ + +V T+ Y PE
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEV 178
Query: 777 YISQQLTDKSDVYSFGVILLEL 798
+ D++S G I E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 39/180 (21%)
Query: 592 CFTLSDIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFT--NEV 648
C L D E + K+G G FG VY ++K G+ +A+K + ++ + T E+
Sbjct: 4 CSKLRDYE-----ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREI 58
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSV--------LVYEFM--------HNGTLKEHLYGTL 692
+L ++ H N+V + E +V +M N ++K L
Sbjct: 59 KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK------L 112
Query: 693 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
T Q ++ +L +GI YLH I+HRD+K++NIL+D K++DFGL++
Sbjct: 113 TESQIKCYMLQL------LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 663
+K+G G + VY G + +G+ +A+KV++ + +G FT E +LL + H N+V
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLH 69
Query: 664 GYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
+ V+E+MH + +H G + R+ + L +G+ Y+H
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL-------RGLAYIHG- 121
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI- 778
I+HRDLK N+L+ K++DFGL++ ++ ++ S +V T+ Y P+ +
Sbjct: 122 --QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLG 177
Query: 779 SQQLTDKSDVYSFGVILLELISGQEA 804
+ + D++ G I +E++ GQ A
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 55/222 (24%), Positives = 104/222 (46%), Gaps = 29/222 (13%)
Query: 605 LEKKIGSGGFGVVYY----GKLKDGKE-------------IAVKVLTSNSYQGKR-EFTN 646
++K+G G FG V+ G K + +AVK+L ++ + R +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 647 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-------GTLTHEQRIN 699
E+ ++SR+ N+++ L C ++ E+M NG L + L I+
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 700 WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759
+ + +A A G++YL + +HRDL + N L+ K+ K++DFG+S+ G
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 760 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ + + ++ E + + T SDV++FGV L E+++
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 62/201 (30%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 661
K IG G FG V + K + K AVKVL + K+E + LL + H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAKGIEYLHTG 720
Q + V ++++ G L HL +R R A + A + YLH+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHL-----QRERCFLEPRARFYAAEIASALGYLHS- 114
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
I++RDLK NILLD ++DFGL K ++ S+ GT YL PE Q
Sbjct: 115 --LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQ 171
Query: 781 QLTDKSDVYSFGVILLELISG 801
D + G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-12
Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 1/99 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
P + + +S+ NL G I S + SL L L N G +PD G L + L NQ
Sbjct: 428 PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQF 487
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS-KNVV 513
+G +P L +L L +L + N LSG +P L S K +V
Sbjct: 488 SGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLV 526
|
Length = 968 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 607 KKIGSGGFGVVYYGKLKDG---KEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQF 662
K+IG+G FG V G++ G ++ VK L + S Q + +F E + H NL+Q
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE-IAEDAAKGIEYLHTGC 721
LG C E +LV EF G LK +L E L+ +A + A G+ +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
IH DL N LL + K+ D+GLS +V+ P +I+ +
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV-----PLRWIAPE 172
Query: 782 LTDK-------------SDVYSFGVILLEL 798
L D+ S+V+S GV + EL
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-12
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 607 KKIGSGGFGVVYYG-KLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 662
K IGSG G+V G +AVK L+ N KR + E+ LL ++H+N++
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 85
Query: 663 LGY-----CQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
L EE + V LV E M + L + ++ L HE R++++ + GI++
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHE-RMSYLLYQMLC-----GIKH 138
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
LH+ IIHRDLK SNI++ K+ DFGL++ A +V T Y PE
Sbjct: 139 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEV 193
Query: 777 YISQQLTDKSDVYSFGVILLELISG 801
+ + D++S G I+ EL+ G
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
L ++IGSG +G VY + + G+ A+KV+ + E+ ++ H N+V +
Sbjct: 13 LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 664 GYCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
G + + EF G+L++ H+ G L+ E +I ++ R + +G+ YLH+
Sbjct: 73 GSYLRRDKLWICMEFCGGGSLQDIYHVTGPLS-ESQIAYVSR-----ETLQGLYYLHS-- 124
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
+HRD+K +NILL + K++DFG+S + S + GT ++ PE ++
Sbjct: 125 -KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVER 182
Query: 782 ---LTDKSDVYSFGVILLEL 798
D+++ G+ +EL
Sbjct: 183 KGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 7e-12
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 607 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 660
K IGSG G+V Y G+ +A+K L+ N KR + E+ L+ ++H+N++
Sbjct: 22 KPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNII 78
Query: 661 QFLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
L EE + V LV E M + L + + L HE R++++ + GI
Sbjct: 79 GLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHE-RMSYLLYQMLC-----GI 131
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
++LH+ IIHRDLK SNI++ K+ DFGL++ A +V T Y P
Sbjct: 132 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAP 186
Query: 775 EYYISQQLTDKSDVYSFGVILLELISGQ 802
E + + D++S G I+ E+I G
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 63/226 (27%), Positives = 109/226 (48%), Gaps = 18/226 (7%)
Query: 594 TLSDIEDATKMLEKKIGSGGFGVVY-YGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 652
+ D D +++E IG G +G V+ K+G + AVK+L + E E +L
Sbjct: 12 SFPDPSDTWEIIET-IGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILK 69
Query: 653 RIH-HRNLVQFLG-YCQEEGRS----VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 706
+ H N+V+F G Y +++ ++ LV E + G++ + + G L +R+ I
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 707 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 766
+A G+++LH V IHRD+K +NILL K+ DFG+S + +
Sbjct: 130 LHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSA-QLTSTRLRRNTSV 185
Query: 767 GTVGYLDPEYYISQQLTDKS-----DVYSFGVILLELISGQEAISN 807
GT ++ PE +Q D + DV+S G+ +EL G +++
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 36/89 (40%), Positives = 54/89 (60%), Gaps = 1/89 (1%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL 475
S+ I+L NL+G IP ++ L+SL L L N+LTGPIP +L+ + L N+L
Sbjct: 213 SLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKL 272
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVP 504
+GP+P S+ +L L L + +N LSG +P
Sbjct: 273 SGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-11
Identities = 38/92 (41%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDN 473
++TV+ LS+ NLTG IP L +L +L L NSL G IP C LR + L+DN
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 505
+G LPS LP + L + NN L G + S
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINS 446
|
Length = 968 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 25/225 (11%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKRE-FTNEVT 649
+I +T +++G FG VY G L + + +A+K L + RE F +E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 650 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH------------EQR 697
+ SR+ H N+V LG +E +++ + + L E L H +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 698 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAV 755
+ + I A G+E+L + V +H+DL + N+L+ + K+SD GL + +A
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHV---VHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
D + + + + ++ PE + + + SD++S+GV+L E+ S
Sbjct: 178 DYYKLMGNSLL-PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 34/219 (15%)
Query: 607 KKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKREFTN----EVTLLSRIHHRN 658
K +G GG+G V+ + G + A+KVL + ++ T E +L + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAK----- 712
+V + Q G+ L+ E++ G L HL +R I ED A
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHL-------------EREGIFMEDTACFYLSE 108
Query: 713 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
+E+LH II+RDLK NILLD K++DFGL K ++ + V+ GT+
Sbjct: 109 ISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTI 164
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808
Y+ PE + D +S G ++ ++++G + E
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 1e-11
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 607 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 661
K IGSG G+V Y + D + +A+K L+ N KR + E+ L+ ++H+N++
Sbjct: 23 KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIS 80
Query: 662 FLGY-----CQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
L EE + V LV E M + L + + L HE R++++ + GI+
Sbjct: 81 LLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 133
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
+LH+ IIHRDLK SNI++ K+ DFGL++ A G S + + T Y PE
Sbjct: 134 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 188
Query: 776 YYISQQLTDKSDVYSFGVILLELI 799
+ + D++S G I+ E++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSN----------SYQGKREFTNEVTLLSRIHHR 657
+G G FG V + K E+ A+K+L + + KR + L +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRV----LALPGKPPF- 62
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---GI 714
L Q Q R V E+++ G L H+ Q++ K AA+ G+
Sbjct: 63 -LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-------QQVGKFKEPHAVFYAAEIAIGL 114
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
+LH+ II+RDLK N++LD K++DFG+ K + G + GT Y+ P
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPDYIAP 170
Query: 775 EYYISQQLTDKS-DVYSFGVILLELISGQ 802
E I+ Q KS D ++FGV+L E+++GQ
Sbjct: 171 E-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 605 LEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
L +++GSG +G VY L G+ AVK++ E+ ++ H N+V +
Sbjct: 13 LIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 664 GYCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
G + + E+ G+L++ H+ G L+ E +I ++ R + +G+ YLH+
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQDIYHVTGPLS-ELQIAYVCR-----ETLQGLAYLHS-- 124
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
+HRD+K +NILL + K++DFG+ +K A S I GT ++ PE +
Sbjct: 125 -KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPEVAAVE 181
Query: 781 Q---LTDKSDVYSFGVILLEL 798
+ D+++ G+ +EL
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 52/199 (26%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 607 KKIGSGGFGVVYYGKLKDGKE-IAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQF 662
K +G+G FG V+ + + + A+KV+ + ++ NE +L + H +++
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
++ ++ E++ G L+ L + R + L A + +EYLH+
Sbjct: 67 FWTEHDQRFLYMLMEYVPGG----ELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS--- 119
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
I++RDLK NILLDK K++DFG +K D + GT YL PE S+
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC----GTPEYLAPEVIQSKGH 175
Query: 783 TDKSDVYSFGVILLELISG 801
D ++ G+++ E++ G
Sbjct: 176 NKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 65/227 (28%), Positives = 110/227 (48%), Gaps = 31/227 (13%)
Query: 593 FTLSDIEDATKMLEKK------IGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQG 640
F +I D+T + K+ IGSG G+V Y L+ + +A+K L+ N
Sbjct: 10 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67
Query: 641 KREFTNEVTLLSRIHHRNLVQFLGY-----CQEEGRSVLVYEFMHNGTLKEHLYGTLTHE 695
KR + E+ L+ ++H+N++ L EE + V + + + L + + L HE
Sbjct: 68 KRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 126
Query: 696 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755
R++++ + GI++LH+ IIHRDLK SNI++ K+ DFGL++ A
Sbjct: 127 -RMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 176
Query: 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
G S + + T Y PE + + D++S G I+ E+I G
Sbjct: 177 -GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 608 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 661
+I G +GVVY + K EI A+K L + ++E T+ E+ +L ++ H N+V
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKL---KMEKEKEGFPITSLREINILLKLQHPNIVT 68
Query: 662 F----LGYCQEEGRSVLVYEFMHNG--TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
+G + + +V E++ + +L E + + + +L G+
Sbjct: 69 VKEVVVGSNLD--KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQL------LSGVA 120
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
+LH I+HRDLK+SN+LL+ K+ DFGL++ + +V T+ Y PE
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPE 176
Query: 776 YYISQQL-TDKSDVYSFGVILLELISG 801
+ + + D++S G I EL++
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 67/260 (25%), Positives = 101/260 (38%), Gaps = 58/260 (22%)
Query: 607 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEV----TLLSRIHHRNLVQ 661
K IG G FG V + KD G A+K L S ++E V +L+ + +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKL-RKSEMLEKEQVAHVRAERDILAEADNPWVVK 65
Query: 662 FLGYC--QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
Y Q+E L+ E++ G + L T T E+ R IAE I+ +
Sbjct: 66 L--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE-----TRFYIAE-TILAIDSI 117
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK---------------------FAVD 756
H IHRD+K N+LLD K+SDFGL F
Sbjct: 118 HK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 757 GASHVSSIVR----------------GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ +SS + GT Y+ PE ++ + D +S GVI+ E++
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 801 GQEAISNEKFGANCRNIVQW 820
G ++ R I+ W
Sbjct: 235 GYPPFCSDNPQETYRKIINW 254
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 5e-11
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQF 662
IG G +G+V K G ++A+K ++ +Q + T E+ +L R H N++
Sbjct: 9 NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGI 68
Query: 663 LGYCQ----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----- 712
L + E V +V E M + LY IK ++ D +
Sbjct: 69 LDIIRPPSFESFNDVYIVQELM-----ETDLYKL---------IKTQHLSNDHIQYFLYQ 114
Query: 713 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--G 767
G++Y+H+ V +HRDLK SN+LL+ + K+ DFGL++ A H +
Sbjct: 115 ILRGLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 768 TVGYLDPEYYISQQLTDKS-DVYSFGVILLELISG 801
T Y PE ++ + K+ D++S G IL E++S
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 662
K +G G FG V K K G+ A+K+L K E + +T +L H L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
Q R V E+ + G L HL + E+ + + + ++YLH+
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSE-- 114
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYISQQ 781
+++RDLK N++LDK K++DFGL K + DGA+ + GT YL PE
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--GTPEYLAPEVLEDND 172
Query: 782 LTDKSDVYSFGVILLELISGQEAISNE 808
D + GV++ E++ G+ N+
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQ 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 7e-11
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 52/217 (23%)
Query: 608 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN--EVTLLSRI-HHRNLVQFL 663
KIG G F V + K GK A+K + ++ + N E+ L R+ H N+++ +
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 664 G--YCQEEGRSVLVYEFMHNGTLKEHLYGTLTH--EQRI-NWIKRLEIAEDAAKGIEYLH 718
+ ++ GR LV+E M + L E + G E+R+ +++ +L K ++++H
Sbjct: 65 EVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQL------LKSLDHMH 117
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY-- 776
I HRD+K NIL+ K++DFG S RG Y P Y
Sbjct: 118 RN---GIFHRDIKPENILIKDD-ILKLADFG-------------SC-RGI--YSKPPYTE 157
Query: 777 YISQQ--------LTD-----KSDVYSFGVILLELIS 800
YIS + LTD K D+++ G + E++S
Sbjct: 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 609 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLG 664
+G GGFG V ++K+ GK A K L + G++ E +L +++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN-LA 59
Query: 665 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
Y E + LV M+ G LK H+Y + + + + GI +LH+
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERV--IHYSAQITCGILHLHS---M 114
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
I++RD+K N+LLD ++SD GL+ DG + GT GY+ PE + +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA--GTNGYMAPEILKEEPYS 172
Query: 784 DKSDVYSFGVILLELISGQEAISNEK 809
D ++ G + E+++G+ + K
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 12/206 (5%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 662
K +G G FG V + K G+ A+K+L K E + VT +L H L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
Q R V E+ + G L HL + E+ + + +EYLH+ V
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRDV 116
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
++RD+K N++LDK K++DFGL K + + + + GT YL PE
Sbjct: 117 ---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDY 172
Query: 783 TDKSDVYSFGVILLELISGQEAISNE 808
D + GV++ E++ G+ N+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 51/229 (22%), Positives = 89/229 (38%), Gaps = 41/229 (17%)
Query: 605 LEKKIGSGGFGVVY-YGKLKDGKEIAVKVLTSNSYQGKRE------------FT--NEVT 649
+G G +G V GK +A+K + FT E+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 650 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 709
+++ I H N++ + E LV + M + K E ++ I L+I
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCI-LLQIL-- 129
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGAS--------- 759
G+ LH +HRDL +NI ++ K++DFGL+ ++ S
Sbjct: 130 --NGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 760 -----HVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 802
S +V T+ Y PE + +++ D++S G I EL++G+
Sbjct: 185 QRREEMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-10
Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 36/227 (15%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-----KREFTNEVTLLSRIHHRNLVQ 661
KKIG+G FG V+ K K +E + SY+G K + EV ++ + H+N+V+
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQEFFC--WKAISYRGLKEREKSQLVIEVNVMRELKHKNIVR 76
Query: 662 FLGYCQEEGRSVL--VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
++ + L + EF G L ++ +I ++I + Y H
Sbjct: 77 YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN 136
Query: 720 ----GCVPAIIHRDLKSSNILLDKHMR-----------------AKVSDFGLSK-FAVDG 757
++HRDLK NI L +R AK+ DFGLSK ++
Sbjct: 137 LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES 196
Query: 758 ASHVSSIVRGTVGYLDPEYYI--SQQLTDKSDVYSFGVILLELISGQ 802
+H S V GT Y PE + ++ DKSD+++ G I+ EL SG+
Sbjct: 197 MAH--SCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 49/149 (32%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIAEDAAKGIEY 716
+V F G +G + E M G+L + L RI N + ++ IA +G+ Y
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQ----VLKKAGRIPENILGKISIA--VLRGLTY 114
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
L I+HRD+K SNIL++ K+ DFG+S +D S +S V GT Y+ PE
Sbjct: 115 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPER 169
Query: 777 YISQQLTDKSDVYSFGVILLELISGQEAI 805
T +SD++S G+ L+E+ G+ I
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 29/205 (14%)
Query: 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 664
+G GGFG V K+K + A+K + + +E +L +H +V+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEY 716
+++ ++ E+ G L L R E A+ EY
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR------------DRGLFDEYTARFYIACVVLAFEY 108
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
LH II+RDLK N+LLD + K+ DFG +K G + GT Y+ PE
Sbjct: 109 LHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC--GTPEYVAPEI 163
Query: 777 YISQQLTDKSDVYSFGVILLELISG 801
+++ D +S G++L EL++G
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG----KREFTNEVTLLSRIHHRNL 659
++ IG G FGVV+ +DGK +A+K + N +Q KR F E+ +L H N+
Sbjct: 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMP-NVFQNLVSCKRVF-RELKMLCFFKHDNV 61
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK------- 712
+ L Q ++ ++ L+ + Q + + D K
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPL--------SSDHVKVFLYQIL 113
Query: 713 -GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVG 770
G++YLH+ I+HRD+K N+L++ + K+ DFGL++ D + H++ V T
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169
Query: 771 YLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 802
Y PE + S+ T D++S G I EL+ +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 608 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 665
++G+G GVV + K I + L + + + E+ +L + +V F G
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 666 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIAEDAAKGIEYLHTGCVP 723
+G + E M G+L + L +RI + ++ IA +G+ YL
Sbjct: 72 FYSDGEISICMEHMDGGSLDQ----VLKEAKRIPEEILGKVSIA--VLRGLAYLREK--H 123
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
I+HRD+K SNIL++ K+ DFG+S +D S +S V GT Y+ PE +
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYS 180
Query: 784 DKSDVYSFGVILLELISGQEAI 805
+SD++S G+ L+EL G+ I
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 9/167 (5%)
Query: 640 GKREFT-NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI 698
G+R T E +L I+H +++Q G + L+ K LY L ++ I
Sbjct: 125 GQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP-----RYKTDLYCYLAAKRNI 179
Query: 699 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758
L I + I+YLH IIHRD+K+ NI ++ + DFG + F VD
Sbjct: 180 AICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236
Query: 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 805
++ GT+ PE D++S G++L E+ + +++
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 609 IGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGY 665
+G G +GVV + K+ KEI K S + +E T E+ +L + N+V+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 666 CQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+ G+ LV+E++ L+ E G + R ++I +L K I + H
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-SYIYQL------IKAIHWCHKN-- 119
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
I+HRD+K N+L+ + K+ DFG ++ +G++ + T Y PE +
Sbjct: 120 -DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178
Query: 783 TDKSDVYSFGVILLELISGQEAISNE 808
D++S G IL EL GQ E
Sbjct: 179 GKAVDMWSVGCILGELSDGQPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 600 DATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRIHH 656
DA + LEK IG G +G VY + GK +A+K +G E++LL +
Sbjct: 1 DAYEKLEK-IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSE 59
Query: 657 RN-LVQFLGYCQEEGRS-----VLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIA 707
+V+ L E ++ LV+E++ + LK+ + IK
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMY- 117
Query: 708 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSK-FAVDGASHVSSIV 765
KG+ + H ++HRDLK N+L+DK K++D GL + F++ S+ IV
Sbjct: 118 -QLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 766 RGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 802
T+ Y PE + S + D++S G I E+ Q
Sbjct: 174 --TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLSR--IHHRN----LVQ 661
+G G FG V + K E+ A+K+L + + E T++ + + ++ L Q
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDV--ECTMVEKRVLALQDKPPFLTQ 65
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
Q R V E+++ G L H+ G Q + + A + + G+ +LH
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISVGLFFLHR 119
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 778
II+RDLK N++LD K++DFG+ K VDG + + GT Y+ PE
Sbjct: 120 ---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTFCGTPDYIAPEIIA 174
Query: 779 SQQLTDKSDVYSFGVILLELISGQEAISNE 808
Q D +++GV+L E+++GQ E
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-10
Identities = 53/185 (28%), Positives = 88/185 (47%), Gaps = 24/185 (12%)
Query: 646 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE 705
+E+ L+ H +V+ + + + +L+ E+ G L + + +QR+ + L
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI------KQRLK--EHLP 165
Query: 706 IAEDAAKGIEY--------LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757
E + Y +H+ ++HRDLKS+NI L K+ DFG SK D
Sbjct: 166 FQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222
Query: 758 AS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 816
S V+S GT YL PE + ++ + K+D++S GVIL EL++ G + R
Sbjct: 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK----GPSQRE 278
Query: 817 IVQWV 821
I+Q V
Sbjct: 279 IMQQV 283
|
Length = 478 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 605 LEKKIGSGGFGVVYY----GKLKDGKEIAVKVLTSNSYQGKREFTNEVT-----LLSRIH 655
L K +G+G +G V+ GK A+KVL + ++ T E T +L +
Sbjct: 4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV-QKAKTVEHTRTERNVLEHVR 62
Query: 656 HRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 712
+ L Y Q E + L+ +++ G + HLY QR N+ +ED +
Sbjct: 63 QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY------QRDNF------SEDEVRFY 110
Query: 713 ------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 766
+E+LH I++RD+K NILLD ++DFGLSK + +
Sbjct: 111 SGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC 167
Query: 767 GTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISG 801
GT+ Y+ PE + K+ D +S G+++ EL++G
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 661
K +G G FG V +LK E+ A+KVL + + T + L H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
Q + R V E+++ G L + ++ + + A + + +LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQI----QRSRKFDEPRSRFYAAEVTLALMFLHRH- 115
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
+I+RDLK NILLD K++DFG+ K + ++ GT Y+ PE +
Sbjct: 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC-GTPDYIAPEILQELE 172
Query: 782 LTDKSDVYSFGVILLELISGQ 802
D ++ GV++ E+++GQ
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 607 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQ 661
K++GSG +G V + G+++A+K L S +Q KR + E+TLL + H N++
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAY-RELTLLKHMQHENVIG 78
Query: 662 FLGY--CQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
L G LV +M K + G E ++ ++ G++
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQK--IMGHPLSEDKVQYL-----VYQMLCGLK 131
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
Y+H+ IIHRDLK N+ +++ K+ DFGL++ A A +V T Y PE
Sbjct: 132 YIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMTGYVV--TRWYRAPE 184
Query: 776 YYIS-QQLTDKSDVYSFGVILLELISGQ 802
++ D++S G I+ E+++G+
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLS-RIHHRN-----LVQ 661
+G G FG V + K E+ A+K+L + + E T++ R+ + L Q
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDV--ECTMVEKRVLALSGKPPFLTQ 65
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR---LEIAEDAAKGIEYLH 718
Q R V E+++ G L + Q++ K + A + A G+ +LH
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQI-------QQVGRFKEPHAVFYAAEIAIGLFFLH 118
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYY 777
+ II+RDLK N++LD K++DFG+ K + DG + + GT Y+ PE
Sbjct: 119 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDYIAPEII 173
Query: 778 ISQQLTDKSDVYSFGVILLELISGQEAISNE 808
Q D ++FGV+L E+++GQ E
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 608 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 665
++G+G GVV+ K I + L + + + E+ +L + +V F G
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 666 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 725
+G + E M G+L + L ++I + ++ IA KG+ YL I
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIA--VIKGLTYLREK--HKI 125
Query: 726 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 785
+HRD+K SNIL++ K+ DFG+S +D S +S V GT Y+ PE + +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYSVQ 182
Query: 786 SDVYSFGVILLELISGQEAI 805
SD++S G+ L+E+ G+ I
Sbjct: 183 SDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 5e-10
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQ 661
+ + +GSG G V K + DG+ AVKV+ K EV L ++V+
Sbjct: 36 ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK 95
Query: 662 FLGYCQEE------------GRSVLVYEFMHNGTLKEHLYGT-------LTHEQRINWIK 702
C E+ LV ++ + G L++ + HE + +I+
Sbjct: 96 ----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151
Query: 703 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHV 761
L + ++H+ +IHRD+KS+NILL + K+ DFG SK +A + V
Sbjct: 152 VL-------LAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201
Query: 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
GT Y+ PE + + + K+D++S GV+L EL++
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 32/163 (19%)
Query: 608 KIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREFT----NEVTLLSRIHHRNLVQ 661
KIG G FG V+ + K K+I KVL N +G F E+ +L + H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVVN 75
Query: 662 FLGYCQEE--------GRSVLVYEFMHNGTLKEH-LYGTLTHEQ---RINWIKRLEIAED 709
+ C+ + G LV+EF EH L G L+++ ++ IK+ + +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFC------EHDLAGLLSNKNVKFTLSEIKK--VMKM 127
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
G+ Y+H I+HRD+K++NIL+ K K++DFGL++
Sbjct: 128 LLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-10
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQF 662
K IG G FG V + K +++ L S KR F E +++ + +VQ
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 714
Q++ +V E+M G L +N + ++ E AK +
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWAKFYTAEVVLAL 155
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 773
+ +H+ +IHRD+K N+LLDKH K++DFG K G + V GT Y+
Sbjct: 156 DAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYIS 211
Query: 774 PEYYISQ----QLTDKSDVYSFGVILLELISG 801
PE SQ + D +S GV L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 662
K IG G FG V + K K++ A+K+L+ + + F E +++ + +VQ
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 714
Q++ +V E+M G L +N + +I E A+ +
Sbjct: 109 HYAFQDDKYLYMVMEYMPGGDL-------------VNLMSNYDIPEKWARFYTAEVVLAL 155
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 773
+ +H+ IHRD+K N+LLDK K++DFG K +G + V GT Y+
Sbjct: 156 DAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYIS 211
Query: 774 PEYYISQ----QLTDKSDVYSFGVILLELISG 801
PE SQ + D +S GV L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 43/214 (20%)
Query: 609 IGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 663
+GSG +G V +A+K L S +Q KR + E+ LL + H N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKL-SRPFQSAIHAKRTY-RELRLLKHMDHENVIGLL 80
Query: 664 -----GYCQEEGRSV-LVYEFMH---NGTLKEHLYGTLTHEQRINWIKRL--EIAEDAAK 712
E+ + V LV M N +K L+ + I+ L +I +
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ---KLSDDH----IQFLVYQIL----R 129
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG-- 770
G++Y+H+ IIHRDLK SNI +++ K+ DFGL A H + G V
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL-------ARHTDDEMTGYVATR 179
Query: 771 -YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 802
Y PE ++ D++S G I+ EL++G+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 37/100 (37%), Positives = 54/100 (54%), Gaps = 3/100 (3%)
Query: 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGPLPS 481
L L+G IP + L L+ L L NSL+G IP+ +L I+HL N TG +P
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326
Query: 482 SLMNLPNLRELYVQNNMLSGTVPSSLLSKN--VVLNYAGN 519
+L +LP L+ L + +N SG +P +L N VL+ + N
Sbjct: 327 ALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL 475
++ ++HL S N TG IP LT L L L L N +G IP + +L ++ L N L
Sbjct: 309 NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL 368
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
TG +P L + NL +L + +N L G +P SL
Sbjct: 369 TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 605 LEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSYQGKREFT----NEVTLLSRIHH 656
L K +G+G +G V+ + GK A+KVL + K + T E +L I
Sbjct: 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 63
Query: 657 RNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK---RLEIAEDAAK 712
+ L Y Q + + L+ ++++ G L HL QR + + ++ E
Sbjct: 64 SPFLVTLHYAFQTDTKLHLILDYINGGELFTHL------SQRERFKEQEVQIYSGE-IVL 116
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGY 771
+E+LH II+RD+K NILLD + ++DFGLSK F D S GT+ Y
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC-GTIEY 172
Query: 772 LDPEYYISQQLT-DKS-DVYSFGVILLELISG 801
+ P+ DK+ D +S GV++ EL++G
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 607 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQ 661
K++GSG +G V + G ++A+K L +Q KR + E+ LL + H N++
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAY-RELRLLKHMKHENVIG 78
Query: 662 FLG-YCQEEGRS-----VLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713
L + + LV FM G L +H E RI ++ KG
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH---EKLSEDRIQFL-----VYQMLKG 130
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV---G 770
++Y+H IIHRDLK N+ +++ K+ DFGL A S + G V
Sbjct: 131 LKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL-------ARQTDSEMTGYVVTRW 180
Query: 771 YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 802
Y PE ++ T D++S G I+ E+++G+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 49/205 (23%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 609 IGSGGFGVVYYGKLKDGK--------EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 660
+G G F ++ G ++ E+ +KVL + F +++S++ H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
G C S++V E++ G+L +L ++ IN +LE+A+ A + +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLK---KNKNLINISWKLEVAKQLAWALHFLED- 118
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVGYLDPE-Y 776
+ H ++ + N+LL + K + K + G S I+ + ++ PE
Sbjct: 119 --KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 777 YISQQLTDKSDVYSFGVILLELISG 801
Q L+ +D +SFG L E+ SG
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 608 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFLGY 665
++G G +G VY + G +A+K + + K + E+ +L + +V F G
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 666 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL---HTGCV 722
EG + E+M G+L + LY + I I KG+++L H
Sbjct: 68 FFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--- 123
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YLDPEYYIS 779
IIHRD+K +N+L++ + + K+ DFG+S + V+S+ + +G Y+ PE S
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 780 QQLTD------KSDVYSFGVILLELISG 801
+SDV+S G+ +LE+ G
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 54/171 (31%), Positives = 79/171 (46%), Gaps = 29/171 (16%)
Query: 598 IEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 656
IE+ + K I G FG VY G K + K AVKV+ K + N+ +
Sbjct: 3 IEEFV--IVKPISRGAFGKVYLGRKKNNSKLYAVKVVK------KADMINKNMVHQVQAE 54
Query: 657 RNLV-----QF---LGYCQEEGRSV-LVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLE 705
R+ + F L Y + +V LV E++ G +K H+YG E + +I +
Sbjct: 55 RDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVA 114
Query: 706 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756
+A D YLH IIHRDLK N+L+ K++DFGLSK ++
Sbjct: 115 LALD------YLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 30/207 (14%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 662
+ +G G FG+V + G+ +A+K + S KR + E+ LL + H N++
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENII-- 72
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE------IAEDAAKGIEY 716
S + + + L GT H R+ + LE +G++Y
Sbjct: 73 -------SLSDIFISPLEDIYFVTELLGTDLH--RLLTSRPLEKQFIQYFLYQILRGLKY 123
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
+H+ V +HRDLK SNIL++++ K+ DFGL++ ++ V T Y PE
Sbjct: 124 VHSAGV---VHRDLKPSNILINENCDLKICDFGLARIQ---DPQMTGYV-STRYYRAPEI 176
Query: 777 YISQQLTD-KSDVYSFGVILLELISGQ 802
++ Q D + D++S G I E++ G+
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 68/267 (25%), Positives = 105/267 (39%), Gaps = 78/267 (29%)
Query: 605 LEKKIGSGGFGVVY------YGKLKDGKEIAVKVL----TSNSYQGKREFTNEVTLLSRI 654
L K +G G FG V K + +AVK+L T++ Y + E+ +L I
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEY---KALMTELKILIHI 67
Query: 655 -HHRNLVQFLG--------------YCQEEGRSVLVYEFMH-------NGTLKEHLYGTL 692
HH N+V LG YC+ S + T K +
Sbjct: 68 GHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKE 127
Query: 693 THEQRIN------------WI--KRLEIAED-----------------------AAKGIE 715
+QR++ +I K L E+ A+G+E
Sbjct: 128 GKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGME 187
Query: 716 YLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLD 773
+L + C IHRDL + NILL ++ K+ DFGL++ +V R + ++
Sbjct: 188 FLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243
Query: 774 PEYYISQQLTDKSDVYSFGVILLELIS 800
PE + T +SDV+SFGV+L E+ S
Sbjct: 244 PESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 42/177 (23%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 647 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR-INWIKRLE 705
E LL ++H ++++ + +V LY LT R + + L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLP-----HYSSDLYTYLTKRSRPLPIDQALI 161
Query: 706 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 765
I + +G+ YLH IIHRD+K+ NI ++ + + D G ++F V + + +
Sbjct: 162 IEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216
Query: 766 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI------SNEKFGANCRN 816
GTV PE + K+D++S G++L E+++ I + E++ +C +
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS 273
|
Length = 357 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 608 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLGY 665
K+G G + V+ G+ K +A+K + +G EV+LL + H N+V
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 666 CQEEGRSVLVYEFMHNGTLKEHL--YGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGC 721
E LV+E++ + LK++L G L H +I + L +G+ Y H
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLL-------RGLSYCHK-- 121
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI-S 779
I+HRDLK N+L+++ K++DFGL++ +V ++ + +V T+ Y P+ + S
Sbjct: 122 -RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGS 178
Query: 780 QQLTDKSDVYSFGVILLELISGQ 802
+ + D++ G IL E+ +G+
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-09
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 1/93 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG-CPDLRIIHLEDNQ 474
P++ + LS+ L+G IP+D+ SSL L L GN L G IP+ L + L NQ
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
L G +P L + +L+ +Y+ N LSG +P +
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI 232
|
Length = 968 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 66/264 (25%), Positives = 105/264 (39%), Gaps = 71/264 (26%)
Query: 605 LEKKIGSGGFGVVY------YGKLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 656
L K +G G FG V K +AVK+L + + + +E+ +L I +H
Sbjct: 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNH 70
Query: 657 RNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHL---------YGTLTHEQRINWIKRLEI 706
N+V LG C + G +++ EF G L L Y + +QR + +E
Sbjct: 71 LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ 130
Query: 707 A------------------------------------------ED-------AAKGIEYL 717
+ ED A+G+E+L
Sbjct: 131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL 190
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEY 776
+ IHRDL + NILL ++ K+ DFGL++ +V R + ++ PE
Sbjct: 191 AS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES 247
Query: 777 YISQQLTDKSDVYSFGVILLELIS 800
+ T +SDV+SFGV+L E+ S
Sbjct: 248 IFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 37/219 (16%)
Query: 607 KKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSY----QGKREFTNEVTLLSRIHHRNLVQ 661
K I +G +G VY + K+ ++ A+K + + Q ++ F E +L+ + +V
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAENPFVVS 65
Query: 662 FLGYCQEEGRSVL--VYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
+C E + L V E++ G TL +++ G L + + R+ AE +EY
Sbjct: 66 M--FCSFETKRHLCMVMEYVEGGDCATLLKNI-GALPVD-----MARMYFAE-TVLALEY 116
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF--------------AVDGASHVS 762
LH I+HRDLK N+L+ K++DFGLSK D +
Sbjct: 117 LHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
V GT Y+ PE + Q D ++ G+IL E + G
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 37/211 (17%)
Query: 609 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 663
+GSG +G V K G +AVK L S +Q KR + E+ LL + H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 82
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 715
RS E ++ L HL G + N +K ++ +D +G++
Sbjct: 83 DVFTP-ARS---LEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 134
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YL 772
Y+H+ IIHRDLK SN+ +++ K+ DFGL A H + G V Y
Sbjct: 135 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL-------ARHTDDEMTGYVATRWYR 184
Query: 773 DPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
PE ++ +++ D++S G I+ EL++G+
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 51/202 (25%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 608 KIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLGY 665
K+G G + VY G+ K +A+K + +G EV+LL + H N+V
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 666 CQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRIN-WIKRLEIAEDAAKGIEYLHTGCV 722
E LV+E++ + LK++L G + + ++ +L +G+ Y H
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQL------LRGLNYCHR--- 122
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI-SQ 780
++HRDLK N+L+++ K++DFGL++ ++ ++ + +V T+ Y P+ + S
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGST 180
Query: 781 QLTDKSDVYSFGVILLELISGQ 802
+ + D++ G I E+ +G+
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 54/226 (23%)
Query: 607 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIH-HRNL 659
K++G G +G+V + + + +A+K +T S KR E+ LL H+N+
Sbjct: 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-RELKLLRHFRGHKNI 64
Query: 660 V-----------QFLG-YCQEEGRSVLVYEFMHNGT------LKEHLYGTLTHEQRINWI 701
F Y EE +++ + +G + +Y L
Sbjct: 65 TCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILC-------- 116
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDG 757
G++Y+H+ V +HRDLK N+L++ K+ DFGL++ +
Sbjct: 117 -----------GLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGEN 162
Query: 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
A ++ V T Y PE +S Q K+ DV+S G IL EL+ +
Sbjct: 163 AGFMTEYV-ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQFLG 664
IG G + V +LK +I A+KV+ + E + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 665 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 715
C Q R LV E+++ G L H+ QR ++ E+ A+ +
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHM-----QRQR-------KLPEEHARFYAAEICIALN 110
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
+LH II+RDLK N+LLD K++D+G+ K + G +S GT Y+ PE
Sbjct: 111 FLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL-GPGDTTSTFCGTPNYIAPE 166
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQ 802
++ D ++ GV++ E+++G+
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 662
K IG G FG V KLK+ ++ A+K+L + E F E +L ++ +
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 663 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
Q+E LV ++ G TL L + ++ + IA D+ + Y
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
+HRD+K NIL+D + +++DFG ++ + SS+ GT Y+ PE I
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE--IL 175
Query: 780 QQLTD-------KSDVYSFGVILLELISGQEAISNEKF 810
Q + D + D +S GV + E++ G+ E
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 711 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTV 769
AKG+E+L + IHRDL + NILL ++ K+ DFGL++ +V R +
Sbjct: 189 AKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
++ PE + T +SDV+SFGV+L E+ S
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-08
Identities = 57/237 (24%), Positives = 92/237 (38%), Gaps = 41/237 (17%)
Query: 607 KKIGSGGFGVVYYG-KLKDGKEIAVKV----LTSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+ IG GG G VY + +A+K L+ N KR F E + + + H +V
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKR-FLREAKIAADLIHPGIVP 66
Query: 662 FLGYCQEEGRSVLVY---EFMHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAA 711
C + VY ++ TLK L ++ + L I
Sbjct: 67 VYSICSD---GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-------------AVDGA 758
IEY+H+ ++HRDLK NILL + D+G + F
Sbjct: 124 ATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 759 SHVS-----SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810
+ S IV GT Y+ PE + ++ +D+Y+ GVIL ++++ +K
Sbjct: 181 CYSSMTIPGKIV-GTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236
|
Length = 932 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEIA---VKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQF 662
++IG+G FG V ++ +A VK L +N S + + EF + + H N++Q
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
LG C E +LV+E+ G LK +L H + + +A + A G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK--- 117
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGL--SKFAVD---GASHVSSIVRGTVGYLDPEYY 777
+H DL N L + KV D+G+ S++ D +R L E++
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 778 ---ISQQLTDKSDVYSFGVILLEL 798
I+ + T S+V++ GV L EL
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 4e-08
Identities = 25/61 (40%), Positives = 33/61 (54%), Gaps = 3/61 (4%)
Query: 441 SLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498
+L L L N LT IPD F G P+L+++ L N LT P + LP+LR L + N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 499 L 499
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 607 KKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLG 664
+K+G G + V+ G+ K + +A+K + +G EV+LL + H N+V
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTG 720
+ LV+E++ + LK+++ G + H +I + L +G+ Y H
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQIL-------RGLAYCHR- 122
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI- 778
++HRDLK N+L+++ K++DFGL++ +V ++ + +V T+ Y P+ +
Sbjct: 123 --RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 178
Query: 779 SQQLTDKSDVYSFGVILLELISGQ 802
S + + + D++ G I E+ SG+
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 607 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTS---NSYQGKREFTNEVTLLSRIHHRNLVQF 662
K IG G +G+V K + +++A+K + + N KR E+ LL + H N++
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL-REIKLLRHLDHENVIAI 69
Query: 663 LGYCQEEGRSV-----LVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIE 715
R +VYE M + L + + TL+ + ++ +L +G++
Sbjct: 70 KDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQL------LRGLK 122
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
Y+H+ ++HRDLK SN+LL+ + K+ DFGL++ + ++ V T Y PE
Sbjct: 123 YIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPE 178
Query: 776 YYIS-QQLTDKSDVYSFGVILLELISGQ 802
++ + T DV+S G I EL+ +
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 608 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFLG 664
K+G G + VY G+ K G+ +A+K + +G FT E +LL + H N+V
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHD 70
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+ LV+E++ LK+++ G + RL + + +G+ Y H
Sbjct: 71 IIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNV----RLFLFQ-LLRGLAYCHQ--- 121
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 781
++HRDLK N+L+ + K++DFGL++ A S S T+ Y P+ + S +
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 782 LTDKSDVYSFGVILLELISGQ 802
+ D++ G I E+ +G+
Sbjct: 181 YSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF----TNEVTLLSRIHHRNLVQFL 663
IG G + V +LK + I A+KV+ + T + +H LV
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 715
Q E R V E+++ G L H+ QR ++ E+ A+ +
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHM-----QRQR-------KLPEEHARFYSAEISLALN 110
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
YLH II+RDLK N+LLD K++D+G+ K + S+ GT Y+ PE
Sbjct: 111 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPE 166
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQ 802
+ D ++ GV++ E+++G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-08
Identities = 67/274 (24%), Positives = 98/274 (35%), Gaps = 77/274 (28%)
Query: 607 KKIGSGGFGVV-YYGKLKDGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 662
K IG G FG V K GK A+K L + K + + E +L+ +V
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
Q+ L+ EF+ G L L Y T + + + R +AE
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED-----VTRFYMAE------------ 109
Query: 721 CVPAI--------IHRDLKSSNILLDKHMRAKVSDFGLS------------------KFA 754
CV AI IHRD+K NIL+D+ K+SDFGLS K
Sbjct: 110 CVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSN 169
Query: 755 VDGASHVSSIV----------------------------RGTVGYLDPEYYISQQLTDKS 786
+ + +S+ GT Y+ PE ++ Q +
Sbjct: 170 KNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229
Query: 787 DVYSFGVILLELISGQEAISNEKFGANCRNIVQW 820
D +S G I+ E + G +E R I+ W
Sbjct: 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINW 263
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF----TNEVTLLSRIHHRNLVQFL 663
IG G + V +LK + I A+KV+ + T + + +H LV
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 715
Q E R V EF+ G L H+ QR ++ E+ A+ +
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHM-----QRQR-------KLPEEHARFYSAEISLALN 110
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
+LH II+RDLK N+LLD K++D+G+ K + +S GT Y+ PE
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI-RPGDTTSTFCGTPNYIAPE 166
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQ 802
+ D ++ GV++ E+++G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 62/254 (24%), Positives = 97/254 (38%), Gaps = 49/254 (19%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 662
K IG G FG V + KD I A+K+L K + + E +L +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
Q++ L+ EF+ G + L TL+ E +I +A DA + +
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF---- 122
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGL---------------------SKFAVDGAS 759
IHRD+K N+LLD K+SDFGL S F+ +
Sbjct: 123 -----IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 760 -------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 806
++ GT Y+ PE ++ D +S GVI+ E++ G
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 807 NEKFGANCRNIVQW 820
+E R ++ W
Sbjct: 238 SETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 9e-08
Identities = 35/102 (34%), Positives = 56/102 (54%), Gaps = 12/102 (11%)
Query: 704 LEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762
L + AKG+ +L + C IHRDL + NILL K+ DFGL++ D + +
Sbjct: 217 LSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR---DIRNDSN 269
Query: 763 SIVRGT----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+V+G V ++ PE + T +SDV+S+G++L E+ S
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 1/88 (1%)
Query: 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPS 481
LS +L+G IP + +L +L L L N+ TG IP + P L+++ L N+ +G +P
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350
Query: 482 SLMNLPNLRELYVQNNMLSGTVPSSLLS 509
+L NL L + N L+G +P L S
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPEGLCS 378
|
Length = 968 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 63/236 (26%), Positives = 90/236 (38%), Gaps = 55/236 (23%)
Query: 607 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQG----KREFTNEVTLLSRIHHRNLVQ 661
K +G G G V+ +LK GK A+KVL KR T E +L+ + H L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT-EQEILATLDHPFLPT 65
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 713
Q E LV ++ G L+ L + K L E+ A+
Sbjct: 66 LYASFQTETYLCLVMDYCPGG----ELFRLLQRQPG----KCLS--EEVARFYAAEVLLA 115
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR------- 766
+EYLH I++RDLK NILL + +SDF LSK + VS +R
Sbjct: 116 LEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 767 ---------------------GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
GT Y+ PE D ++ G++L E++ G
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 607 KKIGSGGFGVVYYGKLKDGK--EIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQ 661
+ +G+G FG V K+ +A+K + +++ +E +L+ I+H V
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
G ++E LV EF+ G + L +R A EYL +
Sbjct: 96 LYGSFKDESYLYLVLEFVIGG----EFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS-- 149
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
I++RDLK N+LLDK K++DFG +K VD ++ + GT Y+ PE ++
Sbjct: 150 -LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYT---LCGTPEYIAPEILLNVG 204
Query: 782 LTDKSDVYSFGVILLELISG 801
+D ++ G+ + E++ G
Sbjct: 205 HGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 53/222 (23%), Positives = 101/222 (45%), Gaps = 42/222 (18%)
Query: 607 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
+ +G G G+V+ D K +AVK + Q + E+ ++ R+ H N+V+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK---- 66
Query: 666 CQEEGRSVLVYEFM-HNGTLKEHLYGTLTHEQRI------------NWIKRLEIAEDAAK 712
VYE + +G+ G+LT + N +++ ++E+ A+
Sbjct: 67 ---------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117
Query: 713 --------GIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSS 763
G++Y+H+ V +HRDLK +N+ ++ + + K+ DFGL++ SH
Sbjct: 118 LFMYQLLRGLKYIHSANV---LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 764 IVRGTVG--YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 802
+ G V Y P +S T D+++ G I E+++G+
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 61/254 (24%), Positives = 97/254 (38%), Gaps = 49/254 (19%)
Query: 607 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 662
K IG G FG V + KD G A+K+L K + + E +L +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
Q++ L+ EF+ G + L TLT E+ +I +A D+ + +
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF---- 122
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGL---------------------SKFAVDGAS 759
IHRD+K N+LLD K+SDFGL S F +
Sbjct: 123 -----IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 760 -------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 806
++ GT Y+ PE ++ D +S GVI+ E++ G
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 807 NEKFGANCRNIVQW 820
+E + ++ W
Sbjct: 238 SETPQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 41/213 (19%)
Query: 609 IGSGGFGVV---YYGKLKDGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 662
+GSG +G V Y +L+ +++AVK L S +Q R E+ LL + H N++
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKL-SRPFQSLIHARRTYRELRLLKHMKHENVIGL 79
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKE----HLYGTLTHEQRINWIKRLEIAEDAA------- 711
L F +++ +L L N +K +++++
Sbjct: 80 LDV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL 127
Query: 712 -KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770
+G++Y+H+ IIHRDLK SN+ +++ ++ DFGL++ A D ++ V T
Sbjct: 128 LRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADD---EMTGYV-ATRW 180
Query: 771 YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
Y PE ++ +++ D++S G I+ EL+ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 12/102 (11%)
Query: 704 LEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762
L A+G+E+L + CV HRDL + N+LL + K+ DFGL++ + +++VS
Sbjct: 240 LSFTYQVARGMEFLASKNCV----HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295
Query: 763 SIVRGT----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+G+ V ++ PE T SDV+S+G++L E+ S
Sbjct: 296 ---KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 662
K IG G FG V K+K+ ++ A+K+L + E F E +L R +
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 663 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
Q+E LV ++ G TL L + ++ + +A D+ + Y
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY--- 123
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYYI 778
+HRD+K N+LLDK+ +++DFG + DG S++ GT Y+ PE I
Sbjct: 124 ------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ-SNVAVGTPDYISPE--I 174
Query: 779 SQQLTD-------KSDVYSFGVILLELISGQ 802
Q + D + D +S GV + E++ G+
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 608 KIGSGGFGVVYYGK-LKDG-KEIAVK-VLTSNSYQGKREFT-NEVTLLSRIH---HRNLV 660
+IG G +G V+ + LK+G + +A+K V +G T EV +L + H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 661 QFLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
+ C E + LV+E + + L +L IK ++ +G++
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLD 124
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
+LH+ ++HRDLK NIL+ + K++DFGL++ + S +V T+ Y PE
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPE 179
Query: 776 YYISQQLTDKSDVYSFGVILLEL 798
+ D++S G I E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 34/212 (16%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQF 662
K IG G FG V + K +++ L S KR F E +++ + +VQ
Sbjct: 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 714
Q++ +V E+M G L +N + ++ E A+ +
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 773
+ +H+ IHRD+K N+LLDK K++DFG K +G + V GT Y+
Sbjct: 156 DAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYIS 211
Query: 774 PEYYISQ----QLTDKSDVYSFGVILLELISG 801
PE SQ + D +S GV L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 609 IGSGGFGVVYYGKLKDGKE-IAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666
IG+G FGVVY D E +A+K VL Y+ + E+ ++ ++H N++ Y
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-----ELLIMKNLNHINIIFLKDYY 128
Query: 667 QEEG-----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE----DAAKGIEYL 717
E +++ + M H Y + H R N L + + + + Y+
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKY--MKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
H+ I HRDLK N+L+D + K+ DFG +K + G VS I + Y PE
Sbjct: 187 HS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC--SRFYRAPEL 241
Query: 777 YI-SQQLTDKSDVYSFGVILLELISGQEAISNE 808
+ + T D++S G I+ E+I G S +
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274
|
Length = 440 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 662
K IG G FG V K+K + I A+K+L + E F E +L + +
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66
Query: 663 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
Q+E LV ++ G TL L + +I + +A + + Y
Sbjct: 67 HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY--- 123
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
+HRD+K N+LLD + +++DFG + SS+ GT Y+ PE I
Sbjct: 124 ------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE--IL 175
Query: 780 QQLTD-------KSDVYSFGVILLELISGQ 802
Q + D + D +S GV + E++ G+
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 58/233 (24%), Positives = 98/233 (42%), Gaps = 43/233 (18%)
Query: 595 LSDIEDATKMLEKKIGSGGFGVVYYGKLK----------------DGKEIAVKVLTSNSY 638
L DI ++K IG GGFG VY + + + I ++ L N+
Sbjct: 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNI 65
Query: 639 QGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE 695
+++ L IH H + ++ G C R + Y F+ L E L T E
Sbjct: 66 YDI----DKIALWKNIHNIDHLGIPKYYG-CGSFKRCRMYYRFI----LLEKLVEN-TKE 115
Query: 696 --QRI-NWIKRL--EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750
+RI K+L I +D +EY+H I H D+K NI++D + R + D+G+
Sbjct: 116 IFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGI 172
Query: 751 SKFAVDGASHVS------SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLE 797
+ + H+ + RGT+ Y + + +T + D+ S G +L+
Sbjct: 173 ASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 43/142 (30%), Positives = 55/142 (38%), Gaps = 46/142 (32%)
Query: 703 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL---------SKF 753
R IAE IE +H IHRD+K NIL+D+ K++DFGL SK+
Sbjct: 104 RFYIAE-LTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 754 AVDGASH----------VSSIVR-----------------------GTVGYLDPEYYISQ 780
G H S I R GT Y+ PE +
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219
Query: 781 QLTDKSDVYSFGVILLELISGQ 802
T D +S GVIL E++ GQ
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 33/102 (32%), Positives = 59/102 (57%), Gaps = 12/102 (11%)
Query: 704 LEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762
L + A+G+++L + C IHRD+ + N+LL AK+ DFGL++ ++ +++V
Sbjct: 215 LRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV- 269
Query: 763 SIVRGT----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
V+G V ++ PE T +SDV+S+G++L E+ S
Sbjct: 270 --VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 608 KIGSGGFGVVYYGKLKDG---KEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLV-- 660
K+G G +G VY K KDG KE A+K + T S R E+ LL + H N++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR----EIALLRELKHPNVIAL 63
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEH-LYGTLT-HEQRINWIKRLEIAEDAAK------ 712
Q + + + L++++ EH L+ + H K +++ K
Sbjct: 64 QKVFLSHSDRKVWLLFDY------AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 713 --GIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSI-- 764
GI YLH V +HRDLK +NIL+ + R K++D G ++ ++ +
Sbjct: 118 LDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174
Query: 765 VRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 802
V T Y PE + ++ T D+++ G I EL++ +
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 26/228 (11%)
Query: 582 LNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK 641
++D PA A + + +T+ E G GK K + IA +V +
Sbjct: 153 IDDLPAGAFGKIFICALRASTEEAEA---RRGVNSTNQGKPKCERLIAKRV--KAGSRAA 207
Query: 642 REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV--------YEFMHNGTLKEHLYGTLT 693
+ NE+ L R++H N+++ + E + ++ Y FM++ L
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLK 267
Query: 694 HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG-LSK 752
+ I +K+L A +EY+H +IHRD+K NI L+ + + DFG
Sbjct: 268 QTRAI--MKQLLCA------VEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316
Query: 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
F + + V GTV PE + +D++S G+ILL+++S
Sbjct: 317 FEKEREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 37/150 (24%), Positives = 63/150 (42%), Gaps = 16/150 (10%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV--QFLG 664
K + G VY KD +K+ S RE EV +L + + L + L
Sbjct: 4 KLLKGGLTNRVYLLGTKDED-YVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLA 60
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
+ +G S L+ E++ TL E ++ E++ + IAE A+ + LH +
Sbjct: 61 SGESDGWSYLLMEWIEGETLDE-----VSEEEKED------IAEQLAELLAKLHQLPLLV 109
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754
+ H DL NIL+D + D+ + +
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLV 660
+++ IG G +GVV G+++A+K + + ++ + T E+ LL + H ++V
Sbjct: 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIV 62
Query: 661 Q----FLGYCQEEGRSV-LVYEFMH---------NGTL-KEH----LYGTLTHEQRINWI 701
+ L + E + + +V+E M N L EH LY L
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL--------- 113
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASH 760
+ ++Y+HT V HRDLK NIL + + K+ DFGL++ A D +
Sbjct: 114 ----------RALKYIHTANV---FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160
Query: 761 V--SSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQ 802
+ + V T Y PE S + T D++S G I E+++G+
Sbjct: 161 IFWTDYV-ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 608 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG-Y 665
K+G G +G VY K KDGK+ L G E+ LL + H N++ +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 666 CQEEGRSV-LVYEFMHNG---TLKEHLYGTLTHEQRINWIKRL--EIAEDAAKGIEYLHT 719
R V L++++ + +K H + +++ + + + + GI YLH
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFH-RASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 720 GCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSI--VRGTVGYLD 773
V +HRDLK +NIL+ + R K++D G ++ ++ + V T Y
Sbjct: 127 NWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 774 PEYYI-SQQLTDKSDVYSFGVILLELISGQ 802
PE + ++ T D+++ G I EL++ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 6e-06
Identities = 28/80 (35%), Positives = 40/80 (50%), Gaps = 8/80 (10%)
Query: 725 IIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
IIH D+K N+L D+ R + D+GL K S GT+ Y PE I
Sbjct: 130 IIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSPE-KIKGHNY 183
Query: 784 DKS-DVYSFGVILLELISGQ 802
D S D ++ GV+ EL++G+
Sbjct: 184 DVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 22/207 (10%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFLG 664
+G G FG V + K +I A+KV+ + + F E +LS + + Q
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
Q++ LV E+ G L L Y E + +AE + +H+
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA----QFYLAEL----VLAIHSVHQ 120
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR-GTVGYLDPEYYISQQ 781
+HRD+K N+L+D+ K++DFG S + V+S + GT Y+ PE +
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 782 LTDKS------DVYSFGVILLELISGQ 802
K D +S GVI E+I G+
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 30/95 (31%), Positives = 56/95 (58%), Gaps = 12/95 (12%)
Query: 711 AKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT- 768
A G+E+L + CV HRDL + N+L+ + K+ DFGL++ + ++++S +G+
Sbjct: 249 ANGMEFLASKNCV----HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS---KGST 301
Query: 769 ---VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ ++ PE + T SDV+SFG++L E+ +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 48/211 (22%), Positives = 82/211 (38%), Gaps = 30/211 (14%)
Query: 610 GSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLGY 665
+V+ K K +AVK + K + E+ ++ H N++ ++
Sbjct: 9 CFEDLMIVHLAKHKPTNTLVAVKK-INLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 666 CQEEGRSVLVYEFMHNGT----LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 720
+ +V M G+ LK H L E I +I + D ++Y+H+ G
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-ELAIAFILK-----DVLNALDYIHSKG 121
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG------YLDP 774
IHR +K+S+ILL + +S S + + +L P
Sbjct: 122 F----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 775 EYYISQQL---TDKSDVYSFGVILLELISGQ 802
E + Q L +KSD+YS G+ EL +G
Sbjct: 178 EV-LQQNLQGYNEKSDIYSVGITACELANGH 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 2/85 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ + LS N ++P ++ LS+L EL L NS+ + S +L + L +N+L
Sbjct: 186 SNLNNLDLSG-NKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKL 244
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLS 500
LP S+ NL NL L + NN +S
Sbjct: 245 E-DLPESIGNLSNLETLDLSNNQIS 268
|
Length = 394 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 45/169 (26%), Positives = 69/169 (40%), Gaps = 18/169 (10%)
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 715
N+V Y E LV + G L H+ + + E W + +A DA
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
LH I+ RDL +NILLD +++ F V+ + ++ Y PE
Sbjct: 101 -LHR---EGIVCRDLNPNNILLDDRGHIQLTYFS-RWSEVEDSCDGEAVENM---YCAPE 152
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR---NIVQWV 821
+ T+ D +S G IL EL++G+ + G N NI +WV
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWV 201
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 609 IGSGGFGVVYYGKLKD---------GKEIAV--KVLTSNSYQGKREFTNEVTLLSRIHHR 657
+G G F +Y G L+ G+E++V KVL S+ ++ F +L+S++ H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD-HRDSLAFFETASLMSQLSHK 61
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN----WIKRLEIAEDAAKG 713
+LV+ G C + +++V E++ G L L H ++ N W +L++A+ A
Sbjct: 62 HLVKLYGVCVRDE-NIMVEEYVKFGPLDVFL-----HREKNNVSLHW--KLDVAKQLASA 113
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKH-------MRAKVSDFGLSKFAVDGASHVSSIVR 766
+ YL ++H ++ NIL+ ++ K+SD G+ + V I
Sbjct: 114 LHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-- 168
Query: 767 GTVGYLDPEYY--ISQQLTDKSDVYSFGVILLELISGQEA 804
++ PE LT +D +SFG LLE+ S E
Sbjct: 169 ---PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 27/88 (30%), Positives = 47/88 (53%), Gaps = 8/88 (9%)
Query: 605 LEKKIGSGGFGVVY------YGKLKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HH 656
K +G+G FG V GK + +AVK+L ++++ +RE +E+ +LS + H
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTL 684
+N+V LG C G +++ E+ G L
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 28/230 (12%)
Query: 580 SSLNDAPAEAAHCFTLSDIEDATKM---LEKKIGSGGFGVVY----YGKLKDGKEIAVKV 632
S D E + SD +M + + G G V+ +G + K++ VK
Sbjct: 68 SPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGD-EQRKKVIVKA 126
Query: 633 LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL-GYCQEEGRSVLVYEFMHNGTLKEHLYGT 691
+T G + E+ +L I HR ++ + Y + +++ ++ + G
Sbjct: 127 VT-----GGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGP 181
Query: 692 LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751
L EQ I +RL A + YLH IIHRD+K+ NI LD+ A + DFG +
Sbjct: 182 LPLEQAITIQRRLLEA------LAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA 232
Query: 752 KFAVDGASHVSSIVRGTVGYLD---PEYYISQQLTDKSDVYSFGVILLEL 798
A + G G L+ PE K+D++S G++L E+
Sbjct: 233 --CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 41/159 (25%), Positives = 68/159 (42%), Gaps = 18/159 (11%)
Query: 645 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 704
+E LL R+ H ++ L G + LV + LY L R+ +
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS-----DLYTYLG--ARLRPLGLA 260
Query: 705 EIAEDAAK---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761
++ A + I+Y+H IIHRD+K+ N+L++ + DFG + FA S
Sbjct: 261 QVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFA--RGSWS 315
Query: 762 SSIVRGTVGYLD---PEYYISQQLTDKSDVYSFGVILLE 797
+ G G +D PE T D++S G+++ E
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 60/248 (24%), Positives = 93/248 (37%), Gaps = 61/248 (24%)
Query: 607 KKIGSGGFG-VVYYGKLKDGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 662
K +G G FG V K+ A+K L + + + E +L+ + +V+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
Q++ V +++ G + L + + R IAE IE +H
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYIAE-LTLAIESVHK--- 119
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGL---------SKFAVDGASHVS----------- 762
IHRD+K NIL+D K++DFGL SK+ G SH+
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG-SHIRQDSMEPSDLWD 178
Query: 763 ----------------------------SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVI 794
S+V GT Y+ PE + + T D +S GVI
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLV-GTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 795 LLELISGQ 802
L E++ GQ
Sbjct: 238 LFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-04
Identities = 72/296 (24%), Positives = 102/296 (34%), Gaps = 105/296 (35%)
Query: 605 LEKKIGSGGFGVVYYG-----KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN- 658
L KK+G G FGVVY + K + +K + Y + NE R N
Sbjct: 136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLK--KATEYGAVEIWMNERV---RRACPNS 190
Query: 659 ----LVQFLGYCQEEGRSV--LVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEI 706
+ FL + LV+ + TL KE Y E + L
Sbjct: 191 CADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNV---EPYL-----LGK 242
Query: 707 AEDAAKGIEY------------------LH-TGCVPAIIHRDLKSSNILLDKHMRA-KVS 746
+D KG+E LH TG I+HRD+K NI+ + + K+
Sbjct: 243 VQDLPKGLERENKIIQTIMRQILFALDGLHSTG----IVHRDVKPQNIIFSEGSGSFKII 298
Query: 747 DFGLSKFAVDGASHVSSIVRGTVGY------LDP------EYYISQQ------------- 781
D G A D +R + Y LDP +Y +S Q
Sbjct: 299 DLGA---AAD--------LRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATAL 347
Query: 782 --------LTDKSDVYSFGVILLE-----LISGQEAIS-NEKFGANCRNIVQWVKS 823
L D+ D+YS G+I L+ L S I N + N ++V W K
Sbjct: 348 SPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL 403
|
Length = 566 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 49/191 (25%), Positives = 84/191 (43%), Gaps = 21/191 (10%)
Query: 624 DGKEIAV--KVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681
+G+E+ V KVL + F +L+S++ H +L G C +++V EF+ +
Sbjct: 41 NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 741
G L L + W ++ +A+ A + YL ++H ++ + NILL +
Sbjct: 101 GPLDVCLRKEKGR-VPVAW--KITVAQQLASALSYLED---KNLVHGNVCAKNILLARLG 154
Query: 742 RA-------KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGV 793
A K+SD G+S A+ V I ++ PE L+ +D +SFG
Sbjct: 155 LAEGTSPFIKLSDPGVSFTALSREERVERI-----PWIAPECVPGGNSLSTAADKWSFGT 209
Query: 794 ILLELISGQEA 804
LLE+ E
Sbjct: 210 TLLEICFDGEV 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 35/114 (30%), Positives = 58/114 (50%), Gaps = 15/114 (13%)
Query: 607 KKIGSGGFGVVY----YGKLKDGK--EIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 658
K +G+G FG V YG K +AVK+L +++ +RE +E+ +LS + +H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHIN 100
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI--KRLEIAEDA 710
+V LG C G ++++ E+ G L L +R ++I K + AE A
Sbjct: 101 IVNLLGACTVGGPTLVITEYCCYGDLLNFL-----RRKRDSFICPKHEDHAEAA 149
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 33/112 (29%)
Query: 710 AAKGIEYLH-TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV--- 765
A +G+ YLH G IHR++K+S+IL +S GL ++ G SH+ S+V
Sbjct: 110 ALRGLNYLHQNGY----IHRNIKASHIL--------ISGDGL--VSLSGLSHLYSLVRNG 155
Query: 766 -RGTVGYLDPEYYIS-----------QQLTD---KSDVYSFGVILLELISGQ 802
+ V Y P++ S Q L KSD+YS G+ EL +G+
Sbjct: 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 824 | |||
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.98 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.98 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.98 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.98 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.98 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.98 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.95 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.94 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.94 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.94 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.93 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.89 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.89 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.87 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.74 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.63 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.63 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.55 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.55 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.43 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.43 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.42 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.35 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.34 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.27 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.22 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.21 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.2 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.16 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.15 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.07 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.06 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.01 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.0 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.95 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.95 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.93 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.92 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.91 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.85 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.83 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.82 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.76 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.75 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.75 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.71 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.7 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.69 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.67 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.65 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.6 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 98.6 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.57 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.54 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.54 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.53 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.43 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.39 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.38 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.38 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.3 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.29 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.22 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.22 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.15 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.11 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.06 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.04 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.02 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.01 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.0 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.95 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.93 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.92 |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-82 Score=746.42 Aligned_cols=498 Identities=24% Similarity=0.387 Sum_probs=395.2
Q ss_pred HHHHHHHHhcccccCCCCceEeecCCCCCc-ccCCCeEEecCCccccCceeeeecCcccccccceeeeecCC-CCcceee
Q 003385 14 ASVLILLLLDSSSAQMPGFVSLNCGGNENF-TDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPAD-SRKYCYK 91 (824)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~~~~idcg~~~~~-~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~tlr~fp~~-~~~~cy~ 91 (824)
++..++++++.++.+.+++++||||++.++ +|.+|++|++|..|+.|...+...++...++|+|+|+||.. ++++||+
T Consensus 7 ~~~~~~~~~~~~~~~~~~~~~I~CGs~~~~~~d~~~~~w~~D~~~~~~~~~~~~~~~~~~~~~~t~R~F~~~~g~~~cY~ 86 (623)
T PLN03150 7 AASALLAVLASLASPEPFTMRISCGARVNVRTAPTNTLWYKDFAYTGGIPANATRPSFIAPPLKTLRYFPLSDGPENCYN 86 (623)
T ss_pred HHHHHHHhhcccccCCCccEEEeCCCCCCcccCCCCCEEcCCcccccCccccccCcccccchhhccccCCcccccccceE
Confidence 333444555556666789999999999987 67899999999998766555555555566889999999963 5667999
Q ss_pred ecccCCceeEEEEEeeecccCCCCCCCceeEEeCCceeeeEeeC--CcCcceEEEEEEEecCCCceEEEeccCCCCceee
Q 003385 92 LDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVIS--DAATIEVRELIFLASSPKIDVCLSNATTGQPFIS 169 (824)
Q Consensus 92 ~~~~~~~~ylvr~~~~yg~~d~~~~~p~fd~~~~~~~w~~v~~~--~~~~~~~~e~~~~~~~~~~~vcl~~~~~~~pfis 169 (824)
||+.++||||||++|+|||||+.+++|.||+++|||+|.+|+.+ ..+...++|+|+.+++++++|||++++.|.||||
T Consensus 87 ~~~~~~g~ylVRl~F~~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~pFIs 166 (623)
T PLN03150 87 INRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAIL 166 (623)
T ss_pred eeecCCCcEEEEEEeecCCcCCCCCCCceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCCcee
Confidence 99999999999999999999999999999999999999999873 3445688999999999999999999999999999
Q ss_pred eeeeeecCCccccCcc--cCceeEEEEEeeecCCCC-CCCccCCCCCC--CCccccCccccccccccccCCccccccccc
Q 003385 170 TLELRQFNGSVYLTPF--EDRYYLSVSARINFGADS-EAPVRYPDDPF--DRIWESDSLKKANYLVDVAAGTEKVSTKLP 244 (824)
Q Consensus 170 ~le~~~l~~~~y~~~~--~~~~~l~~~~r~~~g~~~-~~~irypdD~~--dR~W~~~~~~~~~~~~~~~~~~~~~st~~~ 244 (824)
+||||+|++++|.... +.+.+|.+++|.++|+.. ...+|||||+| ||+|+|+..+. ...+.++++...
T Consensus 167 ~iEv~~l~~~~y~~~~~~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~-------~~~~~~~st~~~ 239 (623)
T PLN03150 167 SIEILQVDDKAYNFGPSWGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFG-------SGSDQAISTENV 239 (623)
T ss_pred EEEEEEcCcccccccccccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccC-------CCcccccccccc
Confidence 9999999999996442 446789999999999853 33589999999 99999975321 112455666666
Q ss_pred cCC--CCCCCChHHHHhhcccccCC--ceEEeecCCCCCCcceeEEeeccccC-CCCCcceEEEEEECCCcCcccccccc
Q 003385 245 IDL--RSDELPPQKVMQTAVVGTNG--SLTYRLNLDGFPGFGWAVTYFAEIED-LDPDESRKFRLVLPGQPDVSKAIVNI 319 (824)
Q Consensus 245 i~~--~~~~~pP~~v~qtA~t~~~~--sl~~~~~~~~~~~~~y~~~yFae~~~-~~~~~~R~F~i~in~~~~~~~~~~~~ 319 (824)
|.. ..++.+|++|||||.++.++ .++|.|++++ ...++++|||+|++. ....++|+|||++||+...+...+..
T Consensus 240 I~~~~~~~~~~P~~VyqTA~~~~~~~~~lty~~~v~~-~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~ 318 (623)
T PLN03150 240 IKKASNAPNFYPESLYQSALVSTDTQPDLSYTMDVDP-NRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVK 318 (623)
T ss_pred cccccCCCccChHHHhhhhccccCCCCceEEEeecCC-CCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhh
Confidence 653 34677899999999887764 5777777543 234467999999984 56778999999999988776544321
Q ss_pred ccccccceeeecccceeccccceeeecccccCCCCCCcccchhhhceeccCC--CCCCcHHHHHHHHHhcCC---CCccc
Q 003385 320 QENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERN--DGSIDGVAIVSVISLYSS---ADWAQ 394 (824)
Q Consensus 320 ~~~~~~~~~~~~~~~t~~~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~--~n~~~~~~l~~lk~~~~~---~~w~~ 394 (824)
. ..+.+..+...+.........++.+.+.. .-||+|||+|+++..... +.+.|..+|..+|+.+.. .+|
T Consensus 319 ~--~g~~~~~~~~~~~v~~~~g~l~isl~p~~--~s~pilNaiEI~~~~~~~~~t~~~~~~aL~~~k~~~~~~~~~~W-- 392 (623)
T PLN03150 319 M--SGERYTALVLNKTVAVSGRTLTIVLQPKK--GTHAIINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFGW-- 392 (623)
T ss_pred h--cCCcccceEEEeEEeecCCeEEEEEeeCC--CCcceeeeeeeeeccccccccCchHHHHHHHHHHhcCCcccCCC--
Confidence 1 11111111111111111233456666654 347999999999998765 467788899999987653 267
Q ss_pred CCCCCCCCC--CCCeeEcCCCC---CCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceE
Q 003385 395 EGGDPCLPV--PWSWLQCNSDP---QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRII 468 (824)
Q Consensus 395 ~~~dpc~~~--~~~~~~c~~~~---~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L 468 (824)
.+|||.|. +|.|+.|+.+. ...++.|+|++|+|+|.+|..|++|++|+.|+|++|+|+|.+|. ++.|++|+.|
T Consensus 393 -~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L 471 (623)
T PLN03150 393 -NGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL 471 (623)
T ss_pred -CCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEE
Confidence 78999875 69999996432 23599999999999999999999999999999999999998885 9999999999
Q ss_pred eecccccCCCCCccccCCCccceeeecccccccccccccccc---ceeccccCCccccCCC
Q 003385 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK---NVVLNYAGNINLHEGG 526 (824)
Q Consensus 469 ~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g~ip~~l~~~---~~~l~~~~n~~lc~~~ 526 (824)
+|++|+|+|.+|+.+++|++|+.|+|++|+|+|.+|..+... ...+.+.+|+.+|+.+
T Consensus 472 dLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 472 DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred ECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999999999999999999999999999999999987543 2456789999999754
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-62 Score=535.51 Aligned_cols=320 Identities=35% Similarity=0.565 Sum_probs=250.4
Q ss_pred eecCCCCC---ccc-CCCeEEecCCccc-cCceeeeec-----CcccccccceeeeecCCCCcceeeeccc--CCceeEE
Q 003385 35 LNCGGNEN---FTD-EIGLQWIADDHLI-YGEISNISV-----ANETRKQYMTLRHFPADSRKYCYKLDVI--TRTRYLI 102 (824)
Q Consensus 35 idcg~~~~---~~~-~~~~~~~~d~~~~-~~~~~~~~~-----~~~~~~~~~tlr~fp~~~~~~cy~~~~~--~~~~ylv 102 (824)
||||++.+ |+| .+|++|++|++|+ +|..++++. .....++|+|+|+||+|.| +||++|+. +|+||||
T Consensus 1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~~~~~~~~~~~y~taR~F~~g~r-~cY~l~~~~~~~~~yli 79 (347)
T PF12819_consen 1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQPDSSSSDSSPPYQTARIFPEGSR-NCYTLPVTPPGGGKYLI 79 (347)
T ss_pred CcCCCCCCCcccccCCCCcEEeCCCCcccCCCccccccccCCcCCccccccceEEEcCCCCc-cEEEeeccCCCCceEEE
Confidence 89998866 555 6899999999999 566677732 1234578999999998877 69999998 5779999
Q ss_pred EEEeeecccCCCC-----CCCceeEEeCCceeeeEeeCCc-CcceEEE-EEEEecCCCceEEEeccCCCC-ceeeeeeee
Q 003385 103 RATFLYGNFDNNN-----VYPKFDISLGPTHWSTIVISDA-ATIEVRE-LIFLASSPKIDVCLSNATTGQ-PFISTLELR 174 (824)
Q Consensus 103 r~~~~yg~~d~~~-----~~p~fd~~~~~~~w~~v~~~~~-~~~~~~e-~~~~~~~~~~~vcl~~~~~~~-pfis~le~~ 174 (824)
|+.|+||||||++ ++|.|||++|+|.|++|+.++. ....++| +|++.++++++|||+++++|+ ||||+||||
T Consensus 80 Rl~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiEl~ 159 (347)
T PF12819_consen 80 RLHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIELR 159 (347)
T ss_pred EEEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEEEE
Confidence 9999999999874 3788999999999999998762 2368899 555555899999999999999 999999999
Q ss_pred ecCCccccCc-ccCceeEEEEEeeecCCCCCCCccCCCCCCCCccccCccccccccccccCCccccccccccC---CCCC
Q 003385 175 QFNGSVYLTP-FEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPID---LRSD 250 (824)
Q Consensus 175 ~l~~~~y~~~-~~~~~~l~~~~r~~~g~~~~~~irypdD~~dR~W~~~~~~~~~~~~~~~~~~~~~st~~~i~---~~~~ 250 (824)
+|++++|+.. ...+.+|.++.|+++|+... .||||+|+|||+|+|+.. ...|.+++++.+|+ ..++
T Consensus 160 ~lp~~ly~~~~~~~s~~L~~~~R~n~G~~~~-~iryp~D~~dR~W~~~~~---------~~~~~~ist~~~i~~~~~~~~ 229 (347)
T PF12819_consen 160 PLPDSLYPDTDANSSQALETVYRLNVGGSSS-FIRYPDDTYDRIWQPYSS---------SPGWSNISTTSNININSSNNP 229 (347)
T ss_pred ECCccceeccccCCCceeEEEEeecCCCccc-ccCCCCCcceeecccccc---------CccccccccceeeecccCCcc
Confidence 9999999633 35678999999999998654 399999999999998521 23467778777675 2348
Q ss_pred CCChHHHHhhcccccCCc--eEEeecCCCCCCcceeEEeeccccCCCCCc-ceEEEEEECCCcCccccccccccccccce
Q 003385 251 ELPPQKVMQTAVVGTNGS--LTYRLNLDGFPGFGWAVTYFAEIEDLDPDE-SRKFRLVLPGQPDVSKAIVNIQENAQGKY 327 (824)
Q Consensus 251 ~~pP~~v~qtA~t~~~~s--l~~~~~~~~~~~~~y~~~yFae~~~~~~~~-~R~F~i~in~~~~~~~~~~~~~~~~~~~~ 327 (824)
+.||++|||||+++.+.+ +.+.|..++....+|++|||||++.+..++ .|+|||||||+.+++ .+.+......+.
T Consensus 230 ~~~P~~V~~TA~~~~~~s~~~nltw~~~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~-~~~~~~~~~~~~- 307 (347)
T PF12819_consen 230 YDAPSAVYQTARTPSNSSDPLNLTWSFVDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYS-DVSPPYLGADTV- 307 (347)
T ss_pred CcChHHHHHhhhcccccccceEEEeccCCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccC-ccCcccccCcce-
Confidence 999999999999998875 888998855555567799999999986444 799999999998876 333212111111
Q ss_pred eeecccceeccccceeeecccccCCCCCCcccchhhhcee
Q 003385 328 RVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKY 367 (824)
Q Consensus 328 ~~~~~~~t~~~l~~l~~L~L~~n~~s~LPP~i~~le~l~~ 367 (824)
.++...........-..++|.++..|+|||+|||||++++
T Consensus 308 ~~~~d~~~~~~~~~~~~isL~~t~~S~lppiLNalEIy~v 347 (347)
T PF12819_consen 308 PYYSDYVVNVPDSGFLNISLGPTPDSTLPPILNALEIYKV 347 (347)
T ss_pred EeecceEEEecCCCEEEEEEEeCCCCCcCceeEeeeeEeC
Confidence 1222111222233345667899999999999999999874
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-49 Score=491.11 Aligned_cols=370 Identities=28% Similarity=0.470 Sum_probs=263.2
Q ss_pred CCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCcccee
Q 003385 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 492 (824)
Q Consensus 414 ~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L 492 (824)
.+++|+.|+|++|+++|.+|+.+++|++|+.|+|++|++++.+|. +.++++|+.|+|++|+++|.+|..+.++++|+.|
T Consensus 497 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l 576 (968)
T PLN00113 497 SLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQV 576 (968)
T ss_pred hhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEE
Confidence 356778888888888888888888888888888888888887775 7788888888888888888888888888888888
Q ss_pred eeccccccccccccc-cccceeccccCCccccCCCC-----------CccceeEEeeehhhhHHHHHHhhheeeeeecCC
Q 003385 493 YVQNNMLSGTVPSSL-LSKNVVLNYAGNINLHEGGR-----------GAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGK 560 (824)
Q Consensus 493 ~l~~N~l~g~ip~~l-~~~~~~l~~~~n~~lc~~~~-----------~~~~~~iii~~~v~~~vl~l~~~l~~~~~~rrk 560 (824)
++++|+++|.+|..- +.......+.||+.+|+... +.....++++.++++++++++++++++++++|+
T Consensus 577 ~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (968)
T PLN00113 577 NISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRN 656 (968)
T ss_pred eccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhh
Confidence 888888888888642 23334456789999996431 111223333333333333322222222222221
Q ss_pred CCcCcccccccCCCCcCCCCCCCCCccccccccCHHHHHHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc
Q 003385 561 KNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ 639 (824)
Q Consensus 561 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~ 639 (824)
+.+ .+..+ . .................+...++... +...+.||+|+||.||+|+++ +++.||||+++....
T Consensus 657 ~~~-~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~- 728 (968)
T PLN00113 657 NLE-LKRVE-N----EDGTWELQFFDSKVSKSITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS- 728 (968)
T ss_pred ccc-ccccc-c----ccccccccccccccchhhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-
Confidence 111 01000 0 00000000000011122334444332 234568999999999999874 789999998864321
Q ss_pred cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHh
Q 003385 640 GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719 (824)
Q Consensus 640 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 719 (824)
...+|++.+++++||||++++++|.+.+..++||||+++|+|.++++ .++|..+..++.|+++||+|||.
T Consensus 729 ---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~ 798 (968)
T PLN00113 729 ---IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHC 798 (968)
T ss_pred ---ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhcc
Confidence 22457889999999999999999999999999999999999999984 27889999999999999999996
Q ss_pred CCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHH
Q 003385 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI 799 (824)
Q Consensus 720 ~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ell 799 (824)
.+.++|+||||||+||+++.++..++. ||........ ....+|+.|+|||++.+..++.++|||||||++|||+
T Consensus 799 ~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~ 872 (968)
T PLN00113 799 RCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELL 872 (968)
T ss_pred CCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHH
Confidence 655699999999999999999888876 6654332111 1235789999999999999999999999999999999
Q ss_pred cCCCCCCC
Q 003385 800 SGQEAISN 807 (824)
Q Consensus 800 tG~~Pf~~ 807 (824)
+|+.||+.
T Consensus 873 tg~~p~~~ 880 (968)
T PLN00113 873 TGKSPADA 880 (968)
T ss_pred hCCCCCCc
Confidence 99999964
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=363.89 Aligned_cols=203 Identities=31% Similarity=0.530 Sum_probs=180.3
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccC--CcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.+.||+|+||+||+|+++ ++.+||||.+... .....+.+..|+++|+.++|||||.+++++...+..++|||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 445677999999999999986 6789999998765 4444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC------CcEEEEecCCccc
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH------MRAKVSDFGLSKF 753 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~------~~vkL~DFGla~~ 753 (824)
.||+|.++++. .+.+++..+..++.||+.||++||++ +||||||||.|||++.. -.+||+|||+|+.
T Consensus 92 ~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 92 NGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 99999999953 45789999999999999999999998 99999999999999864 4589999999998
Q ss_pred ccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccch
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC 814 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~ 814 (824)
..++ ....+.||++-|||||++...+|+.|+|+||+|+|+|||++|+.||+..+..|..
T Consensus 165 L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~ 223 (429)
T KOG0595|consen 165 LQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELL 223 (429)
T ss_pred CCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence 7643 3456789999999999999999999999999999999999999999976655443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=364.47 Aligned_cols=231 Identities=53% Similarity=0.913 Sum_probs=199.4
Q ss_pred cccccCHHHHHHHHHHhh--ccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeecee
Q 003385 589 AAHCFTLSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666 (824)
Q Consensus 589 ~~~~~~~~~~~~~~~~i~--~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 666 (824)
....|++.++..++..|. ..||+|+||.||+|...+|+.||||++........++|..|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 455689999999999986 699999999999999999999999988755433145699999999999999999999999
Q ss_pred ecCC-eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 003385 667 QEEG-RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 745 (824)
Q Consensus 667 ~~~~-~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL 745 (824)
.+.+ +.+||+|||++|+|.++|+..... .++|..+++||.++|+||+|||..+.++|+||||||+|||+|+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9988 599999999999999999765333 7899999999999999999999998889999999999999999999999
Q ss_pred EecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhhhhc
Q 003385 746 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWVK 822 (824)
Q Consensus 746 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~~~~ 822 (824)
+|||+|+..............||.+|+|||++..+..+.|+|||||||++.|+++|+.|.+... +.....+++|+.
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAK 294 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHH
Confidence 9999996553312222111169999999999999999999999999999999999999998765 333445888864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=343.15 Aligned_cols=208 Identities=31% Similarity=0.462 Sum_probs=183.8
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
+++.+.||+|+||+|++++.+ .++.+|+|++++.... +.+...+|..+|.+++||+||+++..|++.+.+|+|+||
T Consensus 27 F~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~ 106 (357)
T KOG0598|consen 27 FEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDY 106 (357)
T ss_pred eeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEec
Confidence 346799999999999999866 5788999999876433 345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+.||.|..+| +.+..+++..+.-++.+|+.||.|||+. |||||||||+|||++.+|+++|+|||+++.....
T Consensus 107 ~~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~- 178 (357)
T KOG0598|consen 107 LNGGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD- 178 (357)
T ss_pred cCCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC-
Confidence 9999999988 4567888998999999999999999998 9999999999999999999999999999854433
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
...+.++|||+.|||||++.+..|+.++|.||+|+++|||++|.+||.+....+.+++|+
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~ 238 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKIL 238 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHh
Confidence 334566899999999999999999999999999999999999999999877555555544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.08 Aligned_cols=212 Identities=25% Similarity=0.449 Sum_probs=190.9
Q ss_pred HHHHHhhccccccCcEEEEEEEE-cCCcEEEEEEeccC---CcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
..+|..++.||+|||+.+|.++. ..|+.||+|++.+. .....+.+.+|+++.++|+|||||+++++|++.++.|||
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 35677789999999999999987 78999999999764 233356788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
+|+|++++|..+++ ....+++.+++.+++||+.||.|||++ +|+|||||..|++++++.++||+|||+|....
T Consensus 97 LELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 97 LELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeec
Confidence 99999999999885 457799999999999999999999998 99999999999999999999999999998776
Q ss_pred CCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
.+ .+...+.||||.|+|||++....++..+||||+||+||.|+.|++||+..+..+++++|+.
T Consensus 170 ~~-~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~ 232 (592)
T KOG0575|consen 170 YD-GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL 232 (592)
T ss_pred Cc-ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh
Confidence 43 2345668999999999999999999999999999999999999999999888877776653
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=344.79 Aligned_cols=204 Identities=28% Similarity=0.498 Sum_probs=173.8
Q ss_pred HHHHHHhhccccccCcEEEEEEE-EcCCcEEEEEEeccCCcc-------cchhhhHHHHHHhhcCCCccceeeceeecCC
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQ-------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 670 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~-~~~g~~vAVK~l~~~~~~-------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 670 (824)
....|.+.+.||+|+||.|-+|. .++|+.||||++++.... ....+++|+++|++++|||||++.++++..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 44566778999999999999996 458999999999764322 2234679999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEEe
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSD 747 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~---~~vkL~D 747 (824)
..||||||++||+|.+.+-.+ ..+.+..-..+++|++.|+.|||+. ||+||||||+|||++.+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 999999999999999988543 3444555577999999999999998 99999999999999876 7899999
Q ss_pred cCCcccccCCCCceeccccCCCCCcchhccccCCC---CchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 748 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL---TDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 748 FGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
||+|+... +.....+.|||+.|.|||++.+... ..++||||+||++|-+++|.+||.+....
T Consensus 323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~ 387 (475)
T KOG0615|consen 323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD 387 (475)
T ss_pred cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC
Confidence 99999775 3456778899999999999987643 34789999999999999999999875533
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=332.79 Aligned_cols=202 Identities=33% Similarity=0.489 Sum_probs=178.5
Q ss_pred cCHHHHHHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccC-CcccchhhhHHHHHHhhcCCCccceeeceeecCC
Q 003385 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 670 (824)
Q Consensus 593 ~~~~~~~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 670 (824)
++.+|++ ..+.||+|..|+||+++|+ +++-+|+|++..+ ....++++.+|+++++.++||+||+++|.|..++
T Consensus 76 i~~~dle-----~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLE-----RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhh-----hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 4555554 3468999999999999987 5778899999544 3344678999999999999999999999999988
Q ss_pred -eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003385 671 -RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (824)
Q Consensus 671 -~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFG 749 (824)
...++||||++|+|.+.+.. .+++++.....++.++++||.|||+. .+||||||||+|||++..|++||||||
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccc
Confidence 59999999999999998853 36688999999999999999999974 299999999999999999999999999
Q ss_pred CcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.++...++ ....++||..|||||.+.+..|+.++||||||+.++|++.|+.||...
T Consensus 225 VS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 225 VSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred ccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 99877654 456678999999999999999999999999999999999999999874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=328.44 Aligned_cols=216 Identities=27% Similarity=0.444 Sum_probs=185.7
Q ss_pred HHHHhhccccccCcEEEEEEE-EcCCcEEEEEEeccC--CcccchhhhHHHHHHhhcCCCccceeec-eeecCCe-EEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLG-YCQEEGR-SVLV 675 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~-~~~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~-~~~~~~~-~~lV 675 (824)
+.|.+.++||+|.||+||++. ..+|+.+|.|.++-. ..+.++++..|+.+|++++|||||+.++ .+.+++. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 456688999999999999997 458999999988743 2334567889999999999999999999 4444555 7899
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~g--IvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
||+|++|+|...+.....+.+.+++..++.++.|++.||.++|.. .+. |+||||||.||+++.+|.+||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999977667788899999999999999999999993 235 89999999999999999999999999997
Q ss_pred ccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
+..... .....+|||.||+||.+...+|+.++||||+||++|||+.-+.||.+...-+.+++|.
T Consensus 178 l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~ 241 (375)
T KOG0591|consen 178 LSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIE 241 (375)
T ss_pred hcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHH
Confidence 755433 3445679999999999999999999999999999999999999999987666666554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=342.99 Aligned_cols=200 Identities=40% Similarity=0.669 Sum_probs=174.9
Q ss_pred HhhccccccCcEEEEEEEEcCCcEEEEEEeccCCccc--chhhhHHHHHHhhcCCCccceeeceeecCC-eEEEEEEecC
Q 003385 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGYCQEEG-RSVLVYEFMH 680 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lV~E~~~ 680 (824)
.+.+.||+|+||+||+|.++....||||++....... .+.|.+|+.+|.+++|||||+++|+|.++. ...+||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3456699999999999999954459999997643322 458999999999999999999999999887 7899999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEecCCCCCCEEEcCCC-cEEEEecCCcccccCCC
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA-IIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~g-IvHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~ 758 (824)
+|+|.++++.. ....+++..++.++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 124 GGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 99999999654 467899999999999999999999998 7 99999999999999997 99999999998665432
Q ss_pred CceeccccCCCCCcchhccc--cCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYI--SQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.......||+.|||||++. ...|+.|+||||||+++|||++|+.||.+..
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~ 250 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA 250 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC
Confidence 1222356999999999999 6699999999999999999999999998765
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=343.31 Aligned_cols=210 Identities=31% Similarity=0.517 Sum_probs=186.8
Q ss_pred HHHHHHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 596 SDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 596 ~~~~~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
.++......+.+.||+|.||+||.|+++....||+|.++... ...+.|.+|+++|++++|++||+++|+|..++.++||
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 355566667889999999999999999988899999998653 3467888999999999999999999999998899999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
||||+.|+|.++|.. .....+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+...
T Consensus 280 tE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccC
Confidence 999999999999965 3466788899999999999999999998 99999999999999999999999999999666
Q ss_pred CCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCccc
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG 811 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~ 811 (824)
++.........-+..|.|||.+....++.|+|||||||+||||+| |+.||.+....
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ 411 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE 411 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH
Confidence 665555555556789999999999999999999999999999999 99999875533
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=314.69 Aligned_cols=204 Identities=28% Similarity=0.408 Sum_probs=182.6
Q ss_pred hhccccccCcEEEEEEEEc-CCcEEEEEEeccCCccc---chhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
+.+.||.|+||.|.+++.+ +|.-+|+|++++..... .+...+|..+|+.+.||+++++.+.+.+.+.++|||||++
T Consensus 48 ~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~ 127 (355)
T KOG0616|consen 48 RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVP 127 (355)
T ss_pred heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccC
Confidence 5688999999999999977 57788999998654333 3446789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
||.|..+++ ..+++++..++-++.||+.||+|||+. +|++|||||+|||+|++|.+||.|||+|+....
T Consensus 128 GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---- 196 (355)
T KOG0616|consen 128 GGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---- 196 (355)
T ss_pred CccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC----
Confidence 999999994 457789999999999999999999998 999999999999999999999999999987643
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
.+.+.||||.|+|||.+++..|..++|.|||||++|||+.|.+||.+.+.-+.+.+|++
T Consensus 197 rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~ 255 (355)
T KOG0616|consen 197 RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE 255 (355)
T ss_pred cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh
Confidence 35677899999999999999999999999999999999999999988776666766654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=336.35 Aligned_cols=212 Identities=26% Similarity=0.377 Sum_probs=185.1
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCccc---chhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.+.+.||+|+||+||+|+-+ +|+.+|+|++++..... .+.++.|-.+|...++|+||+|+..|.+.+++||||||+
T Consensus 144 e~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEyl 223 (550)
T KOG0605|consen 144 ELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYL 223 (550)
T ss_pred hhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEec
Confidence 35689999999999999865 68889999998754332 345778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC---
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD--- 756 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~--- 756 (824)
+||++..+|. ..+.+++..+..++.+++.|++-||+. |+|||||||+|+|||..|++||+|||++.-...
T Consensus 224 PGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 224 PGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred CCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 9999999983 467788899999999999999999998 999999999999999999999999999852211
Q ss_pred -------------------CCCc-----e-------------------eccccCCCCCcchhccccCCCCchHHHHHHHH
Q 003385 757 -------------------GASH-----V-------------------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGV 793 (824)
Q Consensus 757 -------------------~~~~-----~-------------------~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGv 793 (824)
.... . ....+|||.|||||++.+..|+..+|.||+||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 0000 0 01245999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCccccchhcHhhhhc
Q 003385 794 ILLELISGQEAISNEKFGANCRNIVQWVK 822 (824)
Q Consensus 794 il~elltG~~Pf~~~~~~~~~~~iv~~~~ 822 (824)
|||||+.|.+||.++++.+++++|+.|-.
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~ 405 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRE 405 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhh
Confidence 99999999999999999999999999974
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=330.85 Aligned_cols=201 Identities=27% Similarity=0.424 Sum_probs=173.9
Q ss_pred HHHhhccccccCcEEEEEEEE-cCCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecC--CeEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVY 676 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~-~~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV~ 676 (824)
.|+..++||+|.||.||+|+. .+|+.||+|+++.+. ........+||.+|++|+||||++|.+...+. ...|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 344457899999999999975 579999999987553 33345678999999999999999999998776 6899999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
|||+. +|.-++. ...-.+++.++..+++|++.||+|||++ ||+|||||.+||||+++|.+||+|||+|+.+..
T Consensus 198 eYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 198 EYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred ecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99975 6766663 2356789999999999999999999998 999999999999999999999999999997766
Q ss_pred CCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......+..+-|++|+|||.+.+ ..|+.++|+||+||||.||+.|++.|.+.+
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 55554555667999999999986 479999999999999999999999999876
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=334.41 Aligned_cols=200 Identities=31% Similarity=0.445 Sum_probs=175.8
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
+.+++.||+|+|++|++|+.+ .++++|||++.+.- ....+.+..|-..|.+| .||.|++|+..|.++..+|+|+|
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe 154 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE 154 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence 457899999999999999755 68999999997542 22345577899999999 89999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+++|+|.++|. +.+.+++...+.++.||+.||+|||++ |||||||||+|||+++||++||.|||.|+.+.+.
T Consensus 155 ~A~nGdll~~i~----K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 155 YAPNGDLLDLIK----KYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred ecCCCcHHHHHH----HhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 999999999994 347789999999999999999999998 9999999999999999999999999999876542
Q ss_pred CCc----------ee--ccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 758 ASH----------VS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 758 ~~~----------~~--~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
... .. ..++||..|.+||++.....+..+|||+||||+|+|+.|.+||.+..
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 211 11 34789999999999999999999999999999999999999998744
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=309.65 Aligned_cols=199 Identities=24% Similarity=0.354 Sum_probs=169.0
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|+...++|+|+||+||+++++ +|+.||||++.... ..-++-..+|+++|++++|||+|.++++|.....+++|+|||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 344467999999999999987 58999999986432 222455789999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
+..-|.+.-+ ....++...+..++.|++.|+.|+|++ +++||||||+||||+.++.+||||||+|+....+ .
T Consensus 84 dhTvL~eLe~----~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-g 155 (396)
T KOG0593|consen 84 DHTVLHELER----YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-G 155 (396)
T ss_pred chHHHHHHHh----ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC-c
Confidence 8755544321 233467788889999999999999999 9999999999999999999999999999977632 2
Q ss_pred ceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
...+..+.|.+|+|||.+.+ .+|...+||||+||++.||++|.+.|.+..
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S 206 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS 206 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc
Confidence 33445568999999999987 789999999999999999999999998865
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=331.60 Aligned_cols=206 Identities=30% Similarity=0.456 Sum_probs=180.6
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.+.||+|.||.||||+.+ +.+.||+|.+.+.. .++.+.+.+|+++++.++||||+.++++|+...+.++|.||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 455678999999999999865 67889999986543 223456899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
.| +|..+| .....+++..+..++.|++.||.|||+. +|.|||+||+|||++..+.+|+||||+|+.+....
T Consensus 84 ~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t- 154 (808)
T KOG0597|consen 84 VG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT- 154 (808)
T ss_pred hh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc-
Confidence 87 999988 4567899999999999999999999998 99999999999999999999999999999776543
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcH
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i 817 (824)
.......|||-|||||++.++.|+..+|+||+|||+||+++|++||....+.+..+.|
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I 212 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSI 212 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 3445567999999999999999999999999999999999999999876655444443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=299.36 Aligned_cols=200 Identities=26% Similarity=0.404 Sum_probs=174.5
Q ss_pred HHHhhccccccCcEEEEEEEE-cCCcEEEEEEeccCCccc--chhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 602 TKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~-~~g~~vAVK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
+|...++||+|.||.||+|++ ++|+.||||+++.....+ .....+|++.|+.++|+||+.++++|...+...+|+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 455668999999999999975 579999999998653322 34578999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
|+. +|...+++ ....++..++..++.++++|++|||++ .|+||||||+|+|++++|.+||+|||+|+.+....
T Consensus 83 m~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 83 MPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 974 88888864 356688999999999999999999998 99999999999999999999999999999877654
Q ss_pred CceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
...... +-|.+|+|||.+.+ +.|+..+||||.|||+.||+-|.+-|.+++
T Consensus 156 ~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s 206 (318)
T KOG0659|consen 156 RIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS 206 (318)
T ss_pred cccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc
Confidence 443333 57999999999885 579999999999999999999999998866
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=329.74 Aligned_cols=208 Identities=27% Similarity=0.473 Sum_probs=180.4
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccC----Cc-ccchhhhHHHHHHhhcC-CCccceeeceeecCCeEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN----SY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~----~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 673 (824)
..|.+.+.||+|.||.|+.|++. +++.||+|++... .. ...+.+.+|+.++++++ ||||+++++++......+
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 35667899999999999999765 6899999987654 11 23456778999999999 999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCcc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSK 752 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~-~~vkL~DFGla~ 752 (824)
+||||+.+|+|.+++.. ..++.+..+..+++|++.|++|||++ ||+||||||+|||++.+ +.+||+|||++.
T Consensus 97 ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999843 56778899999999999999999998 99999999999999999 999999999998
Q ss_pred cccCCCCceeccccCCCCCcchhccccCC-CC-chHHHHHHHHHHHHHHcCCCCCCCCccccchhc
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQ-LT-DKSDVYSFGVILLELISGQEAISNEKFGANCRN 816 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~ 816 (824)
... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++......+.+
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k 234 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK 234 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 763 3334556788999999999999987 86 678999999999999999999998665544444
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=345.83 Aligned_cols=210 Identities=30% Similarity=0.541 Sum_probs=181.2
Q ss_pred HHHHHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCcc-cchhhhHHHHHHhhcCCCccceeeceeecC
Q 003385 597 DIEDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEE 669 (824)
Q Consensus 597 ~~~~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 669 (824)
++......+.+.||+|+||+||+|+.. +.+.||||.++..... .+.+|++|++++..++|||||+++|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 344444456789999999999999753 3456999999876554 678899999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhcccC------c----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 003385 670 GRSVLVYEFMHNGTLKEHLYGTLT------H----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 739 (824)
Q Consensus 670 ~~~~lV~E~~~~gsL~~~L~~~~~------~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~ 739 (824)
+.+++|+|||..|||.++|..+.. . ..+++..+.+.||.|||.||.||-++ .+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 999999999999999999965422 1 22388999999999999999999998 8999999999999999
Q ss_pred CCcEEEEecCCcccccCCCCceec-cccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 740 HMRAKVSDFGLSKFAVDGASHVSS-IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 740 ~~~vkL~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
+..+||+|||+++.....+++... ...-+.+||+||.++.++++.++|||||||+|||+++ |+.||.+..
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS 710 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS 710 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence 999999999999976555444322 3445789999999999999999999999999999999 999998865
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=295.35 Aligned_cols=216 Identities=28% Similarity=0.469 Sum_probs=188.7
Q ss_pred cccCHHHHHHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeecee
Q 003385 591 HCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYC 666 (824)
Q Consensus 591 ~~~~~~~~~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 666 (824)
..+++.|++ +++.||+|.||.||.|+.+ ++-.||+|++.+.. ....+++.+|+++-..++||||++++++|
T Consensus 17 ~~~~l~dfe-----igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 17 KTWTLDDFE-----IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred cccchhhcc-----ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 445666654 7899999999999999865 56789999987542 33467899999999999999999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 003385 667 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (824)
Q Consensus 667 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~ 746 (824)
.+....|+++||..+|.+...|... ...++++.....+++|+|.||.|+|.+ +++||||||+|+|++.++.+||+
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiA 166 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIA 166 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeecc
Confidence 9999999999999999999999643 345567777788999999999999998 99999999999999999999999
Q ss_pred ecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 747 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 747 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
|||.+.... .....+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||+....++++++|.+
T Consensus 167 dfGwsV~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k 236 (281)
T KOG0580|consen 167 DFGWSVHAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK 236 (281)
T ss_pred CCCceeecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH
Confidence 999986543 3345667899999999999999999999999999999999999999999888888888764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=309.74 Aligned_cols=202 Identities=24% Similarity=0.449 Sum_probs=183.2
Q ss_pred HHHHHHhhccccccCcEEEEEEE-EcCCcEEEEEEeccCCcccch---hhhHHHHHHhhcCCCccceeeceeecCCeEEE
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~-~~~g~~vAVK~l~~~~~~~~~---~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 674 (824)
...+|++.+.||+|.||.|-+|. +..|+.||||.++++...+++ .+.+|+++|..++||||+.++.+|+..+...|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 45678899999999999999996 578999999999877655544 46899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
||||..+|.|.+++ .+.+.+++.++..+++||.+|+.|+|.+ +++|||||.+|||+|+++.+||+|||++..+
T Consensus 131 vMEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence 99999999999998 4567899999999999999999999999 9999999999999999999999999999877
Q ss_pred cCCCCceeccccCCCCCcchhccccCCCC-chHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 755 VDGASHVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 755 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.+. ..-.++||++-|.+||.+.+..|. +.+|-|||||+||.|+.|..||++.+
T Consensus 204 ~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 204 ADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD 257 (668)
T ss_pred ccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence 553 345678999999999999988885 68999999999999999999999854
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=314.86 Aligned_cols=202 Identities=24% Similarity=0.353 Sum_probs=173.9
Q ss_pred HHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcC-CCccceeeceeecCC-eEEE
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEG-RSVL 674 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~-~~~l 674 (824)
...+|.+.++||.|.||.||+|+.+ .|+.||||.++..-. +++-.=.+|++.|++++ ||||+++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 3457888899999999999999854 689999999975532 22223468999999998 999999999998888 8999
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
|||||+. +|.+.++++ .+.+++..+..|+.||++||+|+|++ |+.|||+||||||+.....+||+|||+||..
T Consensus 88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999964 888888754 67799999999999999999999999 9999999999999998889999999999976
Q ss_pred cCCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 755 VDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 755 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.... ..+..+.|++|+|||++.+ .-|+.+.||||+|||++|+.+-++.|.|..
T Consensus 161 ~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 161 RSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred ccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 4432 2344568999999999875 567889999999999999999999998865
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=319.60 Aligned_cols=196 Identities=30% Similarity=0.472 Sum_probs=176.5
Q ss_pred HHhhccccccCcEEEEEEEE-cCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 603 KMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
|.-.++||+|+.|.||.|.. ..++.||||.+.......++-+..|+.+|+..+|+|||.+++.|...+.+++|||||++
T Consensus 275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~g 354 (550)
T KOG0578|consen 275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEG 354 (550)
T ss_pred hcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCC
Confidence 33346899999999999964 57889999999877767677889999999999999999999999888999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|.+.+- ...+++.++..|++++++||+|||.+ ||+|||||..|||++.+|.+||+|||++..+..... .
T Consensus 355 gsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 355 GSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred Cchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 99999873 34488999999999999999999998 999999999999999999999999999987655444 3
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
....+||+.|||||++....|+.++||||||++++||+.|++||-.
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence 4556799999999999999999999999999999999999999974
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=324.87 Aligned_cols=206 Identities=29% Similarity=0.446 Sum_probs=179.2
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCccc---chhhhHHHHHHhhcC-CCccceeeceeecCCeEEEEEEe
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~---~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
.+.+.||+|.||+|+++..+ +++.+|||++++...-. .+....|..++.... ||.++.++..|...++++.||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 46789999999999999877 57789999999875443 345677888887774 99999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+.||++..+ ...+.+++..+.-++..++.||+|||++ ||||||||.+|||+|.+|++||+|||+++... ..
T Consensus 451 ~~Ggdm~~~-----~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-~~ 521 (694)
T KOG0694|consen 451 VAGGDLMHH-----IHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-GQ 521 (694)
T ss_pred cCCCcEEEE-----EecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC-CC
Confidence 999994322 3457789999999999999999999999 99999999999999999999999999998543 23
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
...+.++|||+.|||||++....|+.++|.|||||+||||+.|+.||.+++-.+..+.|+
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~ 581 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV 581 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh
Confidence 346788999999999999999999999999999999999999999999877555565554
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=332.92 Aligned_cols=208 Identities=28% Similarity=0.531 Sum_probs=180.3
Q ss_pred HHHHHHHHHhhccccccCcEEEEEEEEc----CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCC
Q 003385 596 SDIEDATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 670 (824)
Q Consensus 596 ~~~~~~~~~i~~~LG~G~fg~Vy~a~~~----~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 670 (824)
.|+......+++.||.|.||+||+|+++ ....||||.++..-. ..+++|+.|+.||.+++||||++|.|+.....
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 3455556667899999999999999876 234699999986533 34678999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGl 750 (824)
...||+|||++|+|+.+|+.+ ..++.+.+...|++.|+.||.||-+. ++|||||.++||||+.+..+|++|||+
T Consensus 704 PvMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccc
Confidence 999999999999999999754 46699999999999999999999997 999999999999999999999999999
Q ss_pred cccccCCCCceecccc--CCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 751 SKFAVDGASHVSSIVR--GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 751 a~~~~~~~~~~~~~~~--gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
++...++......... -+.+|.|||.+..++++.++||||+|++|||.++ |+.||.+-.
T Consensus 778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS 839 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 839 (996)
T ss_pred eeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc
Confidence 9977665433332222 2479999999999999999999999999999887 999998755
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=307.33 Aligned_cols=204 Identities=30% Similarity=0.483 Sum_probs=171.1
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCC-----eEEEEEEec
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLVYEFM 679 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~lV~E~~ 679 (824)
.+.+|.|+||.||+|... +++.||||..-. +.+.-.+|+++|++++|||||+++-+|.... ...+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~----d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQ----DKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecC----CCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 478999999999999876 468999997643 2344467999999999999999999885432 335899999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCcccccCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~-~~vkL~DFGla~~~~~~~ 758 (824)
+. +|...++.......+++...+.-+..||++||.|||+. +|+||||||.|+|+|.+ |.+||||||.|+....++
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 74 88888876545567788888888999999999999997 99999999999999987 999999999999887776
Q ss_pred CceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 759 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
...+.. -|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.|++.-+....|++
T Consensus 181 pniSYi--cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik 240 (364)
T KOG0658|consen 181 PNISYI--CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIK 240 (364)
T ss_pred CceeEE--EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHH
Confidence 665544 4899999999986 5799999999999999999999999999775555555554
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=295.11 Aligned_cols=208 Identities=24% Similarity=0.317 Sum_probs=172.7
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCccc--chhhhHHHHHHhhcCCCccceeeceeec--CCeEEEEEEe
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEF 678 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~E~ 678 (824)
+....|++|.||.||+|+++ +++.||+|+++-..... .-.-.+|+.+|.+++|||||.+-.+... -+..|+||||
T Consensus 79 e~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~ 158 (419)
T KOG0663|consen 79 EKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEY 158 (419)
T ss_pred HHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHH
Confidence 34578999999999999875 67889999987443111 1234789999999999999999988754 4678999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
|++ +|...+... .+++...++..++.|+++|++|||.+ .|+|||||++|+|+++.|.+||+|||+|+.+..+.
T Consensus 159 ~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 159 VEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 985 888887543 36788899999999999999999998 99999999999999999999999999999887664
Q ss_pred CceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 759 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
... +..+-|.+|+|||.+.+ ..|+.+.|+||+|||+.||+++++.|.+..--+..++|.+
T Consensus 232 k~~-T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ 292 (419)
T KOG0663|consen 232 KPY-TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFK 292 (419)
T ss_pred ccC-cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHH
Confidence 443 33457999999999886 5789999999999999999999999998764444445544
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=320.36 Aligned_cols=211 Identities=25% Similarity=0.374 Sum_probs=178.2
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
+.+.+.||+|+||+||+|+.. +++.||+|+++.... .....+.+|+.++.+++||||+++++.+.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 345688999999999999865 588999999975321 2234678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 83 LPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999998843 35688899999999999999999998 99999999999999999999999999987532210
Q ss_pred C----------------------------------ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCC
Q 003385 759 S----------------------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 804 (824)
Q Consensus 759 ~----------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~P 804 (824)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 001234699999999999999999999999999999999999999
Q ss_pred CCCCccccchhcHhhh
Q 003385 805 ISNEKFGANCRNIVQW 820 (824)
Q Consensus 805 f~~~~~~~~~~~iv~~ 820 (824)
|.+....+..+++++|
T Consensus 236 f~~~~~~~~~~~i~~~ 251 (363)
T cd05628 236 FCSETPQETYKKVMNW 251 (363)
T ss_pred CCCCCHHHHHHHHHcC
Confidence 9887655555555544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=297.22 Aligned_cols=203 Identities=25% Similarity=0.384 Sum_probs=171.2
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--cchhhhHHHHHHhhcCCCc-cceeeceeecCC------eE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRN-LVQFLGYCQEEG------RS 672 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~------~~ 672 (824)
+...++||+|+||+||+|+.+ +|+.||+|+++..... -.....+|+.+++.++|+| |+.+.+++...+ ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 334567999999999999865 7889999999865432 2345689999999999999 999999998877 78
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
++|+||++ -+|..++.........++...+..+++||+.||+|||++ +|+||||||+||||+++|.+||+|||+|+
T Consensus 93 ~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHH
Confidence 99999996 489998865432224566678899999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
...-+... ....++|.+|+|||++.+. .|+...||||+|||++||++++..|.+..-
T Consensus 169 a~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 169 AFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred HhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 66533322 3445689999999999876 788999999999999999999999988663
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.56 Aligned_cols=198 Identities=27% Similarity=0.450 Sum_probs=176.4
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+++.||.|+.|.|..|++. +|+.+|||++.+.. ......+.+|+.+|+-+.||||+++++++++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 457789999999999999875 79999999997652 22245688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|.|.+++. ..+.+++.++.++++||+.|+.|+|+. +|+||||||+|+|++..+++||+|||+|....++
T Consensus 94 v~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 94 VPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred cCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 99999999983 456788889999999999999999997 9999999999999999999999999999765543
Q ss_pred CceeccccCCCCCcchhccccCCCC-chHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
..-.+.||++.|.|||++.+..|+ .++||||+|||||.|++|+.||+++.
T Consensus 166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN 216 (786)
T KOG0588|consen 166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN 216 (786)
T ss_pred -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc
Confidence 344567899999999999999987 57899999999999999999999765
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=306.95 Aligned_cols=209 Identities=30% Similarity=0.436 Sum_probs=171.2
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCccc--------------chhhhHHHHHHhhcCCCccceeecee
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG--------------KREFTNEVTLLSRIHHRNLVQFLGYC 666 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~--------------~~~~~~Ei~il~~l~HpnIv~l~~~~ 666 (824)
.|.+.+.||+|.||.|-+|+.. +++.||||++.+..... .+++.+|+.+|++++|||||+|+++.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 4567889999999999999865 68999999996542211 14678999999999999999999998
Q ss_pred ecC--CeEEEEEEecCCCCHHHHhhcccCcccc-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 003385 667 QEE--GRSVLVYEFMHNGTLKEHLYGTLTHEQR-INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 743 (824)
Q Consensus 667 ~~~--~~~~lV~E~~~~gsL~~~L~~~~~~~~~-l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~v 743 (824)
.+. +..|||+|||..|.+...- .... +.+.+++.++++++.||+|||.+ |||||||||.|+|++++|++
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred cCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcE
Confidence 764 5789999999999875432 2333 88999999999999999999998 99999999999999999999
Q ss_pred EEEecCCcccccCCC----CceeccccCCCCCcchhccccCC---C-CchHHHHHHHHHHHHHHcCCCCCCCCccccchh
Q 003385 744 KVSDFGLSKFAVDGA----SHVSSIVRGTVGYLDPEYYISQQ---L-TDKSDVYSFGVILLELISGQEAISNEKFGANCR 815 (824)
Q Consensus 744 kL~DFGla~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~---~-~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~ 815 (824)
||+|||.+.....+. ...-...+|||.|+|||.+..+. + +.+.||||+||+||-|+.|+.||-++..-++++
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 999999987553221 11123367999999999988733 2 357799999999999999999998876556665
Q ss_pred cHh
Q 003385 816 NIV 818 (824)
Q Consensus 816 ~iv 818 (824)
+|+
T Consensus 330 KIv 332 (576)
T KOG0585|consen 330 KIV 332 (576)
T ss_pred HHh
Confidence 555
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=315.22 Aligned_cols=204 Identities=32% Similarity=0.587 Sum_probs=173.0
Q ss_pred HHHHHHHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeE
Q 003385 595 LSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (824)
Q Consensus 595 ~~~~~~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 672 (824)
..|+......+.+.||+|.||+||+|+|. .+||||+++.... ...+.|+.|+..+++-+|.||+-+.|+|..+..
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 34555555667899999999999999986 5799999986533 345789999999999999999999999998877
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
.||+.+|+|.+|..+|+.. +..+...+.+.|++||++||.|||.+ +|||||||..||++.+++.|||.|||++.
T Consensus 463 AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccccee
Confidence 9999999999999999743 46688889999999999999999998 99999999999999999999999999986
Q ss_pred cccCC-CCceeccccCCCCCcchhcccc---CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 753 FAVDG-ASHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 753 ~~~~~-~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
.-..- ........-|...|||||++.. ..|+..+|||||||++|||++|..||..
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi 595 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI 595 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC
Confidence 32211 1111222347889999999975 4688999999999999999999999984
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=304.24 Aligned_cols=199 Identities=29% Similarity=0.465 Sum_probs=168.3
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCC--eEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lV~E~~ 679 (824)
+...+.||+|+||.||++... +|+..|||..........+.+.+|+.+|.+++|||||+.+|...... .+++.|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 445789999999999999865 48999999887553333566899999999999999999999854444 689999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecCCcccccC--
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVD-- 756 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~-~~~vkL~DFGla~~~~~-- 756 (824)
++|+|.+++... ...+++..+..+.+||++||.|||++ ||+||||||+|||++. ++.+||+|||+++....
T Consensus 99 ~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 99 PGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred CCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999999643 12689999999999999999999998 9999999999999999 69999999999886542
Q ss_pred CCCceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
..........||+.|||||++..+ ....++||||+||++.||+||+.||..
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 222233456799999999999863 333599999999999999999999987
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=317.93 Aligned_cols=211 Identities=25% Similarity=0.375 Sum_probs=176.5
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|+||+||+|+.. +++.||||+++... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 445689999999999999876 68899999997532 12234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 83 LPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999998853 34588899999999999999999998 99999999999999999999999999986432211
Q ss_pred Cc-------------------------------------eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcC
Q 003385 759 SH-------------------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801 (824)
Q Consensus 759 ~~-------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG 801 (824)
.. .....+||+.|+|||++....++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 11124599999999999999999999999999999999999
Q ss_pred CCCCCCCccccchhcHhhh
Q 003385 802 QEAISNEKFGANCRNIVQW 820 (824)
Q Consensus 802 ~~Pf~~~~~~~~~~~iv~~ 820 (824)
..||.+....+....+.+|
T Consensus 236 ~~Pf~~~~~~~~~~~i~~~ 254 (364)
T cd05599 236 YPPFCSDNPQETYRKIINW 254 (364)
T ss_pred CCCCCCCCHHHHHHHHHcC
Confidence 9999876644444444443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.59 Aligned_cols=204 Identities=26% Similarity=0.416 Sum_probs=177.0
Q ss_pred HHHHHhhccccccCcEEEEEEEE-cCCcEEEEEEeccCCccc-chhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~-~~g~~vAVK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
...|++.+.||.|..++||+|+. +.++.||||++..+.... .+.+.+|++.|+.++||||++.+..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 34567889999999999999975 468999999997654433 4789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
||.+|++.+.++.....+ +++..+..|.+++++||.|||.+ |.||||||+.||||+.+|.+||+|||.+..+...
T Consensus 105 fMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999997665443 88899999999999999999998 9999999999999999999999999987654443
Q ss_pred CC-c--eeccccCCCCCcchhcccc--CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 758 AS-H--VSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 758 ~~-~--~~~~~~gt~~y~aPE~l~~--~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.. . ...+++||++|||||++.. ..|+.|+||||||+...||.+|..||..-
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~ 235 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY 235 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC
Confidence 21 1 1155689999999999653 58999999999999999999999999863
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=317.79 Aligned_cols=211 Identities=23% Similarity=0.318 Sum_probs=174.5
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
+.+.+.||+|+||+||+|+++ +++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 345688999999999999865 678999999975422 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++......
T Consensus 83 ~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 83 IPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999998853 34578888889999999999999998 99999999999999999999999999875321000
Q ss_pred ----------------------------------------------CceeccccCCCCCcchhccccCCCCchHHHHHHH
Q 003385 759 ----------------------------------------------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFG 792 (824)
Q Consensus 759 ----------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlG 792 (824)
.......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0001234699999999999998999999999999
Q ss_pred HHHHHHHcCCCCCCCCccccchhcHhhh
Q 003385 793 VILLELISGQEAISNEKFGANCRNIVQW 820 (824)
Q Consensus 793 vil~elltG~~Pf~~~~~~~~~~~iv~~ 820 (824)
|++|||++|+.||......+...+++.|
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~ 263 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINW 263 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHcc
Confidence 9999999999999876544444444433
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=318.07 Aligned_cols=211 Identities=27% Similarity=0.362 Sum_probs=174.9
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|+||.||+++.+ +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 445689999999999999865 68899999986432 12235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 83 LPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999998843 34578888889999999999999998 99999999999999999999999999986321100
Q ss_pred C------------c----------------------------------eeccccCCCCCcchhccccCCCCchHHHHHHH
Q 003385 759 S------------H----------------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFG 792 (824)
Q Consensus 759 ~------------~----------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlG 792 (824)
. . .....+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0 0 00124699999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCccccchhcHhhh
Q 003385 793 VILLELISGQEAISNEKFGANCRNIVQW 820 (824)
Q Consensus 793 vil~elltG~~Pf~~~~~~~~~~~iv~~ 820 (824)
|++|||++|+.||.+....+....+.+|
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~ 263 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYRKIINW 263 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHcc
Confidence 9999999999999876644444444443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=309.82 Aligned_cols=195 Identities=32% Similarity=0.543 Sum_probs=169.9
Q ss_pred cCHHHHHHHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeE
Q 003385 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (824)
Q Consensus 593 ~~~~~~~~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 672 (824)
+.+++|.+. +-||.|+.|.||+|+++ ++.||||+++... ..+|+.|++|+||||+.+.|+|.....+
T Consensus 121 iPFe~IsEL-----eWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 121 IPFEEISEL-----EWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred CCHHHhhhh-----hhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCcee
Confidence 445555433 45899999999999988 7899999875321 2478899999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
+||||||..|.|.+.|+ .++.+.......+..+||.||.|||.+ .|||||||.-||||+.+..+||+|||.++
T Consensus 188 CIiMEfCa~GqL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred EEeeeccccccHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchH
Confidence 99999999999999995 456677778889999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
...+. .....++||..|||||++.....+.|+|||||||+||||+||+.||.+..
T Consensus 261 e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 261 ELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred hhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence 66443 22344689999999999999999999999999999999999999998755
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=304.08 Aligned_cols=196 Identities=27% Similarity=0.399 Sum_probs=171.3
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 456789999999999999876 68899999986432 12345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 83 VPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999998843 34578888899999999999999998 9999999999999999999999999998765332
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~ 202 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 123468999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=308.36 Aligned_cols=195 Identities=28% Similarity=0.401 Sum_probs=168.5
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCC
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 682 (824)
+.||+|+||.||+|+.+ +|+.||+|+++.... .....+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 688999999975421 22345778999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCcee
Q 003385 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (824)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (824)
+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 99888843 35678889999999999999999998 99999999999999999999999999987532221 122
Q ss_pred ccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 763 ~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
...+||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 34569999999999999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=317.50 Aligned_cols=211 Identities=23% Similarity=0.310 Sum_probs=174.4
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
+.+.++||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++.+.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 345688999999999999875 678899999875321 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 83 IPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999998843 34577888889999999999999998 99999999999999999999999999975321000
Q ss_pred ----------------------------------------------CceeccccCCCCCcchhccccCCCCchHHHHHHH
Q 003385 759 ----------------------------------------------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFG 792 (824)
Q Consensus 759 ----------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlG 792 (824)
.......+||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001234689999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCccccchhcHhhh
Q 003385 793 VILLELISGQEAISNEKFGANCRNIVQW 820 (824)
Q Consensus 793 vil~elltG~~Pf~~~~~~~~~~~iv~~ 820 (824)
|++|||++|+.||.+....+...+++.|
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~ 263 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINW 263 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcc
Confidence 9999999999999876644444444443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=310.31 Aligned_cols=205 Identities=26% Similarity=0.376 Sum_probs=175.9
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 456789999999999999876 58899999997542 12345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 83 VPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999843 34578888999999999999999998 999999999999999999999999999875533
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+.
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~ 211 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK 211 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH
Confidence 2234568999999999999999999999999999999999999998765444433333
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=314.32 Aligned_cols=209 Identities=25% Similarity=0.336 Sum_probs=174.4
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
..|.+.+.||+|+||.||+++++ +++.+|+|++.+.. ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 34566789999999999999876 57889999986432 122345788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++.....
T Consensus 123 Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 123 EYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred cCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 99999999998843 2467888889999999999999998 999999999999999999999999999976543
Q ss_pred CCCceeccccCCCCCcchhccccCC----CCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcH
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQ----LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i 817 (824)
.........+||+.|+|||++.... ++.++||||+||++|||++|+.||.+....+...++
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i 259 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 3322334556999999999987643 778999999999999999999999876543333333
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=286.49 Aligned_cols=209 Identities=26% Similarity=0.409 Sum_probs=179.0
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccC--CcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
..|.+.+.||+|.|+.||++.+. +|+.+|+|++..+ ...+.+++.+|+.+.+.++||||+++.+.+.+....++|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 34567788999999999999654 7899999988644 33356789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEEecCCcccc
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKFA 754 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~---~~vkL~DFGla~~~ 754 (824)
+|+|++|..-+-. ..-+++..+-..++||+.+|+|+|.+ +|||||+||+|+|+.+. -.+||+|||+|...
T Consensus 91 ~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 91 LVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred cccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999998776632 24567788889999999999999999 99999999999999643 46899999999877
Q ss_pred cCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 755 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 755 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
. .......++|||.|||||++...+|+..+|||+.|||||-|+.|.+||.+++....+++|+
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~ 225 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK 225 (355)
T ss_pred C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 6 3334456779999999999999999999999999999999999999999977666666654
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=309.26 Aligned_cols=197 Identities=30% Similarity=0.443 Sum_probs=172.2
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
.|.+.+.||+|+||.||+|+++ +++.||+|+++... ....+.+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 3557789999999999999876 58899999987532 1234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+.+|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 99 FVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred CCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999998853 34577888888999999999999998 9999999999999999999999999998765332
Q ss_pred CCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
. ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 1 23468999999999999999999999999999999999999997654
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=305.34 Aligned_cols=195 Identities=27% Similarity=0.409 Sum_probs=167.9
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCC
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 682 (824)
+.||+|+||.||+++.+ +|+.||+|+++.... .....+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999865 689999999975422 22345678999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCcee
Q 003385 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (824)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (824)
+|..++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 99888742 34678899999999999999999998 99999999999999999999999999987532221 122
Q ss_pred ccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 763 ~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 33568999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=297.65 Aligned_cols=199 Identities=30% Similarity=0.450 Sum_probs=170.8
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.+.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|++++++++|++|+++++.+.+.+..++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence 34678999999999999864 789999999865422 22345778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 83 ~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 83 NGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred CCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 999998887532 234578889999999999999999998 99999999999999999999999999987653322
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......||..|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 2233468999999999999999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=316.00 Aligned_cols=210 Identities=23% Similarity=0.300 Sum_probs=174.0
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++.+.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 456789999999999999865 588999999864321 2235578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC-
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG- 757 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~- 757 (824)
+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 83 IPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999843 34577888888999999999999998 9999999999999999999999999997422100
Q ss_pred -----------------------------------------CCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHH
Q 003385 758 -----------------------------------------ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL 796 (824)
Q Consensus 758 -----------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ 796 (824)
........+||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000011346999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCccccchhcHhh
Q 003385 797 ELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 797 elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
||++|+.||.+....+....+..
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~~ 258 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVIN 258 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHhc
Confidence 99999999987664444434433
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=304.07 Aligned_cols=194 Identities=28% Similarity=0.406 Sum_probs=168.2
Q ss_pred ccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCH
Q 003385 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (824)
Q Consensus 609 LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 684 (824)
||+|+||.||+|++. +++.||+|+++... ......+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999876 57889999986432 22345677899999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceecc
Q 003385 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (824)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (824)
.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 998843 34578889999999999999999998 99999999999999999999999999987543222 22334
Q ss_pred ccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 765 ~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
..||+.|+|||++.+..++.++||||+||++|||++|+.||.+...
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~ 198 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV 198 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH
Confidence 5699999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=309.18 Aligned_cols=197 Identities=25% Similarity=0.366 Sum_probs=171.1
Q ss_pred HHHhhccccccCcEEEEEEEEcC--CcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~--g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
.|.+.+.||+|+||.||+|.++. +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 45677899999999999998653 3689999986432 222356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 111 Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 111 EFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999998843 34678888999999999999999998 999999999999999999999999999876532
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 2 233468999999999998889999999999999999999999998755
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=333.25 Aligned_cols=210 Identities=32% Similarity=0.523 Sum_probs=178.8
Q ss_pred HHHHHHHHhhccccccCcEEEEEEEEc--CCc----EEEEEEeccC-CcccchhhhHHHHHHhhcCCCccceeeceeecC
Q 003385 597 DIEDATKMLEKKIGSGGFGVVYYGKLK--DGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE 669 (824)
Q Consensus 597 ~~~~~~~~i~~~LG~G~fg~Vy~a~~~--~g~----~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 669 (824)
.+......+.+.||+|.||+||.|... +|. .||||.++.. +.+...+|.+|..+|++++|||||+++|+|.+.
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 344555566789999999999999865 343 4899988765 445567899999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhccc---CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 003385 670 GRSVLVYEFMHNGTLKEHLYGTL---THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (824)
Q Consensus 670 ~~~~lV~E~~~~gsL~~~L~~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~ 746 (824)
...+|++|||++|+|..+|+... .....++..+.+.++.|||+|+.||+++ ++|||||.++|||++....+||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEc
Confidence 99999999999999999996541 2245688899999999999999999998 99999999999999999999999
Q ss_pred ecCCcccccCCCCceeccc-cCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 747 DFGLSKFAVDGASHVSSIV-RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 747 DFGla~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
|||+|+.+........... .-+..|||||.+..+.++.|+|||||||++||+++ |..||.+.+
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~ 909 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS 909 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc
Confidence 9999996555444333222 23579999999999999999999999999999999 999998755
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=311.72 Aligned_cols=204 Identities=25% Similarity=0.315 Sum_probs=172.8
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
...|.+.+.||+|+||.||+++++ +++.+|+|++.... ....+.+.+|+.+++.++||||+++++.+.+.+..++|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 356677899999999999999876 57889999986422 12234577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
|||+++|+|.+++.. ..++...+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 122 ~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 122 MEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 999999999998843 3467778888999999999999998 99999999999999999999999999997654
Q ss_pred CCCCceeccccCCCCCcchhccccCC----CCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYISQQ----LTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
...........||+.|+|||++.... ++.++|||||||++|||++|+.||.+....
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 253 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH
Confidence 33322334556999999999987543 788999999999999999999999875543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=304.57 Aligned_cols=195 Identities=29% Similarity=0.430 Sum_probs=168.5
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCC
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 682 (824)
+.||+|+||.||+++.+ +++.||+|+++... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 68899999997542 222356778999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCcee
Q 003385 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (824)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (824)
+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 99888743 34688899999999999999999998 99999999999999999999999999987532221 122
Q ss_pred ccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 763 ~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 34569999999999998999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=310.60 Aligned_cols=206 Identities=25% Similarity=0.309 Sum_probs=172.8
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
..|.+.+.||+|+||.||+|+.+ +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 45667789999999999999876 68899999986432 122345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 123 Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 123 EYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred cCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999998843 2467778888999999999999998 999999999999999999999999999876543
Q ss_pred CCCceeccccCCCCCcchhccccC----CCCchHHHHHHHHHHHHHHcCCCCCCCCccccch
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQ----QLTDKSDVYSFGVILLELISGQEAISNEKFGANC 814 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~ 814 (824)
.........+||+.|+|||++... .++.++|||||||++|||++|+.||.+....+..
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~ 256 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY 256 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH
Confidence 322233445699999999998753 3788999999999999999999999876543333
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=289.25 Aligned_cols=212 Identities=28% Similarity=0.356 Sum_probs=180.4
Q ss_pred HHHhhccccccCcEEEEEEEEcC-CcEEEEEEeccCCccc---chhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~-g~~vAVK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
..++.+.||+|.-|+||+++.++ +...|+|++.+..... ..+.+.|.+||+.++||.++.|++.++.++..+++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 34467899999999999999874 5789999998764433 3456779999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC-
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD- 756 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~- 756 (824)
||.||+|...+.. +..+.+++..++-++.+++.||+|||-. |||+|||||+||||.++|++.|+||.++.....
T Consensus 158 yCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 158 YCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred cCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999887743 4677899999999999999999999997 999999999999999999999999998642100
Q ss_pred --------------------------------C-C---------------------CceeccccCCCCCcchhccccCCC
Q 003385 757 --------------------------------G-A---------------------SHVSSIVRGTVGYLDPEYYISQQL 782 (824)
Q Consensus 757 --------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~l~~~~~ 782 (824)
. . ...+..++||-+|.|||++.+..+
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 011233569999999999999999
Q ss_pred CchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 783 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 783 ~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
+.++|.|+|||++|||+.|..||.+..-.++..+|+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv 348 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIV 348 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHh
Confidence 999999999999999999999999977666666664
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=311.47 Aligned_cols=211 Identities=25% Similarity=0.378 Sum_probs=176.6
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
+.+.+.||+|+||.||+++.+ +++.||+|+++... ......+.+|+.++.+++||+|+++++.+.+.+..++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 345688999999999999876 68899999997432 22235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 83 LPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred CCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999998843 35678889999999999999999998 99999999999999999999999999986432110
Q ss_pred C----------------------------------ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCC
Q 003385 759 S----------------------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 804 (824)
Q Consensus 759 ~----------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~P 804 (824)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 011234699999999999999999999999999999999999999
Q ss_pred CCCCccccchhcHhhh
Q 003385 805 ISNEKFGANCRNIVQW 820 (824)
Q Consensus 805 f~~~~~~~~~~~iv~~ 820 (824)
|.+....+...++..|
T Consensus 236 f~~~~~~~~~~~i~~~ 251 (360)
T cd05627 236 FCSETPQETYRKVMNW 251 (360)
T ss_pred CCCCCHHHHHHHHHcC
Confidence 9876655555454443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=304.45 Aligned_cols=208 Identities=28% Similarity=0.460 Sum_probs=169.7
Q ss_pred HHHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCc-ccchhhhHHHHHHhhc-CCCccceeeceeecC-
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE- 669 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~- 669 (824)
...++.+.++||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+.+++++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4456778899999999999999742 356799999875432 2345688999999999 899999999988764
Q ss_pred CeEEEEEEecCCCCHHHHhhcccC--------------------------------------------------------
Q 003385 670 GRSVLVYEFMHNGTLKEHLYGTLT-------------------------------------------------------- 693 (824)
Q Consensus 670 ~~~~lV~E~~~~gsL~~~L~~~~~-------------------------------------------------------- 693 (824)
+..+++|||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 457899999999999998854211
Q ss_pred --ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc-eeccccCCCC
Q 003385 694 --HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVG 770 (824)
Q Consensus 694 --~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~ 770 (824)
....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++........ ......+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 013477888899999999999999998 9999999999999999999999999999765332221 1223346688
Q ss_pred CcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 771 YLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 771 y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999999999999997 999997644
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=291.99 Aligned_cols=205 Identities=26% Similarity=0.450 Sum_probs=170.5
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEecc--CCcccchhhhHHHHHHhhcCCCccceeeceeec-----CCeEEEEEE
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTS--NSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-----EGRSVLVYE 677 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~~lV~E 677 (824)
.+.||+|+||.|+.|..+ +|+.||||++.. ......++..+|+++|+.++|+||+.+.+++.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 578999999999999865 789999998862 344456778899999999999999999998855 357899999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
+| +-+|...++ .++.++..+...++.|++.||.|+|+. +|+||||||.|+|++.+..+||||||+|+.....
T Consensus 107 lM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 107 LM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred HH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeecccc
Confidence 99 457877774 345588899999999999999999998 9999999999999999999999999999976432
Q ss_pred -CCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 758 -ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 758 -~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
.....+..+.|.+|+|||.+.. ..|+.+.||||+|||+.||++|++.|.|.+.-...+.|+
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~ 241 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLIL 241 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 1122234558999999999864 679999999999999999999999999876444444443
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=304.32 Aligned_cols=209 Identities=32% Similarity=0.481 Sum_probs=183.8
Q ss_pred HHHHHHhhccccccCcEEEEEEEEcC-CcEEEEEEeccCCccc---chhhhHHHHHHhhcC-CCccceeeceeecCCeEE
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQG---KREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~~-g~~vAVK~l~~~~~~~---~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 673 (824)
....|.+.+.||+|.||.||+++.+. |+.+|+|++.+..... ...+.+|+++|+++. ||||+.+.+++++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34466777999999999999998875 9999999998665443 357899999999998 999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC----CcEEEEecC
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDFG 749 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~----~~vkL~DFG 749 (824)
+|||++.||.|.+.+... .+++..+..++.|++.++.|||+. ||+||||||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999998654 288999999999999999999997 99999999999999743 479999999
Q ss_pred CcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcH
Q 003385 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (824)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i 817 (824)
++..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.+.+..+...+|
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i 250 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI 250 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH
Confidence 9987765 44556678999999999999999999999999999999999999999987755444433
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=292.79 Aligned_cols=196 Identities=29% Similarity=0.443 Sum_probs=169.1
Q ss_pred ccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCH
Q 003385 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (824)
Q Consensus 609 LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 684 (824)
||+|+||+||++.++ +++.+|+|++...... ..+.+..|++++++++||||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999865 6889999998654222 224567899999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceecc
Q 003385 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (824)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (824)
.+.+.........+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 988765444456789999999999999999999998 9999999999999999999999999998765433222 233
Q ss_pred ccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 765 ~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 46899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=308.90 Aligned_cols=211 Identities=27% Similarity=0.371 Sum_probs=179.7
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|++++..++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 456789999999999999876 689999999975421 2345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++++|.+++... ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 83 MPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 9999999988532 5678889999999999999999997 99999999999999999999999999987654332
Q ss_pred ----------------------------CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 759 ----------------------------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 759 ----------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122334689999999999999999999999999999999999999987665
Q ss_pred ccchhcHhhh
Q 003385 811 GANCRNIVQW 820 (824)
Q Consensus 811 ~~~~~~iv~~ 820 (824)
.+...++.+|
T Consensus 236 ~~~~~~i~~~ 245 (350)
T cd05573 236 QETYNKIINW 245 (350)
T ss_pred HHHHHHHhcc
Confidence 5445555543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=301.98 Aligned_cols=195 Identities=29% Similarity=0.456 Sum_probs=167.0
Q ss_pred ccccccCcEEEEEEEEc----CCcEEEEEEeccCC----cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 607 KKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~----~g~~vAVK~l~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
+.||+|+||.||+++.. .++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999753 57889999987532 12234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+.+++|.+++.. ...+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999988843 34567788888999999999999998 99999999999999999999999999987543222
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 2 2233568999999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=303.36 Aligned_cols=202 Identities=26% Similarity=0.353 Sum_probs=171.3
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 456789999999999999876 58899999986422 12234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 83 YVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred CCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999988431 34578888999999999999999998 99999999999999999999999999987654433
Q ss_pred CceeccccCCCCCcchhcccc-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 759 SHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
........||+.|+|||++.. ..++.++||||+||++|||++|+.||.+...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~ 213 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH
Confidence 333333468999999999873 4578899999999999999999999977543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=301.12 Aligned_cols=196 Identities=26% Similarity=0.408 Sum_probs=167.3
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.||+|+||.||+|+.+ +++.||+|+++.... ...+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 578999999875421 2234567788888866 799999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|...+.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence 999888743 34678888999999999999999998 999999999999999999999999999875432222 2
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~ 201 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE 201 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH
Confidence 2345689999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=293.97 Aligned_cols=207 Identities=24% Similarity=0.370 Sum_probs=171.4
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
|.+.++||+|+||.||+|+.+ +++.||+|+++.... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 556789999999999999876 688999999875432 224467789999999999999999999999999999999997
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 87 ~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 87 S-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred c-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 5 888887432 33467888899999999999999998 999999999999999999999999999875432221
Q ss_pred eeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcH
Q 003385 761 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i 817 (824)
......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+....+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 216 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 1233457999999998875 56899999999999999999999999876644444333
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=311.83 Aligned_cols=201 Identities=34% Similarity=0.537 Sum_probs=171.2
Q ss_pred hhccccccCcEEEEEEEEcC--C--cE-EEEEEeccC---CcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 605 LEKKIGSGGFGVVYYGKLKD--G--KE-IAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~~--g--~~-vAVK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
+.++||+|+||+||+|+++. + .. ||||..+.. ......++.+|+++|++++|||||+++|++.....+++||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 55899999999999998653 2 23 899988752 2344678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
|+|.||+|.++|... ...++..++..++.+.|.||+|||++ +++||||.++|||++.++.+||+|||+++....
T Consensus 241 El~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 999999999999643 23688999999999999999999998 999999999999999999999999999875431
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcccc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGA 812 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~ 812 (824)
- ........-+..|+|||.+....|+.++|||||||++||+++ |..||.+....+
T Consensus 315 ~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~ 370 (474)
T KOG0194|consen 315 Y-VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE 370 (474)
T ss_pred e-eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH
Confidence 1 111112235789999999999999999999999999999999 899999876443
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=301.92 Aligned_cols=199 Identities=27% Similarity=0.390 Sum_probs=168.8
Q ss_pred HHhhccccccCcEEEEEEEEc----CCcEEEEEEeccCCc----ccchhhhHHHHHHhhc-CCCccceeeceeecCCeEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSY----QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~----~g~~vAVK~l~~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 673 (824)
|.+.+.||+|+||.||+++.. +++.||+|+++.... ...+.+.+|+++++++ +||+|+++++++...+..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 446789999999999999753 578999999864321 2234577899999999 5999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 82 lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 82 LILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999998853 34578889999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 544333333345699999999998865 4788999999999999999999999653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=299.21 Aligned_cols=195 Identities=31% Similarity=0.475 Sum_probs=164.8
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.||+|+||.||+|+++ +++.||+|+++.... ...+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 578899999975421 2233455666666654 899999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999988743 34578888999999999999999998 99999999999999999999999999987543322 22
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 334569999999999998899999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=315.55 Aligned_cols=204 Identities=24% Similarity=0.350 Sum_probs=176.5
Q ss_pred HHhhccccccCcEEEEEEEEc-C-CcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-D-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
|.+.+.||+|++|.||+|... + ++.||+|.+..........+.+|+++++.++||||+++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 667889999999999999754 3 57788887765544444567889999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC-
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS- 759 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~- 759 (824)
+|+|.+++.........+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999998876555556788899999999999999999998 999999999999999999999999999986543322
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~ 275 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 12344569999999999999999999999999999999999999997644
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=302.76 Aligned_cols=195 Identities=28% Similarity=0.410 Sum_probs=167.2
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCC
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 682 (824)
+.||+|+||.||+++.+ +++.||+|+++.... .....+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999865 688999999975422 22345678999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
+|.+++. ....+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 9988874 23468889999999999999999997 5 999999999999999999999999999875332222 2
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~ 200 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC
Confidence 233469999999999999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=299.47 Aligned_cols=195 Identities=30% Similarity=0.458 Sum_probs=166.7
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.||+|+||.||+|+.+ +++.||||+++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999876 57899999987532 12234566788888776 699999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 999988743 34678889999999999999999998 99999999999999999999999999987532222 22
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 234569999999999999999999999999999999999999998755
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=293.08 Aligned_cols=200 Identities=24% Similarity=0.352 Sum_probs=170.4
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.+.||+|+||.||+|+++ +++.||+|+++.... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 456788999999999999986 578899999875422 22456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
+++.+..... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 83 EKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9877665432 234578888999999999999999998 999999999999999999999999999986543322
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 22334568999999999998899999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=299.21 Aligned_cols=199 Identities=28% Similarity=0.392 Sum_probs=168.2
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCC-CccceeeceeecCCeEEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV~E 677 (824)
|.+.+.||+|+||.||+|+.+ +++.||||+++... ....+.+..|.+++..++| ++|+++++++.+.+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 346789999999999999876 56789999987542 2234567789999999976 468889999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 82 YVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999988843 34578888999999999999999998 9999999999999999999999999998643222
Q ss_pred CCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 155 GK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred CC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 11 2234568999999999999999999999999999999999999998655
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=300.14 Aligned_cols=197 Identities=27% Similarity=0.412 Sum_probs=166.9
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHH---hhcCCCccceeeceeecCCeEEEEE
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLL---SRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il---~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
.+.+.||+|+||.||+|.++ +++.||||+++... ....+.+.+|++++ ++++||||+++++++...+..++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 45688999999999999875 68899999997542 12234566676655 4567999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++++|...+. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 82 E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 82 EYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred cCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999988773 24588999999999999999999998 999999999999999999999999999875332
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.. ......+|++.|+|||.+.+..++.++|||||||++|||++|+.||.+..
T Consensus 154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 22 22234569999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=302.87 Aligned_cols=201 Identities=25% Similarity=0.315 Sum_probs=170.8
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|+||.||+++++ +++.||+|++.... ......+.+|..++..++|++|+++++++.+.+..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 456789999999999999876 57889999986422 12234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 83 YVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred CCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999998532 34578888889999999999999998 99999999999999999999999999987654433
Q ss_pred CceeccccCCCCCcchhcccc-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
........||+.|+|||++.. ..++.++||||+||++|||++|+.||.+..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 323334569999999999875 467889999999999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=299.77 Aligned_cols=196 Identities=33% Similarity=0.457 Sum_probs=164.6
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHH-HHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVT-LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.||+|+||+||+|+++ +|+.||+|++..... ...+.+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999876 689999999865321 12233444444 56789999999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 999988843 44678888899999999999999998 99999999999999999999999999987532222 22
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 201 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT 201 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH
Confidence 2345689999999999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=299.07 Aligned_cols=199 Identities=27% Similarity=0.376 Sum_probs=168.2
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
+.+.+.||+|+||.||+|+.+ +++.||+|+++.... ...+.+..|..++..+ +|++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 345688999999999999876 577899999875422 1223456677888777 58999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+++|+|.+.+.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 82 YVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999988743 34578889999999999999999998 9999999999999999999999999998753322
Q ss_pred CCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 155 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred C-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 1 12234568999999999999999999999999999999999999998755
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=300.73 Aligned_cols=198 Identities=32% Similarity=0.447 Sum_probs=165.9
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHH-HHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVT-LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.||+|+||+||+|+.+ +|+.+|+|++..... ...+.+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999875 688999999865321 22334455554 56778999999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|..++. ....+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 99988774 345678889999999999999999998 99999999999999999999999999987532221 12
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA 812 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~ 812 (824)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~ 203 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE 203 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH
Confidence 234569999999999999999999999999999999999999998765433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=294.19 Aligned_cols=207 Identities=27% Similarity=0.493 Sum_probs=170.1
Q ss_pred HHHHHhhccccccCcEEEEEEEEcC-----------------CcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccce
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLKD-----------------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQ 661 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~~-----------------g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~ 661 (824)
...+.+.++||+|+||.||+|.+++ +..||+|+++.... ....++.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4456778999999999999997542 33699999875432 23457889999999999999999
Q ss_pred eeceeecCCeEEEEEEecCCCCHHHHhhcccC---------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 003385 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLT---------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 726 (824)
Q Consensus 662 l~~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~---------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIv 726 (824)
+++++.+.+..++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999998854211 113467788899999999999999998 999
Q ss_pred ecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc--CCC
Q 003385 727 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQE 803 (824)
Q Consensus 727 HrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt--G~~ 803 (824)
||||||+|||++.++.+||+|||+++........ ......++..|+|||++....++.++|||||||++|||++ |..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999998765333221 1223345789999999998899999999999999999986 567
Q ss_pred CCCCCc
Q 003385 804 AISNEK 809 (824)
Q Consensus 804 Pf~~~~ 809 (824)
||.+..
T Consensus 241 p~~~~~ 246 (304)
T cd05096 241 PYGELT 246 (304)
T ss_pred CCCcCC
Confidence 886543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=298.99 Aligned_cols=197 Identities=30% Similarity=0.427 Sum_probs=163.9
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHH-HHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEV-TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei-~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.||+|+||.||+|+++ +++.||+|++..... .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 567899999875321 1223344444 456788999999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|.+++.. ...+.+..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~ 152 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-T 152 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-C
Confidence 999988843 34567788888999999999999998 999999999999999999999999999875432221 2
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 202 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA 202 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH
Confidence 33456999999999999999999999999999999999999999865533
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=298.91 Aligned_cols=195 Identities=33% Similarity=0.446 Sum_probs=164.0
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHH-HHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEV-TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei-~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.||+|+||.||+|++. +++.||+|++..... .....+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 578999999865321 1223444554 467889999999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
++|...+. ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (321)
T cd05603 81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-T 152 (321)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-c
Confidence 99988774 235577888889999999999999998 999999999999999999999999999875322221 2
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 234568999999999998899999999999999999999999997754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=300.08 Aligned_cols=214 Identities=27% Similarity=0.463 Sum_probs=186.0
Q ss_pred cccCHHHHHHHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCccc-chhhhHHHHHHhhcCCCccceeeceeecC
Q 003385 591 HCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEE 669 (824)
Q Consensus 591 ~~~~~~~~~~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 669 (824)
......++......+.++||+|.||+|.++....+..||||+++...... +++|.+|+++|.+++||||++++|+|..+
T Consensus 528 k~~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 528 KGPALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred cCcchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 34567788888888999999999999999999888999999999776554 47899999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003385 670 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (824)
Q Consensus 670 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFG 749 (824)
+.+++|+|||++|+|..++..+..+. +.......|+.||++||+||.+. ++|||||.++|||++.++++||+|||
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfg 682 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFG 682 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcc
Confidence 99999999999999999996553222 34455677999999999999997 99999999999999999999999999
Q ss_pred CcccccCCCCce-eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc--CCCCCCCCc
Q 003385 750 LSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEK 809 (824)
Q Consensus 750 la~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt--G~~Pf~~~~ 809 (824)
+++....+..+. ....+-+.+|||+|.+..++++.++|+|+||+.+||+++ .+.||+..+
T Consensus 683 msR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt 745 (807)
T KOG1094|consen 683 MSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT 745 (807)
T ss_pred cccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh
Confidence 999666555443 334456789999999999999999999999999999754 888997644
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=295.46 Aligned_cols=195 Identities=29% Similarity=0.466 Sum_probs=165.4
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.||+|+||+||+|++. +++.||||+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999876 57889999997542 12234456677777764 899999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 999998843 34578888899999999999999998 999999999999999999999999999875322222 2
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 234568999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=303.50 Aligned_cols=202 Identities=25% Similarity=0.303 Sum_probs=172.6
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|+||+||+++.+ +++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 446789999999999999875 688999999975422 2345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 83 QPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999988542 24678888999999999999999998 99999999999999999999999999997654433
Q ss_pred CceeccccCCCCCcchhccc------cCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 759 SHVSSIVRGTVGYLDPEYYI------SQQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~------~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
........||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 214 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH
Confidence 33333446899999999987 45677899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=300.72 Aligned_cols=202 Identities=26% Similarity=0.339 Sum_probs=170.5
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.++||+|+||+||+++++ .++.+|+|++.+.. ......+.+|+.++..++|++|+++++.+.+.+..++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 446789999999999999876 46789999986422 12234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 83 YVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999998532 34578888899999999999999998 99999999999999999999999999987544333
Q ss_pred CceeccccCCCCCcchhccc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 759 SHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
........||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~ 213 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence 33334456999999999986 34678899999999999999999999986543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=295.97 Aligned_cols=195 Identities=31% Similarity=0.467 Sum_probs=165.9
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.||+|+||.||+|+++ +++.||+|+++... ....+.+..|..++... +||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999876 57899999997542 12234566777777754 899999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 999988743 34578888999999999999999998 99999999999999999999999999987432222 22
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~ 200 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 334569999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=290.60 Aligned_cols=192 Identities=34% Similarity=0.537 Sum_probs=159.5
Q ss_pred hhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHh--hcCCCccceeeceeecCC----eEEEEEEe
Q 003385 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS--RIHHRNLVQFLGYCQEEG----RSVLVYEF 678 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~--~l~HpnIv~l~~~~~~~~----~~~lV~E~ 678 (824)
+.+.||+|.||.||||+++ ++.||||++... +++.++.|-.+.+ .++|+||++++++-.... +++||+||
T Consensus 214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 4578999999999999988 599999999743 3456666766654 468999999999876655 88999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
.+.|+|.++|.. ...+|....+|+..+++||+|||+.. .|+|+|||||++||||.+|+++.|+|||+|.
T Consensus 290 h~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 290 HPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred ccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999954 45889999999999999999999743 3689999999999999999999999999998
Q ss_pred cccCCCCc-eeccccCCCCCcchhccccCC-CC-----chHHHHHHHHHHHHHHcCCCCC
Q 003385 753 FAVDGASH-VSSIVRGTVGYLDPEYYISQQ-LT-----DKSDVYSFGVILLELISGQEAI 805 (824)
Q Consensus 753 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~-~~-----~~~DIwSlGvil~elltG~~Pf 805 (824)
.+.++... .....+||.+|||||++.+.. +. .+.||||+|.+||||++.-..+
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 77655433 223367999999999998642 22 3679999999999999876544
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=313.92 Aligned_cols=205 Identities=25% Similarity=0.375 Sum_probs=171.9
Q ss_pred HHHHhhccccccCcEEEEEEEEcCC-cEEEEEEeccCCcccchhhhHHHHHHhhcC-CCccceeece-eec------CCe
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKDG-KEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGY-CQE------EGR 671 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~g-~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~-~~~------~~~ 671 (824)
....+++.|.+|||+.||.|+...+ .++|+|++-..+....+.+.+|+++|++|+ |||||.+++. ... .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3455778999999999999997765 999999987776667788999999999997 9999999993 211 236
Q ss_pred EEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003385 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla 751 (824)
.+|.||||.+|.|-+++..++... |++.++++|+.|+++|+.+||.. .++|||||||-|||||+.+++.||||||.+
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 789999999999999997765443 99999999999999999999985 568999999999999999999999999998
Q ss_pred ccccCCC-Cce-------eccccCCCCCcchhccc---cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 752 KFAVDGA-SHV-------SSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 752 ~~~~~~~-~~~-------~~~~~gt~~y~aPE~l~---~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
....... ... .-...-|+.|+|||++. +...++|+|||||||+||-|+....||++.
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 7433222 110 01123689999999975 568899999999999999999999999875
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=297.80 Aligned_cols=193 Identities=25% Similarity=0.406 Sum_probs=166.8
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.||+|+||.||+|+++ +++.||+|+++.... ...+.+.+|..+++++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999876 688999999975422 2234577899999988 699999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 999888742 35688999999999999999999998 99999999999999999999999999987432221 22
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
....+||+.|+|||++.+..++.++|+|||||++|||++|+.||+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 2345699999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=287.65 Aligned_cols=205 Identities=24% Similarity=0.406 Sum_probs=171.4
Q ss_pred HHHHHHhhccccccCcEEEEEEEEc----CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEE
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~----~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 673 (824)
....+.+.+.||+|+||.||+|.++ .+..||+|+++.... ...+.+.+|++.+++++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 3455677899999999999999764 356899999876532 22456889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+|++|||.+..
T Consensus 83 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 999999999999988532 34678999999999999999999998 999999999999999999999999998764
Q ss_pred ccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.............++..|+|||.+.+..++.++|||||||++||+++ |+.||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~ 213 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 32221111122235678999999999999999999999999999875 999997654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=296.98 Aligned_cols=198 Identities=26% Similarity=0.384 Sum_probs=167.9
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcC-CCccceeeceeecCCeEEEEEEe
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
++.+.||+|+||.||+|+.+ +++.||+|+++.... ...+.+..|..++..+. |++|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 45688999999999999876 688999999875421 22345677888888885 57788899999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 83 VNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999988843 34688899999999999999999998 99999999999999999999999999987543221
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence 12233568999999999999899999999999999999999999998755
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=290.40 Aligned_cols=199 Identities=26% Similarity=0.394 Sum_probs=167.1
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.|.+.+.||+|+||.||+|+.+ +++.||||+++.... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 3556789999999999999876 688999999875432 22345778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
. ++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 86 ~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 86 H-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred C-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 6 6777777432 34577888899999999999999998 99999999999999999999999999987543222
Q ss_pred ceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 760 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 12233458999999999865 45788999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=305.85 Aligned_cols=214 Identities=26% Similarity=0.362 Sum_probs=179.8
Q ss_pred HHHHHHHHHHhhccccccCcEEEEEEEE-cCCcEEEEEEeccCCcccchhhhHHHHHHhhcC-C-----Cccceeeceee
Q 003385 595 LSDIEDATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-H-----RNLVQFLGYCQ 667 (824)
Q Consensus 595 ~~~~~~~~~~i~~~LG~G~fg~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~~~~~ 667 (824)
..|....+|.+.+.||+|.||.|-+|.+ ++++.||||+++... ...++...|+.+|..++ | -|+|+++++|.
T Consensus 180 ~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 180 VNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred ecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 3444444788899999999999999975 469999999997543 33556678999999997 4 48999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC--CcEEE
Q 003385 668 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKV 745 (824)
Q Consensus 668 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~--~~vkL 745 (824)
..++.+||+|.++ -+|.++++.+ ....++...+..|+.||+.||.+||+. +|||+||||||||+.+- ..+||
T Consensus 259 fr~HlciVfELL~-~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 259 FRNHLCIVFELLS-TNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred cccceeeeehhhh-hhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeE
Confidence 9999999999985 5999999764 455688899999999999999999998 99999999999999854 57999
Q ss_pred EecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 746 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 746 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
+|||.|+...+... ....++.|+|||++.+.+|+.+.||||||||++||++|.+.|.++.--+.+..|++
T Consensus 333 IDFGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e 402 (586)
T KOG0667|consen 333 IDFGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIE 402 (586)
T ss_pred EecccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHH
Confidence 99999987644322 34578999999999999999999999999999999999999998774444445544
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-33 Score=295.22 Aligned_cols=196 Identities=25% Similarity=0.434 Sum_probs=172.1
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc-cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCC
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 683 (824)
.+.||+|.||.||+|... .++.||+|++...... ..+++++|+.++.+++++||.+.++.+..+..++++||||.+|+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 478999999999999765 6888999999865433 35788999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceec
Q 003385 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 763 (824)
Q Consensus 684 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 763 (824)
+.+.+.. ...+.+.....++++++.||.|||.+ +.+|||||+.|||+..+|.+|++|||.+-........ ..
T Consensus 98 v~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-r~ 169 (467)
T KOG0201|consen 98 VLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-RK 169 (467)
T ss_pred hhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc-cc
Confidence 9998843 33346667777899999999999998 9999999999999999999999999998765544333 36
Q ss_pred cccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 764 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 764 ~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
+++||+.|||||++....|+.|+||||||++.+||++|.+|+.+..
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h 215 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH 215 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC
Confidence 7789999999999998899999999999999999999999997633
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=296.11 Aligned_cols=192 Identities=26% Similarity=0.419 Sum_probs=165.1
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.||+|+||.||+|+.+ +++.+|+|+++.... ...+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 578899999975422 2234577888888776 799999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~ 152 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence 999887742 35688899999999999999999998 999999999999999999999999999875322221 2
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 806 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~ 806 (824)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 234568999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=298.50 Aligned_cols=195 Identities=31% Similarity=0.459 Sum_probs=168.4
Q ss_pred ccccccCcEEEEEEEE----cCCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 607 KKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~----~~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
+.||+|+||.||+++. .+|+.+|+|+++.... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999975 2578999999975422 223456789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 9999988843 34578999999999999999999998 999999999999999999999999999876543322
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......|++.|+|||.+....++.++|||||||++|||++|+.||....
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 2234568999999999998889999999999999999999999998644
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=286.36 Aligned_cols=190 Identities=29% Similarity=0.507 Sum_probs=157.4
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhc--CCCccceeeceeecC----CeEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI--HHRNLVQFLGYCQEE----GRSVLV 675 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~----~~~~lV 675 (824)
+..+.+.||+|.||+||+|+|+ |+.||||++... +++...+|.++.+.+ +|+||+.+++.-... .+++||
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred eeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 3456789999999999999999 999999999643 355677888888774 999999999875332 367899
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-----GCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-----~~~~gIvHrDLkp~NILl~~~~~vkL~DFGl 750 (824)
++|.+.|+|.|+|. ...++....+.++..+|.||+|||. +..|.|.|||||++||||.+++.+.|+|+|+
T Consensus 288 TdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred eecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 99999999999994 4668888999999999999999995 3347999999999999999999999999999
Q ss_pred cccccCCC---CceeccccCCCCCcchhccccCC----C--CchHHHHHHHHHHHHHHc
Q 003385 751 SKFAVDGA---SHVSSIVRGTVGYLDPEYYISQQ----L--TDKSDVYSFGVILLELIS 800 (824)
Q Consensus 751 a~~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~----~--~~~~DIwSlGvil~ellt 800 (824)
|....... .......+||.+|||||++.... + ...+||||||.++||++.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 97554332 22345678999999999986532 1 246899999999999875
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=290.44 Aligned_cols=204 Identities=25% Similarity=0.401 Sum_probs=177.9
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCccc--chhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
.|.+++.||+|.|++|-+|++- .|+.||||++.+..... ...+.+|++.|+.++|||||+++++......+|+|+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 4567789999999999999865 89999999997664332 45678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCcccccCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~-~~vkL~DFGla~~~~~~ 757 (824)
=++|+|.+++..+ +..+.+..+.+++.||+.|+.|+|+. .+|||||||+|+.+-+. |-+||.|||++..+.++
T Consensus 99 GD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred cCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999543 56688888999999999999999997 89999999999987654 88999999999888776
Q ss_pred CCceeccccCCCCCcchhccccCCCC-chHHHHHHHHHHHHHHcCCCCCCCCccccc
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGAN 813 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DIwSlGvil~elltG~~Pf~~~~~~~~ 813 (824)
.. -.+.||++.|.|||.+.+..|+ +++||||||||||.|++|+.||+....+|+
T Consensus 173 ~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET 227 (864)
T KOG4717|consen 173 KK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET 227 (864)
T ss_pred ch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh
Confidence 53 3567899999999999999998 578999999999999999999986543433
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=293.29 Aligned_cols=195 Identities=31% Similarity=0.460 Sum_probs=166.8
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.||+|+||.||+|+++ +++.||||+++... ......+.+|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999876 57899999997542 22234567888888887 699999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T 152 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence 999888743 34688999999999999999999998 999999999999999999999999999864322221 2
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
....+|++.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 233468999999999999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=303.87 Aligned_cols=202 Identities=29% Similarity=0.494 Sum_probs=171.4
Q ss_pred hhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCC------eEEEEE
Q 003385 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSVLVY 676 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~~~lV~ 676 (824)
..+.||+|+||.||+|+++ .|+.||||.++.... ...+...+|+++|++++|||||++.++-++.. ...+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 3467999999999999965 799999999986543 33455678999999999999999999875543 557999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCCc--EEEEecCCcc
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMR--AKVSDFGLSK 752 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~--~~~~--vkL~DFGla~ 752 (824)
|||.+|+|...|... .....+++.+.+.++.+++.||.|||++ ||+||||||.||++- .+|+ -||+|||.|+
T Consensus 97 EyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 999999999999644 4456689999999999999999999998 999999999999984 3343 6999999999
Q ss_pred cccCCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcccc
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGA 812 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~ 812 (824)
...++. .....+||..|.+||+... +.|+..+|.|||||++||++||..||.....+.
T Consensus 173 el~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk 231 (732)
T KOG4250|consen 173 ELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK 231 (732)
T ss_pred cCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc
Confidence 776544 4556779999999999995 788889999999999999999999998766453
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=298.74 Aligned_cols=213 Identities=27% Similarity=0.413 Sum_probs=186.9
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCe-EEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR-SVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~lV~E 677 (824)
.|...+.+|+|+||.++..+++ +++.+++|.+..... ..++...+|+.++++++|||||...+.+.+++. .+|||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 4566789999999999999876 678899999875432 234467899999999999999999999988888 999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|++||++.+.+.... ..-+++..+..++.|++.|+.|||++ .|+|||||+.||+++.++.+||.|||+|+.....
T Consensus 85 Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred ecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999986542 56688999999999999999999987 9999999999999999999999999999987665
Q ss_pred CCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhhh
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 820 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~~ 820 (824)
.. ......||+.||.||.+.+..|..|+|||||||++|||++-+.+|...+..+...+|.+-
T Consensus 160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~ 221 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG 221 (426)
T ss_pred hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc
Confidence 42 445667999999999999999999999999999999999999999998877777666553
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=294.76 Aligned_cols=199 Identities=24% Similarity=0.397 Sum_probs=165.4
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccC--CcccchhhhHHHHHHhhcCCCccceeeceeecC-----CeEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL 674 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~l 674 (824)
|.+.+.||+|+||.||+|... +++.||||+++.. .......+.+|++++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 456789999999999999865 6899999998643 222345678999999999999999999987543 35799
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
||||+. ++|.+.+.. ...+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 82 v~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 82 VFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999995 688887742 34588999999999999999999998 9999999999999999999999999998754
Q ss_pred cCCCC--ceeccccCCCCCcchhcccc--CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 755 VDGAS--HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 755 ~~~~~--~~~~~~~gt~~y~aPE~l~~--~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 32211 11233468999999999875 678999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=293.76 Aligned_cols=200 Identities=27% Similarity=0.394 Sum_probs=172.4
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
..|.+.+.||+|+||.||+++++ ++..+|+|+++... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 34566789999999999999876 67889999987542 22345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 85 MDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 999999998853 345788889999999999999999852 6999999999999999999999999998755332
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1233468999999999999999999999999999999999999997644
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=287.43 Aligned_cols=194 Identities=23% Similarity=0.334 Sum_probs=165.4
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCCccc---chhhhHHHHHHhhcCCCccceeeceeec----CCeEEEEEEec
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVYEFM 679 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~E~~ 679 (824)
..||+|++|.||+|.+ +|+.||||+++...... .+.+.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 4689999999999998 48999999997653332 3567799999999999999999999876 35678999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++|+|.+++.. ...+++.....++.|++.||.|||+. .+++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999853 35678889999999999999999984 278899999999999999999999999987543221
Q ss_pred ceeccccCCCCCcchhcccc--CCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 760 HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~--~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+..
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~ 228 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK 228 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH
Confidence 22347899999999876 68899999999999999999999999876533
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=280.95 Aligned_cols=203 Identities=31% Similarity=0.537 Sum_probs=172.8
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
.+.+.+.||+|+||.||+++++++..+|+|.++... ...+++.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 345678899999999999999888899999886443 2346788999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.++.........
T Consensus 84 ~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 84 GCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999988532 23578889999999999999999998 99999999999999999999999999987653322222
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCccc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG 811 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~ 811 (824)
.....++..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~ 208 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY 208 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 222335678999999998899999999999999999999 99999875533
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=287.01 Aligned_cols=201 Identities=29% Similarity=0.434 Sum_probs=171.5
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|++.+.||+|+||.||++... +++.||+|++...... ....+.+|++++++++||||+++++.+...+..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 345688999999999999865 6889999998653222 234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+++......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 82 MNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 9999999887532 234588999999999999999999998 99999999999999999999999999987653322
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
. .....|++.|+|||++.+..++.++||||+||++|||++|+.||.+...
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence 1 2234689999999999988999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=286.52 Aligned_cols=209 Identities=23% Similarity=0.365 Sum_probs=169.0
Q ss_pred HHhhccccccCcEEEEEEEEc--CCcEEEEEEeccCCcc--cchhhhHHHHHHhhc---CCCccceeeceee-----cCC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRI---HHRNLVQFLGYCQ-----EEG 670 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~--~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l---~HpnIv~l~~~~~-----~~~ 670 (824)
|.+.+.||+|+||.||+|++. +++.||+|+++..... ....+.+|+++++++ +||||+++++++. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 556789999999999999863 4678999998754322 223456777777766 6999999999875 345
Q ss_pred eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGl 750 (824)
..++||||+. ++|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 6899999996 6888888532 234578889999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 751 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
++..... .......||+.|+|||.+....++.++|||||||++|||++|+.||.+....+...++++
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~ 223 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 223 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 8765332 223345689999999999988999999999999999999999999988664444444443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=273.31 Aligned_cols=202 Identities=27% Similarity=0.446 Sum_probs=170.5
Q ss_pred HHHHHhhccccccCcEEEEEEE-EcCCcEEEEEEeccCCcccchhhhHHHHHHhhcC-CCccceeeceeecCCeEEEEEE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~-~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E 677 (824)
+.+..-.+.||+|+|+.|--+. .++|.++|||++.+.....+.++.+|++++.+++ |+||++++++|+++...|+|||
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfE 156 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFE 156 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEe
Confidence 3333345789999999999885 6789999999998876666788999999999985 9999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEEecCCcccc
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKFA 754 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~---~~vkL~DFGla~~~ 754 (824)
-|.||+|..++. +..-+++.++..+.++|+.||.|||.+ ||.|||+||+|||..+. ..+|||||.+..-+
T Consensus 157 Km~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 157 KMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred cccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccccccc
Confidence 999999999884 456688899999999999999999998 99999999999999754 45899999887532
Q ss_pred cCC------CCceeccccCCCCCcchhccc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 755 VDG------ASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 755 ~~~------~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
... ....-.+.+|+..|||||+.. ...|+.++|.||||||+|-|++|.+||.+.
T Consensus 230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 211 111223456999999999874 346889999999999999999999999763
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=293.47 Aligned_cols=193 Identities=25% Similarity=0.402 Sum_probs=166.4
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 578899999975422 2234577899999888 699999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|..++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 99988774 234688999999999999999999998 99999999999999999999999999987532222 22
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 2345699999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=298.99 Aligned_cols=193 Identities=22% Similarity=0.325 Sum_probs=166.0
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
..|.+.+.||+|+||.||+|... .++.||+|+.. .+.+.+|++++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 34677889999999999999865 68899999753 245678999999999999999999999999999999998
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
. ++|..++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 166 ~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 166 K-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred C-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 5 688877743 34578889999999999999999998 999999999999999999999999999875433222
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 233345699999999999999999999999999999999999988643
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=297.37 Aligned_cols=206 Identities=25% Similarity=0.368 Sum_probs=170.3
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccC--CcccchhhhHHHHHHhhcCCCccceeeceeecCC-----eEEEE
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLV 675 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~lV 675 (824)
.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+++++.++||||+++++++...+ ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 35688999999999999865 7899999998643 2223456889999999999999999999998776 78999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
+||+. ++|.+.+. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 83 TELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred eeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 99996 57777663 245688899999999999999999998 99999999999999999999999999997654
Q ss_pred CCCCceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcH
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i 817 (824)
...........+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+....|
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 217 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 3332223334578999999998764 5789999999999999999999999876644433333
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=293.42 Aligned_cols=193 Identities=28% Similarity=0.455 Sum_probs=161.1
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
+.+.++||+|+||.||+|++. +++.||||++..... ...+.+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 345688999999999999876 689999999865432 234568899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|.+.. ...+..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 156 ~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 156 GGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 99886432 234567778999999999999998 999999999999999999999999999876543221
Q ss_pred eeccccCCCCCcchhccccC-----CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 761 VSSIVRGTVGYLDPEYYISQ-----QLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~-----~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
......||..|+|||++... ..+.++|||||||++|||++|+.||..
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 12334689999999987532 234689999999999999999999974
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=290.94 Aligned_cols=202 Identities=27% Similarity=0.407 Sum_probs=173.0
Q ss_pred HHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
....|.+.++||+|+||.||+|.++ +++.+|+|+++.... .....+.+|++++++++||||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3456778899999999999999876 678899998875422 23456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+.+++|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+|||+++++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999998853 34577888889999999999999974 2799999999999999999999999999875432
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 2 1223458999999999998899999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=307.94 Aligned_cols=205 Identities=26% Similarity=0.379 Sum_probs=173.9
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCC--------
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-------- 670 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-------- 670 (824)
+|.+.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+..+..++|+||+++.+.+...+
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 6678899999999999999864 68999999986542 223456788999999999999999988764322
Q ss_pred eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGl 750 (824)
..++||||+++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 36799999999999999976555556788999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCC-CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 751 SKFAVDGA-SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 751 a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~ 249 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 87654321 122334569999999999999999999999999999999999999998654
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=296.94 Aligned_cols=208 Identities=28% Similarity=0.454 Sum_probs=171.1
Q ss_pred HHHHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCC-cccchhhhHHHHHHhhc-CCCccceeeceeecC
Q 003385 598 IEDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE 669 (824)
Q Consensus 598 ~~~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 669 (824)
+....+.+.+.||+|+||.||+|++. .+..||||+++... ....+.+.+|+++++.+ +||||+++++++.+.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 33455678899999999999999642 35689999987443 23345688999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhcccC--------------------------------------------------------
Q 003385 670 GRSVLVYEFMHNGTLKEHLYGTLT-------------------------------------------------------- 693 (824)
Q Consensus 670 ~~~~lV~E~~~~gsL~~~L~~~~~-------------------------------------------------------- 693 (824)
+..++||||+++|+|.+++.....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999998854210
Q ss_pred ---------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 694 ---------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 694 ---------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 112477888999999999999999998 99999999999999999999999999987654322
Q ss_pred Cc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 003385 759 SH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNE 808 (824)
Q Consensus 759 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~ 808 (824)
.. ......++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 21 1122335678999999999999999999999999999998 89999753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=280.04 Aligned_cols=205 Identities=28% Similarity=0.507 Sum_probs=174.6
Q ss_pred HHHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
....+.+.+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 344567789999999999999998888899999987543 2356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+.+++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999985432 34678999999999999999999998 99999999999999999999999999987654322
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.........+..|+|||.+.+..++.++||||||+++|||++ |+.||.+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 209 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 221111223458999999998899999999999999999999 999997644
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=282.61 Aligned_cols=207 Identities=29% Similarity=0.551 Sum_probs=174.3
Q ss_pred HHHHHhhccccccCcEEEEEEEEcC------CcEEEEEEeccCCcc-cchhhhHHHHHHhhcCCCccceeeceeecCCeE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~~------g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 672 (824)
...+.+.+.||+|+||.||+|++.+ ++.||||+++..... ..+.+.+|++++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3456778999999999999998643 478999998755433 356789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccc----------CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 003385 673 VLVYEFMHNGTLKEHLYGTL----------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 742 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~ 742 (824)
++||||+++++|.+++.... .....+++..+..++.|++.|+.|||++ +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999986431 2234578889999999999999999998 9999999999999999999
Q ss_pred EEEEecCCcccccCCCC-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 743 AKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 743 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
+||+|||+++....... .......+++.|+|||++....++.++|||||||++|||++ |+.||.+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999875432221 11223345788999999999999999999999999999998 999997544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=270.94 Aligned_cols=196 Identities=30% Similarity=0.465 Sum_probs=169.4
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc----c----chhhhHHHHHHhhc-CCCccceeeceeecCCeEE
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ----G----KREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~----~----~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 673 (824)
.-.+.||+|..++|.++.++ +|++.|+|++...... . .+.-.+|+.+|+++ .||+|+++.++++.+...+
T Consensus 20 ~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~F 99 (411)
T KOG0599|consen 20 EPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVF 99 (411)
T ss_pred ChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhh
Confidence 34578999999999998765 6899999998643211 1 12345799999998 5999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+|+|.|+.|.|.++| ...-.+++.....|++|+..|++|||.+ .||||||||+|||++++.++||+|||+++.
T Consensus 100 lVFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 100 LVFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeec
Confidence 999999999999998 4556788999999999999999999998 999999999999999999999999999998
Q ss_pred ccCCCCceeccccCCCCCcchhcccc------CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
..+++. -...||||+|.|||.+.. ..|+..+|+||+|||||.|+.|.+||...
T Consensus 173 l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR 231 (411)
T KOG0599|consen 173 LEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR 231 (411)
T ss_pred cCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH
Confidence 766543 345789999999999863 46788999999999999999999999753
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=280.32 Aligned_cols=204 Identities=27% Similarity=0.496 Sum_probs=173.9
Q ss_pred HHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
...+.+.++||+|++|.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+.+.+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 44566789999999999999998888899999886533 23567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 84 AKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 999999988543 234577888899999999999999998 999999999999999999999999999976543322
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.......++..|+|||.+....++.++|||||||++|||++ |+.||....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 209 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC
Confidence 22222335678999999988889999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=288.10 Aligned_cols=197 Identities=30% Similarity=0.448 Sum_probs=175.1
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
-++||+|+||+||-++.+ +|+.+|.|.+.+.. .........|.++|.+++.+.||.+--+|+..+.+++|+..|.|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 478999999999999866 68999999886542 23345677899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|.-+|++.. ...+++..++-++.+|+.||++||+. +||.||+||+|||+|+.|+++|+|+|+|..+..+....
T Consensus 270 GDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~ 344 (591)
T KOG0986|consen 270 GDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR 344 (591)
T ss_pred CceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCccc
Confidence 99999997653 35688999999999999999999998 99999999999999999999999999998876655443
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
..+||.+|||||++....|+...|.||+||++|||+.|+.||....
T Consensus 345 --~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 345 --GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred --cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 3479999999999999999999999999999999999999997544
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=296.99 Aligned_cols=209 Identities=27% Similarity=0.468 Sum_probs=171.6
Q ss_pred HHHHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCC-cccchhhhHHHHHHhhc-CCCccceeeceeecC
Q 003385 598 IEDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE 669 (824)
Q Consensus 598 ~~~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 669 (824)
+....+.+.+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|+++++.+ +||||+++++++...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 44556778899999999999999753 23579999997543 22345688999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhccc---------------------------------------------------------
Q 003385 670 GRSVLVYEFMHNGTLKEHLYGTL--------------------------------------------------------- 692 (824)
Q Consensus 670 ~~~~lV~E~~~~gsL~~~L~~~~--------------------------------------------------------- 692 (824)
+..++||||+.+|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999885321
Q ss_pred ---------CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc-ee
Q 003385 693 ---------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VS 762 (824)
Q Consensus 693 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~ 762 (824)
.....+++..++.++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++........ ..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 0113477888999999999999999998 9999999999999999999999999998755332221 11
Q ss_pred ccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 763 ~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
....++..|||||++....++.++|||||||++|||++ |+.||....
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 22335678999999999999999999999999999997 999997543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=301.44 Aligned_cols=208 Identities=25% Similarity=0.371 Sum_probs=167.6
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecC--------CeE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--------GRS 672 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--------~~~ 672 (824)
.|.+.+.||+|+||.||+|.+. +++.||||++... .....+|+.++++++||||+++++++... ...
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 4667889999999999999875 6889999988532 23345799999999999999998876321 246
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLS 751 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~-~vkL~DFGla 751 (824)
++||||+++ +|.+++.........+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 789999975 67776654444556788999999999999999999998 999999999999999664 7999999999
Q ss_pred ccccCCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 752 KFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
+....... .....||+.|+|||++.+ ..++.++||||+||++|||++|.+||.+....+...++++
T Consensus 219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 285 (440)
T PTZ00036 219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285 (440)
T ss_pred hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 86543322 223458999999999875 4689999999999999999999999988764444444443
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=279.12 Aligned_cols=193 Identities=27% Similarity=0.457 Sum_probs=165.2
Q ss_pred ccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCH
Q 003385 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (824)
Q Consensus 609 LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 684 (824)
||+|+||.||+++.+ +|+.+|+|++..... ...+.+..|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999865 689999999864321 1234456799999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceecc
Q 003385 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (824)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (824)
.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 9887532 234578888899999999999999998 99999999999999999999999999987654322 2233
Q ss_pred ccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 765 ~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
..|+..|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 45899999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=277.40 Aligned_cols=201 Identities=31% Similarity=0.545 Sum_probs=170.9
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
.+.+.+.||+|+||.||+|++++++.+|+|++..... ....+.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 3557789999999999999988778899999864332 345688899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+|||+++.........
T Consensus 84 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 84 GCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999988543 23678899999999999999999998 99999999999999999999999999987654322222
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.....++..|+|||.+....++.++|||||||++|||++ |+.||....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 206 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC
Confidence 222224568999999998999999999999999999999 899997644
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=267.81 Aligned_cols=225 Identities=21% Similarity=0.341 Sum_probs=186.6
Q ss_pred HHHHHHHhhccccccCcEEEEEEE-EcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecC-----Ce
Q 003385 598 IEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GR 671 (824)
Q Consensus 598 ~~~~~~~i~~~LG~G~fg~Vy~a~-~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 671 (824)
+.+.+|.+.+.||+|||+-||.++ ..+++.+|+|++.....++.+...+|++..++++||||++++++...+ ..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345678899999999999999997 457889999998877767788899999999999999999999987543 35
Q ss_pred EEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003385 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla 751 (824)
.|++++|...|+|.+.+.....++..+++.+.+.++.++++||.+||+. .++++||||||.|||+++++.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999977766777899999999999999999999997 346999999999999999999999999988
Q ss_pred ccccCCC---Cc-e----eccccCCCCCcchhcccc---CCCCchHHHHHHHHHHHHHHcCCCCCCC-------------
Q 003385 752 KFAVDGA---SH-V----SSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISN------------- 807 (824)
Q Consensus 752 ~~~~~~~---~~-~----~~~~~gt~~y~aPE~l~~---~~~~~~~DIwSlGvil~elltG~~Pf~~------------- 807 (824)
+...-.. .. . .....-|..|+|||.+.- ...++++|||||||++|+|+.|..||+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~ 256 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ 256 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence 6432110 00 0 011225889999998863 4567899999999999999999999972
Q ss_pred ---------CccccchhcHhhhhcc
Q 003385 808 ---------EKFGANCRNIVQWVKS 823 (824)
Q Consensus 808 ---------~~~~~~~~~iv~~~~~ 823 (824)
...++...++++||.|
T Consensus 257 n~q~s~P~~~~yse~l~~lik~mlq 281 (302)
T KOG2345|consen 257 NAQISIPNSSRYSEALHQLIKSMLQ 281 (302)
T ss_pred ccccccCCCCCccHHHHHHHHHHhc
Confidence 2355666678888775
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=278.71 Aligned_cols=201 Identities=33% Similarity=0.571 Sum_probs=171.9
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
.+.+.+.||+|+||.||+|+++++..+|+|.++.... ....+.+|++++++++||||+++++++.+.+..+++|||+.+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 4556788999999999999988777899998875432 346788999999999999999999999988889999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.++.........
T Consensus 84 ~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 84 GCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999988532 23578999999999999999999998 99999999999999999999999999987654433222
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.....++..|+|||.+....++.++|||||||++|||++ |+.||....
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 206 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN 206 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 222335678999999988889999999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=276.59 Aligned_cols=204 Identities=30% Similarity=0.512 Sum_probs=177.4
Q ss_pred HHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
...|.+.++||.|+||.||+|...+++.+|+|+++.........+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 34577889999999999999999889999999998766555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|.+++... ....+++..+..++.|++.||.|||++ +++||||||+||++++++.+||+|||.+........
T Consensus 85 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 85 EKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999998643 234578889999999999999999998 999999999999999999999999999876543322
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.. ....++..|+|||.+....++.++||||||+++|+|++ |+.||.+..
T Consensus 160 ~~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~ 209 (261)
T cd05148 160 LS-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209 (261)
T ss_pred cc-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence 21 22335678999999998899999999999999999998 899997644
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=283.89 Aligned_cols=203 Identities=22% Similarity=0.387 Sum_probs=168.8
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc-cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
|.+.++||+|+||.||+|+.+ +++.||+|+++..... ....+.+|++++++++||||+++++++..++..++||||++
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 556789999999999999876 5788999998754322 23457789999999999999999999999999999999997
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 88 ~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 88 K-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred C-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 5 787777432 34477888899999999999999998 999999999999999999999999999875433221
Q ss_pred eeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccc
Q 003385 761 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 813 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~ 813 (824)
......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 213 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 1223457899999998865 4688999999999999999999999987664433
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=292.63 Aligned_cols=193 Identities=31% Similarity=0.409 Sum_probs=161.0
Q ss_pred ccccCcEEEEEEEEc-CCcEEEEEEeccCCccc---chhhhHHHHHHhhc---CCCccceeeceeecCCeEEEEEEecCC
Q 003385 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---KREFTNEVTLLSRI---HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 609 LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~---~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
||+|+||+||+|+.. +++.||||++....... ......|..++.+. +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999876 58899999986432211 22344566666655 699999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 99988874 345688899999999999999999998 99999999999999999999999999987543222 22
Q ss_pred eccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
....+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~ 201 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence 3345699999999998754 57899999999999999999999997754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=276.36 Aligned_cols=203 Identities=32% Similarity=0.510 Sum_probs=171.9
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
..+.+.+.||+|+||.||+|.++ .++.||+|+++... ...+++.+|++++++++||||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34556789999999999999865 58889999987543 33567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|.+++... ....+++..++.++.|+++||+|||++ +++||||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999988542 234578889999999999999999998 999999999999999999999999999876543322
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 22222234678999999998999999999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=274.74 Aligned_cols=203 Identities=29% Similarity=0.512 Sum_probs=171.8
Q ss_pred HHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
...+++.++||+|+||.||+|..+++..+|+|.++.... ..+.+.+|+.++++++|+||+++++++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence 446778899999999999999988888999999875433 34678899999999999999999998754 5678999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|.+++... ....+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+|||.+........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 83 SKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 999999988542 234578899999999999999999998 999999999999999999999999999876543322
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 208 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 22222335678999999988889999999999999999999 899997644
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=272.38 Aligned_cols=201 Identities=29% Similarity=0.406 Sum_probs=175.3
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchh---hhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~---~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.+.+.||+|.||.|-+++-+ .++-+|+|++++.....+++ -..|-++|+..+||.+..+--.|...++++.||||.
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya 250 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA 250 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence 35689999999999999755 68899999998765444433 346888999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
.||.|.-+| +.++.+++.....+-.+|+.||.|||++ +||.||||.+|+|++.||++||.|||+++..- ...
T Consensus 251 nGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g 322 (516)
T KOG0690|consen 251 NGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYG 322 (516)
T ss_pred cCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc-ccc
Confidence 999998777 4466788888888899999999999998 99999999999999999999999999997532 234
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA 812 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~ 812 (824)
....++||||.|.|||++....|..++|.|.+||+||||++|+.||...+...
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k 375 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK 375 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH
Confidence 45677899999999999999999999999999999999999999998765443
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=309.72 Aligned_cols=203 Identities=24% Similarity=0.396 Sum_probs=170.5
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.++||+|+||.||+|++. +++.||+|+++..... ..+++.+|++++++++||||+++++++.+.+..+++|||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 556789999999999999876 5889999998754222 245688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccC-------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003385 679 MHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla 751 (824)
+++|+|.+++..... .....++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcc
Confidence 999999998853211 123456777889999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCC-----------------ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 752 KFAVDGAS-----------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 752 ~~~~~~~~-----------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
+....... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 75521100 0112246999999999999999999999999999999999999999753
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=276.14 Aligned_cols=203 Identities=29% Similarity=0.503 Sum_probs=171.1
Q ss_pred HHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
...|.+.++||+|+||.||+|++.++..||+|+++.... ..+.+.+|++++++++||||+++++.+.+ +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 445778899999999999999988777899999875332 34578899999999999999999998754 5578999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999998542 234568889999999999999999998 999999999999999999999999999876543332
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.......++..|+|||...+..++.++|||||||++|||++ |..||.+..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~ 208 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 208 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 22223346778999999988899999999999999999999 888997644
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=277.63 Aligned_cols=205 Identities=33% Similarity=0.566 Sum_probs=170.8
Q ss_pred HHHhhccccccCcEEEEEEEEcC------CcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~------g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 674 (824)
.+.+.+.||+|+||.||+|.... .+.||+|.++.... .....+.+|++++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 34567899999999999998653 25799999874432 234568899999999999999999999998889999
Q ss_pred EEEecCCCCHHHHhhcccCc------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 003385 675 VYEFMHNGTLKEHLYGTLTH------------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 742 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~ 742 (824)
+|||+++++|.+++...... ...+++..++.++.|++.||.|||+. +++||||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCc
Confidence 99999999999998543211 14578888999999999999999998 9999999999999999999
Q ss_pred EEEEecCCcccccCCCC-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 743 AKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 743 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
+||+|||+++....... .......+++.|+|||.+....++.++|||||||++|||++ |..||.+..
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999875533221 12233346789999999998899999999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=275.13 Aligned_cols=205 Identities=28% Similarity=0.497 Sum_probs=174.0
Q ss_pred HHHHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 598 IEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 598 ~~~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
+....+++.++||+|+||.||+|..++++.||+|.+..... ..+++.+|+.++++++||||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 45567788899999999999999988899999999875443 3467889999999999999999999874 456899999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+.+++|.+++... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999999988542 234678889999999999999999997 9999999999999999999999999998765432
Q ss_pred CCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.........++..|+|||++....++.++||||||+++||+++ |+.||.+..
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 208 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 2222223345678999999988889999999999999999999 999997543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=273.45 Aligned_cols=197 Identities=24% Similarity=0.429 Sum_probs=175.0
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
-+.+.++||+|+||.||+|.++ .|+.+|||....+. +.+++..|+.+|++++.|+||+.+|.|.....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3456688999999999999876 68999999886443 46788899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
.|+..+.++. ..+++.+.++..+++..++||+|||.. .-+|||||+.|||++.+|.+||+|||.+-...+.. .
T Consensus 112 AGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-A 184 (502)
T KOG0574|consen 112 AGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-A 184 (502)
T ss_pred CCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-H
Confidence 9999999864 357789999999999999999999986 77999999999999999999999999986554332 2
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
...++.||+.|||||+++.-.|+.++||||+|+...||..|++||.+
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD 231 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD 231 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc
Confidence 34567799999999999999999999999999999999999999986
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=279.38 Aligned_cols=208 Identities=28% Similarity=0.531 Sum_probs=173.4
Q ss_pred HHHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeE
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 672 (824)
++..+.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3445667889999999999999752 3456899998765544456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccc---------CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 003385 673 VLVYEFMHNGTLKEHLYGTL---------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 743 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~v 743 (824)
++||||+++++|.+++.... .....+++..+..++.|++.||+|||++ +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 99999999999999985432 1223588999999999999999999998 99999999999999999999
Q ss_pred EEEecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 744 KVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 744 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
||+|||+++........ ......++..|+|||++....++.++|||||||++|||++ |..||....
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~ 227 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999998755332211 1122335778999999998899999999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=278.73 Aligned_cols=198 Identities=31% Similarity=0.451 Sum_probs=169.7
Q ss_pred hhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
..+.||+|+||+||+|.+. +++.+|+|++...... ....+.+|++++++++|+||+++.+.+...+..+++|||+.
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 4578999999999999875 6889999998654322 23457789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 84 GGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred CccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 99999888532 234588999999999999999999998 999999999999999999999999999865432221
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....|+..|+|||.+.+..++.++|+||+||++|||++|..||.+..
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 223468999999999998899999999999999999999999997644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=309.36 Aligned_cols=213 Identities=26% Similarity=0.319 Sum_probs=185.8
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccC---CcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
...+.+.+.||+|+||.|...+++ .++.+|+|++++- .......|.+|-.+|...+.+-|+.++-+|.++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 345667899999999999999986 5778899999762 223345789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
||||+||+|...+. ....+++.-+..++..|+.||.-||+- |+|||||||.|||+|..|++||+|||.+-.+.
T Consensus 154 MdY~pGGDlltLlS----k~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLS----KFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EecccCchHHHHHh----hcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 99999999999884 334788888889999999999999997 99999999999999999999999999987776
Q ss_pred CCCCceeccccCCCCCcchhcccc-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
......+...+|||.|++||++.. +.|+..+|.||+||++|||+.|..||..+..-+++.+|++
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~ 295 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMN 295 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhc
Confidence 555556677789999999999863 5688999999999999999999999998777777777765
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=285.51 Aligned_cols=196 Identities=29% Similarity=0.477 Sum_probs=169.6
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCC
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 682 (824)
.+.||+|.||+||-|+++ +|+.||||++.+.. ......+.+|+++|++++||.||.+-.-|+..++.++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 578999999999999875 79999999997643 334567899999999999999999999999999999999999665
Q ss_pred CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEEecCCcccccCCCC
Q 003385 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~---~~vkL~DFGla~~~~~~~~ 759 (824)
-|.-.|. ++..++++.....++.||+.||+|||.+ +|+|+||||+|||+.+. -++||||||.|+.+...
T Consensus 649 MLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 649 MLEMILS---SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred HHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 4544443 3456788888888999999999999998 99999999999999754 57999999999987543
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....++||+.|.|||+++.+.|...-|+||.|||+|--++|..||..+.
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 33455779999999999999999999999999999999999999997543
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=277.40 Aligned_cols=200 Identities=38% Similarity=0.625 Sum_probs=166.4
Q ss_pred hhccccccCcEEEEEEEEc-----CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 605 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~-----~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
+.+.||.|.||.||+|.++ .+..|+||+++... ....+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999877 35679999996532 22367899999999999999999999999988889999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.++|... ....+++..+..++.|++.||.|||++ +++||||+++||++++++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999654 245688999999999999999999998 99999999999999999999999999987653221
Q ss_pred C-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 759 S-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 759 ~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
. ...........|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~ 210 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD 210 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 1 22233446789999999999999999999999999999999 789997654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=273.76 Aligned_cols=205 Identities=29% Similarity=0.535 Sum_probs=175.0
Q ss_pred HHHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
....+.+.+.||+|+||.||+|..++++.+|||.+.... ...+++.+|++++++++||||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 345667789999999999999998888899999987543 2356788999999999999999999999988899999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++++|.+++... ....+++..+..++.|++.||.|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999998543 234678899999999999999999998 99999999999999999999999999987654322
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
........++..|+|||.+.+..++.++||||+||+++|+++ |+.||.+..
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 209 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT 209 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 222222234678999999998889999999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=290.40 Aligned_cols=201 Identities=21% Similarity=0.298 Sum_probs=170.4
Q ss_pred HHHHHHHHhhccccccCcEEEEEEEEc---CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEE
Q 003385 597 DIEDATKMLEKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 597 ~~~~~~~~i~~~LG~G~fg~Vy~a~~~---~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 673 (824)
.+....|.+.+.||+|+||.||++... .++.||+|.+... +...+|++++++++||||+++++++...+..+
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 334456778899999999999999754 3577999987532 34568999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
++||++. ++|.+++. ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 163 lv~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 163 MVMPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EEehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 9999986 67888772 345688999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCC-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 754 AVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 754 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
...... .......||+.|+|||++....++.++|||||||++|||++|+.||.+...
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 543322 122345699999999999999999999999999999999999999977543
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=280.59 Aligned_cols=197 Identities=23% Similarity=0.372 Sum_probs=159.2
Q ss_pred hccccccCcEEEEEEEEc---CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeec--CCeEEEEEEecC
Q 003385 606 EKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEFMH 680 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~---~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ 680 (824)
+++||+|+||+||+|+++ +++.+|+|.++... ....+.+|++++++++||||+++++++.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999865 46789999986432 23457789999999999999999998854 456789999986
Q ss_pred CCCHHHHhhccc-----CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEEecCCc
Q 003385 681 NGTLKEHLYGTL-----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLS 751 (824)
Q Consensus 681 ~gsL~~~L~~~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl----~~~~~vkL~DFGla 751 (824)
++|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 47777764221 1223578888999999999999999998 99999999999999 45578999999999
Q ss_pred ccccCCCCc--eeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 752 KFAVDGASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 752 ~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
+........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 765432211 1233568999999999876 45889999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=277.51 Aligned_cols=199 Identities=32% Similarity=0.477 Sum_probs=169.7
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
...+.||+|+||.||++.+. +++.||+|.+...... ..+.+.+|+.++++++|++|+++++.+.+.+..++||||+
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence 34578999999999999875 6889999988654322 1245678999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 83 ~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 83 NGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred CCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999988532 234578889999999999999999997 999999999999999999999999999875433221
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 123468999999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=291.86 Aligned_cols=193 Identities=27% Similarity=0.470 Sum_probs=169.1
Q ss_pred cccccCcEEEEEEEEcC-CcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCHHH
Q 003385 608 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 686 (824)
Q Consensus 608 ~LG~G~fg~Vy~a~~~~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 686 (824)
.||+|.||+||.|++.+ ...+|||-+........+.+.+|+.+.++++|.|||+.+|.+.+++..-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999774 45689999987766667788999999999999999999999999999999999999999999
Q ss_pred HhhcccCccccC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecCCcccccCCCCceec
Q 003385 687 HLYGTLTHEQRI--NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSS 763 (824)
Q Consensus 687 ~L~~~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~ 763 (824)
.|+.. ..++ .+.+.-.+.+||++||.|||++ .|||||||-.|+||+. .|.+||+|||.++.... ....+.
T Consensus 662 LLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TE 734 (1226)
T KOG4279|consen 662 LLRSK---WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTE 734 (1226)
T ss_pred HHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccc
Confidence 99643 3334 5667778899999999999998 9999999999999986 48999999999986543 344566
Q ss_pred cccCCCCCcchhccccC--CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 764 IVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 764 ~~~gt~~y~aPE~l~~~--~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
++.||..|||||++..+ .|..++|||||||.+.||.||++||-.
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee
Confidence 77899999999999764 689999999999999999999999964
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=291.80 Aligned_cols=206 Identities=27% Similarity=0.454 Sum_probs=170.1
Q ss_pred HHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcC-CCccceeeceeecCCe
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGR 671 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 671 (824)
...+.+.+.||+|+||.||+|++. .+..||||+++.... ...+.+.+|+++++++. ||||+++++++.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 445667899999999999999753 234799999975432 23456889999999996 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhcccC----------------------------------------------------------
Q 003385 672 SVLVYEFMHNGTLKEHLYGTLT---------------------------------------------------------- 693 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~~---------------------------------------------------------- 693 (824)
.++||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998854210
Q ss_pred ----------------------------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 003385 694 ----------------------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 739 (824)
Q Consensus 694 ----------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~ 739 (824)
....+++..+..++.|++.||.|||+. +|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 012477888899999999999999998 9999999999999999
Q ss_pred CCcEEEEecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 003385 740 HMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNE 808 (824)
Q Consensus 740 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~ 808 (824)
++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 999999999998765332221 1222346788999999999999999999999999999997 99998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=277.01 Aligned_cols=206 Identities=25% Similarity=0.438 Sum_probs=170.6
Q ss_pred HHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCcc-cchhhhHHHHHHhhcCCCccceeeceeecCCeEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 673 (824)
..+.+.+.||+|+||.||+|++. .++.||+|+++..... ..+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45667889999999999999864 2478999998754322 2356888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhccc------------CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 003385 674 LVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 741 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~ 741 (824)
+++||+.+++|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999984321 1123578888899999999999999998 999999999999999999
Q ss_pred cEEEEecCCcccccCCCC-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 742 RAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 742 ~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.+||+|||+++....... .......+++.|+|||.+....++.++|||||||++|||++ |..||.+..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 231 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 231 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999875533221 11222345789999999988889999999999999999998 888987644
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=276.68 Aligned_cols=208 Identities=25% Similarity=0.454 Sum_probs=170.6
Q ss_pred HHHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCe
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 671 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 671 (824)
....+.+.+.||+|+||.||+|.++ .+..||+|+++... .....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3455677899999999999999764 24679999986432 2234568899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhcccCc------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 003385 672 SVLVYEFMHNGTLKEHLYGTLTH------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 745 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~~~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL 745 (824)
.++||||+++++|.+++...... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 99999999999999988542211 23457788899999999999999998 9999999999999999999999
Q ss_pred EecCCcccccCCCCce-eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 746 SDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 746 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
+|||+++......... .....++..|+|||.+....++.++|||||||++|||++ |..||.+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~ 226 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999987543322211 112235778999999998899999999999999999999 788987644
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=273.24 Aligned_cols=200 Identities=22% Similarity=0.375 Sum_probs=170.3
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
...|.+.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++++++||||+++++.+...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 345677899999999999999864 6788999998755444455678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999998742 34578889999999999999999998 99999999999999999999999999987653322
Q ss_pred CceeccccCCCCCcchhccc---cCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 759 SHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
. ......|+..|+|||.+. ...++.++|+||+||++|||++|+.||..
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~ 211 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 1 122345889999999885 34577899999999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=271.86 Aligned_cols=200 Identities=28% Similarity=0.440 Sum_probs=169.5
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc-----cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
+.+.+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|++++++++||||+++++++.+.+..++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 456789999999999999864 6899999988643211 2346788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++++|.+.+.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+++....
T Consensus 84 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 84 EYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999998843 34577888899999999999999998 999999999999999999999999999875433
Q ss_pred CCCcee--ccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 757 GASHVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 757 ~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
...... ....++..|+|||.+.+..++.++||||+||++|||++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 211 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE 211 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc
Confidence 211111 23457889999999999889999999999999999999999997643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=282.87 Aligned_cols=203 Identities=26% Similarity=0.446 Sum_probs=168.2
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCc----EEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~----~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 673 (824)
...+.+.+.||+|+||.||+|++. +++ .||+|+++... ....+++.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 345667789999999999999864 333 38999987543 23356788999999999999999999998765 467
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+++||+.+|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999988643 34577888899999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCcee-ccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 754 AVDGASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 754 ~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
......... ....++..|+|||.+....++.++|||||||++|||++ |+.||.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 543322211 12234678999999999999999999999999999997 999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=290.38 Aligned_cols=205 Identities=27% Similarity=0.475 Sum_probs=178.1
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
.|.+.+.||+|.|++|.+|++. .+.+||||++.+.... ..+.+.+|+++|+.++|||||+++.+.+.+..+++||||
T Consensus 57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey 136 (596)
T KOG0586|consen 57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY 136 (596)
T ss_pred ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence 3556789999999999999876 6899999999765332 234588999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+.+|.+.+++..+ .+..+..+..++.|+.+|++|||++ .|||||||++|||++.+..+||+|||++..+..
T Consensus 137 a~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-- 207 (596)
T KOG0586|consen 137 ASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY-- 207 (596)
T ss_pred ccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc--
Confidence 9999999999543 3445577888999999999999998 999999999999999999999999999987753
Q ss_pred CceeccccCCCCCcchhccccCCCC-chHHHHHHHHHHHHHHcCCCCCCCCccccchh
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCR 815 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~ 815 (824)
.......+|++.|.|||++.+..|. +.+|+||+|+++|-|++|..||++....+...
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~ 265 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP 265 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc
Confidence 3455678899999999999988765 68999999999999999999999877554433
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=269.36 Aligned_cols=197 Identities=30% Similarity=0.490 Sum_probs=167.5
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCCcc-cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCHH
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 685 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 685 (824)
+.||+|+||.||+|...+++.+|+|+++..... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 468999999999999888899999998754322 2346889999999999999999999999999999999999999999
Q ss_pred HHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceeccc
Q 003385 686 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 765 (824)
Q Consensus 686 ~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 765 (824)
+++... ...+++..+..++.|++.+|.|||++ +++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 988532 33578889999999999999999998 999999999999999999999999999875433222222223
Q ss_pred cCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 766 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 766 ~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.++..|+|||++.+..++.++|||||||++||+++ |..||.+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~ 199 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT 199 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence 34678999999998899999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=287.67 Aligned_cols=197 Identities=27% Similarity=0.364 Sum_probs=164.1
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecC------Ce
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GR 671 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~ 671 (824)
..|.+.+.||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 45667789999999999999875 68899999986432 22345677899999999999999999988643 35
Q ss_pred EEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003385 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla 751 (824)
.++||||+++ +|.+.+. ..++...+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 101 VYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 7999999975 5555552 2367778888999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 171 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 171 RTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred cccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 7543221 2233458999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=287.72 Aligned_cols=204 Identities=25% Similarity=0.326 Sum_probs=167.6
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecC------Ce
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GR 671 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~ 671 (824)
.+|.+.+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 35667789999999999999865 58889999987532 22345677899999999999999999987543 35
Q ss_pred EEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003385 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla 751 (824)
.++||||+++ +|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred EEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 7999999975 6666653 2367778889999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhc
Q 003385 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 816 (824)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~ 816 (824)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+...+
T Consensus 174 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 236 (364)
T cd07875 174 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 236 (364)
T ss_pred cccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 7653321 22334589999999999999999999999999999999999999987654433333
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=271.74 Aligned_cols=199 Identities=24% Similarity=0.381 Sum_probs=170.6
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
..+.+.+.||+|+||.||+|+.. +++.||+|+++.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 35667789999999999999865 68899999987654444456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|.+++.. ...+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 99999998742 34678899999999999999999998 999999999999999999999999999875433221
Q ss_pred ceeccccCCCCCcchhccc---cCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 760 HVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~---~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
......|+..|+|||++. ...++.++|+||+||++|||++|+.||..
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~ 211 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence 223345899999999875 45688899999999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=270.28 Aligned_cols=200 Identities=27% Similarity=0.456 Sum_probs=172.5
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccC--CcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.+.+.||+|++|.||+|..+ +++.|++|.+... .....+.+.+|++++++++||||+++++.+.+.+..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 45678999999999999876 6889999998643 22345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 83 NGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 99999998643 235678889999999999999999998 9999999999999999999999999998765443222
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....|++.|+|||++.+..++.++|+|||||+++||++|+.||....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 233458899999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=277.80 Aligned_cols=205 Identities=29% Similarity=0.548 Sum_probs=172.7
Q ss_pred HHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 674 (824)
..+.+.+.||+|+||.||+|++. ++..+++|.++.......+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 34556789999999999999753 345689999876555555678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcccC------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 003385 675 VYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 742 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~ 742 (824)
||||+++++|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999854321 224578999999999999999999998 9999999999999999999
Q ss_pred EEEEecCCcccccCCCC-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 003385 743 AKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNE 808 (824)
Q Consensus 743 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~ 808 (824)
+||+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999875433221 12233446789999999999999999999999999999998 99998553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=272.81 Aligned_cols=201 Identities=26% Similarity=0.397 Sum_probs=170.6
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++.+...+..++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3567788999999999999876 477889999876554455678889999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|..++.. ....+++..+..++.|+++||.|||+. +++||||||+||+++.++++||+|||++....... .
T Consensus 86 ~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~ 158 (282)
T cd06643 86 GGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 158 (282)
T ss_pred CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-c
Confidence 9999887743 234688899999999999999999998 99999999999999999999999999987543322 1
Q ss_pred eeccccCCCCCcchhccc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......++..|+|||++. ...++.++||||+||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 223345899999999984 3457789999999999999999999997543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=276.42 Aligned_cols=209 Identities=25% Similarity=0.404 Sum_probs=167.7
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--cchhhhHHHHHHhhc---CCCccceeeceeec-----CCe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRI---HHRNLVQFLGYCQE-----EGR 671 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~-----~~~ 671 (824)
|.+.+.||+|+||+||+|+++ +++.||+|.++..... ....+.+|+++++++ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 456788999999999999876 6889999998754222 123456777777665 69999999998754 345
Q ss_pred EEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003385 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla 751 (824)
.+++|||+.+ +|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred EEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 7899999974 888877532 234578999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
+...... ......||..|+|||++.+..++.++||||+||++|||++|++||.+....+...++.+
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~ 221 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 221 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHH
Confidence 7653321 12234578999999999988999999999999999999999999987654444444433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=270.08 Aligned_cols=202 Identities=26% Similarity=0.410 Sum_probs=173.7
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++|+||+++++.+.+.+..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 456789999999999999877 78999999886422 22245788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++++|.+++.........+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999998865444456688999999999999999999998 99999999999999999999999999987553322
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.. .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||...
T Consensus 161 ~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred cc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 21 22345888999999999888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=272.21 Aligned_cols=202 Identities=25% Similarity=0.401 Sum_probs=171.4
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|+||.||+|+.+ +++.||||.++... ......+.+|++++++++||||+++++++.+.+..++++||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 456789999999999999865 78999999876432 22234678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++++|.+++.........+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999988854333345578888999999999999999998 99999999999999999999999999987654322
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
. ......|++.|+|||.+.+..++.++|+||+|+++|||++|+.||...
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 161 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred H-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 1 112345888999999999888999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=276.19 Aligned_cols=205 Identities=29% Similarity=0.499 Sum_probs=170.0
Q ss_pred HHHhhccccccCcEEEEEEEE-----cCCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~-----~~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
.+.+.+.||+|+||.||+|.. ..++.+|+|.++... ......+.+|++++++++||||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 445678999999999999975 245789999987432 22335788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcccC-------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 003385 676 YEFMHNGTLKEHLYGTLT-------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 742 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~ 742 (824)
|||+.+++|.+++..... ....+++.+.+.++.|++.||+|||++ +++||||||+|||+++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCc
Confidence 999999999998853211 123478888999999999999999998 9999999999999999999
Q ss_pred EEEEecCCcccccCCCC-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 743 AKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 743 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999976543221 12233345678999999988889999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=271.20 Aligned_cols=203 Identities=28% Similarity=0.490 Sum_probs=170.0
Q ss_pred HHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
...+.+.++||+|++|.||+|....+..+|+|.+.... ...+.+.+|++++++++|||++++++++.. +..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 34566778999999999999998877789999886443 234568889999999999999999998754 5678999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
.+++|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 999999998543 234578889999999999999999998 999999999999999999999999999876543322
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+..
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 208 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV 208 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 22222335678999999988899999999999999999999 999997644
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=283.73 Aligned_cols=208 Identities=28% Similarity=0.463 Sum_probs=170.1
Q ss_pred HHHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCc-ccchhhhHHHHHHhhc-CCCccceeeceeec-C
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQE-E 669 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-~ 669 (824)
...++.+.+.||+|+||.||+|... .++.||+|+++.... ...+.+.+|+++++++ +|+||+++++++.. .
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 4557888999999999999999643 347899999874322 2235677899999999 89999999998764 4
Q ss_pred CeEEEEEEecCCCCHHHHhhcccC--------------------------------------------------------
Q 003385 670 GRSVLVYEFMHNGTLKEHLYGTLT-------------------------------------------------------- 693 (824)
Q Consensus 670 ~~~~lV~E~~~~gsL~~~L~~~~~-------------------------------------------------------- 693 (824)
...+++|||+++++|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 568899999999999998853211
Q ss_pred -ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc-eeccccCCCCC
Q 003385 694 -HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGY 771 (824)
Q Consensus 694 -~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y 771 (824)
....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++........ ......++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 013678999999999999999999998 9999999999999999999999999999865432222 12233456789
Q ss_pred cchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 772 LDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 772 ~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~ 280 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=272.36 Aligned_cols=202 Identities=29% Similarity=0.506 Sum_probs=170.1
Q ss_pred HHHhhccccccCcEEEEEEEEcC----CcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~----g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
.+.+.+.||+|+||.||+|.++. ...||||+++.... .....+.+|+.++++++||||+++++++.+.+..+++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence 45567899999999999998752 35799999875432 23456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 85 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 85 EYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999998542 23678999999999999999999998 999999999999999999999999999986642
Q ss_pred CCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 757 GASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 757 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.... ......++..|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~ 213 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence 2221 1222335678999999998999999999999999999998 999986533
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=286.67 Aligned_cols=199 Identities=25% Similarity=0.339 Sum_probs=165.2
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecC------Ce
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GR 671 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~ 671 (824)
.+|.+.+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 35667789999999999999865 68899999986532 22345677899999999999999999987543 35
Q ss_pred EEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003385 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla 751 (824)
.++||||+++ ++.+.+. ..+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 97 ~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred eEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccc
Confidence 6899999975 5666552 2367788889999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 224 (355)
T cd07874 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224 (355)
T ss_pred ccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 754332 1223346899999999999999999999999999999999999999876533
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=271.07 Aligned_cols=198 Identities=35% Similarity=0.575 Sum_probs=171.5
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccch--hhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKR--EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~--~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|++.+.||+|+||+||+++.. +++.+|+|++......... ...+|+.++++++||||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 346789999999999999987 4568999999866433222 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
.+++|.+++. ....+++..+..++.|+++||.+||+. +|+||||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN 152 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred cccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence 9999999985 356678999999999999999999998 999999999999999999999999999875422 22
Q ss_pred ceeccccCCCCCcchhccc-cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 760 HVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~-~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.......++..|+|||.+. ...++.++||||+|+++++|++|..||...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2334456899999999998 788999999999999999999999999876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=284.64 Aligned_cols=205 Identities=27% Similarity=0.472 Sum_probs=178.4
Q ss_pred HHHHHHHhhccccccCcEEEEEEEEc---CCc--EEEEEEeccC-CcccchhhhHHHHHHhhcCCCccceeeceeecCCe
Q 003385 598 IEDATKMLEKKIGSGGFGVVYYGKLK---DGK--EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 671 (824)
Q Consensus 598 ~~~~~~~i~~~LG~G~fg~Vy~a~~~---~g~--~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 671 (824)
+.+....+.++||+|-||.||+|... .|+ .||||..+.+ ...+.+.|.+|..+|++++||+|++++|+|.+. .
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence 34445556789999999999999753 333 4788988864 445577899999999999999999999999765 6
Q ss_pred EEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003385 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla 751 (824)
.+||||.+.-|.|..+|... ...++......++.||+.||.|||+. .+|||||..+|||+.+...+||+|||++
T Consensus 465 ~WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred eeEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence 79999999999999999643 45688888889999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
+...+..........-+..|||||.+.-++++.++|||-|||.|||++. |..||.+.+
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk 597 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK 597 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc
Confidence 9988877666665566789999999999999999999999999999887 999998754
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=283.24 Aligned_cols=196 Identities=26% Similarity=0.389 Sum_probs=164.2
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecC------CeE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS 672 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~~ 672 (824)
+|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++... ...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 5667789999999999999865 678999999865321 2345577899999999999999999987543 356
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
++++|++ +++|.+.+. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 96 ~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 96 YLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred EEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccce
Confidence 8999988 678887763 34588899999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+...
T Consensus 167 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 221 (343)
T cd07878 167 QADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY 221 (343)
T ss_pred ecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 65322 223458999999999876 5688999999999999999999999987553
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=277.30 Aligned_cols=199 Identities=26% Similarity=0.429 Sum_probs=172.6
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
+|.+.+.||+|++|.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++.+......++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 4556688999999999999864 688999999876655556678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|.+++.. ..+++.++..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 101 ~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 101 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 9999998842 3467888999999999999999998 9999999999999999999999999998754332221
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 173 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred -cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 223458899999999998889999999999999999999999997644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=274.01 Aligned_cols=206 Identities=29% Similarity=0.513 Sum_probs=171.7
Q ss_pred HHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 673 (824)
+..+.+.++||+|+||.||++... ++..+|+|.++.........+.+|++++++++|+||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 344556789999999999999642 35678999887655555667999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcccC-----------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 003385 674 LVYEFMHNGTLKEHLYGTLT-----------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 742 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~ 742 (824)
++|||+.+++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 99999999999999854321 113578899999999999999999998 9999999999999999999
Q ss_pred EEEEecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 003385 743 AKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNE 808 (824)
Q Consensus 743 vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~ 808 (824)
+||+|||+++........ ......+++.|+|||++....++.++|||||||++|||++ |..||...
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 228 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence 999999998754332211 1222335688999999999999999999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=270.95 Aligned_cols=200 Identities=28% Similarity=0.380 Sum_probs=160.6
Q ss_pred ccccccCcEEEEEEEEcC---CcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCC
Q 003385 607 KKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~---g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 682 (824)
+.||+|+||.||+|+..+ ...+|+|.+..... .....+.+|++.++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997543 34678887754322 22456788999999999999999999999999999999999999
Q ss_pred CHHHHhhcccC-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc-
Q 003385 683 TLKEHLYGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH- 760 (824)
Q Consensus 683 sL~~~L~~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~- 760 (824)
+|.+++..... .....++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865422 123346777889999999999999998 9999999999999999999999999998653322111
Q ss_pred eeccccCCCCCcchhcccc-------CCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~-------~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
......++..|+|||++.. ..++.++|||||||++|||++ |..||....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS 214 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 1122345778999998753 356789999999999999999 888987654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=274.85 Aligned_cols=211 Identities=27% Similarity=0.369 Sum_probs=177.8
Q ss_pred HHHHhhccccccCcEEEEEEEEcC-CcEEEEEEeccCCcccc---hhhhHHHHHHhhc-CCCccceeeceeecCCeEEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGK---REFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~-g~~vAVK~l~~~~~~~~---~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 675 (824)
...++...||+|+||.|-+|..+. .+.+|||+++++..-.. +.-..|-++|... +-|.+++++..|...++++.|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 345678899999999999998763 56689999987743322 2334566676655 468999999999999999999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
|||+.||+|--++ ++-.++.+..+.-+|.+|+.||-+||++ ||+.||||..|||++.+|++||+|||+++.-.
T Consensus 429 MEyvnGGDLMyhi----QQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHI----QQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEecCchhhhHH----HHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999998877 3455677778888999999999999998 99999999999999999999999999987432
Q ss_pred CCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
- ....+.++|||+.|+|||.+..+.|+.++|.||+||+||||+.|++||++++-.+.++.|.+
T Consensus 502 ~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e 564 (683)
T KOG0696|consen 502 F-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME 564 (683)
T ss_pred c-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 2 23455678999999999999999999999999999999999999999999886666666654
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=273.91 Aligned_cols=208 Identities=26% Similarity=0.452 Sum_probs=172.9
Q ss_pred HHHHHHhhccccccCcEEEEEEEEcC------CcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCe
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 671 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~~------g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 671 (824)
....+.+.+.||+|+||.||+|..+. ++.||+|.+..... .....+.+|+++++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 34456677899999999999997652 36899999865432 234568889999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhcccCc------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 003385 672 SVLVYEFMHNGTLKEHLYGTLTH------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 745 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~~~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL 745 (824)
.++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 99999999999999998653321 23467888999999999999999998 9999999999999999999999
Q ss_pred EecCCcccccCCCC-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 746 SDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 746 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
+|||+++....... .......++..|+|||.+....++.++|||||||++||+++ |+.||.+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 99999876543322 12223346789999999988889999999999999999998 999997544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=275.22 Aligned_cols=196 Identities=30% Similarity=0.456 Sum_probs=171.3
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|++|.||++.+. +++.+|+|+++.... ...+.+.+|++++++++||||+++++.+.+.+..++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 456789999999999999876 588999999864322 2245688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++++|.+++.. ...++...+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 83 VPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999998843 35688889999999999999999998 9999999999999999999999999998765433
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....+++.|+|||.+....++.++||||||+++|+|++|+.||....
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 233458899999999988888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=272.07 Aligned_cols=202 Identities=26% Similarity=0.383 Sum_probs=172.6
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
..|.+.+.||+|+||.||+|.++ +++.+|+|+++.......+.+.+|++++++++||||+++++.+......++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 34778889999999999999875 68899999987655555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 85 DGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999988532 34588899999999999999999998 999999999999999999999999998865433222
Q ss_pred ceeccccCCCCCcchhccc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......++..|+|||.+. ...++.++|+|||||++|||++|+.||....
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence 223345889999999975 3456779999999999999999999997643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=272.70 Aligned_cols=201 Identities=26% Similarity=0.416 Sum_probs=170.9
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
..|++.+.||+|+||.||+|++. +++.+++|++........+.+.+|++++++++||||+++++.+...+..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45677889999999999999876 48899999997665555667889999999999999999999999899999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|..++... ...+++..+..++.|++.+|.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 999998876432 34578899999999999999999998 999999999999999999999999998865433221
Q ss_pred ceeccccCCCCCcchhccc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 760 HVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
......+++.|+|||++. ...++.++|+|||||++|||++|+.||...
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 122345788999999985 345678999999999999999999999653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=275.52 Aligned_cols=202 Identities=25% Similarity=0.391 Sum_probs=167.9
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.|.+.++||+|+||.||+|+.+ +++.||+|.++.... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 3556789999999999999876 578899999864432 22345778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
. ++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 87 ~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 87 D-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred c-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 7 5888877432 34577888999999999999999998 999999999999999999999999999875433221
Q ss_pred ceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 760 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
. .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..
T Consensus 160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~ 211 (301)
T cd07873 160 T-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE 211 (301)
T ss_pred c-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 1 122346889999998865 45788999999999999999999999876543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=270.92 Aligned_cols=204 Identities=26% Similarity=0.475 Sum_probs=172.2
Q ss_pred HHHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
...++.+.++||+|+||.||+|...++..+|+|.++... ...+.+.+|++++++++|+||+++.+.+.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 345667789999999999999998888889999886543 234678899999999999999999999877 678999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999998543 234577888899999999999999998 99999999999999999999999999987654332
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
........++..|+|||++....++.++|+|||||++|++++ |+.||.+..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 208 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence 222222335678999999998889999999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=267.55 Aligned_cols=197 Identities=31% Similarity=0.528 Sum_probs=165.0
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCH
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 684 (824)
+.||+|+||.||+|+++ +++.+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999875 68899999876432 23346688999999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce-ec
Q 003385 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SS 763 (824)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~ 763 (824)
.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......... ..
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9988532 34578889999999999999999998 99999999999999999999999999987543221111 11
Q ss_pred cccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 764 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 764 ~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
....+..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~ 201 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS 201 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 1123457999999998899999999999999999998 999986533
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=285.00 Aligned_cols=209 Identities=30% Similarity=0.502 Sum_probs=180.0
Q ss_pred HHHHHHHHhhccccccCcEEEEEEEEcC-CcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 597 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 597 ~~~~~~~~i~~~LG~G~fg~Vy~a~~~~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
+.++......++||-|.||.||.|.|+. .-.||||.++.+. ...++|..|+.+|+.++|||+|+++|+|..+...|||
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 3444444457899999999999999874 5679999998654 3468899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
+|||..|+|.++|+.. ....++..-.+.|+.||..||+||..+ ++|||||.++||||.++..+|++|||+++.+.
T Consensus 342 TEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 9999999999999764 234466777889999999999999998 99999999999999999999999999999876
Q ss_pred CCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCccc
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG 811 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~ 811 (824)
.+.........-++.|.|||.+....++.|+|||+|||+|||+.| |..||.+.+.+
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS 473 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 473 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH
Confidence 654444343445789999999999999999999999999999998 99999875533
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=271.04 Aligned_cols=191 Identities=29% Similarity=0.417 Sum_probs=165.3
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
+.+.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++.+...+..++||||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 346688999999999999864 68899999986542 2234568899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 83 GGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 99986542 356778889999999999999998 99999999999999999999999999987553321
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
.....|+..|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 2234689999999999999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=274.21 Aligned_cols=199 Identities=26% Similarity=0.423 Sum_probs=173.3
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
..|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 45667789999999999999864 78999999997655555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999998742 3467888999999999999999998 999999999999999999999999999875543322
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
. .....+++.|+|||.+.+..++.++|+|||||++|++++|+.||.+.
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~ 218 (297)
T cd06656 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (297)
T ss_pred C-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 22345889999999999988999999999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=270.33 Aligned_cols=203 Identities=31% Similarity=0.489 Sum_probs=167.0
Q ss_pred HhhccccccCcEEEEEEEEcC----CcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCe------
Q 003385 604 MLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR------ 671 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~~----g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~------ 671 (824)
.+.+.||+|+||.||+|.+.. +..||+|+++.... .....+.+|++.++.++||||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 457889999999999998652 36799999875422 223568899999999999999999998865544
Q ss_pred EEEEEEecCCCCHHHHhhccc--CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003385 672 SVLVYEFMHNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFG 749 (824)
.++++||+++|+|..++.... .....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence 689999999999999885432 1234688899999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCce-eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 750 LSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 750 la~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
+++......... .....++..|+|||.+....++.++|||||||++|||++ |..||.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~ 220 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 988654332221 122235678999999988899999999999999999999 999997654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=268.92 Aligned_cols=203 Identities=24% Similarity=0.399 Sum_probs=173.0
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
.|.+.+.||+|++|.||+|+.+ +++.+|||.+..... ....++.+|+++++.++||||+++++++.+.+..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 3556789999999999999864 789999998764322 223568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+++++|.+++.........+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999998864333455688999999999999999999998 9999999999999999999999999998755332
Q ss_pred CCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.. ......|+..|+|||.+.+..++.++|+||||+++|||++|..||.+.
T Consensus 160 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred Cc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 21 122345889999999999888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=266.27 Aligned_cols=200 Identities=35% Similarity=0.579 Sum_probs=171.9
Q ss_pred ccccccCcEEEEEEEEcC----CcEEEEEEeccCCccc-chhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~----g~~vAVK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.||+|+||.||+|.... +..|++|+++...... .+.+.+|++.++.++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998764 7889999997654332 56788999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCc-----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 682 GTLKEHLYGTLTH-----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 682 gsL~~~L~~~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
++|.+++...... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999998654211 46789999999999999999999998 999999999999999999999999999986544
Q ss_pred CCC-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 757 GAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 757 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
... .......++..|+|||.+....++.++||||+||++|||++ |..||....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 212 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence 321 12233457889999999988889999999999999999999 699997654
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=294.87 Aligned_cols=197 Identities=21% Similarity=0.322 Sum_probs=160.4
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCC------CccceeeceeecC-CeE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH------RNLVQFLGYCQEE-GRS 672 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~~~~~-~~~ 672 (824)
..|.+.++||+|+||+||+|.+. .++.||||+++... ...+.+..|+++++.++| ++++++++++... ...
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 45667889999999999999875 57889999996432 223456678888877765 4588888888654 578
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-----------
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----------- 741 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~----------- 741 (824)
++|||++ +++|.+++.. ...+++..+..++.||+.||+|||++ .+|+||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred EEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccccccccc
Confidence 8999988 6788887743 34688899999999999999999973 2999999999999998765
Q ss_pred -----cEEEEecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 742 -----RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 742 -----~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||++..
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred CCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998754321 2234569999999999999999999999999999999999999998755
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=270.84 Aligned_cols=203 Identities=29% Similarity=0.515 Sum_probs=169.5
Q ss_pred HHHHhhccccccCcEEEEEEEEc-C---CcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-D---GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~---g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
..+.+.+.||+|+||.||+|++. + +..+|+|.++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 34567789999999999999864 2 3368999886543 22345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
|||+++++|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999998532 34578899999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCceec--cccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 756 DGASHVSS--IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 756 ~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
........ ...++..|+|||.+....++.++|+|||||++||+++ |+.||.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 43222211 1223568999999998899999999999999999886 999997644
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=267.40 Aligned_cols=195 Identities=30% Similarity=0.514 Sum_probs=162.0
Q ss_pred cccccCcEEEEEEEEc---CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCC
Q 003385 608 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (824)
Q Consensus 608 ~LG~G~fg~Vy~a~~~---~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 683 (824)
.||+|+||.||+|.++ .+..||+|++..... ...+.+.+|++++++++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999764 345799999875432 224568899999999999999999998864 56799999999999
Q ss_pred HHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCcee-
Q 003385 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS- 762 (824)
Q Consensus 684 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~- 762 (824)
|.+++... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++..........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99988532 34678899999999999999999998 999999999999999999999999999875433322111
Q ss_pred -ccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 763 -SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 763 -~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
....++..|+|||.+....++.++|||||||++||+++ |..||.+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 11223578999999988889999999999999999996 999997644
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=270.67 Aligned_cols=201 Identities=27% Similarity=0.395 Sum_probs=167.7
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.+.||+|++|.||+|+++ +++.||+|+++.... ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 345688999999999999876 688999999864322 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
+ ++|.+++... .....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++........
T Consensus 82 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 82 S-MDLKKYLDSL-PKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred C-CCHHHHHhcC-CCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 7 6888877432 2235688999999999999999999998 999999999999999999999999999875433221
Q ss_pred ceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 1222346889999998865 457889999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=267.56 Aligned_cols=197 Identities=29% Similarity=0.486 Sum_probs=168.1
Q ss_pred ccccccCcEEEEEEEEcC--C--cEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLKD--G--KEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~--g--~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.||+|++|.||+|.+.+ + ..||+|.++.... ...+.+.+|++++++++||||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998753 2 3689999987655 456678999999999999999999999988 889999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc-
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH- 760 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~- 760 (824)
++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999865422 4678999999999999999999998 9999999999999999999999999998865442221
Q ss_pred -eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 761 -VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 761 -~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
......++..|+|||.+....++.++|||||||++|||++ |+.||...+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 205 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS 205 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 1122346789999999998999999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=274.88 Aligned_cols=207 Identities=26% Similarity=0.451 Sum_probs=169.7
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-----------------CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccce
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-----------------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQ 661 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-----------------~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~ 661 (824)
...+.+.++||+|+||.||++.+. +...+|+|+++... ......+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 445678899999999999998543 23468999987543 223467889999999999999999
Q ss_pred eeceeecCCeEEEEEEecCCCCHHHHhhcccCc-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 003385 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH-------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 734 (824)
Q Consensus 662 l~~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~N 734 (824)
+++++...+..+++|||+.+++|.+++...... ...+++.++..++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999998643211 23477888999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEecCCcccccCCCCce-eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc--CCCCCCCCc
Q 003385 735 ILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEK 809 (824)
Q Consensus 735 ILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt--G~~Pf~~~~ 809 (824)
||++.++.+||+|||+++......... .....++..|+|||......++.++|||||||++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 999999999999999987553322111 122234678999999888899999999999999999998 778886543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=306.11 Aligned_cols=208 Identities=27% Similarity=0.410 Sum_probs=169.3
Q ss_pred HHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeec--CCeEE
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSV 673 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~ 673 (824)
....|.+.+.||+|+||+||+|++. .++.+|+|++.... ......+..|+.++++++||||+++++++.+ ....+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3345677899999999999999876 56788999886432 2234568899999999999999999998754 45689
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCCEEEcCC---------
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV----PAIIHRDLKSSNILLDKH--------- 740 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~----~gIvHrDLkp~NILl~~~--------- 740 (824)
+||||+++|+|.++|.........+++..++.|+.||+.||.|||+... .+|+||||||+|||++.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999986544445678999999999999999999998521 259999999999999642
Q ss_pred --------CcEEEEecCCcccccCCCCceeccccCCCCCcchhcccc--CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 741 --------MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 741 --------~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
..+||+|||++....... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 348999999997653321 2234568999999999864 45889999999999999999999999753
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=269.27 Aligned_cols=199 Identities=30% Similarity=0.501 Sum_probs=168.6
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCccc---------chhhhHHHHHHhhcCCCccceeeceeecCCeE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---------KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~---------~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 672 (824)
+.+.+.||+|++|.||+|... +++.+|+|.+....... .+.+.+|++++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 446688999999999999865 57899999886543221 14578899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
++++||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||.++
T Consensus 82 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred EEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999998843 34577888889999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCc-----eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 753 FAVDGASH-----VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 753 ~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
........ ......|+..|+|||.+.+..++.++|+||+||++|+|++|+.||.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 65421111 112234788999999999888999999999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=276.97 Aligned_cols=207 Identities=29% Similarity=0.491 Sum_probs=170.7
Q ss_pred HHHHHhhccccccCcEEEEEEEEc--------CCcEEEEEEeccCC-cccchhhhHHHHHHhhc-CCCccceeeceeecC
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE 669 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~--------~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 669 (824)
...+.+.+.||+|+||.||+|++. ....+|+|+++... .....++.+|+++++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 456778899999999999999753 23469999987542 22345688899999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhcccC------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 003385 670 GRSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 737 (824)
Q Consensus 670 ~~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl 737 (824)
+..++||||+.+|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999865321 234588899999999999999999998 99999999999999
Q ss_pred cCCCcEEEEecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 738 DKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 738 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
+.++.+||+|||.++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 99999999999998755322111 1111224568999999998889999999999999999998 889987644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=273.75 Aligned_cols=195 Identities=29% Similarity=0.462 Sum_probs=169.0
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCH
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 684 (824)
...||+|+||.||++... +++.||||.+........+.+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 357999999999999865 6889999998755444556788999999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceecc
Q 003385 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (824)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (824)
.+++. ...+++..+..++.||+.||.|||++ +|+||||||+||++++++.+||+|||++........ ....
T Consensus 107 ~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 177 (292)
T cd06658 107 TDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKS 177 (292)
T ss_pred HHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCce
Confidence 98873 23478889999999999999999998 999999999999999999999999999865433222 1223
Q ss_pred ccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 765 ~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
..|+..|+|||.+.+..++.++||||+||++|||++|+.||....
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 458899999999988889999999999999999999999997644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=269.06 Aligned_cols=202 Identities=31% Similarity=0.514 Sum_probs=164.1
Q ss_pred hhccccccCcEEEEEEEEcCCc---EEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecC------CeEE
Q 003385 605 LEKKIGSGGFGVVYYGKLKDGK---EIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSV 673 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~~g~---~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~~~ 673 (824)
+++.||+|+||.||+|++.+.. .+|+|.++... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 5688999999999999876432 58999886532 23345688899999999999999999987432 2468
Q ss_pred EEEEecCCCCHHHHhhcc-cC-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003385 674 LVYEFMHNGTLKEHLYGT-LT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~-~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla 751 (824)
++|||+.+|+|.+++... .. ....+++.....++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 999999999999887322 21 234578899999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCce-eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 752 KFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 752 ~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
+......... .....+++.|+|||.+....++.++|||||||++|||++ |+.||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 219 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE 219 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 8654332211 122346778999999999999999999999999999999 899997643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=266.90 Aligned_cols=193 Identities=31% Similarity=0.500 Sum_probs=161.8
Q ss_pred cccccCcEEEEEEEEc---CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCC
Q 003385 608 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (824)
Q Consensus 608 ~LG~G~fg~Vy~a~~~---~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 682 (824)
+||+|+||.||+|.++ +++.+|+|+++.... ...+++.+|+.++++++||||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999753 578899999864432 234578899999999999999999998864 4678999999999
Q ss_pred CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCcee
Q 003385 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (824)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (824)
+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||.||++++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99998843 34578889999999999999999998 999999999999999999999999999876543322211
Q ss_pred --ccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 003385 763 --SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNE 808 (824)
Q Consensus 763 --~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~ 808 (824)
....++..|+|||.+....++.++|+|||||++|||++ |+.||.+.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 12234578999999988889999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=269.01 Aligned_cols=200 Identities=29% Similarity=0.403 Sum_probs=162.4
Q ss_pred ccccccCcEEEEEEEEcC---CcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCC
Q 003385 607 KKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~---g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 682 (824)
+.||+|+||.||+|.+.+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998653 45789998875432 23456888999999999999999999999888999999999999
Q ss_pred CHHHHhhcccC-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc-
Q 003385 683 TLKEHLYGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH- 760 (824)
Q Consensus 683 sL~~~L~~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~- 760 (824)
+|.+++..... .....++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999864322 223456777788999999999999998 9999999999999999999999999998754332211
Q ss_pred eeccccCCCCCcchhccccC-------CCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQ-------QLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~-------~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
......++..|+|||++... .++.++|||||||++|||++ |+.||....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 214 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS 214 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 11234577889999998642 35789999999999999996 999997543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=267.69 Aligned_cols=201 Identities=23% Similarity=0.386 Sum_probs=171.9
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
|.+.+.||+|+||.||+++.. +++.+|+|.++... ....+.+.+|+.++++++||||+++++.+.+.+..+++|||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 346789999999999999876 68899999986432 2334667889999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|.+++... ....++...+..++.|++.||.|||++ +|+|+||||+||++++++.++|+|||.++.......
T Consensus 82 ~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 82 GGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 99999887532 234577888899999999999999998 999999999999999999999999999875543222
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......|++.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 2233458899999999998899999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=274.85 Aligned_cols=197 Identities=24% Similarity=0.382 Sum_probs=158.5
Q ss_pred hccccccCcEEEEEEEEc---CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceee--cCCeEEEEEEecC
Q 003385 606 EKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ--EEGRSVLVYEFMH 680 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~---~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lV~E~~~ 680 (824)
+.+||+|+||.||+|+.+ +++.||+|.++... ....+.+|++++++++||||+++++++. .....++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 367999999999999875 35789999886432 2345778999999999999999999884 3567789999987
Q ss_pred CCCHHHHhhccc-----CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEEecCCc
Q 003385 681 NGTLKEHLYGTL-----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLS 751 (824)
Q Consensus 681 ~gsL~~~L~~~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl----~~~~~vkL~DFGla 751 (824)
+ +|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 6777663211 1223578888999999999999999998 99999999999999 45678999999999
Q ss_pred ccccCCCCc--eeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 752 KFAVDGASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 752 ~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
+........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 865433221 1223458999999999876 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=272.80 Aligned_cols=206 Identities=25% Similarity=0.452 Sum_probs=168.4
Q ss_pred HHHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCe
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 671 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 671 (824)
...++.+.+.||+|+||.||+|..+ .+..||+|.++... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3456778899999999999999754 24579999876432 2223457889999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhcccC------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 003385 672 SVLVYEFMHNGTLKEHLYGTLT------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 745 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL 745 (824)
.++||||+.+|+|.+++..... ......+..+..++.|++.||.|||++ +|+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999854211 123346677888999999999999998 9999999999999999999999
Q ss_pred EecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003385 746 SDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISN 807 (824)
Q Consensus 746 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~ 807 (824)
+|||+++........ ......++..|+|||.+....++.++|||||||++|||++ |..||.+
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~ 224 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG 224 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999998754332211 1122235678999999998899999999999999999998 7889865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=275.28 Aligned_cols=209 Identities=26% Similarity=0.487 Sum_probs=172.4
Q ss_pred HHHHHHHhhccccccCcEEEEEEEEc--------CCcEEEEEEeccCC-cccchhhhHHHHHHhhc-CCCccceeeceee
Q 003385 598 IEDATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQ 667 (824)
Q Consensus 598 ~~~~~~~i~~~LG~G~fg~Vy~a~~~--------~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 667 (824)
+....+.+.+.||+|+||.||+|++. ++..||+|.++... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44556667899999999999999742 24579999886442 23346788999999999 8999999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHhhcccC------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 003385 668 EEGRSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 735 (824)
Q Consensus 668 ~~~~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NI 735 (824)
.....+++|||+.+|+|.+++..... ....+++..+..++.|++.||.|||++ +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 99999999999999999999864321 234578888999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 736 LLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 736 Ll~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
+++.++.+||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999998765432221 1222335678999999998889999999999999999998 888887644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=288.65 Aligned_cols=195 Identities=29% Similarity=0.491 Sum_probs=165.5
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEecc----CCcccchhhhHHHHHHhhcCCCccceeeceeecCCe--EEEEE
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTS----NSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR--SVLVY 676 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~----~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--~~lV~ 676 (824)
.+..+||+|+|-+||+|.+. +|.+||.-.++. .+....++|..|+.+|+.|+||||++++..+.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45678999999999999865 577887643321 123334789999999999999999999998876554 67899
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCccccc
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAV 755 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~-~~vkL~DFGla~~~~ 755 (824)
|.+..|+|..+++. .+..+...+..+++||++||.|||++ .|+|+|||||..||+|+.+ |.+||+|+|+|+...
T Consensus 123 EL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999854 45577778899999999999999996 6899999999999999976 999999999998765
Q ss_pred CCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
... . ..+.|||.|||||+.. ..|+..+||||||+.|+||+|+..||..
T Consensus 198 ~s~--a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE 245 (632)
T KOG0584|consen 198 KSH--A-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE 245 (632)
T ss_pred ccc--c-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh
Confidence 432 2 2267999999999887 8999999999999999999999999975
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=283.86 Aligned_cols=210 Identities=25% Similarity=0.461 Sum_probs=171.7
Q ss_pred HHHHHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCcc-cchhhhHHHHHHhhcC-CCccceeeceeec
Q 003385 597 DIEDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIH-HRNLVQFLGYCQE 668 (824)
Q Consensus 597 ~~~~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 668 (824)
++....+.+.+.||+|+||.||+|+++ .++.||+|+++..... ..+.+.+|++++.++. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 344455667899999999999999864 3467999999754322 2346889999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhhcccC-------------------------------------------------------
Q 003385 669 EGRSVLVYEFMHNGTLKEHLYGTLT------------------------------------------------------- 693 (824)
Q Consensus 669 ~~~~~lV~E~~~~gsL~~~L~~~~~------------------------------------------------------- 693 (824)
.+..++||||+.+|+|.++++....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 9999999999999999999854211
Q ss_pred ---------------------------------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 003385 694 ---------------------------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 734 (824)
Q Consensus 694 ---------------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~N 734 (824)
....+++..+..++.|++.||.|||+. +++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence 112467778889999999999999997 99999999999
Q ss_pred EEEcCCCcEEEEecCCcccccCCCC-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 735 ILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 735 ILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
||+++++.+||+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.||....
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999875432211 11122346789999999998889999999999999999998 899997543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=266.09 Aligned_cols=201 Identities=32% Similarity=0.592 Sum_probs=170.4
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
.+.+.+.||+|+||.||+|.+.+++.+|+|+++.... ...++.+|++++++++||||+++++++......++||||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 3456789999999999999988788999998864432 345788999999999999999999999998999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
++|.+++... ...+++..+..++.|++.+|+|||+. +++||||||+||+++.++.+||+|||.++.........
T Consensus 84 ~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 84 GCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999988532 23577888999999999999999998 99999999999999999999999999987554322211
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 206 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 222235678999999998899999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=271.30 Aligned_cols=208 Identities=27% Similarity=0.438 Sum_probs=172.7
Q ss_pred HHHHHHhhccccccCcEEEEEEEEcC-----CcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeec-CCe
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLKD-----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGR 671 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~~-----g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~ 671 (824)
....+.+.+.||+|+||.||+|.+.+ ++.|++|++.... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34556678899999999999998765 6889999887442 2334568889999999999999999998765 467
Q ss_pred EEEEEEecCCCCHHHHhhcccCc----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 003385 672 SVLVYEFMHNGTLKEHLYGTLTH----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 747 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~D 747 (824)
.++++||+.+++|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 88999999999999998543221 25688999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccCCCCce-eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 748 FGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 748 FGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
||+++......... .....++..|+|||++....++.++|||||||++||+++ |+.||....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 224 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID 224 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC
Confidence 99998654433221 122345778999999998899999999999999999999 999997543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=273.18 Aligned_cols=194 Identities=27% Similarity=0.467 Sum_probs=168.5
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCH
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 684 (824)
...||+|+||.||+|..+ +++.||+|++........+.+.+|+.+++.++||||+++++.+..++..++++||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 357999999999999865 6899999998755444456788999999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceecc
Q 003385 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (824)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (824)
.+++. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........ ....
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 176 (297)
T cd06659 106 TDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKS 176 (297)
T ss_pred HHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccc
Confidence 88763 24578889999999999999999998 999999999999999999999999999865433221 2233
Q ss_pred ccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 765 ~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
..|+..|+|||++.+..++.++|||||||+++||++|+.||...
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 220 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 45899999999999888999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=273.84 Aligned_cols=198 Identities=27% Similarity=0.383 Sum_probs=169.4
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
+.+.+.||+|+||.||++.+. ++..+|+|.++... .....++.+|++++++++||||+++++.+.+++..++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 446688999999999999876 57888999886442 2234568889999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|.+++.. ...+++..+..++.|+++||.|||+. .+++||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 83 GGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 9999999853 35578888999999999999999974 289999999999999999999999999986543221
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....|+..|+|||.+.+..++.++|+|||||++|||++|+.||...+
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 233468899999999988889999999999999999999999997544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=274.21 Aligned_cols=207 Identities=27% Similarity=0.458 Sum_probs=169.0
Q ss_pred HHHHHHhhccccccCcEEEEEEEEcC---------------CcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCcccee
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLKD---------------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQF 662 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~~---------------g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l 662 (824)
....+.+.+.||+|+||.||+++..+ ...||+|+++.... .....+.+|++++++++||||+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 34567788999999999999987642 22489999875422 234568899999999999999999
Q ss_pred eceeecCCeEEEEEEecCCCCHHHHhhcccC--------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 003385 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLT--------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 734 (824)
Q Consensus 663 ~~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~--------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~N 734 (824)
++++...+..++||||+.+++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 9999999999999999999999998854211 112467888999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc--CCCCCCCC
Q 003385 735 ILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNE 808 (824)
Q Consensus 735 ILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt--G~~Pf~~~ 808 (824)
|++++++.+||+|||++......... ......++..|+|||.+....++.++|||||||+++||++ |..||...
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 99999999999999998754332211 1122335678999999998899999999999999999988 66788653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=275.56 Aligned_cols=209 Identities=29% Similarity=0.498 Sum_probs=170.9
Q ss_pred HHHHHHHhhccccccCcEEEEEEEEc--------CCcEEEEEEeccCC-cccchhhhHHHHHHhhc-CCCccceeeceee
Q 003385 598 IEDATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQ 667 (824)
Q Consensus 598 ~~~~~~~i~~~LG~G~fg~Vy~a~~~--------~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 667 (824)
+...++.+.+.||+|+||.||+|++. ....+|+|+++... ......+.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 33456668899999999999999752 24568999987542 22345678899999999 6999999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHhhcccC------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 003385 668 EEGRSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 735 (824)
Q Consensus 668 ~~~~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NI 735 (824)
+.+..+++|||+.+|+|.+++..... ....+++.++..++.|++.||.|||++ |++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence 98899999999999999999854321 234588899999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEecCCcccccCCCCce-eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 736 LLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 736 Ll~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
|+++++.+||+|||+++......... .....++..|+|||.+....++.++|||||||++|||++ |..||.+..
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999997654322111 111224568999999998899999999999999999999 899987644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=267.74 Aligned_cols=199 Identities=26% Similarity=0.411 Sum_probs=172.5
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
+|.+.+.||.|++|.||+|+.. +++.||+|++.... ......+.+|+++++.++|+||+++.+.+.+....++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 3556788999999999999876 68899999987543 233456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++.......
T Consensus 82 ~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 82 GGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999998853 2678899999999999999999998 999999999999999999999999999876644322
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......++..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 2233457889999999998889999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=273.15 Aligned_cols=199 Identities=26% Similarity=0.447 Sum_probs=172.8
Q ss_pred HHHhhccccccCcEEEEEEEE-cCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.|.+.+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+++++.++||||+++++.+...+..++|+||+.
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 345668899999999999986 4689999999876554455678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|.+++.. ..+++.++..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 100 ~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 100 GGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 9999998742 3578899999999999999999998 9999999999999999999999999998754433221
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....++..|+|||.+.+..++.++|+|||||++|+|++|+.||.+..
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred -CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 223458899999999998889999999999999999999999997644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=266.85 Aligned_cols=200 Identities=26% Similarity=0.418 Sum_probs=172.6
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.+.+.+.||+|+||.||+|... +++.+++|++........+.+.+|++++++++||||+++++.+.+.+..+++|||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 3556788999999999999875 578899999976555556788999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++........
T Consensus 84 ~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 84 GGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 99999987432 24678889999999999999999998 999999999999999999999999999875543221
Q ss_pred eeccccCCCCCcchhccccC---CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 761 VSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~---~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
......++..|+|||.+... .++.++|+|||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 12234578899999998876 8889999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=270.27 Aligned_cols=206 Identities=30% Similarity=0.476 Sum_probs=168.7
Q ss_pred HHHHhhccccccCcEEEEEEEEcC------CcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~------g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 673 (824)
..+.+.+.||+|++|.||+|.+.+ +..||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 345667899999999999998753 56789998864432 23456889999999999999999999998888899
Q ss_pred EEEEecCCCCHHHHhhcccC---ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEEEe
Q 003385 674 LVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSD 747 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~---~vkL~D 747 (824)
+||||+++++|.+++..... ....+++..++.++.||+.||+|||+. +++||||||+||+++.++ .+||+|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEecc
Confidence 99999999999998854321 123588999999999999999999998 999999999999998654 599999
Q ss_pred cCCcccccCCCCce-eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 748 FGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 748 FGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||.+.+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~ 226 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99987653221111 112223568999999998999999999999999999997 999998754
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=268.76 Aligned_cols=199 Identities=25% Similarity=0.384 Sum_probs=168.3
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|++.+.||+|++|.||+|+++ +++.||+|++..... ...+.+.+|++++++++||||+++++++......++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 455688999999999999876 588999998864321 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
+++.|...+. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 83 DHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred CccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 9988877653 234578999999999999999999997 999999999999999999999999999876543321
Q ss_pred ceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.+..
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1223347889999999875 457889999999999999999999998655
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=268.71 Aligned_cols=202 Identities=31% Similarity=0.552 Sum_probs=168.2
Q ss_pred HHHhhccccccCcEEEEEEEEcC-C---cEEEEEEeccC-CcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKD-G---KEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~-g---~~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
.+.+.+.||+|+||.||+|.+.. + ..||||+++.. .....+++..|+.++++++||||+++.+++.+.+..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 35678899999999999998753 3 35999998754 2233467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++++|.+++... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999988532 34578899999999999999999998 999999999999999999999999999875543
Q ss_pred CCCcee--cccc--CCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 757 GASHVS--SIVR--GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 757 ~~~~~~--~~~~--gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
...... .... .+..|+|||.+....++.++||||+||++||+++ |..||.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 222111 1111 2457999999999999999999999999999886 999997644
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=269.84 Aligned_cols=200 Identities=26% Similarity=0.402 Sum_probs=170.7
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.+.||+|++|.||+|++. +++.||+|++.... ....+.+.+|+.++++++||||+++++++......++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 456788999999999999875 68899999987543 223457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
+++|.+++... ...+++.++..++.|+++||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 82 -~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 82 -PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred -CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 99999988532 25588999999999999999999998 999999999999999999999999999876544332
Q ss_pred ceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.......|+..|+|||.+.+. .++.++||||+||+++||++|.+||.+..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 205 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC
Confidence 223334589999999998654 46889999999999999999988887654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=268.53 Aligned_cols=200 Identities=26% Similarity=0.393 Sum_probs=159.6
Q ss_pred ccccccCcEEEEEEEEcCCc---EEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCC
Q 003385 607 KKIGSGGFGVVYYGKLKDGK---EIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~---~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 682 (824)
++||+|+||.||+|+..++. .+++|.++... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999765433 45666665433 233567889999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC-Cce
Q 003385 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-SHV 761 (824)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~ 761 (824)
+|.+++..........+...+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999865433334566777788999999999999998 99999999999999999999999999875432211 111
Q ss_pred eccccCCCCCcchhcccc-------CCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~-------~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 223457889999998753 245778999999999999997 577886544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=273.35 Aligned_cols=202 Identities=32% Similarity=0.521 Sum_probs=165.5
Q ss_pred HHhhccccccCcEEEEEEEEcC-Cc--EEEEEEeccC-CcccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKD-GK--EIAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~-g~--~vAVK~l~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
+.+.+.||+|+||.||+|..++ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++++|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 4567899999999999998753 33 4788887642 223345788999999999 79999999999999899999999
Q ss_pred ecCCCCHHHHhhcccC------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 003385 678 FMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 745 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL 745 (824)
|+++++|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence 9999999999854321 123578889999999999999999998 9999999999999999999999
Q ss_pred EecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 746 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 746 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
+|||++....... .......+..|+|||++....++.++|||||||++|||++ |..||.+..
T Consensus 161 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~ 223 (297)
T cd05089 161 ADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223 (297)
T ss_pred CCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999986432111 1111223567999999998899999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=272.83 Aligned_cols=207 Identities=28% Similarity=0.480 Sum_probs=171.6
Q ss_pred HHHHHhhccccccCcEEEEEEEEcC-----------------CcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccce
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLKD-----------------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQ 661 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~~-----------------g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~ 661 (824)
...+.+.+.||+|+||.||+|+... +..||+|++..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3456778999999999999997642 24589999875432 33567889999999999999999
Q ss_pred eeceeecCCeEEEEEEecCCCCHHHHhhcccC-------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 003385 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 734 (824)
Q Consensus 662 l~~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~N 734 (824)
+++++...+..++++||+.+++|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999998999999999999999999865431 123688999999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEecCCcccccCCCC-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc--CCCCCCCCc
Q 003385 735 ILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEK 809 (824)
Q Consensus 735 ILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt--G~~Pf~~~~ 809 (824)
|+++.++.++|+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 9999999999999999875433221 12223346788999999998889999999999999999998 778886543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=268.79 Aligned_cols=203 Identities=25% Similarity=0.405 Sum_probs=168.3
Q ss_pred HHHHHhhccccccCcEEEEEEEEcC----CcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~~----g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 674 (824)
...+.+.+.||+|+||.||+|.+.+ ...||||...... ....+.+.+|+.++++++||||+++++++.+. ..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEE
Confidence 3445677899999999999998653 2468999887554 33456788999999999999999999988764 5689
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999998532 23578999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 755 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 755 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
............++..|+|||.+....++.++|||||||+++|+++ |..||.+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 4432222222334568999999988889999999999999999986 999997654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=273.82 Aligned_cols=208 Identities=28% Similarity=0.479 Sum_probs=171.9
Q ss_pred HHHHHHhhccccccCcEEEEEEEEcC------CcEEEEEEeccCCc-ccchhhhHHHHHHhhc-CCCccceeeceeecCC
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG 670 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~~------g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 670 (824)
....+.+.+.||+|+||.||++.+.. ...+|+|+++.... .....+.+|+++++++ +|+||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 33455677899999999999998642 36789999875422 2335688899999999 7999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhccc------------CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~ 738 (824)
..+++|||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 9999999999999999985421 2345688999999999999999999998 999999999999999
Q ss_pred CCCcEEEEecCCcccccCCCCce-eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 739 KHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 739 ~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
+++.+||+|||+++......... .....++..|+|||.+....++.++|||||||++|||++ |..||.+..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 99999999999987654322111 122235678999999998899999999999999999997 999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=266.32 Aligned_cols=200 Identities=27% Similarity=0.455 Sum_probs=166.7
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeeceeecC------CeE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE------GRS 672 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~------~~~ 672 (824)
..|.+.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +||||+++++++... ...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 34566788999999999999875 57889999986543 3345788899999998 699999999998652 467
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
+++|||+.+++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++.
T Consensus 85 ~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 8999999999999988542 234578888999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeccccCCCCCcchhccc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
....... ......|+..|+|||++. ...++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 160 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred ecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 5433221 223456899999999986 34578899999999999999999999964
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=271.27 Aligned_cols=204 Identities=29% Similarity=0.488 Sum_probs=168.9
Q ss_pred HHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
+.+.+.||+|+||.||+|... ....+++|.+..... ...+++.+|+++++.++||||+++++.+...+..+++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 346688999999999999753 235789998865432 2345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccc--------------------CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 003385 676 YEFMHNGTLKEHLYGTL--------------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 735 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~--------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NI 735 (824)
+||+.+++|.+++.... .....+++..++.++.|++.||.|||+. +++||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheE
Confidence 99999999999875321 1124578899999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 736 LLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 736 Ll~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
++++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999998754332221 1223345778999999988899999999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=264.74 Aligned_cols=203 Identities=25% Similarity=0.375 Sum_probs=173.3
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.+.||+|+||.||.++.. +++.+++|.+.... ....+++.+|++++++++|+||+++++++.+.+..+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 445688999999999999754 68899999876432 333466889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|.+++.... ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 82 NGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred CCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999885432 34578889999999999999999998 999999999999999999999999999876543332
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
......+++.|+|||.+.+..++.++|+|||||++|||++|+.||......
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~ 207 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL 207 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH
Confidence 223345899999999998888899999999999999999999999875533
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=269.07 Aligned_cols=202 Identities=27% Similarity=0.371 Sum_probs=172.7
Q ss_pred HHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
....+.+.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++.+...+..++||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 3456677899999999999999865 68889999886543 233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++++|.+++.. ...+++..+..++.|++.+|.|||+. .+++||||||+||++++++.++|+|||++.....
T Consensus 83 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 83 EFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred ecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 99999999988743 34578889999999999999999974 2899999999999999999999999999865422
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.. .....|+..|+|||++.+..++.++|+|||||++||+++|+.||....
T Consensus 157 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 157 SI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred hc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 21 123468999999999988899999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=269.42 Aligned_cols=201 Identities=27% Similarity=0.436 Sum_probs=164.7
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCc----EEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~----~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
.+.+.+.||+|+||+||+|.+. +++ .+++|.+..... ...+++..|+..+++++||||+++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 3446688999999999999874 344 477777753322 223567778888999999999999998864 456889
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
+||+.+|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++...
T Consensus 87 ~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 87 TQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999998532 34578899999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 756 DGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 756 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
..... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||.+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 33222 2223446788999999998899999999999999999998 999997754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=266.97 Aligned_cols=199 Identities=27% Similarity=0.413 Sum_probs=165.2
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-----ccchhhhHHHHHHhhcCCCccceeeceeecC--CeEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVL 674 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~l 674 (824)
+.+.+.||+|+||.||+|..+ +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+. ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 345688999999999999875 588999998853321 1234678899999999999999999988653 46789
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
+|||+++++|.+++.. ...+++.....++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 84 FMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 9999999999998853 23467788889999999999999998 9999999999999999999999999998754
Q ss_pred cCCCC--ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 755 VDGAS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 755 ~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
..... .......|+..|+|||.+....++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 32111 1122345889999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=275.38 Aligned_cols=204 Identities=31% Similarity=0.523 Sum_probs=166.7
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCc--EEEEEEeccCC-cccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGK--EIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~--~vAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 675 (824)
..+.+.+.||+|+||.||+|.++ ++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 34567789999999999999875 454 35777765432 23345788899999999 899999999999999999999
Q ss_pred EEecCCCCHHHHhhcccC------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 003385 676 YEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 743 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~v 743 (824)
|||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 999999999999854321 123578899999999999999999998 99999999999999999999
Q ss_pred EEEecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 744 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 744 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
||+|||+++...... ......++..|+|||.+....++.++|||||||++|||++ |..||.+..
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 999999986322111 1111224668999999988889999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=286.78 Aligned_cols=191 Identities=23% Similarity=0.313 Sum_probs=163.0
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.|.+.+.||+|+||.||+|.+. .++.||||... ...+.+|++++++++||||+++++++...+..++|||++.
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 3556789999999999999876 47889999642 2345689999999999999999999999999999999995
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC-
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS- 759 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~- 759 (824)
++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 244 -~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 244 -SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred -CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 6888877432 24688999999999999999999998 999999999999999999999999999976533221
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 805 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf 805 (824)
.......||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 1223456999999999999999999999999999999999988764
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=267.11 Aligned_cols=198 Identities=31% Similarity=0.531 Sum_probs=162.8
Q ss_pred ccccccCcEEEEEEEEcC-Cc--EEEEEEeccCC-cccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLKD-GK--EIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~-g~--~vAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.||+|+||.||+|++++ +. .+++|.++... ....+.+.+|+++++++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998764 43 46888876432 23345788999999999 799999999999999999999999999
Q ss_pred CCHHHHhhccc------------CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003385 682 GTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (824)
Q Consensus 682 gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFG 749 (824)
|+|.+++.... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999985432 1123578899999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
++...... ........+..|+|||++....++.++|||||||++|||++ |..||.+..
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 216 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC
Confidence 98532211 11111224567999999988899999999999999999997 999997644
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=263.47 Aligned_cols=198 Identities=28% Similarity=0.460 Sum_probs=172.8
Q ss_pred HHHhhccccccCcEEEEEEEEcC-CcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.|.+.+.||+|+||.||+|.+++ ++.+++|.++.... .+.+.+|++++++++||||+++++.+......++++||+.
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 45667889999999999999874 78999999875432 5688999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|.+++... ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 82 AGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999988432 35678999999999999999999998 999999999999999999999999999876544322
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
......++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 223344788999999999889999999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=267.69 Aligned_cols=202 Identities=29% Similarity=0.509 Sum_probs=168.0
Q ss_pred HHHhhccccccCcEEEEEEEEc-CC---cEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DG---KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g---~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
.+...+.||+|+||.||+|..+ ++ ..+|+|.++... ....+.+.+|++++++++||||+++.+++.+.+..++||
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 3445688999999999999875 33 368999886542 233456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.....
T Consensus 86 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 86 EYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999988532 34678889999999999999999998 999999999999999999999999999875543
Q ss_pred CCCcee--ccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 757 GASHVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 757 ~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
...... .....+..|+|||++....++.++|||||||++|||++ |+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~ 215 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 222111 11223457999999998899999999999999999997 999997644
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=267.63 Aligned_cols=198 Identities=25% Similarity=0.411 Sum_probs=169.9
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
..|...+.||+|+||.||+|.+. +++.||+|.++... ....+.+.+|++++++++||||+++++.+...+..++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34556688999999999999865 57889999987443 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++++|.+++.. ..+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 84 LGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 999999988742 4578888999999999999999998 99999999999999999999999999987654322
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
. ......++..|+|||.+.+..++.++|+|||||++|||++|+.||..
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 156 I-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred h-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 1 12234578899999999988999999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=266.09 Aligned_cols=199 Identities=26% Similarity=0.451 Sum_probs=169.3
Q ss_pred HHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCc------ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
|.+.+.||+|+||+||+|...+++.+|+|.++.... ...+.+.+|++++++++|+||+++++++.+.+..++++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 345688999999999999988899999998864321 11245788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++.....
T Consensus 82 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 82 EFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999998843 24577888889999999999999998 999999999999999999999999999875422
Q ss_pred CC-----CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 757 GA-----SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 757 ~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.. ........|+..|+|||++.+..++.++|+||+||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 211 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC
Confidence 11 11122345889999999999888999999999999999999999999753
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=275.04 Aligned_cols=200 Identities=21% Similarity=0.317 Sum_probs=164.5
Q ss_pred hhcccccc--CcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 605 LEKKIGSG--GFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 605 i~~~LG~G--~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
+.++||+| +|++||+++.+ +|+.||+|+++.... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 77899999865 789999999875422 22356778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999885432 23478889999999999999999998 999999999999999999999999986543221110
Q ss_pred ------ceeccccCCCCCcchhcccc--CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 ------HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ------~~~~~~~gt~~y~aPE~l~~--~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 01122346778999999876 468899999999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=272.95 Aligned_cols=202 Identities=27% Similarity=0.341 Sum_probs=171.0
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+++++.++||||+++++.+.+.+..++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 445678999999999999876 4899999998754332 345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+.+++|.+++... ....+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 83 CPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred cCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999988532 235688899999999999999999998 99999999999999999999999999876432211
Q ss_pred Cc----------------------------eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SH----------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~----------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 10 1112357889999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=268.78 Aligned_cols=202 Identities=28% Similarity=0.472 Sum_probs=166.5
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCc----EEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~----~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 674 (824)
..+.+.++||+|+||+||+|++. +++ .||+|+++... ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 34556789999999999999864 444 48999987543 22346788999999999999999999998754 4679
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
++||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 86 ~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 86 VTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999988532 34578899999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCce-eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 755 VDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 755 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 216 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 4322211 111234678999999998899999999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=263.36 Aligned_cols=201 Identities=26% Similarity=0.442 Sum_probs=169.8
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeec-CCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV~E~ 678 (824)
|.+.+.||+|++|.||++..+ +++.+|+|.+.... ....+.+.+|++++++++|+|++++++.+.. ....+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 456789999999999999865 57889999986432 2234568889999999999999999988764 4467899999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++++|.+++... ....+++.++..++.|++.|+++||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 82 CEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999988642 234578999999999999999999998 99999999999999999999999999987653322
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
. ......+++.|+|||++.+..++.++|+||+||+++||++|+.||....
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 2 2233458899999999999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=271.75 Aligned_cols=207 Identities=28% Similarity=0.454 Sum_probs=171.4
Q ss_pred HHHHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCc-ccchhhhHHHHHHhhc-CCCccceeeceeecC
Q 003385 598 IEDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE 669 (824)
Q Consensus 598 ~~~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 669 (824)
+....+.+.+.||+|+||.||+|... .+..||||+++.... ...+.+.+|+++++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 33445667899999999999999742 345799999875432 2245688999999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003385 670 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (824)
Q Consensus 670 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFG 749 (824)
+..+++|||+.+|+|.+++.... ...+++.++..++.|++.||+|||++ +|+|+||||+|||++.++.+||+|||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999885321 23378999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 750 LSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 750 la~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
+++........ ......++..|+|||.+....++.++||||+||++|||++ |..||.+..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 98755432211 1222335778999999998899999999999999999998 999987543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=291.28 Aligned_cols=203 Identities=21% Similarity=0.308 Sum_probs=159.0
Q ss_pred HHHHHHhhccccccCcEEEEEEEEcC--CcEEEEEEe--------------cc---CCcccchhhhHHHHHHhhcCCCcc
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLKD--GKEIAVKVL--------------TS---NSYQGKREFTNEVTLLSRIHHRNL 659 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~~--g~~vAVK~l--------------~~---~~~~~~~~~~~Ei~il~~l~HpnI 659 (824)
....|.+.++||+|+||+||++.++. +...++|.+ .+ ........+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34567788999999999999987542 222222211 00 011123457889999999999999
Q ss_pred ceeeceeecCCeEEEEEEecCCCCHHHHhhcc-cCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 003385 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGT-LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738 (824)
Q Consensus 660 v~l~~~~~~~~~~~lV~E~~~~gsL~~~L~~~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~ 738 (824)
+++++++...+..++|+|++. ++|.+++... ...........+..++.|++.||+|||++ +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999985 5677766432 12222334566778999999999999998 999999999999999
Q ss_pred CCCcEEEEecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003385 739 KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 805 (824)
Q Consensus 739 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf 805 (824)
.++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999866544333334456999999999999999999999999999999999988644
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=276.95 Aligned_cols=210 Identities=28% Similarity=0.486 Sum_probs=172.4
Q ss_pred HHHHHHHHhhccccccCcEEEEEEEEcC--------CcEEEEEEeccCC-cccchhhhHHHHHHhhc-CCCccceeecee
Q 003385 597 DIEDATKMLEKKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYC 666 (824)
Q Consensus 597 ~~~~~~~~i~~~LG~G~fg~Vy~a~~~~--------g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 666 (824)
++...++.+.+.||+|+||.||+|++.. +..||+|+++... ....+.+.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 3445567888999999999999997531 2368999887542 22346788999999999 799999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHhhccc------------CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 003385 667 QEEGRSVLVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 734 (824)
Q Consensus 667 ~~~~~~~lV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~N 734 (824)
...+..++++||+.+|+|.+++.... .....+++.+++.++.|++.||+|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 99999999999999999999986431 1244678889999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEecCCcccccCCCCce-eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 735 ILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 735 ILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
||++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999999987654322111 111224567999999999999999999999999999998 889997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=276.49 Aligned_cols=209 Identities=30% Similarity=0.466 Sum_probs=169.0
Q ss_pred HHHHHHHhhccccccCcEEEEEEEE------cCCcEEEEEEeccCCc-ccchhhhHHHHHHhhc-CCCccceeeceeecC
Q 003385 598 IEDATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE 669 (824)
Q Consensus 598 ~~~~~~~i~~~LG~G~fg~Vy~a~~------~~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 669 (824)
+...++.+.+.||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 4456788899999999999999974 2467899999975432 2235678899999999 689999999988654
Q ss_pred -CeEEEEEEecCCCCHHHHhhcccC-------------------------------------------------------
Q 003385 670 -GRSVLVYEFMHNGTLKEHLYGTLT------------------------------------------------------- 693 (824)
Q Consensus 670 -~~~~lV~E~~~~gsL~~~L~~~~~------------------------------------------------------- 693 (824)
...+++|||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 467899999999999998854210
Q ss_pred --------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc-eecc
Q 003385 694 --------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSI 764 (824)
Q Consensus 694 --------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~ 764 (824)
....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........ ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 012367888889999999999999998 9999999999999999999999999998764332211 1122
Q ss_pred ccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 765 ~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
..++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 335678999999999999999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=267.84 Aligned_cols=202 Identities=27% Similarity=0.393 Sum_probs=169.0
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.+++.+.||+|+||.||++.++ +++.||+|.++... ......+.+|++++++++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 3567789999999999999876 78999999886532 222457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|..++... .....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 82 DAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred CCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999998887542 1234688999999999999999999974 289999999999999999999999999987543221
Q ss_pred ceeccccCCCCCcchhccccC------CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~------~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....++..|+|||.+.+. .++.++|+||+||++|||++|+.||....
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 211 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET 211 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc
Confidence 2233578899999998554 34789999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=265.65 Aligned_cols=192 Identities=22% Similarity=0.400 Sum_probs=159.3
Q ss_pred ccccccCcEEEEEEEEcC-------------CcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEE
Q 003385 607 KKIGSGGFGVVYYGKLKD-------------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~-------------g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 673 (824)
+.||+|+||.||+|++.. ...|++|++..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997532 2358889886554444557888999999999999999999999988899
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-------EEEE
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-------AKVS 746 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~-------vkL~ 746 (824)
+||||+++++|..++... ...+++..+..++.||++||+|||+. +|+||||||+|||++.++. +|++
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999998887432 34578888999999999999999998 9999999999999987654 8999
Q ss_pred ecCCcccccCCCCceeccccCCCCCcchhccc-cCCCCchHHHHHHHHHHHHHH-cCCCCCCCCc
Q 003385 747 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELI-SGQEAISNEK 809 (824)
Q Consensus 747 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DIwSlGvil~ell-tG~~Pf~~~~ 809 (824)
|||++...... ....++..|+|||.+. ...++.++|||||||++|||+ .|..||....
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 99988654321 2234788999999887 467889999999999999998 5888887543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=291.41 Aligned_cols=200 Identities=30% Similarity=0.472 Sum_probs=170.2
Q ss_pred HHhhccccccCcEEEEEEEE-cCCc----EEEEEEeccC-CcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKL-KDGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~-~~g~----~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
....++||+|+||+||+|.| .+|+ +||+|++... ..+...++.+|+-+|.+++|||+++++|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 33457899999999999975 3444 5899998755 3344678999999999999999999999998765 78999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
+||+.|+|.++++.+ ...+-....+.+..||++||.|||++ +++||||.++||||.+-.++||.|||+++...+
T Consensus 777 q~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999999753 45567778889999999999999998 999999999999999999999999999997665
Q ss_pred CCCcee-ccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 757 GASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 757 ~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
...... ....-.+.|||-|.+....|+.++|||||||.+||++| |..|+++..
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~ 905 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP 905 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC
Confidence 433322 22234578999999999999999999999999999999 999999865
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=265.31 Aligned_cols=198 Identities=24% Similarity=0.421 Sum_probs=170.6
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.|...+.||+|+||.||+|.++ +++.||+|++.... ......+.+|++++++++||||+++++.+.+.+..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4555688999999999999875 58899999987543 233457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|.+++.. ..+++.++..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999998842 3477888899999999999999998 999999999999999999999999999876543222
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
......++..|+|||.+.+..++.++|+|||||++|||++|..||...
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 222345788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=263.25 Aligned_cols=195 Identities=33% Similarity=0.517 Sum_probs=163.2
Q ss_pred ccccccCcEEEEEEEEcC----CcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~----g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
++||+|+||.||+|.+.. +..+|+|.++.... ...+++.+|++++++++||||+++++++.. +..++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 479999999999997542 26899999875543 235678899999999999999999998764 467999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999998532 3678999999999999999999998 99999999999999999999999999988654433222
Q ss_pred ecc--ccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 762 SSI--VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 762 ~~~--~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
... ..++..|+|||.+....++.++|||||||++|||++ |..||....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~ 203 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK 203 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC
Confidence 111 123468999999998899999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=283.14 Aligned_cols=189 Identities=27% Similarity=0.469 Sum_probs=162.3
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
.+.||.|+||.||.|++. +.+.||||++.-... ..-.++..|+.+|++++|||++..-|+|..+...|+|||||-|
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG 110 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG 110 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc
Confidence 367999999999999854 678899999864322 2346789999999999999999999999999999999999965
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
+-.+.+.-+ .+++.+..+..|+.+.++||+|||+. +.||||||+.|||+++.|.+||+|||.|....+
T Consensus 111 -SAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----- 178 (948)
T KOG0577|consen 111 -SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----- 178 (948)
T ss_pred -cHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence 555555322 45577788889999999999999998 999999999999999999999999999876543
Q ss_pred eccccCCCCCcchhccc---cCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003385 762 SSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAIS 806 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~---~~~~~~~~DIwSlGvil~elltG~~Pf~ 806 (824)
...++|||.|||||++. .+.|+.++||||+|++..||...++|+-
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF 226 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 226 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence 34567999999999987 4689999999999999999999999963
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=271.78 Aligned_cols=200 Identities=24% Similarity=0.358 Sum_probs=168.3
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|+||.||++.+. .++.||+|.+..... ...+.+.+|+++++.++||||+++++.+..++..++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 345688999999999999876 578899999875432 2245678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 83 VEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999843 34578888899999999999999998 99999999999999999999999999886321100
Q ss_pred C--------------ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 S--------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~--------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
. .......++..|+|||.+....++.++|+|||||++|||++|..||.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~ 220 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 0 01112347889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=268.57 Aligned_cols=203 Identities=28% Similarity=0.413 Sum_probs=167.9
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeeceee-----cCCeEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQ-----EEGRSVL 674 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~-----~~~~~~l 674 (824)
.|.+.+.||+|+||.||++... +++.+|+|+++... .....+.+|+.+++++ +||||+++++++. ..+..++
T Consensus 19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 97 (286)
T cd06638 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL 97 (286)
T ss_pred ceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence 4456788999999999999875 57899999886432 2235678899999999 6999999999873 3456899
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
||||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 9999999999998865444456688888999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCceeccccCCCCCcchhcccc-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 755 VDGASHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 755 ~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
..... ......|++.|+|||.+.. ..++.++||||+||++|||++|+.||....
T Consensus 175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 175 TSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred ccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 33221 2233458999999998753 457889999999999999999999987543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=283.66 Aligned_cols=200 Identities=26% Similarity=0.462 Sum_probs=172.4
Q ss_pred HhhccccccCcEEEEEEEEc--CCc--EEEEEEeccCCcc-cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 604 MLEKKIGSGGFGVVYYGKLK--DGK--EIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~--~g~--~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
.+.++||+|.||+|++|.|. +|+ .||||.++.+... ...+|.+|+.+|.+|+||++++|+|+..+ ....+|+|+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 35578999999999999886 344 4799999876543 46789999999999999999999999987 677899999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
++.|+|.+.|+. .....+.......++.|||.||.||.++ ++|||||.++|+|+-....+||+|||+.+.....+
T Consensus 192 aplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 192 APLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999976 3455677888899999999999999998 99999999999999999999999999999766544
Q ss_pred Cce--eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 759 SHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 759 ~~~--~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
... .....-...|+|||.+....++.++|||+|||.+|||++ |+.||-+..
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~ 320 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR 320 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence 432 222334568999999999999999999999999999999 889998754
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=263.79 Aligned_cols=198 Identities=34% Similarity=0.556 Sum_probs=171.2
Q ss_pred HHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
..+.+.+.||+|+||.||+|... ++.||+|.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 34567789999999999999876 78999999976544 45678899999999999999999999998899999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|.+++... ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||.++.......
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 84 KGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999988543 223578999999999999999999998 999999999999999999999999999876532221
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
....+..|+|||.+....++.++||||||++++|+++ |+.||....
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 204 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 2234678999999988889999999999999999997 999987653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=268.53 Aligned_cols=196 Identities=24% Similarity=0.347 Sum_probs=163.9
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.+.||+|+||.||+|+++ +|+.+|+|+++.... .....+.+|++++++++||||+++++++.+.+..++++||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 445688999999999999876 688999999865322 22356778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
+ ++|.+++... ...+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 82 D-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred C-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 7 5777776432 34588999999999999999999998 999999999999999999999999999875533222
Q ss_pred ceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCC
Q 003385 760 HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAIS 806 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~ 806 (824)
. .....++..|+|||.+.+. .++.++|||||||++|||++|..|+.
T Consensus 155 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 155 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred C-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 1 1223478899999998764 47899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=244.69 Aligned_cols=210 Identities=26% Similarity=0.396 Sum_probs=171.7
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccC-CcccchhhhHHHHHHhh-cCCCccceeeceeecCCeEEEEEEecCCC
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSR-IHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~-~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 682 (824)
...||+|+||.|-+.++. +|+..|+|.++.. ..+..++..+|+.+..+ ..+|.+|.++|.+.++...++.||.|. -
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-T 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-h
Confidence 467999999999999865 7899999998754 23345566777777555 469999999999999999999999996 4
Q ss_pred CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCcee
Q 003385 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (824)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (824)
+|..+-...+......++.-.-+|+..+.+||.|||++ ..++|||+||+|||++.+|++|+||||++-...++-. .
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA--k 205 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA--K 205 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhH--H
Confidence 77776655666788899999999999999999999998 5899999999999999999999999999987755432 2
Q ss_pred ccccCCCCCcchhcccc----CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhhhhc
Q 003385 763 SIVRGTVGYLDPEYYIS----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWVK 822 (824)
Q Consensus 763 ~~~~gt~~y~aPE~l~~----~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~~~~ 822 (824)
+...|...|||||.+.. ..|+-++||||||+.+.||.+++.||+.-. ..++++.|.|.
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~--tpF~qLkqvVe 267 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG--TPFQQLKQVVE 267 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC--CHHHHHHHHhc
Confidence 33458899999998853 478999999999999999999999998643 22444444443
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=261.39 Aligned_cols=197 Identities=35% Similarity=0.545 Sum_probs=167.1
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCCcc-cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCHH
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 685 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 685 (824)
++||+|+||.||+|...+++.||+|.++..... ....+.+|++++++++||||+++++++.+.+..++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765433 4567889999999999999999999999999999999999999999
Q ss_pred HHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCcee-cc
Q 003385 686 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS-SI 764 (824)
Q Consensus 686 ~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~-~~ 764 (824)
+++... ...+++..+..++.|++.+|.|||++ +++||||||+||+++.++.+||+|||.++.......... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 988542 23577888899999999999999998 999999999999999999999999999875432211111 12
Q ss_pred ccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 765 ~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
...+..|+|||.+.+..++.++|+|||||++|||++ |..||....
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 224567999999988899999999999999999999 888986543
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=266.95 Aligned_cols=203 Identities=27% Similarity=0.438 Sum_probs=169.2
Q ss_pred HHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCcc-cchhhhHHHHHHhhcCCCccceeeceeecCCeEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 674 (824)
.+.+.+.||+|+||.||+|+.+ +.+.+++|.+...... ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (275)
T cd05046 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYM 85 (275)
T ss_pred hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceE
Confidence 4456688999999999999864 2467899988654332 34578899999999999999999999999889999
Q ss_pred EEEecCCCCHHHHhhcccCc-----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003385 675 VYEFMHNGTLKEHLYGTLTH-----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFG 749 (824)
||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred EEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccc
Confidence 99999999999998543211 12588999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003385 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISN 807 (824)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~ 807 (824)
+++..............++..|+|||.+.+..++.++||||||+++|+|++ |..||.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 986543322222233346788999999988888999999999999999998 8888864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=263.52 Aligned_cols=197 Identities=32% Similarity=0.524 Sum_probs=166.4
Q ss_pred HHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceee-cCCeEEEEEEec
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ-EEGRSVLVYEFM 679 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lV~E~~ 679 (824)
..+.+.+.||+|+||.||+|..+ ++.+|+|.++... ..+.+.+|+.++++++|+|++++++++. +.+..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 35567789999999999999876 7889999986432 2456889999999999999999999754 456789999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|.+++... ....+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 83 AKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 999999988543 233478889999999999999999998 99999999999999999999999999987543221
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
....++..|+|||++....++.++|||||||++|||++ |+.||....
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 12235678999999998899999999999999999997 999997644
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=265.67 Aligned_cols=198 Identities=28% Similarity=0.410 Sum_probs=172.5
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||.|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++.+.+.+..++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 346789999999999999876 589999999875432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+.+++|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 82 LLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999988432 4678889999999999999999998 99999999999999999999999999987654332
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......|+..|+|||.+....++.++|+||+|+++|+|++|+.||....
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 1233458889999999998889999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=266.81 Aligned_cols=197 Identities=30% Similarity=0.486 Sum_probs=164.4
Q ss_pred HHhhccccccCcEEEEEEEE-----cCCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecC--CeEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVL 674 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~-----~~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~l 674 (824)
+.+.+.||+|+||+||++.. .+++.||+|+++.... ...+.+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 36678999999999988653 3577899999875432 2356788999999999999999999987653 45789
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
+|||+++++|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999998843 3488999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCc--eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 755 VDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 755 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
...... ......++..|+|||.+....++.++|||||||++|||++|..||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 432211 11222356779999999888899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=267.76 Aligned_cols=198 Identities=27% Similarity=0.394 Sum_probs=166.5
Q ss_pred HhhccccccCcEEEEEEEEc----CCcEEEEEEeccCCc----ccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEE
Q 003385 604 MLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSY----QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVL 674 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~----~g~~vAVK~l~~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 674 (824)
.+.+.||+|+||.||+++.. +|+.||+|+++.... ...+.+.+|+++++++ +|+||+++++.+......++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 45688999999999999863 688999999875322 2235678899999999 59999999999998889999
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+|||+++++.+||+|||+++..
T Consensus 83 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 83 ILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999998853 34577888888999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCceeccccCCCCCcchhccccC--CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 755 VDGASHVSSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 755 ~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
............|+..|+|||.+... .++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 43322222334588999999998753 4678999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=260.90 Aligned_cols=204 Identities=25% Similarity=0.370 Sum_probs=167.9
Q ss_pred HHHhhccccccCcEEEEEEEEc---C--CcEEEEEEeccCCccc--chhhhHHHHHHhhcCCCccceeeceeec-CCeEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK---D--GKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSV 673 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~---~--g~~vAVK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~ 673 (824)
.|+....||+|.||.||+|.-+ + .+.+|+|.++..+... .....+|+.+++.++||||+.+..++.. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 4556678999999999999533 2 3468999997543221 2346789999999999999999999877 77899
Q ss_pred EEEEecCCCCHHHHhhcc-cCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC----CcEEEEec
Q 003385 674 LVYEFMHNGTLKEHLYGT-LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDF 748 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~----~~vkL~DF 748 (824)
+++||.+. +|...++-+ ......++...+..|+.||+.|+.|||++ -|+||||||.||||..+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999976 787777432 33456789999999999999999999998 89999999999999877 89999999
Q ss_pred CCcccccCCCCce--eccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 749 GLSKFAVDGASHV--SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 749 Gla~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
|+++.+..+-... ...++-|.+|+|||.+.+. .|+++.||||.|||+.||++-++.|.+.+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 9999876654332 2345679999999999875 67888999999999999999999887643
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=266.72 Aligned_cols=205 Identities=27% Similarity=0.457 Sum_probs=170.0
Q ss_pred HHHHHhhccccccCcEEEEEEEEcC-Cc----EEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLKD-GK----EIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~~-g~----~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 673 (824)
...+.+.+.||+|+||.||+|.++. |+ .+|+|.+..... .....+.+|++++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3455677899999999999998653 33 589998875543 234578899999999999999999999987 6789
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999998542 33478999999999999999999997 999999999999999999999999999976
Q ss_pred ccCCCCcee-ccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCccc
Q 003385 754 AVDGASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG 811 (824)
Q Consensus 754 ~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~ 811 (824)
......... ....++..|+|||.+....++.++|+|||||++||+++ |+.||.+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 218 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV 218 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 543322211 11223568999999988899999999999999999998 99999876533
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=279.40 Aligned_cols=205 Identities=24% Similarity=0.330 Sum_probs=179.0
Q ss_pred hhccccccCcEEEEEEEEcCCcE-EEEEEeccCCcc---cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 605 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~~g~~-vAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
....||-|+||.|-+.+.+.... +|+|++++.... ..+.+..|-.+|..++.|.||+++..|.+....|+.||-|-
T Consensus 424 ~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaCl 503 (732)
T KOG0614|consen 424 RIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACL 503 (732)
T ss_pred hhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhc
Confidence 34579999999999998774443 799998765433 23457789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
||.|...|++ ...++..+...++..+++|++|||++ +||+|||||+|+|++.+|-+||.|||+|+....+.
T Consensus 504 GGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~-- 574 (732)
T KOG0614|consen 504 GGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR-- 574 (732)
T ss_pred Cchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC--
Confidence 9999999854 45677777888999999999999998 99999999999999999999999999999876543
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
.+-++|||+.|.|||.+....++.++|.||||+++|||++|.+||.+.++-.++..|+
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL 632 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL 632 (732)
T ss_pred ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 4567899999999999999999999999999999999999999999988666666554
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=268.65 Aligned_cols=199 Identities=24% Similarity=0.397 Sum_probs=168.0
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.+.||+|+||.||+|.++ +++.||+|++...... ..+.+.+|++++++++||||+++++++.+.+..++|+||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 445688999999999999886 5889999988643222 2456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
+++.|.++... ...+++..+..++.|+++||.|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 83 DHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred CccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 99988876532 23478999999999999999999998 999999999999999999999999999876543322
Q ss_pred ceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 2223447889999999875 457789999999999999999999997655
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=261.31 Aligned_cols=200 Identities=35% Similarity=0.579 Sum_probs=170.1
Q ss_pred hhccccccCcEEEEEEEEcC-----CcEEEEEEeccCCcc-cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 605 LEKKIGSGGFGVVYYGKLKD-----GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~~-----g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
+.+.||+|+||.||++++.+ ++.||+|+++..... ..+.+.+|+++++.++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 46789999999999998763 378999999765433 456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++......
T Consensus 83 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 83 MEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred cCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999885421 12278999999999999999999998 99999999999999999999999999987665432
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
........++..|+|||.+....++.++||||+||+++||++ |+.||....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~ 209 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS 209 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 222212236789999999988889999999999999999998 889987543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=269.15 Aligned_cols=204 Identities=29% Similarity=0.492 Sum_probs=169.0
Q ss_pred HHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 673 (824)
..+.+.+.||+|+||.||+|.++ +++.||+|+++... ....+++.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 34556789999999999999864 46789999987543 233466889999999999999999999999988999
Q ss_pred EEEEecCCCCHHHHhhccc------------------CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 003385 674 LVYEFMHNGTLKEHLYGTL------------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 735 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NI 735 (824)
+++||+++|+|.+++.... .....+++..++.++.|++.||.|||+. +++||||||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ni 161 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNC 161 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhhe
Confidence 9999999999999985321 1123467888899999999999999998 999999999999
Q ss_pred EEcCCCcEEEEecCCcccccCCCC-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003385 736 LLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISN 807 (824)
Q Consensus 736 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~ 807 (824)
+++.++.+||+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||.+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999875432221 11222235678999999998999999999999999999997 8888854
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=263.97 Aligned_cols=199 Identities=26% Similarity=0.479 Sum_probs=168.4
Q ss_pred HhhccccccCcEEEEEEEE-cCCcEEEEEEeccCCc------ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 604 MLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSY------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~-~~g~~vAVK~l~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
...+.||+|++|.||+|.. .+++.+|+|+++.... ...+.+.+|++++++++|+||+++++++.+.+..++|+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 4567899999999999986 4689999999864321 12356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCccccc
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAV 755 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~-~vkL~DFGla~~~~ 755 (824)
||+++++|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++ .+||+|||.+....
T Consensus 83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 83 EWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred eccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999998853 34578888999999999999999998 999999999999998775 59999999987654
Q ss_pred CCCC---ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 756 DGAS---HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 756 ~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.... .......++..|+|||.+....++.++|+||+||++++|++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 3211 11223457899999999988889999999999999999999999997544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=262.15 Aligned_cols=190 Identities=27% Similarity=0.470 Sum_probs=160.2
Q ss_pred ccccccCcEEEEEEEEcCCc-----------EEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 607 KKIGSGGFGVVYYGKLKDGK-----------EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~-----------~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
+.||+|+||.||+|.+++.. .+++|++...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999876433 5788877654433 5778899999999999999999999887 778999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-------cEEEEec
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-------RAKVSDF 748 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~-------~vkL~DF 748 (824)
|||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999988543 22678888999999999999999998 999999999999999887 7999999
Q ss_pred CCcccccCCCCceeccccCCCCCcchhccccC--CCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 749 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 749 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
|++..... .....++..|+|||++... .++.++|||||||++|||++ |..||...+
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 99876433 1223467789999998876 78899999999999999999 578886653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=263.93 Aligned_cols=200 Identities=27% Similarity=0.426 Sum_probs=166.0
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-----ccchhhhHHHHHHhhcCCCccceeeceeec--CCeEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVL 674 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 674 (824)
|...+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|++++++++||||+++++++.+ ....++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 345688999999999999875 588999998864321 123457889999999999999999998865 356789
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
++||+++++|.+.+.. ...+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 84 FMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 9999999999998853 23477888899999999999999998 9999999999999999999999999998754
Q ss_pred cCCC--CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 755 VDGA--SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 755 ~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.... ........++..|+|||.+.+..++.++||||+||++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~ 213 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE 213 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence 3211 111122447889999999998889999999999999999999999997643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=262.13 Aligned_cols=197 Identities=30% Similarity=0.454 Sum_probs=169.2
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-----ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
|...+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|++++++++|+||+++++++......++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 345678999999999999876 789999998865331 23456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 82 ELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999998843 24577888899999999999999998 999999999999999999999999999876533
Q ss_pred CCCceeccccCCCCCcchhccccCC-CCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.. ......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||...
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 22 223345889999999988776 899999999999999999999999654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=261.31 Aligned_cols=199 Identities=31% Similarity=0.451 Sum_probs=173.7
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
+++.+.||+|++|.||+|+.+ +++.|+||++..... ...+.+.+|++.+.+++|+||+++++++...+..++|+||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 345689999999999999877 589999999876543 345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
+++|.+++... ..++...+..++.|+++||+|||+ . +++||||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 83 GGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999998532 567889999999999999999999 8 999999999999999999999999999876543332
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.. ....++..|+|||.+....++.++|+||||+++|||++|+.||....
T Consensus 156 ~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 156 QC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred cc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 21 23457899999999999899999999999999999999999997663
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=268.18 Aligned_cols=200 Identities=26% Similarity=0.359 Sum_probs=167.7
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc-----cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
|.+.+.||+|++|.||+|..+ +++.||||.++..... ....+..|++++++++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 345678999999999999875 6899999999754322 2345678999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+ +++|.+++... ...+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 82 e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 82 EFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred ccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 999 89999988532 13688999999999999999999998 999999999999999999999999999876544
Q ss_pred CCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
.... .....+++.|+|||.+.+ ..++.++|||||||+++||++|..||.+...
T Consensus 155 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~ 208 (298)
T cd07841 155 PNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD 208 (298)
T ss_pred CCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc
Confidence 3222 122346788999998864 4678899999999999999999888876553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=266.05 Aligned_cols=199 Identities=30% Similarity=0.517 Sum_probs=165.2
Q ss_pred HHHhhccccccCcEEEEEEEEc-----CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeec--CCeEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVL 674 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-----~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 674 (824)
.+.+.+.||+|+||.||+|..+ +++.||+|+++.......+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 4556789999999999999743 578899999876555556678999999999999999999997643 346789
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
|+||+++++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++..
T Consensus 85 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 85 VMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999998532 24578899999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCce--eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003385 755 VDGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 806 (824)
Q Consensus 755 ~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~ 806 (824)
....... .....++..|+|||.+.+..++.++|||||||+++||++|..|+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 4332211 111223456999999988889999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=238.65 Aligned_cols=205 Identities=22% Similarity=0.373 Sum_probs=169.6
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCC
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 682 (824)
.++||+|.||+|++|+.+ .++.||+|..+.+... -.....+|+-+++.++|+|||++++....++...+|+|||..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq- 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence 468999999999999855 5778999998755322 235578999999999999999999999999999999999964
Q ss_pred CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCcee
Q 003385 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (824)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (824)
+|..+... -...++...+..++.|+++||.++|++ ++.|||+||.|+||+.+|+.|++|||+++.+.-+....+
T Consensus 86 dlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 86 DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 67776532 245577788889999999999999998 899999999999999999999999999997765544333
Q ss_pred ccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHc-CCCCCCCCccccchhcHh
Q 003385 763 SIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIV 818 (824)
Q Consensus 763 ~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~iv 818 (824)
. .+-|.+|++|.++.+. -|+...|+||.|||+.|+.. |++.|.+.+..+..++|-
T Consensus 160 a-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif 216 (292)
T KOG0662|consen 160 A-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216 (292)
T ss_pred c-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHH
Confidence 3 3469999999999875 57788899999999999987 777788766555554443
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=266.78 Aligned_cols=200 Identities=25% Similarity=0.361 Sum_probs=170.2
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.+.||+|++|.||+|.++ +++.||+|+++... ....+.+.+|++++++++|+||+++++++...+..+++|||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 456788999999999999876 57899999986532 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
+++.+..... ....+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 83 ERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9877765542 234478889999999999999999998 999999999999999999999999999876554433
Q ss_pred ceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.......++..|+|||++.+. .++.++||||||+++|+|++|+.||.+..
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 206 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 233334578999999999888 88899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=263.93 Aligned_cols=194 Identities=31% Similarity=0.460 Sum_probs=165.7
Q ss_pred ccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCH
Q 003385 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (824)
Q Consensus 609 LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 684 (824)
||+|+||+||++..+ +|+.+|+|++..... ...+.+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999765 688999999864321 2234567899999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceecc
Q 003385 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (824)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (824)
.+++.... ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||.+....... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 99885432 24678899999999999999999998 99999999999999999999999999987553321 1223
Q ss_pred ccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 765 ~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
..++..|+|||++.+..++.++||||+||++++|++|+.||....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 457889999999988889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=276.36 Aligned_cols=189 Identities=22% Similarity=0.346 Sum_probs=161.0
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.|.+.+.||+|+||.||+|+.. +++.||+|+... .....|+.++++++||||+++++++...+..++|+|++.
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 4677889999999999999876 567899997532 234579999999999999999999999999999999995
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
++|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 141 -~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 141 -SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred -CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 688887743 245688999999999999999999998 99999999999999999999999999987533221
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 805 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf 805 (824)
......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 223345899999999999999999999999999999999865554
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=261.73 Aligned_cols=203 Identities=26% Similarity=0.396 Sum_probs=171.4
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeec--CCeEEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYE 677 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~E 677 (824)
|.+.+.||.|+||.||++.+. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.. ....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 345688999999999999865 67889999986432 2234568889999999999999999997753 456789999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-----TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-----~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
|+++++|.+++.........+++..++.++.|++.||.||| +. +++||||||+||++++++.+||+|||++.
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccc
Confidence 99999999998655445667899999999999999999999 65 99999999999999999999999999988
Q ss_pred cccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
........ .....+++.|+|||.+....++.++|+||||+++++|++|+.||....
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 159 ILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred cccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 65443321 223458999999999998889999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=267.87 Aligned_cols=200 Identities=27% Similarity=0.432 Sum_probs=172.1
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.++.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 35566789999999999999764 67899999986554444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999998843 3467888899999999999999998 999999999999999999999999998875543322
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
. .....+++.|+|||.+....++.++|+|||||++||+++|+.||...+
T Consensus 171 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred c-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 223458889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=261.72 Aligned_cols=203 Identities=28% Similarity=0.430 Sum_probs=172.9
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
|.+.+.||.|+||+||+|... +++.+|+|++.... ....+.+.+|++.++.++|+||+++++.+...+..++++|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 456788999999999999865 67889999986543 2245678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|.+++..... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 83 ~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 83 GGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 9999999854322 24578889999999999999999998 9999999999999999999999999998765443222
Q ss_pred ---eeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 761 ---VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 761 ---~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......|+..|+|||++... .++.++|+|||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 22334588999999998877 78899999999999999999999997644
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=266.59 Aligned_cols=202 Identities=31% Similarity=0.438 Sum_probs=167.5
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeeceeecC-----CeEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE-----GRSVLV 675 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~-----~~~~lV 675 (824)
+.+.+.||+|+||.||++..+ +++.+|+|++.... .....+.+|+.+++++ +|||++++++++... +..++|
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv 102 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV 102 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence 456678999999999999875 68899999986432 2245677899999998 799999999998653 357999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
|||+++++|.+++.........+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 999999999998865444456788999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCceeccccCCCCCcchhccccC-----CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYISQ-----QLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.... ......|+..|+|||.+... .++.++|||||||++|||++|+.||....
T Consensus 180 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 180 STRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred cccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 3221 12234588999999998643 36789999999999999999999997643
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=266.73 Aligned_cols=200 Identities=31% Similarity=0.515 Sum_probs=167.2
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-----CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecC--Ce
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GR 671 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-----~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~ 671 (824)
...+.+.+.||+|+||.||+++.. +++.||+|.++... ....+.+.+|++++++++||||+++.+++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 445677889999999999999742 57889999987543 23345788999999999999999999988765 56
Q ss_pred EEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003385 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla 751 (824)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence 88999999999999988432 23578899999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCc--eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003385 752 KFAVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 805 (824)
Q Consensus 752 ~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf 805 (824)
+........ ......++..|+|||++.+..++.++|||||||++|||++++.|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 865433221 122344677899999998888999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=265.97 Aligned_cols=199 Identities=23% Similarity=0.383 Sum_probs=165.8
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc-cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
|.+.+.||+|++|.||+|+.+ +++.||+|.+...... ....+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 456689999999999999876 6889999998654322 23456789999999999999999999999999999999998
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+ +|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 87 ~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 87 T-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred C-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 5 898887533 23578888999999999999999998 999999999999999999999999999865422211
Q ss_pred eeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......++..|+|||++.+ ..++.++||||+||++|||++|+.||.+..
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1122346889999998875 458899999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=262.43 Aligned_cols=199 Identities=27% Similarity=0.427 Sum_probs=166.1
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-----cccchhhhHHHHHHhhcCCCccceeeceeecC--CeEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVL 674 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~l 674 (824)
|.+.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+. +..++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 456789999999999999865 58899999875321 12235688899999999999999999988654 46789
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
++||+++++|.+++.. ...+++.....++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 84 FVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 9999999999998843 23467888889999999999999998 9999999999999999999999999998754
Q ss_pred cCCC--CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 755 VDGA--SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 755 ~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.... ........++..|+|||.+.+..++.++|+|||||+++||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 3211 11112345889999999999888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=264.59 Aligned_cols=199 Identities=26% Similarity=0.421 Sum_probs=166.5
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.+.+.||+|++|.||+|+.. +++.||||+++.... .....+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 45678999999999999875 688999998865432 223568899999999999999999999999999999999996
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
++|.+++... ....+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||+++........
T Consensus 83 -~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 83 -QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred -cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 6888887532 235678899999999999999999998 9999999999999999999999999998755332221
Q ss_pred eeccccCCCCCcchhccccCC-CCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~-~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....++..|+|||.+.+.. ++.++|||||||++|||++|+.||.+..
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 22234688999999887644 5889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=261.49 Aligned_cols=199 Identities=28% Similarity=0.444 Sum_probs=171.1
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.+.||+|+||.||+|... +++.|++|+++..... ..+.+.+|++++++++|+||+++++.+...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 456689999999999999865 6889999998765432 4567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||.+........
T Consensus 82 ~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 82 SGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999998843 33467888889999999999999998 999999999999999999999999999876544332
Q ss_pred ceec---cccCCCCCcchhccccCC---CCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 760 HVSS---IVRGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 760 ~~~~---~~~gt~~y~aPE~l~~~~---~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.... ...++..|+|||++.... ++.++||||||++++|+++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 2211 345788999999998766 889999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=261.01 Aligned_cols=195 Identities=31% Similarity=0.519 Sum_probs=157.6
Q ss_pred ccccccCcEEEEEEEEc----CCcEEEEEEeccC-CcccchhhhHHHHHHhhcCCCccceeeceee-cCCeEEEEEEecC
Q 003385 607 KKIGSGGFGVVYYGKLK----DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ-EEGRSVLVYEFMH 680 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~----~g~~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lV~E~~~ 680 (824)
+.||+|+||.||+|.+. ....+|+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999864 2357999988543 2233467888999999999999999999775 4556789999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|.+++... .....+..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999998532 23356777888999999999999998 9999999999999999999999999998754322111
Q ss_pred ---eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcC-CCCCCC
Q 003385 761 ---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG-QEAISN 807 (824)
Q Consensus 761 ---~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG-~~Pf~~ 807 (824)
......++..|+|||.+....++.++|||||||++|||++| .+||..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 205 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 11123457789999999888999999999999999999995 566654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=262.11 Aligned_cols=202 Identities=27% Similarity=0.449 Sum_probs=168.2
Q ss_pred HHhhccccccCcEEEEEEEEcC--CcEEEEEEeccCCc----------ccchhhhHHHHHHhh-cCCCccceeeceeecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSNSY----------QGKREFTNEVTLLSR-IHHRNLVQFLGYCQEE 669 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~--g~~vAVK~l~~~~~----------~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~ 669 (824)
|.+.+.||+|+||.||+|.++. ++.+|+|.+..... ....++.+|+.++.+ ++||||+++++++.+.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 3456889999999999998765 67899998753211 112346678887765 7999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003385 670 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (824)
Q Consensus 670 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFG 749 (824)
+..+++|||+++++|.+.+.........+++..++.++.|++.||.|||+. .+++||||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEeccc
Confidence 999999999999999988754333455688899999999999999999963 289999999999999999999999999
Q ss_pred CcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.+....... ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 160 LAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred ceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 987654332 223345889999999999888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=262.95 Aligned_cols=210 Identities=24% Similarity=0.388 Sum_probs=172.4
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc-cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
|.+.++||+|++|.||+|+.+ +|+.||||+++..... ....+.+|++++++++||||+++++.+.+.+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 345688999999999999986 6889999998754322 24567789999999999999999999999999999999998
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+ +|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 82 ~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 82 K-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred c-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 5 8888775432 234688999999999999999999998 999999999999999999999999999875433221
Q ss_pred eeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 761 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
......++..|++||.+.+ ..++.++|||||||++|||++|+.||.+....+...++.
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 214 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF 214 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 1223347889999998865 456889999999999999999999998766554444443
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=278.96 Aligned_cols=199 Identities=25% Similarity=0.374 Sum_probs=170.7
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcE-EEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~-vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.+.|...||.|+||.||+|..++... .|-|++...+....+++.-|++||..++||+||++++.|..++.++|..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 45566789999999999998775444 46688877777777889999999999999999999999988999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
||-....+. .-+..+.+.++..+++|++.||.|||++ .|||||||+.|||++-+|.++|+|||.+...... ..
T Consensus 113 GGAVDaiml---EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~q 185 (1187)
T KOG0579|consen 113 GGAVDAIML---ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQ 185 (1187)
T ss_pred CchHhHHHH---HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-Hh
Confidence 999887763 3467788999999999999999999998 9999999999999999999999999987543221 22
Q ss_pred eeccccCCCCCcchhccc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 761 VSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
....+.|||.|||||++. ..+|+.++||||||+.|.||..+.+|-..
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe 237 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE 237 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence 334466999999999975 46799999999999999999999999764
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=265.29 Aligned_cols=191 Identities=25% Similarity=0.418 Sum_probs=157.7
Q ss_pred cccccCcEEEEEEEEcC-------------------------CcEEEEEEeccCCcccchhhhHHHHHHhhcCCCcccee
Q 003385 608 KIGSGGFGVVYYGKLKD-------------------------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF 662 (824)
Q Consensus 608 ~LG~G~fg~Vy~a~~~~-------------------------g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 662 (824)
.||+|+||.||+|.+.. ...||+|++..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13488898865444444578889999999999999999
Q ss_pred eceeecCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-
Q 003385 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM- 741 (824)
Q Consensus 663 ~~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~- 741 (824)
++++.+....++||||+++|+|..++.. ....+++..+..++.|+++||+|||++ +|+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 9999999999999999999999988853 234678888999999999999999998 999999999999997643
Q ss_pred ------cEEEEecCCcccccCCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHH-cCCCCCCCCc
Q 003385 742 ------RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELI-SGQEAISNEK 809 (824)
Q Consensus 742 ------~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~ell-tG~~Pf~~~~ 809 (824)
.+|++|||++...... ....++..|+|||.+.. ..++.++|||||||++|||+ +|+.||....
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 4899999987543221 12346788999998875 56889999999999999984 7999997643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=260.44 Aligned_cols=194 Identities=27% Similarity=0.449 Sum_probs=164.4
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCHH
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 685 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 685 (824)
..||+|+||.||+|++. ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++++||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 57999999999999865 57789999987665555678899999999999999999999999999999999999999999
Q ss_pred HHhhcccCccccC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecCCcccccCCCCcee
Q 003385 686 EHLYGTLTHEQRI--NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVS 762 (824)
Q Consensus 686 ~~L~~~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~ 762 (824)
+++.... ..+ ++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||.+......... .
T Consensus 94 ~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~-~ 166 (268)
T cd06624 94 ALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC-T 166 (268)
T ss_pred HHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc-c
Confidence 9986431 223 6777888999999999999998 9999999999999986 579999999998755332221 2
Q ss_pred ccccCCCCCcchhccccC--CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 763 SIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 763 ~~~~gt~~y~aPE~l~~~--~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
....|+..|+|||.+... .++.++|+||+|+++|+|++|+.||..
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 223478999999998654 378899999999999999999999964
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=264.56 Aligned_cols=199 Identities=25% Similarity=0.414 Sum_probs=164.4
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCccc-chhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
|.+.+.||+|+||.||+|... +++.||+|+++...... ...+.+|+++++.++|+||+++.+++...+..++|+||+.
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 456789999999999999865 68899999987543222 3457789999999999999999999999999999999996
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++.+.+... ...+.+..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 87 -~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 158 (291)
T cd07870 87 -TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ- 158 (291)
T ss_pred -CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-
Confidence 6777666432 23467778888999999999999998 999999999999999999999999999875432221
Q ss_pred eeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||++..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 1223347899999999875 457889999999999999999999997643
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=268.10 Aligned_cols=203 Identities=25% Similarity=0.369 Sum_probs=166.8
Q ss_pred HHhhccccccCcEEEEEEEEcC---CcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecC--CeEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVL 674 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~---g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~l 674 (824)
|.+.++||+|++|.||+|..+. ++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. +..++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 4456789999999999998754 7899999997633 22345677899999999999999999999888 78999
Q ss_pred EEEecCCCCHHHHhhcccCc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC----CCcEEEEecC
Q 003385 675 VYEFMHNGTLKEHLYGTLTH-EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK----HMRAKVSDFG 749 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~----~~~vkL~DFG 749 (824)
||||+++ ++.+.+...... ...++...+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 666666433222 23688889999999999999999998 9999999999999999 8999999999
Q ss_pred CcccccCCCC--ceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 750 LSKFAVDGAS--HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 750 la~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
+++....... .......++..|+|||++.+ ..++.++|||||||+++||++|+.||.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 9876543222 11223457889999998876 457899999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=263.22 Aligned_cols=194 Identities=28% Similarity=0.447 Sum_probs=168.3
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCH
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 684 (824)
.+.||+|++|.||+|... +++.+++|++........+.+.+|+.++++++||||+++++++...+..++++||+.+++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 468999999999999864 6889999998655444456688999999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceecc
Q 003385 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (824)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (824)
.+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+........ ....
T Consensus 104 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 174 (285)
T cd06648 104 TDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKS 174 (285)
T ss_pred HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccc
Confidence 998843 4578888999999999999999998 999999999999999999999999998765433221 2223
Q ss_pred ccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 765 ~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
..|+..|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~ 218 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE 218 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC
Confidence 45889999999998888999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=263.80 Aligned_cols=199 Identities=33% Similarity=0.500 Sum_probs=164.9
Q ss_pred ccccccCcEEEEEEEEcC-------CcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 607 KKIGSGGFGVVYYGKLKD-------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~-------g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
+.||+|+||.||+|++++ ++.+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998653 2578999876443 23356788999999999999999999999998999999999
Q ss_pred cCCCCHHHHhhcccC---ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-----cEEEEecCC
Q 003385 679 MHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-----RAKVSDFGL 750 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~-----~vkL~DFGl 750 (824)
+++++|.+++..... ....+++.+++.++.|++.||+|||+. +++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999864322 224478889999999999999999997 999999999999999877 899999999
Q ss_pred cccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 003385 751 SKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNE 808 (824)
Q Consensus 751 a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~ 808 (824)
++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 8755332211 1122235678999999999999999999999999999998 99998653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=260.29 Aligned_cols=192 Identities=26% Similarity=0.403 Sum_probs=167.4
Q ss_pred ccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCH
Q 003385 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (824)
Q Consensus 609 LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 684 (824)
||+|++|.||+|+.. +++.+|+|++..... ...+.+.+|++++++++||||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999876 488999999875432 2345688999999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceecc
Q 003385 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (824)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (824)
.+++.. ...+++..+..++.|+++||.|||++ +++|+||+|+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 998853 24478888999999999999999998 99999999999999999999999999987654432 2223
Q ss_pred ccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 765 ~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
..++..|++||.+....++.++|+||+|+++|||++|..||....
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 458899999999988889999999999999999999999997655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=261.95 Aligned_cols=199 Identities=30% Similarity=0.464 Sum_probs=166.9
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc----------cchhhhHHHHHHhhcCCCccceeeceeecCCe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ----------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 671 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~----------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 671 (824)
|.+.+.||+|+||.||+|... +++.+|+|.++..... ..+.+.+|++++++++||||+++++++...+.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 445688999999999999765 6889999987532111 12357789999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003385 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla 751 (824)
.++||||+.+++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred eEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999988543 4678888899999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCc-eeccccCCCCCcchhccccCC--CCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 752 KFAVDGASH-VSSIVRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 752 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~--~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
+........ ......|+..|+|||.+.... ++.++|+||||+++||+++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 215 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence 754332111 123345889999999987654 788999999999999999999999653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=274.64 Aligned_cols=209 Identities=25% Similarity=0.366 Sum_probs=176.7
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccc---hhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK---REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
.+.||-|+||+|.+++.. +...+|+|.+++.+...+ ..++.|-.||...+.+-||+|+-.|.+.+.+|+||||++|
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 367999999999999644 456789999986643322 3467899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc-------
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA------- 754 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~------- 754 (824)
|++-.+|.. ...+.+..++.++.++..|+++.|.- |+|||||||.|||||.+|++||.|||+++-+
T Consensus 714 GDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 714 GDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred ccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 999988843 35567777888899999999999997 9999999999999999999999999998522
Q ss_pred --cCCCCc--------------------------------eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc
Q 003385 755 --VDGASH--------------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800 (824)
Q Consensus 755 --~~~~~~--------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt 800 (824)
..+..+ .....+||+.|+|||++....|+..+|.||.|||||||+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 111000 0012349999999999999999999999999999999999
Q ss_pred CCCCCCCCccccchhcHhhhh
Q 003385 801 GQEAISNEKFGANCRNIVQWV 821 (824)
Q Consensus 801 G~~Pf~~~~~~~~~~~iv~~~ 821 (824)
|+.||...+..++..+++.|-
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~ 887 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWR 887 (1034)
T ss_pred CCCCccCCCCCcceeeeeehh
Confidence 999999999888888998884
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=263.64 Aligned_cols=208 Identities=24% Similarity=0.316 Sum_probs=170.0
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--cchhhhHHHHHHhhcCCCccceeeceeecC--CeEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVY 676 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV~ 676 (824)
.|.+.+.||+|+||.||+|+++ +++.+|+|.++..... ....+.+|++++++++||||+++++++... +..++|+
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 4556789999999999999876 5788999998754322 123567899999999999999999998777 8899999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+. ++|.+.+... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 86 e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 86 EYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred hhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 9997 4888877532 23588999999999999999999998 999999999999999999999999999876544
Q ss_pred CCCceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcH
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i 817 (824)
.... .....+++.|+|||.+.+. .++.++|+||+||++|||++|+.||......+...++
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~ 219 (293)
T cd07843 159 PLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI 219 (293)
T ss_pred Cccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 3221 2233478899999988754 4688999999999999999999999876544434333
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=261.91 Aligned_cols=203 Identities=28% Similarity=0.453 Sum_probs=169.2
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeeceeecCC------eE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG------RS 672 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~------~~ 672 (824)
..|.+.+.||+|++|.||+|..+ +++.+++|++..... ..+.+.+|+++++++ +|+||+++++++.... ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 45667899999999999999875 578899999875443 346788999999999 6999999999986544 48
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccce
Confidence 999999999999998854433346788999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeccccCCCCCcchhcccc-----CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
....... ......|+..|+|||++.. ..++.++|||||||++++|++|+.||...
T Consensus 162 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 162 QLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred ecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 5433222 2233458899999998753 34678899999999999999999999753
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=259.61 Aligned_cols=194 Identities=29% Similarity=0.442 Sum_probs=167.1
Q ss_pred ccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCH
Q 003385 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (824)
Q Consensus 609 LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 684 (824)
||+|+||.||++++. +++.+++|++..... ...+.+.+|++++++++||||+++++.+......++++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 489999999875433 2345688899999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC-----
Q 003385 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS----- 759 (824)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~----- 759 (824)
.+++... ..+++..+..++.|+++||+|||+. +++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9988532 3678899999999999999999998 999999999999999999999999999875433211
Q ss_pred --ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 --HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 --~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.......++..|+|||......++.++|+||||+++||+++|+.||....
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 12233457889999999988888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=259.72 Aligned_cols=201 Identities=28% Similarity=0.438 Sum_probs=170.6
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.+.||+|+||.+|+++.+ +++.||+|.+.... ....+++.+|++++++++||||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 456789999999999999865 68899999986432 223457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
.+++|.+++... ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 82 EGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999988532 223567888899999999999999998 999999999999999999999999999875533221
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......|++.|+|||.+.+..++.++|+|||||++++|++|+.||....
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 1223457889999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=260.40 Aligned_cols=198 Identities=26% Similarity=0.433 Sum_probs=169.4
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.+.+.+.||+|+||.||+|... +++.+|+|++.... ....+.+.+|++++++++||||+++++.+..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4556788999999999999865 67899999886432 223456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|.+++.. ..+++..+..++.|++.++.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence 99999988742 3578888999999999999999998 99999999999999999999999999987553322
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.......++..|+|||.+....++.++|+|||||++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 1122345788999999998888899999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=263.85 Aligned_cols=200 Identities=28% Similarity=0.429 Sum_probs=164.0
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHH-HhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTL-LSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
+.+.+.||+|+||.||+|+++ +|+.||+|+++.... ....++..|+.. ++..+||||+++++++...+..+++|||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 345688999999999999876 689999999875422 223445556664 56678999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
+ |+|.+++.........+++..+..++.|++.||+|||++ .+++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 6 688887765444456789999999999999999999985 289999999999999999999999999987653321
Q ss_pred ceeccccCCCCCcchhcccc----CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 760 HVSSIVRGTVGYLDPEYYIS----QQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~----~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
......++..|+|||.+.. ..++.++|+||+||++|||++|+.||..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 159 -AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred -ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 1222457889999998864 4568899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=260.26 Aligned_cols=197 Identities=31% Similarity=0.444 Sum_probs=170.9
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
+++.+.||+|++|.||++.++ +++.+|+|.+..... ...+++.+|++++++++||||+++++.+...+..++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 345678999999999999876 688999999875532 334678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
+++|.+++.... ..+++..+..++.|++.||+|||+ . +++||||||+||++++++.+||+|||.+........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 83 GGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 999999885421 567888889999999999999999 7 999999999999999999999999999875533222
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
. ...++..|+|||.+.+..++.++||||+||++++|++|+.||...
T Consensus 157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 1 155889999999999999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=255.86 Aligned_cols=203 Identities=29% Similarity=0.493 Sum_probs=176.1
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.+.||+|+||.||++.+. +++.+|+|++..... ...+.+.+|++++++++|||++++.+.+...+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 345678999999999999876 688999999875433 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 99999999865443457789999999999999999999998 99999999999999999999999999987654432
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.......|++.|+|||......++.++|+||+|+++++|++|+.||....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 22333468899999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=261.40 Aligned_cols=203 Identities=29% Similarity=0.458 Sum_probs=164.0
Q ss_pred HhhccccccCcEEEEEEEEc----CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCC------e
Q 003385 604 MLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------R 671 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~----~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~ 671 (824)
.+.+.||+|+||.||+|.+. .++.||||+++... ....+++.+|++++++++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 35678999999999999764 36889999987542 223456889999999999999999999875432 2
Q ss_pred EEEEEEecCCCCHHHHhhccc--CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003385 672 SVLVYEFMHNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFG 749 (824)
.++++||+.+|+|.+++.... .....+++...+.++.|++.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECccc
Confidence 368899999999988874321 1223578888999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 750 LSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 750 la~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
+++........ ......++..|++||.+....++.++|||||||++|||++ |+.||.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~ 220 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE 220 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC
Confidence 98765332211 1122335678999999998889999999999999999999 899987654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=262.39 Aligned_cols=204 Identities=24% Similarity=0.304 Sum_probs=165.4
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--cchhhhHHHHHHhhcC-CCccceeeceeecCCe-----EE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGR-----SV 673 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~-----~~ 673 (824)
|.+.+.||+|+||.||+|.+. +++.||+|+++..... ....+.+|++++++++ ||||+++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 445678999999999999876 6889999988654322 2356788999999995 6999999999876655 79
Q ss_pred EEEEecCCCCHHHHhhcccCc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecCCc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTH-EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLS 751 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~-~~~vkL~DFGla 751 (824)
+||||+++ +|.+++...... ...+++..++.++.||++||.|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999985 788887543222 35678999999999999999999998 9999999999999998 899999999998
Q ss_pred ccccCCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 752 KFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
+........ .....+++.|+|||.+.+ ..++.++|||||||++|||++|..||.+....
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~ 218 (295)
T cd07837 159 RAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL 218 (295)
T ss_pred eecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 754332111 122346889999998865 45789999999999999999999999775433
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=260.24 Aligned_cols=198 Identities=25% Similarity=0.453 Sum_probs=168.7
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcC---CCccceeeceeecCCeEEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV~E 677 (824)
|.+.+.||+|+||.||+|.+. +++.+|+|+++... .....++.+|++++++++ |||++++++++.+....++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 445678999999999999864 68899999986542 233456888999999997 9999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+++++|.+++.. ..+++..++.++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 83 YAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred cCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 9999999988743 2578899999999999999999998 9999999999999999999999999998765443
Q ss_pred CCceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
... .....|+..|+|||.+... .++.++|+|||||++|+|++|+.||.+..
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 206 (277)
T cd06917 155 SSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206 (277)
T ss_pred ccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 322 2334588999999988754 46889999999999999999999997644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=257.28 Aligned_cols=200 Identities=30% Similarity=0.445 Sum_probs=169.9
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++.+...+..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 455688999999999999865 68889999986542 223457889999999999999999999999899999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCcccccCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~-~~vkL~DFGla~~~~~~~ 758 (824)
++++|.+++... ....+++..+..++.|++.+|.|||++ +++||||||+||+++++ +.+||+|||.+.......
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 82 PGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999998542 234578889999999999999999998 99999999999999865 568999999987654322
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 1223458899999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=260.49 Aligned_cols=199 Identities=27% Similarity=0.412 Sum_probs=166.3
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.+.+.||.|++|.||+|.++ +|+.||+|++..... ...+.+.+|++++++++|||++++++++.+.+..+++|||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 35678999999999999875 789999999875432 223567889999999999999999999999999999999995
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
++|.+++.... ...+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++.........
T Consensus 82 -~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 82 -LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred -cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 68988874321 24688999999999999999999998 9999999999999999999999999998754332211
Q ss_pred eeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 204 (283)
T cd07835 156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204 (283)
T ss_pred -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1222468899999988654 57889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=260.60 Aligned_cols=191 Identities=28% Similarity=0.406 Sum_probs=157.4
Q ss_pred cccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHHHHhh---cCCCccceeeceeecCCeEEEEEEecC
Q 003385 608 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSR---IHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 608 ~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~---l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.||+|+||.||++... +++.+|+|.+...... ....+.+|..+++. .+||+|+.+++.+...+..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 5889999988654221 12233445444433 479999999999999899999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 9999988743 34588999999999999999999998 999999999999999999999999999865433221
Q ss_pred eeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 761 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
....|+..|+|||.+.. ..++.++||||+||++|||++|+.||...
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 22358999999999864 56889999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=265.21 Aligned_cols=210 Identities=26% Similarity=0.349 Sum_probs=169.4
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCccc--chhhhHHHHHHhhcCCCccceeeceeecC--CeEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVY 676 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV~ 676 (824)
.|.+.+.||+|+||.||+|..+ +|+.||+|+++...... ...+.+|++++++++|+||+++++++.+. +..++||
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 3556788999999999999875 68999999987443221 23456899999999999999999998654 5689999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++ +|.+.+... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 88 e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 88 EYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred ecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 99974 788877432 25578899999999999999999998 999999999999999999999999999876543
Q ss_pred CCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 757 GASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
.... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||.+.+..+....+.+
T Consensus 161 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~ 223 (309)
T cd07845 161 PAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQ 223 (309)
T ss_pred ccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 3211 122335788999999875 5678999999999999999999999987665444444443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=261.33 Aligned_cols=206 Identities=26% Similarity=0.386 Sum_probs=170.4
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecC--CeEEEEEEe
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEF 678 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV~E~ 678 (824)
.+.+.||+|++|.||+|+.. +++.+|+|++.... ....+.+.+|++++++++|||++++++++... +..++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 35678999999999999876 57899999997653 22345678899999999999999999999887 889999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++ +|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 82 MDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 974 888877432 24688899999999999999999998 99999999999999999999999999987665443
Q ss_pred CceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhc
Q 003385 759 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 816 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~ 816 (824)
........++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~ 213 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK 213 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 222233446889999998765 4678999999999999999999999987664433333
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=262.32 Aligned_cols=193 Identities=28% Similarity=0.451 Sum_probs=167.6
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCHH
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 685 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 685 (824)
.+||+|+||.||++..+ +++.||||++..........+.+|+.+++.++|+||+++++.+...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 67999999999999875 68899999986544444567889999999999999999999999999999999999999999
Q ss_pred HHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceeccc
Q 003385 686 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 765 (824)
Q Consensus 686 ~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 765 (824)
+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+........ .....
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 106 DIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 87632 3478888999999999999999998 999999999999999999999999998865433221 12334
Q ss_pred cCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 766 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 766 ~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.|+..|+|||.+.+..++.++|+||+||++|||++|..||.+.
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~ 219 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 5889999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=257.71 Aligned_cols=195 Identities=33% Similarity=0.569 Sum_probs=165.1
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
.+.+.+.||+|+||.||++.. .++.||+|+++... ..+.+.+|+.++++++||||+++++++... ..+++|||+.+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 456788999999999999975 57889999986532 245688999999999999999999998654 46899999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 83 GNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 9999998543 234578888999999999999999998 99999999999999999999999999987543221
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.....+..|+|||.+....++.++|+|||||++|||++ |+.||....
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 202 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence 11224578999999988899999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=261.61 Aligned_cols=198 Identities=29% Similarity=0.415 Sum_probs=168.8
Q ss_pred hhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeec--CCeEEEEEEecC
Q 003385 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEFMH 680 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ 680 (824)
..+.||.|++|.||++... +++.+|+|.+..... ...+++.+|++++++++||||+++++++.+ .+..++||||++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 84 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE 84 (287)
T ss_pred EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence 4578999999999999875 578899999875432 335678899999999999999999998854 346899999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|.+++.........++...+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 160 (287)
T cd06621 85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA- 160 (287)
T ss_pred CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc-
Confidence 9999988754444456678889999999999999999998 999999999999999999999999999865433221
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
....++..|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus 161 --~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 161 --GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred --ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 2234788999999999999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=261.78 Aligned_cols=190 Identities=27% Similarity=0.450 Sum_probs=158.6
Q ss_pred ccccccCcEEEEEEEEcC--------CcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 607 KKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~--------g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
+.||+|+||.||+|..+. ..++|+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997642 234888887654444456788899999999999999999999998899999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--------EEEEecCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--------AKVSDFGL 750 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~--------vkL~DFGl 750 (824)
+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. ++++|||.
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999998543 23578888999999999999999998 9999999999999987764 69999998
Q ss_pred cccccCCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCC-CCCCC
Q 003385 751 SKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ-EAISN 807 (824)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~-~Pf~~ 807 (824)
+...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .||..
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 8654321 22457889999999986 45789999999999999999994 66654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-28 Score=261.84 Aligned_cols=204 Identities=25% Similarity=0.359 Sum_probs=167.0
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCC------
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------ 670 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 670 (824)
...|.+.+.||+|+||.||+|.++ +++.||+|+++.... .....+.+|++++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 345667889999999999999876 588999999875432 22345678999999999999999999887654
Q ss_pred ----eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 003385 671 ----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (824)
Q Consensus 671 ----~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~ 746 (824)
..++|+||+++ ++...+... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999986 666666432 34678999999999999999999998 99999999999999999999999
Q ss_pred ecCCcccccCCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 747 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 747 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
|||++...............++..|+|||.+.+ ..++.++||||+||+++||++|+.||.....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~ 223 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE 223 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999987654433222223346788999998865 4578899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=270.95 Aligned_cols=197 Identities=26% Similarity=0.364 Sum_probs=164.6
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccC--CcccchhhhHHHHHHhhcCCCccceeeceeecC------Ce
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GR 671 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~ 671 (824)
..|.+.+.||+|+||.||+|+.. +++.||+|++... .......+.+|++++++++||||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 45666789999999999999865 6899999998643 222335677899999999999999999987543 35
Q ss_pred EEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003385 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla 751 (824)
.++||||+. ++|.+.+.. .++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 96 VYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred EEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 699999996 477777632 267788889999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
+....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+
T Consensus 166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 166 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred eeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 76533221 223457899999999999999999999999999999999999997655
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=265.22 Aligned_cols=200 Identities=28% Similarity=0.483 Sum_probs=163.6
Q ss_pred HHhhccccccCcEEEEEEEEc-CCc----EEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~----~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
+...+.||+|+||.||+|.+. +++ .||+|.+..... .....+.+|+.++++++||||+++++++... ..++++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~ 87 (303)
T cd05110 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVT 87 (303)
T ss_pred ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeee
Confidence 345678999999999999864 444 478888865432 2234678899999999999999999998754 467999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 88 e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 88 QLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred hhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence 999999999988532 33578888999999999999999998 999999999999999999999999999986543
Q ss_pred CCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 757 GASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 757 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 2221 1122335678999999998899999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=260.70 Aligned_cols=199 Identities=29% Similarity=0.464 Sum_probs=172.0
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.+.+.||+|++|.||+|.++ +++.+++|++..... ..+.+.+|++++++++|+||+++++.+...+..++++||+++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 99 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence 445678999999999999877 688999999976544 456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
++|.+++.... ..+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++........ .
T Consensus 100 ~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 172 (286)
T cd06614 100 GSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K 172 (286)
T ss_pred CcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence 99999985431 3688999999999999999999997 999999999999999999999999998765433221 1
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....++..|++||.+.+..++.++|+|||||++|+|++|+.||....
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 223347889999999988889999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=252.83 Aligned_cols=197 Identities=35% Similarity=0.570 Sum_probs=173.6
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCC
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 682 (824)
.+.+.||+|++|.||++..+ +++.+++|++........+.+.+|++++++++||||+++++.+...+..++++||++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 45678999999999999876 68899999997655445678899999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCcee
Q 003385 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (824)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (824)
+|.+++... ...+++..+..++.|++.+|.|||+. +++||||+|+||++++++.++|+|||.+........ .
T Consensus 83 ~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 83 SLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred cHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999988543 15688999999999999999999997 999999999999999999999999999876654332 2
Q ss_pred ccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 763 ~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
....++..|+|||.+....++.++|+||||+++++|++|+.||...
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 3445889999999998888899999999999999999999999765
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=253.67 Aligned_cols=192 Identities=26% Similarity=0.330 Sum_probs=162.7
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeeceeec----CCeEEEEEEec
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE----EGRSVLVYEFM 679 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----~~~~~lV~E~~ 679 (824)
.++||-|-.|.|-.+.++ +++++|+|++.. ..+..+|+++.-.. .|||||.++++|+. ...+.+|||.|
T Consensus 67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 368999999999999766 688999999852 34567888876555 59999999999854 46778999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEecCCcccccC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~---~~~vkL~DFGla~~~~~ 756 (824)
+||.|...+.++ ....+++.++..|++||+.|+.|||+. +|.||||||+|+|.+. +..+||+|||+|+....
T Consensus 142 eGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 142 EGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred cchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 999999988553 345689999999999999999999998 9999999999999975 45799999999986543
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.. .-.+.|-|+.|.|||++...+|+..+|+||+||++|-|++|.+||....
T Consensus 217 ~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h 267 (400)
T KOG0604|consen 217 PG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_pred Cc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC
Confidence 22 2234567999999999999999999999999999999999999997543
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-28 Score=259.73 Aligned_cols=201 Identities=26% Similarity=0.446 Sum_probs=165.7
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeeceeec------CCeE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE------EGRS 672 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~------~~~~ 672 (824)
..+.+.+.||+|+||.||+|++. +++.+|+|++.... .....+..|+.+++++ +||||+++++++.. .+..
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 45667789999999999999875 67889999986543 2345678899999998 69999999998853 4578
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
+++|||+.+|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.
T Consensus 95 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred EEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 9999999999999988542 234467788889999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeccccCCCCCcchhccc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
....... ......|+..|+|||.+. ...++.++|+|||||++|||++|+.||...
T Consensus 170 ~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 170 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred hhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 5432221 123345889999999986 346788999999999999999999999653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-28 Score=260.84 Aligned_cols=204 Identities=25% Similarity=0.380 Sum_probs=165.1
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.+.||+|++|.||+|..+ +++.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 445688999999999999876 688999998864422 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecCCcccccCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~ 758 (824)
+ ++|.+++... ....+++..+..++.||+.||+|||++ +++||||+|+||+++. ++.+||+|||++.......
T Consensus 84 ~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 84 D-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred c-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 6 5777776432 223356778888999999999999998 9999999999999985 5679999999987543321
Q ss_pred CceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccc
Q 003385 759 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 813 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~ 813 (824)
. ......+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||......+.
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~ 212 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE 212 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 1 1122347889999998876 4578999999999999999999999987553333
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=267.00 Aligned_cols=208 Identities=23% Similarity=0.284 Sum_probs=168.2
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCccc--------------chhhhHHHHHHhhcCCCccceeecee
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG--------------KREFTNEVTLLSRIHHRNLVQFLGYC 666 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~--------------~~~~~~Ei~il~~l~HpnIv~l~~~~ 666 (824)
+..+.+.||+|+||+||+|..+ +++.||||+++...... ...+.+|++++++++||||+++++++
T Consensus 10 y~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (335)
T PTZ00024 10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVY 89 (335)
T ss_pred hhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEE
Confidence 3345678999999999999865 68999999986543221 12467899999999999999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 003385 667 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (824)
Q Consensus 667 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~ 746 (824)
...+..++||||+. |+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 90 VEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred ecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEEC
Confidence 99999999999997 688888742 34578889999999999999999998 99999999999999999999999
Q ss_pred ecCCcccccCCC-------------CceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcccc
Q 003385 747 DFGLSKFAVDGA-------------SHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGA 812 (824)
Q Consensus 747 DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~ 812 (824)
|||+++...... ........++..|+|||.+.+. .++.++|+||+||++|||++|+.||.+....+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999987554110 1111223467899999998764 46889999999999999999999998765443
Q ss_pred chhcH
Q 003385 813 NCRNI 817 (824)
Q Consensus 813 ~~~~i 817 (824)
....+
T Consensus 242 ~~~~i 246 (335)
T PTZ00024 242 QLGRI 246 (335)
T ss_pred HHHHH
Confidence 33333
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-28 Score=256.03 Aligned_cols=191 Identities=27% Similarity=0.402 Sum_probs=160.1
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHHHH-hhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLL-SRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.||+|+||.||+|... +++.||+|+++..... ....+..|..++ ...+|+||+++++.+...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999875 5889999998654321 122344454444 445899999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
++|.+++.. ...+++..+..++.|+++||.|||+. +++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999998843 34578888999999999999999998 999999999999999999999999998875432
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....++..|+|||.+.+..++.++||||+|+++|||++|..||....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 197 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET 197 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 223357889999999988888999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=258.49 Aligned_cols=191 Identities=28% Similarity=0.405 Sum_probs=158.0
Q ss_pred cccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHH---HHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 608 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVT---LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 608 ~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~---il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.||+|+||.||+|... +++.||+|++...... ....+..|.. .++...||+|+++++.+.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 5889999998654222 1122334443 3444579999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 9999988742 34688999999999999999999998 99999999999999999999999999987543222
Q ss_pred eeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 761 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.....|+..|+|||.+.+. .++.++||||+||++|||++|+.||.+.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 1234589999999998754 6889999999999999999999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=268.29 Aligned_cols=199 Identities=26% Similarity=0.408 Sum_probs=163.3
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecC-----CeEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL 674 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~l 674 (824)
.|.+.+.||+|+||.||+|.+. +++.||+|+++... ......+.+|++++++++||||+++++++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 4567789999999999999865 68999999986432 22345677899999999999999999987543 35799
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
++||+.+ +|.+.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 86 VQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred Eehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 9999974 7777663 34588889999999999999999998 9999999999999999999999999998754
Q ss_pred cCCCCc--eeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 755 VDGASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 755 ~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
...... ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~ 214 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD 214 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 332211 1123458899999998764 568899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=260.12 Aligned_cols=202 Identities=29% Similarity=0.520 Sum_probs=169.5
Q ss_pred HHHHhhccccccCcEEEEEEEEc-----CCcEEEEEEeccCCcc-cchhhhHHHHHHhhcCCCccceeeceeec--CCeE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRS 672 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-----~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 672 (824)
..+.+.+.||+|+||.||+|++. .++.+|||+++..... ..+.+.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 34556789999999999999864 3678999999755432 35678999999999999999999999877 5578
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
+++|||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999998543 23588899999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCc--eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 753 FAVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 753 ~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
........ ......++..|+|||.+....++.++|||||||+++||++|+.|+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 66432221 111223566799999998889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=255.07 Aligned_cols=201 Identities=27% Similarity=0.411 Sum_probs=173.2
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.++||+|+||.||+++.+ +++.+|+|.+.... ......+.+|++++++++|+||+++.+++.+....++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 345688999999999999765 67899999987542 223456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|.+++.........+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99999998865444456688899999999999999999998 9999999999999999999999999998766443
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......++..|++||.+.+..++.++|+||+|++++||++|+.||...+
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1222457899999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-29 Score=297.69 Aligned_cols=195 Identities=27% Similarity=0.430 Sum_probs=165.0
Q ss_pred hccccccCcEEEEEEEE-cCCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCC
Q 003385 606 EKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~-~~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 682 (824)
+.+||.|.||.||-|.. .+|+-.|||-++.... ...+.+.+|+.++..++|||+|+.+|+-.+.+..+|.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 45799999999999975 4678889998764432 33466889999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc--
Q 003385 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-- 760 (824)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-- 760 (824)
+|.+.+. ..+..++.....+..|++.|+.|||++ |||||||||+||+++.+|-+|++|||.|.........
T Consensus 1320 sLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1320 SLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred cHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 9999883 234455666667889999999999998 9999999999999999999999999999876554311
Q ss_pred -eeccccCCCCCcchhccccC---CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 761 -VSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 761 -~~~~~~gt~~y~aPE~l~~~---~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
.-....||+.|||||++.+. +...++||||+||++.||+||+.||..
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~ 1443 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAE 1443 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhh
Confidence 12345699999999999853 466789999999999999999999964
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=254.31 Aligned_cols=201 Identities=30% Similarity=0.490 Sum_probs=170.0
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
+.+.+.||+|+||.||+|..+ +|+.+|+|.+.... ....+.+.+|++++++++|+||+++++.+...+..++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 345688999999999999876 57899999986532 223456789999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCcccccCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~ 758 (824)
.+++|.+++... ....+++..+..++.|+++||.|||+. +++|+||||+||++++++ .+||+|||.+.......
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 82 DGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999988542 233578899999999999999999998 999999999999999885 46999999987654332
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
. ......|++.|+|||.+....++.++|+|||||+++||++|+.||....
T Consensus 157 ~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 206 (257)
T cd08225 157 E-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206 (257)
T ss_pred c-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 2 2223458899999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=256.21 Aligned_cols=198 Identities=24% Similarity=0.339 Sum_probs=162.3
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcC-CCccceeeceeecC--CeEEEEEEe
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEE--GRSVLVYEF 678 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~lV~E~ 678 (824)
.+.++||+|+||.||+|+.. +++.||+|+++.... .......+|+.++.++. |+||+++++++.+. +..++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 45678999999999999865 688999999875422 22233457888898885 99999999999887 889999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
++ ++|.+.+... ...+++..+..++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++......
T Consensus 82 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 82 MD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred CC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 97 5777777432 24678999999999999999999998 9999999999999999 999999999987654322
Q ss_pred CceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 759 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
.. ....++..|+|||.+.. ..++.++||||+||++|||++|..||.+.+..
T Consensus 154 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~ 205 (282)
T cd07831 154 PY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL 205 (282)
T ss_pred Cc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH
Confidence 21 22347899999997654 45688999999999999999999999876533
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=260.72 Aligned_cols=196 Identities=27% Similarity=0.450 Sum_probs=164.9
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
..|.+.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+++++.++||||+++.+++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 34667789999999999999875 688999999864322 22346889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+. |++.+.+... ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 5676665322 34578899999999999999999998 999999999999999999999999999865432
Q ss_pred CCCceeccccCCCCCcchhccc---cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 757 GASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
. ....++..|+|||++. ...++.++||||||+++|||++|+.||.+.
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 2 2235788999999875 356888999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=258.71 Aligned_cols=197 Identities=26% Similarity=0.388 Sum_probs=166.1
Q ss_pred HhhccccccCcEEEEEEEEc----CCcEEEEEEeccCCc----ccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEE
Q 003385 604 MLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSY----QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVL 674 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~----~g~~vAVK~l~~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 674 (824)
.+.+.||+|++|.||+++.. +++.||||+++.... ...+.+.+|+++++++ +||||+++++.+......++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 45688999999999999753 567899999864321 2235678899999999 59999999999999999999
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
||||+.+++|.+++.. ...+++..+..++.|++++|.|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 83 ILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999988743 34578888899999999999999997 9999999999999999999999999998765
Q ss_pred cCCCCceeccccCCCCCcchhccccCC--CCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 755 VDGASHVSSIVRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 755 ~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
............|+..|+|||.+.+.. .+.++|+||||+++|||++|..||..
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 443332333345889999999987655 78899999999999999999999953
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=257.95 Aligned_cols=200 Identities=30% Similarity=0.447 Sum_probs=171.7
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcC-CCccceeeceeecCCeEEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E 677 (824)
|.+.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|++++++++ ||||+++++++.+.+..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 456788999999999999876 68999999986532 222456788999999998 9999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
++++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 83 YAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999998843 34689999999999999999999998 9999999999999999999999999998755432
Q ss_pred CC-------------------ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 758 AS-------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 758 ~~-------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.. .......++..|+|||......++.++|+||+|++++++++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 21 12233457899999999988889999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=266.01 Aligned_cols=208 Identities=27% Similarity=0.405 Sum_probs=173.1
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCC-----eEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVL 674 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~l 674 (824)
|.+.+.||+|++|.||+|+.. +++.+|+|++.... ....+.+.+|+++++.++||||+++.+++...+ ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 456789999999999999876 58999999987543 334567889999999999999999999987765 7899
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
+|||+. ++|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 82 v~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 82 VTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred Eecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 999997 478877743 33788999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCC--ceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 755 VDGAS--HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 755 ~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
..... .......++..|+|||.+.+. .++.++|+||+||++|+|++|+.||.+....+....+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 220 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIV 220 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 44321 112233578899999999887 88999999999999999999999998766444343433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=263.63 Aligned_cols=200 Identities=27% Similarity=0.444 Sum_probs=164.7
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccC--CcccchhhhHHHHHHhhc-CCCccceeeceeecC--CeEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE--GRSVL 674 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--~~~~l 674 (824)
..|.+.+.||+|+||.||+|.+. +++.+|+|++... .......+.+|+.+++++ +||||+++++++... ...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 45667789999999999999876 5788999988542 222345577899999999 999999999988643 46799
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
||||+. ++|.+++.. ..+.+..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 87 VFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred Eecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 999997 588887743 2577888889999999999999998 9999999999999999999999999998755
Q ss_pred cCCCC----ceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 755 VDGAS----HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 755 ~~~~~----~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
..... .......|+..|+|||.+.. ..++.++|||||||++|||++|+.||.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 43221 12223458899999998765 467889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=260.72 Aligned_cols=195 Identities=29% Similarity=0.475 Sum_probs=164.0
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
.+...+.||+|+||.||+|+.. +++.+|+|++...... ....+.+|++++++++|||++++++++.+.+..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3556688999999999999865 6889999998644222 23467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+. |+|.+.+... ...+++.++..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 106 YCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 997 4777766432 34578899999999999999999998 9999999999999999999999999988654322
Q ss_pred CCceeccccCCCCCcchhccc---cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 758 ASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
....|+..|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 2235788999999974 456888999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=251.10 Aligned_cols=198 Identities=27% Similarity=0.452 Sum_probs=172.2
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.+.||+|++|.||+|+.. +++.+++|.+..... ...+.+.+|++++++++|||++++++++.+.+..++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 445689999999999999876 678999999976543 33467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 82 ENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999998843 25688999999999999999999998 999999999999999999999999999986654332
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
. .....++..|+|||...+..++.++||||+|+++++|++|+.||...
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~ 202 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL 202 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc
Confidence 2 23345889999999998888899999999999999999999999753
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=260.30 Aligned_cols=205 Identities=21% Similarity=0.272 Sum_probs=152.4
Q ss_pred HHHHHHHHhhccccccCcEEEEEEEEcCC----cEEEEEEeccCCcccc-----------hhhhHHHHHHhhcCCCccce
Q 003385 597 DIEDATKMLEKKIGSGGFGVVYYGKLKDG----KEIAVKVLTSNSYQGK-----------REFTNEVTLLSRIHHRNLVQ 661 (824)
Q Consensus 597 ~~~~~~~~i~~~LG~G~fg~Vy~a~~~~g----~~vAVK~l~~~~~~~~-----------~~~~~Ei~il~~l~HpnIv~ 661 (824)
++....|.+.+.||+|+||.||+|++.++ ..+|+|+......... .....+...+..++|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 44445677889999999999999987643 4566665432221100 01122334455668999999
Q ss_pred eeceeecCC----eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 003385 662 FLGYCQEEG----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 737 (824)
Q Consensus 662 l~~~~~~~~----~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl 737 (824)
+++.+.... ..++++|++.. ++.+.+.. ....++..+..++.|++.||+|||+. +|+||||||+|||+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill 159 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV 159 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 998765443 34677777643 55555422 22346777889999999999999998 99999999999999
Q ss_pred cCCCcEEEEecCCcccccCCCCc------eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 738 DKHMRAKVSDFGLSKFAVDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 738 ~~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
+.++.+||+|||+++........ ......||+.|+|||...+..++.++|||||||+++||++|+.||.+..
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999765322111 1123459999999999999999999999999999999999999998763
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=257.12 Aligned_cols=198 Identities=29% Similarity=0.373 Sum_probs=161.9
Q ss_pred hhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcC-CCccceeeceeecCCeEEEEEEecCC
Q 003385 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
..+.||+|+||.||++.+. +++.+|+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||+..
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 4578999999999999875 58899999987543 233456888999999996 99999999999988899999999864
Q ss_pred CCHHHHhhc-ccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 682 GTLKEHLYG-TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 682 gsL~~~L~~-~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
++.++... .......+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++.......
T Consensus 88 -~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 163 (288)
T cd06616 88 -SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA- 163 (288)
T ss_pred -CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc-
Confidence 55443311 111235688899999999999999999974 2899999999999999999999999999875543221
Q ss_pred eeccccCCCCCcchhccccC---CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 761 VSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~---~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
.....|+..|+|||++... .++.++||||+||++|||++|+.||..
T Consensus 164 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 164 -KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred -cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 1223578999999998866 688999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-29 Score=253.38 Aligned_cols=207 Identities=31% Similarity=0.436 Sum_probs=163.3
Q ss_pred cccCHHHHHHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhh-cCCCccceeeceee
Q 003385 591 HCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSR-IHHRNLVQFLGYCQ 667 (824)
Q Consensus 591 ~~~~~~~~~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~ 667 (824)
+.|+..++.+. ..||.|+||+|++..++ .|+..|||.++.... .+++++..|.+...+ -+.||||+++|++.
T Consensus 59 ~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 59 HTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred cccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 44544444432 46899999999999876 689999999987644 445667777776544 46899999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHhh-cccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 003385 668 EEGRSVLVYEFMHNGTLKEHLY-GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (824)
Q Consensus 668 ~~~~~~lV~E~~~~gsL~~~L~-~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~ 746 (824)
.++..++.||.|. -+|..+-. -...+...+++.-...|....+.||.||.+. ..|||||+||+|||++..|.+|||
T Consensus 134 ~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 134 SEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred cCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeee
Confidence 9999999999995 35543321 1112345577777777888889999999987 489999999999999999999999
Q ss_pred ecCCcccccCCCCceeccccCCCCCcchhcccc--CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 747 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 747 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
|||++-...++ ...+..+|-..|||||.+.. ..|+-++|+||||+.|+|+.||+.|+.+
T Consensus 211 DFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 211 DFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred cccchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 99998765443 23344568899999999973 4589999999999999999999999976
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=252.35 Aligned_cols=189 Identities=24% Similarity=0.389 Sum_probs=157.3
Q ss_pred Hhhcc--ccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEEec
Q 003385 604 MLEKK--IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 604 ~i~~~--LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.+.+. ||+|+||.||+++.+ +++.+|+|++...... . .|+.....+ +||||+++++.+...+..++||||+
T Consensus 17 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~--~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~ 91 (267)
T PHA03390 17 EIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---A--IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYI 91 (267)
T ss_pred ccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---h--hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcC
Confidence 34444 599999999999865 6788999998643221 1 123333222 6999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCcccccCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~ 758 (824)
++++|.+++.. ...+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||+++.....
T Consensus 92 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 92 KDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence 99999998853 23788999999999999999999998 999999999999999998 9999999998755322
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
....++..|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred ----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 12358899999999999899999999999999999999999997543
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=264.90 Aligned_cols=200 Identities=23% Similarity=0.374 Sum_probs=165.3
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeec----CCeEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVL 674 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~l 674 (824)
.|.+.+.||+|++|.||+|..+ +++.||+|++..... ...+.+.+|+.++++++||||+++++++.. ....++
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence 4556788999999999999865 689999999875422 234567789999999999999999998753 356899
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
||||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 86 VMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 999996 588887742 34588999999999999999999998 9999999999999999999999999998755
Q ss_pred cCCCCc---eeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 755 VDGASH---VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 755 ~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
...... ......|+..|+|||.+.. ..++.++||||+||++|||++|+.||.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 332211 1123468899999999865 468899999999999999999999997754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=258.61 Aligned_cols=201 Identities=23% Similarity=0.367 Sum_probs=162.9
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--cchhhhHHHHHHhhcCCCccceeeceeecCC--------
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-------- 670 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-------- 670 (824)
.|.+.++||+|+||.||+|..+ +++.||||++...... ....+.+|++++++++||||+++++++...+
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 3556789999999999999876 6889999988643222 1234568999999999999999999886543
Q ss_pred eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGl 750 (824)
..++||||+.+ +|.+.+.. ....+++.++..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||+
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence 45999999974 77777643 223578999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCc---eeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 751 SKFAVDGASH---VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 751 a~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
+......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 8755332211 11234578899999988654 46889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=259.58 Aligned_cols=207 Identities=27% Similarity=0.414 Sum_probs=172.2
Q ss_pred HHHHHHHhhccccccCcEEEEEEEE-cCCcEEEEEEeccCCcccc-------hhhhHHHHHHhhcCCCccceeeceee-c
Q 003385 598 IEDATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGK-------REFTNEVTLLSRIHHRNLVQFLGYCQ-E 668 (824)
Q Consensus 598 ~~~~~~~i~~~LG~G~fg~Vy~a~~-~~g~~vAVK~l~~~~~~~~-------~~~~~Ei~il~~l~HpnIv~l~~~~~-~ 668 (824)
....+|.+.+.||+|||++||+|.+ ...+-||||+-..+..+.. +...+|..+.+.++||.||++++++. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 4466788889999999999999974 4577899998765433321 23568999999999999999999986 4
Q ss_pred CCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEE
Q 003385 669 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKV 745 (824)
Q Consensus 669 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~---~~~vkL 745 (824)
.+..+-|+|||+|.+|.-+|+. .+.+++.++..|+.||+.||.||.+. .++|||-||||.|||+.+ .|.+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred cccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 5667899999999999999854 45678899999999999999999986 469999999999999965 378999
Q ss_pred EecCCcccccCCCC------ceeccccCCCCCcchhccccC----CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 746 SDFGLSKFAVDGAS------HVSSIVRGTVGYLDPEYYISQ----QLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 746 ~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~----~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.|||+++.+.+... ..+....||.+|++||.+.-+ +.+.|+||||.|||+|+++.|+.||....
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 99999998765432 234567799999999998643 56789999999999999999999998644
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=254.48 Aligned_cols=208 Identities=25% Similarity=0.382 Sum_probs=169.3
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--cchhhhHHHHHHhhc---CCCccceeeceeecCCe-----E
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRI---HHRNLVQFLGYCQEEGR-----S 672 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~-----~ 672 (824)
.+.+.||+|+||.||+|+++ +++.+|+|+++..... ....+.+|+.+++++ +||||+++++++...+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 35678999999999999987 4899999999743222 134566788777666 59999999999987776 8
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
+++|||+.+ +|.+++.... ...+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.+||+|||.+.
T Consensus 82 ~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 82 TLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred EEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 999999974 7888775322 23588999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
....... .....++..|+|||.+.+..++.++|+|||||++|||++|+.||.+....+...++.+
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~ 220 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFD 220 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHH
Confidence 6533221 1223478899999999988999999999999999999999999988765554444444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=248.54 Aligned_cols=193 Identities=35% Similarity=0.471 Sum_probs=167.3
Q ss_pred ccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCH
Q 003385 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (824)
Q Consensus 609 LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 684 (824)
||+|+||.||++..+ +++.+|+|+++..... ....+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999876 5889999998754332 245688899999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceecc
Q 003385 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (824)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (824)
.+++.. ...+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNT 152 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccC
Confidence 998843 23578899999999999999999997 999999999999999999999999999876543321 2233
Q ss_pred ccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 765 ~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
..++..|+|||...+...+.++|+||||+++||+++|+.||....
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 457889999999988888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=254.51 Aligned_cols=197 Identities=26% Similarity=0.401 Sum_probs=167.5
Q ss_pred hhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.+.||+|++|.||+|..+ +++.+++|.++..... ....+.+|++++++++|+||+++++++..++..++|+||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence 4578999999999999875 6888999998754322 345788899999999999999999999999999999999975
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
++.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||.+....... ..
T Consensus 83 -~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 83 -DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred -CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 887777432 24688899999999999999999998 99999999999999999999999999987664433 11
Q ss_pred eccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||.+..
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2223478899999998876 78899999999999999999999997655
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=261.44 Aligned_cols=198 Identities=22% Similarity=0.324 Sum_probs=161.3
Q ss_pred cccccc--CcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSG--GFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G--~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.||+| +||+||+|++. +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999875 789999999875432 2235688899999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc-
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH- 760 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~- 760 (824)
+++.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999886432 23478888889999999999999998 9999999999999999999999999854322111110
Q ss_pred -----eeccccCCCCCcchhccccC--CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 761 -----VSSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 761 -----~~~~~~gt~~y~aPE~l~~~--~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......++..|+|||++.+. .++.++||||+||++|||++|+.||.+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 01112356679999998763 47899999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=258.91 Aligned_cols=203 Identities=24% Similarity=0.374 Sum_probs=163.1
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--cchhhhHHHHHHhhcCCCccceeeceeecC--------C
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEE--------G 670 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--------~ 670 (824)
.|.+.++||+|+||.||+|.++ +++.+|+|++...... ....+.+|++++++++||||+++++++.+. .
T Consensus 9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 88 (311)
T cd07866 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG 88 (311)
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence 4556789999999999999876 6889999988644322 234567899999999999999999987443 3
Q ss_pred eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGl 750 (824)
..++|+||+.+ ++...+.. ....+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 89 ~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 89 SVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred eEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 46899999975 56665532 234688999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCc----------eeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 751 SKFAVDGASH----------VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 751 a~~~~~~~~~----------~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
++........ ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 8754332111 1122346888999998765 45789999999999999999999999875543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=263.30 Aligned_cols=199 Identities=25% Similarity=0.416 Sum_probs=164.6
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccC--CcccchhhhHHHHHHhhcCCCccceeeceeecC-----CeEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSV 673 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~ 673 (824)
+|.+.+.||+|+||.||+|+.. +++.||||.++.. .......+.+|+.+++.++||||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 3556789999999999999865 6899999998643 222234567899999999999999999987644 3479
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+|+||+. ++|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 86 IVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 9999996 688877742 35688999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
..... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+..
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 54322 12223457889999998865 468899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=248.27 Aligned_cols=199 Identities=27% Similarity=0.446 Sum_probs=172.2
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecC--CeEEEEEEe
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEF 678 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV~E~ 678 (824)
.+.+.||+|++|.||+|..+ +++.|++|++..... ...+.+.+|++++++++||||+++++.+... ...++++||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 34578999999999999877 688999999875542 3356788999999999999999999999888 889999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 83 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 83 VSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999988532 3788999999999999999999998 99999999999999999999999999987654433
Q ss_pred Cc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.. ......++..|+|||.+.....+.++||||||+++++|++|..||....
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 1233458899999999988889999999999999999999999997643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=253.61 Aligned_cols=205 Identities=27% Similarity=0.381 Sum_probs=170.6
Q ss_pred hhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.+.||+|++|.||+|+.. +++.+|+|++.... ....+.+..|++++++++|+||+++++++.+.+..++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 4578999999999999876 58999999987653 2224567789999999999999999999999999999999998
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||+|+||++++++.+||+|||.++........
T Consensus 82 ~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 154 (282)
T cd07829 82 MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT- 154 (282)
T ss_pred cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-
Confidence 58999885421 4588999999999999999999998 9999999999999999999999999998765433221
Q ss_pred eccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcH
Q 003385 762 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i 817 (824)
.....++..|+|||.+... .++.++|||||||+++||++|+.||......+...++
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 211 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 2223457889999998776 7889999999999999999999999876544333333
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=256.52 Aligned_cols=198 Identities=20% Similarity=0.284 Sum_probs=160.9
Q ss_pred hhccccccCcEEEEEEEEcCCcEEEEEEeccC--CcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCC
Q 003385 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 682 (824)
+++.+|.|+++.|+++.. +++.||||+++.. .....+.+.+|++++++++||||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 445555555555555544 5899999998754 2334467899999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC---
Q 003385 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--- 759 (824)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--- 759 (824)
+|.+++.... ...+++.....++.|+++||+|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999886432 23477888889999999999999998 999999999999999999999999998864432111
Q ss_pred ---ceeccccCCCCCcchhcccc--CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 760 ---HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 760 ---~~~~~~~gt~~y~aPE~l~~--~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.......++..|+|||.+.. ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11122346788999999876 35889999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=263.23 Aligned_cols=199 Identities=24% Similarity=0.381 Sum_probs=162.8
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecC-----------
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE----------- 669 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----------- 669 (824)
+|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++.+...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 4556789999999999999875 6889999998765555556788999999999999999999876543
Q ss_pred ---CeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEE
Q 003385 670 ---GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKV 745 (824)
Q Consensus 670 ---~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~-~~~vkL 745 (824)
...++|+||++ ++|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 58887763 23578889999999999999999998 9999999999999985 567899
Q ss_pred EecCCcccccCCCCce--eccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 746 SDFGLSKFAVDGASHV--SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 746 ~DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
+|||.++......... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||.+..
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999987543321111 122347889999998754 567889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=251.86 Aligned_cols=201 Identities=28% Similarity=0.428 Sum_probs=166.2
Q ss_pred HHhhccccccCcEEEEEEEEcC-CcEEEEEEeccCC-----cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~-g~~vAVK~l~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
|.+.+.||+|+||.||++.+.. +..+++|+++... ......+.+|+.++++++||||+++++++.+....++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 5567899999999999998653 4556666665322 122335667899999999999999999999988999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++++|.+.+.........+++..++.++.|++.||.|||+. +++|+||||+||++++ +.+||+|||.++....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999988865434456789999999999999999999998 9999999999999975 5699999999876543
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
... ......|+..|+|||.+....++.++|+||||+++|+|++|..||...
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~ 208 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 322 223345788999999998888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-28 Score=261.40 Aligned_cols=202 Identities=27% Similarity=0.359 Sum_probs=166.4
Q ss_pred HHHHHHHhhccccccCcEEEEEEEEcCCcEEEEEEecc--CCcccchhhhHHHHHHhhcC-CCccceeeceeecCCeEEE
Q 003385 598 IEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTS--NSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVL 674 (824)
Q Consensus 598 ~~~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~--~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l 674 (824)
+....|.+.++||+||.+.||++...+.+.+|+|.+.. .+.+...-|..|++.|.+++ |.+|+++++|-..++.+||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 34567788899999999999999988778888886643 23444567899999999995 9999999999999999999
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
|||+= .-+|..+|.... ...+-..+..+..|++.++.++|.+ ||||.||||.|+|+.. |.+||+|||+|..+
T Consensus 438 vmE~G-d~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred Eeecc-cccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 99974 468999886432 2223236778999999999999998 9999999999999864 68999999999876
Q ss_pred cCCCC-ceeccccCCCCCcchhccccCC-----------CCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 755 VDGAS-HVSSIVRGTVGYLDPEYYISQQ-----------LTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 755 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~-----------~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
..... ......+||+.||+||.+.... .+.++||||||||||+|+.|+.||..
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 55433 3445567999999999986433 45689999999999999999999975
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=261.83 Aligned_cols=195 Identities=26% Similarity=0.387 Sum_probs=161.2
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecC------CeE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS 672 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~~ 672 (824)
+|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (345)
T cd07877 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 97 (345)
T ss_pred ceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccE
Confidence 3556788999999999999754 68899999986532 22245677899999999999999999987543 346
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
+++++++ +++|.+.+. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 98 ~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 98 YLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred EEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecccccc
Confidence 7888876 678887763 23578889999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
..... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||....
T Consensus 169 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 222 (345)
T cd07877 169 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222 (345)
T ss_pred ccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 54321 223357899999998866 568889999999999999999999997654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=253.52 Aligned_cols=194 Identities=29% Similarity=0.478 Sum_probs=162.4
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
+...++||+|+||+||+|+.. +++.|++|++...... ..+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 334567999999999999865 6889999998643222 234678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+. |++.+.+.. ....+++.++..++.|++.+|.|||+. +++||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 577776642 234578899999999999999999998 999999999999999999999999998764321
Q ss_pred CceeccccCCCCCcchhccc---cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 759 SHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.....|+..|+|||++. ...++.++|||||||++|||++|..||.+.
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 12345889999999984 356888999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=252.10 Aligned_cols=200 Identities=24% Similarity=0.369 Sum_probs=166.3
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcC-CCccceeeceeecCCeEEEEEEecC
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.+.+.||+|++|+||+|+.. +++.|+||.+..... .......+|+..+++++ ||||+++++++.+.+..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 45688999999999999976 478899999865422 22234557899999999 999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+|+|.+.+.... ...+++..+..++.|++.+|.|||++ +++|+||+|+||++++++.++|+|||.++.......
T Consensus 81 ~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 789988875432 34678999999999999999999998 999999999999999999999999999876543222
Q ss_pred eeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 761 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
.....++..|+|||.+.+ ..++.++|+||||++++||++|+.||......
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~ 205 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI 205 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChH
Confidence 122347889999998754 45789999999999999999999999765533
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=260.43 Aligned_cols=195 Identities=25% Similarity=0.380 Sum_probs=162.5
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCC------eE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RS 672 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~~ 672 (824)
+|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 3556788999999999999754 68999999986432 122346788999999999999999999886543 45
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
++||||+ +++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 96 ~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 96 YLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred EEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 8999998 678888763 24578889999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
..... .....+++.|+|||.+.. ..++.++|+||+||++|++++|+.||.+..
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 167 QTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred ccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 54322 122347889999999876 458889999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=242.26 Aligned_cols=195 Identities=28% Similarity=0.409 Sum_probs=160.8
Q ss_pred hhccccccCcEEEEEEEEc-CCcEEEEEEeccC-CcccchhhhHHHHHHhhcC-CCccceeeceeecCCeEEEEEEecCC
Q 003385 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+...||.|.-|.||+++++ .|..+|||.+... .....+++...+.++.+.+ .|.||+.+|+|......++.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 3467999999999999877 5788999999755 3344556777777766654 7999999999999988999999985
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
..+...++. -..++++.-+.++...+++||.||.+++ +|+|||+||+|||+|+.|.+|+||||++-.+.++..+
T Consensus 175 ~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh- 248 (391)
T KOG0983|consen 175 TCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH- 248 (391)
T ss_pred HHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc-
Confidence 344444432 1344777777888999999999999985 9999999999999999999999999999877665544
Q ss_pred eccccCCCCCcchhccc---cCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 762 SSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~---~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
...+|-+.|||||.+. ...|+.++||||||+.++||.||+.||.+
T Consensus 249 -trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 249 -TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred -ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 3456889999999986 34788999999999999999999999987
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=257.72 Aligned_cols=200 Identities=25% Similarity=0.364 Sum_probs=161.5
Q ss_pred HHhhccccccCcEEEEEEEEc-C--CcEEEEEEeccCC--cccchhhhHHHHHHhhc-CCCccceeeceeec----CCeE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-D--GKEIAVKVLTSNS--YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE----EGRS 672 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~--g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----~~~~ 672 (824)
|.+.+.||+|+||.||+++.. . ++.||+|++.... ....+.+.+|+++++++ +||||+++++.+.. ....
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 345688999999999999876 3 6789999986432 12245677899999999 59999999986532 2457
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
++++||+. ++|.+.+. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 82 ~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 82 YLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 88899886 68888774 245688899999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCc---eeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 753 FAVDGASH---VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 753 ~~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
........ ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||.....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~ 215 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY 215 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH
Confidence 54432211 1123458999999998765 5688999999999999999999999987553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-27 Score=254.35 Aligned_cols=197 Identities=27% Similarity=0.460 Sum_probs=163.9
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
..++...+.||+|+||.||+|+.. +++.+|+|.+..... ...+++.+|+++++.++|+|++++.+++...+..++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 344556688999999999999875 578899998864321 2234677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
|||+. |++.+.+... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 94 MEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 99996 5777766422 34578888999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCceeccccCCCCCcchhccc---cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.. ....++..|+|||.+. ...++.++|||||||++|||++|..||...
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 22 2235788999999975 356788999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=259.20 Aligned_cols=194 Identities=26% Similarity=0.412 Sum_probs=159.9
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecC------CeEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSV 673 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~~~ 673 (824)
|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++... ...+
T Consensus 17 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 96 (342)
T cd07879 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY 96 (342)
T ss_pred eEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence 445688999999999999865 689999999864321 2234578899999999999999999988654 3468
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+|+||+.. +|.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 97 lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 97 LVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 99999964 666554 23477888899999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+...
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~ 220 (342)
T cd07879 167 ADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 220 (342)
T ss_pred CCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 4221 122347889999999876 4688999999999999999999999987653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=277.77 Aligned_cols=208 Identities=30% Similarity=0.486 Sum_probs=174.1
Q ss_pred HHHHHHHHhhccccccCcEEEEEEEEc----C----CcEEEEEEeccCCc-ccchhhhHHHHHHhhc-CCCccceeecee
Q 003385 597 DIEDATKMLEKKIGSGGFGVVYYGKLK----D----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYC 666 (824)
Q Consensus 597 ~~~~~~~~i~~~LG~G~fg~Vy~a~~~----~----g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 666 (824)
++.+....+.+.||+|.||.|++|... . ...||||.++.... .+.+.+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 444444456779999999999999743 1 35689999975533 4467799999999998 599999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHhhccc----------Ccc--ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 003385 667 QEEGRSVLVYEFMHNGTLKEHLYGTL----------THE--QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 734 (824)
Q Consensus 667 ~~~~~~~lV~E~~~~gsL~~~L~~~~----------~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~N 734 (824)
.+.+..++|+||++.|+|.++|+... ... ..++..+.+.++.|||.||+||++. +++||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhhh
Confidence 99999999999999999999997654 111 2388999999999999999999998 89999999999
Q ss_pred EEEcCCCcEEEEecCCcccccCCCCceecccc--CCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003385 735 ILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISN 807 (824)
Q Consensus 735 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~--gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~ 807 (824)
||+.++..+||+|||+++...+.......... -+..|||||.+....|+.++|||||||+||||++ |..||.+
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 99999999999999999865554443322222 2457999999999999999999999999999999 8899987
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-28 Score=243.92 Aligned_cols=200 Identities=25% Similarity=0.410 Sum_probs=162.4
Q ss_pred hhccccccCcEEEEEEEEc-CCcEEEEEEec-cCCcc-cchhhhHHHHHHhhcCCCccceeeceeec--------CCeEE
Q 003385 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLT-SNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQE--------EGRSV 673 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~-~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--------~~~~~ 673 (824)
-..+||+|.||+|++|+.+ +|+.||+|+.- .+... -.....+|+++|+.++|+|++.+++.|.. ....+
T Consensus 21 k~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~y 100 (376)
T KOG0669|consen 21 KLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFY 100 (376)
T ss_pred HHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceee
Confidence 3468999999999999866 57788987542 22222 23456789999999999999999998853 23478
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+||++|+. +|.-.|.+. ..+++..++..++.++..||.|+|+. .|+|||+||+|+||+.++.+||+|||+++.
T Consensus 101 lVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 101 LVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 99999975 677766432 35688899999999999999999998 999999999999999999999999999976
Q ss_pred ccCCCC---ceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 754 AVDGAS---HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 754 ~~~~~~---~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
+...+. ......+-|.+|++||.+.+ ..|+++.|||..|||+.||++|.+-|++.+-+
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq 235 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ 235 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH
Confidence 543322 12333456999999999886 57899999999999999999999999987633
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=255.35 Aligned_cols=195 Identities=23% Similarity=0.378 Sum_probs=162.1
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeec-CCeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV~E 677 (824)
.|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++.+++.. ....++++|
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 4556789999999999999865 78999999876432 2234567889999999999999999998865 557889999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+ +++|.+.+. ...++......++.|+++||+|||+. +|+||||+|+||++++++.+||+|||.+......
T Consensus 91 ~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 91 LL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred hh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 98 568887774 23467777888999999999999998 9999999999999999999999999998754221
Q ss_pred CCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 758 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....++..|+|||.+.+ ..++.++||||+||++|||++|+.||....
T Consensus 162 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 162 ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred ----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 122346889999998766 568999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=250.35 Aligned_cols=197 Identities=28% Similarity=0.413 Sum_probs=160.8
Q ss_pred HHhhccccccCcEEEEEEEEcC-CcEEEEEEeccCCc-ccchhhhHHHHHHhhcC-CCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~-g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
+.+.+.||+|++|.||+|.+++ ++.||||+++.... .....+.+|++++.+.. ||||+++++++.+....+++|||+
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 4567899999999999999874 88999999875432 22345666777776664 999999999999999999999998
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
. +++.+.+... ...+++..+..++.|++.||+|||+. .+|+||||+|+||++++++.+||+|||++........
T Consensus 97 ~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 97 S-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred C-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 5 4666655321 23678888999999999999999973 2899999999999999999999999999876533222
Q ss_pred ceeccccCCCCCcchhccccCC----CCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQ----LTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~----~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
. ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 171 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 171 K--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred c--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 1 2234788999999987554 78899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=277.56 Aligned_cols=143 Identities=31% Similarity=0.413 Sum_probs=126.2
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.++||+|+||.||+|.+. +++.||||+++..... ....+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence 456789999999999999876 6889999999754322 235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
+.+++|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999998843 24577888899999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=260.11 Aligned_cols=195 Identities=23% Similarity=0.429 Sum_probs=166.4
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-----cc---cchhhhHHHHHHhhcC---CCccceeeceeecCC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-----YQ---GKREFTNEVTLLSRIH---HRNLVQFLGYCQEEG 670 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-----~~---~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~ 670 (824)
|...+.+|+|+||.|+.|.++ +..+|+||.+.+.. +. +...+..|+++|..++ |+||++++++|++.+
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 445688999999999999887 46789999887542 11 1234678999999997 999999999999999
Q ss_pred eEEEEEEecC-CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003385 671 RSVLVYEFMH-NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (824)
Q Consensus 671 ~~~lV~E~~~-~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFG 749 (824)
.+||+||-.. +-+|.+++ .....+++.++..|++|++.|+++||+. ||||||||-+|++++.+|-+||+|||
T Consensus 643 ~yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred eeEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeecc
Confidence 9999999764 44788877 3456788999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCceeccccCCCCCcchhccccCCCCch-HHHHHHHHHHHHHHcCCCCCCC
Q 003385 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK-SDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DIwSlGvil~elltG~~Pf~~ 807 (824)
.+.+...+. ...++||..|.|||++.+..|--| -|||++|++||.++..+-||..
T Consensus 716 saa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 716 SAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred chhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 988765443 345679999999999999888654 6999999999999999999853
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=261.49 Aligned_cols=190 Identities=24% Similarity=0.410 Sum_probs=159.9
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.|.+...+|.|+|+.|..+.+. +++..+||++.+. ..+..+|+.++... +||||+++.+.+.+..+.++|||.+
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 4566778999999999999765 6888999999754 34455677666555 7999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE-cCCCcEEEEecCCcccccCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL-DKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl-~~~~~vkL~DFGla~~~~~~~ 758 (824)
.++-+.+.+... . .....+..++.+|+.++.|||++ |+|||||||+|||+ ++.++++|+|||.++.....
T Consensus 399 ~g~ell~ri~~~----~-~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 399 DGGELLRRIRSK----P-EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred cccHHHHHHHhc----c-hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 999887776432 1 22256778999999999999998 99999999999999 58899999999998765443
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
....+-|..|.|||++....|++++|+||||++||+|++|+.||..
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~ 515 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAA 515 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCcccc
Confidence 2223468899999999999999999999999999999999999964
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=274.88 Aligned_cols=213 Identities=28% Similarity=0.442 Sum_probs=161.0
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeec---------------
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--------------- 668 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--------------- 668 (824)
.+.||+||||.||+++.+ ||+.+|||++.... ......+.+|+..+.+++|||||+.+..+.+
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 368999999999999976 89999999997653 2334678899999999999999997653210
Q ss_pred --------------------------------------------------------------------------------
Q 003385 669 -------------------------------------------------------------------------------- 668 (824)
Q Consensus 669 -------------------------------------------------------------------------------- 668 (824)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred ----------------C--------CeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 003385 669 ----------------E--------GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724 (824)
Q Consensus 669 ----------------~--------~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~g 724 (824)
+ ..+||=||||+.-.+.+.+....-.. .....+++++||+.||.|+|+. |
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH~~---g 717 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIHDQ---G 717 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHHhC---c
Confidence 0 12356677777766666664332111 2456678999999999999998 9
Q ss_pred eEecCCCCCCEEEcCCCcEEEEecCCccccc------C-----------CCCceeccccCCCCCcchhccccC---CCCc
Q 003385 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAV------D-----------GASHVSSIVRGTVGYLDPEYYISQ---QLTD 784 (824)
Q Consensus 725 IvHrDLkp~NILl~~~~~vkL~DFGla~~~~------~-----------~~~~~~~~~~gt~~y~aPE~l~~~---~~~~ 784 (824)
||||||||.||+++++..+||+|||+|+... . ......+...||.-|+|||++.+. .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998621 0 011122345699999999999865 4999
Q ss_pred hHHHHHHHHHHHHHHc-----------------CCCCCC---CCccccchhcHhhhhccC
Q 003385 785 KSDVYSFGVILLELIS-----------------GQEAIS---NEKFGANCRNIVQWVKSS 824 (824)
Q Consensus 785 ~~DIwSlGvil~ellt-----------------G~~Pf~---~~~~~~~~~~iv~~~~~~ 824 (824)
|+||||+|||++||+. |..|+. ....-....++++|+.++
T Consensus 798 KiDmYSLGIVlFEM~yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLYPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSH 857 (1351)
T ss_pred hhhhHHHHHHHHHHhccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcC
Confidence 9999999999999974 445555 222223455889998864
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=257.70 Aligned_cols=196 Identities=26% Similarity=0.391 Sum_probs=163.9
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCe------EE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR------SV 673 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~------~~ 673 (824)
|.+.+.||+|++|.||+|++. +++.||+|++.... ....+.+.+|+.++++++||||+++.+++...+. .+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 456788999999999999876 57899999986432 2233557789999999999999999998866554 89
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 97 lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 97 LVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred EEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 999998 5689888742 4588899999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
.... .....++..|+|||.+.. ..++.++||||+||++|||++|+.||.+....
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~ 222 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI 222 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 5332 222357889999998865 36788999999999999999999999765543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=241.76 Aligned_cols=196 Identities=24% Similarity=0.397 Sum_probs=170.6
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCccc---chhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEEe
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---KREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~---~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
.+.+.||+|+|+.|-.++++ +.+.+|+|++++....+ .+=.+.|..+..+. +||.+|-+..+|..+.+++.|.||
T Consensus 253 ~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey 332 (593)
T KOG0695|consen 253 DLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY 332 (593)
T ss_pred eeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence 45689999999999999876 57789999998653322 23356677777666 699999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+.||+|.-++ +..+.+++..+..+..+|+-||.|||++ ||+.||||..|+|++..|++||.|+|+++.... .
T Consensus 333 v~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~-~ 404 (593)
T KOG0695|consen 333 VNGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG-P 404 (593)
T ss_pred ecCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCC-C
Confidence 9999987665 4567799999999999999999999998 999999999999999999999999999875433 3
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
...+.++|||+.|+|||.+.+..|...+|.|++||+|+||+.|+.||+-
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 4456788999999999999999999999999999999999999999973
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=250.01 Aligned_cols=208 Identities=23% Similarity=0.344 Sum_probs=175.4
Q ss_pred cccCHHHHHHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCC--C----ccceee
Q 003385 591 HCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--R----NLVQFL 663 (824)
Q Consensus 591 ~~~~~~~~~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~H--p----nIv~l~ 663 (824)
..+..+|....+|.+.+.+|+|.||.|-.+.++ .+..||||+++.-. ...+...-|+++++++.+ | -++++.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 346678888889999999999999999999765 46889999997433 224556679999999942 3 278899
Q ss_pred ceeecCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-----
Q 003385 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD----- 738 (824)
Q Consensus 664 ~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~----- 738 (824)
+||.-.++.++|+|.+ |-++.+++..+ ...+++..++..|+.|++++++|||+. +++|.||||+|||+.
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence 9999999999999988 55899999653 466788899999999999999999998 999999999999994
Q ss_pred ---------------CCCcEEEEecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCC
Q 003385 739 ---------------KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 803 (824)
Q Consensus 739 ---------------~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~ 803 (824)
.+..+|++|||.|+...... ...+.|..|+|||++.+.+++..+||||+||||.|+++|..
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence 13458999999998653322 44568999999999999999999999999999999999999
Q ss_pred CCCCCc
Q 003385 804 AISNEK 809 (824)
Q Consensus 804 Pf~~~~ 809 (824)
.|...+
T Consensus 308 LFqtHe 313 (415)
T KOG0671|consen 308 LFQTHE 313 (415)
T ss_pred ecccCC
Confidence 998755
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=240.44 Aligned_cols=180 Identities=24% Similarity=0.242 Sum_probs=152.7
Q ss_pred cCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCHHHHhhc
Q 003385 612 GGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG 690 (824)
Q Consensus 612 G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~L~~ 690 (824)
|.+|.||+++++ +++.+|+|+++... .+.+|...+....||||+++++++.+.+..+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999875 68899999986542 233455555666799999999999999999999999999999998843
Q ss_pred ccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceeccccCCCC
Q 003385 691 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770 (824)
Q Consensus 691 ~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~ 770 (824)
...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 23578899999999999999999998 9999999999999999999999999987654322 122345778
Q ss_pred CcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 771 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 771 y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
|+|||.+....++.++|+||+||++|||++|+.|+..
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 9999999888899999999999999999999987753
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=263.77 Aligned_cols=199 Identities=27% Similarity=0.444 Sum_probs=171.7
Q ss_pred HHHhhccccccCcEEEEEEEE-cCCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeeceeec-----CCeEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE-----EGRSVL 674 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-----~~~~~l 674 (824)
.++|.+.||.|.+|.||+++. ++++..|+|++.... ...+++..|..+++.. +|||++.++|++.. ++++++
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 345678999999999999975 468889999986544 3356788889998887 59999999999853 578999
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
|||||.+|+..+.+++.+ ..++.|..+..|++.++.|+.+||.+ .++|||||-.|||++.++.+||+|||.+...
T Consensus 99 VMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred EeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 999999999999998765 78899999999999999999999998 8999999999999999999999999998654
Q ss_pred cCCCCceeccccCCCCCcchhcccc-----CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 755 VDGASHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 755 ~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
.. ......+..||+.|||||++.. ..|+.++|+||||++..||.-|.+|+.+
T Consensus 174 ds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D 230 (953)
T KOG0587|consen 174 DS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD 230 (953)
T ss_pred ec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC
Confidence 33 3344566779999999999974 3467789999999999999999999875
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=244.27 Aligned_cols=207 Identities=27% Similarity=0.387 Sum_probs=171.0
Q ss_pred HHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccC-CcccchhhhHHHHHHhhcCCCccceeeceeec-CCe
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGR 671 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~ 671 (824)
+.+.++...+-+|.||.||+|.|+ +.++|.||.++.. +......+..|.-.+..+.|||+.++.+++.+ ...
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 334444567889999999999665 3456778877644 33334567889889999999999999998865 456
Q ss_pred EEEEEEecCCCCHHHHhhcc----cCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 003385 672 SVLVYEFMHNGTLKEHLYGT----LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 747 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~D 747 (824)
.++++.++.-|+|..+|... ....+.++..+...++.|++.|++|||++ ++||.||.++|++|++..++||+|
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEecc
Confidence 78889999999999999621 23345678888999999999999999998 999999999999999999999999
Q ss_pred cCCcccccCCCCce-eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 748 FGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 748 FGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
-.+++...+.+.+. ......+..||+||.+....|+.++|+|||||+||||++ |+.|+...+
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID 503 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID 503 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC
Confidence 99999877766653 333446789999999999999999999999999999998 999997755
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-27 Score=228.69 Aligned_cols=203 Identities=21% Similarity=0.439 Sum_probs=168.0
Q ss_pred HHHHhhccccccCcEEEEEEE-EcCCcEEEEEEeccCCcccchhhhHHHHHHhhcC-CCccceeeceeecCC--eEEEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEG--RSVLVY 676 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~-~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~--~~~lV~ 676 (824)
..|++.+++|+|.|++|+.|. ..+.++++||+++.- ..+.+.+|+++|+.++ ||||++++++..++. ...+|+
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 356788999999999999996 457889999999753 3578999999999997 999999999997753 457999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCccccc
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAV 755 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~-~~vkL~DFGla~~~~ 755 (824)
||+.+.+.... + +.++...+...+.|+++||.|+|+. ||+|||+||.|++|+.. ..++|+|+|+|....
T Consensus 115 E~v~n~Dfk~l-y------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 115 EYVNNTDFKQL-Y------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhccccHHHH-h------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99998876553 2 4466778888999999999999998 99999999999999976 679999999998776
Q ss_pred CCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhhh
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 820 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~~ 820 (824)
++.. ....+.+..|-.||.+.. ..|+..-|+|||||+++.|+..+.||-... +..+++|+.
T Consensus 185 p~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~--dN~DQLVkI 246 (338)
T KOG0668|consen 185 PGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH--DNYDQLVKI 246 (338)
T ss_pred CCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC--CCHHHHHHH
Confidence 6543 344557889999999875 567888899999999999999999986544 344455544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-28 Score=244.36 Aligned_cols=201 Identities=25% Similarity=0.376 Sum_probs=165.3
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccC--CcccchhhhHHHHHHhhcCCCccceeeceeecCC-----eEEEEEE
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLVYE 677 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~lV~E 677 (824)
.+.||-|+||.||..++. +|+.||+|++..- .....+.+.+|+++|..++|.|++..+++....+ +.|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 368999999999999764 7999999988532 2233567889999999999999999998765432 3467788
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
.|. .+|.+.+ ...+.++...+..+..||++||.|||+. +|.||||||.|+|++++..+||||||+++.....
T Consensus 138 LmQ-SDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 138 LMQ-SDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHH-hhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 774 4665554 4456788888888999999999999998 9999999999999999999999999999977665
Q ss_pred CCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccch
Q 003385 758 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANC 814 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~ 814 (824)
........+-|..|+|||.+.+ +.|+.+.||||.|||+.|++-.+..|....+-+..
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL 267 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQL 267 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHH
Confidence 5555555567999999999986 46888999999999999999999999876644333
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=231.71 Aligned_cols=198 Identities=34% Similarity=0.537 Sum_probs=169.8
Q ss_pred HhhccccccCcEEEEEEEEcC-CcEEEEEEeccCCcc-cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 604 MLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~~-g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
.+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++|++.+
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 356789999999999998875 889999999765444 567888999999999999999999999988899999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
++|.+++.... ..+++..+..++.+++.++.+||+. +++|+|++|.||+++.++.++|+|||.+..........
T Consensus 82 ~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 82 GDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 99999885321 1177889999999999999999998 99999999999999999999999999987664432112
Q ss_pred eccccCCCCCcchhcc-ccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 762 SSIVRGTVGYLDPEYY-ISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l-~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
.....++..|++||.. ....++.++|+|+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2334578899999998 667788899999999999999999999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-26 Score=244.55 Aligned_cols=145 Identities=25% Similarity=0.413 Sum_probs=120.7
Q ss_pred cccccccCHHHHHH-HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcC-----C---
Q 003385 587 AEAAHCFTLSDIED-ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----H--- 656 (824)
Q Consensus 587 ~~~~~~~~~~~~~~-~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-----H--- 656 (824)
....|.+.++|... .+|.+.++||-|-|++||+|.+. +.+-||+|+.+.... ..+....||++|++++ |
T Consensus 63 kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~ 141 (590)
T KOG1290|consen 63 KGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGK 141 (590)
T ss_pred cCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 34567888888877 89999999999999999999764 567899999976543 2456778999999994 3
Q ss_pred Cccceeeceeec----CCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 003385 657 RNLVQFLGYCQE----EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKS 732 (824)
Q Consensus 657 pnIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp 732 (824)
..||+|++.|.. +.+++||+|++ |.+|..+|... ..+.++...+.+|++|++.||.|||++| ||||.||||
T Consensus 142 ~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKP 216 (590)
T KOG1290|consen 142 KCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKP 216 (590)
T ss_pred ceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCc
Confidence 469999999864 56889999998 55777777543 3566888999999999999999999997 999999999
Q ss_pred CCEEE
Q 003385 733 SNILL 737 (824)
Q Consensus 733 ~NILl 737 (824)
+|||+
T Consensus 217 ENvLl 221 (590)
T KOG1290|consen 217 ENVLL 221 (590)
T ss_pred ceeee
Confidence 99999
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=256.34 Aligned_cols=203 Identities=24% Similarity=0.384 Sum_probs=150.6
Q ss_pred HHHhhccccccCcEEEEEEEE-----------------cCCcEEEEEEeccCCcccc--------------hhhhHHHHH
Q 003385 602 TKMLEKKIGSGGFGVVYYGKL-----------------KDGKEIAVKVLTSNSYQGK--------------REFTNEVTL 650 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~-----------------~~g~~vAVK~l~~~~~~~~--------------~~~~~Ei~i 650 (824)
.+.+.++||+|+||.||+|.. ..++.||||.++....... +....|+.+
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 345678999999999999964 2356799999864432222 223346777
Q ss_pred HhhcCCCcc-----ceeeceeec--------CCeEEEEEEecCCCCHHHHhhcccC--------------------cccc
Q 003385 651 LSRIHHRNL-----VQFLGYCQE--------EGRSVLVYEFMHNGTLKEHLYGTLT--------------------HEQR 697 (824)
Q Consensus 651 l~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~L~~~~~--------------------~~~~ 697 (824)
+.+++|.++ ++++++|.. .+..++||||+++++|.++++.... ....
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 777776554 677777643 3567999999999999998864211 1123
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceeccccCCCCCcchhcc
Q 003385 698 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 777 (824)
Q Consensus 698 l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l 777 (824)
+++..+..++.|++.+|.|||+. +|+||||||+|||++.++.+||+|||+++..............+++.|+|||.+
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 46777889999999999999998 999999999999999999999999999875433222111222357899999988
Q ss_pred ccCCC----------------------CchHHHHHHHHHHHHHHcCCC-CCCC
Q 003385 778 ISQQL----------------------TDKSDVYSFGVILLELISGQE-AISN 807 (824)
Q Consensus 778 ~~~~~----------------------~~~~DIwSlGvil~elltG~~-Pf~~ 807 (824)
..... ..+.||||+||+++||++|.. ||.+
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 64321 124699999999999999985 7754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-25 Score=227.70 Aligned_cols=186 Identities=33% Similarity=0.562 Sum_probs=163.4
Q ss_pred CcEEEEEEEEc-CCcEEEEEEeccCCccc-chhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCHHHHhhc
Q 003385 613 GFGVVYYGKLK-DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG 690 (824)
Q Consensus 613 ~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~L~~ 690 (824)
+||.||+|.++ +++.+|+|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48999999997655444 67899999999999999999999999998999999999999999998853
Q ss_pred ccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceeccccCCCC
Q 003385 691 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770 (824)
Q Consensus 691 ~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~ 770 (824)
. ..+++..+..++.+++.++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 2 2278889999999999999999998 99999999999999999999999999987654432 2233457889
Q ss_pred CcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 771 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 771 y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
|++||......++.++||||+|++++++++|..||..
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999888899999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-25 Score=256.32 Aligned_cols=199 Identities=25% Similarity=0.314 Sum_probs=140.3
Q ss_pred HHHhhccccccCcEEEEEEEEc-C----CcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeece------eecCC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-D----GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY------CQEEG 670 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~----g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~------~~~~~ 670 (824)
.|.+.+.||+|+||.||+|++. + ++.||||++..... .+....| .+....+.++..++.. .....
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 3556789999999999999876 4 68999998753221 1111111 1222223333333222 23556
Q ss_pred eEEEEEEecCCCCHHHHhhcccC----------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLT----------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 734 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~N 734 (824)
..++|+||+.+++|.+++..... .........+..++.|++.||.|||++ +|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHH
Confidence 78999999999999988853210 011112334567899999999999998 99999999999
Q ss_pred EEEcC-CCcEEEEecCCcccccCCCCceeccccCCCCCcchhccccC----------------------CCCchHHHHHH
Q 003385 735 ILLDK-HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ----------------------QLTDKSDVYSF 791 (824)
Q Consensus 735 ILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~~~~~DIwSl 791 (824)
||+++ ++.+||+|||+++..............+++.|+|||.+... .++.++||||+
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99996 58999999999986544433334456789999999976432 23456799999
Q ss_pred HHHHHHHHcCCCCCCC
Q 003385 792 GVILLELISGQEAISN 807 (824)
Q Consensus 792 Gvil~elltG~~Pf~~ 807 (824)
||++|||+++..|++.
T Consensus 366 GviL~el~~~~~~~~~ 381 (566)
T PLN03225 366 GLIFLQMAFPNLRSDS 381 (566)
T ss_pred HHHHHHHHhCcCCCch
Confidence 9999999998877654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-25 Score=228.20 Aligned_cols=191 Identities=27% Similarity=0.383 Sum_probs=159.0
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccC--CcccchhhhHHHHHHhhcCCCccceeeceeecC------CeEEEEE
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSVLVY 676 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~~~lV~ 676 (824)
.+.+|.|.- .|..|.+. .++.||+|++... .....+...+|..++..++|+||++++.++.-. ...++||
T Consensus 22 L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~ 100 (369)
T KOG0665|consen 22 LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVM 100 (369)
T ss_pred ecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHH
Confidence 357888888 66666543 6889999987533 334457788999999999999999999998543 4568999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
|+|. .+|...+. ..++-.....+..|++.|++|||+. ||+||||||+||++..++.+||.|||+|+....
T Consensus 101 e~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 101 ELMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred Hhhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCc
Confidence 9996 57777663 3356677788999999999999998 999999999999999999999999999986544
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
. ...+..+.|..|.|||++.+..+.+.+||||+||++.||++|+..|.+..
T Consensus 171 ~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d 221 (369)
T KOG0665|consen 171 D--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD 221 (369)
T ss_pred c--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch
Confidence 3 23445568999999999999999999999999999999999999998766
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-25 Score=240.85 Aligned_cols=215 Identities=20% Similarity=0.297 Sum_probs=181.3
Q ss_pred ccccccccCHHHHHHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcC------CCc
Q 003385 586 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH------HRN 658 (824)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~------Hpn 658 (824)
..+....+.++++.+.+|.+....|+|-|++|.+|.++ .|+.||||+++.+.... +.=++|+++|++|+ .-+
T Consensus 417 DaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 417 DAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred cccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhH
Confidence 45667788999999999999999999999999999865 58899999998765442 33457999999996 247
Q ss_pred cceeeceeecCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 003385 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738 (824)
Q Consensus 659 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~ 738 (824)
+++++..|...+++|||+|-+. .+|.+.|... .....+....+..++.|+.-||..|..+ ||+|.||||.||||+
T Consensus 496 clrl~r~F~hknHLClVFE~Ls-lNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVN 570 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVN 570 (752)
T ss_pred HHHHHHHhhhcceeEEEehhhh-chHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEec
Confidence 8999999999999999999874 6899988543 3455577788899999999999999997 999999999999999
Q ss_pred CC-CcEEEEecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 739 KH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 739 ~~-~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
+. ..+||||||.|.......... ..-+..|.|||.+.+..|+...|+||.||.||||.||+..|.+.+
T Consensus 571 E~k~iLKLCDfGSA~~~~eneitP---YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 571 ESKNILKLCDFGSASFASENEITP---YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cCcceeeeccCccccccccccccH---HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 76 568999999987654432211 224678999999999999999999999999999999999998865
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-25 Score=249.24 Aligned_cols=195 Identities=29% Similarity=0.437 Sum_probs=159.9
Q ss_pred hccccccCcE-EEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEEecCCCC
Q 003385 606 EKKIGSGGFG-VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (824)
Q Consensus 606 ~~~LG~G~fg-~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 683 (824)
.+.+|.|+-| .||+|... |++||||.+-.. ......+|++.|+.- +||||+++++.-.+....||..|.|. -+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS 588 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence 4678999987 68999886 889999987532 234567899999888 59999999999999999999999996 48
Q ss_pred HHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---C--CcEEEEecCCcccccCCC
Q 003385 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---H--MRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 684 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~---~--~~vkL~DFGla~~~~~~~ 758 (824)
|.+++.....+.........+.+..|+++||++||+. +||||||||.||||+. + .+++|+|||+++....+.
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 9999966411222222245677899999999999997 9999999999999986 3 579999999999776554
Q ss_pred Cce--eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcC-CCCCCCC
Q 003385 759 SHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG-QEAISNE 808 (824)
Q Consensus 759 ~~~--~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG-~~Pf~~~ 808 (824)
... .....||-+|+|||++....-+.++||+|+||++|..++| ..||.+.
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence 433 3456699999999999998888899999999999999986 8999763
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-24 Score=213.66 Aligned_cols=208 Identities=22% Similarity=0.397 Sum_probs=159.5
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeece-eecCCeEEEEEEe
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGY-CQEEGRSVLVYEF 678 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~-~~~~~~~~lV~E~ 678 (824)
.|.+.+.+|+|.||.+-+++|+ ..+.+++|.+... ....++|.+|..---.+ .|.||+.-++. |...+.++.++||
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 4667889999999999999987 4677899987643 33467788887654444 48999988864 6677888999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCCcEEEEecCCcccccC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~--~~~~vkL~DFGla~~~~~ 756 (824)
++.|+|.+-+.. ..+-+.....++.|+++||.|||++ .+||||||.+||||- +..++||||||.++....
T Consensus 104 aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 104 APRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred CccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999887632 3456667788999999999999998 999999999999995 346899999999865432
Q ss_pred CCCceeccccCCCCCcchhccccC-----CCCchHHHHHHHHHHHHHHcCCCCCCCCccc-cchhcHhhhhc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQ-----QLTDKSDVYSFGVILLELISGQEAISNEKFG-ANCRNIVQWVK 822 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~DIwSlGvil~elltG~~Pf~~~~~~-~~~~~iv~~~~ 822 (824)
... ...-+..|.+||..... ...+.+|+|.||++++.+++|..||+..... ..+.+..+|.+
T Consensus 176 tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~ 243 (378)
T KOG1345|consen 176 TVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK 243 (378)
T ss_pred eeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc
Confidence 211 12235678999987543 3457789999999999999999999854422 23445566643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-22 Score=202.17 Aligned_cols=183 Identities=38% Similarity=0.662 Sum_probs=157.0
Q ss_pred ccccCcEEEEEEEEcC-CcEEEEEEeccCCcc-cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCHHH
Q 003385 609 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 686 (824)
Q Consensus 609 LG~G~fg~Vy~a~~~~-g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 686 (824)
||+|.+|.||++...+ ++++++|++...... ..+.+.+|++.++.++|++|+++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998764 899999999755432 24678899999999999999999999999899999999999999999
Q ss_pred HhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecCCcccccCCCCceeccc
Q 003385 687 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSSIV 765 (824)
Q Consensus 687 ~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~ 765 (824)
++.... ..+++..+..++.++++++.+||+. +++|+||+|.||+++. +++++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 885321 4578889999999999999999998 9999999999999999 89999999999876543321 12234
Q ss_pred cCCCCCcchhccccC-CCCchHHHHHHHHHHHHH
Q 003385 766 RGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLEL 798 (824)
Q Consensus 766 ~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~el 798 (824)
.+...|++||..... .++.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 478899999998877 888999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-23 Score=231.56 Aligned_cols=197 Identities=25% Similarity=0.399 Sum_probs=169.0
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.|++...+|.|.||.||||+.+ .++..|+|+++.....+..-+++|+-+++..+||||+.++|.+...+..++.||||.
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 3456688999999999999865 688899999988777777888999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+|+|++.-+ ....+++.++..+++..++||.|||+. |-+|||||-.|||+++.|.+|++|||.+-.+.-...
T Consensus 96 ggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~- 167 (829)
T KOG0576|consen 96 GGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA- 167 (829)
T ss_pred CCcccceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhh-
Confidence 999988543 245678888899999999999999998 889999999999999999999999998764432222
Q ss_pred eeccccCCCCCcchhccc---cCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003385 761 VSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAIS 806 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~---~~~~~~~~DIwSlGvil~elltG~~Pf~ 806 (824)
....+.||+.|||||+-. .+.|...+|||++|+...|+-.-++|.-
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf 216 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF 216 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc
Confidence 223456999999999864 5678999999999999999988777743
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-22 Score=215.58 Aligned_cols=195 Identities=25% Similarity=0.409 Sum_probs=160.7
Q ss_pred HHHhhccccccCcEEEEEEEEc----CCcEEEEEEeccCCcccchhhhHHHHHHhhcC-CCccceeeceeecCCeEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~----~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 676 (824)
.+...++||+|.|++||+|.+. ..+.||+|.+...+ ....+..|+++|..+. +.||+++.+++..++...+|+
T Consensus 37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl 114 (418)
T KOG1167|consen 37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL 114 (418)
T ss_pred hhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence 3456789999999999999754 36789999886443 3466889999999995 899999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCccccc
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAV 755 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~-~~vkL~DFGla~~~~ 755 (824)
||+++....++.. .++...+..+++.++.||.++|.+ |||||||||.|+|.+.. +.-.|+|||+|....
T Consensus 115 p~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 115 PYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred cccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHH
Confidence 9999988888763 255778889999999999999998 99999999999999865 788999999986110
Q ss_pred -----------------C--C------------------------CCceeccccCCCCCcchhcccc-CCCCchHHHHHH
Q 003385 756 -----------------D--G------------------------ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSF 791 (824)
Q Consensus 756 -----------------~--~------------------------~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSl 791 (824)
+ + ........+||++|+|||++.. ...++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 0 0 0000122459999999999875 567889999999
Q ss_pred HHHHHHHHcCCCCCCCC
Q 003385 792 GVILLELISGQEAISNE 808 (824)
Q Consensus 792 Gvil~elltG~~Pf~~~ 808 (824)
|||++-+++++.||-..
T Consensus 265 GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKA 281 (418)
T ss_pred cceeehhhccccccccC
Confidence 99999999999998653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=213.11 Aligned_cols=160 Identities=19% Similarity=0.178 Sum_probs=123.2
Q ss_pred HHHhhccccccCcEEEEEEEEc--CCcEEEEEEeccCC-----cccchhhhHHHHHHhhcCCCccce-eeceeecCCeEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQ-FLGYCQEEGRSV 673 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~--~g~~vAVK~l~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~-l~~~~~~~~~~~ 673 (824)
.|.+.+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|+++|++++|+||++ ++++ +..+
T Consensus 19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~ 94 (365)
T PRK09188 19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDG 94 (365)
T ss_pred CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcE
Confidence 4667789999999999999875 46778999875331 112456899999999999999985 4432 4579
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCEEEcCCCcEEEEecCCcc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL-KSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDL-kp~NILl~~~~~vkL~DFGla~ 752 (824)
+||||+++++|... . ... ...++.|++++|.|||+. ||+|||| ||+|||++.++++||+|||+|+
T Consensus 95 LVmE~~~G~~L~~~-~----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 95 LVRGWTEGVPLHLA-R----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred EEEEccCCCCHHHh-C----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 99999999999632 1 111 135788999999999998 9999999 9999999999999999999998
Q ss_pred cccCCCCce-------eccccCCCCCcchhcccc
Q 003385 753 FAVDGASHV-------SSIVRGTVGYLDPEYYIS 779 (824)
Q Consensus 753 ~~~~~~~~~-------~~~~~gt~~y~aPE~l~~ 779 (824)
......... -....+++.|+|||.+.-
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 654432111 124557889999998863
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=206.56 Aligned_cols=203 Identities=25% Similarity=0.348 Sum_probs=166.4
Q ss_pred HHHhhccccccCcEEEEEEEEcCC--cEEEEEEeccCCcccchhhhHHHHHHhhcCC----Cccceeecee-ecCCeEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDG--KEIAVKVLTSNSYQGKREFTNEVTLLSRIHH----RNLVQFLGYC-QEEGRSVL 674 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g--~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~H----pnIv~l~~~~-~~~~~~~l 674 (824)
.|.+.++||+|+||.||.+..... ..+|+|+...........+..|..++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 567889999999999999987653 4789998765543333378889999999873 5888888888 57778899
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-----CcEEEEecC
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-----MRAKVSDFG 749 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~-----~~vkL~DFG 749 (824)
||+.+ |.+|.+...... .+.++..+.+.++.|++.+|++||+. |++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99987 678988664332 57889999999999999999999998 99999999999999865 469999999
Q ss_pred Ccc--cccCCCC----ce---eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 750 LSK--FAVDGAS----HV---SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 750 la~--~~~~~~~----~~---~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
+++ ....... .. .....||..|.+++...+...+.+.|+||++.++.|++.|..||.+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 998 3222111 11 2345599999999999999999999999999999999999999977553
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.5e-19 Score=192.55 Aligned_cols=200 Identities=35% Similarity=0.580 Sum_probs=167.4
Q ss_pred HhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcc---cchhhhHHHHHHhhcCCC-ccceeeceeecCCeEEEEEEec
Q 003385 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHR-NLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.+.+.||.|+||.||++.+. +.+++|.+...... ....+.+|+.+++.+.|+ +|+++.+.+......+++++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 45678999999999999887 88899998765333 256789999999999988 7999999997777789999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCcccccCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~ 758 (824)
.++++.+.+...... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++......
T Consensus 81 ~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 81 DGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999666432111 3677888899999999999999998 899999999999999988 79999999987544332
Q ss_pred Cc-----eeccccCCCCCcchhcccc---CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SH-----VSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~-----~~~~~~gt~~y~aPE~l~~---~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.. ......|+..|+|||.+.. ..+....|+||+|++++++++|..||....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 2345679999999999987 578889999999999999999999977655
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-20 Score=184.14 Aligned_cols=203 Identities=25% Similarity=0.374 Sum_probs=165.4
Q ss_pred HHHHHHhhccccccCcEEEEEEE-EcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCC-CccceeeceeecCCeEEEEE
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~-~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV~ 676 (824)
....|.+.++||+|+||.+|.|. ..+|++||||+-+... ...++..|.++.+.++| ..|..+..+..+.....+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34466788999999999999996 5689999999875433 24567889999999976 67888888888888999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEEecCCccc
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKF 753 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~---~~vkL~DFGla~~ 753 (824)
|.+ |-+|.+...- -.+.++..+++-++.|++.-++|+|.+ +++||||||+|+|+.-+ ..+.++|||+|+.
T Consensus 91 dLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhh
Confidence 988 5677776521 245678889999999999999999998 99999999999999743 5689999999987
Q ss_pred ccCCCCc------eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 754 AVDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 754 ~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
+.+.... ......||.+|.+-....+...+.+.|+=|+|.++..+..|..||++...
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 6553221 12335599999988777777778889999999999999999999998663
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-20 Score=229.13 Aligned_cols=148 Identities=17% Similarity=0.240 Sum_probs=114.0
Q ss_pred hcCC-Cccceeecee-------ecCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 003385 653 RIHH-RNLVQFLGYC-------QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724 (824)
Q Consensus 653 ~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~g 724 (824)
.++| +||++++++| .+....+.++|++ +++|.++|... ...+++.+++.++.||++||+|||++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4456 6888888887 2334567778887 56999998532 35588999999999999999999998 9
Q ss_pred eEecCCCCCCEEEcCC-------------------CcEEEEecCCcccccCCC---------------CceeccccCCCC
Q 003385 725 IIHRDLKSSNILLDKH-------------------MRAKVSDFGLSKFAVDGA---------------SHVSSIVRGTVG 770 (824)
Q Consensus 725 IvHrDLkp~NILl~~~-------------------~~vkL~DFGla~~~~~~~---------------~~~~~~~~gt~~ 770 (824)
|+||||||+||||+.. +.+|++|||+++...... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999653 455666666665321100 000112357899
Q ss_pred CcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 771 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 771 y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
|||||++.+..++.++|||||||+||||++|..|+..
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 9999999999999999999999999999999998764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=183.24 Aligned_cols=139 Identities=19% Similarity=0.175 Sum_probs=107.7
Q ss_pred hccccccCcEEEEEEEEcCCcEEEEEEeccCCccc---------chh-----------------hhHHHHHHhhcCCCcc
Q 003385 606 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG---------KRE-----------------FTNEVTLLSRIHHRNL 659 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~---------~~~-----------------~~~Ei~il~~l~HpnI 659 (824)
...||+|++|.||+|..++|+.||||+++...... ... ..+|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999998889999999997542111 111 2349999999988877
Q ss_pred ceeeceeecCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCCEEEc
Q 003385 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCVPAIIHRDLKSSNILLD 738 (824)
Q Consensus 660 v~l~~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~gIvHrDLkp~NILl~ 738 (824)
.....+... ..++||||++++++..... ....++......++.|++.+|.|+ |+. ||+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 544333222 2389999999877654321 234578888999999999999999 687 999999999999998
Q ss_pred CCCcEEEEecCCcccc
Q 003385 739 KHMRAKVSDFGLSKFA 754 (824)
Q Consensus 739 ~~~~vkL~DFGla~~~ 754 (824)
++.++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-19 Score=185.60 Aligned_cols=199 Identities=23% Similarity=0.373 Sum_probs=166.9
Q ss_pred HHHhhccccccCcEEEEEEE-EcCCcEEEEEEeccCCcccchhhhHHHHHHhhcC-CCccceeeceeecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~-~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
-|.++++||+|.||+++.|+ .-+++.||||.-... ....++..|....+.|. .++|...+-+..++.+..||+|++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 46688999999999999997 457999999975432 33567888999988885 699999998888888999999988
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-----CcEEEEecCCcccc
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-----MRAKVSDFGLSKFA 754 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~-----~~vkL~DFGla~~~ 754 (824)
|-+|.+...- -.++++..+++.+|.|++.-++|+|++ .+|.|||||+|+||..- ..+.|+|||+|+.+
T Consensus 107 -GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 -GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred -CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 5577775521 256789999999999999999999998 89999999999999743 45899999999977
Q ss_pred cCCCCce------eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 755 VDGASHV------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 755 ~~~~~~~------~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.++.... .....||.+||+-....+...+.+.|+=|+|-++...+.|..||++..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 6654321 223459999999999999999999999999999999999999999855
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-19 Score=186.26 Aligned_cols=174 Identities=14% Similarity=0.171 Sum_probs=134.0
Q ss_pred HHHHHHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchh---------hhHHHHHHhhcCCCccceeecee
Q 003385 596 SDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE---------FTNEVTLLSRIHHRNLVQFLGYC 666 (824)
Q Consensus 596 ~~~~~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~---------~~~Ei~il~~l~HpnIv~l~~~~ 666 (824)
.++.+.+|...+.+|.|+||.||.+.. +++.+|||+++.......+. +.+|++.+.++.||+|..+.+++
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 456667788889999999999999766 57789999997554332222 67899999999999999998886
Q ss_pred ecC--------CeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 003385 667 QEE--------GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738 (824)
Q Consensus 667 ~~~--------~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~ 738 (824)
... +..+++|||++|.+|.+... ++. ....+++.+|..+|+. |++|||+||.||+++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~ 169 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS 169 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence 533 35789999999999987631 121 2456999999999998 999999999999999
Q ss_pred CCCcEEEEecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHH
Q 003385 739 KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI 799 (824)
Q Consensus 739 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ell 799 (824)
.++ ++|+|||..+........ ........+..++|+||||+.+..+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 988 999999987644221110 11344455677999999999887554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=175.68 Aligned_cols=140 Identities=20% Similarity=0.199 Sum_probs=109.4
Q ss_pred hccccccCcEEEEEEEEcCCcEEEEEEeccCCccc--------------------------chhhhHHHHHHhhcCCCcc
Q 003385 606 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--------------------------KREFTNEVTLLSRIHHRNL 659 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~--------------------------~~~~~~Ei~il~~l~HpnI 659 (824)
.+.||+|++|.||+|...+|+.||||+++...... ...+..|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999998789999999987542110 0113578899999999988
Q ss_pred ceeeceeecCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEc
Q 003385 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLD 738 (824)
Q Consensus 660 v~l~~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~gIvHrDLkp~NILl~ 738 (824)
.....+.... .++||||++++++..... ....++......++.|++.++.++|+ . ||+||||||+|||++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 5544443332 489999999885433221 12346677888999999999999999 7 999999999999998
Q ss_pred CCCcEEEEecCCccccc
Q 003385 739 KHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 739 ~~~~vkL~DFGla~~~~ 755 (824)
+++++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 8899999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-17 Score=195.46 Aligned_cols=91 Identities=31% Similarity=0.468 Sum_probs=81.0
Q ss_pred CCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCC-Cccce
Q 003385 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNL-PNLRE 491 (824)
Q Consensus 414 ~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l-~~L~~ 491 (824)
.+++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|+ +++|++|+.|+|++|+|+|.+|..++.+ .++..
T Consensus 440 ~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~ 519 (623)
T PLN03150 440 KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRAS 519 (623)
T ss_pred CCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCce
Confidence 356899999999999999999999999999999999999998886 8999999999999999999999999875 46788
Q ss_pred eeecccccccccc
Q 003385 492 LYVQNNMLSGTVP 504 (824)
Q Consensus 492 L~l~~N~l~g~ip 504 (824)
+++.+|......|
T Consensus 520 l~~~~N~~lc~~p 532 (623)
T PLN03150 520 FNFTDNAGLCGIP 532 (623)
T ss_pred EEecCCccccCCC
Confidence 9999998543333
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.3e-18 Score=171.39 Aligned_cols=185 Identities=14% Similarity=0.138 Sum_probs=140.4
Q ss_pred hccccccCcEEEEEEEEcCCcEEEEEEeccCCcccc----hhhhHHHHHHhhcC-CCccceeeceeecCCeEEEEEEecC
Q 003385 606 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK----REFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~----~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
...|++|+||+|+.+.. .+.+++.+.+........ ..+.+|+++|+++. |++|.+++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46799999999997765 578888777765544322 25789999999995 5889999886 34699999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL-KSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDL-kp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
|.+|...+. . ....++.|++.+|.++|++ ||+|||| ||+|||++.++.++|+|||++........
T Consensus 82 G~~L~~~~~----~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 82 GAAMYQRPP----R-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred CccHHhhhh----h-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 998865431 1 1134678999999999998 9999999 79999999999999999999985443221
Q ss_pred c----e--------eccccCCCCCcchhccccC-CCC-chHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 H----V--------SSIVRGTVGYLDPEYYISQ-QLT-DKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~----~--------~~~~~gt~~y~aPE~l~~~-~~~-~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
. . ......++.|++|+.-.-. ..+ .+.+.++.|+-+|+++||+.|..++.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0 1122367888888764422 233 56799999999999999999976654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.3e-18 Score=173.27 Aligned_cols=194 Identities=23% Similarity=0.397 Sum_probs=154.3
Q ss_pred HhhccccccCcEEEEEEEEcCCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
.+..+|.+...|+.|+|+|+ |..+++|++.... ....++|.+|.-.|+.+.||||+.++|.|..+.+..++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 45677899999999999999 6667778876443 23357899999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE--ecCCcccccCCCC
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS--DFGLSKFAVDGAS 759 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~--DFGla~~~~~~~~ 759 (824)
|+|...|+.. ..-..+..++.+++.++++|++|||+. .+-|..--|.++.++++++.+++|. |--++ ....
T Consensus 272 gslynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfs---fqe~- 344 (448)
T KOG0195|consen 272 GSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFS---FQEV- 344 (448)
T ss_pred hHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceee---eecc-
Confidence 9999999754 234456778899999999999999995 3334444688999999999887775 32221 1111
Q ss_pred ceeccccCCCCCcchhccccCCCC---chHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLT---DKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~---~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
...-.+.||+||.+++.+-+ .++|+|||++++||+.|.+.||.+-.
T Consensus 345 ----gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls 393 (448)
T KOG0195|consen 345 ----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS 393 (448)
T ss_pred ----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC
Confidence 11236889999999987654 47899999999999999999998644
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1e-17 Score=166.85 Aligned_cols=107 Identities=26% Similarity=0.296 Sum_probs=93.1
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|.+++... ...+++..+..++.|++.||+|||++ + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 6888888532 34689999999999999999999997 4 999999999999999 99987653321
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
..||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 24899999999999999999999999999999999999999754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-18 Score=194.59 Aligned_cols=185 Identities=29% Similarity=0.405 Sum_probs=157.0
Q ss_pred ccccCcEEEEEEE----EcCCcEEEEEEeccCCccc--chhhhHHHHHHhhcC-CCccceeeceeecCCeEEEEEEecCC
Q 003385 609 IGSGGFGVVYYGK----LKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 609 LG~G~fg~Vy~a~----~~~g~~vAVK~l~~~~~~~--~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+|+|.||.|++.+ ...|+-+|+|++++..... +.....|..++..++ ||.++++.-.+..+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6999999999763 3457778999887553221 224456888888887 99999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|.|...+. ....+.+.........++-+++++|+. +|+|||+|++||+++.+|++++.|||+++.....+..
T Consensus 82 g~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 82 GDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred chhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 99988773 455667777777888999999999998 9999999999999999999999999999876544332
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
|||..|||||.+. .+..++|.||||++++||++|..||.+
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 8999999999887 778899999999999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.2e-17 Score=166.23 Aligned_cols=133 Identities=18% Similarity=0.262 Sum_probs=103.8
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhc-----CCCccceeeceeecCC---eEE-EEEE
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-----HHRNLVQFLGYCQEEG---RSV-LVYE 677 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~---~~~-lV~E 677 (824)
+.||+|+||.||. +++....+||++........+.+.+|+++++.+ .||||++++|++.+.. ..+ +|+|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 6799999999996 544344479988765444567799999999999 5799999999998763 433 7899
Q ss_pred e--cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCCEEEcC----CCcEEEEecCC
Q 003385 678 F--MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI-EYLHTGCVPAIIHRDLKSSNILLDK----HMRAKVSDFGL 750 (824)
Q Consensus 678 ~--~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL-~yLH~~~~~gIvHrDLkp~NILl~~----~~~vkL~DFGl 750 (824)
| +.+++|.+++... .+++. ..++.|++.++ +|||++ +|+||||||+|||++. +.+++|+||+.
T Consensus 86 ~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 86 FDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred CCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 9 5579999999432 24433 34577888777 999998 9999999999999974 34799999544
Q ss_pred c
Q 003385 751 S 751 (824)
Q Consensus 751 a 751 (824)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.4e-18 Score=199.39 Aligned_cols=195 Identities=23% Similarity=0.304 Sum_probs=149.9
Q ss_pred HHhhccccccCcEEEEEEEEcCCcEEEEEEeccCC-cccchhhhHHHHH--HhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS-YQGKREFTNEVTL--LSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~-~~~~~~~~~Ei~i--l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
+...+.||++.|=+|.+|++++|. |+||++-+.. .-..+.+.++++- ...++|||++++..+-......|||-+|+
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 345688999999999999999887 8999986543 3344555544433 44458999999998877777778888888
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
.+ +|.|.+ ..+.-+...+...|+.|++.||..+|.. ||+|||||.+||||+.-.-+.|+||..-+...-+..
T Consensus 104 kh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 104 KH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred hh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 54 565555 5556677888899999999999999998 999999999999999999999999987663322211
Q ss_pred ce------eccccCCCCCcchhccccCC-----------CCchHHHHHHHHHHHHHHc-CCCCCC
Q 003385 760 HV------SSIVRGTVGYLDPEYYISQQ-----------LTDKSDVYSFGVILLELIS-GQEAIS 806 (824)
Q Consensus 760 ~~------~~~~~gt~~y~aPE~l~~~~-----------~~~~~DIwSlGvil~ellt-G~~Pf~ 806 (824)
.. ..+.....+|.|||.+.... .+++.||||+||+++||++ |++||+
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 11 12223446999999876421 5678899999999999988 688886
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.7e-18 Score=198.34 Aligned_cols=197 Identities=25% Similarity=0.351 Sum_probs=155.7
Q ss_pred hhccccccCcEEEEEEEEc-CCcEEEEEEec----cCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLT----SNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~----~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
.++.+|.|++|.|+..... ..+..+.|..+ .... +....+..|..+-..+.|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3578999999988877543 33434444332 1111 111225667777888899999998888877766666699
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
||++ +|...+.. ...+...++..+++|++.|++|||+. ||.|||+|++|+++..++.+||+|||.+....-+
T Consensus 402 ~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 99888732 24677888899999999999999998 9999999999999999999999999998755433
Q ss_pred CC---ceeccccCCCCCcchhccccCCCCch-HHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 758 AS---HVSSIVRGTVGYLDPEYYISQQLTDK-SDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 758 ~~---~~~~~~~gt~~y~aPE~l~~~~~~~~-~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
-. ......+|+..|+|||++....|++. .||||.|+++..|.+|+.||....
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~ 529 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK 529 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence 22 45566789999999999999999875 699999999999999999997644
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-18 Score=164.62 Aligned_cols=159 Identities=22% Similarity=0.369 Sum_probs=132.9
Q ss_pred ccccceeeecccccCCCCCCcccchhhhceeccCCCCCCcH-----HHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcC
Q 003385 337 LSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDG-----VAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCN 411 (824)
Q Consensus 337 ~~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~-----~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~ 411 (824)
++++.++.|+|++|.++.+||.|..|.+|++|++.+|+++. ..+..|+.+....+- ....+-.
T Consensus 30 f~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnr------------l~~lprg 97 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNR------------LNILPRG 97 (264)
T ss_pred cchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhh------------hhcCccc
Confidence 45567889999999999999999999999999999999876 223333333211111 1111122
Q ss_pred CCCCCceeEEEecCCCCC-ccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccc
Q 003385 412 SDPQPSITVIHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 490 (824)
Q Consensus 412 ~~~~~~L~~L~L~~n~l~-g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~ 490 (824)
.+.+|.|+.|||+.|+|. ..+|..|..|+.|+-|+|+.|.+.-+||++++|++||.|.|.+|.+- ++|.+++.|+.|+
T Consensus 98 fgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lr 176 (264)
T KOG0617|consen 98 FGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLR 176 (264)
T ss_pred cCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHH
Confidence 356789999999999997 46899999999999999999999999999999999999999999999 8999999999999
Q ss_pred eeeeccccccccccccccc
Q 003385 491 ELYVQNNMLSGTVPSSLLS 509 (824)
Q Consensus 491 ~L~l~~N~l~g~ip~~l~~ 509 (824)
+|++++|+|+ .+|+++..
T Consensus 177 elhiqgnrl~-vlppel~~ 194 (264)
T KOG0617|consen 177 ELHIQGNRLT-VLPPELAN 194 (264)
T ss_pred HHhcccceee-ecChhhhh
Confidence 9999999999 99998854
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.5e-16 Score=189.75 Aligned_cols=197 Identities=21% Similarity=0.218 Sum_probs=158.6
Q ss_pred HHHHHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcC---CCccceeeceeecCCeEE
Q 003385 597 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 597 ~~~~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~ 673 (824)
++....+.|.+.||+|+||.||+|...+|+.||+|+-+....+.- .-=.+++.+|+ -+.|..+..++.-.+..+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 344455667889999999999999988899999999887766632 11233444444 355666666666677789
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-------CCcEEEE
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-------HMRAKVS 746 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~-------~~~vkL~ 746 (824)
+|+||.+.|+|.+++. ..+.+++.-.+.++.|++..+++||.. +||||||||.|+||.. ...++|+
T Consensus 771 lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEE
Confidence 9999999999999984 556788888999999999999999998 9999999999999962 3469999
Q ss_pred ecCCcccccCC-CCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCC
Q 003385 747 DFGLSKFAVDG-ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 803 (824)
Q Consensus 747 DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~ 803 (824)
|||.+..+..- +.......++|-.+-.+|+..+..|+..+|.|.++-+++-|+.|+.
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99998643322 2224455678999999999999999999999999999999999985
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.4e-16 Score=163.91 Aligned_cols=141 Identities=22% Similarity=0.243 Sum_probs=107.9
Q ss_pred HHhhccccccCcEEEEEEE--EcCCcEEEEEEeccCCccc------------------------chhhhHHHHHHhhcCC
Q 003385 603 KMLEKKIGSGGFGVVYYGK--LKDGKEIAVKVLTSNSYQG------------------------KREFTNEVTLLSRIHH 656 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~--~~~g~~vAVK~l~~~~~~~------------------------~~~~~~Ei~il~~l~H 656 (824)
+.+.+.||+|++|.||+|. ..+|+.||+|+++...... ...+..|++.++++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 5678899999999999998 4689999999987432100 0124679999999976
Q ss_pred Cc--cceeeceeecCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEecCCCCC
Q 003385 657 RN--LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA-IIHRDLKSS 733 (824)
Q Consensus 657 pn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~g-IvHrDLkp~ 733 (824)
.. +.++++. ...++||||+++++|..... ............++.|++.++.+||+. + |+||||||+
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 33 3344432 23489999999988765432 122344556678999999999999998 8 999999999
Q ss_pred CEEEcCCCcEEEEecCCccccc
Q 003385 734 NILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 734 NILl~~~~~vkL~DFGla~~~~ 755 (824)
||+++ ++.++|+|||.+....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccC
Confidence 99999 8899999999886543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.9e-16 Score=159.20 Aligned_cols=135 Identities=24% Similarity=0.427 Sum_probs=112.8
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCCcc--------cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
+.||+|++|.||+|.+ .|..+++|+....... ....+.+|++++..+.|++|.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 5788999987543221 123577899999999999998887777777788999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
++|++|.+.+... .. .+..++.+++.+|.++|+. +++|||++|.|||++ ++.++|+|||.+...
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999887432 11 6778999999999999998 999999999999999 788999999998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.9e-16 Score=156.07 Aligned_cols=131 Identities=26% Similarity=0.450 Sum_probs=105.9
Q ss_pred cccccCcEEEEEEEEcCCcEEEEEEeccCCcc--------cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 608 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 608 ~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.||+|++|.||+|.+. ++.+++|+....... ...++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 3899999999999864 788999986543211 1245678999999999887665555555666678999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
+|++|.+.+... .. .++.|++.+|.+||+. +++|||++|+||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999998876321 00 6889999999999998 999999999999999 889999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.3e-15 Score=159.37 Aligned_cols=196 Identities=20% Similarity=0.283 Sum_probs=125.7
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHHHHhhcCC----------Cccceeecee-----
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHH----------RNLVQFLGYC----- 666 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~H----------pnIv~l~~~~----- 666 (824)
++.||.|+++.||.+++. +++++|||++...... ..+++++|.-....+.+ -.++..++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 578999999999999987 4899999988543322 23445555544444322 1222222221
Q ss_pred ----ecC---C-----eEEEEEEecCCCCHHHHhh---cccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 003385 667 ----QEE---G-----RSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 731 (824)
Q Consensus 667 ----~~~---~-----~~~lV~E~~~~gsL~~~L~---~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLk 731 (824)
... . ..+++|+-+ .++|.+.+. ........+....++.+..|+++.+++||+. |++|+|||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence 111 1 225677766 467877653 2212223345556677889999999999998 99999999
Q ss_pred CCCEEEcCCCcEEEEecCCcccccCCCCceeccccCCCCCcchhccccC--------CCCchHHHHHHHHHHHHHHcCCC
Q 003385 732 SSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ--------QLTDKSDVYSFGVILLELISGQE 803 (824)
Q Consensus 732 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--------~~~~~~DIwSlGvil~elltG~~ 803 (824)
|+|++++++|.++|+||+....... .... ...+..|.+||..... .++.+.|.|++|+++|.|++|+.
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGT---RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTE---EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCc---eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 9999999999999999987654322 1111 2356789999987542 46788999999999999999999
Q ss_pred CCCCCc
Q 003385 804 AISNEK 809 (824)
Q Consensus 804 Pf~~~~ 809 (824)
||+...
T Consensus 249 Pf~~~~ 254 (288)
T PF14531_consen 249 PFGLSS 254 (288)
T ss_dssp STCCCG
T ss_pred CCCCCC
Confidence 998644
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.9e-15 Score=154.20 Aligned_cols=135 Identities=21% Similarity=0.238 Sum_probs=106.1
Q ss_pred HHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcc----------------------cchhhhHHHHHHhhcCCCc--
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ----------------------GKREFTNEVTLLSRIHHRN-- 658 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~----------------------~~~~~~~Ei~il~~l~Hpn-- 658 (824)
+.+.+.||+|+||.||+|..++|+.||||+++..... ....+..|..++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 5567899999999999999888999999987643210 0112567888899988874
Q ss_pred cceeeceeecCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 003385 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738 (824)
Q Consensus 659 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~ 738 (824)
+.+.++. ...++||||+++++|...... .....++.+++.++.++|+. +|+||||||+||+++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~ 159 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVD 159 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEc
Confidence 4444432 345899999999998764310 23456889999999999997 999999999999999
Q ss_pred CCCcEEEEecCCcccc
Q 003385 739 KHMRAKVSDFGLSKFA 754 (824)
Q Consensus 739 ~~~~vkL~DFGla~~~ 754 (824)
+++.++|+|||.+...
T Consensus 160 ~~~~~~liDfg~~~~~ 175 (198)
T cd05144 160 DDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcEEEEECCccccC
Confidence 9999999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.4e-15 Score=175.22 Aligned_cols=134 Identities=22% Similarity=0.335 Sum_probs=108.5
Q ss_pred HhhccccccCcEEEEEEEEcCCcEEEEEEeccCC--c------ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--Y------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~--~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
...+.||+|+||+||+|.+... .+++|+..... . ...+.+.+|++++++++|++++....++......++|
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred CccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 3468899999999999987644 34444322111 0 1124578899999999999999888777777778999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
|||+++++|.+++. ....++.|++++|.+||+. +++||||||+|||+ +++.++|+|||+++..
T Consensus 415 ~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999998873 3457899999999999998 99999999999999 6789999999999764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.7e-15 Score=175.56 Aligned_cols=170 Identities=28% Similarity=0.411 Sum_probs=123.3
Q ss_pred hhccccccCcEEEEEEEEcC-CcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCC
Q 003385 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 683 (824)
..+.|..|+||.||..+|+. .++.|+|+-+.+ .+.+- ++.....|.+| |+
T Consensus 87 ~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv---------------------gD 137 (1205)
T KOG0606|consen 87 TIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV---------------------GD 137 (1205)
T ss_pred eeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee---------------------ch
Confidence 35789999999999999874 567888543211 11110 22222333333 33
Q ss_pred HHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC----
Q 003385 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS---- 759 (824)
Q Consensus 684 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~---- 759 (824)
-.+.++. ...++. +++.+++|||+. ||+|||+||.|.+|+.-|++|+.|||+++.......
T Consensus 138 c~tllk~----~g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 138 CATLLKN----IGPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred hhhhccc----CCCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 3333322 122221 237789999997 999999999999999999999999999874432110
Q ss_pred ----------ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 760 ----------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 760 ----------~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
.....++||+.|+|||++..+.|...+|.|++|+|+||.+.|..||.++++++.+.+++
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi 271 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 271 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence 01234689999999999999999999999999999999999999999998777766554
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.55 E-value=4e-16 Score=171.92 Aligned_cols=188 Identities=21% Similarity=0.293 Sum_probs=134.5
Q ss_pred eeccccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCC---CCCCCCe----
Q 003385 335 TNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPC---LPVPWSW---- 407 (824)
Q Consensus 335 t~~~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc---~~~~~~~---- 407 (824)
--+.|+-|..|+|++|++..|||.+..|..|+.|.|++|++....+..|-.+..+.-+..++..-. .|...+.
T Consensus 145 lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL 224 (1255)
T KOG0444|consen 145 LFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNL 224 (1255)
T ss_pred HHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhh
Confidence 356788899999999999999999999999999999999998877666655544333221111111 0101111
Q ss_pred ----eEcCC--------CCC-----------------------CceeEEEecCCCCCccCChhhhccccccccccccccc
Q 003385 408 ----LQCNS--------DPQ-----------------------PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSL 452 (824)
Q Consensus 408 ----~~c~~--------~~~-----------------------~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l 452 (824)
+.|++ -++ .+|++|+||.|+|+ .+|+.+.+|+.|+.|++.+|+|
T Consensus 225 ~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL 303 (1255)
T KOG0444|consen 225 RDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKL 303 (1255)
T ss_pred hhccccccCCCcchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcc
Confidence 01111 011 34566667777777 7888888888888888888875
Q ss_pred C--CCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeeccccccccccccc--cccceeccccCCccccCC
Q 003385 453 T--GPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEG 525 (824)
Q Consensus 453 ~--~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g~ip~~l--~~~~~~l~~~~n~~lc~~ 525 (824)
+ |+|..++.|.+|+.+++++|+|. ..|+.++.+.+|+.|.|++|+|. .+|+.+ +..+..|++..|+++--.
T Consensus 304 ~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMP 378 (1255)
T KOG0444|consen 304 TFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMP 378 (1255)
T ss_pred cccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCC
Confidence 3 56666888888888888888888 88888888888888888888888 888876 455577888888888533
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=3e-14 Score=143.56 Aligned_cols=135 Identities=22% Similarity=0.275 Sum_probs=96.0
Q ss_pred hccccccCcEEEEEEEEcCCcEEEEEEeccCCccc--chh----------------------hhHHHHHHhhcCCCc--c
Q 003385 606 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KRE----------------------FTNEVTLLSRIHHRN--L 659 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~--~~~----------------------~~~Ei~il~~l~Hpn--I 659 (824)
.+.||+|+||.||+|...+++.||||+++...... ... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999987532211 111 124555555554332 3
Q ss_pred ceeeceeecCCeEEEEEEecCCCCHHHH-hhcccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEE
Q 003385 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEH-LYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILL 737 (824)
Q Consensus 660 v~l~~~~~~~~~~~lV~E~~~~gsL~~~-L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~gIvHrDLkp~NILl 737 (824)
.+.++. ...++||||++++.+... +... . .. .....++.+++.++.++|. . +|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-R----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-h----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 444433 235899999998543221 1110 0 00 4567789999999999999 6 99999999999999
Q ss_pred cCCCcEEEEecCCcccc
Q 003385 738 DKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 738 ~~~~~vkL~DFGla~~~ 754 (824)
+ ++.++|+|||.+...
T Consensus 149 ~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 149 D-DGKVYIIDVPQAVEI 164 (187)
T ss_pred E-CCcEEEEECcccccc
Confidence 9 899999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=5e-14 Score=135.24 Aligned_cols=134 Identities=25% Similarity=0.296 Sum_probs=112.3
Q ss_pred hccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCC--CccceeeceeecCCeEEEEEEecCCCC
Q 003385 606 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--RNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~~gs 683 (824)
.+.||+|.++.||++...+ +.+++|..+.... ...+.+|+..++.++| ..+.+++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999999864 7899999865432 4578899999999976 589999998888788999999999876
Q ss_pred HHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 684 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+... +......++.++++++.++|.....+++|||++|+||++++.+.++++|||.++.
T Consensus 80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 6432 3455667889999999999986444799999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.9e-14 Score=161.68 Aligned_cols=167 Identities=28% Similarity=0.504 Sum_probs=134.7
Q ss_pred HhhcCCCccceeeceeecCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 003385 651 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL 730 (824)
Q Consensus 651 l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDL 730 (824)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....+++.....++++++.||.|||.. +...|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence 4568899999999999999999999999999999999965 466788999999999999999999997 23399999
Q ss_pred CCCCEEEcCCCcEEEEecCCcccccCC-CCceeccccCCCCCcchhccccCC-------CCchHHHHHHHHHHHHHHcCC
Q 003385 731 KSSNILLDKHMRAKVSDFGLSKFAVDG-ASHVSSIVRGTVGYLDPEYYISQQ-------LTDKSDVYSFGVILLELISGQ 802 (824)
Q Consensus 731 kp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~-------~~~~~DIwSlGvil~elltG~ 802 (824)
++.|++++....+||.|||+....... .........-..-|.|||.+.... .+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999997655321 111111112346799999987631 356789999999999999999
Q ss_pred CCCCCCccccchhcHhhhhc
Q 003385 803 EAISNEKFGANCRNIVQWVK 822 (824)
Q Consensus 803 ~Pf~~~~~~~~~~~iv~~~~ 822 (824)
.||+.....+...+++..++
T Consensus 156 ~~~~~~~~~~~~~eii~~~~ 175 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVK 175 (484)
T ss_pred CccccccccCChHHHHHHHH
Confidence 99988654444466666654
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.8e-13 Score=143.53 Aligned_cols=136 Identities=18% Similarity=0.221 Sum_probs=104.2
Q ss_pred hcccc-ccCcEEEEEEEEcCCcEEEEEEeccCC-------------cccchhhhHHHHHHhhcCCCcc--ceeeceeecC
Q 003385 606 EKKIG-SGGFGVVYYGKLKDGKEIAVKVLTSNS-------------YQGKREFTNEVTLLSRIHHRNL--VQFLGYCQEE 669 (824)
Q Consensus 606 ~~~LG-~G~fg~Vy~a~~~~g~~vAVK~l~~~~-------------~~~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~~ 669 (824)
...|| .|+.|+||+.+.. ++.++||.+.... ......+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999875 7789999875321 1123457889999999998875 6677664332
Q ss_pred C----eEEEEEEecCC-CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 003385 670 G----RSVLVYEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 744 (824)
Q Consensus 670 ~----~~~lV~E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vk 744 (824)
. ..++|||++++ .+|.+++.. ..++.. .+.|++.+|.+||+. ||+||||||+|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 688887742 223332 367899999999998 999999999999999989999
Q ss_pred EEecCCcccc
Q 003385 745 VSDFGLSKFA 754 (824)
Q Consensus 745 L~DFGla~~~ 754 (824)
|+|||.+...
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999987653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.5e-14 Score=157.71 Aligned_cols=123 Identities=30% Similarity=0.449 Sum_probs=104.9
Q ss_pred eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGl 750 (824)
+.++.|++|...+|.++|..+. .....++...+.++.|++.|++| + +.+|||+||.||+...+.++||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 5789999999999999996442 33445677888999999999999 4 899999999999999999999999999
Q ss_pred cccccCCC-----CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc
Q 003385 751 SKFAVDGA-----SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800 (824)
Q Consensus 751 a~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt 800 (824)
........ ........||..||+||.+.+..|+.++||||||+|++|++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87554433 122344569999999999999999999999999999999998
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.8e-13 Score=141.79 Aligned_cols=144 Identities=23% Similarity=0.305 Sum_probs=107.1
Q ss_pred CCCccceeeceeec---------------------------CCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHH
Q 003385 655 HHRNLVQFLGYCQE---------------------------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA 707 (824)
Q Consensus 655 ~HpnIv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~ 707 (824)
+|||||++.++|.+ +..+|+||.... .+|..++.. +..+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 59999999887633 345678887664 478888743 334556677789
Q ss_pred HHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CC--CcEEEEecCCcccccC-----CCCceeccccCCCCCcchhccc
Q 003385 708 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KH--MRAKVSDFGLSKFAVD-----GASHVSSIVRGTVGYLDPEYYI 778 (824)
Q Consensus 708 ~qia~gL~yLH~~~~~gIvHrDLkp~NILl~--~~--~~vkL~DFGla~~~~~-----~~~~~~~~~~gt~~y~aPE~l~ 778 (824)
.|+++|+.|||++ ||.|||+|+.|||+. +| -.+.|+|||++---.. +.....-...|...-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999998 999999999999995 33 3579999998742111 1111112234777899999876
Q ss_pred cCC------CCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 779 SQQ------LTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 779 ~~~------~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
... -..|+|.|+.|.+.||++...-||.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 432 24689999999999999999999976
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.6e-13 Score=172.81 Aligned_cols=93 Identities=38% Similarity=0.590 Sum_probs=51.7
Q ss_pred CCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceee
Q 003385 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (824)
Q Consensus 415 ~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~ 493 (824)
+++|+.|+|++|++++.+|..|++|++|+.|+|++|++++.+|. +.++++|+.|+|++|++++.+|..++++++|+.|+
T Consensus 235 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 314 (968)
T PLN00113 235 LTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILH 314 (968)
T ss_pred CCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEE
Confidence 44555555555555555555555555555555555555554443 55555555555555555555555555555555555
Q ss_pred eccccccccccccc
Q 003385 494 VQNNMLSGTVPSSL 507 (824)
Q Consensus 494 l~~N~l~g~ip~~l 507 (824)
+++|.++|.+|..+
T Consensus 315 l~~n~~~~~~~~~~ 328 (968)
T PLN00113 315 LFSNNFTGKIPVAL 328 (968)
T ss_pred CCCCccCCcCChhH
Confidence 55555555555443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.8e-14 Score=155.29 Aligned_cols=165 Identities=19% Similarity=0.157 Sum_probs=106.3
Q ss_pred cccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCC
Q 003385 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (824)
+|++|..|.|+.|++|+||+- +.+|..|+.|+|..|++..+.-..+.++..+++.....++-..-......+| .
T Consensus 195 ~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l-----~ 269 (873)
T KOG4194|consen 195 SLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGL-----E 269 (873)
T ss_pred ccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeee-----c
Confidence 355889999999999999999 6669999999999999887666666666555555443343332222222333 2
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeec
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~ 495 (824)
.+++|+|+.|+++..-..++.+|++|+.|+||+|.|..+.++ +.-+++|+.|+|++|+|+..-|++|..|..|++|+|+
T Consensus 270 kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs 349 (873)
T KOG4194|consen 270 KMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLS 349 (873)
T ss_pred ccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhccc
Confidence 566666666666633344666666666666666666665554 5556666666666666664444566666666666666
Q ss_pred ccccccccccccc
Q 003385 496 NNMLSGTVPSSLL 508 (824)
Q Consensus 496 ~N~l~g~ip~~l~ 508 (824)
+|.+. .+.+..|
T Consensus 350 ~Nsi~-~l~e~af 361 (873)
T KOG4194|consen 350 HNSID-HLAEGAF 361 (873)
T ss_pred ccchH-HHHhhHH
Confidence 66555 4444443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.35 E-value=3e-12 Score=145.77 Aligned_cols=140 Identities=23% Similarity=0.255 Sum_probs=98.2
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCCccc----------------------------------------chhhhH
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG----------------------------------------KREFTN 646 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~----------------------------------------~~~~~~ 646 (824)
+.||.|++|.||+|+.++|++||||+.+...... +-++.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999999999999999986532110 012445
Q ss_pred HHHHHhhcC----CCccceeeceee-cCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHH-HHHHHHhC
Q 003385 647 EVTLLSRIH----HRNLVQFLGYCQ-EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-GIEYLHTG 720 (824)
Q Consensus 647 Ei~il~~l~----HpnIv~l~~~~~-~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~-gL~yLH~~ 720 (824)
|++.+.+++ |.+-+.+-.++. .....++||||++|++|.+...... ... ....++.+++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHhC
Confidence 666665553 222223222222 2345689999999999987653211 111 22346666665 47788987
Q ss_pred CCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 721 ~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
|++|+|+||.||+++.+++++++|||++....
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-13 Score=162.12 Aligned_cols=202 Identities=22% Similarity=0.326 Sum_probs=157.5
Q ss_pred HHhhccccccCcEEEEEEEEcC--CcEEEEEEeccCC--cccchhhhHHHHHHhhcC-CCccceeeceeecCCeEEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSNS--YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~--g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E 677 (824)
+.+.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-+.+. |+|++.+++...+.+..+++++
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 3445679999999999886543 3445666665432 222344556788777776 9999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCccccc
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-TGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAV 755 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~gIvHrDLkp~NILl~~~~-~vkL~DFGla~~~~ 755 (824)
+..++++.+.+.. ......+....-....|+..++.|+| .. ++.|||+||+|.+++..+ ..+++|||+|....
T Consensus 102 ~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 102 YSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999998776621 11113344455678899999999999 76 999999999999999999 99999999998665
Q ss_pred C--CCCceeccccC-CCCCcchhccccCC-CCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 756 D--GASHVSSIVRG-TVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 756 ~--~~~~~~~~~~g-t~~y~aPE~l~~~~-~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
. +........+| ++.|+|||...+.. ..+..|+||.|+++..+++|..|++...
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 5 33334455678 99999999998854 4567899999999999999999997644
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.7e-13 Score=142.79 Aligned_cols=178 Identities=19% Similarity=0.181 Sum_probs=118.9
Q ss_pred cccceeeecccccCCCCCCcccchhhhceeccCCCCCCcH--HHHHHHHHhcC---CCC-----------c-ccCCCCCC
Q 003385 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDG--VAIVSVISLYS---SAD-----------W-AQEGGDPC 400 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~--~~l~~lk~~~~---~~~-----------w-~~~~~dpc 400 (824)
++..+..|+++.|++.++|+.|+.+-.|+.|+..+|++.. .++..+.++.. ..+ | ....-|||
T Consensus 112 s~~~l~~l~~s~n~~~el~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~ 191 (565)
T KOG0472|consen 112 SLISLVKLDCSSNELKELPDSIGRLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCN 191 (565)
T ss_pred hhhhhhhhhccccceeecCchHHHHhhhhhhhccccccccCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccc
Confidence 3445556666666666666666666666666666555332 12222222210 000 0 00122333
Q ss_pred CCCCCCeeEcCCCCCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCC-CCCCCcceEeecccccCCCC
Q 003385 401 LPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGPL 479 (824)
Q Consensus 401 ~~~~~~~~~c~~~~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~-~~l~~L~~L~L~~N~l~g~l 479 (824)
. .-...++-..+.+.+|+.|+|..|+|. .+| +|+.+..|++|+++.|+|..++.+. .+|.+|.+|||.+|+|+ ..
T Consensus 192 ~-N~L~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~ 267 (565)
T KOG0472|consen 192 S-NLLETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EV 267 (565)
T ss_pred h-hhhhcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cC
Confidence 1 111222223345678888889999998 888 6888999999999999998887774 57999999999999999 89
Q ss_pred CccccCCCccceeeecccccccccccccccc-ceeccccCCc
Q 003385 480 PSSLMNLPNLRELYVQNNMLSGTVPSSLLSK-NVVLNYAGNI 520 (824)
Q Consensus 480 P~~l~~l~~L~~L~l~~N~l~g~ip~~l~~~-~~~l~~~~n~ 520 (824)
|++++-|.+|..||+++|.++ .+|.++.+. +..+.+.|||
T Consensus 268 Pde~clLrsL~rLDlSNN~is-~Lp~sLgnlhL~~L~leGNP 308 (565)
T KOG0472|consen 268 PDEICLLRSLERLDLSNNDIS-SLPYSLGNLHLKFLALEGNP 308 (565)
T ss_pred chHHHHhhhhhhhcccCCccc-cCCcccccceeeehhhcCCc
Confidence 999999999999999999999 888888654 3556678886
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.6e-13 Score=147.70 Aligned_cols=181 Identities=19% Similarity=0.168 Sum_probs=107.0
Q ss_pred ccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCc
Q 003385 339 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (824)
+.+++.|+|..|+++.+-.. +-+|+.|+.|+++.|.+..+....+.--..++.+..+++.-.. ... -+...+.+
T Consensus 268 l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~---l~~--~sf~~L~~ 342 (873)
T KOG4194|consen 268 LEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITR---LDE--GSFRVLSQ 342 (873)
T ss_pred ecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEecccccccc---CCh--hHHHHHHH
Confidence 45667788888888888777 7888888888888887765433333222222221111110000 000 00011345
Q ss_pred eeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC----CCCCCCcceEeecccccCCCCC-ccccCCCcccee
Q 003385 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD----FSGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLREL 492 (824)
Q Consensus 418 L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~----~~~l~~L~~L~L~~N~l~g~lP-~~l~~l~~L~~L 492 (824)
|++|+|++|.++..--..|..|++|+.|||++|.|++.+.+ |.+|++|+.|+|.+|+|. .|| .+|..|.+|++|
T Consensus 343 Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE~L 421 (873)
T KOG4194|consen 343 LEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALEHL 421 (873)
T ss_pred hhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchhhhccCccccee
Confidence 66666666666633333566677777777777777776663 666777777777777777 555 477777777777
Q ss_pred eeccccccccccccccccc--eeccccCCccccCCC
Q 003385 493 YVQNNMLSGTVPSSLLSKN--VVLNYAGNINLHEGG 526 (824)
Q Consensus 493 ~l~~N~l~g~ip~~l~~~~--~~l~~~~n~~lc~~~ 526 (824)
+|.+|.+. +|.+..|..+ ..|-+...+.+|.+.
T Consensus 422 dL~~Naia-SIq~nAFe~m~Lk~Lv~nSssflCDCq 456 (873)
T KOG4194|consen 422 DLGDNAIA-SIQPNAFEPMELKELVMNSSSFLCDCQ 456 (873)
T ss_pred cCCCCcce-eecccccccchhhhhhhcccceEEecc
Confidence 77777777 6666666554 333445555667663
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.9e-11 Score=141.07 Aligned_cols=139 Identities=19% Similarity=0.236 Sum_probs=89.6
Q ss_pred ccccccCcEEEEEEEEcC-CcEEEEEEeccCCccc----------------------------------c------hhhh
Q 003385 607 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQG----------------------------------K------REFT 645 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~-g~~vAVK~l~~~~~~~----------------------------------~------~~~~ 645 (824)
+.||+|++|.||+|++++ |++||||+.++..... . -++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 589999999999999987 9999999997542100 0 1234
Q ss_pred HHHHHHhhcC----CCccceeeceeec-CCeEEEEEEecCCCCHHHHh--hcccCccccCCHHHHHHHHHHHHHHHHHHH
Q 003385 646 NEVTLLSRIH----HRNLVQFLGYCQE-EGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718 (824)
Q Consensus 646 ~Ei~il~~l~----HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~L--~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 718 (824)
+|+..+.+++ +.+.+.+-.++.+ ....++||||++|+++.+.- .........+....+..++.| ++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VF 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HH
Confidence 4554444442 3333333333322 34568999999999997742 111001112222222233333 34
Q ss_pred hCCCCCeEecCCCCCCEEEcCCC----cEEEEecCCccccc
Q 003385 719 TGCVPAIIHRDLKSSNILLDKHM----RAKVSDFGLSKFAV 755 (824)
Q Consensus 719 ~~~~~gIvHrDLkp~NILl~~~~----~vkL~DFGla~~~~ 755 (824)
.. |++|+|+||.||+++.++ +++++|||++....
T Consensus 278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 45 999999999999999888 99999999987553
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.21 E-value=6e-11 Score=117.30 Aligned_cols=130 Identities=20% Similarity=0.168 Sum_probs=95.9
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccc-eeeceeecCCeEEEEEEecCCCCHH
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV-QFLGYCQEEGRSVLVYEFMHNGTLK 685 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lV~E~~~~gsL~ 685 (824)
+.|+.|.++.||+++.. ++.+++|+...... ....+..|+++++.+.+.+++ +++.+.. ...++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 56899999999999876 78899998764432 234567899999998765544 4444432 3347999999998765
Q ss_pred HHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 686 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 686 ~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+.. . .....+.+++++|+.||+.. ..+++|||++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 320 0 11235678999999999972 11369999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.4e-12 Score=144.32 Aligned_cols=153 Identities=20% Similarity=0.206 Sum_probs=119.4
Q ss_pred eccccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHH-----HHHHHHHhcCCCCcccCCCCCCCCCCCCeeEc
Q 003385 336 NLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGV-----AIVSVISLYSSADWAQEGGDPCLPVPWSWLQC 410 (824)
Q Consensus 336 ~~~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~-----~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c 410 (824)
.-.++.+++|.|..+.+..+|..++++..|+.|.+..|++..+ .+..|+.+....+-. ..+|++-
T Consensus 28 v~qMt~~~WLkLnrt~L~~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~L----------KnsGiP~ 97 (1255)
T KOG0444|consen 28 VEQMTQMTWLKLNRTKLEQVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNL----------KNSGIPT 97 (1255)
T ss_pred HHHhhheeEEEechhhhhhChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhcccc----------ccCCCCc
Confidence 4456789999999999999999999999999999999987652 222233332221111 1234443
Q ss_pred CCCCCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCcc
Q 003385 411 NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNL 489 (824)
Q Consensus 411 ~~~~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L 489 (824)
+.-.+..|+.||||+|+|+ ..|..+..-+++-.|+||+|+|..+|.. |.+|+.|-.||||+|+|. .+|+.+..|..|
T Consensus 98 diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~L 175 (1255)
T KOG0444|consen 98 DIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSML 175 (1255)
T ss_pred hhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhh
Confidence 3345678889999999998 8999898889999999999999887776 788999999999999998 888888888899
Q ss_pred ceeeecccccc
Q 003385 490 RELYVQNNMLS 500 (824)
Q Consensus 490 ~~L~l~~N~l~ 500 (824)
+.|.|++|+|.
T Consensus 176 qtL~Ls~NPL~ 186 (1255)
T KOG0444|consen 176 QTLKLSNNPLN 186 (1255)
T ss_pred hhhhcCCChhh
Confidence 99999998773
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.1e-10 Score=130.39 Aligned_cols=167 Identities=19% Similarity=0.244 Sum_probs=125.4
Q ss_pred EEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCHHHHhhcccCccccCCH
Q 003385 621 KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 700 (824)
Q Consensus 621 ~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~ 700 (824)
+..++.+|.|++.+...........+.++.|+.++||||+++++..+..+..|+|+|.+. .|..++.. +..
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~ 103 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGK 103 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHH
Confidence 345788999988875544334557788999999999999999999999999999999985 56666632 224
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceeccccCCCCCcchhccccC
Q 003385 701 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780 (824)
Q Consensus 701 ~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 780 (824)
.....-+.||++||.|||..| +++|++|.-..|+|+..|+.||.+|..+........ ......---.|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 555667899999999999765 899999999999999999999999987654322111 01111112345666654322
Q ss_pred CCCchHHHHHHHHHHHHHHcC
Q 003385 781 QLTDKSDVYSFGVILLELISG 801 (824)
Q Consensus 781 ~~~~~~DIwSlGvil~elltG 801 (824)
. -..|.|-|||+++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.8e-10 Score=113.80 Aligned_cols=135 Identities=19% Similarity=0.199 Sum_probs=96.4
Q ss_pred ccccccCcEEEEEEEEcC-------CcEEEEEEeccCCc--c--------c------------chhhh----HHHHHHhh
Q 003385 607 KKIGSGGFGVVYYGKLKD-------GKEIAVKVLTSNSY--Q--------G------------KREFT----NEVTLLSR 653 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~-------g~~vAVK~l~~~~~--~--------~------------~~~~~----~Ei~il~~ 653 (824)
..||.|.-+.||.|...+ +..+|||+.+.... + + .+.+. +|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999997543 47899998763210 0 0 11222 79999999
Q ss_pred cCC--CccceeeceeecCCeEEEEEEecCCCCHHH-HhhcccCccccCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecC
Q 003385 654 IHH--RNLVQFLGYCQEEGRSVLVYEFMHNGTLKE-HLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCVPAIIHRD 729 (824)
Q Consensus 654 l~H--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~-~L~~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~gIvHrD 729 (824)
+.. -++.+++++ ...++||||+.+..+.. .+. ...++..+...+..+++.+|..| |+. ++||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 863 456666654 35689999998754322 121 11233445567789999999999 787 999999
Q ss_pred CCCCCEEEcCCCcEEEEecCCcccc
Q 003385 730 LKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 730 Lkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
|++.|||++ ++.+.|+|||.+...
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999997 468999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.6e-12 Score=138.14 Aligned_cols=90 Identities=28% Similarity=0.404 Sum_probs=84.6
Q ss_pred ceeEEEecCCCCCccCChhhh-cccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeec
Q 003385 417 SITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~-~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~ 495 (824)
.|.+|+++.|+|+ .+|.+.. +|.+|..|||..|++...|.+++-|++|+.||||+|.|+ .+|.++|+| .|+.|-+.
T Consensus 229 ~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~le 305 (565)
T KOG0472|consen 229 LLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALE 305 (565)
T ss_pred HHHHHHhcccHHH-hhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhc
Confidence 7999999999999 8998887 899999999999999999999999999999999999999 899999999 99999999
Q ss_pred ccccccccccccccc
Q 003385 496 NNMLSGTVPSSLLSK 510 (824)
Q Consensus 496 ~N~l~g~ip~~l~~~ 510 (824)
+|++. +|-.++.++
T Consensus 306 GNPlr-TiRr~ii~~ 319 (565)
T KOG0472|consen 306 GNPLR-TIRREIISK 319 (565)
T ss_pred CCchH-HHHHHHHcc
Confidence 99999 887777654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.2e-09 Score=106.70 Aligned_cols=131 Identities=24% Similarity=0.404 Sum_probs=101.9
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCCcc--------cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
..+++|+-+.+|.+.+. |..+++|.-.+.... ..+...+|+.++.+++--.|...+-+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999876 444666654332221 123466799999999877776666667778888999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
++|..|.+.+... ...++..+-.-+.-||.. ||+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888432 245677888888999998 999999999999998765 99999999864
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.1e-11 Score=117.91 Aligned_cols=149 Identities=23% Similarity=0.285 Sum_probs=118.7
Q ss_pred cchhhhceeccCCCCCCcHH--HHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeEEEecCCCCCccCChhh
Q 003385 359 LNAMEINKYLERNDGSIDGV--AIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDL 436 (824)
Q Consensus 359 i~~le~l~~L~l~~n~~~~~--~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~L~L~~n~l~g~lp~~i 436 (824)
+-.+++.+.|.|+.|.+.++ .+..|+.+..+.-|+.. .+.++.+.+.++.|+.|+++-|+|. .+|..|
T Consensus 29 Lf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnq---------ie~lp~~issl~klr~lnvgmnrl~-~lprgf 98 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQ---------IEELPTSISSLPKLRILNVGMNRLN-ILPRGF 98 (264)
T ss_pred ccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccch---------hhhcChhhhhchhhhheecchhhhh-cCcccc
Confidence 55678888899999998774 45666666555555321 2333444566889999999999999 999999
Q ss_pred hcccccccccccccccCC-CCC-CCCCCCCcceEeecccccCCCCCccccCCCccceeeeccccccccccccccc--cce
Q 003385 437 TKLSSLVELWLDGNSLTG-PIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS--KNV 512 (824)
Q Consensus 437 ~~L~~L~~L~L~~N~l~~-~~p-~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g~ip~~l~~--~~~ 512 (824)
|.++.|+.|||.+|++.. ..| .|..|+.|+.|+|++|.+. .+|..+++|++|+.|.+..|.|- ++|.++.. .+.
T Consensus 99 gs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lr 176 (264)
T KOG0617|consen 99 GSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLR 176 (264)
T ss_pred CCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHH
Confidence 999999999999999987 445 4889999999999999999 89999999999999999999999 89988743 234
Q ss_pred eccccCC
Q 003385 513 VLNYAGN 519 (824)
Q Consensus 513 ~l~~~~n 519 (824)
.+...||
T Consensus 177 elhiqgn 183 (264)
T KOG0617|consen 177 ELHIQGN 183 (264)
T ss_pred HHhcccc
Confidence 4555566
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.8e-11 Score=139.39 Aligned_cols=170 Identities=26% Similarity=0.369 Sum_probs=124.3
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcH-------------------------------HHHHHHHHhc
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDG-------------------------------VAIVSVISLY 387 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~-------------------------------~~l~~lk~~~ 387 (824)
.+.|+.|.+..|.++-+||.+.+++.|+.|+|..|.+.. ..+..|..++
T Consensus 286 ~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Ly 365 (1081)
T KOG0618|consen 286 ITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELY 365 (1081)
T ss_pred hhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHH
Confidence 456677777777777777777777777777776665433 1111111111
Q ss_pred CCCCcccCCCCCCCCCCCCeeEcCCCCCCceeEEEecCCCCCccCCh-hhhcccccccccccccccCCCCCCCCCCCCcc
Q 003385 388 SSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPDFSGCPDLR 466 (824)
Q Consensus 388 ~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~L~L~~n~l~g~lp~-~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~ 466 (824)
.-.+. -+|-| |.-+. +.+.|+.|+|++|+|. .+|. .+.+|..|++|+||+|+|+.++..+..++.|+
T Consensus 366 lanN~---Ltd~c----~p~l~----~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~ 433 (1081)
T KOG0618|consen 366 LANNH---LTDSC----FPVLV----NFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLH 433 (1081)
T ss_pred HhcCc---ccccc----hhhhc----cccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhH
Confidence 11111 23334 22222 3578999999999999 7776 78899999999999999999998899999999
Q ss_pred eEeecccccCCCCCccccCCCccceeeecccccccc-cccccc-ccceeccccCCccc
Q 003385 467 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT-VPSSLL-SKNVVLNYAGNINL 522 (824)
Q Consensus 467 ~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g~-ip~~l~-~~~~~l~~~~n~~l 522 (824)
+|...+|+|. ..| ++.+++.|+.+|++.|+|+.. +|..+= .++.-++++||..+
T Consensus 434 tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 434 TLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred HHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 9999999999 889 899999999999999999843 344333 45677889999854
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.3e-09 Score=109.36 Aligned_cols=142 Identities=18% Similarity=0.335 Sum_probs=106.8
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCC--CccceeeceeecC---CeEEEEEEecC
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHH--RNLVQFLGYCQEE---GRSVLVYEFMH 680 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~---~~~~lV~E~~~ 680 (824)
+.|+.|..+.+|++...+|+.+++|+...... .....+.+|+++++.+.+ ..+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887778999999764332 135678899999999976 3457777776653 25689999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--------------------------------------- 721 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--------------------------------------- 721 (824)
|.++.+.+.. ..++..+...++.++++.|..||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9877664310 23555666677778888888887421
Q ss_pred --------------CCCeEecCCCCCCEEEcC--CCcEEEEecCCccc
Q 003385 722 --------------VPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKF 753 (824)
Q Consensus 722 --------------~~gIvHrDLkp~NILl~~--~~~vkL~DFGla~~ 753 (824)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 146799999999999998 56789999997653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.6e-10 Score=117.05 Aligned_cols=154 Identities=25% Similarity=0.408 Sum_probs=119.5
Q ss_pred HHhhcCCCccceeeceeecC-----CeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 003385 650 LLSRIHHRNLVQFLGYCQEE-----GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724 (824)
Q Consensus 650 il~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~g 724 (824)
-+-++.|.|||+++.++.+. .+..++.|||+.|++..+|+........+......+++.||+.||.|||+ |.|+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence 34556799999999988653 35688999999999999998766666778888888999999999999999 6889
Q ss_pred eEecCCCCCCEEEcCCCcEEEEecCCcc--cccC-CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcC
Q 003385 725 IIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVD-GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801 (824)
Q Consensus 725 IvHrDLkp~NILl~~~~~vkL~DFGla~--~~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG 801 (824)
|+|+++..+-|++..++-+|+.--.-.. .... ..........+-++|.+||.-....-+.++|||+||+...||..|
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999999988885321110 0000 001111222356899999988777888899999999999999988
Q ss_pred CCC
Q 003385 802 QEA 804 (824)
Q Consensus 802 ~~P 804 (824)
..-
T Consensus 279 Eiq 281 (458)
T KOG1266|consen 279 EIQ 281 (458)
T ss_pred eec
Confidence 864
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.95 E-value=7.7e-11 Score=130.46 Aligned_cols=132 Identities=21% Similarity=0.312 Sum_probs=68.6
Q ss_pred ceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeE
Q 003385 341 FVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITV 420 (824)
Q Consensus 341 ~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~ 420 (824)
+|+.|.|..|.+..+|+.|..|+.|++|+++.|++.. ..++ -|. --|+.
T Consensus 99 ~Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~NqlS~------------------lp~~---------lC~----lpLkv 147 (722)
T KOG0532|consen 99 SLESLILYHNCIRTIPEAICNLEALTFLDLSSNQLSH------------------LPDG---------LCD----LPLKV 147 (722)
T ss_pred HHHHHHHHhccceecchhhhhhhHHHHhhhccchhhc------------------CChh---------hhc----Cccee
Confidence 4556666677777777777777777777776665543 1111 011 12445
Q ss_pred EEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecccccc
Q 003385 421 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 500 (824)
Q Consensus 421 L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~ 500 (824)
|-+++|+|+ .+|+.|+.+..|..||.+.|.+..+++.+++|.+|+.|++..|++. .+|++++.|+ |..||+++|+++
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis 224 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS 224 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee
Confidence 555555555 5555555555555555555555555555555555555444444444 4444444332 444444444444
Q ss_pred ccccccc
Q 003385 501 GTVPSSL 507 (824)
Q Consensus 501 g~ip~~l 507 (824)
.||.++
T Consensus 225 -~iPv~f 230 (722)
T KOG0532|consen 225 -YLPVDF 230 (722)
T ss_pred -ecchhh
Confidence 444444
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=7.7e-10 Score=132.13 Aligned_cols=72 Identities=33% Similarity=0.421 Sum_probs=37.4
Q ss_pred ccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeeccccccccccccccc--cceeccccC
Q 003385 441 SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS--KNVVLNYAG 518 (824)
Q Consensus 441 ~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g~ip~~l~~--~~~~l~~~~ 518 (824)
+|+.|+|++|+|+++++. .++|+.|+|++|+|+ .+|... .+|+.|+|++|+|+ .+|.++.. .+..+.+++
T Consensus 383 ~L~~LdLs~N~Lt~LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~ 454 (788)
T PRK15387 383 GLKELIVSGNRLTSLPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 454 (788)
T ss_pred ccceEEecCCcccCCCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence 455555555555543322 234555566666655 355422 34556666666666 66665532 234455555
Q ss_pred Cc
Q 003385 519 NI 520 (824)
Q Consensus 519 n~ 520 (824)
|+
T Consensus 455 N~ 456 (788)
T PRK15387 455 NP 456 (788)
T ss_pred CC
Confidence 54
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=9.4e-09 Score=99.96 Aligned_cols=142 Identities=25% Similarity=0.281 Sum_probs=104.5
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCC--------cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--------YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~--------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
..|-+|+-+.|+++.+. |+...||.-.... .-..++..+|++.+.++.--.|.-..-++.+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 56789999999999887 6776676432221 11245678899999998766665555566677777899999
Q ss_pred cCC-CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEEEecCCcccc
Q 003385 679 MHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKFA 754 (824)
Q Consensus 679 ~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~---~vkL~DFGla~~~ 754 (824)
+++ .++.+++....... ........++++|-+.+.-||.+ +|+|+||..+||++..++ .+.++|||++...
T Consensus 92 ~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred ccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 977 46778775543221 11222257889999999999999 999999999999998664 3589999998643
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.7e-09 Score=129.91 Aligned_cols=158 Identities=21% Similarity=0.258 Sum_probs=80.9
Q ss_pred cceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCcee
Q 003385 340 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 419 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~ 419 (824)
++|+.|+|+.|.++.+|..+. ..|+.|+++.|.+..... .+.. .+..+..+++. ...++- .-.++|+
T Consensus 220 ~nL~~L~Ls~N~LtsLP~~l~--~~L~~L~Ls~N~L~~LP~-~l~s--~L~~L~Ls~N~------L~~LP~--~l~~sL~ 286 (754)
T PRK15370 220 GNIKTLYANSNQLTSIPATLP--DTIQEMELSINRITELPE-RLPS--ALQSLDLFHNK------ISCLPE--NLPEELR 286 (754)
T ss_pred cCCCEEECCCCccccCChhhh--ccccEEECcCCccCcCCh-hHhC--CCCEEECcCCc------cCcccc--ccCCCCc
Confidence 467788888888888877653 357778888777654211 1111 12222111100 011110 0123677
Q ss_pred EEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeeccccc
Q 003385 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 499 (824)
Q Consensus 420 ~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l 499 (824)
.|+|++|+|+ .+|..+. ++|+.|+|++|+|+.+++.+. ++|+.|++++|+|+ .+|..+. ++|+.|+|++|+|
T Consensus 287 ~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L 358 (754)
T PRK15370 287 YLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTALPETLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQI 358 (754)
T ss_pred EEECCCCccc-cCcccch--hhHHHHHhcCCccccCCcccc--ccceeccccCCccc-cCChhhc--CcccEEECCCCCC
Confidence 7777777777 5665443 356666666666665443322 34555555555555 3444442 3455555555555
Q ss_pred cccccccccccceeccccCC
Q 003385 500 SGTVPSSLLSKNVVLNYAGN 519 (824)
Q Consensus 500 ~g~ip~~l~~~~~~l~~~~n 519 (824)
+ .+|..+...+..|.+++|
T Consensus 359 ~-~LP~~lp~~L~~LdLs~N 377 (754)
T PRK15370 359 T-VLPETLPPTITTLDVSRN 377 (754)
T ss_pred C-cCChhhcCCcCEEECCCC
Confidence 5 444444433444444444
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.6e-09 Score=122.43 Aligned_cols=203 Identities=24% Similarity=0.248 Sum_probs=153.1
Q ss_pred HHHHHHHHhhccccc--cCcEEEEEEEE---cCCcEEEEEEeccC--CcccchhhhHHHHHHhhcC-CCccceeeceeec
Q 003385 597 DIEDATKMLEKKIGS--GGFGVVYYGKL---KDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQE 668 (824)
Q Consensus 597 ~~~~~~~~i~~~LG~--G~fg~Vy~a~~---~~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 668 (824)
++.+....+.+.+|. |.+|.||.+.. .++..+|+|.-+.. .......=.+|+...++++ |+|.++....+.+
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 444555566788999 99999999976 36788899874322 1122222345666666664 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCCEEEcCC-CcE
Q 003385 669 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----GIEYLHTGCVPAIIHRDLKSSNILLDKH-MRA 743 (824)
Q Consensus 669 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~----gL~yLH~~~~~gIvHrDLkp~NILl~~~-~~v 743 (824)
.+..++-+|++. .+|.++.... ...++....+....+..+ |+.++|+. .++|-|+||.||+...+ ..+
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred CCcceeeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccccee
Confidence 999999999986 6777766432 233455566677777777 99999998 99999999999999999 899
Q ss_pred EEEecCCcccccCCCCc----eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 744 KVSDFGLSKFAVDGASH----VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 744 kL~DFGla~~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
++.|||+...+..+... ......|...|++||.. ...++.+.|++++|.+..+...|..+...
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccC
Confidence 99999998877654422 11222477889999965 45678899999999999999988876544
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.8e-10 Score=127.60 Aligned_cols=141 Identities=21% Similarity=0.277 Sum_probs=124.4
Q ss_pred eccccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCC
Q 003385 336 NLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQ 415 (824)
Q Consensus 336 ~~~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~ 415 (824)
...|+.|+.|+|+.|.++.||+-|+.|. |++|-+++|.+.. .|.+ + +.+
T Consensus 117 i~~L~~lt~l~ls~NqlS~lp~~lC~lp-Lkvli~sNNkl~~-----------------------lp~~---i----g~~ 165 (722)
T KOG0532|consen 117 ICNLEALTFLDLSSNQLSHLPDGLCDLP-LKVLIVSNNKLTS-----------------------LPEE---I----GLL 165 (722)
T ss_pred hhhhhHHHHhhhccchhhcCChhhhcCc-ceeEEEecCcccc-----------------------CCcc---c----ccc
Confidence 3457788999999999999999999999 9999999987663 1111 1 235
Q ss_pred CceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeec
Q 003385 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~ 495 (824)
+.|..||.+.|++. .+|..++.|.+|+.|.+..|++..++++++ .-.|..||+|.|+++ .||-.|.+|+.|++|-|.
T Consensus 166 ~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~Le 242 (722)
T KOG0532|consen 166 PTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLE 242 (722)
T ss_pred hhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeec
Confidence 68999999999999 999999999999999999999999999988 447899999999999 999999999999999999
Q ss_pred cccccccccccccccc
Q 003385 496 NNMLSGTVPSSLLSKN 511 (824)
Q Consensus 496 ~N~l~g~ip~~l~~~~ 511 (824)
+|.|. +-|..++.+.
T Consensus 243 nNPLq-SPPAqIC~kG 257 (722)
T KOG0532|consen 243 NNPLQ-SPPAQICEKG 257 (722)
T ss_pred cCCCC-CChHHHHhcc
Confidence 99999 8999887665
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.9e-09 Score=127.25 Aligned_cols=91 Identities=29% Similarity=0.389 Sum_probs=50.4
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecc
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~ 496 (824)
+|+.|+|++|+|+ .+|... .+|+.|++++|+|++++. + +.+|+.|+|++|+|+ .+|... ++|+.|++++
T Consensus 343 ~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~~LP~-l--~~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~ 411 (788)
T PRK15387 343 GLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLTSLPA-L--PSGLKELIVSGNRLT-SLPVLP---SELKELMVSG 411 (788)
T ss_pred ccceEecCCCccC-CCCCCC---cccceehhhccccccCcc-c--ccccceEEecCCccc-CCCCcc---cCCCEEEccC
Confidence 4555555555555 344321 344445555555554322 1 245777777777777 466432 4677788888
Q ss_pred ccccccccccccccceeccccCCc
Q 003385 497 NMLSGTVPSSLLSKNVVLNYAGNI 520 (824)
Q Consensus 497 N~l~g~ip~~l~~~~~~l~~~~n~ 520 (824)
|+|+ .+|.. ...+..+.+..|.
T Consensus 412 N~Ls-sIP~l-~~~L~~L~Ls~Nq 433 (788)
T PRK15387 412 NRLT-SLPML-PSGLLSLSVYRNQ 433 (788)
T ss_pred CcCC-CCCcc-hhhhhhhhhccCc
Confidence 8887 57753 2333445555553
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.5e-09 Score=130.36 Aligned_cols=142 Identities=23% Similarity=0.261 Sum_probs=79.8
Q ss_pred ceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHH---HHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCc
Q 003385 341 FVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVA---IVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (824)
Q Consensus 341 ~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~---l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (824)
+|+.|+|+.|.++.+|+.+. +.|+.|+++.|.+.... ...|+.+....+. +..++. ...++
T Consensus 263 ~L~~L~Ls~N~L~~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp~sL~~L~Ls~N~------------Lt~LP~--~l~~s 326 (754)
T PRK15370 263 ALQSLDLFHNKISCLPENLP--EELRYLSVYDNSIRTLPAHLPSGITHLNVQSNS------------LTALPE--TLPPG 326 (754)
T ss_pred CCCEEECcCCccCccccccC--CCCcEEECCCCccccCcccchhhHHHHHhcCCc------------cccCCc--ccccc
Confidence 46666777777777666553 35666777766654311 1112222110000 011110 01246
Q ss_pred eeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeeccc
Q 003385 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 418 L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N 497 (824)
|+.|++++|+|+ .+|..+. ++|+.|+|++|+|+.++..+ .++|+.|+|++|+|+ .+|+.+.. .|+.|++++|
T Consensus 327 L~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~~LP~~l--p~~L~~LdLs~N~Lt-~LP~~l~~--sL~~LdLs~N 398 (754)
T PRK15370 327 LKTLEAGENALT-SLPASLP--PELQVLDVSKNQITVLPETL--PPTITTLDVSRNALT-NLPENLPA--ALQIMQASRN 398 (754)
T ss_pred ceeccccCCccc-cCChhhc--CcccEEECCCCCCCcCChhh--cCCcCEEECCCCcCC-CCCHhHHH--HHHHHhhccC
Confidence 777777777777 4666553 56777777777776544433 246777777777777 56665542 5777777777
Q ss_pred cccccccccc
Q 003385 498 MLSGTVPSSL 507 (824)
Q Consensus 498 ~l~g~ip~~l 507 (824)
+|+ .+|.++
T Consensus 399 ~L~-~LP~sl 407 (754)
T PRK15370 399 NLV-RLPESL 407 (754)
T ss_pred Ccc-cCchhH
Confidence 777 666554
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=5.8e-10 Score=118.86 Aligned_cols=91 Identities=24% Similarity=0.255 Sum_probs=64.4
Q ss_pred hhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccccccccccccccccc--
Q 003385 435 DLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN-- 511 (824)
Q Consensus 435 ~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g~ip~~l~~~~-- 511 (824)
.|..|++|+.|+|++|+|+++-+. |.++..|+.|.|..|+|.-.--..|.+|.+|+.|+|.+|+++ .+-+..|+..
T Consensus 269 cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it-~~~~~aF~~~~~ 347 (498)
T KOG4237|consen 269 CFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQIT-TVAPGAFQTLFS 347 (498)
T ss_pred HHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeE-EEecccccccce
Confidence 466777777777777777777664 777777777777777777444456777777777788888877 6666555554
Q ss_pred -eeccccCCccccCCC
Q 003385 512 -VVLNYAGNINLHEGG 526 (824)
Q Consensus 512 -~~l~~~~n~~lc~~~ 526 (824)
..+.+-+||..|.+-
T Consensus 348 l~~l~l~~Np~~CnC~ 363 (498)
T KOG4237|consen 348 LSTLNLLSNPFNCNCR 363 (498)
T ss_pred eeeeehccCcccCccc
Confidence 445567777777763
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.2e-10 Score=135.25 Aligned_cols=180 Identities=18% Similarity=0.149 Sum_probs=133.4
Q ss_pred eccccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHH--HHHHHHHhc-------CCCCccc-----------C
Q 003385 336 NLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGV--AIVSVISLY-------SSADWAQ-----------E 395 (824)
Q Consensus 336 ~~~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~--~l~~lk~~~-------~~~~w~~-----------~ 395 (824)
...+.+|+.+....|.++.+|..|..+..|+.|....|.+..+ .++.++.+- .+.++-. .
T Consensus 260 i~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ 339 (1081)
T KOG0618|consen 260 IGACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNT 339 (1081)
T ss_pred HHhcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHH
Confidence 3456788999999999999999999999999998887776542 122222221 0111100 0
Q ss_pred CCCCCCCCCCCeeEcC-CCCCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeeccc
Q 003385 396 GGDPCLPVPWSWLQCN-SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 473 (824)
Q Consensus 396 ~~dpc~~~~~~~~~c~-~~~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N 473 (824)
-+.-|. +.+-..|. ....+.|+.|.|.+|.|+...=+.|.++++|+.|+|++|+|...+.. +.++..|+.|+||+|
T Consensus 340 ln~s~n--~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGN 417 (1081)
T KOG0618|consen 340 LNVSSN--KLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGN 417 (1081)
T ss_pred Hhhhhc--cccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccc
Confidence 011111 11222232 23467899999999999988877899999999999999999988876 899999999999999
Q ss_pred ccCCCCCccccCCCccceeeeccccccccccccc-cccceeccccCC
Q 003385 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGN 519 (824)
Q Consensus 474 ~l~g~lP~~l~~l~~L~~L~l~~N~l~g~ip~~l-~~~~~~l~~~~n 519 (824)
+|+ .+|.++.+++.|+.|...+|+|. .+|+.. +..+..++++.|
T Consensus 418 kL~-~Lp~tva~~~~L~tL~ahsN~l~-~fPe~~~l~qL~~lDlS~N 462 (1081)
T KOG0618|consen 418 KLT-TLPDTVANLGRLHTLRAHSNQLL-SFPELAQLPQLKVLDLSCN 462 (1081)
T ss_pred hhh-hhhHHHHhhhhhHHHhhcCCcee-echhhhhcCcceEEecccc
Confidence 999 99999999999999999999999 999433 223355666665
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.2e-07 Score=104.91 Aligned_cols=169 Identities=21% Similarity=0.307 Sum_probs=129.6
Q ss_pred EEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceee----cCCeEEEEEEecCC-CCHHHHh
Q 003385 615 GVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ----EEGRSVLVYEFMHN-GTLKEHL 688 (824)
Q Consensus 615 g~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~----~~~~~~lV~E~~~~-gsL~~~L 688 (824)
.+.|++... +|..|++|+++.+..+.......-++.++++.|+|||++.+++. ....+++|++|.++ ++|.+.-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 578999765 89999999996555554445556788999999999999999886 34577899999875 4676654
Q ss_pred hcc-----------cCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 689 YGT-----------LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 689 ~~~-----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
... .......++..++.++.|+..||.++|+. |+..+-|.+++||++.+.+++|...|........
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 332 22345578889999999999999999998 9999999999999999999999887766544332
Q ss_pred CCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCC
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 804 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~P 804 (824)
.. |.+.. -.+-|.=.||.+++.|.+|..-
T Consensus 447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 20 11111 2366889999999999999653
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.9e-08 Score=97.59 Aligned_cols=125 Identities=26% Similarity=0.330 Sum_probs=79.8
Q ss_pred EEEEEEEcCCcEEEEEEeccCCcc---------------------c-----chhhhHHHHHHhhcCCC--ccceeeceee
Q 003385 616 VVYYGKLKDGKEIAVKVLTSNSYQ---------------------G-----KREFTNEVTLLSRIHHR--NLVQFLGYCQ 667 (824)
Q Consensus 616 ~Vy~a~~~~g~~vAVK~l~~~~~~---------------------~-----~~~~~~Ei~il~~l~Hp--nIv~l~~~~~ 667 (824)
.||.|...+|+.+|||+.+..... . .....+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999989999999997642100 0 11246799999999765 456666442
Q ss_pred cCCeEEEEEEecC--CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCCEEEcCCCcEE
Q 003385 668 EEGRSVLVYEFMH--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCVPAIIHRDLKSSNILLDKHMRAK 744 (824)
Q Consensus 668 ~~~~~~lV~E~~~--~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~gIvHrDLkp~NILl~~~~~vk 744 (824)
..++||||++ |..+......... ......++.+++..+..+ |.. ||+||||.+.|||++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~~~------~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVDLS------PEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCGGG------GSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcccc------chhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 2379999998 5554433211111 123345677788866664 676 99999999999999988 999
Q ss_pred EEecCCcccc
Q 003385 745 VSDFGLSKFA 754 (824)
Q Consensus 745 L~DFGla~~~ 754 (824)
|+|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999987644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.75 E-value=3.5e-09 Score=104.80 Aligned_cols=81 Identities=27% Similarity=0.450 Sum_probs=21.1
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCC-CCCCCcceEeecccccCCCCC--ccccCCCccceee
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGPLP--SSLMNLPNLRELY 493 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~-~~l~~L~~L~L~~N~l~g~lP--~~l~~l~~L~~L~ 493 (824)
+|+.|+|++|+|+ .++ .+..|++|+.|+|++|+|+.+.+.+ ..+++|+.|+|++|+|.. +- ..++.|++|+.|+
T Consensus 43 ~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~-l~~l~~L~~l~~L~~L~ 119 (175)
T PF14580_consen 43 KLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISD-LNELEPLSSLPKLRVLS 119 (175)
T ss_dssp T--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---S-CCCCGGGGG-TT--EEE
T ss_pred CCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCC-hHHhHHHHcCCCcceee
Confidence 4444444444444 332 2444444444444444444433322 234444444444444441 11 2334444444444
Q ss_pred ecccccc
Q 003385 494 VQNNMLS 500 (824)
Q Consensus 494 l~~N~l~ 500 (824)
|.+|+++
T Consensus 120 L~~NPv~ 126 (175)
T PF14580_consen 120 LEGNPVC 126 (175)
T ss_dssp -TT-GGG
T ss_pred ccCCccc
Confidence 4444444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.71 E-value=7.5e-09 Score=102.50 Aligned_cols=121 Identities=22% Similarity=0.336 Sum_probs=53.3
Q ss_pred cceeeecccccCCCCCCcccc-hhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 340 PFVLSFKFGKTYDSSRGPLLN-AMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~i~-~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
..++.|+|.+|.++.+. .++ .+..|+.|++++|.+... +++. .+++|
T Consensus 19 ~~~~~L~L~~n~I~~Ie-~L~~~l~~L~~L~Ls~N~I~~l---------------------------~~l~----~L~~L 66 (175)
T PF14580_consen 19 VKLRELNLRGNQISTIE-NLGATLDKLEVLDLSNNQITKL---------------------------EGLP----GLPRL 66 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S-----------------------------TT--------TT-
T ss_pred ccccccccccccccccc-chhhhhcCCCEEECCCCCCccc---------------------------cCcc----Chhhh
Confidence 36789999999999985 566 589999999999988741 1111 25689
Q ss_pred eEEEecCCCCCccCChhhh-cccccccccccccccCCCCC--CCCCCCCcceEeecccccCCCCCc----cccCCCccce
Q 003385 419 TVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDNQLTGPLPS----SLMNLPNLRE 491 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~-~L~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~L~~N~l~g~lP~----~l~~l~~L~~ 491 (824)
+.|+|++|+|+ .+++.+. .|++|+.|+|++|+|...-. .+..|++|+.|+|.+|.++ ..+. -+..+|+|+.
T Consensus 67 ~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~-~~~~YR~~vi~~lP~Lk~ 144 (175)
T PF14580_consen 67 KTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC-EKKNYRLFVIYKLPSLKV 144 (175)
T ss_dssp -EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG-GSTTHHHHHHHH-TT-SE
T ss_pred hhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc-chhhHHHHHHHHcChhhe
Confidence 99999999999 7776664 69999999999999987544 4788999999999999998 4453 4667888888
Q ss_pred eee
Q 003385 492 LYV 494 (824)
Q Consensus 492 L~l 494 (824)
||-
T Consensus 145 LD~ 147 (175)
T PF14580_consen 145 LDG 147 (175)
T ss_dssp ETT
T ss_pred eCC
Confidence 763
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.70 E-value=7.1e-09 Score=84.41 Aligned_cols=59 Identities=37% Similarity=0.573 Sum_probs=32.0
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeeccccc
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQL 475 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l 475 (824)
+|++|+|++|+|+..-+..|.+|++|+.|+|++|+|+.++|. |.++++|+.|+|++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455666666666633234555555555555555555555543 55555555555555543
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.1e-07 Score=98.46 Aligned_cols=135 Identities=21% Similarity=0.242 Sum_probs=99.1
Q ss_pred HHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCc----------------------ccchhhhHHHHHHhhcCCC--c
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY----------------------QGKREFTNEVTLLSRIHHR--N 658 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~----------------------~~~~~~~~Ei~il~~l~Hp--n 658 (824)
+.++.+||.|.-+.||.|..+.|.++|||.-+.... ......++|.++|+++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456789999999999999999999999996432110 0122357899999999755 6
Q ss_pred cceeeceeecCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 003385 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738 (824)
Q Consensus 659 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~ 738 (824)
|.+.+++ ++..+|||+++|-.|...- ++......++..|+.-+.-+-.. ||||+|+.+=||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 7777765 4668999999986654321 11222334555555555555555 999999999999999
Q ss_pred CCCcEEEEecCCccc
Q 003385 739 KHMRAKVSDFGLSKF 753 (824)
Q Consensus 739 ~~~~vkL~DFGla~~ 753 (824)
+||.+.++||-.+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999976644
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.3e-08 Score=82.95 Aligned_cols=60 Identities=45% Similarity=0.608 Sum_probs=55.9
Q ss_pred cccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccccc
Q 003385 440 SSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 499 (824)
Q Consensus 440 ~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l 499 (824)
++|+.|+|++|+|+.++++ |.++++|+.|+|++|+|+...|+.|.+|++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4799999999999999886 89999999999999999977778999999999999999986
|
... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=5.8e-09 Score=123.40 Aligned_cols=208 Identities=21% Similarity=0.235 Sum_probs=147.7
Q ss_pred hhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
+.+.+-+|.++.+..+.-. .|.-.+.|+...... ...+...++-.++-..+||.++...--+.......++++|..
T Consensus 808 i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~ 887 (1205)
T KOG0606|consen 808 ITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLN 887 (1205)
T ss_pred ecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhc
Confidence 3457788999999887543 243334444332211 112233344444444456777776666556677899999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC----
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD---- 756 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~---- 756 (824)
+++|...|+... ..+.......+..+.++++|||.. .+.|||++|.|++...+++.++.|||.......
T Consensus 888 ~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 888 GGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred cCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 999988875432 233333345566788899999996 689999999999999999999999983321100
Q ss_pred -----------------C-------CC--ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 757 -----------------G-------AS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 757 -----------------~-------~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
. .. .......||+.|.+||...+......+|.|+.|++++|.++|..||...+.
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0 00 011234589999999999999999999999999999999999999999888
Q ss_pred ccchhcHhh
Q 003385 811 GANCRNIVQ 819 (824)
Q Consensus 811 ~~~~~~iv~ 819 (824)
+..+++|..
T Consensus 1041 q~~f~ni~~ 1049 (1205)
T KOG0606|consen 1041 QQIFENILN 1049 (1205)
T ss_pred hhhhhcccc
Confidence 877777654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.4e-07 Score=97.44 Aligned_cols=139 Identities=14% Similarity=0.105 Sum_probs=97.9
Q ss_pred cccccCcEEEEEEEEcCCcEEEEEEeccCCcc-----------cchhhhHHHHHHhhcCCCcc--ceeeceeec-----C
Q 003385 608 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ-----------GKREFTNEVTLLSRIHHRNL--VQFLGYCQE-----E 669 (824)
Q Consensus 608 ~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~-----------~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~-----~ 669 (824)
.+-+-....|.+..+ +|+.+.||........ ....+.+|...+.++...+| .+++++.+. .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333344445667665 4788999976433211 01137789999988865444 344555533 2
Q ss_pred CeEEEEEEecCCC-CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-------CC
Q 003385 670 GRSVLVYEFMHNG-TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-------HM 741 (824)
Q Consensus 670 ~~~~lV~E~~~~g-sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~-------~~ 741 (824)
...++|+|++++- +|.+++.... ....+...+..++.+++..+.-||.. ||+|+|++++|||++. +.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 3578999999876 7888874321 12344556678999999999999998 9999999999999975 46
Q ss_pred cEEEEecCCcc
Q 003385 742 RAKVSDFGLSK 752 (824)
Q Consensus 742 ~vkL~DFGla~ 752 (824)
.+.++||+.+.
T Consensus 183 ~~~LIDl~r~~ 193 (268)
T PRK15123 183 KLSVIDLHRAQ 193 (268)
T ss_pred eEEEEECCccc
Confidence 89999999875
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=5.2e-09 Score=111.70 Aligned_cols=86 Identities=27% Similarity=0.369 Sum_probs=81.7
Q ss_pred CCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceee
Q 003385 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (824)
Q Consensus 415 ~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~ 493 (824)
+++|+.|+|++|+|++.-+.+|..+..|++|.|..|+|...-.. |.++..|+.|+|.+|+|+..-|.+|..+..|..|+
T Consensus 273 L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~ 352 (498)
T KOG4237|consen 273 LPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLN 352 (498)
T ss_pred cccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeee
Confidence 68999999999999988899999999999999999999987765 89999999999999999999999999999999999
Q ss_pred ecccccc
Q 003385 494 VQNNMLS 500 (824)
Q Consensus 494 l~~N~l~ 500 (824)
|-.|.+.
T Consensus 353 l~~Np~~ 359 (498)
T KOG4237|consen 353 LLSNPFN 359 (498)
T ss_pred hccCccc
Confidence 9999987
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=98.60 E-value=9.1e-08 Score=95.33 Aligned_cols=134 Identities=25% Similarity=0.439 Sum_probs=75.8
Q ss_pred eEeecCCCCCcccCCCeEEecCCccccCcee--------------eeecCcc-cccccceeeeecCCCCcceeeecccCC
Q 003385 33 VSLNCGGNENFTDEIGLQWIADDHLIYGEIS--------------NISVANE-TRKQYMTLRHFPADSRKYCYKLDVITR 97 (824)
Q Consensus 33 ~~idcg~~~~~~~~~~~~~~~d~~~~~~~~~--------------~~~~~~~-~~~~~~tlr~fp~~~~~~cy~~~~~~~ 97 (824)
+.|+||++.. +|..++.|.+|..|..|... ....... ..+.|+|-|+=| ....|.+|+.+.
T Consensus 3 ~~IN~Gg~~~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~---~~f~Y~ip~~~~ 78 (174)
T PF11721_consen 3 LRINAGGPAY-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGP---SSFSYDIPVVPN 78 (174)
T ss_dssp EEEEETSSSE-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----S---SSEEEEEE--S-
T ss_pred EEEECCCCcc-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCC---CceEEEEecCCC
Confidence 4799999988 88899999999999866551 0111110 114678999933 357999999999
Q ss_pred ceeEEEEEe---eecccCCCCCCC---ceeEEeCCce-eeeEeeC-CcCc---ceEEEE-EEEecCCCceEEEec-----
Q 003385 98 TRYLIRATF---LYGNFDNNNVYP---KFDISLGPTH-WSTIVIS-DAAT---IEVREL-IFLASSPKIDVCLSN----- 160 (824)
Q Consensus 98 ~~ylvr~~~---~yg~~d~~~~~p---~fd~~~~~~~-w~~v~~~-~~~~---~~~~e~-~~~~~~~~~~vcl~~----- 160 (824)
|.|-||+.| +++. ++....| +||+.++|+. ...+++- .++. ....+. -+.+.+..+.++|..
T Consensus 79 G~Y~V~L~FaE~~~~~-~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~~~~ 157 (174)
T PF11721_consen 79 GTYTVRLHFAELYFGA-SGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAGKGT 157 (174)
T ss_dssp EEEEEEEEEE-SSS---------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE--SE
T ss_pred cEEEEEEEeccccccc-cccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecCCCc
Confidence 999999999 3443 4444444 8999999963 2233321 1111 223333 234578889999985
Q ss_pred ------cCCCCceeeee
Q 003385 161 ------ATTGQPFISTL 171 (824)
Q Consensus 161 ------~~~~~pfis~l 171 (824)
...|.|.||+|
T Consensus 158 ~~i~~~~~~~~p~IsaI 174 (174)
T PF11721_consen 158 LCIPFIGSYGNPLISAI 174 (174)
T ss_dssp EEEEEESSSSSSSEEEE
T ss_pred EEeeccccCCCcEEeeC
Confidence 55667999886
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.57 E-value=5.7e-09 Score=107.50 Aligned_cols=130 Identities=18% Similarity=0.173 Sum_probs=108.9
Q ss_pred ceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeE
Q 003385 341 FVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITV 420 (824)
Q Consensus 341 ~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~ 420 (824)
.|+.|+|+.|.++.+-..+--+..++.|+++.|++..+. + -..+++|+.
T Consensus 285 ~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v~-----------n--------------------La~L~~L~~ 333 (490)
T KOG1259|consen 285 ELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTVQ-----------N--------------------LAELPQLQL 333 (490)
T ss_pred hhhhccccccchhhhhhhhhhccceeEEeccccceeeeh-----------h--------------------hhhcccceE
Confidence 578899999999999999998999999999999876521 0 123568999
Q ss_pred EEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCC--ccccCCCccceeeecccc
Q 003385 421 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP--SSLMNLPNLRELYVQNNM 498 (824)
Q Consensus 421 L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP--~~l~~l~~L~~L~l~~N~ 498 (824)
|||++|.|+ .+-.+=.+|-+.+.|.|++|.|..+ ..+..|-+|..||+++|+|. .+- ..||+||.|+.|.|-+|+
T Consensus 334 LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~L-SGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NP 410 (490)
T KOG1259|consen 334 LDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIETL-SGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGNP 410 (490)
T ss_pred eecccchhH-hhhhhHhhhcCEeeeehhhhhHhhh-hhhHhhhhheeccccccchh-hHHHhcccccccHHHHHhhcCCC
Confidence 999999999 7888888899999999999998643 34667788999999999999 444 589999999999999999
Q ss_pred ccccccc
Q 003385 499 LSGTVPS 505 (824)
Q Consensus 499 l~g~ip~ 505 (824)
|. .+|.
T Consensus 411 l~-~~vd 416 (490)
T KOG1259|consen 411 LA-GSVD 416 (490)
T ss_pred cc-ccch
Confidence 99 4443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.57 E-value=5.8e-08 Score=109.92 Aligned_cols=171 Identities=25% Similarity=0.319 Sum_probs=124.1
Q ss_pred cceeeecccccCCCCCCcccchhh-hceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 340 PFVLSFKFGKTYDSSRGPLLNAME-INKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~i~~le-~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+.++.|++..|.++.+||.+..+. +|+.|+++.|++.... ..+..+..+..+....++-+ .+.-....++.|
T Consensus 116 ~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~l~-~~~~~l~~L~~L~l~~N~l~------~l~~~~~~~~~L 188 (394)
T COG4886 116 TNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLP-SPLRNLPNLKNLDLSFNDLS------DLPKLLSNLSNL 188 (394)
T ss_pred cceeEEecCCcccccCccccccchhhcccccccccchhhhh-hhhhccccccccccCCchhh------hhhhhhhhhhhh
Confidence 567888899999999999999985 9999999999877641 22233333333322222211 111111146788
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~ 498 (824)
+.|++++|+++ .+|..+..+.+|+.|++++|.+...+..+..+++|..|.+.+|++. .+|..++.+++|+.|++++|.
T Consensus 189 ~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~ 266 (394)
T COG4886 189 NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQ 266 (394)
T ss_pred hheeccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee-eccchhccccccceecccccc
Confidence 99999999999 8998888888899999999987777777888888888889999988 668888999999999999999
Q ss_pred ccccccc-cccccceeccccCCc
Q 003385 499 LSGTVPS-SLLSKNVVLNYAGNI 520 (824)
Q Consensus 499 l~g~ip~-~l~~~~~~l~~~~n~ 520 (824)
++ .++. .-......+.+++|.
T Consensus 267 i~-~i~~~~~~~~l~~L~~s~n~ 288 (394)
T COG4886 267 IS-SISSLGSLTNLRELDLSGNS 288 (394)
T ss_pred cc-ccccccccCccCEEeccCcc
Confidence 98 7765 112233555666664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.5e-08 Score=111.59 Aligned_cols=189 Identities=21% Similarity=0.218 Sum_probs=138.0
Q ss_pred hhccccccCcEEEEEEEEc--CCcEEEEEEeccCCcccch--hhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEEec
Q 003385 605 LEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSYQGKR--EFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~--~g~~vAVK~l~~~~~~~~~--~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
+...||.|.|+.|++...+ ++..+++|.+......... .-..|+.+...+ .|.+++.....+..-...++=.||+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 4578999999999988644 5778899987654333222 234566666666 4777777766665666667889999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCcccccCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~-~~vkL~DFGla~~~~~~~ 758 (824)
+++++...+ .-...+....++.+..|++.++.++|+. .++|+|+||+||++..+ +..++.|||+.....-.
T Consensus 349 ~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~- 420 (524)
T KOG0601|consen 349 EGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS- 420 (524)
T ss_pred cCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccccee-
Confidence 999877655 1234456667788999999999999987 99999999999999986 78899999987642110
Q ss_pred CceeccccCCCCCc--chhccccCCCCchHHHHHHHHHHHHHHcCCCC
Q 003385 759 SHVSSIVRGTVGYL--DPEYYISQQLTDKSDVYSFGVILLELISGQEA 804 (824)
Q Consensus 759 ~~~~~~~~gt~~y~--aPE~l~~~~~~~~~DIwSlGvil~elltG~~P 804 (824)
.......-+++ +++......+..+.|++|||.-+.|.++|...
T Consensus 421 ---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 421 ---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred ---cccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 11111223334 56666677888999999999999998888753
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.7e-07 Score=119.67 Aligned_cols=60 Identities=32% Similarity=0.419 Sum_probs=43.4
Q ss_pred CCcceEeecccccCCCCCccccCCCccceeeeccccccccccccc-cccceeccccCCccc
Q 003385 463 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGNINL 522 (824)
Q Consensus 463 ~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g~ip~~l-~~~~~~l~~~~n~~l 522 (824)
++|+.|+|++|...+.+|.++++|++|+.|+|++|...+.+|..+ +..+..+.++++..+
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L 838 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRL 838 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCcc
Confidence 578888888887777888889999999999998876444888765 333455566665433
|
syringae 6; Provisional |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.6e-08 Score=108.95 Aligned_cols=139 Identities=18% Similarity=0.220 Sum_probs=91.7
Q ss_pred ccceeeecccccCCCC-CCcccchhhh---ceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCC
Q 003385 339 LPFVLSFKFGKTYDSS-RGPLLNAMEI---NKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDP 414 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~-LPP~i~~le~---l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~ 414 (824)
+++|+.|+|+.|.++. .++.+.++.. |+.|+++.|.+...++..+...... .
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~------------------------~ 135 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKD------------------------L 135 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHh------------------------C
Confidence 5678888888888874 4555767666 8888888887765444433222110 0
Q ss_pred CCceeEEEecCCCCCcc----CChhhhcccccccccccccccCCC-----CCCCCCCCCcceEeecccccCCC----CCc
Q 003385 415 QPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGP-----IPDFSGCPDLRIIHLEDNQLTGP----LPS 481 (824)
Q Consensus 415 ~~~L~~L~L~~n~l~g~----lp~~i~~L~~L~~L~L~~N~l~~~-----~p~~~~l~~L~~L~L~~N~l~g~----lP~ 481 (824)
.++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++. ...+..+++|+.|+|++|++++. ++.
T Consensus 136 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~ 215 (319)
T cd00116 136 PPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAE 215 (319)
T ss_pred CCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHH
Confidence 14678888888887732 344556667788888888887742 11245556788888888877633 344
Q ss_pred cccCCCccceeeeccccccc
Q 003385 482 SLMNLPNLRELYVQNNMLSG 501 (824)
Q Consensus 482 ~l~~l~~L~~L~l~~N~l~g 501 (824)
.+..+++|+.|++++|++++
T Consensus 216 ~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 216 TLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HhcccCCCCEEecCCCcCch
Confidence 56667778888888888774
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.4e-07 Score=106.88 Aligned_cols=155 Identities=22% Similarity=0.264 Sum_probs=120.7
Q ss_pred ceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHH--HHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 341 FVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIV--SVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 341 ~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~--~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+|+.|+++.|.+..+|..+..++.|+.|+++.|++....-. .+..+ .....+++ ...-+++....+..|
T Consensus 141 nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~~~L---~~L~ls~N------~i~~l~~~~~~~~~L 211 (394)
T COG4886 141 NLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNL---NNLDLSGN------KISDLPPEIELLSAL 211 (394)
T ss_pred hcccccccccchhhhhhhhhccccccccccCCchhhhhhhhhhhhhhh---hheeccCC------ccccCchhhhhhhhh
Confidence 78999999999999998899999999999999987763322 22222 21211111 112223322234459
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~ 498 (824)
++|.+++|.+. .++..+.++++|..|.+++|++...+..++.+++|+.|++++|+++ .++. ++.+.+|+.|++++|.
T Consensus 212 ~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~ 288 (394)
T COG4886 212 EELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNS 288 (394)
T ss_pred hhhhhcCCcce-ecchhhhhcccccccccCCceeeeccchhccccccceecccccccc-cccc-ccccCccCEEeccCcc
Confidence 99999999766 7888899999999999999999988777899999999999999999 7776 9999999999999999
Q ss_pred ccccccccc
Q 003385 499 LSGTVPSSL 507 (824)
Q Consensus 499 l~g~ip~~l 507 (824)
+...+|...
T Consensus 289 ~~~~~~~~~ 297 (394)
T COG4886 289 LSNALPLIA 297 (394)
T ss_pred ccccchhhh
Confidence 995555444
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=8.3e-07 Score=102.18 Aligned_cols=139 Identities=22% Similarity=0.256 Sum_probs=90.3
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCCccc----------------------------------------chhhhH
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG----------------------------------------KREFTN 646 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~----------------------------------------~~~~~~ 646 (824)
+.|+.++-|.||+|++++|++||||+.+.+-... +-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6789999999999999999999999976532110 012344
Q ss_pred HHHHHhhcC-----CCccceeeceee-cCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHH-HHHHHh
Q 003385 647 EVTLLSRIH-----HRNLVQFLGYCQ-EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG-IEYLHT 719 (824)
Q Consensus 647 Ei~il~~l~-----HpnIv~l~~~~~-~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~g-L~yLH~ 719 (824)
|...+.+++ .+++. +=.++. -.....++|||++|-.+.+...-. ....+.. .++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~-VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k---~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVY-VPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRK---ELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeE-eceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHH---HHHHHHHHHHHHHHHh
Confidence 555555553 23332 222222 235568999999998887764211 1223322 233333332 233333
Q ss_pred CCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 720 ~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
. |+.|.|.+|.||+++.++++.+.|||+.....
T Consensus 284 d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 284 D---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred c---CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 3 89999999999999999999999999876554
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.4e-06 Score=91.45 Aligned_cols=195 Identities=13% Similarity=0.164 Sum_probs=127.0
Q ss_pred hhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeece----e--ec-CCeEEEEE
Q 003385 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGY----C--QE-EGRSVLVY 676 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~----~--~~-~~~~~lV~ 676 (824)
.++.||+|+-+.+|----- ...+-|++.......+.+ .++.|.+. .||-+-.=+.| . -+ ....-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh--hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3578999999999954211 122447776443222222 22333333 46543321221 1 11 22245677
Q ss_pred EecCCCC-HHHHhhc--ccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 677 EFMHNGT-LKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 677 E~~~~gs-L~~~L~~--~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
..+.+.. ...+... +.+......|...+.+++.++.+.+-||.. |.+-+|+.++|+|+++++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence 7776542 2222211 122334568999999999999999999998 999999999999999999999998654322
Q ss_pred ccCCCCceeccccCCCCCcchhccc-----cCCCCchHHHHHHHHHHHHHHcC-CCCCCCCc
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISG-QEAISNEK 809 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DIwSlGvil~elltG-~~Pf~~~~ 809 (824)
- .........+|..+|.+||... +-.-+...|.|.+|+++++++.| +.||.+..
T Consensus 167 ~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 167 N--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred c--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 2 2223334456899999999754 23345678999999999999987 99998743
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.38 E-value=7.7e-07 Score=113.80 Aligned_cols=155 Identities=15% Similarity=0.133 Sum_probs=103.8
Q ss_pred ceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeE
Q 003385 341 FVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITV 420 (824)
Q Consensus 341 ~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~ 420 (824)
.|+.|.+..+.+..+|+.+ ..++|+.|++..|.+... ...++.+..++....+........+ +...+++|+.
T Consensus 590 ~Lr~L~~~~~~l~~lP~~f-~~~~L~~L~L~~s~l~~L-~~~~~~l~~Lk~L~Ls~~~~l~~ip------~ls~l~~Le~ 661 (1153)
T PLN03210 590 KLRLLRWDKYPLRCMPSNF-RPENLVKLQMQGSKLEKL-WDGVHSLTGLRNIDLRGSKNLKEIP------DLSMATNLET 661 (1153)
T ss_pred ccEEEEecCCCCCCCCCcC-CccCCcEEECcCcccccc-ccccccCCCCCEEECCCCCCcCcCC------ccccCCcccE
Confidence 5778888888888888877 468888888887766531 1112222223322221111010011 1234678999
Q ss_pred EEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecccccc
Q 003385 421 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 500 (824)
Q Consensus 421 L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~ 500 (824)
|+|++|.....+|..|++|++|+.|+|++|...+.+|...++++|+.|+|++|...+.+|.. .++|+.|+|++|.+.
T Consensus 662 L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~ 738 (1153)
T PLN03210 662 LKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE 738 (1153)
T ss_pred EEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc
Confidence 99988776668899999999999999988754455554447889999999988766577753 357888899999988
Q ss_pred ccccccc
Q 003385 501 GTVPSSL 507 (824)
Q Consensus 501 g~ip~~l 507 (824)
.+|..+
T Consensus 739 -~lP~~~ 744 (1153)
T PLN03210 739 -EFPSNL 744 (1153)
T ss_pred -cccccc
Confidence 788765
|
syringae 6; Provisional |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.30 E-value=3.3e-06 Score=86.72 Aligned_cols=106 Identities=26% Similarity=0.317 Sum_probs=81.9
Q ss_pred chhhhHHHHHHhhcCCCc--cceeeceeecC----CeEEEEEEecCCC-CHHHHhhcccCccccCCHHHHHHHHHHHHHH
Q 003385 641 KREFTNEVTLLSRIHHRN--LVQFLGYCQEE----GRSVLVYEFMHNG-TLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713 (824)
Q Consensus 641 ~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~----~~~~lV~E~~~~g-sL~~~L~~~~~~~~~l~~~~~~~i~~qia~g 713 (824)
.....+|...+.++.... +.+.+++.... ...++|+|++++- +|.+++.... ..+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 456778988888886433 45566665442 2458999999874 7888874321 14455667899999999
Q ss_pred HHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEEEecCCccc
Q 003385 714 IEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKF 753 (824)
Q Consensus 714 L~yLH~~~~~gIvHrDLkp~NILl~~~~---~vkL~DFGla~~ 753 (824)
+.-||+. ||+|+|+++.|||++.+. .+.++||+-++.
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999998 999999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.29 E-value=7.9e-08 Score=105.09 Aligned_cols=86 Identities=27% Similarity=0.344 Sum_probs=57.4
Q ss_pred CceeEEEecCCCCCc----cCChhhhcc-cccccccccccccCCCCC-----CCCCCCCcceEeecccccCC----CCCc
Q 003385 416 PSITVIHLSSKNLTG----NIPSDLTKL-SSLVELWLDGNSLTGPIP-----DFSGCPDLRIIHLEDNQLTG----PLPS 481 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g----~lp~~i~~L-~~L~~L~L~~N~l~~~~p-----~~~~l~~L~~L~L~~N~l~g----~lP~ 481 (824)
++|++|+|++|++++ .+...+..+ ++|+.|+|++|.+++... .+..+++|+.|+|++|.+++ .++.
T Consensus 108 ~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~ 187 (319)
T cd00116 108 SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAE 187 (319)
T ss_pred CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHH
Confidence 457888888877762 334455666 777888888887774221 25566778888888887774 2344
Q ss_pred cccCCCccceeeeccccccc
Q 003385 482 SLMNLPNLRELYVQNNMLSG 501 (824)
Q Consensus 482 ~l~~l~~L~~L~l~~N~l~g 501 (824)
.+..+++|+.|+|++|.+++
T Consensus 188 ~l~~~~~L~~L~L~~n~i~~ 207 (319)
T cd00116 188 GLKANCNLEVLDLNNNGLTD 207 (319)
T ss_pred HHHhCCCCCEEeccCCccCh
Confidence 55566678888888887763
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.7e-05 Score=80.48 Aligned_cols=138 Identities=18% Similarity=0.176 Sum_probs=100.4
Q ss_pred ccccCcEEEEEEEEcCCcEEEEEEeccC---C---cccchhhhHHHHHHhhcCCCc--cceeeceee-c----CCeEEEE
Q 003385 609 IGSGGFGVVYYGKLKDGKEIAVKVLTSN---S---YQGKREFTNEVTLLSRIHHRN--LVQFLGYCQ-E----EGRSVLV 675 (824)
Q Consensus 609 LG~G~fg~Vy~a~~~~g~~vAVK~l~~~---~---~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~-~----~~~~~lV 675 (824)
-|+||-+-|++-.+. |+.+-+|.-... + +.....|.+|...++++..-+ +.+.+ ++. . ..+.+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 367899999987766 456888865411 1 335677999999999996433 44444 332 1 2346799
Q ss_pred EEecCC-CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--EEEEecCCcc
Q 003385 676 YEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--AKVSDFGLSK 752 (824)
Q Consensus 676 ~E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~--vkL~DFGla~ 752 (824)
+|-+++ .+|.+++... ...+.+...+..++.++++.+.-||+. |+.|+|+.++||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997764 5788877432 122456666778999999999999998 9999999999999986666 9999998765
Q ss_pred c
Q 003385 753 F 753 (824)
Q Consensus 753 ~ 753 (824)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.1e-07 Score=108.15 Aligned_cols=126 Identities=29% Similarity=0.379 Sum_probs=98.0
Q ss_pred CCCCCCCCCCCe---eEcCCC----------CCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCC-CCCC
Q 003385 396 GGDPCLPVPWSW---LQCNSD----------PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSG 461 (824)
Q Consensus 396 ~~dpc~~~~~~~---~~c~~~----------~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p-~~~~ 461 (824)
.||-|...+|.- ..|+.. -++.|+.|||++|+++ ... .+..|+.|++|||++|.|+..+- ...+
T Consensus 154 ggd~~ns~~Wn~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~-~v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~g 231 (1096)
T KOG1859|consen 154 GGDISNSPVWNKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFT-KVD-NLRRLPKLKHLDLSYNCLRHVPQLSMVG 231 (1096)
T ss_pred ccccccchhhhhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhh-hhH-HHHhcccccccccccchhccccccchhh
Confidence 677776556654 334322 2578999999999999 554 79999999999999999997665 2455
Q ss_pred CCCcceEeecccccCCCCCccccCCCccceeeecccccccc---ccccccccceeccccCCccccCCC
Q 003385 462 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT---VPSSLLSKNVVLNYAGNINLHEGG 526 (824)
Q Consensus 462 l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g~---ip~~l~~~~~~l~~~~n~~lc~~~ 526 (824)
++ |+.|.|++|-++ .+- .+.+|++|+.|||+.|-|++. .|-+.+..+..|.+.|||-.|..-
T Consensus 232 c~-L~~L~lrnN~l~-tL~-gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~ 296 (1096)
T KOG1859|consen 232 CK-LQLLNLRNNALT-TLR-GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW 296 (1096)
T ss_pred hh-heeeeecccHHH-hhh-hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence 66 999999999999 443 488999999999999999853 355555566778889999998763
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.3e-05 Score=81.66 Aligned_cols=139 Identities=15% Similarity=0.231 Sum_probs=85.3
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCc--cceeeceeecCCeEEEEEEecCCCC-
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGYCQEEGRSVLVYEFMHNGT- 683 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gs- 683 (824)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999984 25567888876432 3455788999999986443 4677777777777889999999863
Q ss_pred HHHHh---------------------hcccCccccCCHHHHH-HHHH----------HHHH-HHHHHHhC-CCCCeEecC
Q 003385 684 LKEHL---------------------YGTLTHEQRINWIKRL-EIAE----------DAAK-GIEYLHTG-CVPAIIHRD 729 (824)
Q Consensus 684 L~~~L---------------------~~~~~~~~~l~~~~~~-~i~~----------qia~-gL~yLH~~-~~~gIvHrD 729 (824)
+...+ +........+. ... .+.. .+.. ...+|... ..+.++|+|
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~--~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQ--SYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHH--HHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 11111 10000011110 000 0000 0111 12222211 113679999
Q ss_pred CCCCCEEEcCCCcEEEEecCCccc
Q 003385 730 LKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 730 Lkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+.|.||++++++ +.|+||+.+..
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999888 99999997653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.11 E-value=3e-05 Score=79.88 Aligned_cols=139 Identities=22% Similarity=0.270 Sum_probs=94.0
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCCccc-------------------chh-----hhHHHHHHhhcC--CCccc
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-------------------KRE-----FTNEVTLLSRIH--HRNLV 660 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~-------------------~~~-----~~~Ei~il~~l~--HpnIv 660 (824)
-.|+.|.-+.||+|...++..+|||+++...... .++ ..+|..-|+++. +=.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 3577888889999988889999999986432111 011 235666677764 34455
Q ss_pred eeeceeecCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 003385 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 740 (824)
Q Consensus 661 ~l~~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~ 740 (824)
+.+++. ...|||||+...-. -...+ ..-.+.......+..++++.+.-|-..+ ++||+||+.=|||+. +
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~---pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGL---PAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-D 202 (268)
T ss_pred Cceeec----CCeEEEEeccCCCC---CCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-C
Confidence 566554 34799999965411 11111 1122222245667788888888887732 999999999999999 8
Q ss_pred CcEEEEecCCcccccC
Q 003385 741 MRAKVSDFGLSKFAVD 756 (824)
Q Consensus 741 ~~vkL~DFGla~~~~~ 756 (824)
+.+.|+|+|.|....+
T Consensus 203 ~~p~iID~~QaV~~~h 218 (268)
T COG1718 203 GEPYIIDVSQAVTIDH 218 (268)
T ss_pred CeEEEEECccccccCC
Confidence 8999999998865543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.8e-07 Score=98.25 Aligned_cols=154 Identities=18% Similarity=0.212 Sum_probs=107.4
Q ss_pred ccccceeeecccccCCCCCCcc---cchhhhceeccCCCCCCcH-------HHHHHHHHhcCCCCcccCCCCCCCCCCCC
Q 003385 337 LSLPFVLSFKFGKTYDSSRGPL---LNAMEINKYLERNDGSIDG-------VAIVSVISLYSSADWAQEGGDPCLPVPWS 406 (824)
Q Consensus 337 ~~l~~l~~L~L~~n~~s~LPP~---i~~le~l~~L~l~~n~~~~-------~~l~~lk~~~~~~~w~~~~~dpc~~~~~~ 406 (824)
-.++.++.|+|+.|-+...-|. +..|+.|+.|+++.|.+.- ..+..+|++ .-.-|.- .|.
T Consensus 143 k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L---------~l~~CGl-s~k 212 (505)
T KOG3207|consen 143 KILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQL---------VLNSCGL-SWK 212 (505)
T ss_pred hhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheE---------EeccCCC-CHH
Confidence 3477889999999999988776 6788889999999887432 223333333 2334431 133
Q ss_pred eeEcCCCCCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCC--CCCCCCCCcceEeecccccCCC-CCcc-
Q 003385 407 WLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI--PDFSGCPDLRIIHLEDNQLTGP-LPSS- 482 (824)
Q Consensus 407 ~~~c~~~~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~--p~~~~l~~L~~L~L~~N~l~g~-lP~~- 482 (824)
-|.--....|+|+.|+|..|..-+.-......+..|+.|||++|++-... +-.+.|+.|..|+++.+.+... +|+.
T Consensus 213 ~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~ 292 (505)
T KOG3207|consen 213 DVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVE 292 (505)
T ss_pred HHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCcc
Confidence 23211123578999999998533344445666888999999999988776 4578899999999999988832 3433
Q ss_pred ----ccCCCccceeeecccccc
Q 003385 483 ----LMNLPNLRELYVQNNMLS 500 (824)
Q Consensus 483 ----l~~l~~L~~L~l~~N~l~ 500 (824)
...+++|+.|++..|++.
T Consensus 293 s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 293 SLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred chhhhcccccceeeecccCccc
Confidence 456788999999999985
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.5e-05 Score=89.81 Aligned_cols=139 Identities=18% Similarity=0.201 Sum_probs=88.2
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCCccc-------------------------------------chhhhHHHH
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-------------------------------------KREFTNEVT 649 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~-------------------------------------~~~~~~Ei~ 649 (824)
+.||..+.|.||+|+.++|+.||||+-+..-... +=+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999865421100 012445555
Q ss_pred HHhhc----CCCc------cceeeceeecCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHH-HHH
Q 003385 650 LLSRI----HHRN------LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE-YLH 718 (824)
Q Consensus 650 il~~l----~Hpn------Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~-yLH 718 (824)
-..++ .|-+ |.+++-.+ .....|+||||+|..+.+...- ....++...+ +..+.++.. -|-
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i---~~~l~~~~~~qIf 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAI---DKRGISPHDI---LNKLVEAYLEQIF 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHH---HHcCCCHHHH---HHHHHHHHHHHHH
Confidence 44443 3555 33333222 2356899999999876654321 1222333333 333333211 112
Q ss_pred hCCCCCeEecCCCCCCEEEcC----CCcEEEEecCCcccccC
Q 003385 719 TGCVPAIIHRDLKSSNILLDK----HMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 719 ~~~~~gIvHrDLkp~NILl~~----~~~vkL~DFGla~~~~~ 756 (824)
.. |++|+|=+|.||++.. ++++.+.|||+.....+
T Consensus 319 ~~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 319 KT---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred hc---CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 22 8999999999999994 67899999999765543
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=8.4e-07 Score=82.23 Aligned_cols=90 Identities=23% Similarity=0.315 Sum_probs=70.3
Q ss_pred CceeEEEecCCCCCccCChhhhcc-cccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeee
Q 003385 416 PSITVIHLSSKNLTGNIPSDLTKL-SSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~~i~~L-~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l 494 (824)
..|+..+|++|.+. .+|+.|... +.++.|+|++|+|+..|.++..++.|+.|+++.|.|. ..|.-+..|.+|-.|+.
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 36777788888888 677766654 4788888888888888878888888888888888888 77877777888888888
Q ss_pred cccccccccccccc
Q 003385 495 QNNMLSGTVPSSLL 508 (824)
Q Consensus 495 ~~N~l~g~ip~~l~ 508 (824)
.+|.+. .||-.++
T Consensus 131 ~~na~~-eid~dl~ 143 (177)
T KOG4579|consen 131 PENARA-EIDVDLF 143 (177)
T ss_pred CCCccc-cCcHHHh
Confidence 888887 7776654
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.01 E-value=4e-06 Score=63.24 Aligned_cols=36 Identities=47% Similarity=0.720 Sum_probs=21.7
Q ss_pred CcceEeecccccCCCCCccccCCCccceeeecccccc
Q 003385 464 DLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 500 (824)
Q Consensus 464 ~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~ 500 (824)
+|++|+|++|+|+ .+|+.|++|++|+.|++++|+++
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 5666666666666 55655666666666666666666
|
... |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.00 E-value=1.2e-06 Score=90.80 Aligned_cols=83 Identities=22% Similarity=0.299 Sum_probs=60.6
Q ss_pred CCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeee
Q 003385 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (824)
Q Consensus 415 ~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l 494 (824)
-.-|++|||++|.|+ .+.++..-++.++.|+||+|.|+..-. +..|.+|+.||||+|.|+ .+-..=.+|-|.+.|.|
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 345777888888887 777777777788888888887775433 777777888888888777 56655566667777777
Q ss_pred cccccc
Q 003385 495 QNNMLS 500 (824)
Q Consensus 495 ~~N~l~ 500 (824)
++|.+.
T Consensus 360 a~N~iE 365 (490)
T KOG1259|consen 360 AQNKIE 365 (490)
T ss_pred hhhhHh
Confidence 777766
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.95 E-value=5.2e-07 Score=83.57 Aligned_cols=91 Identities=24% Similarity=0.379 Sum_probs=78.8
Q ss_pred CceeEEEecCCCCCccCChhhhcc---cccccccccccccCCCCCCCCC-CCCcceEeecccccCCCCCccccCCCccce
Q 003385 416 PSITVIHLSSKNLTGNIPSDLTKL---SSLVELWLDGNSLTGPIPDFSG-CPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 491 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~~i~~L---~~L~~L~L~~N~l~~~~p~~~~-l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~ 491 (824)
..+..|+|++++|- .+++....+ ..|+..+|++|.+...++.|.. .+.+++|+|++|+|+ .+|+++..|+.|+.
T Consensus 27 kE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 27 KELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred HHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 35778999999998 788766555 5566669999999999999755 568999999999999 89999999999999
Q ss_pred eeeccccccccccccccc
Q 003385 492 LYVQNNMLSGTVPSSLLS 509 (824)
Q Consensus 492 L~l~~N~l~g~ip~~l~~ 509 (824)
|+++.|.|. ..|.-+++
T Consensus 105 lNl~~N~l~-~~p~vi~~ 121 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAP 121 (177)
T ss_pred cccccCccc-cchHHHHH
Confidence 999999999 88888766
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.93 E-value=6.3e-05 Score=77.84 Aligned_cols=144 Identities=19% Similarity=0.243 Sum_probs=84.1
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCC--ccceeeceee---cCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR--NLVQFLGYCQ---EEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~---~~~~~~lV~E~~~~ 681 (824)
+.|+.|..+.||+....+ +.+++|+.... .....+.+|..+++.+... .+.+++.... .....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578999999999999887 69999997644 3456778899998888533 3456665432 23456899999999
Q ss_pred CCHHH----------------Hh---hcccCccccCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 003385 682 GTLKE----------------HL---YGTLTHEQRINWIK---------RLEI------------AEDAAK-GIEYLHT- 719 (824)
Q Consensus 682 gsL~~----------------~L---~~~~~~~~~l~~~~---------~~~i------------~~qia~-gL~yLH~- 719 (824)
..+.. .+ +............. .... ...+.. .++.+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87776 11 11100111111000 0000 111222 2333332
Q ss_pred ---CCCCCeEecCCCCCCEEEc-CCCcEEEEecCCccc
Q 003385 720 ---GCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKF 753 (824)
Q Consensus 720 ---~~~~gIvHrDLkp~NILl~-~~~~vkL~DFGla~~ 753 (824)
.....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1224799999999999999 667778999997643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.93 E-value=5.4e-05 Score=77.22 Aligned_cols=113 Identities=19% Similarity=0.267 Sum_probs=72.2
Q ss_pred CCcEEEEEEeccCCcccchh---------hhHHHHHHhhcCCC---ccceeeceee-----cCCeEEEEEEecCCCCHHH
Q 003385 624 DGKEIAVKVLTSNSYQGKRE---------FTNEVTLLSRIHHR---NLVQFLGYCQ-----EEGRSVLVYEFMHNGTLKE 686 (824)
Q Consensus 624 ~g~~vAVK~l~~~~~~~~~~---------~~~Ei~il~~l~Hp---nIv~l~~~~~-----~~~~~~lV~E~~~~gsL~~ 686 (824)
+|+.+.+|..+......++. ..+++..+.+++.. ....++.+.. -....+++|||++|..|.+
T Consensus 53 ~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d 132 (229)
T PF06176_consen 53 DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELND 132 (229)
T ss_pred CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeeccc
Confidence 47888888876543222222 23344444444322 2223222222 1234568999999987765
Q ss_pred HhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 687 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 687 ~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
... ++. .++..+.+++.-||+. |+.|+|.+|.|++++++ .++++||+..+
T Consensus 133 ~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 133 IED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred chh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 431 111 2456778889999998 99999999999999865 49999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.92 E-value=2e-06 Score=97.73 Aligned_cols=183 Identities=17% Similarity=0.166 Sum_probs=132.3
Q ss_pred hccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCc-cceeeceeecCCeEEEEEEecCCC-C
Q 003385 606 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN-LVQFLGYCQEEGRSVLVYEFMHNG-T 683 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~~~g-s 683 (824)
-+..++|+++.++|.+....+....+.+... ....-++++|.+++||| .+.-++-+..+...+++++++.++ +
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 3567899999999987554455556655322 34456889999999999 777777778888889999999887 2
Q ss_pred HHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceec
Q 003385 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 763 (824)
Q Consensus 684 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 763 (824)
-..- ....+..+...+...+.+.-+++++++|+. .=+||| ||+..+ +..|..||+......+.. ...
T Consensus 322 ~~~~---~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 322 SALE---MTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred cccc---CChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 1111 011122333444455667778899999986 348998 777655 678999999876554332 234
Q ss_pred cccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003385 764 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 806 (824)
Q Consensus 764 ~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~ 806 (824)
...+++.++|||+.....+..+.|.|+.|+-..++.-|-+|=.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 4568999999999999999999999999987778777777643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 824 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-50 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-49 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-44 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-33 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-32 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-31 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-26 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-26 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-26 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-26 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-26 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-26 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-26 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-26 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-26 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-26 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-26 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-25 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-25 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-25 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-25 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-25 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-25 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-25 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-25 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-25 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-24 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-24 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-24 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-24 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-24 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-24 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-24 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-23 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-23 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-23 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-23 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-23 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-23 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-23 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-23 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-23 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-23 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-23 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-23 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-23 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-22 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-22 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-21 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-20 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-12 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 3e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 4e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 5e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 5e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-06 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 381 bits (981), Expect = e-126
Identities = 105/250 (42%), Positives = 152/250 (60%), Gaps = 7/250 (2%)
Query: 577 RPVSSLNDAPAEAAHCFTLSDIEDATKMLEKK--IGSGGFGVVYYGKLKDGKEIAVKVLT 634
S + ++ L D+E+AT + K IG G FG VY G L+DG ++A+K T
Sbjct: 13 NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT 72
Query: 635 SNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH 694
S QG EF E+ LS H +LV +G+C E +L+Y++M NG LK HLYG+
Sbjct: 73 PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132
Query: 695 EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-F 753
++W +RLEI AA+G+ YLHT IIHRD+KS NILLD++ K++DFG+SK
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 813
+H+S++V+GT+GY+DPEY+I +LT+KSDVYSFGV+L E++ + AI +
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPRE 248
Query: 814 CRNIVQWVKS 823
N+ +W
Sbjct: 249 MVNLAEWAVE 258
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 333 bits (855), Expect = e-108
Identities = 93/237 (39%), Positives = 143/237 (60%), Gaps = 4/237 (1%)
Query: 590 AHCFTLSDIEDATKM--LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTN 646
F+L +++ A+ + +G GGFG VY G+L DG +AVK L QG + +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 647 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 706
EV ++S HRNL++ G+C +LVY +M NG++ L + ++W KR I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 707 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 766
A +A+G+ YLH C P IIHRD+K++NILLD+ A V DFGL+K +HV++ VR
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 767 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-GANCRNIVQWVK 822
GT+G++ PEY + + ++K+DV+ +GV+LLELI+GQ A + + ++ WVK
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 312 bits (803), Expect = e-100
Identities = 84/245 (34%), Positives = 139/245 (56%), Gaps = 22/245 (8%)
Query: 591 HCFTLSDIEDATK--------MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTS----NSY 638
H F+ ++++ T + K+G GGFGVVY G + + +AVK L + +
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 639 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI 698
+ K++F E+ ++++ H NLV+ LG+ + LVY +M NG+L + L L +
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPL 130
Query: 699 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDG 757
+W R +IA+ AA GI +LH IHRD+KS+NILLD+ AK+SDFGL++
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817
+ ++S + GT Y+ PE + ++T KSD+YSFGV+LLE+I+G A+ + + +
Sbjct: 188 QTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR---EPQLL 243
Query: 818 VQWVK 822
+ +
Sbjct: 244 LDIKE 248
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 8e-72
Identities = 64/235 (27%), Positives = 104/235 (44%), Gaps = 26/235 (11%)
Query: 593 FTLSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTL 650
++ + L+ + G FG V+ +L + +AVK+ Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 651 LSRIHHRNLVQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 706
L + H N++QF+G + L+ F G+L + L ++W + I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHI 126
Query: 707 AEDAAKGIEYLHT-------GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759
AE A+G+ YLH G PAI HRD+KS N+LL ++ A ++DFGL+ G S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 760 HVSSIVR-GTVGYLDPEY-----YISQQLTDKSDVYSFGVILLELISGQEAISNE 808
+ + GT Y+ PE + + D+Y+ G++L EL S A
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 5e-71
Identities = 82/240 (34%), Positives = 125/240 (52%), Gaps = 6/240 (2%)
Query: 566 KEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDG 625
K H H + + + + A DI +++KIG+G FG V+ + G
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-G 60
Query: 626 KEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683
++AVK+L + + EF EV ++ R+ H N+V F+G + +V E++ G+
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 743
L L+ + EQ ++ +RL +A D AKG+ YLH P I+HR+LKS N+L+DK
Sbjct: 121 LYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTV 178
Query: 744 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 803
KV DFGLS+ S GT ++ PE + +KSDVYSFGVIL EL + Q+
Sbjct: 179 KVCDFGLSRLKASTFLSSKS-AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 2e-63
Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLV 660
LE+ IG GGFG VY G E+AVK + + E L + + H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
G C +E LV EF G L L +RI + A A+G+ YLH
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDE 124
Query: 721 CVPAIIHRDLKSSNILLDK--------HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 772
+ IIHRDLKSSNIL+ + + K++DFGL++ + S G ++
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMSAA-GAYAWM 181
Query: 773 DPEYYISQQLTDKSDVYSFGVILLELISGQE 803
PE + + SDV+S+GV+L EL++G+
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEV 212
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 8e-63
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 23/209 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQF 662
K+ G ++ G+ + G +I VKVL + + R+F E L H N++
Sbjct: 14 FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 663 LGYCQE--EGRSVLVYEFMHNGTLKEHLYGTLTHEQR---INWIKRLEIAEDAAKGIEYL 717
LG CQ L+ +M G+L L HE ++ + ++ A D A+G+ +L
Sbjct: 73 LGACQSPPAPHPTLITHWMPYGSLYNVL-----HEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 777
HT P I L S ++++D+ M A++S + ++ PE
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG------RMYAPAWVAPEAL 180
Query: 778 ISQQL---TDKSDVYSFGVILLELISGQE 803
+ +D++SF V+L EL++ +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREV 209
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 9e-63
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 16/210 (7%)
Query: 595 LSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI 654
+IE +E+ +G G FGVV K + K++A+K + S S ++ F E+ LSR+
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIVELRQLSRV 58
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
+H N+V+ G C LV E+ G+L L+G + ++G+
Sbjct: 59 NHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGV 115
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMR-AKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
YLH+ A+IHRDLK N+LL K+ DFG + + +G+ ++
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMA 171
Query: 774 PEYYISQQLTDKSDVYSFGVILLELISGQE 803
PE + ++K DV+S+G+IL E+I+ ++
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-62
Identities = 72/214 (33%), Positives = 111/214 (51%), Gaps = 25/214 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK-------REFTNEVTLLSRIHH 656
EK+IG GGFG+V+ G+L D +A+K L +G+ +EF EV ++S ++H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
N+V+ G +V EF+ G L L I W +L + D A GIEY
Sbjct: 83 PNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEY 137
Query: 717 LHTGCVPAIIHRDLKSSNILLDK-----HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
+ P I+HRDL+S NI L + AKV+DFGLS+ + H S + G +
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQW 192
Query: 772 LDPEYYISQQL--TDKSDVYSFGVILLELISGQE 803
+ PE +++ T+K+D YSF +IL +++G+
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 6e-61
Identities = 62/242 (25%), Positives = 100/242 (41%), Gaps = 38/242 (15%)
Query: 593 FTLSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--V 648
S+ L+ + IG G +G VY G L D + +AVKV + + Q F NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSV-----LVYEFMHNGTLKEHLYGTLTHEQRINWIKR 703
+ + H N+ +F+ + LV E+ NG+L ++L +W+
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSS 113
Query: 704 LEIAEDAAKGIEYLHT------GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF---- 753
+A +G+ YLHT PAI HRDL S N+L+ +SDFGLS
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 754 ---AVDGASHVSSIVRGTVGYLDPEY-------YISQQLTDKSDVYSFGVILLELISGQE 803
+ + GT+ Y+ PE + + D+Y+ G+I E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 804 AI 805
+
Sbjct: 234 DL 235
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 7e-61
Identities = 70/205 (34%), Positives = 114/205 (55%), Gaps = 15/205 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQF 662
+ ++IGSG FG VY GK ++AVK+L + + + F NEV +L + H N++ F
Sbjct: 28 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+GY ++ V ++ +L HL+ E + K ++IA A+G++YLH
Sbjct: 86 MGYSTAPQLAI-VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHA--- 138
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPE---YYI 778
+IIHRDLKS+NI L + K+ DFGL+ + SH + G++ ++ PE
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 779 SQQLTDKSDVYSFGVILLELISGQE 803
S + +SDVY+FG++L EL++GQ
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQL 223
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-60
Identities = 53/214 (24%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQF 662
+ + IG G FG VY+G+ E+A++++ + F EV + H N+V F
Sbjct: 37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+G C ++ TL + + ++ K +IA++ KG+ YLH
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA--- 148
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF----AVDGASHVSSIVRGTVGYLDPEYYI 778
I+H+DLKS N+ D + ++DFGL I G + +L PE
Sbjct: 149 KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 779 SQQL---------TDKSDVYSFGVILLELISGQE 803
+ SDV++ G I EL + +
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 6e-60
Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ +G G FG ++ G+ + +K L + +R F EV ++ + H N+++F+
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
G ++ R + E++ GTL+ + + + + W +R+ A+D A G+ YLH+
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLHS---M 127
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-------------VRGTVG 770
IIHRDL S N L+ ++ V+DFGL++ VD + + V G
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 804
++ PE + +K DV+SFG++L E+I A
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-55
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 29/217 (13%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHRNLVQF 662
+ K+IG G +G V+ GK + G+++AVKV + + + E + + H N++ F
Sbjct: 41 MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGF 96
Query: 663 LGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+ + S L+ ++ NG+L ++L ++ L++A + G+ +LH
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLH 151
Query: 719 T-----GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVG 770
T PAI HRDLKS NIL+ K+ ++D GL+ + + V + GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 771 YLDPE------YYISQQLTDKSDVYSFGVILLELISG 801
Y+ PE Q +D+YSFG+IL E+
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 5e-55
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 29/217 (13%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHRNLVQF 662
L + +G G +G V+ G + G+ +AVK+ +S + ++ + E + + H N++ F
Sbjct: 12 LLECVGKGRYGEVWRGSWQ-GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGF 67
Query: 663 LGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+ S L+ + G+L ++L ++ + L I A G+ +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLH 122
Query: 719 T-----GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG--- 770
PAI HRDLKS NIL+ K+ + ++D GL+ + + VG
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 771 YLDPE------YYISQQLTDKSDVYSFGVILLELISG 801
Y+ PE + D+++FG++L E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 9e-53
Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHRNLVQF 662
L++ IG G FG V+ GK + G+E+AVK+ +S + +R + E + + H N++ F
Sbjct: 46 LQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGF 101
Query: 663 LGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+ ++ + LV ++ +G+L ++L + + +++A A G+ +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLH 156
Query: 719 -----TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVG 770
T PAI HRDLKS NIL+ K+ ++D GL+ + + GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 771 YLDPE------YYISQQLTDKSDVYSFGVILLELISGQEA 804
Y+ PE + ++D+Y+ G++ E+
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+ +IG G F VY G + E+A + ++ F E +L + H N+V+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 662 FLGY----CQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 715
F + + VLV E M +GTLK +L + + + +W + +I + G++
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR--QILK----GLQ 143
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
+LHT P IIHRDLK NI + K+ D GL+ + AS +++ GT ++ P
Sbjct: 144 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT--LKRASFAKAVI-GTPEFMAP 199
Query: 775 EYYISQQLTDKSDVYSFGVILLELISGQ 802
E Y ++ + DVY+FG+ +LE+ + +
Sbjct: 200 EMY-EEKYDESVDVYAFGMCMLEMATSE 226
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-40
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGK-EIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 662
L ++IG G FG V+ G+L+ +AVK + K +F E +L + H N+V+
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+G C ++ +V E + G L T R+ L++ DAA G+EYL + C
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-----VRGTVGYLDPEYY 777
IHRDL + N L+ + K+SDFG+S+ DG S V+ T PE
Sbjct: 235 ---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA----PEAL 287
Query: 778 ISQQLTDKSDVYSFGVILLELIS 800
+ + +SDV+SFG++L E S
Sbjct: 288 NYGRYSSESDVWSFGILLWETFS 310
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 73/262 (27%), Positives = 114/262 (43%), Gaps = 52/262 (19%)
Query: 568 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSD---IEDATKMLEKKIGSGGFGVVYYGKL-- 622
H H P + F D E+ +++G G FG V +
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDP 64
Query: 623 ---KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV--LVYE 677
G+ +AVK L ++ + R+F E+ +L + H N+V++ G C GR L+ E
Sbjct: 65 LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124
Query: 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNIL 736
++ G+L+++L H++RI+ IK L+ KG+EYL T IHRDL + NIL
Sbjct: 125 YLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTKRY----IHRDLATRNIL 177
Query: 737 LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL-------------- 782
++ R K+ DFGL+K D EYY ++
Sbjct: 178 VENENRVKIGDFGLTKVLPQ----------------DKEYYKVKEPGESPIFWYAPESLT 221
Query: 783 ----TDKSDVYSFGVILLELIS 800
+ SDV+SFGV+L EL +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 49/222 (22%)
Query: 605 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 659
+++G G FG V + G+ +AVK L ++ + R+F E+ +L + H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 660 VQFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
V++ G C GR L+ E++ G+L+++L H++RI+ IK L+ KG+EYL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 718 HT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
T IHRDL + NIL++ R K+ DFGL+K D E+
Sbjct: 131 GTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQ----------------DKEF 170
Query: 777 YISQQ------------------LTDKSDVYSFGVILLELIS 800
+ ++ + SDV+SFGV+L EL +
Sbjct: 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 17/220 (7%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+KIG G FG K +DG++ +K ++ S + + E EV +L+ + H N+VQ+
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 719
+E G +V ++ G L + + G L E +I +W ++ ++++H
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI------CLALKHVHD 143
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
I+HRD+KS NI L K ++ DFG+++ + + GT YL PE +
Sbjct: 144 ---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICEN 199
Query: 780 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
+ +KSD+++ G +L EL + + A I+
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS 239
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 15/200 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
++IGSG FG+V+ G + ++A+K + + + +F E ++ ++ H LVQ G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
C E+ LV EFM +G L ++L T L + D +G+ YL CV
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEACV-- 125
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 780
IHRDL + N L+ ++ KVSDFG+++F +D +S + V+ PE +
Sbjct: 126 -IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS----PEVFSFS 180
Query: 781 QLTDKSDVYSFGVILLELIS 800
+ + KSDV+SFGV++ E+ S
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-37
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
LE K+G G FG V+ G +A+K L + F E ++ ++ H LVQ
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-QRINWIKRLEIAEDAAKGIEYLHTGCVP 723
EE +V E+M G+L + L + + + +++A A G+ Y+
Sbjct: 247 VVSEEPI-YIVTEYMSKGSLLDFLK---GETGKYLRLPQLVDMAAQIASGMAYVERMN-- 300
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
+HRDL+++NIL+ +++ KV+DFGL++ D + + + PE + + T
Sbjct: 301 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 784 DKSDVYSFGVILLELIS 800
KSDV+SFG++L EL +
Sbjct: 360 IKSDVWSFGILLTELTT 376
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 15/200 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
K++G+G FGVV YGK + ++A+K++ S + EF E ++ + H LVQ G
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
C ++ ++ E+M NG L +L R + LE+ +D + +EYL +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESKQF-- 141
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 780
+HRDL + N L++ KVSDFGLS++ +D +S S VR + PE +
Sbjct: 142 -LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP----PEVLMYS 196
Query: 781 QLTDKSDVYSFGVILLELIS 800
+ + KSD+++FGV++ E+ S
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-36
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
LE K+G G FG V+ G +A+K L + F E ++ ++ H LVQ
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-QRINWIKRLEIAEDAAKGIEYLHTGCVP 723
EE +V E+M G+L + L + + + +++A A G+ Y+
Sbjct: 330 VVSEEPI-YIVTEYMSKGSLLDFLK---GETGKYLRLPQLVDMAAQIASGMAYVERMN-- 383
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
+HRDL+++NIL+ +++ KV+DFGL++ D + + + PE + + T
Sbjct: 384 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 784 DKSDVYSFGVILLELIS 800
KSDV+SFG++L EL +
Sbjct: 443 IKSDVWSFGILLTELTT 459
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 22/226 (9%)
Query: 584 DAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNS 637
+AP +A +++ K +GSG FG VY G E +A+K L + S
Sbjct: 2 EAPNQALLRI----LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 57
Query: 638 YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 697
+ +E +E +++ + + ++ + LG C L+ + M G L +++ H+
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV---REHKDN 113
Query: 698 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757
I L AKG+ YL ++HRDL + N+L+ K++DFGL+K
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 758 ASHVSSIVRGT---VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ G + ++ E + + T +SDV+S+GV + EL++
Sbjct: 171 EKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 65/200 (32%), Positives = 112/200 (56%), Gaps = 15/200 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
L K++GSG FGVV GK K ++AVK++ S + EF E + ++ H LV+F G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
C +E +V E++ NG L +L +H + + + LE+ D +G+ +L +
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESHQF-- 125
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 780
IHRDL + N L+D+ + KVSDFG++++ +D +S + V+ + PE +
Sbjct: 126 -IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA----PEVFHYF 180
Query: 781 QLTDKSDVYSFGVILLELIS 800
+ + KSDV++FG+++ E+ S
Sbjct: 181 KYSSKSDVWAFGILMWEVFS 200
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 50/223 (22%)
Query: 605 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRN 658
+ +G G FG V + G+++AVK L + + E+ +L ++H N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 659 LVQFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
+V++ G C E+G + L+ EF+ +G+LKE+L ++ +IN ++L+ A KG++Y
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDY 141
Query: 717 LHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
L + +HRDL + N+L++ + K+ DFGL+K D E
Sbjct: 142 LGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAI----------------ETDKE 181
Query: 776 YYISQQL------------------TDKSDVYSFGVILLELIS 800
YY + SDV+SFGV L EL++
Sbjct: 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 599 EDATKMLEKKIGSGGFGVVYYGKLKDGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRI 654
D + + ++G G FG V G + K+ +A+KVL E E ++ ++
Sbjct: 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 67
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
+ +V+ +G CQ E +LV E G L + L + + I E+ + G+
Sbjct: 68 DNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGM 123
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYL 772
+YL +HRDL + N+LL AK+SDFGLSK S+ ++ G + +
Sbjct: 124 KYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 773 DPEYYISQQLTDKSDVYSFGVILLELIS 800
PE ++ + +SDV+S+GV + E +S
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 49/222 (22%)
Query: 605 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 659
++G G FG V + G +AVK L + +R+F E+ +L +H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 660 VQFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
V++ G GR LV E++ +G L++ L H R++ + L + KG+EYL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYL 143
Query: 718 HT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
+ C +HRDL + NIL++ K++DFGL+K D +Y
Sbjct: 144 GSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPL----------------DKDY 183
Query: 777 YISQQL------------------TDKSDVYSFGVILLELIS 800
Y+ ++ + +SDV+SFGV+L EL +
Sbjct: 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-36
Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 9/198 (4%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
++ K+G G +G VY G K +AVK L ++ + EF E ++ I H NLVQ L
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 282
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-QRINWIKRLEIAEDAAKGIEYLHTGCV 722
G C E ++ EFM G L ++L Q ++ + L +A + +EYL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKN- 338
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
IHR+L + N L+ ++ KV+DFGLS+ + + + + PE +
Sbjct: 339 --FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 783 TDKSDVYSFGVILLELIS 800
+ KSDV++FGV+L E+ +
Sbjct: 397 SIKSDVWAFGVLLWEIAT 414
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 58/259 (22%), Positives = 105/259 (40%), Gaps = 27/259 (10%)
Query: 571 HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIA 629
S +Q P + + + KKIG G F VY L DG +A
Sbjct: 4 QSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIE--KKIGRGQFSEVYRAACLLDGVPVA 61
Query: 630 VK---VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 686
+K + + + + E+ LL +++H N++++ E+ +V E G L
Sbjct: 62 LKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSR 121
Query: 687 HL-----YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 740
+ L E+ + + +L +E++H+ ++HRD+K +N+ +
Sbjct: 122 MIKHFKKQKRLIPERTVWKYFVQL------CSALEHMHS---RRVMHRDIKPANVFITAT 172
Query: 741 MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
K+ D GL +F + S+V GT Y+ PE KSD++S G +L E+ +
Sbjct: 173 GVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 231
Query: 801 GQEAISNEKFGANCRNIVQ 819
Q F + N+
Sbjct: 232 LQSP-----FYGDKMNLYS 245
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-36
Identities = 72/341 (21%), Positives = 126/341 (36%), Gaps = 24/341 (7%)
Query: 466 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEG 525
I + + P + L L V+ L L + + A N +
Sbjct: 212 LISQDKAGKYCIPEGTKFDTLWQL----VEYLKLKADGLIYCLKEACPNSSASNASGAAA 267
Query: 526 GRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDA 585
H + + L +P+ V +
Sbjct: 268 PTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSP-------DKPRPMPMDTSVFESPFS 320
Query: 586 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE---IAVKVLTSN-SYQGK 641
E L D + + ++G G FG V G + K+ +A+KVL
Sbjct: 321 DPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT 380
Query: 642 REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 701
E E ++ ++ + +V+ +G CQ E +LV E G L + L + + I
Sbjct: 381 EEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL---VGKREEIPVS 436
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761
E+ + G++YL +HR+L + N+LL AK+SDFGLSK S+
Sbjct: 437 NVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493
Query: 762 SSIVRGT--VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
++ G + + PE ++ + +SDV+S+GV + E +S
Sbjct: 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 54/225 (24%), Positives = 90/225 (40%), Gaps = 18/225 (8%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
IG+G +G + DGK + K S + K+ +EV LL + H N+V++
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 664 GYCQEEGRSVL--VYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIEY 716
+ + L V E+ G L + E+ + L + ++
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV-----LRVMTQLTLALKE 126
Query: 717 LHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
H ++HRDLK +N+ LD K+ DFGL++ S + V GT Y+ P
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSP 185
Query: 775 EYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
E +KSD++S G +L EL + + I +
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-36
Identities = 63/199 (31%), Positives = 105/199 (52%), Gaps = 15/199 (7%)
Query: 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
L + IG G FG V G + G ++AVK + +++ + F E ++++++ H NLVQ L
Sbjct: 196 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLL 252
Query: 664 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
G +E+G +V E+M G+L ++L + L+ + D + +EYL
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN- 309
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDPEYYISQQ 781
+HRDL + N+L+ + AKVSDFGL+K + V+ T PE ++
Sbjct: 310 --FVHRDLAARNVLVSEDNVAKVSDFGLTKE-ASSTQDTGKLPVKWTA----PEALREKK 362
Query: 782 LTDKSDVYSFGVILLELIS 800
+ KSDV+SFG++L E+ S
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-36
Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 19/214 (8%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+K+G GGF V + L DG A+K + + Q + E E + +H N+++ +
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 664 GYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
YC E + L+ F GTL + + + L + +G+E +H
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--------GTVGY 771
HRDLK +NILL + + D G A + T+ Y
Sbjct: 153 ---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 772 LDPE---YYISQQLTDKSDVYSFGVILLELISGQ 802
PE + +++DV+S G +L ++ G+
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 63/261 (24%), Positives = 101/261 (38%), Gaps = 58/261 (22%)
Query: 567 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK--- 623
H H + L P + + + +G G FG V
Sbjct: 3 HHHHHHHHHHGALEVLFQGPGDP------TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTN 56
Query: 624 DGKEI--AVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV--LVYEF 678
DG AVK L Q + + E+ +L ++H +++++ G C++ G + LV E+
Sbjct: 57 DGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY 116
Query: 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILL 737
+ G+L+++L I + L A+ +G+ YLH IHRDL + N+LL
Sbjct: 117 VPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHAQHY----IHRDLAARNVLL 167
Query: 738 DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL--------------- 782
D K+ DFGL+K EYY ++
Sbjct: 168 DNDRLVKIGDFGLAKAV----------------PEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 783 ---TDKSDVYSFGVILLELIS 800
SDV+SFGV L EL++
Sbjct: 212 YKFYYASDVWSFGVTLYELLT 232
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 56/221 (25%), Positives = 85/221 (38%), Gaps = 46/221 (20%)
Query: 604 MLEKKIGSGGFGVVYYGKLK--DGKEI--AVKVL---TSNSYQGKREFTNEVTLLSRIHH 656
L +K+G G FGVV G+ GK + AVK L + + +F EV + + H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
RNL++ G +V E G+L + L H+ A A+G+ Y
Sbjct: 81 RNLIRLYGVVLTP-PMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
L + IHRDL + N+LL K+ DFGL + + D Y
Sbjct: 137 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA---------------LPQNDDHY 178
Query: 777 YISQ-----------------QLTDKSDVYSFGVILLELIS 800
+ + + SD + FGV L E+ +
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 603 KMLEKKIGSGGFGVVYYGKLKDGK---EIAVKVL--TSNSYQGKREFTNEVTLLSRIHHR 657
+ +K++GSG FG V G + K +AVK+L +N K E E ++ ++ +
Sbjct: 19 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 78
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
+V+ +G C+ E +LV E G L ++L + + +E+ + G++YL
Sbjct: 79 YIVRMIGICEAESW-MLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYL 133
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPE 775
+HRDL + N+LL AK+SDFGLSK ++ + G V + PE
Sbjct: 134 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190
Query: 776 YYISQQLTDKSDVYSFGVILLELIS 800
+ + KSDV+SFGV++ E S
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 66/254 (25%), Positives = 120/254 (47%), Gaps = 29/254 (11%)
Query: 564 YDKEQHRHS-LPVQR---PVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYY 619
Y H +P ++ P +A FT ++I + +K IG+G FG VY
Sbjct: 4 YHHHHHHDYDIPTTENLYFQGAMGSDPNQAVLKFT-TEIHPSCVTRQKVIGAGEFGEVYK 62
Query: 620 GKLKDGKE-----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673
G LK +A+K L + + + + +F E ++ + H N+++ G + +
Sbjct: 63 GMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122
Query: 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKS 732
++ E+M NG L + L + + ++ + + A G++YL +HRDL +
Sbjct: 123 IITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLANMNY----VHRDLAA 175
Query: 733 SNILLDKHMRAKVSDFGLSKFAVDG-----ASHVSSI-VRGTVGYLDPEYYISQQLTDKS 786
NIL++ ++ KVSDFGLS+ D + I +R T PE ++ T S
Sbjct: 176 RNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA----PEAISYRKFTSAS 231
Query: 787 DVYSFGVILLELIS 800
DV+SFG+++ E+++
Sbjct: 232 DVWSFGIVMWEVMT 245
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 67/269 (24%), Positives = 122/269 (45%), Gaps = 48/269 (17%)
Query: 557 HKGKKNNYDKEQHRHSLPVQRPV--SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGF 614
H + + + LP + + P A FT +IE + +EK IGSG
Sbjct: 4 HHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFT-REIEASRIHIEKIIGSGDS 62
Query: 615 GVVYYGKLK--DGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE 669
G V YG+L+ +++ A+K L + + + +R+F +E +++ + H N+++ G
Sbjct: 63 GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122
Query: 670 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRD 729
+++V E+M NG+L L TH+ + ++ + + G+ YL +HRD
Sbjct: 123 RLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---VHRD 176
Query: 730 LKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ-------- 781
L + N+L+D ++ KVSDFGLS+ D DP+ +
Sbjct: 177 LAARNVLVDSNLVCKVSDFGLSRVLED----------------DPDAAYTTTGGKIPIRW 220
Query: 782 ----------LTDKSDVYSFGVILLELIS 800
+ SDV+SFGV++ E+++
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-35
Identities = 53/196 (27%), Positives = 95/196 (48%), Gaps = 7/196 (3%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
LEKK+G+G FG V+ ++AVK + F E ++ + H LV+
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
+E + + EFM G+L + L + K ++ + A+G+ ++
Sbjct: 251 VVTKEPIYI-ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN--- 304
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
IHRDL+++NIL+ + K++DFGL++ D + + + PE T
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 785 KSDVYSFGVILLELIS 800
KSDV+SFG++L+E+++
Sbjct: 365 KSDVWSFGILLMEIVT 380
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
+ IGSGGFG V+ K DGK +K + N + EV L+++ H N+V + G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGC 72
Query: 666 CQEEGRSVLVYEFMHNGTLKEHLY--------GTLTHEQRINWIKR-----------LEI 706
+ + + L+ GTL WI++ LE+
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ-----WIEKRRGEKLDKVLALEL 127
Query: 707 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 766
E KG++Y+H+ +I+RDLK SNI L + K+ DFGL + S
Sbjct: 128 FEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK-- 182
Query: 767 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
GT+ Y+ PE SQ + D+Y+ G+IL EL+
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC 218
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-35
Identities = 70/250 (28%), Positives = 126/250 (50%), Gaps = 22/250 (8%)
Query: 565 DKEQHRHSLPVQRP-VSSLND-----APAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY 618
+K H + ++ P + + D P + H F +++ ++K +G+G FG V
Sbjct: 4 EKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFA-KELDATNISIDKVVGAGEFGEVC 62
Query: 619 YGKLK--DGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673
G+LK KEI A+K L + + +R+F E +++ + H N+++ G + +
Sbjct: 63 SGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122
Query: 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKS 732
+V E+M NG+L L H+ + I+ + + A G++YL G V HRDL +
Sbjct: 123 IVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV----HRDLAA 175
Query: 733 SNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYISQQLTDKSDVYS 790
NIL++ ++ KVSDFGL + D + G + + PE ++ T SDV+S
Sbjct: 176 RNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWS 235
Query: 791 FGVILLELIS 800
+G++L E++S
Sbjct: 236 YGIVLWEVMS 245
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLK--DGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 659
L + +G G FG VY G G++I AVK + + K +F +E ++ + H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
V+ +G +EE + ++ E G L +L ++ + + + + K + YL +
Sbjct: 76 VKLIGIIEEE-PTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 720 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL-----D 773
C +HRD+ NIL+ K+ DFGLS++ D + +V L
Sbjct: 132 INC----VHRDIAVRNILVASPECVKLGDFGLSRYIED-----EDYYKASVTRLPIKWMS 182
Query: 774 PEYYISQQLTDKSDVYSFGVILLELIS 800
PE ++ T SDV+ F V + E++S
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILS 209
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
L +++G+G FG V+ G ++AVK L S F E L+ ++ H+ LV+
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
+E + + E+M NG+L + L ++ K L++A A+G+ ++
Sbjct: 76 VVTQEPIYI-ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERNY-- 130
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 780
IHRDL+++NIL+ + K++DFGL++ D A + ++ T PE
Sbjct: 131 -IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYG 185
Query: 781 QLTDKSDVYSFGVILLELIS 800
T KSDV+SFG++L E+++
Sbjct: 186 TFTIKSDVWSFGILLTEIVT 205
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 62/198 (31%), Positives = 100/198 (50%), Gaps = 9/198 (4%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGK-EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
++ K+G G +G VY G K +AVK L ++ + EF E ++ I H NLVQ L
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCV 722
G C E ++ EFM G L ++L + Q ++ + L +A + +EYL
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKNF- 132
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
IHRDL + N L+ ++ KV+DFGLS+ + + + + PE +
Sbjct: 133 ---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 783 TDKSDVYSFGVILLELIS 800
+ KSDV++FGV+L E+ +
Sbjct: 190 SIKSDVWAFGVLLWEIAT 207
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 659
L + IG G FG V+ G + +A+K + S + +F E + + H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
V+ +G E ++ E G L+ L + ++ + A + + YL +
Sbjct: 79 VKLIGVITEN-PVWIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 720 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778
+HRD+ + N+L+ + K+ DFGLS++ D + +S + + ++ PE
Sbjct: 135 KRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 190
Query: 779 SQQLTDKSDVYSFGVILLELIS 800
++ T SDV+ FGV + E++
Sbjct: 191 FRRFTSASDVWMFGVCMWEILM 212
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 64/199 (32%), Positives = 106/199 (53%), Gaps = 17/199 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
L + IG G FG V G + G ++AVK + +++ + F E ++++++ H NLVQ LG
Sbjct: 25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLG 81
Query: 665 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCV 722
+E+G +V E+M G+L ++L + L+ + D + +EYL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 138
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDPEYYISQQ 781
+HRDL + N+L+ + AKVSDFGL+K A + V+ T PE ++
Sbjct: 139 ---VHRDLAARNVLVSEDNVAKVSDFGLTKEASS-TQDTGKLPVKWTA----PEALREKK 190
Query: 782 LTDKSDVYSFGVILLELIS 800
+ KSDV+SFG++L E+ S
Sbjct: 191 FSTKSDVWSFGILLWEIYS 209
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 57/222 (25%), Positives = 88/222 (39%), Gaps = 37/222 (16%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
+ +G GGFGVV+ K K D A+K + N + + EV L+++ H +V++
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 665 YCQEEG---------RSVLVY---EFMHNGTLKEHL----YGTLTHEQRINWIKRLEIAE 708
E+ V +Y + LK+ + L I
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC-----LHIFL 125
Query: 709 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-----------FAVDG 757
A+ +E+LH+ ++HRDLK SNI KV DFGL
Sbjct: 126 QIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI 799
A + GT Y+ PE + K D++S G+IL EL+
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 22/226 (9%)
Query: 584 DAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNS 637
+AP +A +++ K +GSG FG VY G E +A+K L + S
Sbjct: 2 EAPNQALLRI----LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 57
Query: 638 YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 697
+ +E +E +++ + + ++ + LG C L+ + M G L +++ H+
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV---REHKDN 113
Query: 698 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757
I L AKG+ YL ++HRDL + N+L+ K++DFGL+K
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 758 ASHVSSIVRGT---VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ G + ++ E + + T +SDV+S+GV + EL++
Sbjct: 171 EKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNL 659
+ K+G GG VY + ++A+K + + K E F EV S++ H+N+
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP-PREKEETLKRFEREVHNSSQLSHQNI 73
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
V + +E+ LV E++ TL E++ ++ + GI++ H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
I+HRD+K NIL+D + K+ DFG++K + + ++ V GTV Y PE
Sbjct: 130 M---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 780 QQLTDKSDVYSFGVILLELISGQ 802
+ + +D+YS G++L E++ G+
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGE 209
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-34
Identities = 74/284 (26%), Positives = 121/284 (42%), Gaps = 26/284 (9%)
Query: 529 AKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAE 588
A + + GS + + + + L+ G +N Y + + + + S+LN +
Sbjct: 22 AAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDL----SALNPELVQ 77
Query: 589 AAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN-SYQGKRE 643
A + + IG G FG VY+G L D AVK L +
Sbjct: 78 AVQHVVI-GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 136
Query: 644 FTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK 702
F E ++ H N++ LG C + EG ++V +M +G L+ +
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKD 193
Query: 703 RLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761
+ AKG+++L + V HRDL + N +LD+ KV+DFGL++ D
Sbjct: 194 LIGFGLQVAKGMKFLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD- 248
Query: 762 SSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
S+ T L E +Q+ T KSDV+SFGV+L EL++
Sbjct: 249 -SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 18/231 (7%)
Query: 580 SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTS 635
S+LN +A + + IG G FG VY+G L D AVK L
Sbjct: 5 SALNPELVQAVQHVVI-GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 63
Query: 636 N-SYQGKREFTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLT 693
+F E ++ H N++ LG C + EG ++V +M +G L+ +
Sbjct: 64 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RN 120
Query: 694 HEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
+ AKG++YL + V HRDL + N +LD+ KV+DFGL++
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYLASKKFV----HRDLAARNCMLDEKFTVKVADFGLAR 176
Query: 753 FAVDG---ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
D + H + + V ++ E +Q+ T KSDV+SFGV+L EL++
Sbjct: 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 18/206 (8%)
Query: 604 MLEKKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNSYQGKREFTNEVTLLSRIHHR 657
K +GSG FG V+ G E + +KV+ + Q + T+ + + + H
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
++V+ LG C LV +++ G+L +H+ H + L AKG+ YL
Sbjct: 76 HIVRLLGLCPGS-SLQLVTQYLPLGSLLDHV---RQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT---VGYLDP 774
++HR+L + N+LL + +V+DFG++ + + ++
Sbjct: 132 EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMAL 186
Query: 775 EYYISQQLTDKSDVYSFGVILLELIS 800
E + T +SDV+S+GV + EL++
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 51/216 (23%), Positives = 97/216 (44%), Gaps = 32/216 (14%)
Query: 604 MLEKKIGSGGFGVVYYGKLKDGK--------EIAVKVLTSNSYQGKREFTNEVTLLSRIH 655
+ + +G G F ++ G ++ E+ +KVL F +++S++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 656 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
H++LV G C ++LV EF+ G+L +L ++ IN + +LE+A+ A +
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAAAMH 127
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMR--------AKVSDFGLSKFAVDGASHVSSIVRG 767
+L + IH ++ + NILL + K+SD G+S + I++
Sbjct: 128 FLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-----KDILQE 179
Query: 768 TVGYLDPE---YYISQQLTDKSDVYSFGVILLELIS 800
+ ++ PE + L +D +SFG L E+ S
Sbjct: 180 RIPWVPPECIENP--KNLNLATDKWSFGTTLWEICS 213
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-34
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 659
++ IG G FGVVY+G+ D + A+K L+ Q F E L+ ++H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 660 VQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+ +G EG ++ +M +G L + + + ++ + A+G+EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 719 T-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT---VGYLDP 774
+HRDL + N +LD+ KV+DFGL++ +D + R V +
Sbjct: 142 EQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 775 EYYISQQLTDKSDVYSFGVILLELIS 800
E + + T KSDV+SFGV+L EL++
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-33
Identities = 59/257 (22%), Positives = 110/257 (42%), Gaps = 43/257 (16%)
Query: 578 PVSSLNDAPAEAAHCFTLS-DIEDATKMLE-----KKIGSGGFGVVYYGKLKDGKEIAVK 631
P+ S+ D + ++ L+ +++ K + + + G F + + KD K A+K
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALK 60
Query: 632 VLTSNSYQGKREFT-----------------NEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674
+ + KR+FT NE+ +++ I + + G +
Sbjct: 61 KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYI 120
Query: 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAII 726
+YE+M N ++ + + ++ I K Y+H I
Sbjct: 121 IYEYMENDSILKFD----EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NIC 174
Query: 727 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-- 784
HRD+K SNIL+DK+ R K+SDFG S++ VD S RGT ++ PE++ ++ +
Sbjct: 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---RGTYEFMPPEFFSNESSYNGA 231
Query: 785 KSDVYSFGVILLELISG 801
K D++S G+ L +
Sbjct: 232 KVDIWSLGICLYVMFYN 248
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNL 659
L + +G GG V+ + L+D +++AVKVL ++ F E + ++H +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAI 74
Query: 660 VQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
V + E + +V E++ TL++ + E + + +E+ DA + +
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALN 130
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV--SSIVRGTVGYLD 773
+ H IIHRD+K +NI++ KV DFG+++ D + V ++ V GT YL
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 774 PEYYISQQLTDKSDVYSFGVILLELISGQ 802
PE + +SDVYS G +L E+++G+
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 60/232 (25%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNL 659
+ IG G FG V ++K A+K + S R+F E+ +L ++ HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLEIA 707
+ LG C+ G L E+ +G L + L + ++ + L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 708 EDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 766
D A+G++YL IHRDL + NIL+ ++ AK++DFGLS+
Sbjct: 149 ADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR-------------- 190
Query: 767 GTVGYLDPEYYISQQL------------------TDKSDVYSFGVILLELIS 800
E Y+ + + T SDV+S+GV+L E++S
Sbjct: 191 ------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 2e-32
Identities = 51/229 (22%), Positives = 97/229 (42%), Gaps = 19/229 (8%)
Query: 578 PVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE----IAVKVL 633
P+ + IE L + IG G FG V+ G + +A+K
Sbjct: 372 DEEDTYTMPSTRDYEIQRERIE-----LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC 426
Query: 634 TSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL 692
+ S + +F E + + H ++V+ +G E ++ E G L+ L
Sbjct: 427 KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL---Q 482
Query: 693 THEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751
+ ++ + A + + YL + V HRD+ + N+L+ + K+ DFGLS
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESKRFV----HRDIAARNVLVSSNDCVKLGDFGLS 538
Query: 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
++ D + +S + + ++ PE ++ T SDV+ FGV + E++
Sbjct: 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRI-HHRNLVQ 661
++G G +G V+ + K DG+ AVK S ++G ++ EV ++ H V+
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMS-PFRGPKDRARKLAEVGSHEKVGQHPCCVR 121
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
+E G L E +L++H +G E ++ D + +LH+
Sbjct: 122 LEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQV-----WGYLRDTLLALAHLHS 175
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
++H D+K +NI L R K+ DFGL + A G Y+ PE +
Sbjct: 176 ---QGLVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQE-GDPRYMAPE-LLQ 229
Query: 780 QQLTDKSDVYSFGVILLELISGQE 803
+DV+S G+ +LE+ E
Sbjct: 230 GSYGTAADVFSLGLTILEVACNME 253
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSNSYQGKREFTNEVTLLSRIHHRN 658
L+ ++G G FG V+ + + +AVK L S +++F E LL+ + H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-----------YGTLTHEQRINWIKRLEIA 707
+V+F G C E ++V+E+M +G L L G + + L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 708 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 767
A G+ YL +HRDL + N L+ + + K+ DFG+S+ + G
Sbjct: 165 SQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY----RVG 217
Query: 768 TVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
L PE + ++ T +SDV+SFGV+L E+ +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 54/233 (23%), Positives = 91/233 (39%), Gaps = 51/233 (21%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+G G FG V + D + A+K + ++ + +EV LL+ ++H+ +V++
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 664 GYCQEEGRSV-------------LVYEFMHNGTLKEHL--YGTLTHEQRI-NWIKRLEIA 707
E V + E+ NGTL + + + +I
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR--QIL 126
Query: 708 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR- 766
E + Y+H+ IIHRDLK NI +D+ K+ DFGL+K + +
Sbjct: 127 E----ALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 767 ------------GTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISG 801
GT Y+ E +Y +K D+YS G+I E+I
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMIYP 227
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 58/241 (24%), Positives = 92/241 (38%), Gaps = 41/241 (17%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 662
+ + + GGF VY + + G+E A+K L SN + R EV + ++ H N+VQF
Sbjct: 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 663 LGYC-------QEEGRSVLVYEFMHNGTLKEHLYGTLTH----EQRINWIKRLEIAEDAA 711
L+ + G L E L + + L+I
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV-----LKIFYQTC 146
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI------- 764
+ ++++H P IIHRDLK N+LL K+ DFG + + S
Sbjct: 147 RAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 765 ----VRGTVGYLDPE---YYISQQLTDKSDVYSFGVILLELI--------SGQEAISNEK 809
T Y PE Y + + +K D+++ G IL L + I N K
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265
Query: 810 F 810
+
Sbjct: 266 Y 266
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 657
+ +++G G FG+VY G K + +A+K + S + + EF NE +++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------YGTLTHEQRINWIKRLEIAEDAA 711
++V+ LG + ++++ E M G LK +L + K +++A + A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
G+ YL+ +HRDL + N ++ + K+ DFG+++ + +G G
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET----DYYRKGGKGL 201
Query: 772 L-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
L PE T SDV+SFGV+L E+ +
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-32
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 27/217 (12%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL---TSNSYQGKREFTNEV 648
+ L D E + + +G G FG VY + K +A+KVL + + EV
Sbjct: 6 WALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 708
+ S + H N+++ GY + R L+ E+ GT+ Y L + + +
Sbjct: 61 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYIT 116
Query: 709 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR-- 766
+ A + Y H+ +IHRD+K N+LL K++DFG S H S R
Sbjct: 117 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV-------HAPSSRRTD 166
Query: 767 --GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
GT+ YL PE + +K D++S GV+ E + G
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 62/232 (26%), Positives = 107/232 (46%), Gaps = 19/232 (8%)
Query: 580 SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY 638
S + + D E +G G +G+VY G+ L + IA+K +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 639 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK---EHLYGTL-TH 694
+ + E+ L + H+N+VQ+LG E G + E + G+L +G L +
Sbjct: 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 695 EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKF 753
EQ I + + +I E G++YLH I+HRD+K N+L++ + K+SDFG SK
Sbjct: 121 EQTIGFYTK-QILE----GLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKR 172
Query: 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISGQ 802
+ GT+ Y+ PE I + +D++S G ++E+ +G+
Sbjct: 173 LAGINPCTET-FTGTLQYMAPE-IIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSNSYQGKREFTNEVTLLSRIHHRN 658
L++++G G FG V+ + + +AVK L + +++F E LL+ + H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLEI 706
+V+F G C + ++V+E+M +G L + L + + + L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 707 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 766
A A G+ YL + +HRDL + N L+ ++ K+ DFG+S+ +
Sbjct: 139 ASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RV 191
Query: 767 GTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
G L PE + ++ T +SDV+SFGVIL E+ +
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVL--TSNSYQGKREFTNEVTLLSRIHHRN 658
L K +G G FG V G LK +AVK + ++S + EF +E + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 659 LVQFLGYCQEEG-----RSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAA 711
+++ LG C E + +++ FM G L +L T + I L+ D A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
G+EYL +HRDL + N +L M V+DFGLSK G + +G +
Sbjct: 158 LGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAK 210
Query: 772 L-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
+ E + T KSDV++FGV + E+ +
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 29/216 (13%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNL--V 660
+ K+IGSGG V+ + + A+K L Q + NE+ L+++ + +
Sbjct: 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+ Y + +V E N L L ++ +R ++ K + E + +H
Sbjct: 92 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLE----AVHTIH 144
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE-- 775
I+H DLK +N L+ M K+ DFG++ D S V GTV Y+ PE
Sbjct: 145 QH---GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 776 ---------YYISQQLTDKSDVYSFGVILLELISGQ 802
+++ KSDV+S G IL + G+
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 26/215 (12%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN--SYQGKREFTNEVTLLSRIHHRN 658
L + +G G FG V +LK +AVK+L ++ + EF E + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 659 LVQFLGYCQEEGRSV------LVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDA 710
+ + +G ++ FM +G L L + + + D
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 711 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770
A G+EYL + IHRDL + N +L + M V+DFGLS+ G + +G
Sbjct: 147 ACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCAS 199
Query: 771 YL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
L E T SDV++FGV + E+++
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 657
L + +G G FG VY G++ ++AVK L S Q + +F E ++S+ +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGI 714
N+V+ +G + ++ E M G LK L + + + L +A D A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
+YL IHRD+ + N LL AK+ DFG+++ S +G
Sbjct: 154 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----SYYRKGGCAM 206
Query: 772 L-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
L PE ++ T K+D +SFGV+L E+ S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRI--HHRNLV 660
+ K+IGSGG V+ + + A+K L Q + NE+ L+++ H ++
Sbjct: 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+ Y + +V E N L L ++ +R ++ K + + + +H
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM------LEAVHTIH 125
Query: 719 T-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE- 775
G I+H DLK +N L+ M K+ DFG++ D S V GTV Y+ PE
Sbjct: 126 QHG----IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 776 ----------YYISQQLTDKSDVYSFGVILLELISGQ 802
+++ KSDV+S G IL + G+
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 35/221 (15%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL---TSNSYQGKREFTNEV 648
FT+ D + + + +G G FG VY + K +A+KVL + + E+
Sbjct: 11 FTIDDFD-----IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 65
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 708
+ S + H N+++ Y + R L+ EF G L Y L R + E
Sbjct: 66 EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFD--------E 113
Query: 709 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760
+ + Y H V IHRD+K N+L+ K++DFG S A
Sbjct: 114 QRSATFMEELADALHYCHERKV---IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170
Query: 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
GT+ YL PE + +K D++ GV+ E + G
Sbjct: 171 TMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 67/267 (25%), Positives = 109/267 (40%), Gaps = 28/267 (10%)
Query: 555 FMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSD---IEDATKMLEKKIGS 611
F E L ++ N A ++SD + L + +G
Sbjct: 22 FQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGH 81
Query: 612 GGFGVVYYGKLKDGK------EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLG 664
G FG VY G++ ++AVK L S Q + +F E ++S+ +H+N+V+ +G
Sbjct: 82 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 141
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
+ ++ E M G LK L + + + L +A D A G +YL
Sbjct: 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 201
Query: 722 VPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL-----D 773
IHRD+ + N LL AK+ DFG+++ +G L
Sbjct: 202 ---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----GYYRKGGCAMLPVKWMP 254
Query: 774 PEYYISQQLTDKSDVYSFGVILLELIS 800
PE ++ T K+D +SFGV+L E+ S
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 51/234 (21%), Positives = 88/234 (37%), Gaps = 59/234 (25%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 657
+++G FG VY G L +A+K L + EF +E L +R+ H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLE 705
N+V LG ++ +++ + +G L E L T + + +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 706 IAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764
+ A G+EYL + V H+DL + N+L+ + K+SD GL +
Sbjct: 133 LVAQIAAGMEYLSSHHVV----HKDLATRNVLVYDKLNVKISDLGLFREVYAA------- 181
Query: 765 VRGTVGYLDPEYYISQQL------------------TDKSDVYSFGVILLELIS 800
+YY + SD++S+GV+L E+ S
Sbjct: 182 ----------DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 60/262 (22%), Positives = 105/262 (40%), Gaps = 34/262 (12%)
Query: 560 KKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYY 619
K+ K + +H + A + A C + ++ + K+IGSGG V+
Sbjct: 18 KETAAAKFERQHMDSPDLGTDDDDKASSSANECIS---VKGRIYSILKQIGSGGSSKVFQ 74
Query: 620 GKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNL--VQFLGYCQEEGRSVLV 675
+ + A+K L Q + NE+ L+++ + ++ Y + +V
Sbjct: 75 VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134
Query: 676 YEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKS 732
E N L L ++ +R ++ K + E + +H G I+H DLK
Sbjct: 135 MEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLE----AVHTIHQHG----IVHSDLKP 183
Query: 733 SNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE-----------YYISQ 780
+N L+ M K+ DFG++ D S V G V Y+ PE
Sbjct: 184 ANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242
Query: 781 QLTDKSDVYSFGVILLELISGQ 802
+++ KSDV+S G IL + G+
Sbjct: 243 KISPKSDVWSLGCILYYMTYGK 264
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-30
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFL 663
+ +G G G + Y + D +++AVK + + EV LL H N++++
Sbjct: 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIRY- 83
Query: 664 GYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 720
+C E+ R + E TL+E++ + ++ + + + G+ +LH+
Sbjct: 84 -FCTEKDRQFQYIAIELC-AATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 721 CVPAIIHRDLKSSNILL-----DKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLD 773
I+HRDLK NIL+ ++A +SDFGL K G S V GT G++
Sbjct: 139 ----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 774 PEYY---ISQQLTDKSDVYSFGVILLELISG 801
PE + T D++S G + +IS
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 43/208 (20%), Positives = 86/208 (41%), Gaps = 23/208 (11%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSN-----SYQGKREFTNEVTLLSRIHHRN 658
L + +G GG G VY + + +A+K+++ ++ + E R+ +
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR--MQREARTAGRLQEPH 95
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEY 716
+V + + +G+ + ++ L L G L + + I ++
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRA------VAIVRQIGSALDA 149
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLDP 774
H HRD+K NIL+ A + DFG++ A + + V GT+ Y+ P
Sbjct: 150 AHAA---GATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTV-GTLYYMAP 204
Query: 775 EYYISQQLTDKSDVYSFGVILLELISGQ 802
E + T ++D+Y+ +L E ++G
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGS 232
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 56/223 (25%), Positives = 105/223 (47%), Gaps = 34/223 (15%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE--------IAVKVLTSN-SYQGKREFTNEVTLLSRI- 654
L K +G G FG V + + +AVK+L + + + + +E+ ++ I
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIK 702
H+N++ LG C ++G ++ E+ G L+E+L E+++ +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 703 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762
+ A+G+EYL + IHRDL + N+L+ ++ K++DFGL++ +
Sbjct: 159 LVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNI----D 211
Query: 763 SIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
+ T G L PE + T +SDV+SFGV++ E+ +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 656
L K +G G FG V + +AVK+L ++ R +E+ +L I HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 657 RNLVQFLGYCQEEGRSVLV-YEFMHNGTLKEHL------------YGTLTHEQRINWIKR 703
N+V LG C + G ++V EF G L +L ++ +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 704 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 763
+ + AKG+E+L + IHRDL + NILL + K+ DFGL++
Sbjct: 151 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PD 203
Query: 764 IVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
VR L PE + T +SDV+SFGV+L E+ S
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 62/249 (24%), Positives = 108/249 (43%), Gaps = 13/249 (5%)
Query: 556 MHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFG 615
MH ++ + +L Q V + A D K IG G G
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVK-IGEGSTG 59
Query: 616 VVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674
+V + G+++AVK++ Q + NEV ++ H N+V+ +
Sbjct: 60 IVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV 119
Query: 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 734
+ EF+ G L + + +E++I + + + YLH +IHRD+KS +
Sbjct: 120 LMEFLQGGALTDIVSQVRLNEEQIATVCE-----AVLQALAYLHA---QGVIHRDIKSDS 171
Query: 735 ILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-KSDVYSFGV 793
ILL R K+SDFG S+V GT ++ PE IS+ L + D++S G+
Sbjct: 172 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPE-VISRSLYATEVDIWSLGI 229
Query: 794 ILLELISGQ 802
+++E++ G+
Sbjct: 230 MVIEMVDGE 238
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 60/224 (26%), Positives = 94/224 (41%), Gaps = 36/224 (16%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 656
K +G+G FG V + +AVK+L + + +E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--------------YGTLTHEQRINWIK 702
N+V LG C G ++++ E+ G L L E ++
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 703 RLEIAEDAAKGIEYLH-TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761
L + AKG+ +L C IHRDL + NILL K+ DFGL++ +
Sbjct: 147 LLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKND---- 198
Query: 762 SSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
S+ V L PE + T +SDV+S+G+ L EL S
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 45/231 (19%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 657
L K +G G FG V K +AVK+L N S R+ +E +L +++H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--------------------YGTLTHEQR 697
++++ G C ++G +L+ E+ G+L+ L E+
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 698 INWIKRLEIAEDAAKGIEYL---HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754
+ + A ++G++YL ++HRDL + NIL+ + + K+SDFGLS+
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMK------LVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 755 VDGASHVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
+ S V+ + G + E T +SDV+SFGV+L E+++
Sbjct: 201 YEE----DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 28/217 (12%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 662
L +G G V+ G+ K G A+KV + S+ + E +L +++H+N+V+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 663 LGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKGIEYL 717
+E VL+ EF G+L L + E D G+ +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVL----EEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 718 HTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
I+HR++K NI+ D K++DFG ++ D VS GT YL
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLH 183
Query: 774 PEYY--------ISQQLTDKSDVYSFGVILLELISGQ 802
P+ Y ++ D++S GV +G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-30
Identities = 45/207 (21%), Positives = 84/207 (40%), Gaps = 26/207 (12%)
Query: 605 LEKKIGSGGFGVVYYGK--LKDGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
++ I GG G +Y +G+ + +K L S + + E L+ + H ++VQ
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 662 FLGYCQEEGRSV-----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
+ + R +V E++ +LK L + I + + Y
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAI------AYLLEILPALSY 197
Query: 717 LHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
LH+ G +++ DLK NI+L + + K+ D G ++ ++ GT G+ PE
Sbjct: 198 LHSIG----LVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYLY----GTPGFQAPE 247
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQ 802
+ T +D+Y+ G L L
Sbjct: 248 I-VRTGPTVATDIYTVGRTLAALTLDL 273
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-29
Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 34/223 (15%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGK--------EIAVKVLTSN-SYQGKREFTNEVTLLSRI- 654
L K +G G FG V + ++AVK+L S+ + + + +E+ ++ I
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIK 702
H+N++ LG C ++G ++ E+ G L+E+L + E++++
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 703 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++
Sbjct: 193 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI----D 245
Query: 763 SIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
+ T G L PE + T +SDV+SFGV+L E+ +
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---EFTNEVTLLSRIHHRNLV 660
+ +G GGF + + A K++ + + + E+++ + H+++V
Sbjct: 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 78
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
F G+ ++ +V E +L E LT + +++++ G +YLH
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI------VLGCQYLH 132
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYY 777
V IHRDLK N+ L++ + K+ DFGL+ K DG GT Y+ PE
Sbjct: 133 RNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPE-V 186
Query: 778 ISQQLTD-KSDVYSFGVILLELISG 801
+S++ + DV+S G I+ L+ G
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVG 211
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---EFTNEVTLLSRIHHRNLV 660
+ +G GGF + + A K++ + + + E+++ + H+++V
Sbjct: 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
F G+ ++ +V E +L E LT + +++++ G +YLH
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI------VLGCQYLH 158
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYY 777
V IHRDLK N+ L++ + K+ DFGL+ K DG GT Y+ PE
Sbjct: 159 RNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPE-V 212
Query: 778 ISQQLTD-KSDVYSFGVILLELISG 801
+S++ + DV+S G I+ L+ G
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVG 237
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 32/220 (14%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 656
K +G+G FG V + +AVK+L S K +E+ ++S + H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL----------YGTLTHEQRINWIKRLEI 706
N+V LG C G +++ E+ G L L + L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 707 AEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 765
+ A+G+ +L + C IHRD+ + N+LL AK+ DFGL++ ++ S+ +
Sbjct: 170 SSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMND----SNYI 221
Query: 766 RGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
L PE T +SDV+S+G++L E+ S
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-29
Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 38/226 (16%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFL 663
EK +G G G V + G+ +AVK + + E+ LL+ H N++++
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRY- 74
Query: 664 GYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKGIEYLH 718
YC E + E N L++ + ++ + K A G+ +LH
Sbjct: 75 -YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 719 TGCVPAIIHRDLKSSNILLD-------------KHMRAKVSDFGLSKFAVDGASHVSSIV 765
+ IIHRDLK NIL+ +++R +SDFGL K G S + +
Sbjct: 133 SLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 766 R---GTVGYLDPE-------YYISQQLTDKSDVYSFGVILLELISG 801
GT G+ PE ++LT D++S G + ++S
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-29
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 28/217 (12%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 662
L +G G V+ G+ K G A+KV + S+ + E +L +++H+N+V+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 663 LGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKGIEYL 717
+E VL+ EF G+L L + E D G+ +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVL----EEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 718 HTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
I+HR++K NI+ D K++DFG ++ D S+ GT YL
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLH 183
Query: 774 PEYY--------ISQQLTDKSDVYSFGVILLELISGQ 802
P+ Y ++ D++S GV +G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 24/205 (11%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
++G G FG V+ K + G + AVK + ++ E+ + + +V G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 666 CQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
+E + E + G+L + + G L E R + A +G+EYLHT
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLP-EDRALYYLG-----QALEGLEYLHTRR-- 170
Query: 724 AIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSI----VRGTVGYLDPEYYI 778
I+H D+K+ N+LL RA + DFG + S + + GT ++ PE +
Sbjct: 171 -ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VV 228
Query: 779 SQQLTD-KSDVYSFGVILLELISGQ 802
+ D K D++S ++L +++G
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLV 660
+ +G G F VY + + G E+A+K++ + + NEV + ++ H +++
Sbjct: 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
+ Y ++ LV E HNG + +L + + +++ ++ G+ YL
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI------ITGMLYL 128
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEY 776
H+ + +HRDL SN+LL ++M K++DFGL+ + + H + GT Y+ PE
Sbjct: 129 HSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYISPEI 183
Query: 777 YISQQLTDKSDVYSFGVILLELISG 801
+SDV+S G + L+ G
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIG 208
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 56/226 (24%), Positives = 104/226 (46%), Gaps = 40/226 (17%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE--------IAVKVLTSN-SYQGKREFTNEVTLLSRI- 654
L K +G G FG V + + +AVK+L + + + + +E+ ++ I
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIK 702
H+N++ LG C ++G ++ E+ G L+E+L E+++ +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 703 RLEIAEDAAKGIEYL---HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759
+ A+G+EYL IHRDL + N+L+ ++ K++DFGL++ +
Sbjct: 205 LVSCTYQLARGMEYLASQK------CIHRDLAARNVLVTENNVMKIADFGLARDINNI-- 256
Query: 760 HVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
+ T G L PE + T +SDV+SFGV++ E+ +
Sbjct: 257 --DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 39/228 (17%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 656
K +GSG FG V + +AVK+L + +E+ +++++ H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-------------YGTLTHEQRINWIKR 703
N+V LG C G L++E+ G L +L Y + +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 704 L------EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757
L A AKG+E+L +HRDL + N+L+ K+ DFGL++ +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 758 ASHVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
S+ V L PE T KSDV+S+G++L E+ S
Sbjct: 226 ----SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 27/271 (9%), Positives = 67/271 (24%), Gaps = 41/271 (15%)
Query: 566 KEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD- 624
+E + + V++ +L + L + + G VV+ + +
Sbjct: 27 EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVER 86
Query: 625 GKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFLGYCQEEGRS--------- 672
++ A+KV T + + E +R+ + + + S
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 673 -----------------VLVYEFMH--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713
+L+ L L + + +
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
L + ++H N+ + R + D V Y
Sbjct: 207 AANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW----KVGTRGPASSVPVTYAP 259
Query: 774 PEYYISQ--QLTDKSDVYSFGVILLELISGQ 802
E+ + T + + G+ + +
Sbjct: 260 REFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 41/229 (17%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 657
+ IG G FG V+ + +AVK+L S + +F E L++ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--------------------YGTLTHEQR 697
N+V+ LG C L++E+M G L E L +
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 698 INWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756
++ ++L IA A G+ YL V HRDL + N L+ ++M K++DFGLS+
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFV----HRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 757 GASHVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
+ PE + T +SDV+++GV+L E+ S
Sbjct: 227 A----DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-28
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 662
+++++G+GGFG V +D G+++A+K RE + E+ ++ +++H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 663 L------GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKG 713
+L E+ G L+++L + +K I D +
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL----NQFENCCGLKEGPIRTLLSDISSA 133
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770
+ YLH IIHRDLK NI+L + + K+ D G +K G + V GT+
Sbjct: 134 LRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GTLQ 188
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
YL PE ++ T D +SFG + E I+G
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 12/212 (5%)
Query: 594 TLSDIEDATKMLEK--KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTL 650
++ + D K + KIG G G VY + G+E+A++ + K NE+ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 651 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 710
+ + N+V +L +V E++ G+L + + T E +I + R +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----EC 125
Query: 711 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770
+ +E+LH+ +IHRD+KS NILL K++DFG S S++V GT
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY 181
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
++ PE + K D++S G++ +E+I G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-28
Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLV 660
++ +G G FG V K K G+E AVKV++ + K + EV LL ++ H N++
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------- 712
+ + +++G LV E G L + I I R +E A
Sbjct: 90 KLYEFFEDKGYFYLVGEVYTGGELFD----------EI--ISRKRFSEVDAARIIRQVLS 137
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
GI Y+H I+HRDLK N+LL K ++ DFGLS I GT
Sbjct: 138 GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTA 192
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
Y+ PE + +K DV+S GVIL L+SG
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-28
Identities = 68/250 (27%), Positives = 103/250 (41%), Gaps = 34/250 (13%)
Query: 568 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKM--LEKKIGSGGFGVVYYGKLK-D 624
H H R F S ++M KK+GSG +G V + K
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 625 GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682
E A+K++ S EV +L + H N+++ + +++ LV E G
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121
Query: 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSN 734
L + I I R++ E A G+ YLH I+HRDLK N
Sbjct: 122 ELFD----------EI--IHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPEN 166
Query: 735 ILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSF 791
+LL +K K+ DFGLS + + GT Y+ PE + ++ +K DV+S
Sbjct: 167 LLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPE-VLRKKYDEKCDVWSI 223
Query: 792 GVILLELISG 801
GVIL L++G
Sbjct: 224 GVILFILLAG 233
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-28
Identities = 40/217 (18%), Positives = 69/217 (31%), Gaps = 22/217 (10%)
Query: 605 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN 658
+ +G G F VY D ++ +KV + T + L
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-YGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
++F + SVLV E GTL + T E+ + + A IE +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRA-----------KVSDFGLSKFA-VDGASHVSSIV 765
H IIH D+K N +L + D G S + + +
Sbjct: 189 HDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 766 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
T G+ E ++ + D + + ++ G
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ +GSG F V+ K + GK A+K + + NE+ +L +I H N+V
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------GIE 715
+ LV + + G L + RI ++R E DA+ ++
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFD----------RI--LERGVYTEKDASLVIQQVLSAVK 120
Query: 716 YLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
YLH G I+HRDLK N+L +++ + ++DFGLSK +G +S+ GT GY
Sbjct: 121 YLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGY 173
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELISG 801
+ PE + + D +S GVI L+ G
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 51/209 (24%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 662
++K+GSG FG V+ + + G E +K + + Q E E+ +L + H N+++
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 663 LGYCQEEGRSVLVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
++ +V E G L + L+ +K++ + Y
Sbjct: 86 FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM------MNALAY 139
Query: 717 LHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 772
H+ ++H+DLK NIL H K+ DFGL++ H ++ GT Y+
Sbjct: 140 FHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAA-GTALYM 193
Query: 773 DPEYYISQQLTDKSDVYSFGVILLELISG 801
PE + +T K D++S GV++ L++G
Sbjct: 194 APE-VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 68/212 (32%), Positives = 97/212 (45%), Gaps = 34/212 (16%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 661
+ +G G FG V K + +E AVKV+ S + K EV LL ++ H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------G 713
++ +V E G L + I IKR +E DAA+ G
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFD----------EI--IKRKRFSEHDAARIIKQVFSG 133
Query: 714 IEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
I Y+H I+HRDLK NILL +K K+ DFGLS + + + GT
Sbjct: 134 ITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTA 187
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
Y+ PE + +K DV+S GVIL L+SG
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 58/226 (25%), Positives = 107/226 (47%), Gaps = 20/226 (8%)
Query: 586 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF 644
E H D + +++ + +G G FG VY K + G A KV+ + S + ++
Sbjct: 5 SREYEHVRRDLDPNEVWEIVGE-LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY 63
Query: 645 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWI 701
E+ +L+ H +V+ LG +G+ ++ EF G + L LT E +I +
Sbjct: 64 IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT-EPQIQVV 122
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761
R + + +LH+ IIHRDLK+ N+L+ +++DFG+S +
Sbjct: 123 CR-----QMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174
Query: 762 SSIVRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 802
S + GT ++ PE + + + D K+D++S G+ L+E+ +
Sbjct: 175 DSFI-GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 27/213 (12%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKV-----LTSNSYQGKREFTNEVTLLSRIHHRN 658
L + IG G F VV ++ G++ AVK+ TS+ + E ++ + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAK 712
+V+ L +G +V+EFM L + + ++++++ +
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI------LE 141
Query: 713 GIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 768
+ Y H IIHRD+K +LL + K+ FG++ + V GT
Sbjct: 142 ALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GT 196
Query: 769 VGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
++ PE + DV+ GVIL L+SG
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 44/309 (14%), Positives = 88/309 (28%), Gaps = 61/309 (19%)
Query: 567 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDG 625
VS+ + + T + +G + G
Sbjct: 39 TSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETG 98
Query: 626 KEIAVKVLTSNSYQG-------KRE---------------------FTNEVTLLSRIHHR 657
+ V V K E F L+ +
Sbjct: 99 ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158
Query: 658 NLVQFLGYCQEEGRS--VLVYEFMH--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713
+++ ++ +Y M T E L + + + RL++ +
Sbjct: 159 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 218
Query: 714 IEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 772
+ LH G ++H L+ +I+LD+ ++ F DGA VS + G+
Sbjct: 219 LASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR--DGARVVS---SVSRGFE 269
Query: 773 DPEYYISQQL-----------TDKSDVYSFGVILLELISGQ-------EAISNEKFGANC 814
PE + T D ++ G+++ + +E +C
Sbjct: 270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSC 329
Query: 815 RNIVQWVKS 823
+NI Q V++
Sbjct: 330 KNIPQPVRA 338
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-27
Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 45/223 (20%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL-------------TSNSYQGKREFTNEVTL 650
+K+GSG +G V K K E A+KV+ N + E NE++L
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 651 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 710
L + H N+++ +++ LV EF G L E +I I R + E
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE----------QI--INRHKFDECD 147
Query: 711 AK--------GIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGA 758
A GI YLH I+HRD+K NILL + + K+ DFGLS F
Sbjct: 148 AANIMKQILSGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD- 202
Query: 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
+ + GT Y+ PE + ++ +K DV+S GVI+ L+ G
Sbjct: 203 YKLRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 56/246 (22%), Positives = 99/246 (40%), Gaps = 37/246 (15%)
Query: 572 SLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AV 630
+ P S + P D + K +G G F V + A+
Sbjct: 6 AEPRPGAGSLQHAQPPPQPRKKRPEDFK-----FGKILGEGSFSTVVLARELATSREYAI 60
Query: 631 KVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH 687
K+L + + E ++SR+ H V+ Q++ + + NG L ++
Sbjct: 61 KILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY 120
Query: 688 LYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDK 739
+ + E + +EYLH IIHRDLK NILL++
Sbjct: 121 IR----KIGSFD--------ETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNE 165
Query: 740 HMRAKVSDFGLSKFAVDGASHV--SSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILL 796
M +++DFG +K + +S V GT Y+ PE ++++ KS D+++ G I+
Sbjct: 166 DMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPE-LLTEKSACKSSDLWALGCIIY 223
Query: 797 ELISGQ 802
+L++G
Sbjct: 224 QLVAGL 229
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 55/220 (25%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE-FTNEVT- 649
D+E ++G G +GVV + G+ +AVK + + +++ ++
Sbjct: 4 VKADDLEP-----IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI 58
Query: 650 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIA 707
+ + V F G EG + E M + +L + + Q I + + + IA
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IA 115
Query: 708 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 767
K +E+LH+ ++IHRD+K SN+L++ + K+ DFG+S + VD + G
Sbjct: 116 VSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--G 171
Query: 768 TVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 802
Y+ PE I+ +L KSD++S G+ ++EL +
Sbjct: 172 CKPYMAPE-RINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 57/263 (21%), Positives = 91/263 (34%), Gaps = 72/263 (27%)
Query: 606 EKKIGSGGFGVVYYGKLK-DGKEIAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ +G GGFGVV+ K K D A+K + N + + EV L+++ H +V++
Sbjct: 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 70
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI------------------------- 698
E E E L+ +
Sbjct: 71 NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130
Query: 699 -------------------NWIKR------------LEIAEDAAKGIEYLHTGCVPAIIH 727
+W+ R L I A+ +E+LH+ ++H
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMH 187
Query: 728 RDLKSSNILLDKHMRAKVSDFGLSK---FAVDGASHVSSIVR--------GTVGYLDPEY 776
RDLK SNI KV DFGL + + ++ + GT Y+ PE
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247
Query: 777 YISQQLTDKSDVYSFGVILLELI 799
+ K D++S G+IL EL+
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELL 270
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 2/94 (2%)
Query: 416 PSITVIHLSSKN-LTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDN 473
P + +++ N L G IP + KL+ L L++ +++G IPDF S L + N
Sbjct: 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
L+G LP S+ +LPNL + N +SG +P S
Sbjct: 136 ALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 2e-26
Identities = 29/107 (27%), Positives = 44/107 (41%), Gaps = 1/107 (0%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 476
++ + LS L G+ + ++ L NSL + +L + L +N++
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIY 257
Query: 477 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGNINL 522
G LP L L L L V N L G +P L + V YA N L
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 40/145 (27%), Positives = 64/145 (44%), Gaps = 9/145 (6%)
Query: 382 SVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP-SITVIHLSSKNLTG--NIPSDLTK 438
+ + + + W C W + C++D Q + + LS NL IPS L
Sbjct: 17 DLGNPTTLSSWL--PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLAN 74
Query: 439 LSSLVELWL-DGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496
L L L++ N+L GPIP + L +++ ++G +P L + L L
Sbjct: 75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY 134
Query: 497 NMLSGTVPSSL--LSKNVVLNYAGN 519
N LSGT+P S+ L V + + GN
Sbjct: 135 NALSGTLPPSISSLPNLVGITFDGN 159
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 28/109 (25%), Positives = 55/109 (50%), Gaps = 12/109 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQ 474
+ ++++ N++G IP L+++ +LV L N+L+G +P S P+L I + N+
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 475 LTGPLPSSLMNLPNLRE-LYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 522
++G +P S + L + + N L+G +P + N+NL
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF----------ANLNL 199
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 21/91 (23%), Positives = 37/91 (40%), Gaps = 1/91 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVE-LWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 474
P++ I ++G IP S L + + N LTG IP +L + L N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM 208
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 505
L G + N +++++ N L+ +
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 17/68 (25%), Positives = 30/68 (44%), Gaps = 2/68 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ + L + + G +P LT+L L L + N+L G IP + +N+
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
Query: 476 T--GPLPS 481
PLP+
Sbjct: 304 LCGSPLPA 311
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 49/210 (23%), Positives = 78/210 (37%), Gaps = 32/210 (15%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
LE IG G +G V K A K + + F E+ ++ + H N+++
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 715
++ LV E G L E R+ + + E A +
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFE----------RV--VHKRVFRESDAARIMKDVLSAVA 120
Query: 716 YLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
Y H + HRDLK N L K+ DFGL+ G + + V GT Y
Sbjct: 121 YCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKV-GTPYY 174
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELISG 801
+ P+ + + D +S GV++ L+ G
Sbjct: 175 VSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 18/230 (7%)
Query: 576 QRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT 634
QR + D E ++G+G GVV+ K + A K++
Sbjct: 13 QRKRLEAFLTQKQKVGELKDDDFE-----KISELGAGNGGVVFKVSHKPSGLVMARKLIH 67
Query: 635 SNSYQGKREF-TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-YGTL 692
R E+ +L + +V F G +G + E M G+L + L
Sbjct: 68 LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR 127
Query: 693 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
EQ + +++ KG+ YL I+HRD+K SNIL++ K+ DFG+S
Sbjct: 128 IPEQILG-----KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180
Query: 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
+D S +S V GT Y+ PE + +SD++S G+ L+E+ G+
Sbjct: 181 QLID--SMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 664
+G GGFG V+ ++K ++ A K L + ++ + E +L+++H R +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS-LA 251
Query: 665 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 715
Y + + LV M+ G ++ H+Y E A G+E
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ--------EPRAIFYTAQIVSGLE 303
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
+LH II+RDLK N+LLD ++SD GL+ G + GT G++ PE
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPE 359
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQ 802
+ ++ D ++ GV L E+I+ +
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 48/206 (23%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ +++GSG FGVV+ K G+ K + + K NE+++++++HH L+
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 664 GYCQEEGRSVLVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
+++ VL+ EF+ G L +++ + + IN+++ + E G++++
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKM---SEAEVINYMR--QACE----GLKHM 165
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
H +I+H D+K NI+ + + K+ DFGL+ ++ V T + PE
Sbjct: 166 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK-LNPDEIVKVTT-ATAEFAAPE 220
Query: 776 YYISQQLTDKSDVYSFGVILLELISG 801
+ + +D+++ GV+ L+SG
Sbjct: 221 IVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-26
Identities = 22/118 (18%), Positives = 50/118 (42%), Gaps = 4/118 (3%)
Query: 402 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG 461
W+ + + + +S ++G++ +++ +L L + N+ + IP
Sbjct: 166 ANVVGWVLSDGCG--ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGD 221
Query: 462 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
C L+ + + N+L+G ++ L+ L + +N G +P L L+ A N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAEN 279
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-25
Identities = 39/111 (35%), Positives = 54/111 (48%), Gaps = 4/111 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
+ +HLS L+G IPS L LS L +L L N L G IP L + L+ N
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLH 523
LTG +PS L N NL + + NN L+G +P + L +L + N +
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN-SFS 527
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-24
Identities = 37/121 (30%), Positives = 57/121 (47%), Gaps = 6/121 (4%)
Query: 402 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFS 460
P+ + Q P+ ++ ++L + TG IP L+ S LV L L N L+G IP
Sbjct: 383 PILPNLCQN---PKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 461 GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAG 518
LR + L N L G +P LM + L L + N L+G +PS L + ++ +
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499
Query: 519 N 519
N
Sbjct: 500 N 500
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-24
Identities = 31/128 (24%), Positives = 58/128 (45%), Gaps = 3/128 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQ 474
++ + L +LTG IPS L+ ++L + L N LTG IP +L I+ L +N
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGGRGAKHL 532
+G +P+ L + +L L + N+ +GT+P+++ S + N+
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKK 585
Query: 533 NIIIGSSV 540
++
Sbjct: 586 ECHGAGNL 593
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-23
Identities = 39/95 (41%), Positives = 54/95 (56%), Gaps = 3/95 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED 472
S+ + LSS N +G I +L ++L EL+L N TG IP S C +L +HL
Sbjct: 368 ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSF 427
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
N L+G +PSSL +L LR+L + NML G +P L
Sbjct: 428 NYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-23
Identities = 38/124 (30%), Positives = 57/124 (45%), Gaps = 13/124 (10%)
Query: 402 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPD-F 459
P+P L S+ + L+ TG IP L+ +L L L GN G +P F
Sbjct: 262 PIPPLPL-------KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFF 314
Query: 460 SGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELYVQNNMLSGTVPSSL--LSKN-VVLN 515
C L + L N +G LP +L+ + L+ L + N SG +P SL LS + + L+
Sbjct: 315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLD 374
Query: 516 YAGN 519
+ N
Sbjct: 375 LSSN 378
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-22
Identities = 31/97 (31%), Positives = 42/97 (43%), Gaps = 4/97 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG--CPDLRIIHLEDN 473
+ ++++SS G IP L SL L L N TG IPDF C L + L N
Sbjct: 247 TELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
G +P + L L + +N SG +P L K
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-20
Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ + LSS N +G +P D L K+ L L L N +G +P+ + L + L
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 473 NQLTGPLPSSLMN--LPNLRELYVQNNMLSGTVPSSL 507
N +GP+ +L L+ELY+QNN +G +P +L
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 7e-20
Identities = 36/128 (28%), Positives = 53/128 (41%), Gaps = 16/128 (12%)
Query: 390 ADWAQEGGDPCLPVPWSWL--QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKLSSLVE 444
DW +PC ++ C D +T I LSSK L + S L L+ L
Sbjct: 31 PDW-SSNKNPC-----TFDGVTCRDD---KVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81
Query: 445 LWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS--SLMNLPNLRELYVQNNMLSGT 502
L+L + + G + F L + L N L+GP+ + SL + L+ L V +N L
Sbjct: 82 LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFP 141
Query: 503 VPSSLLSK 510
S K
Sbjct: 142 GKVSGGLK 149
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-19
Identities = 25/111 (22%), Positives = 44/111 (39%), Gaps = 7/111 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTG--PIPDFSGCPDLRIIHLE 471
S+T + LS +L+G + + L S L L + N+L + L ++ L
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159
Query: 472 DNQLTGPLPSSLM---NLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
N ++G + L+ L + N +SG V S L+ + N
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSN 210
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-18
Identities = 32/108 (29%), Positives = 50/108 (46%), Gaps = 2/108 (1%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQL 475
S+ + +S L+G IP ++ + L L L N ++G IPD L I+ L N+L
Sbjct: 633 SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL 692
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSS-LLSKNVVLNYAGNINL 522
G +P ++ L L E+ + NN LSG +P + N L
Sbjct: 693 DGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGL 740
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-16
Identities = 18/97 (18%), Positives = 37/97 (38%), Gaps = 1/97 (1%)
Query: 412 SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHL 470
+D + G L +LS+ + G F + + +
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM 639
Query: 471 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
N L+G +P + ++P L L + +N +SG++P +
Sbjct: 640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV 676
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 6e-13
Identities = 17/102 (16%), Positives = 33/102 (32%), Gaps = 5/102 (4%)
Query: 423 LSSKNLTGNIPSDLTKLSSLVELWLDGN--SLTGPIP-DFSGCPDLRIIHLEDNQLTGPL 479
+++ + G + E GN G + ++ G
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 480 PSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
+ N ++ L + NMLSG +P + + +LN N
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 5e-04
Identities = 14/56 (25%), Positives = 26/56 (46%), Gaps = 4/56 (7%)
Query: 468 IHLEDNQLT---GPLPSSLMNLPNLRELYVQNNMLSGTVPS-SLLSKNVVLNYAGN 519
I L L + SSL++L L L++ N+ ++G+V + L+ + N
Sbjct: 55 IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRN 110
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 44/223 (19%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKV--------LTSNSYQGKRE-FTNEVTLLSRI 654
++ +G G VV K KE AVK+ ++ Q RE EV +L ++
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 655 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK- 712
H N++Q + LV++ M G L + + +++ ++E +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD----------YL--TEKVTLSEKETRK 128
Query: 713 -------GIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764
I LH I+HRDLK NILLD M K++DFG S +D + +
Sbjct: 129 IMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPGEKLREV 183
Query: 765 VRGTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISG 801
GT YL PE + D++S GVI+ L++G
Sbjct: 184 C-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 66/212 (31%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 661
+ +G G FG V K + +E AVKV+ S + K EV LL ++ H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 713
++ +V E G L + I IKR +E A G
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFD----------EI--IKRKRFSEHDAARIIKQVFSG 133
Query: 714 IEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
I Y+H I+HRDLK NILL +K K+ DFGLS + + + GT
Sbjct: 134 ITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTA 187
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
Y+ PE + +K DV+S GVIL L+SG
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 58/201 (28%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 662
+KIG G FG V+ G + K +A+K++ + + E E+T+LS+ + ++
Sbjct: 26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 85
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
G ++ + ++ E++ G+ + L E +I I R + KG++YLH+
Sbjct: 86 YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHSE-- 138
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
IHRD+K++N+LL +H K++DFG++ D ++ V GT ++ PE I Q
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE-VIKQSA 195
Query: 783 TD-KSDVYSFGVILLELISGQ 802
D K+D++S G+ +EL G+
Sbjct: 196 YDSKADIWSLGITAIELARGE 216
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 4e-26
Identities = 56/258 (21%), Positives = 112/258 (43%), Gaps = 24/258 (9%)
Query: 557 HKGKKNNYDKEQHRHSLPVQRPVSSLNDAP-AEAAHCFTLSDIEDATK------MLEKKI 609
+ ++ YD ++ + + VSS D + + +E + +++
Sbjct: 106 ERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEEL 165
Query: 610 GSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE 668
G+G FGVV+ + G A K + + K E+ +S + H LV ++
Sbjct: 166 GTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED 225
Query: 669 EGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 725
+ V++YEFM G L E + + ++ ++ + +++ ++ + G+ ++H
Sbjct: 226 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR--QVCK----GLCHMHEN---NY 276
Query: 726 IHRDLKSSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
+H DLK NI+ K+ DFGL+ +D V GT + PE + +
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPKQSVKVTT-GTAEFAAPEVAEGKPVG 334
Query: 784 DKSDVYSFGVILLELISG 801
+D++S GV+ L+SG
Sbjct: 335 YYTDMWSVGVLSYILLSG 352
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 22/225 (9%)
Query: 588 EAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREF 644
E FT D++ +IG G +G V K G+ +AVK T + + K+
Sbjct: 14 EQHWDFTAEDLK-----DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLL 68
Query: 645 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIK 702
+ ++ +VQF G EG + E M K + Y + I +
Sbjct: 69 MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128
Query: 703 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762
+ I K + +L IIHRD+K SNILLD+ K+ DFG+S VD +
Sbjct: 129 K--ITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR 184
Query: 763 SIVRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 802
G Y+ PE I + +SDV+S G+ L EL +G+
Sbjct: 185 DA--GCRPYMAPE-RIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 55/247 (22%), Positives = 83/247 (33%), Gaps = 54/247 (21%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKV-----LTSNSYQGKREFTNEVTLLSRIHHRN 658
L+ IG G +GVV A+K+ + + + EV L+ ++HH N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL----------------------------YG 690
+ + ++E LV E H G L + L
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 691 TLTHEQRINWIKRLEIAEDAAK--------GIEYLHT-GCVPAIIHRDLKSSNILL--DK 739
E + YLH G I HRD+K N L +K
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPENFLFSTNK 205
Query: 740 HMRAKVSDFGLSKFAVDGASHVSSIVR---GTVGYLDPE--YYISQQLTDKSDVYSFGVI 794
K+ DFGLSK + + GT ++ PE ++ K D +S GV+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 795 LLELISG 801
L L+ G
Sbjct: 266 LHLLLMG 272
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 30/239 (12%)
Query: 583 NDAPAEAAHCFTLSDIEDATKM--LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQ 639
+D+PA + LS + D + L + +G+G +G VY G+ +K G+ A+KV+
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-D 62
Query: 640 GKREFTNEVTLLSRI-HHRNLVQFLG-YCQEEGRSV-----LVYEFMHNGT----LKEHL 688
+ E E+ +L + HHRN+ + G + ++ + LV EF G+ +K
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 689 YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 748
TL E+ I +I R + +G+ +LH V IHRD+K N+LL ++ K+ DF
Sbjct: 123 GNTLK-EEWIAYICR-----EILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDF 173
Query: 749 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 802
G+S ++ + GT ++ PE + D KSD++S G+ +E+ G
Sbjct: 174 GVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 25/219 (11%)
Query: 596 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEV 648
S +ED + + +++GSG F +V + K GKE A K + +S + E EV
Sbjct: 1 SMVEDHYE-MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREV 59
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEI 706
+L I H N++ + + VL+ E + G L + L +LT ++ ++K +I
Sbjct: 60 NILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK--QI 117
Query: 707 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVS 762
+ G+ YLH+ I H DLK NI+L + R K+ DFG++ ++ +
Sbjct: 118 LD----GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK-IEAGNEFK 169
Query: 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
+I GT ++ PE + L ++D++S GVI L+SG
Sbjct: 170 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 657
+ +++GSG F +V + K G E A K + S + E EV++L ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 715
N++ + VL+ E + G L + L +L+ E+ ++IK +I + G+
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK--QILD----GVN 129
Query: 716 YLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
YLHT I H DLK NI+L K+ DFGL+ ++ +I GT +
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEF 184
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELISG 801
+ PE + L ++D++S GVI L+SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 28/235 (11%), Positives = 59/235 (25%), Gaps = 43/235 (18%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG-------KREFTNEVTLLSRIH--- 655
+G + G+ V V K E L +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 656 ---------------HRNLVQFLGYCQEEGRSVLVYEF-------MHNGTLKEHLYGTLT 693
+ + +E ++ F + T E L +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 694 HEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
+ + RL++ + + LH G ++H L+ +I+LD+ ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQ-----LTDKSDVYSFGVILLELISGQ 802
A Q +T D ++ G+ + +
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 664
+G GGFG V +++ ++ A K L + ++ NE +L +++ R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 250
Query: 665 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTH---EQRINWIKRLEIAEDAAKGIEYLHTG 720
Y + + LV M+ G LK H+Y E R AE G+E LH
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA----VFYAAE-ICCGLEDLHRE 305
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
I++RDLK NILLD H ++SD GL+ +G + + V GTVGY+ PE ++
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNE 360
Query: 781 QLTDKSDVYSFGVILLELISGQ 802
+ T D ++ G +L E+I+GQ
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQ 382
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 59/241 (24%), Positives = 111/241 (46%), Gaps = 24/241 (9%)
Query: 566 KEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKD 624
E + P +R + L++ E+ +LEK +G G +G VY +
Sbjct: 2 LETVQLRNPPRRQLKKLDED-------SLTKQPEEVFDVLEK-LGEGSYGSVYKAIHKET 53
Query: 625 GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684
G+ +A+K + +E E++++ + ++V++ G + +V E+ G++
Sbjct: 54 GQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111
Query: 685 K---EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 741
TLT E I I + KG+EYLH IHRD+K+ NILL+
Sbjct: 112 SDIIRLRNKTLT-EDEIATILQ-----STLKGLEYLHFM---RKIHRDIKAGNILLNTEG 162
Query: 742 RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
AK++DFG++ D + ++++ GT ++ PE +D++S G+ +E+ G
Sbjct: 163 HAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
Query: 802 Q 802
+
Sbjct: 222 K 222
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 596 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTNEVTLLS 652
+ + + K++G G F VV K G+E A K L + E +E+ +L
Sbjct: 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLE 83
Query: 653 RI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIA 707
++ + +L+ E+ G + L ++ I IK +I
Sbjct: 84 LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK--QIL 141
Query: 708 EDAAKGIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSS 763
E G+ YLH I+H DLK NILL K+ DFG+S+ + A +
Sbjct: 142 E----GVYYLHQNN----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK-IGHACELRE 192
Query: 764 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
I+ GT YL PE +T +D+++ G+I L++
Sbjct: 193 IM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 657
+ +++GSG F +V + K G E A K + S + E EV++L ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 715
N++ + VL+ E + G L + L +L+ E+ ++IK +I + G+
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK--QILD----GVN 129
Query: 716 YLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
YLHT I H DLK NI+L K+ DFGL+ ++ +I GT +
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEF 184
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELISG 801
+ PE + L ++D++S GVI L+SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 63/252 (25%), Positives = 111/252 (44%), Gaps = 30/252 (11%)
Query: 566 KEQHRHSLPVQRPVSSLNDAPAEAA---HCFTLS---DIEDATKMLEKK-IGSGGFGVVY 618
R + +R + D PA A H + + + + + +G G FG V+
Sbjct: 47 DLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVH 106
Query: 619 YGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677
+ G ++A K++ + + K E NE+++++++ H NL+Q + + VLV E
Sbjct: 107 KCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166
Query: 678 FMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 731
++ G L + + T I ++K +I E GI ++H I+H DLK
Sbjct: 167 YVDGGELFDRIIDESYNL---TELDTILFMK--QICE----GIRHMHQM---YILHLDLK 214
Query: 732 SSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVY 789
NIL K+ DFGL++ + GT +L PE ++ +D++
Sbjct: 215 PENILCVNRDAKQIKIIDFGLARR-YKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMW 272
Query: 790 SFGVILLELISG 801
S GVI L+SG
Sbjct: 273 SVGVIAYMLLSG 284
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-25
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLLSRIH---HRNL 659
+ IG GGFG VY + D ++ A+K L + K+ T NE +LS + +
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 660 VQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEY 716
V + Y + + + M+ G L HL G + E + R AE G+E+
Sbjct: 255 VC-MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADM----RFYAAE-IILGLEH 307
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
+H +++RDLK +NILLD+H ++SD GL+ H + V GT GY+ PE
Sbjct: 308 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEV 361
Query: 777 YISQQLTDKS-DVYSFGVILLELISGQ 802
D S D +S G +L +L+ G
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 21/218 (9%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE-FTNEV-T 649
++D+E ++GSG G V+ + + + AVK + + + + + ++
Sbjct: 22 AEINDLE-----NLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV 76
Query: 650 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 709
+L +VQ G + E M K L + + + +
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGK--MTVA 132
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
K + YL +IHRD+K SNILLD+ + K+ DFG+S VD + S G
Sbjct: 133 IVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCA 188
Query: 770 GYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 802
Y+ PE T ++DV+S G+ L+EL +GQ
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 662
L++ IGSG VV +++A+K + Q + E+ +S+ HH N+V +
Sbjct: 19 LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY 78
Query: 663 LGYCQEEGRSVLVYEFMHNGTL----------KEHLYGTLTHEQRINWIKRLEIAEDAAK 712
+ LV + + G++ EH G L E I I R + +
Sbjct: 79 YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILR-----EVLE 132
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT-VG- 770
G+EYLH IHRD+K+ NILL + +++DFG+S F G + VR T VG
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 771 --YLDPEYYISQQLTD---KSDVYSFGVILLELISGQ 802
++ PE + +Q+ K+D++SFG+ +EL +G
Sbjct: 190 PCWMAPE--VMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 43/222 (19%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--------FTNEVTLLSRIH 655
+ IG G VV + G E AVK++ + + E E +L ++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 656 -HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 712
H +++ + + LV++ M G L + + +++ ++E +
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFD----------YL--TEKVALSEKETRSI 205
Query: 713 ------GIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 765
+ +LH I+HRDLK NILLD +M+ ++SDFG S G + +
Sbjct: 206 MRSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELC 260
Query: 766 RGTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISG 801
GT GYL PE + D+++ GVIL L++G
Sbjct: 261 -GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 5e-25
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 31/211 (14%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 661
+++++G G F VV K G E A K++ + + E + ++ H N+V+
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KG 713
QEE LV++ + G L E I + R +E A +
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFE----------DI--VAREFYSEADASHCIQQILES 117
Query: 714 IEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770
I Y H+ I+HR+LK N+LL K K++DFGL+ D GT G
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFA-GTPG 172
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELISG 801
YL PE + D+++ GVIL L+ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-25
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLV 660
+ + IG G FG V + D K++ A+K + + E N E+ ++ + H LV
Sbjct: 19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 661 QFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYL 717
L Y Q+E +V + + G L+ HL E+ + +L I E ++YL
Sbjct: 79 N-LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK-EETV----KLFICE-LVMALDYL 131
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 777
IIHRD+K NILLD+H ++DF ++ + + GT Y+ PE +
Sbjct: 132 QNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMF 186
Query: 778 ISQQLT--DKS-DVYSFGVILLELISGQ 802
S++ + D +S GV EL+ G+
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 62/291 (21%), Positives = 110/291 (37%), Gaps = 55/291 (18%)
Query: 567 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKM-----LEKKIGSGGFGVVYYGK 621
H H + AP H L+ ++ + + +GSGGFG VY G
Sbjct: 4 SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGI 63
Query: 622 -LKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIHHR--NLVQFLGYCQEEGRS 672
+ D +A+K + + E N EV LL ++ +++ L + +
Sbjct: 64 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123
Query: 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPA 724
VL+ E ++ L+ +T + E+ A+ + + H V
Sbjct: 124 VLILERPEPV--QD-LFDFITERGALQ--------EELARSFFWQVLEAVRHCHNCGV-- 170
Query: 725 IIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
+HRD+K NIL+D K+ DFG D GT Y PE +I
Sbjct: 171 -LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPE-WIRYHRY 225
Query: 784 D--KSDVYSFGVILLELISG------QEAISNEKFG------ANCRNIVQW 820
+ V+S G++L +++ G E I + + C+++++W
Sbjct: 226 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 276
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 41/228 (17%), Positives = 89/228 (39%), Gaps = 38/228 (16%)
Query: 607 KKIGSGGFGVVYYG-KLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 662
+KIGSG FG V+ K DG A+K ++ EV + + H ++V++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
E+ ++ E+ + G+L + + + ++ +G+ Y+H+
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS--- 133
Query: 723 PAIIHRDLKSSNILLDKH-------------------MRAKVSDFGLSKFAVDGASHVSS 763
+++H D+K SNI + + + K+ D G + +SS
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH-------VTRISS 186
Query: 764 --IVRGTVGYLDPEYYISQQL--TDKSDVYSFGVILLELISGQEAISN 807
+ G +L E + + K+D+++ + ++ + N
Sbjct: 187 PQVEEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 40/219 (18%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH-- 655
L +G GGFG V+ G L D ++A+KV+ N G ++ EV LL ++
Sbjct: 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94
Query: 656 --HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK- 712
H +++ L + + + +LV E + L+ +T + + E ++
Sbjct: 95 GGHPGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLG--------EGPSRC 143
Query: 713 -------GIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSI 764
I++ H+ V +HRD+K NIL+D AK+ DFG D
Sbjct: 144 FFGQVVAAIQHCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD- 199
Query: 765 VRGTVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 801
GT Y PE +IS+ + V+S G++L +++ G
Sbjct: 200 --GTRVYSPPE-WISRHQYHALPATVWSLGILLYDMVCG 235
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 657
+++GSG F VV + K G + A K + +S + + EV++L I H
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 715
N++ + + +L+ E + G L + L +LT E+ ++K +I G+
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK--QILN----GVY 128
Query: 716 YLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
YLH+ I H DLK NI+L R K+ DFGL+ +D + +I GT +
Sbjct: 129 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIF-GTPEF 183
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELISG 801
+ PE + L ++D++S GVI L+SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 37/214 (17%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-----TSNSYQGKREFTNEVTLLSRIHHRN 658
L + +G G +G V + +AVK++ K+E + + ++H N
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHEN 66
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK------ 712
+V+F G+ +E L E+ G L + + + + E A+
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQL 114
Query: 713 --GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTV 769
G+ YLH I HRD+K N+LLD+ K+SDFGL+ + + + GT+
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 770 GYLDPEYYISQQLTD--KSDVYSFGVILLELISG 801
Y+ PE + ++ DV+S G++L +++G
Sbjct: 172 PYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 43/221 (19%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--------FTNEVTLLSRIH 655
+ K +GSG G V + K++A+++++ + E+ +L +++
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 656 HRNLVQFLGYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 712
H +++ + E +V E M G L + ++ + + E K
Sbjct: 199 HPCIIKIKNFFDAE--DYYIVLELMEGGELFD----------KV--VGNKRLKEATCKLY 244
Query: 713 ------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSS 763
++YLH IIHRDLK N+LL ++ K++DFG SK + S + +
Sbjct: 245 FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRT 300
Query: 764 IVRGTVGYLDPE---YYISQQLTDKSDVYSFGVILLELISG 801
+ GT YL PE + D +S GVIL +SG
Sbjct: 301 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 37/203 (18%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ + +G G FG+V+ K K + + E+++L+ HRN++
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
+ V+++EF+ + E + L + ++++ ++ E +++LH+
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH--QVCE----ALQFLHSH 121
Query: 721 CVPAIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778
I H D++ NI+ + K+ +FG ++ + + + Y PE +
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ-LKPGDNFRLLF-TAPEYYAPEVHQ 176
Query: 779 SQQLTDKSDVYSFGVILLELISG 801
++ +D++S G ++ L+SG
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSG 199
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 32/212 (15%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 661
L +++G G F VV G+E A ++ + + E + + H N+V+
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------G 713
EEG L+++ + G L E I + R +E DA+
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFE----------DI--VAREYYSEADASHCIQQILEA 122
Query: 714 IEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
+ + H G ++HR+LK N+LL K K++DFGL+ GT
Sbjct: 123 VLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTP 177
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
GYL PE D+++ GVIL L+ G
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 45/216 (20%), Positives = 82/216 (37%), Gaps = 28/216 (12%)
Query: 605 LEKKIGSG--GFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNL 659
L IG G V + G+ + V+ L + S + E+ + +H N+
Sbjct: 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI 88
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGT----LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
V + + +V FM G+ + H + E I +I + K ++
Sbjct: 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN-ELAIAYILQ-----GVLKALD 142
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR------GTV 769
Y+H +HR +K+S+IL+ + +S + + + +
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 770 GYLDPEYYISQQL---TDKSDVYSFGVILLELISGQ 802
+L PE + Q L KSD+YS G+ EL +G
Sbjct: 200 PWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 31/211 (14%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 661
+++++G G F VV K G E A K++ + + E + ++ H N+V+
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KG 713
QEE LV++ + G L E I + R +E A +
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFE----------DI--VAREFYSEADASHCIQQILES 140
Query: 714 IEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770
I Y H+ I+HR+LK N+LL K K++DFGL+ V+ + GT G
Sbjct: 141 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSEAWHGFA-GTPG 195
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELISG 801
YL PE + D+++ GVIL L+ G
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 67/251 (26%), Positives = 108/251 (43%), Gaps = 26/251 (10%)
Query: 561 KNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYG 620
N + +P SL D + A F D E L + IG G FG VY+
Sbjct: 17 TENLYFQGAMDPMPAGGRAGSLKDP--DVAELFFKDDPEKLFSDLRE-IGHGSFGAVYFA 73
Query: 621 K-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676
+ +++ + +A+K ++ + Q ++ EV L ++ H N +Q+ G E + LV
Sbjct: 74 RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133
Query: 677 EFMHNG--TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 734
E+ L E L E I + A +G+ YLH+ +IHRD+K+ N
Sbjct: 134 EYCLGSASDLLEVHKKPLQ-EVEIAAVTH-----GALQGLAYLHSH---NMIHRDVKAGN 184
Query: 735 ILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD---KSDVYSF 791
ILL + K+ DFG + S V GT ++ PE ++ K DV+S
Sbjct: 185 ILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSL 239
Query: 792 GVILLELISGQ 802
G+ +EL +
Sbjct: 240 GITCIELAERK 250
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 37/214 (17%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-----TSNSYQGKREFTNEVTLLSRIHHRN 658
L + +G G +G V + +AVK++ K+E + + ++H N
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHEN 66
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK------ 712
+V+F G+ +E L E+ G L + + + + E A+
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQL 114
Query: 713 --GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTV 769
G+ YLH I HRD+K N+LLD+ K+SDFGL+ + + + GT+
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 770 GYLDPEYYISQQLTD--KSDVYSFGVILLELISG 801
Y+ PE + ++ DV+S G++L +++G
Sbjct: 172 PYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 59/230 (25%), Positives = 92/230 (40%), Gaps = 39/230 (16%)
Query: 596 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRI 654
ED ++ E +G G V +E AVK++ + EV +L +
Sbjct: 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQC 67
Query: 655 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK 712
HRN+++ + + +EE R LV+E M G++ I KR E +A+
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILS----------HI--HKRRHFNELEASV 115
Query: 713 -------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVS 762
+++LH I HRDLK NIL ++ K+ DF L
Sbjct: 116 VVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172
Query: 763 SIVR------GTVGYLDPE----YYISQQLTDKS-DVYSFGVILLELISG 801
G+ Y+ PE + + DK D++S GVIL L+SG
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 69/267 (25%), Positives = 108/267 (40%), Gaps = 42/267 (15%)
Query: 556 MHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCF--------TLSDIEDATKMLEK 607
MH ++ + +L Q S A A + D + +E
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFE-VES 59
Query: 608 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666
++G G +VY K K K A+KVL K+ E+ +L R+ H N+++
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 667 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------GIEYLH 718
+ LV E + G L + RI +++ +E DAA + YLH
Sbjct: 118 ETPTEISLVLELVTGGELFD----------RI--VEKGYYSERDAADAVKQILEAVAYLH 165
Query: 719 T-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
G I+HRDLK N+L K++DFGLSK V+ + ++ GT GY P
Sbjct: 166 ENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVC-GTPGYCAP 219
Query: 775 EYYISQQLTDKSDVYSFGVILLELISG 801
E + D++S G+I L+ G
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 38/217 (17%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--------TSNSYQGKREFTNEVTLLSRIH 655
+GSG FG V+ + KE+ VK + + T E+ +LSR+
Sbjct: 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE 87
Query: 656 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--- 712
H N+++ L + +G LV E +G L+ + R++ E A
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSGL---DLFAFIDRHPRLD--------EPLASYIF 136
Query: 713 -----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVR 766
+ YL IIHRD+K NI++ + K+ DFG + + G +
Sbjct: 137 RQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--- 190
Query: 767 GTVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 801
GT+ Y PE + + +++S GV L L+
Sbjct: 191 GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 43/221 (19%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--------FTNEVTLLSRIH 655
+ K +GSG G V + K++A+K+++ + E+ +L +++
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 656 HRNLVQFLGYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 712
H +++ + E +V E M G L + ++ + + E K
Sbjct: 74 HPCIIKIKNFFDAE--DYYIVLELMEGGELFD----------KV--VGNKRLKEATCKLY 119
Query: 713 ------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSS 763
++YLH IIHRDLK N+LL ++ K++DFG SK + S + +
Sbjct: 120 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRT 175
Query: 764 IVRGTVGYLDPE---YYISQQLTDKSDVYSFGVILLELISG 801
+ GT YL PE + D +S GVIL +SG
Sbjct: 176 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 38/223 (17%)
Query: 596 SDIEDATKM--LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLS 652
S + +K +G G F + K + AVK+++ + E+T L
Sbjct: 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALK 60
Query: 653 RI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DA 710
H N+V+ ++ + LV E ++ G L E RI K+ +E +A
Sbjct: 61 LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE----------RI--KKKKHFSETEA 108
Query: 711 AK-------GIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGAS 759
+ + ++H G ++HRDLK N+L + ++ K+ DFG ++
Sbjct: 109 SYIMRKLVSAVSHMHDVG----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164
Query: 760 HVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISG 801
+ + T+ Y PE ++Q D+S D++S GVIL ++SG
Sbjct: 165 PLKTPC-FTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 53/222 (23%), Positives = 89/222 (40%), Gaps = 46/222 (20%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--------TSNSYQGKREFTNEVTLLSRIH 655
+ +G G +G V + AVK+L + K+E + LL R+
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKE----IQLLRRLR 64
Query: 656 HRNLVQFLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK- 712
H+N++Q + E + +V E+ G ++E + ++ KR A
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQE-MLDSVPE-------KRFP--VCQAHG 113
Query: 713 -------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS----KFAVDGASHV 761
G+EYLH+ I+H+D+K N+LL K+S G++ FA D
Sbjct: 114 YFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 762 SSIVRGTVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 801
S G+ + PE K D++S GV L + +G
Sbjct: 171 SQ---GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 9e-23
Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 38/213 (17%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSR-IHHRNLVQF 662
+++ IG G + V K E AVK++ + E + +L R H N++
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITL 81
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------GI 714
+ +V E M G L + +I +++ +E +A+ +
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLD----------KI--LRQKFFSEREASAVLFTITKTV 129
Query: 715 EYLHT-GCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
EYLH G ++HRDLK SNIL ++ DFG +K + + T
Sbjct: 130 EYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTA 184
Query: 770 GYLDPEYYISQQLTDKS-DVYSFGVILLELISG 801
++ PE + +Q D + D++S GV+L +++G
Sbjct: 185 NFVAPE-VLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 38/213 (17%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL---TSNSYQGKREFTNEVTLLSRIHHRNLV 660
K IGSG FGV + + +AVK + + +RE + + H N+V
Sbjct: 24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIV 79
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------- 712
+F ++ E+ G L E + +ED A+
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERI------------CNAGRFSEDEARFFFQQLLS 127
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770
G+ Y H+ + HRDLK N LLD R K+ DFG SK +V + S++ GT
Sbjct: 128 GVSYCHSMQI---CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPA 182
Query: 771 YLDPEYYISQQLTD--KSDVYSFGVILLELISG 801
Y+ PE + +Q D +DV+S GV L ++ G
Sbjct: 183 YIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-22
Identities = 58/211 (27%), Positives = 85/211 (40%), Gaps = 25/211 (11%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 662
K IG G F V K+K ++ A+K++ + E F E +L R + Q
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ- 125
Query: 663 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
L + Q+E LV E+ G L L +G + R +AE I+ +H
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA----RFYLAE-IVMAIDSVHR 180
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 778
+HRD+K NILLD+ +++DFG DG V GT YL PE
Sbjct: 181 L---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQ 236
Query: 779 SQQLTDKSDVY-------SFGVILLELISGQ 802
+ + Y + GV E+ GQ
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-22
Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------TSNSYQGKREFTNEVTLLSRIHH 656
L +G G FG V G+ G ++AVK+L + KRE + L H
Sbjct: 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE----IQNLKLFRH 70
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---- 712
++++ +V E++ G L +++ K + E A+
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYI------------CKHGRVEEMEARRLFQ 118
Query: 713 ----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 768
++Y H ++HRDLK N+LLD HM AK++DFGLS DG +S G+
Sbjct: 119 QILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GS 173
Query: 769 VGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 801
Y PE IS +L + D++S GVIL L+ G
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCG 207
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-22
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 39/214 (18%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 657
L K IG G F V + + G+E+A+K++ ++ + RE V ++ ++H
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFRE----VRIMKILNHP 74
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----- 712
N+V+ + E L+ E+ G + ++L + + E A+
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYL------------VAHGRMKEKEARSKFRQ 122
Query: 713 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
++Y H I+HRDLK+ N+LLD M K++DFG S G + + G
Sbjct: 123 IVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFC-GAP 177
Query: 770 GYLDPEYYISQQLTD--KSDVYSFGVILLELISG 801
Y PE + D + DV+S GVIL L+SG
Sbjct: 178 PYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSG 210
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-21
Identities = 66/243 (27%), Positives = 104/243 (42%), Gaps = 30/243 (12%)
Query: 574 PVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVK-V 632
P+ N A + + K IG+G FGVV+ KL + E+A+K V
Sbjct: 13 VKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV 72
Query: 633 LTSNSYQGKREFTN-EVTLLSRIHHRNLVQFLGYCQEEGRSV------LVYEFMHNGTLK 685
L Q KR F N E+ ++ + H N+V + G LV E++ T+
Sbjct: 73 L-----QDKR-FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVY 125
Query: 686 EHLYGTLTHEQRI--NWIKRL--EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 741
+Q + IK ++ + + Y+H+ I HRD+K N+LLD
Sbjct: 126 RASRHYAKLKQTMPMLLIKLYMYQL----LRSLAYIHSI---GICHRDIKPQNLLLDPPS 178
Query: 742 RA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELI 799
K+ DFG +K + G +VS I + Y PE + T D++S G ++ EL+
Sbjct: 179 GVLKLIDFGSAKILIAGEPNVSYIC--SRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236
Query: 800 SGQ 802
GQ
Sbjct: 237 QGQ 239
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-21
Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 33/214 (15%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 662
K IG G FG V KLK+ ++ A+K+L + E F E +L + +
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT- 138
Query: 663 LGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 713
L Y Q++ LV ++ G L L E R+ E+ A+
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLS---KFEDRLP--------EEMARFYLAEMVIA 187
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
I+ +H +HRD+K NIL+D + +++DFG ++ + SS+ GT Y+
Sbjct: 188 IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 774 PEYYISQQLTDKS-----DVYSFGVILLELISGQ 802
PE + + D +S GV + E++ G+
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 51/226 (22%), Positives = 90/226 (39%), Gaps = 44/226 (19%)
Query: 596 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSR 653
+ D ++ ++ +G G G V + G++ A+K+L EV +
Sbjct: 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY------DSPKARQEVDHHWQ 77
Query: 654 I-HHRNLVQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA- 707
++V L + ++ E M G L RI +R + A
Sbjct: 78 ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS----------RI--QERGDQAF 125
Query: 708 --EDAAK-------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAV 755
+AA+ I++LH+ I HRD+K N+L +K K++DFG +K
Sbjct: 126 TEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182
Query: 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
A + + T Y+ PE ++ D++S GVI+ L+ G
Sbjct: 183 QNA--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 58/255 (22%), Positives = 99/255 (38%), Gaps = 47/255 (18%)
Query: 569 HRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKE 627
H + P P ++ + I D K+ + +G G G V K ++
Sbjct: 30 HPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEK 89
Query: 628 IAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV----LVYEFMHN 681
A+K+L EV L R ++V+ + + +V E +
Sbjct: 90 FALKMLQ------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143
Query: 682 GTLKEHLYGTLTHEQRINWIKRLEIA---EDAA-------KGIEYLHT-GCVPAIIHRDL 730
G L RI R + A +A+ + I+YLH+ I HRD+
Sbjct: 144 GELFS----------RI--QDRGDQAFTEREASEIMKSIGEAIQYLHSIN----IAHRDV 187
Query: 731 KSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS- 786
K N+L + K++DFG +K + +++ T Y+ PE + + DKS
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPC-YTPYYVAPE-VLGPEKYDKSC 244
Query: 787 DVYSFGVILLELISG 801
D++S GVI+ L+ G
Sbjct: 245 DMWSLGVIMYILLCG 259
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 4e-21
Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------TSNSYQGKREFTNEVTLLSRIHH 656
L +G G FG V GK G ++AVK+L + +RE + L H
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE----IQNLKLFRH 75
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---- 712
++++ +V E++ G L +++ K + E ++
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYI------------CKNGRLDEKESRRLFQ 123
Query: 713 ----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 768
G++Y H V +HRDLK N+LLD HM AK++DFGLS DG +S G+
Sbjct: 124 QILSGVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GS 178
Query: 769 VGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 801
Y PE IS +L + D++S GVIL L+ G
Sbjct: 179 PNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCG 212
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 38/223 (17%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEV 648
L + K +G+G FG V K K+ A+K+L ++ NE
Sbjct: 38 AQLDQFD-----RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 708
+L ++ LV+ ++ +V E++ G + HL R + E
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFS--------E 140
Query: 709 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760
A+ EYLH+ +I+RDLK N+L+D+ +V+DFG +K
Sbjct: 141 PHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193
Query: 761 VSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
+ + GT L PE I + +K+ D ++ GV++ E+ +G
Sbjct: 194 RTWTLCGTPEALAPE-IILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-21
Identities = 60/223 (26%), Positives = 106/223 (47%), Gaps = 38/223 (17%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEV 648
++L D + + + +G+G FG V+ + + A+KVL ++ +E
Sbjct: 3 YSLQDFQ-----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER 57
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 708
+LS + H +++ G Q+ + ++ +++ G L L QR
Sbjct: 58 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR----KSQRFP--------N 105
Query: 709 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760
AK +EYLH+ II+RDLK NILLDK+ K++DFG +K+ D
Sbjct: 106 PVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 160
Query: 761 VSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
+ GT Y+ PE +S + +KS D +SFG+++ E+++G
Sbjct: 161 --YTLCGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 5e-21
Identities = 68/251 (27%), Positives = 103/251 (41%), Gaps = 23/251 (9%)
Query: 560 KKNNYDKEQHRHSLPVQRP-VSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY 618
KK + R P + + A+ H T+++ E K +G G FG V
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFE-----YLKLLGKGTFGKVI 165
Query: 619 YGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLGYC-QEEGRSV 673
K K A+K+L K E + E +L H L L Y Q R
Sbjct: 166 LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA-LKYSFQTHDRLC 224
Query: 674 LVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 731
V E+ + G L HL + E R R AE ++YLH+ +++RDLK
Sbjct: 225 FVMEYANGGELFFHLSRERVFS-EDRA----RFYGAE-IVSALDYLHSEK--NVVYRDLK 276
Query: 732 SSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSF 791
N++LDK K++DFGL K + + + + GT YL PE D +
Sbjct: 277 LENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGL 335
Query: 792 GVILLELISGQ 802
GV++ E++ G+
Sbjct: 336 GVVMYEMMCGR 346
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 61/245 (24%), Positives = 100/245 (40%), Gaps = 71/245 (28%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------------------TSNSYQGKREF 644
L+ +IG G +GVV D A+KVL T + G +
Sbjct: 17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76
Query: 645 TN-------EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-------- 689
E+ +L ++ H N+V+ + E + + ++HLY
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVK-------------LVEVLDDPN-EDHLYMVFELVNQ 122
Query: 690 GTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHM 741
G + + ++ED A+ GIEYLH IIHRD+K SN+L+ +
Sbjct: 123 GPV-----MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDG 174
Query: 742 RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD----KSDVYSFGVILLE 797
K++DFG+S + +S+ V GT ++ PE +S+ DV++ GV L
Sbjct: 175 HIKIADFGVSNEFKGSDALLSNTV-GTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYC 232
Query: 798 LISGQ 802
+ GQ
Sbjct: 233 FVFGQ 237
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 33/218 (15%)
Query: 604 MLEKKIGSGGFGVVYYGKLKD-GKEIAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+E+ G G FG V GK K G +A+K V+ ++ RE + L+ +HH N+VQ
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-NRELQ-IMQDLAVLHHPNIVQ 83
Query: 662 FLGYCQEEGRS-------VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 712
Y G +V E++ TL R + +++ K
Sbjct: 84 LQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCC--------RNYYRRQVAPPPILIKVF 134
Query: 713 ------GIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIV 765
I LH V + HRD+K N+L+++ K+ DFG +K +V+ I
Sbjct: 135 LFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 766 RGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 802
+ Y PE +Q T D++S G I E++ G+
Sbjct: 194 --SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-20
Identities = 73/247 (29%), Positives = 109/247 (44%), Gaps = 27/247 (10%)
Query: 565 DKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD 624
+ + + P P +N P+ H SD K IG G FG V + K
Sbjct: 8 PELMNANPAPPPAPSQQINLGPSSNPH-AKPSDFH-----FLKVIGKGSFGKVLLARHKA 61
Query: 625 GKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQFLGYC-QEEGRSVLVYEF 678
+ AVKVL + K+E + ++ LL + H LV L + Q + V ++
Sbjct: 62 EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG-LHFSFQTADKLYFVLDY 120
Query: 679 MHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 736
++ G L HL E R R AE A + YLH+ I++RDLK NIL
Sbjct: 121 INGGELFYHLQRERCFL-EPRA----RFYAAE-IASALGYLHSL---NIVYRDLKPENIL 171
Query: 737 LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVIL 795
LD ++DFGL K ++ S S+ GT YL PE + +Q D++ D + G +L
Sbjct: 172 LDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPE-VLHKQPYDRTVDWWCLGAVL 229
Query: 796 LELISGQ 802
E++ G
Sbjct: 230 YEMLYGL 236
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 43/216 (19%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------TSNSYQGKREFTNEVTLLSRIHH 656
+ + +G G FG V K +++A+K + + + +RE ++ L + H
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE----ISYLKLLRH 68
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---- 712
++++ V+V E+ G L +++ +++ + ED +
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYI------------VEKKRMTEDEGRRFFQ 115
Query: 713 ----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRG 767
IEY H I+HRDLK N+LLD ++ K++DFGLS DG S G
Sbjct: 116 QIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---G 169
Query: 768 TVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 801
+ Y PE I+ +L + DV+S G++L ++ G
Sbjct: 170 SPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 24/203 (11%), Positives = 56/203 (27%), Gaps = 43/203 (21%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLV 660
L G + +++A+ + +E + LSRI +
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-T 719
+ L ++V E++ G+L+E + + + + A + H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA------IRAMQSLAAAADAAHRA 148
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
G + S + + ++ T+ +P+
Sbjct: 149 G----VALSIDHPSRVRVSIDGDVVLAYP------------------ATMPDANPQ---- 182
Query: 780 QQLTDKSDVYSFGVILLELISGQ 802
D+ G L L+ +
Sbjct: 183 ------DDIRGIGASLYALLVNR 199
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-20
Identities = 68/218 (31%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 604 MLEKKIGSGGFGVVYYGKLKD-GKEIAVK-VLTSNSYQGKREFTN-EVTLLSRIHHRNLV 660
K IG+G FGVVY KL D G+ +A+K VL Q KR F N E+ ++ ++ H N+V
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKR-FKNRELQIMRKLDHCNIV 110
Query: 661 QFLGYCQEEGRSV------LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 712
+ + G LV +++ E +Y H R + K
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAK----QTLPVIYVKLY 161
Query: 713 ------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIV 765
+ Y+H+ I HRD+K N+LLD K+ DFG +K V G +VS I
Sbjct: 162 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 766 RGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 802
+ Y PE + T DV+S G +L EL+ GQ
Sbjct: 219 --SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-20
Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 34/213 (15%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 662
K IG G FG V + K +++ A+K+L+ + + F E +++ + +VQ
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ- 133
Query: 663 LGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 713
L Y Q++ +V E+M G L + ++ E A+
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLM-------------SNYDVPEKWARFYTAEVVLA 180
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
++ +H+ IHRD+K N+LLDK K++DFG GT Y+
Sbjct: 181 LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237
Query: 774 PEYYISQQLT---DKS-DVYSFGVILLELISGQ 802
PE SQ + D +S GV L E++ G
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 9e-20
Identities = 70/232 (30%), Positives = 116/232 (50%), Gaps = 27/232 (11%)
Query: 581 SLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY---YGKLKDGKEI-AVKVLTSN 636
++ E S E L K +G G FG V+ D +++ A+KVL
Sbjct: 9 AITHHVKEGHEKADPSQFE-----LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA 63
Query: 637 SYQGKREF--TNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GT 691
+ + + E +L ++H +V+ L Y Q EG+ L+ +F+ G L L
Sbjct: 64 TLKVRDRVRTKMERDILVEVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM 122
Query: 692 LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751
T E+ + + +AE A +++LH+ II+RDLK NILLD+ K++DFGLS
Sbjct: 123 FT-EEDV----KFYLAE-LALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLS 173
Query: 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
K ++D S GTV Y+ PE ++++ +S D +SFGV++ E+++G
Sbjct: 174 KESIDHEKKAYSFC-GTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 32/210 (15%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 662
K +G G FG V + K A+K+L K E + E +L H L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA- 69
Query: 663 LGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 713
L Y Q R V E+ + G L HL E+ E+ A+
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFT--------EERARFYGAEIVSA 117
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
+EYLH+ +++RD+K N++LDK K++DFGL K + + + + GT YL
Sbjct: 118 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLA 173
Query: 774 PEYYISQQLTDKS-DVYSFGVILLELISGQ 802
PE + ++ D + GV++ E++ G+
Sbjct: 174 PE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-19
Identities = 24/108 (22%), Positives = 42/108 (38%), Gaps = 4/108 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
++ + +S + LSSL L + GNS F+ +L + L
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN--VVLNYAGN 519
QL P++ +L +L+ L + +N N VL+Y+ N
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-18
Identities = 22/109 (20%), Positives = 39/109 (35%), Gaps = 5/109 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 473
S+ V+ ++ + N D T+L +L L L L P F+ L+++++ N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 504
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS---LLSKNVVLNYAGN 519
L +L+ L N + + S LN N
Sbjct: 505 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 8e-18
Identities = 23/96 (23%), Positives = 36/96 (37%), Gaps = 1/96 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
P + V+ LS + LS L L L GN + FSG L+ + +
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
L + +L L+EL V +N++ S
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-17
Identities = 20/106 (18%), Positives = 37/106 (34%), Gaps = 2/106 (1%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCP 463
++L ++T + LS L P+ LSSL L + N+ +
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 518
Query: 464 DLRIIHLEDNQLTGPLPSSLMNLP-NLRELYVQNNMLSGTVPSSLL 508
L+++ N + L + P +L L + N + T
Sbjct: 519 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSF 564
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 9e-17
Identities = 14/97 (14%), Positives = 29/97 (29%), Gaps = 3/97 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
S+ + LS + + S+ L L L ++L F +L + +
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
L +L L + N + ++
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-15
Identities = 27/109 (24%), Positives = 40/109 (36%), Gaps = 5/109 (4%)
Query: 416 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 473
PS+ + LS L+ G +SL L L N + +F G L + + +
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406
Query: 474 QLTGPLPSS-LMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
L S ++L NL L + + LS VL AGN
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-14
Identities = 21/111 (18%), Positives = 39/111 (35%), Gaps = 7/111 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPD-FSGCPDLRIIHLEDN 473
S+ + NL + L +L EL + N + +P+ FS +L + L N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 474 QLTGPLPSSLMNLPNLR----ELYVQNNMLSGTVPSSLLSKN-VVLNYAGN 519
++ + L L + L + N ++ P + L N
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 17/90 (18%), Positives = 30/90 (33%), Gaps = 4/90 (4%)
Query: 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTG 477
N IP +L S L L N L F P+L+++ L ++
Sbjct: 10 ITYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 478 PLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
+ +L +L L + N + +
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAF 96
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-12
Identities = 23/107 (21%), Positives = 37/107 (34%), Gaps = 4/107 (3%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPD-FSGCPDLRIIH 469
++ L+ + G L SL L L N L+ G G L+ +
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 470 LEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
L N + + S+ + L L L Q++ L S+ L Y
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 6e-10
Identities = 16/102 (15%), Positives = 31/102 (30%), Gaps = 5/102 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSL----VELWLDGNSLTGPIPDFSGCPDLRIIHLE 471
++ + LSS + +DL L + + L L N + P L + L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208
Query: 472 DNQLTGPLPS-SLMNLPNLRELYVQNNMLSGTVPSSLLSKNV 512
+N + + + L L + K+
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 15/125 (12%), Positives = 36/125 (28%), Gaps = 11/125 (8%)
Query: 406 SWLQCNSDPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTG----PIPDFS 460
+++Q + + + + L + + N+ + L+ L L D S
Sbjct: 190 NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
Query: 461 GCPDLRIIHLEDNQLT------GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 514
L + +E+ +L + L N+ + + + S L
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHL 309
Query: 515 NYAGN 519
Sbjct: 310 ELVNC 314
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 9e-08
Identities = 22/130 (16%), Positives = 43/130 (33%), Gaps = 25/130 (19%)
Query: 414 PQPSITVIHLSSKNLTGN-IPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 472
+I L+ + + I L+++ L ++ + DFS + + L +
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVN 313
Query: 473 NQLT-------------------GPLPSSLMNLPNLRELYVQNNMLS--GTVPSSL--LS 509
+ G S ++LP+L L + N LS G S +
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373
Query: 510 KNVVLNYAGN 519
L+ + N
Sbjct: 374 SLKYLDLSFN 383
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 16/100 (16%), Positives = 25/100 (25%), Gaps = 28/100 (28%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPD-LRIIHLEDN 473
S+ V+++S N L+SL L N + P L ++L N
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 474 QLTG--------------------------PLPSSLMNLP 487
PS +P
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 593
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-19
Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 607 KKIGSGGFGVVY---YGKLKDGKEI-AVKVLTSNSYQGKREFT----NEVTLLSRIHHRN 658
+ +G GG+G V+ + +I A+KVL + T E +L + H
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 659 LVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIE 715
+V L Y Q G+ L+ E++ G L L G E +AE + +
Sbjct: 83 IVD-LIYAFQTGGKLYLILEYLSGGELFMQLEREGIFM-EDTA----CFYLAE-ISMALG 135
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
+LH II+RDLK NI+L+ K++DFGL K ++ + + GT+ Y+ PE
Sbjct: 136 HLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPE 191
Query: 776 YYISQQLTDKS-DVYSFGVILLELISGQ 802
+ + +++ D +S G ++ ++++G
Sbjct: 192 -ILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 48/205 (23%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLG 664
+K+G G + V+ + + +++ VK+L K++ E+ +L + N++
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLAD 98
Query: 665 --YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
LV+E ++N K LY TLT ++ + K ++Y H+
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFK-QLYQTLTDYDIRFYMYEI------LKALDYCHSM-- 149
Query: 723 PAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
I+HRD+K N+++D R ++ D+GL++F G + + + + PE + Q
Sbjct: 150 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFKGPELLVDYQ 206
Query: 782 LTDKS-DVYSFGVILLELISGQEAI 805
+ D S D++S G +L +I +E
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 8e-19
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 661
+K+G G +GVVY K G+ +A+K + ++ + E T E++LL +HH N+V
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELHHPNIVS 83
Query: 662 FLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
+ E LV+EFM + + L Q ++ +L +G+ + H
Sbjct: 84 LIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL------LRGVAHCHQ 137
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 778
I+HRDLK N+L++ K++DFGL++ F + S+ +V T+ Y P+ +
Sbjct: 138 HR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLM 192
Query: 779 -SQQLTDKSDVYSFGVILLELISGQ 802
S++ + D++S G I E+I+G+
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 25/212 (11%)
Query: 604 MLEK-----KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN--EVTLLSRIH 655
M+EK KIG G +GVV+ + +D G+ +A+K + + E+ +L ++
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60
Query: 656 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRI-NWIKRLEIAEDAAK 712
H NLV L + + R LV+E+ + T+ L Y E + + + +
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQT------LQ 113
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGY 771
+ + H IHRD+K NIL+ KH K+ DFG ++ + + T Y
Sbjct: 114 AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA--TRWY 168
Query: 772 LDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
PE + DV++ G + EL+SG
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-18
Identities = 63/243 (25%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 576 QRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT 634
+ N +++ + + E + +G G FG V ++K+ ++ AVKVL
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFE-----FIRVLGKGSFGKVMLARVKETGDLYAVKVL- 56
Query: 635 SNSYQGKREF---TNEVT--------LLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNG 682
K++ ++V L +H L Q L C Q R V EF++ G
Sbjct: 57 ------KKDVILQDDDVECTMTEKRILSLARNHPFLTQ-LFCCFQTPDRLFFVMEFVNGG 109
Query: 683 TLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 740
L H+ E R R AE + +LH II+RDLK N+LLD
Sbjct: 110 DLMFHIQKSRRFD-EARA----RFYAAE-IISALMFLHDK---GIIYRDLKLDNVLLDHE 160
Query: 741 MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELI 799
K++DFG+ K + ++ GT Y+ PE + + L + D ++ GV+L E++
Sbjct: 161 GHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEML 218
Query: 800 SGQ 802
G
Sbjct: 219 CGH 221
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFTN--EVTLLSRIHHRNLVQF 662
+G G +G+V + KD I A+K L S+ + + E+ LL ++ H NLV
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQLRHENLVNL 89
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 719
L C+++ R LV+EF+ + T+ + L + Q + ++ ++ GI + H+
Sbjct: 90 LEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQI------INGIGFCHS 142
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 778
IIHRD+K NIL+ + K+ DFG ++ A G + + T Y PE +
Sbjct: 143 HN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA--TRWYRAPELLV 197
Query: 779 -SQQLTDKSDVYSFGVILLELISGQ 802
+ DV++ G ++ E+ G+
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 41/230 (17%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVY---YGKLKDGKEI-AVKVLTSNSYQGKREFT--- 645
+ + E L K +G+G +G V+ D ++ A+KVL + K + T
Sbjct: 51 VGIENFE-----LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT 105
Query: 646 -NEVTLLSRI-HHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK 702
E +L I LV L Y Q E + L+ ++++ G L HL +R
Sbjct: 106 RTERQVLEHIRQSPFLVT-LHYAFQTETKLHLILDYINGGELFTHLS----QRERFT--- 157
Query: 703 RLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754
E + +E+LH II+RD+K NILLD + ++DFGLSK
Sbjct: 158 -----EHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209
Query: 755 VDGASHVSSIVRGTVGYLDPE-YYISQQLTDKS-DVYSFGVILLELISGQ 802
V + + GT+ Y+ P+ DK+ D +S GV++ EL++G
Sbjct: 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-18
Identities = 24/96 (25%), Positives = 41/96 (42%), Gaps = 2/96 (2%)
Query: 417 SITVIHLSSKNL-TGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
I +I++ NL T + + L K+ L L N L G +P F L ++L NQ+
Sbjct: 306 KIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQI 365
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 511
T + + L +N L +P+ +K+
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKS 400
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 7e-16
Identities = 15/111 (13%), Positives = 32/111 (28%), Gaps = 8/111 (7%)
Query: 401 LPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-F 459
PV S + + ++ L G +P+ L L L N +T +
Sbjct: 320 FPVETSLQKM-----KKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFC 373
Query: 460 SGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
+ + N+L P ++ + + N + +
Sbjct: 374 GFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-15
Identities = 25/119 (21%), Positives = 40/119 (33%), Gaps = 14/119 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG--------PIPDFSGCPDLRI 467
+++ I+LS+ ++ + S L + L GN LT +F L
Sbjct: 433 INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTS 492
Query: 468 IHLEDNQLTGPLPSSLM--NLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINL 522
I L N+LT L LP L + + N S P+ S +
Sbjct: 493 IDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDA 549
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 7e-15
Identities = 25/116 (21%), Positives = 42/116 (36%), Gaps = 10/116 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED- 472
+T I L LT + D T L LV + L NS + L+ + +
Sbjct: 488 YLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQ 546
Query: 473 -----NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523
N+ P + P+L +L + +N + V + VL+ N N+
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPNISVLDIKDNPNIS 601
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-14
Identities = 19/115 (16%), Positives = 39/115 (33%), Gaps = 13/115 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEL------WLDGNSLTGPIPD-FSGCPDLRII 468
P + I LS + + P+ S+L GN P+ + CP L +
Sbjct: 513 PYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQL 571
Query: 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNIN 521
+ N + + + PN+ L +++N S + + + +
Sbjct: 572 QIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-14
Identities = 12/104 (11%), Positives = 32/104 (30%), Gaps = 10/104 (9%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED 472
+ + L L ++ + +P P++++I++
Sbjct: 223 ICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVAC 282
Query: 473 NQLT--------GPLPSSLMNLPNLRELYVQNNML-SGTVPSSL 507
N+ + ++ +Y+ N L + V +SL
Sbjct: 283 NRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSL 326
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 9e-14
Identities = 16/128 (12%), Positives = 36/128 (28%), Gaps = 22/128 (17%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP------------------- 457
T I S N+T + + +L+ L + ++ +
Sbjct: 184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED 242
Query: 458 -DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
+ DL + + + LP+ L LP ++ + V N + +
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS-GEQLKDDWQALADA 301
Query: 517 AGNINLHE 524
+
Sbjct: 302 PVGEKIQI 309
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-13
Identities = 21/163 (12%), Positives = 52/163 (31%), Gaps = 19/163 (11%)
Query: 376 DGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ--CNSDPQPSITV--------IHLSS 425
D +A+ + + +W+Q+G W++ + QP +++ + L
Sbjct: 31 DYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEG 90
Query: 426 KNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-----SGCPDLRIIHLEDNQLTGPLP 480
+G +P + +L+ L L L + F S
Sbjct: 91 FGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFV 150
Query: 481 SSLM--NLPNLRELYVQNNMLSGTVPSS--LLSKNVVLNYAGN 519
+ +L + + ++ ++ S + K+ + N
Sbjct: 151 DYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSN 193
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-13
Identities = 13/92 (14%), Positives = 27/92 (29%), Gaps = 4/92 (4%)
Query: 421 IHLSSKNLTGNIPSDLTKL--SSLVELWLDGNSLTGPIPDFSG-CPDLRIIHLEDNQLTG 477
+ + S L++ ++ + I S I N +T
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197
Query: 478 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
+ ++M L LR+ Y+ N+
Sbjct: 198 -VSKAVMRLTKLRQFYMGNSPFVAENICEAWE 228
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-13
Identities = 15/102 (14%), Positives = 31/102 (30%), Gaps = 11/102 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 472
+ ++L+ +T + + L N L IP+ + I
Sbjct: 353 IKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSY 411
Query: 473 NQLTG-------PLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
N++ PL + N+ + + NN +S
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELF 453
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 17/124 (13%), Positives = 37/124 (29%), Gaps = 21/124 (16%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 476
+ ++S +I ++ N++T LR ++ ++
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219
Query: 477 GP-------------------LPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLN 515
NL +L ++ V N +P+ L L + ++N
Sbjct: 220 AENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLIN 279
Query: 516 YAGN 519
A N
Sbjct: 280 VACN 283
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-12
Identities = 18/109 (16%), Positives = 37/109 (33%), Gaps = 11/109 (10%)
Query: 416 PSITVIHLSSKNLTGNIPS--DLTKLSSLVELWLDGNSLTGPI--------PDFSGCPDL 465
+ + + L IP+ D +S + + N + P ++
Sbjct: 377 EQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435
Query: 466 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 514
I+L +NQ++ L + + NML+ +SL +N
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 5e-08
Identities = 14/113 (12%), Positives = 32/113 (28%), Gaps = 10/113 (8%)
Query: 416 PSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIPDFSG---CPDLRII 468
+ V+ L S N P ++ S + D+ DL
Sbjct: 105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKD 164
Query: 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
+ + + S ++ +N ++ V ++ L+K +
Sbjct: 165 CINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNS 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 6e-18
Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 23/204 (11%)
Query: 608 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQF 662
KIG G +GVVY + G+ A+K + + E T E+++L + H N+V+
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELKHSNIVKL 65
Query: 663 LGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
+ R VLV+E + L + G L +++ +L GI Y H
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL------LNGIAYCHDR 119
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI- 778
++HRDLK N+L+++ K++DFGL++ F + + IV T+ Y P+ +
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMG 174
Query: 779 SQQLTDKSDVYSFGVILLELISGQ 802
S++ + D++S G I E+++G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 661
+ IG G + V +LK I A+KV+ + T +H LV
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 662 FLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
L C Q E R V E+++ G L H+ L E+ R AE + + YLH
Sbjct: 75 -LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-EEHA----RFYSAE-ISLALNYLH 127
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778
II+RDLK N+LLD K++D+G+ K + S+ GT Y+ PE +
Sbjct: 128 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPE-IL 182
Query: 779 SQQLTDKS-DVYSFGVILLELISGQ 802
+ S D ++ GV++ E+++G+
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 30/210 (14%)
Query: 608 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGK-----REFTNEVTLLSRIHHRNLVQ 661
K+G+G + VY G K A+K + +S +G RE ++L+ + H N+V+
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKHENIVR 67
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEH-LYGTLTHEQRINWIKRLEIAEDAA------KGI 714
E + LV+EFM ++ L + N + LE+ +G+
Sbjct: 68 LYDVIHTENKLTLVFEFM------DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLD 773
+ H I+HRDLK N+L++K + K+ DFGL++ F + + S +V T+ Y
Sbjct: 122 AFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYRA 176
Query: 774 PEYYI-SQQLTDKSDVYSFGVILLELISGQ 802
P+ + S+ + D++S G IL E+I+G+
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 7e-18
Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 661
+G G FG V + K E+ AVK+L + + + L L Q
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 662 FLGYC-QEEGRSVLVYEFMHNGTLKEHLYGT-LTHEQRINWIKRLEIAEDAAKGIEYLHT 719
L C Q R V E+++ G L H+ E AE A G+ +L +
Sbjct: 407 -LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA----VFYAAE-IAIGLFFLQS 460
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
II+RDLK N++LD K++DFG+ K + + GT Y+ PE I+
Sbjct: 461 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPE-IIA 515
Query: 780 QQLTDKS-DVYSFGVILLELISGQ 802
Q KS D ++FGV+L E+++GQ
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 57/235 (24%), Positives = 98/235 (41%), Gaps = 49/235 (20%)
Query: 598 IEDATKMLEKKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNSYQGKREFTN--EVTLLS 652
+ED + K+G G +G VY K KD K+ A+K + + E+ LL
Sbjct: 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLR 73
Query: 653 RIHHRNLVQFLGYCQEEG-RSV-LVYEFMHNGTLKEH-LYGTL-THEQRINWIKRLEIAE 708
+ H N++ R V L++++ EH L+ + H K +++
Sbjct: 74 ELKHPNVISLQKVFLSHADRKVWLLFDYA------EHDLWHIIKFHRASKANKKPVQLPR 127
Query: 709 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKF--- 753
K GI YLH ++HRDLK +NIL+ + R K++D G ++
Sbjct: 128 GMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 754 AVDGASHVSSIVRGTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISGQ 802
+ + + +V T Y PE +Y T D+++ G I EL++ +
Sbjct: 185 PLKPLADLDPVVV-TFWYRAPELLLGARHY-----TKAIDIWAIGCIFAELLTSE 233
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 26/236 (11%)
Query: 576 QRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT 634
+ + +A+ L D + L + IG G + V +LK I A++V+
Sbjct: 32 EEKEAMNTRESGKASSSLGLQDFD-----LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVK 86
Query: 635 SNSYQGKREFTNEVT----LLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY 689
+ T +H LV L C Q E R V E+++ G L H+
Sbjct: 87 KELVNDDEDIDWVQTEKHVFEQASNHPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQ 145
Query: 690 --GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 747
L E+ R AE + + YLH II+RDLK N+LLD K++D
Sbjct: 146 RQRKLP-EEHA----RFYSAE-ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 196
Query: 748 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
+G+ K + S+ GT Y+ PE + + S D ++ GV++ E+++G+
Sbjct: 197 YGMCKEGLRPGDTTSTFC-GTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 35/212 (16%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF---TNEVT--------LLSRI 654
+G G FG V + K E+ AVK+L K++ ++V L
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKIL-------KKDVVIQDDDVECTMVEKRVLALPG 78
Query: 655 HHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAA 711
L Q L C Q R V E+++ G L H+ G E AE A
Sbjct: 79 KPPFLTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-EPHA----VFYAAE-IA 131
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
G+ +L + II+RDLK N++LD K++DFG+ K + + GT Y
Sbjct: 132 IGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDY 187
Query: 772 LDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
+ PE I+ Q KS D ++FGV+L E+++GQ
Sbjct: 188 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 608 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 661
KIG G +G V+ K ++ EI A+K + + E + E+ LL + H+N+V+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVR 65
Query: 662 FLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
+ + LV+EF + G L E +++ +L KG+ + H+
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL------LKGLGFCHS 119
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 778
++HRDLK N+L++++ K+++FGL++ F + + + +V T+ Y P+
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLF 174
Query: 779 -SQQLTDKSDVYSFGVILLELISGQEAI 805
++ + D++S G I EL + +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 661
K +G G FG V+ + K + A+K L + + + L H L
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 662 FLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+ Q + V E+++ G L H+ + AE G+++LH
Sbjct: 83 -MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-----TFYAAE-IILGLQFLH 135
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778
+ I++RDLK NILLDK K++DFG+ K + G + ++ GT Y+ PE +
Sbjct: 136 SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE-IL 190
Query: 779 SQQLTDKS-DVYSFGVILLELISGQ 802
Q + S D +SFGV+L E++ GQ
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 6e-17
Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLV 660
+G G F VY + + +A+K + ++ T E+ LL + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 661 QFLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
L + LV++FM + + LT ++ +G+EYLH
Sbjct: 76 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT------LQGLEYLH 129
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEY- 776
I+HRDLK +N+LLD++ K++DFGL+K F ++ +V T Y PE
Sbjct: 130 QHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV--TRWYRAPELL 184
Query: 777 YISQQLTDKSDVYSFGVILLELISGQ 802
+ ++ D+++ G IL EL+
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 24/157 (15%)
Query: 608 KIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFTN--EVTLLSRIHHRNLVQFL 663
KIG G FG V+ + + + A+K VL N +G T E+ +L + H N+V +
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQLLKHENVVNLI 82
Query: 664 GYCQEEGRSV--------LVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713
C+ + LV++F + L ++ T + ++ L G
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML------LNG 136
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750
+ Y+H I+HRD+K++N+L+ + K++DFGL
Sbjct: 137 LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 49/206 (23%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 607 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGK-----REFTNEVTLLSRIHHRNLV 660
K+G G + VY GK K +A+K + +G RE V+LL + H N+V
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKHANIV 63
Query: 661 QFLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
E LV+E++ + + ++ +L +G+ Y H
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL------LRGLAYCH 117
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYY 777
++HRDLK N+L+++ K++DFGL++ ++ ++ + +V T+ Y P+
Sbjct: 118 RQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDIL 172
Query: 778 I-SQQLTDKSDVYSFGVILLELISGQ 802
+ S + + D++ G I E+ +G+
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 51/227 (22%), Positives = 82/227 (36%), Gaps = 66/227 (29%)
Query: 596 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSR 653
+ I D K+ + +G G G V K ++ A+K+L EV L R
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWR 66
Query: 654 I-HHRNLVQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA- 707
++V+ + + +V E + G L RI R + A
Sbjct: 67 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS----------RI--QDRGDQAF 114
Query: 708 --EDAA-------KGIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFA 754
+A+ + I+YLH+ I HRD+K N+L + K++DFG +K
Sbjct: 115 TEREASEIMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-- 168
Query: 755 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
G Y D D++S GVI+ L+ G
Sbjct: 169 ---------ETTGE-KY-DKS----------CDMWSLGVIMYILLCG 194
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 2e-16
Identities = 60/272 (22%), Positives = 95/272 (34%), Gaps = 83/272 (30%)
Query: 605 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQG-KREFTNEVTLLSRI-HH 656
L K +G G FG V + +AVK+L + R +E+ +L I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 657 RN--------------------------LVQFL-------------GYCQEEGRSVLVYE 677
N L +L G +G+ +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 678 FMH----------------NGTLKEHLYGTLTHEQRINWIKR--------LEIAEDAAKG 713
+ +G ++E + E+ + + + + AKG
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
+E+L + IHRDL + NILL + K+ DFGL++ VR L
Sbjct: 206 MEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PDYVRKGDARLP 258
Query: 774 -----PEYYISQQLTDKSDVYSFGVILLELIS 800
PE + T +SDV+SFGV+L E+ S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-16
Identities = 26/109 (23%), Positives = 43/109 (39%), Gaps = 5/109 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
P + V++L L+ ++L EL L NS+ + F +L + L N
Sbjct: 73 PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL----LSKNVVLNYAGN 519
L+ + + L NL+EL + NN + L S L + N
Sbjct: 133 LSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-16
Identities = 25/107 (23%), Positives = 41/107 (38%), Gaps = 3/107 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
+T + + ++ P KL L L L N L+ F+ C +L +HL N
Sbjct: 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
+ + + NL L + +N LS T + L L + N
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-16
Identities = 19/97 (19%), Positives = 35/97 (36%), Gaps = 3/97 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 472
++ + LS L+ +L +L EL L N + + L+ + L
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
NQ+ P + L L++ N L ++ L
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCL 217
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-15
Identities = 20/112 (17%), Positives = 45/112 (40%), Gaps = 6/112 (5%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLE 471
+ +++L+ ++ + L L L L N + + + G ++ I+L
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438
Query: 472 DNQLTGPLPSSLMNLPNLRELYVQNNMLSG--TVPSSL--LSKNVVLNYAGN 519
N+ +S +P+L+ L ++ L + PS L +L+ + N
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-15
Identities = 26/116 (22%), Positives = 40/116 (34%), Gaps = 12/116 (10%)
Query: 416 PSITVIHLSSKNLT--------GNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLR 466
+ ++ L NL G L LS L L L+ N + F +L+
Sbjct: 504 EKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563
Query: 467 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 519
II L N L S N +L+ L +Q N+++ L+ N
Sbjct: 564 IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-15
Identities = 25/100 (25%), Positives = 40/100 (40%), Gaps = 8/100 (8%)
Query: 409 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRI 467
+C S V S LT +P DL +++ L L N L +F+ L
Sbjct: 1 KCTV----SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTS 53
Query: 468 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
+ + N ++ P LP L+ L +Q+N LS +
Sbjct: 54 LDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTF 93
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-15
Identities = 24/112 (21%), Positives = 39/112 (34%), Gaps = 4/112 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 472
+I I+LS + + SL L L +L F +L I+ L +
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524
N + L L L L +Q+N L+ + + G +LH
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLA-RLWKHANPGGPIYFLKGLSHLHI 540
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-14
Identities = 15/106 (14%), Positives = 36/106 (33%), Gaps = 5/106 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG---PIPDFSGCP--DLRIIHL 470
+ +++ ++ G + T L +L L L + + F L I++L
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388
Query: 471 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
N+++ + L +L L + N + + +
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFE 434
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-13
Identities = 27/104 (25%), Positives = 43/104 (41%), Gaps = 3/104 (2%)
Query: 410 CNSDPQPSITVIHLSSKNLTGNIPSDLT--KLSSLVELWLDGNSLTGPIPD-FSGCPDLR 466
C SI + LS+ L+ + K ++L L L N+L D F+ P L
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLE 275
Query: 467 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
LE N + SL L N+R L ++ + ++ + L K
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPK 319
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-13
Identities = 20/100 (20%), Positives = 38/100 (38%), Gaps = 6/100 (6%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD----FSGCPDLRIIH 469
S+ + LSS + P + L L+L+ L + + +R +
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLS 228
Query: 470 LEDNQLTGPLPSSLMNL--PNLRELYVQNNMLSGTVPSSL 507
L ++QL+ ++ + L NL L + N L+ S
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-13
Identities = 20/110 (18%), Positives = 38/110 (34%), Gaps = 10/110 (9%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD----------FSGCPDL 465
P + L N+ L L ++ L L + I F L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
Query: 466 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 515
+++EDN + G + L NL+ L + N+ S ++ ++ +
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 15/69 (21%), Positives = 24/69 (34%), Gaps = 2/69 (2%)
Query: 441 SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 500
S LT +PD ++ +++L NQL ++ L L V N +S
Sbjct: 5 SHEVADCSHLKLTQ-VPDDLP-TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 501 GTVPSSLLS 509
P
Sbjct: 63 KLEPELCQK 71
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 662
K IGSG G+V + +A+K L+ N KR + E+ L+ ++H+N++
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 89
Query: 663 L-----GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
L EE + V +V E M L + + L HE+ + ++ GI++
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQM------LCGIKH 142
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
LH+ + IHRDLK SNI++ K+ DFGL++ A +V T Y PE
Sbjct: 143 LHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEV 197
Query: 777 YISQQLTDKSDVYSFGVILLELISGQ 802
+ + D++S G I+ E+I G
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 47/254 (18%), Positives = 94/254 (37%), Gaps = 65/254 (25%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN-EVTLLSRI 654
+ L K +G+G FG+V + GK A+K + + + N E+ ++ +
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVL 57
Query: 655 HHRNLVQFLGYCQEEGRSV--------------------------------------LVY 676
H N+++ + Y G ++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE------DAAKGIEYLHTGCVPAIIHRDL 730
E++ + L+ L R + + + + + ++H+ I HRD+
Sbjct: 118 EYV-----PDTLHKVLKSFIRSG--RSIPMNLISIYIYQLFRAVGFIHSL---GICHRDI 167
Query: 731 KSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDV 788
K N+L++ K+ DFG +K + V+ I + Y PE + + + T D+
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDL 225
Query: 789 YSFGVILLELISGQ 802
+S G + ELI G+
Sbjct: 226 WSIGCVFGELILGK 239
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 50/210 (23%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 608 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 661
K+G G +G VY + +A+K + + + E T EV+LL + HRN+++
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQHRNIIE 97
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
R L++E+ N LK+++ ++ +++ +L G+ + H+
Sbjct: 98 LKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL------INGVNFCHS 150
Query: 720 GCVPAIIHRDLKSSNILLDKHMRA-----KVSDFGLSK-FAVDGASHVSSIVRGTVGYLD 773
+HRDLK N+LL + K+ DFGL++ F + I+ T+ Y
Sbjct: 151 ---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TLWYRP 205
Query: 774 PEYYI-SQQLTDKSDVYSFGVILLELISGQ 802
PE + S+ + D++S I E++
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 1e-15
Identities = 22/116 (18%), Positives = 37/116 (31%), Gaps = 13/116 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI----------PDFSGCPDL 465
+T + L + +P L L L L + N D P +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
Query: 466 RIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPS-SLLSKNVVLNYAGN 519
+I ++ N L P +SL + L L +N + + + K L N
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYN 605
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 19/113 (16%), Positives = 34/113 (30%), Gaps = 10/113 (8%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED 472
+ N + L L ++ L +PD P+L+ +++
Sbjct: 465 IAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC 524
Query: 473 NQLTGP---------LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
N+ L P ++ Y+ N L S+ L K V L
Sbjct: 525 NRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGL 577
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 3e-14
Identities = 23/120 (19%), Positives = 38/120 (31%), Gaps = 16/120 (13%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---------FSGCPDLRI 467
+ + + LS + S + + L N +T IP+ + L
Sbjct: 674 NASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS-IPENSLKPKDGNYKNTYLLTT 732
Query: 468 IHLEDNQLTGPLPSSLM--NLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLH 523
I L N+LT L LP L + V N S + P+ S+ +
Sbjct: 733 IDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAE 790
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 4e-14
Identities = 24/117 (20%), Positives = 44/117 (37%), Gaps = 12/117 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLE- 471
+T I L LT + D T L L + + N + P L+ +
Sbjct: 728 YLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRH 785
Query: 472 -----DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523
N++ P+ + P+L +L + +N + V L + +L+ A N N+
Sbjct: 786 QRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLYILDIADNPNIS 841
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 4e-13
Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 5/98 (5%)
Query: 416 PSITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 474
P I + ++ NL + L K+ L L N + + F L + L+ NQ
Sbjct: 548 PKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTDLKLDYNQ 606
Query: 475 LTGPLPSSLM-NLPNLRELYVQNNMLSGTVPSSLLSKN 511
+ +P + L +N L +P+ +K+
Sbjct: 607 IEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKS 642
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 17/110 (15%), Positives = 30/110 (27%), Gaps = 20/110 (18%)
Query: 422 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--------------------FSG 461
+ N I + +L+ L ++ + T +S
Sbjct: 430 IGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSN 489
Query: 462 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 511
DL + L + LP L +LP L+ L + N
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR 539
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 5e-12
Identities = 21/115 (18%), Positives = 39/115 (33%), Gaps = 15/115 (13%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEL------WLDGNSLTGPIPD-FSGCPDLRII 468
P ++ + +S + P+ S L +GN + P + CP L +
Sbjct: 753 PYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811
Query: 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS----GTVPSSLLSKNVVLNYAGN 519
+ N + + L P L L + +N +V + + VL Y
Sbjct: 812 QIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 5e-11
Identities = 13/102 (12%), Positives = 33/102 (32%), Gaps = 10/102 (9%)
Query: 416 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTGPIPDFSGCPD------LRI 467
+ + S L IP+ + + + N + + S D
Sbjct: 619 DQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST 677
Query: 468 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
+ L N++ + + + NN+++ ++P + L
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLK 718
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 9e-10
Identities = 20/118 (16%), Positives = 35/118 (29%), Gaps = 21/118 (17%)
Query: 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP---- 478
++ I D ++ N +T L+II+ ++ T
Sbjct: 408 INRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV 467
Query: 479 ---------------LPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
S NL +L ++ + N +P L L + LN A N
Sbjct: 468 DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 13/120 (10%), Positives = 38/120 (31%), Gaps = 4/120 (3%)
Query: 398 DPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP 457
+ + + ++ +T + L+ G +P + +L+ L L +S T
Sbjct: 307 ELDMWGDQPGVDLDN--NGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGR 364
Query: 458 DFSG-CPDLRIIHLEDNQLTGPLPS-SLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 515
F + +++ L L + + ++ + K+ ++
Sbjct: 365 LFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRIS 424
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 17/122 (13%), Positives = 41/122 (33%), Gaps = 11/122 (9%)
Query: 412 SDPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHL 470
D + + + + + L L L +++ P+ I L
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKPIKKDSRISL 425
Query: 471 ED-------NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523
+D N++T + ++ L L+ +Y N+ + ++ ++ +YA
Sbjct: 426 KDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTY-DNIAVDWEDANSDYAKQYENE 483
Query: 524 EG 525
E
Sbjct: 484 EL 485
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 9/62 (14%), Positives = 22/62 (35%), Gaps = 3/62 (4%)
Query: 465 LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS---LLSKNVVLNYAGNIN 521
+ + L G +P ++ L L+ L + + + L+ ++ I
Sbjct: 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIR 384
Query: 522 LH 523
+H
Sbjct: 385 MH 386
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 3e-15
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 662
K IGSG G+V + +A+K L+ N KR + E+ L+ ++H+N++
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 126
Query: 663 L-----GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
L EE + V LV E M L + + L HE+ + ++ GI++
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQM------LCGIKH 179
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
LH+ + IHRDLK SNI++ K+ DFGL++ + ++ V T Y PE
Sbjct: 180 LHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYV-VTRYYRAPEV 234
Query: 777 YISQQLTDKSDVYSFGVILLELISGQ 802
+ + D++S G I+ E++ +
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-15
Identities = 18/108 (16%), Positives = 34/108 (31%), Gaps = 4/108 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 473
S+ + ++ + N S+ ++L L L L F L+++++ N
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
L S L +L L N + + N N
Sbjct: 508 NLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 15/101 (14%), Positives = 30/101 (29%), Gaps = 3/101 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDN 473
S+ + LS + ++ L L L ++L F L + +
Sbjct: 376 NSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 514
+ L +L L + N S++ + L
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL 475
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-14
Identities = 20/96 (20%), Positives = 33/96 (34%), Gaps = 1/96 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
+ + LS + L L L L GN + P FSG L + + +
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
L + L L++L V +N + + S
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-14
Identities = 18/99 (18%), Positives = 32/99 (32%), Gaps = 4/99 (4%)
Query: 410 CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRII 468
+ L+ +P D+ SS + L N L FS +L+ +
Sbjct: 5 NPCIEVVPNITYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWL 61
Query: 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
L ++ + L +L L + N + P S
Sbjct: 62 DLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSF 100
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-13
Identities = 14/86 (16%), Positives = 28/86 (32%), Gaps = 1/86 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
++T + LS L L L L + N+L ++ L + N+
Sbjct: 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLS 500
+ +L + NN ++
Sbjct: 533 IETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-11
Identities = 21/116 (18%), Positives = 37/116 (31%), Gaps = 7/116 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPD-FSGCPDLRIIHLEDN 473
S+ + L + +L +L +L + N + +P FS +L + L N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163
Query: 474 QLTGPLPSSLMNLPNLR----ELYVQNNMLSGTVPSSL-LSKNVVLNYAGNINLHE 524
+ + L L L + N + + K L GN N
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSN 219
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-11
Identities = 24/109 (22%), Positives = 40/109 (36%), Gaps = 5/109 (4%)
Query: 416 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 473
PS++ + LS L+ G +SL L L N +F G +L+ + + +
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHS 409
Query: 474 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
L S+ ++L L L + L+ L AGN
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-10
Identities = 20/106 (18%), Positives = 39/106 (36%), Gaps = 4/106 (3%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 473
+I L+ N + L+++ + L G S+ + D + + +
Sbjct: 259 CDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRC 317
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
QL P+ +LP L+ L + N S + L L+ + N
Sbjct: 318 QLKQ-FPTL--DLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRN 360
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 5e-07
Identities = 20/108 (18%), Positives = 35/108 (32%), Gaps = 9/108 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + L DL L L L N + P L + L N L
Sbjct: 307 FKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKGSI-SFKKVALPSLSYLDLSRNAL 362
Query: 476 T--GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
+ G S + +LR L + N + ++ L + L++ +
Sbjct: 363 SFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHS 409
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 14/114 (12%), Positives = 24/114 (21%), Gaps = 10/114 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTG-------PIPDFSGCPDLRI 467
+ + L + NI L L+ L L G D+ I
Sbjct: 204 IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTI 263
Query: 468 IHLED--NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
L N+ + + + K L+
Sbjct: 264 DEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRC 317
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 14/102 (13%), Positives = 30/102 (29%), Gaps = 5/102 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLS----SLVELWLDGNSLTGPIPDFSGCPDLRIIHLE 471
++ + LS + +DL L + L + N + L + L
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR 212
Query: 472 DNQLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNV 512
N + + + L NL L + + ++
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 48/233 (20%), Positives = 87/233 (37%), Gaps = 62/233 (26%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVK--VLTSNSYQGKREFTN---------EVTLLSR 653
+++ I SG +G V G +G +A+K T + + ++ E+ LL+
Sbjct: 26 VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85
Query: 654 IHHRNLVQ----FLGYCQEEGRSV-LVYEFM----------HNGTLKEH-----LYGTLT 693
HH N++ F+ + + + LV E M + +Y L
Sbjct: 86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHIL- 144
Query: 694 HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753
G+ LH V +HRDL NILL + + DF L++
Sbjct: 145 ------------------LGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLARE 183
Query: 754 AVDGAS---HVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
A+ +V+ Y PE + + K D++S G ++ E+ + +
Sbjct: 184 DTADANKTHYVT-----HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 6e-15
Identities = 14/98 (14%), Positives = 31/98 (31%), Gaps = 5/98 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 472
S+ + LS + + S+ L L L ++L + + F +L + +
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISH 430
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
L +L L + N + ++
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-14
Identities = 26/110 (23%), Positives = 45/110 (40%), Gaps = 6/110 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
++ + +S + LSSL L + GNS F+ +L + L
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523
QL P++ +L +L+ L + +N L +VP + + L I LH
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQK---IWLH 526
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-12
Identities = 19/97 (19%), Positives = 33/97 (34%), Gaps = 5/97 (5%)
Query: 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTG 477
N IP +L S L L N L F P+L+++ L ++
Sbjct: 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 478 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 514
+ +L +L L + N + ++ S L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSL 102
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 21/104 (20%), Positives = 37/104 (35%), Gaps = 4/104 (3%)
Query: 416 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 473
PS+ + LS L+ G +SL L L N + +F G L + + +
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406
Query: 474 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
L S ++L NL L + + + + + L
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEV 449
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 19/89 (21%), Positives = 39/89 (43%), Gaps = 2/89 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 473
S+ V+ ++ + N D T+L +L L L L P F+ L+++++ N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGT 502
QL L +L+++++ N +
Sbjct: 505 QLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 20/115 (17%), Positives = 40/115 (34%), Gaps = 8/115 (6%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLE 471
++ + L+ + + LSSL +L +L L+ +++
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132
Query: 472 DNQLT-GPLPSSLMNLPNLRELYVQNNMLSGTVP------SSLLSKNVVLNYAGN 519
N + LP NL NL L + +N + + N+ L+ + N
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 22/86 (25%), Positives = 36/86 (41%), Gaps = 1/86 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 474
P + V+ LS + LS L L L GN + + FSG L+ + +
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLS 500
L + +L L+EL V +N++
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 21/111 (18%), Positives = 39/111 (35%), Gaps = 7/111 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT-GPIPD-FSGCPDLRIIHLEDN 473
S+ + NL + L +L EL + N + +P+ FS +L + L N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 474 QLTGPLPSSLMNLPNLR----ELYVQNNMLSGTVPSSLLSKN-VVLNYAGN 519
++ + L L + L + N ++ P + L N
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 20/73 (27%), Positives = 29/73 (39%), Gaps = 3/73 (4%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGC 462
++L ++T + LS L P+ LSSL L + N L +PD F
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS-VPDGIFDRL 517
Query: 463 PDLRIIHLEDNQL 475
L+ I L N
Sbjct: 518 TSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 17/107 (15%), Positives = 38/107 (35%), Gaps = 5/107 (4%)
Query: 414 PQPSITVIHLSSKNLTGN-IPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 472
+I L+ + + I L+++ L ++ + DFS + + L +
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVN 313
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ P+ + L +L+ L +N L L+ + N
Sbjct: 314 CKFGQ-FPT--LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRN 357
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-15
Identities = 20/96 (20%), Positives = 33/96 (34%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 473
+ S+ I+L + S L EL L L+ G L+ + L N
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSAN 311
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
+ S N P+L L ++ N + + L
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLE 347
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 8e-15
Identities = 23/109 (21%), Positives = 40/109 (36%), Gaps = 5/109 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD----FSGCPDLRIIHLE 471
+ V++LS L + L +L L L GN L I+ L
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484
Query: 472 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGN 519
L+ + +L + + + +N L+ + +L K + LN A N
Sbjct: 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASN 533
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-14
Identities = 20/107 (18%), Positives = 32/107 (29%), Gaps = 3/107 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
S + S L + ++L +L L L + D F L + L N
Sbjct: 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
L ++L L+ L+ +S L L N
Sbjct: 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN 139
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-14
Identities = 19/109 (17%), Positives = 37/109 (33%), Gaps = 5/109 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
+ + L++ L + L+ +L L+ ++ L ++L N
Sbjct: 81 HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH 140
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS----KNVVLNYAGN 519
++ L+ L QNN + + S N+ LN GN
Sbjct: 141 ISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 6e-14
Identities = 21/123 (17%), Positives = 45/123 (36%), Gaps = 4/123 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
++ + ++ L +L L+L N ++ L+++ ++N
Sbjct: 105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164
Query: 475 LTGPLPSSLMNLPNLR--ELYVQNNMLSGTVPSSLLSKNV-VLNYAGNINLHEGGRGAKH 531
+ + +L L + N ++G P + S LN+ G NL +G K+
Sbjct: 165 IHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKN 224
Query: 532 LNI 534
I
Sbjct: 225 STI 227
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-14
Identities = 16/94 (17%), Positives = 27/94 (28%), Gaps = 2/94 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
+ ++LS + L L L L F L++++L +
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
L LP L+ L +Q N
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-13
Identities = 18/99 (18%), Positives = 30/99 (30%), Gaps = 4/99 (4%)
Query: 410 CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRII 468
+ + + L IP L +S L N L FS +L +
Sbjct: 6 QKCIEKEVNKTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFL 62
Query: 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
L Q+ + + L L + N L ++L
Sbjct: 63 DLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETAL 101
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-12
Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 4/105 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLE 471
PS+T + + + + L L +L EL L + + L+ ++L
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 472 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
N+ + P L L + L S +L
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-11
Identities = 21/88 (23%), Positives = 37/88 (42%), Gaps = 2/88 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
+ ++ LS +L+ T L + + L N LT + S + + +L N
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYL-NLASNH 534
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGT 502
++ LPS L L R + ++ N L T
Sbjct: 535 ISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-09
Identities = 21/121 (17%), Positives = 41/121 (33%), Gaps = 8/121 (6%)
Query: 406 SWLQCNSDPQPSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPD-FSGC 462
+ ++ + ++ I L + + SL + P F G
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 463 PD--LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAG 518
+ + I+L+ + ++ L+EL + LS +PS L LS L +
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310
Query: 519 N 519
N
Sbjct: 311 N 311
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 32/210 (15%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 662
+GSG +G V + G+++A+K L+ + KR + E+ LL + H N++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGL 88
Query: 663 L-----GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
L LV FM L++ + + E+ + ++ KG++Y
Sbjct: 89 LDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQML------KGLKY 141
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YLD 773
+H+ ++HRDLK N+ +++ K+ DFGL A H + + G V Y
Sbjct: 142 IHSA---GVVHRDLKPGNLAVNEDCELKILDFGL-------ARHADAEMTGYVVTRWYRA 191
Query: 774 PEYYISQQLTDKS-DVYSFGVILLELISGQ 802
PE +S +++ D++S G I+ E+++G+
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 8e-15
Identities = 53/252 (21%), Positives = 92/252 (36%), Gaps = 68/252 (26%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 660
++ IG G +G VY K +A+K + + KR E+T+L+R+ ++
Sbjct: 30 IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL-REITILNRLKSDYII 88
Query: 661 Q----FLGYCQEEGRSV-LVYEFM---------HNGTLK-EH----LYGTLTHEQRINWI 701
+ + + + +V E L EH LY L
Sbjct: 89 RLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLL--------- 139
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASH 760
G ++H IIHRDLK +N LL++ KV DFGL+ + ++
Sbjct: 140 ----------LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 761 VSSIVRGTVGYLDPEYYISQQLTD--------------------KS-DVYSFGVILLELI 799
+ + + + +QLT KS D++S G I EL+
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 800 SGQEAISNEKFG 811
+ ++ N+
Sbjct: 247 NMLQSHINDPTN 258
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 9e-15
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 32/214 (14%)
Query: 608 KIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFTN----EVTLLSRIH---HRN 658
+IG G +G VY + G +A+K V N G EV LL R+ H N
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 659 LVQFL-----GYCQEEGRSVLVYEFMHN---GTLKEHLYGTLTHEQRINWIKRLEIAEDA 710
+V+ + E + LV+E + L + L E + +++
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF------ 129
Query: 711 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGA-SHVSSIVRGT 768
+G+++LH C I+HRDLK NIL+ K++DFGL++ ++ A + V +V T
Sbjct: 130 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV--VV--T 182
Query: 769 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
+ Y PE + D++S G I E+ +
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 55/229 (24%), Positives = 87/229 (37%), Gaps = 54/229 (23%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQ 661
L+ +G G +GVV G+ +A+K + R E+ +L H N++
Sbjct: 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKHENIIT 73
Query: 662 ----FLGYCQEEGRSV-LVYEFM--------HNGTLK-EH----LYGTLTHEQRINWIKR 703
E V ++ E M L +H +Y TL
Sbjct: 74 IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL----------- 122
Query: 704 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 763
+ ++ LH V IHRDLK SN+L++ + KV DFGL++ + A+ S
Sbjct: 123 --------RAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 764 IVRGTVG---------YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
G Y PE ++ ++ DV+S G IL EL +
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 14/97 (14%), Positives = 29/97 (29%), Gaps = 3/97 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHLEDN 473
S+ + LS + + S+ L L L ++L F +L + +
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
L +L L + N + ++
Sbjct: 137 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 25/104 (24%), Positives = 38/104 (36%), Gaps = 4/104 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG---PIPDFSGCPDLRIIHLED 472
S T + L S L KL+ L +L L N L+ G L+ + L
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
N + + S+ + L L L Q++ L S+ L Y
Sbjct: 88 NGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 130
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 19/97 (19%), Positives = 39/97 (40%), Gaps = 5/97 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
++ + +S + + LSSL L + GNS F+ +L + L
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
QL P++ +L +L+ L + +N ++ +
Sbjct: 185 CQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYK 220
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 5/97 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
S+ V+ ++ + N D T+L +L L L L + F+ L+++++
Sbjct: 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSH 208
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
N L +L+ L N + T L
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQ 244
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 20/97 (20%), Positives = 36/97 (37%), Gaps = 4/97 (4%)
Query: 416 PSITVIHLSSKNLT-GNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 473
+T + LSS L+ S +SL L L N + +F G L + + +
Sbjct: 52 TQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 111
Query: 474 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
L S ++L NL L + + + + +
Sbjct: 112 NLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFN 147
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 17/89 (19%), Positives = 33/89 (37%), Gaps = 6/89 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
++T + LS L + LSSL L + N+ + + L+++
Sbjct: 175 RNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSL 232
Query: 473 NQLTGPLPSSLMNLP-NLRELYVQNNMLS 500
N + L + P +L L + N +
Sbjct: 233 NHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 5e-14
Identities = 21/104 (20%), Positives = 44/104 (42%), Gaps = 3/104 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+T + + + ++ + + L+ L L + N ++ I + L + L +NQL
Sbjct: 243 SQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQL 299
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ L NL L++ N ++ P + LSK ++A
Sbjct: 300 GNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 5/107 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
SIT + ++ + + +I + L++L L L+GN +T I S L +++ N++
Sbjct: 44 ESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKI 100
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 522
T S+L NL NLRELY+ + +S P + L+K LN N NL
Sbjct: 101 TDI--SALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLGANHNL 145
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 5e-12
Identities = 18/86 (20%), Positives = 35/86 (40%), Gaps = 5/86 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
+ ++++ S ++ S L LS L L+L+ N L + G +L + L N
Sbjct: 265 TKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLS 500
+T L +L + N ++
Sbjct: 323 ITDI--RPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 8e-12
Identities = 22/104 (21%), Positives = 46/104 (44%), Gaps = 4/104 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+T +++ + +T S L L++L EL+L+ ++++ I + + ++L N
Sbjct: 88 VKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHN 144
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
S L N+ L L V + + P + L+ L+ N
Sbjct: 145 LS-DLSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYN 187
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 8e-12
Identities = 25/104 (24%), Positives = 41/104 (39%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + L+ + P L L+SL N +T I + L + + +N++
Sbjct: 177 TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKI 233
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
T S L NL L L + N +S L+K +LN N
Sbjct: 234 TDL--SPLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSN 275
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 1e-10
Identities = 21/104 (20%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + ++ + P + L+ L L L+ N + I + L NQ+
Sbjct: 155 TGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQI 211
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
T + + N+ L L + NN ++ P + LS+ L N
Sbjct: 212 TDI--TPVANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTN 253
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 1e-10
Identities = 15/86 (17%), Positives = 36/86 (41%), Gaps = 4/86 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ ++L+ N++ S L L+ + L L N + S L + + ++++
Sbjct: 110 TNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKV 167
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSG 501
+ + NL +L L + N +
Sbjct: 168 KD--VTPIANLTDLYSLSLNYNQIED 191
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 7e-08
Identities = 15/86 (17%), Positives = 28/86 (32%), Gaps = 3/86 (3%)
Query: 434 SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493
L+ + L S+T + + + + ++ + L NL L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVT-QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLN 72
Query: 494 VQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ N ++ P S L K L N
Sbjct: 73 LNGNQITDISPLSNLVKLTNLYIGTN 98
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 9e-14
Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 38/216 (17%)
Query: 608 KIGSGGFGVVYYGK-LKDGKEI-AVK-VLTSNSYQGK-----REFTNEVTLL---SRIHH 656
+IG G +G V+ + LK+G A+K V +G RE V +L H
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE----VAVLRHLETFEH 73
Query: 657 RNLVQFL-----GYCQEEGRSVLVYEFMHN---GTLKEHLYGTLTHEQRINWIKRLEIAE 708
N+V+ E + LV+E + L + + E + + +L
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL---- 129
Query: 709 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGA-SHVSSIVR 766
+G+++LH+ ++HRDLK NIL+ + K++DFGL++ ++ A + V +V
Sbjct: 130 --LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV--VV- 181
Query: 767 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
T+ Y PE + D++S G I E+ +
Sbjct: 182 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 49/221 (22%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQ-- 661
IG G +G+V + +A+K ++ + +R E+ +L R H N++
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGIN 91
Query: 662 --FLGYCQEEGRSV-LVYEFM--------HNGTL-KEH----LYGTLTHEQRINWIKRLE 705
E+ + V +V + M L +H LY L
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL------------- 138
Query: 706 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI- 764
+G++Y+H+ V +HRDLK SN+LL+ K+ DFGL++ A H +
Sbjct: 139 ------RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 765 --VRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
V T Y PE ++ + KS D++S G IL E++S +
Sbjct: 190 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 64/239 (26%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIH-HRNL 659
L KK+G G +G+V+ + G+ +AVK + NS +R F E+ +L+ + H N+
Sbjct: 13 LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENI 71
Query: 660 VQFLGYCQ-EEGRSV-LVYEFM--------HNGTLK-EH----LYGTLTHEQRINWIKRL 704
V L + + R V LV+++M L+ H +Y +
Sbjct: 72 VNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLI------------ 119
Query: 705 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764
K I+YLH+G + +HRD+K SNILL+ KV+DFGLS+ V+ ++I
Sbjct: 120 -------KVIKYLHSGGL---LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 765 VRGTVGYLDPEYYISQQLTD---------------------KSDVYSFGVILLELISGQ 802
+ LTD D++S G IL E++ G+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-13
Identities = 26/104 (25%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ + L+ L L L++L +L L N ++ + SG L + L NQ+
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQI 277
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ S L L L L + N L P S L L N
Sbjct: 278 SNI--SPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN 319
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 31/104 (29%), Positives = 50/104 (48%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++T + L++ ++ P L+ L+ L EL L N ++ I +G L + L +NQL
Sbjct: 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQL 299
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
S + NL NL L + N +S P S L+K L + N
Sbjct: 300 EDI--SPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNN 341
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-13
Identities = 17/106 (16%), Positives = 45/106 (42%), Gaps = 6/106 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++T + L N++ P ++ L+ L L+ N ++ + + ++ + NQ+
Sbjct: 309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQI 365
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 521
+ + L NL + +L + + + P + + + N N+
Sbjct: 366 SDL--TPLANLTRITQLGLNDQAWT-NAPVNYKANVSIPNTVKNVT 408
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-12
Identities = 25/104 (24%), Positives = 45/104 (43%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+T + L + ++ P L L++L L L+ N L I S +L + L N +
Sbjct: 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNI 321
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ P + +L L+ L+ NN +S + L+ L+ N
Sbjct: 322 SDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHN 363
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+T + + + L++L ++ N LT I L I + +NQ+
Sbjct: 46 DQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQI 102
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ L NL NL L + NN ++ P L+ L + N
Sbjct: 103 AD--ITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSN 144
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 24/104 (23%), Positives = 44/104 (42%), Gaps = 6/104 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
S+ + + +T P L L++L L + N ++ I + +L + +NQ+
Sbjct: 156 TSLQQLSFGN-QVTDLKP--LANLTTLERLDISSNKVSD-ISVLAKLTNLESLIATNNQI 211
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ + L L NL EL + N L + L+ L+ A N
Sbjct: 212 SDI--TPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANN 253
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 8e-11
Identities = 28/105 (26%), Positives = 50/105 (47%), Gaps = 5/105 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++T I+ S+ LT P L L+ LV++ ++ N + I + +L + L +NQ+
Sbjct: 68 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQI 124
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 520
T L NL NL L + +N +S S L+ L++ +
Sbjct: 125 TDI--DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQV 167
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 7e-10
Identities = 29/104 (27%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ + LSS ++ S L+ L+SL +L GN +T P + L + + N++
Sbjct: 134 TNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP-LANLTTLERLDISSNKV 189
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ S L L NL L NN +S P +L+ L+ GN
Sbjct: 190 SDI--SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGN 231
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 4e-09
Identities = 19/101 (18%), Positives = 38/101 (37%), Gaps = 7/101 (6%)
Query: 423 LSSKNLTGNIP----SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP 478
L S +T + P T L+ ++ L ++T + + + + + +
Sbjct: 3 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI 61
Query: 479 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ L NL ++ NN L+ P L+K V + N
Sbjct: 62 --DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNN 100
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 12/104 (11%), Positives = 30/104 (28%), Gaps = 3/104 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + + ++ S L L+++ L N ++ + + + + L D
Sbjct: 331 TKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQAW 387
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
T + N+ + L S + N
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWN 431
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 48/250 (19%), Positives = 90/250 (36%), Gaps = 73/250 (29%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 660
+ IG+G +G V + + +A+K + + KR E+ +L+R++H ++V
Sbjct: 57 IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-REIAILNRLNHDHVV 115
Query: 661 Q----FLGYCQEEGRSV-LVYEFMH---------NGTLK-EH----LYGTLTHEQRINWI 701
+ + E+ + +V E L H LY L
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLL--------- 166
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS------KFAV 755
G++Y+H+ + +HRDLK +N L+++ KV DFGL+ +
Sbjct: 167 ----------VGVKYVHSAGI---LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
Query: 756 DGASHVSSIVRGTVGYLDPEYYISQQLTD--------------------KS-DVYSFGVI 794
+ + +QLT ++ DV+S G I
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273
Query: 795 LLELISGQEA 804
EL++ +
Sbjct: 274 FAELLNMIKE 283
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 57/223 (25%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 662
+ +GSG +G V + G ++A+K L + KR + E+ LL + H N++
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHENVIGL 89
Query: 663 L-----GYCQEEGRSV-LVYEFM--------HNGTL-KEH----LYGTLTHEQRINWIKR 703
L ++ LV FM + L ++ +Y L
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML----------- 138
Query: 704 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 763
KG+ Y+H IIHRDLK N+ +++ K+ DFGL A S
Sbjct: 139 --------KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL-------ARQADS 180
Query: 764 IVRGTVG---YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
+ G V Y PE ++ ++ D++S G I+ E+I+G+
Sbjct: 181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 57/223 (25%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 662
+GSG +G V K G +AVK L+ + KR + E+ LL + H N++
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGL 93
Query: 663 L-----GYCQEEGRSV-LVYEFM--------HNGTLK-EH----LYGTLTHEQRINWIKR 703
L EE V LV M L +H +Y L
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----------- 142
Query: 704 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 763
+G++Y+H+ IIHRDLK SN+ +++ K+ DFGL A H +
Sbjct: 143 --------RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL-------ARHTAD 184
Query: 764 IVRGTVG---YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
+ G V Y PE ++ +++ D++S G I+ EL++G+
Sbjct: 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 19/86 (22%), Positives = 35/86 (40%), Gaps = 2/86 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 474
PS+ + L I L +L L L ++ +P+ + L + + N
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNH 229
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLS 500
P S L +L++L+V N+ +S
Sbjct: 230 FPEIRPGSFHGLSSLKKLWVMNSQVS 255
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 26/96 (27%), Positives = 41/96 (42%), Gaps = 4/96 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
+ ++L N+ L L L L NS+ I F+G L + L DN
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ-IEVGAFNGLASLNTLELFDN 133
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
LT + L LREL+++NN + ++PS +
Sbjct: 134 WLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFN 168
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 25/95 (26%), Positives = 49/95 (51%), Gaps = 4/95 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
++ ++L N+ ++P +LT L L EL + GN P F G L+ + + ++Q
Sbjct: 196 FNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
++ ++ L +L EL + +N LS ++P L +
Sbjct: 254 VSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFT 287
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 21/85 (24%), Positives = 33/85 (38%), Gaps = 5/85 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ V+ L ++ I L+SL L L N LT IP F LR + L +
Sbjct: 99 HHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRN 156
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNN 497
N + + +P+L L +
Sbjct: 157 NPIESIPSYAFNRVPSLMRLDLGEL 181
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 5/87 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ + +S + I LSSL +LW+ + ++ I F G L ++L
Sbjct: 218 VGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSL-IERNAFDGLASLVELNLAH 275
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNML 499
N L+ L L EL++ +N
Sbjct: 276 NNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 38/170 (22%), Positives = 65/170 (38%), Gaps = 30/170 (17%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQF 662
+ KKIG G FG + GK L + +A+K+ S + E ++ + Q
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR-------LEIAEDAAKGIE 715
+ + +V E + G E L+ + R L IA +E
Sbjct: 71 YYFGPCGKYNAMVLELL--GPSLEDLF---------DLCDRTFSLKTVLMIAIQLISRME 119
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVS-----DFGLSKFAVDGASH 760
Y+H+ +I+RD+K N L+ + DF L+K +D +
Sbjct: 120 YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 54/232 (23%), Positives = 97/232 (41%), Gaps = 58/232 (25%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHRNLVQF 662
K +G GG G+V+ K +A+K + ++ K E+ ++ R+ H N+V+
Sbjct: 15 DLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKV 73
Query: 663 L-------------GYCQEEGRSV-LVYEFM--------HNGTL-KEH----LYGTLTHE 695
E SV +V E+M G L +EH +Y L
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL--- 130
Query: 696 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFA 754
+G++Y+H+ V +HRDLK +N+ ++ + + K+ DFGL++
Sbjct: 131 ----------------RGLKYIHSANV---LHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 755 VDGASHVSSI---VRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 802
SH + + T Y P +S T D+++ G I E+++G+
Sbjct: 172 DPHYSHKGHLSEGL-VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 19/101 (18%), Positives = 37/101 (36%), Gaps = 3/101 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ ++L + ++ + + L L L N L P+F + I L +N+L
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
+ +L NL ++ N SKN +
Sbjct: 227 VL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT 266
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 19/86 (22%), Positives = 34/86 (39%), Gaps = 3/86 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
+ ++ +L + S ++ EL L GN L+ + L +++L N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLS 500
L L +L LR L + NN +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 18/107 (16%), Positives = 41/107 (38%), Gaps = 7/107 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
PSI +H ++ N++ + ++L N +T + D ++ + L+ N
Sbjct: 99 PSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLN 154
Query: 474 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
++ + L L +Q N + + +K L+ + N
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSN 201
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 5e-10
Identities = 15/82 (18%), Positives = 30/82 (36%), Gaps = 1/82 (1%)
Query: 439 LSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497
+ + +SL + +++ + L N L+ + L L L + +N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 498 MLSGTVPSSLLSKNVVLNYAGN 519
+L T+ LS L+ N
Sbjct: 69 VLYETLDLESLSTLRTLDLNNN 90
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 14/84 (16%), Positives = 32/84 (38%), Gaps = 4/84 (4%)
Query: 427 NLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMN 485
+L N +L S+ L N+++ G + I+L +N++T
Sbjct: 86 DLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQG---KKNIYLANNKITMLRDLDEGC 142
Query: 486 LPNLRELYVQNNMLSGTVPSSLLS 509
++ L ++ N + + L +
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAA 166
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 14/108 (12%), Positives = 28/108 (25%), Gaps = 2/108 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+T I L + L I L +L L GN + R+ + +
Sbjct: 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523
+ + +P+ + + L + L
Sbjct: 273 KKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHALLS 319
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 12/96 (12%), Positives = 22/96 (22%), Gaps = 3/96 (3%)
Query: 422 HLSSKNLTGNIPSDLTKL--SSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPL 479
++L L L L G+ + R I Q +
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVI 352
Query: 480 PSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 515
+ L + L S+ + L+
Sbjct: 353 DQVTLRKQAKITLEQKKKALD-EQVSNGRRAHAELD 387
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 46/246 (18%), Positives = 100/246 (40%), Gaps = 60/246 (24%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIH------- 655
+K+G G F V+ K + + +A+K++ + + E + LL R++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----IKLLQRVNDADNTKE 80
Query: 656 ----HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH-----------LYGTL--THEQRI 698
++++ L + F H G H L + + I
Sbjct: 81 DSMGANHILKLLDH------------FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 128
Query: 699 N--WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA------KVSDFGL 750
++K+ I++ G++Y+H C IIH D+K N+L++ K++D G
Sbjct: 129 PLIYVKQ--ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184
Query: 751 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810
+ + + H ++ ++ T Y PE + +D++S ++ ELI+G ++
Sbjct: 185 ACWYDE---HYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240
Query: 811 GANCRN 816
+ ++
Sbjct: 241 HSYTKD 246
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 25/188 (13%), Positives = 59/188 (31%), Gaps = 46/188 (24%)
Query: 605 LEKKIGSGGFGVVYYGK---------LKDGKEIAVKVLTSNS----------YQGKREFT 645
L+ G++Y ++ ++K+ + K
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 646 NEVTLLSRIHHRNLVQFLGYCQEEGR-SVLVYEFMHNGTLKEHLYGT-LTHEQRINWIKR 703
N+ L + +G+ + + LV G L + ++ +
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLP----------SLGRSL--QSALDVSPK 153
Query: 704 --------LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV--SDFGLSKF 753
L++A +E+LH +H ++ + NI +D +++V + +G +
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
Query: 754 AVDGASHV 761
HV
Sbjct: 211 YCPSGKHV 218
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 9e-13
Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 3/96 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ ++L + ++ + L L L N L P+F + I L +N+L
Sbjct: 169 DTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 511
+ +L NL ++ N SKN
Sbjct: 227 VL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 18/106 (16%), Positives = 40/106 (37%), Gaps = 5/106 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 474
PSI +H ++ N++ + ++L N +T D ++ + L+ N+
Sbjct: 99 PSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 475 LTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ + L L +Q N + + +K L+ + N
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSN 201
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 20/86 (23%), Positives = 35/86 (40%), Gaps = 3/86 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 474
+ ++ +L + S ++ EL L GN L+ D + L +++L N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLS 500
L L +L LR L + NN +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 16/89 (17%), Positives = 31/89 (34%), Gaps = 1/89 (1%)
Query: 432 IPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 490
I + + +SL + +++ + L N L+ + L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 491 ELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
L + +N+L T+ LS L+ N
Sbjct: 62 LLNLSSNVLYETLDLESLSTLRTLDLNNN 90
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 14/85 (16%), Positives = 32/85 (37%), Gaps = 4/85 (4%)
Query: 427 NLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMN 485
+L N +L S+ L N+++ G + I+L +N++T
Sbjct: 86 DLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQG---KKNIYLANNKITMLRDLDEGC 142
Query: 486 LPNLRELYVQNNMLSGTVPSSLLSK 510
++ L ++ N + + L +
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAAS 167
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 15/77 (19%), Positives = 24/77 (31%), Gaps = 9/77 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+T I L + L I L +L L GN C LR ++ ++
Sbjct: 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH--------CGTLRDFFSKNQRV 264
Query: 476 TGPLPSSLMNLPNLREL 492
++ L E
Sbjct: 265 QTVAKQTVKKLTGQNEE 281
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 21/86 (24%), Positives = 36/86 (41%), Gaps = 2/86 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 474
PS+ + L I LS+L L L +L IP+ + L + L N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNH 218
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLS 500
L+ P S L +L++L++ + +
Sbjct: 219 LSAIRPGSFQGLMHLQKLWMIQSQIQ 244
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 23/96 (23%), Positives = 44/96 (45%), Gaps = 4/96 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
+ +++L + + L L L L N + I F+G +L + L DN
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT-IEIGAFNGLANLNTLELFDN 122
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
+LT + + L L+EL+++NN + ++PS +
Sbjct: 123 RLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN 157
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 30/109 (27%), Positives = 52/109 (47%), Gaps = 9/109 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
++ ++L+ NL IP +LT L L EL L GN L+ I F G L+ + + +
Sbjct: 185 SNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQS 241
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 519
Q+ ++ NL +L E+ + +N L+ +P L L ++ N
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 22/89 (24%), Positives = 38/89 (42%), Gaps = 6/89 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ ++ LS ++ I L++L L L N LT IP+ F L+ + L +
Sbjct: 88 RHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRN 145
Query: 473 NQLTGPLPSSLMNLPNLRELYVQ-NNMLS 500
N + + +P+LR L + LS
Sbjct: 146 NPIESIPSYAFNRIPSLRRLDLGELKRLS 174
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 19/87 (21%), Positives = 33/87 (37%), Gaps = 5/87 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ + LS +L+ I L L +LW+ + + I F L I+L
Sbjct: 207 IKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQV-IERNAFDNLQSLVEINLAH 264
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNML 499
N LT L +L +++ +N
Sbjct: 265 NNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 42/224 (18%), Positives = 84/224 (37%), Gaps = 48/224 (21%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQF 662
+ ++IG G FGV++ G L + +++A+K S + +E + +
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR-------LEIAEDAAKGIE 715
+ QE +VLV + + G E L + R A+ ++
Sbjct: 72 YYFGQEGLHNVLVIDLL--GPSLEDLL---------DLCGRKFSVKTVAMAAKQMLARVQ 120
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAK-----VSDFGLSKFAVDGASHV------SSI 764
+H +++RD+K N L+ + V DFG+ KF D +
Sbjct: 121 SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177
Query: 765 VRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQ 802
+ GT Y+S ++ + + D+ + G + + + G
Sbjct: 178 LSGTA------RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 20/98 (20%), Positives = 38/98 (38%), Gaps = 6/98 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ +HL L + L++L L+L N+L +PD F +L + L
Sbjct: 105 GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHG 162
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
N+++ + L +L L + N ++ V
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD 199
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 29/112 (25%), Positives = 52/112 (46%), Gaps = 9/112 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
++ ++L L +P D L +L L+L GN ++ +P+ F G L + L
Sbjct: 129 AALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQ 186
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524
N++ P + +L L LY+ N LS +P+ L+ L Y + L++
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQY---LRLND 234
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 21/102 (20%), Positives = 41/102 (40%), Gaps = 5/102 (4%)
Query: 409 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRI 467
C +P +T + L +P + ++ ++L GN ++ P F C +L I
Sbjct: 5 ACVCYNEPKVTT-SCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTI 60
Query: 468 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
+ L N L ++ L L +L + +N +V +
Sbjct: 61 LWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 23/98 (23%), Positives = 35/98 (35%), Gaps = 5/98 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
+ I L ++ + +L LWL N L I F+G L + L DN
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR-IDAAAFTGLALLEQLDLSDN 90
Query: 474 -QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
QL P++ L L L++ L + L
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRG 127
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 19/85 (22%), Positives = 35/85 (41%), Gaps = 5/85 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
++T + L ++ ++P L SL L L N + + F L ++L
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFA 210
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNN 497
N L+ +L L L+ L + +N
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDN 235
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQF 662
L +KIGSG FG +Y G + G+E+A+K+ + + E + + +
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTI 70
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
E +V+V E + G E L+ + + + + L +A+ IEY+H+
Sbjct: 71 RWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTV--LLLADQMISRIEYIHSKN- 125
Query: 723 PAIIHRDLKSSNILLDKHMRAK---VSDFGLSKFAVDGASHV------SSIVRGTVGYLD 773
IHRD+K N L+ + + DFGL+K D +H + + GT Y
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 774 PEYYISQQLTDKSDVYSFGVILLELISGQ 802
++ + + + D+ S G +L+ G
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 33/94 (35%), Positives = 47/94 (50%), Gaps = 7/94 (7%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
++ I ++ N+T IP L SL EL LDGN +T + G +L + L N
Sbjct: 171 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFN 226
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
++ SL N P+LREL++ NN L VP L
Sbjct: 227 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 22/105 (20%), Positives = 43/105 (40%), Gaps = 9/105 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLT-GPIPD--FSGCPDLRIIHLE 471
++ + + +T + L+ ++ + L N L I + F G L I +
Sbjct: 121 KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179
Query: 472 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
D +T +P L P+L EL++ N ++ V ++ L L
Sbjct: 180 DTNITT-IPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAK 220
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 28/114 (24%), Positives = 43/114 (37%), Gaps = 8/114 (7%)
Query: 399 PCLPVPWSW-LQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP 457
P +P C Q + V+ S L +P DL L L N +T I
Sbjct: 13 PEVPEIEPMGPVCPFRCQCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITE-IK 68
Query: 458 --DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
DF +L + L +N+++ P + L L LY+ N L +P +
Sbjct: 69 DGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK 121
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 14/115 (12%), Positives = 40/115 (34%), Gaps = 12/115 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 474
++ + LS +++ + + L L EL L+ N L + +++++L +N
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 274
Query: 475 LTG------PLPSSLMNLPNLRELYVQNNMLSGT-VPSSL---LSKNVVLNYAGN 519
++ P + + + +N + + S + +
Sbjct: 275 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 21/108 (19%), Positives = 36/108 (33%), Gaps = 24/108 (22%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
P ++ L + +T D L +L L L N ++ I F+ L ++L N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK-ISPGAFAPLVKLERLYLSKN 110
Query: 474 QLT---GPLPSSLM------------------NLPNLRELYVQNNMLS 500
QL +P +L L + + + N L
Sbjct: 111 QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 158
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 24/109 (22%), Positives = 43/109 (39%), Gaps = 7/109 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
+ V+ +S + + +L L + +LT +P LR ++L N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYN 258
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 519
++ S L L L+E+ + L+ V L+ VLN +GN
Sbjct: 259 PISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGN 306
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 20/97 (20%), Positives = 38/97 (39%), Gaps = 6/97 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
++T + +S + + + L +L L + N L I FSG L + LE
Sbjct: 104 SNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEK 161
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
LT +L +L L L +++ ++ +
Sbjct: 162 CNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFK 197
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 24/104 (23%), Positives = 45/104 (43%), Gaps = 6/104 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
S+ + L NLT +IP++ L+ L L+ L L ++ I D F L+++ +
Sbjct: 152 NSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINA-IRDYSFKRLYRLKVLEISH 209
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
+ + + NL L + + L+ VP + V L +
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRF 252
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 23/97 (23%), Positives = 41/97 (42%), Gaps = 6/97 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
P + + L+ ++ + L +L L L N L IP F+G +L + + +
Sbjct: 56 PHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISE 113
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
N++ L +L NL+ L V +N L + S
Sbjct: 114 NKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFS 149
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 20/96 (20%), Positives = 38/96 (39%), Gaps = 5/96 (5%)
Query: 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDN 473
+ K +P + + L L N + +F+ P L + L +N
Sbjct: 10 SAQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN 66
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
++ P + NL NLR L +++N L +P + +
Sbjct: 67 IVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFT 101
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 24/88 (27%), Positives = 41/88 (46%), Gaps = 5/88 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ ++LS ++ I L +L L E+ L G L + F G LR++++
Sbjct: 248 VYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAV-VEPYAFRGLNYLRVLNVSG 305
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLS 500
NQLT S ++ NL L + +N L+
Sbjct: 306 NQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 4e-12
Identities = 23/105 (21%), Positives = 38/105 (36%), Gaps = 4/105 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 474
P + + LS L I K+ L L++ N L P L+++ L N
Sbjct: 254 PGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNH 312
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
L + + L LY+ +N + T+ S L + N
Sbjct: 313 LLH-VERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHN 355
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 1e-11
Identities = 22/107 (20%), Positives = 44/107 (41%), Gaps = 6/107 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+I +++ + +P + + L L L+ N L+ +P F P L + + +
Sbjct: 99 HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSN 156
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
N L + +L+ L + +N L+ V SL+ N + N
Sbjct: 157 NNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYN 202
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 2e-11
Identities = 21/109 (19%), Positives = 39/109 (35%), Gaps = 7/109 (6%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 472
++ + S ++ + + L L L N+LT P L + L
Sbjct: 208 AIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSY 263
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
N+L + + + L LY+ NN L + + VL+ + N
Sbjct: 264 NELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 311
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 17/102 (16%), Positives = 40/102 (39%), Gaps = 6/102 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ ++ + + +P+ L + L L+ + I F+ ++ +++
Sbjct: 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGF 108
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 514
N + P N+P L L ++ N LS ++P + L
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKL 149
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 26/88 (29%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 416 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
P +TV+ L +L+ ++P + L L + N+L I D F L+ + L
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 180
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLS 500
N+LT + SL +P+L V N+LS
Sbjct: 181 NRLTH-VDLSL--IPSLFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 16/104 (15%), Positives = 33/104 (31%), Gaps = 4/104 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ +++S+ L + + +L L L N L + L ++L+ N +
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSI 336
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
L S L+ L + +N +L
Sbjct: 337 V-TLKLS--THHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDA 377
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 7/86 (8%), Positives = 30/86 (34%), Gaps = 2/86 (2%)
Query: 432 IPSDLTKLSSLVELWLDGNSLTGP-IPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 490
I S+L ++ +D + + + +I+ +++ + + L + +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 491 ELYVQNNMLSGTVPSSLLSKNVVLNY 516
L + + + + + + +
Sbjct: 79 LLNLNDLQIE-EIDTYAFAYAHTIQK 103
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 32/122 (26%), Positives = 44/122 (36%), Gaps = 24/122 (19%)
Query: 410 CNSDPQPSITVIHLSSKNLT---GNIPSDLTKL------------------SSLVELWLD 448
C S ++ +NLT ++P D T L + L +L LD
Sbjct: 4 CEVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 449 GNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL 508
LT + P L + L NQL LP LP L L V N L+ ++P L
Sbjct: 64 RAELTK-LQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGAL 120
Query: 509 SK 510
Sbjct: 121 RG 122
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 28/100 (28%), Positives = 47/100 (47%), Gaps = 5/100 (5%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHL 470
P + + LS L ++P L +L L + N LT +P G +L+ ++L
Sbjct: 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYL 131
Query: 471 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
+ N+L P L P L +L + NN L+ +P+ LL+
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNG 170
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 32/92 (34%), Positives = 45/92 (48%), Gaps = 6/92 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
P++TV+ +S LT ++P L L EL+L GN L +P + P L + L +
Sbjct: 100 PALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLAN 157
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 504
N LT L L NL L +Q N L T+P
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 22/107 (20%), Positives = 43/107 (40%), Gaps = 6/107 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+I +++ + +P + L L L+ N L+ +P F P L + + +
Sbjct: 93 HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSN 150
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
N L + +L+ L + +N L+ V SL+ N + N
Sbjct: 151 NNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYN 196
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 18/88 (20%), Positives = 32/88 (36%), Gaps = 4/88 (4%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 472
++ + S ++ + + L L L N+LT P L + L
Sbjct: 202 AIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSY 257
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLS 500
N+L + + + L LY+ NN L
Sbjct: 258 NELEKIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 18/110 (16%), Positives = 43/110 (39%), Gaps = 9/110 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ ++ + + +P+ L + L L+ + I F+ ++ +++
Sbjct: 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGF 102
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN---VVLNYAGN 519
N + P N+P L L ++ N LS ++P + L+ + N
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNN 151
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 23/95 (24%), Positives = 38/95 (40%), Gaps = 5/95 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 474
+T++ L NLT + L LVE+ L N L F L +++ +N+
Sbjct: 226 VELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
L L +P L+ L + +N L V +
Sbjct: 284 LVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 316
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 8/88 (9%)
Query: 416 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
P +TV+ L +L+ ++P + L L + N+L I D F L+ + L
Sbjct: 117 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 174
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLS 500
N+LT + S +P+L V N+LS
Sbjct: 175 NRLTH-VDLS--LIPSLFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 11/100 (11%), Positives = 34/100 (34%), Gaps = 6/100 (6%)
Query: 415 QPSITVIHLSSKNLTGNIPSDLTK--LSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHL 470
Q + T ++ L++ + +++ +P + +++L
Sbjct: 18 QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNL 76
Query: 471 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
D Q+ + +++LY+ N + +P +
Sbjct: 77 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQN 115
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 22/97 (22%), Positives = 39/97 (40%), Gaps = 7/97 (7%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 473
P P++ V+ LS +L ++ + + L L+LD NS+ + S L+ + L N
Sbjct: 293 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHN 349
Query: 474 QLTGPLPSSLMNLP-NLRELYVQNNMLSGTVPSSLLS 509
+SL L N+ V + + L
Sbjct: 350 DWD---CNSLRALFRNVARPAVDDADQHCKIDYQLEH 383
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 8e-12
Identities = 23/96 (23%), Positives = 46/96 (47%), Gaps = 5/96 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 474
+ V S++ T +IPS L +++ L L N +T D C +L+++ L+ ++
Sbjct: 5 DASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
+ + +L +L L + +N LS ++ SS
Sbjct: 62 INTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGP 96
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-10
Identities = 22/97 (22%), Positives = 36/97 (37%), Gaps = 3/97 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
++ + LS +T DL ++L L L + + I F L + L DN
Sbjct: 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLSDN 84
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
L+ S L +L+ L + N +SL
Sbjct: 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 19/111 (17%), Positives = 39/111 (35%), Gaps = 5/111 (4%)
Query: 416 PSITVIHLSSKNLTGNIP-SDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
++ + + + I D L+SL EL + SL D+ + L
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN-YQSQSLKSIRDIHHLTLHL 181
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523
++ L L ++R L +++ L+ S L + V + +
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLA-RFQFSPLPVDEVSSPMKKLAFR 231
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 21/82 (25%), Positives = 39/82 (47%), Gaps = 5/82 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ V+ +S+ NL + L L EL++ N L +PD S P L ++ + NQL
Sbjct: 431 QTLEVLDVSNNNLD-SFSLFLP---RLQELYISRNKLKT-LPDASLFPVLLVMKISRNQL 485
Query: 476 TGPLPSSLMNLPNLRELYVQNN 497
L +L+++++ N
Sbjct: 486 KSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 27/124 (21%), Positives = 47/124 (37%), Gaps = 21/124 (16%)
Query: 416 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 473
PS+ + LS +L L L +L L + N+ +R ++L
Sbjct: 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSST 420
Query: 474 QLT---GPLPSSL--------------MNLPNLRELYVQNNMLSGTVPSSLLSKN-VVLN 515
+ +P +L + LP L+ELY+ N L T+P + L +V+
Sbjct: 421 GIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDASLFPVLLVMK 479
Query: 516 YAGN 519
+ N
Sbjct: 480 ISRN 483
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 16/98 (16%), Positives = 35/98 (35%), Gaps = 3/98 (3%)
Query: 413 DPQPSITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIH 469
P S+ ++L + S L++L L + I DF+G L +
Sbjct: 95 GPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELE 154
Query: 470 LEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
++ L SL ++ ++ L + + + +
Sbjct: 155 IKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFA 192
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-08
Identities = 13/88 (14%), Positives = 33/88 (37%), Gaps = 4/88 (4%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQL 475
+I +H+ L ++ + + L + + ++ + + P L + L +N +
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346
Query: 476 T---GPLPSSLMNLPNLRELYVQNNMLS 500
+ P+L+ L + N L
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 23/104 (22%), Positives = 37/104 (35%), Gaps = 4/104 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
++ V+ L S + L SL L L N L+ + F L+ ++L N
Sbjct: 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGN 108
Query: 474 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
+ S NL NL+ L + N + + LN
Sbjct: 109 PYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNE 152
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 21/107 (19%), Positives = 43/107 (40%), Gaps = 12/107 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ ++LSS + + + + +L L + N+L P L+ +++ N+L
Sbjct: 410 EKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDS-FS--LFLPRLQELYISRNKL 463
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 519
LP + P L + + N L +VP + L+ + N
Sbjct: 464 KT-LPDA-SLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 13/109 (11%), Positives = 38/109 (34%), Gaps = 8/109 (7%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQL 475
+ + S ++ + + ++ L + L + +S ++ I +E++++
Sbjct: 265 GLGDFNPSESDVVSELGK--VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSG-----TVPSSLLSKNVVLNYAGN 519
S +L +L L + N++ + L + N
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN 371
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 11/89 (12%), Positives = 22/89 (24%), Gaps = 1/89 (1%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLE 471
I + L + LSS+ L L +L +
Sbjct: 169 KSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKL 228
Query: 472 DNQLTGPLPSSLMNLPNLRELYVQNNMLS 500
+ + S L L ++ + +
Sbjct: 229 AFRGSVLTDESFNELLKLLRYILELSEVE 257
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 9e-12
Identities = 19/109 (17%), Positives = 49/109 (44%), Gaps = 5/109 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
S+T I L++ N+T ++ + + ++ +L ++ T SG +L + + +
Sbjct: 44 NSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDV 100
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINL 522
T +L L +L L + ++ ++ + + L K ++ + N +
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 15/86 (17%), Positives = 37/86 (43%), Gaps = 2/86 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
S+T++ +S +I + + L + + L N I P+L+ ++++ + +
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGV 171
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSG 501
+ + P L +LY + + G
Sbjct: 172 HD--YRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 19/105 (18%), Positives = 40/105 (38%), Gaps = 2/105 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 474
++ + + K++T + +L+ L+SL L + ++ + + P + I L N
Sbjct: 88 SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ L LP L+ L +Q + + K L
Sbjct: 148 AITDI-MPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQ 191
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 25/104 (24%), Positives = 45/104 (43%), Gaps = 8/104 (7%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++T + + ++T ++ + KL+ L +L N++T D S +L + + N+L
Sbjct: 42 ATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITTL--DLSQNTNLTYLACDSNKL 97
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
T L + L L L N L+ + S LN A N
Sbjct: 98 TN-LD--VTPLTKLTYLNCDTNKLT-KLDVSQNPLLTYLNCARN 137
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 23/104 (22%), Positives = 39/104 (37%), Gaps = 9/104 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+T + S +T D+++ L L D N++T D + L + N+L
Sbjct: 170 TQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITK--LDLNQNIQLTFLDCSSNKL 224
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
T + + L L N L+ + S LSK L+
Sbjct: 225 TE-IDVT--PLTQLTYFDCSVNPLT-ELDVSTLSKLTTLHCIQT 264
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 22/109 (20%), Positives = 37/109 (33%), Gaps = 9/109 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ ++ + N+T + DL + L L N LT D + L N L
Sbjct: 191 KLLNRLNCDTNNIT-KL--DLNQNIQLTFLDCSSNKLTEI--DVTPLTQLTYFDCSVNPL 245
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524
T L S L L L+ L + + ++ + G + E
Sbjct: 246 T-ELDVS--TLSKLTTLHCIQTDLL-EIDLTHNTQLIYFQAEGCRKIKE 290
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 19/99 (19%), Positives = 34/99 (34%), Gaps = 5/99 (5%)
Query: 421 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP 480
I+ ++ D+T + L L +T + D S P L ++L + +LT L
Sbjct: 278 IYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-EL-DLSQNPKLVYLYLNNTELTE-LD 334
Query: 481 SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
S + L+ L N + + A
Sbjct: 335 VS--HNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAEG 371
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 16/105 (15%), Positives = 42/105 (40%), Gaps = 7/105 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ ++ + +T + DL++ LV L+L+ LT + D S L+ + + +
Sbjct: 297 TQLYLLDCQAAGIT-EL--DLSQNPKLVYLYLNNTELTE-L-DVSHNTKLKSLSCVNAHI 351
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 520
S + +P L + +L + ++ + + ++
Sbjct: 352 QD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDL 394
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 20/97 (20%), Positives = 36/97 (37%), Gaps = 5/97 (5%)
Query: 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSS 482
++ + +L++L L +S+T + L + N +T L S
Sbjct: 25 AAAFEMQATDTISEEQLATLTSLDCHNSSITD-MTGIEKLTGLTKLICTSNNITT-LDLS 82
Query: 483 LMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
NL L +N L+ + + L+K LN N
Sbjct: 83 --QNTNLTYLACDSNKLT-NLDVTPLTKLTYLNCDTN 116
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 27/104 (25%), Positives = 43/104 (41%), Gaps = 8/104 (7%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++T + S LT N+ +T L+ L L D N LT D S P L ++ N L
Sbjct: 85 TNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKL--DVSQNPLLTYLNCARNTL 139
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
T + S + L EL N + + ++ L+ + N
Sbjct: 140 T-EIDVS--HNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFN 180
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 19/104 (18%), Positives = 38/104 (36%), Gaps = 8/104 (7%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
P +T ++ + LT I D++ + L EL N D + L + N++
Sbjct: 127 PLLTYLNCARNTLT-EI--DVSHNTQLTELDCHLNKKI-TKLDVTPQTQLTTLDCSFNKI 182
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
T + L L N ++ + + + L+ + N
Sbjct: 183 TE---LDVSQNKLLNRLNCDTNNIT-KLDLNQNIQLTFLDCSSN 222
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 25/123 (20%), Positives = 35/123 (28%), Gaps = 25/123 (20%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+T + SS LT I D+T L+ L N LT D S L +H L
Sbjct: 212 IQLTFLDCSSNKLT-EI--DVTPLTQLTYFDCSVNPLT--ELDVSTLSKLTTLHCIQTDL 266
Query: 476 T----GPLPS---------------SLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
+ + L L Q ++ + S K V L
Sbjct: 267 LEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELDLSQNPKLVYLYL 325
Query: 517 AGN 519
Sbjct: 326 NNT 328
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 18/106 (16%), Positives = 37/106 (34%), Gaps = 8/106 (7%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
P + ++L++ LT + D++ + L L + P L + Q
Sbjct: 318 PKLVYLYLNNTELT-EL--DVSHNTKLKSLSCVNAHIQD-FSSVGKIPALNNNFEAEGQT 373
Query: 476 TGPLPSSLMNLPNLRELYVQNNML--SGTVPSSLLSKNVVLNYAGN 519
+P + +L + V ++L G + V + A N
Sbjct: 374 IT-MPKETLTNNSL-TIAVSPDLLDQFGNPMNIEPGDGGVYDQATN 417
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 33/179 (18%), Positives = 64/179 (35%), Gaps = 28/179 (15%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEI------AVKVLTSNSYQGKREFTNEVTLLSRIHHRN 658
+ IG GGFG +Y + + + VKV S++ E ++
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTEL-KFYQRAAKPEQIQ 97
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEH------LYGT-LTHEQRINWIKR-------L 704
+ G +H+ K + +G+ L ++ + L
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDL--QKIYEANAKRFSRKTVL 155
Query: 705 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV--SDFGLSKFAVDGASHV 761
+++ +EY+H +H D+K+SN+LL+ +V D+GL+ H
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 50/216 (23%), Positives = 93/216 (43%), Gaps = 34/216 (15%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV-QF 662
L +KIGSG FG +Y G ++ +E+A+K+ + + E + + +
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNV 68
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR-------LEIAEDAAKGIE 715
+ E +VLV + + G E L+ N+ R L +A+ +E
Sbjct: 69 RWFGVEGDYNVLVMDLL--GPSLEDLF---------NFCSRKLSLKTVLMLADQMINRVE 117
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAK---VSDFGLSKFAVDGASHV------SSIVR 766
++H+ +HRD+K N L+ RA + DFGL+K D ++H + +
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
Query: 767 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
GT Y ++ + + + D+ S G +L+ + G
Sbjct: 175 GTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 33/93 (35%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQ 474
+ + +S LT IP DL +L EL LD N + I L + L NQ
Sbjct: 173 KLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQ 228
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
+ SL LP LREL++ NN LS VP+ L
Sbjct: 229 IRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 26/113 (23%), Positives = 46/113 (40%), Gaps = 7/113 (6%)
Query: 409 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLR 466
C + V+ S L +P +++ L L N ++ + DF G L
Sbjct: 26 MCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISE-LRKDDFKGLQHLY 81
Query: 467 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ L +N+++ + L L++LY+ N L +P +L S V L N
Sbjct: 82 ALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDN 133
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 17/91 (18%), Positives = 36/91 (39%), Gaps = 10/91 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT-------GPIPDFSGCPDLRII 468
P++ +HL + L+ +P+ L L L ++L N++T P+ I
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGI 299
Query: 469 HLEDNQLTGPL--PSSLMNLPNLRELYVQNN 497
L +N + P++ + + + N
Sbjct: 300 SLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 24/110 (21%), Positives = 41/110 (37%), Gaps = 24/110 (21%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
P T++ L + +++ D L L L L N ++ I + FS L+ +++ N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK-IHEKAFSPLRKLQKLYISKN 112
Query: 474 QLT---GPLPSSL------------------MNLPNLRELYVQNNMLSGT 502
L LPSSL L N+ + + N L +
Sbjct: 113 HLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENS 162
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 17/92 (18%), Positives = 33/92 (35%), Gaps = 8/92 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 474
+ + L + I + L+ L +L EL LD N L+ L++++L N
Sbjct: 217 SKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNN 275
Query: 475 LTG------PLPSSLMNLPNLRELYVQNNMLS 500
+T + + + NN +
Sbjct: 276 ITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 31/111 (27%), Positives = 46/111 (41%), Gaps = 4/111 (3%)
Query: 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 473
QP + L S L P +LS L + +D L +PD L + L N
Sbjct: 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARN 137
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524
L LP+S+ +L LREL ++ +P L S + + G +NL
Sbjct: 138 PLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQS 187
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 22/112 (19%), Positives = 46/112 (41%), Gaps = 7/112 (6%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED-NQL 475
++ + L + ++P+ + L +L L + + L+ P P L + L L
Sbjct: 184 NLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTAL 242
Query: 476 TGPLPSSLMNLPNLRELYVQN-NMLSGTVPSSL--LSKNVVLNYAGNINLHE 524
P L+ L +++ + L T+P + L++ L+ G +NL
Sbjct: 243 RN-YPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSR 292
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 18/95 (18%), Positives = 29/95 (30%), Gaps = 4/95 (4%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWL-DGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
+ + L N P + L L L D ++L +P L + L
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCV 288
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
LPS + LP + V + L +
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPH-LQAQLDQHRPV 322
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 18/119 (15%), Positives = 40/119 (33%), Gaps = 12/119 (10%)
Query: 417 SITVIHLSSKNLTGNIPSDL---------TKLSSLVELWLDGNSLTGPIPDFSGCPDLRI 467
+ + + + +P L L +L L L+ + + +L+
Sbjct: 151 RLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKS 210
Query: 468 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHE 524
+ + ++ L+ L ++ +LP L EL ++ P + L NL
Sbjct: 211 LKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT 268
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 9e-10
Identities = 26/124 (20%), Positives = 46/124 (37%), Gaps = 12/124 (9%)
Query: 406 SWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSS--LVELWLDGNSLTGPIPD-FSGC 462
+W Q NS+ + + + + L L + V L L L PD
Sbjct: 49 AWRQANSN---NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRL 103
Query: 463 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNI 520
L+ + ++ L LP ++ L L + N L +P+S+ L++ L+
Sbjct: 104 SHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACP 161
Query: 521 NLHE 524
L E
Sbjct: 162 ELTE 165
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 20/115 (17%), Positives = 42/115 (36%), Gaps = 15/115 (13%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED-NQ 474
+ + + + L +P + + + L L L N L +P + LR + + +
Sbjct: 105 HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPE 162
Query: 475 LT--------GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
LT L NL+ L ++ + ++P+S+ L L +
Sbjct: 163 LTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 2e-11
Identities = 38/268 (14%), Positives = 73/268 (27%), Gaps = 68/268 (25%)
Query: 590 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL--------TSNSYQGK 641
+HC ++ +KIG G FG V+ +A+K++ + +
Sbjct: 14 SHCLPTEKLQRC-----EKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTF 67
Query: 642 REFTNEVTLLSRIH---------HRNLVQFLGYCQEEGRS-------------------- 672
E E+ + + + +G
Sbjct: 68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127
Query: 673 ----------VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+V EF G E + + + I +
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQM-----RTKLSSLATAKSILHQLTASLAVAEA--S 180
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
HRDL N+LL K K+ K + + + V +D Y +S+
Sbjct: 181 LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGL------QVSIID--YTLSRLE 232
Query: 783 TDKSDVYSFGVILLELISGQEAISNEKF 810
D V+ + +L +G + +
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDGDYQFDIY 260
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 23/99 (23%), Positives = 43/99 (43%), Gaps = 6/99 (6%)
Query: 419 TVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQL 475
+ LS +L I S+ + +L L L N L + + FS L ++ L +N +
Sbjct: 67 HSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHI 124
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 514
++ ++ L++LY+ N +S P L+ L
Sbjct: 125 VVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKL 162
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 25/99 (25%), Positives = 40/99 (40%), Gaps = 7/99 (7%)
Query: 416 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLE 471
++ LS NL+ + ++ T+L++L L L N L I F P+LR + L
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLS 96
Query: 472 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
N L +L L L + NN + V +
Sbjct: 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFED 134
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 28/116 (24%), Positives = 47/116 (40%), Gaps = 12/116 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
P++ + LSS +L + + L +L L L N + + F L+ ++L
Sbjct: 88 PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQ 145
Query: 473 NQLTGPLP----SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524
NQ++ P LP L L + +N L +P + L K G + LH
Sbjct: 146 NQISR-FPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNG-LYLHN 198
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 36/185 (19%), Positives = 64/185 (34%), Gaps = 43/185 (23%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLL--SRIHHRNLVQ 661
L KKIGSGGFG++Y ++ A V+ K E+ L + + R
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVV-------KVEYQENGPLFSELKFYQR---- 89
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR-----------------INWIKR- 703
+ + + + + G + G + R
Sbjct: 90 -VAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTF 148
Query: 704 -----LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV--SDFGLSKFAVD 756
L++ +EY+H +H D+K++N+LL +V +D+GLS
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP 205
Query: 757 GASHV 761
+H
Sbjct: 206 NGNHK 210
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 25/112 (22%), Positives = 48/112 (42%), Gaps = 9/112 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTGPIPD------FSGCPDLRI 467
P + ++ L+ + + D ++ SL +L+L N L F G L++
Sbjct: 426 PHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV 484
Query: 468 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
++L N L P +L LR L + +N L+ + L + +L+ + N
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRN 536
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 8e-11
Identities = 22/104 (21%), Positives = 34/104 (32%), Gaps = 3/104 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
+ + LS + S L L L L I F P+LRI+ L +
Sbjct: 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLS-GTVPSSLLSKNVVLNY 516
++ P + L +L EL + LS + L
Sbjct: 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 2/97 (2%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLED 472
+ S+ + LS + L L L L N + F G +L++++L
Sbjct: 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
N L S+ LP + + +Q N ++ +
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFK 359
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 5e-09
Identities = 19/99 (19%), Positives = 34/99 (34%), Gaps = 7/99 (7%)
Query: 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTGP 478
+ NLT +P L ++ L L N + F L+++ L
Sbjct: 8 IAFYRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 479 L-PSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
+ + NLPNLR L + ++ + + L
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFE 101
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 30/110 (27%), Positives = 42/110 (38%), Gaps = 9/110 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTK-----LSSLVELWLDGNSLTG-PIPDFSGCPDLRIIH 469
PS+ + L L ++L LS L L+L+ N L P FS LR +
Sbjct: 451 PSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLS 510
Query: 470 LEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
L N+LT + L NL L + N L + VL+ N
Sbjct: 511 LNSNRLTVLSHNDL--PANLEILDISRNQLL-APNPDVFVSLSVLDITHN 557
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 23/120 (19%), Positives = 48/120 (40%), Gaps = 2/120 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 474
+ V++L+ + L +L L L N L +F G P + I L+ N
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNI 534
+ + L L+ L +++N L+ T+ ++ L+ + L + A +++
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNALT-TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHL 408
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 22/115 (19%), Positives = 33/115 (28%), Gaps = 9/115 (7%)
Query: 416 PSITVIHLSSKNLTGNI--PSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHLE 471
+ + L L+ + L +L L L N + P F L+ I
Sbjct: 97 FHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFS 156
Query: 472 DNQLTGPLPSSLMNL--PNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524
NQ+ L L L + N L V +N N+ L
Sbjct: 157 SNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGK---CMNPFRNMVLEI 208
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 23/100 (23%), Positives = 43/100 (43%), Gaps = 9/100 (9%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + L LT + + S+ +++L GN L +P + +IHL +N+L
Sbjct: 362 EKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVT-LPKIN--LTANLIHLSENRL 413
Query: 476 TG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 514
+ L+ +P+L+ L + N S S+N L
Sbjct: 414 ENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL 453
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 15/116 (12%), Positives = 36/116 (31%), Gaps = 22/116 (18%)
Query: 415 QPSITVIHLSSKNLTGNIPSDLTKLS------SLVELWLDGNSLTGPIPD---------- 458
+++ L++ +L + D K L L + GN T I
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ 232
Query: 459 ---FSGCPDLRIIHLEDNQLTGPLPSSLMNLP--NLRELYVQNNMLSGTVPSSLLS 509
+ + + P ++ L ++R L + + + ++ S +
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFE 287
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 24/106 (22%), Positives = 49/106 (46%), Gaps = 6/106 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ + + + ++ ++ + L LS L L D N ++ I + P+L +HL++NQ+
Sbjct: 151 TNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQI 207
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 521
+ S L N NL + + N ++ P + VV N +
Sbjct: 208 SDV--SPLANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPS 250
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 29/104 (27%), Positives = 50/104 (48%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
SI + L+S +T P L LS+L L+LD N +T I +G +L+ + + + Q+
Sbjct: 107 QSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITN-ISPLAGLTNLQYLSIGNAQV 163
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ + L NL L L +N +S P + L + ++ N
Sbjct: 164 SDL--TPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNN 205
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 25/104 (24%), Positives = 51/104 (49%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ V++L +T NI S L L++L L + ++ + + L + +DN++
Sbjct: 129 SNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKI 185
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ S L +LPNL E++++NN +S P + S ++
Sbjct: 186 SDI--SPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQ 227
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 22/104 (21%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
IT + +T I + L++L+ L L N +T + + + L N L
Sbjct: 41 DGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPL 97
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
S++ L +++ L + + ++ P + LS VL N
Sbjct: 98 KNV--SAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN 139
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 14/86 (16%), Positives = 35/86 (40%), Gaps = 3/86 (3%)
Query: 434 SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493
L++ +++ +++T + + + + +T + L NL L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLE 69
Query: 494 VQNNMLSGTVPSSLLSKNVVLNYAGN 519
+++N ++ P L+K L +GN
Sbjct: 70 LKDNQITDLAPLKNLTKITELELSGN 95
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 17/100 (17%), Positives = 39/100 (39%), Gaps = 5/100 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+T + ++ +I S L L +L+E+ L N ++ + + +L I+ L + +
Sbjct: 173 SKLTTLKADDNKIS-DI-SPLASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTNQTI 229
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 515
T NL V+ + P+++ +
Sbjct: 230 TNQPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYAS 267
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 27/114 (23%), Positives = 44/114 (38%), Gaps = 6/114 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
++ + LS+ +T SDL + +L L L N + I + FS L + L N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYN 110
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNINLHE 524
L+ S L +L L + N +SL L+K +L +
Sbjct: 111 YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTK 164
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 24/132 (18%), Positives = 40/132 (30%), Gaps = 30/132 (22%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTG----------------- 454
S+ + LS L+ N+ S LSSL L L GN
Sbjct: 97 SSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR 155
Query: 455 ----------PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 504
DF+G L + ++ + L P SL ++ N+ L + +
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLL 214
Query: 505 SSLLSKNVVLNY 516
+ +
Sbjct: 215 EIFVDVTSSVEC 226
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 16/114 (14%), Positives = 35/114 (30%), Gaps = 3/114 (2%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHL 470
+ ++ + + + I L+ L EL +D + L ++ + L
Sbjct: 146 SHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLIL 205
Query: 471 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524
Q L + ++ L +++ L T S LS +
Sbjct: 206 HMKQHILLLEIFVDVTSSVECLELRDTDLD-TFHFSELSTGETNSLIKKFTFRN 258
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 15/93 (16%), Positives = 31/93 (33%), Gaps = 7/93 (7%)
Query: 407 WLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLR 466
L+ + H S L+ + L K + + + SL + + L
Sbjct: 228 ELRDTD-----LDTFHFSE--LSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLL 280
Query: 467 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 499
+ NQL L +L+++++ N
Sbjct: 281 ELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 20/107 (18%), Positives = 32/107 (29%), Gaps = 13/107 (12%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSL---------TGPIPDFSGC 462
+++ + L K + SS+ L L L TG
Sbjct: 195 KSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKK 253
Query: 463 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
R + + D L + L + L EL N L +VP +
Sbjct: 254 FTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFD 298
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 23/117 (19%), Positives = 42/117 (35%), Gaps = 10/117 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
PS + L +L IPS + L ++ +++ + + F + I + +
Sbjct: 31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 473 NQ-LTGPLPSSLMNLPNLRELYVQNNMLSGTVPS----SLLSKNVVLNYAGNINLHE 524
+ LT P +L LP L+ L + N L P +L N +
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTS 145
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 22/111 (19%), Positives = 42/111 (37%), Gaps = 13/111 (11%)
Query: 409 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLR 466
+C+ + ++ K++ IPS S L L L IP FS P++
Sbjct: 9 ECHQE-----EDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLRT-IPSHAFSNLPNIS 58
Query: 467 IIHLEDN-QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
I++ + L S NL + + ++N + L + +L +
Sbjct: 59 RIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 21/113 (18%), Positives = 40/113 (35%), Gaps = 9/113 (7%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSS-LVELWLDGNSLTGPIPD--FSGCPDLRIIHLE 471
++ ++ +IP + L + + L L N T + F+G L ++L
Sbjct: 130 DIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNG-TKLDAVYLN 187
Query: 472 DNQ-LTGPLPSSLMNLPN-LRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 522
N+ LT + + + L V ++ +PS L L L
Sbjct: 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWTL 239
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 19/102 (18%), Positives = 36/102 (35%), Gaps = 5/102 (4%)
Query: 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTG 477
++ S L ++P DL+ L + N ++ D LRI+ + N++
Sbjct: 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59
Query: 478 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
S L L + +N L + L+ + N
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLV-KISCHPTVNLKHLDLSFN 100
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 22/93 (23%), Positives = 44/93 (47%), Gaps = 4/93 (4%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLE 471
S+ + +S +++ + + SL+ L + N LT I P ++++ L
Sbjct: 371 TQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR-CLPPRIKVLDLH 429
Query: 472 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 504
N++ +P ++ L L+EL V +N L +VP
Sbjct: 430 SNKIKS-IPKQVVKLEALQELNVASNQLK-SVP 460
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 20/109 (18%), Positives = 40/109 (36%), Gaps = 6/109 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD----LRIIHLE 471
+ S+ LT + + L+ L L L N L + + L+ + +
Sbjct: 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDIS 382
Query: 472 DNQLTGPLPSSL-MNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
N ++ +L L + +N+L+ T+ L + VL+ N
Sbjct: 383 QNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSN 431
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 19/102 (18%), Positives = 35/102 (34%), Gaps = 4/102 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
T++++S ++ SD+ LS L L + N + F +L + L N+
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
L + NL+ L + N L +
Sbjct: 81 LVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKF 119
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 12/85 (14%), Positives = 27/85 (31%), Gaps = 1/85 (1%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQL 475
++++ + S S++ + + S + +N L
Sbjct: 277 ALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLL 336
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLS 500
T + + +L L L +Q N L
Sbjct: 337 TDTVFENCGHLTELETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 9/96 (9%)
Query: 402 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG 461
SW S+ +++SS LT I L + L L N +
Sbjct: 392 KGDCSWT-------KSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVK 442
Query: 462 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497
L+ +++ NQL L +L+++++ N
Sbjct: 443 LEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 16/105 (15%), Positives = 27/105 (25%), Gaps = 5/105 (4%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHL 470
+ + LS L I +L L L N+ +F L+ + L
Sbjct: 66 KFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGL 122
Query: 471 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 515
L + +L + L V L +
Sbjct: 123 STTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTES 167
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 51/262 (19%), Positives = 92/262 (35%), Gaps = 80/262 (30%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
+K+G G F V+ ++ K +A+KV+ S + + +E+ LL + + +
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDP------ 95
Query: 666 CQEEGRSVLVY---EFMHNGTLKEH-------LYGTLTHEQRINWIKRL------EIAED 709
+ R ++V +F +G H L L + + L +I +
Sbjct: 96 -NDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILL-------------------------------- 737
+G++YLHT C IIH D+K NILL
Sbjct: 155 VLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 738 -----------------DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
+ ++ K++D G A H + ++ T Y E I
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGN---ACWVHKHFTEDIQ-TRQYRSLEVLIGS 268
Query: 781 QLTDKSDVYSFGVILLELISGQ 802
+D++S + EL +G
Sbjct: 269 GYNTPADIWSTACMAFELATGD 290
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 62.1 bits (150), Expect = 2e-10
Identities = 14/93 (15%), Positives = 32/93 (34%), Gaps = 4/93 (4%)
Query: 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLT 476
+ + + + L +L EL+++ + G +LR + + + L
Sbjct: 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 477 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
P + P L L + N L ++ +
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQ 101
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 26/115 (22%), Positives = 45/115 (39%), Gaps = 15/115 (13%)
Query: 398 DPCLPVPWSWLQCNSD----------PQPSITVIHLSSKNLTGNIPS-DLTKLSSLVELW 446
D C P S L+C D ++T +++ ++ ++ DL L L L
Sbjct: 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 447 LDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 499
+ + L + F P L ++L N L L + +L+EL + N L
Sbjct: 63 IVKSGLR-FVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 23/88 (26%), Positives = 37/88 (42%), Gaps = 5/88 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
P + V+ LS + I LS L L L GN + + FSG L+ + +
Sbjct: 52 PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVE 109
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLS 500
L + +L L+EL V +N++
Sbjct: 110 TNLASLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 6e-07
Identities = 18/92 (19%), Positives = 37/92 (40%), Gaps = 8/92 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTG-PIPD-FSGCPDLRIIHLED 472
S+ + NL ++ + L +L EL + N + +P+ FS +L + L
Sbjct: 100 SSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 473 NQLTGPLPSSLMNLPNLR----ELYVQNNMLS 500
N++ + L L + L + N ++
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 19/115 (16%), Positives = 42/115 (36%), Gaps = 13/115 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLE- 471
++ ++++ + + + L++L L L N + D + +++L
Sbjct: 124 KTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 472 ---DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523
N + + L+EL + N L +VP + + L I LH
Sbjct: 183 DLSLNPMNF-IQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQK---IWLH 232
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 19/89 (21%), Positives = 37/89 (41%), Gaps = 10/89 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSD----LTKLSSL-VELWLDGNSLTGPIPD--FSGCPDLRII 468
++ + LSS + +I L ++ L + L L N + I F L+ +
Sbjct: 149 TNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKE-IRLKEL 205
Query: 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNN 497
L+ NQL L +L+++++ N
Sbjct: 206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 28/111 (25%), Positives = 45/111 (40%), Gaps = 9/111 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ + L+ + I + L+ L++L L N L I F L ++ L
Sbjct: 299 TDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSY 356
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523
N + S + LPNL+EL + N L +VP + + L I LH
Sbjct: 357 NHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQK---IWLH 403
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 19/104 (18%), Positives = 36/104 (34%), Gaps = 3/104 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
+ + LS ++ + ++L L L ++ + I + F G L I+ L+ N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNML-SGTVPSSLLSKNVVLNY 516
Q + L NL L + L + + L
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEM 133
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 23/85 (27%), Positives = 40/85 (47%), Gaps = 5/85 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ ++LS N G+I S + L L L L N + + D F G P+L+ + L+
Sbjct: 323 THLLKLNLSQ-NFLGSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDT 380
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNN 497
NQL L +L+++++ N
Sbjct: 381 NQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 9e-06
Identities = 22/118 (18%), Positives = 43/118 (36%), Gaps = 7/118 (5%)
Query: 413 DPQPSITVIHLSSKNLTG-NIPSDL-TKLSSLVELWLDGNSLT--GPIPDFSGCPDLRII 468
+ ++ V+ L+ NL G + + L+SL L L N++ P F ++
Sbjct: 100 NGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVL 159
Query: 469 HLEDNQLTGPLPSSLMNLP--NLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524
L N++ L+N + L + + L + L N N ++
Sbjct: 160 DLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ-DMNEYWLGWEKCGNPFKNTSITT 216
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 29/109 (26%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + +S LT ++P + L EL + GN LT +P L + + NQL
Sbjct: 221 SGLKELIVSGNRLT-SLPVLPS---ELKELMVSGNRLTS-LPM--LPSGLLSLSVYRNQL 273
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524
T LP SL++L + + ++ N LS +L Y+G I +
Sbjct: 274 TR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFD 321
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 25/89 (28%), Positives = 38/89 (42%), Gaps = 8/89 (8%)
Query: 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP 478
V+++ LT +P L + + L + N+LT +P P+LR + + NQLT
Sbjct: 43 AVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPA--LPPELRTLEVSGNQLTS- 95
Query: 479 LPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
LP L L L +PS L
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLP-ALPSGL 123
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 22/92 (23%), Positives = 39/92 (42%), Gaps = 12/92 (13%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + + LT ++P + L EL + N L +P +L + +N+L
Sbjct: 161 SELCKLWAYNNQLT-SLPMLPS---GLQELSVSDNQLAS-LPTLPS--ELYKLWAYNNRL 213
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
T LP+ L+EL V N L+ ++P
Sbjct: 214 T-SLPALP---SGLKELIVSGNRLT-SLPVLP 240
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 30/120 (25%), Positives = 48/120 (40%), Gaps = 33/120 (27%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKL-----------------SSLVELWLDGNSLTGPIPD 458
P + + +S LT ++P L S L +LW+ GN LT +P
Sbjct: 81 PELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTS-LPV 138
Query: 459 FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-------LSKN 511
L+ + + DNQL LP+ L +L+ NN L+ ++P +S N
Sbjct: 139 LPP--GLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLT-SLPMLPSGLQELSVSDN 191
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 14/100 (14%), Positives = 27/100 (27%), Gaps = 9/100 (9%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + + LT +P L LSS + L+GN L+ ++ +
Sbjct: 261 SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA--LREITSAPGYSGPI 317
Query: 476 T------GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
P L ++ P+
Sbjct: 318 IRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWH 357
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 9e-10
Identities = 27/104 (25%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + L ++ +I + L L L L+L N +T I S L + LEDNQ+
Sbjct: 109 KKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 165
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ L L L+ LY+ N +S + L VL
Sbjct: 166 SDI--VPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQ 207
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 4e-09
Identities = 26/104 (25%), Positives = 48/104 (46%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ + L + ++ S L L L L L+ N ++ I P L ++L +N++
Sbjct: 87 KNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKI 143
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
T + L L L L +++N +S VP + L+K L + N
Sbjct: 144 TDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKN 185
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 25/106 (23%), Positives = 49/106 (46%), Gaps = 6/106 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
P + ++L + +T +I + L++L+ L L L+ N ++ I +G L+ ++L N +
Sbjct: 131 PQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHI 187
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 521
+ +L L NL L + + + S VV N N +
Sbjct: 188 SDL--RALAGLKNLDVLELFSQECLNKPINH-QSNLVVPNTVKNTD 230
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 21/104 (20%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+L K++T + +L+S+ ++ + + + + P++ + L N+L
Sbjct: 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKL 77
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
T L NL NL L++ N + L K L+ N
Sbjct: 78 TDI--KPLTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHN 119
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 14/86 (16%), Positives = 30/86 (34%), Gaps = 3/86 (3%)
Query: 434 SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493
+ ++ L S+T + + I ++ + + LPN+ +L+
Sbjct: 15 FPDDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLF 71
Query: 494 VQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ N L+ P + L L N
Sbjct: 72 LNGNKLTDIKPLTNLKNLGWLFLDEN 97
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 22/107 (20%), Positives = 39/107 (36%), Gaps = 16/107 (14%)
Query: 409 QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCP 463
+C + T + S++ L +IP EL L+ N T F P
Sbjct: 8 KCRCEG----TTVDCSNQKLNKIPEHIPQYTA------ELRLNNNEFTVLEATGIFKKLP 57
Query: 464 DLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
LR I+ +N++T + + E+ + +N L V +
Sbjct: 58 QLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKG 103
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 23/91 (25%), Positives = 41/91 (45%), Gaps = 4/91 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDN 473
P + I+ S+ +T +I S + E+ L N L F G L+ + L N
Sbjct: 57 PQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSN 115
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 504
++T S + L ++R L + +N ++ TV
Sbjct: 116 RITCVGNDSFIGLSSVRLLSLYDNQIT-TVA 145
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 25/88 (28%), Positives = 40/88 (45%), Gaps = 5/88 (5%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIH 469
+ + I L+S L N+ + L SL L L N +T + + F G +R++
Sbjct: 78 EGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLS 135
Query: 470 LEDNQLTGPLPSSLMNLPNLRELYVQNN 497
L DNQ+T P + L +L L + N
Sbjct: 136 LYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 24/111 (21%), Positives = 41/111 (36%), Gaps = 26/111 (23%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ +I + + +L +P SL + N L +P+ P L I+ ++N L
Sbjct: 153 SFLKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLEE-LPELQNLPFLTAIYADNNSL 207
Query: 476 TGPLPSSLMNL-------------------PNLRELYVQNNMLSGTVPSSL 507
LP ++L P L +Y NN+L T+P
Sbjct: 208 KK-LPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLP 256
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 28/130 (21%), Positives = 42/130 (32%), Gaps = 40/130 (30%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKL-----------------SSLVELWLDGNSLTGPIPD 458
P + + S +LT +P L L L + N L +P+
Sbjct: 91 PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LPE 148
Query: 459 FSGCPDLRIIHLEDNQLTGPLPSSLMNL-------------------PNLRELYVQNNML 499
L+II +++N L LP +L P L +Y NN L
Sbjct: 149 LQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSL 207
Query: 500 SGTVPSSLLS 509
+P LS
Sbjct: 208 K-KLPDLPLS 216
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 27/99 (27%), Positives = 40/99 (40%), Gaps = 11/99 (11%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 476
S+ I + L +L L L ++ D N L +PD P L +++ DN LT
Sbjct: 216 SLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKT-LPD--LPPSLEALNVRDNYLT 270
Query: 477 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL----LSKN 511
LP +L L + LS +P +L S N
Sbjct: 271 D-LPELPQSLTFLDVSENIFSGLS-ELPPNLYYLNASSN 307
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 12/92 (13%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
P++ ++ SS + ++ SL EL + N L +P + P L + N L
Sbjct: 297 PNLYYLNASSNEIR-SLCD---LPPSLEELNVSNNKLIE-LP--ALPPRLERLIASFNHL 349
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
+P NL++L+V+ N L P
Sbjct: 350 AE-VPEL---PQNLKQLHVEYNPLR-EFPDIP 376
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 24/113 (21%), Positives = 36/113 (31%), Gaps = 22/113 (19%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLS-------------SLVELWLDGNSLTGPIPDFSGC 462
S T + + N P + EL L+ L+ +P+
Sbjct: 34 KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPEL--P 90
Query: 463 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL----LSKN 511
P L + N LT LP +L +L LS +P L +S N
Sbjct: 91 PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSD-LPPLLEYLGVSNN 141
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 26/109 (23%), Positives = 46/109 (42%), Gaps = 23/109 (21%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
PS+ +++S+ L +P+ +L L N L +P +L+ +H+E N L
Sbjct: 317 PSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLAE-VP--ELPQNLKQLHVEYNPL 369
Query: 476 TG--PLPSSLMNL-------------PNLRELYVQNNMLSGTVPSSLLS 509
+P S+ +L NL++L+V+ N L P S
Sbjct: 370 REFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPES 417
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 19/99 (19%), Positives = 31/99 (31%), Gaps = 20/99 (20%)
Query: 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG--------------CPDLRII 468
S NLT +P + + S E + + P +G +
Sbjct: 18 RHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHEL 76
Query: 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
L + L+ LP P+L L N L+ +P
Sbjct: 77 ELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP 110
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 10/79 (12%), Positives = 26/79 (32%), Gaps = 6/79 (7%)
Query: 422 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS 481
L + +P +L +L ++ N L PD + + + ++ P
Sbjct: 381 DLRMNSHLAEVPE---LPQNLKQLHVETNPLRE-FPDIPE--SVEDLRMNSERVVDPYEF 434
Query: 482 SLMNLPNLRELYVQNNMLS 500
+ L + +++
Sbjct: 435 AHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 26/106 (24%), Positives = 38/106 (35%), Gaps = 20/106 (18%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
P +T I+ + L +P SL L + N LT L + + L
Sbjct: 237 PFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 292
Query: 476 TGPLPSSLMNL--------------PNLRELYVQNNMLSGTVPSSL 507
+ LP +L L P+L EL V NN L +P+
Sbjct: 293 S-ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP 336
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 27/104 (25%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + L ++ +I + L L L L+L N +T I S L + LEDNQ+
Sbjct: 112 KKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 168
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ L L L+ LY+ N +S + L VL
Sbjct: 169 SDI--VPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQ 210
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 26/106 (24%), Positives = 50/106 (47%), Gaps = 6/106 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
P + ++L + +T +I + L++L+ L L L+ N ++ I +G L+ ++L N +
Sbjct: 134 PQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHI 190
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 521
+ +L L NL L + + P + S VV N N +
Sbjct: 191 SDL--RALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTVKNTD 233
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 21/104 (20%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+L K++T + +L+S+ ++ + + + + P++ + L N+L
Sbjct: 24 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKL 80
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
T L NL NL L++ N + L K L+ N
Sbjct: 81 TDI--KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN 122
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 22/85 (25%), Positives = 47/85 (55%), Gaps = 5/85 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
SI I ++ ++ ++ + L ++ +L+L+GN LT I + +L + L++N++
Sbjct: 46 NSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTD-IKPLANLKNLGWLFLDENKV 102
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLS 500
SSL +L L+ L +++N +S
Sbjct: 103 KDL--SSLKDLKKLKSLSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 18/101 (17%), Positives = 36/101 (35%), Gaps = 7/101 (6%)
Query: 423 LSSKNLTGNIP----SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP 478
L S+ +T P + ++ L S+T + + I ++ +
Sbjct: 3 LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIKS- 60
Query: 479 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ LPN+ +L++ N L+ P + L L N
Sbjct: 61 -VQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDEN 100
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 32/211 (15%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHR----- 657
K IG G FG V K + +A+K++ + Q E+ +L + +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDNT 158
Query: 658 -NLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713
N++ L + +E + +K++ + + + +++ A +
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFS----LPLVRK--FAHSILQC 212
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGY 771
++ LH IIH DLK NILL + R+ KV DFG S + V + ++ + Y
Sbjct: 213 LDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQ-SRFY 265
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
PE + + D++S G IL EL++G
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.2 bits (145), Expect = 2e-09
Identities = 23/86 (26%), Positives = 36/86 (41%), Gaps = 3/86 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+T + LS L +P L L L L N+L + + P L+ + L +N+L
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRL 520
Query: 476 TG-PLPSSLMNLPNLRELYVQNNMLS 500
L++ P L L +Q N L
Sbjct: 521 QQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 2e-08
Identities = 31/115 (26%), Positives = 48/115 (41%), Gaps = 9/115 (7%)
Query: 409 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRII 468
+ V+HL+ K+LT + L +L + L L N L P + L ++
Sbjct: 434 SVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVL 491
Query: 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS----SLLSKNVVLNYAGN 519
DN L + + NLP L+EL + NN L + + V+LN GN
Sbjct: 492 QASDNALEN-VD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 21/82 (25%), Positives = 33/82 (40%), Gaps = 7/82 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGP--IPDFSGCPDLRIIHLEDN 473
+ V+ S L N+ + L L EL L N L I CP L +++L+ N
Sbjct: 486 RCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
Query: 474 QLTG--PLPSSLMN-LPNLREL 492
L + L LP++ +
Sbjct: 544 SLCQEEGIQERLAEMLPSVSSI 565
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-09
Identities = 18/76 (23%), Positives = 30/76 (39%), Gaps = 1/76 (1%)
Query: 425 SKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLM 484
S++ G + + L L LT I + L+ + L DN+++G L
Sbjct: 27 SRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSDNRVSGGLEVLAE 85
Query: 485 NLPNLRELYVQNNMLS 500
PNL L + N +
Sbjct: 86 KCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 23/89 (25%), Positives = 43/89 (48%), Gaps = 4/89 (4%)
Query: 411 NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFS-GCPDLRIIH 469
+D + + + LT +I ++L KL+ L +L L N ++G + + CP+L ++
Sbjct: 37 LTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94
Query: 470 LEDNQLTGPL-PSSLMNLPNLRELYVQNN 497
L N++ L L NL+ L + N
Sbjct: 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 7e-09
Identities = 30/129 (23%), Positives = 52/129 (40%), Gaps = 16/129 (12%)
Query: 407 WLQCNS---------DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTG-P 455
L+ N+ P + I LS+ ++ + D L SL L L GN +T P
Sbjct: 38 RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELP 96
Query: 456 IPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 515
F G L+++ L N++ + +L NL L + +N L T+ S +
Sbjct: 97 KSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQ 155
Query: 516 YAGNINLHE 524
++L +
Sbjct: 156 T---MHLAQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 27/92 (29%), Positives = 42/92 (45%), Gaps = 13/92 (14%)
Query: 424 SSKNLT---GNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGP 478
K LT N+P +T E+ L+ N++ IP FS LR I L +NQ++
Sbjct: 19 RGKGLTEIPTNLPETIT------EIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISEL 71
Query: 479 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
P + L +L L + N ++ +P SL
Sbjct: 72 APDAFQGLRSLNSLVLYGNKIT-ELPKSLFEG 102
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 22/88 (25%), Positives = 37/88 (42%), Gaps = 5/88 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
+IT I L + P + L + L N ++ + F G L + L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGN 90
Query: 474 QLTGPLPSSLM-NLPNLRELYVQNNMLS 500
++T LP SL L +L+ L + N ++
Sbjct: 91 KITE-LPKSLFEGLFSLQLLLLNANKIN 117
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 19/88 (21%), Positives = 36/88 (40%), Gaps = 5/88 (5%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIH 469
S+ + L +T +P L L SL L L+ N + + F +L ++
Sbjct: 77 QGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLS 134
Query: 470 LEDNQLTGPLPSSLMNLPNLRELYVQNN 497
L DN+L + L ++ +++ N
Sbjct: 135 LYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 17/106 (16%), Positives = 34/106 (32%), Gaps = 6/106 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ + L + L L L +L L + N L I L ++ L N++
Sbjct: 106 ACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKS-IVMLGFLSKLEVLDLHGNEI 162
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 521
T L L + + + P + + N + +
Sbjct: 163 TNT--GGLTRLKKVNWIDLTGQKCV-NEPVKYQPELYITNTVKDPD 205
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 21/95 (22%), Positives = 37/95 (38%), Gaps = 5/95 (5%)
Query: 427 NLTGNIPSDLTKLS--SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLM 484
++ N +L + L L+LD N L +L I+ + +N+L L
Sbjct: 91 SVNRNRLKNLNGIPSACLSRLFLDNNELRD-TDSLIHLKNLEILSIRNNKLKSI--VMLG 147
Query: 485 NLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
L L L + N ++ T + L K ++ G
Sbjct: 148 FLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 27/123 (21%), Positives = 49/123 (39%), Gaps = 22/123 (17%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + + N+ ++ + + ++L EL L N ++ + L + + N+L
Sbjct: 41 SGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQISD-LSPLKDLTKLEELSVNRNRL 97
Query: 476 TG--PLP-----------------SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
+P SL++L NL L ++NN L V LSK VL+
Sbjct: 98 KNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDL 157
Query: 517 AGN 519
GN
Sbjct: 158 HGN 160
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 16/86 (18%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 434 SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493
L++ V+ L S+T + ++ + +++ + + + NL+EL+
Sbjct: 13 FPDPGLANAVKQNLGKQSVTD-LVSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELH 69
Query: 494 VQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ +N +S P L+K L+ N
Sbjct: 70 LSHNQISDLSPLKDLTKLEELSVNRN 95
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 48/211 (22%), Positives = 86/211 (40%), Gaps = 30/211 (14%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHR----- 657
IG G FG V + + +A+K++ + Q + EV LL ++
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMK 115
Query: 658 -NLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713
+V + LV+E + L+ + ++ +N ++ A+
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS----LNLTRK--FAQQMCTA 169
Query: 714 IEYLHTGCVPAIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
+ +L T + +IIH DLK NILL K K+ DFG S + ++ + Y
Sbjct: 170 LLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQ-SRFY 224
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
PE + D++S G IL+E+ +G+
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 24/139 (17%), Positives = 47/139 (33%), Gaps = 25/139 (17%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKL-----------------SSLVELWLDGNSLTGPIPD- 458
+ I+ + LT +P T L SL L + N L +P
Sbjct: 141 LLEYINADNNQLT-MLPELPTSLEVLSVRNNQLTFLPELPESLEALDVSTNLLES-LPAV 198
Query: 459 FSGCPDLR----IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 514
+N++T +P ++++L + +++N LS + SL +
Sbjct: 199 PVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQP 257
Query: 515 NYAGNINLHEGGRGAKHLN 533
+Y G G ++
Sbjct: 258 DYHGPRIYFSMSDGQQNTL 276
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 30/109 (27%), Positives = 46/109 (42%), Gaps = 26/109 (23%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKL-----------------SSLVELWLDGNSLTGPIPD 458
P ITV+ ++ L ++P L +SL L +D N LT +P+
Sbjct: 80 PQITVLEITQNALI-SLPELPASLEYLDACDNRLSTLPELPASLKHLDVDNNQLTM-LPE 137
Query: 459 FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
L I+ ++NQLT LP +L L V+NN L+ +P
Sbjct: 138 LPA--LLEYINADNNQLTM-LPEL---PTSLEVLSVRNNQLT-FLPELP 179
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 22/91 (24%), Positives = 41/91 (45%), Gaps = 11/91 (12%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 476
+ + L+ NL+ ++P +L + L + N+L +P+ L + DN+L+
Sbjct: 60 QFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPA--SLEYLDACDNRLS 113
Query: 477 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
LP +L+ L V NN L+ +P
Sbjct: 114 T-LPEL---PASLKHLDVDNNQLT-MLPELP 139
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 21/87 (24%), Positives = 35/87 (40%), Gaps = 9/87 (10%)
Query: 425 SKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSS 482
S L ++ EL L+ +L+ +PD + P + ++ + N L LP
Sbjct: 42 PGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPD-NLPPQITVLEITQNALI-SLPEL 98
Query: 483 LMNLPNLRELYVQNNMLSGTVPSSLLS 509
+L L +N LS T+P S
Sbjct: 99 ---PASLEYLDACDNRLS-TLPELPAS 121
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 17/101 (16%), Positives = 27/101 (26%), Gaps = 21/101 (20%)
Query: 422 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLT--- 476
+ + +G + L L L NSL L ++L L
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVP 269
Query: 477 GPLPSSL----------------MNLPNLRELYVQNNMLSG 501
LP+ L LP + L ++ N
Sbjct: 270 KGLPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 18/109 (16%), Positives = 36/109 (33%), Gaps = 8/109 (7%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPD----LRIIHL 470
P + V+ ++ + + +L L L N G + CP L+++ L
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208
Query: 471 EDNQLT---GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
+ + G + L+ L + +N L + LN
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 22/115 (19%), Positives = 42/115 (36%), Gaps = 4/115 (3%)
Query: 398 DPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP 457
+PC S SDP+P + + L L +D + G
Sbjct: 4 EPCELDEESCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYL-LKRVDTEADLGQFT 62
Query: 458 DFSGCPDLRIIHLEDNQLTGPLPSS---LMNLPNLRELYVQNNMLSGTVPSSLLS 509
D L+ + + ++ + ++ + L+EL ++N ++GT P LL
Sbjct: 63 DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLE 117
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 27/85 (31%), Positives = 39/85 (45%), Gaps = 9/85 (10%)
Query: 419 TVIHLSSKNLT---GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
TV+ S+K L IP D+T EL+LDGN T + S L +I L +N++
Sbjct: 13 TVVRCSNKGLKVLPKGIPRDVT------ELYLDGNQFTLVPKELSNYKHLTLIDLSNNRI 66
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLS 500
+ S N+ L L + N L
Sbjct: 67 STLSNQSFSNMTQLLTLILSYNRLR 91
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 20/76 (26%), Positives = 31/76 (40%), Gaps = 1/76 (1%)
Query: 425 SKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLM 484
K+ G I + +L L L L + + P L+ + L +N++ G L
Sbjct: 34 CKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSENRIFGGLDMLAE 92
Query: 485 NLPNLRELYVQNNMLS 500
LPNL L + N L
Sbjct: 93 KLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 21/89 (23%), Positives = 39/89 (43%), Gaps = 4/89 (4%)
Query: 411 NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG-CPDLRIIH 469
+ ++ + L + L ++ S+L KL L +L L N + G + + P+L ++
Sbjct: 44 LTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101
Query: 470 LEDNQLTGPLP-SSLMNLPNLRELYVQNN 497
L N+L L L L+ L + N
Sbjct: 102 LSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 20/116 (17%), Positives = 36/116 (31%), Gaps = 6/116 (5%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSD-LTKLSS-LVELWLDGNSLTGPIPD--FSGCPDLRII 468
++ + I + LS V LWL+ N + I + F+G +
Sbjct: 125 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELN 183
Query: 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524
++N L L + + ++PS L L NL +
Sbjct: 184 LSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKK 238
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 17/99 (17%), Positives = 39/99 (39%), Gaps = 5/99 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWL-DGNSLTGPIPD--FSGCPDLRIIHLE 471
+ I +S ++ I +D + L L E+ + N+L I F P+L+ + +
Sbjct: 54 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY-INPEAFQNLPNLQYLLIS 112
Query: 472 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
+ + ++ L +Q+N+ T+ +
Sbjct: 113 NTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 17/84 (20%), Positives = 26/84 (30%), Gaps = 9/84 (10%)
Query: 417 SITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
+ + NL +P+D S V L + + +P LR
Sbjct: 179 LDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST--Y 234
Query: 474 QLTGPLPSSLMNLPNLRELYVQNN 497
L LP+ L L L E +
Sbjct: 235 NLKK-LPT-LEKLVALMEASLTYP 256
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 34/115 (29%), Positives = 48/115 (41%), Gaps = 30/115 (26%)
Query: 410 CNSDPQPSITVIHLSSKNLT---GNIPSDLTKL------------------SSLVELWLD 448
CN++ +V SSK LT NIP+D KL + L L+L+
Sbjct: 14 CNNNKN---SV-DCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLN 69
Query: 449 GNSLTGPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLM-NLPNLRELYVQNNMLS 500
N L +P F +L + + DN+L LP + L NL EL + N L
Sbjct: 70 DNKLQT-LPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK 122
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 6e-07
Identities = 25/101 (24%), Positives = 37/101 (36%), Gaps = 6/101 (5%)
Query: 419 TVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQL 475
+ L L ++P + L+ L L L N L +P F L+ + L +NQL
Sbjct: 112 AELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQL 169
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
+ L L+ L + NN L VP L
Sbjct: 170 KRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKM 209
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 25/82 (30%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 419 TVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQL 475
T + L L ++P + KL+SL EL L N L +P+ F +L+ + L++NQL
Sbjct: 136 TYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQL 193
Query: 476 TGPLPSSLMNLPNLRELYVQNN 497
+ +L L+ L +Q N
Sbjct: 194 KRVPEGAFDSLEKLKMLQLQEN 215
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 23/89 (25%), Positives = 44/89 (49%), Gaps = 4/89 (4%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKL-SSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
S+ + +S +L + S++ L L N LTG + P ++++ L +N++
Sbjct: 404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR-CLPPKVKVLDLHNNRI 462
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVP 504
+P + +L L+EL V +N L +VP
Sbjct: 463 MS-IPKDVTHLQALQELNVASNQLK-SVP 489
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 24/144 (16%), Positives = 43/144 (29%), Gaps = 25/144 (17%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
P + LS +++ D++ LS L L L N + + F DL + + N
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSHN 110
Query: 474 QLTG----------------------PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 511
+L P+ NL L L + + +
Sbjct: 111 RLQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLH 170
Query: 512 VVLNYAGNINLHEGGRGAKHLNII 535
+ ++ H G + L I
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIP 194
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 11/85 (12%), Positives = 28/85 (32%), Gaps = 1/85 (1%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQL 475
S+ + H+ ++ + + + + + L + + ++ N
Sbjct: 306 SLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVF 365
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLS 500
T + L L+ L +Q N L
Sbjct: 366 TDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 37/272 (13%), Positives = 79/272 (29%), Gaps = 21/272 (7%)
Query: 254 PQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVS 313
+ + V + + L L + L
Sbjct: 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263
Query: 314 KAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERND 372
K V + + + V NL++ + + +++ L + ++ +L +
Sbjct: 264 KCSVKLFQFFWPRP-VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322
Query: 373 GSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNI 432
A +++ L S P + + S T ++ + T ++
Sbjct: 323 ALYSVFAEMNIKMLSIS-------DTPFIHMV------CPPSPSSFTFLNFTQNVFTDSV 369
Query: 433 PSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD-LRIIHLEDNQLT----GPLPSSLMNLP 487
+ L L L L N L + + + D L +
Sbjct: 370 FQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE 428
Query: 488 NLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
++ L + +NML+G+V L K VL+ N
Sbjct: 429 SILVLNLSSNMLTGSVFRCLPPKVKVLDLHNN 460
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 21/82 (25%), Positives = 38/82 (46%), Gaps = 2/82 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
SI V++LSS LTG++ L + L L N + D + L+ +++ NQL
Sbjct: 428 ESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQL 485
Query: 476 TGPLPSSLMNLPNLRELYVQNN 497
L +L+ +++ +N
Sbjct: 486 KSVPDGVFDRLTSLQYIWLHDN 507
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 19/113 (16%), Positives = 42/113 (37%), Gaps = 10/113 (8%)
Query: 407 WLQCNS-------DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF 459
L N+ ++ ++ L + I + +L ELW+ N + +
Sbjct: 54 ALSTNNIEKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSGI 111
Query: 460 SGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 511
+LR++++ +N++T L L L +L + N L + +
Sbjct: 112 EKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 18/79 (22%), Positives = 34/79 (43%), Gaps = 3/79 (3%)
Query: 422 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS 481
H + + + L+ L + L L N++ I SG +LRI+ L N + + +
Sbjct: 31 HGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIKK-IEN 87
Query: 482 SLMNLPNLRELYVQNNMLS 500
L EL++ N ++
Sbjct: 88 LDAVADTLEELWISYNQIA 106
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 13/62 (20%), Positives = 24/62 (38%), Gaps = 1/62 (1%)
Query: 439 LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498
L + N + + F L+ + + +N++ LP+L EL + NN
Sbjct: 41 LDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS 99
Query: 499 LS 500
L
Sbjct: 100 LV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 18/82 (21%), Positives = 30/82 (36%), Gaps = 7/82 (8%)
Query: 422 HLSSKNLTGN-IPS--DLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLT 476
+ + + N I L L L ++ N + I + PDL + L +N L
Sbjct: 43 QFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELILTNNSLV 101
Query: 477 GPLP-SSLMNLPNLRELYVQNN 497
L +L +L L + N
Sbjct: 102 ELGDLDPLASLKSLTYLCILRN 123
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 25/97 (25%), Positives = 39/97 (40%), Gaps = 16/97 (16%)
Query: 409 QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPD 464
QC+ T + SK IP++ L +L N +T P F +
Sbjct: 16 QCSCSG----TTVDCRSKRHASVPAGIPTNAQIL------YLHDNQITKLEPGVFDSLIN 65
Query: 465 LRIIHLEDNQLTGPLPSSLMN-LPNLRELYVQNNMLS 500
L+ ++L NQL LP + + L L L + N L+
Sbjct: 66 LKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT 101
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 27/165 (16%), Positives = 48/165 (29%), Gaps = 28/165 (16%)
Query: 35 LNCGGNENFTDEIGLQWIADDHLI-------YGEISNISVANETRKQ-YMTLRHFPADSR 86
+N GG D G+ + D YG I +N + Y T R+
Sbjct: 10 VNAGGES-HVDVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNEDS-- 66
Query: 87 KYCYKLDVITRTRYLIRATFLYGNFDNNN------------VYPKFDISLGPTHWSTIVI 134
+ Y + + Y++ F F + V DI H +
Sbjct: 67 -FGYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDE 125
Query: 135 SDAATIEVRELIF----LASSPKIDVCLSNATTGQPFISTLELRQ 175
+I+ +L + K+ V P + L + +
Sbjct: 126 IIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMK 170
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 25/111 (22%), Positives = 44/111 (39%), Gaps = 28/111 (25%)
Query: 419 TVIHLSSKNLT---GNIPSDLT-------------------KLSSLVELWLDGNSLTGPI 456
T + + + L +IP T +L LV+L L N LTG I
Sbjct: 11 TTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-I 69
Query: 457 PD--FSGCPDLRIIHLEDNQLTGPLPSSLMN-LPNLRELYVQNNMLSGTVP 504
F G ++ + L +N++ + + + L L+ L + +N +S V
Sbjct: 70 EPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQIS-CVM 118
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 5/88 (5%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIH 469
P + + L LT I + S + EL L N + I + F G L+ ++
Sbjct: 51 GRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLN 108
Query: 470 LEDNQLTGPLPSSLMNLPNLRELYVQNN 497
L DNQ++ +P S +L +L L + +N
Sbjct: 109 LYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 3e-05
Identities = 73/619 (11%), Positives = 171/619 (27%), Gaps = 225/619 (36%)
Query: 22 LDSSSAQM------------PGFVS-LNCGGNENFTDEIGLQWIAD---DHLIYGEISNI 65
+D + + FV +C ++ I ++ DH I +
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSI----LSKEEIDH-IIMSKDAV 61
Query: 66 SVANETR--------KQYMTLRHFPADSRKYCY-----KLDVITRTRYLIRATFLYGN-- 110
+ T KQ ++ F + + Y + R ++ ++
Sbjct: 62 ---SGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118
Query: 111 -FDNNNVYPKFDISLGPTHWSTIVISDAATIEVRE-LIFLASSPKI-------------- 154
+++N V+ K+++S + ++R+ L+ L + +
Sbjct: 119 LYNDNQVFAKYNVSRLQPYL-----------KLRQALLELRPAKNVLIDGVLGSGKTWVA 167
Query: 155 -DVCLSNATTGQPFISTLELRQFNGSVY-------------LTPFEDRYYL--------- 191
DVCLS + + ++ L + Y
Sbjct: 168 LDVCLSYKV----------QCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 192 --SVSARINFGADSEAPVR------YP------DDPFD-RIWES---------------- 220
S + ++ + R Y + + + W +
Sbjct: 218 DHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQV 277
Query: 221 -DSLKKANY----LVDVAAG-TEKVSTKL---PIDLRSDELPPQKV----MQTAVVGT-- 265
D L A L + T L +D R +LP + + + +++
Sbjct: 278 TDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI 337
Query: 266 -NGSLTY----RLNLDGFPGFGWAVTYFAE--IEDLDPDESRK-FRL--VLPGQPDV--- 312
+G T+ +N D +T E + L+P E RK F V P P
Sbjct: 338 RDGLATWDNWKHVNCD-------KLTTIIESSLNVLEPAEYRKMFDRLSVFP--PSAHIP 388
Query: 313 ------------------------SKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFG 348
++V ++ + + S+ L K
Sbjct: 389 TILLSLIWFDVIKSDVMVVVNKLHKYSLVE-KQPKESTISIP-------SIYLELKVKLE 440
Query: 349 KTYDSSRGPLLNAMEINKYLERNDGS---IDGVAIVSVISLY--SSADWAQEGGD-PCLP 402
Y R +++ I K + +D +D S I + + + + +
Sbjct: 441 NEYALHR-SIVDHYNIPKTFDSDDLIPPYLDQY-FYSHIG-HHLKNIEHPERMTLFRMVF 497
Query: 403 VPWSWLQ-----------CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNS 451
+ + +L+ + ++ + + N P ++++++
Sbjct: 498 LDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF------ 551
Query: 452 LTGPIPDFSGCPDLRIIHL 470
L + ++ +
Sbjct: 552 LPKIEENLICSKYTDLLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 4e-04
Identities = 78/511 (15%), Positives = 159/511 (31%), Gaps = 144/511 (28%)
Query: 324 QGKYR----VYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVA 379
Q +Y+ V+E FV +F D + +L+ EI+ + D ++ G
Sbjct: 15 QYQYKDILSVFED-------AFVDNFDCKDVQDMPK-SILSKEEIDHIIMSKD-AVSGTL 65
Query: 380 IVSVISLYSSADWAQEGGDPCLPVPWSWL------QCNSDPQPS-ITVIHLSSKNLTGNI 432
+ L + Q+ + L + + +L + QPS +T +++ ++ N
Sbjct: 66 RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR---QPSMMTRMYIEQRDRLYND 122
Query: 433 PSDLTKLS------------SLVEL------WLDG------NSLTGPIPDFSGCPDLRII 468
K + +L+EL +DG + C ++
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVAL-----DVCLSYKVQ 177
Query: 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRG 528
D ++ +NL N P ++L L Y + N
Sbjct: 178 CKMDFKI------FWLNLKNCNS------------PETVLEMLQKLLYQIDPNWTSRSDH 219
Query: 529 AKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAE 588
+ ++ + I S + + L K + + L V V + A
Sbjct: 220 SSNIKLRIHS--------IQAELRRLLKSK---------PYENCLLVLLNVQNAKAWNAF 262
Query: 589 AAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEV 648
C K+L + T ++ T+ +
Sbjct: 263 NLSC----------KIL--------------------------LTTRF-----KQVTDFL 281
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSVLV-YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA 707
+ + H + +E +S+L+ Y L + T+ +R++ I I
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREV--LTTNPRRLSIIAES-IR 338
Query: 708 EDAAKGIEYLHTGCVPAIIHRDLKSS-NILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 766
+ A + H C + ++SS N+L R + F +H+ +I+
Sbjct: 339 DGLATWDNWKHVNCDK--LTTIIESSLNVLEPAEYRKMFDRLSV--FPPS--AHIPTILL 392
Query: 767 GTVGYLDPEYYISQQLTDKSDVYSFGVILLE 797
+ + D + +K YS L+E
Sbjct: 393 SLI-WFDVIKSDVMVVVNKLHKYS----LVE 418
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 5e-04
Identities = 43/313 (13%), Positives = 89/313 (28%), Gaps = 95/313 (30%)
Query: 557 HKGKKNNYDKEQHRHS----LPVQRP-------VSSLNDAP------AEAAHCFTLSDIE 599
H +++ +H++ L V + D P E H D
Sbjct: 2 HHHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAV 61
Query: 600 DATKMLEKKIGSGGFGVVY----------YGKLKDG--KEIAVKVLTSNSYQGKRE-FTN 646
T L + S +V Y L E + + Y +R+ N
Sbjct: 62 SGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYN 121
Query: 647 EVTLLSRIH------HRNLVQFLGYCQEE-----------GRSVLVYEFMHNGTLKEHLY 689
+ + ++ + + L Q L + G++ + + + ++ +
Sbjct: 122 DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMD 181
Query: 690 GTLTHEQRINWIK--RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVS 746
+I W+ E + ++ L P R SSNI L H ++A++
Sbjct: 182 F------KIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR 235
Query: 747 DFGLSKFAVDGASHVSS-IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 805
SK + + +V L +V +
Sbjct: 236 RLLKSK------PYENCLLV------LL-------------NVQNAKAW----------- 259
Query: 806 SNEKFGANCRNIV 818
F +C+ ++
Sbjct: 260 --NAFNLSCKILL 270
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 49/229 (21%), Positives = 83/229 (36%), Gaps = 50/229 (21%)
Query: 607 KKIGSGGFGVVY--YGKLKDGKEIAVKVLTSN-SY--QGKREFTNEVTLLSRIHHR---- 657
+G G FG V + ++A+K++ + Y + E + +L +I +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKEN 80
Query: 658 --NLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAK 712
V + G + +E + T LKE+ + ++ +A
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPH----VRH--MAYQLCH 134
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILL-------------------DKHMRAKVSDFGLSKF 753
+ +LH + H DLK NIL K+ +V+DFG + F
Sbjct: 135 ALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191
Query: 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
+ H ++IV T Y PE + DV+S G IL E G
Sbjct: 192 DHE---HHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 24/83 (28%), Positives = 34/83 (40%), Gaps = 3/83 (3%)
Query: 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTG 477
+ L S L + L+ L L LD N L F +L + L +NQL
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 478 PLPSSLM-NLPNLRELYVQNNML 499
LP + +L L +LY+ N L
Sbjct: 98 -LPLGVFDHLTQLDKLYLGGNQL 119
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 25/86 (29%), Positives = 37/86 (43%), Gaps = 7/86 (8%)
Query: 419 TVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQL 475
T ++L L + + + L+ L L L N L +P F L ++L NQL
Sbjct: 62 TWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQL 119
Query: 476 TGPLPSSLM-NLPNLRELYVQNNMLS 500
LPS + L L+EL + N L
Sbjct: 120 KS-LPSGVFDRLTKLKELRLNTNQLQ 144
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 23/88 (26%), Positives = 38/88 (43%), Gaps = 5/88 (5%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIH 469
D + ++L L +PS + +L+ L EL L+ N L IP F +L+ +
Sbjct: 104 DHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLS 161
Query: 470 LEDNQLTGPLPSSLMNLPNLRELYVQNN 497
L NQL + L L+ + + N
Sbjct: 162 LSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 59/238 (24%), Positives = 90/238 (37%), Gaps = 64/238 (26%)
Query: 607 KKIGSGGFG-VVYYGKLKDGKEIAVKVLTSN-SY--QGKREFTNEVTLLSRI-----HHR 657
+K+G G FG V+ + + K AVKV+ + Y K E +L +I ++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNN 96
Query: 658 NLVQFLGYCQEEGRSVLV--------YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 709
N+V++ G L+ YE + + Y E IK +
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLGPSLYEI-----ITRNNYNGFHIED----IKL--YCIE 145
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILL-------------------------DKHMRAK 744
K + YL ++ H DLK NILL K K
Sbjct: 146 ILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 745 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
+ DFG + F D + SI+ T Y PE ++ SD++SFG +L EL +G
Sbjct: 203 LIDFGCATFKSD---YHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 22/65 (33%), Positives = 35/65 (53%), Gaps = 5/65 (7%)
Query: 438 KLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLMN-LPNLRELYV 494
+L++L L L GN L +P+ F +L+ + L +NQL LP + + L NL L +
Sbjct: 83 ELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNL 140
Query: 495 QNNML 499
+N L
Sbjct: 141 AHNQL 145
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 9e-04
Identities = 17/92 (18%), Positives = 40/92 (43%), Gaps = 12/92 (13%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 476
+L K++T + + +L+S+ ++ + + + + P++R + L N+L
Sbjct: 20 ETIKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-VQGIQYLPNVRYLALGGNKLH 76
Query: 477 GPLPSSLM---NLPNLRELYVQNNMLSGTVPS 505
+ L NL L + N L ++P+
Sbjct: 77 -----DISALKELTNLTYLILTGNQLQ-SLPN 102
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 824 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.98 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.98 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.98 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.98 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.98 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.98 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.98 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.98 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.98 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.98 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.98 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.98 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.98 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.98 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.98 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.98 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.98 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.98 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.98 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.98 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.98 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.98 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.98 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.98 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.98 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.98 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.98 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.98 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.98 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.98 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.98 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.98 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.98 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.98 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.98 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.98 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.98 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.74 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.66 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.64 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.63 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.62 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.62 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.61 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.6 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.59 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.59 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.59 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.59 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.58 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.58 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.58 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.58 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.57 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.57 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.57 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.55 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.55 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.54 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.54 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.52 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.52 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.52 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.52 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.52 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.52 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.52 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.52 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.52 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.5 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.49 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.49 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.48 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.48 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.48 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.48 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.48 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.48 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.47 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.46 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.46 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.45 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.45 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.45 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.45 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.45 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.44 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.43 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.43 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.43 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.43 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.42 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.42 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.42 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.42 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.41 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.41 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.4 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.4 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.4 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.4 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.4 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.4 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.4 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.4 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.4 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.4 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.39 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.39 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.39 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.39 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.39 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.39 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.38 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.38 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.38 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.38 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.38 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.37 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.36 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.36 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.36 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.36 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.36 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.36 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.36 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.35 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.34 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.34 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.34 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.33 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.33 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.33 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.33 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.32 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.32 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.32 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.31 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.3 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.3 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.29 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.29 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.28 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.28 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.28 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.27 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.26 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.24 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.24 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.24 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.23 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.23 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.22 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.21 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.19 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.19 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.18 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.16 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.14 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.13 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.13 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.1 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.1 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.1 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.1 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.04 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.02 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.01 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.0 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.95 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.89 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.88 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.87 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.83 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.78 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.78 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.72 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.72 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 98.62 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.61 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.39 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.35 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.35 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.3 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.24 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.13 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.12 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.1 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.07 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.03 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.02 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.99 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.96 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.82 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.78 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.76 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.72 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.62 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.6 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.55 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.41 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.41 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.38 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.06 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.02 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.0 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.96 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.73 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.64 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.59 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.57 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.53 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.32 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.31 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.14 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.61 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.36 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.61 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 94.35 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 94.26 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 93.86 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 93.16 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 93.0 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 91.6 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 91.14 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 90.06 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 89.27 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.84 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=392.81 Aligned_cols=208 Identities=25% Similarity=0.389 Sum_probs=182.7
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|++.+.||+|+||+||+|+++ +++.||||++++.. ....+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 678899999999999999876 68999999997542 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
|++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+......
T Consensus 114 ~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 114 AKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999853 45689999999999999999999998 99999999999999999999999999998765432
Q ss_pred -CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcH
Q 003385 759 -SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (824)
Q Consensus 759 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i 817 (824)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+..++|
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i 246 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI 246 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 23445678999999999999999999999999999999999999999876644444433
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=394.51 Aligned_cols=199 Identities=27% Similarity=0.406 Sum_probs=179.1
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
|.+.++||+|+||+||+|+++ +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..+||||||++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 556678999999999999986 6899999999766555667789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+....... .
T Consensus 156 g~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 226 (346)
T 4fih_A 156 GALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 226 (346)
T ss_dssp EEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred CcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-c
Confidence 999998842 4589999999999999999999998 999999999999999999999999999987644322 3
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+...
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 275 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 275 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 3456899999999999999999999999999999999999999987553
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=389.61 Aligned_cols=207 Identities=29% Similarity=0.526 Sum_probs=178.4
Q ss_pred HHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
.+.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..++|
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 93 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 93 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 3457789999999999999874 4678999999876666677899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccc---------CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 003385 676 YEFMHNGTLKEHLYGTL---------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~ 746 (824)
||||++|+|.++|.... .....+++.+++.++.||++||+|||++ +|+||||||+|||+++++.+||+
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEEC
Confidence 99999999999996532 2345789999999999999999999998 99999999999999999999999
Q ss_pred ecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCccc
Q 003385 747 DFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG 811 (824)
Q Consensus 747 DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~ 811 (824)
|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~ 237 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 237 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999865443322 2234568999999999999999999999999999999998 99999875533
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=394.10 Aligned_cols=207 Identities=25% Similarity=0.409 Sum_probs=173.9
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
+|.+.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+++..+|||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4667899999999999999976 68999999997543 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
|++|+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 105 ~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 105 CEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999998542 234578889999999999999999998 99999999999999999999999999998653321
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccch
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC 814 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~ 814 (824)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+..
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 234 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV 234 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 2234567999999999999999999999999999999999999999876544333
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=396.41 Aligned_cols=198 Identities=27% Similarity=0.418 Sum_probs=179.0
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
|.+.++||+|+||.||+|+++ +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..|||||||++
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 556788999999999999986 6899999999876666667789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|.+++. ...+++..+..++.||+.||+|||++ +||||||||+|||++.++++||+|||+|+....... .
T Consensus 233 G~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 303 (423)
T 4fie_A 233 GALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 303 (423)
T ss_dssp EEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-C
T ss_pred CcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-c
Confidence 99999884 34588999999999999999999998 999999999999999999999999999987644332 3
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+..
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 351 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 351 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 345679999999999999999999999999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=387.65 Aligned_cols=205 Identities=29% Similarity=0.513 Sum_probs=172.1
Q ss_pred HhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 604 MLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
.+.++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+||||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46789999999999999875 478899999987666667789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccC-----------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 003385 678 FMHNGTLKEHLYGTLT-----------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~ 746 (824)
||++|+|.++++.... ....+++.+++.++.||++||+|||++ +|+||||||+|||+++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence 9999999999965422 234689999999999999999999998 99999999999999999999999
Q ss_pred ecCCcccccCCCC-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCccc
Q 003385 747 DFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG 811 (824)
Q Consensus 747 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~ 811 (824)
|||+|+....... ......+||+.|||||++.+..++.++|||||||++|||+| |+.||.+....
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~ 267 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 267 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH
Confidence 9999986544322 23345679999999999999999999999999999999999 99999875533
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=387.53 Aligned_cols=205 Identities=25% Similarity=0.436 Sum_probs=176.5
Q ss_pred HHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
.++.++||+|+||+||+|++. +++.||||+++.... ...++|.+|+.+|++++|||||+++|+|.+.+..++|
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 456789999999999999873 467899999975432 3346799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhccc------------CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 003385 676 YEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 743 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~v 743 (824)
||||++|+|.++|.... .....+++..++.++.||++||+|||++ +||||||||+|||+++++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCE
Confidence 99999999999996432 1234689999999999999999999998 99999999999999999999
Q ss_pred EEEecCCcccccCCC-CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 003385 744 KVSDFGLSKFAVDGA-SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKF 810 (824)
Q Consensus 744 kL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~ 810 (824)
||+|||+|+...... .......+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+...
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~ 253 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 253 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence 999999998654332 223345679999999999999999999999999999999998 8999987553
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=384.48 Aligned_cols=203 Identities=25% Similarity=0.339 Sum_probs=173.6
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.+.++||+|+||+||+|+++ +|+.||||+++.. ....+|+++|++++|||||++++++.+++..+||||||++
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~-----~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT-----TCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHH-----HhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 445678999999999999986 6899999999743 2335799999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCcccccCCCCc
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~~~ 760 (824)
|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++ ++||+|||+|+........
T Consensus 135 g~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 135 GSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999853 45689999999999999999999998 999999999999999987 6999999999876443211
Q ss_pred ----eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcH
Q 003385 761 ----VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (824)
Q Consensus 761 ----~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i 817 (824)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+...+|
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i 268 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI 268 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 123457999999999999999999999999999999999999999876544444333
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=383.22 Aligned_cols=206 Identities=30% Similarity=0.397 Sum_probs=172.2
Q ss_pred HHhhccccccCcEEEEEEEEc----CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~----~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
|++.+.||+|+||+||+|++. .++.||||+++.... .....+.+|+++|++++|||||++++++.+++..++||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 667899999999999999863 467899999975432 23456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
|||++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+....
T Consensus 106 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 106 DFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp CCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999853 45689999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 816 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~ 816 (824)
... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+....
T Consensus 179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~ 237 (304)
T 3ubd_A 179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM 237 (304)
T ss_dssp --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHH
Confidence 322 23456799999999999999999999999999999999999999987654443333
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=371.37 Aligned_cols=203 Identities=24% Similarity=0.449 Sum_probs=164.3
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
.|.+.+.||+|+||+||+|+++ +|+.||||++++... ...+.+.+|+++|++++||||+++++++.+++..++|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4678899999999999999875 689999999975432 224568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+ +|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+.....
T Consensus 94 y~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 94 YA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp CC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred CC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 99 6799998853 45689999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCceeccccCCCCCcchhccccCCC-CchHHHHHHHHHHHHHHcCCCCCCCCccccch
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANC 814 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~ 814 (824)
. .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||.+....+..
T Consensus 166 ~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~ 221 (275)
T 3hyh_A 166 N--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF 221 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred C--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 2 2345679999999999998876 47999999999999999999999876544333
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=376.02 Aligned_cols=198 Identities=35% Similarity=0.609 Sum_probs=165.7
Q ss_pred HHhhccccccCcEEEEEEEEcCCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
..+.++||+|+||+||+|+++ ..||||+++... ....+.|.+|+++|++++|||||+++|++.+ +..+||||||+
T Consensus 38 l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~ 114 (307)
T 3omv_A 38 VMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCE 114 (307)
T ss_dssp CCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCS
T ss_pred eEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCC
Confidence 346789999999999999875 369999987442 2334679999999999999999999999865 46799999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC-C
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-S 759 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~ 759 (824)
+|+|.++|... ...+++.++..++.||++||+|||++ +||||||||+|||+++++.+||+|||+|+...... .
T Consensus 115 gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 115 GSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp SCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999642 45689999999999999999999998 99999999999999999999999999998654322 2
Q ss_pred ceeccccCCCCCcchhcccc---CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~---~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......+||+.|||||++.. ..|+.++|||||||++|||++|+.||.+..
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence 23345679999999999864 458999999999999999999999998643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=372.51 Aligned_cols=196 Identities=31% Similarity=0.486 Sum_probs=167.4
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeec----CCeEEEEE
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVY 676 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~ 676 (824)
.+.++||+|+||+||+|.++ +++.||+|++.... ....+.|.+|+++|++++|||||++++++.+ ++..++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999886 58899999986442 2334678999999999999999999999864 35679999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecCCccccc
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAV 755 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~-~~~vkL~DFGla~~~~ 755 (824)
|||++|+|.+++.. ...+++..+..++.||+.||+|||++. ++|+||||||+|||++. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999853 456889999999999999999999971 13999999999999985 7999999999997543
Q ss_pred CCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
. ......+||+.|||||++. +.|+.++|||||||++|||++|+.||.+.
T Consensus 184 ~---~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 184 A---SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp T---TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred C---CccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 2 2334567999999999876 46999999999999999999999999753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=375.29 Aligned_cols=212 Identities=29% Similarity=0.447 Sum_probs=179.3
Q ss_pred HHHHHHHHhhccccccCcEEEEEEEEcC------CcEEEEEEeccCCc-ccchhhhHHHHHHhhcCC-Cccceeeceeec
Q 003385 597 DIEDATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHH-RNLVQFLGYCQE 668 (824)
Q Consensus 597 ~~~~~~~~i~~~LG~G~fg~Vy~a~~~~------g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~ 668 (824)
++....+.+.+.||+|+||+||+|++.. ++.||||+++.... ...+.|.+|+++|.+++| ||||+++|+|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 3445567788999999999999998753 35799999976533 335678999999999965 999999999866
Q ss_pred C-CeEEEEEEecCCCCHHHHhhcccC------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 003385 669 E-GRSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 735 (824)
Q Consensus 669 ~-~~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NI 735 (824)
. +..++|||||++|+|.++|+.... ....+++.+++.++.|||+||+|||++ +||||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccce
Confidence 4 568999999999999999965321 134589999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEecCCcccccCCCC-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCccc
Q 003385 736 LLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG 811 (824)
Q Consensus 736 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~ 811 (824)
|+++++.+||+|||+|+....... ......+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999986644333 23445679999999999999999999999999999999998 99999876543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=358.35 Aligned_cols=198 Identities=28% Similarity=0.418 Sum_probs=159.1
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCC----------
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG---------- 670 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---------- 670 (824)
|++.+.||+|+||+||+|+++ +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 567789999999999999976 689999999975432 23467889999999999999999999986544
Q ss_pred --eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 003385 671 --RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 748 (824)
Q Consensus 671 --~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DF 748 (824)
..++|||||++|+|.+++.... ......+..++.++.||++||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccC
Confidence 3689999999999999996542 223345667889999999999999998 9999999999999999999999999
Q ss_pred CCcccccCCCCc-----------eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 749 GLSKFAVDGASH-----------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 749 Gla~~~~~~~~~-----------~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
|+|+........ .....+||+.|||||++.+..|+.++|||||||++|||++ ||.+
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 999865443211 1234579999999999999999999999999999999996 7765
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=363.09 Aligned_cols=197 Identities=27% Similarity=0.431 Sum_probs=160.6
Q ss_pred HHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCC----eEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lV~E~ 678 (824)
+.+.++||+|+||+||+|+++ |+.||||+++..... ...+..|+..+.+++|||||++++++.+++ ..+|||||
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 456789999999999999985 899999999653221 222345666667889999999999997654 57999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-----VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
|++|+|.+++.. ..+++..+..++.|++.||+|||+++ .++|+||||||+|||++.++++||+|||+|+.
T Consensus 83 ~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 83 HEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999953 45889999999999999999999752 35899999999999999999999999999987
Q ss_pred ccCCCCc---eeccccCCCCCcchhccccC------CCCchHHHHHHHHHHHHHHcCCCCCC
Q 003385 754 AVDGASH---VSSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISGQEAIS 806 (824)
Q Consensus 754 ~~~~~~~---~~~~~~gt~~y~aPE~l~~~------~~~~~~DIwSlGvil~elltG~~Pf~ 806 (824)
....... .....+||+.|||||++.+. .++.++|||||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 6543322 12345799999999998754 36679999999999999999987764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=366.52 Aligned_cols=210 Identities=21% Similarity=0.384 Sum_probs=175.7
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeec------CCeE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------EGRS 672 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~~~ 672 (824)
+|.+.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+..
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 4677889999999999999986 68999999997542 2234568899999999999999999998753 4678
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
++|||||+ |+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 135 ~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence 99999996 67988884 346789999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCC---CceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 753 FAVDGA---SHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 753 ~~~~~~---~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
...... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+....|.+
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~ 277 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM 277 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 654321 2233456899999999998875 568999999999999999999999998775555555443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=353.25 Aligned_cols=196 Identities=25% Similarity=0.372 Sum_probs=167.1
Q ss_pred HHHhhccccccCcEEEEEEEEc----CCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~----~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
.|.+.++||+|+||+||+|+++ .++.||||++.... ...++.+|+++|+++ +||||+++++++.+.++.++||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 4667889999999999999864 46789999986543 345678999999998 6999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCccccc
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAV 755 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~-~~vkL~DFGla~~~~ 755 (824)
||+++|+|.+++. .+++.++..++.|++.||+|||++ ||+||||||+|||++.+ +++||+|||+|+...
T Consensus 100 E~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 100 PYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp ECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred eCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 9999999999883 378889999999999999999998 99999999999999877 899999999997543
Q ss_pred CCCC---------------------------ceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 756 DGAS---------------------------HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 756 ~~~~---------------------------~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
+... ......+||+.|||||++.+. .|+.++||||+||++|||++|+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 3211 112345799999999999875 589999999999999999999999965
Q ss_pred Cc
Q 003385 808 EK 809 (824)
Q Consensus 808 ~~ 809 (824)
..
T Consensus 250 ~~ 251 (361)
T 4f9c_A 250 AS 251 (361)
T ss_dssp CS
T ss_pred CC
Confidence 43
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=372.78 Aligned_cols=197 Identities=28% Similarity=0.399 Sum_probs=169.3
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhH---HHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTN---EVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~---Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
|.+.+.||+|+||+||+|+++ +|+.||||++++... .....+.+ ++++++.++|||||++++++.+.+..++|
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 446789999999999999986 689999999975321 11222333 45666777899999999999999999999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
||||+||+|.++|.. ...+++..+..++.||+.||+|||++ |||||||||+|||++.+|++||+|||+|+...
T Consensus 271 mEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp ECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999853 45689999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
... ....+||+.|||||++.. ..|+.++|+||+||++|||++|+.||.+..
T Consensus 344 ~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~ 395 (689)
T 3v5w_A 344 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395 (689)
T ss_dssp SCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred CCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 432 345689999999999975 579999999999999999999999997654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=372.77 Aligned_cols=208 Identities=25% Similarity=0.416 Sum_probs=182.2
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.|.+.+.||+|+||+||+|+++ +|+.||+|++........+.+.+|+++|++++|||||++++++.+.+..++|||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 3667899999999999999886 689999999987655556778999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC--CcEEEEecCCcccccCCC
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~--~~vkL~DFGla~~~~~~~ 758 (824)
+|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+......
T Consensus 238 gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 238 GGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 9999998843 235688999999999999999999998 99999999999999864 899999999998765432
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcH
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i 817 (824)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+.+..|
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i 368 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 368 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 334567999999999999999999999999999999999999999876544443333
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=342.32 Aligned_cols=211 Identities=25% Similarity=0.336 Sum_probs=181.7
Q ss_pred HHhhccccccCcEEEEEEEEcC-CcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~-g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
+.+.++||+|+||+||+|+++. ++.||||++++... ...+.+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey 155 (437)
T 4aw2_A 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY 155 (437)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4567899999999999999874 78899999975321 2234588999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++......
T Consensus 156 ~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 156 YVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 9999999998542 45689999999999999999999998 99999999999999999999999999998665544
Q ss_pred CceeccccCCCCCcchhccc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 759 SHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
.......+||+.|+|||++. ...++.++|||||||++|||++|+.||.+....+.+.+|++
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~ 295 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhh
Confidence 44445567999999999987 46789999999999999999999999988765555555544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=339.45 Aligned_cols=209 Identities=25% Similarity=0.320 Sum_probs=179.9
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|+||.||+|+++ +++.||+|++++.. ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 150 (410)
T 3v8s_A 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 150 (410)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 455689999999999999987 57899999996532 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++......
T Consensus 151 ~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 151 MPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp CTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 999999998843 3578889999999999999999998 99999999999999999999999999998765443
Q ss_pred CceeccccCCCCCcchhccccCC----CCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQ----LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~----~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
.......+||+.|+|||++.... ++.++|||||||++|||++|+.||.+....+.+.+|++
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 287 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 287 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHh
Confidence 33445677999999999998765 78899999999999999999999987665555555544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.26 Aligned_cols=199 Identities=26% Similarity=0.425 Sum_probs=176.7
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
+|.+.+.||+|+||.||+|.+. +++.||||++........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 4556789999999999999864 689999999976655556778999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 101 ~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 101 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp TCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 9999998853 3578899999999999999999998 999999999999999999999999999876544332
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2334569999999999999999999999999999999999999997643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.11 Aligned_cols=199 Identities=27% Similarity=0.384 Sum_probs=174.5
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
+.+.+.||+|+||.||+|+.+ +++.||+|++++.. ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~ 86 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence 456789999999999999886 68999999997542 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++......
T Consensus 87 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 87 ANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp CTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 999999998843 45688999999999999999999998 99999999999999999999999999997543222
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 22345679999999999999999999999999999999999999998755
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=324.98 Aligned_cols=200 Identities=28% Similarity=0.467 Sum_probs=175.5
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 96 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence 567789999999999999984 78999999996542 233456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 97 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 97 SGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp TTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 99999998853 35688999999999999999999998 99999999999999999999999999997654332
Q ss_pred ceeccccCCCCCcchhccccCCCC-chHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~-~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
.....+||+.|+|||++.+..++ .++||||+||++|||++|+.||.+....
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 220 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH
Confidence 23456799999999999988876 7899999999999999999999876533
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=335.71 Aligned_cols=211 Identities=26% Similarity=0.308 Sum_probs=181.2
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
+.+.+.||+|+||.||+|+++ +++.||||++++.. ....+.+.+|..++.+++||||+++++++.+.+..++||||
T Consensus 63 f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~ 142 (412)
T 2vd5_A 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY 142 (412)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence 456789999999999999986 68999999997532 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++......
T Consensus 143 ~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 143 YVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp CCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 9999999998532 24688999999999999999999998 99999999999999999999999999998765443
Q ss_pred CceeccccCCCCCcchhccc-------cCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 759 SHVSSIVRGTVGYLDPEYYI-------SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~-------~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
.......+||+.|+|||++. ...++.++|||||||++|||++|+.||.+....+.+.+|++
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 33344567999999999987 35689999999999999999999999988765555555554
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=330.21 Aligned_cols=205 Identities=28% Similarity=0.403 Sum_probs=173.1
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
.|.+.+.||+|+||.||+|+++ +++.||||++++.. ....+.+.+|.++++.+ +||||+++++++.+.+..++||
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~ 103 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence 4567789999999999999986 58899999997542 22345577899999988 6999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++....
T Consensus 104 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 104 EFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 99999999998843 45688999999999999999999998 999999999999999999999999999975332
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccch
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC 814 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~ 814 (824)
. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+..
T Consensus 177 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~ 233 (353)
T 3txo_A 177 N-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred C-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH
Confidence 2 22334567999999999999999999999999999999999999999876544333
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=321.37 Aligned_cols=204 Identities=48% Similarity=0.821 Sum_probs=179.8
Q ss_pred HHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 682 (824)
|.+.+.||+|+||.||+|++++++.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 41 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 120 (321)
T 2qkw_B 41 FDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120 (321)
T ss_dssp CSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred cCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence 44668899999999999998889999999987665555678899999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC-Cce
Q 003385 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-SHV 761 (824)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~ 761 (824)
+|.+++.........+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 121 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp BTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred cHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 99999865544445689999999999999999999998 99999999999999999999999999997643322 222
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~ 245 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence 334458999999999999999999999999999999999999997654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.84 Aligned_cols=214 Identities=42% Similarity=0.749 Sum_probs=185.4
Q ss_pred cCHHHHHH--HHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcc-cchhhhHHHHHHhhcCCCccceeeceeecC
Q 003385 593 FTLSDIED--ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEE 669 (824)
Q Consensus 593 ~~~~~~~~--~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 669 (824)
++..++.. ..|.+.+.||+|+||.||+|++++++.||||+++..... ....+.+|++++++++||||+++++++.+.
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 44455443 345667899999999999999888999999999765332 344689999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003385 670 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (824)
Q Consensus 670 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFG 749 (824)
+..++||||+++|+|.+++.........+++..+..++.|++.||+|||+++.++|+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 99999999999999999997765566679999999999999999999999765689999999999999999999999999
Q ss_pred CcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003385 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 806 (824)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~ 806 (824)
+++..............||+.|+|||.+.+..++.++|||||||++|||++|+.||+
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 998765544445555669999999999999999999999999999999999999996
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=314.83 Aligned_cols=200 Identities=30% Similarity=0.530 Sum_probs=175.0
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.+.+.+.||+|+||.||+|++. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (310)
T 3s95_A 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90 (310)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence 3456789999999999999986 588999999876665667789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 91 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 91 GGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 99999998642 45688999999999999999999998 9999999999999999999999999999765432221
Q ss_pred e-------------eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 761 V-------------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 761 ~-------------~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
. .....||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~ 224 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence 1 1145699999999999999999999999999999999999999865
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=316.83 Aligned_cols=202 Identities=27% Similarity=0.450 Sum_probs=170.9
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
.+|.+.+.||+|+||.||+|++. +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 35667899999999999999876 6889999998644322 2356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++....
T Consensus 91 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 91 EYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp ECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999853 34688999999999999999999998 999999999999999999999999999986654
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
..........||+.|+|||.+.+..++.++||||+||++|||++|+.||.+..
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 43333444569999999999999999999999999999999999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=320.85 Aligned_cols=198 Identities=28% Similarity=0.469 Sum_probs=174.4
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|+||.||+|+.+ +|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~ 87 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 87 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence 456789999999999999886 689999999975421 2345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++....
T Consensus 88 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 88 IEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp CCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 999999999853 35688899999999999999999998 999999999999999999999999999986532
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 209 (318)
T 1fot_A 159 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 209 (318)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred --ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 223457999999999999999999999999999999999999999875533
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=323.62 Aligned_cols=201 Identities=27% Similarity=0.411 Sum_probs=176.0
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc------cchhhhHHHHHHhhcCCCccceeeceeecCCeEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 674 (824)
.|.+.+.||+|+||.||+|+++ +|+.||+|+++..... ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 3567889999999999999986 6899999999764322 23568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEEecCC
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFGL 750 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~----~vkL~DFGl 750 (824)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus 93 v~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 93 ILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999843 45688999999999999999999998 999999999999998876 799999999
Q ss_pred cccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 751 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
++...... .....+||+.|+|||++....++.++||||+||++|+|++|..||.+....
T Consensus 166 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~ 224 (361)
T 2yab_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224 (361)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred ceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 98664432 223456999999999999999999999999999999999999999875533
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=316.31 Aligned_cols=196 Identities=27% Similarity=0.454 Sum_probs=174.7
Q ss_pred hhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCC
Q 003385 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 683 (824)
..++||+|+||.||+|+.+ +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 49 ~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 128 (321)
T 2c30_A 49 SYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128 (321)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred ccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCC
Confidence 3568999999999999987 799999999986665556778899999999999999999999999999999999999999
Q ss_pred HHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceec
Q 003385 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 763 (824)
Q Consensus 684 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 763 (824)
|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 129 L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~ 199 (321)
T 2c30_A 129 LTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 199 (321)
T ss_dssp HHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBC
T ss_pred HHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-ccc
Confidence 999884 24588999999999999999999998 999999999999999999999999999876544322 223
Q ss_pred cccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 764 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 764 ~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4569999999999999999999999999999999999999997644
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=323.70 Aligned_cols=202 Identities=29% Similarity=0.458 Sum_probs=175.1
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
.|.+.+.||+|+||.||+|+++ +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++||
T Consensus 18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~ 97 (345)
T 1xjd_A 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97 (345)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence 4557789999999999999986 58899999997542 22345577899999887 8999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++....
T Consensus 98 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 98 EYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999853 35688999999999999999999998 999999999999999999999999999975433
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 171 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (345)
T 1xjd_A 171 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 224 (345)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH
Confidence 22 2234567999999999999999999999999999999999999999876533
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=322.89 Aligned_cols=206 Identities=23% Similarity=0.327 Sum_probs=177.3
Q ss_pred HHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-----cccchhhhHHHHHHhhcCCCccceeeceeecCCeE
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 672 (824)
....|.+.+.||+|+||.||+|.++ +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3456788899999999999999876 68999999986432 12346789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEEecC
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFG 749 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~---vkL~DFG 749 (824)
++||||+++++|.+.+.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence 999999999999988855433445688999999999999999999998 9999999999999987654 9999999
Q ss_pred CcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus 179 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 179 VAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp TCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 998664432 2233456999999999999999999999999999999999999999764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=319.00 Aligned_cols=201 Identities=26% Similarity=0.411 Sum_probs=166.2
Q ss_pred HHHhhccccccCcEEEEEEEE----cCCcEEEEEEeccCC----cccchhhhHHHHHHhhcCCCccceeeceeecCCeEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~----~~g~~vAVK~l~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 673 (824)
.|.+.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|++++++++||||+++++++.+.+..+
T Consensus 18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 97 (327)
T 3a62_A 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY 97 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence 456789999999999999987 478999999997542 223456788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 98 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 98 LILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999998843 34578889999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 226 (327)
T 3a62_A 171 SIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR 226 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH
Confidence 43322 223345699999999999999999999999999999999999999987553
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=323.59 Aligned_cols=204 Identities=27% Similarity=0.354 Sum_probs=175.7
Q ss_pred HHHhhccccccCcEEEEEEEEcC-CcEEEEEEeccCC---cccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~-g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
.|.+.+.||+|+||.||+|+++. ++.||||+++... ....+.+..|..++..+ +||+|+++++++.+.+..++||
T Consensus 21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 100 (353)
T 2i0e_A 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 100 (353)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence 35567899999999999999874 7889999997542 12345577899999887 7999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++++||+|||+++....
T Consensus 101 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 101 EYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999853 34688999999999999999999998 999999999999999999999999999975432
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 813 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~ 813 (824)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.
T Consensus 174 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~ 229 (353)
T 2i0e_A 174 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229 (353)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH
Confidence 22 233456799999999999999999999999999999999999999987654333
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.67 Aligned_cols=198 Identities=25% Similarity=0.394 Sum_probs=172.8
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
.+.+.+.||+|+||.||+|+++ +++.||||++++... ...+.+.+|..++.++ +||||+++++++.+.+..++||
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 3567789999999999999987 578899999975432 2345578899999887 8999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++....
T Consensus 133 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 133 EYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999998853 45689999999999999999999998 999999999999999999999999999975332
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 206 ~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 206 P-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp T-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred C-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 2 2234556799999999999999999999999999999999999999964
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=313.97 Aligned_cols=201 Identities=27% Similarity=0.405 Sum_probs=176.1
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc------cchhhhHHHHHHhhcCCCccceeeceeecCCeE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 672 (824)
...|.+.+.||+|+||.||+|+++ +++.||+|+++..... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 345778899999999999999986 6889999998754322 245688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEEec
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDF 748 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~----~vkL~DF 748 (824)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999843 45688999999999999999999998 999999999999999877 8999999
Q ss_pred CCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 749 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 749 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
|+++...... ......||+.|+|||++....++.++|||||||++|||++|+.||.+..
T Consensus 163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 9998654332 2234569999999999998999999999999999999999999997654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.66 Aligned_cols=197 Identities=25% Similarity=0.397 Sum_probs=172.6
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
|.+.+.||+|+||.||+|+++ +++.||+|+++.... ...+.+.+|..+++++ +||||+++++++.+.+..++|||
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e 90 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 90 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence 456789999999999999986 588999999975432 2234578899999988 89999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.....
T Consensus 91 ~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 91 YVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 9999999998853 35688999999999999999999998 9999999999999999999999999999754322
Q ss_pred CCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 2 233456799999999999999999999999999999999999999965
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=321.83 Aligned_cols=198 Identities=26% Similarity=0.350 Sum_probs=174.6
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|+||.||+|+++ +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 43 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 122 (350)
T 1rdq_E 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence 456789999999999999986 689999999965422 2345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 123 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 123 VAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp CTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 999999999853 34588999999999999999999998 9999999999999999999999999999865332
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 244 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH
Confidence 23456999999999999999999999999999999999999999875533
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=312.35 Aligned_cols=210 Identities=25% Similarity=0.377 Sum_probs=174.9
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcc--cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
+|.+.+.||+|+||+||+|++.+++.||+|+++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 22 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 101 (311)
T 3niz_A 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101 (311)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECC
T ss_pred hhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCC
Confidence 35677899999999999999988999999999754322 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++ +|.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 102 ~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 102 EK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp SE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred CC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 85 78777753 234588999999999999999999998 999999999999999999999999999986543322
Q ss_pred ceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 760 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+....+.+
T Consensus 175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 234 (311)
T 3niz_A 175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS 234 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHH
T ss_pred -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 2233468999999999876 5689999999999999999999999988665555444443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=319.89 Aligned_cols=202 Identities=27% Similarity=0.430 Sum_probs=175.9
Q ss_pred HHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
....|.+.+.||+|+||.||+|.++ +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3456778899999999999999876 688999999975432 2345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEEecCCcc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSK 752 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~---~~vkL~DFGla~ 752 (824)
|||+++|+|.+.+.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++
T Consensus 107 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999998843 35688999999999999999999998 99999999999999865 459999999997
Q ss_pred cccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 234 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 654332 2234569999999999999999999999999999999999999997654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=324.02 Aligned_cols=208 Identities=29% Similarity=0.393 Sum_probs=170.2
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHH-HhhcCCCccceeeceeecCCeEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTL-LSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
.|.+.+.||+|+||.||+|+++ +++.||||++++... ...+.+.+|..+ ++.++||||+++++++.+.+..++||
T Consensus 39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~ 118 (373)
T 2r5t_A 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118 (373)
T ss_dssp GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence 3567899999999999999987 578899999975432 223445667666 57789999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++....
T Consensus 119 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 119 DYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999998843 35678889999999999999999998 999999999999999999999999999986433
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcH
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i 817 (824)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+..++|
T Consensus 192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i 251 (373)
T 2r5t_A 192 HN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 251 (373)
T ss_dssp CC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH
T ss_pred CC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 22 2334567999999999999999999999999999999999999999876544444443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=315.12 Aligned_cols=199 Identities=20% Similarity=0.350 Sum_probs=174.6
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.|.+.+.||+|+||.||+|.++ +++.+|+|+++... .....+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 3567789999999999999886 57889999987443 335568899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--CCcEEEEecCCcccccCCC
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~~ 758 (824)
+|+|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+++......
T Consensus 85 g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 85 GLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 9999998843 234688999999999999999999998 9999999999999997 7899999999998764432
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......||+.|+|||++.+..++.++||||+||++|||++|..||.+..
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 207 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence 2334568999999999998889999999999999999999999998755
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=308.24 Aligned_cols=201 Identities=31% Similarity=0.554 Sum_probs=176.2
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
.|.+.+.||+|+||.||+|++.+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 4556789999999999999998899999999975443 356789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 90 ~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 90 GCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp CBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 9999998532 34588999999999999999999998 99999999999999999999999999997654332222
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.....+|+.|+|||.+....++.++||||+||++|||++ |+.||.+..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence 333457788999999999999999999999999999999 999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=321.40 Aligned_cols=208 Identities=27% Similarity=0.486 Sum_probs=176.0
Q ss_pred HHHHhhccccccCcEEEEEEEEc--------CCcEEEEEEeccCCc-ccchhhhHHHHHHhhc-CCCccceeeceeecCC
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG 670 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~--------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 670 (824)
..+.+.+.||+|+||.||+|++. ++..||||+++.... ...+.+.+|+++++++ +||||+++++++.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 34567889999999999999863 345799999975532 2345788999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhcccC------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~ 738 (824)
..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEEC
Confidence 99999999999999999965321 234588999999999999999999998 999999999999999
Q ss_pred CCCcEEEEecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCccc
Q 003385 739 KHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG 811 (824)
Q Consensus 739 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~ 811 (824)
.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999865433221 2233457889999999999999999999999999999999 99999875533
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=307.88 Aligned_cols=202 Identities=32% Similarity=0.536 Sum_probs=177.5
Q ss_pred HHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
..|.+.+.||+|+||.||+|+++++..||+|+++.... ..+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 34567789999999999999999888999999975443 35678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 87 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 87 NGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999998542 34588999999999999999999998 9999999999999999999999999999866554433
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
......+|+.|+|||.+.+..++.++||||+||++|||++ |+.||....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence 3344456788999999999899999999999999999999 999997643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.38 Aligned_cols=204 Identities=36% Similarity=0.590 Sum_probs=167.3
Q ss_pred HHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
...+.+.+.||+|+||.||+|++. ++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 345667889999999999999874 88999999875432 223568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~g--IvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
|+++|+|.+++... .....+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+++...
T Consensus 115 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 115 YLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp CCTTCBHHHHHHST-THHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred cCCCCcHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999998643 1223488999999999999999999998 8 9999999999999999999999999997543
Q ss_pred CCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+..
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 191 STF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred ccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 322 22234569999999999999999999999999999999999999998654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=311.02 Aligned_cols=212 Identities=25% Similarity=0.378 Sum_probs=166.4
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.|.+.+.||+|+||.||+|.++ +++.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 4667789999999999999875 688999999975432 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccc--CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 680 HNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 680 ~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
+ |+|.+++.... .....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 8 59998885432 1234588999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 758 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+.
T Consensus 162 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 222 (317)
T 2pmi_A 162 VN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF 222 (317)
T ss_dssp CC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 22 2233468999999999876 468999999999999999999999998866444444443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=327.89 Aligned_cols=202 Identities=24% Similarity=0.381 Sum_probs=174.3
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
...|.+.+.||+|+||.||+|.+. +|+.+|+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 456778899999999999999875 688999999875432 23456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEEecCCccc
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKF 753 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~---~~~~vkL~DFGla~~ 753 (824)
||+++|+|.+.+.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 90 E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 90 DLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp CCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999998853 35688999999999999999999998 999999999999998 457899999999976
Q ss_pred ccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
...... ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+..
T Consensus 163 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~ 217 (444)
T 3soa_A 163 VEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217 (444)
T ss_dssp CCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc
Confidence 544332 2234569999999999999999999999999999999999999997654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=318.33 Aligned_cols=206 Identities=29% Similarity=0.532 Sum_probs=173.9
Q ss_pred HHHHHHHhhccccccCcEEEEEEEEc----CCcEEEEEEeccC-CcccchhhhHHHHHHhhcCCCccceeeceeecCCeE
Q 003385 598 IEDATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (824)
Q Consensus 598 ~~~~~~~i~~~LG~G~fg~Vy~a~~~----~g~~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 672 (824)
+...+|.+.+.||+|+||.||+|++. .+..||||+++.. .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 44456778899999999999999985 3456999999754 233356789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
++||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 126 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 9999999999999998532 34688999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCc--eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 753 FAVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 753 ~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 259 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence 65443222 2222346778999999999999999999999999999999 999997644
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=332.55 Aligned_cols=202 Identities=27% Similarity=0.438 Sum_probs=176.7
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.+.+.||+|+||.||+|+++ +|+.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 188 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~ 267 (543)
T 3c4z_A 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIM 267 (543)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEec
Confidence 34578999999999999986 689999999975422 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++|+|.+++.........+++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++.......
T Consensus 268 ~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~ 344 (543)
T 3c4z_A 268 NGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344 (543)
T ss_dssp TTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred cCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence 99999999876544456789999999999999999999998 999999999999999999999999999986544322
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 345 -~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 345 -KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp -CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred -ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 2334579999999999999999999999999999999999999998753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.94 Aligned_cols=203 Identities=31% Similarity=0.553 Sum_probs=174.4
Q ss_pred HHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
...|.+.+.||+|+||.||+|++++++.||||+++.... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 345667899999999999999999888999999975443 3567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 102 ANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp TTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred CCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 999999998542 35688999999999999999999998 999999999999999999999999999976543322
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.......+|+.|+|||.+....++.++||||+||++|||++ |+.||....
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~ 226 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence 22333446788999999999999999999999999999998 999998644
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=320.68 Aligned_cols=198 Identities=25% Similarity=0.382 Sum_probs=172.8
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
.|.+.+.||+|+||.||+|+++ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 95 (384)
T 4fr4_A 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD 95 (384)
T ss_dssp GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 3567889999999999999876 57889999986532 2234567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+.+|+|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 96 LLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999998853 45688999999999999999999998 9999999999999999999999999999865433
Q ss_pred CCceeccccCCCCCcchhcccc---CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 758 ASHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
......+||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 22345679999999999874 45889999999999999999999999753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=313.80 Aligned_cols=200 Identities=25% Similarity=0.417 Sum_probs=171.1
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
|.+.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 556789999999999999877 788999999865432 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC-
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS- 759 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~- 759 (824)
+|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 89 GGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp TEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999998874 345688999999999999999999998 999999999999999999999999999976543222
Q ss_pred ceeccccCCCCCcchhccccCCC-CchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~-~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 22334579999999999987775 678999999999999999999997643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=307.42 Aligned_cols=207 Identities=25% Similarity=0.381 Sum_probs=171.7
Q ss_pred HHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcc--cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
|.+.+.||+|+||.||+|+..+++.||+|+++..... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 4567899999999999999988999999999754322 24568899999999999999999999999999999999998
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 84 Q-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp E-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred C-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence 5 888887532 35688899999999999999999998 999999999999999999999999999876543222
Q ss_pred eeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcH
Q 003385 761 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i 817 (824)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+...++
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 213 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 2233458999999999876 45899999999999999999999999876544433333
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=319.32 Aligned_cols=201 Identities=20% Similarity=0.220 Sum_probs=172.1
Q ss_pred HHHHhhccccccCcEEEEEEE------EcCCcEEEEEEeccCCcccchhhhHHHHHHhhcC---CCccceeeceeecCCe
Q 003385 601 ATKMLEKKIGSGGFGVVYYGK------LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGR 671 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~------~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~ 671 (824)
..|.+.+.||+|+||.||+|. ...++.||||+++... ..++.+|++++++++ |+||+++++++...+.
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 345677899999999999994 4468899999997543 456778888888886 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhcccC-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-----------
Q 003385 672 SVLVYEFMHNGTLKEHLYGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK----------- 739 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~----------- 739 (824)
.++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccc
Confidence 9999999999999999854322 346689999999999999999999998 9999999999999998
Q ss_pred CCcEEEEecCCcccccC-CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 740 HMRAKVSDFGLSKFAVD-GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 740 ~~~vkL~DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
++.+||+|||+++.... .........+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 89999999999975432 223344556799999999999999999999999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=316.01 Aligned_cols=199 Identities=25% Similarity=0.439 Sum_probs=172.3
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
.|.+.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 3567789999999999999974 78999999986432 2224578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+ +|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 90 ~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 90 YA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred CC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 99 6889888743 35688999999999999999999998 9999999999999999999999999999765433
Q ss_pred CCceeccccCCCCCcchhccccCCC-CchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
. .....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+...
T Consensus 162 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 213 (336)
T 3h4j_B 162 N--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213 (336)
T ss_dssp B--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS
T ss_pred c--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH
Confidence 2 2234569999999999988776 6899999999999999999999987543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=317.77 Aligned_cols=197 Identities=26% Similarity=0.423 Sum_probs=168.6
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCH
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 684 (824)
.+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 467999999999999875 6899999999876655667899999999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE--cCCCcEEEEecCCcccccCCCCcee
Q 003385 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVS 762 (824)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl--~~~~~vkL~DFGla~~~~~~~~~~~ 762 (824)
.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 988853 234588999999999999999999998 99999999999999 5668999999999986644322 2
Q ss_pred ccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 763 ~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
....||+.|+|||++....++.++|||||||++|||++|+.||.+...
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 293 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND 293 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 334699999999999988999999999999999999999999987553
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=307.40 Aligned_cols=199 Identities=29% Similarity=0.442 Sum_probs=166.1
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--------------------------cchhhhHHHHHHhhc
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--------------------------GKREFTNEVTLLSRI 654 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--------------------------~~~~~~~Ei~il~~l 654 (824)
.|.+.+.||+|+||.||+|++. +++.||||++...... ..+.+.+|+++++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 4567789999999999999875 6889999998654311 135688999999999
Q ss_pred CCCccceeeceeec--CCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 003385 655 HHRNLVQFLGYCQE--EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKS 732 (824)
Q Consensus 655 ~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp 732 (824)
+||||+++++++.+ .+..++||||+++++|.+++ ....+++..+..++.|++.||+|||++ +|+||||||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 165 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP 165 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence 99999999999976 56889999999999987754 245689999999999999999999998 999999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCCCCceeccccCCCCCcchhccccCC---CCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 733 SNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 733 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
+|||++.++.+||+|||+++....... ......||+.|+|||.+.... ++.++|||||||++|||++|+.||.+..
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999999986544322 233456999999999998665 3678999999999999999999997643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=318.64 Aligned_cols=200 Identities=23% Similarity=0.411 Sum_probs=176.0
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.|.+.+.||+|+||.||+|..+ +++.||+|++..........+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 4667889999999999999876 688999999976655556678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--CCcEEEEecCCcccccCCC
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~~ 758 (824)
+|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++......
T Consensus 132 gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 132 GGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 9999998853 234688999999999999999999998 9999999999999974 4789999999998664432
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 2233469999999999999999999999999999999999999998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=329.75 Aligned_cols=200 Identities=27% Similarity=0.382 Sum_probs=165.4
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccC---CcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
.|.+.+.||+|+||.||+|++. +++.||||+++.. .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 3567789999999999999876 6889999999753 22334567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++....
T Consensus 229 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 229 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp CCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred eCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 9999999998843 4568899999999999999999998 7 999999999999999999999999999975433
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 302 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 302 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 22 22344679999999999999999999999999999999999999997654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-34 Score=310.82 Aligned_cols=199 Identities=21% Similarity=0.321 Sum_probs=173.2
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.|.+.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+++++++ +||||+++++++...+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 3556789999999999999874 78899999987543 245788999999999 9999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-----EEEEecCCcccc
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-----AKVSDFGLSKFA 754 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~-----vkL~DFGla~~~ 754 (824)
+++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++..
T Consensus 88 -~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 88 -GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp -CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred -CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99999998542 35689999999999999999999998 9999999999999998887 999999999865
Q ss_pred cCCCCc------eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 755 VDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 755 ~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~ 221 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence 443221 1234579999999999999999999999999999999999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.09 Aligned_cols=203 Identities=25% Similarity=0.392 Sum_probs=172.2
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCC--eEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lV~E 677 (824)
+|.+.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|++++++++||||+++++++.... ..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 3567789999999999999987 489999999975432 23466789999999999999999999987654 7899999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEEecCCccc
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKF 753 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl----~~~~~vkL~DFGla~~ 753 (824)
|+++++|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 90 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 90 FCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp CCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred CCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 999999999986432 223489999999999999999999998 99999999999999 7778899999999986
Q ss_pred ccCCCCceeccccCCCCCcchhccc--------cCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYI--------SQQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
...... .....||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 228 (319)
T 4euu_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228 (319)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 644332 23356999999999986 47788999999999999999999999976443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=316.42 Aligned_cols=201 Identities=28% Similarity=0.379 Sum_probs=164.3
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
+|.+.+.||+|+||.||+|+++ +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 4667899999999999999987 78899999997543 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--EEEEecCCcccccCCC
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--AKVSDFGLSKFAVDGA 758 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~--vkL~DFGla~~~~~~~ 758 (824)
+|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++......
T Consensus 100 ~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 100 GGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp SCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 9999998843 34688999999999999999999998 9999999999999987765 9999999987433221
Q ss_pred CceeccccCCCCCcchhccccCCCCch-HHHHHHHHHHHHHHcCCCCCCCCcccc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDK-SDVYSFGVILLELISGQEAISNEKFGA 812 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DIwSlGvil~elltG~~Pf~~~~~~~ 812 (824)
......||+.|+|||++.+..++.+ +||||+||++|||++|+.||.+....+
T Consensus 173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 225 (361)
T 3uc3_A 173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR 225 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC
T ss_pred --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH
Confidence 2233469999999999988888766 899999999999999999998754333
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=304.13 Aligned_cols=199 Identities=23% Similarity=0.354 Sum_probs=167.9
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.+.||+|+||+||+|+++ +++.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 456789999999999999986 5889999999754322 2356789999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++ ++.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 84 DQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp SE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred CC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 86 55555432 245688999999999999999999998 999999999999999999999999999986543322
Q ss_pred ceeccccCCCCCcchhccccCC-CCchHHHHHHHHHHHHHHcCCCCC-CCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAI-SNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~-~~~~~DIwSlGvil~elltG~~Pf-~~~~ 809 (824)
......||+.|+|||++.+.. ++.++||||+||++|||++|..|| .+..
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~ 207 (292)
T 3o0g_A 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS
T ss_pred -cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC
Confidence 223456899999999998765 799999999999999999988885 4443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.17 Aligned_cols=192 Identities=24% Similarity=0.397 Sum_probs=150.6
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcC-CCccceeeceeecCCeEEEEEEecCCCCH
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 684 (824)
+.||+|+||.||+|.++ +++.||||++... ....+.+|+++++++. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 68999999999999986 6889999998643 3456788999999997 99999999999999999999999999999
Q ss_pred HHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEEEecCCcccccCCCCce
Q 003385 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~---~vkL~DFGla~~~~~~~~~~ 761 (824)
.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++....... .
T Consensus 94 ~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~ 165 (325)
T 3kn6_A 94 FERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-P 165 (325)
T ss_dssp HHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-c
Confidence 999853 35689999999999999999999998 999999999999998765 899999999986543322 2
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 334568999999999999999999999999999999999999997643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=330.85 Aligned_cols=200 Identities=31% Similarity=0.464 Sum_probs=175.1
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
+.+.+.||+|+||.||+|+++ +|+.||||++.... ......+.+|+++|++++||||+++++++.+.+..++||||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 445689999999999999986 68999999996532 22345578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++......
T Consensus 266 ~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 266 MNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp CCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 9999999988643 234588999999999999999999998 99999999999999999999999999998664432
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 341 --~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 341 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp --CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred --cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 2234579999999999999899999999999999999999999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=299.37 Aligned_cols=200 Identities=24% Similarity=0.352 Sum_probs=175.1
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
...|.+.+.||+|+||.||+|.++ +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 346778899999999999999886 4678999999766555567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEEecCCccccc
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl---~~~~~vkL~DFGla~~~~ 755 (824)
+++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999998843 35588999999999999999999998 99999999999999 778999999999997654
Q ss_pred CCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
... ......||+.|+|||.+.+ .++.++||||+||++|||++|+.||.+..
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Ccc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 432 2234568999999998765 48999999999999999999999998644
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=312.69 Aligned_cols=207 Identities=26% Similarity=0.363 Sum_probs=169.7
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccC-----CcccchhhhHHHHHHhhcCCCccceeeceeecCCeEE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-----SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 673 (824)
..+|.+.+.||+|+||.||+|.++ +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 356778899999999999999875 6788999998643 2233467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcccCc------------------------------------cccCCHHHHHHHHHHHHHHHHHH
Q 003385 674 LVYEFMHNGTLKEHLYGTLTH------------------------------------EQRINWIKRLEIAEDAAKGIEYL 717 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~------------------------------------~~~l~~~~~~~i~~qia~gL~yL 717 (824)
+||||+++|+|.+++...... ...+++..+..++.|++.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999988421111 12235677888999999999999
Q ss_pred HhCCCCCeEecCCCCCCEEEcCCC--cEEEEecCCcccccCCCC---ceeccccCCCCCcchhcccc--CCCCchHHHHH
Q 003385 718 HTGCVPAIIHRDLKSSNILLDKHM--RAKVSDFGLSKFAVDGAS---HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYS 790 (824)
Q Consensus 718 H~~~~~gIvHrDLkp~NILl~~~~--~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~--~~~~~~~DIwS 790 (824)
|+. +|+||||||+|||++.++ .+||+|||+++....... .......||+.|+|||.+.. ..++.++||||
T Consensus 185 H~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 998 999999999999998776 899999999986543221 12344569999999999875 67889999999
Q ss_pred HHHHHHHHHcCCCCCCCCc
Q 003385 791 FGVILLELISGQEAISNEK 809 (824)
Q Consensus 791 lGvil~elltG~~Pf~~~~ 809 (824)
|||++|||++|+.||.+..
T Consensus 262 lG~il~el~~g~~pf~~~~ 280 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVN 280 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHCCCCCCCCC
Confidence 9999999999999997644
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=307.43 Aligned_cols=202 Identities=26% Similarity=0.376 Sum_probs=168.8
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCC--------
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-------- 670 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-------- 670 (824)
..|.+.+.||+|+||.||+|+++ +++.||||+++.... ...+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 35667889999999999999987 789999999975432 33567899999999999999999999885543
Q ss_pred -------------------------------------------------eEEEEEEecCCCCHHHHhhcccCccccCCHH
Q 003385 671 -------------------------------------------------RSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 701 (824)
Q Consensus 671 -------------------------------------------------~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~ 701 (824)
..++||||+++++|.+++.... ......+.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~ 164 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHG 164 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhH
Confidence 3799999999999999986543 23445677
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC-----------ceeccccCCCC
Q 003385 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-----------HVSSIVRGTVG 770 (824)
Q Consensus 702 ~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-----------~~~~~~~gt~~ 770 (824)
.++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 7889999999999999998 999999999999999999999999999986654321 12233469999
Q ss_pred CcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003385 771 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 806 (824)
Q Consensus 771 y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~ 806 (824)
|+|||.+.+..++.++|||||||++|||++|..|+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999999988764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=313.05 Aligned_cols=201 Identities=27% Similarity=0.465 Sum_probs=165.3
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCccc---chhhhHHHHHHhhcCCCccceeeceeecCC----eEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSV 673 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~ 673 (824)
+|.+.+.||+|+||.||+|++. +++.||||+++...... ...+.+|++++++++||||+++++++.... ..+
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 4667899999999999999974 68899999997643222 346889999999999999999999986543 348
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 99999999999999853 34688999999999999999999998 999999999999999999999999999976
Q ss_pred ccCCCCc--eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 754 AVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 754 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5433221 2233568999999999999999999999999999999999999998654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=315.04 Aligned_cols=201 Identities=28% Similarity=0.388 Sum_probs=171.7
Q ss_pred HHHhhccccccCcEEEEEEEE----cCCcEEEEEEeccCC----cccchhhhHHHHHHhhc-CCCccceeeceeecCCeE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNS----YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS 672 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~----~~g~~vAVK~l~~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 672 (824)
.|.+.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus 55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 134 (355)
T 1vzo_A 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 134 (355)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence 456789999999999999987 368999999987542 22345678899999999 699999999999999999
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 135 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 135 HLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999853 34688999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCceeccccCCCCCcchhcccc--CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.............+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 654433333344579999999999985 357899999999999999999999997543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=317.87 Aligned_cols=209 Identities=27% Similarity=0.452 Sum_probs=164.9
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccC--CcccchhhhHHHHHHhhcC-CCccceeeceeecC--CeEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEE--GRSVL 674 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~l 674 (824)
.+|.+.+.||+|+||.||+|.++ +++.||||++... .....+.+.+|+.+++++. ||||+++++++... ...++
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 45677899999999999999875 6899999998643 2233456788999999997 99999999998754 37899
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
||||++ ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 89 v~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 999998 588888743 4678889999999999999999998 9999999999999999999999999999764
Q ss_pred cCC--------------------CCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccc
Q 003385 755 VDG--------------------ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 813 (824)
Q Consensus 755 ~~~--------------------~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~ 813 (824)
... ........+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 321 1112234579999999999886 6789999999999999999999999988765544
Q ss_pred hhcHh
Q 003385 814 CRNIV 818 (824)
Q Consensus 814 ~~~iv 818 (824)
...|+
T Consensus 240 ~~~i~ 244 (388)
T 3oz6_A 240 LERII 244 (388)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 44444
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=327.28 Aligned_cols=202 Identities=27% Similarity=0.481 Sum_probs=174.0
Q ss_pred HHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
..+.+.+.||+|+||.||+|++++++.||||+++... ...+.+.+|+++|++++||||+++++++. .+..++||||++
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~ 265 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA 265 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence 3456788999999999999999989999999997644 34678999999999999999999999987 556899999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 266 ~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 266 KGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp TCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred CCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 99999999542 233578889999999999999999998 9999999999999999999999999999865432212
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
......+|+.|+|||++....++.++|||||||++|||++ |+.||.+..
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~ 390 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC
Confidence 2223346789999999999999999999999999999999 999998654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=318.99 Aligned_cols=202 Identities=32% Similarity=0.525 Sum_probs=173.2
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.+.+.+.||+|+||.||+|+++ +++.||||+++... ....+.+.+|+++|++++||||+++++++.+.+..++||||+
T Consensus 115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 194 (377)
T 3cbl_A 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 194 (377)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcC
Confidence 4557789999999999999987 78999999987543 223467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 195 ~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 195 QGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp TTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 99999999853 234588999999999999999999998 999999999999999999999999999975433211
Q ss_pred cee-ccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 760 HVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 760 ~~~-~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
... ....+++.|+|||.+....++.++|||||||++|||++ |+.||.+..
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 111 11235678999999999999999999999999999998 999997644
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=311.01 Aligned_cols=196 Identities=26% Similarity=0.407 Sum_probs=169.7
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
...|.+.+.||+|+||.||+|.++ +++.||||+++... ....+|++++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 345777899999999999999886 68899999996542 3456789999888 79999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC----CcEEEEecCCccc
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSKF 753 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~----~~vkL~DFGla~~ 753 (824)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||+.++ +.+||+|||+++.
T Consensus 97 ~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 97 LMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999998853 35688999999999999999999998 99999999999998543 3599999999986
Q ss_pred ccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence 544322 23445789999999999888899999999999999999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=315.05 Aligned_cols=205 Identities=20% Similarity=0.294 Sum_probs=175.2
Q ss_pred HHHhhcccccc--CcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 602 TKMLEKKIGSG--GFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 602 ~~~i~~~LG~G--~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
.|.+.+.||+| +||.||+|+++ +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 46678999999 99999999987 68999999997543 223456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++|+|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+.....
T Consensus 106 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 106 SFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp ECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999998543 234588999999999999999999998 999999999999999999999999998764322
Q ss_pred CCC------ceeccccCCCCCcchhcccc--CCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 757 GAS------HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 757 ~~~------~~~~~~~gt~~y~aPE~l~~--~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 243 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 111 11223468999999999987 67899999999999999999999999875543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=305.29 Aligned_cols=201 Identities=27% Similarity=0.430 Sum_probs=176.0
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc------cchhhhHHHHHHhhcCCCccceeeceeecCCeE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 672 (824)
...|.+.+.||+|+||.||+|+++ +++.||+|+++..... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 446778899999999999999986 6889999999754322 245688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEEec
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDF 748 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~----~vkL~DF 748 (824)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999853 34678899999999999999999998 999999999999999887 7999999
Q ss_pred CCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 749 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 749 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
|+++....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.+..
T Consensus 164 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 222 (321)
T 2a2a_A 164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (321)
T ss_dssp TTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC
Confidence 99986544322 233468999999999999999999999999999999999999997654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=324.78 Aligned_cols=206 Identities=24% Similarity=0.348 Sum_probs=168.3
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccC--CcccchhhhHHHHHHhhcCCCccceeeceeecC------CeE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS 672 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~~ 672 (824)
+|.+.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+++++.++||||+++++++... ...
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 4667789999999999999876 6889999999754 223356788999999999999999999998654 467
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
++||||++++ |.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 143 ~lv~E~~~~~-l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 143 YLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred EEEEeCCCCC-HHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 9999999864 666553 2378889999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+....|++
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~ 277 (464)
T 3ttj_A 213 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 277 (464)
T ss_dssp ----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 65432 223445699999999999999999999999999999999999999998765444444443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=324.51 Aligned_cols=203 Identities=28% Similarity=0.489 Sum_probs=176.4
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
.|.+.+.||+|+||.||+|++. +|+.||||+++.... ...+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 3567789999999999999986 789999999975422 224568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 97 YVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp CCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 999999999884 345689999999999999999999998 9999999999999999999999999999866443
Q ss_pred CCceeccccCCCCCcchhccccCCC-CchHHHHHHHHHHHHHHcCCCCCCCCccccc
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGAN 813 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DIwSlGvil~elltG~~Pf~~~~~~~~ 813 (824)
. .....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+....+.
T Consensus 170 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~ 224 (476)
T 2y94_A 170 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL 224 (476)
T ss_dssp C--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH
T ss_pred c--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH
Confidence 2 2334579999999999988766 6799999999999999999999987654433
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=312.13 Aligned_cols=208 Identities=28% Similarity=0.459 Sum_probs=174.3
Q ss_pred HHHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCC-cccchhhhHHHHHHhhc-CCCccceeeceeecCC
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG 670 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 670 (824)
....+.+.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3455677899999999999999862 45679999997542 33456789999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhcccCc-------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLTH-------------------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 731 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~~-------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLk 731 (824)
..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||++ +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 999999999999999999653211 13478999999999999999999998 99999999
Q ss_pred CCCEEEcCCCcEEEEecCCcccccCCCC-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 732 SSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 732 p~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
|+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999986544332 22334457889999999999999999999999999999998 999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=304.70 Aligned_cols=216 Identities=24% Similarity=0.375 Sum_probs=174.8
Q ss_pred HHHHHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-----ccchhhhHHHHHHhhcC---CCccceeecee
Q 003385 596 SDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIH---HRNLVQFLGYC 666 (824)
Q Consensus 596 ~~~~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-----~~~~~~~~Ei~il~~l~---HpnIv~l~~~~ 666 (824)
+++...+|.+.+.||+|+||+||+|++. +++.||||+++.... .....+.+|++++++++ ||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 3445567788899999999999999874 688999999864321 11345678888887775 99999999999
Q ss_pred ecCC-----eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 003385 667 QEEG-----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 741 (824)
Q Consensus 667 ~~~~-----~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~ 741 (824)
.... ..++||||+. ++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~ 157 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGG 157 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTS
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCC
Confidence 7654 5789999997 5999988543 233489999999999999999999998 999999999999999999
Q ss_pred cEEEEecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 742 RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 742 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+...++.+
T Consensus 158 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (308)
T 3g33_A 158 TVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233 (308)
T ss_dssp CEEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred CEEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999997654322 23445689999999999999999999999999999999999999988765544444443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=311.03 Aligned_cols=197 Identities=28% Similarity=0.439 Sum_probs=158.3
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.|.+.+.||+|+||.||+|+++ +++.||||+++... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 4567789999999999999987 57889999997543 34668899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEecCCcccccCC
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~---~~~vkL~DFGla~~~~~~ 757 (824)
+++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 132 ~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 132 GGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp SCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999998843 35588999999999999999999998 9999999999999975 789999999998765432
Q ss_pred CCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 205 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 254 (349)
T 2w4o_A 205 --VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred --cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence 12234568999999999999999999999999999999999999997644
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=307.02 Aligned_cols=199 Identities=26% Similarity=0.402 Sum_probs=173.2
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--------cchhhhHHHHHHhhcCCCccceeeceeecCC
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 670 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 670 (824)
...|.+.+.||+|+||.||+|+++ +++.||||+++..... ..+.+.+|++++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 456778899999999999999875 6889999999754321 2346889999999999999999999999999
Q ss_pred eEEEEEEecCCC-CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003385 671 RSVLVYEFMHNG-TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (824)
Q Consensus 671 ~~~lV~E~~~~g-sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFG 749 (824)
..++||||+.+| +|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999999777 99988843 34688999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCceeccccCCCCCcchhccccCCC-CchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
+++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 9986644322 234569999999999988877 7889999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=336.87 Aligned_cols=207 Identities=27% Similarity=0.352 Sum_probs=177.5
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
.|.+.+.||+|+||.||+|+++ +++.||||+++... ....+.+..|..++..+ +||+|+++++++.+.+..++||
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 3566789999999999999976 57889999997542 22345677899999887 7999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++....
T Consensus 422 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred eCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 99999999999853 35688999999999999999999998 999999999999999999999999999985433
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 816 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~ 816 (824)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+..+.
T Consensus 495 ~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~ 553 (674)
T 3pfq_A 495 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 553 (674)
T ss_dssp TT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 22 234456799999999999999999999999999999999999999987654433333
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=311.54 Aligned_cols=206 Identities=28% Similarity=0.487 Sum_probs=174.1
Q ss_pred HHHHhhccccccCcEEEEEEEEcC------CcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~------g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 673 (824)
..|.+.+.||+|+||.||+|++++ ++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 126 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 126 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence 345677899999999999998753 47899999975432 23467899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcccCc--------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 003385 674 LVYEFMHNGTLKEHLYGTLTH--------------------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSS 733 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~--------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~ 733 (824)
+||||+++|+|.+++...... ...+++..++.++.|++.||.|||++ +|+||||||+
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~ 203 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATR 203 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcc
Confidence 999999999999998653211 25689999999999999999999998 9999999999
Q ss_pred CEEEcCCCcEEEEecCCcccccCCCC-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 734 NILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 734 NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
|||++.++.+||+|||+++....... .......+|+.|+|||.+....++.++|||||||++|||++ |+.||.+..
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 99999999999999999975533221 22233457899999999999999999999999999999999 999997654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=300.59 Aligned_cols=203 Identities=24% Similarity=0.426 Sum_probs=171.4
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
..|.+.+.||+|+||.||+|+.+ +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 45778899999999999999876 68899999987543 23356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEEecCCccccc
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~---~~~~vkL~DFGla~~~~ 755 (824)
+++|+|.+.+.........+++..+..++.|++.||+|||++ +|+||||||+||+++ .++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999998865444456789999999999999999999998 999999999999994 45789999999997654
Q ss_pred CCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
... ......||+.|+|||.+. ..++.++|||||||++|||++|+.||.+..
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 322 223456899999999875 578999999999999999999999998654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-34 Score=299.40 Aligned_cols=201 Identities=31% Similarity=0.542 Sum_probs=175.1
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
.+.+.+.||+|+||.||+|++.+++.||+|+++.... ..+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 4556789999999999999998899999999976543 346789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 88 ~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 88 GCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999998542 34578999999999999999999998 99999999999999999999999999987654322222
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.....++..|+|||.+....++.++||||+|+++|||++ |+.||.+..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence 233457789999999999999999999999999999999 899998644
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=314.50 Aligned_cols=209 Identities=28% Similarity=0.489 Sum_probs=177.4
Q ss_pred HHHHHHHhhccccccCcEEEEEEEEc--------CCcEEEEEEeccCCc-ccchhhhHHHHHHhhc-CCCccceeeceee
Q 003385 598 IEDATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQ 667 (824)
Q Consensus 598 ~~~~~~~i~~~LG~G~fg~Vy~a~~~--------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 667 (824)
+...++.+.+.||+|+||.||+|++. .++.||||+++.... ...+.+.+|+++++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 33446678899999999999999863 235799999975532 2346788999999999 8999999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHhhcccC------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 003385 668 EEGRSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 735 (824)
Q Consensus 668 ~~~~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NI 735 (824)
+.+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 99999999999999999999965421 234689999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEecCCcccccCCCC-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 736 LLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 736 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
|++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999986544322 22333457889999999999999999999999999999999 999998654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=305.47 Aligned_cols=202 Identities=32% Similarity=0.545 Sum_probs=169.8
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-----CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeec--CCeE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRS 672 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-----~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 672 (824)
...|.+.+.||+|+||.||+|++. +++.||||+++.......+.+.+|++++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 345667899999999999999852 688999999986665556788999999999999999999998854 3568
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 9999999999999998543 34588999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCc--eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 753 FAVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 753 ~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
........ ......++..|+|||.+.+..++.++|||||||++|||++|..||..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 65433221 22334477889999999999999999999999999999999998864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=327.25 Aligned_cols=202 Identities=31% Similarity=0.508 Sum_probs=176.5
Q ss_pred HHHhhccccccCcEEEEEEEEcC-CcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.+.+.+.||+|+||.||+|.++. ++.||||+++... ...+.+.+|+++|++++||||+++++++.+.+..++||||++
T Consensus 221 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~ 299 (495)
T 1opk_A 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 299 (495)
T ss_dssp GEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccC
Confidence 45677899999999999999874 7899999997543 335779999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 300 ~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 300 YGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp TCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred CCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 99999999643 234588999999999999999999998 9999999999999999999999999999866443333
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
......+++.|+|||++....++.++|||||||++|||++ |+.||.+..
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~ 424 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence 3333456789999999999999999999999999999999 999998654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.42 Aligned_cols=207 Identities=29% Similarity=0.473 Sum_probs=175.6
Q ss_pred HHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 672 (824)
...|.+.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 345667899999999999999862 35789999997543 23346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhcccC--------------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 003385 673 VLVYEFMHNGTLKEHLYGTLT--------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKS 732 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~--------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp 732 (824)
++||||+++++|.+++..... ....+++..++.++.|++.||.|||++ +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999865322 124588999999999999999999998 999999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 733 SNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 733 ~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
+||+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.+..
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999865443222 2233457889999999999999999999999999999999 999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=316.95 Aligned_cols=207 Identities=29% Similarity=0.472 Sum_probs=174.1
Q ss_pred HHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccC-CcccchhhhHHHHHHhhcCCCccceeeceeecCCeE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 672 (824)
...+.+.+.||+|+||.||+|++. +++.||||+++.. .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 345667899999999999999853 4678999999654 233345788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhccc---CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEEE
Q 003385 673 VLVYEFMHNGTLKEHLYGTL---THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVS 746 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~---~vkL~ 746 (824)
++||||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999986532 2234688999999999999999999998 999999999999999554 59999
Q ss_pred ecCCcccccCC-CCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 747 DFGLSKFAVDG-ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 747 DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
|||+++..... .........||+.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999754322 1122233457999999999999999999999999999999998 999997654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=311.49 Aligned_cols=210 Identities=25% Similarity=0.340 Sum_probs=178.0
Q ss_pred CHHHHHHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcC-----CCccceeeceee
Q 003385 594 TLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----HRNLVQFLGYCQ 667 (824)
Q Consensus 594 ~~~~~~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~~~~~ 667 (824)
..+++....|.+.++||+|+||.||+|++. +++.||||+++.. ....+.+..|+++++++. ||||+++++++.
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 334444556778899999999999999985 6889999999643 233456778999999996 999999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--------
Q 003385 668 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-------- 739 (824)
Q Consensus 668 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~-------- 739 (824)
..+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEE
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccccc
Confidence 999999999999 89999998543 233588899999999999999999998 9999999999999975
Q ss_pred -----------------CCcEEEEecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCC
Q 003385 740 -----------------HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802 (824)
Q Consensus 740 -----------------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~ 802 (824)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence 789999999999764332 23356899999999999999999999999999999999999
Q ss_pred CCCCCCccccch
Q 003385 803 EAISNEKFGANC 814 (824)
Q Consensus 803 ~Pf~~~~~~~~~ 814 (824)
.||.+....+..
T Consensus 257 ~pf~~~~~~~~~ 268 (360)
T 3llt_A 257 LLFRTHEHMEHL 268 (360)
T ss_dssp CSCCCSSHHHHH
T ss_pred CCCCCCcHHHHH
Confidence 999876644333
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=315.99 Aligned_cols=203 Identities=28% Similarity=0.518 Sum_probs=162.9
Q ss_pred HHHHhhccccccCcEEEEEEEEc----CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~----~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
..+.+.+.||+|+||.||+|+++ ++..||||+++... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 45567889999999999999875 56789999997543 23356789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
|||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 125 ~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 125 TEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999998532 34688999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCce--eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 756 DGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 756 ~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
...... .....+++.|+|||.+....++.++|||||||++|||++ |+.||.+..
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~ 255 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 432221 122235778999999999999999999999999999998 999997644
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=323.77 Aligned_cols=202 Identities=29% Similarity=0.506 Sum_probs=169.2
Q ss_pred HHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
..+.+.++||+|+||.||+|.++++..||||+++... ...+.+.+|+++|++++||||+++++++.+ +..++||||++
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 3456788999999999999999988899999997544 235678999999999999999999999876 66899999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 262 ~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 262 KGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp TCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 99999998532 234588999999999999999999998 9999999999999999999999999999866443322
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
......+++.|+|||.+....++.++|||||||++|||++ |+.||.+..
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 386 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence 2333457889999999999999999999999999999999 999997644
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-33 Score=298.94 Aligned_cols=217 Identities=39% Similarity=0.683 Sum_probs=181.1
Q ss_pred cccCHHHHHHHHHHhh--------ccccccCcEEEEEEEEcCCcEEEEEEeccCC----cccchhhhHHHHHHhhcCCCc
Q 003385 591 HCFTLSDIEDATKMLE--------KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHRN 658 (824)
Q Consensus 591 ~~~~~~~~~~~~~~i~--------~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~----~~~~~~~~~Ei~il~~l~Hpn 658 (824)
+.++..++...+..+. +.||+|+||.||+|++ +++.||||++.... ....+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 4567777777665543 6799999999999986 58899999986532 122456889999999999999
Q ss_pred cceeeceeecCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 003385 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738 (824)
Q Consensus 659 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~ 738 (824)
|+++++++.+.+..++||||+++++|.+++... .....+++..++.++.|++.||.|||++ +|+||||||+||+++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence 999999999999999999999999999998543 2345689999999999999999999998 999999999999999
Q ss_pred CCCcEEEEecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccc
Q 003385 739 KHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 813 (824)
Q Consensus 739 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~ 813 (824)
.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||.+....+.
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 9999999999999765433222 2334568999999998764 588999999999999999999999987654433
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=303.10 Aligned_cols=196 Identities=28% Similarity=0.428 Sum_probs=164.9
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEEecCCCC
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 683 (824)
.+.||+|+||.||+|++. +++.||||+++.......+.+.+|++++.++ +||||+++++++.+.+..++||||+++++
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 468999999999999865 6899999999766555567789999999985 79999999999999999999999999999
Q ss_pred HHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEEecCCcccccCCC--
Q 003385 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFGLSKFAVDGA-- 758 (824)
Q Consensus 684 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~---vkL~DFGla~~~~~~~-- 758 (824)
|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++......
T Consensus 98 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 98 ILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp HHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred HHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 9999853 34688999999999999999999998 9999999999999998765 9999999987543211
Q ss_pred ----CceeccccCCCCCcchhcccc-----CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 759 ----SHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 759 ----~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.......+||+.|+|||++.. ..++.++|||||||++|||++|+.||.+.
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 229 (316)
T 2ac3_A 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence 111223459999999999875 55789999999999999999999999764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=300.89 Aligned_cols=203 Identities=24% Similarity=0.388 Sum_probs=161.3
Q ss_pred HHHHhhccccccCcEEEEEEEEcC----CcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~----g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
.+|.+.+.||+|+||.||+|.+.. +..||+|+++... ....+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 456678999999999999998753 4569999987543 233467889999999999999999999985 4567899
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
|||+++++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 94 MELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999998532 34588999999999999999999998 99999999999999999999999999998665
Q ss_pred CCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKF 810 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~ 810 (824)
...........+|+.|+|||.+....++.++|||||||++|||++ |..||.+...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~ 223 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 223 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH
Confidence 443333334457889999999999999999999999999999996 9999987543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=298.54 Aligned_cols=202 Identities=28% Similarity=0.502 Sum_probs=174.2
Q ss_pred HHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
..+.+.+.||+|+||.||+|++++++.||||+++... ...+.+.+|++++++++||||+++++++.+ +..++||||++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 90 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence 3456788999999999999999888899999997543 235678999999999999999999999875 45789999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||+++........
T Consensus 91 ~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 91 NGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 99999998532 223688999999999999999999998 9999999999999999999999999999876544333
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
......++..|+|||.+....++.++|||||||++|||++ |+.||.+..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 215 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence 3334457889999999998899999999999999999999 999997644
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=317.58 Aligned_cols=197 Identities=32% Similarity=0.517 Sum_probs=169.6
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCC-eEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-RSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lV~E~~~ 680 (824)
.+.+.+.||+|+||.||+|+++ ++.||||+++... ..+.+.+|+++|++++||||+++++++.+.+ ..++||||++
T Consensus 194 ~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~ 270 (450)
T 1k9a_A 194 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270 (450)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred HeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence 3456789999999999999987 7899999997543 4577999999999999999999999987654 7899999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 271 ~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 271 KGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp TCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 99999999643 223468889999999999999999998 9999999999999999999999999999754321
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKF 810 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~ 810 (824)
.....+++.|+|||.+....++.++|||||||++|||++ |+.||.+...
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~ 392 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 392 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 122357889999999999999999999999999999998 9999987543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=306.32 Aligned_cols=208 Identities=24% Similarity=0.377 Sum_probs=168.5
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc-cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
|.+.+.||+|+||.||+|++. +++.||||+++..... ....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 456789999999999999986 6889999999754322 23456789999999999999999999999999999999997
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 -~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 155 (324)
T 3mtl_A 84 -KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 155 (324)
T ss_dssp -EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred -cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence 5888887532 34588899999999999999999998 999999999999999999999999999875443222
Q ss_pred eeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 761 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+....+.
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 214 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIF 214 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2233468999999999876 568999999999999999999999998876554444443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=306.14 Aligned_cols=207 Identities=27% Similarity=0.443 Sum_probs=159.9
Q ss_pred HHHHHhhccccccCcEEEEEEEEcCCc----EEEEEEeccC--CcccchhhhHHHHHHhhcCCCccceeeceeecCCeE-
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLKDGK----EIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS- 672 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~~g~----~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~- 672 (824)
...|.+.+.||+|+||.||+|++.... .||||+++.. .....+.+.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 345677899999999999999866432 7999999754 233356789999999999999999999999876655
Q ss_pred -----EEEEEecCCCCHHHHhhcccC--ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 003385 673 -----VLVYEFMHNGTLKEHLYGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 745 (824)
Q Consensus 673 -----~lV~E~~~~gsL~~~L~~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL 745 (824)
++||||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEE
Confidence 899999999999999854321 223588999999999999999999998 9999999999999999999999
Q ss_pred EecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 746 SDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 746 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.+..
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 999999765433221 2223446789999999999999999999999999999999 999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=301.71 Aligned_cols=203 Identities=26% Similarity=0.368 Sum_probs=168.5
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.+.||+|+||.||+|++. +++.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence 456789999999999999986 5899999998654322 2456789999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 85 DHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp SEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 99999887742 35588999999999999999999998 999999999999999999999999999976543322
Q ss_pred ceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccc
Q 003385 760 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 813 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~ 813 (824)
......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+.
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 211 (311)
T 4agu_A 158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ 211 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 2234468999999999876 6789999999999999999999999988664433
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.83 Aligned_cols=208 Identities=30% Similarity=0.464 Sum_probs=173.9
Q ss_pred HHHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCc-ccchhhhHHHHHHhhc-CCCccceeeceeecCC
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG 670 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 670 (824)
....|.+.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|+++++++ +||||+++++++.+.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 3455677899999999999999753 457899999975432 2346789999999999 7999999999987754
Q ss_pred -eEEEEEEecCCCCHHHHhhcccCc-------------------------------------------------------
Q 003385 671 -RSVLVYEFMHNGTLKEHLYGTLTH------------------------------------------------------- 694 (824)
Q Consensus 671 -~~~lV~E~~~~gsL~~~L~~~~~~------------------------------------------------------- 694 (824)
..++||||+++|+|.+++......
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 489999999999999999654221
Q ss_pred -------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC-ceecccc
Q 003385 695 -------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVR 766 (824)
Q Consensus 695 -------~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~ 766 (824)
...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .......
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 12288999999999999999999998 999999999999999999999999999986543322 2334456
Q ss_pred CCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 767 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 767 gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
||+.|+|||++.+..++.++|||||||++|||++ |+.||.+..
T Consensus 257 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred CCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 8899999999999999999999999999999998 999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-33 Score=299.77 Aligned_cols=204 Identities=23% Similarity=0.299 Sum_probs=168.0
Q ss_pred CHHHHHHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhc-CCCccceeeceeecC
Q 003385 594 TLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE 669 (824)
Q Consensus 594 ~~~~~~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 669 (824)
..+++....|.+.++||+|+||+||+|+++ +++.||||++..... ........|+..+.++ +||||+++++++.+.
T Consensus 50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp SSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 345666778888999999999999999987 789999999865422 2233445566555555 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003385 670 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (824)
Q Consensus 670 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFG 749 (824)
+..++||||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred CEEEEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence 9999999999 67898887543 34689999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
+++..... .......||+.|+|||++.+ .++.++|||||||++|||++|..|+.+
T Consensus 203 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 203 LLVELGTA--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp TCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred eeeecccC--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 98765432 22334569999999998875 789999999999999999999776654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=313.14 Aligned_cols=208 Identities=25% Similarity=0.348 Sum_probs=172.8
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeec------------
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------------ 668 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------------ 668 (824)
+|.+.+.||+|+||.||+|++. +|+.||||++... .+...+|+++++.++||||+++++++..
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD----PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC----TTSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 4667899999999999999875 7899999998643 3345689999999999999999999843
Q ss_pred --------------------------CCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCC
Q 003385 669 --------------------------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722 (824)
Q Consensus 669 --------------------------~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~ 722 (824)
....++||||++ |+|.+.+.........+++..+..++.|++.||.|||+.
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 160 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-- 160 (383)
T ss_dssp --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 334889999998 588888765545567789999999999999999999998
Q ss_pred CCeEecCCCCCCEEEc-CCCcEEEEecCCcccccCCCCceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHc
Q 003385 723 PAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELIS 800 (824)
Q Consensus 723 ~gIvHrDLkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~ellt 800 (824)
||+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||+||++|||++
T Consensus 161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 999999999999998 679999999999986544322 2334589999999998765 48999999999999999999
Q ss_pred CCCCCCCCccccchhcHhh
Q 003385 801 GQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 801 G~~Pf~~~~~~~~~~~iv~ 819 (824)
|+.||.+....+...++++
T Consensus 238 g~~pf~~~~~~~~~~~i~~ 256 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQ 256 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHH
T ss_pred CCCCCCCCChHHHHHHHHH
Confidence 9999998765555555543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=310.62 Aligned_cols=201 Identities=18% Similarity=0.298 Sum_probs=165.1
Q ss_pred HHHHhhccccccCcEEEEEEEEcC------CcEEEEEEeccCCccc-----------chhhhHHHHHHhhcCCCccceee
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQG-----------KREFTNEVTLLSRIHHRNLVQFL 663 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~------g~~vAVK~l~~~~~~~-----------~~~~~~Ei~il~~l~HpnIv~l~ 663 (824)
..|.+.+.||+|+||.||+|.++. ++.||||++....... ...+.+|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 356678999999999999998864 4789999987543211 12234566677778899999999
Q ss_pred ceeecC----CeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-
Q 003385 664 GYCQEE----GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD- 738 (824)
Q Consensus 664 ~~~~~~----~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~- 738 (824)
+++... ...++||||+ +++|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence 998764 4579999999 99999998542 35689999999999999999999998 999999999999999
Q ss_pred -CCCcEEEEecCCcccccCCCCc------eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 739 -KHMRAKVSDFGLSKFAVDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 739 -~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 8899999999999765432111 113345999999999999999999999999999999999999999863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=301.49 Aligned_cols=200 Identities=28% Similarity=0.476 Sum_probs=172.7
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
...|.+.+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 456778899999999999999986 6899999999865544556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEEecCCccccc
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl---~~~~~vkL~DFGla~~~~ 755 (824)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||+++...
T Consensus 88 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999998843 34688999999999999999999998 99999999999999 678999999999987543
Q ss_pred CCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.. ......||+.|+|||.+.+..++.++||||+||++|||++|+.||.+..
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 211 (304)
T 2jam_A 161 NG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET 211 (304)
T ss_dssp CB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 22 2233458999999999999999999999999999999999999997643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.99 Aligned_cols=205 Identities=31% Similarity=0.511 Sum_probs=178.9
Q ss_pred HHHHHHhhccccccCcEEEEEEEEcC-CcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
....+.+.+.||+|+||.||+|.++. ++.||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 33456678899999999999999874 7889999997543 335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+++++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred cCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999998543 235588999999999999999999998 9999999999999999999999999999876554
Q ss_pred CCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.........+|+.|+|||.+....++.++|||||||++|+|++ |..||.+..
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~ 217 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 4444444557889999999999999999999999999999999 999998654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-33 Score=295.14 Aligned_cols=201 Identities=28% Similarity=0.441 Sum_probs=172.9
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc------cchhhhHHHHHHhhcCCCccceeeceeecCCeE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 672 (824)
...|.+.+.||+|+||.||+|++. +++.||+|+++..... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 345778899999999999999987 6899999998754321 245688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEEec
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDF 748 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~----~vkL~DF 748 (824)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999843 35688999999999999999999998 999999999999998876 8999999
Q ss_pred CCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 749 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 749 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
|++....... ......|++.|+|||.+....++.++||||||+++|||++|+.||.+..
T Consensus 157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 9997654322 2233458999999999999999999999999999999999999998654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=295.83 Aligned_cols=199 Identities=34% Similarity=0.520 Sum_probs=160.5
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcc----cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
.+.+.+.||+|+||.||+|++. ++.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred heeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 3456789999999999999986 889999998754322 23568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--------CCcEEEEecC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--------HMRAKVSDFG 749 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~--------~~~vkL~DFG 749 (824)
|+++++|.+++. ...+++..+..++.|++.||.|||++...+|+||||||+|||++. ++.+||+|||
T Consensus 87 ~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 87 FARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp CCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred cCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999884 346889999999999999999999982222999999999999986 6789999999
Q ss_pred CcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
+++...... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.+..
T Consensus 162 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 162 LAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp C----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred ccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 997654322 223468999999999999999999999999999999999999997633
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=297.40 Aligned_cols=200 Identities=22% Similarity=0.378 Sum_probs=174.1
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
+|.+.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (294)
T 2rku_A 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95 (294)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence 3556789999999999999987 57889999986542 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 96 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 96 LCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp CCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred cCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999998743 35688999999999999999999998 9999999999999999999999999999765432
Q ss_pred CCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.. ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||....
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 169 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp TC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 2234568999999999998899999999999999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=307.85 Aligned_cols=200 Identities=31% Similarity=0.458 Sum_probs=167.1
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCC----eEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lV~E 677 (824)
.|.+.+.||+|+||.||+|++. ++.||||+++.... ......+|+.++++++||||+++++++.+.. ..++|||
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 4567889999999999999887 79999999965432 2345567899999999999999999997743 4699999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCC-------CCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-------VPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-------~~gIvHrDLkp~NILl~~~~~vkL~DFGl 750 (824)
|+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 103 FHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp CCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 9999999999853 34889999999999999999999851 23899999999999999999999999999
Q ss_pred cccccCCCCc-eeccccCCCCCcchhccccC-----CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 751 SKFAVDGASH-VSSIVRGTVGYLDPEYYISQ-----QLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 751 a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~-----~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 9765443222 22335699999999998863 4556789999999999999999999764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=320.02 Aligned_cols=198 Identities=23% Similarity=0.355 Sum_probs=154.4
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccC--CcccchhhhHHHHHHhhcCCCccceeeceeec-----CCeEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-----EGRSV 673 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~~ 673 (824)
+|.+.+.||+|+||.||+|+++ +++.||||++... .....+.+.+|+++|++++||||+++++++.. ....+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 4667899999999999999876 6889999998653 22334678899999999999999999999843 35789
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+||||++ ++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 134 lv~e~~~-~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 134 VVLEIAD-SDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEECCCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEeccc-cchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchh
Confidence 9999985 688888743 45689999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCC--------------------------ceeccccCCCCCcchhcc-ccCCCCchHHHHHHHHHHHHHHc------
Q 003385 754 AVDGAS--------------------------HVSSIVRGTVGYLDPEYY-ISQQLTDKSDVYSFGVILLELIS------ 800 (824)
Q Consensus 754 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~l-~~~~~~~~~DIwSlGvil~ellt------ 800 (824)
...... ......+||+.|+|||++ ....++.++|||||||++|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 542211 112335689999999986 45679999999999999999999
Q ss_pred -----CCCCCCC
Q 003385 801 -----GQEAISN 807 (824)
Q Consensus 801 -----G~~Pf~~ 807 (824)
|+++|.+
T Consensus 286 ~~~~~~~p~f~g 297 (458)
T 3rp9_A 286 AYHADRGPLFPG 297 (458)
T ss_dssp SSGGGCCCSCC-
T ss_pred cccccccccCCC
Confidence 6667755
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-33 Score=295.85 Aligned_cols=199 Identities=27% Similarity=0.447 Sum_probs=172.4
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
.|.+.+.||+|+||.||+|.++ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 3556789999999999999876 58899999986543 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEEecCCccccc
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFGLSKFAV 755 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~---vkL~DFGla~~~~ 755 (824)
+++++|.+.+.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++. +||+|||++....
T Consensus 87 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 87 VTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999888743 35688999999999999999999998 9999999999999986655 9999999997654
Q ss_pred CCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.... .....||+.|+|||.+.+..++.++||||+||++|+|++|+.||.+..
T Consensus 160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 211 (284)
T 3kk8_A 160 DSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211 (284)
T ss_dssp SSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence 3322 233568999999999999999999999999999999999999997644
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=296.78 Aligned_cols=200 Identities=26% Similarity=0.443 Sum_probs=153.5
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence 556789999999999999874 789999999864322 1235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 93 CHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp CTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred CCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999998642 35688999999999999999999998 99999999999999999999999999987654322
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 216 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence 2 2233468999999999998889999999999999999999999997644
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=303.81 Aligned_cols=201 Identities=22% Similarity=0.376 Sum_probs=175.2
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
.+|.+.+.||+|+||.||++++. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 34667889999999999999986 57889999986542 223466889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 121 ELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp CCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999998743 35688999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 194 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 194 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred Ccc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 222 2234568999999999999999999999999999999999999998654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=299.43 Aligned_cols=194 Identities=26% Similarity=0.463 Sum_probs=162.4
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhh--cCCCccceeeceeec----CCeEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSR--IHHRNLVQFLGYCQE----EGRSVLV 675 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~----~~~~~lV 675 (824)
.|.+.+.||+|+||.||+|++ +++.||||++... ..+.+.+|.+++.. ++||||+++++++.. ....++|
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv 84 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI 84 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence 456778999999999999988 5899999998643 23455667777766 789999999998644 3567899
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--------TGCVPAIIHRDLKSSNILLDKHMRAKVSD 747 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~gIvHrDLkp~NILl~~~~~vkL~D 747 (824)
|||+++|+|.+++. ...+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+||+|
T Consensus 85 ~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 85 THYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp ECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECC
T ss_pred hhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEee
Confidence 99999999999984 346889999999999999999999 76 999999999999999999999999
Q ss_pred cCCcccccCCCCce---eccccCCCCCcchhccccC------CCCchHHHHHHHHHHHHHHcC----------CCCCCC
Q 003385 748 FGLSKFAVDGASHV---SSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISG----------QEAISN 807 (824)
Q Consensus 748 FGla~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~------~~~~~~DIwSlGvil~elltG----------~~Pf~~ 807 (824)
||+++......... .....||+.|+|||++... .++.++|||||||++|||++| +.||..
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99997655433322 2234699999999999876 445789999999999999999 888865
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=306.48 Aligned_cols=207 Identities=21% Similarity=0.304 Sum_probs=165.9
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
+|.+.+.||+|+||+||+|++. +++.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 5667899999999999999876 6889999999754322 245678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-----CCCcEEEEecCCccc
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-----KHMRAKVSDFGLSKF 753 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~-----~~~~vkL~DFGla~~ 753 (824)
++ |+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 115 ~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 115 AE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp CS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred CC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 98 489888843 34588999999999999999999998 999999999999994 455699999999976
Q ss_pred ccCCCCceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcH
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i 817 (824)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+...++
T Consensus 187 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 250 (329)
T 3gbz_A 187 FGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI 250 (329)
T ss_dssp HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHH
Confidence 543322 22334589999999999874 4899999999999999999999999876644333333
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=310.14 Aligned_cols=192 Identities=24% Similarity=0.328 Sum_probs=158.7
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhh-cCCCccceeeceeec----CCeEEEEEEec
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSR-IHHRNLVQFLGYCQE----EGRSVLVYEFM 679 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~----~~~~~lV~E~~ 679 (824)
.+.||+|+||.||+|.++ +++.||||+++. ...+.+|++++.+ .+||||+++++++.. .+..++||||+
T Consensus 67 ~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141 (400)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred cceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence 368999999999999876 688999999863 3457788888754 589999999998865 56789999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEecCCcccccC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~---~~~vkL~DFGla~~~~~ 756 (824)
++|+|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 142 ~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 142 DGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp CSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred CCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 999999998643 234588999999999999999999998 9999999999999997 78999999999986543
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.. .....+||+.|+|||++....++.++|||||||++|||++|+.||.+..
T Consensus 217 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 217 HN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp ------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred CC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 22 2234568999999999999999999999999999999999999997644
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-33 Score=303.08 Aligned_cols=201 Identities=26% Similarity=0.447 Sum_probs=167.9
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcE----EEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKE----IAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~----vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
.|.+.+.||+|+||.||+|++. +++. ||+|++.... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v 92 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLV 92 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEEE
Confidence 3456789999999999999875 3443 7888775432 3335678899999999999999999999864 568899
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
|||+.+|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 9999999999998542 34678888999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 756 DGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 756 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
..... ......||..|+|||.+....++.++|||||||++|||++ |+.||.+..
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 43322 2344557889999999999999999999999999999999 999998755
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=295.05 Aligned_cols=199 Identities=20% Similarity=0.342 Sum_probs=172.8
Q ss_pred HHHhhccccccCcEEEEEEEE-cCCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.|.+.+.||+|+||.||+|++ .+++.||||++.... ..+.+.+|+++++++ +|++++++++++.+....++||||+
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 456778999999999999987 478999999986432 346788999999999 7999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-----EEEEecCCcccc
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-----AKVSDFGLSKFA 754 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~-----vkL~DFGla~~~ 754 (824)
+++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++..
T Consensus 89 -~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 89 -GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp -CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred -CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99999998542 34589999999999999999999998 9999999999999987766 999999999865
Q ss_pred cCCCCc------eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 755 VDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 755 ~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 543221 2344569999999999999999999999999999999999999998743
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=296.90 Aligned_cols=198 Identities=27% Similarity=0.472 Sum_probs=169.7
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence 556789999999999999876 56789999986432 12245688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 91 ~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 91 APLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 162 (279)
T ss_dssp CTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence 999999998843 35588999999999999999999998 9999999999999999999999999988544322
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
......||+.|+|||.+.+..++.++||||+||++|||++|+.||.....
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 212 (279)
T 3fdn_A 163 --RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 212 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred --cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH
Confidence 22334689999999999999999999999999999999999999987553
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=301.71 Aligned_cols=206 Identities=29% Similarity=0.461 Sum_probs=175.7
Q ss_pred HHHHhhccccccCcEEEEEEEE------cCCcEEEEEEeccCCc-ccchhhhHHHHHHhhc-CCCccceeeceeecCCeE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS 672 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~------~~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 672 (824)
..|.+.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++.+.+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 4566789999999999999986 2467899999975432 3356788999999999 999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhcccC--------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLT--------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~--------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~ 738 (824)
++||||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +|+||||||+||+++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEc
Confidence 999999999999999864321 123588999999999999999999998 999999999999999
Q ss_pred CCCcEEEEecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 739 KHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 739 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.+..
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999866543322 2233457889999999999999999999999999999999 999997754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=314.75 Aligned_cols=207 Identities=28% Similarity=0.372 Sum_probs=168.5
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeec------CCeEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------EGRSVLV 675 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~~~~lV 675 (824)
|.+.+.||+|+||.||+|++. +++.||||++... .+...+|++++++++||||+++++++.. ....++|
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----chhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 556789999999999999986 5899999998643 3345689999999999999999998843 2236799
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCcccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFA 754 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~-~~vkL~DFGla~~~ 754 (824)
|||+++ ++.+.+.........+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++..
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999985 66666543333456789999999999999999999998 99999999999999965 67899999999865
Q ss_pred cCCCCceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 755 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 755 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+...++++
T Consensus 208 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~ 271 (420)
T 1j1b_A 208 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271 (420)
T ss_dssp CTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 43322 2334689999999998764 789999999999999999999999988764444444443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-33 Score=305.99 Aligned_cols=198 Identities=28% Similarity=0.470 Sum_probs=170.0
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
...|.+.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 345667789999999999999874 7889999999754322 235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
|||+. |+|.+.+.. ....+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 133 ~e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99997 678777743 235688999999999999999999998 99999999999999999999999999997653
Q ss_pred CCCCceeccccCCCCCcchhccc---cCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.. ....||+.|+|||++. ...++.++|||||||++|||++|+.||.+..
T Consensus 206 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 206 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257 (348)
T ss_dssp SB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 2346899999999985 5678999999999999999999999997643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-33 Score=301.33 Aligned_cols=201 Identities=20% Similarity=0.349 Sum_probs=164.4
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
.|.+.+.||+|+||.||+|++. +++.||+|++...... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 2h34_A 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR 114 (309)
T ss_dssp CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence 4667899999999999999976 6889999999754322 23668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 115 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 115 LINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp CCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred ecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999853 34688999999999999999999998 9999999999999999999999999998765443
Q ss_pred CCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.........|++.|+|||.+.+..++.++|||||||++|||++|+.||.+..
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 3333334568999999999999999999999999999999999999997644
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=304.02 Aligned_cols=202 Identities=26% Similarity=0.442 Sum_probs=165.3
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCc----EEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~----~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 674 (824)
..|.+.+.||+|+||.||+|++. +++ +||+|.++... ....+.+.+|++++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 34567789999999999999875 344 35888876432 234567899999999999999999999998765 689
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
|+||+.+|+|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999998643 35688999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 755 VDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 755 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
...... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.+..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 224 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC
Confidence 443222 2233446889999999999999999999999999999999 999998754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=319.08 Aligned_cols=200 Identities=29% Similarity=0.471 Sum_probs=169.4
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
...|.+.+.||+|+||+||+|+++ +++.||+|+++... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456778899999999999999986 68899999997543 233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEEecCCccc
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKF 753 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~---~~vkL~DFGla~~ 753 (824)
||+++|+|.+.+.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.. +.+||+|||+++.
T Consensus 116 e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999988843 35688999999999999999999998 99999999999999764 5599999999986
Q ss_pred ccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
..... .....+||+.|+|||++. ..++.++||||+||++|+|++|+.||.+..
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 241 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 64432 233456999999999875 579999999999999999999999998754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-33 Score=312.75 Aligned_cols=200 Identities=26% Similarity=0.452 Sum_probs=161.8
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--------ccchhhhHHHHHHhhcCCCccceeeceeecCC
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 670 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 670 (824)
...|.+.+.||+|+||.||+|.++ +++.||||++..... .....+.+|++++++++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 445778899999999999999876 578999999865321 123458899999999999999999999854 5
Q ss_pred eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEEe
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSD 747 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~---~~vkL~D 747 (824)
..++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.+ ..+||+|
T Consensus 213 ~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp EEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred ceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 5799999999999988774 345689999999999999999999998 99999999999999754 4599999
Q ss_pred cCCcccccCCCCceeccccCCCCCcchhcccc---CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 748 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 748 FGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
||+++..... ......+||+.|+|||++.. ..++.++|||||||++|||++|+.||.+..
T Consensus 286 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 286 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred cccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 9999865432 22344579999999999863 677889999999999999999999997643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-33 Score=319.00 Aligned_cols=200 Identities=31% Similarity=0.448 Sum_probs=172.2
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
..+|.+.+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 456778899999999999999986 78999999986432 233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEEecCCccc
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKF 753 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~---~~~~vkL~DFGla~~ 753 (824)
||+.+|+|.+.+.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999988843 35688999999999999999999998 999999999999995 456799999999976
Q ss_pred ccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
..... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+..
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 226 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 54332 2334569999999998865 58999999999999999999999997654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-33 Score=319.74 Aligned_cols=201 Identities=31% Similarity=0.483 Sum_probs=175.0
Q ss_pred HHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEE
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 674 (824)
...+|.+.+.||+|+||.||+|+++ +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3457788899999999999999986 78999999996543 2235668899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEEecCCc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLS 751 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl---~~~~~vkL~DFGla 751 (824)
||||+.+|+|.+.+.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 9999999999998853 35688999999999999999999998 99999999999999 46789999999999
Q ss_pred ccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
+...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+..
T Consensus 177 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 177 THFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp HHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence 7654432 2234569999999998865 69999999999999999999999998754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=312.96 Aligned_cols=196 Identities=24% Similarity=0.365 Sum_probs=162.6
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccC--CcccchhhhHHHHHHhhcCCCccceeeceeecC-----CeEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSV 673 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~ 673 (824)
.|.+.+.||+|+||.||+|+++ +++.||||+++.. .....+.+.+|++++++++||||+++++++... +..+
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 4667899999999999999876 5788999999753 223346788999999999999999999998765 5789
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+||||++ ++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 9999987 599988843 35689999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCC---------------------ceeccccCCCCCcchhcc-ccCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003385 754 AVDGAS---------------------HVSSIVRGTVGYLDPEYY-ISQQLTDKSDVYSFGVILLELISGQEAI 805 (824)
Q Consensus 754 ~~~~~~---------------------~~~~~~~gt~~y~aPE~l-~~~~~~~~~DIwSlGvil~elltG~~Pf 805 (824)
...... ......+||+.|+|||++ ....++.++||||+||++|||++|..||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 543221 112445799999999986 4567999999999999999999855444
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=309.02 Aligned_cols=204 Identities=25% Similarity=0.364 Sum_probs=166.4
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecC------CeE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS 672 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~~ 672 (824)
.|.+.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 3566789999999999999875 68999999986432 22345688999999999999999999998765 345
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
++||||+ +++|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 106 ~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp EEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 9999999 7899998843 4588899999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+....|+
T Consensus 177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~ 239 (367)
T 1cm8_A 177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 239 (367)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 65332 233468999999999887 689999999999999999999999998866444444443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=298.26 Aligned_cols=203 Identities=24% Similarity=0.394 Sum_probs=164.1
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
.|.+.+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 4677899999999999999875 78999999997532 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+++++|.+++.........+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999865433456688999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.. ......|++.|+|||.+....++.++|||||||++|||++|+.||.+.
T Consensus 190 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 190 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred Cc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 22 223345899999999999999999999999999999999999999754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-33 Score=304.97 Aligned_cols=197 Identities=25% Similarity=0.373 Sum_probs=164.3
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCC--CccceeeceeecCCeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHH--RNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~E 677 (824)
.|.+.+.||+|+||.||+|...+++.||||++..... ...+.+.+|++++++++| |||+++++++.+.+..++|||
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 89 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 89 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe
Confidence 3567789999999999999988899999999875432 234678899999999986 999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
+.+++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 90 -~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 90 -CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp -CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred -CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 567899999853 35688999999999999999999998 999999999999997 678999999999865443
Q ss_pred CCc-eeccccCCCCCcchhcccc-----------CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 758 ASH-VSSIVRGTVGYLDPEYYIS-----------QQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 758 ~~~-~~~~~~gt~~y~aPE~l~~-----------~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.+
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 222 2334569999999999865 6788999999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=297.85 Aligned_cols=204 Identities=26% Similarity=0.380 Sum_probs=171.6
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceee--cCCeEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQ--EEGRSVLVY 676 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lV~ 676 (824)
.|.+.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|++++++++||||+++++++. ..+..++||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 3456789999999999999886 68899999997543 233466889999999999999999999874 467899999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEecCCCCCCEEEcCCCcEEEEecCCc
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA-----IIHRDLKSSNILLDKHMRAKVSDFGLS 751 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~g-----IvHrDLkp~NILl~~~~~vkL~DFGla 751 (824)
||+++++|.+++.........+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 99999999999865433445689999999999999999999997 7 999999999999999999999999998
Q ss_pred ccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
+....... ......|++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 164 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 164 RILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 76543222 2233458999999999999899999999999999999999999998654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-33 Score=303.06 Aligned_cols=208 Identities=27% Similarity=0.490 Sum_probs=174.6
Q ss_pred HHHHHHhhccccccCcEEEEEEEEc--------CCcEEEEEEeccCCc-ccchhhhHHHHHHhhc-CCCccceeeceeec
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQE 668 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~--------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 668 (824)
....|.+.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|+++++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3456678899999999999999873 467899999975432 2346688999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhhcccC------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 003385 669 EGRSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 736 (824)
Q Consensus 669 ~~~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NIL 736 (824)
.+..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 9999999999999999999965422 123588999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 737 LDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 737 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+..
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 999999999999999865443221 1223447789999999999899999999999999999999 999998654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=327.62 Aligned_cols=202 Identities=29% Similarity=0.506 Sum_probs=173.7
Q ss_pred HHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
..+.+.++||+|+||.||+|++++++.||||+++... ...+.+.+|+++|++++||||+++++++.+ +..++||||++
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~ 344 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 344 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence 3456788999999999999999988899999997544 235679999999999999999999999876 66899999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+|+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 345 ~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 345 KGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp TEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred CCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 99999999532 234588899999999999999999998 9999999999999999999999999999765432111
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
......++..|+|||.+....++.++|||||||++|||++ |+.||.+..
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~ 469 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 469 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 2223346789999999999999999999999999999999 999997644
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=302.02 Aligned_cols=207 Identities=24% Similarity=0.388 Sum_probs=170.6
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
.|.+.+.||+|+||.||+|++. +++.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 4566789999999999999986 5889999998654322 245578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 106 ~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 106 VDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred CCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 99998888763 234588999999999999999999998 99999999999999999999999999997654332
Q ss_pred CceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 816 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~ 816 (824)
. ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+...+
T Consensus 179 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 236 (331)
T 4aaa_A 179 E-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYH 236 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred c-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 2 22345689999999998875 789999999999999999999999988664443333
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=294.87 Aligned_cols=198 Identities=27% Similarity=0.451 Sum_probs=172.8
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
.|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 3567789999999999999886 57789999986432 1224568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 95 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 95 FAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred eCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999998853 34588999999999999999999998 9999999999999999999999999998654332
Q ss_pred CCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 1234568999999999999999999999999999999999999998644
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-33 Score=303.65 Aligned_cols=207 Identities=28% Similarity=0.469 Sum_probs=174.4
Q ss_pred HHHHHhhccccccCcEEEEEEEEcC-C-----cEEEEEEeccCCc-ccchhhhHHHHHHhhc-CCCccceeeceeecCCe
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLKD-G-----KEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 671 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~~-g-----~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 671 (824)
...+.+.+.||+|+||.||+|.+.. + +.||+|+++.... ...+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 3456678999999999999998753 2 4799999975432 3356788999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhcccC----------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 003385 672 SVLVYEFMHNGTLKEHLYGTLT----------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 741 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~~----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~ 741 (824)
.++||||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence 9999999999999999854311 134578999999999999999999998 999999999999999999
Q ss_pred cEEEEecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 742 RAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 742 ~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 9999999999865443322 2233457889999999999999999999999999999998 999998644
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=299.58 Aligned_cols=210 Identities=24% Similarity=0.369 Sum_probs=174.7
Q ss_pred cCHHHHHHHHHHhh-ccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcC-CCccceeeceee
Q 003385 593 FTLSDIEDATKMLE-KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQ 667 (824)
Q Consensus 593 ~~~~~~~~~~~~i~-~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~ 667 (824)
+...+....+|.+. +.||+|+||.||+|..+ +++.||+|+++... ......+.+|+.+++++. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33344555566665 88999999999999876 68999999987543 223467889999999995 699999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEE
Q 003385 668 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAK 744 (824)
Q Consensus 668 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~---~~~vk 744 (824)
+.+..++||||+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+|
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence 999999999999999999987432 245688999999999999999999998 9999999999999997 78999
Q ss_pred EEecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 745 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 745 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
|+|||+++...... ......||+.|+|||++....++.++|||||||++|||++|+.||.+..
T Consensus 175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999998654322 2233569999999999999999999999999999999999999997654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-33 Score=304.75 Aligned_cols=210 Identities=25% Similarity=0.311 Sum_probs=171.1
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc-----cchhhhHHHHHHhhcCCCccceeeceeecCCeEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 674 (824)
..|.+.+.||+|+||.||+|++. +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 45677899999999999999876 5899999998753221 13467899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
||||+++ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 90 v~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999986 888877532 34577788899999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 755 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 755 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+....+...++.
T Consensus 163 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~ 226 (346)
T 1ua2_A 163 GSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 226 (346)
T ss_dssp TSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 43322 23345689999999998754 58899999999999999999999998866444444443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=302.79 Aligned_cols=209 Identities=22% Similarity=0.363 Sum_probs=172.1
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--cchhhhHHHHHHhhcCCCccceeeceeec--------CC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQE--------EG 670 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--------~~ 670 (824)
+|.+.+.||+|+||.||+|+++ +++.||||++...... ....+.+|++++++++||||+++++++.. .+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 4667899999999999999985 7899999998654322 24567899999999999999999999876 45
Q ss_pred eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGl 750 (824)
..++||||+++ +|.+.+... ...+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 68999999985 777766432 34588999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCC---CceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcH
Q 003385 751 SKFAVDGA---SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (824)
Q Consensus 751 a~~~~~~~---~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i 817 (824)
++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i 241 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 241 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 97654221 122234568999999999876 45899999999999999999999999886644333333
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=314.59 Aligned_cols=199 Identities=15% Similarity=0.182 Sum_probs=158.8
Q ss_pred HHHhhccccccCcEEEEEEEE-cCCcEEEEEEeccC---CcccchhhhHHHH---HHhhcCCCccceee-------ceee
Q 003385 602 TKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSN---SYQGKREFTNEVT---LLSRIHHRNLVQFL-------GYCQ 667 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~~Ei~---il~~l~HpnIv~l~-------~~~~ 667 (824)
.|.+.+.||+|+||.||+|++ .+|+.||||++... .....+.+.+|++ ++++++||||++++ +++.
T Consensus 74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~ 153 (377)
T 3byv_A 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153 (377)
T ss_dssp EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence 345678999999999999986 46899999999743 2223467889994 55555799999998 4444
Q ss_pred cCC-----------------eEEEEEEecCCCCHHHHhhcc--cCc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 003385 668 EEG-----------------RSVLVYEFMHNGTLKEHLYGT--LTH-EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIH 727 (824)
Q Consensus 668 ~~~-----------------~~~lV~E~~~~gsL~~~L~~~--~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvH 727 (824)
+.+ ..++||||+ +|+|.+++... ... ...+++..+..++.||+.||+|||++ +|+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 229 (377)
T 3byv_A 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH 229 (377)
T ss_dssp CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 442 278999999 68999998542 111 23344678888999999999999998 9999
Q ss_pred cCCCCCCEEEcCCCcEEEEecCCcccccCCCCceeccccCCCCCcchhccccC-----------CCCchHHHHHHHHHHH
Q 003385 728 RDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-----------QLTDKSDVYSFGVILL 796 (824)
Q Consensus 728 rDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~~~DIwSlGvil~ 796 (824)
|||||+|||++.++.+||+|||+++.... .....+| +.|+|||++... .++.++|||||||++|
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 99999999999999999999999975322 3344567 999999999887 8999999999999999
Q ss_pred HHHcCCCCCCCCc
Q 003385 797 ELISGQEAISNEK 809 (824)
Q Consensus 797 elltG~~Pf~~~~ 809 (824)
||++|+.||.+..
T Consensus 305 elltg~~Pf~~~~ 317 (377)
T 3byv_A 305 WIWCADLPITKDA 317 (377)
T ss_dssp HHHHSSCCC----
T ss_pred HHHHCCCCCcccc
Confidence 9999999997644
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=6e-33 Score=311.98 Aligned_cols=202 Identities=25% Similarity=0.399 Sum_probs=170.5
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCC--eEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lV~E 677 (824)
+|.+.+.||+|+||.||+|+++ +++.||||+++.... ...+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 4567789999999999999987 489999999975432 23456789999999999999999999987654 7899999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEEecCCccc
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKF 753 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl----~~~~~vkL~DFGla~~ 753 (824)
|+++|+|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 90 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 90 FCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred cCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 999999999985432 223389999999999999999999998 99999999999999 7778899999999976
Q ss_pred ccCCCCceeccccCCCCCcchhcccc--------CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYIS--------QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
..... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 54322 2234569999999999875 567789999999999999999999997644
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.9e-33 Score=300.46 Aligned_cols=204 Identities=25% Similarity=0.385 Sum_probs=170.9
Q ss_pred HHHHhhccccccCcEEEEEEEE-cCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceee----cCCeEEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ----EEGRSVLV 675 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~----~~~~~~lV 675 (824)
..|.+.+.||+|+||.||+|+. .+++.||||++........+.+.+|++++++++||||+++++++. .....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 4566789999999999999997 478999999987665556678899999999999999999999986 34578999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
|||+++|+|.+++.........+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999999999865444556789999999999999999999998 99999999999999999999999999886542
Q ss_pred CCCCc--------eeccccCCCCCcchhccccCC---CCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 756 DGASH--------VSSIVRGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 756 ~~~~~--------~~~~~~gt~~y~aPE~l~~~~---~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
..... ......||+.|+|||.+.... ++.++|||||||++|||++|+.||..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 21100 012234799999999987554 68899999999999999999999953
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=290.87 Aligned_cols=202 Identities=24% Similarity=0.415 Sum_probs=173.9
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
..|.+.+.||+|+||.||+|+++ +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 45677899999999999999986 68999999986443 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++++|.+++. ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 87 CSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999998874 345688999999999999999999998 99999999999999999999999999997654322
Q ss_pred C-ceeccccCCCCCcchhccccCCC-CchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 S-HVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~-~~~~~~~gt~~y~aPE~l~~~~~-~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
. .......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 1 12334568999999999987765 678999999999999999999997643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.1e-33 Score=298.99 Aligned_cols=202 Identities=31% Similarity=0.506 Sum_probs=170.5
Q ss_pred HHHHHHhhccccccCcEEEEEEEE-----cCCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecC--C
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--G 670 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~-----~~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~ 670 (824)
....+.+.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|++++++++||||+++++++.+. +
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 344566789999999999999984 3688999999975432 2346788999999999999999999999876 6
Q ss_pred eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGl 750 (824)
..++||||+++++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred eEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccc
Confidence 689999999999999998532 34588999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCc--eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003385 751 SKFAVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 806 (824)
Q Consensus 751 a~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~ 806 (824)
++........ ......||..|+|||.+.+..++.++||||+||++|||++|..|+.
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 9866543321 2234558888999999999999999999999999999999998864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=293.61 Aligned_cols=201 Identities=26% Similarity=0.448 Sum_probs=167.2
Q ss_pred HHHhhccccccCcEEEEEEEEcC----CcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~----g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
.+.+.+.||+|+||.||+|++.. +..||+|+++... ....+.+.+|++++++++||||+++++++.+. ..++||
T Consensus 13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 91 (281)
T 3cc6_A 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIM 91 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEE
T ss_pred ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEE
Confidence 45577899999999999998653 2359999987653 23456788999999999999999999998754 468999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 92 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 92 ELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp ECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred ecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999998532 34578999999999999999999998 999999999999999999999999999986654
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
..........+|+.|+|||.+....++.++|||||||++|||++ |+.||....
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~ 219 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 219 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC
Confidence 33333344557889999999999999999999999999999998 999997543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-32 Score=292.35 Aligned_cols=196 Identities=36% Similarity=0.605 Sum_probs=166.8
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCccc-------chhhhHHHHHHhhcCCCccceeeceeecCCeEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-------KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~-------~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 673 (824)
.|.+.+.||+|+||.||+|++. +++.||+|++....... .+.+.+|++++++++||||+++++++.+.. +
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~ 97 (287)
T 4f0f_A 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--R 97 (287)
T ss_dssp TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--E
T ss_pred cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--e
Confidence 4567789999999999999885 78899999986543222 156889999999999999999999997765 6
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCEEEcCCCc-----EEEE
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMR-----AKVS 746 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~g--IvHrDLkp~NILl~~~~~-----vkL~ 746 (824)
+||||+++|+|.+.+.. ....+++..+..++.|++.||+|||++ + |+||||||+|||++.++. +||+
T Consensus 98 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp EEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred EEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 99999999999988853 345689999999999999999999998 7 999999999999988776 9999
Q ss_pred ecCCcccccCCCCceeccccCCCCCcchhccc--cCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 747 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI--SQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 747 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
|||+++.... ......||+.|+|||++. ...++.++||||+||++|||++|+.||....
T Consensus 172 Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 172 DFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp CCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 9999875432 233456899999999984 4567889999999999999999999997644
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=317.06 Aligned_cols=199 Identities=31% Similarity=0.506 Sum_probs=169.7
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-------------ccchhhhHHHHHHhhcCCCccceeecee
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-------------QGKREFTNEVTLLSRIHHRNLVQFLGYC 666 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-------------~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 666 (824)
..|.+.++||+|+||+||+|+++ +++.||||+++.... ...+.+.+|++++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 35667899999999999999986 578999999875431 2235688999999999999999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cE
Q 003385 667 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RA 743 (824)
Q Consensus 667 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~---~v 743 (824)
.+....++||||+++|+|.+.+.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred EcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence 999999999999999999998843 35689999999999999999999998 999999999999999775 69
Q ss_pred EEEecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 744 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 744 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
||+|||+++...... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||.+..
T Consensus 189 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp EECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999998664432 233456999999999876 568999999999999999999999998755
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-33 Score=300.28 Aligned_cols=196 Identities=28% Similarity=0.485 Sum_probs=168.2
Q ss_pred HHHHhhccccccCcEEEEEEEEcC-C-------cEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKD-G-------KEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~-g-------~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 672 (824)
..|.+.+.||+|+||.||+|+++. + +.||+|++........+.+.+|++++++++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 345678899999999999998653 3 47999999766555567899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--------EE
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--------AK 744 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~--------vk 744 (824)
++||||+++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp EEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999998542 33488999999999999999999998 9999999999999998887 99
Q ss_pred EEecCCcccccCCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCC-CCCCC
Q 003385 745 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ-EAISN 807 (824)
Q Consensus 745 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~-~Pf~~ 807 (824)
|+|||++..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|. .||..
T Consensus 162 l~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~ 221 (289)
T 4fvq_A 162 LSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221 (289)
T ss_dssp ECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred eccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence 999999865422 123457899999999987 67899999999999999999955 45543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=308.67 Aligned_cols=208 Identities=26% Similarity=0.373 Sum_probs=169.2
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCC------eEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSVLV 675 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~~~lV 675 (824)
.|.+.+.||+|+||.||+|++..+..||+|++... .+...+|+++++.++||||+++++++...+ ..++|
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecC----cchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 46678999999999999999988888999987543 233457999999999999999999985433 37899
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEEecCCcccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFA 754 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~-~~~~vkL~DFGla~~~ 754 (824)
|||++++.+ ..+.........+++..+..++.|++.||+|||++ +|+||||||+|||++ .++.+||+|||+++..
T Consensus 117 ~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 117 LEYVPETVY-RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EECCSEEHH-HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eeccCccHH-HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999987543 33332223356788999999999999999999998 999999999999999 7899999999999865
Q ss_pred cCCCCceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 755 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 755 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+...++++
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~ 256 (394)
T 4e7w_A 193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK 256 (394)
T ss_dssp CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 44332 2334689999999998765 589999999999999999999999998765544445444
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=303.80 Aligned_cols=202 Identities=22% Similarity=0.295 Sum_probs=164.2
Q ss_pred HHHHHHHhhccccccCcEEEEEEEEc----CCcEEEEEEeccCCcc-----------cchhhhHHHHHHhhcCCCcccee
Q 003385 598 IEDATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSYQ-----------GKREFTNEVTLLSRIHHRNLVQF 662 (824)
Q Consensus 598 ~~~~~~~i~~~LG~G~fg~Vy~a~~~----~g~~vAVK~l~~~~~~-----------~~~~~~~Ei~il~~l~HpnIv~l 662 (824)
+....|.+.+.||+|+||.||+|.+. .+..+|||++...... ..+.+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 33445677899999999999999986 5678999998754321 12346678889999999999999
Q ss_pred eceeec----CCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 003385 663 LGYCQE----EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738 (824)
Q Consensus 663 ~~~~~~----~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~ 738 (824)
++++.. ....++||||+ +++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLG 185 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEc
Confidence 999877 67889999999 9999998843 33789999999999999999999998 999999999999999
Q ss_pred CCC--cEEEEecCCcccccCCCC------ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 739 KHM--RAKVSDFGLSKFAVDGAS------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 739 ~~~--~vkL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
.++ .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 887 999999999976533211 112345699999999999999999999999999999999999999965
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=309.43 Aligned_cols=197 Identities=24% Similarity=0.370 Sum_probs=152.1
Q ss_pred hccccccCcEEEEEEEEc---CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceee--cCCeEEEEEEecC
Q 003385 606 EKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ--EEGRSVLVYEFMH 680 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~---~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lV~E~~~ 680 (824)
+++||+|+||.||+|+++ +++.||||++.... ..+.+.+|+++|++++||||+++++++. .....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 568999999999999976 57889999996442 2456889999999999999999999994 4678999999997
Q ss_pred CCCHHHHhhccc-----CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEEecCCc
Q 003385 681 NGTLKEHLYGTL-----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLS 751 (824)
Q Consensus 681 ~gsL~~~L~~~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl----~~~~~vkL~DFGla 751 (824)
++|.+++.... .....+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 47777764221 1223488999999999999999999998 99999999999999 67789999999999
Q ss_pred ccccCCCC--ceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 752 KFAVDGAS--HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 752 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
+....... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 86543221 122345689999999999874 5899999999999999999999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=305.62 Aligned_cols=200 Identities=25% Similarity=0.333 Sum_probs=161.9
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCC------eE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RS 672 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~~ 672 (824)
.|.+.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++++.++||||+++++++...+ ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 4567789999999999999876 68899999997532 223456889999999999999999999987654 78
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
++||||+++ +|.+.+. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 106 ~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 106 YIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred EEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 999999975 6877773 3478888999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccc
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 813 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~ 813 (824)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.
T Consensus 176 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 234 (371)
T 2xrw_A 176 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ 234 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 654321 22345689999999999999999999999999999999999999988664333
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-32 Score=290.78 Aligned_cols=200 Identities=19% Similarity=0.314 Sum_probs=170.1
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 675 (824)
...|.+.+.||+|+||.||+|++. +++.||||+++... ......+.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 456777899999999999999986 78999999987542 23345678899999999 899999999999999999999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---------------
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH--------------- 740 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~--------------- 740 (824)
|||+++++|.+++.........+++..+..++.|++.||.|||++ +|+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999965433346689999999999999999999998 99999999999999844
Q ss_pred ----CcEEEEecCCcccccCCCCceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 741 ----MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 741 ----~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
..+||+|||.+....... ...||+.|+|||.+.+. .++.++|||||||++|||++|..|+..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 479999999987654322 23489999999999866 566899999999999999999987644
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-32 Score=302.25 Aligned_cols=200 Identities=27% Similarity=0.439 Sum_probs=172.5
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--------cchhhhHHHHHHhhc-CCCccceeeceeecCC
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG 670 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--------~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 670 (824)
..|.+.+.||+|+||.||+|+++ +|+.||||+++..... ..+.+.+|+.+++++ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 45666789999999999999986 7999999998754311 134578899999999 7999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGl 750 (824)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCc
Confidence 99999999999999998853 35688999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCceeccccCCCCCcchhcccc------CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 751 SKFAVDGASHVSSIVRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
+....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 247 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 247 SCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 87654432 2234569999999999864 357889999999999999999999997643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-32 Score=303.42 Aligned_cols=209 Identities=23% Similarity=0.359 Sum_probs=174.4
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecC-----CeEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL 674 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~l 674 (824)
+|.+.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 4667899999999999999876 678899999975332 2346788999999999999999999998654 46899
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
||||++ |+|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 999997 589888742 4588999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCce--eccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 755 VDGASHV--SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 755 ~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
....... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+....+++
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 246 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHH
Confidence 4322211 233469999999998764 4589999999999999999999999998776655555543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-32 Score=293.36 Aligned_cols=198 Identities=26% Similarity=0.439 Sum_probs=174.0
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 556789999999999999875 688999999975432 334678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 104 ~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 174 (303)
T 3a7i_A 104 GGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 174 (303)
T ss_dssp TEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred CCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence 999999884 24688999999999999999999998 999999999999999999999999999976544322
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......||+.|+|||.+....++.++|||||||++|||++|+.||....
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 2234568999999999999999999999999999999999999997643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.4e-32 Score=295.75 Aligned_cols=201 Identities=26% Similarity=0.455 Sum_probs=167.8
Q ss_pred HHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--------ccchhhhHHHHHHhhcCCCccceeeceeecC
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE 669 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 669 (824)
....|.+.+.||+|+||.||+|++. +++.||||++..... .....+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3456788899999999999999876 578999999864321 1234688999999999999999999998766
Q ss_pred CeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEE
Q 003385 670 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVS 746 (824)
Q Consensus 670 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~---vkL~ 746 (824)
+ .++||||+++++|.+++. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 799999999999999884 345688999999999999999999998 9999999999999987654 9999
Q ss_pred ecCCcccccCCCCceeccccCCCCCcchhccc---cCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 747 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 747 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
|||+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 160 Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 160 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp CCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred cCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 99999765332 2223456899999999974 4678899999999999999999999997644
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=308.19 Aligned_cols=197 Identities=24% Similarity=0.369 Sum_probs=165.4
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCC--cccchhhhHHHHHHhhcC--CCccceeeceeecCCeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIH--HRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~lV~E 677 (824)
.|.+.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++ ||||+++++++...+..++|||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E 136 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence 366788999999999999998889999999987543 233467889999999996 5999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
+.+++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 137 -~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 137 -CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp -CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred -cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 568899998853 34678889999999999999999998 999999999999995 588999999999866443
Q ss_pred CCc-eeccccCCCCCcchhcccc-----------CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 758 ASH-VSSIVRGTVGYLDPEYYIS-----------QQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 758 ~~~-~~~~~~gt~~y~aPE~l~~-----------~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
... .....+||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 222 2344579999999999865 3688999999999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=9.7e-33 Score=305.71 Aligned_cols=200 Identities=27% Similarity=0.402 Sum_probs=172.3
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
..|.+.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 34566789999999999999986 68899999997553 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999999853 346888999999999999999999831 7999999999999999999999999998754322
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1233468999999999999999999999999999999999999997543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=296.25 Aligned_cols=197 Identities=30% Similarity=0.515 Sum_probs=161.7
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
.+.+.+.||+|+||.||+|++. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||+++
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~ 83 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG 83 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred HeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence 3456789999999999999986 789999998643 235678899999999999999999999874 36899999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-EEEEecCCcccccCCCCc
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-AKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~-vkL~DFGla~~~~~~~~~ 760 (824)
|+|.+++... .....+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 84 ~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 84 GSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp CBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999998643 22335788899999999999999999932228999999999999998876 799999998754322
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 12335899999999999999999999999999999999999999753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=303.13 Aligned_cols=209 Identities=23% Similarity=0.339 Sum_probs=167.8
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCccc-----------chhhhHHHHHHhhcCCCccceeeceee---
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-----------KREFTNEVTLLSRIHHRNLVQFLGYCQ--- 667 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~-----------~~~~~~Ei~il~~l~HpnIv~l~~~~~--- 667 (824)
.|.+.+.||+|+||.||+|...+++.||||++....... .+.+.+|++++++++||||+++++++.
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 102 (362)
T 3pg1_A 23 PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFE 102 (362)
T ss_dssp SCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECC
T ss_pred ceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEecc
Confidence 456678999999999999998889999999986432221 256889999999999999999999984
Q ss_pred --cCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 003385 668 --EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 745 (824)
Q Consensus 668 --~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL 745 (824)
.....++||||++ |+|.+.+.. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||
T Consensus 103 ~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 103 EPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp TTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEE
Confidence 3446899999998 688887753 244688999999999999999999998 9999999999999999999999
Q ss_pred EecCCcccccCCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 746 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 746 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
+|||+++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+...++++
T Consensus 176 ~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 248 (362)
T 3pg1_A 176 CDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248 (362)
T ss_dssp CCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999997543322 2233568999999999876 6789999999999999999999999998775555555544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=7.9e-33 Score=307.91 Aligned_cols=204 Identities=25% Similarity=0.383 Sum_probs=156.2
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccC--CcccchhhhHHHHHHhhcCCCccceeeceeecC------CeE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS 672 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~~ 672 (824)
+|.+.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+++++.++||||+++++++... ...
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 4567789999999999999875 6889999998653 223346788999999999999999999998653 567
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
++|+|++ +++|.+++. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 110 ~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp EEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred EEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 9999999 678888774 24688999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+....|+
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~ 243 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 243 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 65322 233468999999999887 678999999999999999999999998866444444443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=297.74 Aligned_cols=197 Identities=30% Similarity=0.493 Sum_probs=169.6
Q ss_pred HHhhccccccCcEEEEEEEEc-----CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeec--CCeEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVL 674 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-----~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 674 (824)
+.+.+.||+|+||.||++.++ +++.||||+++.... ...+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 367899999999999998753 678899999976532 335668999999999999999999999987 467899
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999843 3488999999999999999999998 9999999999999999999999999999866
Q ss_pred cCCCCc--eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 755 VDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 755 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
...... ......+|..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 543322 22334578899999999999999999999999999999999999865
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=291.66 Aligned_cols=196 Identities=24% Similarity=0.373 Sum_probs=167.8
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecC--CeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV~E 677 (824)
.|.+.+.||+|+||.||+|+++ ++.||||+++... ....+.+.+|++++++++||||+++++++.+. +..++|||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 3556789999999999999986 8899999997543 23345789999999999999999999999876 77899999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~g--IvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
|+++|+|.+++... ....+++..+..++.|++.||+|||++ + |+||||||+||+++.++.++|+|||++....
T Consensus 90 ~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 90 WMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp CCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999642 233589999999999999999999997 7 9999999999999999999999998865432
Q ss_pred CCCCceeccccCCCCCcchhccccCCCCc---hHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~---~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
. ....||+.|+|||.+.+..++. ++|||||||++|||++|+.||.+..
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 215 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS 215 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 1 2245899999999998765544 8999999999999999999997644
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-32 Score=291.00 Aligned_cols=196 Identities=30% Similarity=0.501 Sum_probs=168.3
Q ss_pred ccccccCcEEEEEEEEc---CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCC
Q 003385 607 KKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~---~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 682 (824)
+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 48999999999999864 57889999997643 23456788999999999999999999999 455689999999999
Q ss_pred CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce-
Q 003385 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV- 761 (824)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~- 761 (824)
+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 95 ~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 168 (287)
T 1u59_A 95 PLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168 (287)
T ss_dssp EHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred CHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceee
Confidence 99999853 245688999999999999999999998 99999999999999999999999999998664333221
Q ss_pred -eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 762 -SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 762 -~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.....+|+.|+|||.+....++.++|||||||++|||++ |+.||.+..
T Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 218 (287)
T 1u59_A 169 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218 (287)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 222346889999999998899999999999999999998 999997644
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=7e-32 Score=294.70 Aligned_cols=192 Identities=21% Similarity=0.401 Sum_probs=167.1
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcC-CCccceeeceeec--CCeEEEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQE--EGRSVLVY 676 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~~~lV~ 676 (824)
..|.+.+.||+|+||.||+|++. +++.||||+++.. ..+.+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 35667899999999999999874 6889999998643 3467889999999997 9999999999987 66789999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCccccc
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAV 755 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~-~vkL~DFGla~~~~ 755 (824)
||+++++|.+++. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++...
T Consensus 113 e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999998873 377888999999999999999998 999999999999999776 89999999998654
Q ss_pred CCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
.... .....||+.|+|||.+.. ..++.++|||||||++|||++|+.||..
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 4322 234568999999999887 6789999999999999999999999943
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=298.95 Aligned_cols=203 Identities=32% Similarity=0.526 Sum_probs=169.0
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcE--EEEEEeccC-CcccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKE--IAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~--vAVK~l~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
.|.+.+.||+|+||.||+|+++ +++. +|+|+++.. .....+.+.+|+++++++ +||||+++++++.+.+..++||
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 105 (327)
T 1fvr_A 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 105 (327)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEE
Confidence 4557789999999999999875 4554 499988753 233456788999999999 8999999999999999999999
Q ss_pred EecCCCCHHHHhhccc------------CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 003385 677 EFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 744 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vk 744 (824)
||+++++|.+++.... .....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+|
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 106 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEE
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEE
Confidence 9999999999986532 2235689999999999999999999998 999999999999999999999
Q ss_pred EEecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 745 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 745 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
|+|||+++...... ......+++.|+|||.+....++.++|||||||++|||++ |+.||.+..
T Consensus 183 L~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 183 IADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp ECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 99999987432211 1223347889999999998889999999999999999998 999997654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=4.7e-33 Score=298.63 Aligned_cols=203 Identities=37% Similarity=0.621 Sum_probs=160.5
Q ss_pred HHHHHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEE
Q 003385 597 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (824)
Q Consensus 597 ~~~~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 674 (824)
|+....|.+.+.||+|+||.||+|++. ..||||+++.... ...+.+.+|++++++++||||+++++++. ....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEE
Confidence 444556778899999999999999865 4699999975432 23467889999999999999999999764 456799
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 97 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence 9999999999998853 245688999999999999999999998 9999999999999999999999999998754
Q ss_pred cCCC-CceeccccCCCCCcchhccc---cCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 755 VDGA-SHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 755 ~~~~-~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.... ........||+.|+|||.+. ...++.++|||||||++|||++|+.||.+.
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 228 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence 3321 22223456899999999986 567888999999999999999999999763
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.98 E-value=7.9e-32 Score=289.22 Aligned_cols=198 Identities=25% Similarity=0.403 Sum_probs=168.4
Q ss_pred HHHhhccccccCcEEEEEEEE-cCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeecee-ecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~lV~E~~ 679 (824)
.|.+.+.||+|+||.||+|++ .+++.||||++.... ..+.+.+|++++++++|++++..+..+ .+.+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 355678999999999999997 478999999986543 245688999999999998877766655 5667889999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEEecCCcccccC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~---~~~~vkL~DFGla~~~~~ 756 (824)
+++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++ .++.+||+|||+++....
T Consensus 88 -~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 88 -GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp -CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred -CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 89999998532 34689999999999999999999998 999999999999994 789999999999986554
Q ss_pred CCCc------eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 757 GASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 757 ~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence 3321 123456999999999999999999999999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.7e-33 Score=307.73 Aligned_cols=195 Identities=11% Similarity=0.071 Sum_probs=148.4
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhc--CCCccceee-------ceeecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI--HHRNLVQFL-------GYCQEE 669 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l--~HpnIv~l~-------~~~~~~ 669 (824)
|.+.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|+++++.+ +||||++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 456789999999999999976 788999999986542 2345677885555555 699988755 333222
Q ss_pred -----------------CeEEEEEEecCCCCHHHHhhcccCccccCCHHHH------HHHHHHHHHHHHHHHhCCCCCeE
Q 003385 670 -----------------GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR------LEIAEDAAKGIEYLHTGCVPAII 726 (824)
Q Consensus 670 -----------------~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~------~~i~~qia~gL~yLH~~~~~gIv 726 (824)
...++||||++ |+|.+++... ...+.+..+ ..++.||+.||+|||++ +|+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 34799999999 8999999643 122333444 67789999999999998 999
Q ss_pred ecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceeccccCCCCCcchhcccc--CCCCchHHHHHHHHHHHHHHcCCCC
Q 003385 727 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEA 804 (824)
Q Consensus 727 HrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DIwSlGvil~elltG~~P 804 (824)
||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999986532 1213447799999999987 6799999999999999999999999
Q ss_pred CCCC
Q 003385 805 ISNE 808 (824)
Q Consensus 805 f~~~ 808 (824)
|.+.
T Consensus 293 f~~~ 296 (371)
T 3q60_A 293 FGLV 296 (371)
T ss_dssp TTBC
T ss_pred CCCc
Confidence 9876
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=9.8e-33 Score=300.40 Aligned_cols=207 Identities=25% Similarity=0.443 Sum_probs=174.1
Q ss_pred HHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 672 (824)
...|.+.+.||+|+||.||+|++. .++.||||++..... .....+.+|++++++++||||+++++++.+.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 345677899999999999999765 367899999975432 2345688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhcccC------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 003385 673 VLVYEFMHNGTLKEHLYGTLT------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~ 746 (824)
++||||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEEC
Confidence 999999999999999854211 124568899999999999999999998 99999999999999999999999
Q ss_pred ecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 747 DFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 747 DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.+..
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 99999755432221 1223346889999999999999999999999999999999 899997644
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6.5e-32 Score=289.64 Aligned_cols=200 Identities=25% Similarity=0.396 Sum_probs=168.0
Q ss_pred HHHHhhccccccCcEEEEEEEE-cCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeecee-ecCCeEEEEEEe
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEF 678 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~lV~E~ 678 (824)
..|.+.+.||+|+||.||+|++ .+++.||||++.... ..+.+.+|++++++++|++++..++.+ .+.+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 4577889999999999999987 478899999875433 245688999999999988877777665 667788999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEEecCCccccc
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl---~~~~~vkL~DFGla~~~~ 755 (824)
+ +++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 87 ~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 87 L-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp C-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred c-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9 99999988532 34589999999999999999999998 99999999999999 788999999999998654
Q ss_pred CCCC------ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 756 DGAS------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 756 ~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 4322 12234569999999999999999999999999999999999999998643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=297.82 Aligned_cols=207 Identities=30% Similarity=0.467 Sum_probs=173.8
Q ss_pred HHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCc-ccchhhhHHHHHHhhc-CCCccceeeceeecCC-
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG- 670 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~- 670 (824)
...|.+.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 445677899999999999999852 467899999975432 2345788999999999 7999999999987654
Q ss_pred eEEEEEEecCCCCHHHHhhcccCc------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLTH------------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~ 738 (824)
..++||||+++++|.+++...... ...+++..+..++.|++.||.|||++ +|+||||||+||+++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEEC
Confidence 589999999999999999654321 12378899999999999999999998 999999999999999
Q ss_pred CCCcEEEEecCCcccccCCCC-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 739 KHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 739 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+..
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999976544322 22334557899999999999999999999999999999998 999997754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=291.03 Aligned_cols=199 Identities=28% Similarity=0.495 Sum_probs=165.0
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
.|.+.+.||+|+||.||+|+++ +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4567789999999999999987 78999999986532 1224568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 92 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 92 YVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred ccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999999853 34578899999999999999999998 9999999999999999999999999998765432
Q ss_pred CCceeccccCCCCCcchhccccCCC-CchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
. ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||....
T Consensus 165 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 165 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 2 2233468999999999987765 579999999999999999999998654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-32 Score=309.55 Aligned_cols=207 Identities=25% Similarity=0.331 Sum_probs=174.6
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhc------CCCccceeeceeecCCeEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI------HHRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~~~~~~~~~~~ 673 (824)
.+|.+.+.||+|+||.||+|.+. +++.||||+++... ...+.+.+|+++++.+ +|+||+++++++...+..+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 35677899999999999999876 58899999997532 2345677888888887 5779999999999999999
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--EEEEecCCc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--AKVSDFGLS 751 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~--vkL~DFGla 751 (824)
+||||+. ++|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 176 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 9999996 6898888543 234588999999999999999999998 9999999999999999887 999999999
Q ss_pred ccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....++
T Consensus 250 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~ 312 (429)
T 3kvw_A 250 CYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMI 312 (429)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 754322 233568999999999999999999999999999999999999998876544444443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.5e-32 Score=288.44 Aligned_cols=200 Identities=31% Similarity=0.500 Sum_probs=173.1
Q ss_pred HHHHHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeec------
Q 003385 596 SDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------ 668 (824)
Q Consensus 596 ~~~~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------ 668 (824)
.+.....|.+.+.||+|+||.||+|++. +++.||+|+++.. .+.+.+|++++++++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 3445567778899999999999999987 7899999998753 3567899999999999999999998754
Q ss_pred ----------CCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 003385 669 ----------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738 (824)
Q Consensus 669 ----------~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~ 738 (824)
....++||||+++++|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+||+++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV 156 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence 44579999999999999998543 235688999999999999999999998 999999999999999
Q ss_pred CCCcEEEEecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003385 739 KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 806 (824)
Q Consensus 739 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~ 806 (824)
.++.+||+|||+++....... .....||+.|+|||.+.+..++.++|||||||++|||++|..|+.
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred CCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 999999999999876544322 233458999999999999999999999999999999999998874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-32 Score=295.08 Aligned_cols=207 Identities=24% Similarity=0.356 Sum_probs=166.0
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceee-------------
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ------------- 667 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~------------- 667 (824)
+|.+.+.||+|+||.||+|.+. +++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 4566789999999999999987 48999999997665555677899999999999999999998873
Q ss_pred -cCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEE
Q 003385 668 -EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKV 745 (824)
Q Consensus 668 -~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~-~~~~vkL 745 (824)
+.+..++||||++ |+|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+||+++ +++.+||
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence 4467899999998 69999884 24578899999999999999999998 999999999999997 5679999
Q ss_pred EecCCcccccCCCC--ceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcH
Q 003385 746 SDFGLSKFAVDGAS--HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (824)
Q Consensus 746 ~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i 817 (824)
+|||+++....... .......+|..|+|||.+.. ..++.++|||||||++|||++|+.||.+....+..+.+
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999986543211 11233457999999998875 67899999999999999999999999886644433333
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-32 Score=293.31 Aligned_cols=202 Identities=25% Similarity=0.410 Sum_probs=170.7
Q ss_pred HHHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 598 IEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 598 ~~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
.....|.+.+.||+|+||.||+|.+. +|+.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34455667889999999999999886 58999999997543 3567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 99999999998852 245688999999999999999999998 999999999999999999999999999976543
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
... ......||+.|+|||.+....++.++|||||||++|||++|+.||.+.
T Consensus 178 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 178 TMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp TBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred hcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 322 223446899999999999989999999999999999999999999763
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=299.65 Aligned_cols=203 Identities=28% Similarity=0.495 Sum_probs=165.9
Q ss_pred HHHHhhccccccCcEEEEEEEEcC-----CcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKD-----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~-----g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 674 (824)
..+.+.+.||+|+||.||+|.++. +..||||+++.... .....+.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 344567899999999999998653 23599999975432 234568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
||||+++++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 124 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999998532 35688999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCc--eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 755 VDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 755 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
...... ......+|+.|+|||.+....++.++|||||||++|||++ |+.||.+..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 255 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 255 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC
Confidence 433221 1122346789999999999999999999999999999999 999997543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=302.64 Aligned_cols=197 Identities=17% Similarity=0.254 Sum_probs=167.1
Q ss_pred HHHHhhccccccCcEEEEEEEEcC---------CcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccce----------
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKD---------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ---------- 661 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~---------g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~---------- 661 (824)
..|.+.+.||+|+||.||+|++.. ++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 356678999999999999998764 789999998643 56889999999999999998
Q ss_pred -----eeceeec-CCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 003385 662 -----FLGYCQE-EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 735 (824)
Q Consensus 662 -----l~~~~~~-~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NI 735 (824)
+++++.. .+..++||||+ +++|.+++... ....+++..++.++.|++.||.|||++ +|+||||||+||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI 190 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI 190 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence 4556654 67889999999 99999999642 246689999999999999999999998 999999999999
Q ss_pred EEcCCC--cEEEEecCCcccccCCCCc------eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 736 LLDKHM--RAKVSDFGLSKFAVDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 736 Ll~~~~--~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
|++.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999765432211 11334699999999999999999999999999999999999999986
Q ss_pred C
Q 003385 808 E 808 (824)
Q Consensus 808 ~ 808 (824)
.
T Consensus 271 ~ 271 (352)
T 2jii_A 271 C 271 (352)
T ss_dssp G
T ss_pred C
Confidence 4
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=297.43 Aligned_cols=203 Identities=27% Similarity=0.382 Sum_probs=156.2
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcC-CCccceeecee--------ecCC
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYC--------QEEG 670 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~--------~~~~ 670 (824)
.+|.+.+.||+|+||.||+|++. +++.||||++........+.+.+|+.+++++. ||||+++++++ ....
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 35667899999999999999975 68999999987666555677899999999996 99999999988 3445
Q ss_pred eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCEEEcCCCcEEEEec
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDF 748 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~g--IvHrDLkp~NILl~~~~~vkL~DF 748 (824)
..++||||+. |+|.+++... .....+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKM-ESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHH-HTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred eEEEEEEecC-CCHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence 6799999996 7898888542 2244689999999999999999999998 7 999999999999999999999999
Q ss_pred CCcccccCCCCc-----------eeccccCCCCCcchhcc---ccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 749 GLSKFAVDGASH-----------VSSIVRGTVGYLDPEYY---ISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 749 Gla~~~~~~~~~-----------~~~~~~gt~~y~aPE~l---~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
|+++........ ......||+.|+|||++ ....++.++|||||||++|||++|+.||.+.
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 999865432211 11134589999999998 5667889999999999999999999999753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=322.53 Aligned_cols=195 Identities=30% Similarity=0.504 Sum_probs=164.4
Q ss_pred cccccCcEEEEEEEEc---CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCC
Q 003385 608 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (824)
Q Consensus 608 ~LG~G~fg~Vy~a~~~---~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 683 (824)
.||+|+||.||+|.++ ++..||||+++... ....+.+.+|+++|++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 45679999997653 2345678999999999999999999999976 56899999999999
Q ss_pred HHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce--
Q 003385 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-- 761 (824)
Q Consensus 684 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-- 761 (824)
|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 422 L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 99998532 45689999999999999999999998 99999999999999999999999999998654332221
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.....+|+.|+|||++....++.++|||||||++|||++ |+.||.+..
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 122335689999999999999999999999999999998 999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=297.63 Aligned_cols=208 Identities=31% Similarity=0.492 Sum_probs=163.7
Q ss_pred HHHHHHhhccccccCcEEEEEEEEc----CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCC--
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-- 670 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~----~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 670 (824)
....|.+.+.||+|+||.||+|++. .++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3445667889999999999999865 34579999987542 223456889999999999999999999987654
Q ss_pred ---eEEEEEEecCCCCHHHHhhccc--CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 003385 671 ---RSVLVYEFMHNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 745 (824)
Q Consensus 671 ---~~~lV~E~~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL 745 (824)
..++||||+++++|.+++.... .....+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEE
Confidence 3499999999999999984332 2345689999999999999999999998 9999999999999999999999
Q ss_pred EecCCcccccCCCC-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 746 SDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 746 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 254 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 99999976543322 12233457889999999999999999999999999999999 999997654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=292.13 Aligned_cols=201 Identities=31% Similarity=0.530 Sum_probs=165.3
Q ss_pred HHhhccccccCcEEEEEEEEcC----CcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeecee-ecCCeEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVY 676 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~----g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~lV~ 676 (824)
|.+.+.||+|+||.||+|++.+ ...+|+|+++... ....+.+.+|++++++++||||+++++++ ...+..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 4567899999999999998653 2358999987543 23346788999999999999999999985 4556789999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 107 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 107 PYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp ECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred eCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 99999999999853 245578899999999999999999998 999999999999999999999999999975543
Q ss_pred CCC---ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 757 GAS---HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 757 ~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
... .......+|+.|+|||.+.+..++.++||||+||++|||++ |.+||.+..
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 237 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC
Confidence 221 12233457889999999999999999999999999999999 666676543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=300.29 Aligned_cols=212 Identities=24% Similarity=0.338 Sum_probs=163.1
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCe-------E
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR-------S 672 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-------~ 672 (824)
..|.+.+.||+|+||.||+|+++ +++.||||++.... .......+|++.++.++||||+++++++...+. .
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 45677899999999999999986 68999999986543 234456678888899999999999999865333 7
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCCEEEcC-CCcEEEEecC
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--TGCVPAIIHRDLKSSNILLDK-HMRAKVSDFG 749 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--~~~~~gIvHrDLkp~NILl~~-~~~vkL~DFG 749 (824)
++||||+++ +|...+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+||+|||
T Consensus 102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 899999986 555555444445667888999999999999999999 76 9999999999999997 8999999999
Q ss_pred CcccccCCCCceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+...++++
T Consensus 178 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 178 SAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246 (360)
T ss_dssp TCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence 9986544322 2344689999999998765 489999999999999999999999998775555555544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-32 Score=289.08 Aligned_cols=194 Identities=30% Similarity=0.482 Sum_probs=165.9
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeec----CCeEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLV 675 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV 675 (824)
+.+.+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|++++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 456788999999999999876 57889999987542 2334678899999999999999999998765 4568999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCEEEc-CCCcEEEEecCCcc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLD-KHMRAKVSDFGLSK 752 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~g--IvHrDLkp~NILl~-~~~~vkL~DFGla~ 752 (824)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+|||++ .++.+||+|||++.
T Consensus 108 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 108 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999853 35688899999999999999999998 7 99999999999998 78999999999986
Q ss_pred cccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
..... ......||+.|+|||.+. ..++.++||||+||++|+|++|+.||.+
T Consensus 181 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 181 LKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 54332 223346899999999776 5689999999999999999999999976
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=296.91 Aligned_cols=201 Identities=26% Similarity=0.447 Sum_probs=163.1
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcE----EEEEEeccC-CcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~----vAVK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
.|.+.+.||+|+||.||+|++. +++. ||+|.++.. .....+.+.+|++++++++||||+++++++.... .++|
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v 94 (327)
T 3lzb_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEE
T ss_pred HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEE
Confidence 4567789999999999999875 4444 577776543 2334567889999999999999999999998765 7899
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
+|++.+|+|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 95 ~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp ECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999998543 34588999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 756 DGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 756 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
..... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.+..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 224 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 33222 2233446889999999999999999999999999999999 999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=298.48 Aligned_cols=201 Identities=28% Similarity=0.461 Sum_probs=174.0
Q ss_pred HHHHhhccccccCcEEEEEEEE-----cCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceee--cCCeEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ--EEGRSV 673 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~-----~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~ 673 (824)
..|.+.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. +.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 3566789999999999999985 367899999998766555677999999999999999999999886 456789
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 103 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence 999999999999998532 34588999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCc--eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 754 AVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 754 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 6443322 22334578889999999999999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=292.45 Aligned_cols=201 Identities=27% Similarity=0.359 Sum_probs=157.6
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc--cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
.|.+.+.||+|+||.||+|++. +++.||||+++..... ..+.+.++...++.++||||+++++++.+.+..++||||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~ 87 (290)
T 3fme_A 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL 87 (290)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEEC
T ss_pred hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEeh
Confidence 4567789999999999999975 6889999999754222 223344555568888999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
++ |+|.+++.........+++..+..++.|++.||+|||++ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 164 (290)
T 3fme_A 88 MD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV 164 (290)
T ss_dssp CS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred hc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence 97 588888765444567789999999999999999999984 289999999999999999999999999997654332
Q ss_pred CceeccccCCCCCcchhcc----ccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 759 SHVSSIVRGTVGYLDPEYY----ISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l----~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
......||+.|+|||.+ ....++.++||||+||++|||++|+.||..
T Consensus 165 --~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 165 --AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred --cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 22334689999999996 556788999999999999999999999975
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=305.38 Aligned_cols=201 Identities=31% Similarity=0.521 Sum_probs=158.7
Q ss_pred HHhhccccccCcEEEEEEEEc--CC--cEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceee-cCCeEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK--DG--KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQ-EEGRSVLVY 676 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~--~g--~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lV~ 676 (824)
+.+.+.||+|+||.||+|++. ++ ..||||+++... ....+.+.+|++++++++||||+++++++. ..+..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 345688999999999999864 22 358999986532 233567899999999999999999999865 456789999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++|+|.+++... ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 171 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp ECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred ECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999998532 34578889999999999999999998 999999999999999999999999999976543
Q ss_pred CCCc---eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 757 GASH---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 757 ~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.... ......+|+.|+|||.+.+..++.++|||||||++|||++ |.+||.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~ 301 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence 2211 1223457789999999999999999999999999999999 778887644
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=289.56 Aligned_cols=199 Identities=30% Similarity=0.375 Sum_probs=171.2
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---------ccchhhhHHHHHHhhcC-CCccceeeceeecCC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---------QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEG 670 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---------~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 670 (824)
.|.+.+.||+|+||.||+|+++ +++.||||+++.... ...+.+.+|+++++++. ||||+++++++.+.+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 4556789999999999999986 688999999975431 12346788999999995 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGl 750 (824)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccc
Confidence 99999999999999999853 35688999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCceeccccCCCCCcchhccc------cCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 751 SKFAVDGASHVSSIVRGTVGYLDPEYYI------SQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
+....... ......|++.|+|||++. ...++.++|||||||++|||++|+.||.+..
T Consensus 171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 171 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 97654332 223356899999999985 4567889999999999999999999997643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-32 Score=290.08 Aligned_cols=197 Identities=29% Similarity=0.460 Sum_probs=164.6
Q ss_pred hhccccccCcEEEEEEEEcC-C---cEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeE-EEEEEe
Q 003385 605 LEKKIGSGGFGVVYYGKLKD-G---KEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS-VLVYEF 678 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~~-g---~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~-~lV~E~ 678 (824)
+.+.||+|+||.||+|++.+ + ..||+|+++.... ...+.+.+|++++++++||||+++++++.+.+.. ++||||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 45889999999999998643 2 3699999875432 3346788999999999999999999999766655 899999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+.+|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 105 ~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 105 MCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp CTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred ccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999854 245678899999999999999999998 99999999999999999999999999997543321
Q ss_pred ---CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCC-CCC
Q 003385 759 ---SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEA-ISN 807 (824)
Q Consensus 759 ---~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~P-f~~ 807 (824)
........+|+.|+|||.+.+..++.++|||||||++|||++|..| |..
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~ 231 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH 231 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc
Confidence 1122334578999999999999999999999999999999995555 443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=295.67 Aligned_cols=201 Identities=24% Similarity=0.418 Sum_probs=167.9
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.|.+.+.||+|+||.||+|+++ +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (302)
T 2j7t_A 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP 99 (302)
T ss_dssp TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence 4567789999999999999987 588999999976655556788999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 100 ~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 172 (302)
T 2j7t_A 100 GGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-Q 172 (302)
T ss_dssp TEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-H
T ss_pred CCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-c
Confidence 99999987532 35588999999999999999999998 99999999999999999999999999875432111 1
Q ss_pred eeccccCCCCCcchhccc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......||+.|+|||.+. ...++.++|||||||++|||++|+.||....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 122345899999999984 5678899999999999999999999997643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=299.64 Aligned_cols=201 Identities=26% Similarity=0.386 Sum_probs=172.6
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccc-----------------hhhhHHHHHHhhcCCCccceeec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK-----------------REFTNEVTLLSRIHHRNLVQFLG 664 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~-----------------~~~~~Ei~il~~l~HpnIv~l~~ 664 (824)
.|.+.+.||+|+||.||+|+. +++.||||++........ +.+.+|++++++++||||+++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 456778999999999999998 899999999875422211 67899999999999999999999
Q ss_pred eeecCCeEEEEEEecCCCCHHHHhhcc--cC--ccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcC
Q 003385 665 YCQEEGRSVLVYEFMHNGTLKEHLYGT--LT--HEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDK 739 (824)
Q Consensus 665 ~~~~~~~~~lV~E~~~~gsL~~~L~~~--~~--~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~gIvHrDLkp~NILl~~ 739 (824)
++.+.+..++||||+++++|.+++... .. ....+++..+..++.|++.||.|||+ . ||+||||||+||+++.
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDK 187 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECT
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcC
Confidence 999999999999999999999883210 11 25678999999999999999999999 7 9999999999999999
Q ss_pred CCcEEEEecCCcccccCCCCceeccccCCCCCcchhccccC-CCCc-hHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 740 HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTD-KSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 740 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~-~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
++.+||+|||++...... ......||+.|+|||.+.+. .++. ++|||||||++|||++|+.||....
T Consensus 188 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp TSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999765432 33445689999999999877 6666 9999999999999999999997654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-32 Score=288.76 Aligned_cols=196 Identities=27% Similarity=0.447 Sum_probs=166.4
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCCHH
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 685 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 685 (824)
..||+|+||.||+|++. +++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 47999999999999875 67899999998665555677899999999999999999999999999999999999999999
Q ss_pred HHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecCCcccccCCCCceecc
Q 003385 686 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSSI 764 (824)
Q Consensus 686 ~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~ 764 (824)
+++.... ....+++..+..++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||+++...... .....
T Consensus 108 ~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 182 (295)
T 2clq_A 108 ALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTET 182 (295)
T ss_dssp HHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred HHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC-Ccccc
Confidence 9986432 233467888889999999999999998 9999999999999997 8999999999997654322 12234
Q ss_pred ccCCCCCcchhccccCC--CCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 765 VRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 765 ~~gt~~y~aPE~l~~~~--~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
..||+.|+|||.+.... ++.++|||||||++|||++|+.||..
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 56899999999987643 88999999999999999999999964
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=305.36 Aligned_cols=210 Identities=24% Similarity=0.349 Sum_probs=174.1
Q ss_pred ccccCHHHHHHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcC--------CCccc
Q 003385 590 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH--------HRNLV 660 (824)
Q Consensus 590 ~~~~~~~~~~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~--------HpnIv 660 (824)
.+.+..+++...+|.+.++||+|+||.||+|++. +++.||||+++... ...+.+.+|++++++++ |+||+
T Consensus 26 ~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv 104 (397)
T 1wak_A 26 YHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVV 104 (397)
T ss_dssp CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred ceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence 3445555655667888899999999999999875 57889999997432 33567889999999985 78899
Q ss_pred eeeceee----cCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 003385 661 QFLGYCQ----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 736 (824)
Q Consensus 661 ~l~~~~~----~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NIL 736 (824)
++++++. +....++||||+ +++|.+.+... ....+++..+..++.||+.||+|||+++ ||+||||||+|||
T Consensus 105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIl 179 (397)
T 1wak_A 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENIL 179 (397)
T ss_dssp CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEE
T ss_pred eeecceeecCCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHee
Confidence 9999987 556889999999 55666665432 2356889999999999999999999953 8999999999999
Q ss_pred EcCCC-------------------------------------------------cEEEEecCCcccccCCCCceeccccC
Q 003385 737 LDKHM-------------------------------------------------RAKVSDFGLSKFAVDGASHVSSIVRG 767 (824)
Q Consensus 737 l~~~~-------------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~g 767 (824)
++.++ .+||+|||+++..... .....|
T Consensus 180 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~g 255 (397)
T 1wak_A 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQ 255 (397)
T ss_dssp ECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCS
T ss_pred EeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCC
Confidence 99775 7999999999765432 233468
Q ss_pred CCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 768 TVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 768 t~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
|+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 999999999999999999999999999999999999998755
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=323.56 Aligned_cols=195 Identities=31% Similarity=0.496 Sum_probs=164.0
Q ss_pred ccccccCcEEEEEEEEc---CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~---~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.||+|+||.||+|.+. .++.||||+++.... ...+++.+|+++|++++||||+++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999764 467899999975432 234678999999999999999999999965 457899999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc-
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH- 760 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~- 760 (824)
|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999843 45688999999999999999999998 9999999999999999999999999999865443221
Q ss_pred -eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 761 -VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 761 -~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
......+|+.|+|||++....++.++|||||||++|||++ |+.||.+..
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 577 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 577 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 2223346789999999999999999999999999999998 999998754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=301.53 Aligned_cols=203 Identities=25% Similarity=0.398 Sum_probs=168.5
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeE------
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS------ 672 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~------ 672 (824)
.|.+.+.||+|+||.||+|.++ +|+.||||++..... ...+.+.+|++++++++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 4566789999999999999876 688999999975422 2246788999999999999999999999876654
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
++||||+. ++|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 123 ~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp EEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred EEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 68877762 3488999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+...+++
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 255 (371)
T 4exu_A 193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 255 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 54322 233568999999999887 688999999999999999999999998876544444443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=291.47 Aligned_cols=200 Identities=32% Similarity=0.486 Sum_probs=166.8
Q ss_pred HHHhhc-cccccCcEEEEEEEEc---CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 602 TKMLEK-KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 602 ~~~i~~-~LG~G~fg~Vy~a~~~---~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
.+.+.+ .||+|+||.||+|.+. .++.||||+++.... ...+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv 95 (291)
T 1xbb_A 17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV 95 (291)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence 344555 8999999999999653 467899999975432 2246788999999999999999999999 55678999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
|||+++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 96 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 999999999999853 34588999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCCcee--ccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 756 DGASHVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 756 ~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
....... ....+++.|+|||.+.+..++.++|||||||++|||++ |+.||.+..
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 225 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 4333221 22346788999999998889999999999999999999 999998644
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=292.13 Aligned_cols=209 Identities=23% Similarity=0.359 Sum_probs=172.9
Q ss_pred HHHhhccccccCcEEEEEEEEc--CCcEEEEEEeccCCc--ccchhhhHHHHHHhhc---CCCccceeeceee-----cC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRI---HHRNLVQFLGYCQ-----EE 669 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~--~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~-----~~ 669 (824)
.|.+.+.||+|+||.||+|++. +++.||+|+++.... .....+.+|+++++.+ +||||+++++++. ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 4567889999999999999983 678899999874432 2234677888888777 8999999999987 55
Q ss_pred CeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003385 670 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (824)
Q Consensus 670 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFG 749 (824)
...++||||++ |+|.+++... ....+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 92 TKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp EEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCc
Confidence 67899999998 6999988543 234588999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+...+++
T Consensus 166 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 232 (326)
T 1blx_A 166 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232 (326)
T ss_dssp SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 98765322 12234568999999999999999999999999999999999999998866444443443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=289.41 Aligned_cols=196 Identities=33% Similarity=0.528 Sum_probs=162.5
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecC-CeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-GRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lV~E~~~ 680 (824)
.|.+.+.||+|+||.||+|+++ ++.||||+++... ..+.+.+|++++++++||||+++++++.+. +..++||||++
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 22 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 4567789999999999999886 8899999987543 456788999999999999999999987544 47899999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 99 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 99 KGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp TEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 99999998532 123378888999999999999999998 99999999999999999999999999987543321
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
....+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 22357889999999999999999999999999999998 999998654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=292.51 Aligned_cols=201 Identities=26% Similarity=0.452 Sum_probs=165.0
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeeceeec------CCeEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE------EGRSV 673 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~------~~~~~ 673 (824)
.|.+.+.||+|+||.||+|++. +++.||||++.... ...+.+.+|+++++++ +||||+++++++.. .+..+
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 3567789999999999999985 68899999987543 3356788999999999 79999999999876 46789
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+||||+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 104 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp EEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred EEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 999999999999998643 235688899999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCceeccccCCCCCcchhccc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||.+..
T Consensus 179 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 179 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 543221 223346899999999987 5678899999999999999999999997643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=293.63 Aligned_cols=204 Identities=27% Similarity=0.450 Sum_probs=172.2
Q ss_pred cCHHHHHHHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhh--cCCCccceeeceeecCC
Q 003385 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSR--IHHRNLVQFLGYCQEEG 670 (824)
Q Consensus 593 ~~~~~~~~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~ 670 (824)
+...+.....|.+.+.||+|+||.||+|++. ++.||||+++.. ..+.+.+|+++++. ++||||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 3445666678888999999999999999985 899999998643 24567788998887 78999999999998775
Q ss_pred ----eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCEEEc
Q 003385 671 ----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--------TGCVPAIIHRDLKSSNILLD 738 (824)
Q Consensus 671 ----~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~gIvHrDLkp~NILl~ 738 (824)
..++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +. +|+||||||+|||++
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVK 181 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEEC
T ss_pred CccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEEC
Confidence 78999999999999999853 35889999999999999999999 66 999999999999999
Q ss_pred CCCcEEEEecCCcccccCCCCc---eeccccCCCCCcchhccccCC------CCchHHHHHHHHHHHHHHcC--------
Q 003385 739 KHMRAKVSDFGLSKFAVDGASH---VSSIVRGTVGYLDPEYYISQQ------LTDKSDVYSFGVILLELISG-------- 801 (824)
Q Consensus 739 ~~~~vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~------~~~~~DIwSlGvil~elltG-------- 801 (824)
.++.+||+|||+++........ ......||+.|+|||.+.... ++.++|||||||++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999999766543322 123446999999999987653 33689999999999999999
Q ss_pred --CCCCCCC
Q 003385 802 --QEAISNE 808 (824)
Q Consensus 802 --~~Pf~~~ 808 (824)
+.||...
T Consensus 262 ~~~~p~~~~ 270 (342)
T 1b6c_B 262 DYQLPYYDL 270 (342)
T ss_dssp CCCCTTTTT
T ss_pred ccccCcccc
Confidence 7888654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=289.31 Aligned_cols=202 Identities=25% Similarity=0.382 Sum_probs=167.2
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC----cccchhhhHHHHHHhhcCCCccceeecee--ecCCeEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHRNLVQFLGYC--QEEGRSVL 674 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~--~~~~~~~l 674 (824)
.|.+.+.||+|+||.||+|.+. +++.||+|+++... ....+.+.+|++++++++||||+++++++ .+.+..++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 3567789999999999999875 68899999997542 22346788999999999999999999998 44567899
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
||||++++ |.+.+... ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 99999877 76766432 245688999999999999999999998 9999999999999999999999999999765
Q ss_pred cCCC-CceeccccCCCCCcchhccccCCC--CchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 755 VDGA-SHVSSIVRGTVGYLDPEYYISQQL--TDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 755 ~~~~-~~~~~~~~gt~~y~aPE~l~~~~~--~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.... ........||+.|+|||++.+... +.++|||||||++|||++|+.||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 4322 223344568999999999876443 679999999999999999999998754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=294.58 Aligned_cols=204 Identities=26% Similarity=0.423 Sum_probs=155.1
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.|.+.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 95 (303)
T 2vwi_A 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL 95 (303)
T ss_dssp CCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECC
T ss_pred hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhc
Confidence 4567789999999999999864 68899999986543 233567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccc----CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 680 HNGTLKEHLYGTL----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 680 ~~gsL~~~L~~~~----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
++++|.+++.... .....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 96 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 172 (303)
T 2vwi_A 96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLA 172 (303)
T ss_dssp TTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred cCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence 9999999885321 1245588999999999999999999998 99999999999999999999999999987553
Q ss_pred CCCC----ceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 756 DGAS----HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 756 ~~~~----~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.... .......||+.|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230 (303)
T ss_dssp ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence 3211 11233468999999999876 57899999999999999999999999764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=291.12 Aligned_cols=203 Identities=29% Similarity=0.466 Sum_probs=164.8
Q ss_pred HHHHHHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhc--CCCccceeeceeecC----
Q 003385 596 SDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI--HHRNLVQFLGYCQEE---- 669 (824)
Q Consensus 596 ~~~~~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~---- 669 (824)
.......|.+.+.||+|+||.||+|+++ ++.||||++.... .....+|.+++..+ +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3445567888999999999999999987 8999999986432 23445566665554 899999999998876
Q ss_pred CeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCEEEcCCCcEE
Q 003385 670 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-----VPAIIHRDLKSSNILLDKHMRAK 744 (824)
Q Consensus 670 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~gIvHrDLkp~NILl~~~~~vk 744 (824)
...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+++ .++|+||||||+|||++.++.+|
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 788999999999999999843 35889999999999999999999851 23899999999999999999999
Q ss_pred EEecCCcccccCCCCce---eccccCCCCCcchhccccCCCCch------HHHHHHHHHHHHHHcC----------CCCC
Q 003385 745 VSDFGLSKFAVDGASHV---SSIVRGTVGYLDPEYYISQQLTDK------SDVYSFGVILLELISG----------QEAI 805 (824)
Q Consensus 745 L~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~------~DIwSlGvil~elltG----------~~Pf 805 (824)
|+|||+++......... .....||+.|+|||++.......+ +|||||||++|||++| +.||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999997654332221 124569999999999987766654 9999999999999999 7777
Q ss_pred CC
Q 003385 806 SN 807 (824)
Q Consensus 806 ~~ 807 (824)
..
T Consensus 263 ~~ 264 (337)
T 3mdy_A 263 HD 264 (337)
T ss_dssp TT
T ss_pred hh
Confidence 54
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=295.51 Aligned_cols=200 Identities=24% Similarity=0.368 Sum_probs=167.0
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecC-----CeEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL 674 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~l 674 (824)
.|.+.+.||+|+||.||+|++. +|+.||||+++... ......+.+|++++++++||||+++++++... ...++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 3556789999999999999986 68899999996432 22345678999999999999999999987654 67899
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
||||+. ++|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 92 IQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 999997 589888743 4588999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCc---------eeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 755 VDGASH---------VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 755 ~~~~~~---------~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 228 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 432111 1123468999999998765 6789999999999999999999999987653
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=304.39 Aligned_cols=199 Identities=23% Similarity=0.396 Sum_probs=168.8
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCC-CccceeeceeecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.|.+.++||+|+||.||+|++. +++.||||++.... ..+++.+|+++++.++| ++|..+..++...+..++||||+
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 4567789999999999999874 68999999886543 24568899999999987 55556666667788899999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEEecCCcccccC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl---~~~~~vkL~DFGla~~~~~ 756 (824)
+++|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 86 -g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 86 -GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp -CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred -CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 89999998532 35689999999999999999999998 99999999999999 5789999999999986654
Q ss_pred CCCc------eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 757 GASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 757 ~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~ 217 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 3321 1224569999999999999999999999999999999999999998744
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=291.71 Aligned_cols=201 Identities=24% Similarity=0.372 Sum_probs=171.5
Q ss_pred HHHHHhhccccccCcEEEEEEEE-c-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCc------cceeeceeecCCe
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKL-K-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN------LVQFLGYCQEEGR 671 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~-~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~~~~~~~ 671 (824)
..+|.+.+.||+|+||.||+|.+ + +++.||||+++... ...+.+.+|+++++.++|++ |+++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 34567789999999999999987 3 67899999996432 33567888999999987654 9999999999999
Q ss_pred EEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC------------
Q 003385 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK------------ 739 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~------------ 739 (824)
.++||||+ +++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999 88999988543 224578899999999999999999998 9999999999999987
Q ss_pred -------CCcEEEEecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 740 -------HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 740 -------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999764332 23346899999999999999999999999999999999999999876533
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=295.52 Aligned_cols=209 Identities=29% Similarity=0.476 Sum_probs=170.7
Q ss_pred HHHHHHHhhccccccCcEEEEEEEE------cCCcEEEEEEeccC-CcccchhhhHHHHHHhhcCCCccceeeceeecCC
Q 003385 598 IEDATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 670 (824)
Q Consensus 598 ~~~~~~~i~~~LG~G~fg~Vy~a~~------~~g~~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 670 (824)
+....|.+.+.||+|+||.||+|++ .+++.||||++... .......+.+|+.++++++||||+++++++.+.+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 3445667889999999999999984 25778999999644 2334567889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhcccC---ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEE
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAK 744 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~---~~~vk 744 (824)
..++||||+++++|.+++..... ....+++..++.++.|++.||.|||++ +|+||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999965421 224588999999999999999999998 9999999999999994 45699
Q ss_pred EEecCCcccccCCCC-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 745 VSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 745 L~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
|+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 999999875433221 12233457899999999999999999999999999999998 999997644
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-32 Score=293.76 Aligned_cols=201 Identities=32% Similarity=0.545 Sum_probs=171.7
Q ss_pred HHHHhhccccccCcEEEEEEEE-----cCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCC--eEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSV 673 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~-----~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~ 673 (824)
..+.+.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 3456789999999999999985 368899999998665555678999999999999999999999886543 679
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 121 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 999999999999998543 34588999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCce--eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 754 AVDGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 754 ~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
........ .....++..|+|||.+.+..++.++|||||||++|||++|..||..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 64433221 2233467889999999988899999999999999999999998864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=284.59 Aligned_cols=203 Identities=30% Similarity=0.431 Sum_probs=173.1
Q ss_pred HHHHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEE
Q 003385 597 DIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 597 ~~~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 673 (824)
.....+|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 444567888899999999999999986 689999999865432 23467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEEecCC
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGL 750 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~---~~vkL~DFGl 750 (824)
+||||+++++|.+.+.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.+ +.+||+|||+
T Consensus 98 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 99999999999988743 34688999999999999999999998 99999999999999754 4799999999
Q ss_pred cccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 751 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
+........ .....||+.|+|||.+.+ .++.++|||||||++|+|++|+.||.+..
T Consensus 171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 171 STCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp GGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 876543322 223348899999998765 58999999999999999999999997643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=290.66 Aligned_cols=201 Identities=25% Similarity=0.395 Sum_probs=164.1
Q ss_pred HHHHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc------ccchhhhHHHHHHhhc----CCCccceeece
Q 003385 597 DIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY------QGKREFTNEVTLLSRI----HHRNLVQFLGY 665 (824)
Q Consensus 597 ~~~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~------~~~~~~~~Ei~il~~l----~HpnIv~l~~~ 665 (824)
+.....|.+.+.||+|+||.||+|++. +++.||||+++.... .....+.+|++++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 444567888899999999999999875 688999999975432 2345677899999999 89999999999
Q ss_pred eecCCeEEEEEEe-cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcE
Q 003385 666 CQEEGRSVLVYEF-MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRA 743 (824)
Q Consensus 666 ~~~~~~~~lV~E~-~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~-~~~~v 743 (824)
+...+..++|+|+ +.+++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++ .++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 9998899999999 789999999853 34588999999999999999999998 999999999999999 78999
Q ss_pred EEEecCCcccccCCCCceeccccCCCCCcchhccccCCCC-chHHHHHHHHHHHHHHcCCCCCCC
Q 003385 744 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 744 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
||+|||+++...... .....|+..|+|||++.+..+. .++|||||||++|||++|+.||..
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 999999998654322 2344589999999999877765 489999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-32 Score=288.62 Aligned_cols=202 Identities=29% Similarity=0.455 Sum_probs=161.5
Q ss_pred HHHHhhccccccCcEEEEEEEEc--CCc--EEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK--DGK--EIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~--~g~--~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 673 (824)
..|.+.+.||+|+||.||+|++. +++ .||||+++... ....+.+.+|++++++++||||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 35667889999999999999864 233 68999987542 223467889999999999999999999998765 78
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+|+||+++++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 97 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 999999999999998542 34588999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCc--eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 754 AVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 754 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
....... ......+|..|+|||.+....++.++|||||||++|||++ |+.||.+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 6443322 1233457889999999998889999999999999999999 999997644
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=292.46 Aligned_cols=198 Identities=23% Similarity=0.379 Sum_probs=170.1
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc------cchhhhHHHHHHhhcC--CCccceeeceeecCC
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIH--HRNLVQFLGYCQEEG 670 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~------~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~ 670 (824)
...|.+.+.||+|+||.||+|++. +++.||||+++..... ..+.+.+|++++++++ ||||+++++++.+.+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 345677899999999999999875 6889999999754322 2356788999999996 599999999999999
Q ss_pred eEEEEEEecCC-CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEEec
Q 003385 671 RSVLVYEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDF 748 (824)
Q Consensus 671 ~~~lV~E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~-~~~~vkL~DF 748 (824)
..++|+|++.+ ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++ +++.+||+||
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred cEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 99999999986 899998853 35688999999999999999999998 999999999999999 6799999999
Q ss_pred CCcccccCCCCceeccccCCCCCcchhccccCCC-CchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 749 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 749 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
|+++...... .....||+.|+|||++....+ +.++|||||||++|||++|+.||..
T Consensus 195 g~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 195 GSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp TTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred cccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 9998654322 233468999999999987776 6788999999999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=295.91 Aligned_cols=202 Identities=25% Similarity=0.399 Sum_probs=166.3
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCe------E
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR------S 672 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~------~ 672 (824)
.|.+.+.||+|+||.||+|.++ +|+.||||++..... ...+.+.+|+.++++++||||+++++++...+. .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 3556789999999999999876 689999999965422 224568899999999999999999999877643 4
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
++||||++ ++|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 105 ~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp EEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 99999997 57777662 3488899999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcH
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i 817 (824)
..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+....+
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i 236 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 236 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHH
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 54322 233468999999999887 67899999999999999999999999886644433333
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-32 Score=294.91 Aligned_cols=197 Identities=30% Similarity=0.516 Sum_probs=155.5
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHH--HhhcCCCccceeeceee-----cCCeEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTL--LSRIHHRNLVQFLGYCQ-----EEGRSVL 674 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~i--l~~l~HpnIv~l~~~~~-----~~~~~~l 674 (824)
.|.+.+.||+|+||.||+|++ +++.||||+++... ...+..|.++ +..++||||+++++.+. .....++
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 14 NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp SEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred HhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 345678999999999999987 58999999986432 2334444444 45589999999997542 2346789
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCCEEEcCCCcEEEEec
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------VPAIIHRDLKSSNILLDKHMRAKVSDF 748 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------~~gIvHrDLkp~NILl~~~~~vkL~DF 748 (824)
||||+++|+|.+++.. ...++..+..++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+||
T Consensus 90 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 9999999999999843 33478889999999999999999852 228999999999999999999999999
Q ss_pred CCcccccCCC-------CceeccccCCCCCcchhcccc-------CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 749 GLSKFAVDGA-------SHVSSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 749 Gla~~~~~~~-------~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
|+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 9997654321 112234469999999999876 3556789999999999999999777643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=293.92 Aligned_cols=205 Identities=22% Similarity=0.350 Sum_probs=171.6
Q ss_pred HHHHHHHHHhhccccccCcEEEEEEEEc-CC-cEEEEEEeccCCcccchhhhHHHHHHhhcCCCc------cceeeceee
Q 003385 596 SDIEDATKMLEKKIGSGGFGVVYYGKLK-DG-KEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN------LVQFLGYCQ 667 (824)
Q Consensus 596 ~~~~~~~~~i~~~LG~G~fg~Vy~a~~~-~g-~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~~~ 667 (824)
++.....|.+.+.||+|+||.||+|... ++ +.||+|+++... ...+.+.+|++++++++|++ ++.+.+++.
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 3344456778899999999999999875 34 689999997432 33567888999999998766 899999999
Q ss_pred cCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----------
Q 003385 668 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---------- 737 (824)
Q Consensus 668 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl---------- 737 (824)
..+..++||||+ ++++.+.+... ....+++..+..++.||+.||+|||++ +|+||||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEEC
T ss_pred eCCeEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccc
Confidence 999999999999 56777766432 234688999999999999999999998 99999999999999
Q ss_pred ---------cCCCcEEEEecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 738 ---------DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 738 ---------~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 56789999999999764332 23346899999999999999999999999999999999999999876
Q ss_pred ccc
Q 003385 809 KFG 811 (824)
Q Consensus 809 ~~~ 811 (824)
...
T Consensus 243 ~~~ 245 (355)
T 2eu9_A 243 ENR 245 (355)
T ss_dssp SHH
T ss_pred CHH
Confidence 533
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=296.17 Aligned_cols=210 Identities=25% Similarity=0.291 Sum_probs=172.8
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcC-CC-----ccceeeceeecCCeEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HR-----NLVQFLGYCQEEGRSV 673 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~~~~~~~~~~~ 673 (824)
..|.+.+.||+|+||.||+|+++ +++.||||+++... ...+.+..|+++++.++ |+ +|+++++++...+..+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 35667899999999999999876 67889999997432 23456778899888885 55 4999999999999999
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCCcEEEEecCCc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLS 751 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~--~~~~vkL~DFGla 751 (824)
+||||++ ++|.+++... ....+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+|||++
T Consensus 133 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 9999996 5999988543 224588999999999999999999952 13999999999999995 4678999999999
Q ss_pred ccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHhh
Q 003385 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (824)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv~ 819 (824)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+++
T Consensus 209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 272 (382)
T 2vx3_A 209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272 (382)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 865432 2335689999999999999999999999999999999999999998765544444443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-32 Score=295.06 Aligned_cols=193 Identities=20% Similarity=0.241 Sum_probs=159.6
Q ss_pred HHHHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCc--------ccchhhhHHHHHHhhcC---------------
Q 003385 599 EDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--------QGKREFTNEVTLLSRIH--------------- 655 (824)
Q Consensus 599 ~~~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~--------~~~~~~~~Ei~il~~l~--------------- 655 (824)
....|.+.+.||+|+||+||+|++ +|+.||||+++.... ...+.+.+|+++++.++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 356778899999999999999998 589999999975432 12266889999999886
Q ss_pred -----------CCccceeeceeec-------------CCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHH
Q 003385 656 -----------HRNLVQFLGYCQE-------------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 711 (824)
Q Consensus 656 -----------HpnIv~l~~~~~~-------------~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia 711 (824)
||||+++++++.+ .+..++||||+++|++.+.+. ...+++..+..++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHH
Confidence 5555555555554 678999999999997766652 24578999999999999
Q ss_pred HHHHHHH-hCCCCCeEecCCCCCCEEEcCCC--------------------cEEEEecCCcccccCCCCceeccccCCCC
Q 003385 712 KGIEYLH-TGCVPAIIHRDLKSSNILLDKHM--------------------RAKVSDFGLSKFAVDGASHVSSIVRGTVG 770 (824)
Q Consensus 712 ~gL~yLH-~~~~~gIvHrDLkp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~gt~~ 770 (824)
.||+||| ++ +|+||||||+|||++.++ .+||+|||+|+..... ..+||+.
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 87 999999999999999887 8999999999866432 2369999
Q ss_pred CcchhccccCCCCchHHHHHHHHH-HHHHHcCCCCCCC
Q 003385 771 YLDPEYYISQQLTDKSDVYSFGVI-LLELISGQEAISN 807 (824)
Q Consensus 771 y~aPE~l~~~~~~~~~DIwSlGvi-l~elltG~~Pf~~ 807 (824)
|+|||++.+.. +.++||||+|++ .+++++|..||.+
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 99999998666 889999998777 7889999999854
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=316.87 Aligned_cols=203 Identities=24% Similarity=0.392 Sum_probs=168.6
Q ss_pred HHHHHhhccccccCcEEEEEEEEcC----CcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~~----g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 674 (824)
...+.+.+.||+|+||.||+|.+.. +..||||+++... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence 3456678899999999999998753 4579999987543 2334678899999999999999999999854 56799
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
||||+++|+|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 468 v~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 99999999999998532 34588999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 755 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 755 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
............+|+.|+|||++....++.++|||||||++|||++ |..||.+..
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 597 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 5443333334457889999999999999999999999999999997 999998654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=288.13 Aligned_cols=199 Identities=27% Similarity=0.440 Sum_probs=164.3
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.+.+.+.||+|+||.||+|+++. .+|+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 34 ~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~ 111 (319)
T 2y4i_B 34 QLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC 111 (319)
T ss_dssp CEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCC
T ss_pred HeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecc
Confidence 45677899999999999998863 59999987542 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC--
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG-- 757 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-- 757 (824)
++++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++ ++.+||+|||+++.....
T Consensus 112 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 112 KGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred cCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 999999998532 34578899999999999999999998 999999999999998 679999999998654221
Q ss_pred --CCceeccccCCCCCcchhcccc---------CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 758 --ASHVSSIVRGTVGYLDPEYYIS---------QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 758 --~~~~~~~~~gt~~y~aPE~l~~---------~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.........|++.|+|||.+.. ..++.++|||||||++|||++|+.||....
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1112233458999999999874 457889999999999999999999997644
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=280.51 Aligned_cols=193 Identities=26% Similarity=0.416 Sum_probs=158.4
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeec-----------
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----------- 668 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----------- 668 (824)
..|.+.+.||+|+||.||+|++. +++.||||+++... ...+.+.+|++++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 45667899999999999999975 78999999986432 334678899999999999999999998754
Q ss_pred --CCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 003385 669 --EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (824)
Q Consensus 669 --~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~ 746 (824)
.+..++||||+++++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 45679999999999999998642 34567888899999999999999998 99999999999999999999999
Q ss_pred ecCCcccccCCC-------------CceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHc
Q 003385 747 DFGLSKFAVDGA-------------SHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELIS 800 (824)
Q Consensus 747 DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~ellt 800 (824)
|||+++...... ........||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 999987653221 1122344689999999998764 68999999999999999998
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=299.97 Aligned_cols=197 Identities=26% Similarity=0.396 Sum_probs=155.0
Q ss_pred hhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEEecCCCC
Q 003385 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 683 (824)
+.+.||+|+||+||.+...+|+.||||++.... .+.+.+|+++++++ +||||+++++++.+.+..++||||++ |+
T Consensus 19 ~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs 94 (434)
T 2rio_A 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN 94 (434)
T ss_dssp EEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred ccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence 457899999999988777789999999986432 34577899999886 89999999999999999999999996 69
Q ss_pred HHHHhhcccCcccc---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-------------CcEEEEe
Q 003385 684 LKEHLYGTLTHEQR---INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-------------MRAKVSD 747 (824)
Q Consensus 684 L~~~L~~~~~~~~~---l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~-------------~~vkL~D 747 (824)
|.+++......... ..+..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 99998653222111 13334577999999999999998 99999999999999754 4899999
Q ss_pred cCCcccccCCCCc---eeccccCCCCCcchhcccc-------CCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 003385 748 FGLSKFAVDGASH---VSSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELIS-GQEAISNE 808 (824)
Q Consensus 748 FGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~-------~~~~~~~DIwSlGvil~ellt-G~~Pf~~~ 808 (824)
||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 9999876543221 1234569999999999875 678999999999999999999 99999754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-31 Score=283.97 Aligned_cols=199 Identities=25% Similarity=0.363 Sum_probs=164.1
Q ss_pred HHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCC--cccchhhhHHHHHHhhcC--CCccceeeceeecCCeEEEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIH--HRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~lV~ 676 (824)
..|.+.+.||+|+||.||+|..++++.||||++.... ....+.+.+|++++++++ ||||+++++++.+.+..++||
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 107 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence 3466788999999999999998889999999997543 223467889999999997 599999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
| +.+++|.+++.. ...+++..+..++.|+++||.|||++ +|+||||||+|||++ ++.+||+|||+++....
T Consensus 108 e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 108 E-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 178 (313)
T ss_dssp C-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred e-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence 9 667899999853 34678899999999999999999998 999999999999996 48999999999986543
Q ss_pred CCCc-eeccccCCCCCcchhcccc-----------CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 757 GASH-VSSIVRGTVGYLDPEYYIS-----------QQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 757 ~~~~-~~~~~~gt~~y~aPE~l~~-----------~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.... ......||+.|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 3221 2234468999999999875 46888999999999999999999999753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=285.46 Aligned_cols=200 Identities=28% Similarity=0.365 Sum_probs=147.1
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHH-HHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVT-LLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
+.+.+.||+|+||.||+|.++ +++.||||+++.... ....++..|+. +++.++||||+++++++.+.+..++||||+
T Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~ 103 (327)
T 3aln_A 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM 103 (327)
T ss_dssp EEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeec
Confidence 445688999999999999986 688999999975432 22344555555 677789999999999999999999999999
Q ss_pred CCCCHHHHhhccc-CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 680 HNGTLKEHLYGTL-THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 680 ~~gsL~~~L~~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
++ +|.+++.... .....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++......
T Consensus 104 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 180 (327)
T 3aln_A 104 ST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 180 (327)
T ss_dssp SE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred CC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc
Confidence 85 7777664211 1245688999999999999999999995 389999999999999999999999999997654322
Q ss_pred CceeccccCCCCCcchhcc----ccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 759 SHVSSIVRGTVGYLDPEYY----ISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l----~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
. .....||+.|+|||.+ .+..++.++|||||||++|||++|+.||.+
T Consensus 181 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 181 A--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred c--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 1 2233589999999998 456789999999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-31 Score=290.66 Aligned_cols=200 Identities=24% Similarity=0.447 Sum_probs=165.8
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcC-----------CCccceeeceee
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----------HRNLVQFLGYCQ 667 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~~~~~ 667 (824)
...|.+.+.||+|+||.||+|++. +++.||||+++... ...+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 345677899999999999999875 68899999997432 23466788999999886 899999999987
Q ss_pred cCC----eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-----
Q 003385 668 EEG----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD----- 738 (824)
Q Consensus 668 ~~~----~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~----- 738 (824)
..+ ..++|||++ +++|.+++... ....+++..+..++.||+.||+|||+++ +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence 644 789999999 88999988543 2345889999999999999999999952 899999999999995
Q ss_pred -CCCcEEEEecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 739 -KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 739 -~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 3348999999999765432 223468999999999999999999999999999999999999998654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=286.01 Aligned_cols=195 Identities=23% Similarity=0.319 Sum_probs=142.5
Q ss_pred HHh-hccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeec----CCeEEEEE
Q 003385 603 KML-EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVY 676 (824)
Q Consensus 603 ~~i-~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~ 676 (824)
|.+ .+.||+|+||.||+|+++ +++.||||++.... +...+....++.++||||+++++++.. ....++||
T Consensus 30 y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 30 YQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred eEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 444 456999999999999987 68999999986421 222233334566799999999999875 45589999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEecCCccc
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKF 753 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~---~~~vkL~DFGla~~ 753 (824)
||+++|+|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+++.
T Consensus 106 e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 106 ECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp ECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred eccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 999999999998643 234688999999999999999999998 9999999999999986 45599999999976
Q ss_pred ccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.... ......||+.|+|||++....++.++|||||||++|||++|+.||.+..
T Consensus 181 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 181 TTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp C-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 5432 2234568999999999988889999999999999999999999996543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=294.14 Aligned_cols=196 Identities=27% Similarity=0.395 Sum_probs=155.8
Q ss_pred HHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEEecCC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
+.+.+.||+|+||+||.....+++.||||++.... ...+.+|+++++++ +||||+++++++.+.+..++||||+.
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 45568999999999776666789999999986433 34567899999999 79999999999999999999999996
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-----CCcEEEEecCCcccccC
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-----HMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~-----~~~vkL~DFGla~~~~~ 756 (824)
|+|.+++.... .......+..++.||+.||.|||++ +|+||||||+|||++. ...+||+|||+++....
T Consensus 102 g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 102 ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 59999886432 2233344568999999999999998 9999999999999953 24688999999986543
Q ss_pred CCC--ceeccccCCCCCcchhccc---cCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 003385 757 GAS--HVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELIS-GQEAISNE 808 (824)
Q Consensus 757 ~~~--~~~~~~~gt~~y~aPE~l~---~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~ 808 (824)
... .......||+.|+|||++. ...++.++|||||||++|||++ |..||...
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 321 1233456999999999997 4667889999999999999999 99999653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-30 Score=279.11 Aligned_cols=196 Identities=28% Similarity=0.358 Sum_probs=147.2
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc-c-chhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-G-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~-~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.+.||+|+||.||+|+++ +++.||||++...... . .+.+.++..+++.++||||+++++++.+.+..++||||+
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (318)
T 2dyl_A 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM 106 (318)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc
Confidence 456789999999999999986 6899999999754322 1 233445556788889999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
++.+...... ....+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||+++......
T Consensus 107 -~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 107 -GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp -SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred -CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 4455444321 23568899999999999999999998 4 89999999999999999999999999987654322
Q ss_pred CceeccccCCCCCcchhccc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 759 SHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
......||+.|+|||.+. ...++.++|||||||++|||++|+.||..
T Consensus 180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 223345899999999984 55788999999999999999999999976
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=311.10 Aligned_cols=193 Identities=22% Similarity=0.357 Sum_probs=164.0
Q ss_pred HHHHHhhccccccCcEEEEEEEEc--CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCe-----
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR----- 671 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~--~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----- 671 (824)
...|.+.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 346778899999999999999986 58999999986432 2334568899999999999999999999987655
Q ss_pred EEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003385 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla 751 (824)
.++||||+++++|.+++. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 799999999999987663 2688999999999999999999998 99999999999999986 8999999999
Q ss_pred ccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
+..... ....||+.|+|||++.+.. +.++|||||||++|||++|..||.+.
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccc
Confidence 865432 3346999999999887654 88999999999999999999998753
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-30 Score=276.90 Aligned_cols=175 Identities=13% Similarity=0.112 Sum_probs=151.2
Q ss_pred HHHHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHHHHhhcCCCccceeeceeecCCeEE
Q 003385 598 IEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 598 ~~~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 673 (824)
+...+|.+.+.||+|+||.||+|++. +++.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44456778899999999999999986 4899999999765332 2367889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+||||+++++|.+++... ....++..++.|++.||+|||++ ||+||||||+|||++.++.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred EEEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----
Confidence 999999999999998432 34556788999999999999998 99999999999999999999998543
Q ss_pred ccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
|++ .++.++|||||||++|||++|+.||.+..
T Consensus 175 -----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 175 -----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp -----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred -----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 333 36889999999999999999999998754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-30 Score=304.24 Aligned_cols=202 Identities=26% Similarity=0.418 Sum_probs=171.2
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccC-CcccchhhhHHHHHHhhcCCCccceeeceeec------CCeE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------EGRS 672 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~~~ 672 (824)
..|.+.+.||+|+||.||+|.+. +|+.||||+++.. .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 46778899999999999999875 6889999998754 23335668899999999999999999998765 6677
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEEecC
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFG 749 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~---vkL~DFG 749 (824)
++||||+++|+|.+++... .....+++..+..++.|++.||+|||+. ||+||||||+||+++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~-~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSS-SCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 9999999999999998643 2233578888999999999999999998 9999999999999997664 9999999
Q ss_pred CcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
++....... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||.+.
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 998654432 223456999999999999999999999999999999999999999764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=286.61 Aligned_cols=197 Identities=15% Similarity=0.132 Sum_probs=152.2
Q ss_pred hhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhHHHHHHhhcCC-Cccceeec---------------
Q 003385 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHH-RNLVQFLG--------------- 664 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~H-pnIv~l~~--------------- 664 (824)
+.+.||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+.+++.++| +|......
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 4578999999999999965 689999999874322 235678899999999987 32211111
Q ss_pred ------eeec-----CCeEEEEEEecCCCCHHHHhhcc---cCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 003385 665 ------YCQE-----EGRSVLVYEFMHNGTLKEHLYGT---LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL 730 (824)
Q Consensus 665 ------~~~~-----~~~~~lV~E~~~~gsL~~~L~~~---~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDL 730 (824)
++.. ....+++|+++ +++|.+++... ......+++..++.++.|++.||+|||++ +|+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCc
Confidence 1111 12356777765 57898887321 22345577888999999999999999998 9999999
Q ss_pred CCCCEEEcCCCcEEEEecCCcccccCCCCceeccccCCCCCcchhcc----------ccCCCCchHHHHHHHHHHHHHHc
Q 003385 731 KSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY----------ISQQLTDKSDVYSFGVILLELIS 800 (824)
Q Consensus 731 kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~~~~~DIwSlGvil~ellt 800 (824)
||+|||++.++.+||+|||+++..... ....+| +.|+|||++ ....++.++|||||||++|||++
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999998764322 344567 999999999 55568889999999999999999
Q ss_pred CCCCCCCCcc
Q 003385 801 GQEAISNEKF 810 (824)
Q Consensus 801 G~~Pf~~~~~ 810 (824)
|+.||.+...
T Consensus 313 g~~Pf~~~~~ 322 (413)
T 3dzo_A 313 ADLPNTDDAA 322 (413)
T ss_dssp SSCCCCTTGG
T ss_pred CCCCCCCcch
Confidence 9999987543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-28 Score=262.09 Aligned_cols=170 Identities=25% Similarity=0.364 Sum_probs=146.4
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHH-hhcCCCccceeeceeec----CCeEEEEEEec
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLL-SRIHHRNLVQFLGYCQE----EGRSVLVYEFM 679 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~----~~~~~lV~E~~ 679 (824)
.+.||+|+||.||+|.+. +++.||+|+++. ...+.+|++++ +..+||||+++++++.. ....++||||+
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred CcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 478999999999999875 688999999853 34677888888 55689999999999876 67789999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEecCCcccccC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~---~~~vkL~DFGla~~~~~ 756 (824)
++|+|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||++....
T Consensus 98 ~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 98 DGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp CSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 999999998643 234688999999999999999999998 9999999999999998 7889999999885432
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
...++.++||||+||++|||++|+.||.+.
T Consensus 172 ----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 172 ----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp ----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred ----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 134678999999999999999999999653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.5e-28 Score=281.85 Aligned_cols=185 Identities=16% Similarity=0.119 Sum_probs=129.2
Q ss_pred cccccCcEEEEEEE-EcCCcEEEEEEeccCCc----------ccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEE
Q 003385 608 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY----------QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 608 ~LG~G~fg~Vy~a~-~~~g~~vAVK~l~~~~~----------~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 675 (824)
..+.|+.|....++ .--|+.+|||++..... ...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45667777666654 33589999999975421 1235689999999999 699999999999999999999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
|||++|++|.+.|.. ...++.. .|+.||+.||+|+|++ |||||||||+|||+++++++||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999953 3445543 5889999999999998 99999999999999999999999999998654
Q ss_pred CCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCC
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 804 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~P 804 (824)
.... .....+||+.|||||++.+ .+..++|+||+|++++++.+|..+
T Consensus 391 ~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 4322 2345679999999998865 467789999999998877665544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.8e-25 Score=255.26 Aligned_cols=184 Identities=18% Similarity=0.215 Sum_probs=145.0
Q ss_pred hhccccccCcEEEEEEEEcCCcEEEEEEeccCCcc--------cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
..+.||+|+||.||+|+. .++.+++|+....... ..+.+.+|++++++++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 357899999999999954 4788999986543211 1245789999999999999996666666777779999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. ++||+|||+++....
T Consensus 419 E~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 419 SYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp ECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred ECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 99999999999853 357899999999999998 9999999999999998 999999999987644
Q ss_pred CCCce------eccccCCCCCcchhcccc--CCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003385 757 GASHV------SSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAIS 806 (824)
Q Consensus 757 ~~~~~------~~~~~gt~~y~aPE~l~~--~~~~~~~DIwSlGvil~elltG~~Pf~ 806 (824)
..... ....+||+.|||||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32211 234679999999999986 678888999999999999888887764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-21 Score=209.25 Aligned_cols=141 Identities=17% Similarity=0.112 Sum_probs=113.5
Q ss_pred hhccccccCcEEEEEEEEcCCcEEEEEEeccCCcc------------------cchhhhHHHHHHhhcCCCccceeecee
Q 003385 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ------------------GKREFTNEVTLLSRIHHRNLVQFLGYC 666 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~------------------~~~~~~~Ei~il~~l~HpnIv~l~~~~ 666 (824)
+.+.||+|+||.||+|.+.+|+.||||+++..... ....+.+|++++++++ | +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 45899999999999999977999999999643211 2345889999999999 4 6666655
Q ss_pred ecCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 003385 667 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (824)
Q Consensus 667 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~ 746 (824)
.. +..++||||+++++|.+ +.. .....++.|++.||.|||+. ||+||||||+|||++ ++.+||+
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEEC
T ss_pred ec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEE
Confidence 44 45599999999999987 411 12346899999999999998 999999999999999 9999999
Q ss_pred ecCCcccccCCCCceeccccCCCCCcchhccc
Q 003385 747 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778 (824)
Q Consensus 747 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~ 778 (824)
|||+++. +..++|||.+.
T Consensus 235 DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp CCTTCEE--------------TTSTTHHHHHH
T ss_pred ECCCCeE--------------CCCCCHHHHHH
Confidence 9999853 34578999874
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=5.4e-19 Score=215.10 Aligned_cols=113 Identities=28% Similarity=0.433 Sum_probs=104.9
Q ss_pred CCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCcccee
Q 003385 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 492 (824)
Q Consensus 414 ~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L 492 (824)
.+++|+.|||++|+++|.+|..|++|++|+.|+|++|+|+|.+|. +++|++|+.|||++|+|+|.+|..+++|++|+.|
T Consensus 630 ~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L 709 (768)
T 3rgz_A 630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEI 709 (768)
T ss_dssp SSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEE
T ss_pred ccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEE
Confidence 457899999999999999999999999999999999999998886 9999999999999999999999999999999999
Q ss_pred eeccccccccccccc-cccceeccccCCccccCCC
Q 003385 493 YVQNNMLSGTVPSSL-LSKNVVLNYAGNINLHEGG 526 (824)
Q Consensus 493 ~l~~N~l~g~ip~~l-~~~~~~l~~~~n~~lc~~~ 526 (824)
+|++|+|+|.||..- +.......+.||+.+|+.+
T Consensus 710 ~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~ 744 (768)
T 3rgz_A 710 DLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP 744 (768)
T ss_dssp ECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT
T ss_pred ECcCCcccccCCCchhhccCCHHHhcCCchhcCCC
Confidence 999999999999753 5556677899999999764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=4.4e-18 Score=179.50 Aligned_cols=135 Identities=24% Similarity=0.259 Sum_probs=102.7
Q ss_pred HhhccccccCcEEEEEEEE-cCCcE--EEEEEeccCCccc------------------------chhhhHHHHHHhhcCC
Q 003385 604 MLEKKIGSGGFGVVYYGKL-KDGKE--IAVKVLTSNSYQG------------------------KREFTNEVTLLSRIHH 656 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~-~~g~~--vAVK~l~~~~~~~------------------------~~~~~~Ei~il~~l~H 656 (824)
.+.+.||+|+||.||+|.+ .+|+. ||||+++...... ...+.+|++++++++|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 3567899999999999988 67889 9999976432110 1257889999999988
Q ss_pred Ccc--ceeeceeecCCeEEEEEEecCC-C----CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEec
Q 003385 657 RNL--VQFLGYCQEEGRSVLVYEFMHN-G----TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-TGCVPAIIHR 728 (824)
Q Consensus 657 pnI--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~gIvHr 728 (824)
+++ ..+++. +..++||||+.+ | .|.+.... .++..+..++.|++.+|.||| +. ||+||
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givHr 195 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVHA 195 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 864 333332 245899999942 4 66665421 112345678999999999999 87 99999
Q ss_pred CCCCCCEEEcCCCcEEEEecCCcccc
Q 003385 729 DLKSSNILLDKHMRAKVSDFGLSKFA 754 (824)
Q Consensus 729 DLkp~NILl~~~~~vkL~DFGla~~~ 754 (824)
||||+|||++. .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999998654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.66 E-value=1.2e-17 Score=181.06 Aligned_cols=182 Identities=20% Similarity=0.187 Sum_probs=139.0
Q ss_pred cccceeeecccccCCC-CCCcccchhhhceeccCCCCCCcHHHHHHHHHhc-CCCCcccCCCCCCCCCCCCe-eEcCCCC
Q 003385 338 SLPFVLSFKFGKTYDS-SRGPLLNAMEINKYLERNDGSIDGVAIVSVISLY-SSADWAQEGGDPCLPVPWSW-LQCNSDP 414 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s-~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~-~~~~w~~~~~dpc~~~~~~~-~~c~~~~ 414 (824)
.+++|++|+|+.|.++ .+|+.+..++.|+.|+++.|.+.......+..+. .+.....+.+. ..+ +.-....
T Consensus 123 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~------l~~~~~~~~~~ 196 (313)
T 1ogq_A 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR------LTGKIPPTFAN 196 (313)
T ss_dssp GCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSE------EEEECCGGGGG
T ss_pred CCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCe------eeccCChHHhC
Confidence 3567888888888888 6677788888888888888877632222222222 22222211100 000 0011122
Q ss_pred CCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeee
Q 003385 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (824)
Q Consensus 415 ~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l 494 (824)
+. |+.|+|++|++++.+|..|.++++|+.|+|++|++++.+|.+..+++|+.|+|++|+|++.+|..++++++|+.|+|
T Consensus 197 l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 275 (313)
T 1ogq_A 197 LN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275 (313)
T ss_dssp CC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEEC
T ss_pred Cc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEEC
Confidence 33 99999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccc-cccceeccccCCccccCCC
Q 003385 495 QNNMLSGTVPSSL-LSKNVVLNYAGNINLHEGG 526 (824)
Q Consensus 495 ~~N~l~g~ip~~l-~~~~~~l~~~~n~~lc~~~ 526 (824)
++|+++|.+|..- +..+..+.+.+|+.+|+.+
T Consensus 276 s~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 276 SFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp CSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred cCCcccccCCCCccccccChHHhcCCCCccCCC
Confidence 9999999999862 3344677889999999865
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.3e-16 Score=174.25 Aligned_cols=183 Identities=14% Similarity=0.150 Sum_probs=136.1
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeE----cCCCC
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ----CNSDP 414 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~----c~~~~ 414 (824)
+++|++|+|+.|.++.+|+.+..+..|+.|+++.|.+... ...+..+..++.+..++..--...+-.... .....
T Consensus 103 l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~~l-p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~ 181 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181 (328)
T ss_dssp GTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCCCC-CGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEE
T ss_pred CCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccccC-cHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhcc
Confidence 6778888888888888888888888888888888876632 223334333433322111100000100000 00123
Q ss_pred CCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeee
Q 003385 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (824)
Q Consensus 415 ~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l 494 (824)
+++|++|+|++|+|+ .+|..+++|++|+.|+|++|+++++++.+.++++|+.|+|++|++.+.+|..++++++|+.|+|
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L 260 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEEC
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEEC
Confidence 678999999999999 8999999999999999999999998888999999999999999999999999999999999999
Q ss_pred ccccccccccccccc--cceeccccCCcccc
Q 003385 495 QNNMLSGTVPSSLLS--KNVVLNYAGNINLH 523 (824)
Q Consensus 495 ~~N~l~g~ip~~l~~--~~~~l~~~~n~~lc 523 (824)
++|++.+.+|..+.. .+..+.+++|+.+-
T Consensus 261 ~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~ 291 (328)
T 4fcg_A 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291 (328)
T ss_dssp TTCTTCCBCCTTGGGCTTCCEEECTTCTTCC
T ss_pred CCCCchhhcchhhhcCCCCCEEeCCCCCchh
Confidence 999999999987643 34677788876443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.63 E-value=6.4e-16 Score=165.76 Aligned_cols=156 Identities=23% Similarity=0.269 Sum_probs=126.6
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+++|+.|+|+.|.++.+|+. ..+..|+.|+++.|.+.. . +-....+++|
T Consensus 54 l~~L~~L~L~~n~l~~~~~~-~~l~~L~~L~Ls~N~l~~-----------l-------------------~~~~~~l~~L 102 (290)
T 1p9a_G 54 YTRLTQLNLDRAELTKLQVD-GTLPVLGTLDLSHNQLQS-----------L-------------------PLLGQTLPAL 102 (290)
T ss_dssp CTTCCEEECTTSCCCEEECC-SCCTTCCEEECCSSCCSS-----------C-------------------CCCTTTCTTC
T ss_pred CCCCCEEECCCCccCcccCC-CCCCcCCEEECCCCcCCc-----------C-------------------chhhccCCCC
Confidence 45677777777777777665 667777777777776542 0 0011346799
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N 497 (824)
+.|+|++|+|++..|..|.+|++|+.|+|++|+|++.++. |..+++|+.|+|++|+|++..+..+.++++|+.|+|++|
T Consensus 103 ~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N 182 (290)
T 1p9a_G 103 TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182 (290)
T ss_dssp CEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCC
Confidence 9999999999966668899999999999999999999887 789999999999999999555556789999999999999
Q ss_pred ccccccccccccc--ceeccccCCccccCCC
Q 003385 498 MLSGTVPSSLLSK--NVVLNYAGNINLHEGG 526 (824)
Q Consensus 498 ~l~g~ip~~l~~~--~~~l~~~~n~~lc~~~ 526 (824)
+|+ .+|..++.. +..+.+.+|+..|.+.
T Consensus 183 ~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~ 212 (290)
T 1p9a_G 183 SLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (290)
T ss_dssp CCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred cCC-ccChhhcccccCCeEEeCCCCccCcCc
Confidence 999 999998765 3667789999999763
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=6.2e-16 Score=163.81 Aligned_cols=113 Identities=24% Similarity=0.254 Sum_probs=99.8
Q ss_pred CCCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccce
Q 003385 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 491 (824)
Q Consensus 413 ~~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~ 491 (824)
..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..|.++++|+.
T Consensus 106 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 185 (270)
T 2o6q_A 106 DQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKT 185 (270)
T ss_dssp TTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred ccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCE
Confidence 3567999999999999977777899999999999999999998887 899999999999999999766678999999999
Q ss_pred eeeccccccccccccccc---cceeccccCCccccCCC
Q 003385 492 LYVQNNMLSGTVPSSLLS---KNVVLNYAGNINLHEGG 526 (824)
Q Consensus 492 L~l~~N~l~g~ip~~l~~---~~~~l~~~~n~~lc~~~ 526 (824)
|+|++|+++ .+|...+. .+..+.+.+|+..|.+.
T Consensus 186 L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 186 LKLDNNQLK-RVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp EECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred EECCCCcCC-cCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 999999999 77776554 44678889999988764
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.8e-15 Score=158.43 Aligned_cols=156 Identities=19% Similarity=0.203 Sum_probs=131.0
Q ss_pred cceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+.++.|+|+.|.++.++|. +..++.|+.|+++.|.+.. ..+- ....+++|
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-------------------~~~~----------~~~~l~~L 85 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-------------------LSAG----------VFDDLTEL 85 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCC-------------------CCTT----------TTTTCTTC
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCc-------------------cCHh----------HhccCCcC
Confidence 4678899999999999986 8999999999999997763 1110 01346799
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N 497 (824)
+.|+|++|+|++..+..|..+++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..|+.+++|+.|+|++|
T Consensus 86 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 165 (251)
T 3m19_A 86 GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTN 165 (251)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCC
Confidence 9999999999977777889999999999999999999887 789999999999999999666668999999999999999
Q ss_pred cccccccccccc---cceeccccCCccccCC
Q 003385 498 MLSGTVPSSLLS---KNVVLNYAGNINLHEG 525 (824)
Q Consensus 498 ~l~g~ip~~l~~---~~~~l~~~~n~~lc~~ 525 (824)
+++ .+|...+. .+..+.+.+|+..|..
T Consensus 166 ~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 166 QLQ-SVPHGAFDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp CCS-CCCTTTTTTCTTCCEEECCSCCBCTTS
T ss_pred cCC-ccCHHHHhCCCCCCEEEeeCCceeCCc
Confidence 999 66655443 4467888999988874
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.61 E-value=2.1e-15 Score=154.90 Aligned_cols=152 Identities=21% Similarity=0.212 Sum_probs=127.0
Q ss_pred eeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeEEE
Q 003385 343 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 422 (824)
Q Consensus 343 ~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~L~ 422 (824)
+.++++.+.++.+|+.+. +.++.|+++.|.+... .+- ....+++|+.|+
T Consensus 14 ~~v~c~~~~l~~iP~~l~--~~l~~L~l~~n~i~~i-------------------~~~----------~~~~l~~L~~L~ 62 (220)
T 2v9t_B 14 NIVDCRGKGLTEIPTNLP--ETITEIRLEQNTIKVI-------------------PPG----------AFSPYKKLRRID 62 (220)
T ss_dssp TEEECTTSCCSSCCSSCC--TTCCEEECCSSCCCEE-------------------CTT----------SSTTCTTCCEEE
T ss_pred CEEEcCCCCcCcCCCccC--cCCCEEECCCCcCCCc-------------------CHh----------HhhCCCCCCEEE
Confidence 346778999999998876 6899999999877631 000 113467899999
Q ss_pred ecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccccccc
Q 003385 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 501 (824)
Q Consensus 423 L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g 501 (824)
|++|+|++..|..|.+|++|+.|+|++|+|+++++. |.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+
T Consensus 63 Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~- 141 (220)
T 2v9t_B 63 LSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ- 141 (220)
T ss_dssp CCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-
T ss_pred CCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC-
Confidence 999999988899999999999999999999998887 788999999999999999888899999999999999999999
Q ss_pred cccccccc---cceeccccCCccccCCC
Q 003385 502 TVPSSLLS---KNVVLNYAGNINLHEGG 526 (824)
Q Consensus 502 ~ip~~l~~---~~~~l~~~~n~~lc~~~ 526 (824)
.+|...+. .+..+.+.+|+..|.+.
T Consensus 142 ~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 142 TIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred EECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 66665444 34677889999988663
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.2e-16 Score=184.17 Aligned_cols=171 Identities=13% Similarity=0.102 Sum_probs=94.3
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcC-------
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCN------- 411 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~------- 411 (824)
+++|+.|+|++|.++.++| +..+..|+.|+++.|.+..... ...+..+..++ | ....+.|.
T Consensus 57 l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~~---N---~l~~~~~~~l~~L~~ 124 (487)
T 3oja_A 57 FTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAAN---N---NISRVSCSRGQGKKN 124 (487)
T ss_dssp CTTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECCS---S---CCCCEEECCCSSCEE
T ss_pred CCCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECcC---C---cCCCCCccccCCCCE
Confidence 4566777777777776666 6677777777777666543110 01111111100 0 11222221
Q ss_pred ---------------CCCCCceeEEEecCCCCCccCChhhh-cccccccccccccccCCCCCCCCCCCCcceEeeccccc
Q 003385 412 ---------------SDPQPSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475 (824)
Q Consensus 412 ---------------~~~~~~L~~L~L~~n~l~g~lp~~i~-~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l 475 (824)
...+++|+.|+|++|+|++..|..+. .|++|+.|+|++|.|++.+ .+..+++|+.|+|++|+|
T Consensus 125 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~-~~~~l~~L~~L~Ls~N~l 203 (487)
T 3oja_A 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLDLSSNKL 203 (487)
T ss_dssp EECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE-CCCCCTTCCEEECCSSCC
T ss_pred EECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccccc-ccccCCCCCEEECCCCCC
Confidence 12234566666666666655555554 5666666666666666552 233466667777777777
Q ss_pred CCCCCccccCCCccceeeecccccccccccccc--ccceeccccCCccccC
Q 003385 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLNYAGNINLHE 524 (824)
Q Consensus 476 ~g~lP~~l~~l~~L~~L~l~~N~l~g~ip~~l~--~~~~~l~~~~n~~lc~ 524 (824)
++ +|..++.+++|+.|+|++|+|+ .+|..+. ..+..+.+++|+..|.
T Consensus 204 ~~-~~~~~~~l~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 204 AF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp CE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCBCHH
T ss_pred CC-CCHhHcCCCCccEEEecCCcCc-ccchhhccCCCCCEEEcCCCCCcCc
Confidence 63 4445677777777777777777 4666543 2345566677766653
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=6.4e-16 Score=175.52 Aligned_cols=180 Identities=19% Similarity=0.173 Sum_probs=143.7
Q ss_pred ccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEc-CCCCCC
Q 003385 339 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQP 416 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c-~~~~~~ 416 (824)
+++|+.|+|+.|.++.+|+. +..+..|+.|+++.|.+.......+..+..++.+...+... ...+.- ....++
T Consensus 111 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~-----l~~i~~~~~~~l~ 185 (440)
T 3zyj_A 111 LANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKR-----LSYISEGAFEGLS 185 (440)
T ss_dssp CSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTT-----CCEECTTTTTTCS
T ss_pred CccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCC-----cceeCcchhhccc
Confidence 67899999999999999985 99999999999999987753333333333333332211110 111221 234678
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeec
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~ 495 (824)
+|+.|+|++|+|+ .+|. +..+++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus 186 ~L~~L~L~~n~l~-~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 263 (440)
T 3zyj_A 186 NLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLA 263 (440)
T ss_dssp SCCEEECTTSCCS-SCCC-CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECT
T ss_pred ccCeecCCCCcCc-cccc-cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECC
Confidence 9999999999999 7774 89999999999999999999875 9999999999999999998889999999999999999
Q ss_pred cccccccccccccc---cceeccccCCccccCCC
Q 003385 496 NNMLSGTVPSSLLS---KNVVLNYAGNINLHEGG 526 (824)
Q Consensus 496 ~N~l~g~ip~~l~~---~~~~l~~~~n~~lc~~~ 526 (824)
+|+|+ .+|...+. .+..+.+.+|+..|.+.
T Consensus 264 ~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 264 HNNLT-LLPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp TSCCC-CCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred CCCCC-ccChhHhccccCCCEEEcCCCCccCCCC
Confidence 99999 78877654 34678889999999874
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.59 E-value=5e-15 Score=157.07 Aligned_cols=157 Identities=20% Similarity=0.161 Sum_probs=125.8
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+++|+.|+|+.|.++.+ +.+..++.|+.|+++.|.+.. ..+. ....+++|
T Consensus 62 l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~n~l~~-------------------~~~~----------~~~~l~~L 111 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHDI-SALKELTNLTYLILTGNQLQS-------------------LPNG----------VFDKLTNL 111 (272)
T ss_dssp CTTCCEEECTTSCCCCC-GGGTTCTTCCEEECTTSCCCC-------------------CCTT----------TTTTCTTC
T ss_pred CCCCcEEECCCCCCCCc-hhhcCCCCCCEEECCCCccCc-------------------cChh----------HhcCCcCC
Confidence 56777888888888876 467778888888888776552 0000 01346789
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N 497 (824)
++|+|++|++++..|..|++|++|+.|+|++|++++.++. +.++++|+.|+|++|+|++..|..++.+++|+.|+|++|
T Consensus 112 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (272)
T 3rfs_A 112 KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN 191 (272)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence 9999999999977777789999999999999999998887 789999999999999999777778899999999999999
Q ss_pred ccccccccccc---ccceeccccCCccccCCC
Q 003385 498 MLSGTVPSSLL---SKNVVLNYAGNINLHEGG 526 (824)
Q Consensus 498 ~l~g~ip~~l~---~~~~~l~~~~n~~lc~~~ 526 (824)
++++ +|+..+ ..+..+.+.+|+..|..+
T Consensus 192 ~l~~-~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 192 QLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp CCSC-CCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred cCCc-cCHHHHhCCcCCCEEEccCCCccccCc
Confidence 9995 555443 345778889998888765
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=7.1e-16 Score=164.48 Aligned_cols=181 Identities=17% Similarity=0.175 Sum_probs=130.3
Q ss_pred ccceeeecccccCCCCCCc-ccchhhhceeccCCCCC-CcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCee-EcCCCCC
Q 003385 339 LPFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGS-IDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWL-QCNSDPQ 415 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP-~i~~le~l~~L~l~~n~-~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~-~c~~~~~ 415 (824)
+++|+.|+|+.|.++.++| .+..++.|+.|+++.|. +.......+..+..++.+..+++. ...+ ......+
T Consensus 55 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~------l~~~~~~~~~~l 128 (285)
T 1ozn_A 55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG------LQELGPGLFRGL 128 (285)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSC------CCCCCTTTTTTC
T ss_pred CCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCc------CCEECHhHhhCC
Confidence 4566777777777777744 37777777777777665 443222222223233332221110 0111 0112457
Q ss_pred CceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeee
Q 003385 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l 494 (824)
++|++|+|++|++++..+..|+++++|+.|+|++|++++.++. +.++++|+.|+|++|+|++..|..++++++|+.|+|
T Consensus 129 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 208 (285)
T 1ozn_A 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208 (285)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeC
Confidence 7999999999999966666799999999999999999998886 899999999999999999888999999999999999
Q ss_pred cccccccccccccc---ccceeccccCCccccCCC
Q 003385 495 QNNMLSGTVPSSLL---SKNVVLNYAGNINLHEGG 526 (824)
Q Consensus 495 ~~N~l~g~ip~~l~---~~~~~l~~~~n~~lc~~~ 526 (824)
++|+++ .+|...+ ..+..+.+++|+..|.+.
T Consensus 209 ~~n~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 209 FANNLS-ALPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp CSSCCS-CCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred CCCcCC-cCCHHHcccCcccCEEeccCCCccCCCC
Confidence 999999 5665433 344678889999888764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=4.9e-16 Score=189.00 Aligned_cols=82 Identities=27% Similarity=0.427 Sum_probs=52.6
Q ss_pred ccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccccccccccccccc--cceecc
Q 003385 439 LSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS--KNVVLN 515 (824)
Q Consensus 439 L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g~ip~~l~~--~~~~l~ 515 (824)
+++|+.|||++|+++|.+|. +++|++|+.|+|++|+|+|.+|++|++|++|+.|+|++|+++|.+|..+.. .+..++
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 34566666666666666664 666667777777777777677777777777777777777777666666533 334555
Q ss_pred ccCCc
Q 003385 516 YAGNI 520 (824)
Q Consensus 516 ~~~n~ 520 (824)
+++|.
T Consensus 711 ls~N~ 715 (768)
T 3rgz_A 711 LSNNN 715 (768)
T ss_dssp CCSSE
T ss_pred CcCCc
Confidence 56553
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=5.4e-16 Score=171.08 Aligned_cols=138 Identities=15% Similarity=0.158 Sum_probs=95.6
Q ss_pred HHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcc-----cchh-----------------hhHHHHHHhhcCCCccc
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ-----GKRE-----------------FTNEVTLLSRIHHRNLV 660 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~-----~~~~-----------------~~~Ei~il~~l~HpnIv 660 (824)
|.+.++||+|++|.||+|...+|+.||||+++..... ..++ ..+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 4567889999999999999999999999998643111 0010 12344555555433322
Q ss_pred eeeceeecCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 003385 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 740 (824)
Q Consensus 661 ~l~~~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~ 740 (824)
...-+... ..+|||||+++++|..... . .....++.|++.+|.|||+. |||||||||.|||++++
T Consensus 177 vp~p~~~~--~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 177 VPEPIAQS--RHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE 241 (397)
T ss_dssp CCCEEEEE--TTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE
T ss_pred CCeeeecc--CceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC
Confidence 11111111 2369999999988765431 1 12346789999999999998 99999999999999987
Q ss_pred C----------cEEEEecCCccccc
Q 003385 741 M----------RAKVSDFGLSKFAV 755 (824)
Q Consensus 741 ~----------~vkL~DFGla~~~~ 755 (824)
+ .+.|+||+.+....
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCcccccccccceEEEEeCCcccCC
Confidence 6 38999999875443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.8e-15 Score=154.04 Aligned_cols=153 Identities=17% Similarity=0.178 Sum_probs=111.6
Q ss_pred eecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeEEEe
Q 003385 344 SFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHL 423 (824)
Q Consensus 344 ~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~L~L 423 (824)
.+++++|.++.+|+.+.. .++.|+++.|.+... .+- . ....+++|+.|+|
T Consensus 15 ~l~~s~n~l~~iP~~~~~--~~~~L~L~~N~l~~~-------------------~~~-----~----~~~~l~~L~~L~L 64 (220)
T 2v70_A 15 TVDCSNQKLNKIPEHIPQ--YTAELRLNNNEFTVL-------------------EAT-----G----IFKKLPQLRKINF 64 (220)
T ss_dssp EEECCSSCCSSCCSCCCT--TCSEEECCSSCCCEE-------------------CCC-----C----CGGGCTTCCEEEC
T ss_pred EeEeCCCCcccCccCCCC--CCCEEEcCCCcCCcc-------------------Cch-----h----hhccCCCCCEEEC
Confidence 567788888888876643 457888888876530 000 0 0123567888888
Q ss_pred cCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeecccccccc
Q 003385 424 SSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT 502 (824)
Q Consensus 424 ~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g~ 502 (824)
++|+|++..|..|.++++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..|..+++|+.|+|++|++++.
T Consensus 65 ~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 144 (220)
T 2v70_A 65 SNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTV 144 (220)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCB
T ss_pred CCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEE
Confidence 88888866666888888888888888888888876 78888888888888888877788888888888888888888844
Q ss_pred cccccc--ccceeccccCCccccCCC
Q 003385 503 VPSSLL--SKNVVLNYAGNINLHEGG 526 (824)
Q Consensus 503 ip~~l~--~~~~~l~~~~n~~lc~~~ 526 (824)
.|..+. ..+..+.+.+|+..|.+.
T Consensus 145 ~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 145 APGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 454442 234667778888777653
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.58 E-value=2.7e-15 Score=160.86 Aligned_cols=170 Identities=21% Similarity=0.230 Sum_probs=119.1
Q ss_pred cceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCcee
Q 003385 340 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 419 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~ 419 (824)
++++.+++..+.++.+|+.+. +.++.|+++.|.+.......+..+..+.....+++ ....+... ..+++|+
T Consensus 10 ~~l~~l~~~~~~l~~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n------~l~~~~~~-~~l~~L~ 80 (290)
T 1p9a_G 10 ASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA------ELTKLQVD-GTLPVLG 80 (290)
T ss_dssp TTCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTS------CCCEEECC-SCCTTCC
T ss_pred CCccEEECCCCCCCcCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCC------ccCcccCC-CCCCcCC
Confidence 344455555555555555443 34555555555443322222222222222221111 01122221 4578999
Q ss_pred EEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeecccc
Q 003385 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (824)
Q Consensus 420 ~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~ 498 (824)
.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 9999999999 8999999999999999999999999986 8999999999999999997777788999999999999999
Q ss_pred cccccccccccc---ceeccccCCc
Q 003385 499 LSGTVPSSLLSK---NVVLNYAGNI 520 (824)
Q Consensus 499 l~g~ip~~l~~~---~~~l~~~~n~ 520 (824)
|+ .+|...+.. +..+.+++|.
T Consensus 160 l~-~l~~~~~~~l~~L~~L~L~~N~ 183 (290)
T 1p9a_G 160 LT-ELPAGLLNGLENLDTLLLQENS 183 (290)
T ss_dssp CS-CCCTTTTTTCTTCCEEECCSSC
T ss_pred CC-ccCHHHhcCcCCCCEEECCCCc
Confidence 99 888877653 4566777775
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.58 E-value=1.6e-15 Score=152.33 Aligned_cols=154 Identities=18% Similarity=0.162 Sum_probs=125.2
Q ss_pred eeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeEEE
Q 003385 343 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 422 (824)
Q Consensus 343 ~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~L~ 422 (824)
+.++++.|.++.+|+.+.. .++.|+++.|.+.. ..+ .. ....+++|+.|+
T Consensus 11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~-------------------~~~------~~---~~~~l~~L~~L~ 60 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGR-------------------ISS------DG---LFGRLPHLVKLE 60 (192)
T ss_dssp TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCS-------------------BCC------SC---SGGGCTTCCEEE
T ss_pred CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCc-------------------cCC------cc---ccccCCCCCEEE
Confidence 5678899999999998765 89999999997763 000 00 012467999999
Q ss_pred ecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccccccc
Q 003385 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 501 (824)
Q Consensus 423 L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g 501 (824)
|++|+|++..|..|.+|++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++.+|..++.+++|+.|+|++|++++
T Consensus 61 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 61 LKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 999999988899999999999999999999999987 8999999999999999999999999999999999999999998
Q ss_pred ccccccccc-ceeccccCCccccCCC
Q 003385 502 TVPSSLLSK-NVVLNYAGNINLHEGG 526 (824)
Q Consensus 502 ~ip~~l~~~-~~~l~~~~n~~lc~~~ 526 (824)
..+...+.. +....+.++...|..+
T Consensus 141 ~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 141 NCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp SGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred cCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 776443322 2223445666667655
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=5.8e-16 Score=166.83 Aligned_cols=183 Identities=14% Similarity=0.064 Sum_probs=137.1
Q ss_pred cccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHH-HHHHHhcCCCCcccCCCCCCCCCCCCeeE-cCCCCC
Q 003385 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAI-VSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQ 415 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l-~~lk~~~~~~~w~~~~~dpc~~~~~~~~~-c~~~~~ 415 (824)
.+++|+.|+|+.|.++.+|+.+..++.|+.|+++.|.+..... ..+..+..++.+..+++. ..... .....+
T Consensus 76 ~~~~L~~L~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~------l~~~~~~~~~~l 149 (306)
T 2z66_A 76 GTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH------TRVAFNGIFNGL 149 (306)
T ss_dssp SCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSC------CEECSTTTTTTC
T ss_pred cccccCEEECCCCccccChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCc------CCccchhhcccC
Confidence 3567888888888888888888888888888888877654221 222222233333221110 00000 112456
Q ss_pred CceeEEEecCCCCCc-cCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceee
Q 003385 416 PSITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g-~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~ 493 (824)
++|++|+|++|++++ .+|..+..+++|+.|+|++|++++.+|. +.++++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 150 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 229 (306)
T 2z66_A 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 229 (306)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEE
T ss_pred cCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeE
Confidence 799999999999986 5899999999999999999999998775 88999999999999999977777899999999999
Q ss_pred eccccccccccccccc---cceeccccCCccccCCC
Q 003385 494 VQNNMLSGTVPSSLLS---KNVVLNYAGNINLHEGG 526 (824)
Q Consensus 494 l~~N~l~g~ip~~l~~---~~~~l~~~~n~~lc~~~ 526 (824)
|++|++++..|..+.. .+..+.+++|+..|.+.
T Consensus 230 L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 230 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp CTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred CCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 9999999877776654 44678889999888663
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.57 E-value=8.4e-15 Score=151.34 Aligned_cols=150 Identities=21% Similarity=0.172 Sum_probs=123.9
Q ss_pred eeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeEEE
Q 003385 343 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 422 (824)
Q Consensus 343 ~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~L~ 422 (824)
+.++++.+.++.+|+.+. +.|+.|+++.|.+.. ..|- ....+++|+.|+
T Consensus 22 ~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~-------------------~~~~----------~~~~l~~L~~L~ 70 (229)
T 3e6j_A 22 TTVDCRSKRHASVPAGIP--TNAQILYLHDNQITK-------------------LEPG----------VFDSLINLKELY 70 (229)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCC-------------------CCTT----------TTTTCTTCCEEE
T ss_pred CEeEccCCCcCccCCCCC--CCCCEEEcCCCccCc-------------------cCHH----------HhhCccCCcEEE
Confidence 457778999999998776 889999999998763 1110 113467899999
Q ss_pred ecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccccccc
Q 003385 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 501 (824)
Q Consensus 423 L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g 501 (824)
|++|+|++..+..|.+|++|+.|+|++|+|+++++. |..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+
T Consensus 71 L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~- 148 (229)
T 3e6j_A 71 LGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK- 148 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCC-
T ss_pred CCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCC-
Confidence 999999854456679999999999999999998887 788999999999999999 89999999999999999999999
Q ss_pred cccccccc---cceeccccCCccccCC
Q 003385 502 TVPSSLLS---KNVVLNYAGNINLHEG 525 (824)
Q Consensus 502 ~ip~~l~~---~~~~l~~~~n~~lc~~ 525 (824)
.+|...+. .+..+.+.+|+..|.+
T Consensus 149 ~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 149 SIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred ccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 77766544 4467788999988866
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.57 E-value=7.9e-16 Score=168.02 Aligned_cols=174 Identities=10% Similarity=0.086 Sum_probs=97.7
Q ss_pred cccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCc
Q 003385 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (824)
..+.++.|+|+.|.++.+|+.+..++.|+.|+++.|.+.. ....+..+..+..+..+++. ...++.....+++
T Consensus 79 ~~~~l~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~n~l~~-lp~~~~~l~~L~~L~Ls~n~------l~~lp~~l~~l~~ 151 (328)
T 4fcg_A 79 TQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNP------LRALPASIASLNR 151 (328)
T ss_dssp TSTTCCEEEEESSCCSSCCSCGGGGTTCSEEEEESSCCCC-CCSCGGGGTTCSEEEEESCC------CCCCCGGGGGCTT
T ss_pred cccceeEEEccCCCchhcChhhhhCCCCCEEECCCCCccc-hhHHHhccCCCCEEECCCCc------cccCcHHHhcCcC
Confidence 4567899999999999999999999999999999998763 11122222222222221110 0011111223445
Q ss_pred eeEEEecCCCCCccCChhhhc---------ccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCc
Q 003385 418 ITVIHLSSKNLTGNIPSDLTK---------LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPN 488 (824)
Q Consensus 418 L~~L~L~~n~l~g~lp~~i~~---------L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~ 488 (824)
|+.|+|++|++.+.+|..++. +++|+.|+|++|+|+.+++.+.++++|+.|+|++|+|+ .+|..++.+++
T Consensus 152 L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~ 230 (328)
T 4fcg_A 152 LRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPK 230 (328)
T ss_dssp CCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTT
T ss_pred CCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCC-cCchhhccCCC
Confidence 555555555555555555443 55555555555555544434555555555555555555 34555555555
Q ss_pred cceeeecccccccccccccc--ccceeccccCC
Q 003385 489 LRELYVQNNMLSGTVPSSLL--SKNVVLNYAGN 519 (824)
Q Consensus 489 L~~L~l~~N~l~g~ip~~l~--~~~~~l~~~~n 519 (824)
|+.|+|++|++.+.+|..+. ..+..+.+++|
T Consensus 231 L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n 263 (328)
T 4fcg_A 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDC 263 (328)
T ss_dssp CCEEECTTCTTCCBCCCCTTCCCCCCEEECTTC
T ss_pred CCEEECcCCcchhhhHHHhcCCCCCCEEECCCC
Confidence 55555555555555555442 22334444444
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.57 E-value=1.1e-15 Score=174.10 Aligned_cols=181 Identities=18% Similarity=0.190 Sum_probs=142.8
Q ss_pred cccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEc-CCCCC
Q 003385 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQ 415 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c-~~~~~ 415 (824)
.+++|++|+|++|.++.+|+. +..+..|+.|+++.|.+.......+..+..+..+...+ |. ....+.- ....+
T Consensus 121 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~---~~--~l~~i~~~~~~~l 195 (452)
T 3zyi_A 121 GLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGE---LK--KLEYISEGAFEGL 195 (452)
T ss_dssp TCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCC---CT--TCCEECTTTTTTC
T ss_pred CcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCC---CC--CccccChhhccCC
Confidence 367889999999999999987 88899999999999987753333333333333332211 10 0112221 23467
Q ss_pred CceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeee
Q 003385 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l 494 (824)
++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..|.++++|+.|+|
T Consensus 196 ~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 273 (452)
T 3zyi_A 196 FNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNL 273 (452)
T ss_dssp TTCCEEECTTSCCS-SCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccc-ccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEEC
Confidence 89999999999999 566 489999999999999999999886 999999999999999999888999999999999999
Q ss_pred ccccccccccccccc---cceeccccCCccccCCC
Q 003385 495 QNNMLSGTVPSSLLS---KNVVLNYAGNINLHEGG 526 (824)
Q Consensus 495 ~~N~l~g~ip~~l~~---~~~~l~~~~n~~lc~~~ 526 (824)
++|+|+ .+|...+. .+..+.+.+|+..|.+.
T Consensus 274 ~~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 274 AHNNLS-SLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp CSSCCS-CCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred CCCcCC-ccChHHhccccCCCEEEccCCCcCCCCC
Confidence 999999 77776654 44678889999999874
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=7.6e-15 Score=150.76 Aligned_cols=137 Identities=19% Similarity=0.236 Sum_probs=118.8
Q ss_pred ceeeecccccCCCCCCcc--cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 341 FVLSFKFGKTYDSSRGPL--LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 341 ~l~~L~L~~n~~s~LPP~--i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
.++.|+|+.|.++.++|. +..++.|+.|+++.|.+... .+- ....+++|
T Consensus 33 ~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i-------------------~~~----------~~~~l~~L 83 (220)
T 2v70_A 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDI-------------------EEG----------AFEGASGV 83 (220)
T ss_dssp TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEE-------------------CTT----------TTTTCTTC
T ss_pred CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEE-------------------CHH----------HhCCCCCC
Confidence 457899999999999764 89999999999999987641 000 12346799
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N 497 (824)
++|+|++|+|++..|..|.+|++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 84 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 163 (220)
T 2v70_A 84 NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163 (220)
T ss_dssp CEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred CEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCc
Confidence 9999999999977777899999999999999999999876 899999999999999999888999999999999999999
Q ss_pred ccccccccc
Q 003385 498 MLSGTVPSS 506 (824)
Q Consensus 498 ~l~g~ip~~ 506 (824)
++++..+..
T Consensus 164 ~l~c~c~l~ 172 (220)
T 2v70_A 164 PFNCNCYLA 172 (220)
T ss_dssp CEECSGGGH
T ss_pred CCcCCCchH
Confidence 999766543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.55 E-value=7.7e-16 Score=166.90 Aligned_cols=175 Identities=25% Similarity=0.222 Sum_probs=125.1
Q ss_pred cccceeeecccccCCC-CCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCC-eeEcCCCCC
Q 003385 338 SLPFVLSFKFGKTYDS-SRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWS-WLQCNSDPQ 415 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s-~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~-~~~c~~~~~ 415 (824)
.+++|++|+|+.|.++ .+|+.+..++.|+.|+++.|.+.......+..+..++.+..+.+. .. .+......+
T Consensus 99 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~------l~~~~p~~l~~l 172 (313)
T 1ogq_A 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR------ISGAIPDSYGSF 172 (313)
T ss_dssp GCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC------CEEECCGGGGCC
T ss_pred cCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc------ccCcCCHHHhhh
Confidence 4678999999999998 777789999999999999998774333334444344443222111 11 111112234
Q ss_pred C-ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceee
Q 003385 416 P-SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (824)
Q Consensus 416 ~-~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~ 493 (824)
+ +|+.|+|++|++++.+|..+..++ |+.|+|++|++++.+|. +.++++|+.|+|++|++++.+|. ++.+++|++|+
T Consensus 173 ~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~ 250 (313)
T 1ogq_A 173 SKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLD 250 (313)
T ss_dssp CTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEE
T ss_pred hhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEE
Confidence 4 788888888888888888888887 88888888888877775 77888888888888888865555 77888888888
Q ss_pred eccccccccccccccc--cceeccccCCc
Q 003385 494 VQNNMLSGTVPSSLLS--KNVVLNYAGNI 520 (824)
Q Consensus 494 l~~N~l~g~ip~~l~~--~~~~l~~~~n~ 520 (824)
|++|+++|.+|..+.. .+..+.+++|.
T Consensus 251 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 279 (313)
T 1ogq_A 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279 (313)
T ss_dssp CCSSCCEECCCGGGGGCTTCCEEECCSSE
T ss_pred CcCCcccCcCChHHhcCcCCCEEECcCCc
Confidence 8888888888877643 34566667774
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.6e-14 Score=151.20 Aligned_cols=136 Identities=15% Similarity=0.138 Sum_probs=118.4
Q ss_pred cccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCC
Q 003385 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (824)
.+++|+.|+|+.|.++.++|. +..+..|+.|+++.|.+.. ..+. ....++
T Consensus 57 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-------------------~~~~----------~~~~l~ 107 (251)
T 3m19_A 57 GLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS-------------------LPLG----------VFDHLT 107 (251)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCC-------------------CCTT----------TTTTCT
T ss_pred CcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccc-------------------cChh----------HhcccC
Confidence 367899999999999999997 8999999999999997763 0100 013467
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeec
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~ 495 (824)
+|++|+|++|+|++..+..|.++++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..+.++++|+.|+|+
T Consensus 108 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 187 (251)
T 3m19_A 108 QLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLF 187 (251)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEee
Confidence 999999999999966666789999999999999999999985 8999999999999999997777799999999999999
Q ss_pred ccccccc
Q 003385 496 NNMLSGT 502 (824)
Q Consensus 496 ~N~l~g~ 502 (824)
+|++++.
T Consensus 188 ~N~~~c~ 194 (251)
T 3m19_A 188 GNQFDCS 194 (251)
T ss_dssp SCCBCTT
T ss_pred CCceeCC
Confidence 9999965
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.8e-14 Score=163.83 Aligned_cols=186 Identities=13% Similarity=0.081 Sum_probs=132.4
Q ss_pred cceeeecccccCCCCCCcc---------cchhhhceeccCCCCCCcHHHHHHHHHhcCC---CCcccCCC----------
Q 003385 340 PFVLSFKFGKTYDSSRGPL---------LNAMEINKYLERNDGSIDGVAIVSVISLYSS---ADWAQEGG---------- 397 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~---------i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~---~~w~~~~~---------- 397 (824)
..|+.|+++.|.++.+++. +..++.|+.|+++.|.+.......+...... ......+.
T Consensus 180 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~ 259 (455)
T 3v47_A 180 KHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHT 259 (455)
T ss_dssp CEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCC
T ss_pred ccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchh
Confidence 4556666666666666554 2244789999999999888777666655211 11100000
Q ss_pred -----CC-----CCCCCCCeeE----------c-CCCCCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCC
Q 003385 398 -----DP-----CLPVPWSWLQ----------C-NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI 456 (824)
Q Consensus 398 -----dp-----c~~~~~~~~~----------c-~~~~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~ 456 (824)
.+ +.......+. . ....+++|+.|+|++|++++..|..|.++++|+.|+|++|++++.+
T Consensus 260 ~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 339 (455)
T 3v47_A 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSID 339 (455)
T ss_dssp SSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred hhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcC
Confidence 00 0000011111 1 1245678999999999999888889999999999999999998887
Q ss_pred CC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccccccccccccccc---cceeccccCCccccCCC
Q 003385 457 PD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS---KNVVLNYAGNINLHEGG 526 (824)
Q Consensus 457 p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g~ip~~l~~---~~~~l~~~~n~~lc~~~ 526 (824)
|. +.++++|+.|+|++|+|++..|..|+++++|+.|+|++|+++ .+|...+. .+..+.+++|+..|.++
T Consensus 340 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 340 SRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp GGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred hhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccc-cCCHhHhccCCcccEEEccCCCcccCCC
Confidence 75 788999999999999999888889999999999999999999 67776544 44677889999888775
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=2.9e-15 Score=176.85 Aligned_cols=182 Identities=13% Similarity=0.027 Sum_probs=141.8
Q ss_pred cccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHH-HHHHHhcCCCCcccCCCCCCCCCCCCe-eEcCCCCC
Q 003385 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAI-VSVISLYSSADWAQEGGDPCLPVPWSW-LQCNSDPQ 415 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l-~~lk~~~~~~~w~~~~~dpc~~~~~~~-~~c~~~~~ 415 (824)
.++.|+.|+|+.|.++.+|+.+..++.|+.|+++.|.+..... ..+..+..+.....+.+. ... .......+
T Consensus 374 ~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~------l~~~~~~~~~~l 447 (606)
T 3vq2_A 374 GTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTN------TKIDFDGIFLGL 447 (606)
T ss_dssp CCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSC------CEECCTTTTTTC
T ss_pred cCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCC------CCccchhhhcCC
Confidence 4567888888888888888888888899999998887664321 223333333333221111 001 01123457
Q ss_pred CceeEEEecCCCCCc-cCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceee
Q 003385 416 PSITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g-~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~ 493 (824)
++|+.|+|++|++++ .+|..++.+++|+.|+|++|++++.+|. +.++++|+.|+|++|++++.+|..++++++|+.|+
T Consensus 448 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 527 (606)
T 3vq2_A 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLD 527 (606)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEE
Confidence 899999999999997 4799999999999999999999999886 89999999999999999988899999999999999
Q ss_pred eccccccccccccccc---cceeccccCCccccCCC
Q 003385 494 VQNNMLSGTVPSSLLS---KNVVLNYAGNINLHEGG 526 (824)
Q Consensus 494 l~~N~l~g~ip~~l~~---~~~~l~~~~n~~lc~~~ 526 (824)
|++|+++ .+|..+.. .+..+.+.+|+..|.++
T Consensus 528 l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 528 CSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp CTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 9999999 89988544 25678889999999775
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=9.3e-15 Score=155.77 Aligned_cols=176 Identities=15% Similarity=0.124 Sum_probs=127.7
Q ss_pred cceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCee-EcCCCCCCc
Q 003385 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWL-QCNSDPQPS 417 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~-~c~~~~~~~ 417 (824)
+.|+.|+|++|.++.+|+. +..+..|+.|+++.|.+.......+..+..+..+..+.+.-- ..+ .-....+++
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l-----~~~~~~~~~~l~~ 106 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL-----RSVDPATFHGLGR 106 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC-----CCCCTTTTTTCTT
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCc-----cccCHHHhcCCcC
Confidence 4788999999999999986 999999999999999877543333444434444332211101 111 011234678
Q ss_pred eeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeecc
Q 003385 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (824)
Q Consensus 418 L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~ 496 (824)
|++|+|++|++++..|..+.++++|+.|+|++|++++.++. +.++++|+.|+|++|+|++..+..+..+++|+.|+|++
T Consensus 107 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 186 (285)
T 1ozn_A 107 LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186 (285)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCC
Confidence 88888888888877778888888888888888888888776 78888888888888888855555788888888888888
Q ss_pred cccccccccccc--ccceeccccCCc
Q 003385 497 NMLSGTVPSSLL--SKNVVLNYAGNI 520 (824)
Q Consensus 497 N~l~g~ip~~l~--~~~~~l~~~~n~ 520 (824)
|++++..|..+. ..+..+.+++|.
T Consensus 187 n~l~~~~~~~~~~l~~L~~L~l~~n~ 212 (285)
T 1ozn_A 187 NRVAHVHPHAFRDLGRLMTLYLFANN 212 (285)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CcccccCHhHccCcccccEeeCCCCc
Confidence 888855565553 234566666663
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.3e-14 Score=141.95 Aligned_cols=136 Identities=19% Similarity=0.150 Sum_probs=118.8
Q ss_pred ccceeeecccccCCC--CCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCC
Q 003385 339 LPFVLSFKFGKTYDS--SRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (824)
Q Consensus 339 l~~l~~L~L~~n~~s--~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (824)
.+.|+.|+|++|.++ .+|+.+..+..|+.|+++.|.+.. . .....++
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~-------------------~------------~~~~~l~ 71 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-------------------V------------SNLPKLP 71 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCC-------------------C------------SSCCCCS
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCC-------------------h------------hhhccCC
Confidence 467899999999999 999999999999999999997763 0 0113467
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCC--CCCCCCCCcceEeecccccCCCCC---ccccCCCccce
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI--PDFSGCPDLRIIHLEDNQLTGPLP---SSLMNLPNLRE 491 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~--p~~~~l~~L~~L~L~~N~l~g~lP---~~l~~l~~L~~ 491 (824)
+|+.|+|++|++++.+|..+.++++|+.|+|++|+|++.+ +.+..+++|+.|+|++|+|++..+ ..+..+++|+.
T Consensus 72 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~ 151 (168)
T 2ell_A 72 KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTY 151 (168)
T ss_dssp SCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCE
T ss_pred CCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcE
Confidence 9999999999999779999999999999999999999976 569999999999999999995444 48999999999
Q ss_pred eeecccccccccccc
Q 003385 492 LYVQNNMLSGTVPSS 506 (824)
Q Consensus 492 L~l~~N~l~g~ip~~ 506 (824)
|++++|.+. .+|.+
T Consensus 152 L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 152 LDGYDREDQ-EAPDS 165 (168)
T ss_dssp ETTEETTSC-BCCSS
T ss_pred ecCCCCChh-hcccc
Confidence 999999999 77764
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.52 E-value=3.2e-14 Score=150.81 Aligned_cols=138 Identities=20% Similarity=0.159 Sum_probs=119.1
Q ss_pred cccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCC
Q 003385 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (824)
.+++|+.|+|+.|.++.+|+. +..++.|+.|+++.|.+.. ..+. ....++
T Consensus 83 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-------------------~~~~----------~~~~l~ 133 (272)
T 3rfs_A 83 ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS-------------------LPDG----------VFDKLT 133 (272)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCC-------------------CCTT----------TTTTCT
T ss_pred CCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCc-------------------cCHH----------HhccCC
Confidence 467899999999999999998 7999999999999997663 1110 013467
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeec
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~ 495 (824)
+|+.|+|++|++++..|..++++++|+.|+|++|++++.++. +.++++|+.|+|++|+|++..|..++.+++|+.|+|+
T Consensus 134 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 213 (272)
T 3rfs_A 134 NLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLH 213 (272)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEcc
Confidence 899999999999976667789999999999999999998887 7889999999999999998778889999999999999
Q ss_pred ccccccccc
Q 003385 496 NNMLSGTVP 504 (824)
Q Consensus 496 ~N~l~g~ip 504 (824)
+|++.+..|
T Consensus 214 ~N~~~~~~~ 222 (272)
T 3rfs_A 214 DNPWDCTCP 222 (272)
T ss_dssp SSCBCCCTT
T ss_pred CCCccccCc
Confidence 999997766
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=4.6e-15 Score=157.38 Aligned_cols=180 Identities=13% Similarity=0.111 Sum_probs=126.9
Q ss_pred ccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEc-CCCCCC
Q 003385 339 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQP 416 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c-~~~~~~ 416 (824)
++.|+.|+|+.|.++.+++. +..+..|+.|+++.|.+.......+..+..+.......+.- ..+.. ....++
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l------~~~~~~~~~~l~ 124 (276)
T 2z62_A 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL------ASLENFPIGHLK 124 (276)
T ss_dssp CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCC------CCSTTCCCTTCT
T ss_pred ccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCc------cccCchhcccCC
Confidence 45677777777777777773 77777777777777776543322333333333222111110 00000 124567
Q ss_pred ceeEEEecCCCCCc-cCChhhhcccccccccccccccCCCCCC-CCCCCCcc----eEeecccccCCCCCccccCCCccc
Q 003385 417 SITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLR----IIHLEDNQLTGPLPSSLMNLPNLR 490 (824)
Q Consensus 417 ~L~~L~L~~n~l~g-~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~----~L~L~~N~l~g~lP~~l~~l~~L~ 490 (824)
+|++|+|++|++++ .+|..+++|++|+.|+|++|++++.++. +..+++|+ .|+|++|+|++ +|.......+|+
T Consensus 125 ~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~-~~~~~~~~~~L~ 203 (276)
T 2z62_A 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLK 203 (276)
T ss_dssp TCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCE-ECTTSSCSCCEE
T ss_pred CCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccc-cCccccCCCccc
Confidence 99999999999986 3799999999999999999999998774 66666666 89999999994 554455556899
Q ss_pred eeeeccccccccccccccc---cceeccccCCccccCCC
Q 003385 491 ELYVQNNMLSGTVPSSLLS---KNVVLNYAGNINLHEGG 526 (824)
Q Consensus 491 ~L~l~~N~l~g~ip~~l~~---~~~~l~~~~n~~lc~~~ 526 (824)
.|+|++|+++ .+|..++. .+..+.+++|+..|.++
T Consensus 204 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 204 ELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp EEECCSSCCS-CCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred EEECCCCcee-ecCHhHhcccccccEEEccCCcccccCC
Confidence 9999999999 77777654 34677889999998774
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.52 E-value=2.1e-14 Score=147.43 Aligned_cols=133 Identities=17% Similarity=0.185 Sum_probs=114.9
Q ss_pred cceeeecccccCCCCCCc-ccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 340 PFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP-~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+.|+.|+|+.|.++.+|+ .+..++.|+.|+++.|++... .|- ....+++|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~-------------------~~~----------~~~~l~~L 82 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISEL-------------------APD----------AFQGLRSL 82 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEE-------------------CTT----------TTTTCSSC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCc-------------------CHH----------HhhCCcCC
Confidence 468899999999999999 499999999999999987631 000 11346799
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N 497 (824)
+.|+|++|+|++..+..|.+|++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 83 ~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 162 (220)
T 2v9t_B 83 NSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162 (220)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCC
Confidence 9999999999944445578999999999999999999886 899999999999999999777778999999999999999
Q ss_pred cccc
Q 003385 498 MLSG 501 (824)
Q Consensus 498 ~l~g 501 (824)
++..
T Consensus 163 ~~~c 166 (220)
T 2v9t_B 163 PFIC 166 (220)
T ss_dssp CEEC
T ss_pred CcCC
Confidence 9974
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.52 E-value=3.7e-14 Score=143.82 Aligned_cols=136 Identities=19% Similarity=0.165 Sum_probs=100.5
Q ss_pred cceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+.|+.|+|+.|.++.+|+. +..++.|+.|+++.|.+.. ..+. ....+++|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-------------------~~~~----------~~~~l~~L 78 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-------------------LPNG----------VFNKLTSL 78 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-------------------CCTT----------TTTTCTTC
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCc-------------------cChh----------hcCCCCCc
Confidence 4677888888888888886 6788888888888886652 0000 01235678
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N 497 (824)
++|+|++|+|++..+..|.++++|+.|+|++|+|++.++. +.++++|+.|+|++|+|++..+..+..+++|+.|+|++|
T Consensus 79 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 158 (208)
T 2o6s_A 79 TYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158 (208)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSC
T ss_pred CEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCC
Confidence 8888888888855555677888888888888888887776 677888888888888888655556788888888888888
Q ss_pred ccccccc
Q 003385 498 MLSGTVP 504 (824)
Q Consensus 498 ~l~g~ip 504 (824)
++.+..|
T Consensus 159 ~~~~~~~ 165 (208)
T 2o6s_A 159 PWDCTCP 165 (208)
T ss_dssp CBCCCTT
T ss_pred CeecCCC
Confidence 7775544
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.52 E-value=3.7e-14 Score=146.51 Aligned_cols=136 Identities=18% Similarity=0.133 Sum_probs=116.9
Q ss_pred cceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
++|+.|+|+.|.++.++|. +..++.|+.|+++.|.+.. -.+. ....+++|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~-------------------i~~~----------~~~~l~~L 90 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-------------------LPVG----------VFDSLTQL 90 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-------------------CCTT----------TTTTCTTC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCC-------------------cChh----------hcccCCCc
Confidence 6789999999999999765 8999999999999997753 1110 01346799
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~ 498 (824)
+.|+|++|+|++..+..|..|++|+.|+|++|+|+.++..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 91 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 170 (229)
T 3e6j_A 91 TVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170 (229)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred CEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCC
Confidence 99999999999666667899999999999999999887789999999999999999996666789999999999999999
Q ss_pred cccccc
Q 003385 499 LSGTVP 504 (824)
Q Consensus 499 l~g~ip 504 (824)
+.+..+
T Consensus 171 ~~c~c~ 176 (229)
T 3e6j_A 171 WDCECR 176 (229)
T ss_dssp BCTTBG
T ss_pred ccCCcc
Confidence 996554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.52 E-value=8.7e-15 Score=161.84 Aligned_cols=155 Identities=20% Similarity=0.171 Sum_probs=126.2
Q ss_pred ceeeecccccCCCCCCcc-cc-hhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 341 FVLSFKFGKTYDSSRGPL-LN-AMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 341 ~l~~L~L~~n~~s~LPP~-i~-~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
.++.|+|+.|.++.+|+. +. .+..|+.|+++.|.+... .+- ....+++|
T Consensus 40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i-------------------~~~----------~~~~l~~L 90 (361)
T 2xot_A 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFI-------------------SSE----------AFVPVPNL 90 (361)
T ss_dssp TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEE-------------------CTT----------TTTTCTTC
T ss_pred CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCcc-------------------Chh----------hccCCCCC
Confidence 467899999999999998 44 899999999999987631 000 12346799
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccc----cCCCccceee
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSL----MNLPNLRELY 493 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l----~~l~~L~~L~ 493 (824)
+.|+|++|+|++..+..|.+|++|+.|+|++|+|+++.|. |.++++|+.|+|++|+|+ .+|..+ ..+++|+.|+
T Consensus 91 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~~L~ 169 (361)
T 2xot_A 91 RYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLD 169 (361)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTCCEEE
T ss_pred CEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCCEEE
Confidence 9999999999977677899999999999999999998875 999999999999999999 566554 6799999999
Q ss_pred eccccccccccccccccc-----eeccccCCccccCCC
Q 003385 494 VQNNMLSGTVPSSLLSKN-----VVLNYAGNINLHEGG 526 (824)
Q Consensus 494 l~~N~l~g~ip~~l~~~~-----~~l~~~~n~~lc~~~ 526 (824)
|++|+|+ .+|...+..+ ..+.+.+|+..|.+.
T Consensus 170 L~~N~l~-~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 170 LSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp CCSSCCC-CCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred CCCCCCC-ccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 9999999 7776554433 346789999999763
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.50 E-value=4e-14 Score=168.40 Aligned_cols=183 Identities=16% Similarity=0.120 Sum_probs=128.8
Q ss_pred cceeeecccccCCCCCCcc-cc-------hhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcC
Q 003385 340 PFVLSFKFGKTYDSSRGPL-LN-------AMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCN 411 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~-i~-------~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~ 411 (824)
++|+.|+|+.|.++...|. |. .+..|+.|+++.|.+.......++.+..+.....+++.-. ..+-......
T Consensus 402 ~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~ 480 (636)
T 4eco_A 402 SVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDE 480 (636)
T ss_dssp SCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEET
T ss_pred CccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccc
Confidence 3556666666666554333 44 4556666666666655332222333333333222111111 1111111100
Q ss_pred ---CCCCCceeEEEecCCCCCccCChhhh--cccccccccccccccCCCCCCCCCCCCcceEee------cccccCCCCC
Q 003385 412 ---SDPQPSITVIHLSSKNLTGNIPSDLT--KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHL------EDNQLTGPLP 480 (824)
Q Consensus 412 ---~~~~~~L~~L~L~~n~l~g~lp~~i~--~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L------~~N~l~g~lP 480 (824)
..++++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|+++++.+.++++|+.|+| ++|++.+.+|
T Consensus 481 ~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p 559 (636)
T 4eco_A 481 NENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWP 559 (636)
T ss_dssp TEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCSSCCEEECCSCBCTTCCBCCCCCC
T ss_pred cccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCCcChhhhcCCCCCEEECCCCcccccCcccccCh
Confidence 122348999999999999 8999998 999999999999999996666999999999999 5688999999
Q ss_pred ccccCCCccceeeeccccccccccccccccceeccccCCccccCC
Q 003385 481 SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEG 525 (824)
Q Consensus 481 ~~l~~l~~L~~L~l~~N~l~g~ip~~l~~~~~~l~~~~n~~lc~~ 525 (824)
..++++++|+.|+|++|++ +.+|..+...+..+.+++|+..|.+
T Consensus 560 ~~l~~l~~L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 560 EGITLCPSLTQLQIGSNDI-RKVNEKITPNISVLDIKDNPNISID 603 (636)
T ss_dssp TTGGGCSSCCEEECCSSCC-CBCCSCCCTTCCEEECCSCTTCEEE
T ss_pred HHHhcCCCCCEEECCCCcC-CccCHhHhCcCCEEECcCCCCcccc
Confidence 9999999999999999999 5999999988889999999877744
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.49 E-value=2.3e-14 Score=144.25 Aligned_cols=149 Identities=16% Similarity=0.141 Sum_probs=117.5
Q ss_pred ccccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCC
Q 003385 337 LSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (824)
Q Consensus 337 ~~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (824)
..++.|+.|+|+.|.++.+| .+..++.|+.|+++.|.+.. . . ....++
T Consensus 41 ~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~~--------------~-------------~----~l~~l~ 88 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHATN--------------Y-------------N----PISGLS 88 (197)
T ss_dssp HHHHTCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCCSC--------------C-------------G----GGTTCT
T ss_pred hhcCCccEEeccCCCccChH-HHhcCCCCCEEEccCCCCCc--------------c-------------h----hhhcCC
Confidence 45678899999999999998 68999999999999885542 0 0 012356
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccc-cCCCCCccccCCCccceeee
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ-LTGPLPSSLMNLPNLRELYV 494 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~-l~g~lP~~l~~l~~L~~L~l 494 (824)
+|++|+|++|++++..|..|++|++|+.|+|++|++++..+. +.++++|+.|+|++|+ ++ .+| .++.+++|+.|++
T Consensus 89 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l 166 (197)
T 4ezg_A 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNI 166 (197)
T ss_dssp TCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEEC
T ss_pred CCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEEC
Confidence 899999999999987888899999999999999999886554 8889999999999998 55 676 6889999999999
Q ss_pred cccccccccc-ccccccceeccccCCc
Q 003385 495 QNNMLSGTVP-SSLLSKNVVLNYAGNI 520 (824)
Q Consensus 495 ~~N~l~g~ip-~~l~~~~~~l~~~~n~ 520 (824)
++|++++ ++ -.-+..+..+.+++|.
T Consensus 167 ~~n~i~~-~~~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 167 QFDGVHD-YRGIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp TTBCCCC-CTTGGGCSSCCEEEECBC-
T ss_pred CCCCCcC-hHHhccCCCCCEEEeeCcc
Confidence 9999984 54 2224445666777774
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=7.6e-14 Score=140.28 Aligned_cols=107 Identities=23% Similarity=0.289 Sum_probs=76.4
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeec
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~ 495 (824)
+|++|+|++|+|+ .+|..|.++++|+.|+|++|+|+++++. |.++++|+.|+|++|+|++..|..|+.+++|+.|+|+
T Consensus 32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~ 110 (193)
T 2wfh_A 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110 (193)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence 5677777777777 6777777777777777777777777664 7777777777777777776666677777777777777
Q ss_pred cccccccccccccc---cceeccccCCccccCC
Q 003385 496 NNMLSGTVPSSLLS---KNVVLNYAGNINLHEG 525 (824)
Q Consensus 496 ~N~l~g~ip~~l~~---~~~~l~~~~n~~lc~~ 525 (824)
+|+|+ .+|...+. .+..+.+.+|+..|.+
T Consensus 111 ~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 111 GNDIS-VVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp SSCCC-BCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CCCCC-eeChhhhhcCccccEEEeCCCCeecCC
Confidence 77777 66665443 3355666777777755
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.6e-13 Score=139.18 Aligned_cols=151 Identities=21% Similarity=0.165 Sum_probs=123.1
Q ss_pred eecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeEEEe
Q 003385 344 SFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHL 423 (824)
Q Consensus 344 ~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~L~L 423 (824)
.+++..+.++.+|..+. +.++.|+++.|.+.. ..+- ....+++|++|+|
T Consensus 11 ~v~c~~~~l~~~p~~~~--~~l~~L~l~~n~l~~-------------------~~~~----------~~~~l~~L~~L~l 59 (208)
T 2o6s_A 11 TVECYSQGRTSVPTGIP--AQTTYLDLETNSLKS-------------------LPNG----------VFDELTSLTQLYL 59 (208)
T ss_dssp EEECCSSCCSSCCSCCC--TTCSEEECCSSCCCC-------------------CCTT----------TTTTCTTCSEEEC
T ss_pred EEEecCCCccCCCCCCC--CCCcEEEcCCCccCc-------------------CChh----------hhcccccCcEEEC
Confidence 45668899999998764 589999999987663 0000 0134579999999
Q ss_pred cCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeecccccccc
Q 003385 424 SSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT 502 (824)
Q Consensus 424 ~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g~ 502 (824)
++|++++..+..|.++++|+.|+|++|+|++.++. +.++++|+.|+|++|+|++..+..++++++|+.|+|++|+++ .
T Consensus 60 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~ 138 (208)
T 2o6s_A 60 GGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-S 138 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-C
T ss_pred CCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc-e
Confidence 99999965566789999999999999999998887 789999999999999999766677999999999999999999 6
Q ss_pred ccccccc---cceeccccCCccccCCC
Q 003385 503 VPSSLLS---KNVVLNYAGNINLHEGG 526 (824)
Q Consensus 503 ip~~l~~---~~~~l~~~~n~~lc~~~ 526 (824)
+|...+. .+..+.+.+|+..|..+
T Consensus 139 ~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 139 VPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp CCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred eCHHHhccCCCccEEEecCCCeecCCC
Confidence 7766543 45677889998877654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=8e-14 Score=151.77 Aligned_cols=174 Identities=17% Similarity=0.211 Sum_probs=119.8
Q ss_pred cceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcH--HHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCC
Q 003385 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDG--VAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~--~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (824)
++|++|+|+.|.++.+++. +..+..|+.|+++.|.+.. .....+..+..+.......+. ...++ ..-.+
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~------l~~l~--~~~~~ 192 (330)
T 1xku_A 121 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN------ITTIP--QGLPP 192 (330)
T ss_dssp TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSC------CCSCC--SSCCT
T ss_pred ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCc------cccCC--ccccc
Confidence 3556666666666666554 5666666666666665532 111122222222222111100 00111 01126
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeec
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~ 495 (824)
+|++|+|++|++++..|..|.++++|+.|+|++|++++.++. +.++++|+.|+|++|+|+ .+|..+..+++|+.|+|+
T Consensus 193 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~ 271 (330)
T 1xku_A 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 271 (330)
T ss_dssp TCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECC
T ss_pred cCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECC
Confidence 899999999999988889999999999999999999998884 889999999999999999 899999999999999999
Q ss_pred cccccccccccccc---------cceeccccCCcccc
Q 003385 496 NNMLSGTVPSSLLS---------KNVVLNYAGNINLH 523 (824)
Q Consensus 496 ~N~l~g~ip~~l~~---------~~~~l~~~~n~~lc 523 (824)
+|+++ .+|...+. ....+.+.+|+..+
T Consensus 272 ~N~i~-~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~ 307 (330)
T 1xku_A 272 NNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307 (330)
T ss_dssp SSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred CCcCC-ccChhhcCCcccccccccccceEeecCcccc
Confidence 99999 67766552 22456677887543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.48 E-value=4.3e-14 Score=149.56 Aligned_cols=158 Identities=20% Similarity=0.172 Sum_probs=116.4
Q ss_pred ccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEc-CCCCCC
Q 003385 339 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQP 416 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c-~~~~~~ 416 (824)
+++|++|+|+.|.++.+|+. +..++.|+.|+++.|.+.......+..+..++.+..+++. ...+.- ....++
T Consensus 60 l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~------l~~~~~~~~~~l~ 133 (270)
T 2o6q_A 60 LTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQ------LKSLPPRVFDSLT 133 (270)
T ss_dssp CTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSC------CCCCCTTTTTTCT
T ss_pred CCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCc------cCeeCHHHhCcCc
Confidence 56677777788888777776 4677778888887776654322222333333333221111 111111 124578
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeec
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~ 495 (824)
+|+.|+|++|+|++..+..|..+++|+.|+|++|++++.++. |.++++|+.|+|++|+|++..+..+..+++|+.|+|+
T Consensus 134 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 213 (270)
T 2o6q_A 134 KLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213 (270)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEec
Confidence 999999999999965556689999999999999999999886 8999999999999999996666679999999999999
Q ss_pred ccccccc
Q 003385 496 NNMLSGT 502 (824)
Q Consensus 496 ~N~l~g~ 502 (824)
+|++...
T Consensus 214 ~N~~~c~ 220 (270)
T 2o6q_A 214 ENPWDCT 220 (270)
T ss_dssp SSCBCCS
T ss_pred CCCeeCC
Confidence 9999743
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.48 E-value=8.5e-15 Score=157.66 Aligned_cols=185 Identities=15% Similarity=0.082 Sum_probs=135.5
Q ss_pred cccceeeecccccCCCCCCc--ccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCC
Q 003385 338 SLPFVLSFKFGKTYDSSRGP--LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQ 415 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP--~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~ 415 (824)
.+++|+.|+|+.|.++.+|+ .+..++.|+.|+++.|.+.......+..+..+..+...++. - ....+.-....+
T Consensus 99 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l---~~~~~~~~~~~l 174 (306)
T 2z66_A 99 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS-F---QENFLPDIFTEL 174 (306)
T ss_dssp TCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCE-E---GGGEECSCCTTC
T ss_pred CCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCc-c---ccccchhHHhhC
Confidence 36788889999999998886 58888899999998887664332223333333333221110 0 000112223467
Q ss_pred CceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCC-ccceee
Q 003385 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLP-NLRELY 493 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~-~L~~L~ 493 (824)
++|+.|+|++|++++..|..|.++++|+.|+|++|++++.++. +.++++|+.|+|++|+|++..|..+..++ +|+.|+
T Consensus 175 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~ 254 (306)
T 2z66_A 175 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN 254 (306)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEE
T ss_pred cCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEE
Confidence 8999999999999988899999999999999999999998884 89999999999999999999999999995 999999
Q ss_pred ecccccccccccc----ccccceeccccCCccccCCC
Q 003385 494 VQNNMLSGTVPSS----LLSKNVVLNYAGNINLHEGG 526 (824)
Q Consensus 494 l~~N~l~g~ip~~----l~~~~~~l~~~~n~~lc~~~ 526 (824)
|++|++++..+.. .+.....+....+...|..+
T Consensus 255 L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p 291 (306)
T 2z66_A 255 LTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 291 (306)
T ss_dssp CTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEES
T ss_pred ccCCCeecccChHHHHHHHHhhhhhhccccccccCCc
Confidence 9999998654321 12222333445566677655
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.48 E-value=1e-14 Score=172.22 Aligned_cols=182 Identities=17% Similarity=0.151 Sum_probs=117.3
Q ss_pred cccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCC------C-----------
Q 003385 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGD------P----------- 399 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~d------p----------- 399 (824)
.+++|+.|+|+.|.++.+||. +..+..|+.|+++.|.+....+..+..+.. .....+. |
T Consensus 145 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~---L~l~~n~l~~l~~~~~L~~L~ls~n 221 (597)
T 3oja_B 145 NTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFH---ANVSYNLLSTLAIPIAVEELDASHN 221 (597)
T ss_dssp TCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSE---EECCSSCCSEEECCTTCSEEECCSS
T ss_pred cCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhh---hhcccCccccccCCchhheeeccCC
Confidence 466778888888888888775 778888888888877765433222222210 0000000 0
Q ss_pred -------CCCCCCCeeEc---------CCCCCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCC
Q 003385 400 -------CLPVPWSWLQC---------NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCP 463 (824)
Q Consensus 400 -------c~~~~~~~~~c---------~~~~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~ 463 (824)
..+.....+.. ....+++|+.|+|++|.+++..|..|++|++|+.|+|++|+|+++++.+..++
T Consensus 222 ~l~~~~~~~~~~L~~L~L~~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~ 301 (597)
T 3oja_B 222 SINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIP 301 (597)
T ss_dssp CCCEEECSCCSCCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCT
T ss_pred cccccccccCCCCCEEECCCCCCCCChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCC
Confidence 00000001100 01235677777888888877777778888888888888888877666667777
Q ss_pred CcceEeecccccCCCCCccccCCCccceeeeccccccccccccccccceeccccCCccccC
Q 003385 464 DLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524 (824)
Q Consensus 464 ~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g~ip~~l~~~~~~l~~~~n~~lc~ 524 (824)
+|+.|+|++|+|+ .+|..++.+++|+.|+|++|+++ .+|...+..+..+.+++|+..|.
T Consensus 302 ~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 302 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp TCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCC-CCCCCTTCCCSEEECCSSCEEHH
T ss_pred CCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCC-CcChhhcCCCCEEEeeCCCCCCh
Confidence 8888888888887 67777777888888888888887 56666666667777777776664
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.5e-14 Score=161.30 Aligned_cols=181 Identities=17% Similarity=0.150 Sum_probs=110.4
Q ss_pred cccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCC---CCCCCCCeeEc---
Q 003385 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDP---CLPVPWSWLQC--- 410 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dp---c~~~~~~~~~c--- 410 (824)
.+++|++|+|+.|.++.++|. +..++.|+.|+++.|.+....+..+.++. ......+.. ..+.....+..
T Consensus 139 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~---~L~l~~n~l~~~~~~~~L~~L~l~~n 215 (390)
T 3o6n_A 139 NTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLF---HANVSYNLLSTLAIPIAVEELDASHN 215 (390)
T ss_dssp TCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCS---EEECCSSCCSEEECCSSCSEEECCSS
T ss_pred CCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccc---eeecccccccccCCCCcceEEECCCC
Confidence 356788888888888888776 88888888888888876654333332221 100000000 00000000000
Q ss_pred ---------------------------CCCCCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCC
Q 003385 411 ---------------------------NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCP 463 (824)
Q Consensus 411 ---------------------------~~~~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~ 463 (824)
....+++|++|+|++|++++..|..|.++++|+.|+|++|++++.+..+..++
T Consensus 216 ~l~~~~~~~~~~L~~L~l~~n~l~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~ 295 (390)
T 3o6n_A 216 SINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIP 295 (390)
T ss_dssp CCCEEECCCCSSCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCT
T ss_pred eeeeccccccccccEEECCCCCCcccHHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCC
Confidence 01234566777777777776666677777777777777777776655566677
Q ss_pred CcceEeecccccCCCCCccccCCCccceeeeccccccccccccccccceeccccCCcccc
Q 003385 464 DLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523 (824)
Q Consensus 464 ~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g~ip~~l~~~~~~l~~~~n~~lc 523 (824)
+|+.|+|++|+|+ .+|..++.+++|+.|+|++|+++ .+|...+..+..+.+++|+..|
T Consensus 296 ~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 296 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp TCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCC-CCCCCTTCCCSEEECCSSCEEH
T ss_pred CCCEEECCCCcce-ecCccccccCcCCEEECCCCccc-eeCchhhccCCEEEcCCCCccc
Confidence 7777777777776 56666667777777777777776 5565555556666677776555
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=3.2e-15 Score=164.52 Aligned_cols=181 Identities=13% Similarity=0.092 Sum_probs=131.0
Q ss_pred ccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHH-HHHHHhcCCCCcccCCCCCCCCCCCCeeE-cCCCCC
Q 003385 339 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAI-VSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQ 415 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l-~~lk~~~~~~~w~~~~~dpc~~~~~~~~~-c~~~~~ 415 (824)
+++|++|+|+.|.++.+|+. +..++.|+.|+++.|++..... ..+..+..++.+...+++. ...+. .....+
T Consensus 99 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~-----~~~~~~~~~~~l 173 (353)
T 2z80_A 99 LGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT-----FTKIQRKDFAGL 173 (353)
T ss_dssp CTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSS-----CCEECTTTTTTC
T ss_pred CCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcc-----ccccCHHHccCC
Confidence 56788888888888888887 7888888888888887653211 1122222222221111100 11111 123456
Q ss_pred CceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCC----------------
Q 003385 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGP---------------- 478 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~---------------- 478 (824)
++|++|+|++|++++..|..+.++++|+.|+|++|+++..++. +..+++|+.|+|++|++++.
T Consensus 174 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~ 253 (353)
T 2z80_A 174 TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKK 253 (353)
T ss_dssp CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCE
T ss_pred CCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhc
Confidence 7899999999999988899999999999999999998776665 45689999999999999864
Q ss_pred ---------------CCccccCCCccceeeeccccccccccccccc---cceeccccCCccccCC
Q 003385 479 ---------------LPSSLMNLPNLRELYVQNNMLSGTVPSSLLS---KNVVLNYAGNINLHEG 525 (824)
Q Consensus 479 ---------------lP~~l~~l~~L~~L~l~~N~l~g~ip~~l~~---~~~~l~~~~n~~lc~~ 525 (824)
+|+.++++++|+.|+|++|+++ .+|..++. .+..+.+++|+..|..
T Consensus 254 l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 254 FTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp EEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred cccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 3456788999999999999999 89988754 3467788999988865
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=9.1e-14 Score=147.32 Aligned_cols=138 Identities=14% Similarity=0.148 Sum_probs=115.4
Q ss_pred cceeeecccccCCCCCCc-ccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 340 PFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP-~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+.|+.|+|+.|.++.+|+ .+..++.|+.|+++.|.+... .+- ....+++|
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-------------------~~~----------~~~~l~~L 78 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI-------------------EDG----------AYQSLSHL 78 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEE-------------------CTT----------TTTTCTTC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCcc-------------------CHH----------HccCCcCC
Confidence 368899999999999999 599999999999999976531 000 01345689
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCC-CCCCCCCcceEeecccccCC-CCCccccCCCccceeeecc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQN 496 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~g-~lP~~l~~l~~L~~L~l~~ 496 (824)
+.|+|++|++++..|..|.+|++|+.|+|++|++++.++ .+.++++|+.|+|++|++++ .+|..++++++|+.|+|++
T Consensus 79 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~ 158 (276)
T 2z62_A 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158 (276)
T ss_dssp CEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCS
T ss_pred CEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCC
Confidence 999999999997777889999999999999999999888 48899999999999999986 3689999999999999999
Q ss_pred ccccccccccc
Q 003385 497 NMLSGTVPSSL 507 (824)
Q Consensus 497 N~l~g~ip~~l 507 (824)
|+++ .+|...
T Consensus 159 N~l~-~~~~~~ 168 (276)
T 2z62_A 159 NKIQ-SIYCTD 168 (276)
T ss_dssp SCCC-EECGGG
T ss_pred CCCC-cCCHHH
Confidence 9999 555443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.8e-14 Score=165.10 Aligned_cols=181 Identities=21% Similarity=0.119 Sum_probs=132.8
Q ss_pred ccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCc
Q 003385 339 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (824)
+++|+.|+|+.|.++.+|+. +..++.|+.|+++.|.+.......+..+..+.....++. +. ...+.-......+
T Consensus 151 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~-~~----~~~~~~~~~~~~~ 225 (477)
T 2id5_A 151 LNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW-PY----LDTMTPNCLYGLN 225 (477)
T ss_dssp CTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECC-TT----CCEECTTTTTTCC
T ss_pred CCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCC-cc----ccccCcccccCcc
Confidence 56777788888888888775 777778888888777665422212222222222211100 00 0111111122348
Q ss_pred eeEEEecCCCCCccCC-hhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeec
Q 003385 418 ITVIHLSSKNLTGNIP-SDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (824)
Q Consensus 418 L~~L~L~~n~l~g~lp-~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~ 495 (824)
|+.|+|++|+|+ .+| ..+.++++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus 226 L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 304 (477)
T 2id5_A 226 LTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVS 304 (477)
T ss_dssp CSEEEEESSCCC-SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECC
T ss_pred ccEEECcCCccc-ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECC
Confidence 999999999999 555 6899999999999999999998886 8999999999999999998889999999999999999
Q ss_pred cccccccccccccc---cceeccccCCccccCCC
Q 003385 496 NNMLSGTVPSSLLS---KNVVLNYAGNINLHEGG 526 (824)
Q Consensus 496 ~N~l~g~ip~~l~~---~~~~l~~~~n~~lc~~~ 526 (824)
+|+|+ .+|...+. .+..+.+++|+..|.+.
T Consensus 305 ~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~c~c~ 337 (477)
T 2id5_A 305 GNQLT-TLEESVFHSVGNLETLILDSNPLACDCR 337 (477)
T ss_dssp SSCCS-CCCGGGBSCGGGCCEEECCSSCEECSGG
T ss_pred CCcCc-eeCHhHcCCCcccCEEEccCCCccCccc
Confidence 99999 67776654 34678889999988763
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.45 E-value=2e-14 Score=155.57 Aligned_cols=105 Identities=25% Similarity=0.253 Sum_probs=59.3
Q ss_pred CCCceeEEEecCCCCCcc--CChhh--hcccccccccccccccCCCCC---C-CCCCCCcceEeecccccCCCCC-cccc
Q 003385 414 PQPSITVIHLSSKNLTGN--IPSDL--TKLSSLVELWLDGNSLTGPIP---D-FSGCPDLRIIHLEDNQLTGPLP-SSLM 484 (824)
Q Consensus 414 ~~~~L~~L~L~~n~l~g~--lp~~i--~~L~~L~~L~L~~N~l~~~~p---~-~~~l~~L~~L~L~~N~l~g~lP-~~l~ 484 (824)
.+++|++|+|++|++.|. +|..+ +++++|+.|+|++|+|++.+. . +.++++|+.|+|++|+|++.+| ..+.
T Consensus 171 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 250 (312)
T 1wwl_A 171 VFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250 (312)
T ss_dssp CCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCC
T ss_pred cCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhh
Confidence 345666666666666544 23333 566666666666666663221 2 3455666666666666665554 3445
Q ss_pred CCCccceeeeccccccccccccccccceeccccCC
Q 003385 485 NLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519 (824)
Q Consensus 485 ~l~~L~~L~l~~N~l~g~ip~~l~~~~~~l~~~~n 519 (824)
.+++|+.|+|++|+|+ .+|..+...+..+.+++|
T Consensus 251 ~l~~L~~L~Ls~N~l~-~ip~~~~~~L~~L~Ls~N 284 (312)
T 1wwl_A 251 WPSQLNSLNLSFTGLK-QVPKGLPAKLSVLDLSYN 284 (312)
T ss_dssp CCTTCCEEECTTSCCS-SCCSSCCSEEEEEECCSS
T ss_pred hcCCCCEEECCCCccC-hhhhhccCCceEEECCCC
Confidence 5566666666666666 666655544455555555
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.45 E-value=6.6e-14 Score=151.33 Aligned_cols=170 Identities=18% Similarity=0.265 Sum_probs=121.3
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+++|+.|+|+.|.++.+|+ +..++.|+.|+++.|.+... ..+..+..++.+..+++. ...+.. ...+++|
T Consensus 62 l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~------l~~~~~-l~~l~~L 131 (308)
T 1h6u_A 62 LNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQ------ITDVTP-LAGLSNL 131 (308)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSC------CCCCGG-GTTCTTC
T ss_pred cCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCC------CCCchh-hcCCCCC
Confidence 6788999999999999998 89999999999998887652 233333334433222111 111111 2456788
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~ 498 (824)
+.|+|++|++++ +|. ++++++|+.|+|++|++++.++ +.++++|+.|+|++|+|++ +|. +..+++|+.|+|++|+
T Consensus 132 ~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~~N~ 206 (308)
T 1h6u_A 132 QVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQ 206 (308)
T ss_dssp CEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSC
T ss_pred CEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCc-Chh-hcCCCCCCEEEccCCc
Confidence 999999998884 444 8888899999999998888766 8888899999999999884 444 8888889999999999
Q ss_pred ccccccccccccceeccccCCcccc
Q 003385 499 LSGTVPSSLLSKNVVLNYAGNINLH 523 (824)
Q Consensus 499 l~g~ip~~l~~~~~~l~~~~n~~lc 523 (824)
+++..|-.-+..+..+.+++|+..+
T Consensus 207 l~~~~~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 207 ISDVSPLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCBCGGGTTCTTCCEEEEEEEEEEC
T ss_pred cCccccccCCCCCCEEEccCCeeec
Confidence 8854442333445666777776443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=3.8e-14 Score=174.17 Aligned_cols=108 Identities=29% Similarity=0.292 Sum_probs=83.0
Q ss_pred CCceeEEEecCCCCC-----ccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCc
Q 003385 415 QPSITVIHLSSKNLT-----GNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPN 488 (824)
Q Consensus 415 ~~~L~~L~L~~n~l~-----g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~ 488 (824)
+++|+.|+|++|.++ +..|..|.+|++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..+. ++
T Consensus 450 ~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~ 527 (844)
T 3j0a_A 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--AN 527 (844)
T ss_dssp CTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SC
T ss_pred CCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--cc
Confidence 345555666666554 33445678889999999999999998886 78899999999999999966555555 78
Q ss_pred cceeeeccccccccccccccccceeccccCCccccCC
Q 003385 489 LRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEG 525 (824)
Q Consensus 489 L~~L~l~~N~l~g~ip~~l~~~~~~l~~~~n~~lc~~ 525 (824)
|+.|+|++|+|+|..|. .+..+..+.+.+|+..|.+
T Consensus 528 L~~L~Ls~N~l~~~~~~-~~~~L~~l~l~~Np~~C~c 563 (844)
T 3j0a_A 528 LEILDISRNQLLAPNPD-VFVSLSVLDITHNKFICEC 563 (844)
T ss_dssp CCEEEEEEECCCCCCSC-CCSSCCEEEEEEECCCCSS
T ss_pred ccEEECCCCcCCCCChh-HhCCcCEEEecCCCccccc
Confidence 99999999999965554 4556777888899888743
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.4e-13 Score=167.96 Aligned_cols=107 Identities=21% Similarity=0.288 Sum_probs=97.0
Q ss_pred CCceeEEEecCCCCCccCChhhh--cccccccccccccccCCCCCCCCCCCCcceEeecc------cccCCCCCccccCC
Q 003385 415 QPSITVIHLSSKNLTGNIPSDLT--KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED------NQLTGPLPSSLMNL 486 (824)
Q Consensus 415 ~~~L~~L~L~~n~l~g~lp~~i~--~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~------N~l~g~lP~~l~~l 486 (824)
+++|+.|+|++|+|+ .+|..+. .|++|+.|+|++|+|+++++.+.++++|+.|+|++ |++.+.+|..|++|
T Consensus 727 l~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L 805 (876)
T 4ecn_A 727 TYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTC 805 (876)
T ss_dssp GGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGC
T ss_pred cCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCCCcccccccccChHHHhcC
Confidence 348999999999999 8999998 99999999999999999766799999999999976 88999999999999
Q ss_pred CccceeeeccccccccccccccccceeccccCCcccc
Q 003385 487 PNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523 (824)
Q Consensus 487 ~~L~~L~l~~N~l~g~ip~~l~~~~~~l~~~~n~~lc 523 (824)
++|+.|+|++|++ +.+|..+...+..+.+++|+...
T Consensus 806 ~~L~~L~Ls~N~L-~~Ip~~l~~~L~~LdLs~N~l~~ 841 (876)
T 4ecn_A 806 PSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNIS 841 (876)
T ss_dssp SSCCEEECCSSCC-CBCCSCCCSSSCEEECCSCTTCE
T ss_pred CCCCEEECCCCCC-CccCHhhcCCCCEEECCCCCCCc
Confidence 9999999999999 59999998888888999996443
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=1.1e-13 Score=163.31 Aligned_cols=138 Identities=15% Similarity=0.159 Sum_probs=118.5
Q ss_pred ceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCcee
Q 003385 341 FVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 419 (824)
Q Consensus 341 ~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~ 419 (824)
.++.|+|+.|.++.+||. |.+++.|+.|+|+.|.+..+ ++- ...++++|+
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i-------------------~~~----------~f~~L~~L~ 103 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI-------------------EDG----------AYQSLSHLS 103 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEE-------------------CTT----------TTTTCTTCC
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCc-------------------Chh----------HhcCCCCCC
Confidence 678999999999999986 99999999999999987631 100 113567999
Q ss_pred EEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCC-CCCccccCCCccceeeeccc
Q 003385 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 420 ~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g-~lP~~l~~l~~L~~L~l~~N 497 (824)
+|+|++|+|++..|..|.+|++|+.|+|++|+|+++++. |++|++|+.|+|++|+|++ .+|..++.|++|+.|+|++|
T Consensus 104 ~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N 183 (635)
T 4g8a_A 104 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 183 (635)
T ss_dssp EEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSS
T ss_pred EEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCc
Confidence 999999999965567899999999999999999999886 9999999999999999985 47889999999999999999
Q ss_pred cccccccccc
Q 003385 498 MLSGTVPSSL 507 (824)
Q Consensus 498 ~l~g~ip~~l 507 (824)
++++..|..+
T Consensus 184 ~l~~~~~~~l 193 (635)
T 4g8a_A 184 KIQSIYCTDL 193 (635)
T ss_dssp CCCEECGGGG
T ss_pred cccccccccc
Confidence 9995444443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.44 E-value=8.7e-14 Score=151.68 Aligned_cols=172 Identities=16% Similarity=0.174 Sum_probs=130.2
Q ss_pred cceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcH--HHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCC
Q 003385 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDG--VAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~--~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (824)
++|++|+|+.|.++.+|+. +..++.|+.|+++.|.+.. .....+..+ .+.....+.+. ...++. .-.+
T Consensus 123 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~------l~~l~~--~~~~ 193 (332)
T 2ft3_A 123 SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAK------LTGIPK--DLPE 193 (332)
T ss_dssp TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSB------CSSCCS--SSCS
T ss_pred ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCC------CCccCc--cccC
Confidence 5788999999999999986 8999999999999998753 111111111 22222111100 111111 1125
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeec
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~ 495 (824)
+|++|+|++|++++..|..|.++++|+.|+|++|++++.++. +..+++|+.|+|++|+|+ .+|..++.+++|+.|+++
T Consensus 194 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~ 272 (332)
T 2ft3_A 194 TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH 272 (332)
T ss_dssp SCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECC
T ss_pred CCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECC
Confidence 899999999999977778999999999999999999999885 899999999999999999 899999999999999999
Q ss_pred ccccccccccccccc---------ceeccccCCccc
Q 003385 496 NNMLSGTVPSSLLSK---------NVVLNYAGNINL 522 (824)
Q Consensus 496 ~N~l~g~ip~~l~~~---------~~~l~~~~n~~l 522 (824)
+|+++ .+|...+.. ...+.+.+|+..
T Consensus 273 ~N~l~-~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~ 307 (332)
T 2ft3_A 273 TNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307 (332)
T ss_dssp SSCCC-BCCTTSSSCSSCCSSSCCBSEEECCSSSSC
T ss_pred CCCCC-ccChhHccccccccccccccceEeecCccc
Confidence 99999 666654432 245677888755
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.7e-13 Score=152.82 Aligned_cols=157 Identities=18% Similarity=0.218 Sum_probs=132.0
Q ss_pred ceeccccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCC
Q 003385 334 YTNLSLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNS 412 (824)
Q Consensus 334 ~t~~~l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~ 412 (824)
...+.+++++.|++.+|.++.+|+. +..++.|+.|+++.|.+... .+- ..
T Consensus 39 ~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~-------------------~~~----------~~ 89 (390)
T 3o6n_A 39 FEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEI-------------------DTY----------AF 89 (390)
T ss_dssp CSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEE-------------------CTT----------TT
T ss_pred ccccccCCceEEEecCCchhhCChhHhcccccCcEEECCCCccccc-------------------Chh----------hc
Confidence 3467788999999999999999998 68999999999999876631 000 11
Q ss_pred CCCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccce
Q 003385 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 491 (824)
Q Consensus 413 ~~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~ 491 (824)
..+++|++|+|++|++++..|..|+++++|+.|+|++|+++.+++. |.++++|+.|+|++|++++..|..++++++|+.
T Consensus 90 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 169 (390)
T 3o6n_A 90 AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQN 169 (390)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCE
T ss_pred cCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCE
Confidence 3467899999999999977788899999999999999999988887 688999999999999999877888999999999
Q ss_pred eeeccccccccccccccccceeccccCCc
Q 003385 492 LYVQNNMLSGTVPSSLLSKNVVLNYAGNI 520 (824)
Q Consensus 492 L~l~~N~l~g~ip~~l~~~~~~l~~~~n~ 520 (824)
|++++|+++ .++...+..+..+.+++|.
T Consensus 170 L~l~~n~l~-~~~~~~l~~L~~L~l~~n~ 197 (390)
T 3o6n_A 170 LQLSSNRLT-HVDLSLIPSLFHANVSYNL 197 (390)
T ss_dssp EECCSSCCS-BCCGGGCTTCSEEECCSSC
T ss_pred EECCCCcCC-ccccccccccceeeccccc
Confidence 999999999 6676667777777776663
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.43 E-value=4.2e-13 Score=132.41 Aligned_cols=131 Identities=18% Similarity=0.199 Sum_probs=101.6
Q ss_pred eeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeEEE
Q 003385 343 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 422 (824)
Q Consensus 343 ~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~L~ 422 (824)
+.+++..|.++.+|..+. +.++.|+++.|.+.. ..+. ....+++|++|+
T Consensus 10 ~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~-------------------~~~~----------~~~~l~~L~~L~ 58 (177)
T 2o6r_A 10 TEIRCNSKGLTSVPTGIP--SSATRLELESNKLQS-------------------LPHG----------VFDKLTQLTKLS 58 (177)
T ss_dssp TEEECCSSCCSSCCTTCC--TTCSEEECCSSCCCC-------------------CCTT----------TTTTCTTCSEEE
T ss_pred CEEEecCCCCccCCCCCC--CCCcEEEeCCCcccE-------------------eCHH----------HhcCcccccEEE
Confidence 456778888999987654 678888888886653 0000 012456899999
Q ss_pred ecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccccccc
Q 003385 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 501 (824)
Q Consensus 423 L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g 501 (824)
|++|+|++..+..+.++++|+.|+|++|+|++.++. +.++++|+.|+|++|+|++..+..+..+++|+.|+|++|++.+
T Consensus 59 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 59 LSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 999999855556678899999999999999988886 6889999999999999985555567889999999999999987
Q ss_pred ccc
Q 003385 502 TVP 504 (824)
Q Consensus 502 ~ip 504 (824)
..|
T Consensus 139 ~~~ 141 (177)
T 2o6r_A 139 SCP 141 (177)
T ss_dssp CHH
T ss_pred cCc
Confidence 665
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=2.8e-14 Score=167.06 Aligned_cols=175 Identities=21% Similarity=0.197 Sum_probs=100.0
Q ss_pred cccceeeecccccCCCCCCcccchhhhceeccCCCCC-------------Cc---HHHHHHHHHhcCCCCcccCCCCCC-
Q 003385 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGS-------------ID---GVAIVSVISLYSSADWAQEGGDPC- 400 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~-------------~~---~~~l~~lk~~~~~~~w~~~~~dpc- 400 (824)
.++.|+.|+|+.|.++.||+.|+.++.|+.|++++|. .. ...+..+.++..+.... .+..-
T Consensus 347 ~~~~L~~L~Ls~n~L~~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~--~n~~~~ 424 (567)
T 1dce_A 347 TDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMR--AAYLDD 424 (567)
T ss_dssp TTTTSSSCCCCHHHHHHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGG--HHHHHH
T ss_pred cCccceeccCChhhHHhhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchh--hcccch
Confidence 4667889999999999999999999999999997663 11 11222232221111000 00000
Q ss_pred CCC---CCCeeEcCCCCCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCC
Q 003385 401 LPV---PWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTG 477 (824)
Q Consensus 401 ~~~---~~~~~~c~~~~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g 477 (824)
.+. ....+.. -....|+.|+|++|+|+ .+|. |++|++|+.|+|++|+|+.+|+.+++|++|+.|+|++|+|++
T Consensus 425 L~~l~l~~n~i~~--l~~~~L~~L~Ls~n~l~-~lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~ 500 (567)
T 1dce_A 425 LRSKFLLENSVLK--MEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN 500 (567)
T ss_dssp HHHHHHHHHHHHH--HHHTTCSEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC
T ss_pred hhhhhhhcccccc--cCccCceEEEecCCCCC-CCcC-ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCC
Confidence 000 0000000 00124666667777666 3565 666666777777777666554456666667777777776663
Q ss_pred CCCccccCCCccceeeeccccccccc-ccccc--ccceeccccCCc
Q 003385 478 PLPSSLMNLPNLRELYVQNNMLSGTV-PSSLL--SKNVVLNYAGNI 520 (824)
Q Consensus 478 ~lP~~l~~l~~L~~L~l~~N~l~g~i-p~~l~--~~~~~l~~~~n~ 520 (824)
+| .+++|++|+.|+|++|+|++.. |..+. ..+..+.+++|+
T Consensus 501 -lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~ 544 (567)
T 1dce_A 501 -VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 544 (567)
T ss_dssp -CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred -Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCc
Confidence 55 6666666777777777666443 55543 233555556664
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.7e-13 Score=161.83 Aligned_cols=155 Identities=19% Similarity=0.204 Sum_probs=125.1
Q ss_pred eeccccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCC
Q 003385 335 TNLSLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSD 413 (824)
Q Consensus 335 t~~~l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~ 413 (824)
..+.+++++.|++..|.++.+|+. +..++.|+.|+++.|.+... .|- ...
T Consensus 46 ~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~-------------------~~~----------~~~ 96 (597)
T 3oja_B 46 EDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEI-------------------DTY----------AFA 96 (597)
T ss_dssp SSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEE-------------------CTT----------TTT
T ss_pred ccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCC-------------------ChH----------Hhc
Confidence 466788889999999999999998 68899999999998876630 100 113
Q ss_pred CCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCcccee
Q 003385 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 492 (824)
Q Consensus 414 ~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L 492 (824)
.+++|+.|+|++|.|++..|..|++|++|+.|+|++|+|+++++. |.++++|+.|+|++|+|++..|..|+++++|+.|
T Consensus 97 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 176 (597)
T 3oja_B 97 YAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL 176 (597)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEE
Confidence 456899999999999977777888999999999999999988887 6889999999999999998888889999999999
Q ss_pred eeccccccccccccccccceeccccCC
Q 003385 493 YVQNNMLSGTVPSSLLSKNVVLNYAGN 519 (824)
Q Consensus 493 ~l~~N~l~g~ip~~l~~~~~~l~~~~n 519 (824)
+|++|.++ .+|...+..+..+.+++|
T Consensus 177 ~L~~N~l~-~~~~~~l~~L~~L~l~~n 202 (597)
T 3oja_B 177 QLSSNRLT-HVDLSLIPSLFHANVSYN 202 (597)
T ss_dssp ECTTSCCS-BCCGGGCTTCSEEECCSS
T ss_pred ECcCCCCC-CcChhhhhhhhhhhcccC
Confidence 99999998 566666666666666655
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.42 E-value=7.6e-14 Score=133.64 Aligned_cols=127 Identities=17% Similarity=0.184 Sum_probs=109.5
Q ss_pred ccceeeecccccCCC--CCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCC
Q 003385 339 LPFVLSFKFGKTYDS--SRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (824)
Q Consensus 339 l~~l~~L~L~~n~~s--~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (824)
.++|+.|+|+.|.++ .+|+.+..++.|+.|+++.|.+... .....++
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-------------------------------~~~~~l~ 64 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-------------------------------ANLPKLN 64 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-------------------------------TTCCCCT
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-------------------------------hhhhcCC
Confidence 467899999999999 8999999999999999999977630 0113457
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCC--CCCCCCCCcceEeecccccCCCCC---ccccCCCccce
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI--PDFSGCPDLRIIHLEDNQLTGPLP---SSLMNLPNLRE 491 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~--p~~~~l~~L~~L~L~~N~l~g~lP---~~l~~l~~L~~ 491 (824)
+|+.|+|++|++++.+|..+.++++|+.|+|++|++++.+ +.+.++++|+.|+|++|++++..+ ..++.+++|+.
T Consensus 65 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~ 144 (149)
T 2je0_A 65 KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTY 144 (149)
T ss_dssp TCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCE
T ss_pred CCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCccc
Confidence 8999999999999779998999999999999999999964 568999999999999999996555 58999999999
Q ss_pred eeecc
Q 003385 492 LYVQN 496 (824)
Q Consensus 492 L~l~~ 496 (824)
|++++
T Consensus 145 L~l~d 149 (149)
T 2je0_A 145 LDGYD 149 (149)
T ss_dssp ETTBC
T ss_pred ccCCC
Confidence 99864
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.6e-13 Score=163.26 Aligned_cols=175 Identities=13% Similarity=0.100 Sum_probs=133.1
Q ss_pred cccceeeecccccCCC-CCCcccchhhhceeccCCCCC-CcH-HHHHHHHHh------cCCCCcccCCCCCCCCCCCCee
Q 003385 338 SLPFVLSFKFGKTYDS-SRGPLLNAMEINKYLERNDGS-IDG-VAIVSVISL------YSSADWAQEGGDPCLPVPWSWL 408 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s-~LPP~i~~le~l~~L~l~~n~-~~~-~~l~~lk~~------~~~~~w~~~~~dpc~~~~~~~~ 408 (824)
.+++|++|+|+.|.++ .+|+.|..++.|+.|+++.|+ +.. .....+..+ ..+..+....+. ...+
T Consensus 247 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~------l~~i 320 (636)
T 4eco_A 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN------LKTF 320 (636)
T ss_dssp GCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSC------CSSC
T ss_pred ccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCc------CCcc
Confidence 4788999999999855 577789999999999999998 876 555556554 445554332211 1112
Q ss_pred Ec--CCCCCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCC-cceEeecccccCCCCCccccC
Q 003385 409 QC--NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD-LRIIHLEDNQLTGPLPSSLMN 485 (824)
Q Consensus 409 ~c--~~~~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~-L~~L~L~~N~l~g~lP~~l~~ 485 (824)
+- ....+++|+.|+|++|+++|.+| .|+++++|+.|+|++|+++.+++.+.++++ |+.|+|++|+|+ .+|..++.
T Consensus 321 p~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~ 398 (636)
T 4eco_A 321 PVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDA 398 (636)
T ss_dssp CCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCT
T ss_pred CchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhh
Confidence 21 22456789999999999998999 899999999999999999966667888888 999999999998 88888877
Q ss_pred CC--ccceeeecccccccccccccc-------c--cceeccccCCc
Q 003385 486 LP--NLRELYVQNNMLSGTVPSSLL-------S--KNVVLNYAGNI 520 (824)
Q Consensus 486 l~--~L~~L~l~~N~l~g~ip~~l~-------~--~~~~l~~~~n~ 520 (824)
++ +|+.|++++|+++|.+|..+. . .+..+.+++|.
T Consensus 399 ~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~ 444 (636)
T 4eco_A 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQ 444 (636)
T ss_dssp TCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSC
T ss_pred cccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCc
Confidence 65 899999999999988877665 2 33556666663
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=6.7e-14 Score=165.17 Aligned_cols=181 Identities=17% Similarity=0.096 Sum_probs=114.7
Q ss_pred ccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHH-HHHHhcCCCCcccCCCCCCCCCCCCee-EcCCCCC
Q 003385 339 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIV-SVISLYSSADWAQEGGDPCLPVPWSWL-QCNSDPQ 415 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~-~lk~~~~~~~w~~~~~dpc~~~~~~~~-~c~~~~~ 415 (824)
+++|+.|+|+.|.++.++|. +..++.|+.|+++.|.+...... .+..+..+..+..+++. .... ......+
T Consensus 375 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~------l~~~~~~~~~~l 448 (606)
T 3t6q_A 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSL------LDISSEQLFDGL 448 (606)
T ss_dssp CTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCC------CBTTCTTTTTTC
T ss_pred CCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCc------cCCcCHHHHhCC
Confidence 44556666666666655443 55666666666666554421110 01111122222111000 0000 0012346
Q ss_pred CceeEEEecCCCCCcc---CChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccce
Q 003385 416 PSITVIHLSSKNLTGN---IPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 491 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~---lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~ 491 (824)
++|++|+|++|++++. .+..+..+++|+.|+|++|++++.+|. |.++++|+.|+|++|+|++..|+.++++++| .
T Consensus 449 ~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~ 527 (606)
T 3t6q_A 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-Y 527 (606)
T ss_dssp TTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-E
T ss_pred CCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-E
Confidence 7888888888888762 335688888888888888888888765 7888888888888888888888888888888 8
Q ss_pred eeeccccccccccccc--cccceeccccCCccccCCC
Q 003385 492 LYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGG 526 (824)
Q Consensus 492 L~l~~N~l~g~ip~~l--~~~~~~l~~~~n~~lc~~~ 526 (824)
|+|++|++++..|..+ +..+..+.+++|+..|.+.
T Consensus 528 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 528 LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp EECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred EECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 8888888885444433 2344677888999888664
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.7e-13 Score=149.83 Aligned_cols=147 Identities=19% Similarity=0.252 Sum_probs=123.1
Q ss_pred eeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeEEE
Q 003385 343 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 422 (824)
Q Consensus 343 ~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~L~ 422 (824)
..++++.+.++.+|..+.. .++.|+|+.|.+... ...+ . ...+++|+.|+
T Consensus 21 ~~l~c~~~~l~~iP~~~~~--~l~~L~Ls~N~l~~l----------~~~~---------------~---~~~l~~L~~L~ 70 (361)
T 2xot_A 21 NILSCSKQQLPNVPQSLPS--YTALLDLSHNNLSRL----------RAEW---------------T---PTRLTNLHSLL 70 (361)
T ss_dssp TEEECCSSCCSSCCSSCCT--TCSEEECCSSCCCEE----------CTTS---------------S---SSCCTTCCEEE
T ss_pred CEEEeCCCCcCccCccCCC--CCCEEECCCCCCCcc----------Chhh---------------h---hhcccccCEEE
Confidence 4678899999999987754 588999999987640 0011 0 01467999999
Q ss_pred ecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccccccc
Q 003385 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 501 (824)
Q Consensus 423 L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g 501 (824)
|++|+|++..|..|.+|++|+.|+|++|+|+++++. |.++++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|+
T Consensus 71 L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~- 149 (361)
T 2xot_A 71 LSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS- 149 (361)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-
T ss_pred CCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-
Confidence 999999977778899999999999999999999886 899999999999999999878899999999999999999999
Q ss_pred ccccccc------ccceeccccCCc
Q 003385 502 TVPSSLL------SKNVVLNYAGNI 520 (824)
Q Consensus 502 ~ip~~l~------~~~~~l~~~~n~ 520 (824)
.+|..++ ..+..+.+++|.
T Consensus 150 ~l~~~~~~~~~~l~~L~~L~L~~N~ 174 (361)
T 2xot_A 150 RFPVELIKDGNKLPKLMLLDLSSNK 174 (361)
T ss_dssp SCCGGGTC----CTTCCEEECCSSC
T ss_pred eeCHHHhcCcccCCcCCEEECCCCC
Confidence 7888775 344667777774
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.41 E-value=1.1e-13 Score=157.80 Aligned_cols=176 Identities=18% Similarity=0.143 Sum_probs=128.7
Q ss_pred cccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEc-CCCCC
Q 003385 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQ 415 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c-~~~~~ 415 (824)
.+++|+.|+|+.|.++.++|. +.++..|+.|+++.|.+.......+..+..+..+..+++. ...+.. ....+
T Consensus 97 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~------l~~~~~~~~~~l 170 (452)
T 3zyi_A 97 HLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNP------IESIPSYAFNRV 170 (452)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCC------CCEECTTTTTTC
T ss_pred CCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCC------cceeCHhHHhcC
Confidence 467899999999999999876 8999999999999998775333323333333333222111 122221 23457
Q ss_pred CceeEEEecCCCCCccCCh-hhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeee
Q 003385 416 PSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~-~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l 494 (824)
++|+.|+|++|+..+.+|. .|.+|++|+.|+|++|+|++. |.+..+++|+.|+|++|+|++..|..|.++++|+.|+|
T Consensus 171 ~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 249 (452)
T 3zyi_A 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWV 249 (452)
T ss_dssp TTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEEC
T ss_pred CcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-ccccccccccEEECcCCcCcccCcccccCccCCCEEEe
Confidence 8899999998443335554 688999999999999999876 67889999999999999999888899999999999999
Q ss_pred cccccccccccccc--ccceeccccCCc
Q 003385 495 QNNMLSGTVPSSLL--SKNVVLNYAGNI 520 (824)
Q Consensus 495 ~~N~l~g~ip~~l~--~~~~~l~~~~n~ 520 (824)
++|++++..|..+. ..+..+.+++|.
T Consensus 250 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 277 (452)
T 3zyi_A 250 MNSQVSLIERNAFDGLASLVELNLAHNN 277 (452)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCcCceECHHHhcCCCCCCEEECCCCc
Confidence 99999944444432 344667777774
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=1.6e-13 Score=160.34 Aligned_cols=113 Identities=21% Similarity=0.232 Sum_probs=97.8
Q ss_pred CCCCceeEEEecCCCCCccCChhhhcccccccccccccccC-CCCC-CCCCCCCcceEeecccccCCCCCccccCCCccc
Q 003385 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT-GPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 490 (824)
Q Consensus 413 ~~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~-~~~p-~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~ 490 (824)
..+++|+.|+|++|++++..|..+.++++|+.|+|++|+++ +.+| .+..+++|+.|+|++|++++..|..++++++|+
T Consensus 418 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 497 (570)
T 2z63_A 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497 (570)
T ss_dssp TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred hcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCC
Confidence 35679999999999999889999999999999999999998 4455 589999999999999999988899999999999
Q ss_pred eeeecccccccccccccc---ccceeccccCCccccCCC
Q 003385 491 ELYVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEGG 526 (824)
Q Consensus 491 ~L~l~~N~l~g~ip~~l~---~~~~~l~~~~n~~lc~~~ 526 (824)
.|+|++|++++ +|+..+ ..+..+.+.+|+..|.++
T Consensus 498 ~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 498 VLNMASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp EEECCSSCCSC-CCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred EEeCCCCcCCC-CCHHHhhcccCCcEEEecCCcccCCCc
Confidence 99999999995 554443 344678889999888765
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.40 E-value=3.5e-13 Score=144.40 Aligned_cols=143 Identities=24% Similarity=0.342 Sum_probs=98.6
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+++|+.|+|+.|.++.++| +..++.|+.|+++.|.+... ..+ ..+++|
T Consensus 67 l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~--~~l-----------------------------~~l~~L 114 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDL--SSL-----------------------------KDLKKL 114 (291)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCG--GGG-----------------------------TTCTTC
T ss_pred CCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCCC--hhh-----------------------------ccCCCC
Confidence 6788899999999999988 89999999999998876641 001 234567
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~ 498 (824)
+.|+|++|++++ + +.+..|++|+.|+|++|++++. +.+..+++|+.|+|++|+|++. +. ++.+++|+.|+|++|+
T Consensus 115 ~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~-~~-l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 115 KSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDI-VP-LAGLTKLQNLYLSKNH 189 (291)
T ss_dssp CEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCC-GG-GTTCTTCCEEECCSSC
T ss_pred CEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccc-hh-hcCCCccCEEECCCCc
Confidence 777777777773 3 3577777777777777777765 5567777777777777777743 33 7777777777777777
Q ss_pred ccccccccc--cccceeccccCCc
Q 003385 499 LSGTVPSSL--LSKNVVLNYAGNI 520 (824)
Q Consensus 499 l~g~ip~~l--~~~~~~l~~~~n~ 520 (824)
++ .+|. + +..+..+.+.+|+
T Consensus 190 i~-~l~~-l~~l~~L~~L~l~~n~ 211 (291)
T 1h6t_A 190 IS-DLRA-LAGLKNLDVLELFSQE 211 (291)
T ss_dssp CC-BCGG-GTTCTTCSEEEEEEEE
T ss_pred CC-CChh-hccCCCCCEEECcCCc
Confidence 77 4543 2 2233445555554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.40 E-value=4.8e-13 Score=134.19 Aligned_cols=111 Identities=25% Similarity=0.314 Sum_probs=97.2
Q ss_pred CceeEEEecCCCCCccCCh-hhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceee
Q 003385 416 PSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~-~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~ 493 (824)
.+|++|+|++|+|++..+. .|++|++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..|+++++|+.|+
T Consensus 29 ~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 108 (192)
T 1w8a_A 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEE
Confidence 4899999999999955554 499999999999999999999875 99999999999999999988888899999999999
Q ss_pred ecccccccccccccc--ccceeccccCCccccCCC
Q 003385 494 VQNNMLSGTVPSSLL--SKNVVLNYAGNINLHEGG 526 (824)
Q Consensus 494 l~~N~l~g~ip~~l~--~~~~~l~~~~n~~lc~~~ 526 (824)
|++|++++.+|..+. ..+..+.+.+|+..|..+
T Consensus 109 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 999999976676653 345778889999888653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.40 E-value=4.3e-14 Score=152.95 Aligned_cols=103 Identities=22% Similarity=0.185 Sum_probs=82.8
Q ss_pred CCCceeEEEecCCCCCc--cCC-hhhhcccccccccccccccCCCCC--CCCCCCCcceEeecccccCCCCCccccCCCc
Q 003385 414 PQPSITVIHLSSKNLTG--NIP-SDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPN 488 (824)
Q Consensus 414 ~~~~L~~L~L~~n~l~g--~lp-~~i~~L~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~ 488 (824)
.+++|++|+|++|+|++ .++ ..+.++++|+.|+|++|+|++.+| .+..+++|+.|+|++|+|+ .+|..+. ++
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~ 275 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AK 275 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SE
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CC
Confidence 46789999999999983 233 344678999999999999999875 4777999999999999999 8998887 89
Q ss_pred cceeeecccccccccccccc--ccceeccccCCcc
Q 003385 489 LRELYVQNNMLSGTVPSSLL--SKNVVLNYAGNIN 521 (824)
Q Consensus 489 L~~L~l~~N~l~g~ip~~l~--~~~~~l~~~~n~~ 521 (824)
|+.|+|++|+|+ .+|. +. ..+..+.+++|+.
T Consensus 276 L~~L~Ls~N~l~-~~p~-~~~l~~L~~L~L~~N~l 308 (312)
T 1wwl_A 276 LSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPF 308 (312)
T ss_dssp EEEEECCSSCCC-SCCC-TTTSCEEEEEECTTCTT
T ss_pred ceEEECCCCCCC-CChh-HhhCCCCCEEeccCCCC
Confidence 999999999999 4565 32 2335677788864
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=9.7e-14 Score=149.93 Aligned_cols=176 Identities=16% Similarity=0.088 Sum_probs=122.9
Q ss_pred cccceeeecccccCCCCCCcc-c--chhhhceeccCCCCCCcHH----HHHHHHHhcCCCCcccCCCCCCCCCCCCeeEc
Q 003385 338 SLPFVLSFKFGKTYDSSRGPL-L--NAMEINKYLERNDGSIDGV----AIVSVISLYSSADWAQEGGDPCLPVPWSWLQC 410 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~-i--~~le~l~~L~l~~n~~~~~----~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c 410 (824)
.++.|+.|+|++|.++..+|. + ..+..|+.|+++.|.+... ....+..+..++.+..+++. ...+.+
T Consensus 89 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~------l~~~~~ 162 (310)
T 4glp_A 89 AYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAH------SPAFSC 162 (310)
T ss_dssp HHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCS------SCCCCT
T ss_pred ccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCC------cchhhH
Confidence 345688999999998866555 5 8899999999998887641 11122222233333222111 112222
Q ss_pred -CCCCCCceeEEEecCCCCCcc--CC--hhhhcccccccccccccccCCCCCC----CCCCCCcceEeecccccCCCCCc
Q 003385 411 -NSDPQPSITVIHLSSKNLTGN--IP--SDLTKLSSLVELWLDGNSLTGPIPD----FSGCPDLRIIHLEDNQLTGPLPS 481 (824)
Q Consensus 411 -~~~~~~~L~~L~L~~n~l~g~--lp--~~i~~L~~L~~L~L~~N~l~~~~p~----~~~l~~L~~L~L~~N~l~g~lP~ 481 (824)
....+++|++|+|++|++.+. ++ ..++++++|+.|+|++|+|+..++. +.++++|+.|+|++|+|++..|+
T Consensus 163 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~ 242 (310)
T 4glp_A 163 EQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNP 242 (310)
T ss_dssp TSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCS
T ss_pred HHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchh
Confidence 123567899999999988753 32 2347888899999999988765442 46788999999999999977788
Q ss_pred cccCC---CccceeeeccccccccccccccccceeccccCCc
Q 003385 482 SLMNL---PNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 520 (824)
Q Consensus 482 ~l~~l---~~L~~L~l~~N~l~g~ip~~l~~~~~~l~~~~n~ 520 (824)
.++.+ ++|+.|+|++|+|+ .+|..+...+..+.+++|.
T Consensus 243 ~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~ 283 (310)
T 4glp_A 243 SAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNR 283 (310)
T ss_dssp CCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCC
T ss_pred hHHhccCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCc
Confidence 88777 58999999999998 8888887777777777774
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.8e-13 Score=155.39 Aligned_cols=175 Identities=17% Similarity=0.168 Sum_probs=129.0
Q ss_pred cccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEc-CCCCC
Q 003385 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQ 415 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c-~~~~~ 415 (824)
.+++|+.|+|+.|.++.+++. +.++..|+.|+++.|.+.......+..+..++.+..+++. ...+.. ....+
T Consensus 86 ~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~------i~~~~~~~~~~l 159 (440)
T 3zyj_A 86 HLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNP------IESIPSYAFNRI 159 (440)
T ss_dssp SCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCC------CCEECTTTTTTC
T ss_pred CCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCc------ccccCHHHhhhC
Confidence 467899999999999999976 8999999999999998775332233333333333222111 122221 23457
Q ss_pred CceeEEEecCCCCCccCCh-hhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeee
Q 003385 416 PSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~-~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l 494 (824)
++|+.|+|++|+..+.+|. .|.+|++|+.|+|++|+|+.+ |.+..+++|+.|+|++|+|++..|..|.++++|+.|+|
T Consensus 160 ~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 238 (440)
T 3zyj_A 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI-PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWM 238 (440)
T ss_dssp TTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC-CCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc-cccCCCcccCEEECCCCccCccChhhhccCccCCEEEC
Confidence 8899999998544435554 788999999999999999855 57889999999999999999888899999999999999
Q ss_pred ccccccccccccccc---cceeccccCCc
Q 003385 495 QNNMLSGTVPSSLLS---KNVVLNYAGNI 520 (824)
Q Consensus 495 ~~N~l~g~ip~~l~~---~~~~l~~~~n~ 520 (824)
++|+++ .++...+. .+..+.+++|.
T Consensus 239 ~~n~l~-~~~~~~~~~l~~L~~L~L~~N~ 266 (440)
T 3zyj_A 239 IQSQIQ-VIERNAFDNLQSLVEINLAHNN 266 (440)
T ss_dssp TTCCCC-EECTTSSTTCTTCCEEECTTSC
T ss_pred CCCcee-EEChhhhcCCCCCCEEECCCCC
Confidence 999999 55544433 34667777774
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.40 E-value=2.9e-13 Score=158.48 Aligned_cols=158 Identities=17% Similarity=0.197 Sum_probs=127.3
Q ss_pred cccceeeecccccCCCC-CCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCC
Q 003385 338 SLPFVLSFKFGKTYDSS-RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~-LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (824)
.+++|+.|+|+.|.++. +|+.+..++.|+.|+++.|.+.... .+.-....++
T Consensus 351 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---------------------------~~~~~~~~l~ 403 (562)
T 3a79_B 351 SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFF---------------------------KVALMTKNMS 403 (562)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTT---------------------------HHHHTTTTCT
T ss_pred CCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcc---------------------------cchhhhcCCC
Confidence 46788999999999998 5566899999999999988776310 0000113467
Q ss_pred ceeEEEecCCCCCccCCh-hhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeee
Q 003385 417 SITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~-~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l 494 (824)
+|+.|+|++|++++.+|. .+..+++|+.|+|++|++++.+|. +. ++|+.|+|++|+|+ .+|..+.++++|+.|+|
T Consensus 404 ~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L 480 (562)
T 3a79_B 404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNV 480 (562)
T ss_dssp TCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEEC
T ss_pred CCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEEC
Confidence 899999999999976776 488899999999999999887664 33 79999999999999 89998889999999999
Q ss_pred ccccccccccccccc---cceeccccCCccccCCC
Q 003385 495 QNNMLSGTVPSSLLS---KNVVLNYAGNINLHEGG 526 (824)
Q Consensus 495 ~~N~l~g~ip~~l~~---~~~~l~~~~n~~lc~~~ 526 (824)
++|+|+ .+|...+. .+..+.+++|+..|.++
T Consensus 481 ~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 481 ASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp CSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred CCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 999999 89987443 34667889999888763
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=4.1e-13 Score=158.43 Aligned_cols=139 Identities=14% Similarity=0.148 Sum_probs=116.6
Q ss_pred cceeeecccccCCCCCCc-ccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 340 PFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP-~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+.++.|+|+.|.++.+|| .+..++.|+.|+++.|.+... .|- ....+++|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i-------------------~~~----------~~~~l~~L 82 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI-------------------EDK----------AWHGLHHL 82 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEE-------------------CTT----------TTTTCTTC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCccccc-------------------CHH----------Hhhchhhc
Confidence 578899999999999999 599999999999999876530 010 11346789
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCC-CCCCCCCcceEeecccccCC-CCCccccCCCccceeeecc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQN 496 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~g-~lP~~l~~l~~L~~L~l~~ 496 (824)
++|+|++|++++..|..|++|++|++|+|++|++++.++ .++++++|++|+|++|++++ .+|..+++|++|+.|+|++
T Consensus 83 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~ 162 (606)
T 3vq2_A 83 SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162 (606)
T ss_dssp CEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCS
T ss_pred CEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccC
Confidence 999999999997779999999999999999999999886 48999999999999999986 6799999999999999999
Q ss_pred ccccccccccc
Q 003385 497 NMLSGTVPSSL 507 (824)
Q Consensus 497 N~l~g~ip~~l 507 (824)
|++++..|..+
T Consensus 163 n~l~~~~~~~~ 173 (606)
T 3vq2_A 163 NYIQTITVNDL 173 (606)
T ss_dssp SCCCEECTTTT
T ss_pred CcceecChhhh
Confidence 99995444433
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.40 E-value=7.7e-13 Score=155.87 Aligned_cols=125 Identities=26% Similarity=0.399 Sum_probs=78.0
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
|++|+.|+|+.|.++.+|| +..++.|+.|+|+.|.+... ..+ ..+++|
T Consensus 64 l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l--~~l-----------------------------~~l~~L 111 (605)
T 1m9s_A 64 LPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKIKDL--SSL-----------------------------KDLKKL 111 (605)
T ss_dssp CTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCC--TTS-----------------------------TTCTTC
T ss_pred CCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCCCCC--hhh-----------------------------ccCCCC
Confidence 6788889999999999888 88888899999988876531 011 223455
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~ 498 (824)
+.|+|++|+|++ + +.+..|++|+.|+|++|+|+++ +.+..|++|+.|+|++|+|++..| ++.|++|+.|+|++|+
T Consensus 112 ~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~ 186 (605)
T 1m9s_A 112 KSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 186 (605)
T ss_dssp CEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred CEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCC
Confidence 555555555552 3 2355555555555555555554 445555555555555555554333 5555555555555555
Q ss_pred cc
Q 003385 499 LS 500 (824)
Q Consensus 499 l~ 500 (824)
|+
T Consensus 187 i~ 188 (605)
T 1m9s_A 187 IS 188 (605)
T ss_dssp CC
T ss_pred CC
Confidence 55
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.40 E-value=6.2e-14 Score=171.15 Aligned_cols=179 Identities=17% Similarity=0.176 Sum_probs=133.9
Q ss_pred cccceeeecccccCCCC------------------CCcccc--hhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCC
Q 003385 338 SLPFVLSFKFGKTYDSS------------------RGPLLN--AMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGG 397 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~------------------LPP~i~--~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~ 397 (824)
.|++|+.|+|+.|.++. +|+.++ .++.|+.|+++.|.+.......+..+..+..+..+++
T Consensus 446 ~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N 525 (876)
T 4ecn_A 446 RLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525 (876)
T ss_dssp GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTC
T ss_pred cCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCC
Confidence 46789999999999998 999988 9999999999988755433344555555555433222
Q ss_pred C-CCC-CCC--CCeeEcCCCCCCceeEEEecCCCCCccCCh--hhhcccccccccccccccCCCCCCCCCCCCcceEeec
Q 003385 398 D-PCL-PVP--WSWLQCNSDPQPSITVIHLSSKNLTGNIPS--DLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLE 471 (824)
Q Consensus 398 d-pc~-~~~--~~~~~c~~~~~~~L~~L~L~~n~l~g~lp~--~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~ 471 (824)
. -.. ..| +....-....+++|+.|+|++|+|+ .+|. .|++|++|+.|+|++|+|+ .+|.++++++|+.|+|+
T Consensus 526 ~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls 603 (876)
T 4ecn_A 526 RGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLD 603 (876)
T ss_dssp TTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECC
T ss_pred CCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECc
Confidence 1 110 000 1000002234668999999999999 8998 8999999999999999999 55588999999999999
Q ss_pred ccccCCCCCccccCCCc-cceeeecccccccccccccccc----ceeccccCCc
Q 003385 472 DNQLTGPLPSSLMNLPN-LRELYVQNNMLSGTVPSSLLSK----NVVLNYAGNI 520 (824)
Q Consensus 472 ~N~l~g~lP~~l~~l~~-L~~L~l~~N~l~g~ip~~l~~~----~~~l~~~~n~ 520 (824)
+|+|+ .+|..++++++ |+.|+|++|+++ .+|..+... +..+.+++|.
T Consensus 604 ~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~ 655 (876)
T 4ecn_A 604 YNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNK 655 (876)
T ss_dssp SSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSC
T ss_pred CCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCc
Confidence 99999 89999999998 999999999999 888765432 4566667664
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=4e-13 Score=152.59 Aligned_cols=140 Identities=19% Similarity=0.137 Sum_probs=121.2
Q ss_pred ccccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCC
Q 003385 337 LSLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQ 415 (824)
Q Consensus 337 ~~l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~ 415 (824)
...++|+.|+|+.|.++.++|. +..++.|+.|+++.|.+.. ..|. ....+
T Consensus 272 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-------------------~~~~----------~~~~l 322 (455)
T 3v47_A 272 LEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINK-------------------IDDN----------AFWGL 322 (455)
T ss_dssp GTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCE-------------------ECTT----------TTTTC
T ss_pred ccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccc-------------------cChh----------HhcCc
Confidence 3456899999999999998776 9999999999999998763 1110 11346
Q ss_pred CceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeee
Q 003385 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l 494 (824)
++|+.|+|++|++++..|..|+++++|+.|+|++|++++.+|. +.++++|+.|+|++|+|++..+..++.+++|+.|+|
T Consensus 323 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 402 (455)
T 3v47_A 323 THLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWL 402 (455)
T ss_dssp TTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred ccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEc
Confidence 7999999999999988889999999999999999999999775 999999999999999999766667899999999999
Q ss_pred ccccccccccc
Q 003385 495 QNNMLSGTVPS 505 (824)
Q Consensus 495 ~~N~l~g~ip~ 505 (824)
++|++++..|.
T Consensus 403 ~~N~l~~~~~~ 413 (455)
T 3v47_A 403 HTNPWDCSCPR 413 (455)
T ss_dssp CSSCBCCCTTT
T ss_pred cCCCcccCCCc
Confidence 99999988883
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.39 E-value=3.9e-14 Score=146.92 Aligned_cols=99 Identities=17% Similarity=0.107 Sum_probs=65.1
Q ss_pred EEEecCC-CCCccCChhhhcccccc-cccccccccCCCCCCCCCCCCcceEeecccc-cCCCCCccccCC-Cccceeeec
Q 003385 420 VIHLSSK-NLTGNIPSDLTKLSSLV-ELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ-LTGPLPSSLMNL-PNLRELYVQ 495 (824)
Q Consensus 420 ~L~L~~n-~l~g~lp~~i~~L~~L~-~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~-l~g~lP~~l~~l-~~L~~L~l~ 495 (824)
.|+|++| ++++..+..|.++++|+ .|+|++|+++.+++.....++|+.|+|++|+ |++..+..|..+ ++|+.|+|+
T Consensus 134 ~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~ 213 (239)
T 2xwt_C 134 ILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVS 213 (239)
T ss_dssp EEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECT
T ss_pred EEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECC
Confidence 7777777 77744445577777777 7777777777555543233677777777774 774445567777 777777777
Q ss_pred cccccccccccccccceeccccCC
Q 003385 496 NNMLSGTVPSSLLSKNVVLNYAGN 519 (824)
Q Consensus 496 ~N~l~g~ip~~l~~~~~~l~~~~n 519 (824)
+|+++ .+|...+..+..+.+.++
T Consensus 214 ~N~l~-~l~~~~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 214 QTSVT-ALPSKGLEHLKELIARNT 236 (239)
T ss_dssp TCCCC-CCCCTTCTTCSEEECTTC
T ss_pred CCccc-cCChhHhccCceeeccCc
Confidence 77777 666666665555555544
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=5.1e-13 Score=144.28 Aligned_cols=155 Identities=20% Similarity=0.196 Sum_probs=118.8
Q ss_pred cccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCC
Q 003385 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (824)
.+++|+.|+|+.|.++.+||. +..++.|+.|+++.|++..... +. ..-| ...++
T Consensus 143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--~~------------~~~~-----------~~~l~ 197 (310)
T 4glp_A 143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERG--LM------------AALC-----------PHKFP 197 (310)
T ss_dssp BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHH--HH------------TTSC-----------TTSSC
T ss_pred hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchh--hh------------HHHh-----------hhcCC
Confidence 477899999999999999975 8999999999999998643110 00 0001 02456
Q ss_pred ceeEEEecCCCCCccCCh----hhhcccccccccccccccCCCCC-CCCCC---CCcceEeecccccCCCCCccccCCCc
Q 003385 417 SITVIHLSSKNLTGNIPS----DLTKLSSLVELWLDGNSLTGPIP-DFSGC---PDLRIIHLEDNQLTGPLPSSLMNLPN 488 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~----~i~~L~~L~~L~L~~N~l~~~~p-~~~~l---~~L~~L~L~~N~l~g~lP~~l~~l~~ 488 (824)
+|++|+|++|+|+ .+|. .++++++|+.|+|++|+|++..| .+..+ ++|+.|+|++|+|+ .+|..+. ++
T Consensus 198 ~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~ 273 (310)
T 4glp_A 198 AIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AK 273 (310)
T ss_dssp CCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SC
T ss_pred CCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CC
Confidence 8999999999998 5554 25788999999999999999854 46665 69999999999999 8888875 79
Q ss_pred cceeeeccccccccccc-cccccceeccccCCccc
Q 003385 489 LRELYVQNNMLSGTVPS-SLLSKNVVLNYAGNINL 522 (824)
Q Consensus 489 L~~L~l~~N~l~g~ip~-~l~~~~~~l~~~~n~~l 522 (824)
|+.|+|++|++++ +|. .-+..+..+.+++|+..
T Consensus 274 L~~L~Ls~N~l~~-~~~~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 274 LRVLDLSSNRLNR-APQPDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CSCEECCSCCCCS-CCCTTSCCCCSCEECSSTTTS
T ss_pred CCEEECCCCcCCC-CchhhhCCCccEEECcCCCCC
Confidence 9999999999995 332 22345567778888643
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=4.1e-13 Score=158.44 Aligned_cols=184 Identities=14% Similarity=0.071 Sum_probs=136.0
Q ss_pred ccccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHH-HHHHHHHhcCCCCcccCCCCCCCCCCCCeeE-cCCCC
Q 003385 337 LSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGV-AIVSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDP 414 (824)
Q Consensus 337 ~~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~-~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~-c~~~~ 414 (824)
..+.+|+.|++..+....+++.+..++.|+.+++..+..... ....+..+..+.....+. + ....+. .....
T Consensus 394 ~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~---n---~l~~~~~~~~~~ 467 (635)
T 4g8a_A 394 FGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH---T---HTRVAFNGIFNG 467 (635)
T ss_dssp HSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTT---S---CCEECCTTTTTT
T ss_pred hhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccc---c---cccccccccccc
Confidence 345678888899999999988888899999988876543321 001111111111111000 0 001110 12245
Q ss_pred CCceeEEEecCCCC-CccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCcccee
Q 003385 415 QPSITVIHLSSKNL-TGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 492 (824)
Q Consensus 415 ~~~L~~L~L~~n~l-~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L 492 (824)
+++|+.|+|++|++ .+.+|..|..|++|+.|+|++|+|++++|. |.+|++|+.|+|++|+|++..|..|++|++|+.|
T Consensus 468 ~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L 547 (635)
T 4g8a_A 468 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 547 (635)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEE
T ss_pred chhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEE
Confidence 67999999999985 456788999999999999999999999886 8999999999999999998888899999999999
Q ss_pred eecccccccccccccc---ccceeccccCCccccCCC
Q 003385 493 YVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEGG 526 (824)
Q Consensus 493 ~l~~N~l~g~ip~~l~---~~~~~l~~~~n~~lc~~~ 526 (824)
+|++|+|++..|..+. ..+..+.+++|+..|.+.
T Consensus 548 ~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 548 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp ECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred ECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 9999999966666553 345678899999999874
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=5.4e-14 Score=154.72 Aligned_cols=138 Identities=23% Similarity=0.144 Sum_probs=80.8
Q ss_pred ceeeecccccCCCCCCc-ccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCcee
Q 003385 341 FVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 419 (824)
Q Consensus 341 ~l~~L~L~~n~~s~LPP-~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~ 419 (824)
.|+.|+|+.|.++.+|+ .+..++.|+.|+++.|.+.......+ ..+++|+
T Consensus 53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-----------------------------~~l~~L~ 103 (353)
T 2z80_A 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSF-----------------------------SSLGSLE 103 (353)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTT-----------------------------TTCTTCC
T ss_pred cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhc-----------------------------CCCCCCC
Confidence 57788888888888888 48888888888888877653111111 2234566
Q ss_pred EEEecCCCCCccCChhhhcccccccccccccccCCCCC--CCCCCCCcceEeeccc-ccCCCCCccccCCCccceeeecc
Q 003385 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDN-QLTGPLPSSLMNLPNLRELYVQN 496 (824)
Q Consensus 420 ~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~L~~N-~l~g~lP~~l~~l~~L~~L~l~~ 496 (824)
+|+|++|++++..+..|+++++|+.|+|++|++++.++ .+.++++|+.|+|++| .+++..|..++++++|++|++++
T Consensus 104 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~ 183 (353)
T 2z80_A 104 HLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183 (353)
T ss_dssp EEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEE
T ss_pred EEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCC
Confidence 66666666653222235556666666666666655554 2555666666666665 34433345555566666666666
Q ss_pred ccccccccccc
Q 003385 497 NMLSGTVPSSL 507 (824)
Q Consensus 497 N~l~g~ip~~l 507 (824)
|++++..|..+
T Consensus 184 n~l~~~~~~~l 194 (353)
T 2z80_A 184 SDLQSYEPKSL 194 (353)
T ss_dssp TTCCEECTTTT
T ss_pred CCcCccCHHHH
Confidence 66654334433
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=2.1e-13 Score=156.26 Aligned_cols=173 Identities=16% Similarity=0.119 Sum_probs=103.5
Q ss_pred ceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEc-CCCCCCce
Q 003385 341 FVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQPSI 418 (824)
Q Consensus 341 ~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c-~~~~~~~L 418 (824)
.++.|+|+.|.++.++|. +..++.|+.|+++.|.+.......+..+..++.+..+++. ...+.. ....+++|
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~------l~~~~~~~~~~l~~L 106 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR------LKLIPLGVFTGLSNL 106 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC------CCSCCTTSSTTCTTC
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc------CCccCcccccCCCCC
Confidence 455666666666666543 6666666666666665544322233333333332221110 011111 11345678
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N 497 (824)
++|+|++|++++..|..|.++++|+.|+|++|++++..+. |.++++|+.|+|++|++++..+..++++++|+.|+|++|
T Consensus 107 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n 186 (477)
T 2id5_A 107 TKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHL 186 (477)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESC
T ss_pred CEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCC
Confidence 8888888888777777777888888888888888777664 777788888888888877554556777777888888877
Q ss_pred ccccccccccccc---ceeccccCCc
Q 003385 498 MLSGTVPSSLLSK---NVVLNYAGNI 520 (824)
Q Consensus 498 ~l~g~ip~~l~~~---~~~l~~~~n~ 520 (824)
.++ .++...+.. +..+.+++|.
T Consensus 187 ~i~-~~~~~~~~~l~~L~~L~l~~~~ 211 (477)
T 2id5_A 187 NIN-AIRDYSFKRLYRLKVLEISHWP 211 (477)
T ss_dssp CCC-EECTTCSCSCTTCCEEEEECCT
T ss_pred cCc-EeChhhcccCcccceeeCCCCc
Confidence 777 344433322 2444455543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=4.6e-13 Score=155.03 Aligned_cols=157 Identities=17% Similarity=0.217 Sum_probs=127.3
Q ss_pred cccceeeecccccCCCC-CCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCC
Q 003385 338 SLPFVLSFKFGKTYDSS-RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~-LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (824)
.++.|+.|+|++|.++. +|+.+..++.|+.|+++.|.+..... +.. ....++
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~--~~~-------------------------~~~~l~ 374 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSK--IAE-------------------------MTTQMK 374 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHH--HHH-------------------------HHTTCT
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCcccc--chH-------------------------HHhhCC
Confidence 56788999999999998 66679999999999999998774210 000 012356
Q ss_pred ceeEEEecCCCCCccCChh-hhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeee
Q 003385 417 SITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~-i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l 494 (824)
+|+.|+|++|++++.+|.. +..+++|+.|+|++|++++..|. +. ++|+.|+|++|+|+ .+|..+..+++|+.|+|
T Consensus 375 ~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L 451 (520)
T 2z7x_B 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNV 451 (520)
T ss_dssp TCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEEC
T ss_pred CCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEEC
Confidence 8999999999999767774 88899999999999999887664 43 78999999999999 89998889999999999
Q ss_pred ccccccccccccccc---cceeccccCCccccCC
Q 003385 495 QNNMLSGTVPSSLLS---KNVVLNYAGNINLHEG 525 (824)
Q Consensus 495 ~~N~l~g~ip~~l~~---~~~~l~~~~n~~lc~~ 525 (824)
++|+++ .+|...+. .+..+.+++|+..|.+
T Consensus 452 ~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c 484 (520)
T 2z7x_B 452 ASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 484 (520)
T ss_dssp CSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CCCcCC-ccCHHHhccCCcccEEECcCCCCcccC
Confidence 999999 88887443 3467788999988865
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.38 E-value=5e-13 Score=144.37 Aligned_cols=169 Identities=22% Similarity=0.258 Sum_probs=127.7
Q ss_pred ccccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCC
Q 003385 337 LSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (824)
Q Consensus 337 ~~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (824)
..+++|+.|++..|.++.+| .+..++.|+.|+++.|.+..... +..+..++.+..+++. - ..+. ....++
T Consensus 38 ~~l~~L~~L~l~~~~i~~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~-l-----~~~~-~~~~l~ 107 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTTIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP-L-----KNVS-AIAGLQ 107 (308)
T ss_dssp HHHHTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC-C-----SCCG-GGTTCT
T ss_pred HHcCCcCEEEeeCCCccCch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCc-C-----CCch-hhcCCC
Confidence 34778999999999999997 68999999999999998765332 4444445444332211 1 1111 234578
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecc
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~ 496 (824)
+|+.|+|++|++++ +|. +..|++|+.|+|++|++++.++ +..+++|+.|+|++|+|++ +|. ++.+++|+.|+|++
T Consensus 108 ~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~ 182 (308)
T 1h6u_A 108 SIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADD 182 (308)
T ss_dssp TCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCS
T ss_pred CCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCC
Confidence 99999999999994 554 8999999999999999998776 8889999999999999994 555 89999999999999
Q ss_pred ccccccccccccccceeccccCCc
Q 003385 497 NMLSGTVPSSLLSKNVVLNYAGNI 520 (824)
Q Consensus 497 N~l~g~ip~~l~~~~~~l~~~~n~ 520 (824)
|++++..|-.-+..+..+.+++|.
T Consensus 183 n~l~~~~~l~~l~~L~~L~L~~N~ 206 (308)
T 1h6u_A 183 NKISDISPLASLPNLIEVHLKNNQ 206 (308)
T ss_dssp SCCCCCGGGGGCTTCCEEECTTSC
T ss_pred CccCcChhhcCCCCCCEEEccCCc
Confidence 999944333334445667777774
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.8e-13 Score=149.26 Aligned_cols=175 Identities=26% Similarity=0.194 Sum_probs=121.5
Q ss_pred cccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCc
Q 003385 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (824)
.+++|++|+|+.|.++.+|+.+. +.|+.|+++.|.+.......+..+..+......++.-. ...........+ +
T Consensus 100 ~l~~L~~L~L~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~---~~~~~~~~~~~l-~ 173 (332)
T 2ft3_A 100 PLRKLQKLYISKNHLVEIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE---NSGFEPGAFDGL-K 173 (332)
T ss_dssp TCTTCCEEECCSSCCCSCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCB---GGGSCTTSSCSC-C
T ss_pred CcCCCCEEECCCCcCCccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccc---cCCCCcccccCC-c
Confidence 35678888888888888888776 78888888888766432222233323333222111000 000000111223 7
Q ss_pred eeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeecc
Q 003385 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (824)
Q Consensus 418 L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~ 496 (824)
|+.|+|++|+++ .+|..+. ++|+.|+|++|++++.++. +.++++|+.|+|++|+|++..|..++.+++|+.|+|++
T Consensus 174 L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 250 (332)
T 2ft3_A 174 LNYLRISEAKLT-GIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDN 250 (332)
T ss_dssp CSCCBCCSSBCS-SCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCS
T ss_pred cCEEECcCCCCC-ccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCC
Confidence 888888888888 5776654 7899999999999998864 88999999999999999987777899999999999999
Q ss_pred ccccccccccccc--cceeccccCCccc
Q 003385 497 NMLSGTVPSSLLS--KNVVLNYAGNINL 522 (824)
Q Consensus 497 N~l~g~ip~~l~~--~~~~l~~~~n~~l 522 (824)
|+++ .+|..+.. .+..+.+++|...
T Consensus 251 N~l~-~lp~~l~~l~~L~~L~l~~N~l~ 277 (332)
T 2ft3_A 251 NKLS-RVPAGLPDLKLLQVVYLHTNNIT 277 (332)
T ss_dssp SCCC-BCCTTGGGCTTCCEEECCSSCCC
T ss_pred CcCe-ecChhhhcCccCCEEECCCCCCC
Confidence 9999 89887643 3466777777543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=3.3e-13 Score=159.18 Aligned_cols=177 Identities=20% Similarity=0.185 Sum_probs=109.6
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+++|+.|+|+.|.++.+|+.+..+..|+.|+++.|.+.......+..+..+......+..-....+. -....+++|
T Consensus 277 l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~----~~~~~l~~L 352 (606)
T 3t6q_A 277 FSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT----GCLENLENL 352 (606)
T ss_dssp CTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCS----STTTTCTTC
T ss_pred ccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccch----hhhhccCcC
Confidence 5678899999999999999899999999999998887654333333433333332211110000000 012345667
Q ss_pred eEEEecCCCCCccC--ChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCcc-ccCCCccceeee
Q 003385 419 TVIHLSSKNLTGNI--PSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSS-LMNLPNLRELYV 494 (824)
Q Consensus 419 ~~L~L~~n~l~g~l--p~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~-l~~l~~L~~L~l 494 (824)
++|+|++|++++.. |..+.++++|+.|+|++|++++.+|. +.++++|+.|+|++|++++..|.. ++++++|+.|++
T Consensus 353 ~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l 432 (606)
T 3t6q_A 353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432 (606)
T ss_dssp CEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEEC
T ss_pred CEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEEC
Confidence 77777777776544 56677777777777777777666554 666777777777777776655543 667777777777
Q ss_pred ccccccccccccc--cccceeccccCC
Q 003385 495 QNNMLSGTVPSSL--LSKNVVLNYAGN 519 (824)
Q Consensus 495 ~~N~l~g~ip~~l--~~~~~~l~~~~n 519 (824)
++|.+++..|..+ +..+..+.+++|
T Consensus 433 ~~n~l~~~~~~~~~~l~~L~~L~L~~n 459 (606)
T 3t6q_A 433 SHSLLDISSEQLFDGLPALQHLNLQGN 459 (606)
T ss_dssp TTCCCBTTCTTTTTTCTTCCEEECTTC
T ss_pred CCCccCCcCHHHHhCCCCCCEEECCCC
Confidence 7777764444443 223345555555
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=2.7e-13 Score=157.92 Aligned_cols=178 Identities=12% Similarity=0.015 Sum_probs=109.6
Q ss_pred cceeeecccccCCCCCCccc-chhhhceeccCCCCCCcHHHHHH---HHHhcCCCCcccCCCCCCCCCCCCeeE---cCC
Q 003385 340 PFVLSFKFGKTYDSSRGPLL-NAMEINKYLERNDGSIDGVAIVS---VISLYSSADWAQEGGDPCLPVPWSWLQ---CNS 412 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~i-~~le~l~~L~l~~n~~~~~~l~~---lk~~~~~~~w~~~~~dpc~~~~~~~~~---c~~ 412 (824)
..|+.|+|++|.++.+|+.+ ..++.|+.|+++.|.+....+.. +..+..+.....+++. ...+. -..
T Consensus 310 ~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~------l~~~~~~~~~~ 383 (549)
T 2z81_A 310 EKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNH------LRSMQKTGEIL 383 (549)
T ss_dssp TTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSC------CCCHHHHHHHG
T ss_pred ccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCc------ccccccchhhh
Confidence 45667777777777777665 45777777777777766543322 1122222222221110 11100 001
Q ss_pred CCCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCC------------------CCCCCcceEeecccc
Q 003385 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF------------------SGCPDLRIIHLEDNQ 474 (824)
Q Consensus 413 ~~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~------------------~~l~~L~~L~L~~N~ 474 (824)
..+++|++|+|++|+++ .+|..++.+++|+.|+|++|+|++.+..+ .++++|+.|+|++|+
T Consensus 384 ~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~ 462 (549)
T 2z81_A 384 LTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNK 462 (549)
T ss_dssp GGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSC
T ss_pred hcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccccchhcCCceEEECCCCChhhhcccCChhcEEECCCCc
Confidence 23456666666666666 56666666666666666666665433321 368889999999999
Q ss_pred cCCCCCccccCCCccceeeeccccccccccccc--cccceeccccCCccccCCC
Q 003385 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGG 526 (824)
Q Consensus 475 l~g~lP~~l~~l~~L~~L~l~~N~l~g~ip~~l--~~~~~~l~~~~n~~lc~~~ 526 (824)
|+ .+|. .+.+++|+.|+|++|++++..|..+ +..+..+.+++|+..|.++
T Consensus 463 l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 463 LK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred cC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 98 7887 5778999999999999995555433 3345678889999888653
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.38 E-value=3e-13 Score=140.23 Aligned_cols=149 Identities=17% Similarity=0.093 Sum_probs=111.7
Q ss_pred ceeeecccccCCCCCCc-ccchhhhceeccCCCCC-CcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 341 FVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGS-IDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 341 ~l~~L~L~~n~~s~LPP-~i~~le~l~~L~l~~n~-~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
.|+.|+|++|.++.+|+ .+..++.|+.|+++.|. +... .+ .. ...+++|
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i-------------------~~-----~~-----f~~l~~L 82 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQL-------------------ES-----HS-----FYNLSKV 82 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEE-------------------CT-----TT-----EESCTTC
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCccee-------------------CH-----hH-----cCCCcCC
Confidence 67889999999999998 48899999999999885 5531 00 00 1234688
Q ss_pred eEEEecC-CCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcc---eEeeccc-ccCCCCCccccCCCccc-ee
Q 003385 419 TVIHLSS-KNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLR---IIHLEDN-QLTGPLPSSLMNLPNLR-EL 492 (824)
Q Consensus 419 ~~L~L~~-n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~---~L~L~~N-~l~g~lP~~l~~l~~L~-~L 492 (824)
++|+|++ |+|++..+..|.++++|+.|+|++|++++.+ .+..+++|+ .|+|++| ++++..+..|.++++|+ .|
T Consensus 83 ~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~lp-~~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L 161 (239)
T 2xwt_C 83 THIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFP-DLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL 161 (239)
T ss_dssp CEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCSCC-CCTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEE
T ss_pred cEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcccc-ccccccccccccEEECCCCcchhhcCcccccchhcceeEE
Confidence 8888888 8888555567888888888888888888844 477777777 8888888 88855556688888888 88
Q ss_pred eecccccccccccccccc--ceeccccCCc
Q 003385 493 YVQNNMLSGTVPSSLLSK--NVVLNYAGNI 520 (824)
Q Consensus 493 ~l~~N~l~g~ip~~l~~~--~~~l~~~~n~ 520 (824)
++++|+++ .+|...+.. +..+.+++|.
T Consensus 162 ~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~ 190 (239)
T 2xwt_C 162 KLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190 (239)
T ss_dssp ECCSCCCC-EECTTTTTTCEEEEEECTTCT
T ss_pred EcCCCCCc-ccCHhhcCCCCCCEEEcCCCC
Confidence 88888888 888776654 3455666663
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.37 E-value=4.6e-13 Score=134.72 Aligned_cols=130 Identities=14% Similarity=0.226 Sum_probs=107.8
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+++|+.|+|++|.++.++ .+..++.|+.|+++.|.+... .+. ....+++|
T Consensus 65 l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~n~l~~~-------------------~~~----------~l~~l~~L 114 (197)
T 4ezg_A 65 AHNIKDLTINNIHATNYN-PISGLSNLERLRIMGKDVTSD-------------------KIP----------NLSGLTSL 114 (197)
T ss_dssp CTTCSEEEEESCCCSCCG-GGTTCTTCCEEEEECTTCBGG-------------------GSC----------CCTTCTTC
T ss_pred CCCCCEEEccCCCCCcch-hhhcCCCCCEEEeECCccCcc-------------------cCh----------hhcCCCCC
Confidence 568899999999887774 788999999999999987630 000 01246799
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccc-cCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeeccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNS-LTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~-l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N 497 (824)
+.|+|++|++++..|..++++++|+.|+|++|+ ++. +|.+.++++|+.|+|++|+|++ ++ .+..+++|+.|++++|
T Consensus 115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IMPLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CGGGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC
T ss_pred CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-cHhhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCc
Confidence 999999999998899999999999999999998 555 4579999999999999999994 66 7999999999999999
Q ss_pred cccc
Q 003385 498 MLSG 501 (824)
Q Consensus 498 ~l~g 501 (824)
++.+
T Consensus 192 ~i~~ 195 (197)
T 4ezg_A 192 TIGG 195 (197)
T ss_dssp ----
T ss_pred ccCC
Confidence 9873
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.36 E-value=8.9e-14 Score=167.68 Aligned_cols=91 Identities=21% Similarity=0.265 Sum_probs=46.9
Q ss_pred CceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCc-cceeee
Q 003385 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPN-LRELYV 494 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~-L~~L~l 494 (824)
++|+.|+|++|+|+ .+|..|++|++|+.|+|++|.|+.++++|++|++|+.|+|++|+|++.+|..++.+.. +..|+|
T Consensus 270 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l 348 (727)
T 4b8c_D 270 SNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYL 348 (727)
T ss_dssp TTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHH
T ss_pred CCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhh
Confidence 45555555555555 5555555555555555555555544444555555555555555555555554444322 122455
Q ss_pred ccccccccccccc
Q 003385 495 QNNMLSGTVPSSL 507 (824)
Q Consensus 495 ~~N~l~g~ip~~l 507 (824)
++|.++|.+|.++
T Consensus 349 ~~N~l~~~~p~~l 361 (727)
T 4b8c_D 349 RDNRPEIPLPHER 361 (727)
T ss_dssp HHCCCCCCCCCC-
T ss_pred ccCcccCcCcccc
Confidence 5555555555443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.36 E-value=1.2e-12 Score=128.58 Aligned_cols=84 Identities=29% Similarity=0.351 Sum_probs=44.7
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeec
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~ 495 (824)
+|+.|+|++|+|++..|..|.+|++|+.|+|++|+|+++++. |.++++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus 31 ~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 110 (170)
T 3g39_A 31 TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLL 110 (170)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeC
Confidence 445555555555544455555555555555555555555554 4555555555555555553333345555555555555
Q ss_pred ccccc
Q 003385 496 NNMLS 500 (824)
Q Consensus 496 ~N~l~ 500 (824)
+|+++
T Consensus 111 ~N~~~ 115 (170)
T 3g39_A 111 NNPWD 115 (170)
T ss_dssp SSCBC
T ss_pred CCCCC
Confidence 55554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.1e-12 Score=131.85 Aligned_cols=129 Identities=18% Similarity=0.176 Sum_probs=109.0
Q ss_pred eeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeEEE
Q 003385 343 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 422 (824)
Q Consensus 343 ~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~L~ 422 (824)
+.++++.|.++.+|+.+. +.++.|+++.|.+... .. ....+++|+.|+
T Consensus 13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~~i-----------p~-------------------~~~~l~~L~~L~ 60 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFTLV-----------PK-------------------ELSNYKHLTLID 60 (193)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCCSC-----------CG-------------------GGGGCTTCCEEE
T ss_pred CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCchh-----------HH-------------------HhhcccCCCEEE
Confidence 356788999999998765 5799999999877630 00 112457899999
Q ss_pred ecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccccccc
Q 003385 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 501 (824)
Q Consensus 423 L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g 501 (824)
|++|+|++..|..|.+|++|+.|+|++|+|++++|. |.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus 61 Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 61 LSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 999999977778899999999999999999999986 9999999999999999996555679999999999999999974
Q ss_pred cc
Q 003385 502 TV 503 (824)
Q Consensus 502 ~i 503 (824)
.-
T Consensus 141 ~c 142 (193)
T 2wfh_A 141 DC 142 (193)
T ss_dssp SG
T ss_pred CC
Confidence 33
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.5e-12 Score=128.58 Aligned_cols=103 Identities=21% Similarity=0.343 Sum_probs=57.4
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N 497 (824)
+.|++++|+|+ .+|..+. ++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..+..|+++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45666666665 5555543 5566666666666665553 556666666666666666433334456666666666666
Q ss_pred cccccccccccc---cceeccccCCccccCC
Q 003385 498 MLSGTVPSSLLS---KNVVLNYAGNINLHEG 525 (824)
Q Consensus 498 ~l~g~ip~~l~~---~~~~l~~~~n~~lc~~ 525 (824)
+|+ .+|...+. .+..+.+.+|+..|..
T Consensus 92 ~l~-~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 92 HLK-SIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCC-CCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred ccc-eeCHHHhccccCCCEEEeCCCCccccc
Confidence 666 45544322 2344555566555543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.2e-12 Score=127.24 Aligned_cols=121 Identities=24% Similarity=0.268 Sum_probs=102.6
Q ss_pred CCCeeEcCCCC--------CCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccc
Q 003385 404 PWSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474 (824)
Q Consensus 404 ~~~~~~c~~~~--------~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~ 474 (824)
.|..+.|+... .++|+.|+|++|++++..+..|.++++|+.|+|++|+|++.++. +.++++|+.|+|++|+
T Consensus 8 ~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 87 (177)
T 2o6r_A 8 SGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87 (177)
T ss_dssp ETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence 46667775422 36899999999999966666789999999999999999998887 7999999999999999
Q ss_pred cCCCCCccccCCCccceeeeccccccccccccccc---cceeccccCCccccCC
Q 003385 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS---KNVVLNYAGNINLHEG 525 (824)
Q Consensus 475 l~g~lP~~l~~l~~L~~L~l~~N~l~g~ip~~l~~---~~~~l~~~~n~~lc~~ 525 (824)
|++..|..++.+++|+.|+|++|+++ .+|...+. .+..+.+.+|+..|..
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 88 LQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred ccccCHHHhhCCcccCEEECcCCcce-EeCHHHhcCCcccCEEEecCCCeeccC
Confidence 99777777899999999999999999 78877654 4467788999877754
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.36 E-value=5.7e-13 Score=140.60 Aligned_cols=146 Identities=15% Similarity=0.130 Sum_probs=72.6
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
++.|+.|+|+.|.++.+| .+..++.|+.|+++.|.+..... +..+..+..+..+++.-. ..... .. ++|
T Consensus 40 l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~---~l~~~----~~-~~L 108 (263)
T 1xeu_A 40 LSGVQNFNGDNSNIQSLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK---NLNGI----PS-ACL 108 (263)
T ss_dssp HTTCSEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCS---CCTTC----CC-SSC
T ss_pred cCcCcEEECcCCCcccch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccC---CcCcc----cc-Ccc
Confidence 456666666666666665 56666666666666665543111 111111111111000000 00000 01 355
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~ 498 (824)
+.|+|++|+|++ +| .+.+|++|+.|+|++|+|++. +.+..+++|+.|+|++|+|++. ..+..+++|+.|++++|+
T Consensus 109 ~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~ 183 (263)
T 1xeu_A 109 SRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQK 183 (263)
T ss_dssp CEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEE
T ss_pred cEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCc
Confidence 566666666553 33 355556666666666665554 2455555666666666665533 445555566666666665
Q ss_pred cc
Q 003385 499 LS 500 (824)
Q Consensus 499 l~ 500 (824)
++
T Consensus 184 ~~ 185 (263)
T 1xeu_A 184 CV 185 (263)
T ss_dssp EE
T ss_pred cc
Confidence 55
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.36 E-value=5.5e-13 Score=145.89 Aligned_cols=170 Identities=17% Similarity=0.216 Sum_probs=117.7
Q ss_pred cccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCc
Q 003385 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (824)
.+++|+.|+++.|.++.+++ +..++.|+.|+++.|.+..... +..+..+.....++ |. ...+.. ...+++
T Consensus 175 ~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~---n~---l~~~~~-~~~l~~ 244 (347)
T 4fmz_A 175 NLTDLYSLSLNYNQIEDISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGN---NK---ITDLSP-LANLSQ 244 (347)
T ss_dssp GCTTCSEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCS---SC---CCCCGG-GTTCTT
T ss_pred cCCCCCEEEccCCccccccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccC---Cc---cCCCcc-hhcCCC
Confidence 35567777778888777777 7777777777777776554221 22222333322211 10 111111 235678
Q ss_pred eeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeeccc
Q 003385 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 418 L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N 497 (824)
|++|+|++|++++ + +.+..+++|+.|+|++|++++. +.+..+++|+.|+|++|++++..|..++++++|+.|+|++|
T Consensus 245 L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n 321 (347)
T 4fmz_A 245 LTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN 321 (347)
T ss_dssp CCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSS
T ss_pred CCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCC
Confidence 8899999988884 4 4688888999999999988886 56888888999999999988778888888899999999999
Q ss_pred cccccccccccccceeccccCCc
Q 003385 498 MLSGTVPSSLLSKNVVLNYAGNI 520 (824)
Q Consensus 498 ~l~g~ip~~l~~~~~~l~~~~n~ 520 (824)
++++..|-.-+..+..+.+++|+
T Consensus 322 ~l~~~~~~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 322 HITDIRPLASLSKMDSADFANQV 344 (347)
T ss_dssp SCCCCGGGGGCTTCSEESSSCC-
T ss_pred ccccccChhhhhccceeehhhhc
Confidence 98866664445566677777774
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1.4e-12 Score=139.61 Aligned_cols=146 Identities=21% Similarity=0.222 Sum_probs=121.2
Q ss_pred cccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCc
Q 003385 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (824)
.++.|+.|+++.|.++.+|. +..++.|+.|+++.|.+.. ..+ ...+++
T Consensus 44 ~l~~L~~L~l~~~~i~~~~~-~~~l~~L~~L~L~~n~l~~-------------------~~~------------l~~l~~ 91 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTD-------------------IKP------------LANLKN 91 (291)
T ss_dssp HHHTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCC-------------------CGG------------GTTCTT
T ss_pred hcCcccEEEccCCCcccChh-HhcCCCCCEEEccCCccCC-------------------Ccc------------cccCCC
Confidence 57789999999999999964 8999999999999997763 111 134679
Q ss_pred eeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeeccc
Q 003385 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 418 L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N 497 (824)
|+.|+|++|++++ +|. +.+|++|+.|+|++|++++. +.+..+++|+.|+|++|+|++ + +.++.+++|+.|+|++|
T Consensus 92 L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~~n~i~~~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~N 166 (291)
T 1h6t_A 92 LGWLFLDENKVKD-LSS-LKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSLEDN 166 (291)
T ss_dssp CCEEECCSSCCCC-GGG-GTTCTTCCEEECTTSCCCCC-GGGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSS
T ss_pred CCEEECCCCcCCC-Chh-hccCCCCCEEECCCCcCCCC-hhhcCCCCCCEEEccCCcCCc-c-hhhccCCCCCEEEccCC
Confidence 9999999999994 554 99999999999999999986 679999999999999999995 4 68999999999999999
Q ss_pred cccccccccccccceeccccCCc
Q 003385 498 MLSGTVPSSLLSKNVVLNYAGNI 520 (824)
Q Consensus 498 ~l~g~ip~~l~~~~~~l~~~~n~ 520 (824)
++++..|-.-+..+..+.+++|.
T Consensus 167 ~l~~~~~l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 167 QISDIVPLAGLTKLQNLYLSKNH 189 (291)
T ss_dssp CCCCCGGGTTCTTCCEEECCSSC
T ss_pred ccccchhhcCCCccCEEECCCCc
Confidence 99955453334445667777774
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.34 E-value=2.7e-13 Score=163.50 Aligned_cols=136 Identities=24% Similarity=0.164 Sum_probs=99.4
Q ss_pred eeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeEE
Q 003385 342 VLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVI 421 (824)
Q Consensus 342 l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~L 421 (824)
+..+++..|.+...|..+..+..|+.|+|+.|.+.. -.+ ....+++|+.|
T Consensus 203 i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~~-------------------l~~-----------~~~~l~~L~~L 252 (727)
T 4b8c_D 203 IDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIFN-------------------ISA-----------NIFKYDFLTRL 252 (727)
T ss_dssp -------------------CCCCCCEEECTTSCCSC-------------------CCG-----------GGGGCCSCSCC
T ss_pred ccCccccccceecChhhhccCCCCcEEECCCCCCCC-------------------CCh-----------hhcCCCCCCEE
Confidence 344555566666556667788888888888776542 000 01135689999
Q ss_pred EecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeeccccccc
Q 003385 422 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 501 (824)
Q Consensus 422 ~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g 501 (824)
+|++|+|+ .+|..|++|++|+.|+|++|+|+.+++.|++|++|+.|+|++|+|+ .+|.+|++|++|+.|+|++|+|+|
T Consensus 253 ~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~ 330 (727)
T 4b8c_D 253 YLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEK 330 (727)
T ss_dssp BCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCS
T ss_pred EeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCC
Confidence 99999999 9999999999999999999999977667999999999999999998 899999999999999999999998
Q ss_pred cccccccc
Q 003385 502 TVPSSLLS 509 (824)
Q Consensus 502 ~ip~~l~~ 509 (824)
.+|..+..
T Consensus 331 ~~p~~~~~ 338 (727)
T 4b8c_D 331 QFLKILTE 338 (727)
T ss_dssp HHHHHHHH
T ss_pred CChHHHhh
Confidence 88877643
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.34 E-value=7.1e-13 Score=143.66 Aligned_cols=151 Identities=13% Similarity=0.074 Sum_probs=107.3
Q ss_pred cceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCcee
Q 003385 340 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 419 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~ 419 (824)
+.|+.|+|+.|.++.+++.. ++.|+.|+++.|.+... .+ .....+++|+
T Consensus 99 ~~L~~L~l~~n~l~~~~~~~--~~~L~~L~l~~N~l~~~-------------------~~----------~~~~~l~~L~ 147 (317)
T 3o53_A 99 PSIETLHAANNNISRVSCSR--GQGKKNIYLANNKITML-------------------RD----------LDEGCRSRVQ 147 (317)
T ss_dssp TTCCEEECCSSCCSEEEECC--CSSCEEEECCSSCCCSG-------------------GG----------BCTGGGSSEE
T ss_pred CCcCEEECCCCccCCcCccc--cCCCCEEECCCCCCCCc-------------------cc----------hhhhccCCCC
Confidence 45566666666666665542 45566666666655420 00 0112346889
Q ss_pred EEEecCCCCCccCChhhh-cccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecccc
Q 003385 420 VIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (824)
Q Consensus 420 ~L~L~~n~l~g~lp~~i~-~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~ 498 (824)
.|+|++|++++..|..+. .+++|+.|+|++|+|++. +....+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+
T Consensus 148 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~ 225 (317)
T 3o53_A 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225 (317)
T ss_dssp EEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSC
T ss_pred EEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccccccccCCEEECCCCcCC-cchhhhcccCcccEEECcCCc
Confidence 999999999877777664 788999999999998877 44445888999999999998 566678888999999999999
Q ss_pred ccccccccccc--cceeccccCCccccC
Q 003385 499 LSGTVPSSLLS--KNVVLNYAGNINLHE 524 (824)
Q Consensus 499 l~g~ip~~l~~--~~~~l~~~~n~~lc~ 524 (824)
++ .+|..+.. .+..+.+++|+..|.
T Consensus 226 l~-~l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 226 LV-LIEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp CC-EECTTCCCCTTCCEEECTTCCCBHH
T ss_pred cc-chhhHhhcCCCCCEEEccCCCccCc
Confidence 98 78876533 446777888877764
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=2.4e-12 Score=153.99 Aligned_cols=182 Identities=17% Similarity=0.106 Sum_probs=126.6
Q ss_pred cccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHH--HHHHHHHhcCCCCcccCCCCCCCCCCCCeeEc-CCC
Q 003385 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGV--AIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSD 413 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~--~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c-~~~ 413 (824)
.+++|+.|+|+.|.++.+++. +..+..|+.|+++.|.+... ....+..+..+.....+++. ...+.- ...
T Consensus 428 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~------l~~i~~~~~~ 501 (680)
T 1ziw_A 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN------IANINDDMLE 501 (680)
T ss_dssp TCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSC------CCCCCTTTTT
T ss_pred CcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCC------CCcCChhhhc
Confidence 356778888888888777665 77777777777777665310 00111111122222111100 111110 123
Q ss_pred CCCceeEEEecCCCCCccC----C----hhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCcccc
Q 003385 414 PQPSITVIHLSSKNLTGNI----P----SDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLM 484 (824)
Q Consensus 414 ~~~~L~~L~L~~n~l~g~l----p----~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~ 484 (824)
.+++|+.|+|++|++++.. | ..|.+|++|+.|+|++|+|+.+++. |.++++|+.|+|++|+|++..|..|.
T Consensus 502 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~ 581 (680)
T 1ziw_A 502 GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFN 581 (680)
T ss_dssp TCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred cccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhC
Confidence 5678999999999998532 2 2378999999999999999988775 89999999999999999965556788
Q ss_pred CCCccceeeeccccccccccccc----cccceeccccCCccccCCC
Q 003385 485 NLPNLRELYVQNNMLSGTVPSSL----LSKNVVLNYAGNINLHEGG 526 (824)
Q Consensus 485 ~l~~L~~L~l~~N~l~g~ip~~l----~~~~~~l~~~~n~~lc~~~ 526 (824)
++++|+.|+|++|+|++ +|+.. +..+..+.+.+|+..|.+.
T Consensus 582 ~l~~L~~L~L~~N~l~~-~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 582 NQVSLKSLNLQKNLITS-VEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp TCTTCCEEECTTSCCCB-CCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred CCCCCCEEECCCCcCCc-cChhHhcccccccCEEEccCCCcccCCc
Confidence 99999999999999994 55543 3556788899999999874
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.3e-12 Score=156.37 Aligned_cols=155 Identities=14% Similarity=0.077 Sum_probs=86.1
Q ss_pred cceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEc-CCCCCCc
Q 003385 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQPS 417 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c-~~~~~~~ 417 (824)
+.++.|+|+.|.++.+|+. +..++.|+.|+++.|.+.......+..+..++....+++. ...+.. ....+++
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~------l~~l~~~~~~~l~~ 98 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE------LSQLSDKTFAFCTN 98 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSC------CCCCCTTTTTTCTT
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCc------cCccChhhhccCCC
Confidence 4678899999999999986 9999999999999887765333333333333332221100 011111 1223445
Q ss_pred eeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCcccc--CCCccceeee
Q 003385 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLM--NLPNLRELYV 494 (824)
Q Consensus 418 L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~--~l~~L~~L~l 494 (824)
|++|+|++|++++..|..|++|++|+.|+|++|++++.+|. +.++++|+.|+|++|++++..|..++ .+++|+.|++
T Consensus 99 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 178 (680)
T 1ziw_A 99 LTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL 178 (680)
T ss_dssp CSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEEC
T ss_pred CCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEEC
Confidence 55555555555544444555555555555555555555443 45555555555555555544443332 3355555555
Q ss_pred cccccc
Q 003385 495 QNNMLS 500 (824)
Q Consensus 495 ~~N~l~ 500 (824)
++|+++
T Consensus 179 ~~n~l~ 184 (680)
T 1ziw_A 179 SSNQIK 184 (680)
T ss_dssp TTCCCC
T ss_pred CCCccc
Confidence 555555
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.7e-12 Score=159.47 Aligned_cols=140 Identities=19% Similarity=0.163 Sum_probs=88.9
Q ss_pred ccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcH-HHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCC
Q 003385 339 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDG-VAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~-~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (824)
.++|+.|+|+.|.++.++|. +..++.|+.|+++.|.... +...+ ..+++
T Consensus 23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~-----------------------------f~~L~ 73 (844)
T 3j0a_A 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEA-----------------------------FRNLP 73 (844)
T ss_dssp CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTT-----------------------------TSSCT
T ss_pred CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHH-----------------------------hcCCC
Confidence 45788999999999998654 9999999999998873221 00001 12345
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCC-C--CCCCCCcceEeecccccCCCCC-ccccCCCcccee
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-D--FSGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLREL 492 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p-~--~~~l~~L~~L~L~~N~l~g~lP-~~l~~l~~L~~L 492 (824)
+|++|+|++|++++..|..|++|++|+.|+|++|++++.+| . +.+|++|+.|+|++|++++..| ..|++|++|+.|
T Consensus 74 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L 153 (844)
T 3j0a_A 74 NLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSI 153 (844)
T ss_dssp TCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEE
T ss_pred CCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEE
Confidence 66666666666665556666666666666666666665333 2 5666666666666666665433 456666666666
Q ss_pred eeccccccccccccc
Q 003385 493 YVQNNMLSGTVPSSL 507 (824)
Q Consensus 493 ~l~~N~l~g~ip~~l 507 (824)
+|++|.+++..|..+
T Consensus 154 ~Ls~N~i~~~~~~~l 168 (844)
T 3j0a_A 154 DFSSNQIFLVCEHEL 168 (844)
T ss_dssp EEESSCCCCCCSGGG
T ss_pred ECCCCcCCeeCHHHc
Confidence 666666665444443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.33 E-value=1e-12 Score=129.64 Aligned_cols=131 Identities=15% Similarity=0.057 Sum_probs=108.2
Q ss_pred ccccceeeecccccCCCCCCcccchhh-hceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCC
Q 003385 337 LSLPFVLSFKFGKTYDSSRGPLLNAME-INKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQ 415 (824)
Q Consensus 337 ~~l~~l~~L~L~~n~~s~LPP~i~~le-~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~ 415 (824)
..++.|+.|+|++|.++.+|. +..+. .|+.|+++.|.+.. .. ....+
T Consensus 16 ~~~~~L~~L~l~~n~l~~i~~-~~~~~~~L~~L~Ls~N~l~~-----------~~--------------------~l~~l 63 (176)
T 1a9n_A 16 TNAVRDRELDLRGYKIPVIEN-LGATLDQFDAIDFSDNEIRK-----------LD--------------------GFPLL 63 (176)
T ss_dssp ECTTSCEEEECTTSCCCSCCC-GGGGTTCCSEEECCSSCCCE-----------EC--------------------CCCCC
T ss_pred CCcCCceEEEeeCCCCchhHH-hhhcCCCCCEEECCCCCCCc-----------cc--------------------ccccC
Confidence 346788999999999999965 55554 99999999998763 00 11345
Q ss_pred CceeEEEecCCCCCccCChhhhcccccccccccccccCCCCC--CCCCCCCcceEeecccccCCCCCcc----ccCCCcc
Q 003385 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDNQLTGPLPSS----LMNLPNL 489 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~L~~N~l~g~lP~~----l~~l~~L 489 (824)
++|+.|+|++|+|++..|..+..+++|+.|+|++|+|+..++ .+..+++|+.|+|++|+++ .+|.. ++.+++|
T Consensus 64 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L 142 (176)
T 1a9n_A 64 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQV 142 (176)
T ss_dssp SSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTC
T ss_pred CCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCcc
Confidence 789999999999995434455999999999999999988776 6889999999999999999 67775 9999999
Q ss_pred ceeeecccccc
Q 003385 490 RELYVQNNMLS 500 (824)
Q Consensus 490 ~~L~l~~N~l~ 500 (824)
+.|++++|.+.
T Consensus 143 ~~Ld~~~n~~~ 153 (176)
T 1a9n_A 143 RVLDFQKVKLK 153 (176)
T ss_dssp SEETTEECCHH
T ss_pred ceeCCCcCCHH
Confidence 99999999887
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.33 E-value=1.9e-12 Score=152.54 Aligned_cols=147 Identities=20% Similarity=0.211 Sum_probs=122.7
Q ss_pred ccccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCC
Q 003385 337 LSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (824)
Q Consensus 337 ~~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (824)
..|+.|+.|+|+.|.++.+| .|..++.|+.|+|+.|.+.. ..| ...++
T Consensus 40 ~~L~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~Ls~N~l~~-------------------~~~------------l~~l~ 87 (605)
T 1m9s_A 40 NELNSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTD-------------------IKP------------LTNLK 87 (605)
T ss_dssp HHHTTCCCCBCTTCCCCCCT-TGGGCTTCCEEECTTSCCCC-------------------CGG------------GGGCT
T ss_pred hcCCCCCEEECcCCCCCCCh-HHccCCCCCEEEeeCCCCCC-------------------Chh------------hccCC
Confidence 35778899999999999997 58999999999999987663 111 12467
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecc
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~ 496 (824)
+|+.|+|++|+|+ .+| .+..|++|+.|+|++|+|+++ +.+..|++|+.|+|++|+|++ + ..++.|++|+.|+|++
T Consensus 88 ~L~~L~Ls~N~l~-~l~-~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~ 162 (605)
T 1m9s_A 88 NLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSLED 162 (605)
T ss_dssp TCCEEECCSSCCC-CCT-TSTTCTTCCEEECTTSCCCCC-GGGGGCTTCSEEECCSSCCCC-C-GGGGSCTTCSEEECCS
T ss_pred CCCEEECcCCCCC-CCh-hhccCCCCCEEEecCCCCCCC-ccccCCCccCEEECCCCccCC-c-hhhcccCCCCEEECcC
Confidence 9999999999999 455 799999999999999999985 669999999999999999995 4 6899999999999999
Q ss_pred ccccccccccccccceeccccCCc
Q 003385 497 NMLSGTVPSSLLSKNVVLNYAGNI 520 (824)
Q Consensus 497 N~l~g~ip~~l~~~~~~l~~~~n~ 520 (824)
|+|++..|-.-+..+..|.+++|.
T Consensus 163 N~l~~~~~l~~l~~L~~L~Ls~N~ 186 (605)
T 1m9s_A 163 NQISDIVPLAGLTKLQNLYLSKNH 186 (605)
T ss_dssp SCCCCCGGGTTCTTCCEEECCSSC
T ss_pred CcCCCchhhccCCCCCEEECcCCC
Confidence 999976664445556677777774
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.3e-12 Score=150.54 Aligned_cols=138 Identities=14% Similarity=0.149 Sum_probs=115.4
Q ss_pred cceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+.++.|+|+.|.++.+++. +..++.|+.|+++.|.+... .+- ....+++|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i-------------------~~~----------~~~~l~~L 78 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI-------------------EDG----------AYQSLSHL 78 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEE-------------------CTT----------TTTTCTTC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCcc-------------------Ccc----------cccCchhC
Confidence 3678999999999999885 99999999999999876531 000 01345789
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCC-CCCCCCCcceEeecccccCC-CCCccccCCCccceeeecc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQN 496 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~g-~lP~~l~~l~~L~~L~l~~ 496 (824)
++|+|++|++++..|..|++|++|+.|+|++|++++.++ .++++++|++|+|++|++++ .+|..|++|++|+.|++++
T Consensus 79 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~ 158 (570)
T 2z63_A 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158 (570)
T ss_dssp CEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTT
T ss_pred CEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcC
Confidence 999999999997777899999999999999999999887 48999999999999999986 4799999999999999999
Q ss_pred cccccccccc
Q 003385 497 NMLSGTVPSS 506 (824)
Q Consensus 497 N~l~g~ip~~ 506 (824)
|++++..|..
T Consensus 159 n~l~~~~~~~ 168 (570)
T 2z63_A 159 NKIQSIYCTD 168 (570)
T ss_dssp SCCCEECGGG
T ss_pred CccceecHHH
Confidence 9999444443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=2.4e-12 Score=140.00 Aligned_cols=168 Identities=16% Similarity=0.148 Sum_probs=89.0
Q ss_pred ceeeecccccCCCCCCc-ccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCcee
Q 003385 341 FVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 419 (824)
Q Consensus 341 ~l~~L~L~~n~~s~LPP-~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~ 419 (824)
.++.|+|+.|.++.+|+ .+..++.|+.|+++.|.+.......+..+..++....+.+. ...++. .-.++|+
T Consensus 53 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~------l~~l~~--~~~~~L~ 124 (330)
T 1xku_A 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ------LKELPE--KMPKTLQ 124 (330)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC------CSBCCS--SCCTTCC
T ss_pred CCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCc------CCccCh--hhccccc
Confidence 45667777777777776 37777777777777766553211112222112211111000 000000 0113566
Q ss_pred EEEecCCCCCccCChhhhcccccccccccccccCC--CCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeecc
Q 003385 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG--PIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (824)
Q Consensus 420 ~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~--~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~ 496 (824)
+|+|++|++++..+..+.++++|+.|+|++|+++. ..+. +.++++|+.|+|++|+++ .+|..+. ++|+.|+|++
T Consensus 125 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~ 201 (330)
T 1xku_A 125 ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDG 201 (330)
T ss_dssp EEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTT
T ss_pred EEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCC
Confidence 66666666665555556666666666666666653 3333 666666666666666666 4555543 5666666666
Q ss_pred cccccccccccc--ccceeccccCC
Q 003385 497 NMLSGTVPSSLL--SKNVVLNYAGN 519 (824)
Q Consensus 497 N~l~g~ip~~l~--~~~~~l~~~~n 519 (824)
|++++..|..+. ..+..+.+++|
T Consensus 202 n~l~~~~~~~~~~l~~L~~L~Ls~n 226 (330)
T 1xku_A 202 NKITKVDAASLKGLNNLAKLGLSFN 226 (330)
T ss_dssp SCCCEECTGGGTTCTTCCEEECCSS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCC
Confidence 666633333332 12344455555
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=1.6e-12 Score=151.42 Aligned_cols=139 Identities=20% Similarity=0.143 Sum_probs=85.2
Q ss_pred cceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+.|+.|+|+.|.++.++|. +..++.|+.|+++.|.+.......+ ..+++|
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~-----------------------------~~l~~L 76 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAF-----------------------------YSLGSL 76 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTT-----------------------------TTCTTC
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhc-----------------------------cccccC
Confidence 4678888888888888664 8888888888888887653111111 234456
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCC--CCCCCCCCCcceEeecccccCCCCC-ccccCCCccceeeec
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGP--IPDFSGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELYVQ 495 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~--~p~~~~l~~L~~L~L~~N~l~g~lP-~~l~~l~~L~~L~l~ 495 (824)
++|+|++|++++..|..|++|++|+.|+|++|++++. ++.+.++++|+.|+|++|++.+.+| ..++++++|++|+++
T Consensus 77 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~ 156 (549)
T 2z81_A 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156 (549)
T ss_dssp CEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEE
T ss_pred CEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeecc
Confidence 6666666666644444566666666666666666642 2335666666666666666433444 356666666666666
Q ss_pred cccccccccccc
Q 003385 496 NNMLSGTVPSSL 507 (824)
Q Consensus 496 ~N~l~g~ip~~l 507 (824)
+|++++.+|..+
T Consensus 157 ~n~l~~~~~~~l 168 (549)
T 2z81_A 157 ALSLRNYQSQSL 168 (549)
T ss_dssp ETTCCEECTTTT
T ss_pred CCcccccChhhh
Confidence 666665555444
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.5e-12 Score=150.59 Aligned_cols=87 Identities=21% Similarity=0.301 Sum_probs=42.8
Q ss_pred CCceeEEEecCCCCCccCChhhhcccccccccccccccCCC-CC-CCCCCCCcceEeecccccCCCCCccccCCCcc--c
Q 003385 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGP-IP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNL--R 490 (824)
Q Consensus 415 ~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~-~p-~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L--~ 490 (824)
+++|++|+|++|+|+ .+|.. .+++|++|+|++|++++. +| .++++++|+.|+|++|+|++ ..++.+++| +
T Consensus 68 l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~ 141 (520)
T 2z7x_B 68 NQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNIS 141 (520)
T ss_dssp CTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEE
T ss_pred ccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceee
Confidence 345555555555555 44443 455555555555555542 22 35555555555555555543 234444444 5
Q ss_pred eeeeccccc--cccccccc
Q 003385 491 ELYVQNNML--SGTVPSSL 507 (824)
Q Consensus 491 ~L~l~~N~l--~g~ip~~l 507 (824)
.|++++|++ .+.+|..+
T Consensus 142 ~L~l~~n~l~~~~~~~~~l 160 (520)
T 2z7x_B 142 KVLLVLGETYGEKEDPEGL 160 (520)
T ss_dssp EEEEEECTTTTSSCCTTTT
T ss_pred EEEeecccccccccccccc
Confidence 555555555 44444443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.30 E-value=2.6e-12 Score=126.26 Aligned_cols=106 Identities=24% Similarity=0.298 Sum_probs=92.3
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeec
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~ 495 (824)
+.+.|++++|+|+ .+|..+. ++|+.|+|++|+|++++|. |.++++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 4578999999999 7998774 8999999999999999886 8999999999999999997666678999999999999
Q ss_pred cccccccccccccc---cceeccccCCccccCCC
Q 003385 496 NNMLSGTVPSSLLS---KNVVLNYAGNINLHEGG 526 (824)
Q Consensus 496 ~N~l~g~ip~~l~~---~~~~l~~~~n~~lc~~~ 526 (824)
+|+|+ .+|...+. .+..+.+++|+..|.+.
T Consensus 87 ~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 87 DNQLK-SIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SSCCC-CCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CCccC-EeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 99999 67776544 44678889999888763
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.30 E-value=4.9e-13 Score=153.87 Aligned_cols=178 Identities=13% Similarity=-0.000 Sum_probs=115.4
Q ss_pred cccceeeecccccCCCCCCc-ccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCC---CCCCCeeEcCCC
Q 003385 338 SLPFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCL---PVPWSWLQCNSD 413 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP-~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~---~~~~~~~~c~~~ 413 (824)
..++|+.|+|+.|.++.+|| .|..+..|+.|+++.|.+..... +..+..+..+..+++.-.. ......+..+..
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N 109 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANN 109 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSS
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCC
Confidence 34589999999999999987 49999999999999998764111 3333333333221110000 001122222211
Q ss_pred C--------CCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CC-CCCCcceEeecccccCCCCCccc
Q 003385 414 P--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FS-GCPDLRIIHLEDNQLTGPLPSSL 483 (824)
Q Consensus 414 ~--------~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~-~l~~L~~L~L~~N~l~g~lP~~l 483 (824)
. +++|+.|+|++|+|++..|..++++++|+.|+|++|+|++.+|. +. .+++|+.|+|++|+|++. |. +
T Consensus 110 ~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~ 187 (487)
T 3oja_A 110 NISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-Q 187 (487)
T ss_dssp CCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-C
T ss_pred cCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-c
Confidence 1 35677778888888877777788888888888888888876664 54 678888888888888744 32 4
Q ss_pred cCCCccceeeecccccccccccccc--ccceeccccCCc
Q 003385 484 MNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLNYAGNI 520 (824)
Q Consensus 484 ~~l~~L~~L~l~~N~l~g~ip~~l~--~~~~~l~~~~n~ 520 (824)
..+++|+.|+|++|.|+ .+|+.+. ..+..+.+++|.
T Consensus 188 ~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~Ls~N~ 225 (487)
T 3oja_A 188 VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225 (487)
T ss_dssp CCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSC
T ss_pred ccCCCCCEEECCCCCCC-CCCHhHcCCCCccEEEecCCc
Confidence 45778888888888888 4555543 234556666664
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.29 E-value=1.3e-12 Score=152.54 Aligned_cols=147 Identities=18% Similarity=0.145 Sum_probs=103.3
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+++|+.|+|++|.++.+|+ +.. .|+.|++++|.+..... .+..+..+..+++. ..+++. .+++|
T Consensus 99 l~~L~~L~Ls~N~l~~ip~-l~~--~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~------l~~lp~---~l~~L 162 (571)
T 3cvr_A 99 PASLEYLDACDNRLSTLPE-LPA--SLKHLDVDNNQLTMLPE----LPALLEYINADNNQ------LTMLPE---LPTSL 162 (571)
T ss_dssp CTTCCEEECCSSCCSCCCC-CCT--TCCEEECCSSCCSCCCC----CCTTCCEEECCSSC------CSCCCC---CCTTC
T ss_pred cCCCCEEEccCCCCCCcch-hhc--CCCEEECCCCcCCCCCC----cCccccEEeCCCCc------cCcCCC---cCCCc
Confidence 4677888888888888888 665 78888888887664111 11122222211110 111221 35688
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCc-------ceEeecccccCCCCCccccCCCccce
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDL-------RIIHLEDNQLTGPLPSSLMNLPNLRE 491 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L-------~~L~L~~N~l~g~lP~~l~~l~~L~~ 491 (824)
+.|+|++|+|++ +|. |. ++|+.|+|++|+|+.+++ +.+ +| +.|+|++|+|+ .+|..++++++|+.
T Consensus 163 ~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~ 234 (571)
T 3cvr_A 163 EVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCT 234 (571)
T ss_dssp CEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEE
T ss_pred CEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCchhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCE
Confidence 999999999985 777 66 889999999999986666 554 66 89999999998 78888888999999
Q ss_pred eeeccccccccccccccc
Q 003385 492 LYVQNNMLSGTVPSSLLS 509 (824)
Q Consensus 492 L~l~~N~l~g~ip~~l~~ 509 (824)
|+|++|+|+|.+|..+..
T Consensus 235 L~L~~N~l~~~~p~~l~~ 252 (571)
T 3cvr_A 235 IILEDNPLSSRIRESLSQ 252 (571)
T ss_dssp EECCSSSCCHHHHHHHHH
T ss_pred EEeeCCcCCCcCHHHHHH
Confidence 999999998888877644
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.29 E-value=6.2e-13 Score=144.10 Aligned_cols=139 Identities=18% Similarity=0.180 Sum_probs=114.5
Q ss_pred ccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCc
Q 003385 339 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (824)
+++|+.|+|+.|.++.++|. +..+..|+.|+++.|.+..... ..+ ...+++
T Consensus 119 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---------~~~-------------------~~~l~~ 170 (317)
T 3o53_A 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF---------AEL-------------------AASSDT 170 (317)
T ss_dssp CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEG---------GGG-------------------GGGTTT
T ss_pred cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccH---------HHH-------------------hhccCc
Confidence 57799999999999999885 8999999999999998764100 000 013468
Q ss_pred eeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeeccc
Q 003385 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 418 L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N 497 (824)
|++|+|++|++++ +|. ...+++|+.|+|++|+|++.++.+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|
T Consensus 171 L~~L~L~~N~l~~-~~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N 247 (317)
T 3o53_A 171 LEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247 (317)
T ss_dssp CCEEECTTSCCCE-EEC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTC
T ss_pred CCEEECCCCcCcc-ccc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCC
Confidence 9999999999994 444 44599999999999999998888999999999999999999 78989999999999999999
Q ss_pred ccc-cccccccc
Q 003385 498 MLS-GTVPSSLL 508 (824)
Q Consensus 498 ~l~-g~ip~~l~ 508 (824)
++. +.+|..+.
T Consensus 248 ~~~~~~~~~~~~ 259 (317)
T 3o53_A 248 GFHCGTLRDFFS 259 (317)
T ss_dssp CCBHHHHHHHHH
T ss_pred CccCcCHHHHHh
Confidence 998 66665543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.28 E-value=5.8e-12 Score=143.68 Aligned_cols=158 Identities=18% Similarity=0.182 Sum_probs=93.0
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
++.|+.|+|+.|.++.+| +..++.|+.|+++.|.+.... +..+..+..+....+... ..+ ....+++|
T Consensus 105 l~~L~~L~L~~N~l~~l~--~~~l~~L~~L~l~~N~l~~l~---l~~l~~L~~L~l~~n~~~-----~~~--~~~~l~~L 172 (457)
T 3bz5_A 105 LTKLTYLNCDTNKLTKLD--VSQNPLLTYLNCARNTLTEID---VSHNTQLTELDCHLNKKI-----TKL--DVTPQTQL 172 (457)
T ss_dssp CTTCCEEECCSSCCSCCC--CTTCTTCCEEECTTSCCSCCC---CTTCTTCCEEECTTCSCC-----CCC--CCTTCTTC
T ss_pred CCcCCEEECCCCcCCeec--CCCCCcCCEEECCCCccceec---cccCCcCCEEECCCCCcc-----ccc--ccccCCcC
Confidence 445555566666655553 555555666666555544321 111111111111100000 000 12345678
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~ 498 (824)
+.|+|++|++++ +| ++.+++|+.|+|++|++++. ++..+++|+.|+|++|+|++ +| ++.+++|+.|++++|+
T Consensus 173 ~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~ 244 (457)
T 3bz5_A 173 TTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNP 244 (457)
T ss_dssp CEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSC
T ss_pred CEEECCCCccce-ec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCc
Confidence 888888888874 55 77778888888888888776 37777888888888888885 66 7778888888888888
Q ss_pred ccccccccccccceecccc
Q 003385 499 LSGTVPSSLLSKNVVLNYA 517 (824)
Q Consensus 499 l~g~ip~~l~~~~~~l~~~ 517 (824)
+++ +|...+..+..+.+.
T Consensus 245 l~~-~~~~~l~~L~~L~l~ 262 (457)
T 3bz5_A 245 LTE-LDVSTLSKLTTLHCI 262 (457)
T ss_dssp CSC-CCCTTCTTCCEEECT
T ss_pred CCC-cCHHHCCCCCEEecc
Confidence 883 555445444444333
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.6e-11 Score=121.06 Aligned_cols=139 Identities=17% Similarity=0.213 Sum_probs=95.4
Q ss_pred eEeecCCCCCcccCCCeEEecCCccc-cCceeeee----cCc---ccccccceeeeecCCCCcceeeecccCCceeEEEE
Q 003385 33 VSLNCGGNENFTDEIGLQWIADDHLI-YGEISNIS----VAN---ETRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRA 104 (824)
Q Consensus 33 ~~idcg~~~~~~~~~~~~~~~d~~~~-~~~~~~~~----~~~---~~~~~~~tlr~fp~~~~~~cy~~~~~~~~~ylvr~ 104 (824)
+.||||++.. +|..+++|.+|..|. .|..+... ... ...+.|+|-|.||. +.+|.+|+.++|+|+||.
T Consensus 8 ~~INcGg~~~-~d~~gr~w~~D~~~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~~---~~tY~f~v~~~G~Y~VrL 83 (174)
T 2jwp_A 8 WAVNAGGESH-VDVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNED---SFGYDIPIKEEGEYVLVL 83 (174)
T ss_dssp EEEEETSSSE-EETTTEEECSSCSSTTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCCCS---CEEEEEECCSCEEEEEEE
T ss_pred EEEECCCCCc-cCCCCCEEcCCcCcccCCcccccccceEecccCCCCchhhhhhccCCC---CeEEEEEeCCCeEEEEEE
Confidence 4799998864 567899999998886 34322111 110 11246899999995 579999999999999999
Q ss_pred EeeecccCCCCCCCceeEEeCCcee-eeEeeC---CcCcceEEEEEEEe-------------cCCCceEEEeccCCCCce
Q 003385 105 TFLYGNFDNNNVYPKFDISLGPTHW-STIVIS---DAATIEVRELIFLA-------------SSPKIDVCLSNATTGQPF 167 (824)
Q Consensus 105 ~~~yg~~d~~~~~p~fd~~~~~~~w-~~v~~~---~~~~~~~~e~~~~~-------------~~~~~~vcl~~~~~~~pf 167 (824)
.|.--.|.+ ....+||++|+|..- .-.+.. ....+.+.|..+.+ .+..+.|.|.....+.||
T Consensus 84 hF~ei~~~~-~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~~~~a~ 162 (174)
T 2jwp_A 84 KFAEVYFAQ-SQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPK 162 (174)
T ss_dssp EEECCSCCC-SSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSSSCSSS
T ss_pred EEeccccCC-CCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccCCCCcE
Confidence 998776653 456799999999532 122221 12234455555542 455688888864456799
Q ss_pred eeeeeeeec
Q 003385 168 ISTLELRQF 176 (824)
Q Consensus 168 is~le~~~l 176 (824)
||+||+.+-
T Consensus 163 inaIEI~~~ 171 (174)
T 2jwp_A 163 VCALFIMKG 171 (174)
T ss_dssp EEEEEEESS
T ss_pred EEEEEEEeC
Confidence 999999863
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.28 E-value=1.2e-12 Score=138.00 Aligned_cols=169 Identities=17% Similarity=0.207 Sum_probs=100.5
Q ss_pred ccccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCC
Q 003385 337 LSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (824)
Q Consensus 337 ~~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (824)
..+..+..++|+++.++.++ .+..++.|+.|++++|.+.... .+..+..+..+..+++. ...+.. ...++
T Consensus 16 ~~l~~l~~l~l~~~~i~~~~-~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~L~~N~------i~~~~~-l~~l~ 85 (263)
T 1xeu_A 16 PGLANAVKQNLGKQSVTDLV-SQKELSGVQNFNGDNSNIQSLA--GMQFFTNLKELHLSHNQ------ISDLSP-LKDLT 85 (263)
T ss_dssp HHHHHHHHHHHTCSCTTSEE-CHHHHTTCSEEECTTSCCCCCT--TGGGCTTCCEEECCSSC------CCCCGG-GTTCS
T ss_pred HHHHHHHHHHhcCCCccccc-chhhcCcCcEEECcCCCcccch--HHhhCCCCCEEECCCCc------cCCChh-hccCC
Confidence 35667888999999999998 6899999999999999876421 23333333333221111 111111 23455
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecc
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~ 496 (824)
+|+.|+|++|+++ .+|.... ++|+.|+|++|+|++. +.+.++++|+.|+|++|+|++ +| .++.+++|+.|+|++
T Consensus 86 ~L~~L~L~~N~l~-~l~~~~~--~~L~~L~L~~N~l~~~-~~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~ 159 (263)
T 1xeu_A 86 KLEELSVNRNRLK-NLNGIPS--ACLSRLFLDNNELRDT-DSLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHG 159 (263)
T ss_dssp SCCEEECCSSCCS-CCTTCCC--SSCCEEECCSSCCSBS-GGGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTT
T ss_pred CCCEEECCCCccC-CcCcccc--CcccEEEccCCccCCC-hhhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCC
Confidence 6666666666666 3444222 6666666666666664 346666667777777777663 33 566666677777777
Q ss_pred ccccccccccc--cccceeccccCCcccc
Q 003385 497 NMLSGTVPSSL--LSKNVVLNYAGNINLH 523 (824)
Q Consensus 497 N~l~g~ip~~l--~~~~~~l~~~~n~~lc 523 (824)
|++++. ..+ +..+..+.+++|+..+
T Consensus 160 N~i~~~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 160 NEITNT--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp SCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred CcCcch--HHhccCCCCCEEeCCCCcccC
Confidence 766633 222 2233445555665443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.27 E-value=7.1e-12 Score=143.20 Aligned_cols=105 Identities=24% Similarity=0.290 Sum_probs=79.9
Q ss_pred CCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceee
Q 003385 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (824)
Q Consensus 414 ~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~ 493 (824)
.+++|+.|+|++|++++ ++. ++.+++|+.|+|++|++++.+| +..+++|+.|+|++|++++. ..++++++|+.|+
T Consensus 285 ~l~~L~~L~L~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~ 359 (466)
T 1o6v_A 285 GLTALTNLELNENQLED-ISP-ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLS 359 (466)
T ss_dssp TCTTCSEEECCSSCCSC-CGG-GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEE
T ss_pred CCCccCeEEcCCCcccC-chh-hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCCc--hhhccCCCCCEEe
Confidence 45688888888888885 333 7888888888888888888777 77888888888888888853 4688888888888
Q ss_pred eccccccccccccccccceeccccCCcccc
Q 003385 494 VQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523 (824)
Q Consensus 494 l~~N~l~g~ip~~l~~~~~~l~~~~n~~lc 523 (824)
+++|++++..|..-+..+..+.+.+|....
T Consensus 360 l~~n~l~~~~~~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 360 AGHNQISDLTPLANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CCSSCCCBCGGGTTCTTCCEEECCCEEEEC
T ss_pred CCCCccCccchhhcCCCCCEEeccCCcccC
Confidence 888888877774445555666777775443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.26 E-value=7e-12 Score=123.71 Aligned_cols=92 Identities=23% Similarity=0.324 Sum_probs=82.9
Q ss_pred CCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceee
Q 003385 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (824)
Q Consensus 415 ~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~ 493 (824)
.++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|+++++. |.++++|+.|+|++|+|++..+..|..|++|+.|+
T Consensus 32 ~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~ 111 (174)
T 2r9u_A 32 PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIY 111 (174)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEE
Confidence 36899999999999988889999999999999999999999887 68999999999999999965555699999999999
Q ss_pred eccccccccccccc
Q 003385 494 VQNNMLSGTVPSSL 507 (824)
Q Consensus 494 l~~N~l~g~ip~~l 507 (824)
|++|++. ..|..+
T Consensus 112 L~~N~~~-c~~~~~ 124 (174)
T 2r9u_A 112 LYNNPWD-CECRDI 124 (174)
T ss_dssp CCSSCBC-TTBGGG
T ss_pred eCCCCcc-cccccH
Confidence 9999999 555543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.2e-11 Score=144.63 Aligned_cols=133 Identities=17% Similarity=0.121 Sum_probs=72.1
Q ss_pred cceeeecccccCCCCCCc-ccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 340 PFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP-~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+.|+.|+|+.|.++.+|| .+..++.|+.|+++.|.+.. ..|- ....+++|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-------------------~~~~----------~~~~l~~L 102 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS-------------------LDFH----------VFLFNQDL 102 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCE-------------------ECTT----------TTTTCTTC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCc-------------------CCHH----------HhCCCCCC
Confidence 345555555555555554 35555555555555554432 0000 01234566
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCC-C-CCCCCCCcceEeecccccCCCCCccccCCCcc--ceeee
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI-P-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNL--RELYV 494 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~-p-~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L--~~L~l 494 (824)
++|+|++|+|+ .+|.. .|++|+.|+|++|++++.+ | .|+++++|+.|+|++|+|++. .++.+++| +.|+|
T Consensus 103 ~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L 176 (562)
T 3a79_B 103 EYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILL 176 (562)
T ss_dssp CEEECTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEE
T ss_pred CEEECCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEe
Confidence 66666666666 55554 5666666666666666533 2 366666666666666666642 23333333 66666
Q ss_pred ccccc--cccccccc
Q 003385 495 QNNML--SGTVPSSL 507 (824)
Q Consensus 495 ~~N~l--~g~ip~~l 507 (824)
++|++ ++..|..+
T Consensus 177 ~~n~l~~~~~~~~~l 191 (562)
T 3a79_B 177 DLVSYHIKGGETESL 191 (562)
T ss_dssp EESSCCCCSSSCCEE
T ss_pred ecccccccccCcccc
Confidence 66666 55555444
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.24 E-value=3.6e-13 Score=149.95 Aligned_cols=181 Identities=14% Similarity=0.134 Sum_probs=133.9
Q ss_pred cccceeeecccccCCCC-----CCcccchhhhceeccCCCCCCcHHHHHHHHHh-------------cCCCCcccCCCCC
Q 003385 338 SLPFVLSFKFGKTYDSS-----RGPLLNAMEINKYLERNDGSIDGVAIVSVISL-------------YSSADWAQEGGDP 399 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~-----LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~-------------~~~~~w~~~~~dp 399 (824)
.+++|+.|+|+.|.++. +|+.+..+..|+.|+++.|.+.......+... ..+..+..+++.
T Consensus 92 ~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~- 170 (386)
T 2ca6_A 92 KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR- 170 (386)
T ss_dssp TCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC-
T ss_pred hCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCC-
Confidence 46789999999999998 88889999999999999999976555444443 345554332111
Q ss_pred CCCCCCCeeE---cCCCCCCceeEEEecCCCCC--c---cCChhhhcccccccccccccccC----CCCC-CCCCCCCcc
Q 003385 400 CLPVPWSWLQ---CNSDPQPSITVIHLSSKNLT--G---NIPSDLTKLSSLVELWLDGNSLT----GPIP-DFSGCPDLR 466 (824)
Q Consensus 400 c~~~~~~~~~---c~~~~~~~L~~L~L~~n~l~--g---~lp~~i~~L~~L~~L~L~~N~l~----~~~p-~~~~l~~L~ 466 (824)
. ....+. .....+++|+.|+|++|+++ | .+|..+.++++|+.|+|++|.|+ +.+| .+..+++|+
T Consensus 171 l---~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~ 247 (386)
T 2ca6_A 171 L---ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 247 (386)
T ss_dssp C---TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCC
T ss_pred C---CcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcC
Confidence 1 001111 01113468999999999998 3 35558889999999999999995 4444 488899999
Q ss_pred eEeecccccCCC----CCccc--cCCCccceeeeccccccc----cccccc---cccceeccccCCccc
Q 003385 467 IIHLEDNQLTGP----LPSSL--MNLPNLRELYVQNNMLSG----TVPSSL---LSKNVVLNYAGNINL 522 (824)
Q Consensus 467 ~L~L~~N~l~g~----lP~~l--~~l~~L~~L~l~~N~l~g----~ip~~l---~~~~~~l~~~~n~~l 522 (824)
.|+|++|+|++. +|..+ +.+++|+.|+|++|++++ .+|..+ +..+..+.+.+|...
T Consensus 248 ~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~ 316 (386)
T 2ca6_A 248 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316 (386)
T ss_dssp EEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred EEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCC
Confidence 999999999865 67777 448999999999999996 488877 455677788888544
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.24 E-value=8.3e-12 Score=136.48 Aligned_cols=169 Identities=17% Similarity=0.182 Sum_probs=121.8
Q ss_pred cccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCc
Q 003385 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (824)
.+++|+.|+++.|.++.+++ +..++.|+.|+++.|.+..... +..+..+....... |. ...+.. ...+++
T Consensus 153 ~l~~L~~L~l~~~~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~---n~---l~~~~~-~~~~~~ 222 (347)
T 4fmz_A 153 NMTGLNYLTVTESKVKDVTP-IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYV---NQ---ITDITP-VANMTR 222 (347)
T ss_dssp TCTTCCEEECCSSCCCCCGG-GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCS---SC---CCCCGG-GGGCTT
T ss_pred hCCCCcEEEecCCCcCCchh-hccCCCCCEEEccCCccccccc--ccCCCccceeeccc---CC---CCCCch-hhcCCc
Confidence 45678888889999888887 7888889999998887654221 33333333322111 10 111111 234678
Q ss_pred eeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeeccc
Q 003385 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 418 L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N 497 (824)
|+.|+|++|+++ .+|. +..+++|+.|+|++|++++. +.+..+++|+.|+|++|++++ + +.+..+++|+.|++++|
T Consensus 223 L~~L~l~~n~l~-~~~~-~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n 297 (347)
T 4fmz_A 223 LNSLKIGNNKIT-DLSP-LANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNN 297 (347)
T ss_dssp CCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSS
T ss_pred CCEEEccCCccC-CCcc-hhcCCCCCEEECCCCccCCC-hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCC
Confidence 999999999999 4555 88999999999999999885 668889999999999999994 4 46889999999999999
Q ss_pred ccccccccccc--ccceeccccCCcc
Q 003385 498 MLSGTVPSSLL--SKNVVLNYAGNIN 521 (824)
Q Consensus 498 ~l~g~ip~~l~--~~~~~l~~~~n~~ 521 (824)
++++..|..+. ..+..+.+++|..
T Consensus 298 ~l~~~~~~~l~~l~~L~~L~L~~n~l 323 (347)
T 4fmz_A 298 QLGNEDMEVIGGLTNLTTLFLSQNHI 323 (347)
T ss_dssp CCCGGGHHHHHTCTTCSEEECCSSSC
T ss_pred cCCCcChhHhhccccCCEEEccCCcc
Confidence 99866665543 3446677788753
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.23 E-value=9.3e-12 Score=142.22 Aligned_cols=148 Identities=23% Similarity=0.260 Sum_probs=78.7
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+++|+.|+|+.|.++.++| +..++.|+.|+++.|.+... ..+..+..+..+..+++. ...+.. ...+++|
T Consensus 198 l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~------l~~~~~-~~~l~~L 267 (466)
T 1o6v_A 198 LTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQ------ISNLAP-LSGLTKL 267 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSC------CCCCGG-GTTCTTC
T ss_pred CCCCCEEEecCCccccccc-ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCc------cccchh-hhcCCCC
Confidence 4566667777777776666 56666677777766655431 112222222222111100 000000 1234556
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~ 498 (824)
+.|+|++|++++ +|. +..+++|+.|+|++|++++.++ +..+++|+.|+|++|++++..| ++.+++|+.|++++|+
T Consensus 268 ~~L~l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~ 342 (466)
T 1o6v_A 268 TELKLGANQISN-ISP-LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNK 342 (466)
T ss_dssp SEEECCSSCCCC-CGG-GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSC
T ss_pred CEEECCCCccCc-ccc-ccCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCc
Confidence 666666666663 333 5666666666666666665544 5556666666666666664433 5566666666666666
Q ss_pred ccc
Q 003385 499 LSG 501 (824)
Q Consensus 499 l~g 501 (824)
+++
T Consensus 343 l~~ 345 (466)
T 1o6v_A 343 VSD 345 (466)
T ss_dssp CCC
T ss_pred cCC
Confidence 663
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.23 E-value=1e-11 Score=145.03 Aligned_cols=155 Identities=17% Similarity=0.175 Sum_probs=112.6
Q ss_pred cceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCcee
Q 003385 340 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 419 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~ 419 (824)
++|+.|+|++|.++.+| ..++.|+.|+++.|.+..+.. +.. .+..+..+++. ..+++- .+++|+
T Consensus 80 ~~L~~L~Ls~N~l~~ip---~~l~~L~~L~Ls~N~l~~ip~--l~~--~L~~L~Ls~N~------l~~lp~---~l~~L~ 143 (571)
T 3cvr_A 80 PQITVLEITQNALISLP---ELPASLEYLDACDNRLSTLPE--LPA--SLKHLDVDNNQ------LTMLPE---LPALLE 143 (571)
T ss_dssp TTCSEEECCSSCCSCCC---CCCTTCCEEECCSSCCSCCCC--CCT--TCCEEECCSSC------CSCCCC---CCTTCC
T ss_pred CCCCEEECcCCCCcccc---cccCCCCEEEccCCCCCCcch--hhc--CCCEEECCCCc------CCCCCC---cCcccc
Confidence 46889999999999998 557899999999998775211 211 23322222111 111111 457899
Q ss_pred EEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCcc-------cee
Q 003385 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNL-------REL 492 (824)
Q Consensus 420 ~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L-------~~L 492 (824)
.|+|++|+|++ +|. .+++|+.|+|++|+|+++++ |. ++|+.|+|++|+|+ .+|. |.+ +| +.|
T Consensus 144 ~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L 212 (571)
T 3cvr_A 144 YINADNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFF 212 (571)
T ss_dssp EEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEE
T ss_pred EEeCCCCccCc-CCC---cCCCcCEEECCCCCCCCcch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEE
Confidence 99999999994 776 67899999999999998655 65 89999999999999 7887 665 77 999
Q ss_pred eeccccccccccccccc--cceeccccCCccc
Q 003385 493 YVQNNMLSGTVPSSLLS--KNVVLNYAGNINL 522 (824)
Q Consensus 493 ~l~~N~l~g~ip~~l~~--~~~~l~~~~n~~l 522 (824)
+|++|+|+ .+|..++. .+..+.+++|+..
T Consensus 213 ~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~ 243 (571)
T 3cvr_A 213 RCRENRIT-HIPENILSLDPTCTIILEDNPLS 243 (571)
T ss_dssp ECCSSCCC-CCCGGGGGSCTTEEEECCSSSCC
T ss_pred ecCCCcce-ecCHHHhcCCCCCEEEeeCCcCC
Confidence 99999999 89988765 3366777888644
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.6e-11 Score=140.02 Aligned_cols=162 Identities=17% Similarity=0.092 Sum_probs=92.7
Q ss_pred cccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCc
Q 003385 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (824)
.++.|+.|+|+.|.++.+| .+..++.|+.|+++.|.+.... +..+..++....+.+. ...+ ....+++
T Consensus 40 ~l~~L~~L~Ls~n~l~~~~-~l~~l~~L~~L~Ls~n~l~~~~---~~~l~~L~~L~Ls~N~------l~~~--~~~~l~~ 107 (457)
T 3bz5_A 40 QLATLTSLDCHNSSITDMT-GIEKLTGLTKLICTSNNITTLD---LSQNTNLTYLACDSNK------LTNL--DVTPLTK 107 (457)
T ss_dssp HHTTCCEEECCSSCCCCCT-TGGGCTTCSEEECCSSCCSCCC---CTTCTTCSEEECCSSC------CSCC--CCTTCTT
T ss_pred HcCCCCEEEccCCCcccCh-hhcccCCCCEEEccCCcCCeEc---cccCCCCCEEECcCCC------Ccee--ecCCCCc
Confidence 3567777777777777775 5777777777777777765532 2222222222221111 1111 1234566
Q ss_pred eeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeeccc
Q 003385 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 418 L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N 497 (824)
|++|+|++|++++ +| ++++++|+.|+|++|+|++. .++++++|+.|+|++|+..+.+ .++.+++|+.|++++|
T Consensus 108 L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l--~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n 180 (457)
T 3bz5_A 108 LTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI--DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFN 180 (457)
T ss_dssp CCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC--CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSS
T ss_pred CCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee--ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCC
Confidence 7777777777774 44 66777777777777777764 2566666666666666544455 3566666666666666
Q ss_pred cccccccccccccceeccccCC
Q 003385 498 MLSGTVPSSLLSKNVVLNYAGN 519 (824)
Q Consensus 498 ~l~g~ip~~l~~~~~~l~~~~n 519 (824)
+++ .+|-.-+..+..+.+++|
T Consensus 181 ~l~-~l~l~~l~~L~~L~l~~N 201 (457)
T 3bz5_A 181 KIT-ELDVSQNKLLNRLNCDTN 201 (457)
T ss_dssp CCC-CCCCTTCTTCCEEECCSS
T ss_pred ccc-eeccccCCCCCEEECcCC
Confidence 666 355333333344444444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.21 E-value=1.4e-11 Score=120.18 Aligned_cols=104 Identities=22% Similarity=0.266 Sum_probs=87.7
Q ss_pred CCceeEEEecCCCCC-ccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceee
Q 003385 415 QPSITVIHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (824)
Q Consensus 415 ~~~L~~L~L~~n~l~-g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~ 493 (824)
+++|+.|+|++|+++ +.+|..+..+++|+.|+|++|+|++. +.+..+++|+.|+|++|+|++.+|..++++++|+.|+
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 468999999999998 88999899999999999999999988 7789999999999999999977888888899999999
Q ss_pred ecccccccccc--ccc--cccceeccccCCc
Q 003385 494 VQNNMLSGTVP--SSL--LSKNVVLNYAGNI 520 (824)
Q Consensus 494 l~~N~l~g~ip--~~l--~~~~~~l~~~~n~ 520 (824)
|++|+++ .+| ..+ +..+..+.+++|.
T Consensus 102 Ls~N~l~-~~~~~~~l~~l~~L~~L~l~~N~ 131 (168)
T 2ell_A 102 LSGNKLK-DISTLEPLKKLECLKSLDLFNCE 131 (168)
T ss_dssp CBSSSCC-SSGGGGGGSSCSCCCEEECCSSG
T ss_pred ccCCccC-cchhHHHHhcCCCCCEEEeeCCc
Confidence 9999998 554 333 2334666777774
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.19 E-value=1.1e-11 Score=118.41 Aligned_cols=104 Identities=18% Similarity=0.215 Sum_probs=83.7
Q ss_pred CCceeEEEecCCCCC-ccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceee
Q 003385 415 QPSITVIHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (824)
Q Consensus 415 ~~~L~~L~L~~n~l~-g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~ 493 (824)
.++|+.|+|++|+++ +.+|..+..+++|+.|+|++|++++. +.+.++++|+.|+|++|+|++.+|..++.+++|+.|+
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 357889999999988 78888888899999999999998887 6788889999999999999877888888888999999
Q ss_pred ecccccccccc--cccc--ccceeccccCCc
Q 003385 494 VQNNMLSGTVP--SSLL--SKNVVLNYAGNI 520 (824)
Q Consensus 494 l~~N~l~g~ip--~~l~--~~~~~l~~~~n~ 520 (824)
+++|++++ +| ..+. ..+..+.+++|.
T Consensus 95 ls~N~i~~-~~~~~~~~~l~~L~~L~l~~N~ 124 (149)
T 2je0_A 95 LSGNKIKD-LSTIEPLKKLENLKSLDLFNCE 124 (149)
T ss_dssp CTTSCCCS-HHHHGGGGGCTTCCEEECTTCG
T ss_pred CCCCcCCC-hHHHHHHhhCCCCCEEeCcCCc
Confidence 99999884 43 4442 334566677774
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.19 E-value=1.5e-11 Score=134.67 Aligned_cols=102 Identities=19% Similarity=0.217 Sum_probs=69.3
Q ss_pred EEecCC-CCCccCChhhhcccccccccccc-cccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccc
Q 003385 421 IHLSSK-NLTGNIPSDLTKLSSLVELWLDG-NSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 421 L~L~~n-~l~g~lp~~i~~L~~L~~L~L~~-N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N 497 (824)
++++++ +|+ .+|. |..+++|+.|+|++ |+|+++++. |.+|++|+.|+|++|+|++..|..|++|++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 455665 676 5676 77777777777775 777777664 677777777777777777666667777777777777777
Q ss_pred ccccccccccccc--ceeccccCCccccCC
Q 003385 498 MLSGTVPSSLLSK--NVVLNYAGNINLHEG 525 (824)
Q Consensus 498 ~l~g~ip~~l~~~--~~~l~~~~n~~lc~~ 525 (824)
+|+ .+|..++.. +..|.+.+|+..|.+
T Consensus 91 ~l~-~~~~~~~~~~~L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 91 ALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119 (347)
T ss_dssp CCS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred ccc-eeCHHHcccCCceEEEeeCCCccCCC
Confidence 777 566665543 345566667666654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.18 E-value=3.5e-11 Score=142.02 Aligned_cols=85 Identities=31% Similarity=0.342 Sum_probs=62.2
Q ss_pred CceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeec
Q 003385 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~ 495 (824)
++|+.|+|++|+|+ .+| ..+++|+.|+|++|+|+++++ .+++|+.|+|++|+|+ .+|..|+++++|+.|+|+
T Consensus 221 ~~L~~L~Ls~N~L~-~lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 221 SGLKELIVSGNRLT-SLP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292 (622)
T ss_dssp TTCCEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred CCCCEEEccCCccC-cCC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence 56777777777777 466 455777777787777776554 5677778888888887 777778888888888888
Q ss_pred ccccccccccccc
Q 003385 496 NNMLSGTVPSSLL 508 (824)
Q Consensus 496 ~N~l~g~ip~~l~ 508 (824)
+|+++|.+|..+.
T Consensus 293 ~N~l~~~~~~~l~ 305 (622)
T 3g06_A 293 GNPLSERTLQALR 305 (622)
T ss_dssp SCCCCHHHHHHHH
T ss_pred CCCCCCcCHHHHH
Confidence 8888766666543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=6.6e-11 Score=124.15 Aligned_cols=140 Identities=18% Similarity=0.094 Sum_probs=108.7
Q ss_pred HhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcC-CCccceeeceeecCCeEEEEEEecCCC
Q 003385 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~g 682 (824)
.+...++.|+.+.||+.... ++.+++|+...........+.+|+++++.+. |..+.++++++.+.+..++||||++|.
T Consensus 17 ~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 95 (263)
T 3tm0_A 17 RCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGV 95 (263)
T ss_dssp EEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSE
T ss_pred eeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCe
Confidence 34566788888999999754 6899999987533233457899999999985 677889999998888999999999999
Q ss_pred CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 003385 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC----------------------------------------- 721 (824)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~----------------------------------------- 721 (824)
+|.+.+.. ......++.+++++|..||+..
T Consensus 96 ~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 96 LCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp EHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred ehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 98775311 1122367889999999999810
Q ss_pred ---------------CCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 722 ---------------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 722 ---------------~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
.+.++|+|++|.|||++++..+.|+||+.+..
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 03589999999999998765567999997753
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=1.9e-11 Score=143.05 Aligned_cols=90 Identities=26% Similarity=0.293 Sum_probs=82.8
Q ss_pred CCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCC-CccccCCCcccee
Q 003385 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPL-PSSLMNLPNLREL 492 (824)
Q Consensus 414 ~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~l-P~~l~~l~~L~~L 492 (824)
.+++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|+++ |.+++|++|+.|+|++|+|++.. |..|++|++|+.|
T Consensus 461 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~l-p~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L 538 (567)
T 1dce_A 461 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538 (567)
T ss_dssp GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred ccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCCC-cccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEE
Confidence 4568999999999999 9999999999999999999999995 48999999999999999999776 9999999999999
Q ss_pred eecccccccccccc
Q 003385 493 YVQNNMLSGTVPSS 506 (824)
Q Consensus 493 ~l~~N~l~g~ip~~ 506 (824)
+|++|+|++ +|+.
T Consensus 539 ~L~~N~l~~-~~~~ 551 (567)
T 1dce_A 539 NLQGNSLCQ-EEGI 551 (567)
T ss_dssp ECTTSGGGG-SSSC
T ss_pred EecCCcCCC-CccH
Confidence 999999994 4443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.14 E-value=1.8e-10 Score=135.93 Aligned_cols=92 Identities=30% Similarity=0.382 Sum_probs=55.6
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecc
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~ 496 (824)
+|+.|+|++|+|+ .+|.. +++|+.|+|++|+|++++ ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++
T Consensus 202 ~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~ 270 (622)
T 3g06_A 202 ELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYR 270 (622)
T ss_dssp TCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCS
T ss_pred hhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCC
Confidence 4444444444444 33321 256677777777777644 44567777777777777 5665 456777777777
Q ss_pred ccccccccccccc--cceeccccCCc
Q 003385 497 NMLSGTVPSSLLS--KNVVLNYAGNI 520 (824)
Q Consensus 497 N~l~g~ip~~l~~--~~~~l~~~~n~ 520 (824)
|+|+ .+|..+.. .+..+.+++|+
T Consensus 271 N~L~-~lp~~l~~l~~L~~L~L~~N~ 295 (622)
T 3g06_A 271 NQLT-RLPESLIHLSSETTVNLEGNP 295 (622)
T ss_dssp SCCC-SCCGGGGGSCTTCEEECCSCC
T ss_pred CCCC-cCCHHHhhccccCEEEecCCC
Confidence 7777 77766533 23455666664
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.13 E-value=1.4e-10 Score=132.14 Aligned_cols=137 Identities=27% Similarity=0.360 Sum_probs=86.8
Q ss_pred cceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCcee
Q 003385 340 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 419 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~ 419 (824)
++|+.|+|+.|.++.+| .+..++.|+.|+++.|.+... .. ..++|+
T Consensus 131 ~~L~~L~L~~n~l~~lp-~~~~l~~L~~L~l~~N~l~~l-----------p~----------------------~~~~L~ 176 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEKLP-ELQNSSFLKIIDVDNNSLKKL-----------PD----------------------LPPSLE 176 (454)
T ss_dssp TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSCC-----------CC----------------------CCTTCC
T ss_pred CCCCEEECcCCCCCCCc-ccCCCCCCCEEECCCCcCccc-----------CC----------------------Cccccc
Confidence 57788888888888887 588888888888888866520 00 012566
Q ss_pred EEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeeccccc
Q 003385 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 499 (824)
Q Consensus 420 ~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l 499 (824)
+|+|++|++++ +| .+++|++|+.|+|++|++++.+... ++|+.|+|++|+++ .+|+ ++.+++|+.|++++|++
T Consensus 177 ~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~~---~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l 249 (454)
T 1jl5_A 177 FIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDLP---LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLL 249 (454)
T ss_dssp EEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCCC---TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCC
T ss_pred EEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCCc---CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcC
Confidence 66666666663 55 4666666666666666666533221 46666666666666 5663 66666666666666666
Q ss_pred cccccccccccceeccccCC
Q 003385 500 SGTVPSSLLSKNVVLNYAGN 519 (824)
Q Consensus 500 ~g~ip~~l~~~~~~l~~~~n 519 (824)
+ .+|.. ...+..+.+++|
T Consensus 250 ~-~l~~~-~~~L~~L~l~~N 267 (454)
T 1jl5_A 250 K-TLPDL-PPSLEALNVRDN 267 (454)
T ss_dssp S-SCCSC-CTTCCEEECCSS
T ss_pred C-ccccc-ccccCEEECCCC
Confidence 6 45542 234444555544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.13 E-value=4.1e-11 Score=131.19 Aligned_cols=84 Identities=26% Similarity=0.271 Sum_probs=61.4
Q ss_pred CceeEEEecC-CCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceee
Q 003385 416 PSITVIHLSS-KNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (824)
Q Consensus 416 ~~L~~L~L~~-n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~ 493 (824)
++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|++++|. |.+|++|+.|+|++|+|++..|..+..++ |+.|+
T Consensus 31 ~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~ 109 (347)
T 2ifg_A 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELV 109 (347)
T ss_dssp SCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEE
T ss_pred CCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEE
Confidence 4577777775 777765566777888888888888888887775 67788888888888888844444454444 88888
Q ss_pred ecccccc
Q 003385 494 VQNNMLS 500 (824)
Q Consensus 494 l~~N~l~ 500 (824)
|++|+|.
T Consensus 110 l~~N~~~ 116 (347)
T 2ifg_A 110 LSGNPLH 116 (347)
T ss_dssp CCSSCCC
T ss_pred eeCCCcc
Confidence 8888777
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.10 E-value=3.3e-12 Score=138.98 Aligned_cols=158 Identities=16% Similarity=0.160 Sum_probs=96.5
Q ss_pred cccceeeecccccCCCC--CCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCC
Q 003385 338 SLPFVLSFKFGKTYDSS--RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQ 415 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~--LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~ 415 (824)
.+++|+.|+|+.|.++. +|..+..++.|+.|+++.|.+....+..+.++..++.+..++ |.......+......+
T Consensus 91 ~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~---~~~l~~~~l~~~~~~~ 167 (336)
T 2ast_B 91 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG---CSGFSEFALQTLLSSC 167 (336)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT---CBSCCHHHHHHHHHHC
T ss_pred cCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCC---CCCCCHHHHHHHHhcC
Confidence 35677777777777764 666677777777777777777665666665554454443221 1000000111001234
Q ss_pred CceeEEEecCC-CCCcc-CChhhhccc-cccccccccc--ccC-CCCC-CCCCCCCcceEeecccc-cCCCCCccccCCC
Q 003385 416 PSITVIHLSSK-NLTGN-IPSDLTKLS-SLVELWLDGN--SLT-GPIP-DFSGCPDLRIIHLEDNQ-LTGPLPSSLMNLP 487 (824)
Q Consensus 416 ~~L~~L~L~~n-~l~g~-lp~~i~~L~-~L~~L~L~~N--~l~-~~~p-~~~~l~~L~~L~L~~N~-l~g~lP~~l~~l~ 487 (824)
++|++|+|++| ++++. ++..+..++ +|+.|+|++| .++ +.++ .+.++++|+.|+|++|. +++..+..+++++
T Consensus 168 ~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~ 247 (336)
T 2ast_B 168 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 247 (336)
T ss_dssp TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred CCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCC
Confidence 56777777777 77643 566677777 7777777777 343 2333 35567777777777777 6656666777777
Q ss_pred ccceeeecccc
Q 003385 488 NLRELYVQNNM 498 (824)
Q Consensus 488 ~L~~L~l~~N~ 498 (824)
+|+.|+|++|.
T Consensus 248 ~L~~L~l~~~~ 258 (336)
T 2ast_B 248 YLQHLSLSRCY 258 (336)
T ss_dssp TCCEEECTTCT
T ss_pred CCCEeeCCCCC
Confidence 77777777774
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.10 E-value=1e-12 Score=132.28 Aligned_cols=123 Identities=17% Similarity=0.243 Sum_probs=103.3
Q ss_pred ccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeEEEecCCCC
Q 003385 349 KTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNL 428 (824)
Q Consensus 349 ~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~L~L~~n~l 428 (824)
.+.++.+|..+..++.|+.|+++.|.+... + . ...+++|+.|+|++|++
T Consensus 34 ~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l-------------------------~--~----~~~l~~L~~L~l~~n~l 82 (198)
T 1ds9_A 34 IPPIEKMDATLSTLKACKHLALSTNNIEKI-------------------------S--S----LSGMENLRILSLGRNLI 82 (198)
T ss_dssp CTTCCCCHHHHHHTTTCSEEECSEEEESCC-------------------------C--C----HHHHTTCCEEEEEEEEE
T ss_pred cCcHhhhhHHHhcCCCCCEEECCCCCCccc-------------------------c--c----cccCCCCCEEECCCCCc
Confidence 346677777899999999999998876630 0 0 02346899999999999
Q ss_pred CccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCC--ccccCCCccceeeeccccccccccc
Q 003385 429 TGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP--SSLMNLPNLRELYVQNNMLSGTVPS 505 (824)
Q Consensus 429 ~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP--~~l~~l~~L~~L~l~~N~l~g~ip~ 505 (824)
+ .+|..+..+++|+.|+|++|+|++. |.+..+++|+.|+|++|+|+ .+| ..++.+++|+.|++++|++++.+|.
T Consensus 83 ~-~l~~~~~~~~~L~~L~L~~N~l~~l-~~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 83 K-KIENLDAVADTLEELWISYNQIASL-SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp C-SCSSHHHHHHHCSEEEEEEEECCCH-HHHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred c-cccchhhcCCcCCEEECcCCcCCcC-CccccCCCCCEEECCCCcCC-chhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 9 8999999999999999999999985 47888999999999999999 444 4899999999999999999977665
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.10 E-value=1.8e-11 Score=136.19 Aligned_cols=182 Identities=18% Similarity=0.175 Sum_probs=130.4
Q ss_pred cccceeeecccccCCCCC----Cccc-------chhhhceeccCCCCCCcHH----HHHHHHHhcCCCCcccCCCCCCCC
Q 003385 338 SLPFVLSFKFGKTYDSSR----GPLL-------NAMEINKYLERNDGSIDGV----AIVSVISLYSSADWAQEGGDPCLP 402 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~L----PP~i-------~~le~l~~L~l~~n~~~~~----~l~~lk~~~~~~~w~~~~~dpc~~ 402 (824)
.+++|+.|+|+.|.+..+ |+.+ ..++.|+.|+++.|.+... ....+.....+..+..+++. -..
T Consensus 58 ~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~-l~~ 136 (386)
T 2ca6_A 58 SKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNG-LGP 136 (386)
T ss_dssp TCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSC-CHH
T ss_pred hCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCC-CCH
Confidence 367889999999876644 4444 6778999999999998773 33345555556555332111 000
Q ss_pred CCCCeeEcCCCCC---------CceeEEEecCCCCC-ccCC---hhhhcccccccccccccccC--C---CCC-CCCCCC
Q 003385 403 VPWSWLQCNSDPQ---------PSITVIHLSSKNLT-GNIP---SDLTKLSSLVELWLDGNSLT--G---PIP-DFSGCP 463 (824)
Q Consensus 403 ~~~~~~~c~~~~~---------~~L~~L~L~~n~l~-g~lp---~~i~~L~~L~~L~L~~N~l~--~---~~p-~~~~l~ 463 (824)
.....+......+ ++|+.|+|++|+++ +.+| ..+..+++|+.|+|++|+|+ | ..| .+..++
T Consensus 137 ~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~ 216 (386)
T 2ca6_A 137 QAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ 216 (386)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCT
T ss_pred HHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCC
Confidence 0000000000011 68999999999998 5566 57889999999999999998 3 556 688999
Q ss_pred CcceEeecccccC----CCCCccccCCCccceeeecccccccc----ccccc----cccceeccccCCc
Q 003385 464 DLRIIHLEDNQLT----GPLPSSLMNLPNLRELYVQNNMLSGT----VPSSL----LSKNVVLNYAGNI 520 (824)
Q Consensus 464 ~L~~L~L~~N~l~----g~lP~~l~~l~~L~~L~l~~N~l~g~----ip~~l----~~~~~~l~~~~n~ 520 (824)
+|+.|+|++|+|+ +.+|..+..+++|+.|+|++|++++. +|..+ ...+..+.+++|.
T Consensus 217 ~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~ 285 (386)
T 2ca6_A 217 ELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNE 285 (386)
T ss_dssp TCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSC
T ss_pred CccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCc
Confidence 9999999999996 57899999999999999999999865 56655 4556677777774
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.10 E-value=1.3e-11 Score=135.59 Aligned_cols=176 Identities=16% Similarity=0.171 Sum_probs=110.7
Q ss_pred cceeeecccccCCCCCCcc-cchhhhceeccCCCCCC-cHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEc-CCCCCC
Q 003385 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSI-DGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQP 416 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~-~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c-~~~~~~ 416 (824)
++++.|+|+.|.++.+|+. +.+++.|+.|+++.|++ +.+....+..+..+..+...+.+ ....+.- ....++
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N-----~l~~l~~~~f~~l~ 104 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN-----NLLYINPEAFQNLP 104 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEET-----TCCEECTTSBCCCT
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCC-----cccccCchhhhhcc
Confidence 4678899999999999986 89999999999998875 32111111111111110000000 0011110 012344
Q ss_pred ceeEEEecCCCCCc------------------------cC-Chhhhccc-ccccccccccccCCCCCCCCCCCCcceEee
Q 003385 417 SITVIHLSSKNLTG------------------------NI-PSDLTKLS-SLVELWLDGNSLTGPIPDFSGCPDLRIIHL 470 (824)
Q Consensus 417 ~L~~L~L~~n~l~g------------------------~l-p~~i~~L~-~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L 470 (824)
+|+.|+|++|+|++ .+ +..|..+. .|+.|+|++|+|+.+++......+|+.|++
T Consensus 105 ~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l 184 (350)
T 4ay9_X 105 NLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNL 184 (350)
T ss_dssp TCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEEC
T ss_pred ccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhh
Confidence 45555555544442 22 22344443 577888888988888777666778888888
Q ss_pred cc-cccCCCCC-ccccCCCccceeeeccccccccccccccccceeccccCCccc
Q 003385 471 ED-NQLTGPLP-SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 522 (824)
Q Consensus 471 ~~-N~l~g~lP-~~l~~l~~L~~L~l~~N~l~g~ip~~l~~~~~~l~~~~n~~l 522 (824)
++ |+++ .+| +.|..+++|+.|+|++|+|+ .+|...+..+..+....+..+
T Consensus 185 ~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~~~~~L~~L~~l~~~~l 236 (350)
T 4ay9_X 185 SDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNL 236 (350)
T ss_dssp TTCTTCC-CCCTTTTTTEECCSEEECTTSCCC-CCCSSSCTTCCEEECTTCTTC
T ss_pred ccCCccc-CCCHHHhccCcccchhhcCCCCcC-ccChhhhccchHhhhccCCCc
Confidence 75 6666 666 46789999999999999999 899888888777766555433
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.07 E-value=1.7e-10 Score=131.34 Aligned_cols=84 Identities=29% Similarity=0.386 Sum_probs=37.3
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCC--CCCccccCC--------
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTG--PLPSSLMNL-------- 486 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g--~lP~~l~~l-------- 486 (824)
+|+.|+|++|++++ +|.. +++|+.|+|++|+++++++ .+++|+.|+|++|++++ .+|.+++.|
T Consensus 318 ~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~ 390 (454)
T 1jl5_A 318 SLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAEVPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAE 390 (454)
T ss_dssp TCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC----
T ss_pred cCCEEECCCCcccc-cccc---CCcCCEEECCCCccccccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccc
Confidence 56666666666663 5543 3566666666666665333 35666666666666665 556666555
Q ss_pred -----Cccceeeeccccccc--cccccc
Q 003385 487 -----PNLRELYVQNNMLSG--TVPSSL 507 (824)
Q Consensus 487 -----~~L~~L~l~~N~l~g--~ip~~l 507 (824)
++|+.|++++|+++| .+|.++
T Consensus 391 i~~~~~~L~~L~ls~N~l~~~~~iP~sl 418 (454)
T 1jl5_A 391 VPELPQNLKQLHVETNPLREFPDIPESV 418 (454)
T ss_dssp ----------------------------
T ss_pred cccccCcCCEEECCCCcCCccccchhhH
Confidence 556666666666664 455443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.04 E-value=1.9e-10 Score=113.26 Aligned_cols=104 Identities=17% Similarity=0.134 Sum_probs=82.6
Q ss_pred CCceeEEEecCCCCCccCChhhhccc-ccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceee
Q 003385 415 QPSITVIHLSSKNLTGNIPSDLTKLS-SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (824)
Q Consensus 415 ~~~L~~L~L~~n~l~g~lp~~i~~L~-~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~ 493 (824)
+.+|+.|+|++|+++ .+|. +..+. +|+.|+|++|+|++. +.+.++++|+.|+|++|+|++..|..++.+++|+.|+
T Consensus 18 ~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 18 AVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred cCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 358999999999999 6665 66655 999999999999987 7799999999999999999954334458999999999
Q ss_pred eccccccccccc--ccc--ccceeccccCCccc
Q 003385 494 VQNNMLSGTVPS--SLL--SKNVVLNYAGNINL 522 (824)
Q Consensus 494 l~~N~l~g~ip~--~l~--~~~~~l~~~~n~~l 522 (824)
|++|+++ .+|. .+. ..+..+.+.+|+..
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence 9999997 7776 432 33466777888643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.02 E-value=6.3e-10 Score=115.88 Aligned_cols=131 Identities=19% Similarity=0.121 Sum_probs=98.1
Q ss_pred ccc-ccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCc--cceeeceeecCCeEEEEEEecCCCCH
Q 003385 608 KIG-SGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGYCQEEGRSVLVYEFMHNGTL 684 (824)
Q Consensus 608 ~LG-~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL 684 (824)
.++ .|..+.||+....+|+.+++|+.... ....+.+|+++++.+.+.+ +.+++++....+..++||||++|.++
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 344 55569999998777888999997643 2356889999999986544 55688888877788999999999887
Q ss_pred HHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 003385 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------------------------------------------- 721 (824)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------------------- 721 (824)
. .. . .. ...++.++++.|..||+..
T Consensus 103 ~--~~-~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 103 L--SS-H------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp T--TS-C------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred C--cC-c------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 3 21 1 11 1246777888888888641
Q ss_pred ------------CCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 722 ------------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 722 ------------~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
...++|+|++|.|||+++++.+.|+|||.+..
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01399999999999998776677999998754
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.01 E-value=2e-11 Score=132.77 Aligned_cols=175 Identities=14% Similarity=0.109 Sum_probs=132.3
Q ss_pred cceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHH-HHHHhcCCCCcccCCCCCCCCCCCCe-eEcCCCCCCc
Q 003385 340 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIV-SVISLYSSADWAQEGGDPCLPVPWSW-LQCNSDPQPS 417 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~-~lk~~~~~~~w~~~~~dpc~~~~~~~-~~c~~~~~~~ 417 (824)
+.++.|++..|.++..++.+..+..|+.|+++.|.+....+. .+..+..++....++ |. ... ..-....+++
T Consensus 70 ~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~---~~---l~~~~~~~l~~~~~ 143 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG---LR---LSDPIVNTLAKNSN 143 (336)
T ss_dssp TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT---CB---CCHHHHHHHTTCTT
T ss_pred ccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcC---cc---cCHHHHHHHhcCCC
Confidence 578899999999999999999999999999999998765444 444445555553322 21 111 0001134679
Q ss_pred eeEEEecCC-CCCcc-CChhhhccccccccccccc-ccCCC-CCC-CCCCC-CcceEeeccc--ccC-CCCCccccCCCc
Q 003385 418 ITVIHLSSK-NLTGN-IPSDLTKLSSLVELWLDGN-SLTGP-IPD-FSGCP-DLRIIHLEDN--QLT-GPLPSSLMNLPN 488 (824)
Q Consensus 418 L~~L~L~~n-~l~g~-lp~~i~~L~~L~~L~L~~N-~l~~~-~p~-~~~l~-~L~~L~L~~N--~l~-g~lP~~l~~l~~ 488 (824)
|++|+|++| .+++. +|..+.++++|+.|+|++| ++++. ++. +..++ +|+.|+|++| .++ +.+|..++++++
T Consensus 144 L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~ 223 (336)
T 2ast_B 144 LVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPN 223 (336)
T ss_dssp CSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTT
T ss_pred CCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCC
Confidence 999999999 78863 7888999999999999999 89874 344 77899 9999999999 455 467888889999
Q ss_pred cceeeecccc-ccccccccccc--cceeccccCCc
Q 003385 489 LRELYVQNNM-LSGTVPSSLLS--KNVVLNYAGNI 520 (824)
Q Consensus 489 L~~L~l~~N~-l~g~ip~~l~~--~~~~l~~~~n~ 520 (824)
|+.|+|++|. +++..+..+.. .+..+.+++|.
T Consensus 224 L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 224 LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp CSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred CCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence 9999999999 77677766643 34667777775
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.00 E-value=1.6e-11 Score=135.55 Aligned_cols=180 Identities=17% Similarity=0.123 Sum_probs=116.4
Q ss_pred cceeeecccccCCCCCCc-----ccchhh-hceeccCCCCCCcHHHHHHHHHh-----cCCCCcccCCCCCCCCCCCCee
Q 003385 340 PFVLSFKFGKTYDSSRGP-----LLNAME-INKYLERNDGSIDGVAIVSVISL-----YSSADWAQEGGDPCLPVPWSWL 408 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP-----~i~~le-~l~~L~l~~n~~~~~~l~~lk~~-----~~~~~w~~~~~dpc~~~~~~~~ 408 (824)
++|+.|+|+.|.++..++ .+..+. .|+.|+++.|.+.......+... ..++.++.+++.-. ......+
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~-~~~~~~l 100 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLS-YKSSDEL 100 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGG-GSCHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCC-hHHHHHH
Confidence 348899999999999986 366666 89999999998887655555554 34444433211100 0000000
Q ss_pred EcCCCCC-CceeEEEecCCCCCccCChhhhc-----ccccccccccccccCCCCC-----CCCCCC-CcceEeecccccC
Q 003385 409 QCNSDPQ-PSITVIHLSSKNLTGNIPSDLTK-----LSSLVELWLDGNSLTGPIP-----DFSGCP-DLRIIHLEDNQLT 476 (824)
Q Consensus 409 ~c~~~~~-~~L~~L~L~~n~l~g~lp~~i~~-----L~~L~~L~L~~N~l~~~~p-----~~~~l~-~L~~L~L~~N~l~ 476 (824)
....... ++|++|+|++|+|++..+..+.. .++|+.|+|++|+|++... .+..++ +|+.|+|++|+|+
T Consensus 101 ~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~ 180 (362)
T 3goz_A 101 VKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180 (362)
T ss_dssp HHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred HHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCc
Confidence 0000112 58889999999988665555554 2688999999998885333 244554 8899999999988
Q ss_pred CCCCccccC----C-Cccceeeecccccccc----ccccccc---cceeccccCCc
Q 003385 477 GPLPSSLMN----L-PNLRELYVQNNMLSGT----VPSSLLS---KNVVLNYAGNI 520 (824)
Q Consensus 477 g~lP~~l~~----l-~~L~~L~l~~N~l~g~----ip~~l~~---~~~~l~~~~n~ 520 (824)
+..+..++. + ++|+.|+|++|++++. ++..+.. .+..+.+++|.
T Consensus 181 ~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~ 236 (362)
T 3goz_A 181 SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNC 236 (362)
T ss_dssp GSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSC
T ss_pred hhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCC
Confidence 666654443 4 5899999999988842 5555533 45667777774
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.95 E-value=4.1e-12 Score=127.80 Aligned_cols=128 Identities=17% Similarity=0.201 Sum_probs=107.1
Q ss_pred cccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCc
Q 003385 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (824)
.+++|+.|+|+.|.++.+| .+..++.|+.|+++.|.+.. .... . ..+++
T Consensus 46 ~l~~L~~L~ls~n~l~~l~-~~~~l~~L~~L~l~~n~l~~-----------l~~~---------------~----~~~~~ 94 (198)
T 1ds9_A 46 TLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIKK-----------IENL---------------D----AVADT 94 (198)
T ss_dssp HTTTCSEEECSEEEESCCC-CHHHHTTCCEEEEEEEEECS-----------CSSH---------------H----HHHHH
T ss_pred cCCCCCEEECCCCCCcccc-ccccCCCCCEEECCCCCccc-----------ccch---------------h----hcCCc
Confidence 4678999999999999998 99999999999999887652 0000 0 11358
Q ss_pred eeEEEecCCCCCccCChhhhcccccccccccccccCCCCC--CCCCCCCcceEeecccccCCCCCcc----------ccC
Q 003385 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDNQLTGPLPSS----------LMN 485 (824)
Q Consensus 418 L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~L~~N~l~g~lP~~----------l~~ 485 (824)
|+.|+|++|++++ +| .+.++++|+.|+|++|+|++.++ .+..+++|+.|+|++|++++.+|.. +..
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~ 172 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKR 172 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHh
Confidence 9999999999995 66 69999999999999999998665 5899999999999999999776653 889
Q ss_pred CCccceeeecccccc
Q 003385 486 LPNLRELYVQNNMLS 500 (824)
Q Consensus 486 l~~L~~L~l~~N~l~ 500 (824)
+++|+.|+ +|.++
T Consensus 173 l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 173 LPNLKKLD--GMPVD 185 (198)
T ss_dssp CSSCSEEC--CGGGT
T ss_pred CCCcEEEC--CcccC
Confidence 99999887 77776
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.89 E-value=1.1e-10 Score=132.67 Aligned_cols=156 Identities=19% Similarity=0.131 Sum_probs=100.5
Q ss_pred cceeeecccccCCCC-----CCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCC
Q 003385 340 PFVLSFKFGKTYDSS-----RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDP 414 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~-----LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~ 414 (824)
+.|+.|+|+.|.++. +|..+..++.|+.|+++.|.+....+..+.... ...
T Consensus 199 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~------------------------~~~ 254 (461)
T 1z7x_W 199 CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGL------------------------LHP 254 (461)
T ss_dssp CCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHH------------------------TST
T ss_pred CCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHH------------------------hcC
Confidence 356666666666665 455566666666666666666554444443221 012
Q ss_pred CCceeEEEecCCCCCcc----CChhhhcccccccccccccccCCCCCC-C-----CCCCCcceEeecccccCCC----CC
Q 003385 415 QPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIPD-F-----SGCPDLRIIHLEDNQLTGP----LP 480 (824)
Q Consensus 415 ~~~L~~L~L~~n~l~g~----lp~~i~~L~~L~~L~L~~N~l~~~~p~-~-----~~l~~L~~L~L~~N~l~g~----lP 480 (824)
.++|+.|+|++|+++.. ++..+.++++|+.|+|++|.+++..+. + ...++|+.|+|++|++++. +|
T Consensus 255 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 334 (461)
T 1z7x_W 255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 334 (461)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHH
Confidence 35788888888888843 677777788888888888887654332 2 2236788888888888754 56
Q ss_pred ccccCCCccceeeeccccccccccccccc-------cceeccccCC
Q 003385 481 SSLMNLPNLRELYVQNNMLSGTVPSSLLS-------KNVVLNYAGN 519 (824)
Q Consensus 481 ~~l~~l~~L~~L~l~~N~l~g~ip~~l~~-------~~~~l~~~~n 519 (824)
..+..+++|++|+|++|++++..+..+.. .+..+.+++|
T Consensus 335 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n 380 (461)
T 1z7x_W 335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 380 (461)
T ss_dssp HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred HHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCC
Confidence 66777788888888888887554443332 3455555665
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.88 E-value=1.4e-10 Score=131.70 Aligned_cols=140 Identities=20% Similarity=0.188 Sum_probs=103.1
Q ss_pred ccceeeecccccCCCC-----CCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCC
Q 003385 339 LPFVLSFKFGKTYDSS-----RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSD 413 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~-----LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~ 413 (824)
++.|+.|+|+.|.++. +|..+..++.|+.|+++.|.+....+..+..... .
T Consensus 255 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~------------------------~ 310 (461)
T 1z7x_W 255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLL------------------------E 310 (461)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHT------------------------S
T ss_pred CCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhc------------------------c
Confidence 4456666666666666 5555666666666666666665554444443311 1
Q ss_pred CCCceeEEEecCCCCCcc----CChhhhcccccccccccccccCCCCCC-CCC-----CCCcceEeecccccCC----CC
Q 003385 414 PQPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIPD-FSG-----CPDLRIIHLEDNQLTG----PL 479 (824)
Q Consensus 414 ~~~~L~~L~L~~n~l~g~----lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~-----l~~L~~L~L~~N~l~g----~l 479 (824)
..++|+.|+|++|++++. +|..+..+++|+.|+|++|++++..+. +.. +++|+.|+|++|+|++ .+
T Consensus 311 ~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l 390 (461)
T 1z7x_W 311 PGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSL 390 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHH
T ss_pred CCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHH
Confidence 224899999999999865 677888889999999999999875442 322 6799999999999996 78
Q ss_pred CccccCCCccceeeecccccccc
Q 003385 480 PSSLMNLPNLRELYVQNNMLSGT 502 (824)
Q Consensus 480 P~~l~~l~~L~~L~l~~N~l~g~ 502 (824)
|..+..+++|++|+|++|++++.
T Consensus 391 ~~~l~~~~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 391 AATLLANHSLRELDLSNNCLGDA 413 (461)
T ss_dssp HHHHHHCCCCCEEECCSSSCCHH
T ss_pred HHHHHhCCCccEEECCCCCCCHH
Confidence 88999999999999999999843
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.87 E-value=8.7e-11 Score=129.60 Aligned_cols=175 Identities=18% Similarity=0.146 Sum_probs=113.9
Q ss_pred ecccccCCCCCCccc-chhhhceeccCCCCCCcHHHH----HHHHHhc-CCCCcccCCCCCCCCCCCCee-EcCCCCCCc
Q 003385 345 FKFGKTYDSSRGPLL-NAMEINKYLERNDGSIDGVAI----VSVISLY-SSADWAQEGGDPCLPVPWSWL-QCNSDPQPS 417 (824)
Q Consensus 345 L~L~~n~~s~LPP~i-~~le~l~~L~l~~n~~~~~~l----~~lk~~~-~~~~w~~~~~dpc~~~~~~~~-~c~~~~~~~ 417 (824)
+.|+.|.++.+.|.+ .....|+.|+++.|.+..... ..++.+. .+..+..+++.-. ...+..+ .+-....++
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~-~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLG-FKNSDELVQILAAIPAN 81 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGG-GSCHHHHHHHHHTSCTT
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCC-HHHHHHHHHHHhccCCC
Confidence 567889999877774 444559999999999887655 4444443 4554433211100 0000000 000011268
Q ss_pred eeEEEecCCCCCccCChhhhcc-----cccccccccccccCCCCCC-----CCC-CCCcceEeecccccCCC----CCcc
Q 003385 418 ITVIHLSSKNLTGNIPSDLTKL-----SSLVELWLDGNSLTGPIPD-----FSG-CPDLRIIHLEDNQLTGP----LPSS 482 (824)
Q Consensus 418 L~~L~L~~n~l~g~lp~~i~~L-----~~L~~L~L~~N~l~~~~p~-----~~~-l~~L~~L~L~~N~l~g~----lP~~ 482 (824)
|++|+|++|++++..+..+..+ ++|+.|+|++|+|++..+. +.. .++|+.|+|++|+|++. ++..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 9999999999987777665554 8899999999999887663 334 36899999999998853 3444
Q ss_pred ccCCC-ccceeeecccccccccccccc-------ccceeccccCCc
Q 003385 483 LMNLP-NLRELYVQNNMLSGTVPSSLL-------SKNVVLNYAGNI 520 (824)
Q Consensus 483 l~~l~-~L~~L~l~~N~l~g~ip~~l~-------~~~~~l~~~~n~ 520 (824)
+..++ +|++|+|++|++++..+..+. ..+..+.+++|.
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~ 207 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANL 207 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCC
Confidence 55665 899999999999866554442 244566677774
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.83 E-value=6.1e-09 Score=114.52 Aligned_cols=140 Identities=16% Similarity=0.304 Sum_probs=104.3
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEec--cCC-cccchhhhHHHHHHhhcC--CCccceeeceeecC---CeEEEEEEe
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLT--SNS-YQGKREFTNEVTLLSRIH--HRNLVQFLGYCQEE---GRSVLVYEF 678 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~--~~~-~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~---~~~~lV~E~ 678 (824)
+.|+.|.++.||+.+.. ++.+++|+.. ... ......+.+|.++++.+. +..+.+++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 56889999999998866 4678888775 322 123467889999999997 45578888888766 457899999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------------------------------------- 721 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------------- 721 (824)
++|..+.+.. ...++..++..++.++++.|..||+..
T Consensus 123 v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 123 VSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred cCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9987764321 123567777889999999999999721
Q ss_pred ------------------CCCeEecCCCCCCEEEcCCCc--EEEEecCCccc
Q 003385 722 ------------------VPAIIHRDLKSSNILLDKHMR--AKVSDFGLSKF 753 (824)
Q Consensus 722 ------------------~~gIvHrDLkp~NILl~~~~~--vkL~DFGla~~ 753 (824)
.+.++|||+++.|||++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 147999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.78 E-value=3.4e-09 Score=113.82 Aligned_cols=187 Identities=20% Similarity=0.248 Sum_probs=120.7
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcC-CCc--cceeeceeecCC---eEEEEEEecC
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRN--LVQFLGYCQEEG---RSVLVYEFMH 680 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-Hpn--Iv~l~~~~~~~~---~~~lV~E~~~ 680 (824)
+.++.|....||+.. +.+++|+.... .....+.+|.++++.+. +.. +.+++......+ ..++|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 457899999999863 56889986532 23467889999998884 333 344554443332 3478999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG---------------------------------------- 720 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~---------------------------------------- 720 (824)
|.++.+... ..++..++..++.|+++.|..||+.
T Consensus 100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 988765332 2355666677788888888888851
Q ss_pred ---------------CCCCeEecCCCCCCEEEcC--CCcEEEEecCCcccccCCCCceeccccCCCCCcchhcccc----
Q 003385 721 ---------------CVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS---- 779 (824)
Q Consensus 721 ---------------~~~gIvHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~---- 779 (824)
..+.++|+|++|.||++++ +..+.|+||+.+....+ ........... .-..|+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~Dl~~~~~~~-~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DNDFISLMEDD-EEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THHHHTTCCTT-TSCCHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHHHHHHHhhc-cccCHHHHHHHHHH
Confidence 1136899999999999998 45678999998865322 11111100000 0022322111
Q ss_pred -CCC---------CchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 780 -QQL---------TDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 780 -~~~---------~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
... ....+.|+++.++|.+.+|..+|..
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 111 1235899999999999999988743
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.78 E-value=9.2e-09 Score=112.78 Aligned_cols=134 Identities=13% Similarity=0.066 Sum_probs=88.6
Q ss_pred eecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeEEEe
Q 003385 344 SFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHL 423 (824)
Q Consensus 344 ~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~L~L 423 (824)
.++.+++.++.+|..|. +.++.|+|+.|++..+... ...++++|++|+|
T Consensus 13 ~v~C~~~~Lt~iP~~l~--~~l~~L~Ls~N~i~~i~~~-----------------------------~f~~l~~L~~L~L 61 (350)
T 4ay9_X 13 VFLCQESKVTEIPSDLP--RNAIELRFVLTKLRVIQKG-----------------------------AFSGFGDLEKIEI 61 (350)
T ss_dssp EEEEESTTCCSCCTTCC--TTCSEEEEESCCCSEECTT-----------------------------SSTTCTTCCEEEE
T ss_pred EEEecCCCCCccCcCcC--CCCCEEEccCCcCCCcCHH-----------------------------HHcCCCCCCEEEC
Confidence 45667888999988763 5788888888876631000 0134567778888
Q ss_pred cCCCCCccCCh-hhhccccccc-ccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeecc-ccc
Q 003385 424 SSKNLTGNIPS-DLTKLSSLVE-LWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN-NML 499 (824)
Q Consensus 424 ~~n~l~g~lp~-~i~~L~~L~~-L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~-N~l 499 (824)
++|++.+.+|. .|.+|++|+. +.+++|+|+.++|+ |.++++|+.|++++|+|++..+..+..+.++..|++.+ |++
T Consensus 62 s~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i 141 (350)
T 4ay9_X 62 SQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 141 (350)
T ss_dssp ECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTC
T ss_pred cCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccc
Confidence 88777656654 5667777654 55666777777765 67777888888888877755555666666677777755 445
Q ss_pred cccccccccc
Q 003385 500 SGTVPSSLLS 509 (824)
Q Consensus 500 ~g~ip~~l~~ 509 (824)
. .+|...+.
T Consensus 142 ~-~l~~~~f~ 150 (350)
T 4ay9_X 142 H-TIERNSFV 150 (350)
T ss_dssp C-EECTTSST
T ss_pred c-cccccchh
Confidence 5 66655443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.72 E-value=1.3e-09 Score=120.89 Aligned_cols=139 Identities=19% Similarity=0.119 Sum_probs=104.4
Q ss_pred cceeeecccccCCCCC--CcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCc
Q 003385 340 PFVLSFKFGKTYDSSR--GPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~L--PP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (824)
+.|+.|+|+.|.++.- .....++..|+.|+|+.|.+.......+...... ..++
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~------------------------~~~~ 156 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLH------------------------DQCQ 156 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHS------------------------TTCC
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHh------------------------cCCc
Confidence 4678888888887653 2335567788888888888877666666554210 1237
Q ss_pred eeEEEecCCCCCc----cCChhhhcccccccccccccccCCCC----C-CCCCCCCcceEeecccccCC----CCCcccc
Q 003385 418 ITVIHLSSKNLTG----NIPSDLTKLSSLVELWLDGNSLTGPI----P-DFSGCPDLRIIHLEDNQLTG----PLPSSLM 484 (824)
Q Consensus 418 L~~L~L~~n~l~g----~lp~~i~~L~~L~~L~L~~N~l~~~~----p-~~~~l~~L~~L~L~~N~l~g----~lP~~l~ 484 (824)
|++|+|++|+|+. .++..+..+++|+.|+|++|+|+... . .+..+++|+.|+|++|+|+. .++..+.
T Consensus 157 L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~ 236 (372)
T 3un9_A 157 ITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAR 236 (372)
T ss_dssp CCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHH
T ss_pred cceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHH
Confidence 9999999999974 35666788999999999999988632 2 36778899999999999984 3445666
Q ss_pred CCCccceeeecccccccc
Q 003385 485 NLPNLRELYVQNNMLSGT 502 (824)
Q Consensus 485 ~l~~L~~L~l~~N~l~g~ 502 (824)
..++|+.|+|++|.|++.
T Consensus 237 ~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 237 EHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HCSSCCEEECTTSSCCHH
T ss_pred hCCCCCEEeccCCCCCHH
Confidence 778999999999999843
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.72 E-value=6.1e-09 Score=113.14 Aligned_cols=94 Identities=21% Similarity=0.281 Sum_probs=80.7
Q ss_pred CCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcc-eEeecccccCCCCCccccCCCcccee
Q 003385 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLR-IIHLEDNQLTGPLPSSLMNLPNLREL 492 (824)
Q Consensus 415 ~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~-~L~L~~N~l~g~lP~~l~~l~~L~~L 492 (824)
+++|+.|+|++|+++..-+..|.++++|+.|+|++| ++.+.+. |.+|++|+ .|+|.+ +++..-+.+|.+|++|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 468999999999999444457999999999999998 7776665 99999999 999998 7774455799999999999
Q ss_pred eeccccccccccccccccc
Q 003385 493 YVQNNMLSGTVPSSLLSKN 511 (824)
Q Consensus 493 ~l~~N~l~g~ip~~l~~~~ 511 (824)
++++|+++ .|+...|...
T Consensus 303 ~l~~n~i~-~I~~~aF~~~ 320 (329)
T 3sb4_A 303 LATGDKIT-TLGDELFGNG 320 (329)
T ss_dssp EECSSCCC-EECTTTTCTT
T ss_pred EeCCCccC-ccchhhhcCC
Confidence 99999999 8988887654
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=2.7e-08 Score=97.86 Aligned_cols=108 Identities=19% Similarity=0.156 Sum_probs=70.4
Q ss_pred EEEeeecCCCCCCCccCCCCCCCCccccCccccccccccccCCccccccccccCCCCCCCChHHHHhhcccccCCceEEe
Q 003385 193 VSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGSLTYR 272 (824)
Q Consensus 193 ~~~r~~~g~~~~~~irypdD~~dR~W~~~~~~~~~~~~~~~~~~~~~st~~~i~~~~~~~pP~~v~qtA~t~~~~sl~~~ 272 (824)
.+.|.|||+.. +. |..+|.|++|......... ..... .+.....+..|..|+|||=... .+++|.
T Consensus 6 ~~~~INcGg~~---~~---d~~gr~w~~D~~~~~~g~~------~~~~~--~~~~~~~~~~~~~lY~TaR~~~-~~~tY~ 70 (174)
T 2jwp_A 6 VIWAVNAGGES---HV---DVHGIHYRKDPLEGRVGRA------SDYGM--KLPILRSNPEDQVLYQTERYNE-DSFGYD 70 (174)
T ss_dssp EEEEEEETSSS---EE---ETTTEEECSSCSSTTCCCC------CCCCT--TSCCSSSCHHHHHTTTCCCCCC-SCEEEE
T ss_pred EEEEEECCCCC---cc---CCCCCEEcCCcCcccCCcc------ccccc--ceEecccCCCCchhhhhhccCC-CCeEEE
Confidence 45699999842 22 6789999998542211100 00001 1111223456899999997643 467888
Q ss_pred ecCCCCCCcceeEEeeccccCCCCCcceEEEEEECCCcCcccccc
Q 003385 273 LNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIV 317 (824)
Q Consensus 273 ~~~~~~~~~~y~~~yFae~~~~~~~~~R~F~i~in~~~~~~~~~~ 317 (824)
.+++.. ..+.+-|||+|+.. ...+.|+|||++||+...++..+
T Consensus 71 f~v~~~-G~Y~VrLhF~ei~~-~~~~~rvFdV~ing~~~l~~fdi 113 (174)
T 2jwp_A 71 IPIKEE-GEYVLVLKFAEVYF-AQSQQKVFDVRVNGHTVVKDLDI 113 (174)
T ss_dssp EECCSC-EEEEEEEEEECCSC-CCSSSSCEEEEETTEEEEEEECH
T ss_pred EEeCCC-eEEEEEEEEecccc-CCCCCeEeEEEECCEEeecCcCH
Confidence 887543 34457999999974 45789999999999987776554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.61 E-value=2.1e-09 Score=119.02 Aligned_cols=155 Identities=16% Similarity=0.124 Sum_probs=113.6
Q ss_pred cccceeeecccccCCCCCCcc-cchh-----hhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcC
Q 003385 338 SLPFVLSFKFGKTYDSSRGPL-LNAM-----EINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCN 411 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~-i~~l-----e~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~ 411 (824)
.++.|+.|+|+.|.++..... |..+ +.|+.|+|+.|.+....+..+...
T Consensus 70 ~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~------------------------- 124 (372)
T 3un9_A 70 VLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPV------------------------- 124 (372)
T ss_dssp HHTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHH-------------------------
T ss_pred HHhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHH-------------------------
Confidence 356788999999998875544 4444 689999999999877655544332
Q ss_pred CCCCCceeEEEecCCCCCccCChhhh-----cccccccccccccccCCCC-----CCCCCCCCcceEeecccccCC----
Q 003385 412 SDPQPSITVIHLSSKNLTGNIPSDLT-----KLSSLVELWLDGNSLTGPI-----PDFSGCPDLRIIHLEDNQLTG---- 477 (824)
Q Consensus 412 ~~~~~~L~~L~L~~n~l~g~lp~~i~-----~L~~L~~L~L~~N~l~~~~-----p~~~~l~~L~~L~L~~N~l~g---- 477 (824)
+++|+.|+|++|+|+..-...+. ..++|+.|+|++|.|+... ..+..+++|++|+|++|+|+.
T Consensus 125 ---L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~ 201 (372)
T 3un9_A 125 ---FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLE 201 (372)
T ss_dssp ---HHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHH
T ss_pred ---HHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHH
Confidence 23689999999999855444443 3578999999999997622 235778999999999999984
Q ss_pred CCCccccCCCccceeeecccccccc----ccccc--cccceeccccCCc
Q 003385 478 PLPSSLMNLPNLRELYVQNNMLSGT----VPSSL--LSKNVVLNYAGNI 520 (824)
Q Consensus 478 ~lP~~l~~l~~L~~L~l~~N~l~g~----ip~~l--~~~~~~l~~~~n~ 520 (824)
.+++.+..+++|+.|+|++|.+++. ++..+ ...+..+++++|.
T Consensus 202 ~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~ 250 (372)
T 3un9_A 202 LLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNE 250 (372)
T ss_dssp HHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSS
T ss_pred HHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCC
Confidence 2466778889999999999999843 22222 2334667777774
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.39 E-value=1.1e-07 Score=99.75 Aligned_cols=78 Identities=24% Similarity=0.332 Sum_probs=47.8
Q ss_pred CCceeEEEecCCCCCc--cCChhhhcccccccccccccccCCCCCCCCCCC--CcceEeecccccCCCCCc-------cc
Q 003385 415 QPSITVIHLSSKNLTG--NIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCP--DLRIIHLEDNQLTGPLPS-------SL 483 (824)
Q Consensus 415 ~~~L~~L~L~~n~l~g--~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~--~L~~L~L~~N~l~g~lP~-------~l 483 (824)
+++|+.|+|++|+|++ .+|..+..|++|+.|+|++|+|++. .++..++ +|+.|+|++|.|.+.+|+ .+
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il 247 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIR 247 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHH
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhhcccCCcceEEccCCcCccccCcchhHHHHHH
Confidence 4567777777777775 4456666677777777777777665 2222222 666777777776665552 25
Q ss_pred cCCCccceee
Q 003385 484 MNLPNLRELY 493 (824)
Q Consensus 484 ~~l~~L~~L~ 493 (824)
..+++|+.||
T Consensus 248 ~~~P~L~~LD 257 (267)
T 3rw6_A 248 ERFPKLLRLD 257 (267)
T ss_dssp HHCTTCCEES
T ss_pred HHCcccCeEC
Confidence 5566666554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.35 E-value=4.5e-07 Score=98.28 Aligned_cols=78 Identities=18% Similarity=0.092 Sum_probs=57.2
Q ss_pred ccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccc-eeeeccccccccccccccccc---ee
Q 003385 439 LSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR-ELYVQNNMLSGTVPSSLLSKN---VV 513 (824)
Q Consensus 439 L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~-~L~l~~N~l~g~ip~~l~~~~---~~ 513 (824)
+++|+.|+|++|+++.+++. |.+|++|+.|+|.+| ++..-+.+|.++++|+ .|++.+ .++ .|+...|... ..
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~~ 301 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLRY 301 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCCE
Confidence 67888888888888877775 888888888888887 6634445788888888 888877 777 7777776543 34
Q ss_pred ccccCC
Q 003385 514 LNYAGN 519 (824)
Q Consensus 514 l~~~~n 519 (824)
+.+.+|
T Consensus 302 l~l~~n 307 (329)
T 3sb4_A 302 VLATGD 307 (329)
T ss_dssp EEECSS
T ss_pred EEeCCC
Confidence 444444
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.35 E-value=1.5e-08 Score=118.78 Aligned_cols=163 Identities=15% Similarity=0.100 Sum_probs=88.5
Q ss_pred ccceeeeccc-----------ccCCCC--CCcccchhhhceeccCCCCCCcHHHHHHHHH-hcCCCCcccCCCCCCCCCC
Q 003385 339 LPFVLSFKFG-----------KTYDSS--RGPLLNAMEINKYLERNDGSIDGVAIVSVIS-LYSSADWAQEGGDPCLPVP 404 (824)
Q Consensus 339 l~~l~~L~L~-----------~n~~s~--LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~-~~~~~~w~~~~~dpc~~~~ 404 (824)
+++|+.|+|. .|.++. ++.....+..|+.|+++.|.+....+..+.. ...+..+.....+-|....
T Consensus 341 ~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~ 420 (592)
T 3ogk_B 341 CKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERIT 420 (592)
T ss_dssp CTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCS
T ss_pred CCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCcccc
Confidence 4567777777 345543 3333555777777777777777666666655 3333333221111111100
Q ss_pred C----CeeEcCCCCCCceeEEEecCC--CCCccCChhhhc-ccccccccccccccCC-CCCC-CCCCCCcceEeeccccc
Q 003385 405 W----SWLQCNSDPQPSITVIHLSSK--NLTGNIPSDLTK-LSSLVELWLDGNSLTG-PIPD-FSGCPDLRIIHLEDNQL 475 (824)
Q Consensus 405 ~----~~~~c~~~~~~~L~~L~L~~n--~l~g~lp~~i~~-L~~L~~L~L~~N~l~~-~~p~-~~~l~~L~~L~L~~N~l 475 (824)
. .++......+++|+.|+|+++ .+++..+..++. +++|+.|+|++|++++ .++. +.++++|+.|+|++|+|
T Consensus 421 ~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l 500 (592)
T 3ogk_B 421 DLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCF 500 (592)
T ss_dssp SCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCC
T ss_pred CchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCC
Confidence 0 011100112456777777643 355555555544 6677777777777665 2333 45667777777777776
Q ss_pred CCC-CCccccCCCccceeeeccccccc
Q 003385 476 TGP-LPSSLMNLPNLRELYVQNNMLSG 501 (824)
Q Consensus 476 ~g~-lP~~l~~l~~L~~L~l~~N~l~g 501 (824)
++. ++..+..+++|+.|+|++|++++
T Consensus 501 ~~~~~~~~~~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 501 SERAIAAAVTKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp BHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred cHHHHHHHHHhcCccCeeECcCCcCCH
Confidence 543 33444566777777777777663
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=9.6e-06 Score=86.99 Aligned_cols=136 Identities=20% Similarity=0.246 Sum_probs=90.7
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCC---ccceeeceee-cCCeEEEEEEecCCC
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR---NLVQFLGYCQ-EEGRSVLVYEFMHNG 682 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~-~~~~~~lV~E~~~~g 682 (824)
+.++.|....||+. ++.+++|+-+. ......+.+|.++|+.+.+. .+.+.+.+.. ..+..++|||+++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45788888899987 67788998532 22346788999999999753 3556666663 445678999999998
Q ss_pred CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 003385 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG------------------------------------------ 720 (824)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------------------------------------------ 720 (824)
++.+.... .++..+...++.++++.|..||+.
T Consensus 99 ~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 99 ILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp ECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 87653211 122233333444444444444431
Q ss_pred ---------------CCCCeEecCCCCCCEEEcC---CCc-EEEEecCCcccc
Q 003385 721 ---------------CVPAIIHRDLKSSNILLDK---HMR-AKVSDFGLSKFA 754 (824)
Q Consensus 721 ---------------~~~gIvHrDLkp~NILl~~---~~~-vkL~DFGla~~~ 754 (824)
..+.++|+|+++.|||++. ++. +.|+||+.+...
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1236799999999999997 455 489999987643
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.12 E-value=3e-07 Score=107.55 Aligned_cols=159 Identities=13% Similarity=0.063 Sum_probs=82.7
Q ss_pred cccceeeecccccCCCCCCcc-cchh--hhceeccCCCCC-CcHHHHHHHH-HhcCCCCcccCCCCCCCCCCCCeeEcCC
Q 003385 338 SLPFVLSFKFGKTYDSSRGPL-LNAM--EINKYLERNDGS-IDGVAIVSVI-SLYSSADWAQEGGDPCLPVPWSWLQCNS 412 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~-i~~l--e~l~~L~l~~n~-~~~~~l~~lk-~~~~~~~w~~~~~dpc~~~~~~~~~c~~ 412 (824)
.+++|+.|+|+.|.++...+. +..+ ..|+.|+++.+. .....+..+. ....++.+...... -......|+....
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~-~~~~~~~~l~~~~ 188 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESS-FSEKDGKWLHELA 188 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCE-EECCCSHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECcccc-ccCcchhHHHHHH
Confidence 467788888888876654333 5443 348888887665 4444444443 22334433221110 0000111111111
Q ss_pred CCCCceeEEEecCCCCC----ccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccC---CCCCccccC
Q 003385 413 DPQPSITVIHLSSKNLT----GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT---GPLPSSLMN 485 (824)
Q Consensus 413 ~~~~~L~~L~L~~n~l~----g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~---g~lP~~l~~ 485 (824)
..+++|+.|+|++|+++ +.++..+.++++|+.|+|++|.+.+.+..+.++++|+.|+++.+... +..+..++.
T Consensus 189 ~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~ 268 (592)
T 3ogk_B 189 QHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVF 268 (592)
T ss_dssp HHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCC
T ss_pred hcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhhhHHHhhcccccccccchHHHHHHhhc
Confidence 23457777777777776 34555566777777777777777664434555566666666542222 122334444
Q ss_pred CCccceeeeccc
Q 003385 486 LPNLRELYVQNN 497 (824)
Q Consensus 486 l~~L~~L~l~~N 497 (824)
+++|+.|+++++
T Consensus 269 ~~~L~~L~l~~~ 280 (592)
T 3ogk_B 269 PRKLCRLGLSYM 280 (592)
T ss_dssp CTTCCEEEETTC
T ss_pred cccccccCcccc
Confidence 444555444443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.10 E-value=4.3e-07 Score=95.28 Aligned_cols=81 Identities=23% Similarity=0.348 Sum_probs=64.3
Q ss_pred EEecCCCCCccCCh----hhhcccccccccccccccCCCC--CC-CCCCCCcceEeecccccCCCCCccccCCC--ccce
Q 003385 421 IHLSSKNLTGNIPS----DLTKLSSLVELWLDGNSLTGPI--PD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLP--NLRE 491 (824)
Q Consensus 421 L~L~~n~l~g~lp~----~i~~L~~L~~L~L~~N~l~~~~--p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~--~L~~ 491 (824)
++++.|+.. .++. ...+|++|+.|+|++|+|+++. |. +..+++|+.|+|++|+|++. +.+..+. +|++
T Consensus 148 l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~ 224 (267)
T 3rw6_A 148 IDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEE 224 (267)
T ss_dssp CCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSE
T ss_pred ccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcce
Confidence 566777544 3333 3367899999999999999954 44 57899999999999999954 4466666 9999
Q ss_pred eeecccccccccc
Q 003385 492 LYVQNNMLSGTVP 504 (824)
Q Consensus 492 L~l~~N~l~g~ip 504 (824)
|+|++|++++.+|
T Consensus 225 L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 225 LWLDGNSLCDTFR 237 (267)
T ss_dssp EECTTSTTGGGCS
T ss_pred EEccCCcCccccC
Confidence 9999999998777
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=7.2e-06 Score=89.65 Aligned_cols=79 Identities=4% Similarity=0.047 Sum_probs=55.8
Q ss_pred ccc-cccCcEEEEEEEEc-------CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCC---CccceeeceeecC---
Q 003385 607 KKI-GSGGFGVVYYGKLK-------DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHH---RNLVQFLGYCQEE--- 669 (824)
Q Consensus 607 ~~L-G~G~fg~Vy~a~~~-------~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~~--- 669 (824)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+.. -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999988754 26788999865432 1123567889999988853 3467788777654
Q ss_pred CeEEEEEEecCCCCHH
Q 003385 670 GRSVLVYEFMHNGTLK 685 (824)
Q Consensus 670 ~~~~lV~E~~~~gsL~ 685 (824)
+..++|||+++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999986654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.07 E-value=9.4e-08 Score=111.90 Aligned_cols=180 Identities=15% Similarity=0.040 Sum_probs=93.7
Q ss_pred cccceeeecccccCCCC--CCcccchhhhceeccCCCCCCcHHHHHHHHH-hcCCCCcccCCC-----CCCCCCCCCeeE
Q 003385 338 SLPFVLSFKFGKTYDSS--RGPLLNAMEINKYLERNDGSIDGVAIVSVIS-LYSSADWAQEGG-----DPCLPVPWSWLQ 409 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~--LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~-~~~~~~w~~~~~-----dpc~~~~~~~~~ 409 (824)
.+++|+.|+|+.|.++. ++..+..++.|+.|+++.| +....+..+.. ...++.+..... ..|......++.
T Consensus 287 ~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~ 365 (594)
T 2p1m_B 287 VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLV 365 (594)
T ss_dssp HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHH
T ss_pred hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHH
Confidence 46788899998888664 2333667888888888877 44444554443 233444322110 112111111110
Q ss_pred cCCCCCCceeEEEecCCCCCccCChhhh-ccccccccccc--c----cccCCCCCC------CCCCCCcceEeecccccC
Q 003385 410 CNSDPQPSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLD--G----NSLTGPIPD------FSGCPDLRIIHLEDNQLT 476 (824)
Q Consensus 410 c~~~~~~~L~~L~L~~n~l~g~lp~~i~-~L~~L~~L~L~--~----N~l~~~~p~------~~~l~~L~~L~L~~N~l~ 476 (824)
.-...+++|+.|++..|++++..+..+. .+++|+.|+|+ + |++++.+.+ +.++++|+.|+|++ .++
T Consensus 366 ~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~ 444 (594)
T 2p1m_B 366 SVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLT 444 (594)
T ss_dssp HHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCC
T ss_pred HHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-ccc
Confidence 0001135677777777777655555554 46777777776 3 455533221 34456666666655 444
Q ss_pred CCCCccccC-CCccceeeeccccccccccccc---cccceeccccCC
Q 003385 477 GPLPSSLMN-LPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 519 (824)
Q Consensus 477 g~lP~~l~~-l~~L~~L~l~~N~l~g~ip~~l---~~~~~~l~~~~n 519 (824)
+..+..++. +++|+.|+|++|.+++..+..+ +..+..+.+++|
T Consensus 445 ~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n 491 (594)
T 2p1m_B 445 DKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDC 491 (594)
T ss_dssp HHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESC
T ss_pred HHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCC
Confidence 444444444 5566666666666654433333 233444444444
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.03 E-value=1.1e-06 Score=96.74 Aligned_cols=86 Identities=20% Similarity=0.333 Sum_probs=44.9
Q ss_pred CceeEEEecCCCCCccCChhhh--cccccccccccc--cccCCC------CCCC--CCCCCcceEeecccccCCCCCccc
Q 003385 416 PSITVIHLSSKNLTGNIPSDLT--KLSSLVELWLDG--NSLTGP------IPDF--SGCPDLRIIHLEDNQLTGPLPSSL 483 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~~i~--~L~~L~~L~L~~--N~l~~~------~p~~--~~l~~L~~L~L~~N~l~g~lP~~l 483 (824)
++|+.|+|..++++...-..+. .|++|+.|+|+. |...+. -+.+ ..+++|+.|+|++|++....+..+
T Consensus 193 ~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~l 272 (362)
T 2ra8_A 193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMF 272 (362)
T ss_dssp TTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHH
T ss_pred CCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHH
Confidence 4666666666665533333343 566666666642 221111 1112 235667777776666653333223
Q ss_pred c---CCCccceeeeccccccc
Q 003385 484 M---NLPNLRELYVQNNMLSG 501 (824)
Q Consensus 484 ~---~l~~L~~L~l~~N~l~g 501 (824)
. .+++|+.|+|+.|.|.+
T Consensus 273 a~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 273 LESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp HHCSSGGGCSEEECCSSCCBH
T ss_pred HhCccCCCCCEEECCCCCCCh
Confidence 2 45667777777666664
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=1.9e-05 Score=82.54 Aligned_cols=135 Identities=17% Similarity=0.122 Sum_probs=94.7
Q ss_pred cccccCcE-EEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcC-CCccceeeceeecCCeEEEEEEecCCCCH
Q 003385 608 KIGSGGFG-VVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (824)
Q Consensus 608 ~LG~G~fg-~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 684 (824)
.+..|..| .||+.... ++..+++|+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445554 68987755 4667899986532 2456888999998885 33367888888888999999999999887
Q ss_pred HHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 003385 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------------------------------------------- 721 (824)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------------------- 721 (824)
.+..... ......+..+++..|..||+..
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 6654211 0112235556666666666311
Q ss_pred ------------CCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 722 ------------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 722 ------------~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
.+.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12479999999999999877777999998754
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.99 E-value=1.3e-06 Score=86.67 Aligned_cols=119 Identities=10% Similarity=0.095 Sum_probs=90.2
Q ss_pred cccchhhhceeccCCCC-CCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeEEEecCCCCCc----c
Q 003385 357 PLLNAMEINKYLERNDG-SIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTG----N 431 (824)
Q Consensus 357 P~i~~le~l~~L~l~~n-~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~L~L~~n~l~g----~ 431 (824)
..+...+.|+.|+|+.| .+.......+...... .++|++|+|++|+|.. .
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~-------------------------~~~L~~L~Ls~n~i~~~g~~~ 84 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKT-------------------------NTYVKKFSIVGTRSNDPVAFA 84 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTT-------------------------CCSCCEEECTTSCCCHHHHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHh-------------------------CCCcCEEECcCCCCChHHHHH
Confidence 34555677888999988 8888777776655211 1368999999999974 2
Q ss_pred CChhhhcccccccccccccccCCC-----CCCCCCCCCcceEee--cccccCCC----CCccccCCCccceeeecccccc
Q 003385 432 IPSDLTKLSSLVELWLDGNSLTGP-----IPDFSGCPDLRIIHL--EDNQLTGP----LPSSLMNLPNLRELYVQNNMLS 500 (824)
Q Consensus 432 lp~~i~~L~~L~~L~L~~N~l~~~-----~p~~~~l~~L~~L~L--~~N~l~g~----lP~~l~~l~~L~~L~l~~N~l~ 500 (824)
+...+...++|+.|+|++|+|+.. ...+...++|+.|+| ++|+|... +.+.+...++|++|+|++|.+.
T Consensus 85 l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 85 LAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 455666778999999999999863 334777889999999 88999843 4455666689999999999986
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.82 E-value=1.5e-06 Score=101.71 Aligned_cols=37 Identities=22% Similarity=0.314 Sum_probs=26.1
Q ss_pred CCCCcceEeecccccCCCCC-ccccCCCccceeeeccc
Q 003385 461 GCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELYVQNN 497 (824)
Q Consensus 461 ~l~~L~~L~L~~N~l~g~lP-~~l~~l~~L~~L~l~~N 497 (824)
.+++|+.|+|++|.+++..+ ..+.++++|+.|++++|
T Consensus 287 ~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~ 324 (594)
T 2p1m_B 287 VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY 324 (594)
T ss_dssp HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG
T ss_pred hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc
Confidence 56788888888888664322 23567788888888877
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=7e-05 Score=83.13 Aligned_cols=74 Identities=15% Similarity=0.119 Sum_probs=48.6
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-------ccchhhhHHHHHHhhcCC--Cc-cceeeceeecCCeEEEE
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-------QGKREFTNEVTLLSRIHH--RN-LVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-------~~~~~~~~Ei~il~~l~H--pn-Iv~l~~~~~~~~~~~lV 675 (824)
+.||.|..+.||+++.. +++.++||....... .....+..|.++++.+.+ |. +.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 57899999999999754 468899998653211 123456789999988742 33 3455543 33445899
Q ss_pred EEecCCC
Q 003385 676 YEFMHNG 682 (824)
Q Consensus 676 ~E~~~~g 682 (824)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.0001 Score=79.41 Aligned_cols=141 Identities=16% Similarity=0.244 Sum_probs=79.8
Q ss_pred cccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCC--Cccceeec------eeecCCeEEEEEEec
Q 003385 608 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--RNLVQFLG------YCQEEGRSVLVYEFM 679 (824)
Q Consensus 608 ~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~------~~~~~~~~~lV~E~~ 679 (824)
.|+.|..+.||+....+| .+++|+.... ...+..|.++++.+.. -.+.+++. +....+..+++|||+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 455567889999987644 5899988642 2344456666665531 12334443 123456789999999
Q ss_pred CCCCHH-----------HH---hhcc---c--Ccc-----ccCCHHHH-------------------------------H
Q 003385 680 HNGTLK-----------EH---LYGT---L--THE-----QRINWIKR-------------------------------L 704 (824)
Q Consensus 680 ~~gsL~-----------~~---L~~~---~--~~~-----~~l~~~~~-------------------------------~ 704 (824)
+|..+. .. ++.. . ... ....|... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986432 11 1111 0 000 00122110 1
Q ss_pred HHHHHHHHHHHHHHh----------CCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 705 EIAEDAAKGIEYLHT----------GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 705 ~i~~qia~gL~yLH~----------~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
.+..++..++.+|++ .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 112234445666653 0124899999999999998888899999998753
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.72 E-value=2.4e-05 Score=87.24 Aligned_cols=168 Identities=12% Similarity=0.051 Sum_probs=94.9
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcC-CCCCCc
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCN-SDPQPS 417 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~-~~~~~~ 417 (824)
+++|+.++|.+|.++.+|+..-....|+.+.+.++ +..+.-.++.....+...... .....++-. ..+ .+
T Consensus 179 c~~L~~l~l~~n~l~~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~-------~~l~~I~~~aF~~-~~ 249 (401)
T 4fdw_A 179 CYNLKKADLSKTKITKLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP-------ENVSTIGQEAFRE-SG 249 (401)
T ss_dssp CTTCCEEECTTSCCSEECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC-------TTCCEECTTTTTT-CC
T ss_pred cccCCeeecCCCcceEechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecC-------CCccCcccccccc-CC
Confidence 45677777788888888777555677777777643 222111112222122221110 001111110 111 46
Q ss_pred eeEEEecCCCCCccCChhhhcccccccccccccccC-----CCCC-CCCCCCCcceEeecccccCCCCCccccCCCccce
Q 003385 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT-----GPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 491 (824)
Q Consensus 418 L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~-----~~~p-~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~ 491 (824)
|+.|.| .++++..-+..|.++++|+.|+|.+|.+. .+.+ .|.+|++|+.++|. |.++..-..+|.+|++|+.
T Consensus 250 L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~ 327 (401)
T 4fdw_A 250 ITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQ 327 (401)
T ss_dssp CSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCE
T ss_pred ccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccE
Confidence 777777 44566344557778888888888877765 2333 27788888888887 4466333457777788888
Q ss_pred eeeccccccccccccccccc--eeccccCC
Q 003385 492 LYVQNNMLSGTVPSSLLSKN--VVLNYAGN 519 (824)
Q Consensus 492 L~l~~N~l~g~ip~~l~~~~--~~l~~~~n 519 (824)
|.|..| ++ .|+...|... ..+.+.+|
T Consensus 328 l~lp~~-l~-~I~~~aF~~~~L~~l~l~~n 355 (401)
T 4fdw_A 328 LTIPAN-VT-QINFSAFNNTGIKEVKVEGT 355 (401)
T ss_dssp EEECTT-CC-EECTTSSSSSCCCEEEECCS
T ss_pred EEECcc-cc-EEcHHhCCCCCCCEEEEcCC
Confidence 888544 66 6766665543 33444555
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00024 Score=75.14 Aligned_cols=73 Identities=21% Similarity=0.239 Sum_probs=54.7
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCC---ccceeeceeecCCeEEEEEEecCCCC
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR---NLVQFLGYCQEEGRSVLVYEFMHNGT 683 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~~~~~~~lV~E~~~~gs 683 (824)
+.+|.|..+.||+.+..+|+.+++|+...........+..|.+.|+.+... -+.+++++. . .++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEEEEeecccC
Confidence 568999999999999999999999987655444456688999999988522 244555442 2 378999998764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.60 E-value=8.6e-06 Score=80.59 Aligned_cols=113 Identities=12% Similarity=0.103 Sum_probs=88.2
Q ss_pred ccceeeeccccc-CCCC-----CCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCC
Q 003385 339 LPFVLSFKFGKT-YDSS-----RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNS 412 (824)
Q Consensus 339 l~~l~~L~L~~n-~~s~-----LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~ 412 (824)
.+.|++|+|+.| .+.. +...+.....|+.|+|+.|.+.......+......
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~----------------------- 91 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKV----------------------- 91 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHH-----------------------
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHh-----------------------
Confidence 457889999998 7765 44445566789999999999988777776655320
Q ss_pred CCCCceeEEEecCCCCCcc----CChhhhcccccccccc--cccccCCCC-----CCCCCCCCcceEeecccccC
Q 003385 413 DPQPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWL--DGNSLTGPI-----PDFSGCPDLRIIHLEDNQLT 476 (824)
Q Consensus 413 ~~~~~L~~L~L~~n~l~g~----lp~~i~~L~~L~~L~L--~~N~l~~~~-----p~~~~l~~L~~L~L~~N~l~ 476 (824)
.++|++|+|++|+|+.. +...+...++|+.|+| ++|.|+..- ..+...++|+.|+|++|++.
T Consensus 92 --n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 92 --NNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp --CSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred --CCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 13689999999999853 5667888899999999 889998632 23566789999999999986
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.55 E-value=1.1e-05 Score=88.78 Aligned_cols=87 Identities=15% Similarity=0.161 Sum_probs=55.8
Q ss_pred CCCceeEEEecC--CCCCc-----cCChhh--hcccccccccccccccCCCCCC----CCCCCCcceEeecccccCCC--
Q 003385 414 PQPSITVIHLSS--KNLTG-----NIPSDL--TKLSSLVELWLDGNSLTGPIPD----FSGCPDLRIIHLEDNQLTGP-- 478 (824)
Q Consensus 414 ~~~~L~~L~L~~--n~l~g-----~lp~~i--~~L~~L~~L~L~~N~l~~~~p~----~~~l~~L~~L~L~~N~l~g~-- 478 (824)
.+|+|+.|+|+. |...| .+...+ ..+++|+.|+|.+|.+....+. ...+++|+.|+|+.|+|++.
T Consensus 217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~ 296 (362)
T 2ra8_A 217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGA 296 (362)
T ss_dssp BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHH
T ss_pred cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHH
Confidence 356788888753 22111 111122 2467888888888887653221 23477888888888888752
Q ss_pred --CCccccCCCccceeeecccccc
Q 003385 479 --LPSSLMNLPNLRELYVQNNMLS 500 (824)
Q Consensus 479 --lP~~l~~l~~L~~L~l~~N~l~ 500 (824)
++..+..+++|+.|+|++|.++
T Consensus 297 ~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 297 RLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp HHHHTTHHHHTTCSEEECCSBBCC
T ss_pred HHHHhhcccCCcceEEECCCCcCC
Confidence 4555566788888888888777
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.41 E-value=0.0001 Score=82.21 Aligned_cols=156 Identities=11% Similarity=0.007 Sum_probs=103.2
Q ss_pred cceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeE-cCCCCCCc
Q 003385 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQPS 417 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~-c~~~~~~~ 417 (824)
++|+.+.|. +.++.+++. +..+..|+.+.+..+-.. +...++.. ..+..... |.....++ .....+++
T Consensus 203 ~~L~~l~lp-~~l~~I~~~aF~~~~~L~~l~l~~~l~~-I~~~aF~~-~~L~~i~l-------p~~i~~I~~~aF~~c~~ 272 (401)
T 4fdw_A 203 AGIEEVLLP-VTLKEIGSQAFLKTSQLKTIEIPENVST-IGQEAFRE-SGITTVKL-------PNGVTNIASRAFYYCPE 272 (401)
T ss_dssp CCCSEEECC-TTCCEECTTTTTTCTTCCCEECCTTCCE-ECTTTTTT-CCCSEEEE-------ETTCCEECTTTTTTCTT
T ss_pred cccCEEEeC-CchheehhhHhhCCCCCCEEecCCCccC-cccccccc-CCccEEEe-------CCCccEEChhHhhCCCC
Confidence 456677776 447788777 778888888888764211 11011111 01111100 00011121 11234579
Q ss_pred eeEEEecCCCCC-----ccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccce
Q 003385 418 ITVIHLSSKNLT-----GNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 491 (824)
Q Consensus 418 L~~L~L~~n~l~-----g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~ 491 (824)
|+.|+|.+|.+. ..-+..|.++++|+.++|. |+++.+... |.+|++|+.|+|.+| ++..-+.+|.++ +|+.
T Consensus 273 L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~ 349 (401)
T 4fdw_A 273 LAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKE 349 (401)
T ss_dssp CCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCE
T ss_pred CCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCE
Confidence 999999998775 3445689999999999999 557776665 999999999999666 663445789999 9999
Q ss_pred eeeccccccccccccccc
Q 003385 492 LYVQNNMLSGTVPSSLLS 509 (824)
Q Consensus 492 L~l~~N~l~g~ip~~l~~ 509 (824)
|++.+|.+. .++...+.
T Consensus 350 l~l~~n~~~-~l~~~~F~ 366 (401)
T 4fdw_A 350 VKVEGTTPP-QVFEKVWY 366 (401)
T ss_dssp EEECCSSCC-BCCCSSCC
T ss_pred EEEcCCCCc-cccccccc
Confidence 999999988 66665543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00054 Score=73.46 Aligned_cols=138 Identities=19% Similarity=0.243 Sum_probs=90.0
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcC---CCccceeeceeecCCeEEEEEEecCCCC
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV~E~~~~gs 683 (824)
+.|+.|....+|+... +++.+++|+.... ....+..|.+.|+.+. ...+.+++.+....+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 4578899999999875 4778899987532 2456888999998884 3568888888887788999999999875
Q ss_pred HH--------HHh---hcccC-c-----------------cccCCHHHHH---HHH----------------HHHHHHH-
Q 003385 684 LK--------EHL---YGTLT-H-----------------EQRINWIKRL---EIA----------------EDAAKGI- 714 (824)
Q Consensus 684 L~--------~~L---~~~~~-~-----------------~~~l~~~~~~---~i~----------------~qia~gL- 714 (824)
+. ..| +.... . ...-+|.... ++. .+++..+
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 31 111 21111 0 0011343221 011 1122222
Q ss_pred HHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003385 715 EYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (824)
Q Consensus 715 ~yLH~-~~~~gIvHrDLkp~NILl~~~~~vkL~DFG 749 (824)
..|.. ...+.++|+|+.+.|++++.++ +.|+|+.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23421 1236899999999999999887 8999985
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00018 Score=80.50 Aligned_cols=78 Identities=15% Similarity=0.202 Sum_probs=47.9
Q ss_pred CCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceeccc-cCCCCCcchhccccCC---CCchHHHHHHHHHHHHH
Q 003385 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV-RGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLEL 798 (824)
Q Consensus 723 ~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~---~~~~~DIwSlGvil~el 798 (824)
+.++|||+++.|||++.++ ++++||+.+....+... ..... .-...|.+|+...... .....++.+....+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4899999999999998876 99999998865432111 11100 0113456666543211 11234556777788877
Q ss_pred HcCC
Q 003385 799 ISGQ 802 (824)
Q Consensus 799 ltG~ 802 (824)
+.++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7664
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0014 Score=70.10 Aligned_cols=144 Identities=15% Similarity=0.195 Sum_probs=80.4
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCc--cceeece------eecCCeEEEEEEe
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGY------CQEEGRSVLVYEF 678 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~------~~~~~~~~lV~E~ 678 (824)
+.|+.|....+|+....+| .+++|+.... .....+..|.++++.+...+ +.+++.. ....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 3566788889999887655 6889988642 23456677888888774222 3333322 1223567899999
Q ss_pred cCCCCHHH-----------H---hhcc---cCcc--c--c-CCHHHHHH------------HHHHHHHHHHHHHhC----
Q 003385 679 MHNGTLKE-----------H---LYGT---LTHE--Q--R-INWIKRLE------------IAEDAAKGIEYLHTG---- 720 (824)
Q Consensus 679 ~~~gsL~~-----------~---L~~~---~~~~--~--~-l~~~~~~~------------i~~qia~gL~yLH~~---- 720 (824)
++|..+.. . ++.. .... . . ..|..... +...+...++.+++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98864311 1 1111 0000 0 0 01211100 011234445555531
Q ss_pred CCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 721 ~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
...+++|+|+++.|||++++..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 124799999999999998876668999997754
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.02 E-value=8e-05 Score=72.70 Aligned_cols=85 Identities=12% Similarity=0.092 Sum_probs=66.3
Q ss_pred CceeEEEecCCCCCccCChhhhcccccccccccccc-cCCC-CCCCCCC----CCcceEeecccc-cCCCCCccccCCCc
Q 003385 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNS-LTGP-IPDFSGC----PDLRIIHLEDNQ-LTGPLPSSLMNLPN 488 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~-l~~~-~p~~~~l----~~L~~L~L~~N~-l~g~lP~~l~~l~~ 488 (824)
.+|+.|||+++.++..=-..+.++++|+.|+|++|. |+.. +..++.+ ++|+.|+|+++. |+..=-..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999985544568899999999999995 6652 2235554 479999999985 77433346788999
Q ss_pred cceeeecccc-cc
Q 003385 489 LRELYVQNNM-LS 500 (824)
Q Consensus 489 L~~L~l~~N~-l~ 500 (824)
|+.|+|+++. ++
T Consensus 141 L~~L~L~~c~~It 153 (176)
T 3e4g_A 141 LKYLFLSDLPGVK 153 (176)
T ss_dssp CCEEEEESCTTCC
T ss_pred CCEEECCCCCCCC
Confidence 9999999986 44
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0033 Score=67.61 Aligned_cols=142 Identities=13% Similarity=0.107 Sum_probs=74.2
Q ss_pred cccccCcEE-EEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCC--ccceeeceeecCCeEEEEEEecCCCCH
Q 003385 608 KIGSGGFGV-VYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR--NLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (824)
Q Consensus 608 ~LG~G~fg~-Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~~~~~~~lV~E~~~~gsL 684 (824)
.|+.|.... +|+....+++.+++|...... ...+..|+.+++.+... .+.+++.+..+.+ +++||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence 455555444 666654446777777654321 14567788888877432 3456666544333 689999977666
Q ss_pred HHHhhccc---------------------Cc-cccCCHHHHH--------------------HHHHHHHHHHHHHH---h
Q 003385 685 KEHLYGTL---------------------TH-EQRINWIKRL--------------------EIAEDAAKGIEYLH---T 719 (824)
Q Consensus 685 ~~~L~~~~---------------------~~-~~~l~~~~~~--------------------~i~~qia~gL~yLH---~ 719 (824)
.+.+.... .. ...+...... .....+...++.+. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 54332110 00 0011111000 00011112222221 1
Q ss_pred CCCCCeEecCCCCCCEEEcCC----CcEEEEecCCcccc
Q 003385 720 GCVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSKFA 754 (824)
Q Consensus 720 ~~~~gIvHrDLkp~NILl~~~----~~vkL~DFGla~~~ 754 (824)
.....++|||+.+.|||++.+ +.+.|+||+.+...
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 112489999999999999875 67999999988654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0024 Score=67.75 Aligned_cols=70 Identities=11% Similarity=0.126 Sum_probs=44.6
Q ss_pred ccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCcc-ceeeceeecCCeEEEEEEec-CCCCH
Q 003385 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-VQFLGYCQEEGRSVLVYEFM-HNGTL 684 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~-~~gsL 684 (824)
+.|+.|....+|+. +.+++|+...... ......+|..+++.+...++ .++++...+ .-++++||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCccC
Confidence 56888999999998 5688998764321 12234578888887753333 456554432 346899999 55443
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0024 Score=71.56 Aligned_cols=71 Identities=13% Similarity=0.302 Sum_probs=48.7
Q ss_pred ccccccCcEEEEEEEEcC--------CcEEEEEEeccCCcccchhhhHHHHHHhhcCCCcc-ceeeceeecCCeEEEEEE
Q 003385 607 KKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-VQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~--------g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E 677 (824)
+.|+.|-...+|+....+ ++.+++|+.... .....+.+|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 457788889999998753 578999988432 111455679999988853333 566766543 38999
Q ss_pred ecCCCC
Q 003385 678 FMHNGT 683 (824)
Q Consensus 678 ~~~~gs 683 (824)
|++|.+
T Consensus 153 ~l~G~~ 158 (429)
T 1nw1_A 153 YIPSRP 158 (429)
T ss_dssp CCCEEE
T ss_pred EeCCcc
Confidence 998643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0017 Score=60.02 Aligned_cols=37 Identities=32% Similarity=0.328 Sum_probs=20.3
Q ss_pred CcceEeecccccCCCCCccccCCCccceeeecccccc
Q 003385 464 DLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 500 (824)
Q Consensus 464 ~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~ 500 (824)
+|+.|+|++|+|+..-++.|..+++|+.|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 3556666666666333334555666666655555543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0016 Score=60.30 Aligned_cols=56 Identities=32% Similarity=0.520 Sum_probs=47.5
Q ss_pred eEEEecCCCCC-ccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccC
Q 003385 419 TVIHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLT 476 (824)
Q Consensus 419 ~~L~L~~n~l~-g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~ 476 (824)
..++.++++|+ ..+|..|. ++|+.|+|++|+|+.+++. |..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 37888999987 46776543 4799999999999999887 788999999999999876
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.57 E-value=0.01 Score=63.46 Aligned_cols=142 Identities=13% Similarity=0.138 Sum_probs=80.9
Q ss_pred cccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCc--cceeece-----eecCCeEEEEEEecC
Q 003385 608 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGY-----CQEEGRSVLVYEFMH 680 (824)
Q Consensus 608 ~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~-----~~~~~~~~lV~E~~~ 680 (824)
.++ |....||+....+|+.+++|+.+... .....+..|..+++.+.... +.+++.. ....+..+++|++++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 355 77789998877777789999986432 23456777888888774222 3444443 122456688999998
Q ss_pred CCCHH-----------HH---hhcc---cC--ccccCCHHHH----------------------HHHHHHHHHHHHHHHh
Q 003385 681 NGTLK-----------EH---LYGT---LT--HEQRINWIKR----------------------LEIAEDAAKGIEYLHT 719 (824)
Q Consensus 681 ~gsL~-----------~~---L~~~---~~--~~~~l~~~~~----------------------~~i~~qia~gL~yLH~ 719 (824)
|..+. .. ++.. .. .....++... ...+.+++..+.-+..
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75321 11 1110 00 0111121110 1111222222222211
Q ss_pred -CCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 720 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 720 -~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
.....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1123689999999999999 4 899999987754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0049 Score=67.84 Aligned_cols=142 Identities=15% Similarity=0.230 Sum_probs=80.7
Q ss_pred ccccccCcEEEEEEEEc--------CCcEEEEEEeccCCcccchhhhHHHHHHhhcC-CCccceeeceeecCCeEEEEEE
Q 003385 607 KKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~--------~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E 677 (824)
+.|..|-...+|+.... +++.+++|+.... ......+.+|.++++.+. +.-..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 35666777889998764 2478999986332 223455668999998885 3333566666643 28999
Q ss_pred ecCCCCHHH--------------Hh---hcc-cCccccCC--HHHHHHHHHHHH-------------------HHHHHHH
Q 003385 678 FMHNGTLKE--------------HL---YGT-LTHEQRIN--WIKRLEIAEDAA-------------------KGIEYLH 718 (824)
Q Consensus 678 ~~~~gsL~~--------------~L---~~~-~~~~~~l~--~~~~~~i~~qia-------------------~gL~yLH 718 (824)
|++|..|.. .| +.. ........ +.++..+..++. ..+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 998754421 01 111 01111112 233333333321 1223332
Q ss_pred ----hC-CCCCeEecCCCCCCEEEcCC----CcEEEEecCCccc
Q 003385 719 ----TG-CVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSKF 753 (824)
Q Consensus 719 ----~~-~~~gIvHrDLkp~NILl~~~----~~vkL~DFGla~~ 753 (824)
.. ....++|+|+.+.|||++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 12378999999999999876 7899999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.32 E-value=0.017 Score=65.13 Aligned_cols=72 Identities=11% Similarity=0.109 Sum_probs=47.3
Q ss_pred ccccccCcEEEEEEEEcC-CcEEEEEEeccCCcccchhhhHHHHHHhhcCCCcc-ceeeceeecCCeEEEEEEecCCCC
Q 003385 607 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-VQFLGYCQEEGRSVLVYEFMHNGT 683 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~-g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~~gs 683 (824)
+.|+.|-...+|+....+ ++.+++|+..... ...-...+|..+++.+...++ .++++.+. + .+|+||++|.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 467788889999998775 4788999875322 111122589999999875544 56776663 2 25999998744
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.31 E-value=0.0066 Score=66.32 Aligned_cols=72 Identities=15% Similarity=0.179 Sum_probs=44.1
Q ss_pred ccccccCcEEEEEEEEcC---------CcEEEEEEeccCCcccchhhhHHHHHHhhcCCCc-cceeeceeecCCeEEEEE
Q 003385 607 KKIGSGGFGVVYYGKLKD---------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN-LVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~---------g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~ 676 (824)
+.|+.|....+|+....+ ++.+++|+..... ........|.++++.+...+ +.++++.. .+ ++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence 457778888999998754 2688899875432 11123467888888885333 34666544 22 6899
Q ss_pred EecCCCC
Q 003385 677 EFMHNGT 683 (824)
Q Consensus 677 E~~~~gs 683 (824)
||++|..
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.14 E-value=0.021 Score=61.64 Aligned_cols=68 Identities=12% Similarity=0.193 Sum_probs=44.7
Q ss_pred cccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCC---Cccceeece------eecCCeEEEEEEecC
Q 003385 610 GSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH---RNLVQFLGY------CQEEGRSVLVYEFMH 680 (824)
Q Consensus 610 G~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~------~~~~~~~~lV~E~~~ 680 (824)
|.|....||+....+| .+++|+..... ...|+.+++.+.. |.+.+.+.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~------~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYH------DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSS------CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCcc------chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3344679999987766 89999876433 2467777766632 224555533 233567899999999
Q ss_pred CCCH
Q 003385 681 NGTL 684 (824)
Q Consensus 681 ~gsL 684 (824)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.61 E-value=0.0036 Score=62.11 Aligned_cols=112 Identities=13% Similarity=0.077 Sum_probs=61.6
Q ss_pred hhceeccCCCC-CCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeEEEecCCCCCc----cCChhhh
Q 003385 363 EINKYLERNDG-SIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTG----NIPSDLT 437 (824)
Q Consensus 363 e~l~~L~l~~n-~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~L~L~~n~l~g----~lp~~i~ 437 (824)
..|+.|+|++| .+.......|...... -+.|+.|+|++|+|.. .+.+.+.
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~-------------------------N~~L~~L~L~~n~igd~ga~alA~aL~ 95 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACN-------------------------SKHIEKFSLANTAISDSEARGLIELIE 95 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTT-------------------------CSCCCEEECTTSCCBHHHHTTHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhh-------------------------CCCcCEEEccCCCCChHHHHHHHHHHh
Confidence 34666777764 6666555555554321 1257778888887762 2334444
Q ss_pred cccccccccccccccCCC-----CCCCCCCCCcceEeeccccc---CC----CCCccccCCCccceeeeccccc
Q 003385 438 KLSSLVELWLDGNSLTGP-----IPDFSGCPDLRIIHLEDNQL---TG----PLPSSLMNLPNLRELYVQNNML 499 (824)
Q Consensus 438 ~L~~L~~L~L~~N~l~~~-----~p~~~~l~~L~~L~L~~N~l---~g----~lP~~l~~l~~L~~L~l~~N~l 499 (824)
.=+.|+.|+|+.|+|+.. ...+..-+.|+.|+|++|.. .. .+-+.+..-+.|+.|+++.|..
T Consensus 96 ~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 96 TSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred cCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 556777777777777642 11244445577777765432 21 1223344445566666655543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.61 E-value=0.069 Score=59.51 Aligned_cols=72 Identities=11% Similarity=0.086 Sum_probs=47.5
Q ss_pred ccccccCcEEEEEEEEcC--------CcEEEEEEeccCCcccchhhhHHHHHHhhcC-CCccceeeceeecCCeEEEEEE
Q 003385 607 KKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~--------g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E 677 (824)
+.+..|-...+|+....+ ++.+++|+..... ...-+..+|.++++.+. +.-..++++.+. + ++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP--E--GRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEEEE
Confidence 456667788999998763 5789999865322 22223467888888885 333455665432 2 68999
Q ss_pred ecCCCC
Q 003385 678 FMHNGT 683 (824)
Q Consensus 678 ~~~~gs 683 (824)
|++|..
T Consensus 151 fI~G~~ 156 (424)
T 3mes_A 151 FIDGEP 156 (424)
T ss_dssp CCCSEE
T ss_pred EeCCcc
Confidence 999865
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=94.35 E-value=0.054 Score=59.52 Aligned_cols=80 Identities=19% Similarity=0.152 Sum_probs=60.1
Q ss_pred CCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceee
Q 003385 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (824)
Q Consensus 415 ~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~ 493 (824)
..+|+.+.+.++ ++..-...|.++++|+.++|..+ ++.+... |.+|++|+.++|..| ++..-..+|.++++|+.++
T Consensus 296 ~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ 372 (394)
T 4fs7_A 296 CSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVE 372 (394)
T ss_dssp CTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEE
T ss_pred cccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEE
Confidence 457888888765 66334557889999999999754 6665553 899999999999877 6623345899999999998
Q ss_pred eccc
Q 003385 494 VQNN 497 (824)
Q Consensus 494 l~~N 497 (824)
+..|
T Consensus 373 lp~~ 376 (394)
T 4fs7_A 373 LPKR 376 (394)
T ss_dssp EEGG
T ss_pred ECCC
Confidence 8654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=94.26 E-value=0.073 Score=58.00 Aligned_cols=89 Identities=15% Similarity=0.242 Sum_probs=62.9
Q ss_pred CceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCC-ccccCCCccceee
Q 003385 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELY 493 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP-~~l~~l~~L~~L~ 493 (824)
.+|+.+.+.++ ++..-...|.++++|+.+.|.+|.++.+.+. |.+|.+|+.++|.++ ++ .|. .+|.++++|+.+.
T Consensus 263 ~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~ 339 (379)
T 4h09_A 263 TALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALSTIS 339 (379)
T ss_dssp TTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCCCC
T ss_pred ehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEE
Confidence 46777777644 5523344778888888888888888876664 888888888888755 55 444 5788888888888
Q ss_pred eccccccccccccccc
Q 003385 494 VQNNMLSGTVPSSLLS 509 (824)
Q Consensus 494 l~~N~l~g~ip~~l~~ 509 (824)
+..+ ++ .|....|.
T Consensus 340 ip~~-v~-~I~~~aF~ 353 (379)
T 4h09_A 340 YPKS-IT-LIESGAFE 353 (379)
T ss_dssp CCTT-CC-EECTTTTT
T ss_pred ECCc-cC-EEchhHhh
Confidence 7544 55 56555544
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=93.86 E-value=0.0076 Score=59.77 Aligned_cols=83 Identities=14% Similarity=0.245 Sum_probs=62.1
Q ss_pred CceeEEEecCC-CCCc----cCChhhhcccccccccccccccCCCCC-----CCCCCCCcceEeecccccCCC----CCc
Q 003385 416 PSITVIHLSSK-NLTG----NIPSDLTKLSSLVELWLDGNSLTGPIP-----DFSGCPDLRIIHLEDNQLTGP----LPS 481 (824)
Q Consensus 416 ~~L~~L~L~~n-~l~g----~lp~~i~~L~~L~~L~L~~N~l~~~~p-----~~~~l~~L~~L~L~~N~l~g~----lP~ 481 (824)
+.|++|+|++| +|.. .+-+.+..=+.|+.|+|++|+|...-- .+..-+.|+.|+|++|+|... +-+
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 47899999986 7762 245567777899999999999985321 244567899999999999832 334
Q ss_pred cccCCCccceeeecccc
Q 003385 482 SLMNLPNLRELYVQNNM 498 (824)
Q Consensus 482 ~l~~l~~L~~L~l~~N~ 498 (824)
.+..-+.|++|+|++|.
T Consensus 121 aL~~N~tL~~L~L~n~~ 137 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQR 137 (197)
T ss_dssp HTTTTCCCSEEECCCCS
T ss_pred HHhhCCceeEEECCCCc
Confidence 56666779999998763
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=93.16 E-value=0.091 Score=57.69 Aligned_cols=81 Identities=23% Similarity=0.346 Sum_probs=57.3
Q ss_pred CceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCC-ccccCCCccceee
Q 003385 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELY 493 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP-~~l~~l~~L~~L~ 493 (824)
.+|+.+.+. +.++..-...|.++++|+.++|..| ++.+... |.+|++|+.+.|..+ ++ .+. .+|.++++|+.++
T Consensus 288 ~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~ 363 (394)
T 4gt6_A 288 PALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIE 363 (394)
T ss_dssp TTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEE
T ss_pred cccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEE
Confidence 467777775 4566333457888888888888754 5554443 888888888888655 66 454 5788888888888
Q ss_pred ecccccc
Q 003385 494 VQNNMLS 500 (824)
Q Consensus 494 l~~N~l~ 500 (824)
+.+|...
T Consensus 364 ~~~~~~~ 370 (394)
T 4gt6_A 364 YSGSRSQ 370 (394)
T ss_dssp ESSCHHH
T ss_pred ECCceee
Confidence 8877543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=93.00 E-value=0.018 Score=55.93 Aligned_cols=70 Identities=10% Similarity=0.119 Sum_probs=51.4
Q ss_pred cCChhhhcccccccccccccccCCC-CCCCCCCCCcceEeecccc-cCCCCCccccCC----Cccceeeecccc-cc
Q 003385 431 NIPSDLTKLSSLVELWLDGNSLTGP-IPDFSGCPDLRIIHLEDNQ-LTGPLPSSLMNL----PNLRELYVQNNM-LS 500 (824)
Q Consensus 431 ~lp~~i~~L~~L~~L~L~~N~l~~~-~p~~~~l~~L~~L~L~~N~-l~g~lP~~l~~l----~~L~~L~l~~N~-l~ 500 (824)
.+|.....--+|+.|||+++.|+.. +..+.+|++|+.|+|+++. |+..--..++.+ ++|++|+|++|. ++
T Consensus 52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT 128 (176)
T 3e4g_A 52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT 128 (176)
T ss_dssp GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC
T ss_pred cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC
Confidence 3454332234799999999998763 3457899999999999995 774433456665 479999999985 76
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=91.60 E-value=0.22 Score=54.56 Aligned_cols=99 Identities=15% Similarity=0.338 Sum_probs=55.2
Q ss_pred CceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeee
Q 003385 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l 494 (824)
..|+.+.+.++..+ .-...|.++++|+.+.+. +.++.+... |.+|.+|+.++|.+| ++..-..+|.++++|+.+.|
T Consensus 265 ~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~i 341 (394)
T 4gt6_A 265 AYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAI 341 (394)
T ss_dssp SSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred ccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEE
Confidence 35666666554433 334456666777777664 345444443 667777777777654 44122346666777777776
Q ss_pred cccccccccccccccc---ceeccccCC
Q 003385 495 QNNMLSGTVPSSLLSK---NVVLNYAGN 519 (824)
Q Consensus 495 ~~N~l~g~ip~~l~~~---~~~l~~~~n 519 (824)
..+ ++ .|....|.. +..+.+.+|
T Consensus 342 p~s-v~-~I~~~aF~~C~~L~~i~~~~~ 367 (394)
T 4gt6_A 342 PSS-VT-KIPESAFSNCTALNNIEYSGS 367 (394)
T ss_dssp CTT-CC-BCCGGGGTTCTTCCEEEESSC
T ss_pred Ccc-cC-EEhHhHhhCCCCCCEEEECCc
Confidence 433 55 566555443 334444444
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=91.14 E-value=0.25 Score=53.68 Aligned_cols=91 Identities=15% Similarity=0.200 Sum_probs=70.3
Q ss_pred CceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeee
Q 003385 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l 494 (824)
..|+.+.+..+ ++..-...|.++.+|+.+.+..+ +..+... |.++++|+.+.+.+|.++..-..+|.++.+|+.+.|
T Consensus 240 ~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~l 317 (379)
T 4h09_A 240 KALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTL 317 (379)
T ss_dssp SSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEEC
T ss_pred ccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEc
Confidence 47888888776 66344567888999999999754 5555553 899999999999999998333468999999999999
Q ss_pred cccccccccccccccc
Q 003385 495 QNNMLSGTVPSSLLSK 510 (824)
Q Consensus 495 ~~N~l~g~ip~~l~~~ 510 (824)
..+ ++ .|+...|..
T Consensus 318 p~~-l~-~I~~~aF~~ 331 (379)
T 4h09_A 318 PTA-LK-TIQVYAFKN 331 (379)
T ss_dssp CTT-CC-EECTTTTTT
T ss_pred Ccc-cc-EEHHHHhhC
Confidence 654 77 777776643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=90.06 E-value=0.97 Score=45.20 Aligned_cols=120 Identities=12% Similarity=0.091 Sum_probs=76.6
Q ss_pred CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCcee
Q 003385 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (824)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (824)
+|.+.|.. .+.++++.+++.++.|.+.+|.-+-.+.. + ..+=+.|..|++..+|.+...+ ..+.
T Consensus 34 SL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence 68888753 36789999999999999999877622100 1 1233456889999999887764 1110
Q ss_pred ccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCC-CCCCCccccchhcHhhhhc
Q 003385 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE-AISNEKFGANCRNIVQWVK 822 (824)
Q Consensus 763 ~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~-Pf~~~~~~~~~~~iv~~~~ 822 (824)
.....+.+||... ...+.+.=|||+|+++|.-+-=.. +=.....++...+++..|.
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~Mt 154 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHMA 154 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHHHH
Confidence 0123456788653 345678899999999999887444 4444556666777777664
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=89.27 E-value=0.26 Score=54.00 Aligned_cols=75 Identities=16% Similarity=0.205 Sum_probs=58.8
Q ss_pred CCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCcccee
Q 003385 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 492 (824)
Q Consensus 414 ~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L 492 (824)
+..+|+.++|.++ ++..-...|.++++|+.+.|..| ++.+... |.+|++|+.++|..| ++ .+..+|.++++|+.+
T Consensus 318 ~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 318 SCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp TCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred CCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 3458999999754 77334568999999999999877 7665554 999999999999865 44 456788899888865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.84 E-value=2.7 Score=46.10 Aligned_cols=30 Identities=30% Similarity=0.524 Sum_probs=25.3
Q ss_pred CeEecCCCCCCEEE------cCCCcEEEEecCCccc
Q 003385 724 AIIHRDLKSSNILL------DKHMRAKVSDFGLSKF 753 (824)
Q Consensus 724 gIvHrDLkp~NILl------~~~~~vkL~DFGla~~ 753 (824)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46899999999999 3457799999998754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 824 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-51 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 5e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 8e-61
Identities = 72/219 (32%), Positives = 117/219 (53%), Gaps = 11/219 (5%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
+ ++IGSG FG VY GK + + +T+ + Q + F NEV +L + H N++ F+G
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
Y +V ++ +L HL+ E + IK ++IA A+G++YLH +
Sbjct: 72 YSTAPQL-AIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA---KS 124
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYISQQ-- 781
IIHRDLKS+NI L + + K+ DFGL+ + SH + G++ ++ PE Q
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 782 -LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
+ +SDVY+FG++L EL++GQ SN +V
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 6e-59
Identities = 63/219 (28%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
++IGSG FG+V+ G + ++A+K + + +F E ++ ++ H LVQ G
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
C E+ LV+EFM +G L ++ T L + D +G+ YL C
Sbjct: 68 VCLEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 121
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
+IHRDL + N L+ ++ KVSDFG+++F +D S+ + V + PE + + +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 785 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWVKS 823
KSDV+SFGV++ E+ S + + +V+ + +
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIP---YENRSNSEVVEDIST 217
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-58
Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 7/197 (3%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
L +++G+G FG V+ G ++AVK L F E L+ ++ H+ LV+
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
+E ++ E+M NG+L + L ++ K L++A A+G+ ++
Sbjct: 76 VVTQEPI-YIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
IHRDL+++NIL+ + K++DFGL++ D + + + PE T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 785 KSDVYSFGVILLELISG 801
KSDV+SFG++L E+++
Sbjct: 190 KSDVWSFGILLTEIVTH 206
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-58
Identities = 61/199 (30%), Positives = 105/199 (52%), Gaps = 7/199 (3%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
K++G+G FGVV YGK + ++A+K++ + EF E ++ + H LVQ G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
C ++ ++ E+M NG L +L R + LE+ +D + +EYL +
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESKQ--- 120
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
+HRDL + N L++ KVSDFGLS++ +D S + V + PE + + +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 785 KSDVYSFGVILLELISGQE 803
KSD+++FGV++ E+ S +
Sbjct: 181 KSDIWAFGVLMWEIYSLGK 199
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 3e-57
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 662
++G+G GVV+ K G +A K++ R E+ +L + +V F
Sbjct: 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
G +G + E M G+L + L RI +++ KG+ YL
Sbjct: 70 YGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH- 124
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
I+HRD+K SNIL++ K+ DFG+S +D +++ GT Y+ PE
Sbjct: 125 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQGTHY 180
Query: 783 TDKSDVYSFGVILLELISGQ 802
+ +SD++S G+ L+E+ G+
Sbjct: 181 SVQSDIWSMGLSLVEMAVGR 200
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 9e-55
Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 10/219 (4%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
LE K+G G FG V+ G +A+K L F E ++ ++ H LVQ
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
EE +V E+M G+L + L G + + + +++A A G+ Y+
Sbjct: 80 VVSEEPI-YIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN--- 133
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
+HRDL+++NIL+ +++ KV+DFGL++ D + + + PE + + T
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 785 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWVKS 823
KSDV+SFG++L EL + G R ++ V+
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYP---GMVNREVLDQVER 229
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 1e-53
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 14/212 (6%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 655
+ ED +++ ++G G FG VY + K+ A KV+ + S + ++ E+ +L+
Sbjct: 9 NPEDFWEII-GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67
Query: 656 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
H N+V+ L E ++ EF G + + E+ + + + + +
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALN 124
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
YLH IIHRDLK+ NIL K++DFG+S S + GT ++ PE
Sbjct: 125 YLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPE 180
Query: 776 YYISQQLTD-----KSDVYSFGVILLELISGQ 802
+ + D K+DV+S G+ L+E+ +
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-53
Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 8/223 (3%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+ IG+G +G + K DGK + K L S + K+ +EV LL + H N+V+
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 662 FLGYCQEE--GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH- 718
+ + +V E+ G L + Q ++ L + ++ H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 719 -TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 777
+ ++HRDLK +N+ LD K+ DFGL++ S + GT Y+ PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQM 186
Query: 778 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 820
+KSD++S G +L EL + + I +
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG 229
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (470), Expect = 3e-53
Identities = 59/230 (25%), Positives = 108/230 (46%), Gaps = 21/230 (9%)
Query: 599 EDATKMLE--KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK---REFTNEVTLLS 652
+D K+ ++IG G FG VY+ + +++ + +A+K ++ + Q ++ EV L
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 653 RIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 712
++ H N +Q+ G E + LV E+ H++ + ++ + A +
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQ 126
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 772
G+ YLH+ +IHRD+K+ NILL + K+ DFG + S V GT ++
Sbjct: 127 GLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWM 178
Query: 773 DPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
PE ++ Q K DV+S G+ +EL + + N + +I Q
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 6e-53
Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+KIG G G VY + G+E+A++ + K NE+ ++ + N+V +L
Sbjct: 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
+V E++ G+L + + E ++ + + + + +E+LH+
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
+IHRD+KS NILL K++DFG S S++V GT ++ PE +
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 784 DKSDVYSFGVILLELISGQ 802
K D++S G++ +E+I G+
Sbjct: 195 PKVDIWSLGIMAIEMIEGE 213
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 6e-53
Identities = 58/239 (24%), Positives = 106/239 (44%), Gaps = 25/239 (10%)
Query: 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+L++ IG G FG V+ GK + G+E+AVK+ +S + E+ + H N++ F+
Sbjct: 6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFI 63
Query: 664 GYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
++ + LV ++ +G+L ++L + + +++A A G+ +LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 720 GCV-----PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF---AVDGASHVSSIVRGTVGY 771
V PAI HRDLKS NIL+ K+ ++D GL+ A D + GT Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 772 LDPEYYISQ------QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWVKSS 824
+ PE + ++D+Y+ G++ E+ + + S
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 6e-53
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+ +IG G F VY G + E+A L + ++ F E +L + H N+V+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 662 FLGYCQEEGRS----VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
F + + VLV E M +GTLK +L + + KG+++L
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFL 128
Query: 718 HTGCVPAIIHRDLKSSNILL-DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
HT P IIHRDLK NI + K+ D GL+ + + V GT ++ PE
Sbjct: 129 HTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEM 184
Query: 777 YISQQLTDKSDVYSFGVILLELISGQ 802
++ + DVY+FG+ +LE+ + +
Sbjct: 185 -YEEKYDESVDVYAFGMCMLEMATSE 209
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (466), Expect = 7e-53
Identities = 65/231 (28%), Positives = 117/231 (50%), Gaps = 26/231 (11%)
Query: 593 FTLSDIEDATK-----------MLEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN- 636
FT D +A + +E+ IG+G FG V G LK + +A+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 637 SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQ 696
+ + +R+F +E +++ + H N++ G + +++ EFM NG+L L ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDG 123
Query: 697 RINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756
+ I+ + + A G++YL +HRDL + NIL++ ++ KVSDFGLS+F D
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 757 GASHVSSI----VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 803
S + + + + PE ++ T SDV+S+G+++ E++S E
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 182 bits (463), Expect = 2e-52
Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 7/216 (3%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
++ K+G G +G VY G K +AVK L ++ + EF E ++ I H NLVQ L
Sbjct: 21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 79
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
G C E ++ EFM G L ++L + Q ++ + L +A + +EYL
Sbjct: 80 GVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK---K 134
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
IHRDL + N L+ ++ KV+DFGLS+ + + + + PE + +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 784 DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
KSDV++FGV+L E+ + + + +++
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 230
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-52
Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 19/231 (8%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK---REFTNEV 648
+ L D E + + +G G FG VY + K +A+KVL + + EV
Sbjct: 3 WALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 57
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 708
+ S + H N+++ GY + R L+ E+ GT+ L + + +
Sbjct: 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYIT 113
Query: 709 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 768
+ A + Y H+ +IHRD+K N+LL K++DFG S A + GT
Sbjct: 114 ELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGT 167
Query: 769 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
+ YL PE + +K D++S GV+ E + G+ + + I +
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 218
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 4e-52
Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 606 EKKIGSGGFGVVYYGKLKD---GKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLV 660
+K++GSG FG V G + K +AVK+L +N K E E ++ ++ + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
+ +G C+ E +LV E G L ++L + + +E+ + G++YL
Sbjct: 72 RMIGICEAESW-MLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS--IVRGTVGYLDPEYYI 778
+HRDL + N+LL AK+SDFGLSK ++ + + V + PE
Sbjct: 127 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 779 SQQLTDKSDVYSFGVILLELIS 800
+ + KSDV+SFGV++ E S
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFS 205
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-51
Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 18/212 (8%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 652
+ +++ L + IG G FG V G + G ++AVK + +++ + F E ++++
Sbjct: 4 LNMKELK-----LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMT 55
Query: 653 RIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 711
++ H NLVQ LG +E+G +V E+M G+L ++L + L+ + D
Sbjct: 56 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVC 113
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
+ +EYL +HRDL + N+L+ + AKVSDFGL+K A S + V +
Sbjct: 114 EAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKW 166
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELISGQE 803
PE ++ + KSDV+SFG++L E+ S
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIYSFGR 198
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-51
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 603 KMLEKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRN 658
+ + ++G G FG V G + ++A+KVL + + E E ++ ++ +
Sbjct: 11 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPY 70
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+V+ +G CQ E +LV E G L + L G + I E+ + G++YL
Sbjct: 71 IVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLE 126
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGASHVSSIVRGTVGYLDPEY 776
+HRDL + N+LL AK+SDFGLSK A D S + + + PE
Sbjct: 127 E---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 777 YISQQLTDKSDVYSFGVILLELIS 800
++ + +SDV+S+GV + E +S
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALS 207
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 6e-51
Identities = 50/202 (24%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 662
L + +G G +G V + + +AVK++ + E+ + ++H N+V+F
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
G+ +E L E+ G L + + + + G+ YLH
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG--- 121
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
I HRD+K N+LLD+ K+SDFGL+ F + + + + GT+ Y+ PE ++
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 782 L-TDKSDVYSFGVILLELISGQ 802
+ DV+S G++L +++G+
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGE 203
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (447), Expect = 3e-50
Identities = 59/247 (23%), Positives = 103/247 (41%), Gaps = 34/247 (13%)
Query: 605 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHR 657
+ IG G FG V+ + +AVK+L + + +F E L++ +
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH--------------------EQR 697
N+V+ LG C L++E+M G L E L H
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 698 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757
++ ++L IA A G+ YL +HRDL + N L+ ++M K++DFGLS+
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 758 -ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 816
+ ++ PE + T +SDV+++GV+L E+ S +G
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY---YGMAHEE 250
Query: 817 IVQWVKS 823
++ +V+
Sbjct: 251 VIYYVRD 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-49
Identities = 67/254 (26%), Positives = 110/254 (43%), Gaps = 19/254 (7%)
Query: 579 VSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGK----EIAVKVLT 634
+S+LN +A + + IG G FG VY+G L D AVK L
Sbjct: 6 LSALNPELVQAVQHVVI-GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64
Query: 635 SNSYQGK-REFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEFMHNGTLKEHLYGTL 692
+ G+ +F E ++ H N++ LG C EG ++V +M +G L+ +
Sbjct: 65 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR--- 121
Query: 693 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
+ AKG + +HRDL + N +LD+ KV+DFGL++
Sbjct: 122 NETHNPTVKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 753 FAVDG---ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809
D + H + + V ++ E +Q+ T KSDV+SFGV+L EL++ +
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
Query: 810 FGANCRNIVQWVKS 823
N +I ++
Sbjct: 239 ---NTFDITVYLLQ 249
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-49
Identities = 63/244 (25%), Positives = 106/244 (43%), Gaps = 32/244 (13%)
Query: 605 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HH 656
K +GSG FG V ++AVK+L + +RE +E+ +++++ H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH-------------------EQR 697
N+V LG C G L++E+ G L +L
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 698 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757
+ + L A AKG+E+L + +HRDL + N+L+ K+ DFGL++ +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 758 ASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCR 815
+++V R V ++ PE T KSDV+S+G++L E+ S G AN
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277
Query: 816 NIVQ 819
++Q
Sbjct: 278 KLIQ 281
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (441), Expect = 8e-49
Identities = 53/219 (24%), Positives = 92/219 (42%), Gaps = 11/219 (5%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ +++G+G FGVV+ G A K + + K E+ +S + H LV
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
+++ V++YEFM G L E + +++ + +E KG+ ++H
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHENN-- 144
Query: 724 AIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
+H DLK NI+ + K+ DFGL+ S GT + PE +
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--TTGTAEFAAPEVAEGKP 201
Query: 782 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 820
+ +D++S GV+ L+SG E RN+
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC 240
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 3e-48
Identities = 60/223 (26%), Positives = 111/223 (49%), Gaps = 14/223 (6%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE-----IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRN 658
+K IG+G FG VY G LK +A+K L + + +R +F E ++ + H N
Sbjct: 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 70
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+++ G + +++ E+M NG L + L + + ++ + + A G++YL
Sbjct: 71 IIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVGYLDPEY 776
+HRDL + NIL++ ++ KVSDFGLS+ D A++ +S + + + PE
Sbjct: 128 N---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 777 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
++ T SDV+SFG+++ E+++ E E +
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 227
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 3e-48
Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 26/222 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HH 656
K +G+G FG V +AVK+L +++ +RE +E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--------------TLTHEQRINWIK 702
N+V LG C G ++++ E+ G L L E ++
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 703 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-V 761
L + AKG+ +L + IHRDL + NILL K+ DFGL++ + +++ V
Sbjct: 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 803
R V ++ PE + T +SDV+S+G+ L EL S
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-47
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 22/216 (10%)
Query: 605 LEKKIGSGGFGVVYYGKLKDG---KEIAVKVL-TSNSYQGKREFTNEVTLLSRI-HHRNL 659
+ IG G FG V ++K + A+K + S R+F E+ +L ++ HH N+
Sbjct: 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE------------QRINWIKRLEIA 707
+ LG C+ G L E+ +G L + L + E ++ + L A
Sbjct: 74 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133
Query: 708 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 767
D A+G++YL IHRDL + NIL+ ++ AK++DFGLS+ R
Sbjct: 134 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM--GRL 188
Query: 768 TVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 803
V ++ E T SDV+S+GV+L E++S
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-47
Identities = 52/220 (23%), Positives = 93/220 (42%), Gaps = 12/220 (5%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL---TSNSYQGKREFTNEVTLLSRIHHRNLV 660
K +G G F V + L +E A+K+L T E ++SR+ H V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
+ Q++ + + NG L +++ + + +EYLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG- 126
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYIS 779
IIHRDLK NILL++ M +++DFG +K + + ++ GT Y+ PE
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 780 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
+ SD+++ G I+ +L++G + I++
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 224
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 3e-47
Identities = 48/202 (23%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 659
L + IG G FG V+ G + +A+K + + RE F E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
V+ +G E ++ E G L+ L + ++ + A + + YL +
Sbjct: 71 VKLIGVI-TENPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES 126
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
+HRD+ + N+L+ + K+ DFGLS++ D + +S + + ++ PE
Sbjct: 127 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 780 QQLTDKSDVYSFGVILLELISG 801
++ T SDV+ FGV + E++
Sbjct: 184 RRFTSASDVWMFGVCMWEILMH 205
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 169 bits (429), Expect = 4e-47
Identities = 47/218 (21%), Positives = 103/218 (47%), Gaps = 11/218 (5%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ +++GSG FGVV+ G+ K + + K NE+++++++HH L+
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 92
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
+++ VL+ EF+ G L + + + +++ + + A +G++++H
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHE---H 146
Query: 724 AIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
+I+H D+K NI+ + K K+ DFGL+ + + T + PE +
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREP 204
Query: 782 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
+ +D+++ GV+ L+SG + E +N+ +
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 242
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 4e-46
Identities = 55/205 (26%), Positives = 86/205 (41%), Gaps = 16/205 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVL---TSNSYQGKREFTNEVTLLSRIHHR 657
L +K+G G FGVV G+ +AVK L + + +F EV + + HR
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
NL++ G +V E G+L + L H+ A A+G+ YL
Sbjct: 72 NLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTVGYLDPE 775
+ IHRDL + N+LL K+ DFGL + H + + + PE
Sbjct: 128 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 776 YYISQQLTDKSDVYSFGVILLELIS 800
++ + SD + FGV L E+ +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFT 209
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-45
Identities = 51/206 (24%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL-----TSNSYQGKREFTNEVTLLSRIHHRN 658
K +GSG FG VY G +G+++ + V + S + +E +E +++ + + +
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+ + LG C L+ + M G L +++ H+ I L AKG+ YL
Sbjct: 73 VCRLLGICLTSTV-QLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYL- 127
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYY 777
++HRDL + N+L+ K++DFGL+K + + + + + ++ E
Sbjct: 128 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 778 ISQQLTDKSDVYSFGVILLELISGQE 803
+ + T +SDV+S+GV + EL++
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGS 211
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (402), Expect = 6e-44
Identities = 60/229 (26%), Positives = 96/229 (41%), Gaps = 15/229 (6%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI 654
DI D +G+G F V + + K +A+K + + +GK NE+ +L +I
Sbjct: 6 DIRDIYD-FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI 64
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
H N+V + G L+ + + G L + + + + +
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAV 120
Query: 715 EYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
+YLH I+HRDLK N+L D+ + +SDFGLSK G V S GT GY
Sbjct: 121 KYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGY 175
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 820
+ PE + + D +S GVI L+ G +E I++
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA 224
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 8e-44
Identities = 41/218 (18%), Positives = 90/218 (41%), Gaps = 12/218 (5%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ + +G G FG+V+ K K + + E+++L+ HRN++
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
+ V+++EF+ + E + T +N + + + +++LH+
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS---H 121
Query: 724 AIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
I H D++ NI+ + K+ +FG ++ G + ++ Y PE +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDV 179
Query: 782 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
++ +D++S G ++ L+SG E NI+
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 156 bits (395), Expect = 2e-43
Identities = 57/225 (25%), Positives = 108/225 (48%), Gaps = 17/225 (7%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK---REFTNEVTLLSRIHHRNLV 660
L + +G GG V+ + L+ +++AVKVL ++ + F E + ++H +V
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70
Query: 661 QFLGYCQEE----GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
+ E +V E++ TL++ ++ E + + +E+ DA + + +
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNF 126
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV--SSIVRGTVGYLDP 774
H IIHRD+K +NI++ KV DFG+++ D + V ++ V GT YL P
Sbjct: 127 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 775 EYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
E + +SDVYS G +L E+++G+ + + + V+
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (398), Expect = 2e-43
Identities = 53/231 (22%), Positives = 102/231 (44%), Gaps = 20/231 (8%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVL---TSNSYQGKREFTNEV 648
++L D + + + +G+G FG V+ + + +G+ A+KVL + +E
Sbjct: 1 YSLQDFQ-----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER 55
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 708
+LS + H +++ G Q+ + ++ +++ G L L + + E+
Sbjct: 56 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 115
Query: 709 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 768
L II+RDLK NILLDK+ K++DFG +K+ D + GT
Sbjct: 116 -------ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCGT 164
Query: 769 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
Y+ PE ++ D +SFG+++ E+++G + I+
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 3e-43
Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 17/213 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHR 657
+ +++G G FG+VY G K +A+K + + S + + EF NE +++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY------GTLTHEQRINWIKRLEIAEDAA 711
++V+ LG + ++++ E M G LK +L + K +++A + A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG-ASHVSSIVRGTVG 770
G+ YL+ +HRDL + N ++ + K+ DFG+++ + V
Sbjct: 144 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELISGQE 803
++ PE T SDV+SFGV+L E+ + E
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-42
Identities = 60/242 (24%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRI- 654
L K +G G FG V + ++AVK+L S++ + + +E+ ++ I
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY------------GTLTHEQRINWIK 702
H+N++ LG C ++G ++ E+ G L+E+L + E++++
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 703 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++ +
Sbjct: 137 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 763 SIV-RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWV 821
+ R V ++ PE + T +SDV+SFGV+L E+ + + G + + +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP---GVPVEELFKLL 250
Query: 822 KS 823
K
Sbjct: 251 KE 252
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-42
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 25/221 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRI-HH 656
L K +G G FG V + +AVK+L + R +E+ +L I HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 657 RNLVQFLGYCQEEGRSV-LVYEFMHNGTLKEHLYG------------TLTHEQRINWIKR 703
N+V LG C + G + ++ EF G L +L ++ +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 704 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-S 762
+ + AKG+E+L + IHRDL + NILL + K+ DFGL++ +V
Sbjct: 137 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 803
R + ++ PE + T +SDV+SFGV+L E+ S
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 1e-41
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 13/203 (6%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNL 659
L K +G G FG V+ + K + A+K L + + + L H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
Q + V E+++ G L H+ + + + A + G+++LH+
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
I++RDLK NILLDK K++DFG+ K + G + ++ GT Y+ PE +
Sbjct: 122 KG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLG 177
Query: 780 QQLTDKSDVYSFGVILLELISGQ 802
Q+ D +SFGV+L E++ GQ
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 154 bits (389), Expect = 1e-41
Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEV---TLLSRIHHR 657
+ + IG GGFG VY + D GK A+K L QG+ NE +L+S
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
+V + + + M+ G L HL + + A + G+E++
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHM 123
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 777
H +++RDLK +NILLD+H ++SD GL+ H GT GY+ PE
Sbjct: 124 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVL 177
Query: 778 ISQQLTD-KSDVYSFGVILLELISGQ 802
D +D +S G +L +L+ G
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 150 bits (379), Expect = 3e-41
Identities = 61/233 (26%), Positives = 95/233 (40%), Gaps = 26/233 (11%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL---------TSNSYQGKREFTNEVTLLSRI 654
++ +G G VV KE AVK++ + + EV +L ++
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 655 H-HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713
H N++Q + LV++ M G L ++L T + ++ + +I +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEV 122
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
I LH I+HRDLK NILLD M K++DFG S G V GT YL
Sbjct: 123 ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLA 177
Query: 774 PEYYISQQL------TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 820
PE + D++S GVI+ L++G + K R I+
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 147 bits (371), Expect = 5e-40
Identities = 46/200 (23%), Positives = 83/200 (41%), Gaps = 9/200 (4%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQF 662
+KIG G +GVVY + G+ A+K + E+++L + H N+V+
Sbjct: 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+ R VLV+E + K E + + GI Y H
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
++HRDLK N+L+++ K++DFGL++ + + S++
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 783 TDKSDVYSFGVILLELISGQ 802
+ D++S G I E+++G
Sbjct: 179 STTIDIWSVGCIFAEMVNGT 198
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (371), Expect = 6e-40
Identities = 51/229 (22%), Positives = 92/229 (40%), Gaps = 20/229 (8%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
L +KIGSG FG +Y G + G+E+A+K+ + + E + + + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTI 68
Query: 664 GYCQEEGRS-VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+C EG V+V E + + ++ + L +A+ IEY+H+
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKN- 123
Query: 723 PAIIHRDLKSSNIL---LDKHMRAKVSDFGLSKFAVDGASHV------SSIVRGTVGYLD 773
IHRD+K N L K + DFGL+K D +H + + GT Y
Sbjct: 124 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 774 PEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWVK 822
++ + + + D+ S G +L+ G K + + +
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 9e-40
Identities = 47/201 (23%), Positives = 88/201 (43%), Gaps = 9/201 (4%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+KIG G +GVVY + K G+ +A+K + + + E++LL ++H N+V+
Sbjct: 6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 65
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
L E + LV+EF+H K + I +G+ + H+
Sbjct: 66 LLDVIHTENKLYLVFEFLHQDLKKFMD---ASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
++HRDLK N+L++ K++DFGL++ + V +
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 782 LTDKSDVYSFGVILLELISGQ 802
+ D++S G I E+++ +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRR 200
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 58/239 (24%), Positives = 101/239 (42%), Gaps = 21/239 (8%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVL------TSNSYQGKREFT 645
F +++D +++GSG F VV + K G + A K + +S + +
Sbjct: 3 FRQENVDDYYDTG-EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 646 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE 705
EV++L I H N++ + + +L+ E + G L + L ++ + + E
Sbjct: 62 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATE 117
Query: 706 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSKFAVDGASHV 761
+ G+ YLH+ I H DLK NI+L R K+ DFGL+ G
Sbjct: 118 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 173
Query: 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 820
+ GT ++ PE + L ++D++S GVI L+SG + N+
Sbjct: 174 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 51/220 (23%), Positives = 88/220 (40%), Gaps = 15/220 (6%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE-----FTNEVTLLSRIHHRNLV 660
+G G F VY + K + +A+K + ++ E+ LL + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
L + LV++FM + + +G+EYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
I+HRDLK +N+LLD++ K++DFGL+K + V T Y PE
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 781 QLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
++ D+++ G IL EL+ + + I +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 215
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-39
Identities = 50/224 (22%), Positives = 95/224 (42%), Gaps = 9/224 (4%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 662
IG G +G+V + +A+K ++ +Q + E+ +L R H N++
Sbjct: 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 71
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+ + ++ L L Q ++ +G++Y+H+
Sbjct: 72 NDIIRAPTIEQMKDVYLVTH-LMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 129
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI--VRGTVGYLDPEYYISQ 780
++HRDLK SN+LL+ K+ DFGL++ A H + T Y PE ++
Sbjct: 130 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 781 QLTDKS-DVYSFGVILLELISGQEAISNEKFGANCRNIVQWVKS 823
+ KS D++S G IL E++S + + + +I+ + S
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 231
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 9e-39
Identities = 47/210 (22%), Positives = 87/210 (41%), Gaps = 20/210 (9%)
Query: 605 LEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRI---HHR 657
+IG G +G V+ + G+ +A+K + + + EV +L + H
Sbjct: 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 70
Query: 658 NLVQFLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 712
N+V+ C E + LV+E + E + ++ +
Sbjct: 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLR 127
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 772
G+++LH+ ++HRDLK NIL+ + K++DFGL++ + S V T+ Y
Sbjct: 128 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTLWYR 182
Query: 773 DPEYYISQQLTDKSDVYSFGVILLELISGQ 802
PE + D++S G I E+ +
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-38
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 17/223 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
K IG+G FGVVY KL D G+ +A+K + Q KR E+ ++ ++ H N+V+
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 664 GYCQEEGRS------VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
+ G LV +++ + + +Q + I + + Y+
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 718 HTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
H+ I HRD+K N+LLD K+ DFG +K V G S +
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI 194
Query: 777 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
+ + T DV+S G +L EL+ GQ + I++
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 142 bits (359), Expect = 2e-38
Identities = 39/227 (17%), Positives = 91/227 (40%), Gaps = 20/227 (8%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ ++IG G FGV++ G L + +++A+K S + +E + + +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
Y +EG ++ + +L++ L ++ + A+ ++ +H
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHEKS-- 121
Query: 724 AIIHRDLKSSNILLDKHMR-----AKVSDFGLSKFAVDGASHVSSI------VRGTVGYL 772
+++RD+K N L+ + V DFG+ KF D + + GT Y+
Sbjct: 122 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 773 DPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
++ ++ + + D+ + G + + + G K N + +
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 227
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 9e-38
Identities = 48/209 (22%), Positives = 84/209 (40%), Gaps = 20/209 (9%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE------FTNEVTLLSRIH-- 655
+ +GSGGFG VY G + D +A+K + + E EV LL ++
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 656 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
+++ L + + VL+ E +T + + +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDF---ITERGALQEELARSFFWQVLEAVR 124
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
+ H ++HRD+K NIL+D + K+ DFG D V + GT Y P
Sbjct: 125 HCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPP 178
Query: 775 EYYISQQLTDKS-DVYSFGVILLELISGQ 802
E+ + +S V+S G++L +++ G
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-37
Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 17/213 (7%)
Query: 594 TLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVT 649
T++D + K +G G FG V + K G+ A+K+L K E E
Sbjct: 3 TMNDFD-----YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 650 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 709
+L H L Q R V E+ + G L HL R
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-------SRERVFTEERARFY 110
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
A+ + L +++RD+K N++LDK K++DFGL K + + + + GT
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTP 169
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
YL PE D + GV++ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-37
Identities = 50/230 (21%), Positives = 91/230 (39%), Gaps = 21/230 (9%)
Query: 603 KMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLV 660
K+ + +G G G V + ++ A+K+L Q + EV L R ++V
Sbjct: 14 KVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIV 68
Query: 661 QFLGYCQ----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
+ + + ++V E + G L + +Q + EI + + I+Y
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQY 126
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
LH+ I HRD+K N+L K++DFG +K S + T Y+
Sbjct: 127 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVA 181
Query: 774 PEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWVKS 823
PE ++ D++S GVI+ L+ G + A + ++
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 231
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 6e-37
Identities = 42/201 (20%), Positives = 84/201 (41%), Gaps = 10/201 (4%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+KIG G +G V+ K + + +A+K + + E+ LL + H+N+V+
Sbjct: 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR 65
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
+ + LV+EF K ++ KG+ + H+
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
++HRDLK N+L++++ K+++FGL++ S+ V + ++
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 782 LTDKSDVYSFGVILLELISGQ 802
+ D++S G I EL +
Sbjct: 179 YSTSIDMWSAGCIFAELANAG 199
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 1e-35
Identities = 47/230 (20%), Positives = 93/230 (40%), Gaps = 22/230 (9%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 661
KIG G FG V+ + K G+++A+K + + + E+ +L + H N+V
Sbjct: 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN 73
Query: 662 FLGYCQE--------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713
+ C+ +G LV++F + + EI
Sbjct: 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-------NVLVKFTLSEIKRVMQML 126
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF---AVDGASHVSSIVRGTVG 770
+ L+ I+HRD+K++N+L+ + K++DFGL++ A + + + T+
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 771 YLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
Y PE + ++ D++ G I+ E+ + + I Q
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-35
Identities = 48/218 (22%), Positives = 88/218 (40%), Gaps = 9/218 (4%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+ +GSG +G V + G ++A+K L S + E+ LL + H N++
Sbjct: 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG 81
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
L + +F G L +++ + + KG+ Y+H
Sbjct: 82 LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 141
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
IIHRDLK N+ +++ K+ DFGL++ A S ++ V +
Sbjct: 142 ---IIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVILNWMR 195
Query: 782 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
T D++S G I+ E+I+G+ + I++
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (341), Expect = 2e-35
Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 15/200 (7%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 662
K +G+G FG V K + G A+K+L ++ NE +L ++ LV+
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
++ +V E++ G + HL R + A EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD- 161
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
+I+RDLK N+L+D+ +V+DFG +K + GT L PE +S+
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEIILSKGY 215
Query: 783 TDKSDVYSFGVILLELISGQ 802
D ++ GV++ E+ +G
Sbjct: 216 NKAVDWWALGVLIYEMAAGY 235
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (321), Expect = 5e-33
Identities = 43/204 (21%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 662
L +K+G G + V+ + + +++ VK+L K++ E+ +L + N++
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITL 95
Query: 663 LGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
++ LV+E ++N K+ Q + + K ++Y H+
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM 148
Query: 721 CVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
I+HRD+K N+++D +H + ++ D+GL++F G + + + + PE +
Sbjct: 149 G---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVD 203
Query: 780 QQLTD-KSDVYSFGVILLELISGQ 802
Q+ D D++S G +L +I +
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 5e-32
Identities = 58/231 (25%), Positives = 93/231 (40%), Gaps = 18/231 (7%)
Query: 605 LEKKIGSGGFGVVYYGKL----KDGKEIAVKVL----TSNSYQGKREFTNEVTLLSRI-H 655
L K +G+G +G V+ + GK A+KVL + E +L I
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 656 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
LV Q E + L+ ++++ G L HL + I EI
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL------- 140
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
L II+RD+K NILLD + ++DFGLSK V + + GT+ Y+ P+
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 776 YYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWVKSS 824
D +S GV++ EL++G + + + I + + S
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 3e-30
Identities = 48/202 (23%), Positives = 83/202 (41%), Gaps = 11/202 (5%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+GSG +G V K G +AVK L S + E+ LL + H N++
Sbjct: 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
L + L + Q++ + +G++Y+H+
Sbjct: 82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
IIHRDLK SN+ +++ K+ DFGL++ + T Y PE ++
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEIMLNWM 194
Query: 782 LTD-KSDVYSFGVILLELISGQ 802
+ D++S G I+ EL++G+
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 3e-30
Identities = 50/226 (22%), Positives = 93/226 (41%), Gaps = 21/226 (9%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
K IGSG G+V + +A+K L + + E+ L+ ++H+N++
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 662 FLGYC------QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
L +E LV E M + + ++ + + GI+
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQ-------VIQMELDHERMSYLLYQMLCGIK 133
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
+LH+ IIHRDLK SNI++ K+ DFGL++ G S + + T Y PE
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 188
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWV 821
+ + D++S G I+ E++ + + +++ +
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (282), Expect = 1e-27
Identities = 40/233 (17%), Positives = 92/233 (39%), Gaps = 18/233 (7%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL---- 659
L +K+G G F V+ K + + +A+K++ +E+ LL R++ +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 660 -------VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-EIAEDAA 711
++ L + +G + + + + L +E R + + +I++
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVS-SIVRGTV 769
G++Y+H C IIH D+K N+L++ + ++ + T
Sbjct: 136 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWVK 822
Y PE + +D++S ++ ELI+G ++ + ++ +
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 93.7 bits (232), Expect = 1e-22
Identities = 29/158 (18%), Positives = 48/158 (30%), Gaps = 21/158 (13%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVL----------TSNSYQGKREFTNEVTLLSRI 654
+ K +G G V+ + E VK G F+ +R
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
R L + G VY + N L E R+ E+ + + +
Sbjct: 64 EFRALQKLQGLAV-----PKVYAWEGNAVLME--LIDAKELYRVRVENPDEVLDMILEEV 116
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
+ I+H DL N+L+ + + DF S
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFPQSV 150
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 73.1 bits (178), Expect = 3e-14
Identities = 15/93 (16%), Positives = 36/93 (38%), Gaps = 5/93 (5%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD 464
++T + L N++ P ++ L+ L L+ N ++ + +
Sbjct: 296 QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV-SSLANLTN 352
Query: 465 LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497
+ + NQ++ P L NL + +L + +
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 66.6 bits (161), Expect = 3e-12
Identities = 21/81 (25%), Positives = 37/81 (45%), Gaps = 3/81 (3%)
Query: 439 LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498
L +L L L N+++ P S L+ + +N+++ SSL NL N+ L +N
Sbjct: 306 LKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQ 362
Query: 499 LSGTVPSSLLSKNVVLNYAGN 519
+S P + L++ L
Sbjct: 363 ISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 7e-07
Identities = 36/131 (27%), Positives = 52/131 (39%), Gaps = 24/131 (18%)
Query: 412 SDPQPSITVIHLSSKNLTGNI---PSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRII 468
SD P + +L +L GN L L++L +L L N ++ P SG L +
Sbjct: 210 SDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP-LSGLTKLTEL 268
Query: 469 HLEDNQLTGPLP--------------------SSLMNLPNLRELYVQNNMLSGTVPSSLL 508
L NQ++ P S + NL NL L + N +S P S L
Sbjct: 269 KLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSL 328
Query: 509 SKNVVLNYAGN 519
+K L +A N
Sbjct: 329 TKLQRLFFANN 339
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 46.5 bits (109), Expect = 9e-06
Identities = 13/78 (16%), Positives = 30/78 (38%), Gaps = 3/78 (3%)
Query: 439 LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498
L+ ++ L ++T + + + + + + + L NL ++ NN
Sbjct: 21 LAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQ 77
Query: 499 LSGTVPSSLLSKNVVLNY 516
L+ P L+K V +
Sbjct: 78 LTDITPLKNLTKLVDILM 95
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 1e-05
Identities = 24/78 (30%), Positives = 36/78 (46%), Gaps = 3/78 (3%)
Query: 438 KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497
KL++L L N ++ P +L + L NQL +L +L NL +L + NN
Sbjct: 195 KLTNLESLIATNNQISDITPLGI-LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANN 251
Query: 498 MLSGTVPSSLLSKNVVLN 515
+S P S L+K L
Sbjct: 252 QISNLAPLSGLTKLTELK 269
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 69.8 bits (169), Expect = 2e-13
Identities = 19/79 (24%), Positives = 34/79 (43%), Gaps = 2/79 (2%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD 464
++ ++ + L + + G +P LT+L L L + N+L G IP
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQR 292
Query: 465 LRIIHLEDNQ-LTG-PLPS 481
+ +N+ L G PLP+
Sbjct: 293 FDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 21/62 (33%), Positives = 28/62 (45%), Gaps = 1/62 (1%)
Query: 462 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGNI 520
+L + L +N++ G LP L L L L V N L G +P L + V YA N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 521 NL 522
L
Sbjct: 303 CL 304
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.3 bits (134), Expect = 5e-09
Identities = 15/58 (25%), Positives = 22/58 (37%), Gaps = 3/58 (5%)
Query: 446 WLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN-MLSG 501
L N + G +P + L +++ N L G +P NL NN L G
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCG 306
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 62.7 bits (151), Expect = 3e-11
Identities = 25/104 (24%), Positives = 39/104 (37%), Gaps = 5/104 (4%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL 475
+ V+ S L +P DL L L N +T DF +L + L +N++
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ P + L L LY+ N L +P + L N
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHEN 110
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 24/93 (25%), Positives = 38/93 (40%), Gaps = 4/93 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
P ++ L + +T D L +L L L N ++ P F+ L ++L NQ
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
L LP + L+EL V N ++ S
Sbjct: 91 LKE-LPEKMPK--TLQELRVHENEITKVRKSVF 120
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 46.6 bits (109), Expect = 7e-06
Identities = 16/128 (12%), Positives = 38/128 (29%), Gaps = 25/128 (19%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG--------------------- 454
++ + L + ++ P L L L+L N L
Sbjct: 55 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITK 114
Query: 455 ---PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 511
+ + + + + +G + + L + + + ++ T+P L
Sbjct: 115 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSL 173
Query: 512 VVLNYAGN 519
L+ GN
Sbjct: 174 TELHLDGN 181
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.0 bits (92), Expect = 8e-04
Identities = 17/115 (14%), Positives = 38/115 (33%), Gaps = 30/115 (26%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLD------------------------GNS 451
PS+T +HL +T + L L++L +L L N
Sbjct: 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230
Query: 452 LTGPIPDFSGCPDLRIIHLEDNQLTG------PLPSSLMNLPNLRELYVQNNMLS 500
L + +++++L +N ++ P + + + +N +
Sbjct: 231 LVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 39.3 bits (90), Expect = 0.001
Identities = 19/71 (26%), Positives = 31/71 (43%), Gaps = 4/71 (5%)
Query: 438 KLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496
+VEL + +G F G L I + D +T +P L P+L EL++
Sbjct: 124 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDG 180
Query: 497 NMLSGTVPSSL 507
N ++ +SL
Sbjct: 181 NKITKVDAASL 191
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 55.5 bits (133), Expect = 7e-10
Identities = 24/105 (22%), Positives = 38/105 (36%), Gaps = 25/105 (23%)
Query: 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDL-------------- 465
V+HL+ K+LT + L +L + L L N L P + L
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 466 --------RIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNNMLSG 501
+ + L +N+L L++ P L L +Q N L
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.8 bits (87), Expect = 8e-04
Identities = 11/40 (27%), Positives = 17/40 (42%), Gaps = 2/40 (5%)
Query: 466 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 505
R++HL LT L L + L + +N L P+
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA 38
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 5e-08
Identities = 25/97 (25%), Positives = 43/97 (44%), Gaps = 3/97 (3%)
Query: 400 CLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF 459
L + + + S + +LS N + + L LS L L D N ++ I
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPL 191
Query: 460 SGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496
+ P+L +HL++NQ++ P L N NL + + N
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 15/59 (25%), Positives = 30/59 (50%), Gaps = 2/59 (3%)
Query: 457 PDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 515
+ L + +DN+++ P L +LPNL E++++NN +S P + S ++
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVT 223
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 5e-04
Identities = 8/61 (13%), Positives = 26/61 (42%), Gaps = 3/61 (4%)
Query: 439 LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498
L++ +++ +++T + + + + +T + L NL L +++N
Sbjct: 18 LANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74
Query: 499 L 499
+
Sbjct: 75 I 75
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 23/118 (19%), Positives = 37/118 (31%), Gaps = 9/118 (7%)
Query: 392 WAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNS 451
P + + + I S SL EL + N
Sbjct: 236 LTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNK 295
Query: 452 LTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG--TVPSSL 507
L +P + P L + N L +P NL++L+V+ N L +P S+
Sbjct: 296 LIE-LP--ALPPRLERLIASFNHLAE-VPEL---PQNLKQLHVEYNPLREFPDIPESV 346
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 15/75 (20%), Positives = 28/75 (37%), Gaps = 6/75 (8%)
Query: 441 SLVELWLDGNSLT--GPIPDFSGCPDLRIIHLEDNQLTG----PLPSSLMNLPNLRELYV 494
+ L + L+ +++ L+D LT + S+L P L EL +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 495 QNNMLSGTVPSSLLS 509
++N L +L
Sbjct: 63 RSNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 5e-06
Identities = 20/103 (19%), Positives = 34/103 (33%), Gaps = 14/103 (13%)
Query: 404 PWSWLQCNSDPQPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIPD- 458
Q P + V+ L+ +++ + + + L SL EL L N L
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416
Query: 459 -----FSGCPDLRIIHLEDNQLTGPLPSSLMNL----PNLREL 492
L + L D + + L L P+LR +
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 14/55 (25%), Positives = 24/55 (43%), Gaps = 4/55 (7%)
Query: 459 FSGCPDLRIIHLEDNQLTG----PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
LR++ L D ++ L ++L+ +LREL + NN L L+
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.2 bits (108), Expect = 7e-06
Identities = 18/64 (28%), Positives = 32/64 (50%), Gaps = 2/64 (3%)
Query: 435 DLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494
+++K++S +E+ D +LT PD D I+HL +N L ++LM L +L +
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 495 QNNM 498
Sbjct: 63 DRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.002
Identities = 16/95 (16%), Positives = 30/95 (31%), Gaps = 3/95 (3%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDG-NSLTGPIPD-FSGC 462
+ L + N +P L + +E N+LT +G
Sbjct: 112 LTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL 171
Query: 463 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497
+L + L++N L +P L ++ N
Sbjct: 172 ENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (104), Expect = 2e-05
Identities = 20/91 (21%), Positives = 37/91 (40%), Gaps = 1/91 (1%)
Query: 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLT 476
+ +HL L P L++L L+L N+L D F +L + L N+++
Sbjct: 107 LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166
Query: 477 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
+ L +L L + N ++ P +
Sbjct: 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 12/76 (15%), Positives = 28/76 (36%), Gaps = 2/76 (2%)
Query: 425 SKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHLEDNQLTGPLPSS 482
++ ++ + + L + + S C L+ + LE +L+ P+ ++
Sbjct: 31 PRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 90
Query: 483 LMNLPNLRELYVQNNM 498
L NL L +
Sbjct: 91 LAKNSNLVRLNLSGCS 106
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 12/73 (16%), Positives = 29/73 (39%), Gaps = 3/73 (4%)
Query: 437 TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496
+ ++ L S+T + + + I ++ + + LPN+ +L++
Sbjct: 21 DAFAETIKDNLKKKSVTDAVTQ-NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 497 NMLSGTVPSSLLS 509
N L+ P + L
Sbjct: 78 NKLTDIKPLANLK 90
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 10/41 (24%), Positives = 19/41 (46%), Gaps = 2/41 (4%)
Query: 456 IPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496
I +G L+ ++L N ++ +L L NL L + +
Sbjct: 171 IVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 11/66 (16%), Positives = 25/66 (37%), Gaps = 3/66 (4%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD 464
+ + L ++ +P L L+ L L+L N ++ + +G +
Sbjct: 145 KITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRALAGLKN 201
Query: 465 LRIIHL 470
L ++ L
Sbjct: 202 LDVLEL 207
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 2e-04
Identities = 16/72 (22%), Positives = 27/72 (37%), Gaps = 2/72 (2%)
Query: 431 NIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTG--PLPSSLMNLPN 488
DL + V L + P+L ++L +N+L + S + PN
Sbjct: 33 RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPN 92
Query: 489 LRELYVQNNMLS 500
L+ L + N L
Sbjct: 93 LKILNLSGNELK 104
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (85), Expect = 0.003
Identities = 16/90 (17%), Positives = 30/90 (33%), Gaps = 3/90 (3%)
Query: 422 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS 481
L + + + ++K + LD L PD +++ + L
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLRS-DPDLVAQNIDVVLNRRSSMAAT-LRI 59
Query: 482 SLMNLPNLRELYVQNNMLSGTVPSSLLSKN 511
N+P L L + NN L S + +
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQK 89
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 10/43 (23%), Positives = 14/43 (32%)
Query: 455 PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497
P F G I+ + ++ L NL LR N
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.003
Identities = 14/88 (15%), Positives = 24/88 (27%), Gaps = 12/88 (13%)
Query: 404 PWSWLQCNSDPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSG 461
+ + + ++LS N +P+D S V L + +
Sbjct: 164 GIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 223
Query: 462 CPDLRIIHLEDNQLTGPLPSSLMNLPNL 489
LR +L LP L
Sbjct: 224 LKKLRARST----------YNLKKLPTL 241
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 3e-04
Identities = 16/109 (14%), Positives = 35/109 (32%), Gaps = 3/109 (2%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQ 474
+ + + + L +L EL+++ + G +LR + + +
Sbjct: 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523
L P + P L L + N L ++ ++ LH
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 5e-04
Identities = 10/65 (15%), Positives = 25/65 (38%), Gaps = 3/65 (4%)
Query: 437 TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496
T L+ ++ L ++T + + + + + + + L NL ++ N
Sbjct: 15 TALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71
Query: 497 NMLSG 501
N L+
Sbjct: 72 NQLTD 76
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 11/47 (23%), Positives = 18/47 (38%), Gaps = 3/47 (6%)
Query: 446 WLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 492
N +T P + L + + N+++ S L L NL L
Sbjct: 156 NFSSNQVTDLKP-LANLTTLERLDISSNKVSDI--SVLAKLTNLESL 199
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 6/55 (10%), Positives = 17/55 (30%), Gaps = 1/55 (1%)
Query: 456 IPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
++ R + L ++ + + L + +N + LL +
Sbjct: 11 AAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFPLLRR 64
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.5 bits (83), Expect = 0.004
Identities = 15/80 (18%), Positives = 22/80 (27%), Gaps = 3/80 (3%)
Query: 425 SKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLM 484
+ L T EL L G + + I DN++
Sbjct: 4 TAELIEQAAQ-YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFP-- 60
Query: 485 NLPNLRELYVQNNMLSGTVP 504
L L+ L V NN +
Sbjct: 61 LLRRLKTLLVNNNRICRIGE 80
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 824 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.63 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.59 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.55 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.5 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.48 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.4 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.39 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.37 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.37 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.28 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.27 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.23 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.22 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.21 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.17 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.14 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.13 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.13 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.12 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.12 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.1 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.08 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.0 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.94 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.88 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.83 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.49 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.34 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.2 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.15 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.11 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.99 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.94 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.83 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.82 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.81 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.78 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.75 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.62 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.1 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.89 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.51 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.22 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.72 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.29 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.8 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 92.67 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=370.07 Aligned_cols=199 Identities=27% Similarity=0.432 Sum_probs=177.7
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
+|.+.+.||+|+||+||+|+++ +|+.||||+++.......+.+.+|+++|++++||||+++++++.+.+..++||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 4567789999999999999875 689999999976555556779999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+|+|.+++. ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++++||+|||+|+.......
T Consensus 101 gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 101 GGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 999998774 24588999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence 3345579999999999999999999999999999999999999997644
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=364.08 Aligned_cols=199 Identities=27% Similarity=0.476 Sum_probs=176.2
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|+||+||+|+++ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 567889999999999999986 68899999986432 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 88 ~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 88 APLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred cCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 999999998853 45689999999999999999999998 99999999999999999999999999997654322
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
....+||+.|||||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 210 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 210 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH
Confidence 23457999999999999999999999999999999999999999876543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=364.27 Aligned_cols=200 Identities=25% Similarity=0.419 Sum_probs=172.9
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
|++.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+++|++++||||+++++++.+++..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 556789999999999999986 68999999997543 2335678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC-
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS- 759 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~- 759 (824)
+|+|.+++. ....+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 87 gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 87 GGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp TEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999884 345789999999999999999999998 999999999999999999999999999987644332
Q ss_pred ceeccccCCCCCcchhccccCCC-CchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~-~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......+||+.|||||++.+..+ +.++||||+||++|||++|+.||....
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 23345679999999999988876 467999999999999999999997643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-42 Score=366.24 Aligned_cols=203 Identities=25% Similarity=0.375 Sum_probs=177.1
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
|++.+.||+|+||+||+|+++ +++.||||+++.......+.+.+|+++|++++||||+++++++.+++..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 566789999999999999986 6889999999876666678899999999999999999999999999999999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 94 g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 94 GAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 999998743 235689999999999999999999998 99999999999999999999999999997543321 12
Q ss_pred eccccCCCCCcchhccc-----cCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccc
Q 003385 762 SSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGA 812 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~ 812 (824)
....+||+.|||||++. ...|+.++||||+||++|||++|+.||.+....+
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~ 222 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR 222 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH
Confidence 23457999999999984 4568899999999999999999999998755333
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=365.29 Aligned_cols=208 Identities=25% Similarity=0.368 Sum_probs=166.3
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeec--CCeEEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYE 677 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~E 677 (824)
|++.+.||+|+||+||+|+++ +|+.||||+++.... ...+.+.+|+++|++++||||+++++++.+ .+..++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 557789999999999999876 688999999875432 234568899999999999999999998864 456899999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCC--CCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV--PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~--~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
|+++|+|.+++.........+++..++.++.|++.||+|||++.. .+|+||||||+|||++.++.+||+|||+|+...
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 999999999986554456679999999999999999999998610 149999999999999999999999999998765
Q ss_pred CCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
.... .....+||+.|||||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 166 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~ 220 (269)
T d2java1 166 HDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK 220 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH
Confidence 4322 234467999999999999999999999999999999999999999875533
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-42 Score=365.85 Aligned_cols=207 Identities=24% Similarity=0.373 Sum_probs=176.7
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|++.+.||+|+||+||+|+++ +++.||||+++... ....+.+.+|+++|++++||||+++++++.+++..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 567899999999999999985 68999999987532 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 90 ~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 90 AKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999999874 345689999999999999999999998 99999999999999999999999999998764332
Q ss_pred -CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhc
Q 003385 759 -SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 816 (824)
Q Consensus 759 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~ 816 (824)
.......+||+.|||||++.+..++.++||||+||++|||++|+.||.+.+..+..++
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~ 221 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK 221 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHH
Confidence 2233456799999999999999999999999999999999999999987654433333
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=358.69 Aligned_cols=200 Identities=31% Similarity=0.545 Sum_probs=165.1
Q ss_pred HHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 682 (824)
+.+.+.||+|+||+||+|++++++.||||+++... ...+++.+|++++++++||||++++|++.+++..++||||+++|
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence 34678999999999999999989999999997543 34577999999999999999999999999999999999999999
Q ss_pred CHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCcee
Q 003385 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (824)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (824)
+|.+++.. ....+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++..........
T Consensus 86 ~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 86 CLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp BHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred cHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 99998854 245688999999999999999999998 999999999999999999999999999987655444444
Q ss_pred ccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcC-CCCCCCCc
Q 003385 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG-QEAISNEK 809 (824)
Q Consensus 763 ~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG-~~Pf~~~~ 809 (824)
....||+.|+|||++....++.++|||||||++|||++| ++||....
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~ 207 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC
Confidence 445689999999999999999999999999999999995 66666544
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=361.11 Aligned_cols=200 Identities=28% Similarity=0.498 Sum_probs=173.7
Q ss_pred HHHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
..+.+.+.||+|+||+||+|++++++.||||+++... ...+.+.+|++++++++|||||+++|++.+ +..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 3456788999999999999999988999999997543 345679999999999999999999998865 45689999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
+|+|.+++... ....+++..++.++.||++||.|||++ +|+||||||+|||+++++.+||+|||+|+........
T Consensus 91 ~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 91 NGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 99999987432 334689999999999999999999998 9999999999999999999999999999877655444
Q ss_pred eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCC-CCCC
Q 003385 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE-AISN 807 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~-Pf~~ 807 (824)
......||+.|||||++....++.++|||||||++|||++|.. ||..
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~ 213 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 4455678999999999999999999999999999999999655 4544
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-41 Score=362.82 Aligned_cols=201 Identities=31% Similarity=0.485 Sum_probs=177.0
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
..+.+.+.||+|+||+||+|+++ +++.||||+++... ...+++.+|+++|++++|||||++++++.+++..++||||+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 34567889999999999999987 58889999997543 34567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++|+|.+++... ....+++..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 96 ~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 96 TYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp TTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred cCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 999999998543 345688999999999999999999998 999999999999999999999999999987655544
Q ss_pred ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
.......|++.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~ 218 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 218 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 444555689999999999999999999999999999999997766543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-42 Score=372.13 Aligned_cols=198 Identities=27% Similarity=0.404 Sum_probs=174.1
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.|.+.++||+|+||+||+|+++ +|+.||+|+++... ....+.+.+|+++|++++|||||+++++|.++++.++||||+
T Consensus 7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~ 86 (322)
T d1s9ja_ 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 86 (322)
T ss_dssp GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4567789999999999999976 68899999997543 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
++|+|.+++.. ...+++..+..++.|++.||.|||+ + +|+||||||+|||+++++++||+|||+|+...+..
T Consensus 87 ~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 87 DGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp TTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 99999999853 3568999999999999999999996 4 89999999999999999999999999998654322
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+..
T Consensus 160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred ---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 234579999999999999999999999999999999999999997754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-41 Score=350.94 Aligned_cols=207 Identities=31% Similarity=0.553 Sum_probs=181.6
Q ss_pred HhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCCCC
Q 003385 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 683 (824)
.+.++||+|+||+||+|++++++.||||+++.... ..+++.+|++++++++||||++++|++.+.+..++||||+++|+
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence 46789999999999999999889999999986543 45789999999999999999999999999999999999999999
Q ss_pred HHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCceec
Q 003385 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 763 (824)
Q Consensus 684 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 763 (824)
|.+++.. ....+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++...........
T Consensus 86 l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 86 LLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp HHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred HHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 9998753 345678899999999999999999998 9999999999999999999999999999866554444444
Q ss_pred cccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCccccchhcH
Q 003385 764 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 817 (824)
Q Consensus 764 ~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 817 (824)
...||+.|+|||.+....++.++|||||||++|||++ |+.||.+....+..+.+
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i 214 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 214 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH
Confidence 4568999999999999999999999999999999998 89999886644444333
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-41 Score=362.05 Aligned_cols=200 Identities=27% Similarity=0.429 Sum_probs=160.8
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
.|.+.+.||+|+||+||+|+++ +++.||||++..... ...+.+.+|+++|++++||||+++++++.+++..++||||+
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 3667899999999999999986 688999999975432 23456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEEecCCcccccC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~---~~~~vkL~DFGla~~~~~ 756 (824)
++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+|+....
T Consensus 90 ~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 90 SGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred CCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999853 45689999999999999999999998 999999999999995 468999999999986543
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
.. .....+||+.|||||++.+..++.++||||+||++|||++|+.||.+...
T Consensus 163 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 214 (307)
T d1a06a_ 163 GS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH
Confidence 32 23345799999999999999999999999999999999999999987553
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1e-40 Score=365.69 Aligned_cols=206 Identities=25% Similarity=0.407 Sum_probs=180.7
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.|.+.+.||+|+||+||+|+++ +|+.||||++........+.+.+|+++|++++||||+++++++.+.+..++|||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4677899999999999999975 689999999987665556778999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--CCcEEEEecCCcccccCCC
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~~ 758 (824)
+|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++......
T Consensus 107 gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 107 GGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp SCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999998853 235689999999999999999999998 9999999999999964 5789999999998764432
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchh
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 815 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~ 815 (824)
......||+.|||||++.+..++.++||||+||++|||++|+.||.+....+..+
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~ 235 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR 235 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 2344579999999999999999999999999999999999999998765443333
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=352.44 Aligned_cols=196 Identities=31% Similarity=0.485 Sum_probs=166.4
Q ss_pred HhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeec----CCeEEEEE
Q 003385 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVY 676 (824)
Q Consensus 604 ~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~ 676 (824)
++.++||+|+||+||+|+++ +++.||+|++.... ....+.+.+|+++|++++||||+++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 46678999999999999986 57899999986542 2334578999999999999999999999864 34679999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEEecCCccccc
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~-~~~~vkL~DFGla~~~~ 755 (824)
||+++|+|.+++.. ...+++..+..++.||++||+|||++. ++|+||||||+|||++ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999853 456889999999999999999999971 1399999999999997 47899999999997543
Q ss_pred CCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 808 (824)
.. .....+||+.|||||++.+ .++.++||||+||++|||++|+.||.+.
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 22 2334679999999998764 6999999999999999999999999754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.6e-41 Score=361.92 Aligned_cols=201 Identities=27% Similarity=0.455 Sum_probs=176.2
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|++.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 557789999999999999985 68999999997532 22346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|...+. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+.....
T Consensus 86 ~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 86 IEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred cCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 99999988874 345577888889999999999999998 9999999999999999999999999999876432
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccch
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC 814 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~ 814 (824)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+..
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 210 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 210 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH
Confidence 23467999999999999999999999999999999999999999876544333
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-41 Score=364.04 Aligned_cols=202 Identities=26% Similarity=0.378 Sum_probs=178.0
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEe
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 678 (824)
|.+.+.||+|+||.||+|+++ +|+.||||++++.. ....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 557789999999999999975 78999999997542 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++++||+|||+|+......
T Consensus 87 ~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 87 ANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp CTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999884 345688889999999999999999998 99999999999999999999999999998654322
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA 812 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~ 812 (824)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 212 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH
Confidence 23345679999999999999999999999999999999999999998866443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-41 Score=356.58 Aligned_cols=198 Identities=36% Similarity=0.624 Sum_probs=164.9
Q ss_pred HHhhccccccCcEEEEEEEEcCCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
+.+.+.||+|+||+||+|+++ ..||||+++... ....+.|.+|+++|++++||||+++++++.+ +..++||||++
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~ 86 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCE 86 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCC
T ss_pred EEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCC
Confidence 456789999999999999865 469999997542 3335678999999999999999999998765 46799999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC-
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS- 759 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~- 759 (824)
+|+|.+++... ...+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 87 ~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 87 GSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999998532 34689999999999999999999998 999999999999999999999999999986544322
Q ss_pred ceeccccCCCCCcchhcccc---CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~---~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.......||+.|||||++.. ..++.++|||||||++|||++|+.||.+..
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence 23345679999999999864 358899999999999999999999998644
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.8e-40 Score=363.97 Aligned_cols=200 Identities=24% Similarity=0.417 Sum_probs=178.2
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
.|++.+.||+|+||+||+|+++ +|+.||||+++.......+.+.+|+++|++++||||+++++++.+++..++|||||+
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4677899999999999999975 689999999987655556778899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCCcEEEEecCCcccccCCC
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~--~~~~vkL~DFGla~~~~~~~ 758 (824)
+|+|.+.+.. ....+++..+..++.||+.||+|||++ ||+||||||+|||++ .++.+||+|||+|+......
T Consensus 110 gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 110 GGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 9999887642 245689999999999999999999998 999999999999998 56899999999998765432
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 232 (352)
T d1koba_ 184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232 (352)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 2344569999999999999999999999999999999999999998754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-40 Score=358.34 Aligned_cols=198 Identities=27% Similarity=0.447 Sum_probs=172.1
Q ss_pred HHHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
...|...+.||+|+||+||+|++. +++.||||+++..... ..+.+.+|+++|++++|||||++++++.+.+..++|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 345667789999999999999876 6888999999755332 235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
||||.+|+|..++. ....+++..+..++.||+.||.|||++ ||+||||||+|||+++++.+||+|||+|+...
T Consensus 94 ~E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 94 MEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp EECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EEecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 99999999876653 245689999999999999999999998 99999999999999999999999999997653
Q ss_pred CCCCceeccccCCCCCcchhcccc---CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.. ....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+..
T Consensus 167 ~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~ 218 (309)
T d1u5ra_ 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (309)
T ss_dssp SB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 32 33569999999999864 468999999999999999999999997644
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-40 Score=357.53 Aligned_cols=202 Identities=31% Similarity=0.527 Sum_probs=163.0
Q ss_pred HHHhhccccccCcEEEEEEEEcC-C---cEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKD-G---KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~-g---~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
.+.+.+.||+|+||+||+|+++. + ..||||++.... ....+.|.+|+++|++++|||||+++|++.+++..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 34556889999999999998763 3 258899886543 334567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
|||++|+|.+++.. ....+++.+++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 107 Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp ECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999998753 245689999999999999999999998 999999999999999999999999999986654
Q ss_pred CCCce----eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 757 GASHV----SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 757 ~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
..... .....||+.|||||.+.+..++.++|||||||++|||++ |+.||.+..
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 32221 122357899999999999999999999999999999998 899998654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-40 Score=352.99 Aligned_cols=202 Identities=27% Similarity=0.388 Sum_probs=176.7
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc------cchhhhHHHHHHhhcCCCccceeeceeecCCeEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 674 (824)
+|++.+.||+|+||+||+|+++ +|+.||||+++..... ..+.+.+|+++|++++||||+++++++.+.+..++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 5677899999999999999985 6899999998754221 23568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEEecCC
Q 003385 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFGL 750 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~----~vkL~DFGl 750 (824)
|||||++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 91 v~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 91 ILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999853 35689999999999999999999998 999999999999998776 599999999
Q ss_pred cccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccc
Q 003385 751 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA 812 (824)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~ 812 (824)
++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+
T Consensus 164 a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~ 223 (293)
T d1jksa_ 164 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223 (293)
T ss_dssp CEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred hhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH
Confidence 98764432 2334568999999999999999999999999999999999999998765433
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=359.19 Aligned_cols=208 Identities=28% Similarity=0.456 Sum_probs=174.1
Q ss_pred HHHHhhccccccCcEEEEEEEEcCC------cEEEEEEeccC-CcccchhhhHHHHHHhhc-CCCccceeeceeecCCeE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKDG------KEIAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS 672 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~g------~~vAVK~l~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 672 (824)
..+.+.+.||+|+||+||+|+++.. ..||||++... .......+.+|+.+|.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 3466789999999999999987532 36899998654 333456788999999998 899999999999999999
Q ss_pred EEEEEecCCCCHHHHhhcccC-------------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 003385 673 VLVYEFMHNGTLKEHLYGTLT-------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSS 733 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~-------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~ 733 (824)
++||||+++|+|.+++..... ....+++..++.++.|+++||+|||++ +|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 999999999999999965321 124588999999999999999999998 9999999999
Q ss_pred CEEEcCCCcEEEEecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCccc
Q 003385 734 NILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG 811 (824)
Q Consensus 734 NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~ 811 (824)
|||++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||++ |+.||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999866544332 3344568999999999999999999999999999999997 89999875533
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-40 Score=348.50 Aligned_cols=199 Identities=30% Similarity=0.498 Sum_probs=170.1
Q ss_pred hhc-cccccCcEEEEEEEEc---CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 605 LEK-KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 605 i~~-~LG~G~fg~Vy~a~~~---~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
+.+ +||+|+||+||+|.++ ++..||||+++... ....++|.+|+++|++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~ 90 (285)
T d1u59a_ 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA 90 (285)
T ss_dssp EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence 344 4999999999999865 34579999997543 3345679999999999999999999999875 4579999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
++|+|.+++.. ....+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 91 ~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 91 GGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp TTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred CCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 99999998743 245689999999999999999999998 999999999999999999999999999987654332
Q ss_pred c--eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 003385 760 H--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKF 810 (824)
Q Consensus 760 ~--~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~ 810 (824)
. ......||+.|+|||++....++.++|||||||++|||++ |+.||.+...
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~ 218 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 218 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH
Confidence 2 2234468999999999999999999999999999999998 9999987553
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-40 Score=349.12 Aligned_cols=195 Identities=32% Similarity=0.501 Sum_probs=165.5
Q ss_pred ccccccCcEEEEEEEEcC---CcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 607 KKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~---g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
++||+|+||+||+|.+++ ++.||||+++.... ...+++.+|+++|++++|||||+++++|.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 579999999999998753 46799999965422 2346799999999999999999999999654 56899999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999998853 45689999999999999999999998 99999999999999999999999999998665433322
Q ss_pred --eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCc
Q 003385 762 --SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEK 809 (824)
Q Consensus 762 --~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 809 (824)
.....||+.|||||.+....++.++|||||||++|||++ |+.||.+..
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence 233568999999999999999999999999999999998 899998754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.8e-40 Score=359.87 Aligned_cols=199 Identities=26% Similarity=0.351 Sum_probs=175.9
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
.|++.+.||+|+||.||+|+++ +|+.||||+++... ....+.+.+|+++|++++||||+++++++.+.+..++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 3567789999999999999986 68999999986432 2223567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+.+|+|..++.. ...+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 122 ~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 122 YVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp CCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999998843 35689999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccc
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 811 (824)
.....||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 244 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH
Confidence 23456999999999999999999999999999999999999999875533
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=350.80 Aligned_cols=202 Identities=29% Similarity=0.462 Sum_probs=173.8
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC---cccchhhhHHHHHHh-hcCCCccceeeceeecCCeEEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLS-RIHHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
|.+.+.||+|+||+||+|+++ +++.||||++++.. ....+.+..|..++. .++||||+++++++.+++..++|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 557899999999999999986 68999999997532 122345566776665 6899999999999999999999999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (824)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+++.....
T Consensus 84 y~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 84 YLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 9999999999853 45678899999999999999999998 9999999999999999999999999999865443
Q ss_pred CCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCcccc
Q 003385 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA 812 (824)
Q Consensus 758 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~ 812 (824)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~ 210 (320)
T d1xjda_ 157 DA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 210 (320)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 32 3344579999999999999999999999999999999999999998765433
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-40 Score=349.03 Aligned_cols=198 Identities=29% Similarity=0.501 Sum_probs=166.0
Q ss_pred HHHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecCC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 681 (824)
.+.+.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||++++++.+ +..++||||+++
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 467889999999999999999988899999997543 345779999999999999999999999865 557899999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|..++... ....+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.........
T Consensus 96 g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 96 GSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp CBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred Cchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 9999887542 234689999999999999999999998 99999999999999999999999999998765444444
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 806 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~ 806 (824)
.....||+.|+|||.+....++.++|||||||++|||++|..|+.
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~ 215 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 215 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCC
Confidence 444668999999999999999999999999999999999665543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3e-39 Score=343.05 Aligned_cols=201 Identities=27% Similarity=0.443 Sum_probs=166.5
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc---cchhhhHHHHHHhhcCCCccceeeceeecCC----eEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSV 673 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~ 673 (824)
+|.+.+.||+|+||+||+|++. +|+.||||+++..... ..+.+.+|++++++++||||+++++++...+ ..+
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 4667899999999999999875 7899999999754332 2346889999999999999999999987643 478
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
+||||+++++|.+++. ....+++.+++.++.||++||+|||++ +|+||||||+|||++.++..+|+|||.++.
T Consensus 88 lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence 9999999999998874 345689999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCC--ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 754 AVDGAS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 754 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
...... ......+||+.|||||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence 433222 23344579999999999999999999999999999999999999998754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-39 Score=347.60 Aligned_cols=207 Identities=20% Similarity=0.337 Sum_probs=178.1
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
+|.+.+.||+|+||+||+|.++ +++.||||+++.... ....+.+|+++|++++||||+++++++.+++..++|||||+
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 3567889999999999999986 688899999976543 34568899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC--CcEEEEecCCcccccCCC
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~--~~vkL~DFGla~~~~~~~ 758 (824)
+|+|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++......
T Consensus 85 gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 85 GLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999988532 34689999999999999999999998 99999999999999854 589999999998654332
Q ss_pred CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcH
Q 003385 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (824)
Q Consensus 759 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i 817 (824)
......+|+.|+|||.+.+..++.++||||+||++|||++|+.||.+....+...+|
T Consensus 159 --~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i 215 (321)
T d1tkia_ 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred --cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 234456899999999999999999999999999999999999999876644333333
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-39 Score=342.44 Aligned_cols=198 Identities=29% Similarity=0.491 Sum_probs=162.2
Q ss_pred HHhhccccccCcEEEEEEEEcCC-----cEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKDG-----KEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~g-----~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
+.+.+.||+|+||+||+|.++.. ..||||+++.... ....+|.+|++++++++|||||+++|++.+.+..++||
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence 34568899999999999987642 3699999975432 23456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
||+.++++.+.+.. ....+++.++..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 89 e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 89 EYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp ECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999887753 245689999999999999999999998 999999999999999999999999999986544
Q ss_pred CCC--ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003385 757 GAS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 806 (824)
Q Consensus 757 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~ 806 (824)
... .......||+.|||||++....++.++|||||||++|||++|..|+.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~ 214 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence 322 12233468999999999999999999999999999999999766554
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=343.66 Aligned_cols=208 Identities=23% Similarity=0.373 Sum_probs=164.5
Q ss_pred HHHHhhccccccCcEEEEEEEEcC----CcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~----g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
..+++.+.||+|+||.||+|++.. +..||||+++... ....+.+.+|+++|++++||||+++++++.+ +..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 356678999999999999998753 3468899886443 2334678999999999999999999999964 568999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
|||+++|+|.+++.. ....+++..++.++.||++||.|||++ +|+||||||+||++++++.+||+|||+|+...
T Consensus 86 ~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 86 MELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheecc
Confidence 999999999988743 245688999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCccccchh
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCR 815 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~ 815 (824)
...........||+.|+|||++....++.++|||||||++|||++ |..||.+....+..+
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~ 220 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 220 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 544444455668999999999999999999999999999999998 899998766544433
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-39 Score=344.71 Aligned_cols=204 Identities=25% Similarity=0.311 Sum_probs=169.3
Q ss_pred ccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc-----cchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
+.||+|+||+||+|+++ +|+.||||+++..... ..+.+.+|+++|++++||||+++++++.+++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 67999999999999975 6899999998654322 13568899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
++++.... .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 84 TDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp EEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred chHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 88776554 2345678888999999999999999998 9999999999999999999999999999765443322
Q ss_pred eeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 761 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
....+||+.|+|||++... .++.++||||+||++|||++|+.||.+....+...+|.
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~ 214 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 214 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHH
Confidence 2345699999999998754 57899999999999999999999998766444444443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-38 Score=337.69 Aligned_cols=202 Identities=29% Similarity=0.364 Sum_probs=174.6
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCccc---------chhhhHHHHHHhhcC-CCccceeeceeecCC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---------KREFTNEVTLLSRIH-HRNLVQFLGYCQEEG 670 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~---------~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 670 (824)
.|++.+.||+|+||+||+|+++ +++.||||+++...... .+.+.+|++++++++ ||||+++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 3567899999999999999875 68899999987543211 235788999999997 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGl 750 (824)
..++||||+++|+|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999853 45689999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCceeccccCCCCCcchhcccc------CCCCchHHHHHHHHHHHHHHcCCCCCCCCcccc
Q 003385 751 SKFAVDGASHVSSIVRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQEAISNEKFGA 812 (824)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~ 812 (824)
++....... .....||+.|+|||.+.. ..++.++||||+||++|||++|+.||.+....+
T Consensus 157 a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~ 222 (277)
T d1phka_ 157 SCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222 (277)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred eeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH
Confidence 987654322 334569999999999863 356889999999999999999999998765333
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-38 Score=351.50 Aligned_cols=197 Identities=28% Similarity=0.399 Sum_probs=168.3
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc---ccchhhhH---HHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTN---EVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~---~~~~~~~~---Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
|.+.+.||+|+||.||+|+++ +|+.||||++..... .....+.+ |+++++.++||||+++++++.+.+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 456789999999999999986 689999999864321 12223344 46677777899999999999999999999
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 86 mE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp ECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999853 45678899999999999999999998 99999999999999999999999999998664
Q ss_pred CCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 756 DGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 756 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
... ....+||+.|+|||++.. ..++.++|||||||++|||++|+.||.+..
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence 432 234579999999999975 568999999999999999999999998654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-38 Score=335.01 Aligned_cols=212 Identities=23% Similarity=0.416 Sum_probs=176.3
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcc------cchhhhHHHHHHhhcC--CCccceeeceeecCCeE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIH--HRNLVQFLGYCQEEGRS 672 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~------~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~ 672 (824)
+|++.+.||+|+||+||+|++. +|+.||||+++..... ...++.+|+++|++++ ||||+++++++.+.+..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 4677899999999999999875 6899999998754221 2345789999999996 89999999999999999
Q ss_pred EEEEEecCC-CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCC
Q 003385 673 VLVYEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGL 750 (824)
Q Consensus 673 ~lV~E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~-~~vkL~DFGl 750 (824)
++||||+.+ +++.+++. ....+++..+..++.|+++||+|||++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 85 ~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 999999976 57777764 345688999999999999999999998 99999999999999855 7999999999
Q ss_pred cccccCCCCceeccccCCCCCcchhccccCCC-CchHHHHHHHHHHHHHHcCCCCCCCCc------------cccchhcH
Q 003385 751 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEK------------FGANCRNI 817 (824)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DIwSlGvil~elltG~~Pf~~~~------------~~~~~~~i 817 (824)
|+..... ......||+.|+|||++....+ +.++||||+||++|||++|+.||.+.. .++.++++
T Consensus 158 a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~~~l 234 (273)
T d1xwsa_ 158 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHL 234 (273)
T ss_dssp CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHHH
T ss_pred ceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCCCCCCCHHHHHH
Confidence 9765332 2344679999999999988776 467899999999999999999997632 34555566
Q ss_pred hhhhcc
Q 003385 818 VQWVKS 823 (824)
Q Consensus 818 v~~~~~ 823 (824)
+++|.+
T Consensus 235 i~~~L~ 240 (273)
T d1xwsa_ 235 IRWCLA 240 (273)
T ss_dssp HHHHTC
T ss_pred HHHHcc
Confidence 666643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-38 Score=340.01 Aligned_cols=202 Identities=27% Similarity=0.451 Sum_probs=166.9
Q ss_pred HHhhccccccCcEEEEEEEEc-CCc----EEEEEEeccC-CcccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~----~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 676 (824)
|++.+.||+|+||+||+|++. +|+ +||+|+++.. .....+++.+|++++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 556789999999999999875 343 5889988643 333456799999999999999999999999875 467889
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 756 (824)
|++.+|+|.+.+.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 90 e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 90 QLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp ECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 99999999988754 345688999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCccc
Q 003385 757 GASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG 811 (824)
Q Consensus 757 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~ 811 (824)
.... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~ 220 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH
Confidence 3332 2333468999999999999999999999999999999998 89999875533
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-38 Score=342.97 Aligned_cols=192 Identities=25% Similarity=0.335 Sum_probs=165.7
Q ss_pred hccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhc-CCCccceeeceeec----CCeEEEEEEec
Q 003385 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE----EGRSVLVYEFM 679 (824)
Q Consensus 606 ~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----~~~~~lV~E~~ 679 (824)
.+.||+|+||+||+|++. +++.||||+++. .+.+.+|++++.++ +||||+++++++.+ ....++|||||
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 456999999999999875 689999999863 35677899987655 89999999999865 46689999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEecCCcccccC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~---~~~vkL~DFGla~~~~~ 756 (824)
++|+|.+++... ....+++.++..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+|+....
T Consensus 92 ~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 92 DGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp CSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred CCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccC
Confidence 999999999642 235689999999999999999999998 9999999999999985 46799999999986654
Q ss_pred CCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
... ....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+..
T Consensus 167 ~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~ 217 (335)
T d2ozaa1 167 HNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 217 (335)
T ss_dssp CCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred CCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence 332 344579999999999999999999999999999999999999997644
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-38 Score=341.53 Aligned_cols=207 Identities=27% Similarity=0.453 Sum_probs=173.5
Q ss_pred HHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCcc-cchhhhHHHHHHhhcCCCccceeeceeecCCeEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 674 (824)
.+++.+.||+|+||+||+|+++ +++.||||+++..... ..+++.+|+++|++++||||+++++++...+..++
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence 3557789999999999999875 3578999999754333 35679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhccc--------------------CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 003385 675 VYEFMHNGTLKEHLYGTL--------------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 734 (824)
Q Consensus 675 V~E~~~~gsL~~~L~~~~--------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~N 734 (824)
+|||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+|
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~N 170 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 170 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccc
Confidence 999999999999985421 1223478999999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEecCCcccccCCC-CceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCC-CCCCCCccc
Q 003385 735 ILLDKHMRAKVSDFGLSKFAVDGA-SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ-EAISNEKFG 811 (824)
Q Consensus 735 ILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~-~Pf~~~~~~ 811 (824)
||++.++.+||+|||+|+...... ........||+.|+|||.+.+..++.++|||||||++|||++|. +||.+....
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~ 249 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence 999999999999999998654332 22334456899999999999999999999999999999999996 578765533
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-38 Score=331.18 Aligned_cols=197 Identities=32% Similarity=0.524 Sum_probs=163.2
Q ss_pred HHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeec-CCeEEEEEEecCC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEFMHN 681 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV~E~~~~ 681 (824)
+.+.+.||+|+||.||+|+++ |++||||+++... ..+.+.+|++++++++||||++++|++.+ .+..++||||+++
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred eEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 346789999999999999986 7899999996532 35679999999999999999999998854 4567999999999
Q ss_pred CCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCce
Q 003385 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (824)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (824)
|+|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 86 GSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp EEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC----
Confidence 9999998542 234588999999999999999999998 9999999999999999999999999999865332
Q ss_pred eccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCccc
Q 003385 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG 811 (824)
Q Consensus 762 ~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~ 811 (824)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~ 207 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 207 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH
Confidence 223457899999999999999999999999999999998 78888775544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-38 Score=338.65 Aligned_cols=207 Identities=30% Similarity=0.444 Sum_probs=163.1
Q ss_pred HHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCC-cccchhhhHHHHHHhhc-CCCccceeeceeecC-C
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE-G 670 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~-~ 670 (824)
...+.+.++||+|+||.||+|++. +++.||||+++... ....+.+.+|.+++.++ +|+||+.+++++.+. +
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 345677899999999999999864 24689999997543 23345677888888777 689999999987654 5
Q ss_pred eEEEEEEecCCCCHHHHhhcccC------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~ 738 (824)
..++|||||++|+|.+++..... ....+++..+..++.||++||+|||++ +|+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 68999999999999999964321 134588999999999999999999998 999999999999999
Q ss_pred CCCcEEEEecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcC-CCCCCCCc
Q 003385 739 KHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG-QEAISNEK 809 (824)
Q Consensus 739 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG-~~Pf~~~~ 809 (824)
+++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||++| ..||.+..
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999865443322 33445799999999999999999999999999999999987 46787654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=334.42 Aligned_cols=200 Identities=25% Similarity=0.410 Sum_probs=168.0
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|.+.+.||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+++|++++||||+++++++.+++..++||||+
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 456789999999999999975 689999999965432 23567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
.++. .+.+.. .....+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+......
T Consensus 84 ~~~~-~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 84 HQDL-KKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp SEEH-HHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred CCch-hhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 7654 444422 2345689999999999999999999998 99999999999999999999999999998664432
Q ss_pred ceeccccCCCCCcchhccccCC-CCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~-~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.......||+.|+|||++.... ++.++||||+||++|||++|+.||.+.+
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence 2334456999999999987765 4789999999999999999999998755
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-37 Score=332.27 Aligned_cols=203 Identities=24% Similarity=0.359 Sum_probs=171.2
Q ss_pred HHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEecC
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 680 (824)
|.+.++||+|+||+||+|++++|+.||||+++.... ...+.+.+|+.+|++++||||+++++++.+.+..++++|++.
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence 456789999999999999999999999999975532 224678899999999999999999999999999999999998
Q ss_pred CCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCCc
Q 003385 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (824)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (824)
++.+..+. .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+........
T Consensus 84 ~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 84 QDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp EEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred hhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 87766665 2356789999999999999999999998 999999999999999999999999999986544322
Q ss_pred eeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCccccc
Q 003385 761 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGAN 813 (824)
Q Consensus 761 ~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~ 813 (824)
......|++.|+|||.+... .++.++||||+||++|||++|+.||.+....+.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~ 209 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ 209 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH
Confidence 23334589999999998764 568999999999999999999999987653333
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-38 Score=332.78 Aligned_cols=202 Identities=29% Similarity=0.444 Sum_probs=161.6
Q ss_pred HHhhccccccCcEEEEEEEEcC--C--cEEEEEEeccCCc---ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKD--G--KEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~--g--~~vAVK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 675 (824)
+++.+.||+|+||.||+|++.. + ..||||+++.... ...++|.+|+++|++++||||++++|++.++ ..++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chhee
Confidence 5567899999999999998642 2 3689999875422 2245789999999999999999999999764 56899
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
|||+++|++.+.+... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999887532 45689999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCc--eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCccc
Q 003385 756 DGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG 811 (824)
Q Consensus 756 ~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~ 811 (824)
..... ......||..|+|||.+.+..++.++|||||||++|||++ |+.||.+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~ 221 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH
Confidence 44332 2233457889999999999999999999999999999998 89999865533
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-37 Score=330.95 Aligned_cols=209 Identities=22% Similarity=0.338 Sum_probs=171.3
Q ss_pred HHHhhccccccCcEEEEEEEEc-C-CcEEEEEEeccCCc--ccchhhhHHHHHHhhc---CCCccceeeceeec-----C
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-D-GKEIAVKVLTSNSY--QGKREFTNEVTLLSRI---HHRNLVQFLGYCQE-----E 669 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~-g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~-----~ 669 (824)
+|++.++||+|+||+||+|++. + ++.||||+++.... .....+.+|+++|+.+ +||||+++++++.. .
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 4667889999999999999984 4 56799999875422 2244567888887776 79999999998853 3
Q ss_pred CeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 003385 670 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (824)
Q Consensus 670 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFG 749 (824)
...+++|||++++.+..... .....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 46789999999887654432 2345688999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
+++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+...+++
T Consensus 162 ~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 228 (305)
T d1blxa_ 162 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 228 (305)
T ss_dssp SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred hhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 98754332 23345679999999999999999999999999999999999999998876554444443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-37 Score=333.35 Aligned_cols=209 Identities=30% Similarity=0.485 Sum_probs=170.9
Q ss_pred HHhhccccccCcEEEEEEEEcC-Cc--EEEEEEeccC-CcccchhhhHHHHHHhhc-CCCccceeeceeecCCeEEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKD-GK--EIAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~-g~--~vAVK~l~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E 677 (824)
+.+.+.||+|+||+||+|++++ +. .||||+++.. .....+.+.+|+++|+++ +||||+++++++.+++..++|||
T Consensus 12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e 91 (309)
T d1fvra_ 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91 (309)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence 3467899999999999998764 44 4778887543 333456799999999998 79999999999999999999999
Q ss_pred ecCCCCHHHHhhcc------------cCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 003385 678 FMHNGTLKEHLYGT------------LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 745 (824)
Q Consensus 678 ~~~~gsL~~~L~~~------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL 745 (824)
|+++|+|.+++... ......+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEE
Confidence 99999999998643 12346789999999999999999999998 9999999999999999999999
Q ss_pred EecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCC-CCCCCCccccchhc
Q 003385 746 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ-EAISNEKFGANCRN 816 (824)
Q Consensus 746 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~-~Pf~~~~~~~~~~~ 816 (824)
+|||+++...... ......||..|+|||.+....++.++|||||||++|||++|. +||.+....+..+.
T Consensus 169 ~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~ 238 (309)
T d1fvra_ 169 ADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 238 (309)
T ss_dssp CCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred ccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 9999997543322 223445899999999999999999999999999999999975 57876554433333
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-37 Score=335.24 Aligned_cols=215 Identities=28% Similarity=0.442 Sum_probs=178.4
Q ss_pred HHHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCc-ccchhhhHHHHHHhhc-CCCccceeeceeecCCe
Q 003385 600 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 671 (824)
Q Consensus 600 ~~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 671 (824)
...+.+.+.||+|+||.||+|+++ +++.||||+++.... ....++.+|+.+++++ +|||||++++++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 345667899999999999999863 456899999975433 3345788999999999 69999999999999999
Q ss_pred EEEEEEecCCCCHHHHhhccc--------------CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 003385 672 SVLVYEFMHNGTLKEHLYGTL--------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 737 (824)
Q Consensus 672 ~~lV~E~~~~gsL~~~L~~~~--------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl 737 (824)
.++||||+++|+|.+++.... .....+++..+..++.||++||+|||++ +|+||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 999999999999999986432 1234588999999999999999999998 99999999999999
Q ss_pred cCCCcEEEEecCCcccccCCCC-ceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCccccchh
Q 003385 738 DKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCR 815 (824)
Q Consensus 738 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~ 815 (824)
+.++.+||+|||+++....... ......+||+.|+|||++.+..++.++|||||||++|||++ |.+||......+...
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987654433 23344678999999999999999999999999999999999 566666544333333
Q ss_pred cH
Q 003385 816 NI 817 (824)
Q Consensus 816 ~i 817 (824)
++
T Consensus 259 ~~ 260 (311)
T d1t46a_ 259 KM 260 (311)
T ss_dssp HH
T ss_pred HH
Confidence 33
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-37 Score=332.19 Aligned_cols=207 Identities=29% Similarity=0.487 Sum_probs=171.6
Q ss_pred HHHHhhccccccCcEEEEEEEEcC--------CcEEEEEEeccCCc-ccchhhhHHHHHHhhc-CCCccceeeceeecCC
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG 670 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~~--------g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 670 (824)
..+.+.+.||+|+||.||+|+... +..||||+++.+.. ....++.+|...+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 356678999999999999998642 24799999976543 2346788899999888 7999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhhcccC------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~ 738 (824)
..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 99999999999999999965421 235689999999999999999999998 999999999999999
Q ss_pred CCCcEEEEecCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHc-CCCCCCCCcc
Q 003385 739 KHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKF 810 (824)
Q Consensus 739 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~ 810 (824)
.++.+||+|||+++........ ......||+.|+|||.+.++.|+.++|||||||++|||++ |+.||.+...
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 9999999999999866543322 3344568999999999999999999999999999999998 7889976553
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=328.01 Aligned_cols=197 Identities=30% Similarity=0.501 Sum_probs=167.0
Q ss_pred hhccccccCcEEEEEEEEcCC----cEEEEEEeccC-CcccchhhhHHHHHHhhcCCCccceeeceeec-CCeEEEEEEe
Q 003385 605 LEKKIGSGGFGVVYYGKLKDG----KEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEF 678 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~~g----~~vAVK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV~E~ 678 (824)
+.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++||||++++|++.+ ++..++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 357899999999999987542 25899998743 33345679999999999999999999999865 5688999999
Q ss_pred cCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 003385 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (824)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (824)
+++|+|.+++... ....++..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred eecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999988542 44567888999999999999999998 99999999999999999999999999998654432
Q ss_pred Cc---eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 759 SH---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 759 ~~---~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
.. ......||+.|+|||.+....++.++|||||||++|||++|..||..
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 22 22334689999999999999999999999999999999998888754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-37 Score=329.24 Aligned_cols=196 Identities=28% Similarity=0.452 Sum_probs=159.8
Q ss_pred HHhhccccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhh--HHHHHHhhcCCCccceeeceeecCC----eEEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFLGYCQEEG----RSVLVY 676 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~--~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lV~ 676 (824)
+.+.+.||+|+||.||+|+++ |+.||||+++... .+.+. .|+..+.+++||||+++++++.+.+ ..++||
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 446789999999999999975 8999999996432 23333 4555556789999999999997653 678999
Q ss_pred EecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 003385 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-----VPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (824)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~gIvHrDLkp~NILl~~~~~vkL~DFGla 751 (824)
||+++|+|.+++.. ..+++..++.++.|++.||+|||+.. .++|+||||||+||||+.++.+||+|||++
T Consensus 81 Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999953 35889999999999999999999731 249999999999999999999999999999
Q ss_pred ccccCCCCc---eeccccCCCCCcchhccccCC------CCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 752 KFAVDGASH---VSSIVRGTVGYLDPEYYISQQ------LTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 752 ~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~------~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
+........ ......||+.|+|||++.... ++.++|||||||++|||++|..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 876544322 223467999999999987543 56789999999999999999988743
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-37 Score=332.79 Aligned_cols=208 Identities=25% Similarity=0.424 Sum_probs=174.8
Q ss_pred HHHHhhccccccCcEEEEEEEEc------CCcEEEEEEeccCCc-ccchhhhHHHHHHhhcCCCccceeeceeecCCeEE
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~------~g~~vAVK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 673 (824)
..+.+.+.||+|+||+||+|.++ +++.||||+++.... .....+.+|++++++++||||+++++++...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 34567899999999999999864 357899999975432 33456889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhccc------CccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 003385 674 LVYEFMHNGTLKEHLYGTL------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 747 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~D 747 (824)
+||||+++|+|.+++.... .....+++..+..++.|+++||.|||++ +|+||||||+|||+++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence 9999999999999885321 1223468889999999999999999998 999999999999999999999999
Q ss_pred cCCcccccCCCCc-eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCC-CCCCCCccc
Q 003385 748 FGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ-EAISNEKFG 811 (824)
Q Consensus 748 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~-~Pf~~~~~~ 811 (824)
||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|. .||.+....
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~ 242 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999865443322 223345899999999999999999999999999999999984 778765533
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-36 Score=327.76 Aligned_cols=208 Identities=27% Similarity=0.368 Sum_probs=175.6
Q ss_pred HHhhccccccCcEEEEEEEEc----CCcEEEEEEeccCCc----ccchhhhHHHHHHhhcCC-CccceeeceeecCCeEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSY----QGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSV 673 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~----~g~~vAVK~l~~~~~----~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~ 673 (824)
|.+.++||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 667899999999999999863 478999999865421 234568899999999976 89999999999999999
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
++|||+.+|+|.+++.. ...+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999998843 44567888899999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCceeccccCCCCCcchhccccC--CCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcH
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i 817 (824)
.............|++.|+|||.+... .++.++||||+||++|||++|+.||.+....+...++
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i 244 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 644444444556799999999999764 4678999999999999999999999876655444444
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-36 Score=328.72 Aligned_cols=206 Identities=27% Similarity=0.359 Sum_probs=168.1
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCccceeeceeec------CCeEEEE
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------EGRSVLV 675 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~~~~lV 675 (824)
|...++||+|+||+||+|+++ +|+.||||+++... ....+|+++|++++||||+++++++.. ..+.++|
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 445688999999999999986 68999999996532 345689999999999999999999843 3357899
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCcccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFA 754 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~-~vkL~DFGla~~~ 754 (824)
|||++++. .+.+.........+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus 98 ~Ey~~~~~-~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 98 LDYVPETV-YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EECCSEEH-HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EeccCCcc-HHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99998664 333433233456789999999999999999999998 999999999999999775 8999999999866
Q ss_pred cCCCCceeccccCCCCCcchhcccc-CCCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcHh
Q 003385 755 VDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (824)
Q Consensus 755 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~iv 818 (824)
..... .....||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+...+++
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~ 236 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHH
Confidence 44332 234569999999998875 578999999999999999999999998766444444443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-36 Score=324.50 Aligned_cols=206 Identities=21% Similarity=0.340 Sum_probs=167.3
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeec--------CC
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--------EG 670 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--------~~ 670 (824)
+|.+.++||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+++|++++||||+++++++.. .+
T Consensus 11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~ 90 (318)
T d3blha1 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90 (318)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence 5567889999999999999975 78999999986442 2234568899999999999999999998754 34
Q ss_pred eEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 003385 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (824)
Q Consensus 671 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGl 750 (824)
..++||||++++.+.... .....++...+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 91 SIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred eEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecce
Confidence 678999999887665543 2345678888999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCC---ceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCccccch
Q 003385 751 SKFAVDGAS---HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANC 814 (824)
Q Consensus 751 a~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~ 814 (824)
++....... ......+||+.|+|||++... .++.++||||+||++|||++|+.||.+....+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~ 231 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 231 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH
Confidence 976543221 122335699999999998765 6889999999999999999999999876543333
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-35 Score=317.46 Aligned_cols=200 Identities=20% Similarity=0.334 Sum_probs=171.4
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCC-CccceeeceeecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
+|.+.++||+|+||+||+|++. +|+.||||+++... ..+.+.+|++.++.++| +||+.+++++.+....++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 4677899999999999999976 68899999986442 34568889999999975 89999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-----CCcEEEEecCCcccc
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-----HMRAKVSDFGLSKFA 754 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~-----~~~vkL~DFGla~~~ 754 (824)
+++|.+++.. ....++...+..++.|++.||+|||++ ||+||||||+|||++. ++.+||+|||+|+..
T Consensus 84 -~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 84 -GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp -CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred -CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 6899888743 234688999999999999999999998 9999999999999974 578999999999875
Q ss_pred cCCCCc------eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 755 VDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 755 ~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
...... .....+||+.|||||.+.+..++.++|||||||++|||++|+.||.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 443211 22345799999999999999999999999999999999999999986553
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-35 Score=325.64 Aligned_cols=200 Identities=24% Similarity=0.354 Sum_probs=164.0
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC-cccchhhhHHHHHHhhcCCCccceeeceeecCC----eEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVLV 675 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lV 675 (824)
+|.+.++||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+++|++++||||+++++++.... ..+++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 3567799999999999999875 78999999997543 223457889999999999999999999986542 23445
Q ss_pred EEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 003385 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (824)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~ 755 (824)
++++.+|+|.+++.. ..+++..+..++.|++.||+|||++ ||+||||||+|||+++++.+||+|||+++...
T Consensus 89 ~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 89 VTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 566779999999842 4689999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCC--ceeccccCCCCCcchhccc-cCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 756 DGAS--HVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 756 ~~~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.... ......+||+.|+|||++. ...++.++||||+||++|||++|+.||.+..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 3222 1234456999999999985 4567889999999999999999999998765
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-35 Score=325.87 Aligned_cols=196 Identities=26% Similarity=0.375 Sum_probs=161.1
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCC------eE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RS 672 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~~ 672 (824)
+|.+.++||+|+||+||+|+++ +|+.||||+++.... ...+.+.+|+++|++++||||++++++|...+ ..
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 4566789999999999999976 689999999975322 23456889999999999999999999987654 56
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
++||||+ +.+|..... ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+|++|||+|+
T Consensus 99 ~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp EEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence 9999999 556766653 35689999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCcc
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKF 810 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~ 810 (824)
..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+.
T Consensus 170 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~ 224 (346)
T d1cm8a_ 170 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224 (346)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh
Confidence 65332 2345699999999998764 568899999999999999999999987653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-35 Score=314.66 Aligned_cols=199 Identities=25% Similarity=0.347 Sum_probs=164.7
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCcccee-eceeecCCeEEEEEEec
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF-LGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l-~~~~~~~~~~~lV~E~~ 679 (824)
+|.+.+.||+|+||+||+|++. +|+.||||++.... ..+++..|++++++++|++++.. .+++.+.+..++||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 4678899999999999999875 68899999987543 34568899999999987765554 55567778889999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEecCCcccccC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD 756 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~---~~~vkL~DFGla~~~~~ 756 (824)
. +++.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+||+|||+|+....
T Consensus 86 ~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 86 G-PSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred C-Cchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 5 566655532 345689999999999999999999998 9999999999999864 46799999999987654
Q ss_pred CCCc------eeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 757 GASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 757 ~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.... ......||+.|||||.+.+..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 3221 2234579999999999999999999999999999999999999997644
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-35 Score=312.38 Aligned_cols=197 Identities=22% Similarity=0.318 Sum_probs=169.7
Q ss_pred HHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeecCCeEEEEEEec
Q 003385 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (824)
Q Consensus 603 ~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 679 (824)
|++.++||+|+||+||+|++. +++.||||+++.... ...+.+.+|+.+|++++||||+++++++.+....++|+|++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 556789999999999999975 688899999975432 22467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccCCCC
Q 003385 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (824)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (824)
.++++..++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.......
T Consensus 84 ~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 84 DQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp SEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred cccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 9998877764 345678889999999999999999998 999999999999999999999999999987654333
Q ss_pred ceeccccCCCCCcchhccccCC-CCchHHHHHHHHHHHHHHcCCCCCCC
Q 003385 760 HVSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISN 807 (824)
Q Consensus 760 ~~~~~~~gt~~y~aPE~l~~~~-~~~~~DIwSlGvil~elltG~~Pf~~ 807 (824)
. .....+++.|+|||.+.... ++.++||||+||++|||++|+.||..
T Consensus 157 ~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 157 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp C-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred c-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 2 23345788999999987665 68999999999999999999999643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1e-34 Score=315.41 Aligned_cols=193 Identities=21% Similarity=0.398 Sum_probs=165.7
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcC-CCccceeeceeec--CCeEEEEEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQE--EGRSVLVYE 677 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~~~lV~E 677 (824)
.|.+.++||+|+||+||+|+++ +|+.||||+++... .+.+.+|+++|++++ ||||+++++++.. ....++|||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 5778899999999999999985 68899999996432 467889999999995 9999999999864 456899999
Q ss_pred ecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCcccccC
Q 003385 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVD 756 (824)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~-~vkL~DFGla~~~~~ 756 (824)
|+.+++|.... +.+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+....
T Consensus 113 ~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 113 HVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred ecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 99999986643 3588999999999999999999998 999999999999998764 699999999986644
Q ss_pred CCCceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 757 GASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 757 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.. ......+|+.|+|||.+... .++.++||||+||+++||++|+.||....
T Consensus 183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 183 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 32 23445689999999998765 57999999999999999999999997644
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=318.09 Aligned_cols=201 Identities=24% Similarity=0.316 Sum_probs=160.0
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCC--cccchhhhHHHHHHhhcCCCccceeeceeec------CCeE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------EGRS 672 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~~~ 672 (824)
+|++.++||+|+||+||+|++. +|+.||||+++... ......+.+|+.++++++||||+++++++.. ....
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 3667789999999999999986 68999999997543 2234568899999999999999999999853 4688
Q ss_pred EEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 003385 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (824)
Q Consensus 673 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~ 752 (824)
++||||+.++.+ +.+. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+|++|||+++
T Consensus 98 ~iv~Ey~~~~l~-~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 98 YLVMELMDANLC-QVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEECCSEEHH-HHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEeccchHHH-Hhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence 999999976544 4442 3478899999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCccccch
Q 003385 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC 814 (824)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~ 814 (824)
...... .....+||+.|+|||++.+..++.++||||+||+++||++|+.||.+.+.....
T Consensus 168 ~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~ 227 (355)
T d2b1pa1 168 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHH
Confidence 654322 234456899999999999999999999999999999999999999876533333
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-35 Score=318.57 Aligned_cols=204 Identities=25% Similarity=0.351 Sum_probs=166.4
Q ss_pred HHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCc--ccchhhhHHHHHHhhcCCCccceeeceeec-----CCeEE
Q 003385 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQE-----EGRSV 673 (824)
Q Consensus 602 ~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~~ 673 (824)
+|++.++||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+++|++++||||+++++++.. ....+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 4667789999999999999875 689999999975432 234568899999999999999999998853 23446
Q ss_pred EEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 674 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
++++++.+|+|.+++. .+.+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+|++|||++..
T Consensus 99 ~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp EEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred EEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence 6778888999999884 34689999999999999999999998 999999999999999999999999999865
Q ss_pred ccCCCCceeccccCCCCCcchhccccC-CCCchHHHHHHHHHHHHHHcCCCCCCCCccccchhcH
Q 003385 754 AVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (824)
Q Consensus 754 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i 817 (824)
... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.+.+.......+
T Consensus 171 ~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i 231 (348)
T d2gfsa1 171 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231 (348)
T ss_dssp CTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 432 23345689999999987765 4678999999999999999999999876644333333
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=1.3e-30 Score=286.53 Aligned_cols=201 Identities=22% Similarity=0.349 Sum_probs=158.8
Q ss_pred HHHHhhccccccCcEEEEEEEEc-CCcEEEEEEeccCCcccchhhhHHHHHHhhcC-----------CCccceeeceeec
Q 003385 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----------HRNLVQFLGYCQE 668 (824)
Q Consensus 601 ~~~~i~~~LG~G~fg~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~~~~~~ 668 (824)
.+|.+.++||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 45788999999999999999975 689999999975432 2456788999888875 5789999988754
Q ss_pred --CCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-----
Q 003385 669 --EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----- 741 (824)
Q Consensus 669 --~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~----- 741 (824)
....+++++++..+....... .......+++..+..++.|++.||+|||+. .||+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALI-KKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHH-HHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeeccccccccccc-ccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccccc
Confidence 456677777766554332221 123456678889999999999999999983 2999999999999998654
Q ss_pred -cEEEEecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHHHHHHHcCCCCCCCCc
Q 003385 742 -RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (824)
Q Consensus 742 -~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 809 (824)
.+|++|||.+...... ....+||+.|+|||++....++.++||||+||+++||++|+.||....
T Consensus 169 ~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 4999999998754332 234569999999999999999999999999999999999999997644
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=1.1e-21 Score=195.15 Aligned_cols=167 Identities=17% Similarity=0.142 Sum_probs=117.6
Q ss_pred hhccccccCcEEEEEEEEcCCcEEEEEEeccCCcc------------------cchhhhHHHHHHhhcCCCccceeecee
Q 003385 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ------------------GKREFTNEVTLLSRIHHRNLVQFLGYC 666 (824)
Q Consensus 605 i~~~LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~------------------~~~~~~~Ei~il~~l~HpnIv~l~~~~ 666 (824)
++++||+|+||+||+|+..+|++||||+++..... ......+|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 56899999999999999989999999987642110 012234678889999999999887653
Q ss_pred ecCCeEEEEEEecCCCCHHHHhhcccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 003385 667 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (824)
Q Consensus 667 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~gIvHrDLkp~NILl~~~~~vkL~ 746 (824)
. .+++|||+++..+.. ++......++.|++.+|+|||++ ||+||||||+|||++++ .++|+
T Consensus 84 ~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 84 G----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp T----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred C----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 2 279999998765432 22233457899999999999998 99999999999999865 58999
Q ss_pred ecCCcccccCCCCceeccccCCCCCcchhccccCCCCchHHHHHHHHH
Q 003385 747 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVI 794 (824)
Q Consensus 747 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DIwSlGvi 794 (824)
|||+|+...++....... ..... -.| ...+.|..++|+||+.--
T Consensus 145 DFG~a~~~~~~~~~~~l~--rd~~~-~~~-~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWREILE--RDVRN-IIT-YFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHHHHHH--HHHHH-HHH-HHHHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHH--HHHHH-HHH-HHcCCCCCcccHHHHHHH
Confidence 999987654322111000 00000 011 124567888999997543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.63 E-value=2e-17 Score=176.49 Aligned_cols=108 Identities=27% Similarity=0.312 Sum_probs=93.9
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~ 498 (824)
..++++++...|.+|..++.+++|+.|++++|.+++.+|.+..+++|+.|+|++|+|+|.+|++|++|++|+.|+|++|+
T Consensus 200 ~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~ 279 (313)
T d1ogqa_ 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279 (313)
T ss_dssp SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCc
Confidence 45666667777777777788888999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccc-cccceeccccCCccccCCC
Q 003385 499 LSGTVPSSL-LSKNVVLNYAGNINLHEGG 526 (824)
Q Consensus 499 l~g~ip~~l-~~~~~~l~~~~n~~lc~~~ 526 (824)
|+|.+|..- +..+..+.+.+|+.+|+.+
T Consensus 280 l~g~iP~~~~L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 280 LCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp EEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred ccccCCCcccCCCCCHHHhCCCccccCCC
Confidence 999999642 3455677889999999875
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=4.9e-16 Score=161.83 Aligned_cols=177 Identities=22% Similarity=0.201 Sum_probs=135.6
Q ss_pred ceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCcee
Q 003385 341 FVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 419 (824)
Q Consensus 341 ~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~ 419 (824)
.++.|+|+.|.++.+|+. +..++.|+.|+++.|.+.... ....+..++.+..+.+. .....-....+++|+
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~Ls~N~------l~~~~~~~~~l~~L~ 103 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTLDLSHNQ------LQSLPLLGQTLPALT 103 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEEECCSSC------CSSCCCCTTTCTTCC
T ss_pred CCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--ccccccccccccccccc------ccccccccccccccc
Confidence 567788888888888865 778888888888887765311 11111122222221110 111111234578999
Q ss_pred EEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeecccc
Q 003385 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (824)
Q Consensus 420 ~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~ 498 (824)
.|+|++|.+.+..+..+..+.+|+.|++++|.++.+++. +..+++|+.|++++|+|++..|+.|+.+++|+.|+|++|+
T Consensus 104 ~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 183 (266)
T d1p9ag_ 104 VLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183 (266)
T ss_dssp EEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred cccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCC
Confidence 999999999977778889999999999999999999887 6889999999999999998777889999999999999999
Q ss_pred cccccccccccc--ceeccccCCccccCCC
Q 003385 499 LSGTVPSSLLSK--NVVLNYAGNINLHEGG 526 (824)
Q Consensus 499 l~g~ip~~l~~~--~~~l~~~~n~~lc~~~ 526 (824)
|+ .||++++.. +..+.+.||+..|.+.
T Consensus 184 L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 184 LY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp CC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred Cc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence 99 999998764 3678889999999763
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.55 E-value=4.3e-15 Score=158.07 Aligned_cols=144 Identities=30% Similarity=0.504 Sum_probs=121.5
Q ss_pred CcHHHHHHHHHhcC----CCCcccCCCCCCCCCCCCeeEcCCCC-CCceeEEEecCCCCCc--cCChhhhcccccccccc
Q 003385 375 IDGVAIVSVISLYS----SADWAQEGGDPCLPVPWSWLQCNSDP-QPSITVIHLSSKNLTG--NIPSDLTKLSSLVELWL 447 (824)
Q Consensus 375 ~~~~~l~~lk~~~~----~~~w~~~~~dpc~~~~~~~~~c~~~~-~~~L~~L~L~~n~l~g--~lp~~i~~L~~L~~L~L 447 (824)
.|..|+.++|+... +.+|.. ++||| ...|.||.|+... ..+++.|+|++|+++| .+|+.|++|++|++|+|
T Consensus 6 ~e~~aLl~~k~~~~~~~~l~sW~~-~~d~C-~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~L 83 (313)
T d1ogqa_ 6 QDKQALLQIKKDLGNPTTLSSWLP-TTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYI 83 (313)
T ss_dssp HHHHHHHHHHHHTTCCGGGTTCCT-TSCTT-TTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEE
T ss_pred HHHHHHHHHHHHCCCCCcCCCCCC-CCCCC-CCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccccccc
Confidence 46678999998753 577864 68999 3359999997543 4489999999999998 58999999999999999
Q ss_pred cc-cccCCCCC-CCCCCCCcceEeecccccCCCCCccccCCCccceeeecccccccccccccccc--ceeccccCCc
Q 003385 448 DG-NSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK--NVVLNYAGNI 520 (824)
Q Consensus 448 ~~-N~l~~~~p-~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g~ip~~l~~~--~~~l~~~~n~ 520 (824)
++ |+++|.+| +|++|++|++|+|++|+|++..|..+..+.+|+.+++++|.+.+.+|.++... ...+.+.+|.
T Consensus 84 s~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 84 GGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred ccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 87 89998777 49999999999999999999999999999999999999999999999887543 3556666664
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.50 E-value=9.5e-15 Score=144.31 Aligned_cols=154 Identities=19% Similarity=0.169 Sum_probs=117.7
Q ss_pred eeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeEEE
Q 003385 343 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 422 (824)
Q Consensus 343 ~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~L~ 422 (824)
+.++++.+.++++|+.|. +.++.|+|+.|.+.. ..... ....+++|+.|+
T Consensus 11 ~~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~----------~~~~~------------------~f~~l~~L~~L~ 60 (192)
T d1w8aa_ 11 TTVDCTGRGLKEIPRDIP--LHTTELLLNDNELGR----------ISSDG------------------LFGRLPHLVKLE 60 (192)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSCCCCS----------BCCSC------------------SGGGCTTCCEEE
T ss_pred CEEEEeCCCcCccCCCCC--CCCCEEEeCCCCCcc----------ccccc------------------ccCCCceEeeee
Confidence 356778999999998875 678899999998752 00000 013467899999
Q ss_pred ecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccccccc
Q 003385 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 501 (824)
Q Consensus 423 L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g 501 (824)
|++|++++..+..+..+++|+.|+|++|+|+.+++. |.++++|+.|+|++|+|++..|+.|..+++|++|+|++|.+..
T Consensus 61 L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 61 LKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred ccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence 999999988888999999999999999999998886 8999999999999999997777789999999999999999985
Q ss_pred cccccccc-cceeccccCCccccCCC
Q 003385 502 TVPSSLLS-KNVVLNYAGNINLHEGG 526 (824)
Q Consensus 502 ~ip~~l~~-~~~~l~~~~n~~lc~~~ 526 (824)
..+...+. ......+.+|...|..+
T Consensus 141 ~~~~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 141 NCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp SGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred ccchHHHhhhhhhhcccCCCeEeCCC
Confidence 44333222 12333445555556544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=7.9e-15 Score=153.92 Aligned_cols=185 Identities=17% Similarity=0.147 Sum_probs=133.7
Q ss_pred ceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCc------ccCCCCCCCC---CCCCeeE-
Q 003385 341 FVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADW------AQEGGDPCLP---VPWSWLQ- 409 (824)
Q Consensus 341 ~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w------~~~~~dpc~~---~~~~~~~- 409 (824)
.++.|+|++|.++++|+. +.++..|+.|+++.|.+..+....+.....+... .....++..- .....+.
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 467899999999999986 8999999999999887654222222111110000 0000111100 0011111
Q ss_pred ----------cCCCCCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCC
Q 003385 410 ----------CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGP 478 (824)
Q Consensus 410 ----------c~~~~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~ 478 (824)
.......+|+.+++++|+|++..+..|..+++|+.|+|++|+|+++++. |.++++|+.|++++|++++.
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i 192 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence 1123457899999999999965567888999999999999999998886 89999999999999999988
Q ss_pred CCccccCCCccceeeecccccccccccccccc---ceeccccCCccccCCC
Q 003385 479 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK---NVVLNYAGNINLHEGG 526 (824)
Q Consensus 479 lP~~l~~l~~L~~L~l~~N~l~g~ip~~l~~~---~~~l~~~~n~~lc~~~ 526 (824)
.|..|..+++|+.|++++|++. .+|...+.. +..+.+++|+..|.+.
T Consensus 193 ~~~~f~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 193 HPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCS-CCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred ChhHhhhhhhcccccccccccc-cccccccccccccCEEEecCCCCCCCcc
Confidence 8999999999999999999999 555554433 4677889999998763
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.40 E-value=2.3e-13 Score=134.13 Aligned_cols=121 Identities=23% Similarity=0.282 Sum_probs=103.0
Q ss_pred CCeeEcCCCC--------CCceeEEEecCCCCCccC-ChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccc
Q 003385 405 WSWLQCNSDP--------QPSITVIHLSSKNLTGNI-PSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474 (824)
Q Consensus 405 ~~~~~c~~~~--------~~~L~~L~L~~n~l~g~l-p~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~ 474 (824)
+..|.|+..+ .+++++|+|++|+|++.+ +..|.+|++|+.|+|++|++++.++. +..+++|+.|+|++|+
T Consensus 10 ~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~ 89 (192)
T d1w8aa_ 10 GTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp TTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred CCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccc
Confidence 5567776432 257999999999998655 55789999999999999999999886 8889999999999999
Q ss_pred cCCCCCccccCCCccceeeecccccccccccccccc---ceeccccCCccccCCC
Q 003385 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK---NVVLNYAGNINLHEGG 526 (824)
Q Consensus 475 l~g~lP~~l~~l~~L~~L~l~~N~l~g~ip~~l~~~---~~~l~~~~n~~lc~~~ 526 (824)
|++..|+.|.+|++|++|+|++|+|+ .+|+..+.. +..+.+.+|+..|...
T Consensus 90 l~~l~~~~F~~l~~L~~L~L~~N~l~-~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 90 IKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred ccccCHHHHhCCCcccccccCCcccc-ccCHHHhcCCcccccccccccccccccc
Confidence 99777788999999999999999999 888877654 3677889999888653
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=5e-13 Score=138.66 Aligned_cols=132 Identities=18% Similarity=0.163 Sum_probs=107.2
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+++|+.|+|+.|.++..|+.+..+..|+.|+++.|.... ..+ +....+.++
T Consensus 76 l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~-------------------~~~----------~~~~~l~~l 126 (266)
T d1p9ag_ 76 LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS-------------------LPL----------GALRGLGEL 126 (266)
T ss_dssp CTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCC-------------------CCS----------STTTTCTTC
T ss_pred cccccccccccccccccccccccccccccccccccccce-------------------eec----------ccccccccc
Confidence 456667777777777777777777777777776665442 111 112346789
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeeccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N 497 (824)
+.|++++|.+++..+..+..+++|+.|++++|+|++.+++ |..+++|++|+|++|+|+ .+|+++..+++|+.|+|++|
T Consensus 127 ~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~N 205 (266)
T d1p9ag_ 127 QELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205 (266)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSC
T ss_pred ccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCC
Confidence 9999999999966667788899999999999999999987 889999999999999999 99999999999999999999
Q ss_pred ccc
Q 003385 498 MLS 500 (824)
Q Consensus 498 ~l~ 500 (824)
++.
T Consensus 206 p~~ 208 (266)
T d1p9ag_ 206 PWL 208 (266)
T ss_dssp CBC
T ss_pred CCC
Confidence 986
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.37 E-value=3.6e-13 Score=142.31 Aligned_cols=183 Identities=20% Similarity=0.226 Sum_probs=131.6
Q ss_pred cccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHH---------------------HHHHHHhcCCCCcccC
Q 003385 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVA---------------------IVSVISLYSSADWAQE 395 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~---------------------l~~lk~~~~~~~w~~~ 395 (824)
.++.|+.|+++.|.++.++|. +..++.|+.|++++|++.... ...+........+..
T Consensus 53 ~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~- 131 (305)
T d1xkua_ 53 NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVEL- 131 (305)
T ss_dssp TCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEEC-
T ss_pred ccccccccccccccccccchhhhhCCCccCEecccCCccCcCccchhhhhhhhhccccchhhhhhhhhhcccccccccc-
Confidence 467889999999999999776 889999999998877654311 011111100000000
Q ss_pred CCCCCCC-----------CCCCeeEcC--------CCCCCceeEEEecCCCCCccCChhhhcccccccccccccccCCCC
Q 003385 396 GGDPCLP-----------VPWSWLQCN--------SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI 456 (824)
Q Consensus 396 ~~dpc~~-----------~~~~~~~c~--------~~~~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~ 456 (824)
...++.. .....+.++ ....++|+.|+|++|.+++..+..+.+++.++.|++++|++++.+
T Consensus 132 ~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~ 211 (305)
T d1xkua_ 132 GTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD 211 (305)
T ss_dssp CSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEEC
T ss_pred ccccccccCCCccccccccccCccccccCCccccCcccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccc
Confidence 0111100 011112211 123578999999999999889999999999999999999999988
Q ss_pred CC-CCCCCCcceEeecccccCCCCCccccCCCccceeeecccccccccccccccc---------ceeccccCCcccc
Q 003385 457 PD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK---------NVVLNYAGNINLH 523 (824)
Q Consensus 457 p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~g~ip~~l~~~---------~~~l~~~~n~~lc 523 (824)
+. +.++++|++|+|++|+|+ .+|++|.++++|+.|+|++|+|+ .|+...+.. +..+.+++|+.-+
T Consensus 212 ~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 212 NGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp TTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred cccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC-ccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 86 788999999999999999 88999999999999999999999 887765432 2456678887543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.37 E-value=5.4e-13 Score=121.86 Aligned_cols=82 Identities=28% Similarity=0.357 Sum_probs=57.8
Q ss_pred CceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCC--ccccCCCccceee
Q 003385 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP--SSLMNLPNLRELY 493 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP--~~l~~l~~L~~L~ 493 (824)
++|++|+|++|+|+ .+|+.++.|++|+.|+|++|+|++. |++.++++|+.|++++|+|+ .+| ..++.+++|+.|+
T Consensus 20 ~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~~~~L~~L~ 96 (124)
T d1dcea3 20 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLN 96 (124)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCC-SSSTTGGGGGCTTCCEEE
T ss_pred CCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-CccccccccCeEECCCCccC-CCCCchhhcCCCCCCEEE
Confidence 35677777777776 6676777777777777777777765 45777777777777777777 333 4567777777777
Q ss_pred ecccccc
Q 003385 494 VQNNMLS 500 (824)
Q Consensus 494 l~~N~l~ 500 (824)
+++|+++
T Consensus 97 l~~N~i~ 103 (124)
T d1dcea3 97 LQGNSLC 103 (124)
T ss_dssp CTTSGGG
T ss_pred CCCCcCC
Confidence 7777776
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.28 E-value=2.6e-12 Score=117.19 Aligned_cols=101 Identities=33% Similarity=0.435 Sum_probs=85.9
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~ 498 (824)
+.|+|++|+|+ .+|. +.+|++|++|+|++|+|+.+++.++.+++|+.|++++|+|+ .+| .++++++|+.|++++|+
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCC-CCcc-cccCCCCCEEECCCCccCcchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 47999999999 7774 99999999999999999998878999999999999999999 566 59999999999999999
Q ss_pred ccccccc--cc--cccceeccccCCccccC
Q 003385 499 LSGTVPS--SL--LSKNVVLNYAGNINLHE 524 (824)
Q Consensus 499 l~g~ip~--~l--~~~~~~l~~~~n~~lc~ 524 (824)
++ .+|. .+ +..+..+.+++|+....
T Consensus 77 i~-~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 77 LQ-QSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CC-SSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred cC-CCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 99 6653 23 23456778889875443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=1.9e-12 Score=135.35 Aligned_cols=159 Identities=16% Similarity=0.104 Sum_probs=114.5
Q ss_pred ccceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCc
Q 003385 339 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (824)
+++|+.|+|..|.+..+++. +.....|+.++++.|.+.. -++- .....++
T Consensus 104 l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~-------------------i~~~----------~f~~~~~ 154 (284)
T d1ozna_ 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-------------------LPDD----------TFRDLGN 154 (284)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-------------------CCTT----------TTTTCTT
T ss_pred cccCCEEecCCcccccccccccchhcccchhhhccccccc-------------------cChh----------Hhccccc
Confidence 34556666666666555554 4455556666666555442 0000 0123568
Q ss_pred eeEEEecCCCCCccCChhhhcccccccccccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeecc
Q 003385 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (824)
Q Consensus 418 L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~ 496 (824)
|+.|+|++|+|++..|..|.++++|+.|++++|+++++.|. |.++++|+.|++++|++++..|..|+++++|+.|+|++
T Consensus 155 L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~ 234 (284)
T d1ozna_ 155 LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLND 234 (284)
T ss_dssp CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCS
T ss_pred hhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecC
Confidence 99999999999977788999999999999999999999886 89999999999999999987788999999999999999
Q ss_pred ccccccccccccc-cceeccccCCccccCCC
Q 003385 497 NMLSGTVPSSLLS-KNVVLNYAGNINLHEGG 526 (824)
Q Consensus 497 N~l~g~ip~~l~~-~~~~l~~~~n~~lc~~~ 526 (824)
|++.+.-+...+. ....+....+...|..+
T Consensus 235 N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p 265 (284)
T d1ozna_ 235 NPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265 (284)
T ss_dssp SCEECSGGGHHHHHHHHHCCSEECCCBEEES
T ss_pred CCCCCCccchHHHHHHHhCcCCCCceEeCCc
Confidence 9999655432221 12223334455566543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.23 E-value=3.9e-12 Score=121.71 Aligned_cols=124 Identities=14% Similarity=0.055 Sum_probs=97.7
Q ss_pred cccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCc
Q 003385 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (824)
....++.|+|++|.++.+|.....+..|+.|++++|.+.. + ++ ...+++
T Consensus 16 n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~--------------l-------------~~----~~~l~~ 64 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRK--------------L-------------DG----FPLLRR 64 (162)
T ss_dssp CTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCE--------------E-------------CC----CCCCSS
T ss_pred CcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCCc--------------c-------------CC----cccCcc
Confidence 3456889999999999998888889999999999987763 1 00 124568
Q ss_pred eeEEEecCCCCCccCChhhhcccccccccccccccCCCCC--CCCCCCCcceEeecccccCCCCCc----cccCCCccce
Q 003385 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDNQLTGPLPS----SLMNLPNLRE 491 (824)
Q Consensus 418 L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~L~~N~l~g~lP~----~l~~l~~L~~ 491 (824)
|++|+|++|+++...+..+..+++|+.|+|++|+|+.... .+..+++|+.|+|++|.++ ..|. .+..+++|+.
T Consensus 65 L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~ 143 (162)
T d1a9na_ 65 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRV 143 (162)
T ss_dssp CCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSE
T ss_pred hhhhhcccccccCCCccccccccccccceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCe
Confidence 9999999999994444456679999999999999987643 4788899999999999988 5664 5788888888
Q ss_pred ee
Q 003385 492 LY 493 (824)
Q Consensus 492 L~ 493 (824)
||
T Consensus 144 LD 145 (162)
T d1a9na_ 144 LD 145 (162)
T ss_dssp ET
T ss_pred eC
Confidence 76
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.22 E-value=6.1e-12 Score=125.56 Aligned_cols=128 Identities=23% Similarity=0.374 Sum_probs=82.1
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+++|+.|+|++|.++.++| +..++.|+.|+++.|++... ..+ ..+++|
T Consensus 67 l~~L~~L~L~~n~i~~l~~-~~~l~~L~~L~l~~n~i~~l--~~l-----------------------------~~l~~L 114 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDL--SSL-----------------------------KDLKKL 114 (210)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCG--GGG-----------------------------TTCTTC
T ss_pred CCCCCEEeCCCccccCccc-cccCcccccccccccccccc--ccc-----------------------------cccccc
Confidence 6688999999999999886 58899999999998876531 011 123456
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~ 498 (824)
+.|++++|.+. .++ .+..+++|+.+++++|.+++. +.+..+++|+.+++++|++++ +++ +++|++|++|+|++|+
T Consensus 115 ~~L~l~~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~~-~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~ 189 (210)
T d1h6ta2 115 KSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNH 189 (210)
T ss_dssp CEEECTTSCCC-CCG-GGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSC
T ss_pred ccccccccccc-ccc-ccccccccccccccccccccc-ccccccccccccccccccccc-ccc-ccCCCCCCEEECCCCC
Confidence 66666666655 333 356666666666666666542 234556666666666666663 332 6666666666666666
Q ss_pred cccccc
Q 003385 499 LSGTVP 504 (824)
Q Consensus 499 l~g~ip 504 (824)
++ .+|
T Consensus 190 i~-~l~ 194 (210)
T d1h6ta2 190 IS-DLR 194 (210)
T ss_dssp CC-BCG
T ss_pred CC-CCh
Confidence 66 454
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.21 E-value=1.2e-11 Score=122.26 Aligned_cols=128 Identities=23% Similarity=0.309 Sum_probs=98.2
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+++|++|+|++|.++.++| +.++..|+.|+++.|.... ... ...+++|
T Consensus 61 l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~~---------------------------~~~----l~~l~~L 108 (199)
T d2omxa2 61 LNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIAD---------------------------ITP----LANLTNL 108 (199)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC---------------------------CGG----GTTCTTC
T ss_pred CCCcCcCccccccccCccc-ccCCccccccccccccccc---------------------------ccc----ccccccc
Confidence 5677778888888887776 7777778888777765442 000 1245688
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~ 498 (824)
+.|++++|.+.. + +.+..|++|+.|++++|++... +.+..+++|+.|++++|++++ ++ .+++|++|+.|++++|+
T Consensus 109 ~~L~l~~~~~~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~L~ls~N~ 183 (199)
T d2omxa2 109 TGLTLFNNQITD-I-DPLKNLTNLNRLELSSNTISDI-SALSGLTSLQQLNFSSNQVTD-LK-PLANLTTLERLDISSNK 183 (199)
T ss_dssp SEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSC
T ss_pred cccccccccccc-c-cccchhhhhHHhhhhhhhhccc-ccccccccccccccccccccC-Cc-cccCCCCCCEEECCCCC
Confidence 999999988873 3 3488899999999999998754 568889999999999999984 44 48899999999999999
Q ss_pred cccccc
Q 003385 499 LSGTVP 504 (824)
Q Consensus 499 l~g~ip 504 (824)
++ .+|
T Consensus 184 i~-~i~ 188 (199)
T d2omxa2 184 VS-DIS 188 (199)
T ss_dssp CC-CCG
T ss_pred CC-CCc
Confidence 98 565
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.17 E-value=4.1e-11 Score=118.34 Aligned_cols=145 Identities=17% Similarity=0.218 Sum_probs=118.8
Q ss_pred cccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCc
Q 003385 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (824)
.+..++.|++..|.++.++ .|..+++|+.|++++|++.. + .| ...+++
T Consensus 38 ~l~~l~~L~l~~~~i~~l~-~l~~l~nL~~L~Ls~N~l~~--------------~-----~~------------l~~l~~ 85 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKSID-GVEYLNNLTQINFSNNQLTD--------------I-----TP------------LKNLTK 85 (199)
T ss_dssp HHTTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCC--------------C-----GG------------GTTCTT
T ss_pred HhcCCCEEECCCCCCCCcc-ccccCCCcCcCccccccccC--------------c-----cc------------ccCCcc
Confidence 4678899999999999985 58999999999999997662 1 11 134679
Q ss_pred eeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeeccc
Q 003385 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 418 L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N 497 (824)
|+.|++++|.+. .+|. +.++++|+.|++++|.+.... .+..+++|+.|++++|++. .+| .+..+++|+.|++.+|
T Consensus 86 L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~~~~~~~~~-~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n 160 (199)
T d2omxa2 86 LVDILMNNNQIA-DITP-LANLTNLTGLTLFNNQITDID-PLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSN 160 (199)
T ss_dssp CCEEECCSSCCC-CCGG-GTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSS
T ss_pred cccccccccccc-cccc-ccccccccccccccccccccc-ccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccc
Confidence 999999999998 6664 899999999999999998754 4888999999999999998 554 6999999999999999
Q ss_pred cccccccc-cccccceeccccCCc
Q 003385 498 MLSGTVPS-SLLSKNVVLNYAGNI 520 (824)
Q Consensus 498 ~l~g~ip~-~l~~~~~~l~~~~n~ 520 (824)
+++ .++. .-+.++..+.+++|.
T Consensus 161 ~l~-~l~~l~~l~~L~~L~ls~N~ 183 (199)
T d2omxa2 161 QVT-DLKPLANLTTLERLDISSNK 183 (199)
T ss_dssp CCC-CCGGGTTCTTCCEEECCSSC
T ss_pred ccc-CCccccCCCCCCEEECCCCC
Confidence 999 4543 334555777778774
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.14 E-value=2.1e-11 Score=116.52 Aligned_cols=104 Identities=18% Similarity=0.147 Sum_probs=86.7
Q ss_pred CCceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeee
Q 003385 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (824)
Q Consensus 415 ~~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l 494 (824)
..++++|+|++|+|+ .+|..+..+++|+.|+|++|+|+.+ +.+..+++|+.|+|++|+|+...+..+..+++|+.|+|
T Consensus 17 ~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred cCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 458999999999999 7888778899999999999999976 67999999999999999999444445678999999999
Q ss_pred ccccccccccc--cc--cccceeccccCCcc
Q 003385 495 QNNMLSGTVPS--SL--LSKNVVLNYAGNIN 521 (824)
Q Consensus 495 ~~N~l~g~ip~--~l--~~~~~~l~~~~n~~ 521 (824)
++|+++ .++. .+ +..+..+.+.+|+.
T Consensus 95 ~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 95 TNNSLV-ELGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp CSCCCC-CGGGGGGGGGCTTCCEEECCSSGG
T ss_pred cccccc-ccccccccccccccchhhcCCCcc
Confidence 999998 6654 22 33456777888864
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.13 E-value=5.9e-11 Score=124.91 Aligned_cols=141 Identities=13% Similarity=0.100 Sum_probs=114.4
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
++.|+.+++..|.++.+|..+ ++.++.|+++.|.... ..+ +....++.+
T Consensus 149 l~~L~~l~l~~n~l~~l~~~~--~~~L~~L~l~~n~~~~-------------------~~~----------~~~~~~~~l 197 (305)
T d1xkua_ 149 MKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITK-------------------VDA----------ASLKGLNNL 197 (305)
T ss_dssp CTTCCEEECCSSCCCSCCSSC--CTTCSEEECTTSCCCE-------------------ECT----------GGGTTCTTC
T ss_pred ccccCccccccCCccccCccc--CCccCEEECCCCcCCC-------------------CCh----------hHhhccccc
Confidence 567888999999999998764 5788888888775442 111 122345689
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCc-------cccCCCccce
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS-------SLMNLPNLRE 491 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~-------~l~~l~~L~~ 491 (824)
+.|++++|++++..|..+.++++|+.|+|++|+|+.+++++.++++|+.|+|++|+|+ .++. .+..+.+|+.
T Consensus 198 ~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~ 276 (305)
T d1xkua_ 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSG 276 (305)
T ss_dssp CEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSCCCSE
T ss_pred cccccccccccccccccccccccceeeecccccccccccccccccCCCEEECCCCccC-ccChhhccCcchhcccCCCCE
Confidence 9999999999988888999999999999999999988778999999999999999999 5543 3456788999
Q ss_pred eeecccccc-ccccccccccc
Q 003385 492 LYVQNNMLS-GTVPSSLLSKN 511 (824)
Q Consensus 492 L~l~~N~l~-g~ip~~l~~~~ 511 (824)
|+|++|+++ ..+++..|+..
T Consensus 277 L~L~~N~~~~~~~~~~~f~~~ 297 (305)
T d1xkua_ 277 VSLFSNPVQYWEIQPSTFRCV 297 (305)
T ss_dssp EECCSSSSCGGGSCGGGGTTC
T ss_pred EECCCCcCccCcCCHhHhccc
Confidence 999999985 56777777653
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.13 E-value=2.6e-11 Score=115.04 Aligned_cols=105 Identities=17% Similarity=0.174 Sum_probs=88.0
Q ss_pred eEEEecCCCCCccCChhhhccccccccccccc-ccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceeeecc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGN-SLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N-~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~ 496 (824)
+.++++++++. ..|..+..+++|+.|+|++| .|+.+.+. |.++++|+.|+|++|+|+...|.+|..+++|+.|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34666777777 77888999999999999766 48887765 89999999999999999966678899999999999999
Q ss_pred ccccccccccccccc--eeccccCCccccCC
Q 003385 497 NMLSGTVPSSLLSKN--VVLNYAGNINLHEG 525 (824)
Q Consensus 497 N~l~g~ip~~l~~~~--~~l~~~~n~~lc~~ 525 (824)
|+|+ .+|.+++... ..+.+.+|+..|.+
T Consensus 90 N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 90 NALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119 (156)
T ss_dssp SCCS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred CCCc-ccChhhhccccccccccCCCcccCCc
Confidence 9999 8998887654 56778999988866
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.12 E-value=6.5e-11 Score=117.95 Aligned_cols=145 Identities=19% Similarity=0.214 Sum_probs=118.4
Q ss_pred cccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCc
Q 003385 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (824)
.|.+|+.|++..|.++.+++ |..+++|+.|+++.|.+.. -+++ ..+++
T Consensus 44 ~L~~L~~L~l~~~~i~~l~~-l~~l~~L~~L~L~~n~i~~-------------------l~~~------------~~l~~ 91 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTD-------------------IKPL------------ANLKN 91 (210)
T ss_dssp HHHTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCC-------------------CGGG------------TTCTT
T ss_pred HhcCccEEECcCCCCCCchh-HhhCCCCCEEeCCCccccC-------------------cccc------------ccCcc
Confidence 36788999999999999875 7899999999999997662 1111 24679
Q ss_pred eeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeeccc
Q 003385 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 418 L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N 497 (824)
|+.|+|++|+|+ .+| .+.++++|+.|++++|.+.. ++.+.++++|+.+++++|++++ +..++.+++|+.+++++|
T Consensus 92 L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~~-~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n 166 (210)
T d1h6ta2 92 LGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDN 166 (210)
T ss_dssp CCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCCC-CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSS
T ss_pred cccccccccccc-ccc-cccccccccccccccccccc-cccccccccccccccccccccc--cccccccccccccccccc
Confidence 999999999999 576 59999999999999999875 4568899999999999999984 446888999999999999
Q ss_pred cccccccc-cccccceeccccCCc
Q 003385 498 MLSGTVPS-SLLSKNVVLNYAGNI 520 (824)
Q Consensus 498 ~l~g~ip~-~l~~~~~~l~~~~n~ 520 (824)
++++ ++. +-+..+..+.+++|.
T Consensus 167 ~l~~-i~~l~~l~~L~~L~Ls~N~ 189 (210)
T d1h6ta2 167 QISD-IVPLAGLTKLQNLYLSKNH 189 (210)
T ss_dssp CCCC-CGGGTTCTTCCEEECCSSC
T ss_pred cccc-cccccCCCCCCEEECCCCC
Confidence 9994 543 334455677778774
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.12 E-value=5.8e-11 Score=128.38 Aligned_cols=144 Identities=15% Similarity=0.247 Sum_probs=70.6
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
++.|+.|++.+|.++.+++ +..+..|+.|+++.+.+... ..+.....+..... .-| ...++.+ ...++++
T Consensus 240 l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~~~l~~~--~~~~~~~~l~~l~~---~~n---~l~~~~~-~~~~~~l 309 (384)
T d2omza2 240 LTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNI--SPLAGLTALTNLEL---NEN---QLEDISP-ISNLKNL 309 (384)
T ss_dssp CTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEEC---CSS---CCSCCGG-GGGCTTC
T ss_pred ccccchhccccCccCCCCc-ccccccCCEeeccCcccCCC--Cccccccccccccc---ccc---ccccccc-cchhccc
Confidence 4567777777777777765 56677777777776654421 00111111111100 000 0000000 1123455
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeeccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N 497 (824)
+.|+|++|++++ ++ .+..|++|+.|+|++|+|+++ +.+.+|++|++|+|++|+|++..| +++|++|+.|+|++|
T Consensus 310 ~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~~l-~~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 310 TYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVSDV-SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp SEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CeEECCCCCCCC-Cc-ccccCCCCCEEECCCCCCCCC-hhHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 555555555553 22 255555555555555555543 245555555555555555553322 555555555555555
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.10 E-value=6.5e-11 Score=112.28 Aligned_cols=102 Identities=28% Similarity=0.330 Sum_probs=84.4
Q ss_pred CCCCCCCCCeeEcCCC----------CCCceeEEEecCC-CCCccCChhhhcccccccccccccccCCCCCC-CCCCCCc
Q 003385 398 DPCLPVPWSWLQCNSD----------PQPSITVIHLSSK-NLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDL 465 (824)
Q Consensus 398 dpc~~~~~~~~~c~~~----------~~~~L~~L~L~~n-~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~-~~~l~~L 465 (824)
+.|.....+.+.|+.. .+++|++|+|++| .|+..-++.|.+|++|+.|+|++|+|+.+.+. |.++++|
T Consensus 3 ~~C~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L 82 (156)
T d2ifga3 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82 (156)
T ss_dssp SSSCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCC
T ss_pred CCCCcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccc
Confidence 3455556677888542 3578999999876 48854456799999999999999999999887 8999999
Q ss_pred ceEeecccccCCCCCccccCCCccceeeecccccc
Q 003385 466 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 500 (824)
Q Consensus 466 ~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~l~ 500 (824)
+.|+|++|+|+ .+|.......+|+.|+|++|++.
T Consensus 83 ~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred cceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 99999999999 77776666668999999999985
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.08 E-value=5.1e-11 Score=120.00 Aligned_cols=150 Identities=20% Similarity=0.283 Sum_probs=98.6
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+++|+.|+|+.|.++.++| +..++.++.+.++.|..... ..+..+..+..+.. ..|. ..++. .....+.+
T Consensus 62 l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~l~l---~~~~---~~~~~-~~~~~~~~ 131 (227)
T d1h6ua2 62 LNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDL---TSTQ---ITDVT-PLAGLSNL 131 (227)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEEC---TTSC---CCCCG-GGTTCTTC
T ss_pred CCCCcEeecCCceeecccc-cccccccccccccccccccc--cccccccccccccc---cccc---ccccc-hhccccch
Confidence 6677888888888888776 67778888888877665421 12222222222211 1111 11111 11234577
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~ 498 (824)
..|.++++.+... ..+.++++|+.|++++|+++...+ +.++++|+.|+|++|+++ .+|+ ++++++|++|+|++|+
T Consensus 132 ~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~~L~~L~Ls~N~ 206 (227)
T d1h6ua2 132 QVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQ 206 (227)
T ss_dssp CEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECTTSC
T ss_pred hhhhchhhhhchh--hhhccccccccccccccccccchh-hcccccceecccCCCccC-CChh-hcCCCCCCEEECcCCc
Confidence 7888888877733 237778888888888888876544 778888888888888888 4543 7888888888888888
Q ss_pred cccccc
Q 003385 499 LSGTVP 504 (824)
Q Consensus 499 l~g~ip 504 (824)
++ .+|
T Consensus 207 lt-~i~ 211 (227)
T d1h6ua2 207 IS-DVS 211 (227)
T ss_dssp CC-BCG
T ss_pred CC-CCc
Confidence 88 555
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.00 E-value=1.5e-10 Score=125.09 Aligned_cols=80 Identities=28% Similarity=0.384 Sum_probs=41.4
Q ss_pred CceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeec
Q 003385 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~ 495 (824)
+.++.+++..|++++ + ..+..+++|+.|+|++|+++++++ +..+++|+.|+|++|+|+ .+| .+++|++|++|+|+
T Consensus 285 ~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l~~-l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~ 359 (384)
T d2omza2 285 TALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAG 359 (384)
T ss_dssp TTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECC
T ss_pred ccccccccccccccc-c-cccchhcccCeEECCCCCCCCCcc-cccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECC
Confidence 345555555555552 2 235555555555555555555432 455555555555555555 233 35555555555555
Q ss_pred ccccc
Q 003385 496 NNMLS 500 (824)
Q Consensus 496 ~N~l~ 500 (824)
+|+++
T Consensus 360 ~N~l~ 364 (384)
T d2omza2 360 HNQIS 364 (384)
T ss_dssp SSCCC
T ss_pred CCcCC
Confidence 55555
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.94 E-value=5.8e-12 Score=124.65 Aligned_cols=116 Identities=20% Similarity=0.289 Sum_probs=90.7
Q ss_pred CCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeEEEecCCCCCc
Q 003385 351 YDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTG 430 (824)
Q Consensus 351 ~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~L~L~~n~l~g 430 (824)
.+..+|..|+.|+.|+.|+++.|.+... +.+ ..+++|+.|+|++|+|+
T Consensus 36 ~i~~l~~sl~~L~~L~~L~Ls~n~I~~i---------------------------~~l----~~l~~L~~L~Ls~N~i~- 83 (198)
T d1m9la_ 36 PIEKMDATLSTLKACKHLALSTNNIEKI---------------------------SSL----SGMENLRILSLGRNLIK- 83 (198)
T ss_dssp TCCCCHHHHHHTTTCCEEECSEEEESCC---------------------------CCH----HHHTTCCEEECCEEEEC-
T ss_pred chhhhhhHHhcccccceeECcccCCCCc---------------------------ccc----cCCccccChhhcccccc-
Confidence 5677777788888888888888876520 000 12458889999999988
Q ss_pred cCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCC--ccccCCCccceeeecccccc
Q 003385 431 NIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP--SSLMNLPNLRELYVQNNMLS 500 (824)
Q Consensus 431 ~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP--~~l~~l~~L~~L~l~~N~l~ 500 (824)
.+|..+..+++|+.|+|++|+|+.+ +.+.++++|+.|+|++|+|+ .++ ..+..|++|+.|+|++|++.
T Consensus 84 ~i~~~~~~~~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 84 KIENLDAVADTLEELWISYNQIASL-SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SCSSHHHHHHHCCEEECSEEECCCH-HHHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccccccccccccccccccc-ccccccccccccccccchhc-cccccccccCCCccceeecCCCccc
Confidence 7787777778899999999998875 45778889999999999988 555 46888999999999999887
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.88 E-value=8.8e-12 Score=123.30 Aligned_cols=128 Identities=18% Similarity=0.213 Sum_probs=101.2
Q ss_pred cccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCc
Q 003385 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (824)
Q Consensus 338 ~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (824)
.|++|++|+|+.|.++.++ .|..+++|+.|+++.|.+.. + .... ..+++
T Consensus 46 ~L~~L~~L~Ls~n~I~~i~-~l~~l~~L~~L~Ls~N~i~~--------------i-------------~~~~---~~~~~ 94 (198)
T d1m9la_ 46 TLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIKK--------------I-------------ENLD---AVADT 94 (198)
T ss_dssp HTTTCCEEECSEEEESCCC-CHHHHTTCCEEECCEEEECS--------------C-------------SSHH---HHHHH
T ss_pred cccccceeECcccCCCCcc-cccCCccccChhhccccccc--------------c-------------cccc---ccccc
Confidence 4778999999999999996 48999999999999997653 0 0000 01247
Q ss_pred eeEEEecCCCCCccCChhhhcccccccccccccccCCCCC--CCCCCCCcceEeecccccCCCCCcc----------ccC
Q 003385 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDNQLTGPLPSS----------LMN 485 (824)
Q Consensus 418 L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~L~~N~l~g~lP~~----------l~~ 485 (824)
|+.|+|++|+|+ .++ .+.+|++|+.|+|++|+|+.... .+..|++|+.|+|++|++....+.. +..
T Consensus 95 L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~ 172 (198)
T d1m9la_ 95 LEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKR 172 (198)
T ss_dssp CCEEECSEEECC-CHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHH
T ss_pred cccccccccccc-ccc-cccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHH
Confidence 999999999999 554 59999999999999999998653 5899999999999999988444432 567
Q ss_pred CCccceeeecccccc
Q 003385 486 LPNLRELYVQNNMLS 500 (824)
Q Consensus 486 l~~L~~L~l~~N~l~ 500 (824)
|++|+.|| +..++
T Consensus 173 lp~L~~LD--~~~I~ 185 (198)
T d1m9la_ 173 LPNLKKLD--GMPVD 185 (198)
T ss_dssp CSSCCEES--SGGGT
T ss_pred CCCcCEeC--CccCC
Confidence 88888876 44443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.83 E-value=2.1e-09 Score=107.92 Aligned_cols=168 Identities=22% Similarity=0.271 Sum_probs=120.8
Q ss_pred ccccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCC
Q 003385 337 LSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (824)
Q Consensus 337 ~~l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (824)
-.|.+|+.|++.+|.++.++ .|..+++|+.|+++.|.+... ..+..+..+...... +.+. ..+. ....++
T Consensus 38 ~~l~~L~~L~l~~~~i~~l~-~l~~l~~L~~L~ls~n~i~~~--~~l~~l~~l~~l~~~-~n~~-----~~i~-~l~~l~ 107 (227)
T d1h6ua2 38 ADLDGITTLSAFGTGVTTIE-GVQYLNNLIGLELKDNQITDL--APLKNLTKITELELS-GNPL-----KNVS-AIAGLQ 107 (227)
T ss_dssp HHHHTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCC--GGGTTCCSCCEEECC-SCCC-----SCCG-GGTTCT
T ss_pred HHcCCcCEEECCCCCCCcch-hHhcCCCCcEeecCCceeecc--ccccccccccccccc-cccc-----cccc-cccccc
Confidence 34678999999999999995 589999999999999987642 123333233322221 1111 1111 123567
Q ss_pred ceeEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecc
Q 003385 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (824)
Q Consensus 417 ~L~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~ 496 (824)
+|+.|+++++...+. ..+...+.++.|.++++.+....+ +.++++|+.|++++|++++ .+ .++++++|++|+|++
T Consensus 108 ~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~Ls~ 182 (227)
T d1h6ua2 108 SIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSD-LT-PLANLSKLTTLKADD 182 (227)
T ss_dssp TCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCS
T ss_pred ccccccccccccccc--chhccccchhhhhchhhhhchhhh-hcccccccccccccccccc-ch-hhcccccceecccCC
Confidence 899999999888743 237778889999999988876544 7788999999999999984 33 489999999999999
Q ss_pred ccccccccc-cccccceeccccCCc
Q 003385 497 NMLSGTVPS-SLLSKNVVLNYAGNI 520 (824)
Q Consensus 497 N~l~g~ip~-~l~~~~~~l~~~~n~ 520 (824)
|+++ .+|. .-+..+..+.+++|.
T Consensus 183 n~l~-~l~~l~~l~~L~~L~Ls~N~ 206 (227)
T d1h6ua2 183 NKIS-DISPLASLPNLIEVHLKNNQ 206 (227)
T ss_dssp SCCC-CCGGGGGCTTCCEEECTTSC
T ss_pred CccC-CChhhcCCCCCCEEECcCCc
Confidence 9999 5654 224455677777774
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.76 E-value=1.4e-09 Score=110.02 Aligned_cols=169 Identities=15% Similarity=0.117 Sum_probs=94.0
Q ss_pred ceeeecccccCCCCCCcc-cchhhhceeccCCCCCCcH-HHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcC-CCCCCc
Q 003385 341 FVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDG-VAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCN-SDPQPS 417 (824)
Q Consensus 341 ~l~~L~L~~n~~s~LPP~-i~~le~l~~L~l~~n~~~~-~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~-~~~~~~ 417 (824)
++++|+|++|.++.+|+. +.++.+|+.|+++.|.+.. .....+..+..+.......... ..+.... ...+++
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~-----l~~~~~~~~~~l~~ 104 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN-----LLYINPEAFQNLPN 104 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTT-----CCEECTTSEECCTT
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccc-----cccccccccccccc
Confidence 567788888888888875 7888888888887775432 1111111111111100000000 0000000 012334
Q ss_pred eeEEEec-------------------------CCCCCccCChhhhccc-ccccccccccccCCCCCCCCCCCCcc-eEee
Q 003385 418 ITVIHLS-------------------------SKNLTGNIPSDLTKLS-SLVELWLDGNSLTGPIPDFSGCPDLR-IIHL 470 (824)
Q Consensus 418 L~~L~L~-------------------------~n~l~g~lp~~i~~L~-~L~~L~L~~N~l~~~~p~~~~l~~L~-~L~L 470 (824)
|+.|+++ ++++...-+..+..++ .++.|++++|+++.+.+......+++ .+++
T Consensus 105 L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l 184 (242)
T d1xwdc1 105 LQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLS 184 (242)
T ss_dssp CCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECT
T ss_pred ccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccccchhhhccccc
Confidence 4444444 4444422233444443 56667777777777666644445544 4456
Q ss_pred cccccCCCCC-ccccCCCccceeeeccccccccccccccccceeccc
Q 003385 471 EDNQLTGPLP-SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516 (824)
Q Consensus 471 ~~N~l~g~lP-~~l~~l~~L~~L~l~~N~l~g~ip~~l~~~~~~l~~ 516 (824)
++|+|+ .+| ..|.++++|+.|+|++|+++ .+|...+..+..+..
T Consensus 185 ~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~ 229 (242)
T d1xwdc1 185 DNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRA 229 (242)
T ss_dssp TCTTCC-CCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTTCCEEES
T ss_pred cccccc-cccHHHhcCCCCCCEEECCCCcCC-ccCHHHHcCCccccc
Confidence 777887 555 45788888888888888888 788877777655544
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.49 E-value=1e-07 Score=95.76 Aligned_cols=86 Identities=22% Similarity=0.264 Sum_probs=68.0
Q ss_pred CceeEEEecCCCCCccCChhhhcccccccc-cccccccCCCCCC-CCCCCCcceEeecccccCCCCCccccCCCccceee
Q 003385 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEL-WLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~lp~~i~~L~~L~~L-~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~ 493 (824)
..++.|++++|+++ .++....+..+++.+ ++++|+|+.+++. |.++++|+.|+|++|+|+...+..|.+|++|+.|+
T Consensus 153 ~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~ 231 (242)
T d1xwdc1 153 FESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS 231 (242)
T ss_dssp SSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSS
T ss_pred ccceeeeccccccc-ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCc
Confidence 47899999999999 666666666665555 6788999988876 89999999999999999944445789999998877
Q ss_pred eccccccccccc
Q 003385 494 VQNNMLSGTVPS 505 (824)
Q Consensus 494 l~~N~l~g~ip~ 505 (824)
+. ++. .+|.
T Consensus 232 ~~--~l~-~lp~ 240 (242)
T d1xwdc1 232 TY--NLK-KLPT 240 (242)
T ss_dssp EE--SSS-CSCC
T ss_pred CC--CCC-cCCC
Confidence 64 455 5553
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.34 E-value=1.4e-06 Score=91.51 Aligned_cols=96 Identities=19% Similarity=0.179 Sum_probs=61.5
Q ss_pred cceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCcee
Q 003385 340 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 419 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~ 419 (824)
++++.|+|++|.++++|+.+ ..|+.|+++.|++... . ..+.+|+
T Consensus 38 ~~l~~LdLs~~~L~~lp~~~---~~L~~L~Ls~N~l~~l-----------p----------------------~~~~~L~ 81 (353)
T d1jl5a_ 38 RQAHELELNNLGLSSLPELP---PHLESLVASCNSLTEL-----------P----------------------ELPQSLK 81 (353)
T ss_dssp HTCSEEECTTSCCSCCCSCC---TTCSEEECCSSCCSSC-----------C----------------------CCCTTCC
T ss_pred cCCCEEEeCCCCCCCCCCCC---CCCCEEECCCCCCccc-----------c----------------------cchhhhh
Confidence 45778899999999998764 4577888888876530 0 0123566
Q ss_pred EEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccC
Q 003385 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 476 (824)
Q Consensus 420 ~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~ 476 (824)
.|++++|+++ .+++- .+.|++|+|++|.++.. |.++.+++|+.|++++|.++
T Consensus 82 ~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~l~~l-p~~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 82 SLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLEKL-PELQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp EEECCSSCCS-CCCSC---CTTCCEEECCSSCCSSC-CCCTTCTTCCEEECCSSCCS
T ss_pred hhhhhhcccc-hhhhh---ccccccccccccccccc-cchhhhccceeecccccccc
Confidence 6677776666 44431 13466677777766644 34566666777777666666
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.20 E-value=2.3e-06 Score=89.81 Aligned_cols=119 Identities=27% Similarity=0.282 Sum_probs=82.0
Q ss_pred ccceeeecccccCCCCCCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
+++|++|+|+.|.++++|..++ +|+.|++..|++.. +..+ ++.|
T Consensus 57 ~~~L~~L~Ls~N~l~~lp~~~~---~L~~L~l~~n~l~~-----------l~~l----------------------p~~L 100 (353)
T d1jl5a_ 57 PPHLESLVASCNSLTELPELPQ---SLKSLLVDNNNLKA-----------LSDL----------------------PPLL 100 (353)
T ss_dssp CTTCSEEECCSSCCSSCCCCCT---TCCEEECCSSCCSC-----------CCSC----------------------CTTC
T ss_pred CCCCCEEECCCCCCcccccchh---hhhhhhhhhcccch-----------hhhh----------------------cccc
Confidence 3578999999999999998765 56777777776552 1111 2368
Q ss_pred eEEEecCCCCCccCChhhhcccccccccccccccCCCCCCCCCCCCcceEeecccccCCCCCccccCCCccceeeecccc
Q 003385 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (824)
Q Consensus 419 ~~L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~g~lP~~l~~l~~L~~L~l~~N~ 498 (824)
++|+|++|.++ .+|. ++++++|+.|++++|.++..+... ..+..|.+..+... .+..++.++.++.|++++|.
T Consensus 101 ~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~~---~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~ 173 (353)
T d1jl5a_ 101 EYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLP---PSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNS 173 (353)
T ss_dssp CEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSC
T ss_pred ccccccccccc-cccc-hhhhccceeecccccccccccccc---ccccchhhcccccc--ccccccccccceeccccccc
Confidence 99999999999 7885 688999999999999988665432 33444445444443 23345556666666666665
Q ss_pred cc
Q 003385 499 LS 500 (824)
Q Consensus 499 l~ 500 (824)
+.
T Consensus 174 ~~ 175 (353)
T d1jl5a_ 174 LK 175 (353)
T ss_dssp CS
T ss_pred cc
Confidence 55
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.15 E-value=9.3e-08 Score=99.11 Aligned_cols=157 Identities=14% Similarity=0.154 Sum_probs=66.3
Q ss_pred ceeeecccccCCCC--CCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCce
Q 003385 341 FVLSFKFGKTYDSS--RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (824)
Q Consensus 341 ~l~~L~L~~n~~s~--LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L 418 (824)
.|++|+|+.+.++. ++..+..+.+|+.|.+..+.++...+..+.+...+...+.+ -|....-.++..-...+++|
T Consensus 47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls---~c~~itd~~l~~l~~~~~~L 123 (284)
T d2astb2 47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS---GCSGFSEFALQTLLSSCSRL 123 (284)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT---TCBSCCHHHHHHHHHHCTTC
T ss_pred CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc---ccccccccccchhhHHHHhc
Confidence 34455555544432 33334555555555555555544444444433333333211 12100000000000123456
Q ss_pred eEEEecCC-CCCc-cCChhhhcc-ccccccccccc--ccCCC-CCC-CCCCCCcceEeeccc-ccCCCCCccccCCCccc
Q 003385 419 TVIHLSSK-NLTG-NIPSDLTKL-SSLVELWLDGN--SLTGP-IPD-FSGCPDLRIIHLEDN-QLTGPLPSSLMNLPNLR 490 (824)
Q Consensus 419 ~~L~L~~n-~l~g-~lp~~i~~L-~~L~~L~L~~N--~l~~~-~p~-~~~l~~L~~L~L~~N-~l~g~lP~~l~~l~~L~ 490 (824)
++|+|+++ +++. .++..+..+ ++|+.|+|+++ .++.. +.. ..++++|+.|+|++| .+++..+..++++++|+
T Consensus 124 ~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~ 203 (284)
T d2astb2 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203 (284)
T ss_dssp CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred cccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCC
Confidence 66666553 3331 122223332 45555655543 22221 112 233555666666553 35544555555566666
Q ss_pred eeeeccc-ccc
Q 003385 491 ELYVQNN-MLS 500 (824)
Q Consensus 491 ~L~l~~N-~l~ 500 (824)
+|+|++| .++
T Consensus 204 ~L~L~~C~~i~ 214 (284)
T d2astb2 204 HLSLSRCYDII 214 (284)
T ss_dssp EEECTTCTTCC
T ss_pred EEECCCCCCCC
Confidence 6666553 344
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.11 E-value=4.3e-06 Score=84.58 Aligned_cols=131 Identities=18% Similarity=0.130 Sum_probs=90.6
Q ss_pred CcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcC-CCccceeeceeecCCeEEEEEEecCCCCHHHHhhcc
Q 003385 613 GFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGT 691 (824)
Q Consensus 613 ~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~L~~~ 691 (824)
+.+.||+... +++.+++|+...........+.+|...++.+. +--+.+++.+..+++..++||++++|.++.+.....
T Consensus 26 s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~ 104 (263)
T d1j7la_ 26 SPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE 104 (263)
T ss_dssp SSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC
T ss_pred CCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc
Confidence 3468998764 46678888876554444556788999888774 333677888888888899999999998876543110
Q ss_pred cCccccCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------------
Q 003385 692 LTHEQRINWIKRLEIAEDAAKGIEYLHTGC-------------------------------------------------- 721 (824)
Q Consensus 692 ~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-------------------------------------------------- 721 (824)
. ....++.++++.+..||+..
T Consensus 105 ------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (263)
T d1j7la_ 105 ------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp ------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred ------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence 0 11223455555555555311
Q ss_pred ------CCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 722 ------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 722 ------~~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
.+.++|+|+.|.|||+++++..-|+||+.+..
T Consensus 176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12479999999999999876667999998754
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.99 E-value=6.5e-07 Score=84.47 Aligned_cols=78 Identities=26% Similarity=0.291 Sum_probs=44.1
Q ss_pred CceeEEEecCCCCCcc--CChhhhcccccccccccccccCCCCC-CCCCCCCcceEeecccccCCCCCcc-------ccC
Q 003385 416 PSITVIHLSSKNLTGN--IPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSS-------LMN 485 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~--lp~~i~~L~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~g~lP~~-------l~~ 485 (824)
++|++|+|++|+|+.. ++..+..|++|+.|+|++|+|+...+ .+....+|+.|+|++|.++...... +..
T Consensus 65 ~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~ 144 (162)
T d1koha1 65 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRER 144 (162)
T ss_dssp TTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTT
T ss_pred CCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHH
Confidence 4566666666666621 23345566666666666666666544 2223335666666666666443322 445
Q ss_pred CCccceee
Q 003385 486 LPNLRELY 493 (824)
Q Consensus 486 l~~L~~L~ 493 (824)
+|+|+.||
T Consensus 145 ~P~L~~LD 152 (162)
T d1koha1 145 FPKLLRLD 152 (162)
T ss_dssp STTCCEET
T ss_pred CCCCCEEC
Confidence 66666553
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.94 E-value=2.9e-07 Score=97.78 Aligned_cols=146 Identities=17% Similarity=0.217 Sum_probs=75.7
Q ss_pred ccceeeecccccCCCC-----CCcccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCC
Q 003385 339 LPFVLSFKFGKTYDSS-----RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSD 413 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~-----LPP~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~ 413 (824)
.++|+.|+|+.|.++. +...+.....|+.|+++.|.+.......+.+........ ....
T Consensus 92 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~----------------~~~~ 155 (344)
T d2ca6a1 92 CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVN----------------KKAK 155 (344)
T ss_dssp CTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHH----------------HHHH
T ss_pred CCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccc----------------cccc
Confidence 4578899999998877 344455677899999999988765444443321000000 0000
Q ss_pred CCCceeEEEecCCCCCc----cCChhhhcccccccccccccccCCC------CCCCCCCCCcceEeecccccCCC----C
Q 003385 414 PQPSITVIHLSSKNLTG----NIPSDLTKLSSLVELWLDGNSLTGP------IPDFSGCPDLRIIHLEDNQLTGP----L 479 (824)
Q Consensus 414 ~~~~L~~L~L~~n~l~g----~lp~~i~~L~~L~~L~L~~N~l~~~------~p~~~~l~~L~~L~L~~N~l~g~----l 479 (824)
..+.|+.|++++|+++. .+...+..++.|+.|+|++|+|+.. ...+..+++|+.|+|++|+|+.. +
T Consensus 156 ~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L 235 (344)
T d2ca6a1 156 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 235 (344)
T ss_dssp TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHH
T ss_pred cCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccc
Confidence 12245555555555441 1223344455555555555555431 11244455555555555555411 2
Q ss_pred CccccCCCccceeeecccccc
Q 003385 480 PSSLMNLPNLRELYVQNNMLS 500 (824)
Q Consensus 480 P~~l~~l~~L~~L~l~~N~l~ 500 (824)
...+..+++|++|+|++|.++
T Consensus 236 ~~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 236 AIALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp HHHGGGCTTCCEEECTTCCCC
T ss_pred cccccccccchhhhhhcCccC
Confidence 334445555555555555554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.83 E-value=1.7e-06 Score=89.26 Aligned_cols=156 Identities=17% Similarity=0.133 Sum_probs=104.4
Q ss_pred ccceeeecccccCCCC-CCcccchhhhceeccCCC-CCCcHHHHHHHHHh-cCCCCcccCCCCCCCCCCCCeeE-cCCCC
Q 003385 339 LPFVLSFKFGKTYDSS-RGPLLNAMEINKYLERND-GSIDGVAIVSVISL-YSSADWAQEGGDPCLPVPWSWLQ-CNSDP 414 (824)
Q Consensus 339 l~~l~~L~L~~n~~s~-LPP~i~~le~l~~L~l~~-n~~~~~~l~~lk~~-~~~~~w~~~~~dpc~~~~~~~~~-c~~~~ 414 (824)
+++|++|+|.++.++. .+..|..+..|+.|+++. +.+...++..+.+. ..++..+. .-|....-.++. .-...
T Consensus 70 c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~l---s~c~~~~~~~~~~~~~~~ 146 (284)
T d2astb2 70 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNL---SWCFDFTEKHVQVAVAHV 146 (284)
T ss_dssp BCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEEC---CCCTTCCHHHHHHHHHHS
T ss_pred CCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccccc---ccccccccccchhhhccc
Confidence 5678889999888764 334477888899999987 45666666665443 44555532 223211111110 00011
Q ss_pred CCceeEEEecCC--CCCc-cCChhhhccccccccccccc-ccCCCC-CCCCCCCCcceEeecc-cccCCCCCccccCCCc
Q 003385 415 QPSITVIHLSSK--NLTG-NIPSDLTKLSSLVELWLDGN-SLTGPI-PDFSGCPDLRIIHLED-NQLTGPLPSSLMNLPN 488 (824)
Q Consensus 415 ~~~L~~L~L~~n--~l~g-~lp~~i~~L~~L~~L~L~~N-~l~~~~-p~~~~l~~L~~L~L~~-N~l~g~lP~~l~~l~~ 488 (824)
.++|+.|+|++. .++. .+...+.++++|+.|+|++| .+++.. ..+.++++|++|+|++ +.+++.-...++++++
T Consensus 147 ~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~ 226 (284)
T d2astb2 147 SETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226 (284)
T ss_dssp CTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTT
T ss_pred ccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCC
Confidence 357999999864 3442 23444567899999999886 466544 4588899999999999 5688767778899999
Q ss_pred cceeeeccc
Q 003385 489 LRELYVQNN 497 (824)
Q Consensus 489 L~~L~l~~N 497 (824)
|+.|+++++
T Consensus 227 L~~L~l~~~ 235 (284)
T d2astb2 227 LKTLQVFGI 235 (284)
T ss_dssp CCEEECTTS
T ss_pred CCEEeeeCC
Confidence 999999887
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.82 E-value=2.4e-05 Score=78.40 Aligned_cols=74 Identities=20% Similarity=0.164 Sum_probs=54.2
Q ss_pred cccccCc-EEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCC--ccceeeceeecCCeEEEEEEecCCCCH
Q 003385 608 KIGSGGF-GVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR--NLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (824)
Q Consensus 608 ~LG~G~f-g~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~~~~~~~lV~E~~~~gsL 684 (824)
.+..|.. +.||+....++..+++|.-... ....+..|.+.++.+... -+.+++++..+.+..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445554 5799998887888899986543 234678899988877532 356778887888888999999987654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.81 E-value=2.1e-06 Score=93.27 Aligned_cols=110 Identities=26% Similarity=0.352 Sum_probs=81.5
Q ss_pred hceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeEEEecCCCCCc----cCChhhhcc
Q 003385 364 INKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTG----NIPSDLTKL 439 (824)
Q Consensus 364 ~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~L~L~~n~l~g----~lp~~i~~L 439 (824)
.|+.|+++.|++....+.++-.. ++++++|+|++|+|+- .++..+..+
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~----------------------------l~~l~~L~L~~~~i~~~~~~~l~~~L~~~ 54 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPL----------------------------LQQCQVVRLDDCGLTEARCKDISSALRVN 54 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHH----------------------------HTTCSEEEEESSCCCHHHHHHHHHHHHTC
T ss_pred CCCEEEeeCCcCChHHHHHHHHh----------------------------CCCCCEEEeCCCCCCHHHHHHHHHHHhcC
Confidence 46778888777776554443222 2467889999999872 456667889
Q ss_pred cccccccccccccCCC-----CCCCC-CCCCcceEeecccccCCC----CCccccCCCccceeeeccccccc
Q 003385 440 SSLVELWLDGNSLTGP-----IPDFS-GCPDLRIIHLEDNQLTGP----LPSSLMNLPNLRELYVQNNMLSG 501 (824)
Q Consensus 440 ~~L~~L~L~~N~l~~~-----~p~~~-~l~~L~~L~L~~N~l~g~----lP~~l~~l~~L~~L~l~~N~l~g 501 (824)
++|+.|||++|+|+.. ...+. ...+|+.|+|++|+|+.. ++..+..+++|++|+|++|.++.
T Consensus 55 ~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 55 PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 9999999999998631 11232 245799999999999743 56778889999999999999873
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.78 E-value=9.1e-07 Score=83.44 Aligned_cols=81 Identities=23% Similarity=0.291 Sum_probs=60.3
Q ss_pred EEecCCCCCccCChhhhcccccccccccccccCCCCC--C-CCCCCCcceEeecccccCCCCCc-cccCCCccceeeecc
Q 003385 421 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--D-FSGCPDLRIIHLEDNQLTGPLPS-SLMNLPNLRELYVQN 496 (824)
Q Consensus 421 L~L~~n~l~g~lp~~i~~L~~L~~L~L~~N~l~~~~p--~-~~~l~~L~~L~L~~N~l~g~lP~-~l~~l~~L~~L~l~~ 496 (824)
|++.++... .++..+.++++|+.|+|++|+|+...+ . +..+++|+.|+|++|+|+ .+++ ......+|++|++++
T Consensus 47 l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~ 124 (162)
T d1koha1 47 LNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDG 124 (162)
T ss_dssp TTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTT
T ss_pred cchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCC
Confidence 334444333 555556789999999999999998654 3 567999999999999999 5554 334455799999999
Q ss_pred ccccccc
Q 003385 497 NMLSGTV 503 (824)
Q Consensus 497 N~l~g~i 503 (824)
|++++..
T Consensus 125 Npl~~~~ 131 (162)
T d1koha1 125 NSLSDTF 131 (162)
T ss_dssp STTSSSS
T ss_pred CCcCcCc
Confidence 9998543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.75 E-value=2.2e-06 Score=93.18 Aligned_cols=138 Identities=21% Similarity=0.222 Sum_probs=83.7
Q ss_pred cceeeecccccCCCCCCc-----ccchhhhceeccCCCCCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCC
Q 003385 340 PFVLSFKFGKTYDSSRGP-----LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDP 414 (824)
Q Consensus 340 ~~l~~L~L~~n~~s~LPP-----~i~~le~l~~L~l~~n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~ 414 (824)
..++.|++++|.+...+. .+...+.++.++++.|.+....+..+...... .
T Consensus 255 ~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~------------------------~ 310 (460)
T d1z7xw1 255 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLE------------------------P 310 (460)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTS------------------------T
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhccccc------------------------c
Confidence 345667777776654432 23445556667777777766555555433110 1
Q ss_pred CCceeEEEecCCCCCccCChh----hhcccccccccccccccCCC-----CCCCC-CCCCcceEeecccccCC----CCC
Q 003385 415 QPSITVIHLSSKNLTGNIPSD----LTKLSSLVELWLDGNSLTGP-----IPDFS-GCPDLRIIHLEDNQLTG----PLP 480 (824)
Q Consensus 415 ~~~L~~L~L~~n~l~g~lp~~----i~~L~~L~~L~L~~N~l~~~-----~p~~~-~l~~L~~L~L~~N~l~g----~lP 480 (824)
...|+.+++++|.++..-... +...++|+.|+|++|+|+.. ...+. ..+.|+.|+|++|+|+. .++
T Consensus 311 ~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~ 390 (460)
T d1z7xw1 311 GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLA 390 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred ccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHH
Confidence 135777788888777443233 33455788888888877642 11232 35668888888888763 244
Q ss_pred ccccCCCccceeeeccccccc
Q 003385 481 SSLMNLPNLRELYVQNNMLSG 501 (824)
Q Consensus 481 ~~l~~l~~L~~L~l~~N~l~g 501 (824)
+.+..+++|++|+|++|+++.
T Consensus 391 ~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 391 ATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHHHCCCCCEEECCSSSCCH
T ss_pred HHHhcCCCCCEEECCCCcCCH
Confidence 556667778888888888764
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.62 E-value=3.2e-06 Score=89.39 Aligned_cols=85 Identities=24% Similarity=0.290 Sum_probs=51.5
Q ss_pred CceeEEEecCCCCCcc----CChhhhcccccccccccccccCCCCC-----CCCC--CCCcceEeecccccCCC----CC
Q 003385 416 PSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIP-----DFSG--CPDLRIIHLEDNQLTGP----LP 480 (824)
Q Consensus 416 ~~L~~L~L~~n~l~g~----lp~~i~~L~~L~~L~L~~N~l~~~~p-----~~~~--l~~L~~L~L~~N~l~g~----lP 480 (824)
++|+.|+|++|.++.. +...+..+++|+.|+|++|.|++.-. .+.. .+.|+.|+|++|+|+.. +.
T Consensus 215 ~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~ 294 (344)
T d2ca6a1 215 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 294 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHH
T ss_pred hhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHH
Confidence 4677777777776522 44456667777777777777765211 1222 35577777777776621 23
Q ss_pred cccc-CCCccceeeecccccc
Q 003385 481 SSLM-NLPNLRELYVQNNMLS 500 (824)
Q Consensus 481 ~~l~-~l~~L~~L~l~~N~l~ 500 (824)
..+. ++++|+.|+|++|++.
T Consensus 295 ~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 295 TVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHHHHHCTTCCEEECTTSBSC
T ss_pred HHHHccCCCCCEEECCCCcCC
Confidence 3332 4566777777777775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.10 E-value=0.0007 Score=72.42 Aligned_cols=75 Identities=16% Similarity=0.111 Sum_probs=47.5
Q ss_pred ccccccCcEEEEEEEEcC-CcEEEEEEeccCC-------cccchhhhHHHHHHhhcC-C--CccceeeceeecCCeEEEE
Q 003385 607 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNS-------YQGKREFTNEVTLLSRIH-H--RNLVQFLGYCQEEGRSVLV 675 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~-g~~vAVK~l~~~~-------~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~~~~~~lV 675 (824)
+.||.|....||+.+..+ ++.++||.-.... .....+...|.+.|+.+. + ..+.+++.+. ++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 568999999999998654 6788999653211 112234556888887763 2 3455565543 3445789
Q ss_pred EEecCCCC
Q 003385 676 YEFMHNGT 683 (824)
Q Consensus 676 ~E~~~~gs 683 (824)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997643
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.89 E-value=0.00022 Score=66.77 Aligned_cols=82 Identities=11% Similarity=0.068 Sum_probs=45.2
Q ss_pred ceeEEEecCCCCCc----cCChhhhcccccccccccccccCCC-----CCCCCCCCCcceEeecccccCCC-------CC
Q 003385 417 SITVIHLSSKNLTG----NIPSDLTKLSSLVELWLDGNSLTGP-----IPDFSGCPDLRIIHLEDNQLTGP-------LP 480 (824)
Q Consensus 417 ~L~~L~L~~n~l~g----~lp~~i~~L~~L~~L~L~~N~l~~~-----~p~~~~l~~L~~L~L~~N~l~g~-------lP 480 (824)
.|++|+|++|.+.. .+...+...+.|+.|+|++|.|+.. ...+...+.|+.|+|++|++... +.
T Consensus 45 ~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~ 124 (167)
T d1pgva_ 45 HIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMM 124 (167)
T ss_dssp CCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHH
T ss_pred ccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHH
Confidence 46667777776652 2223444556677777777766642 11255556677777776655411 22
Q ss_pred ccccCCCccceeeecccc
Q 003385 481 SSLMNLPNLRELYVQNNM 498 (824)
Q Consensus 481 ~~l~~l~~L~~L~l~~N~ 498 (824)
..+..-+.|+.|+++.+.
T Consensus 125 ~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 125 MAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHHCSSCCEEECCCCC
T ss_pred HHHHhCCCccEeeCcCCC
Confidence 333344556666665543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.51 E-value=0.0039 Score=64.47 Aligned_cols=67 Identities=12% Similarity=0.130 Sum_probs=46.7
Q ss_pred EEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCcc--ceeec-----eeecCCeEEEEEEecCCC
Q 003385 615 GVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL--VQFLG-----YCQEEGRSVLVYEFMHNG 682 (824)
Q Consensus 615 g~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~~-----~~~~~~~~~lV~E~~~~g 682 (824)
-.||+.+..+|+.+++|+.+... ...+++..|.+.+..+...+| +..+. .+...+..+.++++++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 48999999999999999987543 345678889998888753222 11111 234456778899998764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.22 E-value=0.0003 Score=65.81 Aligned_cols=86 Identities=15% Similarity=0.253 Sum_probs=64.7
Q ss_pred CCceeEEEecCC-CCCcc----CChhhhcccccccccccccccCCCC-CC----CCCCCCcceEeecccccCCC----CC
Q 003385 415 QPSITVIHLSSK-NLTGN----IPSDLTKLSSLVELWLDGNSLTGPI-PD----FSGCPDLRIIHLEDNQLTGP----LP 480 (824)
Q Consensus 415 ~~~L~~L~L~~n-~l~g~----lp~~i~~L~~L~~L~L~~N~l~~~~-p~----~~~l~~L~~L~L~~N~l~g~----lP 480 (824)
.++|++|+|+++ .++.. +-..+...+.|+.|+|++|.+...- .. +...+.|+.|+|++|.|+.. +-
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 358999999974 46532 3345667788999999999987422 12 45578899999999998832 33
Q ss_pred ccccCCCccceeeecccccc
Q 003385 481 SSLMNLPNLRELYVQNNMLS 500 (824)
Q Consensus 481 ~~l~~l~~L~~L~l~~N~l~ 500 (824)
..+...+.|++|+|++|.+.
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSC
T ss_pred HHHHhCCcCCEEECCCCcCC
Confidence 46777788999999999766
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.72 E-value=0.014 Score=61.86 Aligned_cols=71 Identities=10% Similarity=0.217 Sum_probs=48.6
Q ss_pred ccccccCcEEEEEEEEcCC--------cEEEEEEeccCCcccchhhhHHHHHHhhcC-CCccceeeceeecCCeEEEEEE
Q 003385 607 KKIGSGGFGVVYYGKLKDG--------KEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYE 677 (824)
Q Consensus 607 ~~LG~G~fg~Vy~a~~~~g--------~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E 677 (824)
+.|+.|-.-.+|+...+++ +.|.+++.... .......+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4677788889999987543 56777776522 22344567999988885 4334577777643 58999
Q ss_pred ecCCCC
Q 003385 678 FMHNGT 683 (824)
Q Consensus 678 ~~~~gs 683 (824)
|+++..
T Consensus 122 fi~g~~ 127 (395)
T d1nw1a_ 122 YIPSRP 127 (395)
T ss_dssp CCCEEE
T ss_pred Eecccc
Confidence 998643
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.29 E-value=0.0019 Score=59.86 Aligned_cols=114 Identities=10% Similarity=0.086 Sum_probs=70.4
Q ss_pred hhhceeccCCC-CCCcHHHHHHHHHhcCCCCcccCCCCCCCCCCCCeeEcCCCCCCceeEEEecCCCCCcc----CChhh
Q 003385 362 MEINKYLERND-GSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGN----IPSDL 436 (824)
Q Consensus 362 le~l~~L~l~~-n~~~~~~l~~lk~~~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~L~~L~L~~n~l~g~----lp~~i 436 (824)
.+.|+.|++++ +.++...+..+.+... ..+.|++|+|++|+++.. +-..+
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~-------------------------~n~~L~~L~Ls~n~l~~~~~~~L~~~l 70 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALK-------------------------TNTYVKKFSIVGTRSNDPVAFALAEML 70 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHT-------------------------TCCSCCEEECTTSCCCHHHHHHHHHHH
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHHHHh-------------------------cCCccCeeeccCCcccHHHHHHHHHHH
Confidence 35567777765 4566656655555421 123677888888887643 33345
Q ss_pred hcccccccccccccccCCC-----CCCCCCCCCcceEee--cccccCC----CCCccccCCCccceeeecccccc
Q 003385 437 TKLSSLVELWLDGNSLTGP-----IPDFSGCPDLRIIHL--EDNQLTG----PLPSSLMNLPNLRELYVQNNMLS 500 (824)
Q Consensus 437 ~~L~~L~~L~L~~N~l~~~-----~p~~~~l~~L~~L~L--~~N~l~g----~lP~~l~~l~~L~~L~l~~N~l~ 500 (824)
...++|+.|++++|.+... ...+...++|+.++| ++|++.. .+.+.+...++|+.|+++.|+..
T Consensus 71 ~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 71 KVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred hhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 5677788888888877542 223566777776444 4566652 24455667778888887766554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.80 E-value=0.066 Score=54.24 Aligned_cols=142 Identities=13% Similarity=0.088 Sum_probs=73.0
Q ss_pred ccccCcEEEEEEEEcCCcEEEEEEeccCCcccchhhhHHHHHHhhcCCCcc--ceeec------eeecCCeEEEEEEecC
Q 003385 609 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL--VQFLG------YCQEEGRSVLVYEFMH 680 (824)
Q Consensus 609 LG~G~fg~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~~------~~~~~~~~~lV~E~~~ 680 (824)
|..|---+.|+.+..+| .+++|+.... ...+++..|++++..+.+.++ ...+. +.........++.+..
T Consensus 26 i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 26 IAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp ECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred CCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 44566678899887755 5899998643 234566778888877753222 11111 1122345566677666
Q ss_pred CCCHHH-----------Hh---hc---cc--Ccccc------------------CCHHHHHHHHHHHHHHHHHHHh-CCC
Q 003385 681 NGTLKE-----------HL---YG---TL--THEQR------------------INWIKRLEIAEDAAKGIEYLHT-GCV 722 (824)
Q Consensus 681 ~gsL~~-----------~L---~~---~~--~~~~~------------------l~~~~~~~i~~qia~gL~yLH~-~~~ 722 (824)
+..... .+ +. .. ..... .........+..+...+.-.+. ...
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 532110 00 00 00 00000 0000111122222222333222 122
Q ss_pred CCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 003385 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (824)
Q Consensus 723 ~gIvHrDLkp~NILl~~~~~vkL~DFGla~~ 753 (824)
.|+||+|+.+.||+++.+...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4899999999999999887778999998753
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=92.67 E-value=0.0064 Score=56.13 Aligned_cols=86 Identities=20% Similarity=0.311 Sum_probs=60.9
Q ss_pred CCceeEEEecC-CCCCcc----CChhhhcccccccccccccccCCCCC-----CCCCCCCcceEeecccccCCC----CC
Q 003385 415 QPSITVIHLSS-KNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIP-----DFSGCPDLRIIHLEDNQLTGP----LP 480 (824)
Q Consensus 415 ~~~L~~L~L~~-n~l~g~----lp~~i~~L~~L~~L~L~~N~l~~~~p-----~~~~l~~L~~L~L~~N~l~g~----lP 480 (824)
.++|++|+|++ +.++.. +-..+...++|+.|+|++|.++...- .+...+.|+.|++++|.+... +-
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence 36899999997 556522 33355678899999999998875321 255678899999999988632 33
Q ss_pred ccccCCCccceeee--cccccc
Q 003385 481 SSLMNLPNLRELYV--QNNMLS 500 (824)
Q Consensus 481 ~~l~~l~~L~~L~l--~~N~l~ 500 (824)
+.+...++|++++| ++|.+.
T Consensus 96 ~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 96 EALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp HGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHhCccccEEeeccCCCcCc
Confidence 56777888887555 456665
|